PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mao, YW; Zhang, XH; Peng, W; Liu, HM; Zhou, XC; Liang, LQ; Xiang, JY; Zhang, HF; Wang, D; Liu, LL; Zhou, YX; Zhang, F; Xiao, Y; Shi, MJ; Wang, YY; Guo, B				Mao, Yanwen; Zhang, Xiaohuan; Peng, Wei; Liu, Huiming; Zhou, Xingchen; Liang, Luqun; Xiang, Jiayi; Zhang, Huifang; Wang, Dan; Liu, Lingling; Zhou, Yuxia; Zhang, Fan; Xiao, Ying; Shi, Mingjun; Wang, Yuanyuan; Guo, Bing			EI24 alleviates renal interstitial fibrosis through inhibition of epithelial-mesenchymal transition and fibroblast activation	FASEB JOURNAL			English	Article						EI24; epithelial&#8208; mesenchymal transition; extracellular matrix; fibroblast activation; renal interstitial fibrosis	NF-KAPPA-B; AUTOPHAGY; GENE; APOPTOSIS; PROTEIN; MYOFIBROBLASTS; INTERLEUKIN-15; INFLAMMATION; REGULATOR; ORIGIN	Etoposide-induced 2.4 (EI24) exerts tumor suppressor activity through participating in cell apoptosis, autophagy, and inflammation. However, its role in renal diseases has not been elucidated. This study showed that the EI24 level decreased gradually in the kidneys of mice with unilateral ureteral obstruction (UUO) and in another fibrosis model induced by diabetic kidney disease. The overexpression of EI24 was used to investigate the possible role both in vivo and in vitro. The overexpression 1 day after UUO through tail vein injection alleviated the progression of renal interstitial fibrosis (RIF). EI24 inhibited epithelial-mesenchymal transition, excessive deposition of the extracellular matrix, and activation of fibroblasts. Furthermore, administration of EI24-overexpressing plasmids restrained the phosphorylation of nuclear factor-kappa B (NF-kappa B) and c-Jun kinase (JNK) through regulating the proteasome-dependent degradation of TRAF2, and then, inhibited the expression of downstream inflammation-associated cytokines (interleukin-6, tumor necrosis factor-alpha, and monocyte chemotactic protein-1) and infiltration of macrophages and neutrophils in mouse kidney after UUO. In conclusion, the data indicated that EI24, a novel anti-fibrosis regulator, was important in the progression of RIF.	[Mao, Yanwen; Zhang, Xiaohuan; Peng, Wei; Liu, Huiming; Zhou, Xingchen; Liang, Luqun; Xiang, Jiayi; Zhang, Huifang; Wang, Dan; Liu, Lingling; Zhou, Yuxia; Zhang, Fan; Xiao, Ying; Shi, Mingjun; Wang, Yuanyuan] Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China; [Mao, Yanwen; Zhang, Xiaohuan; Peng, Wei; Liu, Huiming; Zhou, Xingchen; Liang, Luqun; Xiang, Jiayi; Zhang, Huifang; Wang, Dan; Liu, Lingling; Zhou, Yuxia; Zhang, Fan; Xiao, Ying; Shi, Mingjun; Wang, Yuanyuan; Guo, Bing] Guizhou Med Univ, Guizhou Prov Key Lab Pathogenesis & Drug Res Comm, Guiyang, Guizhou, Peoples R China; [Guo, Bing] Guizhou Med Univ, Guizhou Prov Key Lab Pharmaceut, State Key Lab Funct & Applicat Med Plants, Guiyang, Peoples R China	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University	Wang, YY (corresponding author), Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China.; Guo, B (corresponding author), Guizhou Med Univ, Guizhou Prov Key Lab Pathogenesis & Drug Res Comm, Guiyang, Guizhou, Peoples R China.	yuanyuanwang18180@gmc.edu.com; guobingbs@126.com	Wang, Yu/GZL-9655-2022; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022; Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022; wangwangwang, yuanyaun/HHN-6432-2022	guo, bing/0000-0001-8998-2597				Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Andrade-Oliveira V, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01192; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Azpilikueta A, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1368605; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Choi JM, 2013, ONCOTARGET, V4, P2383, DOI 10.18632/oncotarget.1434; Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4; Devkota S, 2016, AUTOPHAGY, V12, P2038, DOI 10.1080/15548627.2016.1217371; Devocelle A, 2019, INT J CELL BIOL, V2019; Eini H, 2010, J INTERF CYTOK RES, V30, P1, DOI 10.1089/jir.2009.0005; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hefetz-Sela S, 2014, P NATL ACAD SCI USA, V111, P17582, DOI 10.1073/pnas.1409700111; Hung TW, 2016, CELL PHYSIOL BIOCHEM, V40, P1029, DOI 10.1159/000453159; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lehar SM, 1996, ONCOGENE, V12, P1181; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu B, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0760-6; Liu RX, 2012, KIDNEY BLOOD PRESS R, V35, P517, DOI 10.1159/000339172; Liu XM, 2018, BIOCHEM BIOPH RES CO, V497, P1110, DOI 10.1016/j.bbrc.2018.02.187; Loeffler I, 2015, CELLS-BASEL, V4, P631, DOI 10.3390/cells4040631; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Ma JJ, 2016, CELL BIOL INT, V40, P448, DOI 10.1002/cbin.10585; Duong MTH, 2020, COMPUT STRUCT BIOTEC, V18, P1440, DOI 10.1016/j.csbj.2020.06.013; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Nam SA, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1356-0; Nam T, 2017, MOL CELLS, V40, P897, DOI 10.14348/molcells.2017.0226; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI200214574; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sung YH, 2013, J BIOL CHEM, V288, P31261, DOI 10.1074/jbc.M113.477570; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tubben A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122104; Yang M, 2018, INT J MED SCI, V15, P1433, DOI 10.7150/ijms.26954; Yuan L, 2018, J BIOL CHEM, V293, P10128, DOI 10.1074/jbc.RA118.002399; Yuan Q, 2019, ADV EXP MED BIOL, V1165, P253, DOI 10.1007/978-981-13-8871-2_12; Zang Y, 2018, GASTROENT RES PRACT, V2018, DOI [10.1080/00207543.2018.1471238, 10.1155/2018/2626545]; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377; Zhao YG, 2012, J BIOL CHEM, V287, P42053, DOI 10.1074/jbc.M112.415968; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zheng PL, 2018, CELL RES, V28, P833, DOI 10.1038/s41422-018-0065-z	46	0	2	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21239	10.1096/fj.202002089R	http://dx.doi.org/10.1096/fj.202002089R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368642				2022-12-28	WOS:000605626600024
J	Lee, BS; Jang, JY; Seo, C; Kim, CH				Lee, Bok-Soon; Jang, Jeon Yeob; Seo, Chorong; Kim, Chul-Ho			Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling	FASEB JOURNAL			English	Article						CXCL5; HNSCC; invasion; lymph node; migration	EPITHELIAL-MESENCHYMAL TRANSITION; CXCL5/CXCR2 AXIS; NODE METASTASIS; CXCL5; LYMPHANGIOGENESIS; SURVIVAL; CONTRIBUTES; CARCINOMAS; ACTIVATION; CHEMOKINES	Head and neck squamous cell carcinoma (HNSCC) metastasizes to the locoregional lymph nodes at high rates and is related to poor clinical outcomes. However, the mechanism by which cancer cells migrate to the lymph nodes is unclear. To address this, we established a conditioned medium culture system for HNSCC cells and lymphatic endothelial cells (LECs) and investigated their crosstalk. Stimulation with tumor-conditioned medium (TCM) activated LECs, resulting in a robust increase in cell proliferation to induce lymphatic hyperplasia. Further, stimulation of HNSCC cells with activated LEC Conditioned media (TCM-LEC CM) induced cell invasion. Among various chemokines, CXCL5 promoted the invasion of TCM-LEC CM-treated HNSCC cells. The level of CXCL5 protein was higher in cancer tissues than those in normal tissues from HNSCC patients. Furthermore, treatment with SB225002, a CXCR2 (CXCL5 receptor) inhibitor, resulted in decreased lymph node metastasis in vivo. In conclusion, inhibition of CXCL5-CXCR2 signaling between cancer cells and LECs suppresses cancer cell invasion and metastasis in vitro and in vivo. This novel therapeutic strategy might be a practical approach to the clinical management of HNSCC.	[Lee, Bok-Soon; Jang, Jeon Yeob; Seo, Chorong; Kim, Chul-Ho] Ajou Univ, Dept Otolaryngol, Sch Med, Suwon, South Korea; [Jang, Jeon Yeob] Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon, South Korea; [Kim, Chul-Ho] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea	Ajou University; Ajou University; Ajou University	Kim, CH (corresponding author), Ajou Univ, Dept Otolaryngol, Sch Med, Dept Mol Sci & Technol, 164 Worldcup Ro, Suwon 16499, South Korea.	ostium@ajou.ac.kr			National Research Foundation of Korea (NRF) [2018R1A2B3009008, 2020R1C1C1011647]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2018R1A2B3009008 and 2020R1C1C1011647	Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Beasley NJP, 2002, CANCER RES, V62, P1315; CEREZO L, 1992, CANCER, V69, P1224; Cheng Y, 2019, BBA-REV CANCER, V1871, P289, DOI 10.1016/j.bbcan.2019.01.005; Chow LQM, 2020, NEW ENGL J MED, V382, P60, DOI 10.1056/NEJMra1715715; Das S, 2008, ANN NY ACAD SCI, V1131, P235, DOI 10.1196/annals.1413.021; Feng XN, 2018, BIOMED PHARMACOTHER, V107, P1496, DOI 10.1016/j.biopha.2018.08.149; Gao Y, 2015, INT J ONCOL, V47, P690, DOI 10.3892/ijo.2015.3041; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Han L, 2012, MED ONCOL, V29, P2466, DOI 10.1007/s12032-011-0152-1; Hsu YL, 2013, ONCOGENE, V32, P4436, DOI 10.1038/onc.2012.444; Jang JY, 2016, CANCER RES TREAT, V48, P54, DOI 10.4143/crt.2014.332; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Keeley EC, 2010, ADV CANCER RES, V106, P91, DOI 10.1016/S0065-230X(10)06003-3; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Le Tourneau C, 2005, HEAD NECK-J SCI SPEC, V27, P801, DOI 10.1002/hed.20254; Lee E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5715; Lee E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05853; Lee E, 2014, CLIN EXP METASTAS, V31, P67, DOI 10.1007/s10585-013-9610-9; LEEMANS CR, 1993, CANCER, V71, P452, DOI 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B; Mao ZY, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-00249-z; Nicholls DJ, 2015, J PHARMACOL EXP THER, V353, P340, DOI 10.1124/jpet.114.221358; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Qiu WZ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0722-6; Romero-Moreno R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12108-6; SHAH JP, 1990, AM J SURG, V160, P405, DOI 10.1016/S0002-9610(05)80554-9; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Wang L, 2018, J PHYSIOL BIOCHEM, V74, P313, DOI 10.1007/s13105-018-0619-z; Wang ZX, 2017, CANCER LETT, V385, P28, DOI 10.1016/j.canlet.2016.10.043; Xing Y, 2016, CANCER-AM CANCER SOC, V122, P534, DOI 10.1002/cncr.29780; Xu JB, 2012, INT J CANCER, V130, P787, DOI 10.1002/ijc.26035; Zhang D, 2017, CLIN IMMUNOL, V175, P34, DOI 10.1016/j.clim.2016.11.009; Zhao JK, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0629-4; Zhao YY, 2018, ONCOL LETT, V15, P1403, DOI 10.3892/ol.2017.7522	36	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001455R	http://dx.doi.org/10.1096/fj.202001455R		NOV 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33231340	hybrid			2022-12-28	WOS:000592544500001
J	Pretz, D; Le Foll, C; Rizwan, MZ; Lutz, TA; Tups, A				Pretz, Dominik; Le Foll, Christelle; Rizwan, Mohammed Z.; Lutz, Thomas A.; Tups, Alexander			Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity	FASEB JOURNAL			English	Article						diabetes; diet&#8208; induced obesity; energy metabolism; hypothalamus; inflammation	DIET-INDUCED OBESITY; LEPTIN RESISTANCE; ARCUATE NUCLEUS; BODY-WEIGHT; MICE; INSULIN; HOMEOSTASIS; MECHANISM; DECREASE; GHRELIN	Obesity has emerged as a major risk factor for insulin resistance leading to the development of type 2 diabetes (T2D). The condition is characterized by high circulating levels of the adipose-derived hormone leptin and a state of chronic low-grade inflammation. Pro-inflammatory signaling in the hypothalamus is associated with a decrease of central leptin- and insulin action leading to impaired systemic glucose tolerance. Intriguingly, leptin not only regulates body weight and glucose homeostasis but also acts as a pro-inflammatory cytokine. Here we demonstrate that increasing leptin levels (62,5 mu g/kg/d, PEGylated leptin) in mice fed a high-fat diet (HFD) exacerbated body weight gain and aggravated hypothalamic micro- as well as astrogliosis. In contrast, administration of a predetermined dose of a long-acting leptin antagonist (100 mu g/kg/d, PESLAN) chosen to block excessive leptin signaling during diet-induced obesity (DIO) showed the opposite effect and significantly improved glucose tolerance as well as decreased the total number of microglia and astrocytes in the hypothalamus of mice fed HFD. These results suggest that high levels of leptin, such as in obesity, worsen HFD-induced micro-and astrogliosis, whereas the partial reduction of hyperleptinemia in DIO mice may have beneficial metabolic effects and improves hypothalamic gliosis.	[Pretz, Dominik; Rizwan, Mohammed Z.; Tups, Alexander] Univ Otago, Sch Med Sci, Dept Physiol, Ctr Neuroendocrinol, Dunedin, New Zealand; [Pretz, Dominik; Tups, Alexander] Philipps Univ Marburg, Dept Anim Physiol, Fac Biol, Marburg, Germany; [Le Foll, Christelle; Lutz, Thomas A.] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland	University of Otago; Philipps University Marburg; University of Zurich	Tups, A (corresponding author), Univ Otago, Dept Physiol, POB 56, Dunedin, New Zealand.	alexander.tups@otago.ac.nz	Le Foll, Christelle/N-4847-2019	Le Foll, Christelle/0000-0002-6677-5488; Lutz, Thomas/0000-0002-5056-8548				Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Alquier T, 2018, DIABETOLOGIA, V61, P526, DOI 10.1007/s00125-017-4495-9; Balland E, 2019, CELL REP, V26, P346, DOI 10.1016/j.celrep.2018.12.061; Benzler J, 2015, DIABETES, V64, P2015, DOI 10.2337/db14-0093; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; DEPAOLI A, 2018, DIABETES S1, V67, DOI DOI 10.2337/DB18-296-LB; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gao Y, 2014, GLIA, V62, P17, DOI 10.1002/glia.22580; Hsuchou H, 2009, BRAIN, V132, P889, DOI 10.1093/brain/awp029; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Koch CE, 2014, J NEUROENDOCRINOL, V26, P58, DOI 10.1111/jne.12131; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Korek E, 2013, PRZ GASTROENTEROL, V8, P383, DOI 10.5114/pg.2013.39922; Lafrance V, 2010, BRAIN BEHAV IMMUN, V24, P358, DOI 10.1016/j.bbi.2009.11.003; Lee H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225738; Leon-Cabrera S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00062; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Myers MG, 2012, CELL METAB, V15, P150, DOI 10.1016/j.cmet.2012.01.002; Neseliler S, 2019, CELL METAB, V29, P39, DOI 10.1016/j.cmet.2018.09.024; Nikodemova M, 2015, J NEUROIMMUNOL, V278, P280, DOI 10.1016/j.jneuroim.2014.11.018; Ogus S, 2003, ENDOCRINOLOGY, V144, P2865, DOI 10.1210/en.2002-0178; Ottaway N, 2015, CELL METAB, V21, P877, DOI 10.1016/j.cmet.2015.04.015; Pan WH, 2008, ENDOCRINOLOGY, V149, P2798, DOI 10.1210/en.2007-1673; Pan WH, 2008, ENDOCRINOLOGY, V149, P877, DOI 10.1210/en.2007-0893; Pinteaux E, 2007, J NEUROCHEM, V102, P826, DOI 10.1111/j.1471-4159.2007.04559.x; Ravussin Y, 2018, CELL METAB, V28, DOI 10.1016/j.cmet.2018.05.029; Ravussin Y, 2014, MOL METAB, V3, P432, DOI 10.1016/j.molmet.2014.02.003; Rottkamp DM, 2015, MOL METAB, V4, P881, DOI 10.1016/j.molmet.2015.08.005; Santos CL, 2018, METAB BRAIN DIS, V33, P2059, DOI 10.1007/s11011-018-0311-6; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Skowronski AA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6629; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Valdearcos M, 2017, CELL METAB, V26, P185, DOI 10.1016/j.cmet.2017.05.015; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Zhao SG, 2019, CELL METAB, V30, P706, DOI 10.1016/j.cmet.2019.08.005	40	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001147R	http://dx.doi.org/10.1096/fj.202001147R		NOV 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33230896				2022-12-28	WOS:000592381300001
J	Jiang, YP; Xie, FF; Lv, X; Wang, ST; Liao, XH; Yu, Y; Dai, Q; Zhang, Y; Meng, J; Hu, GY; Peng, ZZ; Tao, LJ				Jiang, Yupeng; Xie, Feifei; Lv, Xin; Wang, Shuting; Liao, Xiaohua; Yu, Yue; Dai, Qin; Zhang, Yan; Meng, Jie; Hu, Gaoyun; Peng, Zhangzhe; Tao, Lijian			Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice	FASEB JOURNAL			English	Article						diabetic kidney disease; EMT; fibrosis; inflammation; mefunidone; oxidative distress	TO-MESENCHYMAL TRANSITION; TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; MESANGIAL CELLS; NEPHROPATHY; MECHANISMS; PROTECTS; COMPLICATIONS; INFLAMMATION; MODULATION	Diabetic kidney disease (DKD) is a major cause of end stage renal diseases worldwide. Despite successive interventions for delaying the progression of DKD, current treatments cannot reverse the pathological progression. Mefunidone (MFD) is a new compound with potent antifibrotic properties, but the effect of MFD on DKD remains unknown. Therefore, we investigated the protective effects of MFD in both models of the db/db type 2 diabetes (T2D) and streptozotocin (STZ)-induced type 1 diabetes (T1D) models. Compared with the model group, MFD treatment significantly reduced pathological changes observed by PAS staining, PASM staining, and Masson staining in vivo. To further elucidate the potential mechanisms, we discovered MFD treatment notably restored podocyte function, alleviated inflammation, abated ROS generation, inhibited the TGF-beta 1/SAMD2/3 pathway, suppressed the phosphorylation levels of MAPKs (ERK1/2, JNK, and P38), and reduced epithelial-to-mesenchymal transition(EMT). In conclusion, these findings demonstrate the effectiveness of MFD in diabetic nephropathy and elucidate its possible mechanism.	[Jiang, Yupeng; Xie, Feifei; Lv, Xin; Liao, Xiaohua; Yu, Yue; Dai, Qin; Zhang, Yan; Peng, Zhangzhe; Tao, Lijian] Cent South Univ, Dept Nephrol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Wang, Shuting] Cent South Univ, Dept Oncol, Xiangya Hosp, Changsha, Peoples R China; [Meng, Jie] Cent South Univ, Dept Pulm & Crit Care Med, Xiangya Hosp 3, Changsha, Peoples R China; [Hu, Gaoyun] Cent South Univ, Fac Pharmaceut Sci, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University	Peng, ZZ; Tao, LJ (corresponding author), Cent South Univ, Dept Nephrol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	pengzhangzhe@csu.edu.cn; taolj@csu.edu.cn	TAO, Li/HIR-4254-2022	Jiang, Yupeng/0000-0001-8971-2079	National Natural Science Foundation of China (NSFC) [81673499]; Natural Science Foundation of Hunan Province [2017SK2051, 2018JJ3835]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81673499; Natural Science Foundation of Hunan Province, Grant/Award Number: 2017SK2051 and 2018JJ3835	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Adelusi TI, 2020, BIOMED PHARMACOTHER, V123, DOI 10.1016/j.biopha.2019.109732; Audzeyenka I, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118723; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Chang AS, 2016, AM J PHYSIOL-RENAL, V310, pF689, DOI 10.1152/ajprenal.00502.2015; Chen KH, 2011, CHEM-BIOL INTERACT, V190, P45, DOI 10.1016/j.cbi.2011.01.033; Chen Y, 2020, BIOL OPEN, V9, DOI 10.1242/bio.048462; Cui FQ, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/2981705; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Donate-Correa J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020458; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Fernandez-Fernandez B, 2014, NAT REV NEPHROL, V10, P325, DOI 10.1038/nrneph.2014.74; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gheith Osama, 2016, J Nephropharmacol, V5, P49; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Jiang YP, 2019, FASEB J, V33, P14325, DOI 10.1096/fj.201901468RR; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Kaminska B, 2020, ADV EXP MED BIOL, V1202, P179, DOI 10.1007/978-3-030-30651-9_9; Kang SW, 2001, KIDNEY INT, V60, P543, DOI 10.1046/j.1523-1755.2001.060002543.x; Kanlaya R, 2020, J NUTR BIOCHEM, V76, DOI 10.1016/j.jnutbio.2019.108266; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Khalil H, 2017, J CLIN INVEST, V127, P3770, DOI 10.1172/JCI94753; Kondo M, 2020, N-S ARCH PHARMACOL, V393, P1197, DOI 10.1007/s00210-020-01816-2; LI XF, 2016, SCI REP UK, V6; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129283; Liu WJ, 2016, KIDNEY INT, V90, P1023, DOI 10.1016/j.kint.2016.06.018; Liu WT, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104506; Loeffler I, 2018, CELL TISSUE RES, V372, P115, DOI 10.1007/s00441-017-2754-1; Nair A, 2018, DRUG DEVELOP RES, V79, P373, DOI 10.1002/ddr.21461; Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942; Parsamanesh N, 2018, PHARMACOL RES, V136, P181, DOI 10.1016/j.phrs.2018.09.012; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Purvis GSD, 2018, DIABETOLOGIA, V61, P482, DOI 10.1007/s00125-017-4469-y; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Scuto M, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8060177; Soetikno V, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/968681; Tahara A, 2017, EUR J PHARMACOL, V809, P163, DOI 10.1016/j.ejphar.2017.05.019; Taniguchi K, 2013, DIABETES, V62, P3874, DOI 10.2337/db12-1010; Tomar A, 2017, PHYTOMEDICINE, V34, P154, DOI 10.1016/j.phymed.2017.05.007; Tuomilehto J, 1998, DIABETOLOGIA, V41, P784, DOI 10.1007/s001250050988; Wang JN, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101479; Wang LH, 2011, PHARMACOLOGY, V88, P88, DOI 10.1159/000329419; Wang YY, 2020, EXP MOL PATHOL, V113, DOI 10.1016/j.yexmp.2020.104375; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wu XM, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106108; Xiang X, 2019, PHARMACOL RES, V139, P26, DOI 10.1016/j.phrs.2018.10.030; Xiong X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111242; Xu J, 2020, J CELL BIOCHEM, V121, P4142, DOI 10.1002/jcb.29666; Xu Y, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109920; Yiu WH, 2016, KIDNEY INT, V89, P386, DOI 10.1038/ki.2015.331; Zhang CX, 2019, DIABETES METAB SYNDR, V12, P1297, DOI 10.2147/DMSO.S199802; Zhang J, 2016, INT J BIOCHEM CELL B, V80, P109, DOI 10.1016/j.biocel.2016.10.005; Zhu YC, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/4946181	55	12	13	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001138RR	http://dx.doi.org/10.1096/fj.202001138RR		NOV 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33225469				2022-12-28	WOS:000592339800001
J	Zhao, P; Deng, Y; Wu, Y; Guo, QH; Zhou, LT; Yang, XQ; Wang, CF				Zhao, Ping; Deng, Yu; Wu, Yong; Guo, Qinhao; Zhou, Luting; Yang, Xiaoqun; Wang, Chaofu			Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1 alpha in clear cell renal cell carcinoma	FASEB JOURNAL			English	Article						clear cell renal cell carcinoma; SNHG6; YBX1	SMALL NUCLEOLAR RNA; CANCER CELLS; HOST GENES; PROLIFERATION; EXPRESSION; GLYCOLYSIS; MIGRATION; INVASION; HYPOXIA; EZH2	Recent studies have showed that Small nucleolar RNA host genes (SNHGs) acted as a subset of long noncoding RNAs (lncRNAs) have critical roles in human cancer carcinogenesis. However, the biological functions of SNHGs in clear cell renal cell carcinoma (ccRCC) have not been fully investigated. In this study, we screened an oncogenic lncRNA termed SNHG6 using RNA-Seq data of ccRCC from The Cancer Genome Atlas (TCGA). Quantitative real-time PCR was then used to demonstrate the expression of SNHG6 in ccRCC tissues. SNHG6 overexpression is highly associated with malignant features in patients and is a prognostic indicator. SNHG6 significantly promotes ccRCC cell proliferation and metastasis in vitro and in vivo. Mechanistic investigations identified that SNHG6 exerts oncogenic effects by interacting with YBX1, and then, enhancing HIF1 alpha translation. Taken together, SNHG6 promotes ccRCC progression by binding YBX1 and may serve as a novel molecular target for ccRCC therapy.	[Zhao, Ping; Zhou, Luting; Yang, Xiaoqun; Wang, Chaofu] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pathol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China; [Deng, Yu] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou, Peoples R China; [Wu, Yong; Guo, Qinhao] Fudan Univ Shanghai, Dept Gynecol Oncol, Ctr Canc, Shanghai, Peoples R China; [Wu, Yong; Guo, Qinhao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Wu, Yong; Guo, Qinhao] Fudan Univ, Inst Canc, Shanghai Canc Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Zhejiang University; Fudan University; Fudan University; Fudan University	Yang, XQ; Wang, CF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pathol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.	yxq11964@rjh.com.cn; wangchaofu@126.com	Wang, Chao/GXF-8353-2022		National Natural Science Foundation of China [82002747, 81903050]; Science and Technology Commission of Shanghai Municipality [17ZR1417500]; Shanghai Sailing Program; Shanghai Anticancer Association EYAS Project [20YF1408000, SACA-CY19A07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Sailing Program; Shanghai Anticancer Association EYAS Project	This work was supported in part by grants from the National Natural Science Foundation of China to YXQ (81903050) and from the Science and Technology Commission of Shanghai Municipality to WCF (17ZR1417500), and from the Shanghai Sailing Program and Shanghai Anticancer Association EYAS Project to WY (20YF1408000, SACA-CY19A07) and the National Natural Science Foundation of China to WY (82002747).	Calle AS, 2018, CANCER SCI, V109, P2093, DOI 10.1111/cas.13642; Cao C, 2017, ONCOGENE, V36, P1112, DOI 10.1038/onc.2016.278; Chang L, 2016, CANCER LETT, V383, P183, DOI 10.1016/j.canlet.2016.09.034; Chen SY, 2019, BIOCHEM BIOPH RES CO, V519, P901, DOI 10.1016/j.bbrc.2019.09.091; Chow RD, 2018, ONCOGENE, V37, P6442, DOI 10.1038/s41388-018-0420-z; DeOcesano-Pereira C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072611; Dong JY, 2018, CELL PHYSIOL BIOCHEM, V51, P2262, DOI 10.1159/000495871; Duan JY, 2019, ONCOTARGETS THER, V12, P4729, DOI 10.2147/OTT.S202938; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Gluz O, 2009, J CLIN ONCOL, V27, P6144, DOI 10.1200/JCO.2008.19.6261; Gogolevskaya IK, 2002, GENE, V292, P199, DOI 10.1016/S0378-1119(02)00678-9; Han WF, 2018, BIOMED PHARMACOTHER, V97, P911, DOI 10.1016/j.biopha.2017.11.014; Hayashi Y, 2019, CANCER SCI, V110, P1510, DOI 10.1111/cas.13990; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Lee YK, 2017, J BIOL CHEM, V292, P20208, DOI 10.1074/jbc.M117.809012; Li WH, 2019, EBIOMEDICINE, V44, P298, DOI 10.1016/j.ebiom.2019.05.055; Malakar P, 2019, CANCER RES, V79, P2480, DOI 10.1158/0008-5472.CAN-18-1432; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qin Y, 2020, ONCOTARGETS THER, V13, P7699, DOI 10.2147/OTT.S267140; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song EL, 2019, AGING-US, V11, P5705, DOI 10.18632/aging.102154; Su LM, 2019, ARTIF CELL NANOMED B, V47, P2670, DOI 10.1080/21691401.2019.1633338; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195; Wu Y, 2019, J CELL MOL MED, V23, P5025, DOI 10.1111/jcmm.14359; Xie ZY, 2019, IUBMB LIFE, V71, P1962, DOI 10.1002/iub.2140; Xu M, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-018-0690-5; Yu LL, 2017, CANCER RES, V77, P1564, DOI 10.1158/0008-5472.CAN-16-2074; Zhang MY, 2019, ONCOTARGETS THER, V12, P3349, DOI 10.2147/OTT.S197433; Zhang PF, 2016, EMBO REP, V17, P1204, DOI 10.15252/embr.201642067	34	10	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000732RR	http://dx.doi.org/10.1096/fj.202000732RR		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33150667				2022-12-28	WOS:000589712400001
J	Arao, Y; Hamilton, KJ; Grimm, SA; Korach, KS				Arao, Yukitomo; Hamilton, Katherine J.; Grimm, Sara A.; Korach, Kenneth S.			The genomic regulatory elements for estrogen receptor alpha transactivation-function-1 regulated genes	FASEB JOURNAL			English	Article						estrogen receptor alpha; estrogen-responsive element; SERM; tamoxifen; transactivation domain	ACTIVATION; PHOSPHORYLATION; BINDING; AF-2; IDENTIFICATION; ANTIESTROGEN; SYNERGISM; CONTAINS; DOMAINS	Estrogen receptor alpha (ER alpha) is a ligand-dependent transcription regulator, containing two transactivation functional domains, AF-1 and AF-2. The selective estrogen receptor modulators (SERMs), including 4-hydroxytamoxifen (4OHT), activate AF-1 preferentially rather than AF-2. However, it is unclear whether this specific function is related to the tissue-selective functionality of SERMs. Moreover, there is no information determining AF-1-dependent estrogenic-genes existing in tissues. We sought to identify AF-1-dependent estrogenic-genes using the AF-2 mutated knock-in (KI) mouse model, AF2ERKI. AF2ER is an AF-2 disrupted estradiol (E2)-insensitive mutant ER alpha, but AF-1-dependent transcription can be activated by the estrogen-antagonists, fulvestrant (ICI) and 4OHT. Gene profiling and ChIP-Seq analysis identifiedKlk1b21as an ICI-inducible gene in AF2ERKI uterus. The regulatory activity was analyzed further using a cell-based reporter assay. The 5 '-flanking 0.4k bp region ofKlk1b21gene responded as an ER alpha AF-1-dependent estrogen-responsive promoter. The 150 bp minimum ER alpha binding element (EBE) consists of three direct repeats. These three half-site sequences were essential for the ER alpha-dependent transactivation and were differentially recognized by E2 and 4OHT for the gene activation. This response was impaired when the minimum EBE was fused with a thymidine-kinase promoter but could be restored by fusion with the 100 bp minimum transcription initiation element (TIE) ofKlk1b21, suggesting that the cooperative function of EBE and TIE is essential for mediating AF-1-dependent transactivation. These findings provide the first in vivo evidence that endogenous ER alpha AF-1 dominant estrogenic-genes exist in estrogen-responsive organs. Such findings will aid in understanding the mechanism of ER alpha-dependent tissue-selective activity of SERMs.	[Arao, Yukitomo; Hamilton, Katherine J.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA; [Grimm, Sara A.] NIEHS, Integrat Bioinformat Support Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Arao, Y; Korach, KS (corresponding author), NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	araoy@niehs.nih.gov; korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021		Division of Intramural Research of the NIEHS/NIH [1ZIAES070065]	Division of Intramural Research of the NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr Kevin Gerrish and the NIEHS Microarray Group from the Molecular Genomics Core Laboratory for conducting the microarray analysis. We thank Ms Sylvia Hewitt and Dr Tatsuya Sueyoshi for the critical reading of the manuscript. This study was supported by the Division of Intramural Research of the NIEHS/NIH 1ZIAES070065 (to KSK).	Arao Y, 2018, J BIOL CHEM, V293, P8495, DOI 10.1074/jbc.RA117.001212; Arao Y, 2015, J BIOL CHEM, V290, P17611, DOI 10.1074/jbc.M115.638650; Arao Y, 2013, J BIOL CHEM, V288, P21105, DOI 10.1074/jbc.M113.463455; Arao Y, 2012, P NATL ACAD SCI USA, V109, P21140, DOI 10.1073/pnas.1216189110; Arao Y, 2011, P NATL ACAD SCI USA, V108, P14986, DOI 10.1073/pnas.1109180108; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Dutertre M, 2000, J PHARMACOL EXP THER, V295, P431; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; HART JE, 1990, PHARMACOL THERAPEUT, V47, P203, DOI 10.1016/0163-7258(90)90087-I; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewitt SC, 2006, ENDOCRINOLOGY, V147, P2203, DOI 10.1210/en.2005-1292; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2014, MOL ENDOCRINOL, V28, P899, DOI 10.1210/me.2014-1051; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KATO S, 1995, MOL CELL BIOL, V15, P5858; KATO S, 1992, CELL, V68, P731, DOI 10.1016/0092-8674(92)90148-6; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Lahooti H, 1995, J STEROID BIOCHEM, V55, P305, DOI 10.1016/0960-0760(95)00188-3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike ACW, 2000, J STEROID BIOCHEM, V74, P261, DOI 10.1016/S0960-0760(00)00102-3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Valdes G, 2011, PLACENTA, V32, pS170, DOI 10.1016/j.placenta.2011.01.008; Yoon K, 2000, MOL CELL ENDOCRINOL, V162, P211, DOI 10.1016/S0303-7207(99)00261-0	38	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16003	16021		10.1096/fj.202001435R	http://dx.doi.org/10.1096/fj.202001435R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33064339	Green Accepted			2022-12-28	WOS:000581162000001
J	Wang, G; Huang, Y; Hu, TX; Zhang, BZ; Tang, ZS; Yao, RJ; Huang, Y; Fan, XJ; Ni, X				Wang, Gang; Huang, Yan; Hu, Tianxiao; Zhang, Baozhen; Tang, Zhengshan; Yao, Ruojing; Huang, Ying; Fan, Xiujun; Ni, Xin			Contribution of placental 11 beta-HSD2 to the pathogenesis of preeclampsia	FASEB JOURNAL			English	Article						11 beta-HSD2; ADAM17; glucocorticoids; placenta; preeclampsia	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; BETA-HYDROXYSTEROID DEHYDROGENASE; FETAL-GROWTH; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; GLUCOCORTICOID-RECEPTOR; BLOOD-PRESSURE; EXPRESSION; INVASION; PREGNANCY; WOMEN	Preeclampsia, a major human pregnancy-specific disorder, leads to maternal and fetal morbidity and mortality. Here we reported that 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2), an enzyme that degrades active glucocorticoids, is one of the key factors that contributes to preeclampsia development. In the pregnant rat model, we firstly confirmed that administration of 11 beta-HSD2 inhibitor carbenoxolone (CBX) subcutaneously or by placenta-targeted delivery system could lead to a decrease in placental 11 beta-HSD2 expression and activity and an increase in corticosterone level in placenta and maternal circulation. Then, we showed that subcutaneous administration and placenta-targeted delivery of CBX resulted in the hallmark of preeclampsia-like features including hypertension, proteinuria, renal damages as well as elevated circulatory soluble fms-like tyrosine kinase 1 (sFlt1) and increased sFlt1/placental growth factor (PlGF) ratio in pregnant rats. These animals displayed decreased trophoblast invasion in uterus, impaired spiral artery remodeling, and reduced placental blood flow. Preeclampsia-like features could also be induced by administration of dexamethasone in pregnant rats. In the cultured human trophoblast models, we found that cortisol only inhibited migration and invasion of the extravillous trophoblasts with 11 beta-HSD2 knockdown, and promoted sFlt1 release in the cultured syncytiotrophoblasts with 11 beta-HSD2 knockdown. Furthermore, we elucidated that cortisol stimulated a disintegrin and metalloprotease (ADAM)17 expression in placentas, thereby promoting sFlt1 release in placenta. Collectively, our study provided the evidence that placental 11 beta-HSD2 dysfunction plays a key role in the development of preeclampsia and immediately identified innovative target to counteract preeclampsia.	[Wang, Gang; Huang, Yan; Tang, Zhengshan; Yao, Ruojing; Ni, Xin] Cent South Univ, Xiangya Hosp, Dept Gynecol & Obstet, Changsha, Peoples R China; [Wang, Gang; Huang, Yan; Tang, Zhengshan; Yao, Ruojing; Ni, Xin] Cent South Univ, Xiangya Hosp, Res Ctr Mol Metab, Changsha 410008, Peoples R China; [Wang, Gang; Huang, Yan; Hu, Tianxiao; Ni, Xin] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Zhang, Baozhen; Fan, Xiujun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Reprod & Hlth Dev, Shenzhen, Peoples R China; [Zhang, Baozhen; Fan, Xiujun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, CAS Key Lab Hlth Informat,Guangdong Key Lab Nanom, Shenzhen, Peoples R China; [Zhang, Baozhen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Ying] Matern & Child Hlth Hosp Pudong Shanghai, Shanghai, Peoples R China; [Ni, Xin] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China	Central South University; Central South University; Naval Medical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central South University	Ni, X (corresponding author), Cent South Univ, Xiangya Hosp, Res Ctr Mol Metab, Changsha 410008, Peoples R China.	xj.fan@siat.ac.cn; xinni2018@csu.edu.cn			State Key Research and Development Program of China [2017YFC1001404, 2018YFC1002802, 2016YFC1000402]; Natural Science Foundation of China [81741011, 81701481, 81620108013, 81571445]; Science and Technology Commission of Shanghai Municipals [1814090300]; Hunan Provincial Science and Technology Department [2018RS3030]	State Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipals; Hunan Provincial Science and Technology Department	State Key Research and Development Program of China, Grant/Award Number: 2017YFC1001404, 2018YFC1002802 and 2016YFC1000402; Natural Science Foundation of China, Grant/Award Number: 81741011, 81701481, 81620108013 and 81571445; Science and Technology Commission of Shanghai Municipals, Grant/Award Number: 1814090300; Hunan Provincial Science and Technology Department, Grant/Award Number: 2018RS3030	Alfaidy N, 2002, J CLIN ENDOCR METAB, V87, P4797, DOI 10.1210/jc.2002-020310; BRIDGMAN J, 1948, J MORPHOL, V83, P61, DOI 10.1002/jmor.1050830104; Brown RW, 1996, BIOCHEM J, V313, P1007, DOI 10.1042/bj3131007; Burton PJ, 1999, BIOL REPROD, V60, P234, DOI 10.1095/biolreprod60.2.234; Causevic M, 2007, MOL ASPECTS MED, V28, P220, DOI 10.1016/j.mam.2007.04.003; Chen Hong-Chen, 2004, V294, P15; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Diao HL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110106; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; Fahlbusch FB, 2015, J STEROID BIOCHEM, V152, P155, DOI 10.1016/j.jsbmb.2015.05.014; Fahlbusch FB, 2013, STEROIDS, V78, P888, DOI 10.1016/j.steroids.2013.04.015; Fowden AL, 2015, EXP PHYSIOL, V100, P1477, DOI 10.1113/EP085212; Fraser TB, 2001, CLIN EXP PHARMACOL P, V28, P831, DOI 10.1046/j.1440-1681.2001.03531.x; He P, 2014, ENDOCRINOLOGY, V155, P299, DOI 10.1210/en.2013-1350; Heussner K, 2016, PLACENTA, V37, P79, DOI 10.1016/j.placenta.2015.11.009; Hodel M, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/4096847; Hofmann M, 2001, J PERINAT MED, V29, P23, DOI 10.1515/JPM.2001.003; Hu T, 2015, PLACENTA, V36, P947, DOI 10.1016/j.placenta.2015.05.007; Hung TH, 2008, REPROD SCI, V15, P195, DOI 10.1177/1933719107310709; Hunter RW, 2015, CURR OPIN PHARMACOL, V21, P105, DOI 10.1016/j.coph.2015.01.005; Jones JC, 2016, ANNU REV PHYSIOL, V78, P243, DOI 10.1146/annurev-physiol-021014-071720; Kisanga EP, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12974; Li XQ, 2014, PLACENTA, V35, P291, DOI 10.1016/j.placenta.2014.03.005; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; Lindsay RS, 1996, HYPERTENSION, V27, P1200, DOI 10.1161/01.HYP.27.6.1200; Liu YJ, 2008, J MOL ENDOCRINOL, V41, P53, DOI 10.1677/JME-08-0004; Ma R, 2011, PLACENTA, V32, P975, DOI 10.1016/j.placenta.2011.09.015; Mandl M, 2006, REPRODUCTION, V132, P159, DOI 10.1530/rep.1.00976; Mirazi N, 2004, J SOC GYNECOL INVEST, V11, P22, DOI 10.1016/j.jsgi.2003.07.005; Murphy KE, 2012, OBSTET GYNECOL, V119, P917, DOI 10.1097/AOG.0b013e31825189dc; Patel FA, 1999, J CLIN ENDOCR METAB, V84, P395, DOI 10.1210/jc.84.2.395; Pavek P, 2007, PLACENTA, V28, P1004, DOI 10.1016/j.placenta.2007.05.001; Peng B, 2016, MOL HUM REPROD, V22, P119, DOI 10.1093/molehr/gav070; Phookan S, 2015, EXP NEUROL, V265, P160, DOI 10.1016/j.expneurol.2015.01.004; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Sakamuri SSVP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050216; Saleh L, 2017, HYPERTENSION, V70, P594, DOI 10.1161/HYPERTENSIONAHA.117.09741; Saleh L, 2016, EUR J OBSTET GYN R B, V199, P121, DOI 10.1016/j.ejogrb.2016.02.013; Sanna PP, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.13; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; Seki H, 2014, ACTA OBSTET GYN SCAN, V93, P959, DOI 10.1111/aogs.12473; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; STEWART PM, 1990, CLIN SCI, V78, P49, DOI 10.1042/cs0780049; Strevens H, 2003, BJOG-INT J OBSTET GY, V110, P825; Szpera-Gozdziewicz A, 2014, FRONT BIOSCI-LANDMRK, V19, P734, DOI 10.2741/4240; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Wyrwoll CS, 2016, P NATL ACAD SCI USA, V113, P6265, DOI 10.1073/pnas.1520356113; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100; Yang YY, 2012, J CLIN ENDOCR METAB, V97, pE1390, DOI 10.1210/jc.2012-1150; Zannas AS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad3022; Zeisler H, 2016, OBSTET GYNECOL, V128, P261, DOI 10.1097/AOG.0000000000001525; Zha YP, 2013, CNS NEUROSCI THER, V19, P244, DOI 10.1111/cns.12065; Zhang BZ, 2018, THERANOSTICS, V8, P2765, DOI 10.7150/thno.22904; Zhang H, 2013, HUM REPROD, V28, P2350, DOI 10.1093/humrep/det258; Zhao S, 2010, PLACENTA, V31, P512, DOI 10.1016/j.placenta.2010.03.014; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	57	8	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15379	15399		10.1096/fj.202001003RR	http://dx.doi.org/10.1096/fj.202001003RR		SEP 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32978833				2022-12-28	WOS:000574540500001
J	Sears, AE; Albiez, S; Gulati, S; Wang, BL; Kiser, P; Kovacik, L; Engel, A; Stahlberg, H; Palczewski, K				Sears, Avery E.; Albiez, Stefan; Gulati, Sahil; Wang, Benlian; Kiser, Philip; Kovacik, Lubomir; Engel, Andreas; Stahlberg, Henning; Palczewski, Krzysztof			Single particle cryo-EM of the complex between interphotoreceptor retinoid-binding protein and a monoclonal antibody	FASEB JOURNAL			English	Article						cryo-EM; interphotoreceptor retinoid-binding protein; monoclonal antibody; single particle analysis; visual cycle	ALL-TRANS-RETINOL; RHODOPSIN REGENERATION; VITAMIN-A; IRBP; PREDICTION; IDENTIFICATION; SEQUENCES; MUTATION; RELEASE; RBP3	Interphotoreceptor retinoid-binding protein (IRBP) is a highly expressed protein secreted by rod and cone photoreceptors that has major roles in photoreceptor homeostasis as well as retinoid and polyunsaturated fatty acid transport between the neural retina and retinal pigment epithelium. Despite two crystal structures reported on fragments of IRBP and decades of research, the overall structure of IRBP and function within the visual cycle remain unsolved. Here, we studied the structure of native bovine IRBP in complex with a monoclonal antibody (mAb5) by cryo-electron microscopy, revealing the tertiary and quaternary structure at sufficient resolution to clearly identify the complex components. Complementary mass spectrometry experiments revealed the structure and locations ofN-linked carbohydrate post-translational modifications. This work provides insight into the structure of IRBP, displaying an elongated, flexible three-dimensional architecture not seen among other retinoid-binding proteins. This work is the first step in elucidation of the function of this enigmatic protein.	[Sears, Avery E.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave,Cleveland, Cleveland, OH 44106 USA; [Sears, Avery E.] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Sears, Avery E.; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA 92697 USA; [Albiez, Stefan; Kovacik, Lubomir; Engel, Andreas; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, Mattenstr 26, CH-4058 Basel, Switzerland; [Gulati, Sahil] Gatan Inc, Pleasanton, CA USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Kiser, Philip; Palczewski, Krzysztof] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Kiser, Philip] VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA USA; [Palczewski, Krzysztof] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	Case Western Reserve University; Case Western Reserve University; University of California System; University of California Irvine; University of Basel; Case Western Reserve University; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	Sears, AE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave,Cleveland, Cleveland, OH 44106 USA.; Stahlberg, H (corresponding author), Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, Mattenstr 26, CH-4058 Basel, Switzerland.; Sears, AE; Palczewski, K (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA.; Sears, AE; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA.	aes31@case.edu; henning.stahlberg@unibas.ch; kpalczew@uci.edu	Stahlberg, Henning/H-1868-2011	Stahlberg, Henning/0000-0002-1185-4592; Gulati, Sahil/0000-0002-8255-479X	HHS | NIH | National Eye Institute (NEI) [EY009339]; U.S. Department of Veterans Affairs (VA) [IK2BX002683]; HHS | National Institutes of Health (NIH) [T32 GM002750]	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY009339; U.S. Department of Veterans Affairs (VA), Grant/Award Number: IK2BX002683; HHS | National Institutes of Health (NIH), Grant/Award Number: T32 GM002750	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADLER AJ, 1987, J BIOL CHEM, V262, P13198; Arno G, 2015, INVEST OPHTH VIS SCI, V56, P2358, DOI 10.1167/iovs.15-16520; Babrak L, 2017, MOL IMMUNOL, V90, P287, DOI 10.1016/j.molimm.2017.08.014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BORST DE, 1989, J BIOL CHEM, V264, P1115; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Chen CH, 2017, J BIOL CHEM, V292, P19356, DOI 10.1074/jbc.M117.795187; CHEN Y, 1993, BIOCHEMISTRY-US, V32, P11311, DOI 10.1021/bi00093a007; CHEN Y, 1994, BIOCHEMISTRY-US, V33, P10658, DOI 10.1021/bi00201a013; Chen Y, 1996, J BIOL CHEM, V271, P20507, DOI 10.1074/jbc.271.34.20507; Cook JD, 2017, J BIOL CHEM, V292, P21407, DOI [10.1074/jbc.M117.812701, 10.1074/jbc.m117.812701]; Crabb JW, 1998, J BIOL CHEM, V273, P20712, DOI 10.1074/jbc.273.33.20712; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; Dettai A, 2008, MOL PHYLOGENET EVOL, V48, P258, DOI 10.1016/j.ympev.2008.04.003; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; DUFFY M, 1993, EXP EYE RES, V57, P771, DOI 10.1006/exer.1993.1185; Edwards RB, 2000, EXP EYE RES, V70, P235, DOI 10.1006/exer.1999.0781; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLANNERY JG, 1990, EXP EYE RES, V51, P717, DOI 10.1016/0014-4835(90)90057-2; Fong S L, 1985, Prog Clin Biol Res, V190, P111; Ghosh D, 2015, EXP EYE RES, V140, P149, DOI 10.1016/j.exer.2015.08.026; Gonzalez-Fernandez F, 2014, EXP EYE RES, V120, P167, DOI 10.1016/j.exer.2014.01.002; GONZALEZFERNANDEZ F, 1990, J CELL BIOL, V111, P2775, DOI 10.1083/jcb.111.6.2775; Holzlohner P, 2017, JOVE-J VIS EXP, DOI 10.3791/54832; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Kiessling LL, 2013, CHEM SOC REV, V42, P4476, DOI 10.1039/c3cs60097a; Kiser P. D., 2011, BIOCHIM BIOPHYS ACTA, V1821, P137; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Lepore R, 2017, NUCLEIC ACIDS RES, V45, pW17, DOI 10.1093/nar/gkx334; LIOU GI, 1994, DEV BIOL, V161, P345, DOI 10.1006/dbio.1994.1036; Loew A, 2002, STRUCTURE, V10, P43, DOI 10.1016/S0969-2126(01)00698-0; MARMOR MF, 1978, SURV OPHTHALMOL, V22, P279, DOI 10.1016/0039-6257(78)90074-7; Martin TGB, 2016, FIGSHARE, DOI [10.6084/m9.figshare.3178669.v1, DOI 10.6084/M9.FIGSHARE.3178669.V1]; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Moretti R, 2018, PROTEIN SCI, V27, P259, DOI 10.1002/pro.3313; Noy N, 1998, METH MOL B, V89, P177; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; OKAJIMA TIL, 1989, EXP EYE RES, V49, P629, DOI 10.1016/S0014-4835(89)80059-4; OKAJIMA TIL, 1990, P NATL ACAD SCI USA, V87, P6907, DOI 10.1073/pnas.87.17.6907; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Peterman SM, 2006, J AM SOC MASS SPECTR, V17, P168, DOI 10.1016/j.jasms.2005.10.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFEFFER B, 1983, J CELL PHYSIOL, V117, P333, DOI 10.1002/jcp.1041170308; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; WALD G, 1950, SCIENCE, V111, P179, DOI 10.1126/science.111.2877.179; Wald G, 1935, J GEN PHYSIOL, V18, P905, DOI 10.1085/jgp.18.6.905; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036772; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	62	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13918	13934		10.1096/fj.202000796RR	http://dx.doi.org/10.1096/fj.202000796RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32860273	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000565918900001
J	Olivares-Gonzalez, L; Velasco, S; Millan, JM; Rodrigo, R				Olivares-Gonzalez, Lorena; Velasco, Sheyla; Maria Millan, Jose; Rodrigo, Regina			Intravitreal administration of adalimumab delays retinal degeneration in rd10 mice	FASEB JOURNAL			English	Article						NLRP3 inflammasome; PARP; photoreceptor degeneration; TNF alpha	PHOTORECEPTOR CELL-DEATH; TUMOR-NECROSIS-FACTOR; PROLYL HYDROXYLASE INHIBITION; NLRP3 INFLAMMASOME ACTIVATION; APOPTOSIS-INDUCING FACTOR; NF-KAPPA-B; MICROGLIAL ACTIVATION; POLY(ADP-RIBOSE) POLYMERASE; OXIDATIVE STRESS; MOUSE MODEL	Retinitis pigmentosa (RP) is a group of inherited retinal dystrophies characterized by the progressive and irreversible loss of vision. We previously found that intraperitoneal administration of Adalimumab, a monoclonal anti-TNF alpha antibody, slowed down retinal degeneration in the murine model of RP, therd10mice. The aims of this study were to improve its neuroprotective effect and to deepen understanding of the molecular mechanisms involved in this effect. We analyzed (i) the in vitro effect of Adalimumab on the TNF alpha-mediated cell death in retinal cells; (ii) the effect of a single intravitreal injection of Adalimumab on retinal degeneration inrd10mice at postnatal day (P) 23. In vitro studies showed that TNF alpha induced caspase and poly ADP ribose polymerase (PARP) activation, downregulation of (kinase receptor-interacting protein 1) RIPK1 and upregulation of RIPK3 in retinal cells. Adalimumab reduced cell death probably through the inhibition of caspase 3 activation. In vivo studies suggested that PARP and NLRP3 inflammasome are mainly activated and to a lesser extent caspase-dependent mechanisms inrd10retinas at P23. Necroptosis seems to be inhibited by the downregulation of RIPK1. Adalimumab prevented from retinal degeneration without affecting caspase -dependent mechanisms but decreasing PARP activation, microglia activation as well as NLRP3 inflammasome.	[Olivares-Gonzalez, Lorena; Velasco, Sheyla; Rodrigo, Regina] Principe Felipe Res Ctr, Pathophysiol & Therapies Vis Disorders, Eduardo Primo Yufera 3, Valencia 46012, Spain; [Maria Millan, Jose; Rodrigo, Regina] Rare Dis Networking Biomed Res Ctr CIBERER, Madrid, Spain; [Maria Millan, Jose; Rodrigo, Regina] CIPF La Fe, Joint Unit Rare Dis, Valencia, Spain; [Maria Millan, Jose] Hlth Res Inst La Fe, Mol Cellular & Genom Biomed, Valencia, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe)	Rodrigo, R (corresponding author), Principe Felipe Res Ctr, Pathophysiol & Therapies Vis Disorders, Eduardo Primo Yufera 3, Valencia 46012, Spain.	rrodrigo@cipf.es	Olivares-González, Lorena/ABG-8737-2020; Rodrigo, Regina/I-1868-2015	Olivares-González, Lorena/0000-0001-8180-1229; Rodrigo, Regina/0000-0001-5875-986X; Velasco Gomariz, Sheyla/0000-0002-4242-7112	European Regional Development Fund; ISCIII [PI15/00052, PI18/00252]; MEHUER Foundation; CIBERER [CB06/07/1030]; National Health System [CP15/00019]; MINECO	European Regional Development Fund(European Commission); ISCIII(Instituto de Salud Carlos III); MEHUER Foundation; CIBERER; National Health System; MINECO(Spanish Government)	European Regional Development Fund; MINECO; ISCIII, Grant/Award Number: PI15/00052 and PI18/00252; MEHUER Foundation; CIBERER, Grant/Award Number: CB06/07/1030; National Health System, Grant/Award Number: CP15/00019	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Akhtar-Schafer I, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708259; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Appelbaum T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177224; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Benlloch-Navarro S, 2019, J STEROID BIOCHEM, V189, P291, DOI 10.1016/j.jsbmb.2019.01.007; Bode C, 2003, MOL VIS, V9, P144; Campochiaro PA, 2018, PROG RETIN EYE RES, V62, P24, DOI 10.1016/j.preteyeres.2017.08.004; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Catara G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14156-8; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; P NATL ACAD SCI US, V114, pE5762; Corton M, 2010, CLIN GENET, V78, P495, DOI 10.1111/j.1399-0004.2010.01487.x; Cottet S, 2009, CURR MOL MED, V9, P375, DOI 10.2174/156652409787847155; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Cvenkel B, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/939602; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Daiger S, 1996, 1996 2014 RETINAL IN; Di Pierdomenico J, 2019, NEURAL REGEN RES, V14, P1186, DOI 10.4103/1673-5374.251204; Durrani Khayyam, 2007, Compr Ophthalmol Update, V8, P225; Ebert S, 2009, J NEUROCHEM, V110, P1863, DOI 10.1111/j.1471-4159.2009.06286.x; Estornes Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.175; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Gao JY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1062-3; Genini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085408; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hwang Narae, 2016, Korean J Ophthalmol, V30, P468; Japiassu RM, 2008, OPHTHAL SURG LAS IM, V39, P348, DOI 10.3928/15428877-20080701-09; Jiao K, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.40; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kaur H, 2011, NEUROCHEM RES, V36, P1435, DOI 10.1007/s11064-011-0469-3; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kruk J, 2016, MINI-REV MED CHEM, V16, P241, DOI 10.2174/1389557516666151120114605; Lane DJR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149922; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leal I, 2018, ACTA OPHTHALMOL, V96, pE665, DOI 10.1111/aos.13699; Liao Y, 2019, INVEST OPHTH VIS SCI, V60, P3034, DOI 10.1167/iovs.18-26360; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Malik A, 2017, J CELL SCI, V130, P3955, DOI 10.1242/jcs.207365; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Margolin N, 1997, J BIOL CHEM, V272, P7223, DOI 10.1074/jbc.272.11.7223; de la Camara CMF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11764; de la Camara CMF, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0172-9; de la Camara CMF, 2013, EXP EYE RES, V111, P122, DOI 10.1016/j.exer.2013.03.015; McLaughlin T, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00267; Moriwaki K, 2017, INT REV CEL MOL BIO, V328, P253, DOI 10.1016/bs.ircmb.2016.08.007; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; MURRAY PI, 1990, INVEST OPHTH VIS SCI, V31, P917; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Nakatake S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87781; NEWTON I, 1994, PESTIC SCI, V41, P187, DOI 10.1002/ps.2780410304; Noailles A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33356; Olivares-Gonzalez L, 2018, FASEB J, V32, P2438, DOI 10.1096/fj.201700985R; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Power M, 2020, PROG RETIN EYE RES, V74, DOI 10.1016/j.preteyeres.2019.07.005; Qiu XB, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1886-3; Rana T, 2017, BBA-MOL BASIS DIS, V1863, P92, DOI 10.1016/j.bbadis.2016.10.008; Rivas MA, 2009, HISTOL HISTOPATHOL, V24, P1295, DOI 10.14670/HH-24.1295; Roche SL, 2018, GLIA, V66, P295, DOI 10.1002/glia.23243; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sahaboglu A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181374; Sasahara M, 2008, AM J PATHOL, V172, P1693, DOI 10.2353/ajpath.2008.080024; Saxena S, 2011, PATHOBIOLOGY, V78, P261, DOI 10.1159/000329589; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; Sears JE, 2008, P NATL ACAD SCI USA, V105, P19898, DOI 10.1073/pnas.0805817105; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Sheets KG, 2013, MOL VIS, V19, P1747; Shen HM, 2012, EXP CELL RES, V318, P1304, DOI 10.1016/j.yexcr.2012.02.006; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Syeda S, 2015, EXP NEUROL, V267, P1, DOI 10.1016/j.expneurol.2015.02.027; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Ting AT, 2016, TRENDS IMMUNOL, V37, P535, DOI 10.1016/j.it.2016.06.002; Totsuka K, 2019, EXP EYE RES, V181, P316, DOI 10.1016/j.exer.2018.08.019; Trichonas G, 2013, INVEST OPHTH VIS SCI, V54, P4919, DOI 10.1167/iovs.13-12171; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Vanden Berghe T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975093; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Viringipurampeer IA, 2019, MOL NEUROBIOL, V56, P1637, DOI 10.1007/s12035-018-1192-8; Viringipurampeer IA, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/581751; Viringipurampeer IA, 2016, HUM MOL GENET, V25, P1501, DOI 10.1093/hmg/ddw029; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Wegner A, 2017, INNATE IMMUN-LONDON, V23, P432, DOI 10.1177/1753425917707026; Wegner KW, 2017, TRENDS PHARMACOL SCI, V38, P202, DOI 10.1016/j.tips.2016.12.005; Wu L, 2013, J OCUL PHARMACOL TH, V29, P366, DOI 10.1089/jop.2012.0203; Xu JG, 2016, GLIA, V64, P1869, DOI 10.1002/glia.23026; Yang H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0202-z; Yerramothu P, 2018, EYE, V32, P491, DOI 10.1038/eye.2017.241; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298	110	10	10	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13839	13861		10.1096/fj.202000044RR	http://dx.doi.org/10.1096/fj.202000044RR		AUG 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32816354	hybrid			2022-12-28	WOS:000563409100001
J	Chen, WC; Lu, YC; Kuo, SJ; Lin, CY; Tsai, CH; Liu, SC; Chen, YL; Wang, SW; Tang, CH				Chen, Wei-Cheng; Lu, Yung-Chang; Kuo, Shu-Jui; Lin, Chih-Yang; Tsai, Chun-Hao; Liu, Shan-Chi; Chen, Yen-Ling; Wang, Shih-Wei; Tang, Chih-Hsin			Resistin enhances IL-1 beta and TNF-alpha expression in human osteoarthritis synovial fibroblasts by inhibiting miR-149 expression via the MEK and ERK pathways	FASEB JOURNAL			English	Article						IL-1 beta; miR-149; osteoarthritis; resistin; TNF-alpha	HISTOLOGICAL ASSESSMENTS; ANGIOGENESIS; MICRORNAS; CARTILAGE; RECOMMENDATIONS; INTERLEUKIN-6; DEGRADATION; RECEPTOR; MODEL; FLUID	Resistin is a cysteine-rich adipokine that promotes the release of inflammatory cytokines, particularly interleukin 1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha), which are critical pro-inflammatory mediators in osteoarthritis (OA) pathogenesis. We describe evidence of significantly higher levels of resistin, IL-1 beta, and TNF-alpha expression in OA knee synovial tissue compared with that from non-OA knees. Resistin-induced enhancement of IL-1 beta and TNF-alpha expression in human OA synovial fibroblasts (OASFs) were attenuated by MEK and ERK inhibitors, as well as their respective siRNAs. Our data reveal that resistin enhances the expression of TNF-alpha and IL-1 beta in OASFs by inhibiting miR-149 expression via MEK and ERK signaling. Our findings elucidate the inter-relationships between resistin and pro-inflammatory mediators during OA pathogenesis and could help to facilitate the development of synovium-targeted therapy in OA.	[Chen, Wei-Cheng; Lu, Yung-Chang; Lin, Chih-Yang; Wang, Shih-Wei] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Chen, Wei-Cheng; Lu, Yung-Chang] MacKay Mem Hosp, Dept Orthoped Surg, Div Sports Med & Surg, Taipei, Taiwan; [Kuo, Shu-Jui; Lin, Chih-Yang; Tang, Chih-Hsin] China Med Univ, Sch Med, Taichung, Taiwan; [Kuo, Shu-Jui; Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Coll Hlth Care, Dept Sports Med, Taichung, Taiwan; [Liu, Shan-Chi] China Med Univ, Dept Med Educ & Res, Beigang Hosp, Beigang Township, Yunlin, Taiwan; [Chen, Yen-Ling] Kaohsiung Med Univ, Coll Pharm, Dept Fragrance & Cosmet Sci, Kaohsiung, Taiwan; [Wang, Shih-Wei] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	Mackay Medical College; Mackay Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; China Medical University Taiwan; Asia University Taiwan	Wang, SW (corresponding author), MacKay Med Coll, Dept Med, New Taipei, Taiwan.; Tang, CH (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan.	shihwei@mmc.edu.tw; chtang@mail.cmu.edu.tw	Wang, Shih-Wei/AAH-1967-2020	Wang, Shih-Wei/0000-0001-7522-6352; Chen, Yen-Ling/0000-0002-9975-7382	Ministry of Science and Technology, Taiwan (MOST) [MOST 108-2320-B-039-026, MOST 1082314-B-039-011, MOST 106-2320-B-715001-MY3, MOST 109-2314-B-195-005, MOST 109-2314-B-039 -018 -MY3]; China Medical University Hospital [DMR-109-081]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); China Medical University Hospital	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 108-2320-B-039-026, MOST 1082314-B-039-011, MOST 106-2320-B-715001-MY3, MOST 109-2314-B-195-005 and MOST 109-2314-B-039 -018 -MY3; China Medical University Hospital, Grant/Award Number: DMR-109-081	Chen WC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061369; Chen Wei-Cheng, 2019, Cell Physiol Biochem, V52, P408, DOI 10.33594/000000029; Chien SY, 2016, CLIN SCI, V130, P667, DOI 10.1042/CS20150622; Cong L, 2017, OSTEOARTHR CARTILAGE, V25, P1362, DOI 10.1016/j.joca.2017.03.012; DINGLE JT, 1987, ANN RHEUM DIS, V46, P527, DOI 10.1136/ard.46.7.527; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Huang PY, 2010, PROTEIN CELL, V1, P218, DOI 10.1007/s13238-010-0019-9; Jin Z, 2020, CELL TISSUE RES, V381, P99, DOI 10.1007/s00441-020-03193-x; Kim JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194288; Koskinen A, 2014, SCAND J RHEUMATOL, V43, P249, DOI 10.3109/03009742.2013.853096; Kuo SJ, 2019, AGING-US, V11, P4075, DOI 10.18632/aging.102038; Kuo SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176052; Larsson S, 2015, OSTEOARTHR CARTILAGE, V23, P1906, DOI 10.1016/j.joca.2015.05.035; Lee HP, 2020, FOOD AGR IMMUNOL, V31, P193, DOI 10.1080/09540105.2020.1713055; Lee HP, 2019, FOOD AGR IMMUNOL, V30, P1033, DOI 10.1080/09540105.2019.1660623; Lee JH, 2009, OSTEOARTHR CARTILAGE, V17, P613, DOI 10.1016/j.joca.2008.08.007; Lien MY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00412; Little CB, 2012, OSTEOARTHR CARTILAGE, V20, P261, DOI 10.1016/j.joca.2012.01.017; Little CB, 2010, OSTEOARTHR CARTILAGE, V18, pS80, DOI 10.1016/j.joca.2010.04.016; Liu JF, 2018, BIOCHEM PHARMACOL, V155, P537, DOI 10.1016/j.bcp.2018.07.024; Liu SC, 2015, TOXICOL APPL PHARM, V289, P20, DOI 10.1016/j.taap.2015.08.020; Liu SC, 2013, BBA-MOL CELL RES, V1833, P1114, DOI 10.1016/j.bbamcr.2012.12.014; Loeser RF, 2008, CURR OPIN RHEUMATOL, V20, P581, DOI 10.1097/BOR.0b013e3283090463; MacDonald IJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061505; MacDonald IJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072012; Maximus PS, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155144; Nugent M, 2016, OSTEOARTHR CARTILAGE, V24, P573, DOI 10.1016/j.joca.2015.10.018; Siu KK, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0717-3; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Su CM, 2018, BIOCHEM PHARMACOL, V154, P234, DOI 10.1016/j.bcp.2018.05.001; Su CM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010029; Su CM, 2015, STEM CELLS, V33, P2243, DOI 10.1002/stem.2024; Swingler TE, 2019, CLIN EXP RHEUMATOL, V37, P40; Taipaleenmaki H, 2018, CURR OSTEOPOROS REP, V16, P1, DOI 10.1007/s11914-018-0417-0; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tong KM, 2008, CELL SIGNAL, V20, P1478, DOI 10.1016/j.cellsig.2008.04.003; TSAI CH, 2020, CELLS-BASEL, V9; Wang MF, 2019, BIOCHEM PHARMACOL, V166, P23, DOI 10.1016/j.bcp.2019.05.005; Wang YH, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030594; Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074; Wu KM, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0356-5; Wu TJ, 2018, ENVIRON TOXICOL, V33, P1061, DOI 10.1002/tox.22618; Xie CX, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0868-z; Yang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064581; Yang YC, 2019, ENVIRON TOXICOL, V34, P203, DOI 10.1002/tox.22674	45	13	14	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13671	13684		10.1096/fj.202001071R	http://dx.doi.org/10.1096/fj.202001071R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32790946				2022-12-28	WOS:000561411600001
J	Lin, YH; Wang, YC; Wu, MS; Lu, KC; Lin, HY; Kuo, HS; Chang, GD; Lin, CM; Hsiao, CAL				Lin, Yuan-Hau; Wang, Ying-Chi; Wu, Mai-Szu; Lu, Kuo-Cheng; Lin, Hsin-Yi; Kuo, Hsien-Shou; Chang, Geen-Dong; Lin, Chun-Mao; Hsiao, Chiaolong			The study of isotopic enrichment of water in human plasma and erythrocyte	FASEB JOURNAL			English	Article						blood plasma; end-stage renal disease; erythrocyte; stable isotope hydrogen and oxygen; water	RED-BLOOD-CELL; HUMAN URINE; AQUAPORIN-1; TRANSPORT; MEMBRANE; KIDNEY; EXPRESSION; DEUTERIUM; CHANNELS; HYDROGEN	Life does not sustain without water. For water, there is a natural abundance of stable isotope hydrogen and oxygen. Water molecules get across cell membranes through a plasma membrane protein, named aquaporin. Moreover, the kidney is the main organ to maintain water homeostasis. Here, we study the stable isotopic ratios of hydrogen and oxygen in human blood plasma and erythrocyte corresponding to kidney functions. We extract waters from human plasma and erythrocyte, collected from 110 participants, including 51 clinically stable outpatients with end-stage renal disease (ESRD) and 59 subjects with normal renal function (NRF). We observed that (i) both extracellular (blood plasma) and intracellular (erythrocyte) biology waters are isotopic differences between the ESRD and NRF participants, (ii) the natural abundance of isotopic waters of ESRD is hypo-isotopic, and (iii) the isotopic enrichment of water between erythrocyte and blood plasma are distinct. In addition, we introduce an empirical formula using entropy transformation to describe isotopic water enrichment for biology. Accordingly, the natural abundance of stable isotope water of blood plasma and erythrocyte may be possibly put in practice a new sign for assessments of kidney dysfunctions.	[Lin, Yuan-Hau; Wu, Mai-Szu; Kuo, Hsien-Shou; Lin, Chun-Mao] Taipei Med Univ, Coll Med, 250 Wuxing St, Taipei 11031, Taiwan; [Wang, Ying-Chi; Lin, Hsin-Yi; Chang, Geen-Dong; Hsiao, Chiaolong] Natl Taiwan Univ, Inst Biochem Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Wang, Ying-Chi; Lin, Hsin-Yi; Hsiao, Chiaolong] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Wu, Mai-Szu] Taipei Med Univ, Div Nephrol, Shuang Ho Hosp, Taipei, Taiwan; [Lu, Kuo-Cheng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan	Taipei Medical University; National Taiwan University; Academia Sinica - Taiwan; Taipei Medical University; Shuang Ho Hospital; Fu Jen Catholic University	Lin, CM (corresponding author), Taipei Med Univ, Coll Med, 250 Wuxing St, Taipei 11031, Taiwan.; Hsiao, CAL (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	chiaolong@ntu.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [MOST-105-2628-B-002-020-MY3, MOST 108-2628-B-002-012-]; National Taiwan University (NTU) [NTU-109L7729]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Taiwan University (NTU)(National Taiwan UniversityNanyang Technological University)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST-105-2628-B-002-020-MY3 and MOST 108-2628-B-002-012-; National Taiwan University (NTU), Grant/Award Number: NTU-109L7729	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; AGRE P, 1993, AM J PHYSIOL, V265, pF463; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Bekheirnia MR, 2006, CURR OPIN PHARMACOL, V6, P202, DOI 10.1016/j.coph.2005.09.008; BENGA G, 1986, BIOCHEMISTRY-US, V25, P1535, DOI 10.1021/bi00355a011; BENGA G, 1988, PROG BIOPHYS MOL BIO, V51, P193, DOI 10.1016/0079-6107(88)90002-8; Berdea P, 2001, STUD U BABES BOLYAI, V1, P256; Berman ESF, 2015, EUR J CLIN NUTR, V69, P1091, DOI 10.1038/ejcn.2015.10; Berman ESF, 2012, ANAL CHEM, V84, P9768, DOI 10.1021/ac3016642; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; BODNER GM, 1986, J CHEM EDUC, V63, P673, DOI 10.1021/ed063p673; Cadnapaphornchai MA, 2001, CARDIOLOGY, V96, P122, DOI 10.1159/000047396; Chao CY, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.247801; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; Crisp RL, 2016, ANN HEMATOL, V95, P1595, DOI 10.1007/s00277-016-2757-0; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Duncan D, 2006, BRIT J ANAESTH, V96, P590, DOI 10.1093/bja/ael064; Evans BC, 2013, JOVE-J VIS EXP, DOI 10.3791/50166; Feynman RP, 1963, FEYNMAN LECT PHYS, pc1963; HAGEMANN R, 1970, TELLUS, V22, P712, DOI 10.1111/j.2153-3490.1970.tb00540.x; HAINES TH, 1994, FEBS LETT, V346, P115, DOI 10.1016/0014-5793(94)00470-6; Hasler CR, 1998, NEPHROL DIAL TRANSPL, V13, P3132, DOI 10.1093/ndt/13.12.3132; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Johansen KL, 2009, ADV CHRONIC KIDNEY D, V16, P501, DOI 10.1053/j.ackd.2009.07.007; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; King LS, 2002, TRENDS ENDOCRIN MET, V13, P355, DOI 10.1016/S1043-2760(02)00665-3; Kreuzer-Martin HW, 2005, P NATL ACAD SCI USA, V102, P17337, DOI 10.1073/pnas.0506531102; Kuchel PW, 2005, BIOSYSTEMS, V82, P189, DOI 10.1016/j.biosystems.2005.07.002; Kuo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032137; Li H, P NAT ACAD SCI US, V113, P5862; Lloyd S., 2003, IEEE T INFORM THEORY, V28, P129; LOGE JP, 1958, AM J MED, V24, P4, DOI 10.1016/0002-9343(58)90357-7; Lohmann K, 1934, BIOCHEM Z, V273, P60; Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P1; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; O'Brien DM, 2007, RAPID COMMUN MASS SP, V21, P2422, DOI 10.1002/rcm.3108; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; Roudier N, 2002, J BIOL CHEM, V277, P45854, DOI 10.1074/jbc.M208999200; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; SOMLYAI G, 1993, FEBS LETT, V317, P1, DOI 10.1016/0014-5793(93)81479-J; SZENTGYORGYI A, 1971, PERSPECT BIOL MED, V14, P239; Tea I, 2017, METHOD ENZYMOL, V596, P113, DOI 10.1016/bs.mie.2017.07.020; Tea I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34251; TRANSONTAY R, 1990, J BIOMECH ENG-T ASME, V112, P257, DOI 10.1115/1.2891182; Trevisan R, 2006, J AM SOC NEPHROL, V17, pS145, DOI 10.1681/ASN.2005121320; Visconti L, 2016, J CLIN TRANSL ENDOCR, V6, P8, DOI 10.1016/j.jcte.2016.08.002; Wassenaar LI, 2016, RAPID COMMUN MASS SP, V30, P415, DOI 10.1002/rcm.7459; WESTHEIMER FH, 1961, CHEM REV, V61, P265, DOI 10.1021/cr60211a004; Wiback SJ, 2002, BIOPHYS J, V83, P808, DOI 10.1016/S0006-3495(02)75210-7; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Yang BX, 2001, J BIOL CHEM, V276, P624, DOI 10.1074/jbc.M008664200; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631	57	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13049	13062		10.1096/fj.202000388RR	http://dx.doi.org/10.1096/fj.202000388RR		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32779304	hybrid			2022-12-28	WOS:000558379800001
J	Balic, Z; Misra, S; Willard, B; Reinhardt, DP; Apte, SS; Hubmacher, D				Balic, Zerina; Misra, Saurav; Willard, Belinda; Reinhardt, Dieter P.; Apte, Suneel S.; Hubmacher, Dirk			Alternative splicing of the metalloprotease ADAMTS17 spacer regulates secretion and modulates autoproteolytic activity	FASEB JOURNAL			English	Article						ADAMTS proteases; fibrillin microfibrils; Weill&#8208; Marchesani syndrome; extracellular matrix; alternative splicing	PROTEOLYTIC ACTIVITIES; AGGRECAN DEGRADATION; FIBRILLIN-1; BINDING; ACTIVATION; TRANSCRIPT; PROTEINASE; MUTATIONS; EXOSITES; CLEAVAGE	ADAMTS proteases mediate biosynthesis and breakdown of secreted extracellular matrix (ECM) molecules in numerous physiological and disease processes. In addition to their catalytic domains, ADAMTS proteases contain ancillary domains, which mediate substrate recognition and ECM binding and confer distinctive properties and roles to individual ADAMTS proteases. Although alternative splicing can greatly expand the structural and functional diversity of ADAMTS proteases, it has been infrequently reported and functional consequences have been rarely investigated. Here, we characterize the structural and functional impact of alternative splicing of ADAMTS17, mutations in which cause Weill-Marchesani syndrome 4. Two novel ADAMTS17 splice variants, ADAMTS17A and ADAMTS17B, were investigated by structural modeling, mass spectrometry, and biochemical approaches. Our results identify a novel disulfide-bridged insertion in the ADAMTS17A spacer that originates from inclusion of a novel exon. This insertion results in differential autoproteolysis of ADAMTS17, and thus, predicts altered proteolytic activity against other substrates. The second variant, ADAMTS17B, results from an in-frame exon deletion and prevents ADAMTS17B secretion. Thus, alternative splicing of the ADAMTS spacer significantly regulates the physiologically relevant proteolytic activity of ADAMTS17, either by altering proteolytic specificity (ADAMTS17A) or by altering cellular localization (ADAMTS17B).	[Balic, Zerina; Hubmacher, Dirk] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Misra, Saurav] Kansas State Univ, Manhattan, KS 66506 USA; [Reinhardt, Dieter P.] McGill Univ, Montreal, PQ, Canada; [Willard, Belinda; Apte, Suneel S.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	Icahn School of Medicine at Mount Sinai; Kansas State University; McGill University; Cleveland Clinic Foundation	Hubmacher, D (corresponding author), Icahn Sch Med Mt Sinai, Orthopaed Res Labs, Dept Orthopaed, 1 Gustave L Levy Pl, New York, NY 10029 USA.		Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872; Hubmacher, Dirk/0000-0003-1569-9451	NCRR NIH HHS [S10 RR031537] Funding Source: Medline; NEI NIH HHS [R01 EY021151] Funding Source: Medline; NIAMS NIH HHS [R01 AR070748] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akiyama M, 2013, J THROMB HAEMOST, V11, P1399, DOI 10.1111/jth.12279; Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Bevitt DJ, 2005, GENE, V359, P99, DOI 10.1016/j.gene.2005.06.011; Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; Brouillard P, 2017, HUM MOL GENET, V26, P4095, DOI 10.1093/hmg/ddx297; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Dupuis LE, 2019, ARTERIOSCL THROM VAS, V39, P2067, DOI 10.1161/ATVBAHA.119.313077; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans DR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66978-8; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Foulcer SJ, 2015, METHODS MOL BIOL, V1229, P587, DOI 10.1007/978-1-4939-1714-3_46; Foulcer SJ, 2014, J BIOL CHEM, V289, P27859, DOI 10.1074/jbc.M114.573287; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601; Hubmacher D, 2020, METHODS MOL BIOL, V2043, P195, DOI 10.1007/978-1-4939-9698-8_16; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Hubmacher D, 2014, BIOMACROMOLECULES, V15, P1456, DOI 10.1021/bm5000696; Jeanes Emily C, 2019, Canine Genet Epidemiol, V6, P5, DOI 10.1186/s40575-019-0071-6; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Karoulias SZ, 2020, MATRIX BIOL, V88, P1, DOI 10.1016/j.matbio.2019.11.001; Karoulias SZ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040596; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Khan AO, 2012, OPHTHALMIC GENET, V33, P235, DOI 10.3109/13816810.2012.666708; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kutz WE, 2008, HUM MUTAT, V29, P1425, DOI 10.1002/humu.20797; Majumdar MK, 2007, ARTHRITIS RHEUM, V56, P3670, DOI 10.1002/art.23027; Mead TJ, 2018, MATRIX BIOL, V71-72, P225, DOI 10.1016/j.matbio.2018.06.002; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Nandadasa S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08520-7; Oichi T, 2019, CELL MOL LIFE SCI, V76, P4795, DOI 10.1007/s00018-019-03188-0; Oliver JAC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140436; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Santamaria S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47494-w; Satz-Jacobowitz B, 2021, DEV DYNAM, V250, P8, DOI 10.1002/dvdy.248; Silva SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165061; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanley S, 2021, ANN NY ACAD SCI, V1490, P57, DOI 10.1111/nyas.14465; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Takeda S, 2016, TOXINS, V8, DOI 10.3390/toxins8050155; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Wainwright SD, 2006, MATRIX BIOL, V25, P317, DOI 10.1016/j.matbio.2006.03.006; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	56	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21310	10.1096/fj.202001120RR	http://dx.doi.org/10.1096/fj.202001120RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484187	Bronze, Green Accepted			2022-12-28	WOS:000647789600048
J	Adeyemi, OO; Ward, JC; Snowden, JS; Herod, MR; Rowlands, DJ; Stonehouse, NJ				Adeyemi, Oluwapelumi O.; Ward, Joseph C.; Snowden, Joseph S.; Herod, Morgan R.; Rowlands, David J.; Stonehouse, Nicola J.			Functional advantages of triplication of the 3B coding region of the FMDV genome	FASEB JOURNAL			English	Article						3B; evolution; FMDV; gene duplication; picornavirus; trans&#8208; complementation	MOUTH-DISEASE; GENE DUPLICATION; CRYSTAL-STRUCTURE; POSITIVE-STRAND; LINKED PROTEIN; POLYMERASE; COMPLEMENTATION; VISUALIZATION; REPLICATION; SEQUENCE	For gene duplication to be maintained, particularly in the small genomes of RNA viruses, this should offer some advantages. We have investigated the functions of a small protein termed VPg or 3B, which acts as a primer in the replication of foot-and-mouth disease virus (FMDV). Many related picornaviruses encode a single copy but uniquely the FMDV genome includes three (nonidentical) copies of the 3B coding region. Using sub-genomic replicons incorporating nonfunctional 3Bs and 3B fusion products in competition and complementation assays, we investigated the contributions of individual 3Bs to replication and the structural requirements for functionality. We showed that a free N-terminus is required for 3B to function as a primer and although a single 3B can support genome replication, additional copies provide a competitive advantage. However, a fourth copy confers no further advantage. Furthermore, we find that a minimum of two 3Bs is necessary for trans replication of FMDV replicons, which is unlike other picornaviruses where a single 3B can be used for both cis and trans replication. Our data are consistent with a model in which 3B copy number expansion within the FMDV genome has allowed evolution of separate cis and trans acting functions, providing selective pressure to maintain multiple copies of 3B.	[Adeyemi, Oluwapelumi O.; Ward, Joseph C.; Snowden, Joseph S.; Herod, Morgan R.; Rowlands, David J.; Stonehouse, Nicola J.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Adeyemi, Oluwapelumi O.; Ward, Joseph C.; Snowden, Joseph S.; Herod, Morgan R.; Rowlands, David J.; Stonehouse, Nicola J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Adeyemi, Oluwapelumi O.] Univ Ilorin, Dept Med Microbiol & Parasitol, Coll Hlth Sci, Fac Basic Med Sci, Ilorin, Nigeria	University of Leeds; University of Leeds; University of Ilorin	Herod, MR; Stonehouse, NJ (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.; Herod, MR; Stonehouse, NJ (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	M.R.Herod@leeds.ac.uk; N.J.Stonehouse@leeds.ac.uk	Adeyemi, Oluwapelumi Olufemi/W-4095-2018	Adeyemi, Oluwapelumi Olufemi/0000-0002-0848-5917; Snowden, Joseph/0000-0001-7857-0634; Herod, Morgan/0000-0002-8626-6787; Stonehouse, Nicola/0000-0003-1146-5519	Wellcome Trust (Wellcome) [102174/B/13/Z]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/P001459/1, BB/K003801/1, BB/F01614X/1]; BBSRC [BB/P001459/1, BB/K003801/1] Funding Source: UKRI	Wellcome Trust (Wellcome); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Wellcome Trust (Wellcome), Grant/Award Number: 102174/B/13/Z; Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/P001459/1, BB/K003801/1 and BB/F01614X/1	Adeyemi OO, 2019, J VIROL, V93, DOI 10.1128/JVI.01447-18; Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022; BERNSTEIN HD, 1986, J VIROL, V60, P1040, DOI 10.1128/JVI.60.3.1040-1049.1986; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; Chen C, 2013, J VIROL, V87, P5755, DOI 10.1128/JVI.02733-12; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; FALK MM, 1992, J VIROL, V66, P2251, DOI 10.1128/JVI.66.4.2251-2260.1992; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; FORSS S, 1982, NUCLEIC ACIDS RES, V10, P6441, DOI 10.1093/nar/10.20.6441; Gao H, 2009, GENETICS, V182, P251, DOI 10.1534/genetics.108.099796; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; GORDON CF, 1960, ANAL CHEM, V32, P574, DOI 10.1021/ac60160a045; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Herod MR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006666; Herod MR, 2016, J VIROL, V90, P6864, DOI 10.1128/JVI.00469-16; KING AMQ, 1980, J VIROL, V34, P627, DOI 10.1128/JVI.34.3.627-634.1980; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Magadum S, 2013, J GENET, V92, P155, DOI 10.1007/s12041-013-0212-8; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Morasco BJ, 2003, J VIROL, V77, P5136, DOI 10.1128/JVI.77.9.5136-5144.2003; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oh HS, 2009, J VIROL, V83, P9370, DOI 10.1128/JVI.02076-08; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Pathak Harsh B, 2008, J Biol Chem, V283, P30677, DOI 10.1074/jbc.M806101200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reams AB, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016592; REUER Q, 1990, J VIROL, V64, P2967, DOI 10.1128/JVI.64.6.2967-2975.1990; Rio DC, 2010, COLD SPRING HARBOR P, V5; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; Sharma N, 2005, J VIROL, V79, P3565, DOI 10.1128/JVI.79.6.3565-3577.2005; Shimomura O, 2014, NOBEL LECT CHEM 2006, V48, P77; Simon-Loriere E, 2013, MOL BIOL EVOL, V30, P1263, DOI 10.1093/molbev/mst044; Tulloch F, 2014, J VIROL METHODS, V209, P35, DOI 10.1016/j.jviromet.2014.08.020; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; Walker JM, 2003, PROTEIN PROTOCOLS HD, P307; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911	37	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001473RR	http://dx.doi.org/10.1096/fj.202001473RR		NOV 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33230899	Green Published, hybrid			2022-12-28	WOS:000592381800001
J	Wu, XQ; Liu, Y; Mo, S; Wei, WL; Ye, ZL; Su, Q				Wu, Xianqiu; Liu, Yang; Mo, Song; Wei, Wuli; Ye, Ziliang; Su, Qiang			LncRNA TUG1 competitively binds to miR-340 to accelerate myocardial ischemia-reperfusion injury	FASEB JOURNAL			English	Article						GLUT1; HDAC4; long noncoding RNA TUG1; microRNA&#8208; 340; myocardial ischemia&#8208; reperfusion injury; &#946; &#8208; catenin	INHIBITION; APOPTOSIS	The aberrant expression of long noncoding RNA (lncRNA) taurine-upregulated gene 1 (TUG1) has been previously associated with myocardial ischemia-reperfusion injury (MIRI), but the underlying molecular mechanisms remain elusive. The current study aimed to clarify the functional role of TUG1/microRNA (miR)-340/histone deacetylase 4 (HDAC4)/beta-catenin/glucose transporter type 1 (GLUT1) axes in MIRI. The database-based analyses performed predicted the downstream factors of lncRNA TUG1. In the MIRI mouse models and hypoxia/reoxygenation (H/R)-induced cardiomyocyte models, the expression of TUG1/miR-340/HDAC4/beta-catenin/GLUT1 was manipulated to examine their effects on the infarction area, cardiomyocyte viability and apoptosis employing the Evans blue/TTC double staining, CCK-8 and TUNEL assays. Furthermore, the dual luciferase reporter and RIP assays verified the binding affinity of miR-340 to TUG1 and HDAC4. Subsequently, a negative correlation between miR-340 and TUG1 or HDAC4 expression was identified in myocardial tissues of MIRI mice and H/R-induced cardiomyocyte models, along with a positive correlation between TUG1 and HDAC4. Additionally, it was established that TUG1 bound to miR-340, and miR-340 targeted HDAC4. TUG1 upregulated HDAC4 expression, thereby promoting MIRI in the mouse models. HDAC4 was proven to repress the expression of beta-catenin and its target gene GLUT1. Moreover, the in vivo experiments validated that the inhibition of TUG1/miR-340/HDAC4/beta-catenin/GLUT1 axes alleviated MIRI in mice. Collectively, the current study uncovered the role of TUG1/miR-340/HDAC4/beta-catenin/GLUT1 axes in MIRI mouse models and H/R-induced cardiomyocyte models which may be a potential therapeutic target for MIRI treatment.	[Wu, Xianqiu; Wei, Wuli] Guangxi Med Univ, Affiliated Hosp 4, Dept Cardiothorac Surg, Liuzhou, Peoples R China; [Liu, Yang] Guangxi Med Univ, Affiliated Hosp 3, Nanning Peoples Hosp 2, Dept Cardiol, Nanning, Peoples R China; [Mo, Song] Guangxi Med Univ, Affiliated Hosp 4, Dept Intens Care Unit, Liuzhou, Peoples R China; [Ye, Ziliang; Su, Qiang] Guilin Med Univ, Affiliated Hosp, Dept Cardiol, 15 Lequn Rd, Guilin 541001, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guilin Medical University	Su, Q (corresponding author), Guilin Med Univ, Affiliated Hosp, Dept Cardiol, 15 Lequn Rd, Guilin 541001, Guangxi Zhuang, Peoples R China.	suqiang1983@foxmail.com	Zi, Ye/GWM-3932-2022		Key Research and Development Program of Guangxi; Guangxi Natural Science Foundation [2020GXNSFDA238007]	Key Research and Development Program of Guangxi; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study was supported by the Key Research and Development Program of Guangxi (Grant No. AB20159005), and Guangxi Natural Science Foundation (Grant No. 2020GXNSFDA238007)	Abraham DM, 2014, CIRC RES, V114, P938, DOI 10.1161/CIRCRESAHA.113.303238; Barzegar M, 2019, STEM CELL RES, V37, DOI 10.1016/j.scr.2019.101421; Cai JY, 2018, INT J ONCOL, V53, P2758, DOI 10.3892/ijo.2018.4564; Cui XJ, 2017, J CARDIOVASC PHARM, V70, P225, DOI 10.1097/FJC.0000000000000507; De Cecco L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058849; Du JF, 2015, J CELL PHYSIOL, V230, P1321, DOI 10.1002/jcp.24871; Fang Y, 2019, NAT COMMUN, V10; Han Y, 2020, INT J MOL MED, V45, P858, DOI 10.3892/ijmm.2020.4471; Hu SQ, 2017, EXP THER MED, V14, P771, DOI 10.3892/etm.2017.4564; Li D, 2019, J CELL BIOCHEM, V120, P14618, DOI 10.1002/jcb.28723; Li LH, 2012, AM J PHYSIOL-HEART C, V302, pH2112, DOI 10.1152/ajpheart.00339.2011; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Lu D, 2016, LAB INVEST, V96, P239, DOI 10.1038/labinvest.2015.145; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Pei YH, 2020, NANOTOXICOLOGY, V14, P638, DOI 10.1080/17435390.2020.1731857; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Ruan ZH, 2019, INT J CARDIOL, V286, P136, DOI 10.1016/j.ijcard.2019.03.046; Senchenkova EY, 2019, CIRCULATION, V140, P319, DOI 10.1161/CIRCULATIONAHA.118.039345; Song JK, 2018, J CELL BIOCHEM, V119, P6665, DOI 10.1002/jcb.26850; Su Q, 2020, AM J PHYSIOL-HEART C, V318, pH332, DOI 10.1152/ajpheart.00444.2019; Su Q, 2019, J MOL CELL CARDIOL, V133, P12, DOI 10.1016/j.yjmcc.2019.05.021; Sun ZW, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0178-y; Tan H, 2018, CELL PHYSIOL BIOCHEM, V51, P46, DOI 10.1159/000495161; Wang GH, 2019, MOL MED REP, V19, P994, DOI 10.3892/mmr.2018.9734; Wang K, 2016, CELL DEATH DIFFER, V23, P1394, DOI 10.1038/cdd.2016.28; Wang T, 2017, ONCOL REP, V37, P1059, DOI 10.3892/or.2016.5322; Wu ZW, 2018, MOL MED REP, V17, P2422, DOI 10.3892/mmr.2017.8116; Xu BH, 2019, FUTURE ONCOL, V15, P3243, DOI 10.2217/fon-2019-0222; Yang DR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11817-2; Yang J, 2016, EXP THER MED, V12, P3249, DOI 10.3892/etm.2016.3777; Yang M, 2019, J CELL PHYSIOL, V234, P17757, DOI 10.1002/jcp.28401; Yu SY, 2017, INT J CARDIOL, V247, P31, DOI 10.1016/j.ijcard.2017.05.055; Zhang L, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0037-2; Zhao ZM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9250; Zhu LJ, 2020, J CELL PHYSIOL, V235, P7791, DOI 10.1002/jcp.29427	35	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000827RR	http://dx.doi.org/10.1096/fj.202000827RR		NOV 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33164260				2022-12-28	WOS:000590785700001
J	Gerbier, R; Ndiaye-Lobry, D; de Morentin, PMB; Cecon, E; Heisler, LK; Delagrange, P; Gbahou, F; Jockers, R				Gerbier, Romain; Ndiaye-Lobry, Delphine; Martinez de Morentin, Pablo B.; Cecon, Erika; Heisler, Lora K.; Delagrange, Philippe; Gbahou, Florence; Jockers, Ralf			Pharmacological evidence for transactivation within melatonin MT2 and serotonin 5-HT2C receptor heteromers in mouse brain	FASEB JOURNAL			English	Article						cerebellum; GPCR heteromerization; hypothalamus; melatonin receptors; receptor transactivation; 5&#8208; HT2C	MOLECULAR CHARACTERIZATION; INTERNATIONAL UNION; PHASE ADVANCES; RAT-BRAIN; PROTEIN; LOCALIZATION; ACTIVATION; IDENTIFICATION; EXPRESSION; AGONIST	Association of G protein-coupled receptors into heterodimeric complexes has been reported for over 50 receptor pairs in vitro but functional in vivo validation remains a challenge. Our recent in vitro studies defined the functional fingerprint of heteromers composed of G(i)-coupled melatonin MT2 receptors and G(q)-coupled serotonin 5-HT2C receptors, in which melatonin transactivates phospholipase C (PLC) through 5-HT2C. Here, we identified this functional fingerprint in the mouse brain. G(q) protein activation was probed by [S-35]GTP gamma S incorporation followed by G(q) immunoprecipitation, and PLC activation by determining the inositol phosphate levels in brain lysates of animals previously treated with melatonin. Melatonin concentration-dependently activated G(q) proteins and PLC in the hypothalamus and cerebellum but not in cortex. These effects were inhibited by the 5-HT2C receptor-specific inverse agonist SB-243213, and were absent in MT2 and 5-HT2C knockout mice, fully recapitulating previous in vitro data and indicating the involvement of MT2/5-HT2C heteromers. The antidepressant agomelatine had a similar effect than melatonin when applied alone but blocked the melatonin-promoted G(q) activation due to its 5-HT2C antagonistic component. Collectively, we provide strong functional evidence for the existence of MT2/5-HT2C heteromeric complexes in mouse brain. These heteromers might participate in the in vivo effects of agomelatine.	[Gerbier, Romain; Ndiaye-Lobry, Delphine; Cecon, Erika; Gbahou, Florence; Jockers, Ralf] Univ Paris, CNRS, Inst Cochin, INSERM, 22 Rue Mechain, F-75014 Paris, France; [Martinez de Morentin, Pablo B.; Heisler, Lora K.] Univ Aberdeen, Rowett Inst, Aberdeen, Scotland; [Delagrange, Philippe] Inst Rech Servier, Croissy Sur Seine, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Aberdeen; Servier; Institut de Recherches Internationales Servier	Jockers, R (corresponding author), Univ Paris, CNRS, Inst Cochin, INSERM, 22 Rue Mechain, F-75014 Paris, France.	ralf.jockers@inserm.fr	de Morentin, Pablo B Martinez/K-5403-2014; Cecon, Erika/F-9842-2014; Jockers, Ralf/P-2272-2017; Cecon, Erika/B-3444-2016; Gbahou, Florence/L-4664-2017	de Morentin, Pablo B Martinez/0000-0002-0684-3215; Cecon, Erika/0000-0003-2387-9313; Jockers, Ralf/0000-0002-4354-1750; Cecon, Erika/0000-0003-2387-9313; Gerbier, Romain/0000-0003-4617-4850	Fondation Recherche Medicale (Equipe FRM2013) [DEQ 20130326503]; Fondation Recherche Medicale (Equipe FRM 2019) [EQU201903008055]; French National Research Agency (ANR) [ANR-19-CE16-0025-01]; Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2"; INSERM; CNRS; Who am I? laboratory of excellence - French Government through its "Investments for the Future" program [ANR-11-LABX- 0071, ANR-11-IDEX-0005-01]; La Ligue Contre le Cancer [RS19/75-127]; Biotechnology and Biological Sciences Research Council [BB/R01857X/1, BB/N017838/1]	Fondation Recherche Medicale (Equipe FRM2013); Fondation Recherche Medicale (Equipe FRM 2019); French National Research Agency (ANR)(French National Research Agency (ANR)); Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2"; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Who am I? laboratory of excellence - French Government through its "Investments for the Future" program; La Ligue Contre le Cancer(Ligue nationale contre le cancer); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to E. Trinquet (Cisbio) for advice in the in vivo IP1 protocol. This work was supported by grants from the Fondation Recherche Medicale (Equipe FRM2013, DEQ 20130326503 and Equipe FRM 2019, EQU201903008055 to RJ); The French National Research Agency (ANR) ANR-19-CE16-0025-01 (Mito-GPCR) to RJ, Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2"; INSERM; CNRS and the Who am I? laboratory of excellence ANR-11-LABX- 0071 funded by the French Government through its "Investments for the Future" program operated by the ANR under Grant ANR-11-IDEX-0005-01; La Ligue Contre le Cancer N/Ref: RS19/75-127 and the Biotechnology and Biological Sciences Research Council (BB/R01857X/1 and BB/N017838/1 to LKH).	Abramowski D, 1995, NEUROPHARMACOLOGY, V34, P1635, DOI 10.1016/0028-3908(95)00138-7; Al-Ghoul WM, 1998, NEUROREPORT, V9, P4063, DOI 10.1097/00001756-199812210-00011; Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Benleulmi-Chaachoua A, 2018, CELL MOL LIFE SCI, V75, P4357, DOI 10.1007/s00018-018-2876-y; Bromidge SM, 2000, J MED CHEM, V43, P1123, DOI 10.1021/jm990388c; Burke LK, 2016, MOL METAB, V5, P245, DOI 10.1016/j.molmet.2016.01.005; Cecon E, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12540; Cecon E, 2018, BRIT J PHARMACOL, V175, P3263, DOI 10.1111/bph.13950; de Bodinat C, 2010, NAT REV DRUG DISCOV, V9, P628, DOI 10.1038/nrd3140; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dubocovich ML, 2005, J PINEAL RES, V39, P113, DOI 10.1111/j.1600-079X.2005.00230.x; Dubocovich ML, 1998, FASEB J, V12, P1211, DOI 10.1096/fasebj.12.12.1211; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Franco DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106332; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Fujita W, 2014, BIOCHEM PHARMACOL, V92, P448, DOI 10.1016/j.bcp.2014.09.015; Gobbi G, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12544; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Gomes I, 2013, P NATL ACAD SCI USA, V110, P12072, DOI 10.1073/pnas.1222044110; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guardiola-Lemaitre B, 2014, BRIT J PHARMACOL, V171, P3604, DOI 10.1111/bph.12720; Guitart X, 2019, MOL NEUROBIOL, V56, P6756, DOI 10.1007/s12035-019-1564-8; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hunt AE, 2001, AM J PHYSIOL-CELL PH, V280, pC110, DOI 10.1152/ajpcell.2001.280.1.C110; Jiao S, 2004, J PINEAL RES, V36, P109, DOI 10.1046/j.1600-079X.2003.00104.x; Jockers R, 2016, BRIT J PHARMACOL, V173, P2702, DOI 10.1111/bph.13536; Johansson LC, 2019, NATURE, V569, P289, DOI 10.1038/s41586-019-1144-0; Kamal M, 2015, J BIOL CHEM, V290, P11537, DOI 10.1074/jbc.M114.559542; Karamitri A, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan6622; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Klosen P, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12575; Lacoste B, 2015, J PINEAL RES, V58, P397, DOI 10.1111/jpi.12224; LAUDON M, 1988, NEUROENDOCRINOLOGY, V48, P577, DOI 10.1159/000125066; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Liu LY, 2007, J NEUROCHEM, V102, P333, DOI 10.1111/j.1471-4159.2007.04669.x; Luo Y, 2017, MED SCI MONITOR, V23, P5951, DOI 10.12659/MSM.907592; Markus RP, 2003, J PHARMACOL EXP THER, V305, P525, DOI 10.1124/jpet.102.045625; Maroteaux L, 2017, PHARMACOL THERAPEUT, V170, P14, DOI 10.1016/j.pharmthera.2016.10.008; Martinez-Pinilla E, 2015, BIOCHEM PHARMACOL, V96, P131, DOI 10.1016/j.bcp.2015.05.006; Mazzucchelli C, 1996, MOL BRAIN RES, V39, P117, DOI 10.1016/0169-328X(96)00017-4; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; Millan MJ, 2011, INT J NEUROPSYCHOPH, V14, P768, DOI 10.1017/S1461145710001045; Moyer RW, 1999, NEUROSCI LETT, V271, P147, DOI 10.1016/S0304-3940(99)00536-4; Palacios JM, 2017, PSYCHOPHARMACOLOGY, V234, P1395, DOI 10.1007/s00213-017-4545-5; Peng Y, 2018, CELL, V172, P719, DOI 10.1016/j.cell.2018.01.001; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Racagni G, 2011, WORLD J BIOL PSYCHIA, V12, P574, DOI 10.3109/15622975.2011.595823; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Sleno R, 2019, NEUROPHARMACOLOGY, V152, P4, DOI 10.1016/j.neuropharm.2019.01.018; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Vischer HF, 2015, MOL PHARMACOL, V88, P561, DOI 10.1124/mol.115.099440; WEAVER DR, 1989, J NEUROSCI, V9, P2581; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022	58	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000305R	http://dx.doi.org/10.1096/fj.202000305R		NOV 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33156577				2022-12-28	WOS:000592447500001
J	Choe, MS; Kim, JS; Yeo, HC; Bae, CM; Han, HJ; Baek, K; Chang, W; Lim, KS; Yun, SP; Shin, IS; Lee, MY				Choe, Mu Seog; Kim, Joong Sun; Yeo, Han Cheol; Bae, Chang Min; Han, Ho Jae; Baek, Kyungmin; Chang, Woochul; Lim, Kyung Seob; Yun, Seung Pil; Shin, In-Sik; Lee, Min Young			A simple metastatic brain cancer model using human embryonic stem cell-derived cerebral organoids	FASEB JOURNAL			English	Article						brain metastasis; lung cancer; MBCCO model	EXTRACELLULAR-MATRIX; LUNG-CANCER; 3RD-DIMENSION; CULTURE; GAP	Every year, hundreds of thousands of people die because of metastatic brain cancer. Most metastatic cancer research uses 2D cell culture or animal models, but they have a few limitations, such as difficulty reproducing human tissue structures. This study developed a simple 3D in vitro model to better replicate brain metastasis using human cancer cells and human embryonic stem cell-derived cerebral organoids (metastatic brain cancer cerebral organoid [MBCCO]). The MBCCO model successfully reproduced metastatic cancer processes, including cell adhesion, proliferation, and migration, in addition to cell-cell interactions. Using the MBCCO model, we demonstrated that lung-specific X protein (LUNX) plays an important role in cell proliferation and migration or invasion. We also observed astrocyte accumulation around and their interaction with cancer cells through connexin 43 in the MBCCO model. We analyzed whether the MBCCO model can be used to screen drugs by measuring the effects of gefitinib, a well-known anticancer agent. We also examined the toxicity of gefitinib using normal cerebral organoids (COs). Therefore, the MBCCO model is a powerful tool for modeling human metastatic brain cancer in vitro and can also be used to screen drugs.	[Choe, Mu Seog; Yeo, Han Cheol; Bae, Chang Min; Lee, Min Young] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Vessel Organ Interact Res Ctr MRC, Daegu, South Korea; [Kim, Joong Sun] Korea Inst Oriental Med, K Herb Res Ctr, Daejeon, South Korea; [Han, Ho Jae] Seoul Natl Univ, Dept Vet Physiol, Coll Vet Med, Seoul, South Korea; [Baek, Kyungmin] Daegu Haany Univ, Dept Cardiovasc & Neurol Dis, Coll Oriental Med, Daegu, South Korea; [Chang, Woochul] Pusan Natl Univ, Dept Biol Educ, Coll Educ, Busan, South Korea; [Lim, Kyung Seob] Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Cheongju, South Korea; [Yun, Seung Pil] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju, South Korea; [Shin, In-Sik] Chonnam Natl Univ, Dept Vet Pharmacol, Coll Vet Med, BK21 Project Team, Gwangju, South Korea	Kyungpook National University; Korea Institute of Oriental Medicine (KIOM); Seoul National University (SNU); Daegu Haany University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Gyeongsang National University; Chonnam National University	Lee, MY (corresponding author), Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea.	vetmedic@knu.ac.kr		Chang, Woochul/0000-0001-7367-2586	National Research Foundation of Korea [2018R1D1A1A02044017, NRF-2020R1A5A2017323]	National Research Foundation of Korea(National Research Foundation of Korea)	National Research Foundation of Korea, Grant/Award Number: 2018R1D1A1A02044017 and NRF-2020R1A5A2017323	Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Fan YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25062; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Heiland DH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10493-6; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Laubli H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02120; Lee JS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55150-6; Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017; Lin CM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00307; Lin J, 2015, ONCOLOGY-NY, V29, P250; Linkous A, 2019, CELL REP, V26, P3203, DOI 10.1016/j.celrep.2019.02.063; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mancino M, 2011, BBA-REV CANCER, V1816, P105, DOI 10.1016/j.bbcan.2011.04.005; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; O'Brien ER, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00040; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Placone AL, 2016, TUMOR BIOL, V37, P61, DOI 10.1007/s13277-015-4242-0; Qian XY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166074; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rubenstein BM, 2008, BIOPHYS J, V95, P5661, DOI 10.1529/biophysj.108.140624; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Shi L, 2014, LUNG CANCER, V83, P231, DOI 10.1016/j.lungcan.2013.11.016; Sutcliffe M, 2019, METHODS MOL BIOL, V1576, P1, DOI 10.1007/7651_2017_2; Theis M, 2012, BRAIN RES, V1487, P88, DOI 10.1016/j.brainres.2012.06.045; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zheng XH, 2015, CANCER RES, V75, P1080, DOI 10.1158/0008-5472.CAN-14-1831	34	9	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16464	16475		10.1096/fj.202000372R	http://dx.doi.org/10.1096/fj.202000372R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33099835				2022-12-28	WOS:000583915500001
J	Itani, N; Skeffington, KL; Beck, C; Niu, YG; Katzilieris-Petras, G; Smith, N; Giussani, DA				Itani, Nozomi; Skeffington, Katie L.; Beck, Christian; Niu, Youguo; Katzilieris-Petras, Georgios; Smith, Nicola; Giussani, Dino A.			Protective effects of pravastatin on the embryonic cardiovascular system during hypoxic development	FASEB JOURNAL			English	Article						cardiovascular disease; fetus; hypoxia; statins	SARCOPLASMIC-RETICULUM CA2+-ATPASE; OXIDATIVE STRESS; GROWTH RESTRICTION; MELATONIN SUPPLEMENTATION; GENE-EXPRESSION; DOWN-REGULATION; FETAL HYPOXIA; RAT MODEL; PREECLAMPSIA; PREGNANCY	The use of statins in complicated pregnancy is being considered, as they protect endothelial function in the mother and placenta. However, whether statins affect cardiovascular function in the fetus is completely unknown. Here, we have determined the effects of pravastatin and underlying mechanisms on the cardiovascular system of the hypoxic chicken embryo, a model system that permits the direct effects of pravastatin on the developing offspring to be isolated independently of additional effects on the mother and/or placenta. Chicken embryos were incubated under normoxia or hypoxia (14% O-2) from day 1 +/- pravastatin (1 mg/kg/d) from day 13 of incubation (term is 21 days). On day 19 of incubation, hearts and vessels were isolated to determine changes in the cardiovascular structure and function. The data show that pravastatin protected the hypoxic chicken embryo against impaired cardiovascular dysfunction. Mechanisms involved in this protection included reduced oxidative stress, enhanced NO bioavailability, restored antioxidant defenses and normalized protein expression of RhoA in the embryonic heart, and improved NO-dependent vasodilator mechanisms in the peripheral circulation. Therefore, we show that the treatment of the chronically hypoxic chicken embryo with pravastatin from day 13 of incubation, equivalent toca. 25 weeks of gestation in human pregnancy, has direct beneficial effects on the embryonic cardiovascular system. Therefore, pravastatin may be a candidate for human clinical translation to rescue fetal cardiovascular dysfunction in risky pregnancy.	[Itani, Nozomi; Skeffington, Katie L.; Beck, Christian; Niu, Youguo; Katzilieris-Petras, Georgios; Smith, Nicola; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England	University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	dag26@cam.ac.uk	Skeffington, Katie/AAJ-8756-2021	Katzilieris-Petras, Georgios/0000-0002-3037-464X; Smith, Nicola/0000-0002-5137-1384	British Heart Foundation (BHF) [PG/10/99/28656]	British Heart Foundation (BHF)(British Heart Foundation)	British Heart Foundation (BHF), Grant/Award Number: PG/10/99/28656	Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; Ahmed A, 2011, THROMB RES, V127, pS72, DOI 10.1016/S0049-3848(11)70020-2; Altimiras J, 2000, AM J PHYSIOL-REG I, V278, pR980, DOI 10.1152/ajpregu.2000.278.4.R980; ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; Bauer AJ, 2013, HYPERTENSION, V61, P1103, DOI 10.1161/HYPERTENSIONAHA.111.00226; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bilardo CM, 2017, ULTRASOUND OBST GYN, V50, P285, DOI 10.1002/uog.18815; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bourque SL, 2012, PLACENTA, V33, P449, DOI 10.1016/j.placenta.2012.01.012; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Carver AR, 2014, INT J DEV NEUROSCI, V33, P33, DOI 10.1016/j.ijdevneu.2013.11.004; Cetin I, 2020, HYPERTENSION, V75, P748, DOI 10.1161/HYPERTENSIONAHA.119.13727; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Costantine M, 2016, AM J OBSTET GYNECOL, V214, pS201, DOI 10.1016/j.ajog.2015.10.399; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Danson EJ, 2009, J MOL CELL CARDIOL, V46, P482, DOI 10.1016/j.yjmcc.2008.12.013; Darby JRT, 2020, THERIOGENOLOGY, V150, P84, DOI 10.1016/j.theriogenology.2020.01.080; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Elahi MM, 2008, HYPERTENSION, V51, P939, DOI 10.1161/HYPERTENSIONAHA.107.100982; Esteve-Valverde E, 2018, OBSTET GYNECOL SURV, V73, P40, DOI 10.1097/OGX.0000000000000522; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 2016, J PHYSIOL-LONDON, V594, P1215, DOI 10.1113/JP271099; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Guioli S, 2014, SEX DEV, V8, P227, DOI 10.1159/000358406; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Holm ACBS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12182; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Itani N, 2018, J PHYSIOL-LONDON, V596, P2991, DOI 10.1113/JP274111; Itani N, 2017, J PHYSIOL-LONDON, V595, P1563, DOI 10.1113/JP273393; Itani N, 2016, J PINEAL RES, V60, P16, DOI 10.1111/jpi.12283; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Karalis DG, 2016, J CLIN LIPIDOL, V10, P1081, DOI 10.1016/j.jacl.2016.07.002; Kendall G, 2005, EARLY HUM DEV, V81, P27, DOI 10.1016/j.earlhumdev.2004.10.012; Kobayashi N, 2002, CARDIOVASC RES, V55, P757, DOI 10.1016/S0008-6363(02)00457-1; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Lemley CO, 2012, AM J PHYSIOL-REG I, V302, pR454, DOI 10.1152/ajpregu.00407.2011; Li FQ, 1997, AM J PHYSIOL-REG I, V273, pR518, DOI 10.1152/ajpregu.1997.273.2.R518; Lindgren I, 2013, AM J PHYSIOL-REG I, V305, pR1093, DOI 10.1152/ajpregu.00320.2013; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; McDonnold M, 2014, AM J OBSTET GYNECOL, V210, pS354, DOI 10.1016/j.ajog.2013.10.756; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Munch G, 1998, J MOL MED-JMM, V76, P434, DOI 10.1007/s001090050235; Nanovskaya TN, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.038; Nuzzo AM, 2018, AM J PATHOL, V188, P2704, DOI 10.1016/j.ajpath.2018.07.027; OKAMURA K, 1990, J PERINAT MED, V18, P441, DOI 10.1515/jpme.1990.18.6.441; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; PEDERSEN TR, 1994, LANCET, V344, P1383; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Phillips TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06300-1; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Ronkainen VP, 2011, J MOL CELL CARDIOL, V50, P1008, DOI 10.1016/j.yjmcc.2011.02.017; Shukla P, 2014, PLACENTA, V35, P461, DOI 10.1016/j.placenta.2014.04.007; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Sugishita Y, 2004, DEV BIOL, V273, P285, DOI 10.1016/j.ydbio.2004.05.036; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Thuc LC, 2010, APOPTOSIS, V15, P669, DOI 10.1007/s10495-010-0473-0; Tijsseling D, 2013, PEDIATR RES, V74, P639, DOI 10.1038/pr.2013.152; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Tong W, 2019, J DEV ORIG HLTH DIS, V10, P322, DOI 10.1017/S204017441900014X; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Umeji K, 2006, AM J PHYSIOL-HEART C, V291, pH2522, DOI 10.1152/ajpheart.01198.2005; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wyrwoll CS, 2016, P NATL ACAD SCI USA, V113, P6265, DOI 10.1073/pnas.1520356113; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhuang TF, 2014, NUTRIENTS, V6, P3968, DOI 10.3390/nu6093968	79	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16504	16515		10.1096/fj.202001743R	http://dx.doi.org/10.1096/fj.202001743R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33094855	Green Submitted, hybrid			2022-12-28	WOS:000583912400001
J	Valantine, HA				Valantine, Hannah A.			NIH's scientific approach to inclusive excellence	FASEB JOURNAL			English	Review						diversity; inclusion; scientific workforce	BIAS; SCIENCE; HEALTH; WOMEN	The representation of women and scientists from underrepresented groups (URGs), including Black/African Americans, Hispanic/Latinx, Pacific Islanders, and American Indians, diminishes as individuals advance in their careers from training to senior leadership positions. Correcting this imbalance requires integrated strategies to achieve inclusive excellence within the scientific workforce reflected by creating and sustaining environments, in which diverse talent thrives. The National Institutes of Health (NIH) Scientific Workforce Diversity office has led the charge to develop and implement evidence-informed interventions toward achieving this goal that undergirds NIH's mission to improve the nation's health. Past and current efforts aiming to enhance workforce diversity but targeted to individuals are necessary but insufficient for lasting change. Thus, NIH-funded institutions should develop and prioritize integrated, systems-targeted efforts as foundational components of a well-supported, productive workforce. At the heart of these endeavors is institutional accountability that ties progress toward inclusive excellence to institutional values and reward systems.	[Valantine, Hannah A.] NIH, Sci Workforce Divers, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Valantine, HA (corresponding author), NIH, Sci Workforce Divers, Bldg 10, Bethesda, MD 20892 USA.	hannah.valantine@nih.gov						[Anonymous], 2020, 120 M ADV COMM DIR J; Banchefsky S, 2016, SEX ROLES, V75, P95, DOI 10.1007/s11199-016-0586-1; Bian L, 2017, SCIENCE, V355, P389, DOI 10.1126/science.aah6524; Brawley OW, 2020, THE CANCER LETTER; Carnes M, 2015, ACAD MED, V90, P221, DOI 10.1097/ACM.0000000000000552; Carr PL, 2019, J GEN INTERN MED, V34, P356, DOI 10.1007/s11606-018-4547-y; Dzirasa K, 2020, CELL, V182, P263, DOI 10.1016/j.cell.2020.06.028; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Gibbs KD, 2016, ELIFE, V5, DOI 10.7554/eLife.21393; Girod S, 2016, ACAD MED, V91, P1143, DOI 10.1097/ACM.0000000000001099; Goclowska MA, 2013, THINK SKILLS CREAT, V8, P72, DOI 10.1016/j.tsc.2012.07.001; Graves J, 2020, SCIENTIST; Hechtman LA, 2018, P NATL ACAD SCI USA, V115, P7943, DOI 10.1073/pnas.1800615115; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Hurtado S, 2017, BMC P BIOMED CENTRAL, V11, P1; Jones CP, 2000, AM J PUBLIC HEALTH, V90, P1212, DOI 10.2105/AJPH.90.8.1212; Mervis J, 2020, SCIENCE, V367, P726, DOI 10.1126/science.367.6479.726; National Institutes of Health (NIH), NAT I HLTH NIH GEND; Nielsen MW, 2017, P NATL ACAD SCI USA, V114, P1740, DOI 10.1073/pnas.1700616114; NIH Workplace Climate and Harassment Survey Key Findings, 2019, 119 M ADV COMM DIR D; Plank-Bazinet JL, 2017, J WOMENS HEALTH, V26, P525, DOI 10.1089/jwh.2016.6012; Roper RL, 2019, MICROBIOL MOL BIOL R, V83, DOI 10.1128/MMBR.00018-19; Rosser SV, 2019, LANCET, V393, P604, DOI 10.1016/S0140-6736(18)33213-6; Sgoutas-Emch S., 2006, THOUGHT ACTION, V32, P91; Thorp HH, 2020, SCIENCE, V368, P1161, DOI 10.1126/science.abd1896; U.S. Medical School Faculty, US MED SCH FAC; Urban Universities for Health, 2015, FAC CLUST HIR DIV I; Valantine HA, 2015, P NATL ACAD SCI USA, V112, P12240, DOI 10.1073/pnas.1515612112; Williams DR, 2018, J HEALTH SOC BEHAV, V59, P466, DOI 10.1177/0022146518814251; Williams J. C., 2014, HARVARD BUSINESS REV; Winn RA, 2020, THE CANCER LETTER	31	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13085	13090		10.1096/fj.202001937	http://dx.doi.org/10.1096/fj.202001937			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	33373164	Bronze			2022-12-28	WOS:000576326700005
J	Liu, SY; Gao, Y; Zhang, LP; Yin, Y; Zhang, WZ				Liu, Shiying; Gao, Yuan; Zhang, Liping; Yin, Yue; Zhang, Weizhen			Rspo1/Rspo3-LGR4 signaling inhibits hepatic cholesterol synthesis through the AMPK alpha-SREBP2 pathway	FASEB JOURNAL			English	Article						AMPK; cholesterol; LGR4; liver; R-spondins	LGR4; AMPK; METABOLISM; ABLATION	R-spondins (Rspos) are endogenous ligands of leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4). Rspos-LGR4 signaling plays important roles in embryogenesis, gastrointestinal homeostasis, and food intake. Here, we investigated the impacts of Rspos-LGR4 on hepatic cholesterol synthesis. Rspo1/3 andLgr4knockdown mice were used to investigate the impacts of Rspo1/3-LGR4 on hepatic cholesterol synthesis. AMPK alpha agonist, antagonist, and shRNA were used to explore the downstream targets of Rspos-LGR4 signaling. In our study, we reported that LGR4, Rspo1, and Rspo3 were highly expressed in hepatocytes and their expressions were sensitive to energy states. Rspo1 and Rspo3 reversed OA-induced cholesterol synthesis, accompanying with increased the phosphorylation of AMPK alpha Thr172, reduced SREBP2 nuclear translocation, andSrebf2mRNA expression. Conversely, hepatic LGR4 knockdown increased hepatic cholesterol synthesis and decreased the phosphorylation of AMPK alpha both in vitro and in vivo. Activation or inhibition of AMPK alpha significantly abolished the effects of LGR4 deficiency or Rspos, respectively, on cholesterol synthesis. Knockdown of AMPK alpha 1 or/and AMPK alpha 2 repressed Rspos-induced inhibition on cholesterol synthesis. Our study indicates that Rspo1/Rspo3-LGR4 signaling in hepatocytes suppresses cholesterol synthesis via the AMPK alpha-SREBP2 pathway.	[Liu, Shiying; Gao, Yuan; Yin, Yue; Zhang, Weizhen] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Zhang, Liping; Zhang, Weizhen] Univ Michigan, Med Ctr, Ann Arbor, MI USA	Peking University; University of Michigan System; University of Michigan	Yin, Y; Zhang, WZ (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China.	yueyin@bjmu.edu.cn; weizhenzhang@bjmu.edu.cn			National Key R&D Program of China [2017YFC0908900]; National Natural Science Foundation of China [81730020, 81930015]; National Institutes of Health [1R01DK110273, R01DK112755]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Key R&D Program of China, Grant/Award Number: 2017YFC0908900; National Natural Science Foundation of China, Grant/Award Number: 81730020 and 81930015; National Institutes of Health, Grant/Award Number: 1R01DK110273 and R01DK112755	de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Dongiovanni P, 2015, J HEPATOL, V63, P705, DOI 10.1016/j.jhep.2015.05.006; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Li JY, 2014, ENDOCRINOLOGY, V155, P429, DOI 10.1210/en.2013-1550; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li ZR, 2019, AM J PHYSIOL-GASTR L, V316, pG123, DOI 10.1152/ajpgi.00056.2018; Li ZR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00131; Liu SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124951; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Natali F, 2007, J LIPID RES, V48, P1966, DOI 10.1194/jlr.M700051-JLR200; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Sun YK, 2015, BIOCHEM BIOPH RES CO, V464, P396, DOI 10.1016/j.bbrc.2015.06.066; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tang H, 2016, EBIOMEDICINE, V6, P139, DOI 10.1016/j.ebiom.2016.02.041; Wang F, 2014, J MOL ENDOCRINOL, V52, P133, DOI 10.1530/JME-13-0042; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x; Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036; Zou YY, 2017, OBESITY, V25, P252, DOI 10.1002/oby.21704	26	9	9	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14946	14959		10.1096/fj.202001234R	http://dx.doi.org/10.1096/fj.202001234R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32926477	Green Accepted, Green Published			2022-12-28	WOS:000570668600001
J	Huo, W; Li, Y; Zhang, Y; Li, H				Huo, Wei; Li, Yang; Zhang, Yun; Li, Hai			Mesenchymal stem cells-derived exosomal microRNA-21-5p downregulates PDCD4 and ameliorates erectile dysfunction in a rat model of diabetes mellitus	FASEB JOURNAL			English	Article						apoptosis; corpus cavernosum smooth muscle cells; diabetes mellitus; erectile dysfunction; exosomes; microRNA-21-5p; mesenchymal stem cells; PDCD4	PROLIFERATION; MIR-21-5P; INFLAMMATION; APOPTOSIS	Erectile dysfunction (ED) is a common comorbidity in males with diabetes mellitus (DM), whose pathogenesis might be induced by dysregulation of corpus cavernosum smooth muscle cells (CCSMCs). Gene Expression Omnibus repository-based analysis identified the differentially expressed PDCD4 in DM rats. PDCD4 has also been determined as a putative gene under the regulatory control of microRNA-21-5p (miR-21-5p). This study aimed to further determine the functional role of miR-21-5p in CCSMCs in a rat model of diabetes mellitus-induced erectile dysfunction (DMED). CCSMCs were isolated from penile cavernous tissue and cultured in high glucose (HG) medium. The expression of miR-21-5p and/or PDCD4 was altered in CCSMCs, as directly or indirectly measured by CCK-8 assay, flow cytometry, and TUNEL assays. Furthermore, exosomes were isolated from mesenchymal stem cells (MSCs) transfected with miR-21-5p mimic or miR-21-5p inhibitor and co-cultured with CCSMCs. DMED rats were injected with lentivirus carrying PDCD4/siRNA-PDCD4 plasmids, or exosomes from MSCs containing miR-21-5p-agomir to explore their roles in vivo. The experimental data validated that PDCD4 was upregulated in cavernous tissue of DMED rats. miR-21-5p targeted and inhibited PDCD4. miR-21-5p was enriched in MSC-exosomes. Moreover, PDCD4 downregulation, miR-21-5p elevation or MSC-derived exosomal miR-21-5p reduced apoptosis and enhanced proliferation of CCSMCs cultured in HG medium. PDCD4 silencing or miR-21-5p-containing MSC-exosomes improved erectile function and smooth muscle density in DMED rats. Collectively, our findings suggested that MSC-derived exosomal miR-21-5p suppressed PDCD4 expression and ED in rats with DM.	[Huo, Wei; Li, Yang; Zhang, Yun; Li, Hai] Jilin Univ, China Japan Union Hosp, Dept Urol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China	Jilin University	Li, H (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Urol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China.	lihai@jlu.edu.cn						Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Cellek S, 2013, INT J IMPOT RES, V25, P1, DOI 10.1038/ijir.2012.30; Chen FZ, 2017, J SEX MED, V14, P1084, DOI 10.1016/j.jsxm.2017.07.005; Cheng XF, 2018, J CELL MOL MED, V22, P261, DOI 10.1111/jcmm.13316; Fandel TM, 2012, EUR UROL, V61, P201, DOI 10.1016/j.eururo.2011.07.061; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Guo YB, 2018, MOL NEUROBIOL, V55, P2494, DOI 10.1007/s12035-017-0484-8; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Li XH, 2018, CHEM-BIOL INTERACT, V288, P76, DOI 10.1016/j.cbi.2018.04.021; LIU XJ, 2010, AM J PHYSIOL-CELL PH, V298; Liu Y, 2015, EXP LUNG RES, V41, P535, DOI 10.3109/01902148.2015.1090501; Matsuhashi S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092304; Matz EL, 2019, SEX MED REV, V7, P321, DOI 10.1016/j.sxmr.2017.12.008; McMahon CG, 2014, INTERN MED J, V44, P18, DOI 10.1111/imj.12325; Olivieri F, 2015, ONCOTARGET, V6, P35372, DOI 10.18632/oncotarget.6164; Ouyang X, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1003-1; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Sun YX, 2018, ACS NANO, V12, P7613, DOI 10.1021/acsnano.7b07643; Tao L, 2019, NEOPLASMA, V66, P746, DOI 10.4149/neo_2018_181207N930; Wang H, 2018, EUR J CELL BIOL, V97, P180, DOI 10.1016/j.ejcb.2018.02.001; Wang Q, 2013, DIABETES, V62, P4132, DOI 10.2337/db13-0097; Wei AY, 2012, INT J IMPOT RES, V24, P196, DOI 10.1038/ijir.2012.16; Yu WH, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0034-5; Zhang SP, 2018, BIOMATERIALS, V156, P16, DOI 10.1016/j.biomaterials.2017.11.028; Zhang X, 2018, EXP CELL RES, V362, P252, DOI 10.1016/j.yexcr.2017.11.025; ZHU LL, 2018, ANDROLOGIA, V50	31	17	16	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13345	13360		10.1096/fj.202000102RR	http://dx.doi.org/10.1096/fj.202000102RR		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32808325				2022-12-28	WOS:000562546000001
J	Pavlov, TS; Palygin, O; Isaeva, E; Levchenko, V; Khedr, S; Blass, G; Ilatovskaya, DV; Cowley, AW; Staruschenko, A				Pavlov, Tengis S.; Palygin, Oleg; Isaeva, Elena; Levchenko, Vladislav; Khedr, Sherif; Blass, Gregory; Ilatovskaya, Daria, V; Cowley, Allen W., Jr.; Staruschenko, Alexander			NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease	FASEB JOURNAL			English	Article						chronic kidney disease; diabetic nephropathy; ENaC; H2O2; NOX4; salt-sensitive hypertension	SALT-INDUCED HYPERTENSION; COLLECTING DUCT CELLS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NADPH OXIDASE; RENAL INJURY; PRESSURE NATRIURESIS; SODIUM DELIVERY; ROS PRODUCTION; NITRIC-OXIDE	NADPH oxidase 4 (NOX4) is the most abundant NOX isoform in the kidney; however, its importance for renal function has only recently emerged. The NOX4-dependent pathway regulates many factors essential for proper sodium handling in the distal nephron. However, the functional significance of this pathway in the control of sodium reabsorption during the initiation of chronic kidney disease is not established. The goal of this study was to test Nox4-dependent ENaC regulation in two models: SS hypertension and STZ-induced type 1 diabetes. First, we showed that genetic ablation ofNox4in Dahl salt-sensitive (SS) rat attenuated a high-salt (HS)-induced increase in epithelial Na(+)channel (ENaC) activity in the cortical collecting duct. We also found that H(2)O(2)upregulated ENaC activity, and H(2)O(2)production was reduced in both the renal cortex and medulla in SS(Nox4-/-)rats fed an HS diet. Second, in the streptozotocin model of hyperglycemia-induced renal injury ENaC activity in hyperglycemic animals was elevated in SS but not SS(Nox4-/-)rats. NaCl cotransporter (NCC) expression was increased compared to healthy controls, while expression values between SS and SS(Nox4-/-)groups were similar. These data emphasize a critical contribution of the NOX4-mediated pathway in maladaptive upregulation of ENaC-mediated sodium reabsorption in the distal nephron in the conditions of HS- and hyperglycemia-induced kidney injury.	[Pavlov, Tengis S.; Palygin, Oleg; Isaeva, Elena; Levchenko, Vladislav; Khedr, Sherif; Blass, Gregory; Ilatovskaya, Daria, V; Cowley, Allen W., Jr.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Pavlov, Tengis S.] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Detroit, MI USA; [Khedr, Sherif] Ain Shams Univ, Fac Med, Dept Physiol, Cairo, Egypt; [Staruschenko, Alexander] Clement J Zablocki VA Med Ctr, Milwaukee, WI USA; [Ilatovskaya, Daria, V] Med Univ South Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Blass, Gregory] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA	Medical College of Wisconsin; Henry Ford Health System; Henry Ford Hospital; Egyptian Knowledge Bank (EKB); Ain Shams University; Medical University of South Carolina; Western Kentucky University	Staruschenko, A (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	staruschenko@mcw.edu		Staruschenko, Alexander/0000-0002-5190-8356; Khedr, Sherif/0000-0001-5772-8199; Ilatovskaya, Daria/0000-0003-4832-4170; Palygin, Oleg/0000-0002-3680-5527; Isaeva, Elena/0000-0002-0587-6322	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [R35 HL135749, P01 HL116264, R01 HL122662, R00 HL116603]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R00 DK105160]; American Heart Association (AHA) [16EIA26720006, 17SDG33660149]; American Society of Nephrology (ASN); U.S. Department of Veterans Affairs (VA) [I01 BX004024]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American Heart Association (AHA)(American Heart Association); American Society of Nephrology (ASN); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R35 HL135749, P01 HL116264, R01 HL122662 and R00 HL116603; HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R00 DK105160; American Heart Association (AHA), Grant/Award Number: 16EIA26720006 and 17SDG33660149; American Society of Nephrology (ASN), Grant/Award Number: Carl W. Gottschalk Grant; U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01 BX004024	Abais-Battad JM, 2019, HYPERTENSION, V74, P854, DOI 10.1161/HYPERTENSIONAHA.119.12927; Abe M, 2006, AM J PHYSIOL-RENAL, V291, pF350, DOI 10.1152/ajprenal.00407.2005; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Bankir L, 2010, AM J PHYSIOL-RENAL, V299, pF917, DOI 10.1152/ajprenal.00413.2010; Bardoux P, 2003, NEPHROL DIAL TRANSPL, V18, P1755, DOI 10.1093/ndt/gfg277; Bardoux P, 1999, P NATL ACAD SCI USA, V96, P10397, DOI 10.1073/pnas.96.18.10397; Bell RC, 2000, BRIT J NUTR, V84, P575; Bouabout G, 2018, ARCH CARDIOVASC DIS, V111, P41, DOI 10.1016/j.acvd.2017.03.011; Conway BR, 2012, J AM SOC NEPHROL, V23, P405, DOI 10.1681/ASN.2011060577; Cowley AW, 2016, HYPERTENSION, V67, P440, DOI 10.1161/HYPERTENSIONAHA.115.06280; Cowley AW, 2015, AM J PHYSIOL-RENAL, V308, pF179, DOI 10.1152/ajprenal.00455.2014; Culshaw GJ, 2019, J PHYSIOL-LONDON, V597, P767, DOI 10.1113/JP277332; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Feraille E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087239; Furusho T, 2020, HYPERTENS RES, V43, P733, DOI 10.1038/s41440-020-0437-x; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Haque MZ, 2011, AM J PHYSIOL-RENAL, V300, pF1096, DOI 10.1152/ajprenal.00600.2010; Hills CE, 2006, CELL PHYSIOL BIOCHEM, V18, P337, DOI 10.1159/000097611; Ilatovskaya DV, 2018, J AM SOC NEPHROL, V29, P1917, DOI 10.1681/ASN.2018030280; Ilatovskaya DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17637; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V304, pC102, DOI 10.1152/ajpcell.00231.2012; Isaeva E, 2019, AM J PHYSIOL-RENAL, V317, pF1398, DOI 10.1152/ajprenal.00448.2019; Ishimoto Y, 2018, CLIN EXP PHARMACOL P, V45, P1097, DOI 10.1111/1440-1681.13018; Jha JC, 2018, CLIN SCI, V132, P1811, DOI 10.1042/CS20171459; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jin CH, 2009, HYPERTENSION, V53, P1048, DOI 10.1161/HYPERTENSIONAHA.109.128827; Kakizoe Y, 2009, J HYPERTENS, V27, P1679, DOI 10.1097/HJH.0b013e32832c7d23; Khedr S, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1329-7; Klein Janet D, 2009, J Epithel Biol Pharmacol, V2, P23; Kumar V, 2020, HYPERTENSION, V76, P133, DOI 10.1161/HYPERTENSIONAHA.120.15058; Lu XH, 2016, AM J PHYSIOL-RENAL, V310, pF1243, DOI 10.1152/ajprenal.00492.2015; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Markadieu N, 2005, AM J PHYSIOL-RENAL, V288, pF1201, DOI 10.1152/ajprenal.00383.2004; McPherson KC, 2019, AM J PHYSIOL-RENAL, V316, pF316, DOI 10.1152/ajprenal.00162.2018; McPherson KC, 2016, AM J PHYSIOL-RENAL, V311, pF793, DOI 10.1152/ajprenal.00590.2015; O'Connor PM, 2010, CURR HYPERTENS REP, V12, P86, DOI 10.1007/s11906-010-0094-6; Oh YK, 2007, J KOREAN MED SCI, V22, P1034, DOI 10.3346/jkms.2007.22.6.1034; Ohsaki Y, 2012, AM J PHYSIOL-RENAL, V302, pF95, DOI 10.1152/ajprenal.00469.2011; Palygin O, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006658; Palygin O, 2015, JOVE-J VIS EXP, DOI 10.3791/53059; Palygin O, 2013, AM J PHYSIOL-RENAL, V305, pF134, DOI 10.1152/ajprenal.00129.2013; Pavlov TS, 2017, AM J PHYSIOL-RENAL, V313, pF135, DOI 10.1152/ajprenal.00427.2016; Pavlov TS, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316653858; Pavlov TS, 2013, J AM SOC NEPHROL, V24, P1053, DOI 10.1681/ASN.2012080839; Polina I, 2020, AM J PHYSIOL-RENAL, V319, pF63, DOI 10.1152/ajprenal.00125.2020; Rajaram RD, 2019, NEPHROL DIAL TRANSPL, V34, P567, DOI 10.1093/ndt/gfy161; Ray EC, 2015, ADV CHRONIC KIDNEY D, V22, P179, DOI 10.1053/j.ackd.2014.11.006; Riazi S, 2006, KIDNEY INT, V69, P471, DOI 10.1038/sj.ki.5000140; Riazi S, 2006, AM J NEPHROL, V26, P245, DOI 10.1159/000093783; ROMAN RJ, 1991, AM J PHYSIOL, V261, pR595, DOI 10.1152/ajpregu.1991.261.3.R595; Ruiz-Ortega M, 2020, NAT REV NEPHROL, V16, P269, DOI 10.1038/s41581-019-0248-y; Schroder K, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101512; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Shi Q, 2020, MOL METAB, V36, DOI 10.1016/j.molmet.2020.02.011; Silva GB, 2006, HYPERTENSION, V48, P467, DOI 10.1161/01.HYP.0000236646.83354.51; Slaughter TN, 2013, AM J PHYSIOL-REG I, V305, pR727, DOI 10.1152/ajpregu.00382.2012; Song J, 2003, AM J PHYSIOL-RENAL, V285, pF1125, DOI 10.1152/ajprenal.00143.2003; Soodvilai S, 2007, AM J PHYSIOL-RENAL, V293, pF1571, DOI 10.1152/ajprenal.00132.2007; Spires D, 2019, CURR TOP MEMBR, V83, P353, DOI 10.1016/bs.ctm.2019.01.001; Spires D, 2018, AM J PHYSIOL-RENAL, V315, pF1091, DOI 10.1152/ajprenal.00155.2018; Spires D, 2018, AM J PHYSIOL-RENAL, V315, pF977, DOI 10.1152/ajprenal.00182.2018; Staruschenko A, 2017, HYPERTENSION, V69, P787, DOI 10.1161/HYPERTENSIONAHA.117.08671; Staruschenko A, 2013, AM J PHYSIOL-RENAL, V305, pF12, DOI 10.1152/ajprenal.00112.2013; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; Stockand JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00304; Tanaka M, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0964-5; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Thallas-Bonke V, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12192; Thallas-Bonke V, 2015, CURR OPIN NEPHROL HY, V24, P74, DOI 10.1097/MNH.0000000000000082; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Urner S, 2020, ANTIOXID REDOX SIGN, V33, P415, DOI 10.1089/ars.2020.8047; Van Vliet BN, 2006, J HYPERTENS, V24, P1599, DOI 10.1097/01.hjh.0000239296.25260.e0; Wang Z, 2017, HYPERTENSION, V69, P879, DOI 10.1161/HYPERTENSIONAHA.116.08560; Wyse B, 2002, AM J PHYSIOL-RENAL, V282, pF424, DOI 10.1152/ajprenal.0028.2001; Yang Q, 2018, FREE RADICAL BIO MED, V124, P466, DOI 10.1016/j.freeradbiomed.2018.06.042; Zheleznova NN, 2016, AM J PHYSIOL-RENAL, V311, pF450, DOI 10.1152/ajprenal.00187.2016; Zicha J, 2019, PHYSIOL RES, V68, P873, DOI 10.33549/physiolres.934334	79	11	11	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13396	13408		10.1096/fj.202000966RR	http://dx.doi.org/10.1096/fj.202000966RR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32799394	Green Accepted			2022-12-28	WOS:000562872300001
J	Liu, N; Sun, QQ; Xu, H; Yu, XJ; Chen, WT; Wei, HQ; Jiang, J; Xu, YZ; Lu, WJ				Liu, Ning; Sun, Qianqian; Xu, Hu; Yu, Xiaojuan; Chen, Wentong; Wei, Hongquan; Jiang, Jie; Xu, Youzhi; Lu, Wenjie			Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver	FASEB JOURNAL			English	Article						lipidomics; SREBP-1c; STAT3	SERUM URIC-ACID; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; BLOOD-PRESSURE; POTENTIAL-ROLE; RECEPTOR LXR; ER STRESS; KAPPA-B	Potential underlying molecular mechanisms for uric acid-induced lipid metabolic disturbances had not been elucidated clearly. This study investigated the effects and underlying mechanisms of uric acid on the development of lipid metabolic disorders. We collected blood samples from 100 healthy people and 100 patients with hyperuricemia for whom serum lipid analysis was performed. Meanwhile, a mouse model of hyperuricemia was generated, and lipidomics was performed on liver tissues, comparing control and hyperuricemia groups, to analyze lipid profiles and key metabolic enzymes. Uric acid directly induced serum lipid metabolic disorders in both humans and mice based on triglycerides, total cholesterol, and low-density lipoprotein cholesterol. Through lipidomic analysis, 46 lipids were differentially expressed in hyperuricemic mouse livers, and the phosphatidylcholine composition was altered, which was mediated by LPCAT3 upregulation. High-uric acid levels-induced p-STAT3 inhibition and SREBP-1c activation in vivo and in vitro. Moreover, LPCAT3-knockdown significantly attenuated uric acid-induced p-STAT3 inhibition, SREBP-1c activation, and lipid metabolic disorders in L02 cells. In conclusion, uric acid induces lipid metabolic disturbances through LPCAT3-mediated p-STAT3 inhibition and SREBP-1c activation. LPCAT3 could be a key regulatory factor linking hyperuricemia and lipid metabolic disorders. These results might provide novel insights into the clinical treatment of hyperuricemia.	[Liu, Ning; Sun, Qianqian; Xu, Hu; Yu, Xiaojuan; Chen, Wentong; Wei, Hongquan; Jiang, Jie; Xu, Youzhi; Lu, Wenjie] Anhui Med Univ, Basic Med Coll, 81 Mei Shan Rd, Hefei 230032, Peoples R China; [Jiang, Jie] Anhui Med Univ, Coll Pharm, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Xu, YZ; Lu, WJ (corresponding author), Anhui Med Univ, Basic Med Coll, 81 Mei Shan Rd, Hefei 230032, Peoples R China.	xuyouzhi@ahmu.edu.cn; wenjie63136@163.com		LIU, NING/0000-0003-2822-0577	National Natural Science Foundation of China (NSFC) [81700763, 81402947]; Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation) [1608085QH209]; China Postdoctoral Science Foundation [2015M581974]; Postdoctoral Science Foundation of Anhui Province [2017B162]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Anhui Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81700763 and 81402947; Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation), Grant/Award Number: 1608085QH209; China Postdoctoral Science Foundation, Grant/Award Number: 2015M581974; Postdoctoral Science Foundation of Anhui Province, Grant/Award Number: 2017B162	Bovenga F, 2015, CELL METAB, V21, P517, DOI 10.1016/j.cmet.2015.03.002; Chini LSN, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20176048, 10.1590/1414-431x20176048]; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Choi YJ, 2014, FASEB J, V28, P3197, DOI 10.1096/fj.13-247148; Cintra DEC, 2006, NUTRITION, V22, P197, DOI 10.1016/j.nut.2005.09.003; Civantos Modino Soralla, 2012, Endocrinol Nutr, V59, P533, DOI 10.1016/j.endonu.2012.06.010; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Drake TA, 2007, J LIPID RES, V48, P1, DOI 10.1194/jlr.R600027-JLR200; Gicquel T, 2015, FASEB J, V29, P4162, DOI 10.1096/fj.14-267393; Guo Shuyuan, 2018, Cardiovascular & Hematological Disorders - Drug Targets, V18, P27, DOI 10.2174/1871529X18666180302113713; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu W, 2018, PROG LIPID RES, V70, P17, DOI 10.1016/j.plipres.2018.04.002; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jurowski K, 2017, CRIT REV ANAL CHEM, V47, P418, DOI 10.1080/10408347.2017.1310613; Kinoshita Shinichi, 2008, Kobe J Med Sci, V54, pE200; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Liu XY, 2020, ENDOCRINE, V68, P71, DOI 10.1007/s12020-019-02176-5; Lu J, 2019, NAT REV RHEUMATOL, V15, P413, DOI 10.1038/s41584-019-0222-x; Lu WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12144; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Meikle PJ, 2014, PHARMACOL THERAPEUT, V143, P12, DOI 10.1016/j.pharmthera.2014.02.001; Mortada I, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0770-x; Peng T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/735056; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Puchades-Carrasco L, 2015, CURR OPIN BIOTECH, V35, P73, DOI 10.1016/j.copbio.2015.04.004; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rong X, 2017, J CLIN INVEST, V127, P3640, DOI 10.1172/JCI93616; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Stelmach MJ, 2015, IRISH J MED SCI, V184, P463, DOI 10.1007/s11845-014-1146-8; Thomas C, 2018, ATHEROSCLEROSIS, V275, P409, DOI 10.1016/j.atherosclerosis.2018.05.023; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vekic J, 2009, ATHEROSCLEROSIS, V203, P236, DOI 10.1016/j.atherosclerosis.2008.05.047; Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022; Wang B, 2019, ANNU REV PHYSIOL, V81, P165, DOI 10.1146/annurev-physiol-020518-114444; Wang B, 2018, NAT REV ENDOCRINOL, V14, P452, DOI 10.1038/s41574-018-0037-x; Wang B, 2018, CELL STEM CELL, V22, P206, DOI 10.1016/j.stem.2017.12.017; Wang M, 2016, BIOMED PHARMACOTHER, V83, P975, DOI 10.1016/j.biopha.2016.07.025; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang DM, 2012, FOOD CHEM, V134, P2184, DOI 10.1016/j.foodchem.2012.04.026; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	56	8	8	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13474	13493		10.1096/fj.202000950R	http://dx.doi.org/10.1096/fj.202000950R		AUG 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780898				2022-12-28	WOS:000558417500001
J	Marzolla, V; Feraco, A; Gorini, S; Mammi, C; Marrese, C; Mularoni, V; Boitani, C; Lombes, M; Kolkhof, P; Ciriolo, MR; Armani, A; Caprio, M				Marzolla, Vincenzo; Feraco, Alessandra; Gorini, Stefania; Mammi, Caterina; Marrese, Carmen; Mularoni, Valentina; Boitani, Carla; Lombes, Marc; Kolkhof, Peter; Ciriolo, Maria Rosa; Armani, Andrea; Caprio, Massimiliano			The novel non-steroidal MR antagonist finerenone improves metabolic parameters in high-fat diet-fed mice and activates brown adipose tissue via AMPK-ATGL pathway	FASEB JOURNAL			English	Article						aldosterone; adipocyte; metabolic syndrome; obesity	CHRONIC KIDNEY-DISEASE; MINERALOCORTICOID RECEPTOR ANTAGONIST; CHRONIC HEART-FAILURE; INSULIN-RESISTANCE; ADIPOCYTE DYSFUNCTION; UNCOUPLING PROTEIN-1; PLASMA-ALDOSTERONE; ACID OXIDATION; LIPOLYSIS; EXPRESSION	Mineralocorticoid receptor antagonists (MRAs) are recommended for the treatment of heart failure and hypertension, mainly due to their natriuretic and anti-fibrotic mode of action. Rodent studies have shown that MRAs can prevent adverse metabolic consequences of obesity but an elucidation of underlying molecular mechanisms is missing. Here, we investigated metabolic effects of the novel non-steroidal MRA finerenone (FIN) in a mouse model of high-fat diet (HFD)-induced obesity and the signaling pathways activated by MR antagonism at level of interscapular brown adipose tissue (iBAT). C57BL/6J male mice were fed a normal diet or a HFD (with60% kcal from fat) containing or not FIN for 3 months. Metabolic parameters, adipose tissue morphology, gene and protein expression analysis were assessed. We also used brown adipocyte cultures (T37i cells) to investigate the effects of FIN-mediated MR antagonism upon lipid and mitochondrial metabolism. HFD + FIN-treated mice showed improved glucose tolerance together with increased multilocularity and higher expression of thermogenic markers at the level of iBAT, without differences in white adipose depots, suggesting an iBAT-specific effect of FIN. Mechanistically, FIN increased activation of AMP-activated protein kinase which, in turn, stimulated adipose triglyceride lipase activation, with subsequent increased expression of uncoupling protein-1 in brown adipocytes.	[Marzolla, Vincenzo; Feraco, Alessandra; Gorini, Stefania; Mammi, Caterina; Marrese, Carmen; Armani, Andrea; Caprio, Massimiliano] IRCCS San Raffaele Pisana, Lab Cardiovasc Endocrinol, Rome, Italy; [Mularoni, Valentina; Boitani, Carla] Sapienza Univ Rome, Dept Anat Histol Forens & Orthoped Sci, Sect Histol & Med Embryol, Rome, Italy; [Lombes, Marc] Univ Paris Saclay, Univ Paris Sud, Fac Med Paris Sud, INSERM UMR S U1185, Orsay, France; [Kolkhof, Peter] Bayer AG, R&D Preclin Res Cardiovasc, Wuppertal, Germany; [Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Ciriolo, Maria Rosa] IRCCS San Raffaele Pisana, Rome, Italy; [Armani, Andrea; Caprio, Massimiliano] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy	IRCCS San Raffaele Pisana; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; University of Rome Tor Vergata; IRCCS San Raffaele Pisana	Caprio, M (corresponding author), IRCCS San Raffaele Pisana, San Raffaele Res Inst, Lab Cardiovasc Endocrinol, Via Val Cannuta 247, I-00166 Rome, Italy.	massimiliano.caprio@sanraffaele.it	Mularoni, Valentina/AAC-2947-2020; Caprio, Massimiliano/J-3020-2012; Marzolla, Vincenzo/AAB-2300-2019; Feraco, Alessandra/K-5920-2016; gorini, stefania/ABI-6853-2020	Caprio, Massimiliano/0000-0003-0722-7163; Marzolla, Vincenzo/0000-0002-2943-7631; Feraco, Alessandra/0000-0002-7074-0480; MULARONI, VALENTINA/0000-0002-9996-3725; mammi, caterina/0000-0002-2687-4422; Ciriolo, Maria Rosa/0000-0002-7863-9029	Ministry of Health, Italy \ Agenzia Italiana del Farmaco, Ministero della Salute (AIFA) [GR-2013-02357959]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2017A5TXC3]	Ministry of Health, Italy \ Agenzia Italiana del Farmaco, Ministero della Salute (AIFA); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	Ministry of Health, Italy vertical bar Agenzia Italiana del Farmaco, Ministero della Salute (AIFA), Grant/Award Number: GR-2013-02357959 and Ricerca Corrente; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: 2017A5TXC3	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Anders HJ, 2018, NAT REV NEPHROL, V14, P361, DOI 10.1038/s41581-018-0001-y; Anthony NM, 2009, OBESITY, V17, P1312, DOI 10.1038/oby.2008.645; Armani A, 2014, INT J OBESITY, V38, P1580, DOI 10.1038/ijo.2014.68; Armani A, 2019, DIABETES OBES METAB, V21, P2024, DOI 10.1111/dom.13756; Armani A, 2015, J MOL ENDOCRINOL, V55, pR1, DOI 10.1530/JME-15-0122; Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415; Arner P, 2018, CELL METAB, V28, P45, DOI 10.1016/j.cmet.2018.05.004; Bakris GL, 2015, JAMA-J AM MED ASSOC, V314, P884, DOI 10.1001/jama.2015.10081; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Bochud M, 2006, HYPERTENSION, V48, P239, DOI 10.1161/01.HYP.0000231338.41548.fc; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Celi FS, 2017, RES PERSPECT END INT, P1, DOI 10.1007/978-3-319-72790-5_1; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feraco A, 2020, TRENDS ENDOCRIN MET, V31, P205, DOI 10.1016/j.tem.2019.11.006; Filippatos G, 2016, EUR HEART J, V37, P2105, DOI 10.1093/eurheartj/ehw132; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Hankir MK, 2018, EMBO REP, V19, DOI 10.15252/embr.201846404; Hirata A, 2012, BIOCHEM BIOPH RES CO, V419, P182, DOI 10.1016/j.bbrc.2012.01.139; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kolkhof P, 2017, J ENDOCRINOL, V234, pT125, DOI 10.1530/JOE-16-0600; Kolkhof P, 2017, HANDB EXP PHARMACOL, V243, P271, DOI 10.1007/164_2016_76; Kolkhof P, 2015, CURR OPIN NEPHROL HY, V24, P417, DOI 10.1097/MNH.0000000000000147; Kovesdy CP, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1435; Kraus D, 2005, HORM METAB RES, V37, P455, DOI 10.1055/s-2005-870240; Kuhn E, 2019, ANN ENDOCRINOL-PARIS, V80, P1, DOI 10.1016/j.ando.2018.04.018; Lainscak M, 2015, INT J CARDIOL, V200, P25, DOI 10.1016/j.ijcard.2015.05.127; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu LCY, 2015, EXPERT OPIN INV DRUG, V24, P1123, DOI 10.1517/13543784.2015.1059819; Loutradis C, 2015, AM J NEPHROL, V42, P351, DOI 10.1159/000442393; Modica S, 2016, CELL REP, V16, P2243, DOI 10.1016/j.celrep.2016.07.048; Mottillo EP, 2016, CELL METAB, V24, P118, DOI 10.1016/j.cmet.2016.06.006; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Mummidi S, 2016, J MOL CELL CARDIOL, V98, P95, DOI 10.1016/j.yjmcc.2016.07.006; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P542, DOI 10.2215/CJN.04750908; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Penfornis P, 2000, AM J PHYSIOL-ENDOC M, V279, pE386, DOI 10.1152/ajpendo.2000.279.2.E386; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Rossi GP, 2008, J CLIN ENDOCR METAB, V93, P2566, DOI 10.1210/jc.2008-0251; Schweiger M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14859, 10.1038/ncomms15490]; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Thuzar M, 2019, DIABETES OBES METAB, V21, P509, DOI 10.1111/dom.13539; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Urbanet R, 2015, HYPERTENSION, V66, P149, DOI 10.1161/HYPERTENSIONAHA.114.04981; Viengchareun S, 2001, AM J PHYSIOL-ENDOC M, V280, pE640, DOI 10.1152/ajpendo.2001.280.4.E640; Wada T, 2017, J ENDOCRINOL, V235, P179, DOI 10.1530/JOE-17-0351; Wu CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113742; Wu LY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1706-y; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915	63	22	23	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12450	12465		10.1096/fj.202000164R	http://dx.doi.org/10.1096/fj.202000164R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729974				2022-12-28	WOS:000556800100001
J	Le Billan, F; Perrot, J; Carceller, E; Travers, S; Viengchareun, S; Kolkhof, P; Lombes, M; Fagart, J				Le Billan, Florian; Perrot, Julie; Carceller, Elena; Travers, Simon; Viengchareun, Say; Kolkhof, Peter; Lombes, Marc; Fagart, Jerome			Antagonistic effects of finerenone and spironolactone on the aldosterone-regulated transcriptome of human kidney cells	FASEB JOURNAL			English	Article						mineralocorticoid; nuclear receptor; RNA&#8208; sequencing; steroid hormone	EPITHELIAL SODIUM-CHANNEL; BASE-LINE CHARACTERISTICS; MINERALOCORTICOID RECEPTOR; HEART-FAILURE; BAY 94-8862; DISEASE; MODULATION; MECHANISMS; EXPRESSION; PROTECTS	Aldosterone, the main mineralocorticoid hormone in humans, plays a pivotal role in the control of water and salt reabsorption via activation of the mineralocorticoid receptor (MR). Alterations in MR signaling pathway lead to renal dysfunction, including chronic kidney disease and renal fibrosis, that can be prevented or treated with mineralocorticoid receptor antagonists (MRAs). Here, we used RNA-Sequencing to analyze effects of two MRAs, spironolactone and finerenone, on the aldosterone-induced transcriptome of a human renal cell line stably expressing the MR. Bioinformatics analysis of the data set reveals the identity of hundreds of genes induced or repressed by aldosterone. Their regulation is modulated in a time-dependent manner and, for the induced genes, depends on the aldosterone-driven direct binding of the MR onto its genomic targets that we have previously characterized. Although both MRAs block aldosterone-induced as well as aldosterone-repressed genes qualitatively similarly, finerenone has a quantitatively more efficient antagonism on some aldosterone-induced genes. Our data provide the first complete transcriptome for aldosterone on a human renal cell line and identifies pro-inflammatory markers (IL6, IL11, CCL7, and CXCL8) as aldosterone-repressed genes.	[Le Billan, Florian; Perrot, Julie; Carceller, Elena; Travers, Simon; Viengchareun, Say; Lombes, Marc; Fagart, Jerome] Univ Paris Saclay, INSERM, Physiol & Physiopathol Endocriniennes, Le Kremlin Bicetre, France; [Kolkhof, Peter] Bayer AG, Preclin Res Cardiovasc Pharmaceut Res & Dev, Wuppertal, Germany; [Le Billan, Florian] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Fagart, Jerome] Ecole Polytech, CNRS UMR 7654, Lab Biochim BIOC, Palaiseau, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; University of Toronto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Lombes, M; Fagart, J (corresponding author), Inserm U1185, Fac Med Paris Saclay, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.; Fagart, J (corresponding author), Ecole Polytech, CNRS UMR 7654, Lab Biochim BIOC, Palaiseau, France.	marc.lombes@u-psud.fr; jerome.fagart@inserm.fr	Fagart, Jerome/S-4581-2018; Viengchareun, Say/GOV-6812-2022	Fagart, Jerome/0000-0002-7965-0553; viengchareun, say/0000-0003-4280-3250; Le Billan, Florian/0000-0002-3400-9295				Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Amazit L, 2015, J BIOL CHEM, V290, P21876, DOI 10.1074/jbc.M115.657957; Amrouche L, 2017, J AM SOC NEPHROL, V28, P479, DOI 10.1681/ASN.2016010045; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Baker ME, 2017, J ENDOCRINOL, V234, pT1, DOI 10.1530/JOE-16-0661; Bakris GL, 2019, AM J NEPHROL, V50, P333, DOI 10.1159/000503713; Barrera-Chimal J, 2018, KIDNEY INT, V93, P1344, DOI 10.1016/j.kint.2017.12.016; Belden Z, 2017, AM J NEPHROL, V46, P298, DOI 10.1159/000480652; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Bonny O, 2013, NEPHROL DIAL TRANSPL, V28, P2421, DOI 10.1093/ndt/gft319; Corden B, 2020, BRIT J PHARMACOL, V177, P1695, DOI 10.1111/bph.15013; Cui SY, 2017, ENDOCRINOLOGY, V158, P1671, DOI 10.1210/en.2016-1781; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Ewels Philip, 2016, F1000Res, V5, P2824, DOI 10.12688/f1000research.10335.2; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Fraccarollo D, 2008, HYPERTENSION, V51, P905, DOI 10.1161/HYPERTENSIONAHA.107.100941; Gauer S, 2007, KIDNEY INT, V72, P1081, DOI 10.1038/sj.ki.5002473; Ge YN, 2019, MOL THER-NUCL ACIDS, V17, P741, DOI 10.1016/j.omtn.2019.07.007; Gong YY, 2018, MOL CELL ENDOCRINOL, V471, P22, DOI 10.1016/j.mce.2017.05.024; Gonzalez J, 2013, BIOCHEM BIOPH RES CO, V438, P257, DOI 10.1016/j.bbrc.2013.07.025; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Grune J, 2018, HYPERTENSION, V71, P599, DOI 10.1161/HYPERTENSIONAHA.117.10360; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Gumz ML, 2003, AM J PHYSIOL-RENAL, V285, pF664, DOI 10.1152/ajprenal.00353.2002; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolkhof P, 2017, J ENDOCRINOL, V234, pT125, DOI 10.1530/JOE-16-0600; Kolkhof P, 2014, J CARDIOVASC PHARM, V64, P69, DOI 10.1097/FJC.0000000000000091; Lattenist L, 2017, HYPERTENSION, V69, P870, DOI 10.1161/HYPERTENSIONAHA.116.08526; Le Billan F, 2018, FASEB J, V32, P5626, DOI 10.1096/fj.201800391RR; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; Liu SY, 2018, J DIABETES INVEST, V9, P1182, DOI 10.1111/jdi.12828; Magno AL, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7010019; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Miyata KN, 2020, TRANSL RES, V217, P1, DOI 10.1016/j.trsl.2019.11.001; Morgado-Pascual JL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/783538; Moritoh Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32072; Park EJ, 2018, AM J PHYSIOL-RENAL, V314, pF329, DOI 10.1152/ajprenal.00358.2017; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Poulsen SB, 2018, PHYSIOL GENOMICS, V50, P343, DOI 10.1152/physiolgenomics.00084.2017; Quinkler M, 2005, CIRCULATION, V112, P1435, DOI 10.1161/CIRCULATIONAHA.105.539122; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruilope LM, 2019, AM J NEPHROL, V50, P345, DOI 10.1159/000503712; Sheng JQ, 2019, J CELL PHYSIOL, V234, P3043, DOI 10.1002/jcp.27124; Shibata S, 2017, J ENDOCRINOL, V234, pT35, DOI 10.1530/JOE-16-0669; Shrestha A, 2019, ADV EXP MED BIOL, V1165, P325, DOI 10.1007/978-981-13-8871-2_15; Swanson EA, 2019, PHYSIOL GENOMICS, V51, P125, DOI 10.1152/physiolgenomics.00119.2018; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Wang Q, 2004, J STEROID BIOCHEM, V91, P197, DOI 10.1016/j.jsbmb.2004.04.007; Yamada Y, 2018, INT J MOL MED, V42, P2415, DOI 10.3892/ijmm.2018.3852; Yang FQ, 2014, INT J CLIN EXP PATHO, V7, P110; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zhao XP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24220-6; Zhao XP, 2014, DIABETOLOGIA, V57, P1986, DOI 10.1007/s00125-014-3297-6; Zhou YF, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0236-5; Zhu HQ, 2017, INT J BIOL SCI, V13, P1489, DOI 10.7150/ijbs.21637	59	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21314	10.1096/fj.202002043RR	http://dx.doi.org/10.1096/fj.202002043RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417258				2022-12-28	WOS:000647789600054
J	Zhou, YF; Bennett, TM; Shiels, A				Zhou, Yuefang; Bennett, Thomas M.; Shiels, Alan			Mutation of the TRPM3 cation channel underlies progressive cataract development and lens calcification associated with pro-fibrotic and immune cell responses	FASEB JOURNAL			English	Article						cataract; calcium; lens; myofibroblast; macrophage; TRP&#8208; channel	POTENTIAL MELASTATIN 3; IN-VIVO; MODEL; MEMBRANE; POLYMORPHISMS; ACTIVATION; EXPRESSION; MUTANT; LOCUS; MICE	Transient-receptor-potential cation channel, subfamily M, member 3 (TRPM3) serves as a polymodal calcium sensor in diverse mammalian cell-types. Mutation of the human TRPM3 gene (TRPM3) has been linked with inherited forms of early-onset cataract with or without other eye abnormalities. Here, we have characterized the ocular phenotypes of germline "knock-in" mice that harbor a human cataract-associated isoleucine-to-methionine mutation (p.I65M) in TRPM3 (Trpm3-mutant) compared with germline "knock-out" mice that functionally lack TRPM3 (Trpm3-null). Despite strong expression of Trpm3 in lens epithelial cells, neither heterozygous (Trpm3(+/-)) nor homozygous (Trpm3(-/-)) Trpm3-null mice developed cataract; however, the latter exhibited a mild impairment of lens growth. In contrast, homozygous Trpm3-M/M mutants developed severe, progressive, anterior pyramid-like cataract with microphthalmia, whereas heterozygous Trpm3-I/M and hemizygous Trpm3-M/- mutants developed anterior pyramidal cataract with delayed onset and progression-consistent with a semi-dominant lens phenotype. Histochemical staining revealed abnormal accumulation of calcium phosphate-like deposits and collagen fibrils in Trpm3-mutant lenses and immunoblotting detected increased alpha II-spectrin cleavage products consistent with calpain hyper-activation. Immunofluorescent confocal microscopy of Trpm3-M/M mutant lenses revealed fiber cell membrane degeneration that was accompanied by accumulation of alpha-smooth muscle actin positive (alpha-SMA+ve) myofibroblast-like cells and macrosialin positive (CD68+ve) macrophage-like cells. Collectively, our mouse model data support an ocular disease association for TRPM3 in humans and suggest that (1) Trpm3 deficiency impaired lens growth but not lens transparency and (2) Trpm3 dysfunction resulted in progressive lens degeneration and calcification coupled with pro-fibrotic (alpha-SMA+ve) and immune (CD68+ve) cell responses.	[Zhou, Yuefang; Bennett, Thomas M.; Shiels, Alan] Washington Univ, Ophthalmol & Visual Sci, Sch Med, Box 8096,660 S Euclid Ave, St Louis, MO 63110 USA	Washington University (WUSTL)	Shiels, A (corresponding author), Washington Univ, Ophthalmol & Visual Sci, Sch Med, Box 8096,660 S Euclid Ave, St Louis, MO 63110 USA.	shiels@wustl.edu		Zhou, Yuefang/0000-0002-8517-1292	NEI NIH HHS [P30 EY002687, R01 EY028899] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Agathe JMD, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.103942; Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Alonso-Carbajo L, 2019, J MOL CELL CARDIOL, V129, P219, DOI 10.1016/j.yjmcc.2019.03.003; Alkozi HA, 2015, EXP EYE RES, V136, P34, DOI 10.1016/j.exer.2015.04.019; Badheka D, 2015, J GEN PHYSIOL, V146, P65, DOI 10.1085/jgp.201411336; Belvisi MG, 2017, EUR RESPIR J, V50, DOI [10.1183/13993003.00579-2017, 10.1183/13993003.01357-2016]; Bennett TM, 2016, BIOCHEM BIOPH RES CO, V478, P988, DOI 10.1016/j.bbrc.2016.08.068; Bennett TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104000; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; Brown RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117615; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; de Iongh RU, 2005, CELLS TISSUES ORGANS, V179, P43, DOI 10.1159/000084508; De Maria A, 2009, J BIOL CHEM, V284, P13542, DOI 10.1074/jbc.M900561200; DeDreu J, 2020, FASEB J, V34, P9316, DOI 10.1096/fj.202000289R; Dyment DA, 2019, EUR J HUM GENET, V27, P1611, DOI 10.1038/s41431-019-0462-x; Eldred JA, 2011, PHILOS T R SOC B, V366, P1301, DOI 10.1098/rstb.2010.0341; Forrester JV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00338; Fruhwald J, 2012, J BIOL CHEM, V287, P36663, DOI 10.1074/jbc.M112.396663; Gao JY, 2015, BIOPHYS J, V109, P1830, DOI 10.1016/j.bpj.2015.09.018; Gerhart J, 2019, INVEST OPHTH VIS SCI, V60, P1813, DOI 10.1167/iovs.19-26713; Gerhart J, 2018, EXP EYE RES, V171, P101, DOI 10.1016/j.exer.2018.03.016; Grebert C, 2019, CELL CALCIUM, V81, P29, DOI 10.1016/j.ceca.2019.05.007; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Held Katharina, 2015, Temperature (Austin), V2, P201, DOI 10.4161/23328940.2014.988524; Held K, 2015, P NATL ACAD SCI USA, V112, pE1363, DOI 10.1073/pnas.1419845112; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Hwangbo Y, 2018, J CLIN ENDOCR METAB, V103, P4384, DOI 10.1210/jc.2017-02439; Inoue R, 2019, SEMIN CELL DEV BIOL, V94, P40, DOI 10.1016/j.semcdb.2018.11.002; Irie S, 2014, HANDB EXP PHARMACOL, V222, P387, DOI 10.1007/978-3-642-54215-2_15; Janssen LJ, 2015, AM J RESP CELL MOL, V53, P135, DOI 10.1165/rcmb.2014-0269TR; Jo AO, 2016, P NATL ACAD SCI USA, V113, P3885, DOI 10.1073/pnas.1515895113; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112; Kim J, 2018, P NATL ACAD SCI USA, V115, pE7212, DOI 10.1073/pnas.1800455115; Kulinski J, 2000, BIOTECHNIQUES, V29, P44, DOI 10.2144/00291bm07; Kuniba H, 2009, J HUM GENET, V54, P304, DOI 10.1038/jhg.2009.30; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; LeFur N, 1996, GENOMICS, V37, P245; Li JY, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0828-0; Logan CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16456-5; Mackay DS, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0019-6; Marshall-Gradisnik S, 2016, APPL CLIN GENET, V9, P39, DOI 10.2147/TACG.S99405; MCGEERUSSELL SM, 1958, J HISTOCHEM CYTOCHEM, V6, P22, DOI 10.1177/6.1.22; Mirnezami SA, 2013, J LASERS MED SCI, V4, P175; Nakamura Y, 2000, INVEST OPHTH VIS SCI, V41, P1460; Narayanankutty A, 2016, LUNG, V194, P273, DOI 10.1007/s00408-016-9852-9; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Oberwinkler J, 2014, HANDB EXP PHARMACOL, V222, P427, DOI 10.1007/978-3-642-54215-2_17; Oztuzcu S, 2015, IN VIVO, V29, P763; Pagnamenta AT, 2011, J NEURODEV DISORD, V3, P124, DOI 10.1007/s11689-011-9076-5; Park SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S13; Rigueur D, 2014, METHODS MOL BIOL, V1130, P113, DOI 10.1007/978-1-62703-989-5_9; Sakamoto-Mizutani K, 2002, EXP EYE RES, V75, P611, DOI 10.1006/exer.2002.2065; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Shiels A, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00258-4; Shirai K, 2018, DEV DYNAM, V247, P340, DOI 10.1002/dvdy.24518; Shu DY, 2017, PROG RETIN EYE RES, V60, P44, DOI 10.1016/j.preteyeres.2017.08.001; Simirskii VN, 2006, INVEST OPHTH VIS SCI, V47, P4931, DOI 10.1167/iovs.06-0423; Toth BI, 2015, J GEN PHYSIOL, V146, P51, DOI 10.1085/jgp.201411339; van den Berg MCW, 2019, CELL REP, V27, P2837, DOI 10.1016/j.celrep.2019.05.029; Van Hoeymissen E, 2020, ELIFE, V9, DOI 10.7554/eLife.57190; Vandewauw I, 2018, NATURE, V555, P662, DOI 10.1038/nature26137; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wormstone IM, 2009, EXP EYE RES, V88, P257, DOI 10.1016/j.exer.2008.10.016; Xiao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08362; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Zeitz C, 2015, PROG RETIN EYE RES, V45, P58, DOI 10.1016/j.preteyeres.2014.09.001; Zhao PY, 2015, INVEST OPHTH VIS SCI, V56, P1916, DOI 10.1167/iovs.14-15738; Zhao S, 2020, ELIFE, V9, DOI 10.7554/eLife.55634; Zhou YF, 2019, DIFFERENTIATION, V109, P16, DOI 10.1016/j.diff.2019.07.003; Zhou YF, 2016, BBA-MOL BASIS DIS, V1862, P1433, DOI 10.1016/j.bbadis.2016.05.003	74	8	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21288	10.1096/fj.202002037R	http://dx.doi.org/10.1096/fj.202002037R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484482	Green Accepted, Bronze			2022-12-28	WOS:000647789600069
J	Sun, R; Jang, JH; Lauzon, AM; Martin, JG				Sun, Rui; Jang, Joyce H.; Lauzon, Anne-Marie; Martin, James G.			Interferon-gamma amplifies airway smooth muscle-mediated CD4+T cell recruitment by promoting the secretion of C-X-C-motif chemokine receptor 3 ligands	FASEB JOURNAL			English	Article						airway smooth muscle; CXCL10; CXCL11; CXCR3; IFN&#8208; &#947; T cell chemotaxis	CD4(+) T-CELLS; IFN-GAMMA; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; ASTHMA; CXCR3; ALPHA; HYPERPLASIA; EXPRESSION; ENDOTYPES	Asthmatic airways feature increased ASM mass that is largely attributable to hyperplasia, and which potentially contributes to excessive airway narrowing. T cells induce ASMC proliferation via contact-dependent mechanisms in vitro that may have importance for asthmatic ASM growth, as CD4+ T cells infiltrate ASM bundles in asthmatic human airways. In this study, we used an in vitro migration assay to investigate the pathways responsible for the trafficking of human CD4+ T cells to ASM. ASMCs induced chemotaxis of activated CD4+ T cells, which was inhibited by the CXCR3 antagonist AMG487 and neutralizing antibodies against its ligands CXCL10 and 11, but not CCR3 or CCR5 antagonists. CXCR3 expression was upregulated among all T cells following anti-CD3/CD28-activation. CD4+ T cells upregulated CXCL9, 10, and 11 expression in ASMCs in an IFN-gamma/STAT1-dependent manner. Disruption of IFN-gamma-signaling resulted in reduced T cell migration, along with the inhibition of CD4+ T cell-mediated STAT1 activation and CXCR3 ligand secretion by ASMCs. ASMCs derived from healthy and asthmatic donors demonstrated similar T cell-recruiting capacities. In vivo CXCL10 and 11 expression by asthmatic ASM was confirmed by immunostaining. We conclude that the CXCL10/11-CXCR3 axis causes CD4+ T cell recruitment to ASM that is amplified by T cell-derived IFN-gamma.	[Sun, Rui; Jang, Joyce H.; Lauzon, Anne-Marie; Martin, James G.] McGill Univ, Ctr Hlth, Res Inst, Meakins Christie Labs, 1001 Blvd Decarie,Room EM3-2210, Montreal, PQ H4A 3J1, Canada	McGill University	Martin, JG (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Meakins Christie Labs, 1001 Blvd Decarie,Room EM3-2210, Montreal, PQ H4A 3J1, Canada.	james.martin@mcgill.ca		Martin, James/0000-0001-7574-5363				Al Heialy S, 2015, J IMMUNOL, V194, P5626, DOI 10.4049/jimmunol.1401718; Al Heialy S, 2013, AM J RESP CELL MOL, V49, P563, DOI 10.1165/rcmb.2012-0356OC; Begueret H, 2007, THORAX, V62, P8, DOI 10.1136/thx.2006.062141; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Berair R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-145; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Bochner BS, 2003, J ALLERGY CLIN IMMUN, V112, P930, DOI 10.1016/j.jaci.2003.08.012; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Cheong HS, 2005, BIOCHEM BIOPH RES CO, V334, P1219, DOI 10.1016/j.bbrc.2005.07.019; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Coyle AJ, 1996, J IMMUNOL, V156, P2680; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; Gregor CE, 2017, ADV IMMUNOL, V135, P119, DOI 10.1016/bs.ai.2017.03.001; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Koch M, 2006, AM J RESP CELL MOL, V35, P211, DOI 10.1165/rcmb.2005-0293OC; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Kumar RK, 2004, AM J RESP CRIT CARE, V170, P1043, DOI 10.1164/rccm.200405-681OC; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Lack G, 1996, J IMMUNOL, V157, P1432; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mahnke YD, 2013, CYTOM PART A, V83A, P439, DOI 10.1002/cyto.a.22269; Matheson JM, 2005, TOXICOL SCI, V84, P99, DOI 10.1093/toxsci/kfi051; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Ramos-Barbon D, 2005, J CLIN INVEST, V115, P1580, DOI 10.1172/JCI19711; Ramos-Barbon D, 2010, AM J RESP CRIT CARE, V182, P317, DOI 10.1164/rccm.200905-0745OC; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Suzaki Y, 2008, EUR RESPIR J, V31, P783, DOI 10.1183/09031936.00111507; Takaku Yotaro, 2016, Asthma Res Pract, V2, P6, DOI 10.1186/s40733-016-0021-y; Tan X, 2013, AM J PHYSIOL-LUNG C, V304, pL790, DOI 10.1152/ajplung.00356.2012; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Weigt H, 2005, AM J RESP CRIT CARE, V172, P566, DOI 10.1164/rccm.200411-1490OC; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573	49	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21228	10.1096/fj.202001480R	http://dx.doi.org/10.1096/fj.202001480R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337555				2022-12-28	WOS:000605626600034
J	Wang, YL; Wu, YQ; Chen, J; Guo, XR; Yan, L; Guo, YM; Wang, B; Yuan, JM				Wang, Youli; Wu, Yuqin; Chen, Jing; Guo, Xiaorui; Yan, Lei; Guo, Yuming; Wang, Bo; Yuan, Jianmin			The duration of food withdrawal affects the intestinal structure, nutrients absorption, and utilization in broiler chicken	FASEB JOURNAL			English	Article						&#946; &#8208; hydroxybutyrate; ether extract digestibility; food withdrawal; glutamate oxidation; intestinal morphology	TRUE METABOLIZABLE ENERGY; GROWTH-PERFORMANCE; ACID HOMEOSTASIS; FUEL METABOLISM; TRANSPORTER 1; URIC-ACID; DIGESTIBILITY; PROTEIN; STARVATION; CELLS	Food withdrawal is usually used for accurate feed metabolizable energy (ME) assessment in poultry, but its effects on intestinal structure and the absorption of nutrients are unclear. In this study, broilers were fed ad libitum (CT) or withdrew food for 12 (FH12), 24 (FH24), 36 (FH36), or 48 hours (FH48). We showed that food withdrawal increased the energy assimilation when compared with the CT. Food withdrawal improved the digestibility of ether extract and the level of lipid substances and fatty acid-derived beta-hydroxybutyrate in serum. Compared to the CT, food withdrawal did not influence the digestibility of starch. Due to 12 hours or longer food withdrawal duration increased glutamate oxidation and uric acid excretion, the analyzed digestibility of crude protein was underestimated, although the upregulated amino acid transporter genes. In addition, histological analysis showed that short-term food withdrawal (12 hours) increased intestinal villus height, crypt depth, and proliferative cell, whereas prolonged food withdrawal (more than 24 hours) impaired villus structure due to the decreased cell proliferation. Moreover, proteomics analysis revealed upregulated pathways in birds withdrawn food for 36 hours involved in nutrient absorption and amino acid oxidation. In conclusion, food withdrawal changes nutrient absorption and utilization, especially for amino acid and ether extract, and results in increased ME. Both glutamate oxidation and fatty acid incomplete oxidation are involved in energy supply after refeeding. In contrast to short-term food withdrawal, prolonged food withdrawal impairs the intestinal structure and villus renewal. Our findings deserve attention from nutritionists who are analyzing food digestibility.	[Wang, Youli; Wu, Yuqin; Chen, Jing; Guo, Xiaorui; Yan, Lei; Guo, Yuming; Wang, Bo; Yuan, Jianmin] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China; [Yan, Lei] Shandong New Hope Liuhe Grp Co Ltd, Qingdao, Peoples R China	China Agricultural University	Wang, B; Yuan, JM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	wangbo123@cau.edu.cn; yuanjm@cau.edu.cn	Wu, Yuqin/O-1316-2019; Yuan, Jianmin/AAD-6116-2020	Wu, Yuqin/0000-0002-1762-1896; wang, youli/0000-0003-0347-778X	National Natural Science Foundation of China [32072752, 31772620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	the National Natural Science Foundation of China, Grant/Award Number: 32072752 and 31772620	Abbasi J, 2018, JAMA-J AM MED ASSOC, V319, P215, DOI 10.1001/jama.2017.20639; ALTMANN GG, 1972, AM J ANAT, V133, P391, DOI 10.1002/aja.1001330403; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Bjornvad CR, 2004, J COMP PHYSIOL B, V174, P625, DOI 10.1007/s00360-004-0452-2; Broer S, 2017, BIOCHEM J, V474, P1935, DOI 10.1042/BCJ20160822; Burkholder KM, 2008, POULTRY SCI, V87, P1734, DOI 10.3382/ps.2008-00107; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cancedda FD, 2002, MOL CELL BIOCHEM, V239, P221, DOI 10.1023/A:1020548118241; Caruso G, 2014, FISH PHYSIOL BIOCHEM, V40, P1373, DOI 10.1007/s10695-014-9931-x; Dermadi D, 2017, CANCER RES, V77, P3352, DOI 10.1158/0008-5472.CAN-16-2860; Donsbough AL, 2010, POULTRY SCI, V89, P287, DOI 10.3382/ps.2009-00401; Gilani S, 2018, J ANIM PHYSIOL AN N, V102, pE653, DOI 10.1111/jpn.12808; HEVIA P, 1977, J NUTR, V107, P959, DOI 10.1093/jn/107.6.959; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Ito J, 2010, AM J PHYSIOL-GASTR L, V298, pG916, DOI 10.1152/ajpgi.00429.2009; Kadim IT, 1997, BRIT POULTRY SCI, V38, P285, DOI 10.1080/00071669708417988; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karunakaran S, 2011, J BIOL CHEM, V286, P31830, DOI 10.1074/jbc.M111.229518; Kerr BJ, 2015, J ANIM SCI, V93, P2183, DOI 10.2527/jas.2014-8633; KROGDAHL A, 1981, POULTRY SCI, V60, P2480, DOI 10.3382/ps.0602480; Krogdahl A, 2005, COMP BIOCHEM PHYS A, V141, P450, DOI 10.1016/j.cbpb.2005.06.002; Li YX, 2018, J PROTEOME RES, V17, P129, DOI 10.1021/acs.jproteome.7b00431; Li YX, 2018, J ANIM SCI, V96, P3804, DOI 10.1093/jas/sky237; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; LONGSTAFF M, 1986, BRIT POULTRY SCI, V27, P435, DOI 10.1080/00071668608416901; Madsen SL, 2011, POULTRY SCI, V90, P2295, DOI 10.3382/ps.2010-01173; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Mihaylova MM, 2018, CELL STEM CELL, V22, P769, DOI 10.1016/j.stem.2018.04.001; Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279; Morgan NK, 2014, ANIMAL, V8, P529, DOI 10.1017/S1751731114000068; Mountzouris KC, 2010, POULTRY SCI, V89, P58, DOI 10.3382/ps.2009-00308; Mustafa AF, 2017, POULTRY SCI, V96, P681, DOI 10.3382/ps/pew290; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Norton M, 2017, CURR OPIN PHARMACOL, V37, P16, DOI 10.1016/j.coph.2017.07.005; PALOU A, 1980, HORM METAB RES, V12, P505, DOI 10.1055/s-2007-999187; Pan XY, 2004, J NUTR, V134, P2211, DOI 10.1093/jn/134.9.2211; Peron A, 2005, BRIT POULTRY SCI, V46, P223, DOI 10.1080/00071660500066142; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Richmond CA, 2015, CELL REP, V13, P2403, DOI 10.1016/j.celrep.2015.11.035; SHIRES A, 1979, POULTRY SCI, V58, P602, DOI 10.3382/ps.0580602; Sibbald I.R., 1989, RECENT DEV POULTRY N, P12; SIBBALD IR, 1976, POULTRY SCI, V55, P303, DOI 10.3382/ps.0550303; SIBBALD IR, 1975, POULTRY SCI, V54, P1990, DOI 10.3382/ps.0541990; Siddiqi S, 2013, BBA-MOL CELL BIOL L, V1831, P1311, DOI 10.1016/j.bbalip.2013.05.001; Song JQ, 2009, JPEN-PARENTER ENTER, V33, P411, DOI 10.1177/0148607108325178; Spanier B, 2018, COMPR PHYSIOL, V8, P843, DOI 10.1002/cphy.c170038; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Thompson KL, 2006, POULTRY SCI, V85, P1535, DOI 10.1093/ps/85.9.1535; Tome D, 2018, ANN NUTR METAB, V73, P15, DOI 10.1159/000494777; Toney MD, 2014, ARCH BIOCHEM BIOPHYS, V544, P119, DOI 10.1016/j.abb.2013.10.002; van der Schoor SRD, 2002, GASTROENTEROLOGY, V123, P1931, DOI 10.1053/gast.2002.37062; Waheed AA, 1997, LIFE SCI, V61, P2425, DOI 10.1016/S0024-3205(97)00977-6; Wang TY, 2013, EUR J CLIN INVEST, V43, P1203, DOI 10.1111/eci.12161; Wu WC, 2020, FASEB J, V34, P4852, DOI 10.1096/fj.201901994R; Yamauchi K, 1996, BRIT POULTRY SCI, V37, P909, DOI 10.1080/00071669608417922; Zeng LQ, 2012, COMP BIOCHEM PHYS A, V162, P200, DOI 10.1016/j.cbpa.2012.02.022; Zhou M, 2018, INT J CANCER, V143, P921, DOI 10.1002/ijc.31374	58	1	1	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001773R	http://dx.doi.org/10.1096/fj.202001773R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33190300				2022-12-28	WOS:000592656600001
J	Paskevicius, T; Jung, J; Pujol, M; Eggleton, P; Qin, WY; Robinson, A; Gutowski, N; Holley, J; Smallwood, M; Newcombe, J; Zochodne, D; Chen, XZ; Tang, JF; Kraus, A; Michalak, M; Agellon, LB				Paskevicius, Tautvydas; Jung, Joanna; Pujol, Myriam; Eggleton, Paul; Qin, Wenying; Robinson, Alison; Gutowski, Nick; Holley, Janet; Smallwood, Miranda; Newcombe, Jia; Zochodne, Douglas; Chen, Xing-Zhen; Tang, Jingfeng; Kraus, Allison; Michalak, Marek; Agellon, Luis B.			The Fabp5/calnexin complex is a prerequisite for sensitization of mice to experimental autoimmune encephalomyelitis	FASEB JOURNAL			English	Article						blood brain barrier; calnexin; chaperone; fatty acid binding protein; multiple sclerosis	ACID-BINDING-PROTEIN; BLOOD-BRAIN-BARRIER; FLUORESCENCE COMPLEMENTATION BIFC; MULTIPLE-SCLEROSIS; QUALITY-CONTROL; CALNEXIN CONTROLS; DEFICIENT; FABP; ER; EXPRESSION	We previously showed that calnexin (Canx)-deficient mice are desensitized to experimental autoimmune encephalomyelitis (EAE) induction, a model that is frequently used to study inflammatory demyelinating diseases, due to increased resistance of the blood-brain barrier to immune cell transmigration. We also discovered that Fabp5, an abundant cytoplasmic lipid-binding protein found in brain endothelial cells, makes protein-protein contact with the cytoplasmic C-tail domain of Canx. Remarkably, both Canx-deficient and Fabp5-deficient mice commonly manifest resistance to EAE induction. Here, we evaluated the importance of Fabp5/Canx interactions on EAE pathogenesis and on the patency of a model blood-brain barrier to T-cell transcellular migration. The results demonstrate that formation of a complex comprised of Fabp5 and the C-tail domain of Canx dictates the permeability of the model blood-brain barrier to immune cells and is also a prerequisite for EAE pathogenesis.	[Paskevicius, Tautvydas; Jung, Joanna; Pujol, Myriam; Robinson, Alison; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Eggleton, Paul; Gutowski, Nick; Holley, Janet; Smallwood, Miranda] Univ Exeter, Dept Biomed & Clin Sci, Med Sch, Exeter, Devon, England; [Qin, Wenying; Chen, Xing-Zhen; Tang, Jingfeng; Michalak, Marek] Hubei Univ Technol, Natl Ctr Cellular Regulat & Mol Pharmaceut 111, Wuhan, Peoples R China; [Newcombe, Jia] UCL, UCL Queen Sq Inst Neurol, Dept Neuroinflammat, NeuroResource, London, England; [Zochodne, Douglas] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Kraus, Allison] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Agellon, Luis B.] McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada	University of Alberta; University of Exeter; Hubei University of Technology; University of London; University College London; University of Alberta; University of Alberta; Case Western Reserve University; McGill University	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.; Agellon, LB (corresponding author), McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	marek.michalak@ualberta.ca; luis.agellon@mcgill.ca	Pujol Moris, Myriam/AAC-9149-2022	Pujol Moris, Myriam/0000-0003-1833-3746; Tang, jingfeng/0000-0002-5524-4518; Newcombe, Jia/0000-0001-9609-7975	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [MOP-15291, MOP-15415, PS-153325, MOP-86750, PS 168843]; Multiple Sclerosis Society (MS Society) [207495]; Multiple Sclerosis Society of Canada (MSSOC)	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society (MS Society); Multiple Sclerosis Society of Canada (MSSOC)	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP-15291, MOP-15415, PS-153325, MOP-86750 and PS 168843; Multiple Sclerosis Society (MS Society), Grant/Award Number: 207495; Multiple Sclerosis Society of Canada (MSSOC)	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Agellon LB, 2017, ADV EXP MED BIOL, V981, P61, DOI 10.1007/978-3-319-55858-5_4; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; Balasa R, 2020, HUM IMMUNOL, V81, P237, DOI 10.1016/j.humimm.2020.02.009; Bjelobaba I, 2018, J NEUROSCI RES, V96, P1021, DOI 10.1002/jnr.24224; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Dudek E, 2015, BIOCHEM BIOPH RES CO, V468, P889, DOI 10.1016/j.bbrc.2015.11.052; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Glatigny S, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028977; Haile Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0788-z; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Hunegnaw R, 2016, ARTERIOSCL THROM VAS, V36, P1758, DOI 10.1161/ATVBAHA.116.307997; Jung J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98410; Jung J, 2017, BIOCHEM BIOPH RES CO, V493, P202, DOI 10.1016/j.bbrc.2017.09.046; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Lakkaraju AKK, 2013, MOL CELL, V51, P386, DOI 10.1016/j.molcel.2013.07.009; Lee D, 2015, J BIOL CHEM, V290, P5725, DOI 10.1074/jbc.M114.635474; Li B, 2009, J IMMUNOL, V182, P7625, DOI 10.4049/jimmunol.0804192; Li H. Y., 2011, PLOS ONE, V6; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; MADSEN P, 1992, J INVEST DERMATOL, V99, P299, DOI 10.1111/1523-1747.ep12616641; Masouye I, 1997, CIRC RES, V81, P297, DOI 10.1161/01.RES.81.3.297; Miller KE, 2015, J MOL BIOL, V427, P2039, DOI 10.1016/j.jmb.2015.03.005; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Myrum C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00294; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Owada Y, 2002, MOL CELL BIOCHEM, V239, P83, DOI 10.1023/A:1020524621933; Owada Y, 2002, J INVEST DERMATOL, V118, P430, DOI 10.1046/j.0022-202x.2001.01616.x; Owada Y, 2008, TOHOKU J EXP MED, V214, P213, DOI 10.1620/tjem.214.213; Pan YJ, 2016, J NEUROSCI, V36, P11755, DOI 10.1523/JNEUROSCI.1583-16.2016; Rao EY, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0091-2; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; 't Hart Bert A, 2019, Primate Biol, V6, P17, DOI 10.5194/pb-6-17-2019; WADA I, 1991, J BIOL CHEM, V266, P19599; Watanabe T, 2013, BIOL PHARM BULL, V36, P492, DOI 10.1248/bpb.b12-00915; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	53	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16662	16675		10.1096/fj.202001539RR	http://dx.doi.org/10.1096/fj.202001539RR		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124722	Bronze			2022-12-28	WOS:000589709600001
J	Zhang, Y; Zhang, ZY; Li, LW; Xu, KY; Ma, ZS; Chow, HM; Herrup, K; Li, JL				Zhang, Ying; Zhang, Zhongyu; Li, Lianwei; Xu, Kaiyu; Ma, Zhanshan; Chow, Hei-Man; Herrup, Karl; Li, Jiali			Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						5hmC; Alzheimer's disease; neurodegeneration; TET enzymes	GLOBAL DNA METHYLATION; A-BETA; 5-HYDROXYMETHYLCYTOSINE; HYDROXYMETHYLATION; EPIGENETICS; GENES; BRAIN; TET1; HIPPOCAMPUS; MECHANISMS	5-hydroxymethylcytosine (5hmC) is an intermediate stage of DNA de-methylation. Its location in the genome also serves as an important regulatory signal for many biological processes and its levels change significantly with the etiology of Alzheimer's disease (AD). In keeping with this relationship, the TET family of enzymes which convert 5-methylcytosine (5mC) to 5hmC are responsive to the presence of A beta. Using hMeDIP-seq, we show that there is a genome-wide reduction of 5hmC that is found in neurons but not in astrocytes from 3xTg mice (an AD mouse model). Decreased TET enzymatic activities in the brains of persons who died with AD suggest that this reduction is the main cause for the loss of 5hmC. Overexpression of human TET catalytic domains (hTETCDs) from the TET family members, especially for hTET3CD, significantly attenuates the neurodegenerative process, including reduced A beta accumulation as well as tau hyperphosphorylation, and improve synaptic dysfunction in 3xTg mouse brain. Our findings define a crucial role of deregulated 5hmC epigenetics in the events leading to AD neurodegeneration.	[Zhang, Ying; Xu, Kaiyu; Li, Jiali] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Zhang, Ying; Li, Lianwei; Xu, Kaiyu] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zhang, Zhongyu; Li, Jiali] Peking Univ, Natl Inst Drug Dependence, Beijing, Peoples R China; [Li, Lianwei; Chow, Hei-Man] Chinese Univ Hongkong, Sch Life Sci, Hong Kong, Peoples R China; [Ma, Zhanshan] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Herrup, Karl] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Li, Jiali] Peking Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Li, Jiali] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Chinese University of Hong Kong; Chinese Academy of Sciences; Kunming Institute of Zoology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; Chinese Academy of Sciences	Li, JL (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	jialili@bjmu.edu.cn	li, Jiali/HGF-2395-2022	li, Jiali/0000-0001-6202-7741	National Science Foundation of China [81471313]; Ministry of Science and Technology of China [2016YFC1305902]; Peking University [BMU2019YJ001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Peking University(Peking University)	The authors are grateful to Gongping Chen (Huazhong University of Science and Technology) for providing 3xTg mice. This work was financially supported by the National Science Foundation of China (81471313) to JL; the Ministry of Science and Technology of China (2016YFC1305902) to JL; and Peking University (BMU2019YJ001) to J	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Alagiakrishnan K, 2012, POSTGRAD MED J, V88, P522, DOI 10.1136/postgradmedj-2011-130363; Bakulski KM, 2012, CURR ALZHEIMER RES, V9, P563; Barbash S, 2012, CURR ALZHEIMER RES, V9, P425, DOI 10.2174/156720512800492512; Benito E, 2015, J CLIN INVEST, V125, P3572, DOI 10.1172/JCI79942; Bernstein AI, 2016, HUM MOL GENET, V25, P2437, DOI 10.1093/hmg/ddw109; Bihaqi SW, 2012, CURR ALZHEIMER RES, V9, P574; Bradley-Whitman MA, 2013, MECH AGEING DEV, V134, P486, DOI 10.1016/j.mad.2013.08.005; Cheng Y, 2018, CELL REP, V25, P3194, DOI 10.1016/j.celrep.2018.11.061; Chhatwal JP, 2018, BRAIN, V141, P1486, DOI 10.1093/brain/awy053; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Chouliaras L, 2012, CURR ALZHEIMER RES, V9, P536, DOI 10.2174/156720512800618035; Condliffe D, 2014, NEUROBIOL AGING, V35, P1850, DOI 10.1016/j.neurobiolaging.2014.02.002; Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031; Coppieters N, 2011, CURR PHARM DESIGN, V17, P3398, DOI 10.2174/138161211798072544; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Ellison EM, 2017, J MOL NEUROSCI, V63, P185, DOI 10.1007/s12031-017-0969-y; Feng J, 2015, NAT NEUROSCI, V18, P536, DOI 10.1038/nn.3976; Fetahu IS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2880; Gasparoni G, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0211-3; Gontier G, 2018, CELL REP, V22, P1974, DOI 10.1016/j.celrep.2018.02.001; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Haffner MC, 2011, ONCOTARGET, V2, P627; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang DW, 2015, BRAIN, V138, P3520, DOI 10.1093/brain/awv284; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Konsoula Z, 2012, J PHARMACOL TOX MET, V66, P215, DOI 10.1016/j.vascn.2012.08.001; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lashley T, 2015, NEUROPATH APPL NEURO, V41, P497, DOI 10.1111/nan.12183; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Li JL, 2009, CURR BIOL, V19, P2091, DOI 10.1016/j.cub.2009.10.039; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Maekawa M, 2007, CURR MED CHEM, V14, P2642, DOI 10.2174/092986707782023172; Malzkorn B, 2011, BRAIN PATHOL, V21, P619, DOI 10.1111/j.1750-3639.2011.00536.x; Marques SCF, 2011, PROG NEURO-PSYCHOPH, V35, P348, DOI 10.1016/j.pnpbp.2010.08.008; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Phipps AJ, 2016, NEUROBIOL AGING, V45, P30, DOI 10.1016/j.neurobiolaging.2016.05.003; Shu LQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2731-1; Sims R, 2020, NAT NEUROSCI, V23, P311, DOI 10.1038/s41593-020-0599-5; Smith AR, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0636-y; Sun ZX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11905-3; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; van den Hove DLA, 2012, CURR ALZHEIMER RES, V9, P545; Wang T, 2012, HUM MOL GENET, V21, P5500, DOI 10.1093/hmg/dds394; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao JY, 2017, ALZHEIMERS DEMENT, V13, P674, DOI 10.1016/j.jalz.2016.10.004	72	13	14	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16364	16382		10.1096/fj.202001271R	http://dx.doi.org/10.1096/fj.202001271R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058355				2022-12-28	WOS:000581159000001
J	Luo, J; Zhu, H; Chang, HM; Lin, YM; Yang, J; Leung, PCK				Luo, Jin; Zhu, Hua; Chang, Hsun-Ming; Lin, Yung-Ming; Yang, Jing; Leung, Peter C. K.			The regulation of IGFBP3 by BMP2 has a role in human endometrial remodeling	FASEB JOURNAL			English	Article						ALK3; BMP2; endometrium; IGFBP3; ID1; MMP2	FACTOR-BINDING PROTEIN-3; GROWTH-FACTOR SYSTEM; LOOP-HELIX PROTEINS; GENE-EXPRESSION; STROMAL CELLS; SIGNALING PATHWAY; RAT UTERUS; DECIDUALIZATION; MOUSE; ID3	In mammals, bone morphogenetic protein 2 (BMP2) is a critical regulator of endometrial decidualization and early implantation. Insulin-like growth factor-binding protein 3 (IGFBP3) is highly expressed in the endometrium and at the maternal-fetal interface in multiple species, including humans. BMP2-induced IGFBP3 signaling has been confirmed to have a role in trophoblast cell invasion; however, the involvement of this signaling pathway in endometrial remodeling remains poorly understood. To determine the roles of BMP2 in regulating IGFBP3 expression during the transformation of endometrial stromal cells, we employed immortalized human endometrial stromal cells (HESCs) and primary human decidual stromal cells (HDSCs) as study models. We showed that BMP2 significantly increased the expression of IGFBP3 in a dose- and time-dependent manner in both HESCs and primary HDSCs. Additionally, the BMP2-induced upregulation of IGFBP3 is mediated by the inhibitor of DNA-binding 1 (ID1), and knockdown of ALK3 completely abolished BMP2-induced upregulation of ID1. Moreover, BMP2 increased the expression of matrix metalloproteinases 2 (MMP2) and promoted cell migration in HESCs and primary HDSCs. Knockdown of either IGFBP3 or ID1 significantly suppressed the basal and the BMP2-induced increase in MMP2 expression as well as the cell migration in both cell models. These data demonstrated that BMP2 upregulated the expression of ID1, which in turn induced the expression of IGFBP3, and these BMP2-induced cell activities were most likely mediated by the ALK3 type I receptor. The increased expression of IGFBP3 promoted the MMP2 expression and cell migration in both HESCs and HDSCs. These findings deepen our understanding of a newly identified mechanism by which BMP2 and IGFBP3 regulate endometrial remodeling in humans, which provides insight into potential therapies for endometrium-related diseases and pregnancy-induced complications.	[Luo, Jin; Yang, Jing] Wuhan Univ, Reprod Med Ctr, Res Ctr Assisted Reprod Technol & Embryon Dev, Renmin Hosp,Hubei Clin, Wuhan, Peoples R China; [Luo, Jin; Zhu, Hua; Chang, Hsun-Ming; Lin, Yung-Ming; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp, Dept Obstet & Gynaecol, Res Inst, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada	Wuhan University; BC Childrens Hospital; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp, Dept Obstet & Gynaecol, Res Inst, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.; Yang, J (corresponding author), Wuhan Univ, Renmin Hosp, Reprod Med Ctr, JieFang Rd 238, Wuhan 430060, Peoples R China.	dryangqing@hotmail.com; peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	China Scholarship Council; Canadian Institutes of Health Research Foundation Scheme Grant [143317]; National Natural Science Foundation of China [81501306]	China Scholarship Council(China Scholarship Council); Canadian Institutes of Health Research Foundation Scheme Grant(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Jin Luo is the recipient of a scholarship from the China Scholarship Council. This work was supported by the Canadian Institutes of Health Research Foundation Scheme Grant (#143317) to PCKL and by the National Natural Science Foundation of China (Grant no. 81501306) to JL	Akoum A, 1999, FERTIL STERIL, V72, P1085, DOI 10.1016/S0015-0282(99)00443-4; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Bai L, 2017, ENDOCRINOLOGY, V158, P3501, DOI 10.1210/en.2017-00436; Brown SE, 2000, FERTIL STERIL, V74, P338, DOI 10.1016/S0015-0282(00)00596-3; Cerro JA, 1997, DEV BIOL, V184, P278, DOI 10.1006/dbio.1997.8533; Chang HM, 2017, HUM REPROD UPDATE, V23, P1, DOI 10.1093/humupd/dmw039; Chen JJ, 2017, PROG MOL BIOL TRANSL, V148, P87, DOI 10.1016/bs.pmbts.2017.04.001; DERYNCK R, 1994, TRENDS BIOCHEM SCI, V19, P548, DOI 10.1016/0968-0004(94)90059-0; Dunk C, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00160; Erickson GF, 2004, J ENDOCRINOL, V182, P203, DOI 10.1677/joe.0.1820203; Garrido-Gomez T, 2017, P NATL ACAD SCI USA, V114, pE8468, DOI 10.1073/pnas.1706546114; Gellersen B, 2010, HUM REPROD, V25, P862, DOI 10.1093/humrep/dep468; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Grzechocinska B, 2017, GINEKOL POL, V88, P337, DOI 10.5603/GP.a2017.0063; Han JY, 2006, MOL CELLS, V22, P168; Han J, 2018, THERIOGENOLOGY, V108, P46, DOI 10.1016/j.theriogenology.2017.11.029; Han VKM, 1996, J CLIN ENDOCR METAB, V81, P2680, DOI 10.1210/jcem.81.7.8675597; Hong SH, 2010, PLACENTA, V31, P240, DOI 10.1016/j.placenta.2009.11.015; Hong SH, 2004, J ENDOCRINOL, V181, P157, DOI 10.1677/joe.0.1810157; Huang CY, 2017, REPROD BIOL ENDOCRIN, V15, P1, DOI 10.1186/s12958-017-0243-8; IRWIN JC, 1991, ENDOCRINOLOGY, V129, P2385, DOI 10.1210/endo-129-5-2385; Jen Y, 1996, DEV DYNAM, V207, P235; Kubelac MP, 2014, ANTICANCER RES, V34, P413; Lai YM, 1996, HUM REPROD, V11, P1281; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mannaerts I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084071; Mody AA, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20472; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Okada H, 2018, REPROD MED BIOL, V17, P220, DOI 10.1002/rmb2.12088; Ozkan H, 1999, BIOL NEONATE, V76, P274, DOI 10.1159/000014169; PANSINI F, 1984, GYNECOL OBSTET INVES, V18, P174, DOI 10.1159/000299076; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Reynolds TS, 1997, ENDOCRINOLOGY, V138, P886, DOI 10.1210/en.138.3.886; Sahu MB, 2019, PREGNANCY HYPERTENS, V15, P64, DOI 10.1016/j.preghy.2018.11.003; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Doria PLS, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8704346; Stankic M, 2013, CELL REP, V5, P1228, DOI 10.1016/j.celrep.2013.11.014; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; TARANTINO S, 1992, ENDOCRINOLOGY, V130, P2354, DOI 10.1210/en.130.4.2354; Thota B, 2014, J NEUROSURG, V121, P374, DOI 10.3171/2014.4.JNS131198; Weimar CHE, 2013, HUM REPROD UPDATE, V19, P542, DOI 10.1093/humupd/dmt025; Xue WC, 2005, HISTOPATHOLOGY, V47, P303, DOI 10.1111/j.1365-2559.2005.02190.x; Yang J, 2008, CIRC RES, V102, P1212, DOI 10.1161/CIRCRESAHA.108.173567; Yen YC, 2015, ONCOTARGET, V6, P41837, DOI 10.18632/oncotarget.5995; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhang XH, 2013, REPROD SCI, V20, P354, DOI 10.1177/1933719112472738; Zhao HJ, 2020, FASEB J, V34, P3151, DOI 10.1096/fj.201902168RR; Zhao HJ, 2018, ENDOCRINOLOGY, V159, P2815, DOI 10.1210/en.2018-00301; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1; Zhao QS, 2011, DEV BIOL, V349, P53, DOI 10.1016/j.ydbio.2010.10.004; ZHOU J, 1994, J CLIN ENDOCR METAB, V79, P1723, DOI 10.1210/jc.79.6.1723; Zhu H, 2007, HUM REPROD, V22, P63, DOI 10.1093/humrep/del356	57	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15462	15479		10.1096/fj.202000508R	http://dx.doi.org/10.1096/fj.202000508R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32975335				2022-12-28	WOS:000574534600001
J	Zheng, HT; Zhang, HY; Chen, ST; Li, MY; Fu, T; Yang, ZM				Zheng, Hong-Tao; Zhang, Hai-Yi; Chen, Si-Ting; Li, Meng-Yuan; Fu, Tao; Yang, Zeng-Ming			The detrimental effects of stress-induced glucocorticoid exposure on mouse uterine receptivity and decidualization	FASEB JOURNAL			English	Article						collagen; corticosterone; decidualization; receptivity; stress	MESSENGER-RIBONUCLEIC-ACID; RESTRAINT STRESS; BLASTOCYST IMPLANTATION; EPITHELIAL TRANSITION; EMBRYO IMPLANTATION; PERINATAL-PERIOD; GENE-EXPRESSION; MATERNAL STRESS; EARLY-PREGNANCY; PRETERM BIRTH	Glucocorticoids (GCs), stress-induced steroid hormones, are released by adrenal cortex and essential for stress adaptation. Recently, there has been renewed interest in the relationship between GCs and pregnancy following the discovery that glucocorticoid receptor is necessary for implantation. It has been widely recognized that stress is detrimental to pregnancy. However, effects of stress-induced GC exposure on uterine receptivity and decidualization are still poorly understood. This study aims to explore the effects of GCs exposure on uterine receptivity, decidualization, and their underlying mechanisms in mice. Single prolonged stress (SPS) and corticosterone (Cort) injection models were used to analyze effects of GC exposure on early pregnancy, respectively. SPS or Cort injection inhibits embryo implantation by interfering Lif signaling and stimulating the uterine deposition of collagen types I, III, and IV on day 4 of pregnancy. Uterine decidualization is also attenuated by SPS or Cort injection through suppressing Cox-2 expression. Cort-induced collagen disorder also suppresses decidualization through regulating mesenchymal-epithelial transition. Our data should shed lights for a better understanding for the effects of GCs on embryo implantation for clinical research.	[Zheng, Hong-Tao; Zhang, Hai-Yi; Chen, Si-Ting; Li, Meng-Yuan; Fu, Tao; Yang, Zeng-Ming] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Peoples R China	South China Agricultural University	Yang, ZM (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Peoples R China.	zmyang@scau.edu.cn			National Key Research and Development Program of China [2018YFC1004403]; National Nature Science Foundation of China [31871511, 31671563]	National Key Research and Development Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1004403; National Nature Science Foundation of China, Grant/Award Number: 31871511 and 31671563	Adams NR, 2015, ADV ANAT EMBRYOL CEL, V216, P27, DOI 10.1007/978-3-319-15856-3_3; Adiguzel D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216814; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; BLANKENSHIP TN, 1995, ANAT REC, V243, P27, DOI 10.1002/ar.1092430105; Castro-Vale I, 2016, NEUROSCI BIOBEHAV R, V63, P143, DOI 10.1016/j.neubiorev.2016.02.005; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cook N, 2018, J AFFECT DISORDERS, V225, P18, DOI 10.1016/j.jad.2017.07.045; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Csemiczky G, 2000, ACTA OBSTET GYN SCAN, V79, P113, DOI 10.1034/j.1600-0412.2000.079002113.x; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Diao HL, 2011, BIOL REPROD, V84, P255, DOI 10.1095/biolreprod.110.086942; Du LL, 2017, HYPERTENS RES, V40, P67, DOI 10.1038/hr.2016.97; Endo Toshiaki, 2006, Reproductive Medicine and Biology, V5, P235, DOI 10.1111/j.1447-0578.2006.00147.x; FARRAR JD, 1992, BIOL REPROD, V46, P1095, DOI 10.1095/biolreprod46.6.1095; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; GRAHAM MF, 1995, GASTROENTEROLOGY, V109, P1454, DOI 10.1016/0016-5085(95)90630-4; Horejs CM, 2016, EUR J CELL BIOL, V95, P427, DOI 10.1016/j.ejcb.2016.06.002; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hurst PR, 1997, REPROD FERT DEVELOP, V9, P403, DOI 10.1071/R97003; Jamaluddin MFB, 2018, ENDOCRINOLOGY, V159, P1106, DOI 10.1210/en.2017-03018; JOHNSON DC, 1980, BIOL REPROD, V22, P1136, DOI 10.1093/biolreprod/22.5.1136; Kimura F, 2001, GYNECOL ENDOCRINOL, V15, P426, DOI 10.1080/713602980; Kondoh E, 2009, HUM REPROD, V24, P945, DOI 10.1093/humrep/den461; Laukova M, 2014, ENDOCRINOLOGY, V155, P3920, DOI 10.1210/en.2014-1192; Lee B, 2016, KOREAN J PHYSIOL PHA, V20, P357, DOI 10.4196/kjpp.2016.20.4.357; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Li QN, 2018, HUM REPROD, V33, P2285, DOI 10.1093/humrep/dey322; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Li SY, 2017, FEBS LETT, V591, P1394, DOI 10.1002/1873-3468.12645; Liang YX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18643-w; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Liu GH, 2014, STRESS, V17, P494, DOI 10.3109/10253890.2014.966263; Matsuo M, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqz005; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; Oefner CM, 2015, PLACENTA, V36, P59, DOI 10.1016/j.placenta.2014.10.012; OIKARINEN A, 1987, BIOCHEM J, V245, P235, DOI 10.1042/bj2450235; Pawar S, 2015, MOL ENDOCRINOL, V29, P1362, DOI 10.1210/me.2015-1142; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; POIANI GJ, 1994, AM J RESP CRIT CARE, V149, P994, DOI 10.1164/ajrccm.149.4.8143066; RABIN DS, 1990, BIOL REPROD, V42, P74, DOI 10.1095/biolreprod42.1.74; RAHIMA A, 1977, J REPROD FERTIL, V49, P161, DOI 10.1530/jrf.0.0490161; Rhen T, 2003, FASEB J, V17, P1849, DOI 10.1096/fj.02-1099com; Salleh N, 2014, SCI WORLD J, DOI 10.1155/2014/968141; Sandeep TC, 2001, TRENDS ENDOCRIN MET, V12, P446, DOI 10.1016/S1043-2760(01)00499-4; Shapiro GD, 2013, J PERINAT MED, V41, P631, DOI 10.1515/jpm-2012-0295; Silver RM, 2013, AM J EPIDEMIOL, V177, P228, DOI 10.1093/aje/kws384; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Spiess K, 2007, CONNECT TISSUE RES, V48, P99, DOI 10.1080/03008200601166194; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun JY, 2018, CELL CYCLE, V17, P1591, DOI 10.1080/15384101.2018.1471316; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Tan XW, 2017, HUM REPROD, V32, P1583, DOI 10.1093/humrep/dex217; Thiruchelvam U, 2016, J LEUKOCYTE BIOL, V99, P1165, DOI 10.1189/jlb.5A0215-061RR; Torche F, 2011, DEMOGRAPHY, V48, P1473, DOI 10.1007/s13524-011-0054-z; Tranguch S, 2005, CELL MOL LIFE SCI, V62, P1964, DOI 10.1007/s00018-005-5230-0; Tsartsara E, 2006, J PSYCHOSOM OBST GYN, V27, P173, DOI 10.1080/01674820600646198; Valsamakis G, 2019, PSYCHONEUROENDOCRINO, V100, P48, DOI 10.1016/j.psyneuen.2018.09.031; Vasquez YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007787; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Vignato J, 2017, J CLIN NURS, V26, P3859, DOI 10.1111/jocn.13800; Wang HT, 2009, INT J MOL MED, V24, P227, DOI 10.3892/ijmm_00000225; Wang TS, 2015, BIOL OPEN, V4, P893, DOI 10.1242/bio.011890; Wetendorf M, 2014, INT J DEV BIOL, V58, P95, DOI 10.1387/ijdb.140069mw; Whirledge S, 2017, TRENDS ENDOCRIN MET, V28, P399, DOI 10.1016/j.tem.2017.02.005; Whirledge SD, 2015, P NATL ACAD SCI USA, V112, P15166, DOI 10.1073/pnas.1508056112; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; WIEBOLD JL, 1986, J REPROD FERTIL, V78, P185, DOI 10.1530/jrf.0.0780185; Wu SP, 2018, TRENDS ENDOCRIN MET, V29, P481, DOI 10.1016/j.tem.2018.04.001; Zhang XH, 2013, REPROD SCI, V20, P354, DOI 10.1177/1933719112472738; Zhao LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080472; Zheng HT, 2020, J ENDOCRINOL, V244, P177, DOI 10.1530/JOE-19-0349; Zuo RJ, 2015, J BIOL CHEM, V290, P21280, DOI 10.1074/jbc.M115.656629	79	6	6	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14200	14216		10.1096/fj.201902911RR	http://dx.doi.org/10.1096/fj.201902911RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918762				2022-12-28	WOS:000570679100001
J	Koponen, A; Pan, GP; Kivela, AM; Ralko, A; Taskinen, JH; Arora, A; Kosonen, R; Kari, OK; Ndika, J; Ikonen, E; Cho, W; Yan, DG; Olkkonen, VM				Koponen, Annika; Pan, Guoping; Kivela, Annukka M.; Ralko, Arthur; Taskinen, Juuso H.; Arora, Amita; Kosonen, Riikka; Kari, Otto K.; Ndika, Joseph; Ikonen, Elina; Cho, Wonhwa; Yan, Daoguang; Olkkonen, Vesa M.			ORP2, a cholesterol transporter, regulates angiogenic signaling in endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; cholesterol trafficking; Osbpl2; VEGF receptor	OXYSTEROL-BINDING-PROTEIN; GROWTH-FACTOR; VE-CADHERIN; SUPPRESSES ANGIOGENESIS; MAMMALIAN TARGET; UP-REGULATION; LIPID RAFTS; MEMBRANE; RECEPTOR; TRAFFICKING	Oxysterol-binding protein-related protein 2 (ORP2), a cholesterol-PI(4,5)P(2)countercurrent transporter, was recently identified as a novel regulator of plasma membrane (PM) cholesterol and PI(4,5)P(2)content in HeLa cells. Here, we investigate the role of ORP2 in endothelial cell (EC) cholesterol and PI(4,5)P(2)distribution, angiogenic signaling, and angiogenesis. We show that ORP2 knock-down modifies the distribution of cholesterol accessible to a D4H probe, between late endosomes and the PM. Depletion of ORP2 from ECs inhibits their angiogenic tube formation capacity, alters the gene expression of angiogenic signaling pathways such as VEGFR2, Akt, mTOR, eNOS, and Notch, and reduces EC migration, proliferation, and cell viability. We show that ORP2 regulates the integrity of VEGFR2 at the PM in a cholesterol-dependent manner, the depletion of ORP2 resulting in proteolytic cleavage by matrix metalloproteinases, and reduced activity of VEGFR2 and its downstream signaling. We demonstrate that ORP2 depletion increases the PM PI(4,5)P(2)coincident with altered F-actin morphology, and reduces both VEGFR2 and cholesterol in buoyant raft membranes. Moreover, ORP2 knock-down suppresses the expression of the lipid raft-associated proteins VE-cadherin and caveolin-1. Analysis of the retinal microvasculature in ORP2 knock-out mice generated during this study demonstrates the subtle alterations of morphology characterized by reduced vessel length and increased density of tip cells and perpendicular sprouts. Gene expression changes in the retina suggest disturbance of sterol homeostasis, downregulation of VE-cadherin, and a putative disturbance of Notch signaling. Our data identifies ORP2 as a novel regulator of EC cholesterol and PI(4,5)P(2)homeostasis and cholesterol-dependent angiogenic signaling.	[Koponen, Annika; Kivela, Annukka M.; Taskinen, Juuso H.; Arora, Amita; Kosonen, Riikka; Ikonen, Elina; Olkkonen, Vesa M.] Minerva Fdn, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland; [Pan, Guoping; Yan, Daoguang] Jinan Univ, Dept Biol, Guangzhou, Peoples R China; [Ralko, Arthur; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL USA; [Kari, Otto K.] Univ Helsinki, Div Pharmaceut Biosci, Fac Pharm, Drug Res Program, Helsinki, Finland; [Ndika, Joseph] Univ Helsinki, Human Microbiome Res, Fac Med, Helsinki, Finland; [Ikonen, Elina; Olkkonen, Vesa M.] Univ Helsinki, Dept Anat, Fac Med, Helsinki, Finland	Jinan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Helsinki; University of Helsinki; University of Helsinki	Olkkonen, VM (corresponding author), Minerva Fdn, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland.	vesa.olkkonen@helsinki.fi	Ndika, Joseph/AAI-1074-2020	Ndika, Joseph/0000-0003-0669-1300; Taskinen, Juuso/0000-0002-4348-9550; Arora, Amita/0000-0001-8556-4072	Academy of Finland (Suomen Akatemia) [285223, 322647, 282192, 307415]; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; National Institutes of Health [R35GM122530]; NSFC, China [8170438, 91439122]; Leducq Foundation for Cardiovascular Research	Academy of Finland (Suomen Akatemia)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC, China(National Natural Science Foundation of China (NSFC)); Leducq Foundation for Cardiovascular Research(Leducq Foundation)	Academy of Finland (Suomen Akatemia), Grant/Award Number: 285223, 322647, 282192 and 307415; The Sigrid Juselius Foundation; The Magnus Ehrnrooth Foundation; The Finnish Foundation for Cardiovascular Research; The Emil Aaltonen Foundation; The Ida Montin Foundation; The National Institutes of Health, Grant/Award Number: R35GM122530; NSFC, China, Grant/Award Number: 8170438 and 91439122; The Leducq Foundation for Cardiovascular Research.	Abhinand CS, 2016, J CELL COMMUN SIGNAL, V10, P347, DOI 10.1007/s12079-016-0352-8; Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Basagiannis D, 2016, J BIOL CHEM, V291, P16892, DOI 10.1074/jbc.M116.730309; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Calay D, 2010, J INVEST DERMATOL, V130, P1136, DOI 10.1038/jid.2009.415; Calera MR, 2004, EXP CELL RES, V300, P248, DOI 10.1016/j.yexcr.2004.07.007; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Davies Elizabeth Michele, 2019, Advances in Biological Regulation, V71, P69, DOI 10.1016/j.jbior.2018.11.008; Endapally S, 2019, METHODS MOL BIOL, V1949, P153, DOI 10.1007/978-1-4939-9136-5_12; Escajadillo T, 2016, MOL CELL ENDOCRINOL, V427, P73, DOI 10.1016/j.mce.2016.03.006; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Head SA, 2017, ACS CHEM BIOL, V12, P174, DOI 10.1021/acschembio.6b00849; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hynynen R, 2005, BIOCHEM J, V390, P273, DOI 10.1042/BJ20042082; Ikonen E, 2018, CURR OPIN CELL BIOL, V53, P77, DOI 10.1016/j.ceb.2018.06.002; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Kentala H, 2018, CELL MOL LIFE SCI, V75, P4041, DOI 10.1007/s00018-018-2850-8; Kentala H, 2018, FASEB J, V32, P1281, DOI 10.1096/fj.201700604R; Kentala H, 2016, INT REV CEL MOL BIO, V321, P299, DOI 10.1016/bs.ircmb.2015.09.006; Koponen A, 2019, BIOCHIMIE, V158, P90, DOI 10.1016/j.biochi.2018.12.013; Lai CJ, 2017, FASEB J, V31, P5568, DOI 10.1096/fj.201700374R; Laitinen S, 2002, J LIPID RES, V43, P245; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu SL, 2018, MOL CELL, V71, P1092, DOI 10.1016/j.molcel.2018.07.035; Liu SL, 2014, ANGEW CHEM INT EDIT, V53, P14387, DOI 10.1002/anie.201408153; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyu JF, 2018, INT J BIOL SCI, V14, P1175, DOI 10.7150/ijbs.26011; Lyu JF, 2017, CANCER LETT, V409, P91, DOI 10.1016/j.canlet.2017.09.009; Mao RF, 2017, CIRC RES, V120, P1727, DOI 10.1161/CIRCRESAHA.116.309754; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mohamed A, 2019, NUCLEIC ACIDS RES, V47, pD459, DOI 10.1093/nar/gky948; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; Pan WJ, 2012, BLOOD, V120, P489, DOI 10.1182/blood-2012-02-408328; Potente M, 2017, ANNU REV PHYSIOL, V79, P43, DOI 10.1146/annurev-physiol-021115-105134; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Tran J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151556; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Weber-Boyvat M, 2015, CELL MOL LIFE SCI, V72, P1967, DOI 10.1007/s00018-014-1786-x; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yamamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7429; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]; Zarkada G, 2015, P NATL ACAD SCI USA, V112, P761, DOI 10.1073/pnas.1423278112; Zhang C, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111512; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6; Zhao KX, 2020, MOL BIOL CELL, V31, P793, DOI 10.1091/mbc.E19-12-0697; Zhu Laurence, 2015, Methodist Debakey Cardiovasc J, V11, P160, DOI 10.14797/mdcj-11-3-160	69	6	6	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14671	14694		10.1096/fj.202000202R	http://dx.doi.org/10.1096/fj.202000202R		SEP 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32914503				2022-12-28	WOS:000570302100001
J	Pan, Z; Yang, K; Wang, HB; Xiao, YS; Zhang, M; Yu, X; Xu, T; Bai, T; Zhu, HC				Pan, Zhou; Yang, Kang; Wang, Huibo; Xiao, Yusha; Zhang, Ming; Yu, Xi; Xu, Tao; Bai, Tao; Zhu, Hengcheng			MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-kappa B and TGF-beta/Smad signaling pathways	FASEB JOURNAL			English	Article						inflammation; MFAP4; NF-kappa B pathway; renal fibrosis; TGF-beta; Smad	GROWTH-FACTOR-BETA; PROTEIN 4 MFAP4; IN-VIVO; INFLAMMATION; MECHANISMS; EXPRESSION; GENE	Renal fibrosis, which is characterized by excessive extracellular matrix (ECM) accumulation in the renal tubulointerstitium, can lead to chronic kidney disease (CKD). The role of microfiber-associated protein 4 (MFAP4), which is an ECM protein that interacts with elastin and collagen, in renal fibrosis has not been investigated. The aim of this study was to examine the role of MFAP4 in the pathogenesis of renal fibrosis and the underlying mechanism using in vivo and in vitro models. The MFAP4(-/-)mice were subjected to unilateral ureteral obstruction (UUO) to elucidate the role of MFAP4 in renal fibrosis in vivo. Compared to the wild-type mice, the MFAP4(-/-)mice exhibited decreased protein expression of p-p65 and p-IKB alpha and ECM deposition after UUO. The MFAP4(-/-)mice exhibited attenuated nuclear translocation of p65 (the hub subunit of nuclear factor (NF)-kappa B signaling pathway), suppressed activation of transforming growth factor (TGF)-beta/Smad pathways, and downregulated expression of fibronectin, collagen I, and plasminogen activator inhibitor-1. The knockdown of MFAP4 mitigated the TGF-beta-induced upregulated expression of fibronectin, collagen I, and plasminogen activator inhibitor-1 in the human proximal tubular epithelial cells (HK-2). Compared to the HK-2 cells transfected with sh-MFAP4, the HK-2 cells co-transfected with sh-MFAP4 and Ad-MFAP4 exhibited severe inflammatory response and increased fibrosis-related proteins expression. Mechanistically, the knockdown of MFAP4 inhibited the activation of NF-kappa B and TGF-beta/Smad signaling pathways and downregulated the expression of fibrosis-related proteins. The findings of this study indicate that MFAP4 is involved in UUO-induced renal fibrosis through regulation of NF-kappa B and TGF-beta/Smad pathways.	[Pan, Zhou; Yang, Kang; Yu, Xi; Xu, Tao; Bai, Tao; Zhu, Hengcheng] Wuhan Univ, Renmin Hosp, Dept Urol, 238 Jie Fang Ave, Wuhan 430060, Hubei, Peoples R China; [Wang, Huibo] Three Gorges Univ Peoples Hosp, Peoples Hosp Yichang 1, Dept Cardiol, Yichang, Peoples R China; [Xiao, Yusha] Wuhan Univ, Zhongnan Hosp, Res Ctr Digest Dis, Dept Gen Surg, Wuhan, Peoples R China; [Zhang, Ming] Wuhan Univ Sci & Technol, Puren Hosp, Dept Orthoped Trauma, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University of Science & Technology	Zhu, HC (corresponding author), Wuhan Univ, Renmin Hosp, Dept Urol, 238 Jie Fang Ave, Wuhan 430060, Hubei, Peoples R China.	zhcheng2018@outlook.com						Bracht T, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0952-3; Chou DHI, 1996, J IMMUNOL, V156, P4354; Christensen AF, 2019, APMIS, V127, P588, DOI 10.1111/apm.12974; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF92, DOI 10.1152/ajprenal.00184.2006; Guo W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153434; Holm AT, 2015, AM J PHYSIOL-LUNG C, V308, pL1114, DOI 10.1152/ajplung.00351.2014; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Liu B, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0760-6; Liu P, 2014, DIABETES RES CLIN PR, V105, P206, DOI 10.1016/j.diabres.2014.04.020; Lu QL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10116-0; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Melenovsky V, 2018, KIDNEY BLOOD PRESS R, V43, P1437, DOI 10.1159/000493657; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Molleken C, 2009, HEPATOLOGY, V49, P1257, DOI 10.1002/hep.22764; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Pilecki B, 2016, J BIOL CHEM, V291, P1103, DOI 10.1074/jbc.M115.681775; Pilecki B, 2015, THORAX, V70, P862, DOI 10.1136/thoraxjnl-2014-206609; Schlosser A, 2016, ARTERIOSCL THROM VAS, V36, P122, DOI 10.1161/ATVBAHA.115.306672; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Toyoshima T, 1999, J HISTOCHEM CYTOCHEM, V47, P1049, DOI 10.1177/002215549904700809; Toyoshima T, 2008, CELL TISSUE RES, V332, P271, DOI 10.1007/s00441-008-0587-7; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Wulf-Johansson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082243; Yamaguchi Junna, 2015, F1000Res, V4, DOI 10.12688/f1000research.6970.1; Yang K, 2020, J CELL MOL MED, V24, P5740, DOI 10.1111/jcmm.15236; Zhang M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.206; Zhang XL, 2019, ARCH MED SCI, V15, P632, DOI 10.5114/aoms.2018.74953; Zhou XJ, 2017, INT IMMUNOPHARMACOL, V42, P18, DOI 10.1016/j.intimp.2016.11.006	38	13	13	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14250	14263		10.1096/fj.202001026R	http://dx.doi.org/10.1096/fj.202001026R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32905637	hybrid			2022-12-28	WOS:000568306000001
J	Jha, R; Li, D; Wu, QL; Ferguson, KE; Forghani, P; Gibson, GC; Xu, CH				Jha, Rajneesh; Li, Dong; Wu, Qingling; Ferguson, Katherine E.; Forghani, Parvin; Gibson, Gregory C.; Xu, Chunhui			A long non-coding RNAGATA6-AS1adjacent toGATA6is required for cardiomyocyte differentiation from human pluripotent stem cells	FASEB JOURNAL			English	Article						cardiomyocyte; differentiation; hiPSC; hPSC; lncRNA; RNA-seq	GATA TRANSCRIPTION FACTORS; GENE-EXPRESSION; RNAS; HEART; DISCOVERY; LNCRNAS	Long noncoding RNAs (lncRNAs) are crucial in many cellular processes, yet relatively few have been shown to regulate human cardiomyocyte differentiation. Here, we demonstrate an essential role of GATA6 antisense RNA 1 (GATA6-AS1)in cardiomyocyte differentiation from human pluripotent stem cells (hPSCs).GATA6-AS1is adjacent to cardiac transcription factorGATA6. We found thatGATA6-AS1was nuclear-localized and transiently upregulated along withGATA6during the early stage of cardiomyocyte differentiation. The knockdown ofGATA6-AS1did not affect undifferentiated cell pluripotency but inhibited cardiomyocyte differentiation, as indicated by no or few beating cardiomyocytes and reduced expression of cardiomyocyte-specific proteins. Upon cardiac induction, the knockdown ofGATA6-AS1decreasedGATA6expression, altered Wnt-signaling gene expression, and reduced mesoderm development. Further characterization of the intergenic region between genomic regions ofGATA6-AS1andGATA6indicated that the expression ofGATA6-AS1andGATA6were regulated by a bidirectional promoter within the intergenic region. Consistently,GATA6-AS1andGATA6were co-expressed in several human tissues including the heart, similar to the mirror expression pattern ofGATA6-AS1andGATA6during cardiomyocyte differentiation. Overall, these findings reveal a previously unrecognized and functional role of lncRNAGATA6-AS1in controlling human cardiomyocyte differentiation.	[Jha, Rajneesh; Li, Dong; Wu, Qingling; Forghani, Parvin; Xu, Chunhui] Emory Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Atlanta, GA USA; [Jha, Rajneesh; Li, Dong; Wu, Qingling; Forghani, Parvin; Xu, Chunhui] Childrens Healthcare Atlanta, Atlanta, GA USA; [Wu, Qingling; Xu, Chunhui] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Wu, Qingling; Xu, Chunhui] Emory Univ, Atlanta, GA 30322 USA; [Ferguson, Katherine E.; Gibson, Gregory C.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	Emory University; Children's Healthcare of Atlanta (CHOA); University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology	Xu, CH (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	chunhui.xu@emory.edu		Forghani, Parvin/0000-0001-9727-3344	CASIS [GA-2017-266]; NIH/NIAAA [R21AA025723]; NIH/NHLBI [R01HL136345]; Emory University	CASIS; NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Emory University	CASIS, Grant/Award Number: GA-2017-266; NIH/NIAAA, Grant/Award Number: R21AA025723; NIH/NHLBI, Grant/Award Number: R01HL136345; Emory University	Afouda BA, 2008, DEVELOPMENT, V135, P3185, DOI 10.1242/dev.026443; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Frank S, 2019, CELL STEM CELL, V24, P318, DOI 10.1016/j.stem.2018.11.005; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guo XD, 2018, CELL STEM CELL, V22, P893, DOI 10.1016/j.stem.2018.04.013; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Jha R, 2017, STEM CELL REP, V9, P513, DOI 10.1016/j.stemcr.2017.07.006; Jha R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30956; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liu JL, 2017, DEV CELL, V42, P333, DOI 10.1016/j.devcel.2017.07.023; Liu Q, 2017, CIRC RES, V121, P376, DOI 10.1161/CIRCRESAHA.116.310456; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Molkentin JD, 2000, DEV BIOL, V217, P301, DOI 10.1006/dbio.1999.9544; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Neumann P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02431-1; Ono K, 2018, CIRC J, V82, P1231, DOI 10.1253/circj.CJ-18-0169; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P17, DOI 10.1016/j.yjmcc.2015.09.013; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; R Development Core Team, 2014, R LANG ENV STAT COMP; Ronaldson-Bouchard K, 2018, NATURE, V556, P239, DOI 10.1038/s41586-018-0016-3; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tsoi LC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0570-4; van Berlo JH, 2010, CIRC RES, V107, P1032, DOI 10.1161/CIRCRESAHA.110.220764; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	47	8	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14336	14352		10.1096/fj.202000206R	http://dx.doi.org/10.1096/fj.202000206R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32888237	Green Accepted			2022-12-28	WOS:000568280900001
J	Li, C; Chen, QB; Zhou, Y; Niu, Y; Wang, XY; Li, X; Zheng, H; Wei, TT; Zhao, LC; Gao, HC				Li, Chen; Chen, Qinbo; Zhou, Yi; Niu, Yan; Wang, Xinyi; Li, Xiang; Zheng, Hong; Wei, Tingting; Zhao, Liangcai; Gao, Hongchang			S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer	FASEB JOURNAL			English	Article						Glycolysis; GLUT1; metabolic reprogramming; proliferation	AEROBIC GLYCOLYSIS; PROSTATE-CANCER; DOWN-REGULATION; PHOSPHORYLATION; EXPRESSION; CELLS; METABOLISM; ACTIVATION; HALLMARKS; BENEFIT	The deregulation of S100A2 has been implicated in the pathogenesis of several types of cancers. However, the molecular mechanisms underlying the protumorigenic capacities of S100A2 have not been fully elucidated. Here, we demonstrated the molecular mechanisms underlying the roles of S100A2 in glycolysis reprogramming and proliferation of colorectal cancer (CRC) cells. The results indicated that S100A2 overexpression raises glucose metabolism and proliferation. Mechanistically, S100A2 activated the PI3K/AKT signaling pathway, upregulated GLUT1 expression, induced glycolytic reprogramming, and consequently increased proliferation. Clinical data showed significantly increased S100A2 levels in CRC tissues and the Oncomine database. In addition, analysis revealed a positive correlation between S100A2 and GLUT1 mRNA expression in CRC tissues. Together, these results demonstrate that the S100A2/GLUT1 axis can promote the progression of CRC by modulating glycolytic reprogramming. Our results further suggest that targeting S100A2 could present a promising therapeutic avenue for the prevention of colorectal cancer progression.	[Li, Chen; Chen, Qinbo; Zhou, Yi; Niu, Yan; Wang, Xinyi; Zheng, Hong; Wei, Tingting; Zhao, Liangcai; Gao, Hongchang] Wenzhou Med Univ, Sch Pharmaceut Sci, Inst Metabon & Med NMR, Wenzhou 325035, Peoples R China; [Li, Xiang] Minist Educ, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Li, Xiang] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Gao, HC (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Inst Metabon & Med NMR, Wenzhou 325035, Peoples R China.	gaohc27@wmu.edu.cn	Zheng, Hong/ABG-7392-2021	Zheng, Hong/0000-0002-3401-721X	Key Research and Development Program of Zhejiang Province [2019C03030]; Public Welfare Technology Application Research Foundation of Zhejiang Province [LQ18H160027, 2017C33066]	Key Research and Development Program of Zhejiang Province; Public Welfare Technology Application Research Foundation of Zhejiang Province	The Key Research and Development Program of Zhejiang Province, Grant/Award Number: 2019C03030; The Public Welfare Technology Application Research Foundation of Zhejiang Province, Grant/Award Number: LQ18H160027 and 2017C33066	Alajez NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167455; Avanzato D, 2018, CANCER RES, V78, P3432, DOI 10.1158/0008-5472.CAN-17-3018; Bachet JB, 2013, EUR J CANCER, V49, P2643, DOI 10.1016/j.ejca.2013.04.017; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Buckley NE, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.31; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Hu QX, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0138-y; Hua TNM, 2019, EBIOMEDICINE, V41, P134, DOI 10.1016/j.ebiom.2019.02.015; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; LEE SW, 1992, P NATL ACAD SCI USA, V89, P2504, DOI 10.1073/pnas.89.6.2504; Li J, 2011, MOL VIS, V17, P2263; Li L, 2018, CANCER CELL, V33, pe367; Lian G, 2019, EBIOMEDICINE, V49, P291, DOI 10.1016/j.ebiom.2019.09.041; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Lin HY, 2017, ONCOTARGET, V8, P34750, DOI 10.18632/oncotarget.16160; Malik H, 2015, EJSO-EUR J SURG ONC, V41, P499, DOI 10.1016/j.ejso.2015.01.032; Masuda T, 2016, INT J ONCOL, V48, P975, DOI 10.3892/ijo.2016.3329; Naz S, 2014, CARCINOGENESIS, V35, P14, DOI 10.1093/carcin/bgt287; Ni QZ, 2017, J PHYS CHEM B, V121, P8132, DOI 10.1021/acs.jpcb.7b07213; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schwartz L, 2017, SEMIN CANCER BIOL, V43, P134, DOI 10.1016/j.semcancer.2017.01.005; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Tsai WC, 2006, MOL CANCER RES, V4, P539, DOI 10.1158/1541-7786.MCR-05-0266; Wang W, 2019, SEMIN CANCER BIOL, V55, P37, DOI 10.1016/j.semcancer.2018.05.002; Weber GF, 2016, INT J CANCER, V138, P2061, DOI 10.1002/ijc.29839; Wu HB, 2017, FASEB J, V31, P1731, DOI [10.1096/fj.201601085R, 10.1096/fj.201601085r]; Zhang HH, 2015, CANCER LETT, V356, P781, DOI 10.1016/j.canlet.2014.10.029; Zhang J, 2019, ONCOGENE, V38, P4669, DOI 10.1038/s41388-019-0749-y; Zhang X, 2018, MOLECULES, V23, DOI 10.3390/molecules23040807; Zhang YJ, 2018, MOL CELL, V71, P201, DOI 10.1016/j.molcel.2018.06.023; Zhao LC, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00207; Zheng H, 2017, ANAL CHIM ACTA, V991, P68, DOI 10.1016/j.aca.2017.09.019; Zheng H, 2017, BBA-MOL BASIS DIS, V1863, P266, DOI 10.1016/j.bbadis.2016.11.003; Zhong XY, 2017, EMBO REP, V18, P809, DOI 10.15252/embr.201643617	44	15	15	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13333	13344		10.1096/fj.202000555R	http://dx.doi.org/10.1096/fj.202000555R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32816365				2022-12-28	WOS:000563239500001
J	Kumar, A; Singh, PK; Zhang, KZ; Kumar, A				Kumar, Ajay; Singh, Pawan Kumar; Zhang, Kezhong; Kumar, Ashok			Toll-like receptor 2 (TLR2) engages endoplasmic reticulum stress sensor IRE1 alpha to regulate retinal innate responses inStaphylococcus aureusendophthalmitis	FASEB JOURNAL			English	Article						endophthalmitis; endoplasmic reticulum (ER) stress; inflammation; microglia; reactive oxygen species (ROS); retina; S aureus; toll-like receptor 2 (TLR2)	UNFOLDED PROTEIN RESPONSE; ER STRESS; IMMUNE-RESPONSES; MESSENGER-RNA; ACTIVATION; TRANSCRIPTION; KINASE; INFECTION; EXPRESSION; TARGET	Endoplasmic reticulum (ER) stress response has been implicated in a variety of pathophysiological conditions, including infectious and inflammatory diseases. However, its contribution in ocular bacterial infections, such as endophthalmitis, which often cause blindness is not known. Here, using a mouse model ofStaphylococcus(S.)aureusendophthalmitis, our study demonstrates the induction of inositol-requiring enzyme 1 alpha (IRE1 alpha) and splicing of X-box binding protein-1 (Xbp1) branch of the ER-stress pathway, but not the other classical ER stress sensors. Interestingly,S aureus-induced ER stress response was found to be dependent on Toll-like receptor 2 (TLR2), as evident by reduced expression of IRE1 alpha andXbp1mRNA splicing in TLR2 knockout mouse retina. Pharmacological inhibition of IRE1 alpha using 4 mu 8C or experiments utilizing IRE1 alpha(-/-)macrophages revealed that IRE1 alpha positively regulatesS aureus-induced inflammatory responses. Moreover, IRE1 alpha inhibition attenuatedS aureus-triggered NF-kappa B, p38, and ERK pathways activation and cells treated with these pathway-specific inhibitors reducedXbp1splicing, suggesting a positive feedback inhibition. In vivo, inhibition of IRE1 alpha diminished the intraocular inflammation and reduced PMN infiltration in mouse eyes, but, increased the bacterial burden and caused more retinal tissue damage. These results revealed a critical role of the IRE1 alpha/XBP1 pathway as a regulator of TLR2-mediated protective innate immune responses inS aureus-induced endophthalmitis.	[Kumar, Ajay; Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Visual & Anat Sci Kresge Eye Inst, Dept Ophthalmol, Sch Med, 4717 St Antoine, Detroit, MI 48201 USA; [Zhang, Kezhong] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48201 USA; [Zhang, Kezhong; Kumar, Ashok] Wayne State Univ, Dept Biochem Microbiol & Immunol, Sch Med, Detroit, MI 48201 USA; [Kumar, Ajay] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Wayne State University; Wayne State University; Wayne State University; University of Michigan System; University of Michigan	Kumar, A (corresponding author), Wayne State Univ, Visual & Anat Sci Kresge Eye Inst, Dept Ophthalmol, Sch Med, 4717 St Antoine, Detroit, MI 48201 USA.	akuma@med.wayne.edu			NIH/NEI [R01EY026964, R01EY027381]; NIH/NIAID [R21AI140033, R21AI135583]; NIH [DK090313]	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH/NEI, Grant/Award Number: R01EY026964 and R01EY027381; NIH/NIAID, Grant/Award Number: R21AI140033 and R21AI135583; NIH, Grant/Award Number: DK090313	Abuaita BH, 2015, MBIO, V6, DOI 10.1128/mBio.00705-15; Bhatta M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0501-5; Blumenthal A, 2005, INFECT IMMUN, V73, P3330, DOI 10.1128/IAI.73.6.3330-3341.2005; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Chen SH, 2015, FEBS OPEN BIO, V5, P91, DOI 10.1016/j.fob.2015.01.004; Choi JA, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03147; Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771; Coburn PS, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0764-8; Coope A, 2012, J BIOL CHEM, V287, P15580, DOI 10.1074/jbc.M111.315218; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cunard R, 2015, J CLIN MED, V4, P715, DOI 10.3390/jcm4040715; Dandekar A, 2016, J BIOL CHEM, V291, P23149, DOI 10.1074/jbc.M116.755728; de Jong MF, 2013, MBIO, V4, DOI 10.1128/mBio.00418-12; Hanscom T, 1996, ARCH OPHTHALMOL-CHIC, V114, P1029, DOI 10.1001/archopht.1996.01100140233036; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Kim HT, 2005, J NEUROVIROL, V11, P166, DOI 10.1080/13550280590922810; Kochan T, 2012, INFECT IMMUN, V80, P2076, DOI 10.1128/IAI.00149-12; Kroeger H, 2019, FEBS J, V286, P399, DOI 10.1111/febs.14522; Kumar A, 2016, CELL MICROBIOL, V18, P1815, DOI 10.1111/cmi.12625; Kumar A, 2007, INVEST OPHTH VIS SCI, V48, P4664, DOI 10.1167/iovs.07-0473; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Liao K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0501-2; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Miller FC, 2019, PROG RETIN EYE RES, V73, DOI 10.1016/j.preteyeres.2019.05.004; Miller JJ, 2005, AM J OPHTHALMOL, V139, P983, DOI 10.1016/j.ajo.2005.01.025; Morinaga N, 2008, CELL MICROBIOL, V10, P921, DOI 10.1111/j.1462-5822.2007.01094.x; MUSHER DM, 1994, MEDICINE, V73, P186, DOI 10.1097/00005792-199407000-00002; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Newton PM, 2007, PHARMACOL RES, V55, P570, DOI 10.1016/j.phrs.2007.04.008; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Ozgur R, 2018, J EXP BOT, V69, P3333, DOI 10.1093/jxb/ery040; Pandey RK, 2013, INDIAN J MED RES, V138, P609; Parkunan SM, 2015, INFECT IMMUN, V83, P3926, DOI 10.1128/IAI.00502-15; Pillich Helena, 2016, Mol Cell Pediatr, V3, P9, DOI 10.1186/s40348-016-0037-7; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; Qin QM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000110; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Rajamani D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21502; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340; Singh PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119541; Singh PK, 2014, ANTIMICROB AGENTS CH, V58, P4621, DOI 10.1128/AAC.00126-14; Singh PK, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-33; Singh S, 2020, J IMMUNOL, V204, P1810, DOI 10.4049/jimmunol.1901310; Smith JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003785; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Talreja D, 2015, INVEST OPHTH VIS SCI, V56, P1719, DOI 10.1167/iovs.14-16087; Webster SJ, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.010; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774	61	7	7	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13826	13838		10.1096/fj.202001393R	http://dx.doi.org/10.1096/fj.202001393R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32813318	Green Published, Green Accepted			2022-12-28	WOS:000562900600001
J	Xiong, XF; Cui, DR; Bi, YL; Sun, Y; Zhao, YC				Xiong, Xiufang; Cui, Danrui; Bi, Yanli; Sun, Yi; Zhao, Yongchao			Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival	FASEB JOURNAL			English	Article						MDM2; NEDD8; Neddylation; NEDP1; RPS27; RPS27L	NEDD8-ACTIVATING ENZYME; P53; INHIBITOR	Neddylation plays a distinct role in stabilization of a subset of ribosomal proteins. Whether the family of ribosomal proteins S27 (RPS27 and RPS27-like) is subjected to neddylation regulation with associated biological consequence is totally unknown. Here, we report that both family members are subjected to neddylation by MDM2 E3 ubiquitin ligase, and deneddylation by NEDP1. Blockage of neddylation with MLN4924, a small molecule inhibitor of neddylation-activating enzyme, destabilizes RPS27L and RPS27 by shortening their protein half-lives. Biologically, knockdown of RPS27L and RPS27 sensitizes, whereas ectopic expression of RPS27L and RPS27 desensitizes cancer cells to MLN4924-induced apoptosis. Taken together, our study demonstrates that neddylation stabilizes RPS27L and RPS27 to confer the survival of cancer cells.	[Xiong, Xiufang; Sun, Yi] Zhejiang Univ, Canc Inst, Affiliated Hosp 2, Sch Med, 268 Kai Xuan Rd, Hangzhou 310029, Zhejiang, Peoples R China; [Cui, Danrui; Bi, Yanli; Zhao, Yongchao] Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Sch Med, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Xiong, Xiufang; Cui, Danrui; Bi, Yanli; Sun, Yi; Zhao, Yongchao] Zhejiang Univ, Inst Translat Med, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Sun, Y (corresponding author), Zhejiang Univ, Canc Inst, Affiliated Hosp 2, Sch Med, 268 Kai Xuan Rd, Hangzhou 310029, Zhejiang, Peoples R China.; Zhao, YC (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Sch Med, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	yisun@zju.edu.cn; yongchao@zju.edu.cn		Xiong, Xiufang/0000-0001-6842-3673	National Key R&D Program of China [2016YFA0501800]; National Natural Science Foundation of China [81672728, 81972591, 81721091, 81974429, 81572708]; Natural Science Foundation of Zhejiang Province [LR16C050001]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	National Key R&D Program of China, Grant/Award Number: 2016YFA0501800; National Natural Science Foundation of China, Grant/Award Number: 81672728, 81972591, 81721091, 81974429 and 81572708; Natural Science Foundation of Zhejiang Province, Grant/Award Number: LR16C050001	Barbier-Torres L, 2015, ONCOTARGET, V6, P2509, DOI 10.18632/oncotarget.3191; Cui DR, 2020, CELL REP, V30, P497, DOI 10.1016/j.celrep.2019.12.032; Cui DR, 2020, CELL DEATH DIFFER, V27, P1119, DOI 10.1038/s41418-019-0402-x; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Li LH, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju083; Maghames CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06365-0; Milhollen MA, 2012, CANCER CELL, V21, P388, DOI 10.1016/j.ccr.2012.02.009; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Toth JI, 2012, CELL REP, V1, P309, DOI 10.1016/j.celrep.2012.02.006; Watson IR, 2010, ONCOGENE, V29, P297, DOI 10.1038/onc.2009.314; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Xiong XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1168-7; Xiong XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02236; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu XL, 2016, SCI CHINA LIFE SCI, V59, P656, DOI 10.1007/s11427-016-0018-0; Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.125; Zhao YC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0192-3; Zhao YC, 2014, ANTIOXID REDOX SIGN, V21, P2383, DOI 10.1089/ars.2013.5795; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zhou LS, 2018, CELL SIGNAL, V44, P92, DOI 10.1016/j.cellsig.2018.01.009	31	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13419	13429		10.1096/fj.202000530RRR	http://dx.doi.org/10.1096/fj.202000530RRR		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32779270	hybrid			2022-12-28	WOS:000558415900001
J	Perez-Gonzalez, R; Kim, Y; Miller, C; Pacheco-Quinto, J; Eckman, EA; Levy, E				Perez-Gonzalez, Rocio; Kim, Yohan; Miller, Chelsea; Pacheco-Quinto, Javier; Eckman, Elizabeth A.; Levy, Efrat			Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-beta oligomerizes	FASEB JOURNAL			English	Article						A beta oligomers; Alzheimer's disease; APP-CTFs; APP metabolism; exosomes	IMPAIR SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; MOUSE MODEL; A-BETA; DOWN-SYNDROME; LYSOSOMAL DYSFUNCTION; IN-VIVO; SECRETASE CLEAVAGE; MEMORY DEFICITS; GM1 GANGLIOSIDE	Pleiotropic roles are proposed for brain extracellular vesicles (EVs) in the development of Alzheimer's disease (AD). Our previous studies have suggested a beneficial role for EVs in AD, where the endosomal system in vulnerable neurons is compromised, contributing to the removal of accumulated material from neurons. However, the involvement of EVs in propagating AD amyloidosis throughout the brain has been considered because the amyloid-beta precursor protein (APP), APP metabolites, and key APP cleaving enzymes were identified in association with EVs. Here, we undertook to determine whether the secretase machinery is actively processing APP in EVs isolated from the brains of wild-type and APP overexpressing Tg2576 mice. We found that full-length APP is cleaved in EVs incubated in the absence of cells. The resulting metabolites, both alpha- and beta-APP carboxyl-terminal fragments and APP intracellular domain accumulate in EVs over time and amyloid-beta dimerizes. Thus, EVs contribute to the removal from neurons and transport of APP-derived neurotoxic peptides. While this is potentially a venue for propagation of the pathology throughout the brain, it may contribute to efficient removal of neurotoxic peptides from the brain.	[Perez-Gonzalez, Rocio; Kim, Yohan; Miller, Chelsea; Levy, Efrat] Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY USA; [Perez-Gonzalez, Rocio; Kim, Yohan; Levy, Efrat] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Pacheco-Quinto, Javier; Eckman, Elizabeth A.] Biomed Res Inst New Jersey Cedar Knolls & Atlanti, Morristown, NJ USA; [Levy, Efrat] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Levy, Efrat] NYU, Sch Med, Neurosci Inst, New York, NY USA; [Perez-Gonzalez, Rocio] Hosp Santa Creu & Sant Pau, St Pau Biomed Res Inst IIB St Pau, Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Barcelona, Spain; [Perez-Gonzalez, Rocio] Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain	Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau	Perez-Gonzalez, R (corresponding author), St Pau Biomed Res Inst IIB St Pau, St Quinti 77-79, Barcelona 08041, Spain.	rperezgo@santpau.cat	Perez-Gonzalez, Rocio/GQH-7068-2022; Eckman, Elizabeth/AAL-7316-2021	Perez-Gonzalez, Rocio/0000-0002-0641-2001; Eckman, Elizabeth/0000-0002-5391-4960; Kim, Yohan/0000-0003-2550-8751	Alzheimer's Association [NIRG-14-316622]; National Institute on Aging [AG017617, AG056732]	Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Alzheimer's Association, Grant/Award Number: NIRG-14-316622; National Institute on Aging, Grant/Award Number: AG017617 and AG056732	Baghallab I, 2018, J ALZHEIMERS DIS, V66, P1235, DOI 10.3233/JAD-180582; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Colacurcio DJ, 2018, FREE RADICAL BIO MED, V114, P40, DOI 10.1016/j.freeradbiomed.2017.10.001; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; D'Acunzo P, 2019, DEV NEUROBIOL, V79, P656, DOI 10.1002/dneu.22708; Deyts C, 2012, J NEUROSCI, V32, P1714, DOI 10.1523/JNEUROSCI.5433-11.2012; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Gauthier SA, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0466-0; Ghosal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011866; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jiang Y, 2019, J NEUROSCI, V39, P5255, DOI 10.1523/JNEUROSCI.0578-19.2019; Jiang Y, 2016, NEUROBIOL AGING, V39, P90, DOI 10.1016/j.neurobiolaging.2015.11.013; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Joshi P, 2014, CELL DEATH DIFFER, V21, P582, DOI 10.1038/cdd.2013.180; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kaur G, 2017, MOL PSYCHIATR, V22, P981, DOI 10.1038/mp.2016.189; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Laulagnier K, 2018, CELL MOL LIFE SCI, V75, P757, DOI 10.1007/s00018-017-2664-0; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lauritzen I, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0176-6; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lauritzen L, 2019, CURR ALZHEIMER RES, V16, P453, DOI 10.2174/1567205016666190325092841; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; McPhie DL, 2001, MOL BRAIN RES, V97, P103, DOI 10.1016/S0169-328X(01)00294-7; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Pacheco-Quinto J, 2019, FASEB J, V33, P3758, DOI 10.1096/fj.201801319R; Pardossi-Piquard R, 2016, CURR ALZHEIMER RES, V13, P942, DOI 10.2174/1567205013666160404120106; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Peng KY, 2019, BRAIN, V142, P163, DOI 10.1093/brain/awy289; Perez-Gonzalez R, 2019, NEUROBIOL AGING, V84, P26, DOI 10.1016/j.neurobiolaging.2019.07.016; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Portelius E, 2013, J ALZHEIMERS DIS, V33, P85, DOI 10.3233/JAD-2012-120994; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sanderson RD, 2019, MATRIX BIOL, V75-76, P160, DOI 10.1016/j.matbio.2017.10.007; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Sinha MS, 2018, ACTA NEUROPATHOL, V136, P41, DOI 10.1007/s00401-018-1868-1; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Welzel AT, 2014, BIOCHEMISTRY-US, V53, P3908, DOI 10.1021/bi5003053; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yuyama K, 2008, J NEUROCHEM, V105, P217, DOI 10.1111/j.1471-4159.2007.05128.x; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	77	18	18	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12922	12931		10.1096/fj.202000823R	http://dx.doi.org/10.1096/fj.202000823R		AUG 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772431	Green Published, hybrid			2022-12-28	WOS:000560235000001
J	Abu-El-Rub, E; Sareen, N; Sequiera, GL; Ammar, HI; Yan, WA; ShamsEldeen, AM; Rubinchik, I; Moudgil, M; Shokry, HS; Rashed, LA; Dhingra, S				Abu-El-Rub, Ejlal; Sareen, Niketa; Sequiera, Glen Lester; Ammar, Hania, I; Yan, Weiang; ShamsEldeen, Asmaa M.; Rubinchik, Ilan; Moudgil, Meenal; Shokry, Heba S.; Rashed, Laila A.; Dhingra, Sanjiv			Hypoxia-induced increase in Sug1 leads to poor post-transplantation survival of allogeneic mesenchymal stem cells	FASEB JOURNAL			English	Article						immunogenicity; MHC-II; MSCs	STROMAL CELLS; MYOCARDIAL-INFARCTION; IMMUNOGENICITY; EXPRESSION; BENEFITS; ATPASE; REPAIR	Allogeneic mesenchymal stem cells (MSCs) from young and healthy donors are immunoprivileged and have the potential to treat numerous degenerative diseases. However, recent reviews of clinical trials report poor long-term survival of transplanted cells in the recipient that turned down the enthusiasm regarding MSC therapies. Increasing evidence now confirm that though initially immunoprivileged, MSCs eventually become immunogenic after transplantation in the ischemic or hypoxic environment of diseased tissues and are rejected by the host immune system. We performed in vitro (in rat and human cells) and in vivo (in a rat model) investigations to understand the mechanisms of the immune switch in the phenotype of MSCs. The immunoprivilege of MSCs is preserved by the absence of cell surface immune antigen, major histocompatibility complex II (MHC-II) molecule. We found that the ATPase subunit of 19S proteasome "Sug1" regulates MHC-II biosynthesis in MSCs. Exposure to hypoxia upregulates Sug1 in MSCs and its binding to class II transactivator (CIITA), a coactivator of MHC-II transcription. Sug1 binding to CIITA in hypoxic MSCs promotes the acetylation and K63 ubiquitination of CIITA leading to its activation and translocation to the nucleus, and ultimately MHC-II upregulation. In both rat and human MSCs, knocking down Sug1 inactivated MHC-II and preserved immunoprivilege even following hypoxia. In a rat model of myocardial infarction, transplantation of Sug1-knockdown MSCs in ischemic heart preserved immunoprivilege and improved the survival of transplanted cells. Therefore, the current study provides novel mechanisms of post-transplantation loss of immunoprivilege of MSCs. This study may help in facilitating better planning for future clinical trials.	[Abu-El-Rub, Ejlal; Sareen, Niketa; Sequiera, Glen Lester; Yan, Weiang; Rubinchik, Ilan; Moudgil, Meenal; Dhingra, Sanjiv] St Boniface Gen Hosp, Inst Cardiovasc Sci, Regenerat Med Program, Albrechtsen Res Ctr, Winnipeg, MB, Canada; [Abu-El-Rub, Ejlal; Sareen, Niketa; Sequiera, Glen Lester; Yan, Weiang; Rubinchik, Ilan; Moudgil, Meenal; Dhingra, Sanjiv] Univ Manitoba, Coll Med, Fac Hlth Sci, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Ammar, Hania, I; ShamsEldeen, Asmaa M.; Shokry, Heba S.; Rashed, Laila A.] Cairo Univ, Fac Med, Dept Physiol & Biochem, Giza, Egypt	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Egyptian Knowledge Bank (EKB); Cairo University	Dhingra, S (corresponding author), St Boniface Gen Hosp, Inst Cardiovasc Sci, Regenerat Med Program, Res Ctr, R-3028-2,351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	sdhingra@sbrc.ca	Shamseldeen, Asmaa/AAR-2357-2020; Shams, A/HHZ-1192-2022; Dhingra, Sanjiv/D-8766-2014	Shamseldeen, Asmaa/0000-0002-4250-0818; Dhingra, Sanjiv/0000-0002-2664-7633; Yan, Weiang/0000-0002-1065-4847	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [PJT156148]; Yarmouk University; Research Manitoba	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Yarmouk University; Research Manitoba	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT156148; Yarmouk University; Research Manitoba	Abu-El-Rub E, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1359-x; Ammar HI, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0142-x; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Axelrod ML, 2019, CLIN CANCER RES, V25, P2392, DOI 10.1158/1078-0432.CCR-18-3200; Badiavas AR, 2011, EXPERT OPIN BIOL TH, V11, P1447, DOI 10.1517/14712598.2011.606212; Bagno L, 2018, MOL THER, V26, P1610, DOI 10.1016/j.ymthe.2018.05.009; Berglund AK, 2017, STEM CELL RES THER, V8, P1; Bocelli-Tyndall C, 2007, RHEUMATOLOGY, V46, P403, DOI 10.1093/rheumatology/kel267; Chidgey AP, 2008, CELL STEM CELL, V3, P357, DOI 10.1016/j.stem.2008.09.011; Consentius C, 2015, REGEN MED, V10, P305, DOI [10.2217/rme.15.14, 10.2217/RME.15.14]; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; Dhingra S, 2013, CIRCULATION, V128, pS69, DOI 10.1161/CIRCULATIONAHA.112.000324; Drozina G, 2005, CURR TOP MICROBIOL, V290, P147; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Girdlestone J, 2016, IMMUNOTHERAPY-UK, V8, P1405, DOI 10.2217/imt-2016-0098; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Gu LH, 2015, CELL MOL IMMUNOL, V12, P444, DOI 10.1038/cmi.2014.70; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Huang XP, 2016, FASEB J, V30, P3069, DOI 10.1096/fj.201600331R; Inostroza-Nieves Y, 2012, IMMUNOL LETT, V147, P67, DOI 10.1016/j.imlet.2012.06.005; Jabrane-Ferrat N, 2003, INT IMMUNOL, V15, P467, DOI 10.1093/intimm/dxg048; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Lohan P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01626; Lukomska B, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/9628536; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Majka M, 2017, STEM CELL TRANSL MED, V6, P1859, DOI 10.1002/sctm.16-0484; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Morgan J, 2018, ORYX, V52, P744, DOI 10.1017/S003060531700031X; Morgan JE, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150091; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Olaitan AO, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007693; Oliveira RL, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9824698; Perico N, 2018, J AM SOC NEPHROL, V29, P362, DOI 10.1681/ASN.2017070781; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rad F, 2019, MOL BIOL REP, V46, P1533, DOI 10.1007/s11033-019-04588-y; Rameshwar P, 2009, MOL THER, V17, P216, DOI 10.1038/mt.2008.296; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Roux C, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01991; Sareen N, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0867-4; Soland MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036163; Takeda A, 2012, CLIN TRANSPLANT, V26, P43, DOI 10.1111/j.1399-0012.2012.01642.x; Tanaka S., 2016, RENAL REPLACE THER, V2, P25, DOI DOI 10.1186/S41100-016-0038-Y; Tompkins BA, 2017, J GERONTOL A-BIOL, V72, P1513, DOI 10.1093/gerona/glx137; Tsai CC, 2012, AM J BLOOD RES, V2, P148; Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651; Wu XY, 2009, MOL CELL BIOL, V29, P5639, DOI 10.1128/MCB.00661-09; Yin JQ, 2019, NAT BIOMED ENG, V3, P90, DOI 10.1038/s41551-018-0325-8; Zhang J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0240-9; Zhao LF, 2019, J CELL MOL MED, V23, P720, DOI 10.1111/jcmm.14035; Zhao L, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0816-2	56	5	5	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12860	12876		10.1096/fj.202000454R	http://dx.doi.org/10.1096/fj.202000454R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32770803				2022-12-28	WOS:000558807800001
J	Foligne, B; George, F; Standaert, A; Garat, A; Poiret, S; Peucelle, V; Ferreira, S; Sobry, H; Muharram, G; Lucau-Danila, A; Daniel, C				Foligne, Benoit; George, Fanny; Standaert, Annie; Garat, Anne; Poiret, Sabine; Peucelle, Veronique; Ferreira, Stephanie; Sobry, Helene; Muharram, Ghaffar; Lucau-Danila, Anca; Daniel, Catherine			High-dose dietary supplementation with zinc prevents gut inflammation: Investigation of the role of metallothioneins and beyond by transcriptomic and metagenomic studies	FASEB JOURNAL			English	Article						colitis; dietary zinc; metallothionein; microbiota; mouse; transcriptomics	DEXTRAN SULFATE SODIUM; EXPERIMENTAL COLITIS; IN-VITRO; INTESTINAL MICROBIOTA; REGIONAL-DISTRIBUTION; RESISTANCE; EXPRESSION; OXIDE; ACID; ACCUMULATION	Although it is known that zinc has several beneficial roles in the context of gut inflammation, the underlying mechanisms have not been extensively characterized. Zinc (Zn) is known to be the primary physiological inducer of the expression of the metallothionein (MT) superfamily of small stress-responsive proteins. The expression of MTs in various tissues is induced or enhanced (including the gastrointestinal tract (GIT)) by a variety of stimuli, including infection and inflammation. However, the MTs' exact role in inflammation is still subject to debate. In order to establish whether or not MTs are the sole vectors in the Zn-based modulation of intestinal inflammation, we used transcriptomic and metagenomic approaches to assess the potential effect of dietary Zn, the mechanisms underlying the MTs' beneficial effects, and the induction of previously unidentified mediators. We found that the expression of endogenous MTs in the mouse GIT was stimulated by an optimized dietary supplementation with Zn. The protective effects of dietary supplementation with Zn were then evaluated in mouse models of chemically induced colitis. The potential contribution of MTs and other pathways was explored via transcriptomic analyses of the ileum and colon in Zn-treated mice. The microbiota's role was also assessed via fecal 16S rRNA sequencing. We found that high-dose dietary supplementation with Zn induced the expression of MT-encoding genes in the colon of healthy mice. We next demonstrated that the Zn diet significantly protected mice in the two models of induced colitis. When comparing Zn-treated and control mice, various genes were found to be differentially expressed in the colon and the ileum. Finally, we found that Zn supplementation did not modify the overall structure of the fecal microbiota, with the exception of (i) a significant increase in endogenousClostridiaceae, and (ii) some subtle but specific changes at the family and genus levels. Our results emphasize the beneficial effects of excess dietary Zn on the prevention of colitis and inflammatory events in mouse models. The main underlying mechanisms were driven by the multifaceted roles of MTs and the other potential molecular mediators highlighted by our transcriptomic analyses although we cannot rule out contributions by other factors from the host and/or the microbiota.	[Foligne, Benoit; George, Fanny; Standaert, Annie] Univ Lille, CHU Lille, INSERM, U1286,Infinite,Inst Translat Res Inflammat, Lille, France; [George, Fanny; Garat, Anne] Univ Lille, CHU Lille, Inst Pasteur Lille, ULR 4483,IMPECS,IMPact Environm Chim Sante Humain, Lille, France; [Garat, Anne] CHU Lille, Unite Fonct Toxicol, Lille, France; [Poiret, Sabine; Peucelle, Veronique; Sobry, Helene; Muharram, Ghaffar; Daniel, Catherine] Univ Lille, CNRS, INSERM,Ctr Infect & Immun Lille, CHU Lille,Inst Pasteur Lille,U1019,UMR 9017,CIIL, Lille, France; [Ferreira, Stephanie] GenoScreen, Lille, France; [Lucau-Danila, Anca] ULille, ULiege, UArtois, BIOECOAGRO INRAe,ULCO,UPJV,YNCREA,Inst Charles Vi, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; INRAE; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale	Daniel, C (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, Team Cellular Microbiol & Phys Infect, INSERM U1019,CNRS UMR 8204, 1 Rue Prof Calmette, F-59019 Lille, France.	catherine.daniel@ibl.cnrs.fr	Standaert, Annie/R-5826-2018; poiret, sabine/GLQ-5349-2022; Garat, Anne/AAC-6868-2022; George, Fanny FG/M-3667-2018; Lucau-Danila, Anca/AAE-7674-2021; daniel, catherine/C-3051-2012; Muharram, Ghaffar/I-6686-2017; Foligne, Benoit/B-2754-2014	Standaert, Annie/0000-0002-7752-3964; George, Fanny FG/0000-0003-2727-5680; daniel, catherine/0000-0002-5299-2799; LUCAU-DANILA, Anca/0000-0002-9379-6241; Muharram, Ghaffar/0000-0003-4309-8450; Foligne, Benoit/0000-0001-9263-9706	Institut National de la Sante et de la Recherche Medicale (INSERM); Center National de la Recherche Scientifique (CNRS); Lille University via the "Romarin" grant, as part of the Infectious, Inflammatory, and Immune Diseases Research Federation (SF3I) program	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Center National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Lille University via the "Romarin" grant, as part of the Infectious, Inflammatory, and Immune Diseases Research Federation (SF3I) program	This work was funded by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Center National de la Recherche Scientifique (CNRS), and Lille University via the "Romarin" grant, as part of the Infectious, Inflammatory, and Immune Diseases Research Federation (SF3I) program.	Ameho CK, 1997, GUT, V41, P487, DOI 10.1136/gut.41.4.487; Arab HH, 2014, FOOD CHEM TOXICOL, V69, P294, DOI 10.1016/j.fct.2014.04.032; Barada KA, 2007, CYTOKINE, V37, P236, DOI 10.1016/j.cyto.2007.04.005; Beaugerie L, 2020, CLIN GASTROENTEROL H, V18, P1324, DOI 10.1016/j.cgh.2020.02.009; Beaumont M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3514-z; Blindauer CA, 2010, NAT PROD REP, V27, P720, DOI 10.1039/b906685n; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Breton J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19200; Breton J, 2013, TOXICOL LETT, V222, P132, DOI 10.1016/j.toxlet.2013.07.021; Bruwer M, 2001, INFLAMM RES, V50, P289, DOI 10.1007/PL00000246; Castillo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137463; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Chen PR, 2008, CURR OPIN CHEM BIOL, V12, P214, DOI 10.1016/j.cbpa.2007.12.010; Choi EK, 2020, FASEB J, V34, P2929, DOI 10.1096/fj.201902396R; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Click Benjamin, 2019, Curr Gastroenterol Rep, V21, P1, DOI 10.1007/s11894-019-0669-6; COOPER HS, 1993, LAB INVEST, V69, P238; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Danese Silvio, 2017, Gastroenterology, V153, P603, DOI 10.1053/j.gastro.2017.06.040; de Queiroz CAA, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-136; Devisscher L, 2014, J PATHOL, V233, P89, DOI 10.1002/path.4330; Di Leo V, 2001, DIGEST LIVER DIS, V33, P135, DOI 10.1016/S1590-8658(01)80068-2; Dostie KE, 2018, CURR PHARM DESIGN, V24, P3155, DOI 10.2174/1381612824666180717110236; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dziegiel P, 2016, ADV ANAT EMBRYOL CEL, V218, P1, DOI 10.1007/978-3-319-27472-0_1; Foligne B, 2007, GASTROENTEROLOGY, V133, P862, DOI 10.1053/j.gastro.2007.06.018; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Foligne B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060577; FORTINA MG, 1993, LETT APPL MICROBIOL, V17, P303, DOI 10.1111/j.1472-765X.1993.tb01473.x; Gericke A, 2013, ADV EXP MED BIOL, V991, P85, DOI 10.1007/978-94-007-6331-9_6; Gielda LM, 2012, MBIO, V3, DOI 10.1128/mBio.00171-12; Giles DA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02585; Gopalsamy GL, 2015, NUTRIENTS, V7, P572, DOI 10.3390/nu7010572; Hamouda HE, 2011, WORLD J GASTROENTERO, V17, P2417, DOI 10.3748/wjg.v17.i19.2417; Hardyman JEJ, 2016, METALLOMICS, V8, P337, DOI 10.1039/c5mt00305a; Hedblom GA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01991; Hennigar SR, 2019, COMPR PHYSIOL, V9, P59, DOI 10.1002/cphy.c180001; Higashimura Y, 2019, J CROHNS COLITIS, V14, P856; Hill GM, 2019, BIOL TRACE ELEM RES, V188, P148, DOI 10.1007/s12011-018-1578-5; Hojberg O, 2005, APPL ENVIRON MICROB, V71, P2267, DOI 10.1128/AEM.71.5.2267-2277.2005; Iwaya H, 2011, J NUTR, V141, P1077, DOI 10.3945/jn.111.138180; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kanai T, 2015, J GASTROENTEROL, V50, P928, DOI 10.1007/s00535-015-1084-x; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Kondaiah P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081885; Kumari MVR, 1998, FREE RADICAL RES, V29, P93, DOI 10.1080/10715769800300111; Lahiri A, 2014, GASTROENTEROLOGY, V147, P835, DOI 10.1053/j.gastro.2014.06.024; Li Weimin, 2013, Advances in Biological Regulation, V53, P64, DOI 10.1016/j.jbior.2012.10.004; Liedtke J, 2012, VET MICROBIOL, V160, P251, DOI 10.1016/j.vetmic.2012.05.013; Lim Wee-Chian, 2004, Rev Gastroenterol Disord, V4, P104; Liu HS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131273; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu JH, 2017, TOXICOL RES-UK, V6, P134, DOI 10.1039/c6tx00370b; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Lopez CA, 2018, CELL HOST MICROBE, V23, P737, DOI 10.1016/j.chom.2018.05.008; Martin L, 2013, J NUTR, V143, P1205, DOI 10.3945/jn.113.177881; Mascaraque C, 2015, BRIT J NUTR, V113, P618, DOI 10.1017/S0007114514004292; Maxwell Joseph R, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0558s47; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Miyoshi Y, 2016, AM J PHYSIOL-GASTR L, V311, pG105, DOI 10.1152/ajpgi.00405.2015; Mizoguchi E, 2020, INTEST RES, V18, P151, DOI 10.5217/ir.2019.09154; MORRIS GP, 1989, AM J MED, V86, P10, DOI 10.1016/0002-9343(89)90150-2; Nakase H, 2020, IMMUNOL MED, V43, P1; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; O'Brien FG, 2002, J ANTIMICROB CHEMOTH, V50, P313, DOI 10.1093/jac/dkf153; Ohashi W, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/8396878; Owczarek D, 2016, WORLD J GASTROENTERO, V22, P895, DOI 10.3748/wjg.v22.i3.895; Oz HS, 2005, MED SCI MONITOR, V11, pBR69; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Podany A, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800947; Podany AB, 2016, CELL MOL GASTROENTER, V2, P369, DOI 10.1016/j.jcmgh.2015.12.006; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Raudenska M, 2014, METALLOMICS, V6, P55, DOI 10.1039/c3mt00132f; Reed S, 2018, J AGR FOOD CHEM, V66, P6291, DOI 10.1021/acs.jafc.8b01481; Reed S, 2015, NUTRIENTS, V7, P9768, DOI 10.3390/nu7125497; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sauer AK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01295; SILVER S, 1992, MICROBIOL REV, V56, P195, DOI 10.1128/MMBR.56.1.195-228.1992; Skrypnik K, 2018, J SCI FOOD AGR, V98, P2449, DOI 10.1002/jsfa.8724; Star L, 2012, POULTRY SCI, V91, P3115, DOI 10.3382/ps.2012-02314; Starke IC, 2014, FEMS MICROBIOL ECOL, V87, P416, DOI 10.1111/1574-6941.12233; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Suwendi E, 2012, BIOMED RES-TOKYO, V33, P329, DOI 10.2220/biomedres.33.329; Takagishi T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122708; Tran CD, 2007, DIGEST DIS SCI, V52, P2113, DOI 10.1007/s10620-007-9765-9; Tran CD, 1998, BIOL TRACE ELEM RES, V63, P239, DOI 10.1007/BF02778942; Tran CD, 1999, SCAND J GASTROENTERO, V34, P689, DOI 10.1080/003655299750025895; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tsuji T, 2013, INT J MOL MED, V31, P1037, DOI 10.3892/ijmm.2013.1294; Vagianos K, 2007, JPEN-PARENTER ENTER, V31, P311, DOI 10.1177/0148607107031004311; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; Van Acker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110015; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Vignesh KS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102197; Vowinkel T, 2004, DIGEST DIS SCI, V49, P556, DOI 10.1023/B:DDAS.0000026298.72088.f7; Waeytens A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/729172; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wang XX, 2010, IUBMB LIFE, V62, P176, DOI 10.1002/iub.291; Weisshof R, 2015, CURR OPIN CLIN NUTR, V18, P576, DOI 10.1097/MCO.0000000000000226; Wessels I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121286; Wiegand S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45649; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Xia T, 2017, ONCOTARGET, V8, P64878, DOI 10.18632/oncotarget.17612; Yeshi K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051273; Zackular JP, 2016, NAT MED, V22, P1330, DOI 10.1038/nm.4174	110	9	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12615	12633		10.1096/fj.202000562RR	http://dx.doi.org/10.1096/fj.202000562RR		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729971				2022-12-28	WOS:000556799500001
J	Mao, Y; Lv, M; Cao, WH; Liu, XY; Cui, J; Wang, YM; Wang, YY; Nie, G; Liu, XP; Wang, HB				Mao, Yan; Lv, Meng; Cao, Weihong; Liu, Xiaoyi; Cui, Jian; Wang, Yongmei; Wang, Yuanyuan; Nie, Gang; Liu, Xiangping; Wang, Haibo			Circular RNA 000554 represses epithelial-mesenchymal transition in breast cancer by regulating microRNA-182/ZFP36 axis	FASEB JOURNAL			English	Article						breast cancer; circular RNA 000554; epithelial-to-mesenchymal transition; microRNA-182; ZFP36	CELL-CYCLE; METASTASIS; INVASION; PROLIFERATION; PROGRESSION; BIOMARKERS; MICRORNAS; AUTOPHAGY; THERAPY	Increasing evidence indicates that circular RNAs (circRNAs) play a crucial role in regulating microRNAs (miRs) and mRNAs during breast cancer (BC) progression. Based on the in silico analysis of circRNA/miR/mRNA in BC, we aim to define an important role of circRNA_000554 in BC in relation to miR-182 and zinc finger protein 36 (ZFP36). Low expression of circRNA_000554 and ZFP36, and high miR-182 expression were determined in the clinical BC tissues. CircRNA_000554 acted as a sponge of miR-182, and miR-182 directly targeted ZFP36. After that, in order to evaluate the effects of circRNA_000554, miR-182, and ZFP36 on cellular process, we evaluated in vitro epithelial-mesenchymal transition (EMT) and in vivo tumor growth after delivering a series of overexpression plasmids, mimic, inhibitor, or shRNAs into BC cells. Increasing circRNA_000554 suppressed EMT, cell invasion and migration during BC by depleting miR-182 and increasing ZFP36. The inhibitory effect of circRNA_000554 on tumor growth was validated in vivo. Taken together, the present study confirms that circRNA_000554 functioned as an inhibitor of EMT in BC and suggests a molecular mechanism that circRNA_000554 bound to miR-182 to upregulate ZFP36 in this process.	[Mao, Yan; Lv, Meng; Cao, Weihong; Liu, Xiaoyi; Cui, Jian; Wang, Yongmei; Wang, Yuanyuan; Nie, Gang; Wang, Haibo] Qingdao Univ, Breast Dis Ctr, Affiliated Hosp, 59 Haier Rd, Qingdao 266071, Shandong, Peoples R China; [Liu, Xiangping] Qingdao Univ, Cent Lab Mol Biol, Affiliated Hosp, Qingdao, Peoples R China	Qingdao University; Qingdao University	Mao, Y; Wang, HB (corresponding author), Qingdao Univ, Breast Dis Ctr, Affiliated Hosp, 59 Haier Rd, Qingdao 266071, Shandong, Peoples R China.	nancyelin@yeah.net; hbwang66@126.com	wangwangwang, yuanyaun/HHN-6432-2022; Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; Wang, Yu/GZL-9655-2022		Natural Science Doctoral Funding of Shandong Province [ZR2017BH061, ZR2018BH023, ZR2019BH013]; Qingdao Science and Technology Innovation Plan [17-1-1-54-jch]; Qingdao University; Qingdao University Affiliated Hospital	Natural Science Doctoral Funding of Shandong Province; Qingdao Science and Technology Innovation Plan; Qingdao University; Qingdao University Affiliated Hospital	This study was supported by the Natural Science Doctoral Funding of Shandong Province (ZR2017BH061, ZR2018BH023 and ZR2019BH013), Funding from Qingdao Science and Technology Innovation Plan (17-1-1-54-jch), Postdoctoral Funding from Qingdao City, Youth Funding from Qingdao University, and Excellent Funding from Qingdao University Affiliated Hospital	Barrios-Garcia T, 2014, J BIOL CHEM, V289, P15554, DOI 10.1074/jbc.M114.548552; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Chen YN, 2018, ADV SCI, V5, DOI 10.1002/advs.201700964; Cheng Z, 2017, ONCOTARGET, V8, P67933, DOI 10.18632/oncotarget.18913; Chiang CH, 2016, AM J CANCER RES, V6, P1785; Dai XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0485-1; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Ding JJ, 2019, LIFE SCI, V228, P112, DOI 10.1016/j.lfs.2019.04.069; Dittmer J, 2018, SEMIN CANCER BIOL, V53, P59, DOI 10.1016/j.semcancer.2018.07.007; Dong F, 2018, EXP CELL RES, V367, P89, DOI 10.1016/j.yexcr.2018.03.028; Du WW, 2018, ONCOGENE, V37, P5829, DOI 10.1038/s41388-018-0369-y; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Fu B, 2018, EPIGENOMICS-UK, V10, P1619, DOI 10.2217/epi-2018-0090; Garcia-Estevez L, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1124-1; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Hsieh TH, 2015, ONCOTARGET, V6, P494, DOI 10.18632/oncotarget.2674; Li P, 2018, CELL PHYSIOL BIOCHEM, V46, P1606, DOI 10.1159/000489208; Li X, 2018, MOL CELL, V71, P428, DOI 10.1016/j.molcel.2018.06.034; Liguori M, 2018, HUM MOL GENET, V27, P66, DOI 10.1093/hmg/ddx385; Liu ZH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1287-1; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Nassar FJ, 2017, PHARMACOL THERAPEUT, V172, P34, DOI 10.1016/j.pharmthera.2016.11.012; Nicolini A, 2018, SEMIN CANCER BIOL, V52, P56, DOI 10.1016/j.semcancer.2017.08.010; Ponde NF, 2019, NAT REV CLIN ONCOL, V16, P27, DOI 10.1038/s41571-018-0089-9; Ren CN, 2018, MOL ONCOL, V12, P690, DOI 10.1002/1878-0261.12192; Su M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1002-6; Szabo L, 2016, NAT REV GENET, V17, P679, DOI 10.1038/nrg.2016.114; Wang XH, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0870-8; Wu X, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0382-1; Xu JZ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1382-y; Xu L, 2015, ONCOTARGET, V6, P41679, DOI 10.18632/oncotarget.6149; Yang R, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0933-7; Yin RT, 2013, J VASC RES, V50, P157, DOI 10.1159/000345697; Yoon NA, 2016, ONCOTARGET, V7, P8931, DOI 10.18632/oncotarget.7094; Yu JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13884; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhang WJ, 2015, J BIOL CHEM, V290, P13812, DOI 10.1074/jbc.M115.653261; Zhang XZ, 2017, ONCOL LETT, V14, P4805, DOI 10.3892/ol.2017.6778; Zhao JZ, 2018, CELL CYCLE, V17, P2731, DOI 10.1080/15384101.2018.1556058; Zhao YS, 2019, YONSEI MED J, V60, P148, DOI 10.3349/ymj.2019.60.2.148	40	16	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11405	11420		10.1096/fj.201903047R	http://dx.doi.org/10.1096/fj.201903047R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729957				2022-12-28	WOS:000556800900001
J	Hao, DD; Wang, Y; Li, LY; Qian, G; Liu, J; Li, MM; Zhang, YH; Zhou, RX; Yan, DP				Hao, Doudou; Wang, Yu; Li, Liuyan; Qian, Gui; Liu, Jing; Li, Manman; Zhang, Yihua; Zhou, Ruixue; Yan, Dapeng			SHP-1 suppresses the antiviral innate immune response by targeting TRAF3	FASEB JOURNAL			English	Article						immune signaling transduction; immunoregulation; protein-protein interaction; type I interferon; virus infection	CYCLIC GMP-AMP; NEGATIVE REGULATION; IFN-BETA; ACTIVATION; PROTEIN; UBIQUITINATION; PHOSPHATASES; EXPRESSION; INDUCTION; SENSOR	Type I interferons play a pivotal role in innate immune response to virus infection. The protein tyrosine phosphatase SHP-1 was reported to function as a negative regulator of inflammatory cytokine production by inhibiting activation of NF-kappa B and MAPKs during bacterial infection, however, the role of SHP-1 in regulating type I interferons remains unknown. Here, we demonstrated that knockout or knockdown of SHP-1 in macrophages promoted both HSV-1- and VSV-induced antiviral immune response. Conversely, overexpression of SHP-1 in L929 cells suppressed the HSV-1- and VSV-induced immune response; suppression was directly dependent on phosphatase activity. We identified a direct interaction between SHP-1 and TRAF3; the association between these two proteins resulted in diminished recruitment of CK1 epsilon to TRAF3 and inhibited its K63-linked ubiquitination; SHP-1 inhibited K63-linked ubiquitination of TRAF3 by promoting dephosphorylation at Tyr116 and Tyr446. Taken together, our results identify SHP-1 as a negative regulator of antiviral immunity and suggest that SHP-1 may be a target for intervention in acute virus infection.	[Hao, Doudou; Li, Liuyan; Qian, Gui; Liu, Jing; Li, Manman; Zhang, Yihua; Zhou, Ruixue; Yan, Dapeng] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Dongan Rd 130, Shanghai 200032, Peoples R China; [Hao, Doudou; Li, Liuyan; Qian, Gui; Liu, Jing; Li, Manman; Zhang, Yihua; Zhou, Ruixue; Yan, Dapeng] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dongan Rd 130, Shanghai 200032, Peoples R China; [Wang, Yu] Army Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing, Peoples R China; [Wang, Yu] Army Med Univ, NCO Sch, Dept Basic Courses, Shijiazhuang, Hebei, Peoples R China	Fudan University; Fudan University; Army Medical University; Army Medical University	Yan, DP (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, Dongan Rd 130, Shanghai 200032, Peoples R China.; Yan, DP (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dongan Rd 130, Shanghai 200032, Peoples R China.	dapengyan@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [31972900, 31670901, 81871249]; Shanghai Institutions of Higher Learning [TP2016007]; Outstanding Youth Training Program of Shanghai Municipal Commission of Health and Family Planning [2017YQ012]; National Key Research and Development Program of China [2016YFC1305103, 2018YFC1705505]; National Megaproject on Key Infectious Diseases [2017ZX10202102]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Institutions of Higher Learning; Outstanding Youth Training Program of Shanghai Municipal Commission of Health and Family Planning; National Key Research and Development Program of China; National Megaproject on Key Infectious Diseases	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31972900, 31670901 and 81871249; Shanghai Institutions of Higher Learning, Grant/Award Number: TP2016007; Outstanding Youth Training Program of Shanghai Municipal Commission of Health and Family Planning, Grant/Award Number: 2017YQ012; National Key Research and Development Program of China, Grant/Award Number: 2016YFC1305103 and 2018YFC1705505; National Megaproject on Key Infectious Diseases, Grant/Award Number: 2017ZX10202102	Abram CL, 2017, J LEUKOCYTE BIOL, V102, P657, DOI 10.1189/jlb.2MR0317-105R; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0; Chen XJ, 2014, PROTEIN CELL, V5, P369, DOI 10.1007/s13238-014-0026-3; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Garg M, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2019.09.006; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hutchinson EC, 2018, TRENDS MICROBIOL, V26, P809, DOI 10.1016/j.tim.2018.05.013; Khoury JD, 2004, BLOOD, V104, P1580, DOI 10.1182/blood-2004-03-1151; Kim SSY, 2014, J IMMUNOL, V193, P840, DOI 10.4049/jimmunol.1301601; Li HY, 2015, MICROBES INFECT, V17, P109, DOI 10.1016/j.micinf.2014.11.012; Liu JG, 2015, SCIENCE, V347, DOI 10.1126/science.1258832; Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Mao HT, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050146; Matthys VS, 2014, J VIROL, V88, P2246, DOI 10.1128/JVI.02647-13; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Nandan D, 2000, J LEUKOCYTE BIOL, V67, P464, DOI 10.1002/jlb.67.4.464; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2012, J BIOCHEM, V151, P5, DOI 10.1093/jb/mvr111; Radoshevich L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00313; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Towers GJ, 2014, CELL HOST MICROBE, V16, P10, DOI 10.1016/j.chom.2014.06.009; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Varble AJ, 2016, VIROLOGY, V499, P99, DOI 10.1016/j.virol.2016.09.009; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang S, 2013, J VIROL, V87, P11851, DOI 10.1128/JVI.01211-13; Watson NB, 2015, J IMMUNOL, V194, P2796, DOI 10.4049/jimmunol.1402210; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan DP, 2012, NAT IMMUNOL, V13, P1063, DOI 10.1038/ni.2417; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang LP, 2018, SCI CHINA TECHNOL SC, V6, P1; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zhao BY, 2016, P NATL ACAD SCI USA, V113, pE3403, DOI 10.1073/pnas.1603269113; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052; Zhou RX, 2019, EMERG MICROBES INFEC, V8, P734, DOI 10.1080/22221751.2019.1620589; Zhou Y, 2016, NAT IMMUNOL, V17, P397, DOI 10.1038/ni.3395; Zhu Z, 2010, IMMUNOL RES, V47, P3, DOI 10.1007/s12026-009-8134-5	48	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12392	12405		10.1096/fj.202000600RR	http://dx.doi.org/10.1096/fj.202000600RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32779804	Green Published			2022-12-28	WOS:000555047300001
J	Liu, FK; Yuan, MT; Li, CL; Guan, X; Li, B				Liu, Fukai; Yuan, Mengtong; Li, Chenlong; Guan, Xue; Li, Bai			The protective function of taurine on pesticide-induced permanent neurodevelopmental toxicity in juvenile rats	FASEB JOURNAL			English	Article						hippocampal; maneb; neuroprotection; paraqua	TRANSCRIPTION FACTORS; PARKINSONS-DISEASE; DEVELOPMENTAL EXPOSURE; SYNAPTIC PLASTICITY; C-FOS; PARAQUAT; MEMORY; MANEB; NEUROGENESIS; HIPPOCAMPAL	Numerous studies have confirmed that prenatal or early postnatal exposure to pesticides can lead to functional deficits in the developing brain. This study aimed to investigate whether combined exposure to paraquat (PQ) and maneb (MB) during puberty could cause permanent toxic effects in the neural system of rats. In addition, the neuroprotective function of taurine (T) and its possible mechanism were investigated. Rats were administered PQ + MB intragastrically for 12 continuous weeks, while taurine dissolved in water was fed to the rats for 24 continuous weeks. In the behavioral tests, the rats' trajectories became complex, and the reaction latencies and mistake frequencies increased. Significant changes were found in the hippocampal neurons of the PQ + MB groups but not in the taurine treatment groups. PQ + MB stimulated cAMP to reduce the production of protein kinase A (PKA) and inhibited the activation of other elements, such as brain-derived neurotrophic factor (BDNF), cAMP response element binding protein (CREB), phospho-CREB (p-CREB), immediate-early genes (IEGs)Arc, and c-Fos. Importantly, taurine regulated the level of cAMP and the expression of the abovementioned proteins. Together, our findings implied that adolescent exposure to PQ + MB may impact the behavior and cognitive function of rats via the cAMP-PKA-CREB signaling pathway, while taurine may in turn exert neuroprotection by diminishing these impacts.	[Liu, Fukai] Harbin Med Univ, Affiliated Hosp 1, Anim Lab Ctr, Harbin, Peoples R China; [Yuan, Mengtong] Harbin Med Univ, Affiliated Hosp 2, Dept Prosthodont, Harbin, Peoples R China; [Li, Chenlong] Harbin Med Univ, Canc Hosp, Dept Neurosurg, Harbin, Peoples R China; [Guan, Xue] Harbin Med Univ, Affiliated Hosp 2, Anim Lab Ctr, Harbin, Peoples R China; [Li, Bai] Harbin Med Univ, Coll Publ Hlth, Dept Toxicol, Harbin 150081, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, B (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Toxicol, Harbin 150081, Peoples R China.; Guan, X (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Anim Lab Ctr, Xuefu Rd 246, Harbin 150081, Peoples R China.	guanxue2019@163.com; hmuleetina@163.com	li, bai/GRJ-4913-2022; li, bz/GVR-7133-2022					ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; Andersen HR, 2015, NEUROTOXICOL TERATOL, V47, P1, DOI 10.1016/j.ntt.2014.10.006; Che YN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0468-2; Chen WQ, 2001, J NEUROSCI RES, V66, P612, DOI 10.1002/jnr.10027; Colle D, 2020, NEUROTOX RES, V37, P210, DOI 10.1007/s12640-019-00097-9; Colle D, 2018, NEUROTOX RES, V34, P820, DOI 10.1007/s12640-018-9916-0; De Felice A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0617-4; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; El Idrissi A, 2019, ADV EXP MED BIOL, V1155, P977, DOI 10.1007/978-981-13-8023-5_81; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Gonzalez-Alzaga B, 2015, ENVIRON INT, V85, P229, DOI 10.1016/j.envint.2015.09.019; GULDNER FH, 1980, NEUROSCI LETT, V17, P27, DOI 10.1016/0304-3940(80)90056-7; Guo BQ, 2013, TOXICOLOGY, V304, P57, DOI 10.1016/j.tox.2012.11.019; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hagler DJ, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116091; Han Z, 2016, EUR J PHARMACOL, V777, P129, DOI 10.1016/j.ejphar.2016.03.006; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Hou LY, 2019, TOXICOLOGY, V417, P64, DOI 10.1016/j.tox.2019.02.011; Hou LY, 2018, AMINO ACIDS, V50, P547, DOI 10.1007/s00726-018-2547-1; Huang YH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01754; JONES DG, 1978, BRAIN RES, V147, P47, DOI 10.1016/0006-8993(78)90771-0; KACZMAREK L, 1993, J NEUROSCI RES, V34, P377, DOI 10.1002/jnr.490340402; Kaptan Z, 2015, BRAIN RES, V1618, P194, DOI 10.1016/j.brainres.2015.05.041; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kumari R, 2016, J SEP SCI, V39, P1725, DOI 10.1002/jssc.201501048; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Li B, 2016, MOL BIOSYST, V12, P3088, DOI 10.1039/c6mb00284f; Liu J, 2013, NUTR NEUROSCI, V16, P282, DOI 10.1179/1476830513Y.0000000057; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luciana M, 2018, DEV COGN NEUROS-NETH, V32, P67, DOI 10.1016/j.dcn.2018.02.006; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Ma J, 2013, NEUROCHEM INT, V62, P84, DOI 10.1016/j.neuint.2012.11.010; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mersman B, 2020, FRONT SYNAPTIC NEURO, V12, DOI 10.3389/fnsyn.2020.00029; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Narayan S, 2017, ENVIRON INT, V107, P266, DOI 10.1016/j.envint.2017.04.010; Nicol X, 2014, EUR J NEUROSCI, V39, P1742, DOI 10.1111/ejn.12543; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Rashid MA, 2016, NEUROPHARMACOLOGY, V102, P174, DOI 10.1016/j.neuropharm.2015.11.011; Roede JR, 2011, TOXICOL SCI, V121, P368, DOI 10.1093/toxsci/kfr058; Rosa AI, 2018, MOL NEUROBIOL, V55, P9139, DOI 10.1007/s12035-018-1062-4; Rudyk CA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00222; Sadeghian A, 2019, BASIC CLIN NEUROSCI, V10, P461, DOI 10.32598/bcn.9.10.330; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Shimizu-Sasamata M, 1998, J NEUROSCI, V18, P9564; Sobrido-Camean D, 2020, J NEUROTRAUM, V37, P899, DOI 10.1089/neu.2019.6604; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Sudhof TC, 2017, CELL, V171, P745, DOI 10.1016/j.cell.2017.10.024; Thiruchelvam M, 2002, NEUROTOXICOLOGY, V23, P621, DOI 10.1016/S0161-813X(02)00092-X; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Wu W, 2013, BEHAV BRAIN RES, V253, P212, DOI 10.1016/j.bbr.2013.07.052; Zhu XY, 2016, BRAIN RES BULL, V124, P295, DOI 10.1016/j.brainresbull.2016.06.010	57	4	4	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21273	10.1096/fj.202001290R	http://dx.doi.org/10.1096/fj.202001290R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368748				2022-12-28	WOS:000605626600019
J	Al Khazal, F; Kang, S; Holte, MN; Choi, DS; Singh, R; Ortega-Saenz, P; Lopez-Barneo, J; Maher, LJ				Al Khazal, Fatimah; Kang, Seungwoo; Holte, Molly Nelson; Choi, Doo-Sup; Singh, Ravinder; Ortega-Saenz, Patricia; Lopez-Barneo, Jose; Maher, L. James, III			Unexpected obesity, rather than tumorigenesis, in a conditional mouse model of mitochondrial complex II deficiency	FASEB JOURNAL			English	Article						catecholamines; dopaminergic cells; familial paraganglioma; mouse; mitochondrial disease; obesity; succinate dehydrogenase; tyrosine hydroxylase	CLINICAL-PRACTICE; PHEOCHROMOCYTOMA; HYPOXIA; SUCCINATE; PARAGANGLIOMA; MECHANISMS; MUTATIONS; CELLS; SDHB	Mutations in any of the genes encoding the four subunits of succinate dehydrogenase (SDH), a mitochondrial membrane-bound enzyme complex that is involved in both the tricarboxylic acid cycle and the electron transport chain, can lead to a variety of disorders. Recognized conditions with such mutations include Leigh syndrome and hereditary tumors such as pheochromocytoma and paraganglioma (PPGL), renal cell carcinoma, and gastrointestinal stromal tumor. Tumors appear in SDH mutation carriers with dominant inheritance due to loss of heterozygosity in susceptible cells. Here, we describe a mouse model intended to reproduce hereditary PPGL through Cre-mediated loss of SDHC in cells that express tyrosine hydroxylase (TH), a compartment where PPGL is known to originate. We report that while there is modest expansion of TH+ glomus cells in the carotid body upon SDHC loss, PPGL is not observed in such mice, even in the presence of a conditional dominant negative p53 protein and chronic hypoxia. Instead, we report an unexpected phenotype of nondiabetic obesity beginning at about 20 weeks of age. We hypothesize that this obesity is caused by TH+ cell loss or altered phenotype in key compartments of the central nervous system responsible for regulating feeding behavior, coupled with metabolic changes due to loss of peripheral catecholamine production.	[Al Khazal, Fatimah; Holte, Molly Nelson; Maher, L. James, III] Mayo Clin, Dept Biochem & Mol Biol, Coll Med & Sci, 200 First St SW, Rochester, MN 55905 USA; [Kang, Seungwoo; Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Singh, Ravinder] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Ortega-Saenz, Patricia; Lopez-Barneo, Jose] Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain	Mayo Clinic; Mayo Clinic; Mayo Clinic; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Maher, LJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Coll Med & Sci, 200 First St SW, Rochester, MN 55905 USA.	maher@mayo.edu	; Kang, Seungwoo/K-5130-2015; Lopez Barneo, Jose/B-4050-2013	Choi, Doo-Sup/0000-0002-6796-9938; Kang, Seungwoo/0000-0003-1301-8480; Maher, Louis/0000-0002-5043-6422; Lopez Barneo, Jose/0000-0003-4101-6095	Paradifference Foundation; NIH NIAAA [AA018779, AA027773]; Spanish Ministries of Science and Innovation and Health [SAF2016-74990-R]; European Research Council [ERC-ADGPRJ201502629]	Paradifference Foundation; NIH NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Spanish Ministries of Science and Innovation and Health; European Research Council(European Research Council (ERC)European Commission)	Paradifference Foundation (FAK, MNH, LJM); NIH NIAAA AA018779 (SK, D-SC); NIH NIAAA AA027773 (SK); Spanish Ministries of Science and Innovation and Health SAF2016-74990-R (PO-S, JL-B); European Research Council ERC-ADGPRJ201502629 (PO-S, JL-B)	Al Khazal F, 2019, FASEB J, V33, P13189, DOI 10.1096/fj.201802655RR; Amorim-Pires D, 2016, CYTOGENET GENOME RES, V150, P227, DOI 10.1159/000457479; Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426; BAHNSEN M, 1984, AM J PHYSIOL, V247, pE173, DOI 10.1152/ajpendo.1984.247.2.E173; Bayley JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007987; Bishop T, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aba1302; Bishop T, 2013, J PHYSIOL-LONDON, V591, P3565, DOI 10.1113/jphysiol.2012.247254; Boekhoudt L, 2017, INT J OBESITY, V41, P1131, DOI 10.1038/ijo.2017.74; Buffet A, 2020, BEST PRACT RES CL EN, V34, DOI 10.1016/j.beem.2020.101416; Castro-Vega LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7044; Dadalko OI, 2015, HELIYON, V1, DOI 10.1016/j.heliyon.2015.e00025; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Diaz-Castro B, 2012, MOL CELL BIOL, V32, P3347, DOI 10.1128/MCB.00128-12; Fielding JW, 2018, J PHYSIOL-LONDON, V596, P4393, DOI 10.1113/JP275996; Gill AJ, 2010, HUM PATHOL, V41, P805, DOI 10.1016/j.humpath.2009.12.005; Her YF, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/296167; Hill Jennifer W, 2012, Indian J Endocrinol Metab, V16, pS627, DOI 10.4103/2230-8210.105581; Hockman D, 2018, DEV BIOL, V444, pS308, DOI 10.1016/j.ydbio.2018.05.016; Jochmanova I, 2015, HORM CANCER-US, V6, P191, DOI 10.1007/s12672-015-0231-4; Kluckova K, 2018, CELL TISSUE RES, V372, P367, DOI 10.1007/s00441-018-2801-6; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Lepoutre-Lussey C, 2016, MOL CELL ENDOCRINOL, V421, P40, DOI 10.1016/j.mce.2015.06.027; Lopez-Barneo J, 2016, AM J PHYSIOL-CELL PH, V310, pC629, DOI 10.1152/ajpcell.00265.2015; Lussey-Lepoutre C, 2018, CELL TISSUE RES, V372, P379, DOI 10.1007/s00441-018-2797-y; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Maher LJ, 2011, PHEOCHROMOCYTOMA NEW; Millan-Ucles A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085528; Morin A, 2020, CELL REP, V30, P4551, DOI 10.1016/j.celrep.2020.03.022; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943; Pang Y, 2019, CANCERS, V11, DOI 10.3390/cancers11040436; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Powers JF, 2020, ENDOCR-RELAT CANCER, V27, P337, DOI 10.1530/ERC-19-0474; Preite NZ, 2016, J ENDOCRINOL, V231, P259, DOI 10.1530/JOE-16-0199; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Smestad J, 2018, ONCOTARGET, V9, P5864; Smestad J, 2018, ISCIENCE, V2, P63, DOI 10.1016/j.isci.2018.03.012; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Ushiama S, 2016, EBIOMEDICINE, V8, P60, DOI 10.1016/j.ebiom.2016.04.031; van Nederveen FH, 2003, MODERN PATHOL, V16, P849, DOI 10.1097/01.MP.0000084111.03922.4D; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wagener A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.4	45	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002100R	http://dx.doi.org/10.1096/fj.202002100R		NOV 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33247500	hybrid, Green Published			2022-12-28	WOS:000594744000001
J	Li, HB; Cui, XJ; Sun, LX; Deng, XY; Liu, S; Zou, XH; Li, BB; Wang, CL; Wang, YM; Liu, YM; Lu, BH; Cao, B				Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Deng, Xiaoyan; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin			High concentration of Cas12a effector tolerates more mismatches on ssDNA	FASEB JOURNAL			English	Article						Cas12a; CRISPR; Cas; Mycobacterium tuberculosis; pathogen detection; trans&#8208; cleavage activity	RNA; CRISPR-CAS9; DIAGNOSTICS; PCR	Rapid pathogen detection is critical for prompt treatment, interrupting transmission routes, and decreasing morbidity and mortality. The V-type CRISPR system had been used for rapid pathogen detection. However, whether single-stranded DNA in CRISPR system can cause false positives remains undetermined. Herein, we show that high molar concentration of Cas12a effector tolerated more mismatches on ssDNA and activated its trans-cleavage activity at six base matches. Reducing Cas12a and crRNA molar concentration increased the minimal base-match number required for Cas12a ssDNA activation to 11, which reducing nonspecific activation. We then established a Cas12a-based M tuberculosis detection system with a primer having an 8 bp overlap with crRNA. This system did not exhibit primer-induced false positives, and minimum detection copy reached 1 copy/uL (inputting 1-mu L sample) in standard strains. The Cas12a-based M tuberculosis detection system showed 80.0% sensitivity and 100.0% specificity in verification using clinical specimens, compared with Xpert MTB/RIF, which showed 72.0% sensitivity and 90.9% specificity. All these results prove that appropriate concentration of cas12a effector can effectively perform nucleic acid detection.	[Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Deng, Xiaoyan; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Dis, Lab Clin Microbiol & Infect Dis, 2 East Yinghua Rd, Beijing 100029, Peoples R China; [Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China; [Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin] Capital Med Univ, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Deng, Xiaoyan; Liu, Shuai; Wang, Yeming; Cao, Bin] Capital Med Univ, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Clin Ctr Pulm Infect, Beijing, Peoples R China	China-Japan Friendship Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Capital Medical University	Lu, BH; Cao, B (corresponding author), China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Dis, Lab Clin Microbiol & Infect Dis, 2 East Yinghua Rd, Beijing 100029, Peoples R China.	zs25041@126.com; caobin_ben@163.com	Li, Haibo/AAZ-5395-2021		Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019TX320004]; Sanming Project of Medicine in Shenzhen [SZSM201911009]	Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; Sanming Project of Medicine in Shenzhen	This work supported by the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2019TX320004) and Sanming Project of Medicine in Shenzhen (No. SZSM201911009).	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006; Barrangou R, 2017, MOL CELL, V65, P582, DOI 10.1016/j.molcel.2017.02.002; Bhattacharyya RP, 2018, ACS INFECT DIS, V4, P1278, DOI 10.1021/acsinfecdis.8b00170; Bratovic M, 2020, NAT CHEM BIOL, V16, P587, DOI 10.1038/s41589-020-0490-4; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Chertow DS, 2018, SCIENCE, V360, P381, DOI 10.1126/science.aat4982; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; de la Fuente-Nunez C, 2017, INTEGR BIOL-UK, V9, P109, DOI 10.1039/c6ib00140h; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Hamano-Hasegawa Keiko, 2008, Journal of Infection and Chemotherapy, V14, P424, DOI 10.1007/s10156-008-0648-6; Harrington LB, 2018, SCIENCE, V362, P839, DOI 10.1126/science.aav4294; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jain I, 2019, RNA BIOL, V16, P413, DOI 10.1080/15476286.2018.1495492; Kim S, 2020, NATURE, V579, P141, DOI 10.1038/s41586-020-2018-1; Kothari A, 2014, CLIN INFECT DIS, V59, P272, DOI 10.1093/cid/ciu292; Li HB, 2019, PROTEIN CELL, V10, P20, DOI 10.1007/s13238-018-0556-1; Li SY, 2018, CELL RES, V28, P491, DOI 10.1038/s41422-018-0022-x; Maxmen A, 2019, NATURE, V566, P437, DOI 10.1038/d41586-019-00601-3; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Piatek A, 2017, CRIT REV BIOTECHNOL, V37, P429, DOI 10.3109/07388551.2016.1165180; Rappo U, 2016, J CLIN MICROBIOL, V54, P2096, DOI 10.1128/JCM.00549-16; Sashital DG, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0543-4; Stower H, 2018, NAT MED, V24, P702, DOI 10.1038/s41591-018-0073-z; Teng F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1742-z; Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396; Xu L, 2019, NEW ENGL J MED, V381, P1240, DOI 10.1056/NEJMoa1817426; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yan WX, 2018, MOL CELL, V70, P327, DOI 10.1016/j.molcel.2018.02.028; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang C, 2018, CELL, V175, P212, DOI 10.1016/j.cell.2018.09.001	31	2	2	13	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001475R	http://dx.doi.org/10.1096/fj.202001475R		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33159392				2022-12-28	WOS:000592448100001
J	Yee, SW; Buitrago, D; Stecula, A; Ngo, HX; Chien, HC; Zou, L; Koleske, ML; Giacomini, KM				Yee, Sook Wah; Buitrago, Dina; Stecula, Adrian; Ngo, Huy X.; Chien, Huan-Chieh; Zou, Ling; Koleske, Megan L.; Giacomini, Kathleen M.			Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies	FASEB JOURNAL			English	Article						carnitine; carnosine; ergothioneine; metabolomic; transporter	THIAMINE TRANSPORTER; CARNITINE DEFICIENCY; CATION TRANSPORTERS; WIDE ASSOCIATION; PROTEIN-SEQUENCE; ERGOTHIONEINE; CARNOSINE; ACID; IDENTIFICATION; DISCOVERY	The human solute carrier 22A (SLC22A) family consists of 23 members, representing one of the largest families in the human SLC superfamily. Despite their pharmacological and physiological importance in the absorption and disposition of a range of solutes, eight SLC22A family members remain classified as orphans. In this study, we used a multifaceted approach to identify ligands of orphan SLC22A15. Ligands of SLC22A15 were proposed based on phylogenetic analysis and comparative modeling. The putative ligands were then confirmed by metabolomic screening and uptake assays in SLC22A15 transfected HEK293 cells. Metabolomic studies and transporter assays revealed that SLC22A15 prefers zwitterionic compounds over cations and anions. We identified eight zwitterions, including ergothioneine, carnitine, carnosine, gabapentin, as well as four cations, including MPP+, thiamine, and cimetidine, as substrates of SLC22A15. Carnosine was a specific substrate of SLC22A15 among the transporters in the SLC22A family. SLC22A15 transport of several substrates was sodium-dependent and exhibited a higher Km for ergothioneine, carnitine, and carnosine compared to previously identified transporters for these ligands. This is the first study to characterize the function of SLC22A15. Our studies demonstrate that SLC22A15 may play an important role in determining the systemic and tissue levels of ergothioneine, carnosine, and other zwitterions.	[Yee, Sook Wah; Buitrago, Dina; Stecula, Adrian; Ngo, Huy X.; Chien, Huan-Chieh; Zou, Ling; Koleske, Megan L.; Giacomini, Kathleen M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Giacomini, Kathleen M.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Giacomini, KM (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	kathy.giacomini@ucsf.edu	Giacomini, Kathleen/AEF-2452-2022	Koleske, Megan/0000-0002-9826-6442; Buitrago Silva, Dina/0000-0003-1656-2406	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK108722]; National Science Foundation Graduate Research Fellowship Program (NSF GRFP)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD))	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK108722; National Science Foundation Graduate Research Fellowship Program (NSF GRFP)	Bennett KM, 2011, MOL CELL BIOCHEM, V352, P143, DOI 10.1007/s11010-011-0748-y; BRIGGS I, 1972, J NEUROCHEM, V19, P27, DOI 10.1111/j.1471-4159.1972.tb01250.x; Chaleckis R, 2016, P NATL ACAD SCI USA, V113, P4252, DOI 10.1073/pnas.1603023113; Cheah IK, 2016, BIOCHEM BIOPH RES CO, V478, P162, DOI 10.1016/j.bbrc.2016.07.074; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Chmielewska K, 2020, CHEM RES TOXICOL, V33, P1561, DOI 10.1021/acs.chemrestox.0c00010; Christie David L., 2007, V46, P99; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Dodd JR, 2010, J NEUROCHEM, V115, P684, DOI 10.1111/j.1471-4159.2010.06957.x; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Drake KA, 2014, J ALLERGY CLIN IMMUN, V133, P370, DOI 10.1016/j.jaci.2013.06.043; Dubail J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05191-8; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062002; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051791; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Eraly SA, 2002, BIOCHEM BIOPH RES CO, V297, P1159, DOI 10.1016/S0006-291X(02)02343-4; Fernandes CF, 2007, BIOCHEM BIOPH RES CO, V361, P26, DOI 10.1016/j.bbrc.2007.06.160; Franzoni F, 2006, BIOMED PHARMACOTHER, V60, P453, DOI 10.1016/j.biopha.2006.07.015; Geier EG, 2013, P NATL ACAD SCI USA, V110, P5480, DOI 10.1073/pnas.1218165110; Ghodsi R, 2018, AMINO ACIDS, V50, P1177, DOI 10.1007/s00726-018-2592-9; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Goswami S, 2016, CLIN PHARMACOL THER, V100, P537, DOI 10.1002/cpt.428; Grigat S, 2007, BIOCHEM PHARMACOL, V74, P309, DOI 10.1016/j.bcp.2007.04.015; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Hatano T, 2016, J NEUROL NEUROSUR PS, V87, P295, DOI 10.1136/jnnp-2014-309676; Hipkiss AR, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-38; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; Hwang B, 2019, J NUTR BIOCHEM, V74, DOI 10.1016/j.jnutbio.2019.108230; Ito S, 2019, PHARM RES-DORDR, V36, DOI 10.1007/s11095-018-2565-4; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kamal MA, 2009, AM J PHYSIOL-REG I, V296, pR986, DOI 10.1152/ajpregu.90744.2008; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kim HI, 2017, AM J HUM GENET, V101, P489, DOI 10.1016/j.ajhg.2017.08.008; Knottnerus SJG, 2018, REV ENDOCR METAB DIS, V19, P93, DOI 10.1007/s11154-018-9448-1; Koepsell H, 2020, PHARMACOL REV, V72, P253, DOI 10.1124/pr.118.015578; Liang XM, 2015, MOL PHARMACEUT, V12, P4301, DOI 10.1021/acs.molpharmaceut.5b00501; LIU W, 1995, BBA-BIOMEMBRANES, V1235, P461, DOI 10.1016/0005-2736(95)80036-F; Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809; Maruyama SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36468; Masuo Y, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2507-1; Meixner E, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209652; Menon K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020623; Mikula-Pietrasik J, 2016, ANTICANCER RES, V36, P665; Mitsuyama H, 1999, CLIN SCI, V97, P407, DOI 10.1042/CS19990111; Morrissey KM, 2013, ANNU REV PHARMACOL, V53, P503, DOI 10.1146/annurev-pharmtox-011112-140317; MOTOHASHI N, 1986, J INORG BIOCHEM, V26, P205, DOI 10.1016/0162-0134(86)80042-3; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Ohashi R, 2001, MOL PHARMACOL, V59, P358, DOI 10.1124/mol.59.2.358; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; Okada R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121535; Parvez MM, 2016, ANTIMICROB AGENTS CH, V60, P6558, DOI 10.1128/AAC.01151-16; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Perland E, 2017, TRENDS PHARMACOL SCI, V38, P305, DOI 10.1016/j.tips.2016.11.008; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; ROUGEE M, 1988, PHOTOCHEM PHOTOBIOL, V47, P485, DOI 10.1111/j.1751-1097.1988.tb08835.x; Rusu V, 2017, CELL, V170, P199, DOI 10.1016/j.cell.2017.06.011; Sakrak O, 2008, J SURG RES, V144, P36, DOI 10.1016/j.jss.2007.04.020; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Shen H, 1999, AM J PHYSIOL-RENAL, V276, pF658, DOI 10.1152/ajprenal.1999.276.5.F658; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Sugiura T, 2010, DRUG METAB DISPOS, V38, P1665, DOI 10.1124/dmd.110.032763; Superti-Furga G, 2020, NAT REV DRUG DISCOV, V19, P429, DOI 10.1038/d41573-020-00056-6; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Todesco L, 2008, CELL MOL LIFE SCI, V65, P1596, DOI 10.1007/s00018-008-8065-7; Tschirka J, 2018, DRUG METAB DISPOS, V46, P779, DOI 10.1124/dmd.118.080440; Uemura T, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-020-2779-0; Urban TJ, 2007, PHARMACOGENET GENOM, V17, P773, DOI 10.1097/FPC.0b013e3281c6d08e; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; WABER LJ, 1982, J PEDIATR-US, V101, P700, DOI 10.1016/S0022-3476(82)80294-1; Wagner CA, 2000, AM J PHYSIOL-RENAL, V279, pF584, DOI 10.1152/ajprenal.2000.279.3.F584; Wang LZ, 2013, J MASS SPECTROM, V48, P406, DOI 10.1002/jms.3150; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wright SH, 2019, AM J PHYSIOL-RENAL, V317, pF1669, DOI 10.1152/ajprenal.00422.2019; Wu GY, 2020, AMINO ACIDS, V52, P329, DOI 10.1007/s00726-020-02823-6; Xiang JM, 2006, BRAIN RES, V1122, P18, DOI 10.1016/j.brainres.2006.09.013; Yee SW, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008208; Zamek-Gliszczynski MJ, 2018, CLIN PHARMACOL THER, V104, P890, DOI 10.1002/cpt.1112; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang ZW, 2014, J CANCER, V5, P382, DOI 10.7150/jca.8024; Zhu GQ, 2019, CARCINOGENESIS, V40, P1121, DOI 10.1093/carcin/bgz010; Zou L, 2018, MOL PHARMACOL, V94, P689, DOI 10.1124/mol.117.111153	86	12	12	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15734	15752		10.1096/fj.202001497R	http://dx.doi.org/10.1096/fj.202001497R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124720	Green Accepted, Bronze			2022-12-28	WOS:000586276400001
J	Zhen, H; Deng, HK; Song, Q; Zheng, MY; Yuan, ZQ; Cao, ZH; Pang, QX; Zhao, BS				Zhen, Hui; Deng, Hongkuan; Song, Qian; Zheng, Mingyue; Yuan, Zuoqing; Cao, Zhonghong; Pang, Qiuxiang; Zhao, Bosheng			The Wnt/Ca2+ signaling pathway is essential for the regeneration of GABAergic neurons in planarian Dugesia japonica	FASEB JOURNAL			English	Article						brain regeneration; function; GABAergic neuron; Wnt; Ca2+ signaling pathway	CONVERGENT EXTENSION MOVEMENTS; CENTRAL-NERVOUS-SYSTEM; ADULT ZEBRAFISH BRAIN; PROTEIN-KINASE-II; STEM-CELLS; DOPAMINERGIC-NEURONS; GABA(A) RECEPTORS; NEURAL-NETWORK; WNT; NEUROGENESIS	The growth and differentiation of neurons are critical events in the establishment of proper neuron connectivity and function. Planarians have a remarkable ability to completely regenerate a functional nervous system from a pluripotent stem cell population. Thus, planarians provide a powerful model to identify genes required for neuronal differentiation in vivo. The Wnt/Ca2+ signaling pathway is crucial for cancer development, arousing inflammatory responses, and neurodegeneration. We analyzed the expression patterns and RNAi phenotypes for members of the Wnt/Ca2+ signaling pathway in the planarian, Dugesia japonica. The expression of DjWnt5a, DjPLC-beta, DjCamKII, and DjCaln during regeneration was surprisingly similar and revealing in the regenerated brain. RNAi knockdown of DjWnt5a, DjPLC-beta, DjCamKII, and DjCaln led to defects in regenerated brains including brain partial deletions, incompact phenotypes at the posterior of the new brain, and lateral branches, which could not regenerate. Furthermore, the expressions of GAD and the number of GABAergic neurons decreased. Together, these results suggest that the Wnt/Ca2+ signaling pathway is required for GABAergic neuron regeneration.	[Zhen, Hui; Deng, Hongkuan; Song, Qian; Yuan, Zuoqing; Cao, Zhonghong; Zhao, Bosheng] Shandong Univ Technol, Lab Dev & Evolutionary Biol, 266 Xincun West Rd, Zibo 255000, Shandong, Peoples R China; [Deng, Hongkuan; Yuan, Zuoqing; Cao, Zhonghong; Pang, Qiuxiang] Shandong Univ Technol, Sch Life Sci, Zibo, Shandong, Peoples R China; [Zheng, Mingyue] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Shandong University of Technology; Shandong University of Technology; Ocean University of China	Zhao, BS (corresponding author), Shandong Univ Technol, Lab Dev & Evolutionary Biol, 266 Xincun West Rd, Zibo 255000, Shandong, Peoples R China.	zhaobosheng@sdut.edu.cn	Zheng, Mingyue/HHZ-4062-2022	Zheng, Mingyue/0000-0002-3323-3092	National Natural Science Foundation of China [31970430, 31572263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31970430 and 31572263	Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Brown DDR, 2018, DEV BIOL, V433, P374, DOI 10.1016/j.ydbio.2017.08.024; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Cajal S., 1928, DEGENERATION REGENER; Cebria F, 2007, DEV GENES EVOL, V217, P733, DOI 10.1007/s00427-007-0188-6; Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Coullery RP, 2016, NEUROTOXICOLOGY, V52, P150, DOI 10.1016/j.neuro.2015.12.004; Cowles MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004746; Cowles MW, 2013, DEVELOPMENT, V140, P4691, DOI 10.1242/dev.098616; Cowles MW, 2012, DEV DYNAM, V241, P901, DOI 10.1002/dvdy.23775; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Currie KW, 2016, ELIFE, V5, DOI 10.7554/eLife.19735; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GOTO S, 1986, ACTA NEUROPATHOL, V72, P150, DOI 10.1007/BF00685977; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GUPTA RC, 1985, CAN J PHYSIOL PHARM, V63, P1000, DOI 10.1139/y85-165; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Hill EM, 2015, DEVELOPMENT, V142, P4217, DOI 10.1242/dev.123612; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Houston CM, 2006, EUR J NEUROSCI, V24, P2504, DOI 10.1111/j.1460-9568.2006.05145.x; Houston CM, 2007, J BIOL CHEM, V282, P17855, DOI 10.1074/jbc.M611533200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; KARLS U, 1992, MOL CELL BIOL, V12, P3644, DOI 10.1128/MCB.12.8.3644; Kempermann G, 1998, NERVENARZT, V69, P851, DOI 10.1007/s001150050353; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; KING MM, 1984, J BIOL CHEM, V259, P8080; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Kury S, 2017, AM J HUM GENET, V101, P768, DOI 10.1016/j.ajhg.2017.10.003; Lauter G, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-43; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Lu QQ, 2017, GENE, V615, P25, DOI 10.1016/j.gene.2017.03.017; Marsal M, 2003, GENE EXPR PATTERNS, V3, P489, DOI 10.1016/S1567-133X(03)00058-9; Martin C, 2007, NEUROENDOCRINOLOGY, V85, P257, DOI 10.1159/000103557; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Nishimura K, 2008, NEUROSCIENCE, V153, P1103, DOI 10.1016/j.neuroscience.2008.03.026; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Nishimura K, 2007, NEUROSCI RES, V59, P101, DOI 10.1016/j.neures.2007.05.014; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nishimura K, 2011, J NEUROCHEM, V119, P1217, DOI 10.1111/j.1471-4159.2011.07518.x; Nishimura K, 2008, NEUROCHEM INT, V53, P184, DOI 10.1016/j.neuint.2008.09.006; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Qi YL, 2009, BIOCHEM BIOPH RES CO, V381, P129, DOI 10.1016/j.bbrc.2009.02.058; ROSS CA, 1989, P NATL ACAD SCI USA, V86, P2923, DOI 10.1073/pnas.86.8.2923; Stuckemann T, 2017, DEV CELL, V40, P248, DOI 10.1016/j.devcel.2016.12.024; Talabattula VAN, 2017, BIOCHEM BIOPH RES CO, V491, P40, DOI 10.1016/j.bbrc.2017.07.030; TANAKA O, 1994, NEUROSCI LETT, V182, P17, DOI 10.1016/0304-3940(94)90194-5; Tazaki A, 1999, BIOCHEM BIOPH RES CO, V260, P426, DOI 10.1006/bbrc.1999.0933; Umesono Y, 1999, DEV GENES EVOL, V209, P31, DOI 10.1007/s004270050224; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Zanardelli S, 2013, DEV BIOL, V384, P83, DOI 10.1016/j.ydbio.2013.09.017; Zeng A, 2018, CELL, V173, P1593, DOI 10.1016/j.cell.2018.05.006; Zhang XH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/758097; Zhen H, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111540	75	4	5	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16567	16580		10.1096/fj.201903040RR	http://dx.doi.org/10.1096/fj.201903040RR		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33094857				2022-12-28	WOS:000586259000001
J	Scisciola, L; Rizzo, MR; Cataldo, V; Fontanella, RA; Balestrieri, ML; D'Onofrio, N; Marfella, R; Paolisso, G; Barbieri, M				Scisciola, Lucia; Rizzo, Maria Rosaria; Cataldo, Vittoria; Fontanella, Rosaria Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Marfella, Raffaele; Paolisso, Giuseppe; Barbieri, Michelangela			Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complications	FASEB JOURNAL			English	Article						atherosclerosis progression; DNA methylation; incretin based drugs; type 2 diabetes	EXTRACELLULAR-SUPEROXIDE DISMUTASE; DNA METHYLATION; RECEPTOR AGONIST; PLAQUE STABILITY; ATHEROSCLEROSIS; INHIBITION; EXPRESSION	The effect of GLP-1R agonists on DNA methylation levels ofNF-kappa BandSOD2genes in human aortic endothelial cells exposed to high glucose and in diabetic patients treated and not with incretin-based drugs, was evaluated. Methylation levels, mRNA and protein expression ofNF-kappa BandSOD2genes were measured in human endothelial cells exposed to high glucose for 7 days and treated with GLP-1R agonists. Methylation status ofNF-kappa BandSOD2promoter was also analyzed in 128 diabetics and 116 nondiabetics and correlated with intima media thickness (ITM), an early marker of atherosclerotic process. Cells exposed to high glucose showed lowerNF-kappa BandSOD2methylation levels, increased NF-kappa B and reduced SOD2 expression compared to normal glucose cells. Co-treatment with GLP-1 agonists prevented methylation and genes expression changes induced by high glucose. Both high glucose and incretins exposure increased DNA methyltransferases and demethylases levels. In diabetics, incretin treatment resulted a significant predictor ofNF-kappa BDNA methylation, independently of age, sex, body mass index (BMI), glucose and plasma lipid levels.NF-kappa BDNA methylation inversely correlated with IMT after adjusting for multiple covariates. Our results firstly provide new evidences of an additional mechanism by which incretin drugs could prevent vascular diabetic complications.	[Scisciola, Lucia; Rizzo, Maria Rosaria; Cataldo, Vittoria; Fontanella, Rosaria Anna; Marfella, Raffaele; Paolisso, Giuseppe; Barbieri, Michelangela] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Piazza Miraglia 2, I-80138 Naples, Italy; [Balestrieri, Maria Luisa; D'Onofrio, Nunzia] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Barbieri, M (corresponding author), Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Piazza Miraglia 2, I-80138 Naples, Italy.	michelangela.barbieri@unicampania.it	Rizzo, Maria/HGD-6576-2022; D'Onofrio, Nunzia/M-2081-2019; Rizzo, Maria Rosaria/AHH-3649-2022; paolisso, giuseppe/AAP-8516-2020; Scisciola, Lucia/AEY-3523-2022; Barbieri, Michelangela/K-2192-2016	D'Onofrio, Nunzia/0000-0002-5300-9530; Rizzo, Maria Rosaria/0000-0002-1023-4260; paolisso, giuseppe/0000-0002-2137-455X; Scisciola, Lucia/0000-0003-3636-4298; Barbieri, Michelangela/0000-0002-9223-5792; marfella, raffaele/0000-0003-3960-9270; Balestrieri, Maria Luisa/0000-0001-6001-1789	Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica	Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica (grants PRIN 2015)	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS98, DOI 10.2337/dc20-S009; Barbieri M, 2017, J DIABETES COMPLICAT, V31, P295, DOI 10.1016/j.jdiacomp.2016.10.001; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Chen Z, 2017, ANNU REV BIOMED ENG, V19, P195, DOI 10.1146/annurev-bioeng-071516-044720; Dhliwayo N, 2014, DIABETES, V63, P3069, DOI 10.2337/db13-1916; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gallego-Colon E, 2018, ATHEROSCLEROSIS, V278, P29, DOI 10.1016/j.atherosclerosis.2018.09.011; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Garczorz W, 2018, CARDIOVASC THER, V36, DOI 10.1111/1755-5922.12317; He J, 2019, ARTERIOSCL THROM VAS, V39, P1682, DOI 10.1161/ATVBAHA.119.312613; Jenkins AJ, 2018, CURR OPIN LIPIDOL, V29, P346, DOI 10.1097/MOL.0000000000000532; Jin JY, 2019, J MOL ENDOCRINOL, V63, pR103, DOI 10.1530/JME-19-0170; Jojima T, 2017, ATHEROSCLEROSIS, V261, P44, DOI 10.1016/j.atherosclerosis.2017.04.001; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Khullar M, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00237; Kowluru RA, 2016, LAB INVEST, V96, P1040, DOI 10.1038/labinvest.2016.78; Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mishra M, 2015, INVEST OPHTH VIS SCI, V56, P5133, DOI 10.1167/iovs.15-16937; Muka T, 2016, NUTR METAB CARDIOVAS, V26, P553, DOI 10.1016/j.numecd.2016.04.002; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Pinney SE, 2011, DIABETOLOGIA, V54, P2606, DOI 10.1007/s00125-011-2250-1; Sommese L, 2017, EPIGENETICS-US, V12, P401, DOI 10.1080/15592294.2016.1278097; Sudo M, 2017, ATHEROSCLEROSIS, V265, P283, DOI 10.1016/j.atherosclerosis.2017.06.920; Tabaei S, 2019, ARTIF CELL NANOMED B, V47, P2031, DOI 10.1080/21691401.2019.1617724; Vincent AM, 2013, HAND CLINIC, V115, P591, DOI 10.1016/B978-0-444-52902-2.00034-5; Wei H, 2017, METHYLATION NF B ITS, DOI [10.5772/intechopen.72552, DOI 10.5772/INTECHOPEN.72552]; Yasuda H, 2016, J CLIN BIOCHEM NUTR, V59, P174, DOI 10.3164/jcbn.16-26; Yasuda H, 2016, J CLIN BIOCHEM NUTR, V58, P34, DOI 10.3164/jcbn.15-16; Yuan EF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0660-y; Zhang H, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160141; Ziyadeh FN, 2003, J AM SOC NEPHROL, V14, P1355, DOI 10.1097/01.ASN.0000065608.37756.58	34	10	10	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16489	16503		10.1096/fj.202000860RR	http://dx.doi.org/10.1096/fj.202000860RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33090591				2022-12-28	WOS:000582261500001
J	Zhang, XT; Di, CX; Chen, YH; Wang, J; Su, RW; Huang, GM; Xu, CP; Chen, XH; Long, F; Yang, HY; Zhang, H				Zhang, Xuetian; Di, Cuixia; Chen, Yuhong; Wang, Jing; Su, Ruowei; Huang, Guomin; Xu, Caipeng; Chen, Xiaohua; Long, Feng; Yang, Hongying; Zhang, Hong			Multilevel regulation and molecular mechanism of poly (rC)-binding protein 1 in cancer	FASEB JOURNAL			English	Review						cancer therapy; gene expression; mechanisms; PCBP1; tumor suppressor	R(C) BINDING-PROTEIN; NUCLEAR RIBONUCLEOPROTEIN E1; RNA-BINDING; MESSENGER-RNA; KH-DOMAIN; STEM-CELLS; POLY(C)-BINDING PROTEINS; IN-VITRO; TRANSLATIONAL REGULATION; NEGATIVE REGULATOR	Poly (rC)-binding protein 1 (PCBP1), an RNA- or DNA-binding protein with a relative molecular weight of 38 kDa, which is characterized by downregulation in many cancer types. Numerous cases have indicated that PCBP1 could be considered as a tumor suppressor to inhibit tumorigenesis, development, and metastasis. In the current review, we described the multilevel regulatory roles of PCBP1, including gene transcription, alternative splicing, and translation of many cancer-related genes. Additionally, we also provided a brief overview about the inhibitory effect of PCBP1 on most common tumors. More importantly, we summarized the current research status about PCBP1 in hypoxic microenvironment, autophagy, apoptosis, and chemotherapy of cancer cells, aiming to clarify the molecular mechanisms of PCBP1 in cancer. Taken together, in-depth study of PCBP1 in cancer may provide new ideas for cancer therapy.	[Zhang, Xuetian; Di, Cuixia; Chen, Yuhong; Huang, Guomin; Xu, Caipeng; Chen, Xiaohua; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Biomed Res Ctr, Lanzhou, Gansu, Peoples R China; [Zhang, Xuetian; Di, Cuixia; Chen, Yuhong; Huang, Guomin; Xu, Caipeng; Chen, Xiaohua; Zhang, Hong] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Gansu, Peoples R China; [Zhang, Xuetian; Di, Cuixia; Chen, Yuhong; Huang, Guomin; Xu, Caipeng; Chen, Xiaohua; Zhang, Hong] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Zhang, Xuetian; Di, Cuixia; Chen, Yuhong; Huang, Guomin; Xu, Caipeng; Chen, Xiaohua; Zhang, Hong] Univ Chinese Acad Sci, Sch Nucl Sci & Technol, Beijing, Peoples R China; [Wang, Jing] Lanzhou Univ, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China; [Su, Ruowei] Xiamen Univ, Affiliated Hosp 1, Sch Med, Xiamen, Fujian, Peoples R China; [Long, Feng] Gansu Univ Tradit Chinese Med, Lanzhou, Gansu, Peoples R China; [Yang, Hongying] Med Coll Soochow, Sch Radiat Med & Protect, Suzhou, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University; Xiamen University; Gansu University of Chinese Medicine	Di, CX; Zhang, H (corresponding author), Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou 730000, Gansu, Peoples R China.	dicx@impcas.ac.cn; zhangh@impcas.ac.cn			National Key R&D project of the Chinese Ministry of Science and Technology [2018YFE0205100]; Key Program of the National Natural Science Foundation of China [U1632270]; National Natural Science Foundation of China [11675234]; Natural Science Foundation of Gansu Province, China [17JR5RA310]	National Key R&D project of the Chinese Ministry of Science and Technology; Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province, China	This work was supported by grants from the National Key R&D project of the Chinese Ministry of Science and Technology [2018YFE0205100]; the Key Program of the National Natural Science Foundation of China [U1632270]; the National Natural Science Foundation of China [11675234]; and the Natural Science Foundation of Gansu Province, China [17JR5RA310].	AASHEIM HC, 1994, NUCLEIC ACIDS RES, V22, P959, DOI 10.1093/nar/22.6.959; Akker SA, 2007, MOL ENDOCRINOL, V21, P2529, DOI 10.1210/me.2007-0038; Alcindor T, 2011, CURR ONCOL, V18, P18; Ansa-Addo EA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz3865; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Behbod F, 2005, CARCINOGENESIS, V26, P703, DOI 10.1093/carcin/bgh293; Brown AS, 2016, NUCLEIC ACIDS RES, V44, P5892, DOI 10.1093/nar/gkw241; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen Q, 2021, CELL MOL LIFE SCI, V78, P949, DOI 10.1007/s00018-020-03544-5; Chen Q, 2015, CELL PHYSIOL BIOCHEM, V35, P1052, DOI 10.1159/000373931; Chkheidze AN, 2003, MOL CELL BIOL, V23, P8405, DOI 10.1128/MCB.23.23.8405-8415.2003; Cloke B, 2010, ENDOCRINOLOGY, V151, P3954, DOI [10.1210/en.2009-1264, 10.1210//en.2009-1264]; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Conforti F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.27; Costello RT, 2000, CANCER RES, V60, P4403; Dai Chen-Xin, 2009, BMC Cancer, V9, P418, DOI 10.1186/1471-2407-9-418; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Di CX, 2019, CELL DEATH DIFFER, V26, P1181, DOI 10.1038/s41418-018-0231-3; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Fang L, 1999, J CELL BIOL, V147, P823, DOI 10.1083/jcb.147.4.823; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gamarnik AV, 1997, RNA, V3, P882; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; Grelet S, 2017, NAT CELL BIOL, V19, P1105, DOI 10.1038/ncb3595; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Guo JN, 2017, ONCOTARGET, V8, P13312, DOI 10.18632/oncotarget.14516; Guo JH, 2019, J CELL PHYSIOL, V234, P33, DOI 10.1002/jcp.26873; Hennessey D, 2013, UROL ONCOL-SEMIN ORI, V31, P1106, DOI 10.1016/j.urolonc.2011.10.008; Hodgson NC, 2004, ANN SURG ONCOL, V11, P1093, DOI 10.1245/ASO.2004.03.066; Horiguchi H, 2016, HAEMATOLOGICA, V101, P437, DOI 10.3324/haematol.2015.134932; Howley BV, 2016, ONCOGENE, V35, P1725, DOI 10.1038/onc.2015.238; Huang YH, 2014, AUTOPHAGY, V10, P1787, DOI 10.4161/auto.29989; Huo LR, 2008, BBA-PROTEINS PROTEOM, V1784, P1524, DOI 10.1016/j.bbapap.2008.06.017; Huo LR, 2010, BBA-PROTEINS PROTEOM, V1804, P1954, DOI 10.1016/j.bbapap.2010.07.002; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Ishii T, 2018, P NATL ACAD SCI USA, V115, P6715, DOI 10.1073/pnas.1806912115; Jiang P, 2017, INT J ONCOL, V51, P169, DOI 10.3892/ijo.2017.4018; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Ko JL, 2005, J NEUROCHEM, V93, P749, DOI 10.1111/j.1471-4159.2005.03089.x; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Kuhn H, 1999, LIPIDS, V34, pS273, DOI 10.1007/BF02562317; Lanvin O, 2013, EUR J CANCER, V49, P2884, DOI 10.1016/j.ejca.2013.05.003; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li JD, 2016, TUMOR BIOL, V37, P15221, DOI 10.1007/s13277-016-5347-9; Link LA, 2016, MOL CANCER RES, V14, P634, DOI 10.1158/1541-7786.MCR-16-0018; Liu YF, 2015, INT J CLIN EXP PATHO, V8, P7165; Lu J, 2016, BIOMED REP, V4, P657, DOI 10.3892/br.2016.642; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 2002, RNA, V8, P1160, DOI 10.1017/S135583820202808X; Marie-Egyptienne DT, 2013, CANCER LETT, V341, P63, DOI 10.1016/j.canlet.2012.11.019; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Nishimura K, 2004, VIROLOGY, V325, P364, DOI 10.1016/j.virol.2004.04.041; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Peng X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.297; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Pillai MR, 2003, J CLIN PATHOL, V56, P569, DOI 10.1136/jcp.56.8.569; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778; Semenza GL, 2016, ANNU REV CELL DEV BI, V15, P551; Seong-Jun C, 2013, PLOS ONE, V8; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Shi HS, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0840-1; Sidiqi M, 2005, NUCLEIC ACIDS RES, V33, P1213, DOI 10.1093/nar/gki265; Song KY, 2017, J CELL PHYSIOL, V232, P576, DOI 10.1002/jcp.25455; Song LN, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01576-0; Stephanie G, 2012, PLOS ONE, V7; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thakur S, 2003, MOL CELL BIOL, V23, P3774, DOI 10.1128/MCB.23.11.3774-3787.2003; Tripathi V, 2016, MOL CELL, V64, P549, DOI 10.1016/j.molcel.2016.09.013; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wang H, 2011, INTEGR CANCER THER, V10, P160, DOI 10.1177/1534735410383171; Wang XL, 2019, INT J BIOL SCI, V15, P1177, DOI 10.7150/ijbs.33103; Wei M, 2019, J CELL PHYSIOL, V234, P17392, DOI 10.1002/jcp.28361; Xia S, 2016, TUMOR BIOL, V37, P14773, DOI 10.1007/s13277-016-5234-4; Yoshino K, 2011, BIOCHEM BIOPH RES CO, V404, P1070, DOI 10.1016/j.bbrc.2010.12.115; Zhang HY, 2014, MOL BIOL REP, V41, P5519, DOI 10.1007/s11033-014-3428-7; Zhang M. P., 2017, BIOSCIENCE REP, V37, P708; Zhang MP, 2017, AM J TRANSL RES, V9, P708; Zhang MP, 2016, AM J TRANSL RES, V8, P3567; Zhang T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-72; Zhang WL, 2016, INT J BIOCHEM CELL B, V73, P127, DOI 10.1016/j.biocel.2016.02.009; Zhang YY, 2018, CELL PHYSIOL BIOCHEM, V48, P1747, DOI 10.1159/000492315; Zhang ZZ, 2015, MOL CANCER THER, V14, P1162, DOI 10.1158/1535-7163.MCT-14-0695; Zhao L, 2019, IUBMB LIFE, V71, P177, DOI 10.1002/iub.1948; Zhou MF, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0377-y	104	12	12	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15647	15658		10.1096/fj.202000911R	http://dx.doi.org/10.1096/fj.202000911R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058239				2022-12-28	WOS:000581157600001
J	Lee, KY; Lee, HJ; Choi, HJ; Han, ST; Lee, KH; Park, KJ; Park, JS; Jung, KM; Kim, YM; Han, HJ; Han, JY				Lee, Kyung Youn; Lee, Hong Jo; Choi, Hee Jung; Han, Soo Taek; Lee, Kyu Hyuk; Park, Kyung Je; Park, Jin Se; Jung, Kyung Min; Kim, Young Min; Han, Ho Jae; Han, Jae Yong			Highly elevated base excision repair pathway in primordial germ cells causes low base editing activity in chickens	FASEB JOURNAL			English	Article						base editing; base excision repair; chicken; editing activity; primordial germ cell; uracil N-glycosylase	RECOMBINATION; TRANSFERRIN; PERFORMANCE; KNOCKOUT; RECEPTOR; PROTEIN; TRAITS; DNA	Base editing technology enables the generation of precisely genome-modified animal models. In this study, we applied base editing to chicken, an important livestock animal in the fields of agriculture, nutrition, and research through primordial germ cell (PGC)-mediated germline transmission. Using this approach, we successfully produced two genome-modified chicken lines harboring mutations in the genes encoding ovotransferrin (TF) and myostatin (MSTN); however, only 55.5% and 35.7% of genome-modified chickens had the desired base substitutions inTFandMSTN, respectively. To explain the low base-editing activity, we performed molecular analysis to compare DNA repair pathways between PGCs and the chicken fibroblast cell line DF-1. The results revealed that base excision repair (BER)-related genes were significantly elevated in PGCs relative to DF-1 cells. Subsequent functional studies confirmed that the editing activity could be regulated by modulating the expression of uracil N-glycosylase (UNG), an upstream gene of the BER pathway. Collectively, our findings indicate that the distinct DNA repair property of chicken PGCs causes low editing activity during genome modification, however, modulation of BER functions could promote the production of genome-modified organisms with the desired genotypes.	[Lee, Kyung Youn; Lee, Hong Jo; Choi, Hee Jung; Han, Soo Taek; Lee, Kyu Hyuk; Park, Kyung Je; Park, Jin Se; Jung, Kyung Min; Kim, Young Min; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Kyung Youn; Lee, Hong Jo; Choi, Hee Jung; Han, Soo Taek; Lee, Kyu Hyuk; Park, Kyung Je; Park, Jin Se; Jung, Kyung Min; Kim, Young Min; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea; [Han, Ho Jae] Seoul Natl Univ, Dept Vet Physiol, Coll Vet Med, Res Inst Vet Sci,PLUS Program Creat Vet Sci Res B, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr		Jung, Kyung Min/0000-0002-5791-2655	National Research Foundation of Korea (NRF) [NRF-2015R1A3A2033826]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2015R1A3A2033826	Aird EJ, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0054-2; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Giannesini B, 2013, AM J PHYSIOL-ENDOC M, V305, pE33, DOI 10.1152/ajpendo.00651.2012; Giansanti F, 2012, BBA-GEN SUBJECTS, V1820, P218, DOI 10.1016/j.bbagen.2011.08.004; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0234-4; II I, 1982, DEV BIOL, V94, P366, DOI 10.1016/0012-1606(82)90354-2; Intano GW, 2001, NUCLEIC ACIDS RES, V29, P1366, DOI 10.1093/nar/29.6.1366; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Kim GD, 2020, FASEB J, V34, P5688, DOI 10.1096/fj.201903035R; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lee HJ, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0333-x; Lee HJ, 2019, FASEB J, V33, P8519, DOI 10.1096/fj.201802671R; Lee HJ, 2016, FASEB J, V30, P555, DOI 10.1096/fj.15-274712; Lee J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041504; Lei M, 2007, POULTRY SCI, V86, P835, DOI 10.1093/ps/86.5.835; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Liu RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061172; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Liu ZQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05232-2; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Molla KA, 2019, TRENDS BIOTECHNOL, V37, P1121, DOI 10.1016/j.tibtech.2019.03.008; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; OH TH, 1986, DEV BRAIN RES, V30, P207, DOI 10.1016/0165-3806(86)90111-2; Oishi I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28438-2; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Olsen AK, 2001, NUCLEIC ACIDS RES, V29, P1781, DOI 10.1093/nar/29.8.1781; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Qin L, 2020, PLANT BIOTECHNOL J, V18, P45, DOI 10.1111/pbi.13168; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Rengaraj D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-757; Sasaguri H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05262-w; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Taylor L, 2017, DEVELOPMENT, V144, P928, DOI 10.1242/dev.145367; Testa E, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214411; Wang LJ, 2017, CELL RES, V27, P1289, DOI 10.1038/cr.2017.111; Xu K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072584; Ye XH, 2007, GENET SEL EVOL, V39, P73, DOI 10.1051/gse:2006029; Zhang H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4252-y; Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6; Zheng K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0035-5; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	47	7	7	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15907	15921		10.1096/fj.202001065RRR	http://dx.doi.org/10.1096/fj.202001065RRR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33031594				2022-12-28	WOS:000576979800001
J	Zegarra-Valdivia, JA; Pignatelli, J; de Sevilla, MEF; Fernandez, AM; Munive, V; Martinez-Rachadell, L; Nunez, A; Aleman, IT				Zegarra-Valdivia, Jonathan A.; Pignatelli, Jaime; Fernandez de Sevilla, Maria Estrella; Fernandez, Ana M.; Munive, Victor; Martinez-Rachadell, Laura; Nunez, Angel; Torres Aleman, Ignacio			Insulin-like growth factor I modulates sleep through hypothalamic orexin neurons	FASEB JOURNAL			English	Article						IGF-I; orexin neurons; sleep	OREXIN/HYPOCRETIN NEURONS; HORMONE-SECRETION; HYPOCRETIN; BRAIN; IGF-1; RECEPTORS; AGE; SOMATOSTATIN; DEFICIENCY; METABOLISM	Although sleep disturbances are common co-morbidities of metabolic diseases, the underlying processes linking both are not yet fully defined. Changes in the duration of sleep are paralleled by changes in the levels of insulin-like growth factor-I (IGF-I), an anabolic hormone that shows a circadian pattern in the circulation and activity-dependent entrance in the brain. However, the specific role, if any, of IGF-I in this universal homeostatic process remains poorly understood. We now report that the activity of orexin neurons, a discrete cell population in the lateral hypothalamus that is involved in the circadian sleep/wake cycle and arousal, is modulated by IGF-I. Furthermore, mice with blunted IGF-I receptor activity in orexin neurons have lower levels of orexin in the hypothalamus, show altered electro-corticographic patterns with predominant slow wave activity, and reduced onset-sleep latency. Collectively, these results extend the role in the brain of this pleiotropic growth factor to shaping sleep architecture through the regulation of orexin neurons. We speculate that poor sleep quality associated to diverse conditions may be related to disturbed brain IGF-I input to orexin neurons.	[Zegarra-Valdivia, Jonathan A.; Pignatelli, Jaime; Fernandez de Sevilla, Maria Estrella; Fernandez, Ana M.; Munive, Victor; Martinez-Rachadell, Laura; Torres Aleman, Ignacio] CSIC, Cajal Inst, Funct & Syst Neurobiol Dept, Madrid, Spain; [Zegarra-Valdivia, Jonathan A.; Pignatelli, Jaime; Fernandez de Sevilla, Maria Estrella; Fernandez, Ana M.; Munive, Victor; Martinez-Rachadell, Laura; Torres Aleman, Ignacio] CIBERNED, Madrid, Spain; [Zegarra-Valdivia, Jonathan A.] Univ Nacl San Agustin de Arequipa, Arequipa, Peru; [Nunez, Angel] UAM, Dept Anat Histol & Neurosci, Sch Med, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Universidad Nacional de San Agustin de Arequipa; Autonomous University of Madrid	Aleman, IT (corresponding author), CSIC, Cajal Inst, Madrid 28002, Spain.	torres@cajal.csic.es	pignatelli, jaime/AAY-8734-2021; Zegarra-Valdivia, Jonathan Adrián/I-5382-2016; Nuñez, Angel/Y-9137-2019; Torres Aleman, Ignacio/A-1613-2008	pignatelli, jaime/0000-0002-8431-2241; Zegarra-Valdivia, Jonathan Adrián/0000-0003-0497-5270; Nuñez, Angel/0000-0002-8013-4812; Torres Aleman, Ignacio/0000-0001-8107-7947; Fernandez de Sevilla, Maria Estrella/0000-0002-2693-1861	Ministerio de Economia y Competitividad (MINECO) [SAF2016-76462]; Ciberned [CB06/05/0001]; National Council of Science, Technology and Technological Innovation	Ministerio de Economia y Competitividad (MINECO); Ciberned(Instituto de Salud Carlos III); National Council of Science, Technology and Technological Innovation	Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: SAF2016-76462; Ciberned, Grant/Award Number: CB06/05/0001; National Council of Science, Technology and Technological Innovation	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arrigoni E, 2019, NEUROPHARMACOLOGY, V154, P34, DOI 10.1016/j.neuropharm.2018.11.017; Ashlin TG, 2018, CELL REP, V24, P1389, DOI 10.1016/j.celrep.2018.07.012; Bastianini S, 2012, J SLEEP RES, V21, P185, DOI 10.1111/j.1365-2869.2011.00945.x; Blair LAC, 1999, J NEUROSCI, V19, P1940; BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180; Breit A, 2018, J BIOL CHEM, V293, P17278, DOI 10.1074/jbc.RA118.004429; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Carro E, 2004, EUR J PHARMACOL, V490, P127, DOI 10.1016/j.ejphar.2004.02.050; Carro E, 2000, J NEUROSCI, V20, P2926; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Chaudhari A, 2017, MOL BIOL CELL, V28, P834, DOI 10.1091/mbc.E16-08-0624; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen JC, 2016, ALZHEIMERS DEMENT, V12, P21, DOI 10.1016/j.jalz.2015.03.004; Chennaoui M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112439; Chennaoui M, 2016, APPL PHYSIOL NUTR ME, V41, P963, DOI 10.1139/apnm-2016-0110; Cipriani G, 2015, PSYCHOGERIATRICS, V15, P65, DOI 10.1111/psyg.12069; Crosby P, 2019, CELL, V177, P896, DOI 10.1016/j.cell.2019.02.017; Date Y, 2000, MOL BRAIN RES, V76, P1, DOI 10.1016/S0169-328X(99)00317-4; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Franco C, 2017, MOL CELL NEUROSCI, V80, P100, DOI 10.1016/j.mcn.2017.02.008; Grubbs JJ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000220; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Herrera CG, 2017, FRONT NEUROENDOCRIN, V44, P27, DOI 10.1016/j.yfrne.2016.11.002; Honda M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004254; Hung CM, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1623-0; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Karnani MM, 2020, PROG NEUROBIOL, V187, DOI 10.1016/j.pneurobio.2020.101771; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; KERN W, 1993, J CLIN ENDOCR METAB, V76, P1428, DOI 10.1210/jc.76.6.1428; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Kotz CM, 2006, PHYSIOL BEHAV, V88, P294, DOI 10.1016/j.physbeh.2006.05.031; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Larsson SC, 2018, J ALZHEIMERS DIS, V66, P579, DOI 10.3233/JAD-180529; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Mander BA, 2017, NEURON, V94, P19, DOI 10.1016/j.neuron.2017.02.004; Martinez-Rachadell L, 2019, GROWTH HORM IGF RES, V45, P25, DOI 10.1016/j.ghir.2019.02.003; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; McGregor R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178573; Metaxakis A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001824; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Monico-Neto M, 2017, GROWTH FACTORS, V35, P12, DOI 10.1080/08977194.2017.1314277; Monyak RE, 2017, MOL PSYCHIATR, V22, P1140, DOI 10.1038/mp.2016.51; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Obal F, 1999, BRAIN RES, V818, P267, DOI 10.1016/S0006-8993(98)01286-4; Peyron C, 1998, J NEUROSCI, V18, P9996; PRINZ PN, 1995, J GERONTOL A-BIOL, V50, pM222, DOI 10.1093/gerona/50A.4.M222; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sakurai T, 2014, NAT REV NEUROSCI, V15, P719, DOI 10.1038/nrn3837; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; Sindi S, 2018, ALZHEIMERS DEMENT, V14, P1235, DOI 10.1016/j.jalz.2018.05.012; Skora S, 2018, CELL REP, V22, P953, DOI 10.1016/j.celrep.2017.12.091; Stanojlovic M, 2019, AM J PHYSIOL-REG I, V316, pR571, DOI 10.1152/ajpregu.00383.2018; STEIGER A, 1992, NEUROENDOCRINOLOGY, V56, P566, DOI 10.1159/000126275; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Tortorella S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00216; Trueba-Saiz A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.102; Tsuneki H, 2018, PHARMACOL THERAPEUT, V186, P25, DOI 10.1016/j.pharmthera.2017.12.010; Van Cauter E, 1998, SLEEP, V21, P553; van Oostrom SH, 2018, SLEEP MED, V41, P78, DOI 10.1016/j.sleep.2017.07.029; Venner A, 2016, CURR BIOL, V26, P2137, DOI 10.1016/j.cub.2016.05.078; Wennberg A, 2019, ENDOCRINE, V66, P634, DOI 10.1007/s12020-019-02061-1; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Zegarra-Valdivia JA, 2019, J ALZHEIMERS DIS, V69, P979, DOI 10.3233/JAD-190241; Ziegenbein M, 2004, NEUROPSYCHOPHARMACOL, V29, P146, DOI 10.1038/sj.npp.1300298; Zink AN, 2018, INT J OBESITY, V42, P737, DOI 10.1038/ijo.2017.276	78	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15975	15990		10.1096/fj.202001281RR	http://dx.doi.org/10.1096/fj.202001281RR		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070417	Green Submitted			2022-12-28	WOS:000581148600001
J	Alexander, MR; Schoeder, CT; Brown, JA; Smart, CD; Moth, C; Wikswo, JP; Capra, JA; Meiler, J; Chen, WB; Madhur, MS				Alexander, Matthew R.; Schoeder, Clara T.; Brown, Jacquelyn A.; Smart, Charles D.; Moth, Chris; Wikswo, John P.; Capra, John A.; Meiler, Jens; Chen, Wenbiao; Madhur, Meena S.			Predicting susceptibility to SARS-CoV-2 infection based on structural differences in ACE2 across species	FASEB JOURNAL			English	Article						angiotensin-converting enzyme 2; COVID-19; protein structural elements; severe acute respiratory syndrome coronavirus 2	PROTEINS	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global pandemic of coronavirus disease-2019 (COVID-19). SARS-CoV-2 is a zoonotic disease, but little is known about variations in species susceptibility that could identify potential reservoir species, animal models, and the risk to pets, wildlife, and livestock. Certain species, such as domestic cats and tigers, are susceptible to SARS-CoV-2 infection, while other species such as mice and chickens are not. Most animal species, including those in close contact with humans, have unknown susceptibility. Hence, methods to predict the infection risk of animal species are urgently needed. SARS-CoV-2 spike protein binding to angiotensin-converting enzyme 2 (ACE2) is critical for viral cell entry and infection. Here we integrate species differences in susceptibility with multiple in-depth structural analyses to identify key ACE2 amino acid positions including 30, 83, 90, 322, and 354 that distinguish susceptible from resistant species. Using differences in these residues across species, we developed a susceptibility score that predicts an elevated risk of SARS-CoV-2 infection for multiple species including horses and camels. We also demonstrate that SARS-CoV-2 is nearly optimal for binding ACE2 of humans compared to other animals, which may underlie the highly contagious transmissibility of this virus among humans. Taken together, our findings define potential ACE2 and SARS-CoV-2 residues for therapeutic targeting and identification of animal species on which to focus research and protection measures for environmental and public health.	[Alexander, Matthew R.; Madhur, Meena S.] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Med Ctr VUMC, Nashville, TN 37232 USA; [Alexander, Matthew R.; Madhur, Meena S.] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Med Ctr, Nashville, TN 37232 USA; [Schoeder, Clara T.; Moth, Chris; Capra, John A.; Meiler, Jens] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA; [Schoeder, Clara T.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Brown, Jacquelyn A.; Wikswo, John P.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37232 USA; [Brown, Jacquelyn A.; Wikswo, John P.] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37232 USA; [Smart, Charles D.; Wikswo, John P.; Chen, Wenbiao; Madhur, Meena S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, 735B Light Hall,2215 Garland Ave, Nashville, TN 37232 USA; [Moth, Chris; Capra, John A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Wikswo, John P.; Meiler, Jens] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA; [Meiler, Jens] Univ Leipzig, Inst Drug Discovery, Med Sch, Leipzig, Germany; [Madhur, Meena S.] Vanderbilt Inst Infect Immunol & Inflammat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Leipzig University	Chen, WB (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 735B Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.; Madhur, MS (corresponding author), Vanderbilt Univ, Dept Med, 2215 Garland Ave,P415D MRB 4, Nashville, TN 37232 USA.	wenbiao.chen@vanderbilt.edu; meena.madhur@vanderbilt.edu	Chen, Wenbiao/ABG-1276-2020	Chen, Wenbiao/0000-0002-0750-8275; Smart, Charles/0000-0003-0391-3916; Schoeder, Clara/0000-0002-4664-961X; Alexander, Matthew/0000-0003-4739-7204	National Institutes of Health [F32HL144048-01, DK117147, UH3TR002097, U01TR002383, U19AI117905, U01AI150739, R01AI141661, R35GM127087, DP2HL137166]; American Heart Association [20PRE35080177, EIA34480023]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	National Institutes of Health, Grant/Award Number: F32HL144048-01, DK117147, UH3TR002097, U01TR002383, U19AI117905, U01AI150739, R01AI141661, R35GM127087 and DP2HL137166; American Heart Association, Grant/Award Number: 20PRE35080177 and EIA34480023	Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; APHISpress@usda.gov, 2020, CONF CAS SARS COV 2; APHISpress@usda.gov, 2020, USDA STAT CONF COVID; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Chan JFW, 2022, CLIN INFECT DIS, V75, pE1101, DOI 10.1093/cid/ciab817; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; CLEARY SJ, 2020, BRIT J PHARMACO 0719; Damas J, 2020, P NATL ACAD SCI USA, V117, P22311, DOI 10.1073/pnas.2010146117; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Ferreira IG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020580; Fu JW, 2020, MOL BIOL REP, V47, P4383, DOI 10.1007/s11033-020-05478-4; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Halfmann PJ, 2020, NEW ENGL J MED, V383, P592, DOI 10.1056/NEJMc2013400; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Korber B, 2020, SPIKE MUTATION PIPEL; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lam S, 2020, BIORXIV, DOI 10.1101/2020.05.01.072371; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li F, 2013, ANTIVIR RES, V100, P246, DOI 10.1016/j.antiviral.2013.08.014; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Liu ZX, 2020, J MED VIROL, V92, P595, DOI 10.1002/jmv.25726; Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mallapaty S, 2020, NATURE, V579, P183, DOI 10.1038/d41586-020-00660-x; Melin Amanda D, 2020, bioRxiv, DOI 10.1101/2020.04.09.034967; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Ou J., 2020, RBD MUTATIONS CIRCUL, DOI [10.1101/2020.03.15.991844, DOI 10.1101/2020.03.15.991844]; Pearson William R, 2013, Curr Protoc Bioinformatics, V43, DOI 10.1002/0471250953.bi0305s43; Praharaj MR, 2020, BIORXIV, DOI 10.1101/2020.05.08.084327; Procko Erik, 2020, bioRxiv, DOI 10.1101/2020.03.16.994236; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodrigues JP, 2020, BIORXIV, DOI 10.1101/2020.06.05.136861; Saha P, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201312; Sauer MF, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007339; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schrodinger LLC, 2015, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S13398-014-0173-7.2; Sevy AM, 2019, P NATL ACAD SCI USA, V116, P1597, DOI 10.1073/pnas.1806004116; Sevy AM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004300; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang YJ, 2020, P NATL ACAD SCI USA, V117, P13967, DOI 10.1073/pnas.2008209117; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yu P, 2020, ANIM MODEL EXP MED, V3, P93, DOI 10.1002/ame2.12108; Zhai XF, 2020, J VIROL, V94, DOI 10.1128/JVI.00831-20; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	58	25	26	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15946	15960		10.1096/fj.202001808R	http://dx.doi.org/10.1096/fj.202001808R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33015868	Green Published			2022-12-28	WOS:000576515300001
J	Maehara, T; Higashitarumi, F; Kondo, R; Fujimori, K				Maehara, Toko; Higashitarumi, Fumiyoshi; Kondo, Risa; Fujimori, Ko			Prostaglandin F-2 alpha receptor antagonist attenuates LPS-induced systemic inflammatory response in mice	FASEB JOURNAL			English	Article						FP receptor antagonist; neutrophil; prostaglandin F-2 alpha; systemic inflammation	SEVERE SEPSIS; TNF-ALPHA; IL-10; INTERLEUKIN-10; SUPPRESSION; ACTIVATION; EXPRESSION; REGULATOR; MEDIATE; KIDNEY	Although it is known that prostaglandin (PG) F-2 alpha level is elevated in the plasma of patients with sepsis, the roles of PGF(2 alpha) is still unknown. We aimed to clarify the roles of PGF(2 alpha) in the regulation of lipopolysaccharide (LPS)-induced systemic inflammation. At 24 hours after LPS administration, neutrophil infiltration in peritoneal cavity, the mRNA expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, and macrophage inflammatory protein-2, and tissue damages in lung, liver, and kidney were all increased. Inhibition of FP receptors significantly decreased LPS-induced neutrophil infiltration and lowered the mRNA expression of the pro-inflammatory cytokines. At 6 hour after LPS administration, the level of anti-inflammatory cytokine, IL-10 in peritoneal lavage fluid was higher than that in naive mice. Inhibition of FP receptors in these mice increased IL-10 level further. Stimulation of isolated peritoneal neutrophils by LPS increased the gene expression of IL-10, which was further increased by AL8810 treatment. Administration of an anti-IL-10 antibody antagonized the AL8810-decreased mRNA expression of pro-inflammatory cytokines and tissue damages. These results indicate that inhibition of FP receptors by AL8810 attenuated LPS-induced systemic inflammation in mice via enhanced IL-10 production.	[Maehara, Toko; Higashitarumi, Fumiyoshi; Kondo, Risa; Fujimori, Ko] Osaka Univ Pharmaceut Sci, Dept Pathobiochem, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan	Osaka University of Pharmaceutical Sciences	Fujimori, K (corresponding author), Osaka Univ Pharmaceut Sci, Dept Pathobiochem, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	fujimori@gly.oups.ac.jp	Fujimori, Ko/AAD-5428-2021	Fujimori, Ko/0000-0002-2506-0769	Japan Society for the Promotion of Science [19K21235]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science, Grant/Award Number: 19K21235	Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Aman MJ, 1996, BLOOD, V87, P4731, DOI 10.1182/blood.V87.11.4731.bloodjournal87114731; Aronoff DM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/696897; Burdon PCE, 2005, BLOOD, V105, P2543, DOI 10.1182/blood-2004-08-3193; Chaudhry H, 2013, IN VIVO, V27, P669; CHOUDHRY MA, 1995, INFECT IMMUN, V63, P3101, DOI 10.1128/IAI.63.8.3101-3105.1995; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dalli J, 2017, CRIT CARE MED, V45, P58, DOI 10.1097/CCM.0000000000002014; Foey AD, 1998, J IMMUNOL, V160, P920; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hou TY, 2015, INT J CLIN EXP MED, V8, P15238; Huhn RD, 1996, BLOOD, V87, P699, DOI 10.1182/blood.V87.2.699.bloodjournal872699; Ishii M, 2012, J IMMUNOL, V188, P5655, DOI 10.4049/jimmunol.1102330; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Kim WY, 2016, TUBERC RESPIR DIS, V79, P53, DOI 10.4046/trd.2016.79.2.53; Klompas M, 2018, JAMA-J AM MED ASSOC, V320, P1433, DOI 10.1001/jama.2018.12179; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Lee SJ, 2008, ONCOL REP, V19, P1007; Maehara T, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158654; Majumdar A, 2010, INDIAN J CRIT CARE M, V14, P14, DOI 10.4103/0972-5229.63031; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; OETTINGER WKE, 1983, BRIT J SURG, V70, P237, DOI 10.1002/bjs.1800700417; Peng QY, 2016, J SURG RES, V201, P480, DOI 10.1016/j.jss.2015.11.029; Raghuwanshi SK, 2012, J IMMUNOL, V189, P2824, DOI 10.4049/jimmunol.1201114; Recknagel P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001338; Reinhart K, 2001, CRIT CARE MED, V29, P765, DOI 10.1097/00003246-200104000-00015; Rios-Santos F, 2007, AM J RESP CRIT CARE, V175, P490, DOI 10.1164/rccm.200601-103OC; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Takayama K, 2005, NAT MED, V11, P562, DOI 10.1038/nm1231; Teng Tie-Shan, 2017, J Immunol Res, V2017, P9671604, DOI 10.1155/2017/9671604; Ueno T, 2011, FEBS J, V278, P2901, DOI 10.1111/j.1742-4658.2011.08213.x; Yan J, 2014, INT REV IMMUNOL, V33, P498, DOI 10.3109/08830185.2014.889129; Zhao WY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01526	39	7	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15197	15207		10.1096/fj.202001481R	http://dx.doi.org/10.1096/fj.202001481R		SEP 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32985737				2022-12-28	WOS:000574546600001
J	Nio, Y; Ookawara, M; Yamasaki, M; Hanauer, G; Tohyama, K; Shibata, S; Sano, T; Shimizu, F; Anayama, H; Hazama, M; Matsuo, T				Nio, Yasunori; Ookawara, Mitsugi; Yamasaki, Midori; Hanauer, Guido; Tohyama, Kimio; Shibata, Sachio; Sano, Tomoya; Shimizu, Fumi; Anayama, Hisashi; Hazama, Masatoshi; Matsuo, Takanori			Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate-salt hypertensive uni-nephrectomized KKA(y)mice	FASEB JOURNAL			English	Article						deoxycorticosterone acetate-salt hypertensive KKA(y)mouse; diabetic nephropathy; hypertension; phosphodiesterase 4; phosphodiesterase 5; uni-nephrectomy	PDE4 INHIBITORS; MOLECULAR-MECHANISMS; EJECTION FRACTION; HEART-FAILURE; RENAL INJURY; KIDNEY; ROFLUMILAST; RESVERATROL; PROGRESSION; SILDENAFIL	Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD). Hypertension increases kidney stress, which deteriorates function, and leads to peripheral renal vascular resistance. Long-term hypoperfusion promotes interstitial fibrosis and glomerular sclerosis, resulting in nephrosclerosis. Although hypertension and DN are frequent ESRD complications, relevant animal models remain unavailable. We generated a deoxycorticosterone acetate (DOCA)-salt hypertensive uni-nephrectomized (UNx) KKA(y)mouse model demonstrating hypertension, hyperglycemia, cardiac hypertrophy, kidney failure, increased urinary albumin creatinine ratio (UACR), and increased renal PDE4D and cardiac PDE5A mRNA levels. We hypothesized that the novel PDE4 selective inhibitor, compound A, and PDE5 inhibitor, sildenafil, exhibit nephroprotective, and cardioprotective effects in this new model. Compound A, sildenafil, and the angiotensin II receptor blocker, irbesartan, significantly reduced ventricular hypertrophy and pleural effusion volume. Meanwhile, compound A and sildenafil significantly suppressed the UACR, urinary kidney injury molecule-1, and monocyte chemoattractant protein-1 levels, as well as that of renal pro-fibrotic marker mRNAs, including collagen 1A1, fibronectin, and transforming growth factor-beta (TGF-beta). Moreover, compound A significantly suppressed TGF-beta-induced pro-fibrotic mRNA expression in vitro in all major kidney lesions, including within the glomerular mesangial region, podocytes, and epithelial region. Hence, PDE4 and PDE5 inhibitors may be promising treatments, in combination with irbesartan, for DN with hypertension as they demonstrate complementary mechanisms.	[Nio, Yasunori; Ookawara, Mitsugi; Yamasaki, Midori; Hazama, Masatoshi; Matsuo, Takanori] Takeda Pharmaceut Co Ltd, Extra Value Generat & Gen Med DDU, 26-1 Muraoka Higashi,2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Hanauer, Guido] Takeda Pharmaceut Co Ltd, Takeda Pharmaceut Int AG, Fujisawa, Kanagawa, Japan; [Tohyama, Kimio; Shibata, Sachio] Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, Fujisawa, Kanagawa, Japan; [Sano, Tomoya; Shimizu, Fumi; Anayama, Hisashi] Takeda Pharmaceut Co Ltd, Drug Safety Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Nio, Y (corresponding author), Takeda Pharmaceut Co Ltd, Extra Value Generat & Gen Med DDU, 26-1 Muraoka Higashi,2 Chome, Fujisawa, Kanagawa 2518555, Japan.	yasunori.nio@takeda.com	Nio, Yasunori/AFE-2456-2022		Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.)	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.)	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.)	Aoki M, 2000, J PHARMACOL EXP THER, V295, P255; Azevedo MF, 2014, ENDOCR REV, V35, P195, DOI 10.1210/er.2013-1053; Bae EH, 2012, KIDNEY BLOOD PRESS R, V36, P248, DOI 10.1159/000343414; Chertow GM, 2016, J AM SOC NEPHROL, V27, P40, DOI 10.1681/ASN.2015101125; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; Czirok S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10125-3; Fang L, 2013, NEPHROL DIAL TRANSPL, V28, P1751, DOI 10.1093/ndt/gfs391; Gentile G, 2014, EXPERT OPIN EMERG DR, V19, P571, DOI 10.1517/14728214.2014.979151; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Gong KZ, 2011, MOL ENDOCRINOL, V25, P1794, DOI 10.1210/me.2011-1009; Guabiraba R, 2010, EUR J PHARMACOL, V633, P85, DOI 10.1016/j.ejphar.2010.01.021; Hajhosseiny R, 2014, EXPERT OPIN INV DRUG, V23, P511, DOI 10.1517/13543784.2014.892580; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Iordache AM, 2020, FOOD CHEM TOXICOL, V143, DOI 10.1016/j.fct.2020.111535; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Kim KH, 2015, AM HEART J, V169, P813, DOI 10.1016/j.ahj.2015.03.018; Krishnan SM, 2019, CARDIOVASC RES, V115, P776, DOI 10.1093/cvr/cvy252; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Liang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28715; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Matyas C, 2017, EUR J HEART FAIL, V19, P326, DOI 10.1002/ejhf.711; Mehanna OM, 2018, ARCH PHYSIOL BIOCHEM, V124, P424, DOI 10.1080/13813455.2017.1419267; Mennuni S, 2014, J HUM HYPERTENS, V28, P74, DOI 10.1038/jhh.2013.55; Nio Y, 2017, FASEB J, V31, P5307, DOI 10.1096/fj.201700249R; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peng HM, 2001, HYPERTENSION, V37, P974, DOI 10.1161/01.HYP.37.3.974; Pofi R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44584; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Radovits T, 2009, BRIT J PHARMACOL, V156, P909, DOI 10.1111/j.1476-5381.2008.00098.x; Randi EB, 2020, ANTIOXID REDOX SIGN, V32, P1155, DOI 10.1089/ars.2019.7868; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P2131, DOI 10.1111/j.1523-1755.2005.00669.x; Ruzicka M, 2014, J HYPERTENS, V32, P1388, DOI 10.1097/HJH.0000000000000182; Sanz MJ, 2005, PHARMACOL THERAPEUT, V106, P269, DOI 10.1016/j.pharmthera.2004.12.001; Schinner E, 2015, INT J MOL SCI, V16, P2320, DOI 10.3390/ijms16022320; Sisson TH, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13753; Song K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159872; Tahara A, 2018, EUR J PHARMACOL, V830, P68, DOI 10.1016/j.ejphar.2018.04.024; Tian M, 2018, AM J PHYSIOL-RENAL, V315, pF558, DOI 10.1152/ajprenal.00137.2018; Togo S, 2009, AM J PHYSIOL-LUNG C, V296, pL959, DOI 10.1152/ajplung.00508.2007; Vollert S, 2012, DIABETOLOGIA, V55, P2779, DOI 10.1007/s00125-012-2632-z; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Xu M, 2020, AM J PHYSIOL-RENAL, V318, pF576, DOI 10.1152/ajprenal.00477.2019; Xu W, 2015, CLIN EXP PHARMACOL P, V42, P1075, DOI 10.1111/1440-1681.12459; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	45	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14997	15014		10.1096/fj.202001084R	http://dx.doi.org/10.1096/fj.202001084R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939821	Bronze			2022-12-28	WOS:000572318600001
J	Gutierrez-Munoz, C; Mendez-Barbero, N; Svendsen, P; Sastre, C; Fernandez-Laso, V; Quesada, P; Egido, J; Escola-Gil, JC; Martin-Ventura, JL; Moestrup, SK; Blanco-Colio, LM				Gutierrez-Munoz, Carmen; Mendez-Barbero, Nerea; Svendsen, Pia; Sastre, Cristina; Fernandez-Laso, Valvanera; Quesada, Patricia; Egido, Jesus; Escola-Gil, Joan C.; Martin-Ventura, Jose L.; Moestrup, Soren K.; Blanco-Colio, Luis M.			CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice	FASEB JOURNAL			English	Article						atherosclerosis; CD163; inflammation; TWEAK	NECROSIS-FACTOR-ALPHA; SCAVENGER RECEPTOR; ALTERNATIVE ACTIVATION; HUMAN MONOCYTES; M2 MACROPHAGES; HEMOGLOBIN; TWEAK; ANGIOGENESIS; INFLAMMATION; EXPRESSION	Atherosclerosis is an inflammatory disease characterized by the accumulation of macrophages in the vessel wall. Macrophages depend on their polarization to exert either pro-inflammatory or anti-inflammatory effects. Macrophages of the anti-inflammatory phenotype express high levels of CD163, a scavenger receptor for the hemoglobin-haptoglobin complex. CD163 can also bind to the pro-inflammatory cytokine TWEAK. UsingApoE-deficient orApoE/CD163double-deficient mice we aim to investigate the involvement of CD163 in atherosclerosis development and its capacity to neutralize the TWEAK actions.ApoE/CD163double-deficient mice displayed a more unstable plaque phenotype characterized by an increased lipid and macrophage content, plaque size, and pro-inflammatory cytokine expression. In vitro experiments demonstrated that the absence of CD163 in M2-type macrophages-induced foam cell formation through upregulation of CD36 expression. Moreover, exogenous TWEAK administration increased atherosclerotic lesion size, lipids, and macrophages content inApoE(-/-)/CD163(-/-)compared withApoE(-/-)/CD163(+/+)mice. Treatment with recombinant CD163 was able to neutralize the proatherogenic effects of TWEAK inApoE/CD163 double-deficient mice. Recombinant CD163 abolished the pro-inflammatory actions of TWEAK on vascular smooth muscle cells, decreasing NF-kB activation, cytokines and metalloproteinases expression, and macrophages migration. In conclusion, CD163-expressing macrophages serve as a protective mechanism to prevent the deleterious effects of TWEAK on atherosclerotic plaque development and progression.	[Gutierrez-Munoz, Carmen; Mendez-Barbero, Nerea; Fernandez-Laso, Valvanera; Quesada, Patricia; Martin-Ventura, Jose L.; Blanco-Colio, Luis M.] Jimenez Diaz Univ Hosp, IIS Fdn, Vasc Res Lab, Av Reyes Catolicos 2, Madrid 28040, Spain; [Mendez-Barbero, Nerea; Fernandez-Laso, Valvanera; Martin-Ventura, Jose L.; Blanco-Colio, Luis M.] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Svendsen, Pia] Aarhus Univ Hosp, Dept Clin Med, Aarhus, Denmark; [Sastre, Cristina] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Egido, Jesus] IIS Fdn Jimenez Diaz, Renal Vasc & Diabet Res Lab, Madrid, Spain; [Egido, Jesus; Escola-Gil, Joan C.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Escola-Gil, Joan C.] Inst Invest Biomed IIB St Pau, Barcelona, Spain; [Moestrup, Soren K.] Univ Southern Denmark, Dept Mol Med, Oddense, Denmark; [Moestrup, Soren K.] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Aarhus University; Harvard University; Massachusetts General Hospital; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Southern Denmark; Aarhus University	Blanco-Colio, LM (corresponding author), Jimenez Diaz Univ Hosp, IIS Fdn, Vasc Res Lab, Av Reyes Catolicos 2, Madrid 28040, Spain.	lblanco@fjd.es	Escolà-Gil, Joan Carles/H-9522-2014	Escola-Gil, Joan Carles/0000-0001-9021-2485	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III [ISCiii/FEDER PI16/01419, PI19/00128]; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM); Cardiovascular Disease (CIBERCV), Spain	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM); Cardiovascular Disease (CIBERCV), Spain	This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCiii/FEDER PI16/01419, PI19/00128) and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) and Cardiovascular Disease (CIBERCV), Spain.	Akahori H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8792; Blanco-Colio LM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00003; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Boyle JJ, 2012, CIRC RES, V110, P20, DOI 10.1161/CIRCRESAHA.111.247577; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Escola-Gil JC, 2013, BBA-MOL CELL BIOL L, V1831, P691, DOI 10.1016/j.bbalip.2013.01.003; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Finn AV, 2012, J AM COLL CARDIOL, V59, P166, DOI 10.1016/j.jacc.2011.10.852; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Guo L, 2018, J CLIN INVEST, V128, P1106, DOI 10.1172/JCI93025; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2010, IMMUNOBIOLOGY, V215, P406, DOI 10.1016/j.imbio.2009.05.003; Moreno JA, 2010, ARTERIOSCL THROM VAS, V30, P1253, DOI 10.1161/ATVBAHA.110.203364; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Munoz-Garcia B, 2011, CARDIOVASC RES, V89, P225, DOI 10.1093/cvr/cvq278; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Pamukcu B, 2011, THROMB RES, V128, P117, DOI 10.1016/j.thromres.2011.03.025; PULFORD K, 1992, IMMUNOLOGY, V75, P588; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Rekhter MD, 2002, CARDIOVASC RES, V54, P36, DOI 10.1016/S0008-6363(01)00537-5; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Sastre C, 2014, J CELL MOL MED, V18, P721, DOI 10.1111/jcmm.12221; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schapira K, 2009, ARTERIOSCL THROM VAS, V29, P2021, DOI 10.1161/ATVBAHA.109.195040; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tarin C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000723; Tarin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17135; Timmermann M, 2005, FREE RADICAL BIO MED, V39, P98, DOI 10.1016/j.freeradbiomed.2005.02.031; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Zheng TS, 2008, J LEUKOCYTE BIOL, V84, P338, DOI 10.1189/jlb.0308165	45	8	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14960	14976		10.1096/fj.202000177R	http://dx.doi.org/10.1096/fj.202000177R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32924185	hybrid, Green Published			2022-12-28	WOS:000570666300001
J	Rademacher, M; Kuhn, H; Borchert, A				Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid			Systemic deficiency of mouse arachidonate 15-lipoxygenase induces defective erythropoiesis and transgenic expression of the human enzyme rescues this phenotype	FASEB JOURNAL			English	Article						biomembranes; differentiation; eicosanoids; lipid peroxidation; redox equilibrium; reticulocytes	FLOW-CYTOMETRIC DETECTION; RABBIT RETICULOCYTES; MESSENGER-RNA; PHOSPHATIDYLSERINE EXPRESSION; LIPOXYGENASE PRODUCTS; OXIDATIVE STRESS; 12/15-LIPOXYGENASE; MITOCHONDRIA; MATURATION; MEMBRANES	Arachidonic acid 15-lipoxygenases (ALOX15) are lipid peroxidizing enzymes, which has previously been implicated in the maturational breakdown of intracellular organelles and plasma membrane remodeling during reticulocyte-erythrocyte transition. ConventionalAlox15(-/-)mice are viable, develop normally but do not exhibit a major defective erythropoietic phenotype. To characterize the putative in vivo relevance of Alox15 for red blood cell development, we explored the impact of systemic inactivation of theAlox15gene on mouse erythropoiesis. We found thatAlox15(-/-)mice exhibited reduced erythrocyte counts, elevated reticulocyte counts and red cell hyperchromia. The structure of the plasma membrane ofAlox15(-/-)erythrocytes is altered and a significant share of the red cells was present as echinocytes and/or acanthocytes. An increased share of the Alox15(-/-)erythrocytes cells were annexin V positive, which indicates a loss of plasma membrane asymmetry. Erythrocytes ofAlox15(-/-)mice were more susceptible to osmotic hemolysis and exhibited a reduced ex vivo life span. When we transgenically expressed human ALOX15 inAlox15(-/-)mice under the control of the aP2 promoter the defective erythropoietic system was rescued and the impaired osmotic resistance was normalized. Together these data suggest the involvement Alox15 in the maturational remodeling of the plasma membrane during red cell development.	[Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid] Charite Univ Med Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany; [Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid] Free Univ Berlin, Humboldt Univ Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany; [Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid] Berlin Inst Hlth, Inst Biochem, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health	Borchert, A (corresponding author), Charite Univ Med Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany.; Borchert, A (corresponding author), Free Univ Berlin, Humboldt Univ Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany.; Borchert, A (corresponding author), Berlin Inst Hlth, Inst Biochem, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany.	astrid.borchert@charite.de		Borchert, Astrid/0000-0003-3551-5592	Deutsche Forschungsgemeinschaft (DFG) [Ku 961/11-1, Ku 961/13-1, Ku 961/14-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: Ku 961/11-1, Ku 961/13-1 and Ku 961/14-1	Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Bigdelou P, 2020, JOVE-J VIS EXP, DOI 10.3791/60659; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Cozza G, 2017, FREE RADICAL BIO MED, V112, P1, DOI 10.1016/j.freeradbiomed.2017.07.010; DUBIEL W, 1989, RBC-CELL BIOL REV, V21, P505; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Foretz M, 2010, FEBS LETT, V584, P3667, DOI 10.1016/j.febslet.2010.07.041; Fulda S, 2016, BIOL CHEM, V397, P657, DOI 10.1515/hsz-2016-0102; Funk CD, 1996, J BIOL CHEM, V271, P23338, DOI 10.1074/jbc.271.38.23338; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Gutteridge JMC, 2018, BIOCHEM BIOPH RES CO, V502, P183, DOI 10.1016/j.bbrc.2018.05.045; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; HOHNE M, 1983, BIOMED BIOCHIM ACTA, V42, P1129; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; Vallejo MJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4586068; Kim TS, 2015, J CLIN INVEST, V125, P3965, DOI 10.1172/JCI81919; Kinder M, 2010, BLOOD, V115, P5012, DOI 10.1182/blood-2009-09-243139; King MJ, 2013, INT J LAB HEMATOL, V35, P237, DOI 10.1111/ijlh.12070; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KROSCHWALD P, 1986, BIOMED BIOCHIM ACTA, V45, P1237; KROSCHWALD P, 1989, BIOCHEM BIOPH RES CO, V160, P954, DOI 10.1016/0006-291X(89)92528-X; KUHN H, 1990, EUR J BIOCHEM, V191, P221, DOI 10.1111/j.1432-1033.1990.tb19113.x; KUHN H, 1990, J BIOL CHEM, V265, P18351; KUHN H, 1990, J BIOL CHEM, V265, P1454; Kuhn H, 2018, PROG LIPID RES, V72, P55, DOI 10.1016/j.plipres.2018.09.002; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kumar TR, 2009, METHODS MOL BIOL, V590, P335, DOI 10.1007/978-1-60327-378-7_22; Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001; Lang E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17316; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; NADEL JA, 1991, J CLIN INVEST, V87, P1139, DOI 10.1172/JCI115110; Nakano M, 2005, GENES CELLS, V10, P47, DOI 10.1111/j.1365-2443.2005.00814.x; O'Connell KE, 2015, COMPARATIVE MED, V65, P96; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Poeckel D, 2009, J BIOL CHEM, V284, P21077, DOI 10.1074/jbc.M109.000901; Raabe BM, 2011, J AM ASSOC LAB ANIM, V50, P680; RAPOPORT S, 1985, FEBS LETT, V180, P249, DOI 10.1016/0014-5793(85)81080-2; RAPOPORT SM, 1986, BIOCHIM BIOPHYS ACTA, V864, P471, DOI 10.1016/0304-4157(86)90006-7; RAPOPORT SM, 1979, EUR J BIOCHEM, V96, P545, DOI 10.1111/j.1432-1033.1979.tb13068.x; Schewe T, 1981, Methods Enzymol, V71 Pt C, P430; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; SCHEWE T, 1986, ADV ENZYMOL RAMB, V58, P191; SCHEWE T, 1990, BIOMED BIOCHIM ACTA, V49, pS42; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Taylor PR, 2012, BLOOD, V119, P6173, DOI 10.1182/blood-2012-02-410928; THIELE BJ, 1982, EUR J BIOCHEM, V129, P133, DOI 10.1111/j.1432-1033.1982.tb07031.x; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yaribeygi H, 2018, CNS NEUROL DISORD-DR, V17, P207, DOI 10.2174/1871527317666180425122557; Zhang LX, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101284	56	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14318	14335		10.1096/fj.202000408RR	http://dx.doi.org/10.1096/fj.202000408RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918502	Green Published, hybrid			2022-12-28	WOS:000570675200001
J	Shen, BZ; Cao, ZJ; Wu, YL; Yi, W; Zhu, ZY; Lv, ZH; Zhu, CL; Yu, Y				Shen, Bingzheng; Cao, Zhijian; Wu, Yingliang; Yi, Wei; Zhu, Zhanyong; Lv, Zhihua; Zhu, Chengliang; Yu, Yan			Purlisin, a toxin-like defensin derived from clinical pathogenic fungusPurpureocillium lilacinumwith both antimicrobial and potassium channel inhibitory activities	FASEB JOURNAL			English	Article						antibacterial effect; hKv1; 3 blocker; purlisin-NT; purlisin-CT; toxin-like peptide	IMMUNE-RESPONSES; PLECTASIN; PEPTIDES; INSIGHTS; FUNGI; MODE; SKIN	Clinical fungal infections always cause a negative impact on human health. Moreover, during the interaction of pathogenic fungi with the environment and host, many biologically active substances are produced. Here, we report a new toxin-like defensin of purlisin derived from a clinical pathogenic isolate ofPurpureocillium lilacinum. The analysis of its genomic and mRNA sequences revealed an open reading frame of 444 bp without introns. The deduced precursor peptide was composed of 147 amino acids, and the mature peptide were identified at protein level by LC-ESI-Q-TOF-MS/MS. After posttranslational processing, the precursor peptide of purlisin was split into two independent peptides. The two mature defensins, purlisin-NT and purlisin-CT, are consisting of 36 and 38 amino acid residues, which can form three and four intramolecular disulfide bonds, respectively. The results of circular dichroism and homology modeling revealed that they adopted a representative cysteine-stabilized alpha-helical and beta-sheet motif. The purlisin-NT showed a dose-dependent selective inhibition of immune-relatedhKv1.3 target channel with IC(50)value of 0.2 +/- 0.04 mu M but no obvious antibacterial activity, while the purlisin-CT displayed antimicrobial activities against gram-positive bacteria as well as clinical isolates of MRSA and low affinities for potassium channels. Our findings suggest that purlisin-NT with immunosuppressive effects and purlisin-CT possessing antibacterial activities are adapted to the survival and pathogenicity of clinicalP lilacinumis. Moreover, they can also be used as templates for the design of novel antibacterial peptide and immunosuppressive agents.	[Shen, Bingzheng] Wuhan Univ, Dept Pharm, Renmin Hosp, Wuhan, Peoples R China; [Shen, Bingzheng; Cao, Zhijian; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China; [Yi, Wei] Wuhan Univ, Dept Neurosurg, Renmin Hosp, Wuhan, Peoples R China; [Zhu, Zhanyong] Wuhan Univ, Dept Plast Surg, Renmin Hosp, Wuhan, Peoples R China; [Lv, Zhihua; Zhu, Chengliang] Wuhan Univ, Dept Clin Lab, Renmin Hosp, Wuhan, Peoples R China; [Yu, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, 1095 Jie Fang Ave, Wuhan 430030, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Huazhong University of Science & Technology	Yu, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, 1095 Jie Fang Ave, Wuhan 430030, Peoples R China.	yyu_hust@yeah.net			National Natural Science Foundation of China [31700086, 81900476, 81601691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31700086, 81900476 and 81601691	Accelrys Software Inc, 2012, DISC STUD MOD ENV RE; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Bueno-Pallero FA, 2018, J INVERTEBR PATHOL, V154, P85, DOI 10.1016/j.jip.2018.04.004; Cabezas-Cruz A, 2019, TICKS TICK-BORNE DIS, V10, DOI 10.1016/j.ttbdis.2019.101269; Chew R, 2016, CAN J OPHTHALMOL, V51, P382, DOI 10.1016/j.jcjo.2016.05.013; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Dash TS, 2019, STRUCTURE, V27, P315, DOI 10.1016/j.str.2018.10.022; Dias RD, 2015, PEPTIDES, V72, P64, DOI 10.1016/j.peptides.2015.04.017; Essig A, 2014, J BIOL CHEM, V289, P34953, DOI 10.1074/jbc.M114.599878; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Fiedler Z, 2007, BIOCONTROL, V52, P547, DOI 10.1007/s10526-006-9052-2; Franzoi M, 2017, BIOCHEMISTRY-US, V56, P4992, DOI 10.1021/acs.biochem.7b00697; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Holland DB, 2009, FEMS MICROBIOL LETT, V290, P149, DOI 10.1111/j.1574-6968.2008.01402.x; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Jung S, 2009, J BIOL CHEM, V284, P1896, DOI 10.1074/jbc.M804713200; Kirk R, 2008, TLS-TIMES LIT SUPPL, P10; Koo GC, 1997, J IMMUNOL, V158, P5120; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lang YG, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171282; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Luo XD, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22244; Lysek H, 1996, ACTA U PALACKI OLOMU, V40, P83; Madio B, 2019, MAR DRUGS, V17, DOI 10.3390/md17060325; Mikov A N, 2015, Bioorg Khim, V41, P511; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Norton RS, 2017, NEUROPHARMACOLOGY, V127, P124, DOI 10.1016/j.neuropharm.2017.07.002; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Parisi K, 2019, SEMIN CELL DEV BIOL, V88, P107, DOI 10.1016/j.semcdb.2018.02.004; Raghavan Ramya, 2018, Curr Med Mycol, V4, P36, DOI 10.18502/cmm.4.2.62; Richardson MD., 2012, FUNGAL INFECT DIAGNO, V4th ed.; Santussi WM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00984; Sathoff AE, 2019, MOL PLANT MICROBE IN, V32, P507, DOI 10.1094/MPMI-08-18-0229-CR; Shen BZ, 2018, PEPTIDES, V107, P61, DOI 10.1016/j.peptides.2018.08.003; STIRLING G R, 1991, Australasian Plant Pathology, V20, P149, DOI 10.1071/APP9910149; Trinh SA, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12689; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wu JJ, 2018, PEPTIDES, V99, P82, DOI 10.1016/j.peptides.2017.11.009; Xiang F, 2015, TOXINS, V7, P34, DOI 10.3390/toxins7010034; Xie JL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01084; Yang N, 2019, APPL MICROBIOL BIOT, V103, P5193, DOI 10.1007/s00253-019-09785-0; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Ye F, 2016, TOXINS, V8, DOI 10.3390/toxins8040115; Zhao YH, 2019, MOLECULES, V24, DOI 10.3390/molecules24112045; Zhao YH, 2019, TOXICON, V157, P101, DOI 10.1016/j.toxicon.2018.11.304; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	49	4	4	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15093	15107		10.1096/fj.202000029RR	http://dx.doi.org/10.1096/fj.202000029RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918769				2022-12-28	WOS:000570692500001
J	Kwak, SY; Seo, IH; Chung, I; Kim, SA; Lee, JO; Lee, HJ; Kim, SE; Han, JA; Kang, MJ; Kim, SJ; Lim, S; Kim, KM; Chung, JH; Lim, E; Hwang, JI; Kim, HS; Shin, MJ				Kwak, So-Young; Seo, Il Hyeok; Chung, InHyeok; Kim, Shin Ae; Lee, Jung Ok; Lee, Hye Jeong; Kim, Sung Eun; Han, Jeong Ah; Kang, Min Ju; Kim, Su Jin; Lim, Soo; Kim, Kyoung Min; Chung, Ji Hyung; Lim, Eunice; Hwang, Jong-Ik; Kim, Hyeon Soo; Shin, Min-Jeong			Effect of chitinase-3-like protein 1 on glucose metabolism: In vitro skeletal muscle and human genetic association study	FASEB JOURNAL			English	Article						AMPK; Chitinase-3-like protein 1; glucose metabolism; glucose uptake; myokine	KINASE-BETA; 3-LIKE 1; INSULIN; EXERCISE; YKL-40; INFLAMMATION; GLUT4; AMPK; GLYCOPROTEIN; STIMULATION	We investigated the effect of chitinase-3-like protein 1 (CHI3L1) on glucose metabolism and its underlying mechanisms in skeletal muscle cells, and evaluated whether the observed effects are relevant in humans. CHI3L1 was associated with increased glucose uptake in skeletal muscles in an AMP-activated protein kinase (AMPK)-dependent manner, and with increased intracellular calcium levels via PAR2. The improvement in glucose metabolism observed in an intraperitoneal glucose tolerance test on male C57BL/6J mice supported this association. Inhibition of the CaMKK was associated with suppression of CHI3L1-mediated glucose uptake. Additionally, CHI3L1 was found to influence glucose uptake through the PI3K/AKT pathway. Results suggested that CHI3L1 stimulated the phosphorylation of AS160 and p38 MAPK downstream of AMPK and AKT, and the resultant GLUT4 translocation. In primary myoblast cells, stimulation of AMPK and AKT was observed in response to CHI3L1, underscoring the biological relevance of CHI3L1. CHI3L1 levels were elevated in cells under conditions that mimic exercise in vitro and in exercised mice in vivo, indicating that CHI3L1 is secreted during muscle contraction. Finally, similar associations between CHI3L1 and metabolic parameters were observed in humans alongside genotype associations between CHI3L1 and diabetes at the population level. CHI3L1 may be a potential therapeutic target for the treatment of diabetes.	[Kwak, So-Young; Chung, InHyeok; Shin, Min-Jeong] Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul, South Korea; [Seo, Il Hyeok; Kim, Shin Ae; Lee, Jung Ok; Lee, Hye Jeong; Han, Jeong Ah; Kang, Min Ju; Kim, Su Jin; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 02841, South Korea; [Kim, Sung Eun; Shin, Min-Jeong] Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Seoul 02841, South Korea; [Lim, Soo; Kim, Kyoung Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Chung, Ji Hyung] CHA Univ, Coll Life Sci, Dept Biotechnol, Gyconggi Do, South Korea; [Lim, Eunice] Univ Michigan, Ann Arbor, MI 48109 USA; [Hwang, Jong-Ik] Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Korea University; Seoul National University (SNU); Pochon Cha University; University of Michigan System; University of Michigan; Korea University; Korea University Medicine (KU Medicine)	Kim, HS (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 02841, South Korea.; Shin, MJ (corresponding author), Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Seoul 02841, South Korea.	anatomykim@korea.ac.kr; mjshin@korea.ac.kr		Hwang, Jong-Ik/0000-0002-0729-1782	National Research Foundation of Korea (NRF) [2020R1A2C2005580, 2012M3A9C4048761]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2020R1A2C2005580 and 2012M3A9C4048761	Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cicala C, 2002, BRIT J PHARMACOL, V135, P14, DOI 10.1038/sj.bjp.0704438; Di Rosa M, 2016, PATHOBIOLOGY, V83, P228, DOI 10.1159/000444855; Gogh IJAEV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10944; Gorgens SW, 2016, ACTA PHYSIOL, V216, P330, DOI 10.1111/apha.12579; Gorgens SW, 2014, BIOCHEM J, V459, P479, DOI 10.1042/BJ20131151; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jairaman A, 2015, J IMMUNOL, V195, P2122, DOI 10.4049/jimmunol.1500396; Johansen JS, 2006, DAN MED BULL, V53, P172; Kim Y, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv316; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Kyrgios I, 2012, METABOLISM, V61, P562, DOI 10.1016/j.metabol.2011.09.004; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; MORRISON BW, 1994, ONCOGENE, V9, P3417; Musi N, 2003, ACTA PHYSIOL SCAND, V178, P337, DOI 10.1046/j.1365-201X.2003.01168.x; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nielsen KR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3391; Niu WY, 2003, J BIOL CHEM, V278, P17953, DOI 10.1074/jbc.M211136200; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Rathcke CN, 2006, INFLAMM RES, V55, P53, DOI 10.1007/s00011-005-0010-8; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schultz Nicolai A, 2010, Cancers (Basel), V2, P1453, DOI 10.3390/cancers2031453; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Thomsen SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133672; Toloza FJK, 2017, J DIABETES COMPLICAT, V31, P1423, DOI 10.1016/j.jdiacomp.2017.06.002; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200	47	2	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13445	13460		10.1096/fj.202000925R	http://dx.doi.org/10.1096/fj.202000925R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32816366	Green Published			2022-12-28	WOS:000563239100001
J	Yang, MC; Zhang, DQ; Zhao, ZF; Sit, JL; Saint-Sume, M; Shabandri, O; Zhang, KZ; Yin, L; Tong, X				Yang, Meichan; Zhang, Deqiang; Zhao, Zifeng; Sit, Julian; Saint-Sume, Mischael; Shabandri, Omar; Zhang, Kezhong; Yin, Lei; Tong, Xin			Hepatic E4BP4 induction promotes lipid accumulation by suppressing AMPK signaling in response to chemical or diet-induced ER stress	FASEB JOURNAL			English	Article						de novo lipogenesis; ER stress; high-fat; low-methionine; and choline-deficient diet; lipid accumulation; lipid droplet	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; LIVER-INJURY; CELL-DEATH; INSULIN-RESISTANCE; METABOLISM; ACTIVATION; STEATOSIS; KINASE; STEATOHEPATITIS	Prolonged ER stress has been known to be one of the major drivers of impaired lipid homeostasis during the pathogenesis of non-alcoholic liver disease (NAFLD). However, the downstream mediators of ER stress pathway in promoting lipid accumulation remain poorly understood. Here, we present data showing the b-ZIP transcription factor E4BP4 in both the hepatocytes and the mouse liver is potently induced by the chemical ER stress inducer tunicamycin or by high-fat, low-methionine, and choline-deficient (HFLMCD) diet. We showed that such an induction is partially dependent on CHOP, a known mediator of ER stress and requires the E-box element of theE4bp4promoter. Tunicamycin promotes the lipid droplet formation and alters lipid metabolic gene expression in primary mouse hepatocytes fromE4bp4(flox/flox)but notE4bp4 liver-specific KO(E4bp4-LKO) mice. Compared withE4bp4(flox/flox)mice,E4bp4-LKOfemale mice exhibit reduced liver lipid accumulation and partially improved liver function after 10-week HFLMCD diet feeding. Mechanistically, we observed elevated AMPK activity and the AMPK beta 1 abundance in the liver ofE4bp4-LKOmice. We have evidence supporting that E4BP4 may suppress the AMPK activity via promoting the AMPK beta 1 ubiquitinationanddegradation. Furthermore, acute depletion of theAmpk beta 1subunit restores lipid droplet formation inE4bp4-LKOprimary mouse hepatocytes. Our study highlighted hepatic E4BP4 as a key factor linking ER stress and lipid accumulation in the liver. Targeting E4BP4 in the liver may be a novel therapeutic avenue for treating NAFLD.	[Yang, Meichan; Zhang, Deqiang; Sit, Julian; Shabandri, Omar; Yin, Lei; Tong, Xin] Univ Michigan, Dept Mol & Integrat Physiol, Med Sch, 1137 Catherine St,Med Sci 2 7712, Ann Arbor, MI 48109 USA; [Yang, Meichan] Cent South Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Peoples R China; [Zhao, Zifeng] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat, Nanjing, Peoples R China; [Saint-Sume, Mischael] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Zhang, Kezhong] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA	University of Michigan System; University of Michigan; Central South University; China Pharmaceutical University; Howard University; Wayne State University	Yin, L; Tong, X (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Med Sch, 1137 Catherine St,Med Sci 2 7712, Ann Arbor, MI 48109 USA.	leiyin@umich.edu; xintong@umich.edu		TONG, XIN/0000-0002-4832-8940	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK121170, DK077449, DK099593, DK090313, DK089503, DK020572, DK034933]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK121170, DK077449, DK099593, DK090313, DK089503, DK089503, DK020572, DK034933 and DK020572	Bandla H, 2018, HEPATOL RES, V48, P479, DOI 10.1111/hepr.13052; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Byun S, 2017, EMBO J, V36, P1755, DOI 10.15252/embj.201695500; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Cho EJ, 2014, DIGEST DIS SCI, V59, P1461, DOI 10.1007/s10620-014-3217-0; Deng M, 2016, MOL CELL, V61, P614, DOI 10.1016/j.molcel.2016.01.010; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Han CY, 2018, CELL REP, V24, P2985, DOI 10.1016/j.celrep.2018.07.068; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522; Iracheta-Vellve A, 2016, J BIOL CHEM, V291, P26794, DOI 10.1074/jbc.M116.736991; Kang G, 2017, METABOLISM, V77, P13, DOI 10.1016/j.metabol.2017.08.007; Keniry Megan, 2014, Discoveries (Craiova), V2, pe15; Khoury T, 2015, WORLD J GASTROENTERO, V21, P7443, DOI 10.3748/wjg.v21.i24.7443; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kostrzewski T, 2018, J IMMUNOL, V200, P1370, DOI 10.4049/jimmunol.1700981; Kwon E, 2019, FASEB J, V33, P6539, DOI 10.1096/fj.201801766RRR; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4; Li YY, 2017, MOL ONCOL, V11, P1806, DOI 10.1002/1878-0261.12151; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liu XY, 2015, AM J PHYSIOL-GASTR L, V309, pG965, DOI 10.1152/ajpgi.00132.2015; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Noureddin Mazen, 2018, Curr Hepatol Rep, V17, P350, DOI 10.1007/s11901-018-0425-7; Ohta Y, 2017, EBIOMEDICINE, V18, P146, DOI 10.1016/j.ebiom.2017.03.040; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Qiu Bo, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1912; Rahman K, 2016, LAB INVEST, V96, P895, DOI 10.1038/labinvest.2016.61; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Ren LP, 2013, INT J MOL MED, V32, P1029, DOI 10.3892/ijmm.2013.1493; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Smith BK, 2017, CURR OPIN CLIN NUTR, V20, P248, DOI 10.1097/MCO.0000000000000380; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401; Tong X, 2016, J LIPID RES, V57, P1219, DOI 10.1194/jlr.M067181; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Woods A, 2017, CELL REP, V18, P3043, DOI 10.1016/j.celrep.2017.03.011; Xu G, 2018, CURR MED CHEM, V25, P889, DOI 10.2174/0929867324666170404142450; Xu YQ, 2015, BBA-GEN SUBJECTS, V1850, P2552, DOI 10.1016/j.bbagen.2015.09.008; Yang FJ, 2019, CELL IMMUNOL, V336, P40, DOI 10.1016/j.cellimm.2018.12.008; Yoo J, 2018, TOXICOL APPL PHARM, V360, P18, DOI 10.1016/j.taap.2018.09.032; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298; Zhu L, 2018, MOL METAB, V8, P106, DOI 10.1016/j.molmet.2017.12.012	62	5	5	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13533	13547		10.1096/fj.201903292RR	http://dx.doi.org/10.1096/fj.201903292RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780887	Green Accepted, Green Submitted			2022-12-28	WOS:000558418200001
J	Zacheja, T; Toth, A; Harami, GM; Yang, QL; Schwindt, E; Kovacs, M; Paeschke, K; Burkovics, P				Zacheja, Theresa; Toth, Agnes; Harami, Gabor M.; Yang, Qianlu; Schwindt, Eike; Kovacs, Mihaly; Paeschke, Katrin; Burkovics, Peter			Mgs1 protein supports genome stability via recognition of G-quadruplex DNA structures	FASEB JOURNAL			English	Article						DNA replication; genome stability; G-quadruplex; helicase; protein-DNA interaction	SACCHAROMYCES-CEREVISIAE HOMOLOG; STALLED REPLICATION FORKS; RECQ HELICASES; IN-VITRO; PIF1; SGS1; INSTABILITY; GENE; MAINTENANCE; WRNIP1	The integrity of the genetic material is crucial for every organism. One intrinsic attack to genome stability is stalling of the replication fork which can result in DNA breakage. Several factors, such as DNA lesions or the formation of stable secondary structures (eg, G-quadruplexes) can lead to replication fork stalling. G-quadruplexes (G4s) are well-characterized stable secondary DNA structures that can form within specific single-stranded DNA sequence motifs and have been shown to block/pause the replication machinery. In most genomes several helicases have been described to regulate G4 unfolding to preserve genome integrity, however, different experiments raise the hypothesis that processing of G4s during DNA replication is more complex and requires additional, so far unknown, proteins. Here, we show that theSaccharomyces cerevisiaeMgs1 protein robustly binds to G4 structures in vitro and preferentially acts at regions with a strong potential to form G4 structures in vivo. Our results suggest that Mgs1 binds to G4-forming sites and has a role in the maintenance of genome integrity.	[Zacheja, Theresa; Schwindt, Eike; Paeschke, Katrin] Univ Hosp Bonn, Dept Oncol Hematol & Rheumatol, Bonn, Germany; [Toth, Agnes; Burkovics, Peter] Biol Res Ctr, Inst Genet, Temesvari Krt 62, H-6726 Szeged, Hungary; [Toth, Agnes] Univ Szeged, Fac Sci & Informat, Doctoral Sch Biol, Szeged, Hungary; [Harami, Gabor M.; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, EITE MTA Momentum Motor Enzymol Res Grp, Budapest, Hungary; [Yang, Qianlu; Paeschke, Katrin] Univ Wurzburg, Dept Biochem, Bioctr, Wurzburg, Germany; [Yang, Qianlu] Nanjing Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Nanjing, Peoples R China; [Kovacs, Mihaly] Eotvos Lorand Univ, MTA ELTE Motor Pharmacol Res Grp, Dept Biochem, Budapest, Hungary	University of Bonn; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Eotvos Lorand University; University of Wurzburg; Nanjing Medical University; Eotvos Lorand University	Burkovics, P (corresponding author), Biol Res Ctr, Inst Genet, Temesvari Krt 62, H-6726 Szeged, Hungary.; Paeschke, K (corresponding author), Univ Klin Bonn, Med Klin 3, Venusberg Campus 1,Gebaude 13,3OG029, H-53127 Bonn, Hungary.	katrin.paeschke@ukbonn.de; burkovics.peter@brc.hu		Kovacs, Mihaly/0000-0002-1200-4741	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft; EC | European Research Council (ERC) [638988-G4DSB]; NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [31700716]; Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal (NKFI Office) [119361, 116072, ERC_ HU117680, 123989]; Eotvos Lorand Tudomanyegyetem (ELTE) [4.2.1/BOP 6072]	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EC | European Research Council (ERC); NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal (NKFI Office); Eotvos Lorand Tudomanyegyetem (ELTE)	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft; EC | European Research Council (ERC), Grant/Award Number: 638988-G4DSB; NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 31700716; Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal (NKFI Office), Grant/Award Number: 119361, 116072, ERC_ HU117680 and 123989; Eotvos Lorand Tudomanyegyetem (ELTE), Grant/Award Number: 4.2.1/BOP 6072	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bosch PC, 2014, EMBO J, V33, P2521, DOI 10.15252/embj.201488663; Branzei D, 2002, MOL GENET GENOMICS, V268, P371, DOI 10.1007/s00438-002-0757-3; Branzei D, 2002, DNA REPAIR, V1, P671, DOI 10.1016/S1568-7864(02)00073-3; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Buzovetsky O, 2017, CELL REP, V21, P1707, DOI 10.1016/j.celrep.2017.10.079; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dahan D, 2018, NUCLEIC ACIDS RES, V46, P11847, DOI 10.1093/nar/gky1065; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008; Eddy S, 2014, NUCLEIC ACIDS RES, V42, P3272, DOI 10.1093/nar/gkt1314; Estep KN, 2017, CURR MED CHEM, P2881; Garcia-Rodriguez N, 2018, NUCLEIC ACIDS RES, V46, P8347, DOI 10.1093/nar/gky648; Gotz S, 2019, MOLECULES, V24, DOI 10.3390/molecules24091774; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gyimesi M, 2016, METHODS, V108, P24, DOI 10.1016/j.ymeth.2016.04.028; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2001, P NATL ACAD SCI USA, V98, P8283, DOI 10.1073/pnas.121009098; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; Kawabe YI, 2006, DNA REPAIR, V5, P816, DOI 10.1016/j.dnarep.2006.04.006; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kitts C, 2012, IEEE-ASME T MECH, V17, P1, DOI 10.1109/TMECH.2011.2177855; Kopylov M, 2019, MOLECULES, V24, DOI 10.3390/molecules24101988; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lee JY, 2008, J BIOL CHEM, V283, P29847, DOI 10.1074/jbc.M804760200; Lerner LK, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020095; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Marsico G, 2019, NUCLEIC ACIDS RES, V47, P3862, DOI 10.1093/nar/gkz179; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Monchaud D, 2008, BIOCHIMIE, V90, P1207, DOI 10.1016/j.biochi.2008.02.019; Motegi A, 2007, METHODS, V41, P168, DOI 10.1016/j.ymeth.2006.07.025; Motlagh NDV, 2006, DNA REPAIR, V5, P1459, DOI 10.1016/j.dnarep.2006.07.006; Moye AL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8643; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Noer SL, 2016, NUCLEIC ACIDS RES, V44, P464, DOI 10.1093/nar/gkv1320; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Putnam C. D., 2010, COLD SPRING HARB PRO, V2010; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rogers CM, 2017, NUCLEIC ACIDS RES, V45, P5217, DOI 10.1093/nar/gkx151; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07378-5; Rossi SE, 2015, CELL REP, V13, P80, DOI 10.1016/j.celrep.2015.08.073; Sabouri N, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0101-5; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; Saugar I, 2012, NUCLEIC ACIDS RES, V40, P245, DOI 10.1093/nar/gkr738; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Suhasini AN, 2013, MUTAT RES-REV MUTAT, V752, P138, DOI 10.1016/j.mrrev.2012.12.004; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Todd AK, 2011, NUCLEIC ACIDS RES, V39, P4917, DOI 10.1093/nar/gkr104; Tsurimoto T, 2005, GENES CELLS, V10, P13, DOI 10.1111/j.1365-2443.2004.00812.x; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; van Wietmarschen N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02760-1; Wanzek K, 2017, NUCLEIC ACIDS RES, V45, P7796, DOI 10.1093/nar/gkx467; Watt PM, 1996, GENETICS, V144, P935; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; Yoshida W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21514-7; Yoshimura A, 2017, CELL CYCLE, V16, P515, DOI 10.1080/15384101.2017.1282585; You J, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170771; Zeraati M, 2018, NAT CHEM, V10, P631, DOI 10.1038/s41557-018-0046-3	89	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12646	12662		10.1096/fj.202000886R	http://dx.doi.org/10.1096/fj.202000886R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32748509	Green Accepted, hybrid			2022-12-28	WOS:000558208300001
J	Gu, YL; Chen, J; Zhang, H; Shen, ZY; Liu, H; Lv, SQ; Yu, XX; Zhang, D; Ding, XQ; Zhang, XY				Gu, Yulu; Chen, Jing; Zhang, Han; Shen, Ziyan; Liu, Hong; Lv, Shiqi; Yu, Xixi; Zhang, Di; Ding, Xiaoqiang; Zhang, Xiaoyan			Hydrogen sulfide attenuates renal fibrosis by inducing TET-dependent DNA demethylation on Klotho promoter	FASEB JOURNAL			English	Article						CKD; Fe2+; hypoxia; ROS	FIBROBLAST ACTIVATION; GENE-EXPRESSION; KIDNEY INJURY; METHYLATION; HYDROXYMETHYLATION; HYPOXIA; H2S; VASORELAXANT; FIBROGENESIS; CONTRIBUTES	Hypoxia is a key pathogenetic characteristic of chronic kidney disease (CKD). Klotho has renoprotective effect and its expression is commonly suppressed in CKD patients. We showed that chronic hypoxia in unilateral ureteral obstruction model mice is associated with renal Klotho promoter methylation and expression silencing. Administration of low-dose of sodium hydrosulfide (NaHS) effectively ameliorated renal tubulointerstitial fibrosis in the mouse model by demethylating Klotho promoter and restoring its expression. Mechanistically, hypoxia microenvironment in CKD reduced cellular oxygen availability and Fe(2+)concentration, and led to impaired activity of ten-eleven translocation (TET), which is critical in maintaining Klotho promoter demethylation status. NaHS treatment greatly improved hypoxia condition, restored TET activity, reversed DNA methylation, and thus, increased Klotho expression. Our results strongly suggested that correcting hypoxia condition to restore TET activity could be a promising therapeutic strategy against CKD.	[Gu, Yulu; Chen, Jing; Zhang, Han; Shen, Ziyan; Liu, Hong; Lv, Shiqi; Yu, Xixi; Zhang, Di; Ding, Xiaoqiang; Zhang, Xiaoyan] Fudan Univ, Zhongshan Hosp, Dept Nephrol, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Gu, Yulu; Lv, Shiqi; Yu, Xixi; Zhang, Di; Ding, Xiaoqiang; Zhang, Xiaoyan] Shanghai Key Lab Kidney & Blood Purificat, Shanghai, Peoples R China; [Chen, Jing; Zhang, Han; Shen, Ziyan; Liu, Hong; Ding, Xiaoqiang; Zhang, Xiaoyan] Shanghai Med Ctr Kidney Dis, Shanghai, Peoples R China; [Ding, Xiaoqiang; Zhang, Xiaoyan] Shanghai Inst Kidney & Dialysis, 136 Med Coll Rd, Shanghai 200032, Peoples R China	Fudan University	Ding, XQ; Zhang, XY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Nephrol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Ding, XQ; Zhang, XY (corresponding author), Shanghai Inst Kidney & Dialysis, 136 Med Coll Rd, Shanghai 200032, Peoples R China.	ding.xiaoqiang@zs-hospital.sh.cn; zhang.xiaoyan@zs-hospital.sh.cn			Ministry of Science and Technology of People's Republic of China [2016YFC1305500]; Shanghai Municipal Health Commission [2017ZZ01015]; Innovation Program of Shanghai Municipal Education Commission [2017-01-07-0007-E00009]; National Natural Science Foundation of China [81700646, 81970637]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Shanghai Municipal Health Commission; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Ministry of Science and Technology of People's Republic of China (2016YFC1305500), Shanghai Municipal Health Commission (2017ZZ01015), Innovation Program of Shanghai Municipal Education Commission (2017-01-07-0007-E00009), and National Natural Science Foundation of China (81700646 and 81970637)	Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Dressler GR, 2008, J AM SOC NEPHROL, V19, P2060, DOI 10.1681/ASN.2008010119; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hore TA, 2016, P NATL ACAD SCI USA, V113, P12202, DOI 10.1073/pnas.1608679113; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuang Q, 2018, AM J NEPHROL, V47, P361, DOI 10.1159/000489606; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Morgado-Pascual JL, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2931049; Madala HR, 2018, CANCERS, V10, DOI 10.3390/cancers10020049; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Salminen A, 2014, AGEING RES REV, V16, P45, DOI 10.1016/j.arr.2014.05.004; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Sun Y, 2015, J MOL MED, V93, P439, DOI 10.1007/s00109-014-1227-1; Tampe B, 2017, KIDNEY INT, V91, P157, DOI 10.1016/j.kint.2016.07.042; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xia M, 2009, J PHARMACOL EXP THER, V329, P1056, DOI 10.1124/jpet.108.149963; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu XB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05766-5; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Yin WJ, 2012, EUR J RADIOL, V81, P1426, DOI 10.1016/j.ejrad.2011.03.045; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893; Zhang Q, 2017, KIDNEY INT, V91, P144, DOI 10.1016/j.kint.2016.07.040; Zhao BL, 2014, NUCLEIC ACIDS RES, V42, P1593, DOI 10.1093/nar/gkt1090; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	42	12	12	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11474	11487		10.1096/fj.201902957RR	http://dx.doi.org/10.1096/fj.201902957RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729950				2022-12-28	WOS:000556805800001
J	Abdrabou, A; Wang, ZX				Abdrabou, Abdalla; Wang, Zhixiang			Regulation of the nuclear speckle localization and function of Rac1	FASEB JOURNAL			English	Article						hnRNPA1; nuclear speckle; nucleus; PBR; phosphorylation; pre&#8208; mRNA splicing; Rac1; SRSF2; U2 snRNP; U2A&#8242	HNRNP A1; PHOSPHORYLATION; PROTEINS; ACTIVATION; MECHANISM; DYNAMICS; GTPASES; KINASE	Despite significant evidence that Rac1 is localized to the nucleus, little is known regarding the function and biological significance of nuclear Rac1. Here, we showed that in response to EGF Rac1 was translocated to nuclear speckles and co-localized with the nuclear speckle marker Serine/arginine-rich splicing factor 2 (SRSF2) in Cos-7 cells. We also showed that the nuclear speckle localization of Rac1 was dependent on its T108 phosphorylation and facilitated by Rac1 polybasic region (PBR) that contains a nuclear localization signal and Rac1 GTPase activity. To gain insight into the function of Rac1 in nuclear speckles, we searched for Rac1 binding proteins in the nucleus. We isolated nuclear fraction of HEK 293 cells and incubated with GST-Rac1 and the phosphomimetic GST-Rac1T108E. We identified 463 proteins that were associated with GST-Rac1T108E, but not with GST-Rac1 by LC-MS/MS. Three notable groups of these proteins are: the heterogeneous nuclear ribonucleoproteins (hnRNPs), small nuclear ribonucleoproteins (snRNPs), and SRSFs, all of which are involved in pre-mRNA splicing and associated with nuclear speckles. We further showed by co-immunoprecipitation that Rac1 interacts with SRSF2, hnRNPA1, and U2A ' in response to EGF. The interaction is dependent on T108 phosphorylation and facilitated by Rac1 PBR and GTPase activity. We showed that hnRNPA1 translocated in and out of nucleus in response to EGF in a similar pattern to Rac1. Rac1 only partially colocalized with U2A ' that localizes to the actual splicing sites adjacent to nuclear speckle. Finally, we showed that Rac1 regulated EGF-induced pre-mRNA splicing and this is mediated by T108 phosphorylation. We conclude that in response to EGF, T108 phosphorylated Rac1 is targeted to nuclear speckles, interacts with multiple groups of proteins involved in pre-mRNA splicing, and regulates EGF-induced pre-mRNA splicing.	[Abdrabou, Abdalla; Wang, Zhixiang] Univ Alberta, Fac Med & Dent, Dept Med Genet & Signal, Transduct Res Grp, Edmonton, AB, Canada	University of Alberta	Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada.; Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB T6G 2H7, Canada.	zhixiang.wang@ualberta.ca			CIHR [RES0030993] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Abdrabou A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091006; Abdrabou A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120263; ANDO S, 1992, J BIOL CHEM, V267, P25709; Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; Carrizzo A, 2014, CURR DRUG TARGETS, V15, P1231, DOI 10.2174/1389450115666141027110156; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Eilbracht J, 2001, P NATL ACAD SCI USA, V98, P3849, DOI 10.1073/pnas.071042298; Falaleeva M, 2016, P NATL ACAD SCI USA, V113, pE1625, DOI 10.1073/pnas.1519292113; Galganski L, 2017, NUCLEIC ACIDS RES, V45, P10350, DOI 10.1093/nar/gkx759; Goncalves V, 2014, RNA, V20, P474, DOI 10.1261/rna.041376.113; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Karpel-Massler G, 2013, MOL CANCER THER, V12, P1783, DOI 10.1158/1535-7163.MCT-13-0052; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lamond AI, 2003, CURR BIOL, V13, pR825, DOI 10.1016/j.cub.2003.10.012; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liu M, 2012, TRENDS CELL BIOL, V22, P365, DOI 10.1016/j.tcb.2012.04.004; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Moissoglu K., 2014, CELL LOGIST, V4, pe943618, DOI [10.4161/21592780.2014.943618, DOI 10.4161/21592780.2014.943618]; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Navarro-Lerida I, 2015, DEV CELL, V32, P318, DOI 10.1016/j.devcel.2014.12.019; Olson Michael F, 2018, Small GTPases, V9, P203, DOI 10.1080/21541248.2016.1218407; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Pelisch F, 2012, J CELL BIOCHEM, V113, P2319, DOI 10.1002/jcb.24103; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Schoentaube J, 2009, CELL MICROBIOL, V11, P1816, DOI 10.1111/j.1462-5822.2009.01373.x; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044358; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Tong JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147103; Tong JF, 2013, MOL CELL BIOL, V33, P4538, DOI 10.1128/MCB.00822-13; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang F, 2017, CELL RES, V27, P540, DOI 10.1038/cr.2017.7; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	49	1	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21235	10.1096/fj.202001694R	http://dx.doi.org/10.1096/fj.202001694R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417283				2022-12-28	WOS:000647789600100
J	Kozai, K; Iqbal, K; Moreno-Irusta, A; Scott, RL; Simon, ME; Dhakal, P; Fields, PE; Soares, MJ				Kozai, Keisuke; Iqbal, Khursheed; Moreno-Irusta, Ayelen; Scott, Regan L.; Simon, Mikaela E.; Dhakal, Pramod; Fields, Patrick E.; Soares, Michael J.			Protective role of IL33 signaling in negative pregnancy outcomes associated with lipopolysaccharide exposure	FASEB JOURNAL			English	Article						fetal growth restriction; IL33; lipopolysaccharide; pregnancy outcome; placental development	GROWTH RESTRICTION IMPACTS; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; HEMOCHORIAL PLACENTATION; INTERLEUKIN 33; SOLUBLE ST2; FETAL-DEATH; IN-VIVO; INFLAMMATION; IL-33	Interleukin 33 (IL33) signaling has been implicated in the establishment and maintenance of pregnancy and in pregnancy disorders. The goal of this project was to evaluate the role of IL33 signaling in rat pregnancy. The rat possesses hemochorial placentation with deep intrauterine trophoblast invasion; features also characteristic of human placentation. We generated and characterized a germline mutant rat model for IL33 using CRISPR/Cas9 genome editing. IL33 deficient rats exhibited deficits in lung responses to an inflammatory stimulus (Sephadex G-200) and to estrogen-induced uterine eosinophilia. Female rats deficient in IL33 were fertile and exhibited pregnancy outcomes (gestation length and litter size) similar to wild-type rats. Placental weight was adversely affected by the disruption of IL33 signaling. A difference in pregnancy-dependent adaptations to lipopolysaccharide (LPS) exposure was observed between wild-type and IL33 deficient pregnancies. Pregnancy in wild-type rats treated with LPS did not differ significantly from pregnancy in vehicle-treated wild-type rats. In contrast, LPS treatment decreased fetal survival rate, fetal and placental weights, and increased fetal growth restriction in IL33 deficient rats. In summary, a new rat model for investigating IL33 signaling has been established. IL33 signaling participates in the regulation of placental development and protection against LPS-induced fetal and placental growth restriction.	[Kozai, Keisuke; Iqbal, Khursheed; Moreno-Irusta, Ayelen; Scott, Regan L.; Simon, Mikaela E.; Dhakal, Pramod; Fields, Patrick E.; Soares, Michael J.] Univ Kansas, Inst Reprod & Perinatal Res, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA; [Soares, Michael J.] Univ Kansas, Dept Pediat, Med Ctr, Kansas City, KS 66160 USA; [Soares, Michael J.] Univ Kansas, Dept Obstet & Gynecol, Med Ctr, Kansas City, KS 66160 USA; [Soares, Michael J.] Childrens Mercy, Childrens Mercy Res Inst, Ctr Perinatal Res, Kansas City, MO USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital	Kozai, K; Soares, MJ (corresponding author), Univ Kansas, Dept Pathol & Lab Med, Med Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kkozai@kumc.edu; msoares@kumc.edu	Fields, Patrick E/G-4878-2012	Iqbal, Khursheed/0000-0002-6742-4591; Fields, Patrick/0000-0002-6797-4139; Moreno, Ayelen/0000-0001-6810-6475; Kozai, Keisuke/0000-0003-2645-7431				Ain R, 2006, METH MOLEC MED, V121, P295; Ain R, 2005, J ENDOCRINOL, V185, P253, DOI 10.1677/joe.1.06039; Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Altara R, 2018, CARDIOVASC RES, V114, P1578, DOI 10.1093/cvr/cvy166; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Briffa JF, 2017, PLACENTA, V59, P30, DOI 10.1016/j.placenta.2017.09.006; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Bronson SL, 2014, ENDOCRINOLOGY, V155, P2635, DOI 10.1210/en.2014-1040; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Celik H, 2002, EUR J OBSTET GYN R B, V103, P22, DOI 10.1016/S0301-2115(02)00018-0; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chakraborty D, 2016, P NATL ACAD SCI USA, V113, pE7212, DOI 10.1073/pnas.1612626113; Chakraborty D, 2011, P NATL ACAD SCI USA, V108, P16295, DOI 10.1073/pnas.1109478108; Chakraborty S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26590-3; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chan JC, 2018, BIOL PSYCHIAT, V83, P886, DOI 10.1016/j.biopsych.2017.10.005; Chavan AR, 2017, CURR OPIN GENET DEV, V47, P24, DOI 10.1016/j.gde.2017.08.004; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Cotechini T, 2014, PLACENTA, V35, P575, DOI 10.1016/j.placenta.2014.05.002; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Cotechini T, 2012, THROMB HAEMOSTASIS, V107, P864, DOI 10.1160/TH11-10-0730; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Dyer KD, 2013, IMMUNOL LETT, V150, P41, DOI 10.1016/j.imlet.2012.12.002; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Falcon BJ, 2012, THROMB HAEMOSTASIS, V107, P438, DOI 10.1160/TH11-09-0626; FINN CA, 1986, BIOL REV, V61, P313, DOI 10.1111/j.1469-185X.1986.tb00657.x; Fock V, 2013, J IMMUNOL, V191, P3734, DOI 10.4049/jimmunol.1300490; Gokdemir IE, 2016, J MATERN-FETAL NEO M, V29, P2450, DOI 10.3109/14767058.2015.1087497; Granne I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024463; Guimond MJ, 1997, BIOL REPROD, V56, P169, DOI 10.1095/biolreprod56.1.169; Haddad EB, 2002, J IMMUNOL, V168, P3004, DOI 10.4049/jimmunol.168.6.3004; Horton MA, 1996, J LEUKOCYTE BIOL, V60, P285, DOI 10.1002/jlb.60.2.285; Howerton CL, 2012, HORM BEHAV, V62, P237, DOI 10.1016/j.yhbeh.2012.03.007; Hu WT, 2015, J REPROD IMMUNOL, V109, P52, DOI 10.1016/j.jri.2015.01.004; Huang BH, 2017, NAT MED, V23, P128, DOI 10.1038/nm.4244; Johnston LK, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00051; Johnston LK, 2016, J IMMUNOL, V197, P3445, DOI 10.4049/jimmunol.1600611; Kaitu'u-Lino TJ, 2012, J REPROD IMMUNOL, V95, P46, DOI 10.1016/j.jri.2012.06.003; Kamrani A, 2020, HORM MOL BIOL CLIN I, V41, DOI 10.1515/hmbci-2020-0010; Kleemann R, 1996, EXP TOXICOL PATHOL, V48, P233, DOI 10.1016/S0940-2993(96)80004-2; Krey G, 2008, J MOL MED, V86, P999, DOI 10.1007/s00109-008-0379-2; Kubota K, 2016, P NATL ACAD SCI USA, V113, P4212, DOI 10.1073/pnas.1601825113; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lin Y, 2006, J REPROD IMMUNOL, V71, P87, DOI 10.1016/j.jri.2006.01.005; Liu J, 2018, EBIOMEDICINE, V33, P196, DOI 10.1016/j.ebiom.2018.06.003; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; Matsubara S, 1998, INT ARCH ALLERGY IMM, V116, P67, DOI 10.1159/000023927; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Nteeba J, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001243; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2; Pijnenborg R., 2010, PLACENTAL BED DISORD, P127; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; POLLARD JW, 1991, DEV BIOL, V148, P273, DOI 10.1016/0012-1606(91)90336-2; Renaud SJ, 2017, BIOL REPROD, V96, P145, DOI 10.1095/biolreprod.116.142752; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Robb KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175805; Romero R, 2018, J MATERN-FETAL NEO M, V31, P418, DOI 10.1080/14767058.2017.1286319; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Scott LM, 2017, CYTOKINE, V99, P194, DOI 10.1016/j.cyto.2017.07.005; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; SILVER RM, 1994, BIOL REPROD, V50, P1108, DOI 10.1095/biolreprod50.5.1108; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Soares MJ, 2018, BIOL REPROD, V99, P196, DOI 10.1093/biolre/ioy049; SOARES MJ, 1987, J REPROD FERTIL, V79, P93; SPICER BA, 1990, BRIT J PHARMACOL, V101, P821, DOI 10.1111/j.1476-5381.1990.tb14164.x; Stojkovic S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25171; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; TCHERNITCHIN A, 1974, NATURE, V248, P142, DOI 10.1038/248142a0; TCHERNITCHIN X, 1976, DIFFERENTIATION, V5, P151, DOI 10.1111/j.1432-0436.1976.tb00906.x; Tondeleir D, 2009, CELL MOTIL CYTOSKEL, V66, P798, DOI 10.1002/cm.20350; Topping V, 2013, J MATERN-FETAL NEO M, V26, P327, DOI 10.3109/14767058.2012.735724; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wang D, 2000, J ENDOCRINOL, V167, P15, DOI 10.1677/joe.0.1670015; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wiemers D, 2003, J ENDOCRINOL, V179, P335, DOI 10.1677/joe.0.1790335; Yuan SM, 2015, REV BRAS CIR CARDIOV, V30, P644, DOI 10.5935/1678-9741.20150081; Zhang JH, 2016, CELL TISSUE RES, V363, P249, DOI 10.1007/s00441-015-2315-4; Zhou X., 2018, MEDIAT INFLAMM, V2018, DOI DOI 10.1155/2018/9787239	88	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21272	10.1096/fj.202001782RR	http://dx.doi.org/10.1096/fj.202001782RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423320	Green Accepted			2022-12-28	WOS:000647789600059
J	Truman, JP; Ruiz, CF; Trayssac, M; Mao, CG; Hannun, YA; Obeid, LM				Truman, Jean-Philip; Ruiz, Christian F.; Trayssac, Magali; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.			Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation	FASEB JOURNAL			English	Article						serine; sphingolipids; sphingosine; sphingosine kinase 1	MITOCHONDRIAL DYSFUNCTION; CANCER; METABOLISM; STRESS; CELLS; SPHINGOSINE-1-PHOSPHATE; SPHINGOLIPIDS; DOXORUBICIN; INHIBITORS; LEUKEMIA	It has been well-established that cancer cells often display altered metabolic profiles, and recent work has concentrated on how cancer cells adapt to serine removal. Serine can be either taken exogenously or synthesized from glucose, and its regulation forms an important mechanism for nutrient integration. One of the several important metabolic roles for serine is in the generation of bioactive sphingolipids since it is the main substrate for serine palmitoyltransferase, the initial and rate-limiting enzyme in the synthesis of sphingolipids. Previously, serine deprivation has been connected to the action of the tumor suppressor p53, and we have previously published on a role for p53 regulating sphingosine kinase 1 (SK1), an enzyme that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P). SK1 is a key enzyme in sphingolipid synthesis that functions in pro-survival and tumor-promoting pathways and whose expression is also often elevated in cancers. Here we show that SK1 was degraded during serine starvation in a time and dose-dependent manner, which led to sphingosine accumulation. This was independent of effects on p53 but required the action of the proteasome. Furthermore, we show that overexpression of SK1, to compensate for SK1 loss, was detrimental to cell growth under conditions of serine starvation, demonstrating that the suppression of SK1 under these conditions is adaptive. Mitochondrial oxygen consumption decreased in response to SK1 degradation, and this was accompanied by an increase in intracellular reactive oxygen species (ROS). Suppression of ROS with N-acteylcysteine resulted in suppression of the metabolic adaptations and in decreased cell growth under serine deprivation. The effects of SK1 suppression on ROS were mimicked by D-erythro-sphingosine, whereas S1P was ineffective, suggesting that the effects of loss of SK1 were due to the accumulation of its substrate sphingosine. This study reveals a new mechanism for regulating SK1 levels and a link of SK1 to serine starvation as well as mitochondrial function.	[Truman, Jean-Philip; Trayssac, Magali; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Truman, Jean-Philip; Trayssac, Magali; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Ruiz, Christian F.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu		Ruiz, Christian/0000-0003-1470-8061	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R35GM118128] Funding Source: Medline; NCI NIH HHS [P01 CA097132] Funding Source: Medline; NIGMS NIH HHS [R01 GM130878] Funding Source: Medline	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahan CE, 2010, INVEST OPHTH VIS SCI, V51, P1171, DOI 10.1167/iovs.09-3909; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Byun HS, 2013, MEDCHEMCOMM, V4, P1394, DOI [10.1039/c3md00201b, 10.1039/C3MD00201B]; Carroll BL, 2018, FEBS OPEN BIO, V8, P27, DOI 10.1002/2211-5463.12344; Chen W, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1323-0; Cheung EC, 2016, GENE DEV, V30, P52, DOI 10.1101/gad.271130.115; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Diers AR, 2013, REDOX BIOL, V1, P1, DOI 10.1016/j.redox.2012.11.003; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Duan JJ, 2015, J BIOL CHEM, V290, P15380, DOI 10.1074/jbc.R115.658823; Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Han Y, 2018, FREE RADICAL RES, V52, P1271, DOI 10.1080/10715762.2018.1459594; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harijith A, 2013, AM J PATHOL, V183, P1169, DOI 10.1016/j.ajpath.2013.06.018; Hassoun SM, 2006, MITOCHONDRION, V6, P149, DOI 10.1016/j.mito.2006.05.001; Hernandez-Corbacho MJ, 2017, BBA-MOL CELL BIOL L, V1862, P56, DOI 10.1016/j.bbalip.2016.09.019; Huwiler A, 2011, BRIT J PHARMACOL, V162, P532, DOI 10.1111/j.1476-5381.2010.01053.x; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kim S, 2018, CELL REP, V24, P2932, DOI 10.1016/j.celrep.2018.08.037; Liu GL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-495; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Lucas S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800036; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Momose I, 2016, INT IMMUNOPHARMACOL, V37, P23, DOI 10.1016/j.intimp.2015.11.013; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Muthusamy T, 2020, NATURE, V586, P790, DOI 10.1038/s41586-020-2609-x; Norris GH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111180; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Pchejetski D, 2007, CIRC RES, V100, P41, DOI 10.1161/01.RES.0000253900.66640.34; Powell JA, 2019, BIOCHEM J, V476, P3211, DOI 10.1042/BCJ20190245; Pulkoski-Gross MJ, 2018, J LIPID RES, V59, P462, DOI 10.1194/jlr.M081307; Pyszko J, 2014, MOL NEUROBIOL, V50, P38, DOI 10.1007/s12035-013-8622-4; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Ravez S, 2017, J MED CHEM, V60, P1227, DOI 10.1021/acs.jmedchem.6b01167; Ren SY, 2010, CELL PHYSIOL BIOCHEM, V26, P97, DOI 10.1159/000315110; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2004, J BIOL CHEM, V279, P20546, DOI 10.1074/jbc.M401259200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Takahashi N, 2018, CANCER CELL, V33, P985, DOI 10.1016/j.ccell.2018.05.001; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wang Q, 2017, CELL CHEM BIOL, V24, P55, DOI 10.1016/j.chembiol.2016.11.013; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yi JK, 2016, ONCOTARGET, V7, P21124, DOI 10.18632/oncotarget.8195; Yu HY, 2012, BIOCHEM BIOPH RES CO, V417, P1242, DOI 10.1016/j.bbrc.2011.12.117	66	4	4	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21284	10.1096/fj.202001814RR	http://dx.doi.org/10.1096/fj.202001814RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484475	Bronze, Green Accepted			2022-12-28	WOS:000647789600080
J	Lai, YH; Lee, PY; Lu, CY; Liu, YR; Wang, SC; Liu, CC; Chang, YC; Chen, YH; Su, CC; Li, CY; Liu, PL				Lai, Yu-Hung; Lee, Po-Yen; Lu, Chi-Yu; Liu, Yu-Ru; Wang, Shu-Chi; Liu, Ching-Chih; Chang, Yo-Chen; Chen, Yung-Hsiang; Su, Chia-Cheng; Li, Chia-Yang; Liu, Po-Len			Thrombospondin 1-induced exosomal proteins attenuate hypoxia-induced paraptosis in corneal epithelial cells and promote wound healing	FASEB JOURNAL			English	Article						exosomes; human corneal epithelium; hypoxia; paraptosis; thrombospondin&#8208; 1	POTENTIAL ROLE; RECEPTOR; NEOVASCULARIZATION; LOCALIZATION; APOPTOSIS; MIGRATION; PATHWAYS; TISSUES; REPAIR; EYE	Thrombospondin-1 (TSP1) is involved in corneal wound healing caused by chemical injury. Herein, we examined the effects of TSP1 on hypoxia-induced damages and wound-healing activity in human corneal epithelial (HCE) cells. Exosomal protein expression was determined using liquid chromatography-tandem mass spectrometry, and HCE cell migration and motility were examined through wound-healing assay and time-lapse microscopy. Reestablishment of cell junctions by TSP1 was assessed through confocal microscopy and 3D image reconstruction. Our results show that CoCl2-induced hypoxia promoted HCE cell death by paraptosis. TSP1 protected these cells against paraptosis by attenuating mitochondrial membrane potential depletion, swelling and dilation of endoplasmic reticulum and mitochondria, and mitochondrial fission. Exosomes isolated from HCE cells treated with TSP1 contained wound healing-associated proteins that were taken up by HCE cells to promote tissue remodeling and repair. TSP1 protected HCE cells against hypoxia-induced damages and inhibited paraptosis progression by promoting cell migration, cell-cell adhesion, and extracellular matrix remodeling. These findings indicate that TSP1 ameliorates hypoxia-induced paraptosis in HCE cells and promotes wound healing and remodeling by regulating exosomal protein expression. TSP1 may, therefore, play important roles in the treatment of hypoxia-associated corneal diseases.	[Lai, Yu-Hung; Lee, Po-Yen; Chang, Yo-Chen; Su, Chia-Cheng; Li, Chia-Yang] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan; [Lai, Yu-Hung; Lee, Po-Yen; Chang, Yo-Chen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lai, Yu-Hung; Chang, Yo-Chen] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Kaohsiung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Liu, Yu-Ru; Liu, Po-Len] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung 80708, Taiwan; [Wang, Shu-Chi] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Liu, Ching-Chih] Chi Mei Med Ctr, Dept Ophthalmol, Tainan, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Li, Chia-Yang; Liu, Po-Len] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan; [Liu, Po-Len] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Chi Mei Hospital; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Li, CY (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan.; Liu, PL (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung 80708, Taiwan.	chiayangli@kmu.edu.tw; kisa@kmu.edu.tw	Lai, Yu-Hung/HGA-2767-2022; Chen, Yung-Hsiang/K-6766-2015	Lai, Yu-Hung/0000-0003-1997-0587; Chen, Yung-Hsiang/0000-0002-8756-5113; LI, CHIA-YANG/0000-0001-5689-9850; Lee, Po Yen/0000-0002-1825-0003				Adams J.C., 2011, CSH PERSPECT BIOL, V3, pA009712, DOI [10.1101/cshperspect.a009712, DOI 10.1101/cshperspect.a009712]; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Akberova SI, 2016, DOKL BIOCHEM BIOPHYS, V467, P150, DOI 10.1134/S1607672916020198; Armstrong DJ, 2002, INT J BIOCHEM CELL B, V34, P588, DOI 10.1016/S1357-2725(01)00157-1; Bashir Hasan, 2017, J Ophthalmic Vis Res, V12, P305, DOI 10.4103/jovr.jovr_114_17; Boost M, 2017, CLIN EXP OPTOM, V100, P459, DOI 10.1111/cxo.12582; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; EPSTEIN RJ, 1987, CORNEA, V6, P250, DOI 10.1097/00003226-198706040-00004; Esco MA, 2001, J CELL SCI, V114, P4033; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Foulsham W, 2019, OCUL SURF, V17, P374, DOI 10.1016/j.jtos.2019.06.001; Guo XQ, 2016, EXP EYE RES, V146, P233, DOI 10.1016/j.exer.2016.03.011; Han KY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40548; Hannan MA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030223; Hara Y, 2009, MOL VIS, V15, P2515; Hessen Michelle, 2014, J Ophthalmic Vis Res, V9, P240; Hiscott P, 2006, PROG RETIN EYE RES, V25, P1, DOI 10.1016/j.preteyeres.2005.05.001; Hiscott P, 1997, CELL TISSUE RES, V289, P307, DOI 10.1007/s004410050877; Hiscott P, 1999, HISTOL HISTOPATHOL, V14, P1309, DOI 10.14670/HH-14.1309; Hornung S, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00038; HOYNG PFJ, 1986, INVEST OPHTH VIS SCI, V27, P1217; Huang WT, 2019, CANCER LETT, V442, P287, DOI 10.1016/j.canlet.2018.10.031; Kanda A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16499-8; Kang S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0023-4; Kim HK, 2017, CORNEA, V36, P1116, DOI 10.1097/ICO.0000000000001268; Kuo HF, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060794; Kurpakus-Wheater M, 2003, APOPTOSIS, V8, P681, DOI 10.1023/A:1026164332473; Li H, 2006, IMMUNOLOGY, V117, P167, DOI 10.1111/j.1365-2567.2005.02275.x; Liu PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179321; Masli S, 2014, CURR EYE RES, V39, P759, DOI 10.3109/02713683.2013.877936; Matsuba M, 2011, EXP EYE RES, V93, P534, DOI 10.1016/j.exer.2011.06.018; Matsuda A, 1999, CURR EYE RES, V19, P368, DOI 10.1076/ceyr.19.4.368.5306; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Rao P, 2019, J IMMUNOL, V202, P514, DOI 10.4049/jimmunol.1800422; Safvati A, 2009, CURR EYE RES, V34, P501, DOI 10.1080/02713680902919557; Sanyal S, 2017, EXP EYE RES, V164, P1, DOI 10.1016/j.exer.2017.08.002; Shanmughapriya S, 2015, MOL CELL, V60, P47, DOI 10.1016/j.molcel.2015.08.009; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Teranishi S, 2008, INVEST OPHTH VIS SCI, V49, P2432, DOI 10.1167/iovs.07-1464; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tsai JR, 2014, ARCH PHARM RES, V37, P548, DOI 10.1007/s12272-013-0232-1; Uno K, 2004, BIOCHEM BIOPH RES CO, V315, P928, DOI 10.1016/j.bbrc.2004.01.146; Voiculescu O B, 2015, J Med Life, V8, P444; Wang G, 2016, INT HEART J, V57, P483, DOI 10.1536/ihj.16-091; Wang YJ, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109203; WEISS L, 1988, BONE MARROW TRANSPL, V3, P207; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Zhu JD, 2019, INT J OPHTHALMOL-CHI, V12, P66, DOI 10.18240/ijo.2019.01.10; Zieske JD, 2020, ANAT REC, V303, P1727, DOI 10.1002/ar.24181	51	4	6	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21200	10.1096/fj.202001106RRR	http://dx.doi.org/10.1096/fj.202001106RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33341997	hybrid			2022-12-28	WOS:000605626600011
J	Li, B; Lee, C; Chuslip, S; Lee, D; Biouss, G; Wu, R; Koike, Y; Miyake, H; Ip, W; Gonska, T; Pierro, A				Li, Bo; Lee, Carol; Chuslip, Sinobol; Lee, Dorothy; Biouss, George; Wu, Richard; Koike, Yuhki; Miyake, Hiromu; Ip, Wan; Gonska, Tanja; Pierro, Agostino			Intestinal epithelial tight junctions and permeability can be rescued through the regulation of endoplasmic reticulum stress by amniotic fluid stem cells during necrotizing enterocolitis	FASEB JOURNAL			English	Article						amniotic fluid stem cells; endoplasmic reticulum stress; intestine permeability; necrotizing enterocolitis; tight junction	BARRIER DYSFUNCTION; ABSORPTION; PHYSIOLOGY; PATHWAY; PROTEIN; INJURY; MOUSE; STATE	Necrotizing enterocolitis (NEC) is one of the most severe gastrointestinal diseases affecting premature infants. It has been shown that NEC is associated with disrupted intestinal barrier and dysregulated endoplasmic reticulum (ER)-stress response. It has also been shown that stem cells derived from amniotic fluid (AFSC) rescued intestinal injury in experimental NEC. Herein, we hypothesized that the beneficial effects of AFSC in the injured intestine are due to the restoration of intestinal barrier function. We evaluated intestinal barrier function using an ex vivo intestinal organoid model of NEC. We found that AFSC restored the expression and localization of tight junction proteins in intestinal organoids, and subsequently decreased epithelial permeability. AFSC rescued tight junction expression by inducing a protective ER stress response that prevents epithelial cell apoptosis in injured intestinal organoids. Finally, we validated these results in our experimental mouse model of NEC and confirmed that AFSC induced sustained ER stress and prevented intestinal apoptosis. This response led to the restoration of tight junction expression and localization, which subsequently reduced intestinal permeability in NEC pups. These findings confirm that intestinal barrier function is disrupted during NEC intestinal injury, and further demonstrate the disruption can be reversed by the administration of AFSC through the activation of the ER stress pathway. This study provides insight into the pathogenesis of NEC and highlights potential therapeutic targets for the treatment of NEC.	[Li, Bo; Lee, Carol; Chuslip, Sinobol; Lee, Dorothy; Biouss, George; Wu, Richard; Koike, Yuhki; Miyake, Hiromu; Pierro, Agostino] Hosp Sick Children, Div Gen & Thorac Surg, Translat Med, Toronto, ON, Canada; [Ip, Wan; Gonska, Tanja] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Translat Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Pierro, A (corresponding author), Univ Toronto, Hosp Sick Children, Div Gen & Thorac Surg, Surg, 1526-555 Univ Ave, Toronto, ON M5G 1X8, Canada.	agostino.pierro@sickkids.ca	Li, Bo/AAP-6556-2020	Li, Bo/0000-0002-8298-8344	CIHR [353857] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Afrazi A, 2014, J BIOL CHEM, V289, P9584, DOI 10.1074/jbc.M113.526517; Ares G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41442-4; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Blackwood Brian P, 2017, J Probiotics Health, V5, DOI 10.4172/2329-8901.1000159; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Chen WY, 2017, AM J PATHOL, V187, P2686, DOI 10.1016/j.ajpath.2017.08.015; Chen Y, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.040998; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Drucker NA, 2018, SEMIN PEDIATR SURG, V27, P57, DOI 10.1053/j.sempedsurg.2017.11.011; Fu D, 2019, AGING-US, V11, P8294, DOI 10.18632/aging.102320; Gephart SM, 2012, ADV NEONAT CARE, V12, P77, DOI 10.1097/ANC.0b013e31824cee94; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Halpern MD, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2014.1000707; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirsch D, 2014, CARCINOGENESIS, V35, P849, DOI 10.1093/carcin/bgt377; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Hu H, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03083; Huang GJ, 2006, J CELL SCI, V119, P153, DOI 10.1242/jcs.02731; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Koike Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18750-9; Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54; Lee C, 2018, PEDIATR SURG INT, V34, P155, DOI 10.1007/s00383-017-4183-3; Li B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211431; Li B, 2019, PEDIATR SURG INT, V35, P3, DOI 10.1007/s00383-018-4369-3; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep46616; Li B, 2016, J PEDIATR SURG, V51, P1001, DOI 10.1016/j.jpedsurg.2016.02.073; Li B, 2014, PEDIATR SURG INT, V30, P1217, DOI 10.1007/s00383-014-3611-x; Lu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078491; Lu Z, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0387-0; Ma JH, 2016, INVEST OPHTH VIS SCI, V57, P5244, DOI 10.1167/iovs.16-19232; McCulloh CJ, 2017, J SURG RES, V214, P278, DOI 10.1016/j.jss.2017.03.026; Menard S, 2012, AM J PATHOL, V180, P608, DOI 10.1016/j.ajpath.2011.10.019; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250; Moore SA, 2016, J PEDIATR SURG, V51, P1907, DOI 10.1016/j.jpedsurg.2016.09.011; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; P Blackwood M D Brian, 2015, J Neonatal Surg, V4, P43; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Pradhan S, 2020, CELL MOL GASTROENTER, V10, P171, DOI 10.1016/j.jcmgh.2020.02.006; Qie XJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00639; Ravisankar S, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1346-x; Rosenthal R, 2017, ACTA PHYSIOL, V219, P521, DOI 10.1111/apha.12742; Rouwet EV, 2002, PEDIATR RES, V51, P64, DOI 10.1203/00006450-200201000-00012; SCHULTZ SG, 1970, PHYSIOL REV, V50, P637, DOI 10.1152/physrev.1970.50.4.637; Thompson AM, 2008, DRUGS, V68, P1227, DOI 10.2165/00003495-200868090-00004; Tian RL, 2010, INT J CLIN EXP MED, V3, P293; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Weber CR, 2015, ELIFE, V4, DOI 10.7554/eLife.09906; Wu RY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800658; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yee WH, 2012, PEDIATRICS, V129, pE298, DOI 10.1542/peds.2011-2022; Yoon YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39838; Zani A, 2016, PEDIATR SURG INT, V32, P65, DOI 10.1007/s00383-015-3813-x; Zhu XL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63309-9; Zietek T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16831	59	9	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21265	10.1096/fj.202001426R	http://dx.doi.org/10.1096/fj.202001426R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33373067				2022-12-28	WOS:000605626600041
J	Kakizaki, T; Ohshiro, T; Itakura, M; Konno, K; Watanabe, M; Mushiake, H; Yanagawa, Y				Kakizaki, Toshikazu; Ohshiro, Tomokazu; Itakura, Makoto; Konno, Kohtarou; Watanabe, Masahiko; Mushiake, Hajime; Yanagawa, Yuchio			Rats deficient in the GAD65 isoform exhibit epilepsy and premature lethality	FASEB JOURNAL			English	Article						epilepsy; GABA; genome editing; glutamate decarboxylase; rat	GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; MICE LACKING; DIFFERENTIAL EXPRESSION; 65-KDA ISOFORM; PROTEIN-LEVELS; MESSENGER-RNA; RODENT MODELS; CLEFT-PALATE; MOUSE	GABA is synthesized by glutamate decarboxylase (GAD), which has two isoforms, namely, GAD65 and GAD67, encoded by the Gad2 and Gad1 genes, respectively. GAD65-deficient (Gad2(-/-)) mice exhibit a reduction in brain GABA content after 1 month of age and show spontaneous seizures in adulthood. Approximately 25% of Gad2(-/-) mice died by 6 months of age. Our Western blot analysis demonstrated that the protein expression ratio of GAD65 to GAD67 in the brain was greater in rats than in mice during postnatal development, suggesting that the contribution of each GAD isoform to GABA functions differs between these two species. To evaluate whether GAD65 deficiency causes different phenotypes between rats and mice, we generated Gad2(-/-) rats using TALEN genome editing technology. Western blot and immunohistochemical analyses with new antibodies demonstrated that the GAD65 protein was undetectable in the Gad2(-/-) rat brain. Gad2(-/-) pups exhibited spontaneous seizures and paroxysmal discharge in EEG at postnatal weeks 3-4. More than 80% of the Gad2(-/-) rats died at postnatal days (PNDs) 17-23. GABA content in Gad2(-/-) brains was significantly lower than those in Gad2(+/-) and Gad2(+/+) brains at PND17-19. These results suggest that the low levels of brain GABA content in Gad2(-/-) rats may lead to epilepsy followed by premature death, and that Gad2(-/-) rats are more severely affected than Gad2(-/-) mice. Considering that the GAD65/GAD67 ratio in human brains is more similar to that in rat brains than in mouse brains, Gad2(-/-) rats would be useful for further investigating the roles of GAD65 in vivo.	[Kakizaki, Toshikazu; Yanagawa, Yuchio] Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gumma 3718511, Japan; [Ohshiro, Tomokazu; Mushiake, Hajime] Tohoku Univ, Dept Physiol, Grad Sch Med, Sendai, Miyagi, Japan; [Itakura, Makoto] Kitasato Univ, Dept Biochem, Sch Med, Sagamihara, Kanagawa, Japan; [Konno, Kohtarou; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Fac Med, Sapporo, Hokkaido, Japan	Gunma University; Tohoku University; Kitasato University; Hokkaido University	Kakizaki, T; Yanagawa, Y (corresponding author), Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gumma 3718511, Japan.	toshi-kakizaki@gunma-u.ac.jp; yuchio@gunma-u.ac.jp		Mushiake, Hajime/0000-0002-5130-4720	Ministry of Education Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Collaborative Research Project of the Brain Research Institute, Niigata University; Japan Society for the Promotion of Science [26290002, 15H05872, 17H05550, 19K06881]; Gunma University Medical Innovation Project	Ministry of Education Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Collaborative Research Project of the Brain Research Institute, Niigata University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Gunma University Medical Innovation Project	Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; The Collaborative Research Project of the Brain Research Institute, Niigata University; Japan Society for the Promotion of Science, Grant/Award Number: 26290002, 15H05872, 17H05550 and 19K06881; The Gunma University Medical Innovation Project	Ahmed OJ, 2014, J NEUROSCI, V34, P7395, DOI 10.1523/JNEUROSCI.1168-14.2014; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Arain FM, 2012, EPILEPSIA, V53, pE161, DOI 10.1111/j.1528-1167.2012.03596.x; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Battaglia M, 2014, TISSUE ANTIGENS, V83, P1, DOI 10.1111/tan.12280; Baulac S, 2012, HUM MOL GENET, V21, P3546, DOI 10.1093/hmg/dds184; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chi ZH, 2008, NEUROCHEM INT, V52, P1305, DOI 10.1016/j.neuint.2008.02.008; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Colic L, 2018, J NEUROSCI, V38, P5067, DOI 10.1523/JNEUROSCI.1985-17.2018; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Farhy-Tselnicker I, 2018, NEURAL DEV, V13, DOI 10.1186/s13064-018-0104-y; Glausier JR, 2015, BIOL PSYCHIAT, V77, P167, DOI 10.1016/j.biopsych.2014.05.010; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; GOTTESMANN C, 1992, NEUROSCI BIOBEHAV R, V16, P31, DOI 10.1016/S0149-7634(05)80048-X; Hanamura K, 2010, NEUROSCIENCE, V169, P1489, DOI 10.1016/j.neuroscience.2010.06.043; Hines RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05481-1; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Johnson KR, 2006, BRAIN RES, V1091, P79, DOI 10.1016/j.brainres.2006.02.021; Kakizaki T, 2015, NEUROSCIENCE, V288, P86, DOI 10.1016/j.neuroscience.2014.12.030; KARLSEN AE, 1991, P NATL ACAD SCI USA, V88, P8337, DOI 10.1073/pnas.88.19.8337; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Katzir H, 2000, EPILEPSIA, V41, P1390, DOI 10.1111/j.1528-1157.2000.tb00114.x; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Kubo K, 2009, J PHARMACOL EXP THER, V331, P162, DOI 10.1124/jpet.109.156034; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; LEE DS, 1993, BIOCHIM BIOPHYS ACTA, V1216, P157, DOI 10.1016/0167-4781(93)90056-J; Magri C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33924-8; Manto M, 2019, CEREBELLUM, V18, P153, DOI 10.1007/s12311-018-0986-6; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Mashimo T, 2014, DEV GROWTH DIFFER, V56, P46, DOI 10.1111/dgd.12110; Mitoma H, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2913297; Muller I, 2015, GENES BRAIN BEHAV, V14, P37, DOI 10.1111/gbb.12188; Noebels JL, 2010, EPILEPSIA, V51, P1, DOI 10.1111/j.1528-1167.2010.02792.x; PETERSEN JS, 1993, DIABETES, V42, P484, DOI 10.2337/diabetes.42.3.484; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; ROBERTS EUGENE, 1968, BRAIN RES, V8, P1, DOI 10.1016/0006-8993(68)90170-4; Rocco BR, 2016, BIOL PSYCHIAT, V79, P1006, DOI 10.1016/j.biopsych.2015.07.022; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Schwab C, 2013, J ALZHEIMERS DIS, V33, P1073, DOI 10.3233/JAD-2012-121330; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Shimoyama M, 2016, DIS MODEL MECH, V9, P1089, DOI 10.1242/dmm.026021; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Vercueil L, 2006, NEUROPHYSIOL CLIN, V36, P327, DOI 10.1016/j.neucli.2006.12.002; Wang YQ, 2018, CURR NEUROPHARMACOL, V16, P5, DOI 10.2174/1570159X15666170509101237; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Xu G, 2011, J NEUROPATH EXP NEUR, V70, P841, DOI 10.1097/NEN.0b013e31822f471c; Yamamori S, 2011, J COMP NEUROL, V519, P916, DOI 10.1002/cne.22558; Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	67	3	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001935R	http://dx.doi.org/10.1096/fj.202001935R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33236473				2022-12-28	WOS:000593296700001
J	Lyu, Q; Bai, YG; Cheng, JH; Liu, H; Li, SH; Yang, J; Wang, ZC; Ma, Y; Jiang, M; Dong, D; Yan, YQ; Shi, QX; Ren, XL; Ma, J				Lyu, Qiang; Bai, Yungang; Cheng, Jiuhua; Liu, Huan; Li, Shaohua; Yang, Jing; Wang, Zhongchao; Ma, Yan; Jiang, Min; Dong, Dong; Yan, Yiquan; Shi, Qixin; Ren, Xinling; Ma, Jin			Intermittent short-duration reoxygenation protects against simulated high altitude-induced pulmonary hypertension in rats	FASEB JOURNAL			English	Article						artery remodeling; high&#8208; altitude pulmonary hypertension; human pulmonary artery smooth muscle cells; intermittent reoxygenation	OXIDE-MEDIATED RELAXATION; ENDOTHELIAL GROWTH-FACTOR; HYPOXIA; RESISTANCE; ARTERIES; VASOCONSTRICTION; PROLIFERATION; DYSFUNCTION; EXPRESSION; APOPTOSIS	High-altitude pulmonary hypertension (HAPH) is a severe and progressive disease caused by chronic hypoxia and subsequent pulmonary vascular remodeling. No cure is currently available owing to an incomplete understanding about vascular remodeling. It is believed that hypoxia-induced diseases can be prevented by treating hypoxia. Thus, this study aimed to determine whether daily short-duration reoxygenation at sea level attenuates pulmonary hypertension under high-altitude hypoxia. To this end, a simulated 5000-m hypoxia rat model and hypoxic cultured human pulmonary artery smooth muscle cells were used to evaluate the effect of short-duration reoxygenation. Results show that intermittent, not continuous, short-duration reoxygenation effectively attenuates hypoxia-induced pulmonary hypertension. The mechanisms underlining the protective effects involved that intermittent, short-duration reoxygenation prevented functional and structural remodeling of pulmonary arteries and proliferation, migration, and phenotypic conversion of pulmonary artery smooth muscle cells under hypoxia. The specific genes or potential molecular pathways responsible for mediating the protective effects were also characterised by RNA sequencing. Further, the frequency and the total time of intermittent reoxygenation affected its preventive effect of HAPH, which was likely attributable to augmented oxidative stress. Hence, daily intermittent, not continuous, short-duration reoxygenation partially prevented pulmonary hypertension induced by 5000-m hypoxia in rats. This study is novel in revealing a new potential method in preventing HAPH. It gives insights into the selection and optimisation of oxygen supply schemes in high-altitude areas.	[Lyu, Qiang; Bai, Yungang; Cheng, Jiuhua; Liu, Huan; Li, Shaohua; Yang, Jing; Wang, Zhongchao; Ma, Yan; Jiang, Min; Dong, Dong; Yan, Yiquan; Shi, Qixin; Ma, Jin] Fourth Mil Med Univ, Dept Aerosp Physiol, Xian, Peoples R China; [Ren, Xinling] Dept Resp Dis, Xian, Peoples R China	Air Force Military Medical University	Ma, J (corresponding author), Fourth Mil Med Univ, Dept Aerosp Physiol, Xian, Peoples R China.; Ren, XL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Resp Dis, Xian, Peoples R China.	majrenxl@fmmu.edu.cn; jin-ma@fmmu.edu.cn		Jiang, Min/0000-0002-4952-1283	National Natural Science Foundation of China [31571230]; Fourth Military Medical University [2018HKTS03, 2017D07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fourth Military Medical University	The work was supported by grants from the National Natural Science Foundation of China (No. 31571230 to Jin Ma) and Fourth Military Medical University (No. 2018HKTS03 to Jin Ma and No. 2017D07 to Qiang Lyu). The funders had no role in the study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication	Aggarwal S, 2013, COMPR PHYSIOL, V3, P1011, DOI 10.1002/cphy.c120024; Aldashev AA, 2005, THORAX, V60, P683, DOI 10.1136/thx.2005.041954; Austin ED, 2014, CIRC RES, V115, P189, DOI 10.1161/CIRCRESAHA.115.303404; Bartoszewski R, 2019, FASEB J, V33, P7929, DOI 10.1096/fj.201802650RR; Bonnet S, 2001, AM J PHYSIOL-LUNG C, V281, pL193, DOI 10.1152/ajplung.2001.281.1.L193; Christou H, 2018, J PHARMACOL EXP THER, V364, P258, DOI 10.1124/jpet.117.244798; Crawford JE, 2017, AM J HUM GENET, V101, P752, DOI 10.1016/j.ajhg.2017.09.023; Cui Jian-Hua, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P391; Feng B, 2016, CHINESE MED J-PEKING, V129, P1322, DOI 10.4103/0366-6999.182831; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Grimminger J, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/8381653; GROVES BM, 1993, J APPL PHYSIOL, V74, P312, DOI 10.1152/jappl.1993.74.1.312; Hansen T, 2016, PHARMACOL THERAPEUT, V165, P50, DOI 10.1016/j.pharmthera.2016.05.005; Herrera EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009250; Hirose S, 2000, PATHOL INT, V50, P472, DOI 10.1046/j.1440-1827.2000.01068.x; HISLOP A, 1976, BRIT J EXP PATHOL, V57, P542; Hoffmann J, 2016, EUR RESPIR J, V48, P229, DOI 10.1183/13993003.02030-2015; Holland M, 1996, BRIT J PHARMACOL, V117, P119, DOI 10.1111/j.1476-5381.1996.tb15163.x; Jiang CH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-701; Jiang M, 2018, CAN J PHYSIOL PHARM, V96, P772, DOI 10.1139/cjpp-2017-0665; JIANG MJ, 1994, LIFE SCI, V54, P2005, DOI 10.1016/0024-3205(94)90135-X; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Kojonazarov B, 2012, EUR RESPIR J, V39, P496, DOI 10.1183/09031936.00095211; Mam V, 2010, J PHARMACOL EXP THER, V332, P455, DOI 10.1124/jpet.109.160119; Minutoli L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2183026; Naeije R, 2013, HIGH ALT MED BIOL, V14, P117, DOI 10.1089/ham.2012.1124; Omura J, 2016, CIRC RES, V119, P197, DOI 10.1161/CIRCRESAHA.115.308178; Papaioannou Andriana I, 2009, BMC Pulm Med, V9, P18, DOI 10.1186/1471-2466-9-18; Perros F, 2015, J AM COLL CARDIOL, V65, P668, DOI 10.1016/j.jacc.2014.11.050; Ponnuchamy B, 2009, AM J PHYSIOL-REG I, V296, pR1001, DOI 10.1152/ajpregu.90960.2008; Ren XL, 2011, CLIN EXP PHARMACOL P, V38, P683, DOI 10.1111/j.1440-1681.2011.05565.x; Richalet JP, 2008, AM J RESP CRIT CARE, V177, P1370, DOI 10.1164/rccm.200802-196OC; Shaw L, 2004, BRIT J PHARMACOL, V141, P678, DOI 10.1038/sj.bjp.0705647; Shimoda LA, 2014, J APPL PHYSIOL, V116, P867, DOI 10.1152/japplphysiol.00643.2013; Shimoda LA, 2013, J MOL MED, V91, P297, DOI 10.1007/s00109-013-0998-0; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Tykocki NR, 2017, COMPR PHYSIOL, V7, P485, DOI 10.1002/cphy.c160011; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Wang ZC, 2015, J PHYSIOL BIOCHEM, V71, P205, DOI 10.1007/s13105-015-0398-8; Waypa GB, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01929-2019; Weisel FC, 2014, CIRCULATION, V129, P1510, DOI 10.1161/CIRCULATIONAHA.113.006402; West JB, 2017, NEW ENGL J MED, V376, P1965, DOI 10.1056/NEJMra1612008; West JB, 2012, AM J RESP CRIT CARE, V186, P1229, DOI 10.1164/rccm.201207-1323CI; Wilkins MR, 2015, CIRCULATION, V131, P582, DOI 10.1161/CIRCULATIONAHA.114.006977; You BY, 2018, CARDIOVASC RES, V114, P188, DOI 10.1093/cvr/cvx234; Zhang LF, 2003, J APPL PHYSIOL, V95, P207, DOI 10.1152/japplphysiol.00969.2002; Zhang LF, 2013, EUR J APPL PHYSIOL, V113, P2873, DOI 10.1007/s00421-013-2597-8	48	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000533RR	http://dx.doi.org/10.1096/fj.202000533RR		NOV 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33230951	hybrid			2022-12-28	WOS:000592381900001
J	Tang, YT; Tao, Y; Wang, L; Yang, LY; Jing, YP; Jiang, XK; Lei, L; Yang, ZL; Wang, X; Peng, MX; Xiao, QL; Ren, J; Zhang, L				Tang, Yuting; Tao, Yao; Wang, Lu; Yang, Liyuan; Jing, Yipei; Jiang, Xueke; Lei, Li; Yang, Zailin; Wang, Xin; Peng, Meixi; Xiao, Qiaoling; Ren, Jun; Zhang, Ling			NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia	FASEB JOURNAL			English	Article						autophagy; gene mutation; kinase activity; nucleophosmin 1; unc51&#8208; like kinase 1	ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; NUCLEOPHOSMIN; COMPLEX; KINASE; MUTATIONS; DELOCALIZATION; IDENTIFICATION; RESISTANCE; INDUCTION	Nucleophosmin (NPM1) mutations are the most frequent genetic alteration in acute myeloid leukemia (AML) and aberrant cytoplasm-dislocated NPM1 mutant is a distinct biological characterization of this disease. Our group previously reported that NPM1 mutant elevated autophagy activity and autophagy activation contributed to leukemic cell survival. However, the molecular mechanisms by which cytoplasmic NPM1 mutant involving in the autophagy pathway has not been fully elucidated. Here, we showed that Unc-51-like kinase 1 (ULK1) as a core autophagy protein was highly expressed in NPM1-mA positive OCI-AML3 cells and primary NPM1-mutated AML blasts. Meanwhile, we found that NPM1-mA could interact with ULK1 protein and positively regulated ULK1 protein levels. Mechanically, NPM1-mA promoted TRAF6-dependent K63 ubiquitination and further maintained ULK1 stability and kinase activity via miR-146a. In addition, ULK1 high expression-mediated autophagy activation and facilitated to leukemic cell proliferation. Finally, we demonstrated that restoring ULK1 expression, ULK1 inhibitor SBI-0206965 treatment and using shULK1 partially rescued the effect of NPM1-mA on autophagy and cell survival. In conclusion, our findings suggest that NPM1 mutant interacts with ULK1, and thus, maintains its protein stability, which is required for NPM1 mutant-mediated autophagic cell survival. These data extend our understanding of the functions of NPM1 mutant in the regulation of autophagy activation in NPM1-mutated AML.	[Tang, Yuting; Tao, Yao; Yang, Liyuan; Jing, Yipei; Jiang, Xueke; Lei, Li; Peng, Meixi; Xiao, Qiaoling; Ren, Jun; Zhang, Ling] Chongqing Med Univ, Sch Lab Med, Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China; [Wang, Lu] Chongqing Med Univ, Univ Town Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Yang, Zailin] Chongqing Med Univ, Dept Clin Lab, Affiliated Hosp 3, Chongqing, Peoples R China; [Wang, Xin] Chongqing Med Univ, Dept Hematol, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Zhang, L (corresponding author), Chongqing Med Univ, Sch Lab Med, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	lingzhang@cqmu.edu.cn	Zhang, Ling/AHD-9516-2022	Zhang, Ling/0000-0003-1097-6034	National Natural Science Foundation of China [81873973]; Natural Science Foundation of CQ CSTC [cstc2019jcyj-msxmX0229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by a grant from the National Natural Science Foundation of China (grant no. 81873973), the Natural Science Foundation of CQ CSTC (grant no. cstc2019jcyj-msxmX0229). The authors declare no conflicts of interest.	Altman JK, 2014, CLIN CANCER RES, V20, P2400, DOI 10.1158/1078-0432.CCR-13-3218; Amaravadi RK, 2019, CANCER DISCOV, V9, P1167, DOI 10.1158/2159-8290.CD-19-0292; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Auberger P, 2017, BLOOD, V129, P547, DOI 10.1182/blood-2016-07-692707; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Box JK, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0073-9; Brunetti L, 2019, INT J HEMATOL, V110, P150, DOI 10.1007/s12185-018-02578-7; Brunetti L, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030320; Cagnetta A, 2014, LEUKEMIA RES, V38, P649, DOI 10.1016/j.leukres.2014.03.006; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Duffy A, 2015, CANCER CHEMOTH PHARM, V75, P439, DOI 10.1007/s00280-014-2637-z; Duployez N, 2018, HAEMATOLOGICA, V103, pE575, DOI 10.3324/haematol.2018.190959; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2015, BRIT J HAEMATOL, V170, P305, DOI 10.1111/bjh.13409; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Gu XR, 2018, J CLIN INVEST, V128, P4260, DOI 10.1172/JCI97117; Han SH, 2019, AUTOPHAGY, V15, P2076, DOI 10.1080/15548627.2019.1596492; Heath EM, 2017, LEUKEMIA, V31, P798, DOI 10.1038/leu.2017.30; Jang JE, 2017, AUTOPHAGY, V13, P761, DOI 10.1080/15548627.2016.1278328; Jiao H, 2015, CELL DEATH DIFFER, V22, P1812, DOI [10.1038/cdd.2015.34, 10.1038/xyza.2015.34]; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kunchala P, 2018, BLOOD REV, V32, P167, DOI 10.1016/j.blre.2017.11.001; Kuroyanagi H, 1998, GENOMICS, V51, P76, DOI 10.1006/geno.1998.5340; Lebovitz CB, 2015, AUTOPHAGY, V11, P1668, DOI 10.1080/15548627.2015.1067362; Leong SM, 2010, BLOOD, V116, P3286, DOI 10.1182/blood-2009-12-256149; Liang PQ, 2018, NEOPLASMA, V65, P807, DOI 10.4149/neo_2018_171028N691; Lin JH, 2017, NUCLEIC ACIDS RES, V45, P3707, DOI 10.1093/nar/gkw1285; Lin MG, 2016, CURR OPIN CELL BIOL, V39, P61, DOI 10.1016/j.ceb.2016.02.010; Lu J, 2018, EBIOMEDICINE, V34, P85, DOI 10.1016/j.ebiom.2018.07.034; Luo HC, 2018, BLOOD, V132, P837, DOI 10.1182/blood-2017-11-814319; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Ni XH, 2019, EMBO J, V38, DOI 10.15252/embj.201899766; Noguera NI, 2013, LEUKEMIA, V27, P1037, DOI 10.1038/leu.2012.314; Ouyang L, 2018, J MED CHEM, V61, P2776, DOI 10.1021/acs.jmedchem.7b01575; Papinski D, 2016, J MOL BIOL, V428, P1725, DOI 10.1016/j.jmb.2016.03.030; Short NJ, 2018, LANCET, V392, P593, DOI 10.1016/S0140-6736(18)31041-9; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi TS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02345-y; Tang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12033-8; Thayer JA, 2020, AUTOPHAGY, V16, P140, DOI 10.1080/15548627.2019.1598754; Vascotto C, 2014, ONCOGENE, V33, P2876, DOI 10.1038/onc.2013.251; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Wang XW, 2015, J BIOL CHEM, V290, P29086, DOI 10.1074/jbc.M115.664573; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zhang L, 2018, J MED CHEM, V61, P6491, DOI 10.1021/acs.jmedchem.7b01684; Zou Q, 2017, THERANOSTICS, V7, P2289, DOI 10.7150/thno.19439	60	7	7	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.201903183RRR	http://dx.doi.org/10.1096/fj.201903183RRR		NOV 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33201521				2022-12-28	WOS:000592662100001
J	Yang, H; Ma, JY; Wan, Z; Wang, Q; Wang, ZB; Zhao, J; Wang, F; Zhang, YL				Yang, Hua; Ma, Jianyu; Wan, Zhen; Wang, Qi; Wang, Zhibo; Zhao, Jie; Wang, Feng; Zhang, Yanli			Characterization of sheep spermatogenesis through single-cell RNA sequencing	FASEB JOURNAL			English	Article						scRNA&#8208; seq; sheep; spermatogenesis; testis	SPERMATOGONIAL STEM-CELLS; SERTOLI-CELLS; TRANSCRIPTOME; SYCP2; GENE	Spermatogenesis is an important biological process in male reproduction. The interaction between male germ cells and somatic cells during spermatogenesis, is necessary for male reproductive activities. This cellular heterogeneity has made it difficult to profile distinct cell types at different stages of development. Here, we present the first comprehensive, unbiased single-cell transcriptomic study of sheep spermatogenesis using 10x genomics single cell sequencing (scRNA-seq). We collected scRNA-seq data from 11 772 cells from the adult sheep testis and identified all known germ cells (including early primary spermatocytes, late primary spermatocytes, round spermatids, elongated spermatids, and sperm), and somatic cells (Sertoli cells and Leydig cells), as well as one somatic cell that unexpectedly contained leukocytes. The functional enrichment analysis indicated that several pathways of cell cycle, gamete generation, protein processing, and mRNA surveillance pathways were significantly enriched in testicular germ cell types, and ribosome pathway was significantly enriched in testicular somatic cell types. Further analysis identified several stage-specific marker genes of sheep germ cells, such as EZH2, SOX18, SCP2, PCNA, and PRKCD. Our research explored for the first time of the changes in the transcription level of various cell types during the process of sheep spermatogenesis, providing new insights for sheep spermatogenesis and spermatogenic cell development.	[Yang, Hua; Ma, Jianyu; Wan, Zhen; Wang, Qi; Wang, Zhibo; Zhao, Jie; Wang, Feng; Zhang, Yanli] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Livestock Embryo Engn Lab, 1 Weigang, Nanjing 210095, Peoples R China	Nanjing Agricultural University	Zhang, YL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Livestock Embryo Engn Lab, 1 Weigang, Nanjing 210095, Peoples R China.	zhangyanli@njau.edu.cn	Wang, Zhibo/GSD-3371-2022	Wang, Feng/0000-0002-4965-836X	National Natural Science Foundation of China [31872359]; Youth Talent Project for Animal Science Collage of Nanjing Agricultural University [DKQB201901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Talent Project for Animal Science Collage of Nanjing Agricultural University	This study was financially supported by the National Natural Science Foundation of China (31872359) and Youth Talent Project for Animal Science Collage of Nanjing Agricultural University (DKQB201901). We sincerely thank all the members of our laboratory for their technical assistance in preparation for the study, especially Dr. Mingtian Deng. And thank the High-Performance Computing Platform of Bioinformatics Center, Nanjing Agricultural University for their data analysis support.	Balaton BP, 2018, HUM MOL GENET, V27, pR242, DOI 10.1093/hmg/ddy148; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bryant JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50648; Cardoso-Moreira M, 2019, NATURE, V571, P505, DOI 10.1038/s41586-019-1338-5; Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8; Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019; Chen XX, 2017, REPRODUCTION, V154, P789, DOI [10.1530/rep-17-0441, 10.1530/REP-17-0441]; Da Ros M, 2019, JOVE-J VIS EXP, DOI 10.3791/60271; Fraune J, 2014, CYTOGENET GENOME RES, V144, P299, DOI 10.1159/000381080; Glazkov M V, 1981, Ontogenez, V12, P470; Green CD, 2018, DEV CELL, V46, P651, DOI 10.1016/j.devcel.2018.07.025; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Guo JT, 2020, CELL STEM CELL, V26, P262, DOI 10.1016/j.stem.2019.12.005; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Hai YA, 2014, SEMIN CELL DEV BIOL, V29, P66, DOI 10.1016/j.semcdb.2014.04.007; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hinz S, 2010, WORLD J UROL, V28, P631, DOI 10.1007/s00345-009-0498-6; Liu Y, 2014, CELL DEATH DIS, V5, pe1361; Lukassen S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24725-0; Lukassen S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.192; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Mahalingam M, 2018, METHODS MOL BIOL, V1723, P1, DOI 10.1007/978-1-4939-7558-7_1; Rebourcet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105687; Roumaud P, 2018, MOL CELL BIOCHEM, V447, P175, DOI 10.1007/s11010-018-3302-3; Royo H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005461; Shah MA, 2018, ANIM REPROD SCI, V193, P182, DOI 10.1016/j.anireprosci.2018.04.067; Sohni A, 2019, CELL REP, V26, P1501, DOI 10.1016/j.celrep.2019.01.045; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Toocheck C, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.132068; UM JY, 1995, J UROLOGY, V154, P1237, DOI 10.1016/S0022-5347(01)67038-1; Verderame M, 2018, CR BIOL, V341, P371, DOI 10.1016/j.crvi.2018.07.002; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wang M, 2018, CELL STEM CELL, V23, P599, DOI 10.1016/j.stem.2018.08.007; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yang H, 2018, BIOL REPROD, V99, P650, DOI 10.1093/biolre/ioy088; Yu Y, 2018, STEM CELL REP, V11, P1579, DOI 10.1016/j.stemcr.2018.11.013; Zhang QW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103083; Zhang XN, 2019, MOL CELL, V73, P130, DOI 10.1016/j.molcel.2018.10.020; Zhao WP, 2018, BIOL TRACE ELEM RES, V186, P489, DOI 10.1007/s12011-018-1338-6; Zhou Q, 2015, J CELL MOL MED, V19, P521, DOI 10.1111/jcmm.12407; Zhou R, 2019, CELL MOL LIFE SCI, V76, P2681, DOI 10.1007/s00018-019-03101-9; Zhu ZJ, 2015, ASIAN J ANDROL, V17, P961, DOI 10.4103/1008-682X.159721; Zuo HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164874	45	15	18	6	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001035RRR	http://dx.doi.org/10.1096/fj.202001035RRR		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33197070				2022-12-28	WOS:000592668500001
J	Barnes, JN; Charkoudian, N				Barnes, Jill N.; Charkoudian, Nisha			Integrative cardiovascular control in women: Regulation of blood pressure, body temperature, and cerebrovascular responsiveness	FASEB JOURNAL			English	Article						cerebral blood flow; estradiol; sex differences; thermoregulation; vasodilation	DYNAMIC CEREBRAL AUTOREGULATION; SYMPATHETIC-NERVE ACTIVITY; MENSTRUAL-CYCLE PHASE; SEX-DIFFERENCES; HEAT-STRESS; AEROBIC FITNESS; THERMOEFFECTOR RESPONSES; VASOMOTOR REACTIVITY; REPLACEMENT THERAPY; AUTONOMIC CONTROL	Over the past several decades, it has become increasingly clear that women have distinct cardiovascular profiles compared to men. In this review, our goal is to provide an overview of the literature regarding the influences of female sex and reproductive hormones (primarily estradiol) on mechanisms of cardiovascular control relevant to regulation of blood pressure, body temperature, and cerebral blood flow. Young women tend to have lower resting blood pressure compared with men. This sex difference is reversed at menopause, when women develop higher sympathetic nerve activity and the risk of systemic hypertension increases sharply as postmenopausal women age. Vascular responses to thermal stress, including cutaneous vasodilation and vasoconstriction, are also affected by reproductive hormones in women, where estradiol appears to promote vasodilation and heat dissipation. The influence of reproductive hormones on cerebral blood flow and sex differences in the ability of the cerebral vasculature to increase its blood flow (cerebrovascular reactivity) are relatively new areas of investigation. Sex and hormonal influences on integrative blood flow regulation have further implications during challenges to physiological homeostasis, including exercise. We propose that increasing awareness of these sex-specific mechanisms is important for optimizing health care and promotion of wellness in women across the life span.	[Barnes, Jill N.] Univ Wisconsin, Dept Kinesiol, Bruno Balke Biodynam Lab, 1300 Univ Ave,253 Bardeen Med Labs, Madison, WI 53706 USA; [Charkoudian, Nisha] US Army Res Inst Environm Med, Natick, MA USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Defense; United States Army	Barnes, JN (corresponding author), Univ Wisconsin, Dept Kinesiol, Bruno Balke Biodynam Lab, 1300 Univ Ave,253 Bardeen Med Labs, Madison, WI 53706 USA.	jnbarnes@wisc.edu	Barnes, Jill N/AAG-2520-2020	Barnes, Jill N/0000-0001-6317-4153	HHS | National Institutes of Health (NIH) [HL118154]; Alzheimer's Association [AARG17-499398]; DOD | United States Army | MEDCOM | U.S. Army Research Institute of Environmental Medicine (USARIEM)	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); DOD | United States Army | MEDCOM | U.S. Army Research Institute of Environmental Medicine (USARIEM)	HHS | National Institutes of Health (NIH), Grant/Award Number: HL118154; Alzheimer's Association, Grant/Award Number: AARG17-499398; DOD | United States Army | MEDCOM | U.S. Army Research Institute of Environmental Medicine (USARIEM)	Abidi S, 2017, J APPL PHYSIOL, V123, P375, DOI 10.1152/japplphysiol.00035.2017; Acar M, 2005, MATURITAS, V52, P127, DOI 10.1016/j.maturitas.2005.01.006; Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; Alba BK, 2019, EXP PHYSIOL, V104, P1202, DOI 10.1113/EP087718; Ances BM, 2001, NEUROSCI LETT, V304, P57, DOI 10.1016/S0304-3940(01)01768-2; Arkuszewski M, 2013, NEURORADIOL J, V26, P191; Auger N, 2017, CAN MED ASSOC J, V189, pE235, DOI 10.1503/cmaj.161064; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Bain AR, 2015, COMPR PHYSIOL, V5, P1345, DOI 10.1002/cphy.c140066; Bain AR, 1985, J APPL PHYSL 1985, V115, P653; Bain CAL, 2004, HUM REPROD, V19, P2411, DOI 10.1093/humrep/deh396; Baker SE, 2020, HYPERTENSION, V75, P1497, DOI [10.1161/HYPERTENSIONAHA.119.14580, 10.1161/HYPERTENSIONAHA.119.14042]; Barnes JN, 2019, CLIMACTERIC, V22, P182, DOI 10.1080/13697137.2018.1538340; Barnes JN, 2017, EXP PHYSIOL, V102, P1385, DOI 10.1113/EP086531; Barnes JN, 2014, HYPERTENSION, V63, P303, DOI 10.1161/HYPERTENSIONAHA.113.02393; Barnes JN, 2013, J APPL PHYSIOL, V114, P1383, DOI 10.1152/japplphysiol.01258.2012; Barnes JN, 1985, J APPL PHYSIOL, V112, P1884; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Boulant JA, 1985, J APPL PHYSL 1985, V100, P1347; Brassard P, 2017, AUTON NEUROSCI-BASIC, V207, P37, DOI 10.1016/j.autneu.2017.05.003; Braz ID, 2017, SCAND J MED SCI SPOR, V27, P634, DOI 10.1111/sms.12674; Brooks EM, 1997, J APPL PHYSIOL, V83, P477, DOI 10.1152/jappl.1997.83.2.477; Brothers RM, 2009, J APPL PHYSIOL, V107, P1722, DOI 10.1152/japplphysiol.00475.2009; Charkoudian N, 2005, J PHYSIOL-LONDON, V568, P315, DOI 10.1113/jphysiol.2005.090076; Charkoudian N, 1999, AM J PHYSIOL-HEART C, V276, pH1634, DOI 10.1152/ajpheart.1999.276.5.H1634; Charkoudian N, 2014, COMPR PHYSIOL, V4, P827, DOI 10.1002/cphy.c130038; Charkoudian N, 1985, J APPL PHYSL 1985, V83, P2012; Charkoudian N, 2017, CLIN AUTON RES, V27, P149, DOI 10.1007/s10286-017-0420-z; Charkoudian N, 2016, AUTON NEUROSCI-BASIC, V196, P75, DOI 10.1016/j.autneu.2015.11.004; Charkoudian N, 2014, COMPR PHYSIOL, V4, P793, DOI 10.1002/cphy.c130029; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Crandall CG, 2015, COMPR PHYSIOL, V5, P17, DOI 10.1002/cphy.c140015; Deegan BM, 2011, STROKE, V42, P1988, DOI 10.1161/STROKEAHA.110.605618; Edgell H, 2012, J APPL PHYSIOL, V112, P1482, DOI 10.1152/japplphysiol.01204.2011; Fagius J, 1993, Clin Auton Res, V3, P201; Favre ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229049; Favre ME, 2019, AM J PHYSIOL-HEART C, V316, pH920, DOI 10.1152/ajpheart.00474.2018; Fisher JP, 2014, EXP PHYSIOL, V99, P300, DOI 10.1113/expphysiol.2013.074377; Fu Q, 2019, J PHYSIOL SCI, V69, P851, DOI 10.1007/s12576-019-00727-z; Gagnon D, 2012, J PHYSIOL-LONDON, V590, P5963, DOI 10.1113/jphysiol.2012.240739; Gagnon D, 2012, J APPL PHYSIOL, V113, P746, DOI 10.1152/japplphysiol.00637.2012; Geary GG, 2000, AM J PHYSIOL-HEART C, V279, pH511, DOI 10.1152/ajpheart.2000.279.2.H511; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; GLASS RI, 1979, LANCET, V1, P485; Gonzales RJ, 2007, J CEREBR BLOOD F MET, V27, P1841, DOI 10.1038/sj.jcbfm.9600483; Gonzales RJ, 2005, AM J PHYSIOL-HEART C, V289, pH578, DOI 10.1152/ajpheart.00958.2004; Hart EC, 2011, J PHYSIOL-LONDON, V589, P5285, DOI 10.1113/jphysiol.2011.212753; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; Harvey RE, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13535; Harvey RE, 2015, HYPERTENSION, V66, P590, DOI 10.1161/HYPERTENSIONAHA.115.05179; HESSEMER V, 1985, J APPL PHYSIOL, V59, P1902, DOI 10.1152/jappl.1985.59.6.1902; Hoiland RL, 2019, COMPR PHYSIOL, V9, P1101, DOI 10.1002/cphy.c180021; Joyner MJ, 2017, J PHYSIOL-LONDON, V595, P2949, DOI 10.1113/JP272268; Joyner MJ, 2015, COMPR PHYSIOL, V5, P193, DOI 10.1002/cphy.c140005; Kantarci K, 2018, NEUROLOGY, V90, pE1404, DOI 10.1212/WNL.0000000000005325; Kassner A, 2010, J MAGN RESON IMAGING, V31, P298, DOI 10.1002/jmri.22044; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; Kastrup A, 1998, STROKE, V29, P1311, DOI 10.1161/01.STR.29.7.1311; Kaya E, 2008, MATURITAS, V59, P72, DOI 10.1016/j.maturitas.2007.10.004; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; Kolka MA, 1997, ANN NY ACAD SCI, V813, P204, DOI 10.1111/j.1749-6632.1997.tb51694.x; Krause DN, 2011, ACTA PHYSIOL, V203, P181, DOI 10.1111/j.1748-1716.2011.02323.x; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Labrecque L, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13984; Lee JF, 2014, CLIN AUTON RES, V24, P135, DOI 10.1007/s10286-014-0241-2; Liu WJ, 2016, NEURORADIOLOGY, V58, P943, DOI 10.1007/s00234-016-1713-y; Low DA, 2008, J APPL PHYSIOL, V104, P976, DOI 10.1152/japplphysiol.01040.2007; Low DA, 2009, AM J PHYSIOL-REG I, V296, pR1598, DOI 10.1152/ajpregu.90900.2008; Lucas RAI, 2008, EXP PHYSIOL, V93, P1104, DOI 10.1113/expphysiol.2008.042580; Madden CJ, 2019, NEUROSCI LETT, V696, P225, DOI 10.1016/j.neulet.2018.11.027; Madureira J, 2017, J STROKE CEREBROVASC, V26, P500, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.003; Miller KB, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.01910; Miller KB, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00281; Miller VM, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12777; Miller VM, 2019, MENOPAUSE, V26, P1071, DOI 10.1097/GME.0000000000001326; Miller VM, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-6; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; Ogoh S, 2014, J APPL PHYSIOL, V117, P46, DOI 10.1152/japplphysiol.01078.2013; Ota A, 2019, EUR J APPL PHYSIOL, V119, P1261, DOI 10.1007/s00421-019-04118-5; Periard JD, 2015, BRIT J SPORT MED, V51, P264; Portegies MLP, 2014, STROKE, V45, P42, DOI 10.1161/STROKEAHA.113.002348; Robison LS, 2019, BRAIN RES, V1710, P43, DOI 10.1016/j.brainres.2018.12.030; Rocca WA, 2010, NEURODEGENER DIS, V7, P163, DOI 10.1159/000289229; Rogers SM, 1997, EUR J APPL PHYSIOL, V75, P34; ROWELL LB, 1984, J AUTONOM NERV SYST, V11, P101, DOI 10.1016/0165-1838(84)90069-9; ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; Schlader ZJ, 2016, AUTON NEUROSCI-BASIC, V196, P37, DOI 10.1016/j.autneu.2015.12.005; SEALS DR, 1991, HYPERTENSION, V17, P36, DOI 10.1161/01.HYP.17.1.36; Slopien R, 2003, MATURITAS, V46, P255, DOI 10.1016/S0378-5122(03)00144-0; Stachenfeld NS, 2008, EXERC SPORT SCI REV, V36, P152, DOI 10.1097/JES.0b013e31817be928; Stachenfeld NS, 2002, AM J PHYSIOL-ENDOC M, V283, pE711, DOI 10.1152/ajpendo.00192.2002; STEPHENSON LA, 1985, AM J PHYSIOL, V249, pR186, DOI 10.1152/ajpregu.1985.249.2.R186; TANKERSLEY CG, 1992, J APPL PHYSIOL, V73, P1238, DOI 10.1152/jappl.1992.73.4.1238; Tarumi T, 2015, MED SCI SPORT EXER, V47, P2595, DOI 10.1249/MSS.0000000000000717; ter Laan M, 2013, BRIT J ANAESTH, V111, P361, DOI 10.1093/bja/aet122; Trubee NW, 2014, J STRENGTH COND RES, V28, P1673, DOI 10.1519/JSC.0000000000000295; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; Usselman CW, 2015, AM J PHYSIOL-HEART C, V308, pH664, DOI 10.1152/ajpheart.00345.2014; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Wang SX, 2020, AM J PHYSIOL-HEART C, V318, pH1219, DOI 10.1152/ajpheart.00722.2019; Wenner MM, 2012, J PHYSIOL-LONDON, V590, P5949, DOI 10.1113/jphysiol.2012.236752; Yanovich R, 2020, PHYSIOLOGY, V35, P177, DOI 10.1152/physiol.00035.2019	104	17	17	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001387R	http://dx.doi.org/10.1096/fj.202001387R		NOV 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33151577	Green Accepted			2022-12-28	WOS:000589711800001
J	Gao, J; Wei, T; Huang, CL; Sun, MW; Shen, WL				Gao, Jing; Wei, Tong; Huang, Chenglin; Sun, Mengwei; Shen, Weili			Sirtuin 3 governs autophagy-dependent glycolysis during Angiotensin II-induced endothelial-to-mesenchymal transition	FASEB JOURNAL			English	Article						autophagy; endothelial&#8208; to&#8208; mesenchymal transition; glycolysis; PKM2; SIRT3	CELL-METABOLISM; PKM2; DYSFUNCTION; GROWTH; FLUX	The impairment of autophagy can cause cellular metabolic perturbations involved in endothelial-to-mesenchymal transition (EndoMT). However, the interplay between the cellular autophagy machinery and endothelial metabolism remains elusive. Sirtuin 3 (SIRT3), an NAD-dependent deacetylase, is a major cellular sensor of energy metabolism. The aim of this work was to determine the role of SIRT3-mediated autophagy in cellular metabolism and the process of EndoMT. We demonstrated that Angiotensin II (Ang II) led to defective autophagic flux and high levels of glycolysis in endothelial cells (ECs) accompanied by a loss of mitochondrial SIRT3 during EndoMT. The loss of SIRT3 further induced the hyperacetylation of endogenous autophagy-regulated gene 5 (ATG5), which in turn inhibited autophagosome maturation and increased pyruvate kinase M2 (PKM2) dimer expression. The M2 dimer is the less active form of PKM2, which drives glucose through aerobic glycolysis. Additionally, TEPP-46, a selective PKM2 tetramer activator, produced lower concentrations of lactate and led to the reduction of EndoMT both in vitro and in vivo. In parallel, the blockade of lactate influx from ECs into vascular smooth muscle cells (VSMCs) downregulated synthetic VSMC markers. EC-specific SIRT3 transgenic mice exhibited reduced endothelial cell transition but partial rescue of vascular fibrosis and collagen accumulation. Taken together, these findings reveal that SIRT3 regulates EndoMT by improving the autophagic degradation of PKM2. Pharmacological targeting of glycolysis metabolism may, therefore, represent an effective therapeutic strategy for hypertensive vascular remodeling.	[Gao, Jing; Wei, Tong; Huang, Chenglin; Shen, Weili] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Cardiovasc Med, Dept Hypertens,Sch Med, Shanghai, Peoples R China; [Gao, Jing; Wei, Tong; Huang, Chenglin; Shen, Weili] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai Key Lab Hypertens,Sch Med, Shanghai, Peoples R China; [Sun, Mengwei] Shanghai Res Inst Sports Sci, Key Lab State Gen Adm Sport, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Shen, WL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Hypertens, Dept Hypertens, Sch Med,Ruijin Hosp, Shanghai 200025, Peoples R China.	wlshen@sibs.ac.cn			National Natural Science Foundation of China (NSFC) [81970235, 81370255, 81472099, 91439113]; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation) [19ZR1443200, 20ZR1454300]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81970235, 81370255, 81472099 and 91439113; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation), Grant/Award Number: 19ZR1443200 and 20ZR1454300	Bender T, 2016, BBA-MOL CELL RES, V1863, P2436, DOI 10.1016/j.bbamcr.2016.01.017; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Bharath LP, 2017, ARTERIOSCL THROM VAS, V37, P1646, DOI 10.1161/ATVBAHA.117.309510; Cao Y, 2017, THERANOSTICS, V7, P3021, DOI 10.7150/thno.18992; Chen JC, 2012, MOL CELL BIOL, V32, P981, DOI 10.1128/MCB.06410-11; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Cui Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129834; Dasgupta S, 2015, J CLIN INVEST, V125, P1174, DOI 10.1172/JCI76029; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Esteban-Martinez L, 2017, EMBO J, V36, P1688, DOI 10.15252/embj.201695916; Feng YL, 2018, INT J BIOL SCI, V14, P775, DOI 10.7150/ijbs.26077; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Kim B, 2018, J CLIN INVEST, V128, P4543, DOI 10.1172/JCI120912; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lin JR, 2015, ARTERIOSCL THROM VAS, V35, P1413, DOI 10.1161/ATVBAHA.115.305706; Liu PH, 2018, BBA-MOL BASIS DIS, V1864, P764, DOI 10.1016/j.bbadis.2017.12.027; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Moonen JRAJ, 2010, CARDIOVASC RES, V86, P506, DOI 10.1093/cvr/cvq012; Morciano G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030892; Mukherjee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057610; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Robinson GL, 2012, ONCOGENE, V31, P4996, DOI 10.1038/onc.2012.13; Ryter SW, 2019, ANTIOXID REDOX SIGN, V30, P138, DOI 10.1089/ars.2018.7518; Sasaki N, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00533-w; Schaaf MB, 2019, CELL DEATH DIFFER, V26, P665, DOI 10.1038/s41418-019-0287-8; Shan HY, 2014, APMIS, V122, P985, DOI 10.1111/apm.12242; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Singh KK, 2015, J BIOL CHEM, V290, P2547, DOI 10.1074/jbc.M114.604603; Takagaki Y, 2020, AUTOPHAGY, V16, P1905, DOI 10.1080/15548627.2020.1713641; Tan VP, 2015, AUTOPHAGY, V11, P963, DOI 10.1080/15548627.2015.1042195; Vandekeere S, 2015, MICROCIRCULATION, V22, P509, DOI 10.1111/micc.12229; Wei T, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006114; Xu YM, 2014, ARTERIOSCL THROM VAS, V34, P1231, DOI 10.1161/ATVBAHA.113.303041; Yang LB, 2017, CIRC RES, V121, P1251, DOI 10.1161/CIRCRESAHA.117.311819; Young JD, 2013, CURR OPIN BIOTECH, V24, P1108, DOI 10.1016/j.copbio.2013.04.016; Yue ZB, 2016, EXP CELL RES, V347, P261, DOI 10.1016/j.yexcr.2016.07.006; Zhang T, 2020, CELL DEATH DIFFER, V27, P329, DOI 10.1038/s41418-019-0356-z	43	6	6	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16645	16661		10.1096/fj.202001494R	http://dx.doi.org/10.1096/fj.202001494R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131100	Bronze			2022-12-28	WOS:000586603900001
J	Palander, O; Trimble, WS				Palander, Oliva; Trimble, William S.			DIAPH1 regulates ciliogenesis and trafficking in primary cilia	FASEB JOURNAL			English	Article						(3-5); DIAPH1; formin; ciliogenesis; primary cilia; intraflagellar transport	DIAPHANOUS-RELATED FORMIN; PLANAR CELL POLARITY; ADENOMATOUS POLYPOSIS-COLI; ACTIN NUCLEATION; RHO; PROTEIN; MDIA1; ROLES; GENE; EB1	Primary cilia are critical hubs for several signaling pathways, and defects in ciliogenesis or cilia maintenance produce a range of diseases collectively known as ciliopathies. Ciliogenesis requires vesicle trafficking along a network of microtubules and actin filaments to the basal body. The DIAPH1 (Diaphanous-related formin) family of formins promotes both actin polymerization and EB1-dependent microtubule (MT) stability. EB1 and EB3 have previously been implicated in cilia biogenesis to carry out centrosome-related functions. However, the role of DIAPH1 proteins had not been examined. Here we show that the depletion of DIAPH1 decreased ciliogenesis, cilia length, and reduced trafficking within cilia. Additionally, both actin nucleating and microtubule-stabilizing properties of DIAPH1 are important for their cilia functions. To assess their roles in ciliogenesis in isolation, we targeted DIAPH1 specifically to the basal body, which caused an increase in cilia length and increased trafficking within cilia. Intriguingly, expression of DIAPH1 mutants associated with human deafness and microcephaly impaired ciliation and caused cilia elongation and bulb formation. These results suggest that the actin and microtubule functions of DIAPH1 proteins regulate cilia maintenance in part by regulating vesicular trafficking to the base of the primary cilia.	[Palander, Oliva; Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Palander, Oliva; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Trimble, WS (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada.	wtrimble@sickkids.ca			CIHR grant [PJT-162194]	CIHR grant(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from CIHR grant PJT-162194 to WST.	Al-Maawali A, 2016, AM J MED GENET A, V170, P435, DOI 10.1002/ajmg.a.37422; Baudoin JP, 2012, NEURON, V76, P1108, DOI 10.1016/j.neuron.2012.10.027; Cao MQ, 2015, ELIFE, V4, DOI 10.7554/eLife.05242; Chen HY, 2021, SEMIN CELL DEV BIOL, V110, P70, DOI 10.1016/j.semcdb.2020.07.013; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Copeland SJ, 2018, MOL BIOL CELL, V29, P1611, DOI 10.1091/mbc.E18-02-0088; COTANCHE DA, 1991, HEARING RES, V52, P379, DOI 10.1016/0378-5955(91)90027-7; Daou P, 2014, MOL BIOL CELL, V25, P658, DOI 10.1091/mbc.E13-08-0482; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Ercan-Sencicek AG, 2015, EUR J HUM GENET, V23, P165, DOI 10.1038/ejhg.2014.82; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Garcia EBG, 2009, LANCET ONCOL, V10, P727, DOI 10.1016/S1470-2045(09)70167-6; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Insinna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08872-0; Jones C, 2008, CURR TOP DEV BIOL, V85, P197, DOI 10.1016/S0070-2153(08)00808-9; Kang TH, 2016, GENES GENET SYST, V91, P289, DOI 10.1266/ggs.16-00041; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Lechtreck KF, 2018, CYTOSKELETON, V75, P352, DOI 10.1002/cm.21457; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Li Z, 2012, ONCOGENE, V31, P1475, DOI 10.1038/onc.2011.351; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; May-Simera HL, 2015, DEVELOPMENT, V142, P555, DOI 10.1242/dev.113696; Mukhopadhyay S, 2014, SEMIN CELL DEV BIOL, V33, P63, DOI 10.1016/j.semcdb.2014.05.002; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Nigg EA, 2017, COLD SH Q B, V82, P137, DOI 10.1101/sqb.2017.82.034421; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2016, TRENDS BIOCHEM SCI, V41, P784, DOI 10.1016/j.tibs.2016.06.002; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Schoen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056520; Schroder JM, 2007, CURR BIOL, V17, P1134, DOI 10.1016/j.cub.2007.05.055; Schroder JM, 2011, J CELL SCI, V124, P2539, DOI 10.1242/jcs.085852; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Sipe CW, 2011, DEVELOPMENT, V138, P3441, DOI 10.1242/dev.065961; Song L, 2014, INT J BIOCHEM CELL B, V55, P79, DOI 10.1016/j.biocel.2014.08.010; Soykan T, 2017, NEURON, V93, P854, DOI 10.1016/j.neuron.2017.02.011; Surel C, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0295-16.2016; Tao BL, 2009, J AM SOC NEPHROL, V20, P2570, DOI 10.1681/ASN.2009020188; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Ueyama T, 2016, EMBO MOL MED, V8, P1310, DOI 10.15252/emmm.201606609; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yasunaga T, 2015, J CELL BIOL, V211, P963, DOI 10.1083/jcb.201502043; Zilberman Y, 2011, MOL BIOL CELL, V22, P2900, DOI 10.1091/mbc.E11-01-0007	66	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16516	16535		10.1096/fj.202001178R	http://dx.doi.org/10.1096/fj.202001178R		OCT 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124112	hybrid			2022-12-28	WOS:000589709400001
J	Chen, YT; Xu, CM				Chen, Yanting; Xu, Chuanming			The interaction partners of (pro)renin receptor in the distal nephron	FASEB JOURNAL			English	Review						apelin; COX-2/PGE(2); ELABELA; intrarenal RAS; (Pro)renin receptor; vacuolar H+-ATPase; Wnt/beta-catenin	VACUOLAR H+-ATPASE; RENIN-ANGIOTENSIN SYSTEM; RENAL TUBULAR-ACIDOSIS; PRORENIN RECEPTOR; PROSTAGLANDIN E-2; CYCLOOXYGENASE-2 EXPRESSION; BETA-CATENIN; V-ATPASE; KIDNEY INJURY; UP-REGULATION	The (pro)renin receptor (PRR), a key regulator of intrarenal renin-angiotensin system (RAS), is predominantly presented in podocytes, proximal tubules, distal convoluted tubules, and the apical membrane of collecting duct A-type intercalated cells, and plays a crucial role in hypertension, cardiovascular disease, kidney disease, and fluid homeostasis. In addition to its well-known renin-regulatory function, increasing evidence suggests PRR can also act in a variety of intracellular signaling cascades independently of RAS in the renal medulla, including Wnt/beta-catenin signaling, cyclooxygenase-2 (COX-2)/prostaglandin E-2(PGE(2)) signaling, and the apelinergic system, and work as a component of the vacuolar H+-ATPase. PRR and these pathways regulate the expression/activity of each other that controlling blood pressure and renal functions. In this review, we highlight recent findings regarding the antagonistic interaction between PRR and ELABELA/apelin, the mutually stimulatory relationship between PRR and COX-2/PGE(2)or Wnt/beta-catenin signaling in the renal medulla, and their involvement in the regulation of intrarenal RAS thereby control blood pressure, renal injury, and urine concentrating ability in health and patho-physiological conditions. We also highlight the latest progress in the involvement of PRR for the vacuolar H+-ATPase activity.	[Chen, Yanting] Sun Yat Sen Univ, Sch Med, Inst Hypertens, Guangzhou, Peoples R China; [Chen, Yanting; Xu, Chuanming] Univ Utah, Div Nephrol & Hypertens, Internal Med, Salt Lake City, UT USA; [Chen, Yanting; Xu, Chuanming] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Xu, Chuanming] Jiangxi Univ Tradit Chinese Med, Ctr Translat Med, Nanchang 330004, Jiangxi, Peoples R China	Sun Yat Sen University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jiangxi University of Traditional Chinese Medicine	Xu, CM (corresponding author), Jiangxi Univ Tradit Chinese Med, Ctr Translat Med, Nanchang 330004, Jiangxi, Peoples R China.	xuchuanming2008@163.com	Xu, Chuanming/ABH-9190-2020	Xu, Chuanming/0000-0001-7082-2833	Initial Scientific Research Fund in Jiangxi University of Traditional Chinese Medicine [19POST34410068]; American Heart Association	Initial Scientific Research Fund in Jiangxi University of Traditional Chinese Medicine; American Heart Association(American Heart Association)	This work was supported by Initial Scientific Research Fund in Jiangxi University of Traditional Chinese Medicine and postdoctoral fellowship award 19POST34410068 from American Heart Association.	Abbas YM, 2020, SCIENCE, V367, P1240, DOI 10.1126/science.aaz2924; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Akcilar R, 2013, CLIN EXP HYPERTENS, V35, P550, DOI 10.3109/10641963.2013.764889; ALLEN HM, 1989, ARCH INTERN MED, V149, P1123, DOI 10.1001/archinte.149.5.1123; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Araki Y, 2003, CANCER RES, V63, P728; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Bernhard SM, 2012, BIOCHEM PHARMACOL, V84, P1643, DOI 10.1016/j.bcp.2012.09.020; Boulkeroua Chahrazed, 2019, Cell Physiol Biochem, V53, P687, DOI 10.33594/000000165; Buechling T, 2010, CURR BIOL, V20, P1263, DOI 10.1016/j.cub.2010.05.028; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Chen H, 2015, BBA-MOL BASIS DIS, V1852, P1278, DOI 10.1016/j.bbadis.2015.02.013; Chen J, 2008, AM J PHYSIOL-RENAL, V295, pF818, DOI 10.1152/ajprenal.90253.2008; Cheng HF, 2011, J AM SOC NEPHROL, V22, P1240, DOI 10.1681/ASN.2010111149; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cudnoch-Jedrzejewska A, 2015, CLIN EXP PHARMACOL P, V42, P52, DOI 10.1111/1440-1681.12324; Cuevas CA, 2015, AM J PHYSIOL-RENAL, V308, pF358, DOI 10.1152/ajprenal.00429.2014; Daryadel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147831; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Deng C, 2015, J BIOL CHEM, V290, P18261, DOI 10.1074/jbc.M115.648238; Dubos A, 2015, HUM MOL GENET, V24, P6736, DOI 10.1093/hmg/ddv380; EauClaire SF, 2012, DEV BIOL, V365, P434, DOI 10.1016/j.ydbio.2012.03.009; Facemire CS, 2011, AM J PHYSIOL-RENAL, V301, pF1035, DOI 10.1152/ajprenal.00054.2011; Fang H, 2017, AM J PHYSIOL-CELL PH, V313, pC632, DOI 10.1152/ajpcell.00006.2017; Friis UG, 2005, AM J PHYSIOL-RENAL, V289, pF989, DOI 10.1152/ajprenal.00201.2005; Gatineau E, 2019, HYPERTENSION, V74, P1014, DOI 10.1161/HYPERTENSIONAHA.119.12906; Geng Z, 2020, AM J PHYSIOL-HEART C, V318, pH124, DOI 10.1152/ajpheart.00449.2019; Gonzalez AA, 2017, AM J PHYSIOL-RENAL, V313, pF1038, DOI 10.1152/ajprenal.00194.2017; Gonzalez AA, 2014, AM J PHYSIOL-RENAL, V307, pF962, DOI 10.1152/ajprenal.00267.2014; Gonzalez AA, 2013, HYPERTENSION, V61, P443, DOI 10.1161/HYPERTENSIONAHA.112.196303; Guida MC, 2018, MOL BIOL CELL, V29, P2156, DOI 10.1091/mbc.E18-04-0234; Gupta HV, 2015, PARKINSONISM RELAT D, V21, P1473, DOI 10.1016/j.parkreldis.2015.10.001; GURWITZ JH, 1994, JAMA-J AM MED ASSOC, V272, P781, DOI 10.1001/jama.272.10.781; Hall JBBM, 1993, RENIN ANGIOTENSIN SY, V26, P1; Han X, 2013, CAN J PHYSIOL PHARM, V91, P708, DOI 10.1139/cjpp-2013-0046; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Harding P, 2000, J HYPERTENS, V18, P1107, DOI 10.1097/00004872-200018080-00016; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; He WJ, 2014, PFLUG ARCH EUR J PHY, V466, P357, DOI 10.1007/s00424-013-1328-7; Hirose T, 2019, J CLIN INVEST, V129, P2145, DOI 10.1172/JCI79990; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Hocherl K, 2002, AM J PHYSIOL-RENAL, V283, pF294, DOI 10.1052/ajprenal.00347.2001; Huang JQ, 2009, ENDOCRINOLOGY, V150, P5557, DOI 10.1210/en.2009-0442; Hum JM, 2017, J AM SOC NEPHROL, V28, P1162, DOI 10.1681/ASN.2015111266; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Hus-Citharel A, 2014, ENDOCRINOLOGY, V155, P4483, DOI 10.1210/en.2014-1257; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V296, P221, DOI 10.1016/S0006-291X(02)00824-0; Kinouchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078603; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kocer D, 2016, THER APHER DIAL, V20, P517, DOI 10.1111/1744-9987.12412; Kortenoeven MLA, 2012, AM J PHYSIOL-CELL PH, V302, pC131, DOI 10.1152/ajpcell.00197.2011; Korvatska O, 2013, HUM MOL GENET, V22, P3259, DOI 10.1093/hmg/ddt180; Kouchi M, 2017, J NEUROSURG, V127, P819, DOI 10.3171/2016.9.JNS16431; Lacquaniti A, 2013, PEPTIDES, V49, P1, DOI 10.1016/j.peptides.2013.08.007; Li CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089233; Li JH, 2009, J CLIN INVEST, V119, P3115, DOI 10.1172/JCI39680; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Li WC, 2015, AM J PHYSIOL-REG I, V309, pR138, DOI 10.1152/ajpregu.00319.2014; Li XJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01487; Li YT, 2020, CLIN EXP HYPERTENS, V42, P239, DOI 10.1080/10641963.2019.1619756; Li Z, 2017, J AM SOC NEPHROL, V28, P2393, DOI 10.1681/ASN.2016070811; Liakos CI, 2016, AM J HYPERTENS, V29, P549, DOI 10.1093/ajh/hpv136; Lin Y, 2017, AM J PHYSIOL-RENAL, V313, pF914, DOI 10.1152/ajprenal.00553.2016; Liu J, 2019, AM J PHYSIOL-LUNG C, V317, pL202, DOI 10.1152/ajplung.00295.2018; Liu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25035; Lu XH, 2016, AM J PHYSIOL-RENAL, V310, pF1243, DOI 10.1152/ajprenal.00492.2015; Lu XH, 2016, P NATL ACAD SCI USA, V113, pE1898, DOI 10.1073/pnas.1602397113; Lu XF, 2013, AM J PHYSIOL-RENAL, V305, pF417, DOI 10.1152/ajprenal.00037.2013; Lu XH, 2020, RENAL FAILURE, V42, P667, DOI 10.1080/0886022X.2020.1792926; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; MA NX, 2017, EVID-BASED COMPL ALT, V2017, DOI DOI 10.1155/2017/3039450; Matzdorf C, 2007, AM J PHYSIOL-RENAL, V292, pF1782, DOI 10.1152/ajprenal.00513.2006; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Najafipour H, 2015, J PHYSIOL BIOCHEM, V71, P165, DOI 10.1007/s13105-015-0394-z; Najafipour H, 2012, REGUL PEPTIDES, V178, P43, DOI 10.1016/j.regpep.2012.06.006; Nakagawa T, 2017, J BIOCHEM, V161, P369, DOI 10.1093/jb/mvw080; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nishida M, 2012, NEPHRON EXTRA, V2, P39, DOI 10.1159/000337091; Nusing RM, 2005, J AM SOC NEPHROL, V16, P2354, DOI 10.1681/ASN.2004070556; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; O'Carroll AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183094; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Olesen ETB, 2011, P NATL ACAD SCI USA, V108, P12949, DOI 10.1073/pnas.1104691108; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Papadopoulos DP, 2014, J CLIN HYPERTENS, V16, P198, DOI 10.1111/jch.12260; Pathare G, 2018, KIDNEY INT, V93, P871, DOI 10.1016/j.kint.2017.10.018; Poschke A, 2012, AM J PHYSIOL-RENAL, V303, pF1435, DOI 10.1152/ajprenal.00512.2011; Pope GR, 2012, PEPTIDES, V33, P139, DOI 10.1016/j.peptides.2011.12.005; Przewlocka-Kosmala M, 2011, J HYPERTENS, V29, P971, DOI 10.1097/HJH.0b013e328344da76; Quadri SS, 2018, CLIN EXP PHARMACOL P, V45, P133, DOI 10.1111/1440-1681.12868; Ramkumar N, 2015, AM J PHYSIOL-RENAL, V309, pF48, DOI 10.1152/ajprenal.00126.2015; Rao R, 2005, AM J PHYSIOL-RENAL, V288, pF642, DOI 10.1152/ajprenal.00287.2004; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Reyes-Martinez C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00803; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Ripoll E, 2011, GENE THER, V18, P945, DOI 10.1038/gt.2011.39; Riquier-Brison ADM, 2018, AM J PHYSIOL-RENAL, V315, pF521, DOI 10.1152/ajprenal.00029.2018; Rujano MA, 2017, J EXP MED, V214, P3707, DOI 10.1084/jem.20170453; Salinas-Parra N, 2017, AM J MED SCI, V354, P310, DOI 10.1016/j.amjms.2017.05.018; Sato T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020239; Sato T, 2017, CARDIOVASC RES, V113, P760, DOI 10.1093/cvr/cvx061; Sato T, 2013, J CLIN INVEST, V123, P5203, DOI 10.1172/JCI69608; Schreiber CA, 2016, CURR GENE THER, V16, P349, DOI 10.2174/1566523217666161121111906; Schweda F, 2004, AM J PHYSIOL-RENAL, V287, pF427, DOI 10.1152/ajprenal.00072.2004; Sekerci R, 2018, ACTA HISTOCHEM, V120, P196, DOI 10.1016/j.acthis.2018.01.007; Shibayama Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08854; Siddiquee K, 2013, BRIT J PHARMACOL, V168, P1104, DOI 10.1111/j.1476-5381.2012.02192.x; Singh N, 2018, TOXICOL APPL PHARM, V356, P224, DOI 10.1016/j.taap.2018.08.009; Smith RC, 2012, J CLIN INVEST, V122, P4710, DOI 10.1172/JCI64986; Song R, 2017, AM J PHYSIOL-RENAL, V312, pF407, DOI 10.1152/ajprenal.00563.2016; Stegbauer J, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92720; SUGAWARA M, 1988, AM J PHYSIOL, V254, pR863, DOI 10.1152/ajpregu.1988.254.6.R863; Takenaka T, 2018, HYPERTENSION, V72, P1151, DOI 10.1161/HYPERTENSIONAHA.118.11176; Takenaka T, 2017, NEPHROL DIAL TRANSPL, V32, P791, DOI 10.1093/ndt/gfw340; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tigerstedt R., 1898, SKAND ARCH PHYSIOL, V8, P223, DOI [10.1111/j.1748-1716.1898.tb00272.x, DOI 10.1111/J.1748-1716.1898.TB00272.X]; Trepiccione F, 2016, J AM SOC NEPHROL, V27, P3320, DOI 10.1681/ASN.2015080915; Wang F, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.128061; Wang F, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124174; Wang F, 2016, J AM SOC NEPHROL, V27, P3022, DOI 10.1681/ASN.2015050592; Wang F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0514-1; Wang F, 2014, HYPERTENSION, V64, P369, DOI 10.1161/HYPERTENSIONAHA.114.03654; Wang F, 2014, AM J PHYSIOL-RENAL, V307, pF25, DOI 10.1152/ajprenal.00548.2013; Wang J, 2019, BRIT J CANCER, V120, P229, DOI 10.1038/s41416-018-0350-0; Wang LJ, 2019, PLACENTA, V87, P38, DOI 10.1016/j.placenta.2019.08.077; Wang R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17762-9; Wendling O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08845-7; Xiao LX, 2019, BBA-MOL BASIS DIS, V1865, P1313, DOI 10.1016/j.bbadis.2019.01.027; Xu CM, 2020, AM J PHYSIOL-RENAL, V318, pF1122, DOI 10.1152/ajprenal.00606.2019; Xu CM, 2017, HYPERTENSION, V69, P339, DOI 10.1161/HYPERTENSIONAHA.116.08240; Yang KT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13410; Yang TX, 2017, J AM SOC NEPHROL, V28, P1040, DOI 10.1681/ASN.2016070734; Yang TX, 2000, J BIOL CHEM, V275, P23281, DOI 10.1074/jbc.M910237199; Yang TX, 2000, J BIOL CHEM, V275, P37922, DOI 10.1074/jbc.M006218200; Yang TX, 2000, AM J PHYSIOL-RENAL, V279, pF819, DOI 10.1152/ajprenal.2000.279.5.F819; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF1, DOI 10.1152/ajprenal.1999.277.1.F1; Yang TX, 1998, AM J PHYSIOL-RENAL, V274, pF481, DOI 10.1152/ajprenal.1998.274.3.F481; Ye WL, 2006, AM J PHYSIOL-RENAL, V290, pF542, DOI 10.1152/ajprenal.00232.2005; Yoshida N, 2019, AGING CELL, V18, DOI 10.1111/acel.12991; Zeng XJ, 2009, PEPTIDES, V30, P1144, DOI 10.1016/j.peptides.2009.02.010; Zhang F, 2014, ACTA PHYSIOL, V212, P17, DOI 10.1111/apha.12342; Zhang H, 2018, CELL PHYSIOL BIOCHEM, V48, P1347, DOI 10.1159/000492093; Zhang JN, 2014, AM J PHYSIOL-RENAL, V307, pF1063, DOI 10.1152/ajprenal.00408.2014; Zhang MZ, 2018, HYPERTENSION, V72, P1172, DOI 10.1161/HYPERTENSIONAHA.118.11694; Zhang YX, 2019, PEPTIDES, V114, P29, DOI 10.1016/j.peptides.2019.04.005; Zhang ZZ, 2017, HYPERTENSION, V70, P1165, DOI 10.1161/HYPERTENSIONAHA.117.10156; Zhao HY, 2003, AM J PHYSIOL-RENAL, V285, pF281, DOI 10.1152/ajprenal.00030.2003; Zhou LL, 2015, AM J PATHOL, V185, P3211, DOI 10.1016/j.ajpath.2015.08.004; Zhou LL, 2015, J AM SOC NEPHROL, V26, P107, DOI 10.1681/ASN.2014010085; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zhou L, 2019, AM J PHYSIOL-ENDOC M, V316, pE773, DOI 10.1152/ajpendo.00383.2018; Zhuo Jia L, 2013, Front Endocrinol (Lausanne), V4, P166, DOI 10.3389/fendo.2013.00166	158	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14136	14149		10.1096/fj.202001711R	http://dx.doi.org/10.1096/fj.202001711R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32975331				2022-12-28	WOS:000574536100001
J	Huang, CY; Ogawa, R				Huang, Chenyu; Ogawa, Rei			Systemic factors that shape cutaneous pathological scarring	FASEB JOURNAL			English	Review						diet preference; keloids; lifestyle profile; molecular circulating changes	ENDOTHELIAL GROWTH-FACTOR; VITAMIN-D-RECEPTOR; KELOID FIBROBLASTS; COLLAGEN EXPRESSION; BURN SCAR; ANGIOGENESIS; DISEASE; VEGF; TAMOXIFEN; SMOKING	Cutaneous pathological scars are fibrotic lesions that grow continuously, invade the adjacent skin, and are erythematous, itchy, and painful. Their etiology remains unclear but may involve genetic, local mechanical, and systemic factors. Here, we will summarize the main systemic factors that shape cutaneous pathological scarring, especially keloid formation and aggravation. They include circulating cytokines, chemokines, growth factors, particular cell types, sex hormones, the systemic renin-angiotensin system, and vitamin D, all of which directly shape the angiogenesis, inflammation, fibrosis, and remodeling in pathological scars. There are also several environmental factors that more indirectly influence pathological scar formation or progression, namely diet, smoking, psychological stress, and exercise. Notably, much of the evidence on these systemic factors focus on their effects on one pathological scar characteristic, namely their fibrosis. However, systemic factors probably also shape other pathological scar characteristics. We describe two new avenues of keloid research that may greatly improve our understanding of pathological scarring and the systemic factors that affect it. One is the multiple similarities between keloids and tumors; the other is the different stem-cell populations in keloids. We expect this research will greatly aid the development of diagnostic biomarkers for cutaneous pathological scars and drugs/techniques/regimens that prevent, improve, or cure these scars.	[Huang, Chenyu] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Dermatol, Beijing, Peoples R China; [Ogawa, Rei] Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Tokyo, Japan	Tsinghua University; Nippon Medical School	Ogawa, R (corresponding author), Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	r.ogawa@nms.ac.jp	Huang, Chenyu/I-4410-2018; HUANG, CHENYU/GVT-7299-2022	Huang, Chenyu/0000-0001-9521-5650; 				Abdou AG, 2011, AM J DERMATOPATH, V33, P84, DOI 10.1097/DAD.0b013e3181d0c3ad; Abdu Allah Azza Mohamed Kamel, 2019, Cell Mol Biol (Noisy-le-grand), V65, P43, DOI 10.14715/cmb/2019.65.5.7; Akaishi S, 2008, MED HYPOTHESES, V71, P32, DOI 10.1016/j.mehy.2008.01.032; Alonso PE, 2016, BURNS, V42, P535, DOI 10.1016/j.burns.2015.09.019; Alonso PE, 2013, BURNS, V39, P534, DOI 10.1016/j.burns.2012.06.014; Appleton I, 1996, AM J PATHOL, V149, P1441; Ardekani GS, 2009, PLAST RECONSTR SURG, V123, p112E, DOI 10.1097/PRS.0b013e31819a34db; Arima J, 2015, WOUND REPAIR REGEN, V23, P213, DOI 10.1111/wrr.12277; Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Bagabir R, 2012, BRIT J DERMATOL, V167, P1053, DOI 10.1111/j.1365-2133.2012.11190.x; Bang RL, 1995, NUTRITION, V11, P527; Bayat A, 2003, PLAST RECONSTR SURG, V111, P535, DOI 10.1097/01.PRS.0000041536.02524.A3; BLOCH EF, 1984, PLAST RECONSTR SURG, V73, P448, DOI 10.1097/00006534-198403000-00020; Breitenstein A, 2017, THROMB HAEMOSTASIS, V117, P83, DOI 10.1160/TH16-05-0351; [蔡红雁 Cai Hongyan], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P6755; Canedo-Dorantes L, 2019, INT J INFLAMM, V2019, DOI 10.1155/2019/3706315; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chin MS, 2009, PLAST RECONSTR SURG, V124, P102, DOI 10.1097/PRS.0b013e3181a81542; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Damanik Vira Indhiratamin, 2019, Open Access Maced J Med Sci, V7, P65, DOI 10.3889/oamjms.2019.022; Davidson Steven, 2009, Medscape J Med, V11, P18; Deliaert AEK, 2019, WOUNDS, V31, P200; Deliaert AEK, 2012, EUR J PLAST SURG, V35, P421, DOI 10.1007/s00238-011-0661-3; Dhall S, 2016, CLIN SCI, V130, P1269, DOI 10.1042/CS20160236; Efremov YM, 2014, BBA-MOL CELL RES, V1843, P1013, DOI 10.1016/j.bbamcr.2014.01.032; Ehnert S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030406; ELHEFNAWI H, 1962, DERMATOLOGICA, V125, P387, DOI 10.1159/000255013; ELIAS JA, 1987, AM REV RESPIR DIS, V135, P62; FORD LC, 1983, J DERMATOL SURG ONC, V9, P545, DOI 10.1111/j.1524-4725.1983.tb00851.x; Furtado F, 2012, J PSYCHOSOM RES, V72, P282, DOI 10.1016/j.jpsychores.2011.12.010; GEORGE AO, 1993, INT J DERMATOL, V32, P714, DOI 10.1111/j.1365-4362.1993.tb02739.x; Ghazizadeh Mohammad, 2007, Journal of Nippon Medical School, V74, P11, DOI 10.1272/jnms.74.11; Glass Donald A 2nd, 2017, J Investig Dermatol Symp Proc, V18, pS50, DOI 10.1016/j.jisp.2016.10.024; Gong ZH, 2017, KAOHSIUNG J MED SCI, V33, P24, DOI 10.1016/j.kjms.2016.10.013; Goodsell DS, 2002, STEM CELLS, V20, P267, DOI 10.1634/stemcells.20-3-267; GRANSTEIN RD, 1990, J INVEST DERMATOL, V95, pS75, DOI 10.1111/1523-1747.ep12874789; Grant C, 2016, J CLIN PATHOL, V69, P643, DOI 10.1136/jclinpath-2015-203483; Hahn JM, 2017, BURNS, V43, P1506, DOI 10.1016/j.burns.2017.04.009; Hedayatyanfard K, 2018, WOUND REPAIR REGEN, V26, P340, DOI 10.1111/wrr.12648; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hochman B, 2015, CLIN COSMET INVESTI, V8, P67, DOI 10.2147/CCID.S49195; Hosnuter M, 2007, J Wound Care, V16, P251; Hsu CK, 2018, J INVEST DERMATOL, V138, P208, DOI 10.1016/j.jid.2017.05.041; Huang C, 2017, BRIT J DERMATOL, V177, P1248, DOI 10.1111/bjd.15576; Huang CY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072542; Huang CY, 2019, INT WOUND J, V16, P852, DOI 10.1111/iwj.13104; Huang CY, 2014, WOUND REPAIR REGEN, V22, P462, DOI 10.1111/wrr.12197; Huang CY, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0b013e31829c4597; Huang CY, 2014, INT WOUND J, V11, P517, DOI 10.1111/j.1742-481X.2012.01118.x; Huang CY, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-60; Huang CY, 2012, ARCH DERMATOL RES, V304, P589, DOI 10.1007/s00403-012-1278-5; HUGHES JE, 1983, BRIT J PSYCHIAT, V143, P51, DOI 10.1192/bjp.143.1.51; Humphries H, 2019, PLAST RECONSTR SURG, V144, P372, DOI 10.1097/PRS.0000000000005867; Jia L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6152769; Johnson KE, 2014, ADV WOUND CARE, V3, P647, DOI 10.1089/wound.2013.0517; Jurzak M, 2014, ACTA POL PHARM, V71, P972; Kang YY, 2020, J INVEST DERMATOL, V140, P2157, DOI 10.1016/j.jid.2020.01.036; Kay-Rivest E, 2020, OTOLARYNG HEAD NECK, V162, P108, DOI 10.1177/0194599819889622; KAZEEM AA, 1988, J SURG ONCOL, V38, P16, DOI 10.1002/jso.2930380106; Khattab FM, 2020, J COSMET DERMATOL-US, V19, P2428, DOI 10.1111/jocd.13290; Kotronoulas A, 2020, J TISSUE ENG REGEN M, V14, P441, DOI 10.1002/term.3005; Kwak DH, 2016, ARCH PLAST SURG-APS, V43, P491, DOI 10.5999/aps.2016.43.6.491; Kwak IS, 2014, BURNS, V40, P1661, DOI 10.1016/j.burns.2014.04.004; Lai XF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22556-7; Lauermann FT, 2016, AN BRAS DERMATOL, V91, P291, DOI 10.1590/abd1806-4841.20164405; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Lee NP, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0468-7; Li JR, 2014, PHARM RES-DORDR, V31, P1632, DOI 10.1007/s11095-013-1266-2; Li LF, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0684-1; Liu Zhe-Liang, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P267; Lodyga M, 2020, SEMIN CELL DEV BIOL, V101, P123, DOI 10.1016/j.semcdb.2019.12.010; Louw L, 2000, PROSTAG LEUKOTR ESS, V63, P247, DOI 10.1054/plef.2000.0208; Lu LL, 2017, BIOL TRACE ELEM RES, V176, P270, DOI 10.1007/s12011-016-0827-8; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Lv C, 2012, INDIAN J DERMATOL VE, V78, DOI 10.4103/0378-6323.98098; Majumder Anusree, 2019, Med J Armed Forces India, V75, P222, DOI 10.1016/j.mjafi.2018.07.018; Maquirriain Javier, 2007, J Foot Ankle Surg, V46, P317, DOI 10.1053/j.jfas.2007.02.007; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; MCCAULEY RL, 1992, J CLIN IMMUNOL, V12, P300, DOI 10.1007/BF00918154; Mogili NS, 2012, TRANSL RES, V159, P182, DOI 10.1016/j.trsl.2011.10.002; Moon JH, 2008, STEM CELLS DEV, V17, P713, DOI 10.1089/scd.2007.0210; Mousavi SR, 2010, DERMATOL SURG, V36, P665, DOI 10.1111/j.1524-4725.2010.01526.x; Murata A, 1991, World Rev Nutr Diet, V64, P31; Noishiki C, 2019, DERMATOLOGY THER, V9, P747, DOI 10.1007/s13555-019-00327-0; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Ogawa R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030606; Ogawa R, 2013, PLAST RECONSTR SURG, V132, p1074E, DOI 10.1097/PRS.0b013e3182a97f9e; Ogawa R, 2012, WOUND REPAIR REGEN, V20, P149, DOI 10.1111/j.1524-475X.2012.00766.x; Olaitan PB, 2011, WOUNDS, V23, P97; Onishi N, 2007, INT ARCH ALLERGY IMM, V144, P95, DOI 10.1159/000103220; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Park G, 2008, J INVEST DERMATOL, V128, P2429, DOI 10.1038/jid.2008.103; Park TH, 2012, AESTHET PLAST SURG, V36, P1271, DOI 10.1007/s00266-012-9947-5; Pehote G, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3028082; Quong WL, 2017, PRS-GLOB OPEN, V5, DOI 10.1097/GOX.0000000000001336; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Renner R, 2019, EUR J DERMATOL, V29, P619, DOI 10.1684/ejd.2019.3678; Robinson RT, 2007, J IMMUNOL, V179, P71, DOI 10.4049/jimmunol.179.1.71; Rorison P, 2010, BURNS, V36, P89, DOI 10.1016/j.burns.2009.03.008; Schierle HP, 1997, PLAST RECONSTR SURG, V100, P390, DOI 10.1097/00006534-199708000-00017; Shin JM, 2020, INT FORUM ALLERGY RH, V10, P356, DOI 10.1002/alr.22479; Shirakami E, 2020, BURNS TRAUMA, V8, DOI 10.1093/burnst/tkz003; SIANA JE, 1989, SCAND J PLAST RECONS, V23, P207, DOI 10.3109/02844318909075119; Soares-Lopes LR, 2017, EXP BIOL MED, V242, P926, DOI 10.1177/1535370217700524; Steinbrech DS, 1999, ANN PLAS SURG, V42, P514, DOI 10.1097/00000637-199905000-00009; Sudha S, 2018, J MED SCI CLIN RES, V6, P471; Syed F, 2013, LAB INVEST, V93, P946, DOI 10.1038/labinvest.2013.82; Tachi M, 2008, EXP DERMATOL, V17, P318, DOI 10.1111/j.1600-0625.2007.00647.x; Tanaka R, 2019, INT J DERMATOL, V58, P1398, DOI 10.1111/ijd.14575; Terzi R, 2016, J BURN CARE RES, V37, pE263, DOI 10.1097/BCR.0000000000000241; Torii K, 2017, AN BRAS DERMATOL, V92, P183, DOI 10.1590/abd1806-4841.20176198; Tsai Chia-Hsuan, 2019, Scars Burn Heal, V5, p2059513119868659, DOI 10.1177/2059513119868659; Tu Yiji, 2017, Scars Burn Heal, V3, p2059513117709943, DOI 10.1177/2059513117709943; Turegun M, 1997, BURNS, V23, P496, DOI 10.1016/S0305-4179(97)00041-7; Viera MH, 2012, ADV WOUND CARE, V1, P200, DOI 10.1089/wound.2011.0313; Vincent AS, 2008, J INVEST DERMATOL, V128, P702, DOI 10.1038/sj.jid.5701107; Walia A, 2015, BBA-GEN SUBJECTS, V1850, P2422, DOI 10.1016/j.bbagen.2015.09.007; Wang CY, 2019, JAMA FACIAL PLAST SU, V21, P407, DOI 10.1001/jamafacial.2019.0243; Wang P, 2016, AFR HEALTH SCI, V16, P542, DOI 10.4314/ahs.v16i2.23; Wang YQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42642; Wu X, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21922; Zegarska B, 2006, PHARMACOL REP, V58, P13; Zhang GY, 2016, CLIN EXP DERMATOL, V41, P152, DOI 10.1111/ced.12695; Zhang GY, 2011, BRIT J DERMATOL, V164, P729, DOI 10.1111/j.1365-2133.2010.10130.x; Zhang QZ, 2006, J INVEST DERMATOL, V126, P2607, DOI 10.1038/sj.jid.5700472; Zhang QZ, 2009, PLOS ONE, V4, pA192, DOI 10.1371/journal.pone.0007798	128	9	11	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13171	13184		10.1096/fj.202001157R	http://dx.doi.org/10.1096/fj.202001157R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32856341				2022-12-28	WOS:000566009300001
J	Ohsugi, Y; Katagiri, S; Hirota, T; Niimi, H; Hatasa, M; Watanabe, K; Shimohira, T; Mizutani, K; Kitazawa, M; Matsuzawa, A; Kadokura, H; Yokose, S; Iwata, T; Aoki, A				Ohsugi, Yujin; Katagiri, Sayaka; Hirota, Tomomitsu; Niimi, Hiromi; Hatasa, Masahiro; Watanabe, Kazuki; Shimohira, Tsuyoshi; Mizutani, Koji; Kitazawa, Moe; Matsuzawa, Ayumi; Kadokura, Hiroshi; Yokose, Satoshi; Iwata, Takanori; Aoki, Akira			Laser irradiation decreases sclerostin expression in bone and osteogenic cells	FASEB JOURNAL			English	Article						bone; Er; YAG laser; microarray; osteogenic cell; sclerostin	ER-YAG LASER; TARGETED DELETION; WNT; OSTEOBLASTS; DIFFERENTIATION; CATENIN; TISSUE; GENE; SOST; PROLIFERATION	Anti-sclerostin monoclonal antibody romosozumab, a treatment for osteoporosis, reduced vertebral fracture risk and clinical fracture. Laser irradiation triggers various effects, including bio-stimulation, which can induce beneficial therapeutic effects and biological responses. Originally, we performed in vivo experiments to clarify the mechanism of better bone healing in laser-ablated bone. Here, we evaluated comprehensive and sequential gene expression in Er:YAG laser-ablated, bur-drilled, and nontreated control bones, and found laser irradiation suppressedSost(coding protein: sclerostin) expression in the bone, possibly via stimulation of mechanotransducers. Surprisingly, bio-stimulation effect of laser suppressedSostexpression in the primary osteogenic cells. Decreased sclerostin expression after laser irradiation was also validated both in vivo and in vitro. In addition, sequential microarray analysis revealed that the gene expression pattern was clearly different at 24 hours after bone ablation between bur-drilled and laser-ablated bones. The Hippo signaling pathway was significantly enriched, whereas inflammation-related pathways were not affected at 6 hours after the laser ablation, indicating that laser irradiation caused mechanical stimulation. Only bur-drilled bone showed enriched inflammation-related gene sets and pathways at 24 hours, not in the laser-ablated bone. Our study suggests that laser irradiation may become a new treatment modality for osteoporosis, by inhibiting sclerostin expression without inducing inflammation.	[Ohsugi, Yujin; Katagiri, Sayaka; Niimi, Hiromi; Hatasa, Masahiro; Watanabe, Kazuki; Shimohira, Tsuyoshi; Mizutani, Koji; Iwata, Takanori; Aoki, Akira] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Hirota, Tomomitsu] Jikei Univ, Res Ctr Med Sci, Div Mol Genet, Sch Med, Tokyo, Japan; [Kitazawa, Moe; Matsuzawa, Ayumi] Tokyo Med & Dent Univ TMDU, Med Res Inst, Dept Epigenet, Tokyo, Japan; [Kadokura, Hiroshi; Yokose, Satoshi] Meikai Univ, Sch Dent, Dept Restorat & Biomat Sci, Div Endodont & Operat Dent, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Jikei University; Tokyo Medical & Dental University (TMDU); Meikai University	Katagiri, S; Aoki, A (corresponding author), Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	katagiri.peri@tmd.ac.jp; aoperi@tmd.ac.jp		Ohsugi, Yujin/0000-0002-2843-173X	Japan Society for the Promotion of Science KAKENHI [16K11825, 20K09971, 20K18501]; Academy of Laser Dentistry; Nanken-Kyoten, TMDU	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Academy of Laser Dentistry; Nanken-Kyoten, TMDU	This work was supported by the Japan Society for the Promotion of Science KAKENHI (16K11825 and 20K09971 to AA, and 20K18501 to YO) and Dr. Eugene Seidner Research Grants from the Academy of Laser Dentistry to SK. This study was supported by Nanken-Kyoten, TMDU. The authors would like to appreciate Drs. Masahiro Noda, Taichen Lin, Toru Takagi, Sho Kakizaki, Yutaro Kitanaka, Naoki Sasaki, and Rina Komazaki at Department of Periodontology, TMDU, and Mayumi Tamari at Division of Molecular Genetics, Research Center for Medical Science, The Jikei University School of Medicine for their kind support, and the staff at TMDU's experimental animal center.	Aoki A, 2015, PERIODONTOL 2000, V68, P217, DOI 10.1111/prd.12080; de Mello EDA, 2008, LASER MED SCI, V23, P253, DOI 10.1007/s10103-007-0475-5; Baek K, 2014, J CELL PHYSIOL, V229, P640, DOI 10.1002/jcp.24487; Baht GS, 2018, CURR OSTEOPOROS REP, V16, P138, DOI 10.1007/s11914-018-0423-2; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Caverzasio J, 2009, IBMS BONEKEY, V6, P9; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Collette NM, 2012, P NATL ACAD SCI USA, V109, P14092, DOI 10.1073/pnas.1207188109; Compton JT, 2014, J BONE JOINT SURG AM, V96A, P1659, DOI 10.2106/JBJS.M.01096; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; ERIKSSON AR, 1983, J PROSTHET DENT, V50, P101, DOI 10.1016/0022-3913(83)90174-9; Evenepoel P, 2014, NEW ENGL J MED, V370, P1664, DOI 10.1056/NEJMc1402396; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Izumi Y, 2011, PERIODONTOL 2000, V56, P166, DOI 10.1111/j.1600-0757.2010.00366.x; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kong S, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700157; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.3.CO;2-E; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Niimi H, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00459; Ohsugi Y, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800245; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Perussi LR, 2012, LASER MED SCI, V27, P95, DOI 10.1007/s10103-011-0920-3; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Pourzarandian A, 2004, PHOTOMED LASER SURG, V22, P342, DOI 10.1089/1549541041797913; Ransom RC, 2018, NATURE, V563, P514, DOI 10.1038/s41586-018-0650-9; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saag KG, 2017, NEW ENGL J MED, V377, P1417, DOI 10.1056/NEJMoa1708322; Sebastian A, 2017, BONE, V96, P76, DOI 10.1016/j.bone.2016.10.009; Seo J, 2018, BMB REP, V51, P151, DOI 10.5483/BMBRep.2018.51.3.012; Shimohira T, PHOTOBIOMOD PHOTOMED; Shippy R, 2006, NAT BIOTECHNOL, V24, P1123, DOI 10.1038/nbt1241; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Stuebinger S, 2007, J PERIODONTOL, V78, P2389, DOI 10.1902/jop.2007.070162; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wenzel PL, 2011, DEV BIOL, V351, P35, DOI 10.1016/j.ydbio.2010.12.025; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yokose S, 1996, ENDOCRINOLOGY, V137, P469, DOI 10.1210/en.137.2.469; Yokose S, 2013, J BIOINTEG, V3, P8, DOI DOI 10.32176/BIOINTEG.3.1_53; You L, 2015, BIOCHEM BIOPH RES CO, V456, P598, DOI 10.1016/j.bbrc.2014.11.120; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112	56	4	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12877	12893		10.1096/fj.202001032R	http://dx.doi.org/10.1096/fj.202001032R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32757452				2022-12-28	WOS:000558305000001
J	Machcinska, S; Kopcewicz, M; Bukowska, J; Walendzik, K; Gawronska-Kozak, B				Machcinska, Sylwia; Kopcewicz, Marta; Bukowska, Joanna; Walendzik, Katarzyna; Gawronska-Kozak, Barbara			Impairment of the Hif-1 alpha regulatory pathway in Foxn1-deficient (Foxn1(-/-)) mice affects the skin wound healing process	FASEB JOURNAL			English	Article						Foxn1; hypoxia; Hif&#8208; 1&#945; skin; scarless healing	HYPOXIA-INDUCIBLE FACTOR; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MOUSE; FETAL; FACTOR-1-ALPHA; REPAIR; CELLS; HIF-1	Hypoxia and hypoxia-regulated factors (eg, hypoxia-inducible factor-1 alpha [Hif-1 alpha], factor inhibiting Hif-1 alpha [Fih-1], thioredoxin-1 [Trx-1], aryl hydrocarbon receptor nuclear translocator 2 [Arnt-2]) have essential roles in skin wound healing. Using Foxn1(-/-) mice that can heal skin injuries in a unique scarless manner, we investigated the interaction between Foxn1 and hypoxia-regulated factors. The Foxn1(-/-) mice displayed impairments in the regulation of Hif-1 alpha, Trx-1, and Fih-1 but not Arnt-2 during the healing process. An analysis of wounded skin showed that the skin of the Foxn1(-/-) mice healed in a scarless manner, displaying rapid re-epithelialization and an increase in transforming growth factor beta (Tgf beta-3) and collagen III expression. An in vitro analysis revealed that Foxn1 overexpression in keratinocytes isolated from the skin of the Foxn1(-/-) mice led to reduced Hif-1 alpha expression in normoxic but not hypoxic cultures and inhibited Fih-1 expression exclusively under hypoxic conditions. These data indicate that in the skin, Foxn1 affects hypoxia-regulated factors that control the wound healing process and suggest that under normoxic conditions, Foxn1 is a limiting factor for Hif-1 alpha.	[Machcinska, Sylwia; Kopcewicz, Marta; Bukowska, Joanna; Walendzik, Katarzyna; Gawronska-Kozak, Barbara] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Gawronska-Kozak, B (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland.	b.kozak@pan.olsztyn.pl	KOPCEWICZ, Marta/H-7199-2017; GAWRONSKA-KOZAK, Barbara/A-2980-2017; WISNIEWSKA, Joanna/H-7164-2017	KOPCEWICZ, Marta/0000-0002-9776-4941; MACHCINSKA-ZIELINSKA, Sylwia/0000-0003-3892-4519; WALENDZIK, Katarzyna/0000-0001-8349-6387; GAWRONSKA-KOZAK, Barbara/0000-0002-2006-8534; WISNIEWSKA, Joanna/0000-0001-5887-450X				Andrikopoulou E, 2011, CURR MOL MED, V11, P218, DOI 10.2174/156652411795243414; Ansell DM, 2014, WOUND REPAIR REGEN, V22, P281, DOI 10.1111/wrr.12148; Aragona M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14684; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Bukowska J, 2018, CELL TISSUE RES, V374, P149, DOI 10.1007/s00441-018-2836-8; Chen L, 2012, J DENT RES, V91, P871, DOI 10.1177/0022034512454435; Chen R, 2011, ONCOGENE, V30, P2570, DOI 10.1038/onc.2010.623; Chen W, 2005, WOUND REPAIR REGEN, V13, P68, DOI 10.1111/j.1067-1927.2005.130109.x; Gonzalez ACD, 2016, AN BRAS DERMATOL, V91, P614, DOI 10.1590/abd1806-4841.20164741; Deng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063777; Elson DA, 2000, CANCER RES, V60, P6189; Fosen KM, 2014, ANTIOXID REDOX SIGN, V21, P1634, DOI 10.1089/ars.2014.5940; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gawronska-Kozak B, 2004, TISSUE ENG, V10, P1251, DOI 10.1089/ten.2004.10.1251; Gawronska-Kozak B, 2006, WOUND REPAIR REGEN, V14, P265, DOI 10.1111/j.1743-6109.2006.00121.x; Gawronska-Kozak B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150635; Gawronska-Kozak B, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-7; Gawronska-Kozak B, 2011, MATRIX BIOL, V30, P290, DOI 10.1016/j.matbio.2011.04.004; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hong WX, 2014, ADV WOUND CARE, V3, P390, DOI 10.1089/wound.2013.0520; Kalucka J, 2013, MOL CELL BIOL, V33, P3426, DOI 10.1128/MCB.00609-13; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kopcewicz M, 2020, AGING-US, V12, P7066, DOI 10.18632/aging.103064; Kopcewicz MM, 2017, WOUND REPAIR REGEN, V25, P248, DOI 10.1111/wrr.12524; Kur-Piotrowska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23794-5; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; LEVINE JH, 1993, AM J PATHOL, V143, P368; Li J, 2007, DIFFERENTIATION, V75, P694, DOI 10.1111/j.1432-0436.2007.00176.x; Lo DD, 2012, BIRTH DEFECTS RES C, V96, P237, DOI 10.1002/bdrc.21018; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; LONGAKER MT, 1990, J PEDIATR SURG, V25, P63, DOI 10.1016/S0022-3468(05)80165-4; Manuel JA, 2006, MATRIX BIOL, V25, P505, DOI 10.1016/j.matbio.2006.07.008; Mori H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21520; Mori K, 2010, CELL IMMUNOL, V260, P66, DOI 10.1016/j.cellimm.2009.09.007; Naranjo-Suarez S, 2013, MOL CELLS, V36, P151, DOI 10.1007/s10059-013-0121-y; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Ramirez H, 2014, ADV WOUND CARE, V3, P482, DOI 10.1089/wound.2013.0466; Rezvani HR, 2011, J CELL SCI, V124, P4172, DOI 10.1242/jcs.082370; Rong Y, 2006, CANCER RES, V66, P7067, DOI 10.1158/0008-5472.CAN-06-0346; ROWLATT U, 1979, VIRCHOWS ARCH A, V381, P353, DOI 10.1007/BF00432477; Ruthenborg RJ, 2014, MOL CELLS, V37, P637, DOI 10.14348/molcells.2014.0150; Scheid A, 2002, FASEB J, V16, P411, DOI 10.1096/fj.01-0496fje; Scheid A, 2000, PEDIATR SURG INT, V16, P232, DOI 10.1007/s003830050735; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; SHAH M, 1995, J CELL SCI, V108, P985; Shaikh IA, 2017, J SURG RES, V216, P158, DOI 10.1016/j.jss.2017.04.019; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Taylor CT, 2010, PHYSIOLOGY, V25, P272, DOI 10.1152/physiol.00029.2010; Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561; Walendzik K, 2020, J INVEST DERMATOL, V140, P1166, DOI 10.1016/j.jid.2019.11.010; Wang D, 2016, IUBMB LIFE, V68, P748, DOI 10.1002/iub.1537; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Wen Y, 2019, ONCOGENE, V38, P1845, DOI 10.1038/s41388-018-0552-1; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Xia JH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051022; Xiong AJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00326; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	75	4	4	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21289	10.1096/fj.202001907R	http://dx.doi.org/10.1096/fj.202001907R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475195	Green Submitted, hybrid			2022-12-28	WOS:000647789600064
J	Park, JW; Kim, JE; Choi, YJ; Kang, MJ; Choi, HJ; Bae, SJ; Hong, JT; Lee, H; Hwang, DY				Park, Ji Won; Kim, Ji Eun; Choi, Yun Ju; Kang, Mi Ju; Choi, Hyeon Jun; Bae, Su Ji; Hong, Jin Tae; Lee, Ho; Hwang, Dae Youn			Deficiency of complement component 3 may be linked to the development of constipation in FVB/N-C3(em1Hlee)/Korl mice	FASEB JOURNAL			English	Article						complement C3; constipation; knockout mice; mucin; stool; transverse colon	LOPERAMIDE-INDUCED CONSTIPATION; C3-DEFICIENT MICE; C3A; ACTIVATION; RECEPTOR; CELLS; SECRETION; COLITIS; PATHWAY; INNATE	Alterations in complement component 3 (C3) expression has been reported to be linked to several bowel diseases including Crohn's disease, inflammatory bowel disease, and ulcerative colitis; however, the association with constipation has never been investigated. In this study, we aimed to investigate the correlation between C3 regulation and constipation development using a C3 deficiency model. To achieve these, alterations in stool excretion, transverse colon histological structure, and mucin secretion were analyzed in FVB/N-C3(em1Hlee)/Korl (C3 knockout, C3 KO) mice with the deletion of 11 nucleotides in exon 2 of the C3 gene. The stool excretion parameters, gastrointestinal transit, and intestine length were remarkably decreased in C3 KO mice compared with wild-type (WT) mice, although there was no specific change in feeding behavior. Furthermore, C3 KO mice showed a decrease in mucosal and muscle layer thickness, alterations in crypt structure, irregular distribution of goblet cells, and an increase of mucin droplets in the transverse colon. Mucin secretion was suppressed, and they accumulated in the crypts of C3 KO mice. In addition, the constipation phenotypes detected during C3 deficiency were confirmed in FVB/N mice treated with C3 convertase inhibitor (rosmarinic acid (RA)). Similar phenotypes were observed with respect to stool excretion parameters, gastrointestinal transit, intestine length, alterations in crypt structure, and mucin secretion in RA-treated FVB/N mice. Therefore, the results of the present study provide the first scientific evidence that C3 deficiency may play an important role in the development of constipation phenotypes in C3 KO mice.	[Park, Ji Won; Kim, Ji Eun; Choi, Yun Ju; Kang, Mi Ju; Choi, Hyeon Jun; Bae, Su Ji; Hwang, Dae Youn] Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci,Program BK21 FOUR, Miryang, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungju, South Korea; [Lee, Ho] Natl Canc Ctr, Res Inst, Grad Sch Canc Sci & Policy, Goyang, South Korea	Pusan National University; Chungbuk National University; National Cancer Center - Korea (NCC)	Hwang, DY (corresponding author), Pusan Natl Univ, Lab Anim Resources Ctr, Coll Nat Resources & Life Sci, Dept Biomat Sci,Program BK21 FOUR, 50 Cheonghak Ri, Miryang Si 627706, Gyeongsangnam D, South Korea.	dyhwang@pusan.ac.kr		Lee, Ho/0000-0001-5573-742X				AHRENSTEDT O, 1990, NEW ENGL J MED, V322, P1345, DOI 10.1056/NEJM199005103221903; Andoh A, 1996, GASTROENTEROLOGY, V110, P1919, DOI 10.1053/gast.1996.v110.pm8964419; Andrews Christopher N, 2011, Can J Gastroenterol, V25 Suppl B, p16B; Bassotti Gabrio, 2011, Gastroenterol Hepatol Bed Bench, V4, P109; Boos L, 2005, NEUROSCI LETT, V387, P68, DOI 10.1016/j.neulet.2005.07.015; Choi JS, 2014, EXP THER MED, V8, P1847, DOI 10.3892/etm.2014.2030; Choi JS, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/878503; Choi JY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100377; Chumpitazi BP, 2016, NEUROGASTROENT MOTIL, V28, P443, DOI 10.1111/nmo.12738; COLTEN HR, 1986, BIOESSAYS, V4, P249, DOI 10.1002/bies.950040604; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Davoust N, 1999, GLIA, V26, P201, DOI 10.1002/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M; Dinasarapu AR, 2012, MOL PAGE, V1, P34; Emmanuel AV, 2009, NEUROGASTROENT MOTIL, V21, P41, DOI 10.1111/j.1365-2982.2009.01403.x; ENGLBERGER W, 1988, INT J IMMUNOPHARMACO, V10, P729, DOI 10.1016/0192-0561(88)90026-4; ERDEI A, 1991, IMMUNOL TODAY, V12, P332, DOI 10.1016/0167-5699(91)90011-H; Fischer WH, 1997, J IMMUNOL, V159, P4279; Forootan M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010631; HALSTENSEN TS, 1992, GUT, V33, P902, DOI 10.1136/gut.33.7.902; Honczarenko M, 2005, J IMMUNOL, V175, P3698, DOI 10.4049/jimmunol.175.6.3698; Kim JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215205; Kim JE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040946; Kim JE, 2019, J MED FOOD, V22, P294, DOI 10.1089/jmf.2018.4234; Kim JE, 2018, PHARM BIOL, V56, P309, DOI 10.1080/13880209.2018.1474932; Kim JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161144; Kim JE, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-333; Laufer J, 2000, CLIN EXP IMMUNOL, V120, P30, DOI 10.1046/j.1365-2249.2000.01168.x; Lee HY, 2012, FOOD CHEM TOXICOL, V50, P895, DOI 10.1016/j.fct.2011.12.001; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Liang C, 2016, WORLD J GASTROENTERO, V22, P2799, DOI 10.3748/wjg.v22.i9.2799; Lin F, 2004, J IMMUNOL, V172, P3836, DOI 10.4049/jimmunol.172.6.3836; McCallum IJD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b831; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Prather CM, 1998, MAYO CLIN PROC, V73, P881, DOI 10.4065/73.9.881; Ratajczak J, 2004, BLOOD, V103, P2071, DOI 10.1182/blood-2003-06-2099; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Ricklin D, 2016, IMMUNOL REV, V274, P33, DOI 10.1111/imr.12500; Riordan SM, 1996, SCAND J GASTROENTERO, V31, P1098, DOI 10.3109/00365529609036893; Schiller LR, 2001, ALIMENT PHARM THER, V15, P749, DOI 10.1046/j.1365-2036.2001.00982.x; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Sugihara T, 2010, CLIN EXP IMMUNOL, V160, P386, DOI 10.1111/j.1365-2249.2010.04093.x; Ueki T, 1996, CLIN EXP IMMUNOL, V104, P286, DOI 10.1046/j.1365-2249.1996.17721.x; Verdeguer F, 2007, CARDIOVASC RES, V76, P340, DOI 10.1016/j.cardiores.2007.06.028; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Yao EH, 2008, BIOCHEM BIOPH RES CO, V367, P468, DOI 10.1016/j.bbrc.2007.12.160; Zhang YG, 2018, DRUG DES DEV THER, V12, P2403, DOI 10.2147/DDDT.S160628; Zhou WD, 2006, BLOOD, V107, P2461, DOI 10.1182/blood-2005-08-3144	53	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21221	10.1096/fj.202000376R	http://dx.doi.org/10.1096/fj.202000376R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337564	hybrid			2022-12-28	WOS:000605626600040
J	Cheng, X; Xiao, F; Xie, R; Hu, HJ; Wan, Y				Cheng, Xing; Xiao, Fan; Xie, Rong; Hu, Haijun; Wan, Yong			Alternate thermal stimulation ameliorates thermal sensitivity and modulates calbindin-D 28K expression in lamina I and II and dorsal root ganglia in a mouse spinal cord contusion injury model	FASEB JOURNAL			English	Article						alternate thermal stimulation; calbindin&#8208; D 28K; correlation; neuropathic pain; parvalbumin; spinal cord injury	CALCIUM-BINDING PROTEINS; NEUROPATHIC PAIN; HORN NEURONS; PARVALBUMIN; RAT; MECHANISMS; MANAGEMENT; HEAT; IMMUNOREACTIVITY; HYPERALGESIA	Neuropathic pain (NP) is a common complication that negatively affects the lives of patients with spinal cord injury (SCI). The disruption in the balance of excitatory and inhibitory neurons in the spinal cord dorsal horn contributes to the development of SCI and induces NP. The calcium-binding protein (CaBP) calbindin-D 28K (CaBP-28K) is highly expressed in excitatory interneurons, and the CaBP parvalbumin (PV) is present in inhibitory neurons in the dorsal horn. To better define the changes in the CaBPs contributing to the development of SCI-induced NP, we examined the changes in CaBP-28K and PV staining density in the lumbar (L4-6) lamina I and II, and their relationship with NP after mild spinal cord contusion injury in mice. We additionally examined the effects of alternate thermal stimulation (ATS). Compared with sham mice, injured animals developed mechanical allodynia in response to light mechanical stimuli and exhibited mechanical hyporesponsiveness to noxious mechanical stimuli. The decreased response latency to heat stimuli and increased response latency to cold stimuli at 7 days post injury suggested that the injured mice developed heat hyperalgesia and cold hypoalgesia, respectively. Temperature preference tests showed significant warm allodynia after injury. Animals that underwent ATS (15-18 and 35-40 degrees C; +5 minutes/stimulation/day; 5 days/week) displayed significant amelioration of heat hyperalgesia, cold hypoalgesia, and warm allodynia after 2 weeks of ATS. In contrast, mechanical sensitivity was not influenced by ATS. Analysis of the CaBP-28K positive signal in L4-6 lamina I and II indicated an increase in staining density after SCI, which was associated with an increase in the number of CaBP-28K-stained L4-6 dorsal root ganglion (DRG) neurons. ATS decreased the CaBP-28K staining density in L4-6 spinal cord and DRG in injured animals, and was significantly and strongly correlated with ATS alleviation of pain behavior. The expression of PV showed no changes in lamina I and II after ATS in SCI animals. Thus, ATS partially decreases the pain behavior after SCI by modulating the changes in CaBP-associated excitatory-inhibitory neurons.	[Cheng, Xing; Wan, Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine Surg, Guangzhou 510080, Peoples R China; [Cheng, Xing] Heidelberg Univ, Spinal Cord Injury Ctr, Heidelberg, Germany; [Xiao, Fan; Hu, Haijun] Nanchang Univ, Dept Anesthesiol, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Xie, Rong] Nanchang Univ, Dept Thyroid Surg, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Wan, Yong] Guangdong Prov Key Lab Orthopaed & Traumatol, Guangzhou, Peoples R China	Sun Yat Sen University; Ruprecht Karls University Heidelberg; Nanchang University; Nanchang University	Wan, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine Surg, Guangzhou 510080, Peoples R China.	wanyong@mail.sysu.edu.cn						Al-Kaisy A, 2018, NEUROMODULATION, V21, P457, DOI 10.1111/ner.12771; ANTAL M, 1991, J COMP NEUROL, V314, P114, DOI 10.1002/cne.903140111; ANTAL M, 1990, J COMP NEUROL, V295, P467, DOI 10.1002/cne.902950310; Baastrup C, 2008, CNS DRUGS, V22, P455, DOI 10.2165/00023210-200822060-00002; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Batista CM, 2019, SOMATOSENS MOT RES, V36, P14, DOI 10.1080/08990220.2018.1563537; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boldt I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009177.pub2; Budh CN, 2004, COMPLEMENT THER MED, V12, P189, DOI 10.1016/j.ctim.2004.10.003; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burke D, 2017, EUR J PAIN, V21, P29, DOI 10.1002/ejp.905; Castany S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22217-9; Caylor Jacob, 2019, Bioelectron Med, V5, DOI 10.1186/s42234-019-0023-1; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen SY, 2019, TAIWAN J OPHTHALMOL, V9, P18, DOI 10.4103/tjo.tjo_108_18; Christensen MD, 1997, EXP NEUROL, V147, P463, DOI 10.1006/exnr.1997.6608; Christensen MD, 1996, PAIN, V68, P97, DOI 10.1016/S0304-3959(96)03224-1; Cote MP, 2017, J NEUROTRAUM, V34, P1841, DOI 10.1089/neu.2016.4577; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Detloff MR, 2014, EXP NEUROL, V255, P38, DOI 10.1016/j.expneurol.2014.02.013; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Dugan EA, 2015, J NEUROTRAUM, V32, P622, DOI 10.1089/neu.2014.3692; Egea J, 2012, PFLUG ARCH EUR J PHY, V463, P449, DOI 10.1007/s00424-011-1063-x; Eldabe S, 2016, PAIN MED, V17, P325, DOI 10.1093/pm/pnv025; Engholm G, 2010, EUR J PAIN, V14, P918, DOI 10.1016/j.ejpain.2010.02.008; Fan W, 2020, PAIN, V161, P1650, DOI 10.1097/j.pain.0000000000001836; Finnerup NB, 2014, J PAIN, V15, P40, DOI 10.1016/j.jpain.2013.09.008; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Hachem LD, 2017, J SPINAL CORD MED, V40, P665, DOI 10.1080/10790268.2017.1329076; Hameed S, 2019, MOL PAIN, V15, DOI 10.1177/1744806919858801; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Hoschouer EL, 2009, EXP NEUROL, V216, P22, DOI 10.1016/j.expneurol.2008.10.025; Hu D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0679-3; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; ITO K, 1978, JPN J PHYSIOL, V28, P737; Iwasawa H, 2016, CLIN ORTHOP RELAT R, V474, P2692, DOI 10.1007/s11999-016-5030-x; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Kim EJ, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0800-4; King CD, 2007, NEUROSCIENCE, V147, P174, DOI 10.1016/j.neuroscience.2007.04.012; King CD, 2003, BRAIN RES, V987, P214, DOI 10.1016/S0006-8993(03)03339-0; Lee K, 2017, NEURON, V93, P1451, DOI 10.1016/j.neuron.2017.02.033; Lee S, 2013, CURR NEUROPHARMACOL, V11, P606, DOI 10.2174/1570159X11311060005; LEHMANN JUSTUS F., 1964, ARCH PHYS MED REHABIL, V45, P555; Loy K, 2019, NEURAL REGEN RES, V14, P405, DOI 10.4103/1673-5374.245951; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Marcinkiewcz CA, 2009, BRAIN RES, V1251, P112, DOI 10.1016/j.brainres.2008.11.042; Meacham K, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0629-5; MENETREY D, 1992, EUR J NEUROSCI, V4, P70, DOI 10.1111/j.1460-9568.1992.tb00110.x; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; MIZE RR, 1992, J COMP NEUROL, V320, P243, DOI 10.1002/cne.903200208; Nees TA, 2016, PAIN, V157, P687, DOI 10.1097/j.pain.0000000000000422; Norrbrink C, 2009, J REHABIL RES DEV, V46, P85, DOI 10.1682/JRRD.2008.04.0051; NURMIKKO T, 1992, PAIN, V49, P43, DOI 10.1016/0304-3959(92)90186-F; Ondarza AB, 2003, EXP NEUROL, V184, P373, DOI 10.1016/j.expneurol.2003.07.002; Petitjean H, 2015, CELL REP, V13, P1246, DOI 10.1016/j.celrep.2015.09.080; Potter LE, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0609-4; Reinhardt T, 2013, PAIN MED, V14, P676, DOI 10.1111/pme.12090; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sdrulla AD, 2015, PAIN, V156, P1008, DOI 10.1097/01.j.pain.0000460353.15460.a3; Shields SD, 2018, J NEUROSCI, V38, P10180, DOI 10.1523/JNEUROSCI.1049-18.2018; Shim B, 2005, NEUROSCIENCE, V132, P193, DOI 10.1016/j.neuroscience.2004.12.036; Siddall PJ, 2009, SPINAL CORD, V47, P352, DOI 10.1038/sc.2008.136; Smith TM, 2020, J NEUROSCI METH, V330, DOI 10.1016/j.jneumeth.2019.108479; Stebbing MJ, 2016, NEUROSCIENCE, V324, P330, DOI 10.1016/j.neuroscience.2016.03.016; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tsantoulas C, 2015, CURR OPIN SUPPORT PA, V9, P147, DOI 10.1097/SPC.0000000000000131; VANBREDERODE JFM, 1991, NEUROSCIENCE, V44, P157, DOI 10.1016/0306-4522(91)90258-P; Widerstrom-Noga E, 2017, DRUGS, V77, P967, DOI 10.1007/s40265-017-0747-8; YAMAMOTO T, 1989, BRAIN RES BULL, V23, P493, DOI 10.1016/0361-9230(89)90195-0; Zewdie ET, 2015, PROG BRAIN RES, V218, P127, DOI 10.1016/bs.pbr.2014.12.005; Zhang MD, 2018, J CLIN INVEST, V128, P3757, DOI 10.1172/JCI120913	75	3	3	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001775R	http://dx.doi.org/10.1096/fj.202001775R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33225523				2022-12-28	WOS:000592381100001
J	Song, LN; Liu, JY; Shi, TT; Zhang, YC; Xin, Z; Cao, X; Yang, JK				Song, Li-Ni; Liu, Jing-Yi; Shi, Ting-Ting; Zhang, Yi-Chen; Xin, Zhong; Cao, Xi; Yang, Jin-Kui			Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism	FASEB JOURNAL			English	Article						ACE2 | Ang-(1-7); glucose metabolism; hepatic steatosis; Mas; mitochondrial function	FATTY LIVER-DISEASE; OXIDATIVE STRESS; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; SIGNALING PATHWAYS; PHOSPHORYLATION; PATHOGENESIS; ASSOCIATION; DEFICIENCY; STEATOSIS	Nonalcoholic fatty liver disease (NAFLD) is the most general liver disease characterized by a continuum of liver abnormalities ranging from simple fatty liver to advanced stage of nonalcoholic steatohepatitis, cirrhosis, and even hepatocellular carcinoma. The pathological drivers of NAFLD are complex and largely undefined. It is increasingly identified that the imbalance between renin-angiotensin system and ACE2/Ang-(1-7)/Mas axis, as well as mitochondrial dysfunction associated with NAFLD. However, no known empirical research has focused on exploring the effect of the regulation of mitochondrial respiration chain activity by Ang-(1-7)/Mas on the prevention of NAFLD. Here, we evaluated the interaction and relevance of hepatic Ang-(1-7)/Mas-axis challenge with glucolipid metabolism and mitochondrial condition in vivo and in vitro. In this context, we found thatMasdeletion in mice contributed to the severe glucose intolerance, insulin resistance, and hepatic steatosis which accompanied by elevated levels of serum/ hepatic alanine aminotransferase, aspartate aminotransferase, and triglycerides, as well as the mitochondrial dysfunction. Whereas forced upregulation of Mas or Ang-(1-7) administration could significantly attenuate these consequences by downregulating the expression of hepatic lipogenic proteins and enzymes for gluconeogenesis. Furthermore, activation of Ang-(1-7)/Mas arm could improve the IRS-1/Akt/AMPK pathway and enhance the mitochondrial energy utilization. Considered together, it is becoming extremely hopeful to provide a new perspective for Ang-(1-7)/Mas axis for the therapeutics of NAFLD.	[Song, Li-Ni; Liu, Jing-Yi; Shi, Ting-Ting; Zhang, Yi-Chen; Xin, Zhong; Cao, Xi; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing Key Lab Diabet Res & Care,Dept Endocrinol, Beijing 100730, Peoples R China	Capital Medical University	Cao, X; Yang, JK (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing Key Lab Diabet Res & Care,Dept Endocrinol, Beijing 100730, Peoples R China.	tide005@126.com; jinkui.yang@gmail.com			National Natural Science Foundation of China [81670774, 81561128015]; Beijing Municipal Administration of Hospitals' Youth Program [QML20170205]; National Key R&D Program of China [2017YFC0909600]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201823]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals' Youth Program; National Key R&D Program of China; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support	This work was supported by grants from the National Natural Science Foundation of China (81670774, 81561128015), Beijing Municipal Administration of Hospitals' Youth Program (QML20170205), National Key R&D Program of China (2017YFC0909600), and Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201823)	Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Bindom SM, 2009, MOL CELL ENDOCRINOL, V302, P193, DOI 10.1016/j.mce.2008.09.020; Braga JF, 2017, ENDOCR CONNECT, V6, P27, DOI 10.1530/EC-16-0098; Cao X, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3123; Cao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21592; Cao X, 2014, MOL CELL ENDOCRINOL, V393, P30, DOI 10.1016/j.mce.2014.05.024; Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025; Chen Z, 2019, TRENDS ENDOCRIN MET, V30, P903, DOI 10.1016/j.tem.2019.08.006; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Durik M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/536426; Duseja A, 2015, J CLIN EXP HEPATOL, V5, P51, DOI 10.1016/j.jceh.2015.02.006; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gao J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101366; Giani JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE262, DOI 10.1152/ajpendo.90678.2008; Han QA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27932-x; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Kido K, 2017, AM J PHYSIOL-REG I, V313, pR110, DOI 10.1152/ajpregu.00063.2017; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Li Y, 2019, J CELL BIOCHEM, V120, P8008, DOI 10.1002/jcb.28078; Li Y, 2019, GASTROENT RES PRACT, V2019, DOI 10.1155/2019/5647161; Liu C, 2012, ACTA DIABETOL, V49, P291, DOI 10.1007/s00592-011-0348-z; Liu DH, 2017, J MOL CELL CARDIOL, V105, P77, DOI 10.1016/j.yjmcc.2017.01.017; Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; Lu Y, 2016, CHEMOSPHERE, V158, P143, DOI 10.1016/j.chemosphere.2016.05.071; Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613; Matsuda S, 2013, PPAR RES, V2013, DOI 10.1155/2013/256508; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Santos SHS, 2010, ARTERIOSCL THROM VAS, V30, P953, DOI 10.1161/ATVBAHA.109.200493; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Serviddio G, 2013, FREE RADICAL BIO MED, V65, P952, DOI 10.1016/j.freeradbiomed.2013.08.174; Shi TT, 2018, BIOCHEM BIOPH RES CO, V495, P860, DOI 10.1016/j.bbrc.2017.11.055; Silva AR, 2013, AM J PHYSIOL-REG I, V305, pR1323, DOI 10.1152/ajpregu.00249.2013; Tan MJ, 2020, CELL DEATH DIFFER, V27, P2143, DOI 10.1038/s41418-020-0491-6; Tang AL, 2017, HEPATOL RES, V47, P116, DOI 10.1111/hepr.12707; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093; Tassone EJ, 2013, CARDIOVASC RES, V99, P129, DOI 10.1093/cvr/cvt065; Valbusa F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173398; Wei Y, 2008, J HEPATOL, V49, P417, DOI 10.1016/j.jhep.2008.03.018; Xu YZ, 2013, INTERNAL MED, V52, P855, DOI 10.2169/internalmedicine.52.8839; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	52	8	9	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16291	16306		10.1096/fj.202001639R	http://dx.doi.org/10.1096/fj.202001639R		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078906	Bronze			2022-12-28	WOS:000581625200001
J	Ohlsson, C; Gustafsson, KL; Farman, HH; Henning, P; Lionikaite, V; Moverare-Skrtic, S; Sjogren, K; Tornqvist, AE; Andersson, A; Islander, U; Bernardi, AI; Poutanen, M; Chambon, P; Lagerquist, MK				Ohlsson, Claes; Gustafsson, Karin L.; Farman, Helen H.; Henning, Petra; Lionikaite, Vikte; Moverare-Skrtic, Sofia; Sjogren, Klara; Tornqvist, Anna E.; Andersson, Annica; Islander, Ulrika; Bernardi, Angelina I.; Poutanen, Matti; Chambon, Pierre; Lagerquist, Marie K.			Phosphorylation site S122 in estrogen receptor alpha has a tissue-dependent role in female mice	FASEB JOURNAL			English	Article						adipose tissue; bone; estrogen; posttranslational modifications	ADIPOSE-TISSUE; ER-ALPHA; INDEPENDENT ACTIVATION; PROMOTER INTERACTION; KINASE PATHWAY; SERINE 118; BONE; ESTRADIOL; SEX; EXPRESSION	Estrogen treatment increases bone mass and reduces fat mass but is associated with adverse effects in postmenopausal women. Knowledge regarding tissue-specific estrogen signaling is important to aid the development of new tissue-specific treatments. We hypothesized that the posttranslational modification phosphorylation in estrogen receptor alpha (ER alpha) may modulate ER alpha activity in a tissue-dependent manner. Phosphorylation of site S122 in ER alpha has been shown in vitro to affect ER alpha activity, but the tissue-specific role in vivo is unknown. We herein developed and phenotyped a novel mouse model with a point mutation at the phosphorylation site 122 in ER alpha (S122A). Female S122A mice had increased fat mass and serum insulin levels but unchanged serum sex steroid levels, uterus weight, bone mass, thymus weight, and lymphocyte maturation compared to WT mice. In conclusion, phosphorylation site S122 in ER alpha has a tissue-dependent role with an impact specifically on fat mass in female mice. This study is the first to demonstrate in vivo that a phosphorylation site in a transactivation domain in a nuclear steroid receptor modulates the receptor activity in a tissue-dependent manner.	[Ohlsson, Claes; Gustafsson, Karin L.; Farman, Helen H.; Henning, Petra; Lionikaite, Vikte; Moverare-Skrtic, Sofia; Sjogren, Klara; Tornqvist, Anna E.; Poutanen, Matti; Lagerquist, Marie K.] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden; [Andersson, Annica; Islander, Ulrika; Bernardi, Angelina I.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Turku, Finland; [Chambon, Pierre] Coll France, ULP, Natl Sante & Rech Med, CNRS,Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	University of Gothenburg; University of Gothenburg; University of Turku; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gustafsson, KL (corresponding author), Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad,Klinfarmlab, Vita Straket 11, S-41345 Gothenburg, Sweden.	Karin.gustafsson.4@gu.se	Lagerquist, Marie/A-9531-2010; Ohlsson, Claes/AGP-3544-2022; Islander, Ulrika/S-4824-2019; Ohlsson, Claes/HIR-6959-2022	Lagerquist, Marie/0000-0002-9089-8605; Ohlsson, Claes/0000-0002-9633-2805; Islander, Ulrika/0000-0002-8493-1739; Ohlsson, Claes/0000-0002-9633-2805; Henning, Petra/0000-0002-9330-6265; Tornqvist, Anna/0000-0003-2621-9038; Sjogren, Klara/0000-0001-5776-7278	Swedish Research Council; Swedish Foundation for Strategic Research; Swedish government [ALFGBG-721581]; Swedish county councils, the ALF-agreement [ALFGBG-721581]; Gustaf V 80-years fund; Swedish Rheumatism Association; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundations; Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0010513, NNF18OC0033898, NNF19OC0055250, NNF13OC0005785] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish government; Swedish county councils, the ALF-agreement; Gustaf V 80-years fund; Swedish Rheumatism Association; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundations; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The Swedish Research Council, the Swedish Foundation for Strategic Research, the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-721581), the Gustaf V 80-years fund, the Swedish Rheumatism Association, the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundations, the Knut and Alice Wallenberg Foundation and the Novo Nordisk Foundation	Al-Dhaheri MH, 2007, MOL ENDOCRINOL, V21, P439, DOI 10.1210/me.2006-0059; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Barrett-Connor E, 2005, ANNU REV PUBL HEALTH, V26, P115, DOI 10.1146/annurev.publhealth.26.021304.144637; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Eaton SA, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010008; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; ETTINGER B, 1988, OBSTET GYNECOL, V72, pS1; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Huderson BP, 2012, ENDOCRINOLOGY, V153, P4144, DOI 10.1210/en.2011-2001; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iwaniec UT, 2016, J ENDOCRINOL, V230, pR115, DOI 10.1530/JOE-16-0089; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3569, DOI 10.1210/jc.2010-0856; Kim TH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005537; KINCADE PW, 1994, IMMUNOL REV, V137, P119, DOI 10.1111/j.1600-065X.1994.tb00661.x; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LAUBER AH, 1991, ENDOCRINOLOGY, V129, P3180, DOI 10.1210/endo-129-6-3180; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Lindberg MK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740167; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Lovre D, 2017, THER ADV CARDIO DIS, V11, P33, DOI 10.1177/1753944716649358; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Ludwik KA, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107931; Maggi A, 2011, BBA-MOL BASIS DIS, V1812, P1054, DOI 10.1016/j.bbadis.2011.05.001; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Marjoribanks J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004143.pub5; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Miyagawa S, 2004, ONCOGENE, V23, P340, DOI 10.1038/sj.onc.1207207; Moverare-Skrtic S, 2014, NAT MED, V20, P1279, DOI 10.1038/nm.3654; Murphy LC, 2004, CLIN CANCER RES, V10, P5902, DOI 10.1158/1078-0432.CCR-04-0191; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Murphy LC, 2009, J STEROID BIOCHEM, V114, P90, DOI 10.1016/j.jsbmb.2009.01.017; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Ohlsson C, 2000, BIOCHEM BIOPH RES CO, V278, P640, DOI 10.1006/bbrc.2000.3827; Panotopoulos G., 1997, Human Reproduction (Oxford), V12, P126; Patrone C, 1998, MOL ENDOCRINOL, V12, P835, DOI 10.1210/me.12.6.835; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Vazquez-Martinez ER, 2016, ENDOCRINE, V52, P618, DOI 10.1007/s12020-015-0825-1; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rijhsinghani AG, 1996, AM J REPROD IMMUNOL, V36, P269; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shah YM, 2005, MOL ENDOCRINOL, V19, P732, DOI 10.1210/me.2004-0298; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tao ZP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0372-9; Turner RT, 1999, LUPUS, V8, P388, DOI 10.1177/096120339900800512; Ueda K, 2013, STEROIDS, V78, P589, DOI 10.1016/j.steroids.2012.12.006; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Vanderschueren D, 2014, ENDOCR REV, V35, P906, DOI 10.1210/er.2014-1024; Walker VR, 2004, ILAR J, V45, P455, DOI 10.1093/ilar.45.4.455; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Williams CC, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-36; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Xu SH, 2016, ACTA HISTOCHEM, V118, P317, DOI 10.1016/j.acthis.2016.01.008; Xu Y, 2018, MOL METAB, V15, P104, DOI 10.1016/j.molmet.2018.05.012; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	75	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15991	16002		10.1096/fj.201901376RR	http://dx.doi.org/10.1096/fj.201901376RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33067917	hybrid			2022-12-28	WOS:000581162300001
J	Imhof, BA; Ballet, R; Hammel, P; Jemelin, S; Garrido-Urbani, S; Ikeya, M; Matthes, T; Miljkovic-Licina, M				Imhof, Beat A.; Ballet, Romain; Hammel, Philippe; Jemelin, Stephane; Garrido-Urbani, Sarah; Ikeya, Makoto; Matthes, Thomas; Miljkovic-Licina, Marijana			Olfactomedin-like 3 promotes PDGF-dependent pericyte proliferation and migration during embryonic blood vessel formation	FASEB JOURNAL			English	Article						angiogenesis; pericyte recruitment; vascular development	FOCAL ADHESION KINASE; BETA-RECEPTOR; GROWTH; BRAIN; MICE; MECHANISMS; DEFICIENT; PROTEINS; FAMILY; CELLS	Pericytes promote vessel stability and their dysfunction causes pathologies due to blood vessel leakage. Previously, we reported that Olfactomedin-like 3 (Olfml3) is a matricellular protein with proangiogenic properties. Here, we explored the role of Olfml3 in a knockout mouse model engineered to suppress this protein. The mutant mice exhibited vascular defects in pericyte coverage, suggesting that pericytes influence blood vessel formation in an Olfml3-dependent manner.Olfml3-deficient mice exhibited abnormalities in the vasculature causing partial lethality of embryos and neonates. Reduced pericyte coverage was observed at embryonic day 12.5 and persisted throughout development, resulting in perinatal death of 35% ofOlfml3-deficient mice. CulturedOlfml3-deficient pericytes exhibited aberrant motility and altered pericyte association to endothelial cells. Furthermore, the proliferative response ofOlfml3(-/-)pericytes upon PDGF-B stimulation was significantly diminished. Subsequent experiments revealed that intact PDGF-B signaling, mediated via Olfml3 binding, is required for pericyte proliferation and activation of downstream kinase pathways. Our findings suggest a model wherein pericyte recruitment to endothelial cells requires Olfml3 to provide early instructive cue and retain PDGF-B along newly formed vessels to achieve optimal angiogenesis.	[Imhof, Beat A.; Jemelin, Stephane; Garrido-Urbani, Sarah; Miljkovic-Licina, Marijana] Univ Geneva, Med Sch, Dept Pathol & Immunol, Geneva, Switzerland; [Ballet, Romain] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA; [Hammel, Philippe] Univ Geneva, Med Sch, Dept Cell Physiol & Metab, Geneva, Switzerland; [Ikeya, Makoto] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Matthes, Thomas; Miljkovic-Licina, Marijana] Geneva Univ Hosp, Dept Oncol, Hematol Serv, Geneva, Switzerland; [Matthes, Thomas] Geneva Univ Hosp, Dept Diagnost, Clin Pathol Serv, Geneva, Switzerland; [Matthes, Thomas; Miljkovic-Licina, Marijana] Univ Geneva, Med Sch, Translat Res Ctr Oncohaematol, Geneva, Switzerland	University of Geneva; Stanford University; University of Geneva; Kyoto University; University of Geneva; University of Geneva; University of Geneva	Miljkovic-Licina, M (corresponding author), Univ Geneva, Med Sch, Translat Res Ctr Oncohaematol, Lab R&D Hematol, A07-2711A,1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	marijana.licina@unige.ch		Miljkovic-Licina, Marijana/0000-0001-9023-2208	Institut Clayton de la Recherche; Swiss National Science Foundation [310030_153456]	Institut Clayton de la Recherche; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Institut Clayton de la Recherche; Swiss National Science Foundation, Grant/Award Number: 310030_153456	ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dunn LL, 2016, WOUND REPAIR REGEN, V24, P1030, DOI 10.1111/wrr.12485; Fiore R, 2005, MOL CELL BIOL, V25, P2310, DOI 10.1128/MCB.25.6.2310-2319.2005; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Kallapur S, 1999, MOL REPROD DEV, V52, P341, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;341::AID-MRD2&gt;3.0.CO;2-N; Lee CK, 2007, CARDIOVASC RES, V74, P159, DOI 10.1016/j.cardiores.2007.01.012; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu WL, 2016, CANCER METAST REV, V35, P201, DOI 10.1007/s10555-016-9624-2; Miljkovic-Licina M, 2012, MOL CANCER THER, V11, P2588, DOI 10.1158/1535-7163.MCT-12-0245; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Neidert N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01728; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PIALI L, 1993, EUR J IMMUNOL, V23, P2464, DOI 10.1002/eji.1830231013; Porsch H, 2014, J BIOL CHEM, V289, P19747, DOI 10.1074/jbc.M114.547273; Roberts RB, 2004, CANCER CELL, V5, P115, DOI 10.1016/S1535-6108(04)00032-7; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tigges U, 2012, MICROVASC RES, V84, P74, DOI 10.1016/j.mvr.2012.03.008; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Trost A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8	39	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15559	15576		10.1096/fj.202000751RR	http://dx.doi.org/10.1096/fj.202000751RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32997357				2022-12-28	WOS:000574660800001
J	Chen, T; Zhu, J; Wang, YH				Chen, Tao; Zhu, Jie; Wang, Yu-Hai			RNF216 mediates neuronal injury following experimental subarachnoid hemorrhage through the Arc/Arg3.1-AMPAR pathway	FASEB JOURNAL			English	Article						AMPA receptors; Arc/Arg3.1; RNF216; subarachnoid hemorrhage	METABOTROPIC GLUTAMATE RECEPTORS; DELAYED CEREBRAL-ISCHEMIA; EARLY BRAIN-INJURY; AMPA RECEPTOR; RNA INTERFERENCE; POSTSYNAPTIC DENSITY; NMDA RECEPTOR; 4 TLR4; VASOSPASM; TRIAD3A	Subarachnoid hemorrhage (SAH), mostly caused by aneurysm rupture, is a pathological condition associated with oxidative stress and neuroinflammation. Toll-like receptors (TLRs) are a family of key regulators of neuroinflammation, and RNF216 is an E3 ubiquitin-protein ligase that regulates TLRs via ubiquitination and proteolytic degradation. However, the role of RNF216 in SAH has not been determined. In this study, we investigated the biological function of RNF216 in experimental SAH models both in vitro and in vivo. The expression of RNF216 was found to be upregulated in cortical neurons after oxyhemoglobin (OxyHb) treatment, and increased RNF216 expression was also observed in brain tissues in the single-hemorrhage model of SAH. Downregulation of RNF216 expression by short interfering RNA (siRNA) transfection significantly reduced cytotoxicity and apoptosis after OxyHb exposure. The results of western blot showed that the RNF216-mediated neuronal injury in vitro was associated with the regulation of the Arc-AMPAR pathway, which was related to intracellular Ca2+ dysfunction, as evidenced by Ca2+ imaging. In addition, knockdown of RNF216 in vivo using intraventricular injection of siRNA was found to attenuate brain injury and neuroinflammation via the Arc-AMPAR pathway after SAH in the animal model. In summary, we demonstrated that silence of RNF216 expression protects against neuronal injury and neurological dysfunction in experimental SAH models. These data support for the first time that RNF216 may represent a novel candidate for therapies against SAH.	[Chen, Tao; Zhu, Jie; Wang, Yu-Hai] Anhui Med Univ, Dept Neurosurg, Hosp PLA 904, Med Sch, Wuxi 214044, Jiangsu, Peoples R China	Anhui Medical University	Chen, T; Wang, YH (corresponding author), Anhui Med Univ, Dept Neurosurg, Hosp PLA 904, Med Sch, Wuxi 214044, Jiangsu, Peoples R China.	fmmuchentao@163.com; prof_wyh101@163.com			NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [81701932]; National Natural Science Foundation of China (NSFC) [81871598, 81601719]; Wuxi Health Commission's major project in translational medicine [ZZ001]	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wuxi Health Commission's major project in translational medicine	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81701932; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81871598 and 81601719; Wuxi Health Commission's major project in translational medicine, Grant/Award Number: ZZ001	Arenz C, 2003, NATURWISSENSCHAFTEN, V90, P345, DOI 10.1007/s00114-003-0441-4; Bogason ET, 2014, NEUROSURGERY, V74, P227, DOI 10.1227/NEU.0000000000000240; Chang DTW, 2006, NEUROSCIENCE, V141, P727, DOI 10.1016/j.neuroscience.2006.01.034; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Chen T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2198-5; Chen T, 2017, NEUROSCI LETT, V661, P23, DOI 10.1016/j.neulet.2017.09.024; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen YJ, 2015, NEUROSCI LETT, V588, P131, DOI 10.1016/j.neulet.2015.01.005; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Colak A, 2009, CENT EUR NEUROSURG, V70, P187, DOI 10.1055/s-0029-1202357; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; Feng D, 2014, NEUROSCIENCE, V268, P21, DOI 10.1016/j.neuroscience.2014.02.053; Han HY, 2018, METHODS MOL BIOL, V1706, P293, DOI 10.1007/978-1-4939-7471-9_16; Han SM, 2014, J CEREBR BLOOD F MET, V34, P108, DOI 10.1038/jcbfm.2013.170; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hayman EG, 2017, NEUROCRIT CARE, V26, P301, DOI 10.1007/s12028-016-0354-7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Inage YW, 2000, PEDIATR NEUROL, V23, P42, DOI 10.1016/S0887-8994(00)00142-9; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Kooijman E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-2; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kumar V, 2012, J BIOL CHEM, V287, P5412, DOI 10.1074/jbc.M111.301366; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Li FF, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00012; Li YY, 2015, J ASIAN CERAM SOC, V3, P1, DOI [10.1016/j.jascer.2014.12.002, 10.1016/j.jascer.2014.12.0022]; Lu Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1118-4; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Ma CX, 2015, NEUROL MED-CHIR, V55, P878, DOI 10.2176/nmc.oa.2015-0077; Ma CX, 2015, J NEUROL SCI, V359, P67, DOI 10.1016/j.jns.2015.10.018; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Masilamoni GJ, 2018, CURR OPIN PHARMACOL, V38, P72, DOI 10.1016/j.coph.2018.03.004; Melnick AF, 2019, BIOL REPROD, V100, P1132, DOI 10.1093/biolre/ioz006; Miyazaki T, 2012, BRAIN RES, V1435, P1, DOI 10.1016/j.brainres.2011.11.033; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Turan N, 2018, WORLD NEUROSURG, V110, pE150, DOI 10.1016/j.wneu.2017.10.118; Wadhwa R, 2004, MUTAT RES-REV MUTAT, V567, P71, DOI 10.1016/j.mrrev.2004.06.002; Wan H, 2014, EXPERT OPIN PHARMACO, V15, P231, DOI 10.1517/14656566.2014.865724; Whitehead G, 2017, NEUROPHARMACOLOGY, V112, P221, DOI 10.1016/j.neuropharm.2016.08.022; Wilkerson JR, 2014, CELL REP, V7, P1589, DOI 10.1016/j.celrep.2014.04.035; Will O, 2007, GASTROENTEROLOGY, V132, P527, DOI 10.1053/j.gastro.2006.11.043; Zhang ZY, 2018, EXP NEUROL, V301, P13, DOI 10.1016/j.expneurol.2017.12.005	46	13	13	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15080	15092		10.1096/fj.201903151RRRR	http://dx.doi.org/10.1096/fj.201903151RRRR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918771	Bronze			2022-12-28	WOS:000570684600001
J	Muyyarikkandy, MS; McLeod, M; Maguire, M; Mahar, R; Kattapuram, N; Zhang, CE; Surugihalli, C; Muralidaran, V; Vavilikolanu, K; Mathews, CE; Merritt, ME; Sunny, NE				Muyyarikkandy, Muhammed S.; McLeod, Marc; Maguire, Meghan; Mahar, Rohit; Kattapuram, Nathan; Zhang, Christine; Surugihalli, Chaitra; Muralidaran, Vaishna; Vavilikolanu, Kruthi; Mathews, Clayton E.; Merritt, Matthew E.; Sunny, Nishanth E.			Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD	FASEB JOURNAL			English	Article						fatty liver; hepatic insulin resistance; lipogenesis; liver mitochondria	NONALCOHOLIC FATTY LIVER; TCA CYCLE; DIET; GLUCOSE; ADAPTATION; METABOLISM; STRESS; HUMANS; MICE; ACETOACETATE	Mitochondrial adaptation during non-alcoholic fatty liver disease (NAFLD) include remodeling of ketogenic flux and sustained tricarboxylic acid (TCA) cycle activity, which are concurrent to onset of oxidative stress. Over 70% of obese humans have NAFLD and ketogenic diets are common weight loss strategies. However, the effectiveness of ketogenic diets toward alleviating NAFLD remains unclear. We hypothesized that chronic ketogenesis will worsen metabolic dysfunction and oxidative stress during NAFLD. Mice (C57BL/6) were kept (for 16-wks) on either a low-fat, high-fat, or high-fat diet supplemented with 1.5X branched chain amino acids (BCAAs) by replacing carbohydrate calories (ketogenic). The ketogenic diet induced hepatic lipid oxidation and ketogenesis, and produced multifaceted changes in flux through the individual steps of the TCA cycle. Higher rates of hepatic oxidative fluxes fueled by the ketogenic diet paralleled lower rates of de novo lipogenesis. Interestingly, this metabolic remodeling did not improve insulin resistance, but induced fibrogenic genes and inflammation in the liver. Under a chronic "ketogenic environment," the hepatocyte diverted more acetyl-CoA away from lipogenesis toward ketogenesis and TCA cycle, a milieu which can hasten oxidative stress and inflammation. In summary, chronic exposure to ketogenic environment during obesity and NAFLD has the potential to aggravate hepatic mitochondrial dysfunction.	[Muyyarikkandy, Muhammed S.; Maguire, Meghan; Kattapuram, Nathan; Zhang, Christine; Surugihalli, Chaitra; Muralidaran, Vaishna; Vavilikolanu, Kruthi; Sunny, Nishanth E.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [McLeod, Marc; Mahar, Rohit; Mathews, Clayton E.; Merritt, Matthew E.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida	Sunny, NE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	nsunny@umd.edu	Muyyarikkandy, Muhammed/AAG-3402-2020	Muyyarikkandy, Muhammed/0000-0003-3405-5440; MAHAR, ROHIT/0000-0002-9801-4173; Merritt, Matthew/0000-0003-4617-9651; Kattapuram, Nathan/0000-0002-6766-7235	HHS | National Institutes of Health (NIH) [RO1-DK-112865, P41-122698, 5U2CDK119889, R01-105346]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: RO1-DK-112865, P41-122698, 5U2CDK119889 and R01-105346	Abbasi J, 2018, JAMA-J AM MED ASSOC, V319, P215, DOI 10.1001/jama.2017.20639; Anekwe CV, 2020, CUREUS, V12, DOI 10.7759/cureus.6605; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Belopolsky Y, 2020, J TRANSL INTERN MED, V8, P26, DOI 10.2478/jtim-2020-0005; Boland ML, 2018, WORLD J GASTROENTERO, V24, P1748, DOI 10.3748/wjg.v24.i16.1748; Caprio M, 2019, J ENDOCRINOL INVEST, V42, P1365, DOI 10.1007/s40618-019-01061-2; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; Crown SB, 2015, METAB ENG, V28, P151, DOI 10.1016/j.ymben.2015.01.001; Delgado TC, 2009, NMR BIOMED, V22, P310, DOI 10.1002/nbm.1327; Duarte JAG, 2014, J LIPID RES, V55, P2541, DOI 10.1194/jlr.M052308; Ericksen RE, 2019, CELL METAB, V29, P1151, DOI 10.1016/j.cmet.2018.12.020; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fletcher JA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127737; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Jain SK, 2002, DIABETES, V51, P2287, DOI 10.2337/diabetes.51.7.2287; Joshi S, 2019, JAMA INTERN MED, V179, P1163, DOI 10.1001/jamainternmed.2019.2633; Kanikarla-Marie P, 2015, CELL PHYSIOL BIOCHEM, V35, P364, DOI 10.1159/000369702; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kosinski C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050517; Kujala UM, 2016, FRONT MED-LAUSANNE, V3, P1, DOI 10.3389/fmed.2016.00057; Lerin C, 2016, MOL METAB, V5, P926, DOI 10.1016/j.molmet.2016.08.001; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Luukkonen PK, 2020, P NATL ACAD SCI USA, V117, P7347, DOI 10.1073/pnas.1922344117; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Moore MP, 2020, APPL PHYSIOL NUTR ME, V45, P35, DOI 10.1139/apnm-2019-0042; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nishikata N, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.1; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Patterson RE, 2016, AM J PHYSIOL-ENDOC M, V310, pE484, DOI 10.1152/ajpendo.00492.2015; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Ragavan M, 2017, AM J PHYSIOL-HEART C, V312, pH1215, DOI 10.1152/ajpheart.00016.2017; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rosenbaum M, 2019, OBESITY, V27, P971, DOI 10.1002/oby.22468; Satapati S, 2016, J CLIN INVEST, V126, P1605, DOI 10.1172/JCI86695; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Schugar RC, 2012, CURR OPIN CLIN NUTR, V15, P374, DOI 10.1097/MCO.0b013e3283547157; Sunny NE, 2011, J ANIM SCI, V89, P3945, DOI 10.2527/jas.2011-3985; Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006; Sunny NE, 2015, AM J PHYSIOL-ENDOC M, V309, pE311, DOI 10.1152/ajpendo.00161.2015; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Trimboli P, 2020, REV ENDOCR METAB DIS, V21, P1, DOI 10.1007/s11154-020-09546-9; Xin LJ, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00062; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632; Zhang FY, 2016, EBIOMEDICINE, V13, P157, DOI 10.1016/j.ebiom.2016.10.013; Zhenyukh O, 2018, J CELL MOL MED, V22, P4948, DOI 10.1111/jcmm.13759	53	11	11	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14832	14849		10.1096/fj.202001495R	http://dx.doi.org/10.1096/fj.202001495R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918763	Green Accepted			2022-12-28	WOS:000570677900001
J	Wang, XY; Lin, Y; Liu, S; Zhu, Y; Lu, KF; Broering, R; Lu, MJ				Wang, Xueyu; Lin, Yong; Liu, Shi; Zhu, Ying; Lu, Kefeng; Broering, Ruth; Lu, Mengji			O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels	FASEB JOURNAL			English	Article						Akt; mTOR signaling; autophagy; autophagosome-lysosome fusion; ER stress; HBV; O-GlcNAcylation	HEPATITIS-C VIRUS; N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; ADENOVIRUS TYPE-2; ER STRESS; B-VIRUS; GLYCOSYLATION; MACHINERY; INDUCTION; PROTEINS	O-GlcNAcylation is a form of posttranslational modification, and serves various functions, including modulation of location, stability, and activity for the modified proteins.O-linked-N-acetylglucosamine (O-GlcNAc) transferase (OGT) is an essential cellular enzyme that posttranslationally modifies the cellular proteins withO-GlcNAc moiety. Early studies reported that the decreasedO-GlcNAcylation regulates cellular autophagy, a process relevant for hepatitis B virus replication (HBV) and assembly. Therefore, we addressed the question howO-GlcNAcylation regulates cellular autophagy and HBV replication. Inhibition of OGT activity with a small molecule inhibitor OSMI-1 or silencing OGT significantly enhanced HBV replication and HBsAg production in hepatoma cells and primary human hepatocytes (PHHs). Western blotting analysis showed that inhibition ofO-GlcNAcylation-induced endoplasmic reticulum (ER) stress and cellular autophagy, two processes subsequently leading to enhanced HBV replication. Importantly, the numbers of autophagosomes and the levels of autophagic markers LC3-II and SQSTM1/p62 in hepatoma cells were elevated after inhibition ofO-GlcNAcylation. Further analysis revealed that inhibition ofO-GlcNAcylation blocked autophagosome-lysosome fusion and thereby prevented autophagic degradation of HBV virions and proteins. Moreover, OSMI-1 further promoted HBV replication by inducing autophagosome formation via inhibiting theO-GlcNAcylation of Akt and mTOR. In conclusion, decreasedO-GlcNAcylation enhanced HBV replication through increasing autophagosome formation at multiple levels, including triggering ER-stress, Akt/mTOR inhibition, and blockade of autophagosome-lysosome fusion.	[Wang, Xueyu; Lin, Yong; Liu, Shi; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Hufelandstr 55, D-45122 Essen, Germany; [Lin, Yong] Chongqing Med Univ, Chinese Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Liu, Shi; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China; [Lu, Kefeng] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Dept Neurosurg,State Key Lab Biotherapy, Chengdu, Peoples R China; [Broering, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany	University of Duisburg Essen; Chongqing Medical University; Wuhan University; Sichuan University; University of Duisburg Essen	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Hufelandstr 55, D-45122 Essen, Germany.	mengji.lu@uni-due.de	Broering, Ruth/W-9401-2019; Lu, Mengji/ABF-9410-2020; Wang, Xueyu/AAC-1669-2022	Broering, Ruth/0000-0002-7125-3246; 	Deutsche Forschungsgemeinschaft [TRR60]; University Duisburg-Essen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Duisburg-Essen	Deutsche Forschungsgemeinschaft, Grant/Award Number: TRR60; University Duisburg-Essen	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Alejandro EU, 2015, CELL REP, V13, P2527, DOI 10.1016/j.celrep.2015.11.020; Angelova M, 2015, J VIROL, V89, P8474, DOI 10.1128/JVI.01002-15; Brimble S, 2010, CURR SIGNAL TRANSD T, V5, P12, DOI 10.2174/157436210790226465; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; GONZALEZ SA, 1991, VIROLOGY, V182, P8, DOI 10.1016/0042-6822(91)90642-O; GREIS KD, 1994, J VIROL, V68, P8339, DOI 10.1128/JVI.68.12.8339-8349.1994; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Jang I, 2015, BBA-MOL CELL RES, V1853, P1860, DOI 10.1016/j.bbamcr.2015.04.017; Jensen RV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020404; Jochmann R, 2013, GLYCOBIOLOGY, V23, P1114, DOI 10.1093/glycob/cwt028; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; Ko YC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-12; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Lefebvre T, 2016, CELL CYCLE, V15, P1954, DOI 10.1080/15384101.2016.1192449; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lima VV, 2009, J AM SOC HYPERTENS, V3, P374, DOI 10.1016/j.jash.2009.09.004; Lin YH, 2019, ADV CIV ENG, V2019, DOI 10.1155/2019/5858094; Lin Y, 2019, FASEB J, V33, P6023, DOI 10.1096/fj.201801995RR; Lin Y, 2019, PROTEIN CELL, V10, P60, DOI 10.1007/s13238-018-0555-2; Lin Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12709; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Mariappa D, 2013, EMBO J, V32, P612, DOI 10.1038/emboj.2013.26; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mishra S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-1; MULLIS KG, 1990, J VIROL, V64, P5317, DOI 10.1128/JVI.64.11.5317-5323.1990; NOVELLI A, 1991, VIROLOGY, V185, P365, DOI 10.1016/0042-6822(91)90784-9; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; SHI J, 2015, SCI REP UK, V5; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Wan YS, 2017, CELL MOL IMMUNOL, V14, P607, DOI 10.1038/cmi.2017.1; Wang JW, 2019, HEPATOLOGY, V69, P974, DOI 10.1002/hep.30248; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037427; Wang XY, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13131; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zhang XY, 2018, DEV CELL, V45, P245, DOI 10.1016/j.devcel.2018.03.023; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	54	14	14	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14473	14489		10.1096/fj.202001168RR	http://dx.doi.org/10.1096/fj.202001168RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892442	hybrid			2022-12-28	WOS:000568297800001
J	Toro, TB; Watt, TJ				Toro, Tasha B.; Watt, Terry J.			Critical review of non-histone human substrates of metal-dependent lysine deacetylases	FASEB JOURNAL			English	Review						histone deacetylases; HDAC; KDAC; substrate specificity	HISTONE DEACETYLASE; HDAC6 DEACETYLATES; ALPHA-TUBULIN; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL ACTIVITY; CHAPERONE FUNCTION; STEM-CELLS; ACETYLATION; INHIBITION; P53	Lysine acetylation is a posttranslational modification that occurs on thousands of human proteins, most of which are cytoplasmic. Acetylated proteins are involved in numerous cellular processes and human diseases. Therefore, how the acetylation/deacetylation cycle is regulated is an important question. Eleven metal-dependent lysine deacetylases (KDACs) have been identified in human cells. These enzymes, along with the sirtuins, are collectively responsible for reversing lysine acetylation. Despite several large-scale studies which have characterized the acetylome, relatively few of the specific acetylated residues have been matched to a proposed KDAC for deacetylation. To understand the function of lysine acetylation, and its association with diseases, specific KDAC-substrate pairs must be identified. Identifying specific substrates of a KDAC is complicated both by the complexity of assaying relevant activity and by the non-catalytic interactions of KDACs with cellular proteins. Here, we discuss in vitro and cell-based experimental strategies used to identify KDAC-substrate pairs and evaluate each for the purpose of directly identifying non-histone substrates of metal-dependent KDACs. We propose criteria for a combination of reproducible experimental approaches that are necessary to establish a direct enzymatic relationship. This critical analysis of the literature identifies 108 proposed non-histone substrate-KDAC pairs for which direct experimental evidence has been reported. Of these, five pairs can be considered well-established, while another thirteen pairs have both cell-based and in vitro evidence but lack independent replication and/or sufficient cell-based evidence. We present a path forward for evaluating the remaining substrate leads and reliably identifying novel KDAC substrates.	[Toro, Tasha B.; Watt, Terry J.] Xavier Univ Louisiana, Dept Chem, New Orleans, LA USA	Xavier University of Louisiana	Watt, TJ (corresponding author), Xavier Univ Louisiana, 1 Drexel Dr, New Orleans, LA 70125 USA.	tjwatt@xula.edu			National Science Foundation (NSF) [MCB 1817358]; HHS | National Institutes of Health (NIH) [5G1200MD7595, UL1GM118967, R15GM129682]; DOD | United States Army | RDECOM | Army Research Office (ARO) [W911NF1810450]; Louisiana Cancer Research Consortium	National Science Foundation (NSF)(National Science Foundation (NSF)); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD | United States Army | RDECOM | Army Research Office (ARO); Louisiana Cancer Research Consortium	Funding information National Science Foundation (NSF), Grant/Award Number: MCB 1817358; HHS | National Institutes of Health (NIH), Grant/Award Number: 5G1200MD7595, UL1GM118967 and R15GM129682; DOD | United States Army | RDECOM | Army Research Office (ARO), Grant/Award Number: W911NF1810450; Louisiana Cancer Research Consortium	Aka Juliette Adjo, 2011, Handb Exp Pharmacol, V206, P1, DOI 10.1007/978-3-642-21631-2_1; Alam N, 2016, STRUCTURE, V24, P458, DOI 10.1016/j.str.2016.02.002; Ali I, 2018, CHEM REV, V118, P340, DOI 10.1021/acs.chemrev.7b00181; An PP, 2020, ONCOGENE, V39, P4956, DOI 10.1038/s41388-020-1337-x; Avrahami EM, 2018, ACS SYNTH BIOL, V7, P2348, DOI 10.1021/acssynbio.8b00314; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bendinelli P, 2009, MOL CANCER RES, V7, P1328, DOI 10.1158/1541-7786.MCR-08-0548; Bitler BG, 2017, NAT CELL BIOL, V19, P962, DOI 10.1038/ncb3582; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Castaneda CA, 2017, J BIOL CHEM, V292, P21568, DOI 10.1074/jbc.M117.811026; Chang YW, 2016, ONCOGENE, V35, P1517, DOI 10.1038/onc.2015.214; Chen K, 2014, J AM CHEM SOC, V136, P11636, DOI 10.1021/ja501548p; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen SY, 2015, CELL CYCLE, V14, P2520, DOI 10.1080/15384101.2015.1055426; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Choi MC, 2012, MOL CELL, V47, P122, DOI 10.1016/j.molcel.2012.04.025; Choi SJ, 2016, EMBO J, V35, P429, DOI 10.15252/embj.201592586; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang JY, 2011, BIOCHEM BIOPH RES CO, V407, P587, DOI 10.1016/j.bbrc.2011.03.068; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Depetter Y, 2019, INT J CANCER, V145, P735, DOI 10.1002/ijc.32169; Dowling DP, 2010, BIOCHEMISTRY-US, V49, P5048, DOI 10.1021/bi1005046; Eom GH, 2014, CIRC RES, V114, P1133, DOI 10.1161/CIRCRESAHA.114.303429; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fogg PCM, 2014, J BIOL CHEM, V289, P34341, DOI 10.1074/jbc.M114.606392; Gal J, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00052-19; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Gantt SL, 2010, J BIOL CHEM, V285, P6036, DOI 10.1074/jbc.M109.033399; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hadden MJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092630; Hagelkruys A, 2014, DEVELOPMENT, V141, P604, DOI 10.1242/dev.100487; Hai Y, 2016, NAT CHEM BIOL, V12, P741, DOI 10.1038/nchembio.2134; Higashitsuji H, 2007, J BIOL CHEM, V282, P13716, DOI 10.1074/jbc.M609751200; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iaconelli J, 2017, ACS CHEM BIOL, V12, P2139, DOI 10.1021/acschembio.6b01014; Ishfaq M, 2012, BIOSCI BIOTECH BIOCH, V76, P2165, DOI 10.1271/bbb.120620; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kozyreva VK, 2014, MOL CANCER RES, V12, P681, DOI 10.1158/1541-7786.MCR-13-0654; Kuhlmann N, 2016, J BIOL CHEM, V291, P5484, DOI 10.1074/jbc.M115.707091; Kunze MBA, 2013, J AM CHEM SOC, V135, P17862, DOI 10.1021/ja408184x; Kutil Z, 2019, FASEB J, V33, P4035, DOI 10.1096/fj.201801680R; Kutil Z, 2018, ACS CHEM BIOL, V13, P685, DOI 10.1021/acschembio.7b00942; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Leng KRW, 2019, BIOCHEMISTRY-US, V58, P4480, DOI 10.1021/acs.biochem.9b00653; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li L, 2016, ONCOGENE, V35, P4048, DOI 10.1038/onc.2015.476; Li WB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071616; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Liu NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16869; Liu YQ, 2019, J MOL CELL BIOL, V11, P564, DOI 10.1093/jmcb/mjz060; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; Lopez JE, 2017, J AM CHEM SOC, V139, P16222, DOI 10.1021/jacs.7b07603; Lozada EM, 2016, ONCOTARGET, V7, P20425, DOI 10.18632/oncotarget.7966; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Medler TR, 2016, MOL CANCER RES, V14, P994, DOI 10.1158/1541-7786.MCR-16-0109; Milazzo G, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050556; Mizuguchi Y, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-20; Moreno-Yruela C, 2018, CELL CHEM BIOL, V25, P849, DOI 10.1016/j.chembiol.2018.04.007; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Noritsugu K, 2017, BIOCHEM BIOPH RES CO, V489, P455, DOI 10.1016/j.bbrc.2017.05.170; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Pang MY, 2011, J CELL BIOCHEM, V112, P2138, DOI 10.1002/jcb.23135; Park SY, 2017, BIOCHEM BIOPH RES CO, V494, P51, DOI 10.1016/j.bbrc.2017.10.087; Parra M, 2015, FEBS J, V282, P1736, DOI 10.1111/febs.13061; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Qi J, 2015, CELL STEM CELL, V17, P597, DOI 10.1016/j.stem.2015.08.004; Qian H, 2017, J CLIN INVEST, V127, P1353, DOI 10.1172/JCI85963; Radhakrishnan R, 2015, J BIOL CHEM, V290, P22795, DOI 10.1074/jbc.M114.612945; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Rao R, 2008, BLOOD, V112, P1886, DOI 10.1182/blood-2008-03-143644; Riolo MT, 2012, J BIOL CHEM, V287, P10885, DOI 10.1074/jbc.M111.308791; Ryu HW, 2017, CANCER LETT, V391, P162, DOI 10.1016/j.canlet.2017.01.033; Sadoul K, 2016, BIOCHEM J, V473, P1859, DOI 10.1042/BCJ20160172; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Sen N, 2013, MOL CELL, V52, P406, DOI 10.1016/j.molcel.2013.09.003; Seo JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12882; Shan CL, 2014, MOL CELL, V55, P552, DOI 10.1016/j.molcel.2014.06.020; Skoge RH, 2016, J CELL SCI, V129, P2972, DOI 10.1242/jcs.187518; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Tang JH, 2013, CLIN SCI, V124, P651, DOI 10.1042/CS20120504; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Toro TB, 2018, ANAL BIOCHEM, V540, P9, DOI 10.1016/j.ab.2017.10.024; Toro TB, 2017, BIOCHEMISTRY-US, V56, P4549, DOI 10.1021/acs.biochem.7b00270; Toro TB, 2015, PROTEIN SCI, V24, P2020, DOI 10.1002/pro.2813; Vanaja GR, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0231-4; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wu JY, 2018, J BIOL CHEM, V293, P1976, DOI 10.1074/jbc.M117.795955; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yoshida M, 2017, P JPN ACAD B-PHYS, V93, P297, DOI 10.2183/pjab.93.019; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang LL, 2015, PROTEIN CELL, V6, P42, DOI 10.1007/s13238-014-0102-8; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang YH, 2020, FASEB J, V34, P7295, DOI 10.1096/fj.201903254R; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao ZQ, 2010, PROTEIN PEPTIDE LETT, V17, P555, DOI 10.2174/092986610791112620; Zheng G, 2005, J BIOL CHEM, V280, P40773, DOI 10.1074/jbc.M504334200; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	120	7	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13140	13155		10.1096/fj.202001301RR	http://dx.doi.org/10.1096/fj.202001301RR		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32862458	Green Accepted			2022-12-28	WOS:000565931100001
J	Deng, CJ; Liu, L; Liu, LZ; Wang, QQ; Guo, XL; Lee, WH; Li, SA; Zhang, Y				Deng, Cheng-Jie; Liu, Long; Liu, Ling-Zhen; Wang, Qi-Quan; Guo, Xiao-Long; Lee, Wen-Hui; Li, Sheng-An; Zhang, Yun			A secreted pore-forming protein modulates cellular endolysosomes to augment antigen presentation	FASEB JOURNAL			English	Article						antigen presentation; dendritic cells; extracellular vesicles; pore-forming protein; beta gamma-CAT	MHC CLASS-I; DENDRITIC CELLS; EXTRACELLULAR VESICLES; EXOGENOUS ANTIGENS; ADAPTIVE IMMUNITY; INNATE; TOXIN; HOST; ACTIVATION; MATURATION	Bacterial pore-forming toxin aerolysin-like proteins are widely distributed in animals and plants. Emerging evidence supports their roles in host innate immunity, but their direct actions in adaptive immunity remain elusive. In this study, we found that beta gamma-CAT, an aerolysin-like protein and trefoil factor complex identified in the frogBombina maxima, modulated several steps of endocytic pathways during dendritic cell antigen presentation. The protein augmented the antigen uptake of dendritic cells and actively neutralized the acidification of cellular endocytic organelles to favor antigen presentation. In addition, the release of functional exosome-like extracellular vesicles was largely enhanced in the presence of beta gamma-CAT. The cellular action of beta gamma-CAT increased the number of major histocompatibility complex (MHC) I-ovalbumin and MHC II molecules on dendritic cell surfaces and the released exosome-like extracellular vesicles. An enhanced antigen presentation capacity of dendritic cell for priming of naive T cells was detected in the presence of beta gamma-CAT. Collectively, these effects led to strong cytotoxic T lymphocyte responses and antigen-specific antibody responses. Our findings provide evidence that a vertebrate-secreted pore-forming protein can augment antigen presentation by directly modulating cellular endocytic and exocytic pathways, leading to robust activation of adaptive immunity.	[Deng, Cheng-Jie; Liu, Long; Liu, Ling-Zhen; Wang, Qi-Quan; Guo, Xiao-Long; Lee, Wen-Hui; Zhang, Yun] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Deng, Cheng-Jie; Liu, Long; Liu, Ling-Zhen; Wang, Qi-Quan] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Li, Sheng-An] Kunming Med Univ, Fac Basic Med Sci, Dept Pathogen Biol & Immunol, Kunming 650500, Yunnan, Peoples R China; [Zhang, Yun] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University; Chinese Academy of Sciences	Zhang, Y (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China.; Li, SA (corresponding author), Kunming Med Univ, Fac Basic Med Sci, Dept Pathogen Biol & Immunol, Kunming 650500, Yunnan, Peoples R China.	lishengan@163.com; zhangy@mail.kiz.ac.cn		Zhang, Yun/0000-0002-8636-183X	National Natural Science Foundation of China [81872839, 31572268, U1602225, 31872226]; Yunling Scholar Program; Yunnan Top-notch Young Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunling Scholar Program; Yunnan Top-notch Young Talents Program	This work was supported by grants from the National Natural Science Foundation of China (grant numbers 31572268, U1602225, and 31872226) and the Yunling Scholar Program to Yun Zhang, the National Natural Science Foundation of China (grant number 81872839), and the Yunnan Top-notch Young Talents Program to Sheng-An Li.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bagley KC, 2011, CLIN VACCINE IMMUNOL, V18, P922, DOI 10.1128/CVI.05019-11; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Blander JM, 2018, ANNU REV IMMUNOL, V36, P717, DOI 10.1146/annurev-immunol-041015-055523; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Cabezas S, 2017, BBA-BIOMEMBRANES, V1859, P982, DOI 10.1016/j.bbamem.2017.02.001; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cruz-Leal Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02473; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Dalod M, 2014, EMBO J, V33, P1104, DOI 10.1002/embj.201488027; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Dingjan I, 2016, SCI REP-UK, V6, DOI 10.1038/srep22064; Dragovic RA, 2015, METHODS, V87, P64, DOI 10.1016/j.ymeth.2015.03.028; Embgenbroich M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01643; Gao ZH, 2019, FASEB J, V33, P782, DOI 10.1096/fj.201800087R; Gros M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00041; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guo XL, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0304-y; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; Ho NI, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02874; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Iacovache I, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P773, DOI 10.1016/B978-0-12-800188-2.00026-4; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Laborde RJ, 2017, J IMMUNOL, V198, P2772, DOI 10.4049/jimmunol.1600310; Li SA, 2017, J INFECT DIS, V215, P1753, DOI 10.1093/infdis/jix183; Liao DF, 2018, SMALL, V14, DOI 10.1002/smll.201704520; Lindenbergh MFS, 2018, ANNU REV IMMUNOL, V36, P435, DOI 10.1146/annurev-immunol-041015-055700; Liu Q, 2016, J CLIN INVEST, V126, P2805, DOI 10.1172/JCI84577; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mantegazza AR, 2013, TRAFFIC, V14, P135, DOI 10.1111/tra.12026; McCormack RM, 2015, ELIFE, V4, DOI 10.7554/eLife.06508; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Oussa NAE, 2016, J IMMUNOL, V197, P3927, DOI 10.4049/jimmunol.1601116; PORGADOR A, 1995, J EXP MED, V182, P255, DOI 10.1084/jem.182.1.255; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Romero M, 2017, CELL DEATH DIFFER, V24, P798, DOI 10.1038/cdd.2017.11; Royo F, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1575678; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Steenbeek SC, 2018, EMBO J, V37, DOI 10.15252/embj.201798357; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thiery Jerome, 2014, Subcell Biochem, V80, P197, DOI 10.1007/978-94-017-8881-6_10; Tkach M, 2017, EMBO J, V36, P3012, DOI 10.15252/embj.201696003; Wang QQ, 2020, J BIOL CHEM, V295, P10293, DOI 10.1074/jbc.RA120.013556; Wang Y, 2018, NANOSCALE, V10, P13857, DOI 10.1039/c8nr04255a; Xiang Y, 2014, P NATL ACAD SCI USA, V111, P6702, DOI 10.1073/pnas.1321317111; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yuba E, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040041; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhang Yun, 2015, Zoological Research, V36, P183, DOI 10.13918/j.issn.2095-8137.2015.4.183; Zhao F, 2014, DNA RES, V21, P1, DOI 10.1093/dnares/dst035	65	5	5	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13609	13625		10.1096/fj.202001176R	http://dx.doi.org/10.1096/fj.202001176R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32786030	Bronze			2022-12-28	WOS:000561322500001
J	Hansen, LB; Kaludjerovic, J; Nielsen, JE; Rehfeld, A; Poulsen, NN; Ide, N; Skakkebaek, NE; Frederiksen, H; Juul, A; Lanske, B; Jensen, MB				Hansen, Lasse Bollehuus; Kaludjerovic, Jovana; Nielsen, John Erik; Rehfeld, Anders; Poulsen, Nadia Nicholine; Ide, Noriko; Skakkebaek, Niels Erik; Frederiksen, Hanne; Juul, Anders; Lanske, Beate; Jensen, Martin Blomberg			Influence of FGF23 and Klotho on male reproduction: Systemic vs direct effects	FASEB JOURNAL			English	Article						calcium; fertility; FGF23; klotho; phosphate; reproduction; sperm; vitamin D	VITAMIN-D; ELEMENTAL COMPOSITION; SEMINIFEROUS TUBULES; INTRALUMINAL FLUIDS; RETE TESTIS; BONE; EXPRESSION; KIDNEY; RECEPTOR; HORMONE	Currently, no treatment exists to improve semen quality in most infertile men. Here, we demonstrate systemic and direct effects of Fibroblast growth factor 23 (FGF23) and Klotho, which normally regulate vitamin D and mineral homeostasis, on testicular function. Direct effects are plausible because KLOTHO is expressed in both germ cells and spermatozoa and forms with FGFR1 a specific receptor for the bone-derived hormone FGF23. Treatment with FGF23 increased testicular weight in wild-type mice, while mice with global loss of either FGF23 or Klotho had low testicular weight, reduced sperm count, and sperm motility. Mice with germ cell-specific Klotho (gcKL) deficiency neither had a change in sperm count nor sperm motility. However, a tendency toward fewer pregnancies was detected, and significantly fewer Klotho heterozygous pups originated from gcKL knockdown mice than would be expected by mendelian inheritance. Moreover, gcKL mice had a molecular phenotype with higher testicular expression of Slc34a2 and Trpv5 than wild-type littermates, which suggests a regulatory role for testicular phosphate and calcium homeostasis. KLOTHO and FGFR1 were also expressed in human germ cells and spermatozoa, and FGF23 treatment augmented the calcium response to progesterone in human spermatozoa. Moreover, cross-sectional data revealed that infertile men with the highest serum Klotho levels had significantly higher serum Inhibin B and total sperm count than men with the lowest serum Klotho concentrations. In conclusion, this translational study suggests that FGF23 and Klotho influence gonadal function and testicular mineral ion homeostasis both directly and indirectly through systemic changes in vitamin D and mineral homeostasis.	[Hansen, Lasse Bollehuus; Poulsen, Nadia Nicholine; Jensen, Martin Blomberg] Univ Copenhagen, Dept Growth & Reprod, Grp Skeletal Mineral & Gonadal Endocrinol, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Hansen, Lasse Bollehuus; Kaludjerovic, Jovana; Ide, Noriko; Lanske, Beate; Jensen, Martin Blomberg] Harvard Med Sch, Div Bone & Mineral Res, Harvard Sch Dent Med, Boston, MA 02115 USA; [Nielsen, John Erik; Rehfeld, Anders; Skakkebaek, Niels Erik; Frederiksen, Hanne; Juul, Anders] Univ Copenhagen, Rigshosp, Int Ctr Res & Res Training Endocrine Disrupt Male, Dept Growth & Reprod, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Harvard University; Harvard Medical School; Harvard School of Dental Medicine; Rigshospitalet; University of Copenhagen	Jensen, MB (corresponding author), Univ Copenhagen, Dept Growth & Reprod, Grp Skeletal Mineral & Gonadal Endocrinol, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	blombergjensen@gmail.com	Rehfeld, Anders/ABA-1208-2020; Frederiksen, Hanne/N-8632-2013; Juul, Anders/F-5864-2013	Rehfeld, Anders/0000-0001-5315-2022; Frederiksen, Hanne/0000-0002-3180-9879; Juul, Anders/0000-0002-0534-4350; Bollehuus Hansen, Lasse/0000-0001-7523-2306; Poulsen, Nadia Nicholine/0000-0002-0625-1770; Lanske, Beate/0000-0003-4638-804X	Rigshospitalet; Novo-Nordisk Foundation; Innovationsfonden; Knud Hojgaards fond; Lundbeck Foundation; Aase and Ejnar Danielsens Foundation; Danish Cancer Society; Danish Agency for Science, Technology and Innovation; Horslev Fonden	Rigshospitalet; Novo-Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Innovationsfonden; Knud Hojgaards fond; Lundbeck Foundation(Lundbeckfonden); Aase and Ejnar Danielsens Foundation; Danish Cancer Society(Danish Cancer Society); Danish Agency for Science, Technology and Innovation; Horslev Fonden	Rigshospitalet, Novo-Nordisk Foundation, Innovationsfonden, Knud Hojgaards fond, The Lundbeck Foundation, Aase and Ejnar Danielsens Foundation, Danish Cancer Society and Danish Agency for Science, Technology and Innovation, Horslev Fonden	Andrukhova O, 2017, J BONE MINER RES, V32, P2049, DOI 10.1002/jbmr.3195; Anour R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031376; Bernstein P, 2010, REV CARDIOVASC MED, V11, pE141, DOI 10.3909/ricm0557; BOllehuus Hansen L, 2016, J CLIN ENDOCR METAB, V2016; Chanakul A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072816; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; DeLuca S, 2008, J PATHOL, V216, P345, DOI 10.1002/path.2409; Fauconnier C, 2019, CLIN BIOCHEM, V66, P1, DOI 10.1016/j.clinbiochem.2019.03.002; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; Geneva: World Health Organization . World Health Organization, WHO LAB MAN EX PROC, V2010; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Hansen LB, 2019, J STEROID BIOCHEM, V191, DOI 10.1016/j.jsbmb.2019.04.002; Haussler MR, 2012, REV ENDOCR METAB DIS, V13, P57, DOI 10.1007/s11154-011-9199-8; Hu MC, 2013, SEMIN NEPHROL, V33, P118, DOI 10.1016/j.semnephrol.2012.12.013; Ide N, 2018, AM J PHYSIOL-RENAL, V315, pF1261, DOI 10.1152/ajprenal.00650.2017; JENKINS AD, 1983, J ANDROL, V4, P272; JENKINS AD, 1980, BIOL REPROD, V23, P981, DOI 10.1095/biolreprod23.5.981; Jensen MB, 2012, INT J ANDROL, V35, P499, DOI 10.1111/j.1365-2605.2012.01256.x; Jensen MB, 2018, J CLIN ENDOCR METAB, V103, P870, DOI 10.1210/jc.2017-01656; Jensen MB, 2014, NAT REV ENDOCRINOL, V10, P175, DOI 10.1038/nrendo.2013.262; Jensen MB, 2013, MOL CELL ENDOCRINOL, V377, P93, DOI 10.1016/j.mce.2013.06.036; Jensen MB, 2011, HUM REPROD, V26, P1307, DOI 10.1093/humrep/der059; JONES RC, 1987, J REPROD FERTIL, V81, P583; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Komaba H, 2017, KIDNEY INT, V92, P599, DOI 10.1016/j.kint.2017.02.014; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lanske B, 2014, KIDNEY INT, V86, P1071, DOI 10.1038/ki.2014.316; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Rehfeld A, 2019, JOVE-J VIS EXP, V145; Saji F, 2009, NEPHRON PHYSIOL, V111, P59, DOI 10.1159/000210389; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Soeborg T, 2017, CLIN CHIM ACTA, V468, P180, DOI 10.1016/j.cca.2017.03.002; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017	42	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12436	12449		10.1096/fj.202000061RR	http://dx.doi.org/10.1096/fj.202000061RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729975				2022-12-28	WOS:000556803200001
J	Killoy, KM; Pehar, M; Harlan, BA; Vargas, MR				Killoy, Kelby M.; Pehar, Mariana; Harlan, Benjamin A.; Vargas, Marcelo R.			Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model	FASEB JOURNAL			English	Article						circadian; neurodegeneration; Nampt; Sirt6; astrocytes	BODY-MASS INDEX; MOTOR-NEURON DEGENERATION; REV-ERB-ALPHA; CIRCADIAN TRANSCRIPTION; HSOD1(G93A) MICE; SPINAL-CORD; SIRT6; METABOLISM; ASTROCYTES; PATHWAY	Most physiological processes in mammals are subjected to daily oscillations that are governed by a circadian system. The circadian rhythm orchestrates metabolic pathways in a time-dependent manner and loss of circadian timekeeping has been associated with cellular and system-wide alterations in metabolism, redox homeostasis, and inflammation. Here, we investigated the expression of clock and clock-controlled genes in multiple tissues (suprachiasmatic nucleus, spinal cord, gastrocnemius muscle, and liver) from mutant hSOD1-linked amyotrophic lateral sclerosis (ALS) mouse models. We identified tissue-specific changes in the relative expression, as well as altered daily expression patterns, of clock genes, sirtuins (Sirt1, Sirt3, and Sirt6), metabolic enzymes (Pfkfb3, Cpt1, and Nampt), and redox regulators (Nrf2, G6pd, and Pgd). In addition, astrocytes transdifferentiated from induced pluripotent stem cells from SOD1-linked and FUS RNA binding protein-linked ALS patients also displayed altered expression of clock genes. Overall, our results raise the possibility of disrupted cross-talk between the suprachiasmatic nucleus and peripheral tissues in hSOD1(G93A) mice, preventing proper peripheral clock regulation and synchronization. Since these changes were observed in symptomatic mice, it remains unclear whether this dysregulation directly drives or it is a consequence of the degenerative process. However, because metabolism and redox homeostasis are intimately entangled with circadian rhythms, our data suggest that altered expression of clock genes may contribute to metabolic and redox impairment in ALS. Since circadian dyssynchrony can be rescued, these results provide the groundwork for potential disease-modifying interventions.	[Killoy, Kelby M.; Harlan, Benjamin A.] Med Univ South Carolina, Biomed Sci Training Program, Charleston, SC 29425 USA; [Pehar, Mariana] Univ Wisconsin, Dept Med, Div Geriatr & Gerontol, Madison, WI 53792 USA; [Vargas, Marcelo R.] Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA	Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vargas, MR (corresponding author), Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA.	mvargas@wisc.edu			NINDS NIH HHS [R01 NS089640, R21 NS102599] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barca-Mayo O, 2020, GLIA, V68, P1131, DOI 10.1002/glia.23764; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Baxter PS, 2016, FREE RADICAL BIO MED, V100, P147, DOI 10.1016/j.freeradbiomed.2016.06.027; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Braun MC, 2019, EXP NEUROL, V311, P305, DOI 10.1016/j.expneurol.2018.07.008; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Early JO, 2018, P NATL ACAD SCI USA, V115, pE8460, DOI 10.1073/pnas.1800431115; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Fidler JA, 2011, FASEB J, V25, P4369, DOI 10.1096/fj.11-190819; FISMAN M, 1987, ARCH NEUROL-CHICAGO, V44, P997, DOI 10.1001/archneur.1987.00520220007005; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harlan BA, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113219; Harlan BA, 2019, FASEB J, V33, P7084, DOI 10.1096/fj.201802752R; Huisman MHB, 2015, JAMA NEUROL, V72, P1155, DOI 10.1001/jamaneurol.2015.1584; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Lawton KA, 2012, AMYOTROPH LATERAL SC, V13, P110, DOI 10.3109/17482968.2011.619197; Lim MA, 2014, HUM MOL GENET, V23, P4995, DOI 10.1093/hmg/ddu214; Lundsgaard AM, 2018, TRENDS ENDOCRIN MET, V29, P18, DOI 10.1016/j.tem.2017.10.011; Marin B, 2016, NEURODEGENER DIS, V16, P225, DOI 10.1159/000442444; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Mattis J, 2016, TRENDS ENDOCRIN MET, V27, P192, DOI 10.1016/j.tem.2016.02.003; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Monachelli Gisella Gargiulo, 2011, Horm Mol Biol Clin Investig, V6, P167, DOI 10.1515/HMBCI.2011.006; Morselli LL, 2006, CLIN ENDOCRINOL, V65, P385, DOI 10.1111/j.1365-2265.2006.02609.x; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Patacchioli FR, 2003, J ENDOCRINOL INVEST, V26, pRC23, DOI 10.1007/BF03349149; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pehar M, 2017, CURR PHARM DESIGN, V23, P5010, DOI 10.2174/1381612823666170622095802; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2016, CELL METAB, V24, P462, DOI 10.1016/j.cmet.2016.07.024; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2015, COLD SH Q B, V80, P223, DOI 10.1101/sqb.2015.80.027490; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Spataro R, 2015, J NEUROL SCI, V358, P282, DOI 10.1016/j.jns.2015.09.011; Spiga F, 2015, MOL CELL ENDOCRINOL, V408, P227, DOI 10.1016/j.mce.2015.02.005; Steyn FJ, 2012, ENDOCRINOLOGY, V153, P3735, DOI 10.1210/en.2011-2171; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tevy MF, 2013, TRENDS ENDOCRIN MET, V24, P229, DOI 10.1016/j.tem.2012.12.002; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vargas MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056625; Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Videnovic A, 2014, NAT REV NEUROL, V10, P683, DOI 10.1038/nrneurol.2014.206; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wible RS, 2018, ELIFE, V7, DOI 10.7554/eLife.31656; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	75	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21343	10.1096/fj.202000386RR	http://dx.doi.org/10.1096/fj.202000386RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33508151	Green Accepted, Bronze			2022-12-28	WOS:000647789600030
J	Nelson, JW; Phillips, SC; Ganesh, BP; Petrosino, JF; Durgan, DJ; Bryan, RM				Nelson, James W.; Phillips, Sharon C.; Ganesh, Bhanu P.; Petrosino, Joseph F.; Durgan, David J.; Bryan, Robert M.			The gut microbiome contributes to blood-brain barrier disruption in spontaneously hypertensive stroke prone rats	FASEB JOURNAL			English	Article						cerebral small vessel disease; gut microbiome; hypertension; microbiota&#8208; gut&#8208; brain axis; vascular cognitive impairment; vascular dementia; white matter disease	SMALL VESSEL DISEASE; WHITE-MATTER; MODEL; PATHOGENESIS; DYSFUNCTION; SHIFT	In recent years, it has become apparent that the gut microbiome can influence the functioning and pathological states of organs and systems throughout the body. In this study, we tested the hypothesis that the gut microbiome has a major role in the disruption of the blood-brain barrier (BBB) in the spontaneously hypertensive stroke prone rats (SHRSP), an animal model for hypertensive cerebral small vessel disease (CSVD). Loss of BBB is thought to be an early and initiating component to the full expression of CSVD in animal models and humans. To test this hypothesis, newly born SHRSP pups were placed with foster dams of the SHRSP strain or dams of the WKY strain, the control strain that does not demonstrate BBB dysfunction or develop hypertensive CSVD. Similarly, WKY pups were placed with foster dams of the same or opposite strain. The rationale for cross fostering is that the gut microbiomes are shaped by environmental bacteria of the foster dam and the nesting surroundings. Analysis of the bacterial genera in feces, using 16S rRNA analysis, demonstrated that the gut microbiome in the rat pups was influenced by the foster dam. SHRSP offspring fostered on WKY dams had systolic blood pressures (SBPs) that were significantly decreased by 26 mmHg (P < .001) from 16-20 weeks, compared to SHRSP offspring fostered on SHRSP dams. Similarly WKY offspring fostered on SHRSP dams had significantly increased SBP compared to WKY offspring fostered on WKY dams, although the magnitude of SBP change was not as robust. At ~20 weeks of age, rats fostered on SHRSP dams showed enhanced inflammation in distal ileum regardless of the strain of the offspring. Disruption of BBB integrity, an early marker of CSVD onset, was improved in SHRSPs that were fostered on WKY dams when compared to the SHRSP rats fostered on SHRSP dams. Although SHRSP is a genetic model for CSVD, environmental factors such as the gut microbiota of the foster dam have a major influence in the loss of BBB integrity.	[Nelson, James W.; Phillips, Sharon C.; Durgan, David J.; Bryan, Robert M.] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; [Nelson, James W.] Baylor Coll Med, Integrated Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Ganesh, Bhanu P.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Durgan, David J.; Bryan, Robert M.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bryan, RM (corresponding author), Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA.	rbryan@bcm.edu		Ganesh, Bhanu/0000-0003-1575-7914	NCI NIH HHS [P30 CA125123] Funding Source: Medline; NHLBI NIH HHS [R01 HL134838] Funding Source: Medline; NIDDK NIH HHS [P30 DK056338] Funding Source: Medline; NIGMS NIH HHS [T32 GM008231] Funding Source: Medline; NINDS NIH HHS [R01 NS102594, R21 NS094806, R56 NS102594] Funding Source: Medline; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK56338 to the Texas Medical Center Digestive Disease Center] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)		Adnan S, 2017, PHYSIOL GENOMICS, V49, P96, DOI 10.1152/physiolgenomics.00081.2016; Bailey EL, 2011, NEUROPATH APPL NEURO, V37, P711, DOI 10.1111/j.1365-2990.2011.01170.x; Bailey EL, 2011, INT J STROKE, V6, P434, DOI 10.1111/j.1747-4949.2011.00659.x; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bridges LR, 2014, J NEUROPATH EXP NEUR, V73, P1026, DOI 10.1097/NEN.0000000000000124; Brittain JF, 2013, J CEREBR BLOOD F MET, V33, P760, DOI 10.1038/jcbfm.2013.14; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Daft JG, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0080-y; Durgan DJ, 2019, STROKE, V50, P2270, DOI 10.1161/STROKEAHA.119.025140; Durgan DJ, 2016, HYPERTENSION, V67, P469, DOI 10.1161/HYPERTENSIONAHA.115.06672; Faraco G, 2018, NAT NEUROSCI, V21, P240, DOI 10.1038/s41593-017-0059-z; FREDRIKSSON K, 1987, ACTA NEUROPATHOL, V74, P259, DOI 10.1007/BF00688190; Fulling C, 2019, NEURON, V101, P998, DOI 10.1016/j.neuron.2019.02.008; Ganesh BP, 2018, HYPERTENSION, V72, P1141, DOI 10.1161/HYPERTENSIONAHA.118.11695; Ihara M, 2016, STROKE, V47, P554, DOI 10.1161/STROKEAHA.115.009627; Jalal FY, 2015, J CEREBR BLOOD F MET, V35, P1145, DOI 10.1038/jcbfm.2015.21; Kim MS, 2020, GUT, V69, P283, DOI 10.1136/gutjnl-2018-317431; Krafft PR, 2012, INT J STROKE, V7, P398, DOI 10.1111/j.1747-4949.2012.00838.x; Marini S, 2020, STROKE, V51, P12, DOI 10.1161/STROKEAHA.119.024151; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Osadchiy V, 2019, CLIN GASTROENTEROL H, V17, P322, DOI 10.1016/j.cgh.2018.10.002; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Pasi M, 2020, STROKE, V51, P47, DOI 10.1161/STROKEAHA.119.024148; Rosenberg GA, 2016, J CEREBR BLOOD F MET, V36, P6, DOI 10.1038/jcbfm.2015.172; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sanchez-Rodriguez E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030605; Schmidtke K, 2005, J NEUROL SCI, V229, P13, DOI 10.1016/j.jns.2004.11.048; Schrijver IA, 2001, BRAIN, V124, P1544, DOI 10.1093/brain/124.8.1544; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Tonomura S, 2020, J CEREBR BLOOD F MET, V40, P1368, DOI 10.1177/0271678X20918031; Toral M, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13285; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Welling MM, 2015, ALZHEIMERS DEMENT, V11, P51, DOI 10.1016/j.jalz.2013.12.020; YAMORI Y, 1977, STROKE, V8, P456, DOI 10.1161/01.STR.8.4.456	36	14	14	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21201	10.1096/fj.202001117R	http://dx.doi.org/10.1096/fj.202001117R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496989	Green Accepted			2022-12-28	WOS:000647789600065
J	Ye, QH; Zeng, XF; Wang, S; Zeng, XZ; Yang, GX; Ye, CCA; Cai, S; Chen, MX; Li, SY; Qiao, SY				Ye, Qianhong; Zeng, Xiangfang; Wang, Shuai; Zeng, Xiangzhou; Yang, Guangxin; Ye, Changchuan; Cai, Shuang; Chen, Meixia; Li, Siyu; Qiao, Shiyan			Butyrate drives the acetylation of histone H3K9 to activate steroidogenesis through PPAR gamma and PGC1 alpha pathways in ovarian granulosa cells	FASEB JOURNAL			English	Article						estradiol; mitochondrial dynamics; mitochondrial function; oxidative stress; progesterone	OXIDATIVE STRESS; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; PROGESTERONE; IMPLANTATION; DECIDUALIZATION; PROLIFERATION; COACTIVATOR; MECHANISMS; APOPTOSIS	Maintaining ovarian steroidogenesis is of critical importance, considering that steroid hormones are required for successful establishment and maintenance of pregnancy and proper development of embryos and fetuses. Investigating the mechanism that butyrate modulates the ovarian steroidogenesis is beneficial for understanding the impact of lipid nutrition on steroidogenesis. Herein, we identified that butyrate improved estradiol and progesterone synthesis in rat primary ovarian granulosa cells and human granulosa KGN cells and discovered the related mechanism. Our data indicated that butyrate was sensed by GPR41 and GPR43 in ovarian granulosa cells. Butyrate primarily upregulated the acetylation of histone H3K9 (H3K9ac). Chromatin immune-precipitation and sequencing (ChIP-seq) data of H3K9ac revealed the influenced pathways involving in the mitochondrial function (including cellular metabolism and steroidogenesis) and cellular antioxidant capacity. Additionally, increasing H3K9ac by butyrate further stimulated the PPAR gamma/CD36/StAR pathways to increase ovarian steroidogenesis and activated PGC1 alpha to enhance mitochondrial dynamics and alleviate oxidative damage. The improvement in antioxidant capacity and mitochondrial dynamics by butyrate enhanced ovarian steroidogenesis. Collectively, butyrate triggers histone H3K9ac to activate steroidogenesis through PPAR gamma and PGC1 alpha pathways in ovarian granulosa cells.	[Ye, Qianhong; Zeng, Xiangfang; Wang, Shuai; Zeng, Xiangzhou; Yang, Guangxin; Ye, Changchuan; Cai, Shuang; Chen, Meixia; Li, Siyu; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Ye, Qianhong; Zeng, Xiangfang; Zeng, Xiangzhou; Yang, Guangxin; Ye, Changchuan; Cai, Shuang; Chen, Meixia; Li, Siyu; Qiao, Shiyan] Beijing Key Lab Biofeed Addit, Beijing, Peoples R China; [Wang, Shuai] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Zeng, XF (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	zengxf@cau.edu.cn						Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Calvo D, 1998, J LIPID RES, V39, P777; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; CHECK JH, 1987, INT J FERTIL, V32, P192; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Danielian PJ., 2010, BR J OBSTET GYNAECOL, V102, P364; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; DAYA S, 1989, BRIT J OBSTET GYNAEC, V96, P275, DOI 10.1111/j.1471-0528.1989.tb02386.x; Dhungana S, 2016, MATURITAS, V92, P134, DOI 10.1016/j.maturitas.2016.07.008; Diemer T, 2003, ENDOCRINOLOGY, V144, P2882, DOI 10.1210/en.2002-0090; Duan LJ, 2010, EARLY HUM DEV, V86, P41, DOI 10.1016/j.earlhumdev.2009.12.007; Elis S, 2015, THERIOGENOLOGY, V83, P840, DOI 10.1016/j.theriogenology.2014.11.019; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Haas DM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003511.pub3; Hong J, 2016, ONCOTARGET, V7, P56071, DOI 10.18632/oncotarget.11267; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kodama A, 2010, HUM REPROD, V25, P751, DOI 10.1093/humrep/dep455; Lin Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097838, 10.1371/journal.pone.0098312]; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Lu NS, 2017, J STEROID BIOCHEM, V172, P89, DOI 10.1016/j.jsbmb.2017.06.004; McRae RS, 2005, ENDOCRINOLOGY, V146, P309, DOI 10.1210/en.2004-0999; Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427; Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924; Mumford SL, 2016, AM J CLIN NUTR, V103, P868, DOI 10.3945/ajcn.115.119321; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Potdar N, 2005, CURR OPIN OBSTET GYN, V17, P424, DOI 10.1097/01.gco.0000175363.20094.bd; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUINN PG, 1985, J BIOL CHEM, V260, P2092; Rose S, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0089-z; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sharov AA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-24; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Tailor D, 2014, MITOCHONDRION, V16, P55, DOI 10.1016/j.mito.2013.10.004; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Ye QH, 2019, J NUTR BIOCHEM, V69, P98, DOI 10.1016/j.jnutbio.2019.03.015; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131	46	6	6	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21316	10.1096/fj.202000444R	http://dx.doi.org/10.1096/fj.202000444R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433947				2022-12-28	WOS:000647789600063
J	Jo, YR; Kim, HR; Jang, SY; Go, H; Song, MY; Park, DK; Oh, Y; Jo, J; Shin, YK; Lee, SJ; Cheon, SM; Lee, HK; Lee, KE; Kim, YH; Park, HT				Jo, Young Rae; Kim, Hye Ran; Jang, So Young; Go, Hana; Song, Min-Young; Park, Da Kyeong; Oh, Yuna; Jo, Juyeon; Shin, Yoon Kyung; Lee, Sung Joong; Cheon, Sang-Myung; Lee, Hyun Kyoung; Lee, Kyung Eun; Kim, Young Hye; Park, Hwan Tae			Potential neuron-autonomous Purkinje cell degeneration by 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase promoter/Cre-mediated autophagy impairments	FASEB JOURNAL			English	Article						CNP; myelination; neurodegeneration; oligodendrocyte; p62	ALPHA-SYNUCLEIN; MOUSE MODEL; OLIGODENDROCYTES; MYELIN; EXPRESSION; PROTEIN; CNP	Studies of neuroglial interaction largely depend on cell-specific gene knockout (KO) experiments using Cre recombinase. However, genes known as glial-specific genes have recently been reported to be expressed in neuroglial stem cells, leading to the possibility that a glia-specific Cre driver results in unwanted gene deletion in neurons, which may affect sound interpretation. 2 ',3 '-Cyclic nucleotide 3 '-phosphodiesterase (CNP) is generally considered to be an oligodendrocyte (OL) marker. Accordingly, Cnp promoter-controlled Cre recombinase has been used to create OL-specific gene targeting mice. However, in this study, using Rosa26-tdTomato-reporter/Cnp-Cre mice, we found that many forebrain neurons and cerebellar Purkinje neurons belong to the lineages of Cnp-expressing neuroglial stem cells. To answer whether gene targeting by Cnp-Cre can induce neuron-autonomous defects, we conditionally deleted an essential autophagy gene, Atg7, in Cnp-Cre mice. The Cnp-Cre-mediated Atg7 KO mice showed extensive p62 inclusion in neurons, including cerebellar Purkinje neurons with extensive neurodegeneration. Furthermore, neuronal areas showing p62 inclusion in Cnp-Cre-mediated Atg7 KO mice overlapped with the neuronal lineage of Cnp-expressing neuroglial stem cells. Moreover, Cnp-Cre-mediated Atg7-KO mice did not develop critical defects in myelination. Our results demonstrate that a large population of central neurons are derived from Cnp-expressing neuroglial stem cells; thus, conditional gene targeting using the Cnp promoter, which is known to be OL-specific, can induce neuron-autonomous phenotypes.	[Jo, Young Rae; Kim, Hye Ran; Jang, So Young; Go, Hana; Shin, Yoon Kyung; Park, Hwan Tae] Dong A Univ, Peripheral Neuropathy Res Ctr PNRC, Dept Mol Neurosci, Coll Med,Dept Translat Biomed Sci,Grad Sch, Busan, South Korea; [Song, Min-Young; Park, Da Kyeong; Kim, Young Hye] Korea Basic Sci Inst, Biomed Om Grp, Cheongju 363883, Chungbuk, South Korea; [Oh, Yuna; Lee, Kyung Eun] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul, South Korea; [Jo, Juyeon; Lee, Hyun Kyoung] Texas Childrens Hosp, Baylor Coll Med, Neurol Res Inst, Dept Pediat, Houston, TX 77030 USA; [Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul, South Korea; [Cheon, Sang-Myung] Dong A Univ, Coll Med, Dept Neurol, Busan, South Korea	Dong A University; Korea Basic Science Institute (KBSI); Korea Institute of Science & Technology (KIST); Baylor College of Medicine; Seoul National University (SNU); Dong A University	Kim, YH (corresponding author), Korea Basic Sci Inst, Biomed Om Grp, Cheongju 363883, Chungbuk, South Korea.; Park, HT (corresponding author), Dong A Univ, Coll Med, Dept Mol Neurosci, Peripheral Neuropathy Res Ctr PNRC, Busan, South Korea.	yhkim74@kbsi.re.kr; phwantae@dau.ac.kr		Lee, Hyun Kyoung/0000-0001-5793-4398				Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Baburina Y, 2017, BBA-BIOMEMBRANES, V1859, P94, DOI 10.1016/j.bbamem.2016.11.003; Bankston AN, 2019, GLIA, V67, P1745, DOI 10.1002/glia.23646; Cho SJ, 2003, MOL CELLS, V16, P128; Fellner L, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0431-2; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Gravel M, 1997, ALTSCHUL SY, V4, P75; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230; Hayashi C, 2019, ADV EXP MED BIOL, V1190, P53, DOI 10.1007/978-981-32-9636-7_5; Jang SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116624; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Luders KA, 2017, GLIA, V65, P1762, DOI 10.1002/glia.23193; Meireles AM, 2018, DEV CELL, V47, P319, DOI 10.1016/j.devcel.2018.10.003; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Nixon Ralph A, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a008839; Nunes GDF, 2017, GLIA, V65, P1626, DOI 10.1002/glia.23184; Pukass K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00163; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Saab AS, 2016, NEURON, V91, P119, DOI 10.1016/j.neuron.2016.05.016; Sato S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21325-w; Sun LO, 2018, CELL, V175, P1811, DOI 10.1016/j.cell.2018.10.044; Tognatta R, 2017, GLIA, V65, P342, DOI 10.1002/glia.23095; Viader A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027727; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zuchero JB, 2015, DEV CELL, V34, P152, DOI 10.1016/j.devcel.2015.06.011	36	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21225	10.1096/fj.202001366RR	http://dx.doi.org/10.1096/fj.202001366RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337568				2022-12-28	WOS:000605626600036
J	Zhu, SQ; Li, ZY; Cui, LL; Ban, YL; Leung, PCK; Li, Y; Ma, JL				Zhu, Shiqin; Li, Zeyan; Cui, Linlin; Ban, Yanli; Leung, Peter C. K.; Li, Yan; Ma, Jinlong			Activin A increases human trophoblast invasion by upregulating integrin beta 1 through ALK4	FASEB JOURNAL			English	Article						in vitro fertilization (IVF); ITGB1; predictive; diagnostic value; preeclampsia; pregnancy&#8208; induced hypertension	GROWTH-FACTOR-BETA; HYPERTENSIVE DISORDERS; 1ST TRIMESTER; INHIBIN-A; CELLS; EXPRESSION; RECEPTORS; PREECLAMPSIA; FOLLISTATIN; PREGNANCY	Activin A promotes human trophoblast invasion during the first trimester of pregnancy and is associated with preeclampsia and pregnancy-induced hypertension (PE/PIH) in naturally conceived pregnancies. However, whether integrin beta 1 mediates activin A-increased trophoblast invasion remains unknown and the evidence is limited regarding the predictive value of activin A for PE/PIH in women receiving in vitro fertilization (IVF) treatment. Here, we studied the role and underlying molecular mechanisms of integrin beta 1 in activin A-promoted invasion in immortalized (HTR8/SVneo) and primary human extravillous trophoblast (EVT) cells. A nest case-control study was designed to investigate the predictive/diagnostic value of activin A in IVF pregnancies. Results showed that integrin beta 1 expression increased after activin A treatment and knockdown of integrin beta 1 significantly decreased both basal and activin A-increased HTR8/SVneo cell invasion. SB431542 (TGF-beta type I receptors inhibitor) abolished activin A-induced SMAD2/SMAD3 phosphorylation and integrin beta 1 overexpression. Activin A-upregulated integrin beta 1 expression was attenuated after the depletion of ALK4 or SMAD4 in both HTR8/SVneo and primary EVT cells. Furthermore, we found similar first-trimester activin A levels in IVF patients with or without subsequent PE/PIH. These results reveal that integrin beta 1 mediates activin A-promoted trophoblast invasion through ALK4-activated SMAD2/3-SMAD4 pathway, and the predictive/diagnostic value of first-trimester maternal serum activin A for hypertensive disorders of pregnancy might be different in IVF population.	[Zhu, Shiqin; Cui, Linlin; Li, Yan; Ma, Jinlong] Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Zhu, Shiqin; Cui, Linlin; Li, Yan; Ma, Jinlong] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Zhu, Shiqin; Cui, Linlin; Li, Yan; Ma, Jinlong] Shandong Univ, Key Lab Reprod Endocrinol, Minist Educ, Jinan, Peoples R China; [Zhu, Shiqin; Cui, Linlin; Li, Yan; Ma, Jinlong] Shandong Univ, Shandong Prov Clin Med Res Ctr Reprod Hlth, Jinan, Peoples R China; [Zhu, Shiqin; Li, Zeyan; Leung, Peter C. K.; Li, Yan] Shandong Univ, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Ban, Yanli] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan, Peoples R China; [Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Li, Yan] Shandong Univ, Suzhou Inst, Jinan, Jiangsu, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; University of British Columbia; Shandong University	Li, Y; Ma, JL (corresponding author), Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Li, Y (corresponding author), Shandong Univ, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	yanli.sdu@gmail.com; majinlong_sdu@163.com	Li, Zeyan/AHA-2626-2022; Zhu, Shiqin/AAB-6070-2022	Li, Zeyan/0000-0002-9124-032X; Zhu, Shiqin/0000-0002-0235-1766; Leung, Peter/0000-0003-3152-3800; Li, Yan/0000-0003-1813-8115	Natural Science Fund of Jiangsu Province [SBK2020040489]; Fundamental Research Funds of Shandong University [21520079614029]	Natural Science Fund of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds of Shandong University	This study was supported by The Natural Science Fund of Jiangsu Province (SBK2020040489) and The Fundamental Research Funds of Shandong University (21520079614029) to Y.L.	Akolekar R, 2009, FETAL DIAGN THER, V25, P320, DOI 10.1159/000235878; Aoki A, 2018, AM J PATHOL, V188, P2474, DOI 10.1016/j.ajpath.2018.07.021; APLIN JD, 1991, J CELL SCI, V99, P681; Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Bearfield C, 2005, EUR J ENDOCRINOL, V152, P909, DOI 10.1530/eje.1.01928; Bloise E, 2019, PHYSIOL REV, V99, P739, DOI 10.1152/physrev.00002.2018; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Burton GJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2381; D'Antona D, 2000, J ENDOCRINOL, V165, P157, DOI 10.1677/joe.0.1650157; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; DIVERS MJ, 1995, PLACENTA, V16, P245, DOI 10.1016/0143-4004(95)90112-4; Florio P, 2004, MOL CELL ENDOCRINOL, V225, P93, DOI 10.1016/j.mce.2004.02.018; Florio P, 2003, PLACENTA, V24, P279, DOI 10.1053/plac.2002.0896; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; He ZY, 1999, J ASSIST REPROD GEN, V16, P73, DOI 10.1023/A:1022564722353; Huppertz B, 2008, J CLIN PATHOL, V61, P1296, DOI 10.1136/jcp.2008.055277; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jones RL, 2002, TRENDS ENDOCRIN MET, V13, P144, DOI 10.1016/S1043-2760(01)00559-8; Jones RL, 2000, MOL HUM REPROD, V6, P1107, DOI 10.1093/molehr/6.12.1107; Jones RL, 2002, J CLIN ENDOCR METAB, V87, P4001, DOI 10.1210/jc.87.8.4001; Kimber SJ, 2000, SEMIN REPROD MED, V18, P237, DOI 10.1055/s-2000-12562; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Lash GE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023010; Lau MT, 2012, CANCER LETT, V320, P198, DOI 10.1016/j.canlet.2012.02.028; Le HT, 2018, MOL HUM REPROD, V24, P495, DOI 10.1093/molehr/gay034; Li Y, 2015, J CLIN ENDOCR METAB, V100, pE1415, DOI 10.1210/jc.2015-2134; Li Y, 2014, J CLIN ENDOCR METAB, V99, pE2216, DOI 10.1210/jc.2014-2118; Li ZY, 2018, ONCOL REP, V39, P764, DOI 10.3892/or.2017.6139; Li ZY, 2016, REJUV RES, V19, P467, DOI 10.1089/rej.2015.1798; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mylonas I, 2006, ENDOCR PATHOL, V17, P19, DOI 10.1385/EP:17:1:19; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; Poon LCY, 2010, ULTRASOUND OBST GYN, V35, P662, DOI 10.1002/uog.7628; Qin JB, 2016, FERTIL STERIL, V105, P73, DOI 10.1016/j.fertnstert.2015.09.007; QU JP, 1995, ENDOCR REV, V16, P485, DOI 10.1210/er.16.4.485; Reddy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004453; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Sites CK, 2017, FERTIL STERIL, V108, P784, DOI 10.1016/j.fertnstert.2017.08.035; Spencer K, 2008, ULTRASOUND OBST GYN, V32, P622, DOI 10.1002/uog.6212; Tarca AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217273; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vatansever HS, 2003, ACTA HISTOCHEM, V105, P253, DOI 10.1078/0065-1281-00708; Wang WH, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.11; Wijayarathna R, 2016, HUM REPROD UPDATE, V22, P342, DOI 10.1093/humupd/dmv058; Yeh YC, 2010, AM J PATHOL, V177, P1743, DOI 10.2353/ajpath.2010.091183; Yu L, 2012, J CLIN ENDOCR METAB, V97, pE1370, DOI 10.1210/jc.2011-2729; Zou AX, 2018, EUR REV MED PHARMACO, V22, P2199, DOI 10.26355/eurrev_201804_14804	55	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001604R	http://dx.doi.org/10.1096/fj.202001604R		NOV 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33230889	hybrid			2022-12-28	WOS:000592381700001
J	Mok, J; Park, TS; Kim, S; Kim, D; Choi, CS; Park, J				Mok, Jongsoo; Park, Tae Sub; Kim, Sunhong; Kim, Daehoon; Choi, Cheol Soo; Park, Joonghoon			Prokineticin receptor 1 ameliorates insulin resistance in skeletal muscle	FASEB JOURNAL			English	Article						glucose; insulin resistance; Prokr1; PROK2; skeletal muscle	FREE FATTY-ACID; DEPENDENT ACTIVATION; GLUCOSE-TRANSPORT; IDENTIFICATION; PALMITATE; OBESITY; LIGAND; MEN	Type 2 diabetes mellitus may result from insulin resistance in skeletal muscle. Prokineticin receptor 1 (Prokr1) improves metabolic phenotype in adipose tissue and the cardiovascular system; however, its effects on skeletal muscle have not been investigated. We investigated the Prokr1 signaling pathways and its metabolic function in murine myoblast, satellite cells, and their differentiated myotubes. We measured the expression levels of Prokr1 in the skeletal muscle of mice as well as human skeletal muscle cell-derived myotubes. Prokineticin 2 (PROK2), a ligand of PROKR1, induced calcium mobilization in a dose-dependent manner and altered the mRNA levels of 578 genes in PROKR1-overexpressed HEK293T cells. Functional enrichment of differentially expressed genes revealed that PROKR1 activated Gq-mediated PI3K/AKT and MAPK/ERK signaling pathways in skeletal muscle cells. Prokr1 significantly activated the PI3K/AKT signaling pathway in myotubes derived from C2C12 and satellite cells, regardless of the presence or absence of insulin. Prokr1 also promoted the translocation of glucose transporter 4 (GLUT4) into the plasma membrane. In palmitate-induced insulin-resistant myotubes, Prokr1 enhanced insulin-stimulated AKT phosphorylation, GLUT4 translocation, and glucose uptake. mRNA and protein levels of Prokr1 were significantly decreased in skeletal muscle and white adipose tissue of diet-induced obese mice, and the amount of PROKR1 protein was significantly decreased in human skeletal muscle cell-derived myotubes under insulin resistance conditions. Taken together, these results demonstrate that Prokr1 plays an important role in insulin sensitivity and is a potential therapeutic target to ameliorate insulin resistance in skeletal muscle.	[Mok, Jongsoo; Park, Tae Sub; Park, Joonghoon] Seoul Natl Univ, Grad Sch Int Agr Technol, Dept Int Agr Technol, Seoul, South Korea; [Park, Tae Sub; Park, Joonghoon] Seoul Natl Univ, Inst Green Bio Sci & Technol, Seoul, South Korea; [Kim, Sunhong] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Cheongwon Gun, South Korea; [Kim, Sunhong] Korea Univ Sci & Technol, KRIBB Sch Biosci, Dept Biomol Sci, Daejeon, South Korea; [Kim, Daehoon] Hyundai Pharm Co, New Drug Discovery Ctr, Pharmacol Res Div, Cheonan Si, South Korea; [Choi, Cheol Soo] Gachon Univ, Sch Med, Lee Gil Ya Canc & Diabet Inst, Korea Mouse Metab Phenotyping Ctr, Seongnam Si, South Korea; [Choi, Cheol Soo] Gachon Univ, Gil Med Ctr, Internal Med, Endocrinol, Seongnam Si, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Gachon University; Gachon University	Park, J (corresponding author), Seoul Natl Univ, Grad Sch Int Agr Technol, Dept Int Agr Technol, Seoul, South Korea.	joonghoon@snu.ac.kr		Park, Joonghoon/0000-0002-3458-2913	Korea Health Industry Development Institute; Ministry of Health and Welfare [KHIDI-HI14C1135]; National Research Foundation [NRF-2018R1D1A1B07048516]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); National Research Foundation	Korea Health Industry Development Institute; Ministry of Health and Welfare, Grant/Award Number: KHIDI-HI14C1135; National Research Foundation, Grant/Award Number: NRF-2018R1D1A1B07048516	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Beale KEL, 2013, BRIT J PHARMACOL, V168, P403, DOI 10.1111/j.1476-5381.2012.02191.x; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; Chaly AL, 2016, ELIFE, V5, DOI 10.7554/eLife.12397; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Gasser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121027; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim S, 2017, J AGR FOOD CHEM, V65, P3819, DOI 10.1021/acs.jafc.7b00578; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li JN, 2013, J AM CHEM SOC, V135, P8749, DOI 10.1021/ja404391q; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lin R, 2002, J BIOL CHEM, V277, P8724, DOI 10.1074/jbc.M110594200; Liu TM, 2013, CELL METAB, V18, P309, DOI 10.1016/j.cmet.2013.08.016; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Park JG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40322-1; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Rowley WR, 2017, POPUL HEALTH MANAG, V20, P6, DOI 10.1089/pop.2015.0181; Shin E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17784; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Szatkowski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081175; Tahrani AA, 2016, NAT REV ENDOCRINOL, V12, P566, DOI 10.1038/nrendo.2016.86; Taylor R, 2012, DIABETES, V61, P778, DOI 10.2337/db12-0073; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Wang X, 2010, EXP CLIN ENDOCR DIAB, V118, P657, DOI 10.1055/s-0030-1252069; Wang Y, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-015-0172-5; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001; Yang M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-104; Yin WQ, 2014, CELL SIGNAL, V26, P1118, DOI 10.1016/j.cellsig.2014.01.031; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504	42	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001641R	http://dx.doi.org/10.1096/fj.202001641R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184929	hybrid			2022-12-28	WOS:000590890100001
J	Wu, WY; Xia, XB; Tang, LS; Yao, F; Xu, HZ; Lei, HT				Wu, Wenyi; Xia, Xiaobo; Tang, Luosheng; Yao, Fei; Xu, Huizuo; Lei, Hetian			Normal vitreous promotes angiogenesis via activation of Axl	FASEB JOURNAL			English	Article						Akt; Alx; angiogenesis; endothelial cell; vitreous	IN-VITRO; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; GROWTH; MODEL; AKT	Vitreous has been reported to prevent tumor angiogenesis, but our previous findings indicate that vitreous activate the signaling pathway of phosphoinositide 3-kinase (PI3K)/Akt, which plays a critical role in angiogenesis. The goal of this research is to determine which role of vitreous plays in angiogenesis-related cellular responses in vitro. We found that in human retinal microvascular endothelial cells (HRECs) vitreous activates a number of receptor tyrosine kinases including Anexelekto (Axl), which plays an important role in angiogenesis. Subsequently, we discovered that depletion of Axl using CRISPR/Cas9 and an Axl-specific inhibitor R428 suppress vitreous-induced Akt activation and cell proliferation, migration, and tuber formation of HRECs. Therefore, this line of research not only demonstrate that vitreous promotes angiogenesis in vitro, but also reveal that Axl is one of receptor tyrosine kinases to mediate vitreous-induced angiogenesis in vitro, thereby providing a molecular basis for removal of vitreous as cleanly as possible when vitrectomy is performed in treating patients with proliferative diabetic retinopathy.	[Wu, Wenyi; Xia, Xiaobo; Tang, Luosheng; Yao, Fei; Xu, Huizuo] Cent South Univ, Xiangya Hosp, Dept Ophthalmol, 86 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Wu, Wenyi; Xia, Xiaobo; Tang, Luosheng; Yao, Fei; Xu, Huizuo] Hunan Key Lab Ophthalmol, Changsha, Peoples R China; [Wu, Wenyi; Lei, Hetian] Harvard Med Sch, Dept Ophthalmol, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA; [Tang, Luosheng] Cent South Univ, Second Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China; [Lei, Hetian] Shenzhen Eye Hosp, Shenzhen Eye Inst, 18 Zetain Rd, Shenzhen 518040, Peoples R China	Central South University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Central South University	Xu, HZ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Ophthalmol, 86 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.; Lei, HT (corresponding author), Shenzhen Eye Hosp, Shenzhen Eye Inst, 18 Zetain Rd, Shenzhen 518040, Peoples R China.	xhz1030@163.com; leihetian18@hotmail.com		Xia, Xiaobo/0000-0003-1720-7860; Lei, Hetian/0000-0003-4091-1936	Department of central laboratory (Xiangya hospital); Schepens eye research institute (Massachusetts Eye and Ear Infirmary); Science and Technology Plan Project of Hunan Province [2019RS2011]; National Natural Science Foundation of China [8197413, 81900893]; NIH [R01EY01250]; Natural Science Foundation of Hunan [33030135080]; Laboratory of Medical Genetics (Central South University); Department Research to Prevent Blindness	Department of central laboratory (Xiangya hospital); Schepens eye research institute (Massachusetts Eye and Ear Infirmary); Science and Technology Plan Project of Hunan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province); Laboratory of Medical Genetics (Central South University); Department Research to Prevent Blindness(Research to Prevent Blindness (RPB))	We thank Xueyan Yao, Lijun Dong and Jiantao Wang for animal experiment. Special thanks go to the Department of central laboratory (Xiangya hospital) and Laboratory of Medical Genetics (Central South University) and Schepens eye research institute (Massachusetts Eye and Ear Infirmary) for supporting this research. This work was supported by a grant to W.W. from National Natural Science Foundation of China (81900893) and Science and Technology Plan Project of Hunan Province (2019RS2011), National Natural Science Foundation of China (8197413) (X.X), NIH (R01EY01250) (H.L), Natural Science Foundation of Hunan 33030135080 (H.X), Department Research to Prevent Blindness (H.L).	Aranda J, 2012, DIABETES, V61, P1225, DOI 10.2337/db11-1189; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bilanges B, 2019, NAT REV MOL CELL BIO, V20, P515, DOI 10.1038/s41580-019-0129-z; BREM S, 1976, CANCER RES, V36, P2807; Carrel A, 1913, J EXP MED, V17, P14, DOI 10.1084/jem.17.1.14; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen N, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107716; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DAMORE PA, 1981, P NATL ACAD SCI-BIOL, V78, P3068, DOI 10.1073/pnas.78.5.3068; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GLASER BM, 1980, OPHTHALMOLOGY, V87, P440; Gupta SR, 2012, PLOS ONE, V6, P122, DOI 10.1097/ICB.0b013e31821608e8; Han HT, 2019, J BIOL CHEM, V294, P15408, DOI 10.1074/jbc.RA119.010130; Huang XG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00140-3; Kawamoto A, 2001, CIRCULATION, V103, P634; Lam JD, 2017, DIABETES, V66, P1950, DOI 10.2337/db16-1035; Lei HT, 2015, MOL CELL BIOL, V35, P1673, DOI 10.1128/MCB.01248-14; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lei H, 2010, AM J PATHOL, V177, P132, DOI 10.2353/ajpath.2010.090604; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LUTTY GA, 1983, INVEST OPHTH VIS SCI, V24, P52; LUTTY GA, 1985, J CELL SCI, V76, P53; Nawaz IM, 2019, PROG RETIN EYE RES, V72, DOI 10.1016/j.preteyeres.2019.03.002; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Skeie JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127567; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Taniguchi H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08074-0; Wu WY, 2020, DIABETES, V69, P736, DOI 10.2337/db19-0713; Wu WY, 2017, INVEST OPHTH VIS SCI, V58, P6082, DOI 10.1167/iovs.17-21902	36	3	3	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.201903105R	http://dx.doi.org/10.1096/fj.201903105R		NOV 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33151576	hybrid			2022-12-28	WOS:000589712000001
J	Efron, PA; Darden, DB; Wang, ZK; Nacionales, DC; Lopez, MC; Hawkins, RB; Cox, MC; Rincon, JC; Ungaro, R; Dirain, ML; Ghita, GL; Chen, TM; Billiar, TR; Delano, MJ; Leeuwenburgh, C; Bihorac, A; Brakenridge, SC; Moore, FA; Mohr, AM; Tompkins, RG; Brumback, BA; Baker, HV; Upchurch, GR; Moldawer, LL				Efron, Philip A.; Darden, Dijoia B.; Wang, Zhongkai; Nacionales, Dina C.; Lopez, Maria-Cecilia; Hawkins, Russell B.; Cox, Michael C.; Rincon, Jaimar C.; Ungaro, Ricardo; Dirain, Marvin L.; Ghita, Gabriela L.; Chen, Tianmeng; Billiar, Timothy R.; Delano, Matthew J.; Leeuwenburgh, Christiaan; Bihorac, Azra; Brakenridge, Scott C.; Moore, Frederick A.; Mohr, Alicia M.; Tompkins, Ronald G.; Brumback, Babette A.; Baker, Henry, V; Upchurch, Gilbert R.; Moldawer, Lyle L.			Transcriptomic responses from improved murine sepsis models can better mimic human surgical sepsis	FASEB JOURNAL			English	Article						inflammation; sepsis; transcriptome; translational medicine	CHRONIC CRITICAL ILLNESS; IMMUNE SUPPRESSION; DANGER SIGNALS; RECOGNITION; EXPRESSION; TRAUMA; CELLS	Historically, murine models of inflammation in biomedical research have been shown to minimally correlate with genomic expression patterns from blood leukocytes in humans. In 2019, our laboratory reported an improved surgical sepsis model of cecal ligation and puncture (CLP) that provides additional daily chronic stress (DCS), as well as adhering to the Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS) guidelines. This model phenotypically recapitulates the persistent inflammation, immunosuppression, and catabolism syndrome observed in adult human surgical sepsis survivors. Whether these phenotypic similarities between septic humans and mice are replicated at the circulating blood leukocyte transcriptome has not been demonstrated. Our analysis, in contrast with previous findings, demonstrated that genome-wide expression in our new murine model more closely approximated human surgical sepsis patients, particularly in the more chronic phases of sepsis. Importantly, our new model of murine surgical sepsis with chronic stress did not reflect well gene expression patterns from humans with community-acquired sepsis. Our work indicates that improved preclinical murine sepsis modeling can better replicate both the phenotypic and transcriptomic responses to surgical sepsis, but cannot be extrapolated to other sepsis etiologies. Importantly, these improved models can be a useful adjunct to human-focused and artificial intelligence-based forms of research in order to improve septic patients' morbidity and mortality.	[Efron, Philip A.; Darden, Dijoia B.; Nacionales, Dina C.; Hawkins, Russell B.; Cox, Michael C.; Rincon, Jaimar C.; Ungaro, Ricardo; Dirain, Marvin L.; Brakenridge, Scott C.; Moore, Frederick A.; Mohr, Alicia M.; Upchurch, Gilbert R.; Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA; [Wang, Zhongkai; Ghita, Gabriela L.; Brumback, Babette A.] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL 32610 USA; [Lopez, Maria-Cecilia; Baker, Henry, V] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Chen, Tianmeng; Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Delano, Matthew J.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Leeuwenburgh, Christiaan] Univ Florida, Coll Med, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA; [Bihorac, Azra] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; [Tompkins, Ronald G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Harvard Medical School; Massachusetts General Hospital	Efron, PA (corresponding author), Univ Florida, Coll Med, Dept Surg, Shands Hosp, Room 6116,1600 SW Archer Rd, Gainesville, FL 32610 USA.	philip.efron@surgery.ufl.edu	Brakenridge, Scott/AAD-6691-2019; Lopez, Maria/HHC-3659-2022; Wang, Zhongkai/AAA-2393-2021	Brakenridge, Scott/0000-0002-7327-3718; Wang, Zhongkai/0000-0002-1883-2265; Moldawer, Lyle/0000-0002-9041-9838; Delano, Matthew/0000-0001-7540-5166; Leeuwenburgh, Christiaan/0000-0003-0826-4257	National Institutes of Health [R01 GM-040586, R01 GM-104481, R01 GM-113945, P50 GM-111152]; National Institute of General Medical Sciences [T32 GM-008721]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health, Grant/Award Number: R01 GM-040586, R01 GM-104481, R01 GM-113945 and P50 GM-111152; National Institute of General Medical Sciences, Grant/Award Number: T32 GM-008721	Alhayo S, 2020, ANZ J SURG, V90, P1647, DOI 10.1111/ans.16003; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Brakenridge SC, 2019, ANN SURG, V270, P502, DOI 10.1097/SLA.0000000000003458; Brakenridge SC, 2018, J TRAUMA ACUTE CARE, V85, P247, DOI [10.1097/TA.0000000000001921, 10.1097/ta.0000000000001921]; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Chung TP, 2006, J AM COLL SURGEONS, V203, P585, DOI 10.1016/j.jamcollsurg.2006.06.028; Croft CA, 2014, J TRAUMA ACUTE CARE, V76, P311, DOI 10.1097/TA.0000000000000121; Cuenca AG, 2012, INTENS CARE MED, V38, P928, DOI 10.1007/s00134-012-2575-3; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron PA, 2018, SURGERY, V164, P178, DOI 10.1016/j.surg.2018.04.011; Efron PA, 2015, J LEUKOCYTE BIOL, V98, P945, DOI 10.1189/jlb.5MR0315-127R; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Ferreira RG, 2018, J INFECTION, V77, P391, DOI 10.1016/j.jinf.2018.06.010; Fitousis K, 2010, AM J SURG, V200, P776, DOI 10.1016/j.amjsurg.2010.09.001; Gardner AK, 2019, CRIT CARE MED, V47, P566, DOI 10.1097/CCM.0000000000003655; Gentile LF, 2014, CRIT CARE MED, V42, P1406, DOI 10.1097/CCM.0000000000000222; Hollen MK, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2628-x; Horiguchi H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00595; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lian S, 2019, EBIOMEDICINE, V42, P281, DOI 10.1016/j.ebiom.2019.03.018; Lu FL, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2550-2; Mankowski RT, 2020, J AM GERIATR SOC, V68, P1962, DOI 10.1111/jgs.16435; Masopust D, 2017, J IMMUNOL, V199, P383, DOI 10.4049/jimmunol.1700453; Mathias B, 2017, ANN SURG, V265, P827, DOI 10.1097/SLA.0000000000001783; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mira JC, 2017, CRIT CARE MED, V45, P253, DOI [10.1097/CCM.0000000000002074, 10.1097/ccm.0000000000002074]; Mishra BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059616; Nasioudis D, 2015, MED MICROBIOL IMMUN, V204, P471, DOI 10.1007/s00430-015-0394-1; Norde WJ, 2011, CANCER RES, V71, P5111, DOI 10.1158/0008-5472.CAN-11-0108; Osuchowski MF, 2018, INFECTION, V46, P745, DOI 10.1007/s15010-018-1197-2; Osuchowski MF, 2018, INFECTION, V46, P687, DOI 10.1007/s15010-018-1183-8; Osuchowski MF, 2018, SHOCK, V50, P377, DOI 10.1097/SHK.0000000000001212; Raymond SL, 2017, BBA-MOL BASIS DIS, V1863, P2564, DOI 10.1016/j.bbadis.2017.01.013; Raymond SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184159; Remick DG, 2019, SHOCK, V51, P4, DOI 10.1097/SHK.0000000000001164; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Schenck EJ, 2018, CRIT CARE MED, V46, P791, DOI 10.1097/CCM.0000000000003007; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stortz JA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02917-3; Stortz JA, 2019, CRIT CARE MED, V47, pE919, DOI 10.1097/CCM.0000000000003926; Stortz JA, 2018, SHOCK, V49, P249, DOI 10.1097/SHK.0000000000000981; Stortz JA, 2017, ILAR J, V58, P90, DOI 10.1093/ilar/ilx007; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Thompson K, 2019, INTERN MED J, V49, P160, DOI 10.1111/imj.14199; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Yorulmaz H, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180308	57	7	8	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002150R	http://dx.doi.org/10.1096/fj.202002150R		NOV 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33140449	Green Published, Green Accepted			2022-12-28	WOS:000586613900001
J	Whitmore, HAB; Amarnani, D; O'Hare, M; Delgado-Tirado, S; Gonzalez-Buendia, L; An, M; Pedron, J; Bushweller, JH; Arboleda-Velasquez, JF; Kim, LA				Whitmore, Hannah A. B.; Amarnani, Dhanesh; O'Hare, Michael; Delgado-Tirado, Santiago; Gonzalez-Buendia, Lucia; An, Miranda; Pedron, Julien; Bushweller, John H.; Arboleda-Velasquez, Joseph F.; Kim, Leo A.			TNF-alpha signaling regulates RUNX1 function in endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; endothelial cell; RUNX1; TNF&#8208; &#945; signaling pathway	NECROSIS-FACTOR-ALPHA; PROLIFERATIVE DIABETIC-RETINOPATHY; SMALL-MOLECULE INHIBITOR; GROWTH-FACTOR; PANRETINAL PHOTOCOAGULATION; INTRAVITREAL BEVACIZUMAB; INDUCED APOPTOSIS; ACTIVATION; RANIBIZUMAB; KINASE	Runt-related transcription factor 1 (RUNX1) acts as a mediator of aberrant retinal angiogenesis and has been implicated in the progression of proliferative diabetic retinopathy (PDR). Patients with PDR, retinopathy of prematurity (ROP), and wet age-related macular degeneration (wet AMD) have been found to have elevated levels of Tumor Necrosis Factor-alpha (TNF-alpha) in the eye. In fibrovascular membranes (FVMs) taken from patients with PDR RUNX1 expression was increased in the vasculature, while in human retinal microvascular endothelial cells (HRMECs), TNF-alpha stimulation causes increased RUNX1 expression, which can be modulated by RUNX1 inhibitors. Using TNF-alpha pathway inhibitors, we determined that in HRMECs, TNF-alpha-induced RUNX1 expression occurs via JNK activation, while NF-kappa B and p38/MAPK inhibition did not affect RUNX1 expression. JNK inhibitors were also effective at stopping high D-glucose-stimulated RUNX1 expression. We further linked JNK to RUNX1 through Activator Protein 1 (AP-1) and investigated the JNK-AP-1-RUNX1 regulatory feedback loop, which can be modulated by VEGF. Additionally, stimulation with TNF-alpha and D-glucose had an additive effect on RUNX1 expression, which was downregulated by VEGF modulation. These data suggest that the downregulation of RUNX1 in conjunction with anti-VEGF agents may be important in future treatments for the management of diseases of pathologic ocular angiogenesis.	[Whitmore, Hannah A. B.; Amarnani, Dhanesh; O'Hare, Michael; Delgado-Tirado, Santiago; Gonzalez-Buendia, Lucia; An, Miranda; Arboleda-Velasquez, Joseph F.; Kim, Leo A.] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02143 USA; [Whitmore, Hannah A. B.; Amarnani, Dhanesh; O'Hare, Michael; Delgado-Tirado, Santiago; Gonzalez-Buendia, Lucia; An, Miranda; Arboleda-Velasquez, Joseph F.; Kim, Leo A.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Pedron, Julien; Bushweller, John H.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Virginia	Kim, LA (corresponding author), Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02143 USA.	leo_kim@meei.harvard.edu	Gonzalez-Buendia, Lucia/AAC-9445-2022		National Eye Institute of the National Institutes of Health [R01EY027739]; E. Matilda Zieger Foundation for the Blind; Karl Kirchgessner Foundation; National Cancer Institute of the National Institutes of Health [R01CA234478]	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); E. Matilda Zieger Foundation for the Blind; Karl Kirchgessner Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Eye Institute of the National Institutes of Health, Grant/Award Number: R01EY027739; E. Matilda Zieger Foundation for the Blind; Karl Kirchgessner Foundation; Michel Plantevin; National Cancer Institute of the National Institutes of Health, Grant/Award Number: R01CA234478	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Bressler SB, 2017, OPHTHALMOLOGY, V124, P431, DOI 10.1016/j.ophtha.2016.12.005; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; COSTAGLIOLA C, 2013, MEDIAT INFLAMM, V2013; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Elsasser A, 2003, ONCOGENE, V22, P5646, DOI 10.1038/sj.onc.1206673; Ennis BW, 2005, J PHARMACOL EXP THER, V313, P325, DOI 10.1124/jpet.104.078873; FAJARDO LF, 1992, AM J PATHOL, V140, P539; Fan YP, 2019, CANCERS, V11, DOI 10.3390/cancers11010022; Fernandez-Vega B, 2016, CASE REP OPHTHAL, V7, P154, DOI 10.1159/000445102; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hellgren G, 2018, GROWTH HORM IGF RES, V39, P19, DOI 10.1016/j.ghir.2017.11.006; Hernandez C, 2017, J ENDOCRINOL INVEST, V40, P925, DOI 10.1007/s40618-017-0648-4; Huang H. Y., 2014, J NANOMED NANOTECHNO, V5, P1, DOI DOI 10.4172/2157-7439.1000199; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Illendula A, 2016, EBIOMEDICINE, V8, P117, DOI 10.1016/j.ebiom.2016.04.032; Ishikawa M, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/138070; Jayakumar AR, 2018, NEUROCHEM RES, V43, P397, DOI 10.1007/s11064-017-2434-2; Khalilpourfarshbafi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218792; Krishnaswamy G, 1999, J INTERF CYTOK RES, V19, P91, DOI 10.1089/107999099314234; Lam JD, 2017, DIABETES, V66, P1950, DOI 10.2337/db16-1035; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Limb GA, 1996, GRAEF ARCH CLIN EXP, V234, P213, DOI 10.1007/BF00430412; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Martinez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149119; Mason JO, 2006, AM J OPHTHALMOL, V142, P685, DOI 10.1016/j.ajo.2006.04.058; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Morita K, 2017, J CLIN INVEST, V127, P2815, DOI 10.1172/JCI91788; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Reiter CEN, 2003, PROG RETIN EYE RES, V22, P545, DOI 10.1016/S1350-9462(03)00035-1; Rivera JC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0943-1; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Sato T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19594-6; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Simo-Servat O, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5263798; Souvannaseng L, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007418; Spandau U, 2019, PEDIAT RETINAL VASCU, P149; Stadheim TA, 2002, LEUKEMIA RES, V26, P55, DOI 10.1016/S0145-2126(01)00099-6; Tranos P, 2013, DRUG DES DEV THER, V7, P485, DOI 10.2147/DDDT.S43470; Watanabe H, 2018, CELL REP, V23, P3721, DOI 10.1016/j.celrep.2018.05.081; Xiao GY, 2018, P NATL ACAD SCI USA, V115, pE9570, DOI 10.1073/pnas.1810209115; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733; Zhang BC, 2015, MOL MED REP, V11, P3101, DOI 10.3892/mmr.2014.3002; Zhao Yue, 2018, Drugs Context, V7, P212532, DOI 10.7573/dic.212532; Zhou P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00464; Zou WJ, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20193256	61	6	6	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001668R	http://dx.doi.org/10.1096/fj.202001668R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33135824	Green Published, hybrid			2022-12-28	WOS:000586610800001
J	Balderas, PMD; Nunez, MM; Picones, A; Hernandez-Cruz, A				de Oca Balderas, Pavel Montes; Matus Nunez, Mauricio; Picones, Arturo; Hernandez-Cruz, Arturo			NMDAR in cultured astrocytes: Flux-independent pH sensor and flux-dependent regulator of mitochondria and plasma membrane-mitochondria bridging	FASEB JOURNAL			English	Article						astrocyte; calcium; flux&#8208; independent; mitochondria; NMDAR; organelle communication	D-ASPARTATE RECEPTOR; GLUTAMATE UPTAKE; NERVOUS-SYSTEM; CALCIUM; MODULATION; CONTRIBUTES; SENSITIVITY; SECRETION; CHANNELS; DYNAMICS	Glutamate N-methyl-D-aspartate (NMDA) receptor (NMDAR) is critical for neurotransmission as a Ca2+ channel. Nonetheless, flux-independent signaling has also been demonstrated. Astrocytes express NMDAR distinct from its neuronal counterpart, but cultured astrocytes have no electrophysiological response to NMDA. We recently demonstrated that in cultured astrocytes, NMDA at pH6 (NMDA/pH6) acting through the NMDAR elicits flux-independent Ca2+ release from the Endoplasmic Reticulum (ER) and depletes mitochondrial membrane potential (m Delta psi). Here we show that Ca2+ release is due to pH6 sensing by NMDAR, whereas m Delta psi depletion requires both: pH6 and flux-dependent NMDAR signaling. Plasma membrane (PM) NMDAR guard a non-random distribution relative to the ER and mitochondria. Also, NMDA/pH6 induces ER stress, endocytosis, PM electrical capacitance reduction, mitochondria-ER, and -nuclear contacts. Strikingly, it also produces the formation of PM invaginations near mitochondria along with structures referred to here as PM-mitochondrial bridges (PM-m-br). These and earlier data strongly suggest PM-mitochondria communication. As proof of the concept of mass transfer, we found that NMDA/pH6 provoked mitochondria labeling by the PM dye FM-4-64FX. NMDA/pH6 caused PM depolarization, cell acidification, and Ca2+ release from most mitochondria. Finally, the MCU and microtubules were not involved in m Delta psi depletion, while actin cytoskeleton was partially involved. These findings demonstrate that NMDAR has concomitant flux-independent and flux-dependent actions in cultured astrocytes.	[de Oca Balderas, Pavel Montes] Inst Nacl Neurol & Neurocirug, Dept Neurochem, Unidad Neurobiol Dinam, Mexico City 14269, DF, Mexico; [de Oca Balderas, Pavel Montes; Matus Nunez, Mauricio; Picones, Arturo; Hernandez-Cruz, Arturo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Lab Nacl Canalopatias, Dept Cognit Neurosci, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Balderas, PMD (corresponding author), Inst Nacl Neurol & Neurocirug, Dept Neurochem, Unidad Neurobiol Dinam, Mexico City 14269, DF, Mexico.	pavel73@hotmail.com	Picones, Arturo/ABG-5749-2020		Consejo Nacional de Ciencia y Tecnologia (CONACYT) [132706]; UNAM | Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM) [AG200119]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM | Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM)	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Grant/Award Number: 132706; UNAM | Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM), Grant/Award Number: AG200119	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Bondarenko A, 2001, GLIA, V34, P134, DOI 10.1002/glia.1048; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Christie DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037144; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Balderas PMD, 2018, BMC BIOPHYS, V11, DOI 10.1186/s13628-018-0043-3; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Dolgin E, 2019, NATURE, V567, P162, DOI 10.1038/d41586-019-00792-9; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Elbaz-Alon Y, 2017, BIOCHEM SOC T, V45, P477, DOI 10.1042/BST20160130; Bastian-Eugenio CE, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0338-1; Fernandez-Tenorio M, 2011, CIRC RES, V108, P1348, DOI 10.1161/CIRCRESAHA.111.240127; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; Gerard F, 2012, BRAIN RES, V1473, P1, DOI 10.1016/j.brainres.2012.07.032; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Hansen KB, 2018, J GEN PHYSIOL, V150, P1081, DOI 10.1085/jgp.201812032; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hogan-Cann AD, 2016, TRENDS PHARMACOL SCI, V37, P750, DOI 10.1016/j.tips.2016.05.012; Hu B, 2004, ACTA PHARMACOL SIN, V25, P714; Innocenti B, 2000, J NEUROSCI, V20, P1800; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; Jimenez-Blasco D, 2015, CELL DEATH DIFFER, V22, P1877, DOI 10.1038/cdd.2015.49; Juaristi I, 2019, GLIA, V67, P759, DOI 10.1002/glia.23574; Kasymov V, 2013, J NEUROSCI, V33, P435, DOI 10.1523/JNEUROSCI.2813-12.2013; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; Kolikova J, 2006, BRAIN CELL BIOL, V35, P75, DOI 10.1007/s11068-006-9000-1; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; KOYAMA Y, 1991, NEUROSCI LETT, V124, P235, DOI 10.1016/0304-3940(91)90102-Y; Kucharz K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005250; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Low CM, 2003, MOL PHARMACOL, V63, P1212, DOI 10.1124/mol.63.6.1212; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miro-Casas E, 2009, CARDIOVASC RES, V83, P747, DOI 10.1093/cvr/cvp157; Montes de Oca Balderas P, 2018, INT J MOL SCI, V19, P3800; Montes de Oca Balderas P, 2015, PLOS ONE, V10; Montes de Oca Balderas P, 2017, PROTEASES PHYSL PATH, P121; Montes de Oca Balderas P, 2019, BIORXIV, DOI [10.1101/633875, DOI 10.1101/633875]; Montes de Oca Balderas P, 2018, ASTROCYTE PHYSL PATH, P51, DOI [10.5772/intechopen.72975, DOI 10.5772/INTECHOPEN.72975]; Montes de Oca-B Pavel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P337; Ng AN, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0060-3; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Obara-Michlewska M, 2015, NEUROCHEM INT, V88, P20, DOI 10.1016/j.neuint.2014.10.006; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Patrushev I, 2013, CELL CALCIUM, V54, P343, DOI 10.1016/j.ceca.2013.08.003; Peng TI, 1998, MOL PHARMACOL, V53, P974; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Pivneva T, 2008, CELL CALCIUM, V43, P591, DOI 10.1016/j.ceca.2007.10.004; Schipke CG, 2001, FASEB J, V15, P1270, DOI 10.1096/fj.00-0439fje; Stephen TL, 2015, J NEUROSCI, V35, P15996, DOI 10.1523/JNEUROSCI.2068-15.2015; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valbuena S, 2016, NEURON, V92, P316, DOI 10.1016/j.neuron.2016.10.016; Vardjan N, 2016, GLIA, V64, P655, DOI 10.1002/glia.22920; Verkhratsky A, 2020, NEUROCHEM RES, V45, P122, DOI 10.1007/s11064-019-02750-3; Vickery ON, 2016, CURR OPIN PHARMACOL, V30, P44, DOI 10.1016/j.coph.2016.06.011; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WALZ W, 1989, BRAIN RES, V504, P82, DOI 10.1016/0006-8993(89)91600-4; Wang M, 2012, BRAIN RES, V1476, P154, DOI 10.1016/j.brainres.2012.03.029; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Zhang JB, 2018, CELL REP, V25, P3582, DOI 10.1016/j.celrep.2018.11.071	74	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16622	16644		10.1096/fj.202001300R	http://dx.doi.org/10.1096/fj.202001300R		NOV 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131132	Green Submitted, Bronze			2022-12-28	WOS:000586601800001
J	Xia, XJ; Fu, XN; Du, J; Wu, BB; Zhao, XG; Zhu, JS; Zhao, ZW				Xia, Xiju; Fu, Xiaonan; Du, Juan; Wu, Binbin; Zhao, Xianguo; Zhu, Jinsong; Zhao, Zhangwu			Regulation of circadian rhythm and sleep by miR-375-timeless interaction in Drosophila	FASEB JOURNAL			English	Article						CLEAR-CLIP; circadian rhythm; miRNAs; miR-375; sleep	MIRNA-TARGET INTERACTIONS; MOLECULAR OSCILLATIONS; INTEGRATIVE ANALYSIS; EMERGING ROLES; MICRORNA; PERIOD; CLOCK; IDENTIFICATION; TRANSCRIPTION; BEHAVIOR	MicroRNAs are important coordinators of circadian regulation that mediate the fine-tuning of gene expression. Although many studies have shown the effects of individual miRNAs on the circadian clock, the global functional miRNA-mRNA interaction network involved in the circadian system remains poorly understood. Here, we used CLEAR (Covalent Ligation of Endogenous Argonaute-bound RNAs)-CLIP (Cross-Linking and Immuno-Precipitation) to explore the regulatory functions of miRNAs in the circadian system by comparing the miRNA-mRNA interactions betweenDrosophilawild-type strainW(1118)and a mutant of the key circadian transcriptional regulator Clock (Clk(jrk)). This experimental approach unambiguously identified tens of thousands of miRNA-mRNA interactions in both the head and body. The miRNA-mRNA interactome showed dramatic changes in theClk(jrk)flies. Particularly, among similar to 300 miRNA-mRNA circadian relevant interactions, multiple interactions involving core clock genespdp1,tim,andvridisplayed distinct changes as a result of theClkmutation. Based on the CLEAR-CLIP analysis, we found a novel regulation of the circadian rhythm and sleep by themiR-375-timelessinteraction. The results indicated thatClkdisruption abolished normal rhythmic expression ofmiR-375and the functional regulation occurred in the l-LNv neurons, wheremiR-375modulated the circadian rhythm and sleep via targetingtimeless. This work provides the first global view of miRNA regulation in the circadian rhythm.	[Xia, Xiju; Du, Juan; Wu, Binbin; Zhao, Xianguo; Zhao, Zhangwu] China Agr Univ, Coll Plant Protect, Dept Entomol, Beijing 100193, Peoples R China; [Xia, Xiju; Du, Juan; Wu, Binbin; Zhao, Xianguo; Zhao, Zhangwu] China Agr Univ, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China; [Fu, Xiaonan] Virginia Tech, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA USA; [Zhu, Jinsong] Virginia Tech, Dept Biochem, 340 West Campus Dr, Blacksburg, VA 24061 USA	China Agricultural University; China Agricultural University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Zhao, ZW (corresponding author), China Agr Univ, Coll Plant Protect, Dept Entomol, Beijing 100193, Peoples R China.; Zhao, ZW (corresponding author), China Agr Univ, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China.; Zhu, JS (corresponding author), Virginia Tech, Dept Biochem, 340 West Campus Dr, Blacksburg, VA 24061 USA.	zhujin@vt.edu; zhaozw@cau.edu.cn		Wu, Binbin/0000-0002-0879-4904; Zhu, Jinsong/0000-0002-1587-753X	National Natural Science Foundation of China (NSFC) [31730076, 31970458]; Foundation for the National Institutes of Health (FNIH) [R01 AI122743]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation for the National Institutes of Health (FNIH)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31730076 and 31970458; Foundation for the National Institutes of Health (FNIH), Grant/Award Number: R01 AI122743	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Chen X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14707; Chen X, 2016, P NATL ACAD SCI USA, V113, pE2965, DOI 10.1073/pnas.1605837113; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cusumano P, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007500; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan X, 2015, BRIEF BIOINFORM, V16, P780, DOI 10.1093/bib/bbu044; Flores O, 2014, NUCLEIC ACIDS RES, V42, P4629, DOI 10.1093/nar/gkt1393; Garaulet DL, 2016, J NEUROSCI, V36, P3414, DOI 10.1523/JNEUROSCI.3287-15.2016; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Goodwin PR, 2018, CELL REP, V23, P3776, DOI 10.1016/j.celrep.2018.05.078; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Hafner A, 2017, NAT STRUCT MOL BIOL, V24, P840, DOI 10.1038/nsmb.3452; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Helwak A, 2014, NAT PROTOC, V9, P711, DOI 10.1038/nprot.2014.043; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lerner I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8056; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rosbash M, 2007, COLD SPRING HARB SYM, V72, P75, DOI 10.1101/sqb.2007.72.062; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Scheel TKH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07880-8; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Ueda M, 2018, GENES CELLS, V23, P80, DOI 10.1111/gtc.12555; Vodala S, 2012, CELL METAB, V16, P601, DOI 10.1016/j.cmet.2012.10.002; Xue YB, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0401-8; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; You S, 2018, GENETICS, V208, P1195, DOI 10.1534/genetics.117.300342; Zhang Y, 2016, J NEUROSCI, V36, P2007, DOI 10.1523/JNEUROSCI.3286-15.2016; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	58	4	4	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16536	16551		10.1096/fj.202001107R	http://dx.doi.org/10.1096/fj.202001107R		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078445	Green Accepted			2022-12-28	WOS:000581624500001
J	Zhou, Y; Yang, DC; Chen, H; Zheng, CF; Jiang, HC; Liu, XY; Huang, XZ; Ye, SM; Song, SS; Jiang, N; Zhao, ZY; Ma, SQ; Ma, J; Huang, K; Chen, CS; Fan, XF; Gong, YS; Wang, XC; Fan, JM; Liu, R; Shentu, YP				Zhou, Ying; Yang, Dichen; Chen, Hao; Zheng, Chenfei; Jiang, Huanchang; Liu, Xiaoyuan; Huang, Xingzhou; Ye, Simin; Song, Shuangshuang; Jiang, Nan; Zhao, Zhongyuan; Ma, Shuqing; Ma, Jun; Huang, Kate; Chen, Chaosheng; Fan, Xiaofang; Gong, Yongsheng; Wang, Xiaochuan; Fan, Junming; Liu, Rong; Shentu, Yangping			Polyphyllin I attenuates cognitive impairments and reduces AD-like pathology through CIP2A-PP2A signaling pathway in 3XTg-AD mice	FASEB JOURNAL			English	Article						cancerous inhibitor of PP2A (CIP2A); cognitive impairments; polyphyllin I (PPI)	PROTEIN PHOSPHATASE 2A; ALZHEIMERS-DISEASE; MEMORY DEFICITS; TAU; PP2A; PHOSPHORYLATION; INHIBITION; METHYLTRANSFERASE; DEPHOSPHORYLATION; BRAIN	Polyphyllin I (PPI) is a natural phytochemical drug isolated from plants which can inhibit the proliferation of cancer cells. One of the PPI tumor-inhibitory effects is through downregulating the expression of Cancerous Inhibitor of PP2A (CIP2A), the latter, is found upregulated in Alzheimer's disease (AD) brains and participates in the development of AD. In this study, we explored the application of PPI in experimental AD treatment in CIP2A-overexpressed cells and 3XTg-AD mice. In CIP2A-overexpressed HEK293 cells or primary neurons, PPI effectively reduced CIP2A level, activated PP2A, and decreased the phosphorylation of tau/APP and the level of A beta. Furthermore, synaptic protein levels were restored by PPI in primary neurons overexpressing CIP2A. Animal experiments in 3XTg-AD mice revealed that PPI treatment resulted in decreased CIP2A expression and PP2A re-activation. With the modification of CIP2A-PP2A signaling, the hyperphosphorylation of tau/APP and A beta overproduction were prevented, and the cognitive impairments of 3XTg-AD mice were rescued. In summary, PPI ameliorated AD-like pathology and cognitive impairment through modulating CIP2A-PP2A signaling pathway. It may be a potential drug candidate for the treatment of AD.	[Zhou, Ying; Zheng, Chenfei; Chen, Chaosheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Nephrol, Wenzhou, Peoples R China; [Zhou, Ying; Shentu, Yangping] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Di, Wenzhou, Peoples R China; [Yang, Dichen; Chen, Hao; Jiang, Huanchang; Liu, Xiaoyuan; Ye, Simin; Song, Shuangshuang; Jiang, Nan; Zhao, Zhongyuan; Ma, Shuqing] Wenzhou Med Univ, Wenzhou, Peoples R China; [Huang, Xingzhou] Wenzhou Med Univ, Affiliated Hosp 1, Cent Lab, Wenzhou, Peoples R China; [Ma, Jun; Huang, Kate; Shentu, Yangping] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Fanhai West Rd 1, Wenzhou 325035, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng; Fan, Junming] Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou, Peoples R China; [Wang, Xiaochuan; Liu, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Disorders, Sch Basic Med,Dept Pathophysiol,Key Lab, Hangkong Rd 13, Wuhan 430030, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Huazhong University of Science & Technology	Shentu, YP (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Fanhai West Rd 1, Wenzhou 325035, Peoples R China.; Liu, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Disorders, Sch Basic Med,Dept Pathophysiol,Key Lab, Hangkong Rd 13, Wuhan 430030, Peoples R China.	rong.liu@hust.edu.cn; styp@wmu.edu.cn		Liu, Rong/0000-0001-7477-6520	National Natural Science Foundation of China [31900685, 31771189]; Natural Science Foundation of Zhejiang Province [LQ19H050002]; Wenzhou Municipal Science and Technology Bureau [Y20201001, ZS2017008, Y20180159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Bureau	National Natural Science Foundation of China, Grant/Award Number: 31900685 and 31771189; Natural Science Foundation of Zhejiang Province, Grant/Award Number: LQ19H050002; Wenzhou Municipal Science and Technology Bureau, Grant/Award Number: Y20201001, ZS2017008 and Y20180159	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2017, INT J CLIN PHARM TOX; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Chen YZ, 2014, ANTI-CANCER DRUG, V25, P983, DOI 10.1097/CAD.0000000000000127; Cheng Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00195-1; Clark AR, 2019, PHARMACOL THERAPEUT, V201, P181, DOI 10.1016/j.pharmthera.2019.05.016; Dal Pra I, 2014, CURR NEUROPHARMACOL, V12, P353, DOI 10.2174/1570159X12666140828214701; Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hefter D, 2020, NEUROSCIENTIST, V26, P231, DOI 10.1177/1073858419882619; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; IQBAL K, 1986, LANCET, V2, P421; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janus C, 2001, Curr Neurol Neurosci Rep, V1, P451, DOI 10.1007/s11910-001-0105-8; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kilian JG, 2017, NEUROSCIENCE, V348, P191, DOI 10.1016/j.neuroscience.2017.02.011; Li DX, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00133; Li GB, 2017, ONCOTARGET, V8, P10359, DOI 10.18632/oncotarget.14413; Li JL, 2020, ARCH BIOCHEM BIOPHYS, V687, DOI 10.1016/j.abb.2020.108363; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu GP, 2013, MOL THER, V21, P2247, DOI 10.1038/mt.2013.189; Liu XW, 2018, INT J ONCOL, V53, P1279, DOI 10.3892/ijo.2018.4464; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Naseri NN, 2019, NEUROSCI LETT, V705, P183, DOI 10.1016/j.neulet.2019.04.022; Negi JS, 2014, ANTI-CANCER AGENT ME, V14, P833, DOI 10.2174/1871520614666140611101040; Panza F, 2016, IMMUNOTHERAPY-UK, V8, P1119, DOI 10.2217/imt-2016-0019; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shaik MM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040174; Shentu YP, 2018, CELL REP, V24, P713, DOI 10.1016/j.celrep.2018.06.009; Shi QQ, 2017, MOL IMMUNOL, V88, P79, DOI 10.1016/j.molimm.2017.06.017; Shi YM, 2015, PHYTOMEDICINE, V22, P1139, DOI 10.1016/j.phymed.2015.08.014; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sun BL, 2018, NEUROSCI BULL, V34, P1111, DOI 10.1007/s12264-018-0249-z; Sun L, 2003, NEUROSCIENCE, V118, P1175, DOI 10.1016/S0306-4522(02)00697-8; Sun XY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.329; Sweeney MD, 2019, ALZHEIMERS DEMENT, V15, P158, DOI 10.1016/j.jalz.2018.07.222; Tian Y, 2020, CHEM-BIOL INTERACT, V316, DOI 10.1016/j.cbi.2019.108936; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Yu F.L., 2018, EUR J DRUG METAB PH, V3, P1; Yue GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065164; Zhang YL, 2018, GLOB ENV HLTH SAF, V2, P2, DOI DOI 10.1155/2018/2540681; Zheng HY, 2018, CURR MED SCI, V38, P115, DOI 10.1007/s11596-018-1854-9	53	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16414	16431		10.1096/fj.202001499R	http://dx.doi.org/10.1096/fj.202001499R		OCT 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070372	hybrid			2022-12-28	WOS:000581165700001
J	Yang, T; Xing, LY; Yu, WW; Cai, YY; Cui, SS; Chen, G				Yang, Tuo; Xing, Lingyan; Yu, Weiwei; Cai, Yunyun; Cui, Shusen; Chen, Gang			Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury	FASEB JOURNAL			English	Article						astrocytes; cellular reprogramming; spinal cord injuries; neurons; rehabilitation	SULFATE PROTEOGLYCANS NEUROCAN; CORTICOSPINAL TRACT AXONS; FUNCTIONAL RECOVERY; REACTIVE ASTROCYTES; PROGENITOR CELLS; REGENERATION; NEUROGENESIS; PHOSPHACAN; DELETION; GROWTH	After spinal cord injury (SCI), the irreversible loss of neurons and the dense glial scar are two of the leading causes of axon regeneration failure. The adult mammalian spinal cord lacks the ability to spontaneously produce new neurons, making it a key challenge to provide new neurons for spinal cord regeneration. Additionally, the dual role of the glial scar (both inhibitory and protective) makes it difficult to manipulate it for therapeutic purposes. In this study, using a single transcription factor Sry-related HMG-box 2 (Sox2) delivered by adeno-associated virus (AAV), we reprogrammed some of the astrocytes targeted by the viral vectors in the glial scar into neurons in a severe SCI model. We show that this astrocytic reprogramming alone can propel axon regeneration by not only replenishing the lost neurons, but also moderately reducing the density of the glial scar without interrupting its integrity. Beyond that, astrocytic reprogramming can significantly improve functional recovery when combined with running wheel rehabilitation, which provides use-dependent plasticity. These findings may provide us with a new idea for how to manipulate the glial scar and a promising therapeutic strategy that combines biological intervention with a rehabilitation strategy.	[Yang, Tuo; Cui, Shusen] Jilin Univ, China Japan Union Hosp, Dept Hand Surg, Changchun 130033, Peoples R China; [Yang, Tuo; Xing, Lingyan; Yu, Weiwei; Cai, Yunyun] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Yang, Tuo; Xing, Lingyan; Yu, Weiwei; Cai, Yunyun] Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong, Peoples R China; [Chen, Gang] Nantong Univ, Coinnovat Ctr Neuroregenerat, Med Sch, Dept Tissue & Embryol, Nantong, Peoples R China; [Chen, Gang] Nantong Univ, Affiliated Hosp, Dept Anesthesiol, Nantong, Peoples R China	Jilin University; Nantong University; Nantong University; Nantong University; Nantong University	Cui, SS (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Hand Surg, Changchun 130033, Peoples R China.; Chen, G (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Med Sch, Nantong 226001, Peoples R China.	cuiss@jlu.edu.cn; chengang6626@ntu.edu.cn	Xing, Lingyan/GPS-6294-2022; yang, tuo/AAP-1737-2021	Xing, Lingyan/0000-0002-7646-2522; Chen, Gang/0000-0003-3669-5687	National Key Research and Development Program of China [2017YFA0104704]; National Natural Science Foundation of China [81701127, 31872773]; Natural Science Foundation of Jiangsu Province [BK20181460]; Basic Research Program of the Education Department of Jiangsu Province [17KJA180009]; Priority Academic Program Development of Jiangsu Higher Education Institutions [2017YFA0104704, BK20181460, 17KJA180009]; Jiangsu Province	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Basic Research Program of the Education Department of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province	the National Key Research and Development Program of China, Grant/Award Number: 2017YFA0104704; the National Natural Science Foundation of China, Grant/Award Number: 31872773; the National Natural Science Foundation of China, Grant/Award Number: 81701127; the Natural Science Foundation of Jiangsu Province, Grant/Award Number: BK20181460; Basic Research Program of the Education Department of Jiangsu Province, Grant/Award Number: 17KJA180009; Priority Academic Program Development of Jiangsu Higher Education Institutions, Grant/Award Number: PAPD; Research and Development, Grant/Award Number: 2017YFA0104704, BK20181460 and 17KJA180009; National Natural Science Foundation of China; Natural Science Foundation of Jiangsu Province; Jiangsu Province	Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Anderson MA, 2018, NATURE, V561, P396, DOI 10.1038/s41586-018-0467-6; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ashammakhi N, 2019, TISSUE ENG PART B-RE, V25, P471, DOI [10.1089/ten.teb.2019.0182, 10.1089/ten.TEB.2019.0182]; Chen CH, 2019, CEREB CORTEX, V29, P54, DOI 10.1093/cercor/bhx303; Chen YC, 2020, MOL THER, V28, P217, DOI 10.1016/j.ymthe.2019.09.003; CLEMENTE CD, 1954, J COMP NEUROL, V101, P691, DOI 10.1002/cne.901010304; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2019, NAT MED, V25, P898, DOI 10.1038/s41591-019-0475-6; Dias DO, 2018, CELL, V173, P153, DOI 10.1016/j.cell.2018.02.004; Du KM, 2015, J NEUROSCI, V35, P9754, DOI 10.1523/JNEUROSCI.3637-14.2015; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Griffin JM, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911505; Griffin JM, 2019, GENE THER, V26, P198, DOI 10.1038/s41434-019-0075-6; Griffiths BB, 2020, NEURAL REGEN RES, V15, P973, DOI 10.4103/1673-5374.270292; Gu YK, 2019, BRAIN BEHAV IMMUN, V80, P394, DOI 10.1016/j.bbi.2019.04.016; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Hesp ZC, 2018, J NEUROSCI, V38, P1366, DOI 10.1523/JNEUROSCI.3953-16.2017; Horner PJ, 2000, J NEUROSCI, V20, P2218; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lapointe NP, 2006, BEHAV NEUROSCI, V120, P826, DOI 10.1037/0735-7044.120.4.826; Lee DH, 2013, NEUROSCI BULL, V29, P436, DOI 10.1007/s12264-013-1365-4; Matsui T, 2014, EXP NEUROL, V260, P12, DOI 10.1016/j.expneurol.2012.09.016; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Narayan S, 2017, CELL REP, V20, P1585, DOI 10.1016/j.celrep.2017.07.071; Nishimura S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-3; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Richards TM, 2019, J NEUROTRAUM, V36, P2698, DOI 10.1089/neu.2018.6152; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Ryu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171937; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Sugar O, 1940, J NEUROPHYSIOL, V3, P1; Trudler D, 2019, TRENDS MOL MED, V25, P72, DOI 10.1016/j.molmed.2018.12.005; Nguyen T, 2017, NEURAL REGEN RES, V12, P1073, DOI 10.4103/1673-5374.211182; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vismara I, 2017, TRENDS MOL MED, V23, P831, DOI 10.1016/j.molmed.2017.07.005; Wang L, 2018, CELL PHYSIOL BIOCHEM, V50, P1535, DOI 10.1159/000494652; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Xu AK, 2019, J ZHEJIANG UNIV-SC B, V20, P205, DOI 10.1631/jzus.B1800280; Yang T, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00078; Zarei-Kheirabadi M, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1448-x; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	51	14	15	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15504	15515		10.1096/fj.202001657RR	http://dx.doi.org/10.1096/fj.202001657RR		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32975845	hybrid			2022-12-28	WOS:000574537900001
J	Nay, K; Koechlin-Ramonatxo, C; Rochdi, S; Island, ML; Orfila, L; Treffel, L; Bareille, MP; Beck, A; Gauquelin-Koch, G; Ropert, M; Loreal, O; Derbre, F				Nay, Kevin; Koechlin-Ramonatxo, Christelle; Rochdi, Sarah; Island, Marie-Laure; Orfila, Luz; Treffel, Loic; Bareille, Marie-Pierre; Beck, Arnaud; Gauquelin-Koch, Guillemette; Ropert, Martine; Loreal, Olivier; Derbre, Frederic			Simulated microgravity disturbs iron metabolism and distribution in humans: Lessons from dry immersion, an innovative ground-based human model	FASEB JOURNAL			English	Article						bedrest; erythropoiesis; iron misdistribution; muscle atrophy; spaceflight	RED-BLOOD-CELL; SKELETAL-MUSCLE; SPACE-FLIGHT; NUTRITIONAL-STATUS; BONE LOSS; ERYTHROPOIETIN; MACROPHAGES; DISORDERS; MASS	The objective of the present study was to determine the effects of dry immersion, an innovative ground-based human model of simulated microgravity and extreme physical inactivity, on iron homeostasis and distribution. Twenty young healthy men were recruited and submitted to 5 days of dry immersion (DI). Fasting blood samples and MRI were performed before and after DI exposure to assess iron status, as well as hematological responses. DI increased spleen iron concentrations (SIC), whereas hepatic iron store (HIC) was not affected. Spleen iron sequestration could be due to the concomitant increase in serum hepcidin levels (P < .001). Increased serum unconjugated bilirubin, as well as the rise of serum myoglobin levels support that DI may promote hemolysis and myolysis. These phenomena could contribute to the concomitant increase of serum iron and transferrin saturation levels (P < .001). As HIC remained unchanged, increased serum hepcidin levels could be due both to higher transferrin saturation level, and to low-grade pro-inflammatory as suggested by the significant rise of serum ferritin and haptoglobin levels after DI (P = .003 andP = .003, respectively). These observations highlight the need for better assessment of iron metabolism in bedridden patients, and an optimization of the diet currently proposed to astronauts.	[Nay, Kevin; Rochdi, Sarah; Orfila, Luz; Derbre, Frederic] Univ Rennes ENS Rennes, Lab Movement Sport & Hlth Sci EA 7470, F-35170 Bruz, France; [Nay, Kevin; Koechlin-Ramonatxo, Christelle] Univ Montpellier, DMEM, INRAE, Montpellier, France; [Nay, Kevin] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Exercise & Nutr Res Program, Melbourne, Vic, Australia; [Island, Marie-Laure; Ropert, Martine; Loreal, Olivier] Univ Rennes, INSERM, Nutr Metab & Canc NuMeCan Inst, INRAE,UMR 1241,AEM2 Platform, Rennes, France; [Island, Marie-Laure; Ropert, Martine] CHU Rennes, Dept Biochem, Rennes, France; [Treffel, Loic] Inst NeuroMyoGene, Fac Med Lyon Est, Lyon, France; [Bareille, Marie-Pierre; Beck, Arnaud] Inst Space Med & Physiol MEDES, Toulouse, France; [Gauquelin-Koch, Guillemette] Ctr Natl Etud Spatiales CNES, Paris, France	INRAE; Universite de Montpellier; Australian Catholic University; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes	Derbre, F (corresponding author), Univ Rennes ENS Rennes, Lab Movement Sport & Hlth Sci EA 7470, F-35170 Bruz, France.; Loreal, O (corresponding author), Univ Rennes, INSERM, Nutr Metab & Canc NuMeCan Inst, INRAE,UMR 1241,AEM2 Platform,CHU Pontchaillou, 2 Rue Henri Le Guilloux, F-35033 Rennes, France.	olivier.loreal@univ-rennes1.fr; frederic.derbre@univ-rennes2.fr	Loreal, Olivier/G-3366-2013; Derbre, Frederic/R-8776-2017	Loreal, Olivier/0000-0002-7428-3766; Nay, Kevin/0000-0003-0859-992X; Martine, Ropert/0000-0003-1227-9427; Treffel, Loic/0000-0001-7962-1026; Derbre, Frederic/0000-0002-1531-6425; Koechlin-Ramonatxo, Christelle/0000-0001-6112-0864	Centre National d'Etudes Spatiales; Brittany Council; AlimH department grant; INRAE	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Brittany Council; AlimH department grant; INRAE	The authors thank the volunteers and the staff of MEDES for participation in this protocol at the MEDES space clinic in 2018 and in 2019. This work was supported by the Centre National d'Etudes Spatiales. The work was also supported by INRAE and Brittany Council and partially supported by an AlimH department grant. The authors thank Stephanie Zindilis and Elisabetta Andermarcher for expert manuscript editing.	Alfrey CP, 1997, LANCET, V349, P1389, DOI 10.1016/S0140-6736(96)09208-2; Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Barcellini W, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/635670; Bosutti A, 2008, J CLIN ENDOCR METAB, V93, P3226, DOI 10.1210/jc.2007-1684; Cavey T, 2019, FASEB J, V33, P11072, DOI 10.1096/fj.201801381RR; Cavey T, 2017, EXP PHYSIOL, V102, P291, DOI 10.1113/EP086188; Cavey T, 2015, BIOMETALS, V28, P733, DOI 10.1007/s10534-015-9862-8; Convertino VA, 1996, MED SCI SPORT EXER, V28, pS45; Corna G, 2016, J IMMUNOL, V197, P1914, DOI 10.4049/jimmunol.1501417; De Abreu S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00799; De Santo NG, 2005, SEMIN NEPHROL, V25, P379, DOI 10.1016/j.semnephrol.2005.05.006; Demangel R, 2017, J PHYSIOL-LONDON, V595, P4301, DOI 10.1113/JP273895; Dirks ML, 2019, AM J PHYSIOL-ENDOC M, V316, pE536, DOI 10.1152/ajpendo.00378.2018; Fitts RH, 2001, J EXP BIOL, V204, P3201; Fung E, 2013, HAEMATOLOGICA, V98, P1667, DOI 10.3324/haematol.2013.084624; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Hansen SL, 2010, J ANIM SCI, V88, P275, DOI 10.2527/jas.2009-1846; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Loreal O, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00128; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Morgan JLL, 2012, J APPL PHYSIOL, V113, P1519, DOI 10.1152/japplphysiol.01064.2012; Munoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046; Nairz M, 2017, PFLUG ARCH EUR J PHY, V469, P397, DOI 10.1007/s00424-017-1944-8; Navasiolava NM, 2011, EUR J APPL PHYSIOL, V111, P1235, DOI 10.1007/s00421-010-1750-x; Nay K, 2021, EXP PHYSIOL, V106, P28, DOI 10.1113/EP088339; Pavy-Le Traon A, 1986, EUR J APPL PHYSL, V2007, P143; Reardon TF, 2009, EXP PHYSIOL, V94, P720, DOI 10.1113/expphysiol.2008.046045; Risso A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00054; Robin A, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00383; Ryan BJ, 2016, EXP PHYSIOL, V101, P628, DOI 10.1113/EP085665; Shenkman B S, 1997, J Gravit Physiol, V4, pP137; Smith SM, 2013, PROC FOOD SCI, V2, P27, DOI 10.1016/j.profoo.2013.04.006; Smith SM, 2005, J NUTR, V135, P437, DOI 10.1093/jn/135.3.437; Smith SM, 2002, NUTRITION, V18, P864, DOI 10.1016/S0899-9007(02)00912-7; Tomilovskaya E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00284; Treffel L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150052; Trial J, 2001, J INVEST MED, V49, P335, DOI 10.2310/6650.2001.33899; Trudel G, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13469; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; VALBERG LS, 1969, GASTROENTEROLOGY, V56, P241; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Xu Z, 2017, BONE, V94, P152, DOI 10.1016/j.bone.2016.09.023; Yang JC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092608; Yang JC, 2018, BONE, V114, P235, DOI 10.1016/j.bone.2018.06.012; Zhang AS, 2010, ADV NUTR, V1, P38, DOI 10.3945/an.110.1009; Zhang An-Sheng, 2009, Hematology Am Soc Hematol Educ Program, P207, DOI 10.1182/asheducation-2009.1.207; Zwart SR, 2013, AM J CLIN NUTR, V98, P217, DOI 10.3945/ajcn.112.056465	50	8	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14920	14929		10.1096/fj.202001199RR	http://dx.doi.org/10.1096/fj.202001199RR		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918768	Green Submitted			2022-12-28	WOS:000570784200001
J	Kim, G; Lee, SG; Han, SS; Jung, J; Jeong, HS; Hyun, JK; Rhee, DK; Kim, HM; Lee, S				Kim, Gyuhee; Lee, Seong-Gyu; Han, Seungsu; Jung, Jaeeun; Jeong, Hyeong Seop; Hyun, Jae-kyung; Rhee, Dong-Kwon; Kim, Ho Min; Lee, Sangho			ClpL is a functionally active tetradecameric AAA plus chaperone, distinct from hexameric/dodecameric ones	FASEB JOURNAL			English	Article						chaperone; ClpL; Hsp100; S; pneumoniae; tetradecamer	CRYO-EM STRUCTURE; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; ATPASE CYCLE; MIDDLE DOMAIN; PROTEIN; BINDING; HSP104; OLIGOMERIZATION; DYNAMICS	AAA+ (ATPases associated with diverse cellular activities) chaperones are involved in a plethora of cellular activities to ensure protein homeostasis. The function of AAA+ chaperones is mostly modulated by their hexameric/dodecameric quaternary structures. Here we report the structural and biochemical characterizations of a tetradecameric AAA+ chaperone, ClpL fromStreptococcus pneumoniae. ClpL exists as a tetradecamer in solution in the presence of ATP. The cryo-EM structure of ClpL at 4.5 angstrom resolution reveals a striking tetradecameric arrangement. Solution structures of ClpL derived from small-angle X-ray scattering data suggest that the tetradecameric ClpL could assume a spiral conformation found in active hexameric/dodecameric AAA+ chaperone structures. Vertical positioning of the middle domain accounts for the head-to-head arrangement of two heptameric rings. Biochemical activity assays with site-directed mutagenesis confirmed the critical roles of residues both in the integrity of the tetradecameric arrangement and activities of ClpL. Non-conserved Q321 and R670 are crucial in the heptameric ring assembly of ClpL. These results establish that ClpL is a functionally active tetradecamer, clearly distinct from hexameric/dodecameric AAA+ chaperones.	[Kim, Gyuhee; Han, Seungsu; Jung, Jaeeun; Lee, Sangho] Sungkyunkwan Univ, Dept Biol Sci, Suwon 16419, South Korea; [Lee, Seong-Gyu; Kim, Ho Min] Inst Basic Sci IBS, Ctr Biomol & Cellular Struct, Daejeon 34141, South Korea; [Lee, Seong-Gyu; Kim, Ho Min] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Jeong, Hyeong Seop; Hyun, Jae-kyung] Korea Basic Sci Inst, Cheongju, South Korea; [Rhee, Dong-Kwon] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Hyun, Jae-kyung] Okinawa Inst Sci & Technol Grad Univ, Okinawa, Japan; [Lee, Sangho] Sungkyunkwan Univ, Biomed Inst Convergence SKKU, Suwon, South Korea	Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI); Sungkyunkwan University (SKKU); Okinawa Institute of Science & Technology Graduate University; Sungkyunkwan University (SKKU)	Lee, S (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon 16419, South Korea.; Kim, HM (corresponding author), Inst Basic Sci IBS, Ctr Biomol & Cellular Struct, Daejeon 34141, South Korea.	kimhm@ibs.re.kr; sangholee@skku.edu	Hyun, Jaekyung/AAK-2521-2020	Hyun, Jaekyung/0000-0003-2914-537X	National Research Foundation of Korea (NRF) [NRF-2018R1A2B6004367, NRF-2017R1A5A1014560]; Rural Development Agency [PJ01367602]; Institute of Basic Science [IBS-R030-C1]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Rural Development Agency; Institute of Basic Science	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2B6004367 and NRF-2017R1A5A1014560; Rural Development Agency, Grant/Award Number: PJ01367602; Institute of Basic Science, Grant/Award Number: IBS-R030-C1	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Bin Masood T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0545-9; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Carroni Marta, 2017, Elife, V6, DOI 10.7554/eLife.30120; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Corrales FJ, 1996, P NATL ACAD SCI USA, V93, P4509, DOI 10.1073/pnas.93.9.4509; DeSantis ME, 2014, J BIOL CHEM, V289, P848, DOI 10.1074/jbc.M113.520759; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Duran EC, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00054; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewens CA, 2016, STRUCTURE, V24, P657, DOI 10.1016/j.str.2016.03.018; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Kater L, 2020, NAT STRUCT MOL BIOL, V27, P142, DOI 10.1038/s41594-019-0364-1; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Li T, 2015, BIOCHEM J, V470, P39, DOI 10.1042/BJ20141457; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Liu J, 2013, J BIOL CHEM, V288, P17597, DOI 10.1074/jbc.M113.458752; Lopez KE, 2020, NAT STRUCT MOL BIOL, V27, P406, DOI 10.1038/s41594-020-0409-5; Miller JM, 2018, J STRUCT BIOL, V201, P52, DOI 10.1016/j.jsb.2017.11.003; Miyata T, 2000, J STRUCT BIOL, V131, P83, DOI 10.1006/jsbi.2000.4290; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Park SS, 2015, FEBS J, V282, P1352, DOI 10.1111/febs.13228; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Ripstein ZA, 2020, ELIFE, V9, DOI 10.7554/eLife.52158; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Saeed IA, 2009, INT J BIOL MACROMOL, V45, P236, DOI 10.1016/j.ijbiomac.2009.05.010; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuck P, 2014, ANALYST, V139, P79, DOI 10.1039/c3an01507f; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Shorter J, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a034033; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Yamasaki T, 2015, J BIOL CHEM, V290, P9789, DOI 10.1074/jbc.M114.617696; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE9560, DOI 10.1073/pnas.1810648115; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501; Zheng JX, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-1719-9; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	70	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14353	14370		10.1096/fj.202000843R	http://dx.doi.org/10.1096/fj.202000843R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910525				2022-12-28	WOS:000570574700001
J	Wang, B; Ding, XM; Ding, CG; Tesch, G; Zheng, J; Tian, PX; Ricardo, SR; Shen, HH; Xue, WJ				Wang, Bo; Ding, Xiaoming; Ding, Chenguang; Tesch, Greg; Zheng, Jin; Tian, PuXun; Ricardo, Sharon; Shen, Hsin-Hui; Xue, Wujun			WNT1-inducible-signaling pathway protein 1 regulates the development of kidney fibrosis through the TGF-beta 1 pathway	FASEB JOURNAL			English	Article						kidney fibrosis; TGF-beta 1; WISP1; UUO model	MESENCHYMAL STEM-CELLS; TGF-BETA; RENAL FIBROSIS; GROWTH-FACTOR; WISP-1; WNT; PROLIFERATION; FIBROGENESIS; BLOCKADE; THERAPY	Fibrosis is a pathological feature of chronic kidney disease and its progression correlates with declining renal function. Kidney fibrosis is driven by multiple profibrotic factors. This project examined the regulatory function of WNT1-inducible-signaling pathway protein 1 (WISP1) in the development of kidney fibrosis. Induction of WISP1 by transforming growth factor beta 1 (TGF-beta 1), and the role of WISP1 in TGF-beta 1/Smad signaling and fibrotic responses, was examined in multiple kidney cells. Kidney expression of WISP1 was examined in mouse models of unilateral ureter obstruction (UUO) and streptozotocin-induced diabetic nephropathy. WISP1 antibody was administered to UUO mice during the induction of kidney injury and the impact on kidney fibrosis was examined. WISP1 expression was upregulated in both mouse models. TGF-beta 1-induced expression of WISP1 and profibrotic genes in cultured kidney cells via TGF-beta R1. Recombinant WISP1-induced expression of TGF-beta R1 in kidney cells. Suppression of WISP1 by shRNA or neutralizing antibody reduced TGF-beta 1-mediated activation of Smad3, fibrotic gene expression, and fibroblast proliferation. Treatment with WISP1 antibody inhibited the development of kidney fibrosis in UUO mice. WISP1 mediates the profibrotic effects of TGF-beta 1 in kidney cells and in kidney disease. Pharmacological blockade of WISP1 exhibits potential as a novel therapy for inhibiting kidney fibrosis.	[Wang, Bo; Ding, Xiaoming; Ding, Chenguang; Zheng, Jin; Tian, PuXun; Xue, Wujun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Nephropathy Hosp, Dept Kidney Transplantat, Xian 710061, Shaanxi, Peoples R China; [Wang, Bo; Shen, Hsin-Hui] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic, Australia; [Tesch, Greg] Monash Univ, Dept Nephrol, Clayton, Vic, Australia; [Tesch, Greg] Monash Med Ctr, Dept Med, Clayton, Vic, Australia; [Ricardo, Sharon] Monash Univ, Dept Pharmacol, Monash Biomed Discovery Inst, Clayton, Vic, Australia	Xi'an Jiaotong University; Monash University; Monash University; Monash University; Monash University	Wang, B; Xue, WJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Nephropathy Hosp, Dept Kidney Transplantat, Xian 710061, Shaanxi, Peoples R China.	bo.wang@monash.edu; xwujun126@xjtu.edu.cn		Shen, Hsin-Hui/0000-0002-8541-4370; Ricardo, Sharon/0000-0003-1724-3669	National Natural Science Foundation of China (NSFC) [81670681, 81970670]; Fundamental Research Funds for the Central Universities [xjj2018091]; Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University [XJTU1AF-CRF-2019-008]; Special Supportive Program for Organ Transplantation by COTDF [2019JYJH04]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University; Special Supportive Program for Organ Transplantation by COTDF	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670681 and 81970670; Fundamental Research Funds for the Central Universities, Grant/Award Number: xjj2018091; Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University, Grant/Award Number: XJTU1AF-CRF-2019-008; Special Supportive Program for Organ Transplantation by COTDF, Grant/Award Number: 2019JYJH04	Chow FY, 2004, NEPHROL DIAL TRANSPL, V19, P2987, DOI 10.1093/ndt/gfh441; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Gu LB, 2013, LAB INVEST, V93, P450, DOI 10.1038/labinvest.2013.4; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Huuskes BM, 2015, FASEB J, V29, P540, DOI 10.1096/fj.14-254789; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Jian YC, 2014, CLIN LAB, V60, P29, DOI 10.7754/Clin.Lab.2013.121035; Klee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20547; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; Lemos DR, 2018, J AM SOC NEPHROL, V29, P1690, DOI 10.1681/ASN.2017121283; Li XF, 2015, ARCH MED SCI, V11, P647, DOI 10.5114/aoms.2015.52371; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Maarouf OH, 2016, J AM SOC NEPHROL, V27, P781, DOI 10.1681/ASN.2014121188; Mason RM, 2009, J CELL COMMUN SIGNAL, V3, P95, DOI 10.1007/s12079-009-0038-6; McGaraughty S, 2017, J AM SOC NEPHROL, V28, P3616, DOI 10.1681/ASN.2017010013; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Murahovschi V, 2015, DIABETES, V64, P856, DOI 10.2337/db14-0444; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Parada C, 2013, MOL CELL BIOL, V33, P3482, DOI 10.1128/MCB.00615-13; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Tan RJ, 2014, KIDNEY INT SUPPL, V4, P84, DOI 10.1038/kisup.2014.16; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Wang B, 2016, MOL THER, V24, P1290, DOI 10.1038/mt.2016.90; Wang B, 2014, KIDNEY INT, V85, P352, DOI 10.1038/ki.2013.372; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x; Wright LH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95824; Xu LF, 2000, GENE DEV, V14, P585; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhong X, 2017, AM J TRANSL RES, V9, P2920	37	6	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14507	14520		10.1096/fj.202000953R	http://dx.doi.org/10.1096/fj.202000953R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32896021				2022-12-28	WOS:000568303400001
J	Chen, L; Fu, CY; Zhang, Q; He, CQ; Zhang, F; Wei, Q				Chen, Li; Fu, Chenying; Zhang, Qing; He, Chengqi; Zhang, Feng; Wei, Quan			The role of CD44 in pathological angiogenesis	FASEB JOURNAL			English	Review						angiogenesis; cancer; CD44; HA; ischemia; ocular disease	MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; ENDOTHELIAL-CELL PROLIFERATION; CANCER STEM-CELLS; BREAST-CANCER; GROWTH-FACTOR; BIVATUZUMAB MERTANSINE; VASCULOGENIC MIMICRY; ERM PROTEINS; UP-REGULATION; LIPID RAFTS	Angiogenesis is required for normal development and occurs as a pathological step in a variety of disease settings, such as cancer, ocular diseases, and ischemia. Recent studies have revealed the role of CD44, a widely expressed cell surface adhesion molecule, in promoting pathological angiogenesis and the development of its associated diseases through its regulation of diverse function of endothelial cells, such as proliferation, migration, adhesion, invasion, and communication with the microenvironment. Conversely, the absence of CD44 expression or inhibition of its function impairs pathological angiogenesis and disease progression. Here, we summarize the current understanding of the roles of CD44 in pathological angiogenesis and the underlying cellular and molecular mechanisms.	[Chen, Li; Zhang, Qing; He, Chengqi; Wei, Quan] Sichuan Univ, West China Hosp, Dept Rehabil Med Ctr, Chengdu, Peoples R China; [Chen, Li; Zhang, Qing; He, Chengqi; Wei, Quan] Sichuan Univ, West China Hosp, Key Lab Rehabil Med Sichuan Prov, Chengdu, Peoples R China; [Chen, Li; Zhang, Feng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Fu, Chenying] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sun Yat Sen University; Sichuan University	Wei, Q (corresponding author), Sichuan Univ, West China Hosp, Dept Rehabil Med Ctr, Chengdu, Peoples R China.; Zhang, F (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China.	zhangfeng@mail.sysu.edu.cn; weiquan@scu.edu.cn	Wei, Quan/AAV-4474-2021; fu, chenying/AAG-6333-2020	Zhang, Feng/0000-0002-6103-1498	National Natural Science Foundation of China [81572231]; Project of the Science and Technology Department in Sichuan province [2019YJ0119]; Fundamental Research Funds for the Central Universities [20ykzd19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of the Science and Technology Department in Sichuan province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China, Grant/Award Number: 81572231; Project of the Science and Technology Department in Sichuan province, Grant/Award Number: 2019YJ0119; Fundamental Research Funds for the Central Universities, Grant/Award Number: 20ykzd19	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Avolio E, 2017, PHARMACOL THERAPEUT, V171, P83, DOI 10.1016/j.pharmthera.2016.11.002; Babina IS, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3614; Bhatavdekar JM, 1998, ANN SURG ONCOL, V5, P495, DOI 10.1007/BF02303641; Bonafe F, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0100-4; Borjesson PKE, 2003, CLIN CANCER RES, V9, p3961S; Bot PT, 2013, CURR VASC PHARMACOL, V11, P13; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caers J, 2006, BRIT J HAEMATOL, V132, P469, DOI 10.1111/j.1365-2141.2005.05886.x; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chan-Ling T, 2011, INVEST OPHTH VIS SCI, V52, P399, DOI 10.1167/iovs.10-5403; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Chen CJ, 2015, NEUROLOGY, V85, P1980, DOI 10.1212/WNL.0000000000002176; Chen JQ, 2014, BMC CANCER, V14, DOI [10.1186/1471-2407-14-15, 10.1186/1471-2407-14-802]; Chen MJ, 2005, ACTA OBSTET GYN SCAN, V84, P322, DOI 10.1111/j.0001-6349.2005.00707.x; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Chipps TJ, 2013, GRAEF ARCH CLIN EXP, V251, P1245, DOI 10.1007/s00417-012-2103-8; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; Dew L, 2015, REGEN MED, V10, P211, DOI [10.2217/RME.14.83, 10.2217/rme.14.83]; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; Felemban M, 2018, ACTA BIOMATER, V74, P207, DOI 10.1016/j.actbio.2018.05.023; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Forster-Horvath C, 2004, MICROVASC RES, V68, P110, DOI 10.1016/j.mvr.2004.05.001; Fujisaki T, 1999, CANCER RES, V59, P4427; Fukuda Y, 2000, GENE CHROMOSOME CANC, V29, P315, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1047>3.0.CO;2-E; Garcia LF, 2015, EINSTEIN-SAO PAULO, V13, P89, DOI 10.1590/S1679-45082015AO2970; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Griffioen AW, 1997, BLOOD, V90, P1150, DOI 10.1182/blood.V90.3.1150.1150_1150_1159; Gutjahr JC, 2018, BLOOD, V131, P1337, DOI 10.1182/blood-2017-08-802462; Han ZQ, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0486-9; Harkonen K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030276; Heider KH, 2004, CANCER IMMUNOL IMMUN, V53, P567, DOI 10.1007/s00262-003-0494-4; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hill A, 2006, ONCOGENE, V25, P6079, DOI 10.1038/sj.onc.1209628; Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625; Irani S, 2018, J INT SOC PREV COMMU, V8, P110, DOI 10.4103/jispcd.JISPCD_408_17; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jelicic J, 2016, PATHOL ONCOL RES, V22, P567, DOI 10.1007/s12253-015-0032-7; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Jiang W, 2015, MOL CANCER RES, V13, P9, DOI 10.1158/1541-7786.MCR-14-0076; Jones M, 2000, J BIOL CHEM, V275, P7964, DOI 10.1074/jbc.275.11.7964; Jung WY, 2013, HISTOPATHOLOGY, V63, P474, DOI 10.1111/his.12202; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kanazawa M, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X19834158; Katagiri YU, 1999, CANCER RES, V59, P219; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Kobayashi H, 2002, INT J CANCER, V102, P379, DOI 10.1002/ijc.10710; Krettek A, 2004, AM J PATHOL, V165, P1571, DOI 10.1016/S0002-9440(10)63414-1; Kusuhara S, 2018, DIABETES METAB J, V42, P364, DOI 10.4093/dmj.2018.0182; Ladeda V, 1998, EXP CELL RES, V242, P515, DOI 10.1006/excr.1998.4094; Lee JL, 2008, MOL CELL BIOL, V28, P5710, DOI 10.1128/MCB.00186-08; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Liu YL, 2017, J CELL MOL MED, V21, P1979, DOI 10.1111/jcmm.13118; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Ludwig N, 2019, CANCER LETT, V467, P85, DOI 10.1016/j.canlet.2019.10.010; Luo Dahu, 2017, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V33, P977; Ma LX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1265-7; Makkar S, 2019, MOL CANCER THER, V18, P2446, DOI 10.1158/1535-7163.MCT-18-1225; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Meier P, 2012, EUR HEART J, V33, P614, DOI 10.1093/eurheartj/ehr308; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Mochimaru H, 2009, INVEST OPHTH VIS SCI, V50, P4410, DOI 10.1167/iovs.08-3044; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Murai T, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00420; Murai T, 2013, J CELL SCI, V126, P3284, DOI 10.1242/jcs.120014; Murata M, 2005, OPHTHALMOLOGICA, V219, P287, DOI 10.1159/000086113; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; NEAME SJ, 1995, J CELL SCI, V108, P3127; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Oliferenko S, 2000, J CELL BIOL, V148, P1159, DOI 10.1083/jcb.148.6.1159; Olofsson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090921; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Ozer E, 1997, CANCER LETT, V121, P119, DOI 10.1016/S0304-3835(97)00346-7; Park D, 2012, MOL CELLS, V33, P563, DOI 10.1007/s10059-012-2294-1; Paulis YWJ, 2015, ONCOTARGET, V6, P19634, DOI 10.18632/oncotarget.3839; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Riechelmann H, 2008, ORAL ONCOL, V44, P823, DOI 10.1016/j.oraloncology.2007.10.009; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Robertson BW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-260; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Rupp U, 2007, ANTI-CANCER DRUG, V18, P477, DOI 10.1097/CAD.0b013e32801403f4; Ryu D, 2018, BIOMOL THER, V26, P487, DOI 10.4062/biomolther.2018.116; Saha AK, 2017, BIOPHYS J, V112, P1481, DOI 10.1016/j.bpj.2017.02.021; Sakimoto S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89906; Sauter A, 2007, INT J ONCOL, V30, P927; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; SAVANI RC, 2003, LUNG BIOL HEALTH DIS, V168, P73; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Senbanjo LT, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00018; Shen WY, 1998, BRIT J OPHTHALMOL, V82, P1063, DOI 10.1136/bjo.82.9.1063; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Siamakpour-Reihani S, 2015, GYNECOL ONCOL, V139, P23, DOI 10.1016/j.ygyno.2015.08.001; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Singleton PA, 2004, EXP CELL RES, V295, P102, DOI 10.1016/j.yexcr.2003.12.025; Singleton PA, 2002, CELL MOTIL CYTOSKEL, V53, P293, DOI 10.1002/cm.10078; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Song G, 2008, CANCER SCI, V99, P1901, DOI 10.1111/j.1349-7006.2008.00911.x; Song JM, 2019, MOL CARCINOGEN, V58, P321, DOI 10.1002/mc.22930; Sottnik Joseph L, 2016, Oncoscience, V3, P320, DOI 10.18632/oncoscience.335; Stroomer JWG, 2000, CLIN CANCER RES, V6, P3046; Suleiman M, 2018, LIFE SCI, V209, P197, DOI 10.1016/j.lfs.2018.08.009; Sun HM, 2013, CLIN TRANSL ONCOL, V15, P46, DOI 10.1007/s12094-012-0891-2; Sun HZ, 2016, INT J CLIN EXP PATHO, V9, P11523; Terawaki S, 2015, GENES CELLS, V20, P847, DOI 10.1111/gtc.12276; Teye K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160952; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; Tsuneki M, 2014, J BIOL CHEM, V289, P5357, DOI 10.1074/jbc.M113.529313; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894; van Oordt CWMV, 2016, ONCOTARGET, V7, P80046, DOI 10.18632/oncotarget.11098; van Royen N, 2004, CIRCULATION, V109, P1647, DOI 10.1161/01.CIR.0000124066.35200.18; Vey N, 2016, ONCOTARGET, V7, P32532, DOI 10.18632/oncotarget.8687; Wang H, 2001, STROKE, V32, P1020, DOI 10.1161/01.STR.32.4.1020; Wang YZ, 2011, EXP BIOL MED, V236, P84, DOI 10.1258/ebm.2010.010206; Weber GF, 2002, CANCER RES, V62, P2281; Wei Q, 2014, CIRCULATION, V130, P1493, DOI 10.1161/CIRCULATIONAHA.114.011096; Xu HX, 2015, ONCOTARGETS THER, V8, P3783, DOI 10.2147/OTT.S95470; Yabushita H, 2004, ONCOL REP, V12, P739; Yan YM, 2015, STEM CELL TRANSL MED, V4, P1033, DOI 10.5966/sctm.2015-0048; Yang ZT, 2017, J CANCER RES CLIN, V143, P243, DOI 10.1007/s00432-016-2273-6; Yanga YL, 2013, P NATL ACAD SCI USA, V110, P12018, DOI 10.1073/pnas.1301331110; Yeter E, 2009, EXPERT OPIN PHARMACO, V10, P19, DOI [10.1517/14656560802627952, 10.1517/14656560802627952 ]; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu G, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0115-4; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Zhang YH, 2013, J SURG ONCOL, V108, P414, DOI 10.1002/jso.23402; Zhang YY, 2002, CANCER RES, V62, P3962; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200; Zhu B, 2018, DIAGN PATHOL, V13, DOI 10.1186/s13000-018-0722-z; Zhu SN, 1997, BRIT J OPHTHALMOL, V81, P80, DOI 10.1136/bjo.81.1.80	176	30	31	5	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13125	13139		10.1096/fj.202000380RR	http://dx.doi.org/10.1096/fj.202000380RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32830349				2022-12-28	WOS:000564368300001
J	Huang, R; Vi, LD; Zong, XH; Baht, GS				Huang, Rong; Vi, Linda; Zong, Xiaohua; Baht, Gurpreet S.			Maresin 1 resolves aged-associated macrophage inflammation to improve bone regeneration	FASEB JOURNAL			English	Article						bone; fracture healing; inflammaging; macrophage; osteoblast	LIPID MEDIATORS; FRACTURE; RESOLUTION; CELLS; OSTEOBLASTS	Inflammaging is associated with poor tissue regeneration observed in advanced age. Specifically, protracted inflammation after acute injury has been associated with decreased bone fracture healing and increased rates of nonunion in elderly patients. Here, we investigated the efficacy of using Maresin 1 (MaR1), an omega-3 fatty acid-derived pro-resolving agent, to resolve inflammation after tibial fracture injury and subsequently improving aged bone healing. Aged (24-month-old mice) underwent tibial fracture surgery and were either treated with vehicle or MaR1 3 days after injury. Fracture calluses were harvested 7 days, 14 days, 21 days, and 28 days after injury to investigate inflammatory response, cartilage development, bone deposition, and mechanical integrity, respectively. Healing bones from MaR1-treated mice displayed decreased cartilage formation and increased bone deposition which resulted in increased structural stiffness and increased force to fracture in the later stages of repair. In the early stages, MaR1 treatment decreased the number of pro-inflammatory macrophages within the fracture callus and decreased the level of inflammatory biomarkers in circulation. In tissue culture models, MaR1 treatment of bone marrow-derived macrophages from aged mice protected cells form a pro-inflammatory phenotype and induced an anti-inflammatory fate. Furthermore, the secretome of MaR1-treated bone marrow-derived macrophages was identified as osteoinductive, enhancing osteoblast differentiation of bone marrow stromal cells. Our findings here identify resolution of inflammation, and MaR1 itself, to be a point of intervention to improve aged bone healing.	[Huang, Rong; Zong, Xiaohua; Baht, Gurpreet S.] Duke Univ, Duke Mol Physiol Inst, 300 North Duke St, Durham, NC 27701 USA; [Huang, Rong; Zong, Xiaohua; Baht, Gurpreet S.] Duke Univ, Dept Orthopaed Surg, Durham, NC 27701 USA; [Vi, Linda] Univ Toronto, Div Phys Med & Rehabil, Toronto, ON, Canada; [Baht, Gurpreet S.] Duke Univ, Dept Pathol, Durham, NC 27701 USA	Duke University; Duke University; University of Toronto; Duke University	Baht, GS (corresponding author), Duke Univ, Duke Mol Physiol Inst, 300 North Duke St, Durham, NC 27701 USA.	gurpreet.baht@duke.edu		Vi, Linda/0000-0003-4693-0572	Borden Scholar Award; Duke Aging Center/Pepper Pilot Award [AG028716]	Borden Scholar Award; Duke Aging Center/Pepper Pilot Award	The authors would like to thank Natalie Pang for help with manuscript preparation and Niccolo Terrando for scientific insights. This work was supported a Borden Scholar Award and a Duke Aging Center/Pepper Pilot Award (AG028716).	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313; Baht GS, 2018, CURR OSTEOPOROS REP, V16, P138, DOI 10.1007/s11914-018-0423-2; Baht GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8131; Batoon L, 2017, CURR OSTEOPOROS REP, V15, P385, DOI 10.1007/s11914-017-0384-x; Buttner R, 2018, AGING CELL, V17, DOI 10.1111/acel.12833; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Clark D, 2017, CURR OSTEOPOROS REP, V15, P601, DOI 10.1007/s11914-017-0413-9; Clark D, 2020, AGING CELL, V19, DOI 10.1111/acel.13112; Colas RA, 2016, J IMMUNOL, V197, P4444, DOI 10.4049/jimmunol.1600837; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Giannoudis PV, 2011, INJURY, V42, P549, DOI 10.1016/j.injury.2011.03.037; Gibon E, 2016, REGEN ENG TRANSL MED, V2, P98, DOI 10.1007/s40883-016-0016-5; Giovannone D, 2019, ELIFE, V8, DOI 10.7554/eLife.42736; Hong S, 2014, CHEM BIOL, V21, P1318, DOI 10.1016/j.chembiol.2014.06.010; Huang R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129144; Josephson AM, 2019, P NATL ACAD SCI USA, V116, P6995, DOI 10.1073/pnas.1810692116; Krishnamoorthy N, 2015, J IMMUNOL, V194, P863, DOI 10.4049/jimmunol.1402534; Loi F, 2016, BONE, V86, P119, DOI 10.1016/j.bone.2016.02.020; Loi F, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0276-5; Lubelski D, 2015, J SPINAL DISORD TECH, V28, pE277, DOI 10.1097/BSD.0b013e318287f2e2; Lubelski D, 2013, J NEUROSURG-SPINE, V18, P126, DOI 10.3171/2012.11.SPINE12389; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Moldovan NI, 2000, CIRC RES, V87, P378; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2; Ng AH, 2015, CALCIFIED TISSUE INT, V97, P476, DOI 10.1007/s00223-015-0032-3; Okuno Y, 2011, BLOOD, V117, P5264, DOI 10.1182/blood-2011-01-330720; Pajarinen J, 2019, BIOMATERIALS, V196, P80, DOI 10.1016/j.biomaterials.2017.12.025; Park J, 2015, BIOL OPEN, V4, P608, DOI 10.1242/bio.201411031; Ruiz A, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105694; Sendama W, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.101000; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Vi L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07666-0; Vi L, 2015, J BONE MINER RES, V30, P1090, DOI 10.1002/jbmr.2422; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Xiong C, 2018, JOVE-J VIS EXP, DOI 10.3791/56701; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yang T, 2019, BRIT J ANAESTH, V122, P350, DOI 10.1016/j.bja.2018.10.062; Zhang LL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00412	46	16	16	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13521	13532		10.1096/fj.202001145R	http://dx.doi.org/10.1096/fj.202001145R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32794246	hybrid, Green Accepted			2022-12-28	WOS:000561437300001
J	Wen, YX; Shi, HS; Wu, ZX; Xiao, H; Wang, H; Chen, LB				Wen, Yinxian; Shi, Huasong; Wu, Zhixin; Xiao, Hao; Wang, Hui; Chen, Liaobin			GR/Sp3/HDAC1/UGDH signaling participated in the maternal dexamethasone-induced dysplasia of the rat fetal growth plate	FASEB JOURNAL			English	Article						fetal growth plate; histone acetylation; maternal dexamethasone; proteoglycan; UDP-glucose dehydrogenase	UDP-GLUCOSE DEHYDROGENASE; GLUCOCORTICOID-RECEPTOR; DEVELOPMENTAL TOXICITY; HISTONE DEACETYLASES; GENE-EXPRESSION; CARTILAGE; EXPOSURE; CORTICOSTEROIDS; INHIBITION; MATRIX	Maternal dexamethasone decreases the body length of the newborn. However, whether dexamethasone inhibits the development of the growth plate of the fetal long bone is still unknown. Here, we found that lengths of fetal femur and growth plate were both shorter in the fetuses with maternal dexamethasone (0.2 mg/kg.d from gestation day 9 to 20), with a decreased proteoglycan content of the growth plate in the fetal rat. Notable decreases in both the gene expression and H3K9 acetylation of UDP-glucose dehydrogenase (Ugdh) gene, which codes a key enzyme in the proteoglycan biosynthesis in the chondrocyte, were also observed. Meanwhile, up-regulation of glucocorticoid receptor (GR), specific protein 3 (Sp3), and histone deacetylase 1 (Hdac1) gene expression were detected in the fetal growth plate. Similar changes were also observed in the chondrogenic rat bone marrow stromal cells (BMSCs) with excessive exogenous dexamethasone. However, antagonizing GR with RU486 and silencingHdac1orSp3with specific siRNAs could all stimulate the H3K9 acetylation and gene expression ofUgdhpreviously inhibited by dexamethasone. Meanwhile, dexamethasone also induced the nuclear translocation of GR, which further directly bound to theUgdhpromoter and interacted with HDAC1 and Sp3, respectively. Collectively, our study revealed that maternal dexamethasone induced the direct binding of GR to theUgdhpromoter of the chondrocyte in the rat fetal growth plate, which recruited HDAC1 and Sp3, induced deacetylation of the H3K9, and subsequently inhibitedUgdhgene expression. Such changes further led to attenuated proteoglycan synthesis in the developing chondrocyte and therefore disrupted the development of growth plate and fetal long bone.	[Wen, Yinxian; Shi, Huasong; Wu, Zhixin; Xiao, Hao; Chen, Liaobin] Wuhan Univ, Zhongnan Hosp, Dept Joint Surg & Sports Med, Wuhan 430071, Peoples R China; [Wen, Yinxian; Wang, Hui; Chen, Liaobin] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China; [Wang, Hui] Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Chen, LB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Joint Surg & Sports Med, Wuhan 430071, Peoples R China.; Wang, H (corresponding author), Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430071, Peoples R China.	wanghui19@whu.edu.cn; lbchen@whu.edu.cn			National Natural Science Foundation of China [81603214, 81673490, 81673524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81603214, 81673490 and 81673524	Beauchef G, 2005, BIOCHEM BIOPH RES CO, V333, P1123, DOI 10.1016/j.bbrc.2005.06.020; Bontemps Y, 2003, J BIOL CHEM, V278, P21566, DOI 10.1074/jbc.M209366200; Bradley EW, 2015, PHYSIOL REV, V95, P1359, DOI 10.1152/physrev.00004.2015; Chen Z, 2018, TOXICOL APPL PHARM, V351, P12, DOI 10.1016/j.taap.2018.05.005; Chen Z, 2018, TOXICOL LETT, V286, P1, DOI 10.1016/j.toxlet.2018.01.008; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; Crowther CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub3; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hansen DK, 1999, TOXICOL SCI, V48, P230, DOI 10.1093/toxsci/48.2.230; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129803; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; LABORDE JB, 1992, FUND APPL TOXICOL, V19, P545, DOI 10.1016/0272-0590(92)90093-W; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Lv F, 2018, ENDOCRINOLOGY, V159, P1401, DOI 10.1210/en.2018-00044; Melrose J, 2016, MATRIX BIOL, V52-54, P363, DOI 10.1016/j.matbio.2016.01.008; Minina E, 2001, DEVELOPMENT, V128, P4523; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Murphy KE, 2012, OBSTET GYNECOL, V119, P917, DOI 10.1097/AOG.0b013e31825189dc; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; Pan JM, 2019, J RECEPT SIG TRANSD, V39, P80, DOI 10.1080/10799893.2019.1625061; Prydz K, 2000, J CELL SCI, V113, P193; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sun H, 2008, MOL ENDOCRINOL, V22, P2076, DOI 10.1210/me.2007-0302; Tan KS, 2000, AM J MED, V109, P727, DOI 10.1016/S0002-9343(00)00615-X; Tomaszewska E, 2013, J ANIM PHYSIOL AN N, V97, P785, DOI 10.1111/j.1439-0396.2012.01319.x; Vatsyayan J, 2005, J BIOCHEM, V137, P703, DOI 10.1093/jb/mvi082; Viviano BL, 2005, DEV BIOL, V282, P152, DOI 10.1016/j.ydbio.2005.03.003; Wen YX, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0484-2; Xiao H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0701-z; Zhang XR, 2016, BRIT J PHARMACOL, V173, P2250, DOI 10.1111/bph.13506	38	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12834	12846		10.1096/fj.202000106R	http://dx.doi.org/10.1096/fj.202000106R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32767431				2022-12-28	WOS:000558271200001
J	Wilkerson, A; Bhat, N; Pham, HQH; Yuksel, S; Butovich, I				Wilkerson, Amber; Bhat, Nita; Hoang Quoc Hai Pham; Yuksel, Seher; Butovich, Igor			Physiological effects of inactivation and the roles of Elovl3/ELOVL3 in maintaining ocular homeostasis	FASEB JOURNAL			English	Article						Elovl3; elongase of very long chain fatty acids; lipid homeostasis; meibogenesis; meibomian glands; meibum; transcriptomics	CHAIN FATTY-ACIDS; MEIBOMIAN GLANDS; HUMAN MEIBUM; ACOX2 DEFICIENCY; WAX ESTERS; TEAR FILM; EXPRESSION; LIPIDS; GENE; BIOSYNTHESIS	Recently, elongase of very long chain fatty acids-3 (ELOVL3) was demonstrated to play a pivotal role in physiology and biochemistry of the ocular surface by maintaining a proper balance in the lipid composition of meibum. The goal of this study was to further investigate the effects of ELOVL3 ablation in homozygous Elovl3-knockout mice (E3hom) in comparison with age and sex matched wild-type controls (E3wt). Slit lamp examination of the ocular surface of mice, and histological examination of their ocular tissues, highlighted a severe negative impact of Elovl3 inactivating mutation on the Meibomian glands (MG) and conjunctiva of mice. MG transcriptomes of the E3hom and E3wt mice were assessed and revealed a range of up- and downregulated genes related to lipid biosynthesis, inflammation, and stress response, compared with E3wt mice. Heat stage polarized light microscopy was used to assess melting characteristics of normal and abnormal meibum. The loss of Elovl3 led to a 8 degrees C drop in the melting temperature of meibum in E3hom mice, and increased its fluidity. Also noted were the excessive accumulation of lipid material and tears around the eye and severe ocular inflammation, among other abnormalities.	[Wilkerson, Amber; Bhat, Nita; Hoang Quoc Hai Pham; Yuksel, Seher; Butovich, Igor] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Bhat, Nita] Howard Univ Hosp, Dept Internal Med, Washington, DC USA; [Hoang Quoc Hai Pham] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Butovich, Igor] Univ Texas Southwestern Med Ctr Dallas, Grad Sch Biomed Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard University; City of Hope; Beckman Research Institute of City of Hope; University of Texas System; University of Texas Southwestern Medical Center Dallas	Butovich, I (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	igor.butovich@utsouthwestern.edu		Pham, Hoang Quoc Hai/0000-0002-9044-5008	NEI NIH HHS [R01 EY024324] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andres-Benito P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00546; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; BRAUNINGER GE, 1972, AM J OPHTHALMOL, V73, P132, DOI 10.1016/0002-9394(72)90315-7; Butovich IA, 2007, J LIPID RES, V48, P2220, DOI 10.1194/jlr.M700237-JLR200; Butovich IA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184539; Butovich IA, 2019, FASEB J, V33, P10034, DOI 10.1096/fj.201900725R; Butovich IA, 2019, OCUL SURF, V17, P793, DOI 10.1016/j.jtos.2019.03.002; Butovich IA, 2009, METHODS MOL BIOL, V579, P221, DOI 10.1007/978-1-60761-322-0_11; Butovich IA, 2017, EXP EYE RES, V163, P2, DOI 10.1016/j.exer.2017.06.020; Butovich IA, 2016, BBA-MOL CELL BIOL L, V1861, P538, DOI 10.1016/j.bbalip.2016.03.024; Butovich IA, 2014, INVEST OPHTH VIS SCI, V55, P87, DOI 10.1167/iovs.13-13355; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P3766, DOI 10.1167/iovs.11-9333; Butovich IA, 2010, INVEST OPHTH VIS SCI, V51, P5508, DOI 10.1167/iovs.10-5419; CASON J, 1948, J ORG CHEM, V13, P227, DOI 10.1021/jo01160a010; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; EFRON N, 1989, CURR EYE RES, V8, P901; Ferdinandusse S, 2018, BBA-MOL BASIS DIS, V1864, P952, DOI 10.1016/j.bbadis.2017.12.032; GINSBURG GS, 1984, PROG LIPID RES, V23, P135, DOI 10.1016/0163-7827(84)90002-X; IYENGAR BTR, 1969, LIPIDS, V4, P28, DOI 10.1007/BF02531790; Jansen PAM, 2009, J INVEST DERMATOL, V129, P2167, DOI 10.1038/jid.2009.67; Jeyalatha MV, 2017, EXP EYE RES, V163, P29, DOI 10.1016/j.exer.2017.06.009; Jia F, 2016, J BIOL CHEM, V291, P2967, DOI 10.1074/jbc.M115.676650; Jump DB, 2009, METHODS MOL BIOL, V579, P375, DOI 10.1007/978-1-60761-322-0_19; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Klinngam W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45966-7; Knothe G, 2009, J AM OIL CHEM SOC, V86, P843, DOI 10.1007/s11746-009-1423-2; Koh S, 2016, CORNEA, V35, pS83, DOI 10.1097/ICO.0000000000000998; Lamort AS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080815; Lu H, 2013, CHEM PHYS LIPIDS, V170, P55, DOI 10.1016/j.chemphyslip.2013.03.005; MCCULLEY J P, 1984, International Ophthalmology Clinics, V24, P65, DOI 10.1097/00004397-198402420-00008; McCulley J P, 1997, Trans Am Ophthalmol Soc, V95, P79; McCulley James P, 2003, Ocul Surf, V1, P97; McMahon A, 2013, LIPIDS, V48, P513, DOI 10.1007/s11745-013-3755-9; McMahon A, 2011, J LIPID RES, V52, P1128, DOI 10.1194/jlr.M014415; Miyamoto M, 2020, ELIFE, V9, DOI 10.7554/eLife.53582; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; MONDINO BJ, 1984, AM J OPHTHALMOL, V97, P496, DOI 10.1016/S0002-9394(14)76134-3; MORGAN PB, 1995, EYE, V9, P615, DOI 10.1038/eye.1995.149; Mudgil P, 2014, INVEST OPHTH VIS SCI, V55, P7272, DOI 10.1167/iovs.14-15512; Mueller N, 2019, J MED GENET, V56, P164, DOI 10.1136/jmedgenet-2018-105711; Nakamura K, 2015, NEUROPATHOLOGY, V35, P432, DOI 10.1111/neup.12204; NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522; Reneker LW, 2020, BRIT J OPHTHALMOL, V104, P999, DOI 10.1136/bjophthalmol-2019-314466; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Sassa T, 2018, FASEB J, V32, P2966, DOI 10.1096/fj.201700947R; Shi HB, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060389; SINGH H, 1990, J LIPID RES, V31, P217; Sledge S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091862; Sperl W, 2000, EUR J PEDIATR, V159, P54, DOI 10.1007/s004310050010; Suzuki T, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.18; Suzuki Tomo, 2012, Cornea, V31 Suppl 1, pS41, DOI 10.1097/ICO.0b013e31826a04dd; Tiffany John M, 2008, Dev Ophthalmol, V41, P1, DOI 10.1159/000131066; Tjondrokoesoemo A, 2016, J BIOL CHEM, V291, P9920, DOI 10.1074/jbc.M116.719054; Tsai PS, 2006, BRIT J OPHTHALMOL, V90, P372, DOI 10.1136/bjo.2005.080846; Urata K, 1997, FETT-LIPID, V99, P327, DOI 10.1002/lipi.19970990905; Vilarinho S, 2016, P NATL ACAD SCI USA, V113, P11289, DOI 10.1073/pnas.1613228113; Villarreal-Gonzalez AJ, 2020, RHEUMATOL INT, V40, P1249, DOI 10.1007/s00296-020-04568-7; Vogel B, 2016, METHODSX, V3, P407, DOI 10.1016/j.mex.2016.05.002; Wang B, 2017, J STRUCT BIOL, V200, P279, DOI 10.1016/j.jsb.2017.08.001; Wilkerson A, 2019, INVEST OPHTH VIS SCI, V60; Yuksel S, 2019, INVEST OPHTH VIS SCI, V60	63	4	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21327	10.1096/fj.202002323R	http://dx.doi.org/10.1096/fj.202002323R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33455016	Green Accepted			2022-12-28	WOS:000647789600004
J	Williams, CM; Calderon, JH; Hock, E; Jimenez, Y; Barringer, K; Carbonaro, M; Molina-Portela, MD; Thurston, G; Li, Z; Daly, C				Williams, Courtney M.; Calderon, Jessica Harper; Hock, E.; Jimenez, Yasalp; Barringer, Kevin; Carbonaro, Marisa; Molina-Portela, Maria del Pilar; Thurston, Gavin; Li, Zhe; Daly, Christopher			Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function	FASEB JOURNAL			English	Article						bile; carcinogenesis; FGFR4 protein; FGF19 protein; hepatocytes; hepatocellular carcinoma; liver regeneration; structure&#8208; activity relationship	FIBROBLAST-GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; MOUSE; FGF19; FIBROSIS; MICE	Human Fibroblast Growth Factor 19 (FGF19) and mouse ortholog Fgf15 play similar roles in liver regeneration and metabolism via the activation of Fgfr4/b-klotho (Klb). Monomeric FGF19 and dimeric Fgf15 are both necessary for liver regeneration and proper bile acid (BA) metabolism. FGF19 elicits stronger effects than Fgf15 on glucose and fatty acid metabolism and only FGF19 induces hepatocellular carcinoma (HCC). However, inhibiting FGF19/FGFR4 signaling in HCC patients is associated with toxicity due to elevated BA levels. Here, we examine the structure/function relationship in Fgf15/FGF19 to better understand the molecular basis for their distinct functions. We demonstrate that FGF19 is a more effective activator of Fgfr4 and of downstream signaling (Erk, Plcg1) than Fgf15. Furthermore, we use site-directed mutagenesis to show that the presence or absence of an unpaired cysteine in Fgf15/19 modulates ligand structure and determines the ability of these molecules to induce hepatocyte proliferation, with monomers being more potent activators. Consistent with these findings, an engineered dimeric variant of FGF19 is less effective than wild-type FGF19 at inducing liver growth in cooperation with the Wnt-enhancer RSPO3. In contrast to effects on proliferation, monomeric and dimeric ligands equally inhibited the expression of Cyp7a1, the enzyme catalyzing the rate limiting step in BA production. Thus, structure and function of Fgf15/FGF19 are intricately linked, explaining why FGF19, but not Fgf15, induces liver tumorigenesis. Our data provide insight into FGF19/FGFR4 signaling and may inform strategies to target this pathway while limiting on-target toxicity due to dysregulation of BA production or induction of hepatocyte proliferation.	[Williams, Courtney M.; Calderon, Jessica Harper; Hock, E.; Jimenez, Yasalp; Barringer, Kevin; Carbonaro, Marisa; Molina-Portela, Maria del Pilar; Thurston, Gavin; Li, Zhe; Daly, Christopher] Regeneron Pharmaceut Inc, Oncol & Angiogenesis Dept, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	Regeneron	Williams, CM (corresponding author), Regeneron Pharmaceut Inc, Oncol & Angiogenesis Dept, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	courtney.williams@regeneron.com		Thurston, Gavin/0000-0002-4105-5919; Williams, Courtney/0000-0001-8618-8320				Alberts R, 2018, GUT, V67, P1517, DOI 10.1136/gutjnl-2016-313598; Hammad S, 2014, ARCH TOXICOL, V88, P1161, DOI 10.1007/s00204-014-1243-5; Harrison SA, 2020, HEPATOLOGY, V71, P1198, DOI 10.1002/hep.30590; Harrison SA, 2018, LANCET, V391, P1174, DOI 10.1016/S0140-6736(18)30474-4; Hirschfield GM, 2019, J HEPATOL, V70, P483, DOI 10.1016/j.jhep.2018.10.035; Kaibori M, 2016, ONCOTARGET, V7, P49091, DOI 10.18632/oncotarget.10077; Kim RD, 2019, CANCER DISCOV, V9, P1696, DOI 10.1158/2159-8290.CD-19-0555; Kong B, 2014, AM J PHYSIOL-GASTR L, V306, pG893, DOI 10.1152/ajpgi.00337.2013; Li Q, 2018, J PHYSIOL BIOCHEM, V74, P247, DOI 10.1007/s13105-018-0610-8; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mayo MJ, 2018, HEPATOL COMMUN, V2, P1037, DOI 10.1002/hep4.1209; Naugler WE, 2015, GASTROENTEROLOGY, V149, P728, DOI 10.1053/j.gastro.2015.05.043; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Nishikawa K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103103; Pai R, 2012, TOXICOL SCI, V126, P446, DOI 10.1093/toxsci/kfs011; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Uriarte I, 2015, INT J CANCER, V136, P2469, DOI 10.1002/ijc.29287; Wilson DH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14283-3; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Zhang MJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229445; Zhou M, 2017, HEPATOL COMMUN, V1, P1024, DOI 10.1002/hep4.1108; Zhou M, 2017, J HEPATOL, V66, P1182, DOI 10.1016/j.jhep.2017.01.027; Zhou M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15433; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208	26	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21286	10.1096/fj.202002203R	http://dx.doi.org/10.1096/fj.202002203R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484478	hybrid			2022-12-28	WOS:000647789600072
J	Watanabe, K; Katagiri, S; Takahashi, H; Sasaki, N; Maekawa, S; Komazaki, R; Hatasa, M; Kitajima, Y; Maruyama, Y; Shiba, T; Komatsu, K; Ohsugi, Y; Tanaka, K; Matsuzawa, A; Hirota, T; Tohara, H; Eguchi, Y; Anzai, K; Hattori, A; Iwata, T				Watanabe, Kazuki; Katagiri, Sayaka; Takahashi, Hirokazu; Sasaki, Naoki; Maekawa, Shogo; Komazaki, Rina; Hatasa, Masahiro; Kitajima, Yoichiro; Maruyama, Yusuke; Shiba, Takahiko; Komatsu, Keiji; Ohsugi, Yujin; Tanaka, Kenichi; Matsuzawa, Ayumi; Hirota, Tomomitsu; Tohara, Haruka; Eguchi, Yuichiro; Anzai, Keizo; Hattori, Atsuhiko; Iwata, Takanori			Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota	FASEB JOURNAL			English	Article						glucose uptake; metabolic syndrome; periodontal disease; Porphyromonas gingivalis; skeletal muscle	NECROSIS-FACTOR-ALPHA; PERIODONTAL-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; SARCOPENIA; OBESITY	Skeletal muscles have a high metabolic capacity, which play key roles in glucose metabolism. Although periodontal disease increases the risk of metabolic syndrome, the relationship between periodontal bacterial infection and skeletal muscle metabolic dysfunction is unclear. We found that anti-Porphyromonas gingivalis (Pg) antibody titers positively correlated with intramuscular adipose tissue content (IMAC), fasting blood glucose, and HOMA-IR in metabolic syndrome patients. In C57BL/6J mice fed a high-fat diet, recipients of oral Pg (HFPg) had impaired glucose tolerance, insulin resistance, and higher IMAC compared to recipients of saline (HFco). The soleus muscle in HFPg mice exhibited fat infiltration and lower glucose uptake with higher Tnfa expression and lower insulin signaling than in HFco mice. Gene set enrichment analysis showed that TNF alpha signaling via NF kappa B gene set was enriched in the soleus muscle of HFPg mice. Moreover, TNF-alpha also decreased glucose uptake in C2C12 myoblast cells in vitro. Based on 16S rRNA sequencing, Pg administration altered the gut microbiome, particularly by decreasing the abundance of genus Turicibacter. Microbial network of the gut microbiome was dramatically changed by Pg administration. Our findings suggest that infection with Pg is a risk factor for metabolic syndrome and skeletal muscle metabolic dysfunction via gut microbiome alteration.	[Watanabe, Kazuki; Katagiri, Sayaka; Sasaki, Naoki; Maekawa, Shogo; Komazaki, Rina; Hatasa, Masahiro; Shiba, Takahiko; Komatsu, Keiji; Ohsugi, Yujin; Iwata, Takanori] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Takahashi, Hirokazu; Kitajima, Yoichiro; Tanaka, Kenichi; Anzai, Keizo] Saga Univ, Div Endocrinol & Metab, Facil Med, 5-1-1 Nabeshima, Saga 8498501, Japan; [Takahashi, Hirokazu; Eguchi, Yuichiro] Saga Univ, Saga Univ Hosp, Liver Ctr, Saga, Japan; [Kitajima, Yoichiro] Eguchi Hosp, Dept Radiol, Saga, Japan; [Maruyama, Yusuke; Hattori, Atsuhiko] Tokyo Med & Dent Univ TMDU, Dept Biol, Coll Liberal Arts & Sci, Tokyo, Japan; [Matsuzawa, Ayumi] Tokyo Med & Dent Univ TMDU, Med Res Inst, Dept Epigenet, Tokyo, Japan; [Hirota, Tomomitsu] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Mol Genet, Tokyo, Japan; [Tohara, Haruka] Tokyo Med & Dent Univ TMDU, Dysphagia Rehabil, Dept Gerontol & Gerodontol, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Saga University; Saga University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Jikei University; Tokyo Medical & Dental University (TMDU)	Takahashi, H (corresponding author), Saga Univ, Div Endocrinol & Metab, Facil Med, 5-1-1 Nabeshima, Saga 8498501, Japan.; Katagiri, S (corresponding author), Tokyo Med & Dent Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	katagiri.peri@tmd.ac.jp; katagiri.peri@tmd.ac.jp	Maekawa, Shogo/GQH-4094-2022; MAEKAWA, SHOGO/AAX-6288-2021	MAEKAWA, SHOGO/0000-0002-6207-7826	MEXT \ Japan Society for the Promotion of Science (JSPS) [JP17K11982, JP18K15754, JP19K24062, JP19K18989, JP19K10221, JP18K11016, JP20J13034, JP20H03863]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP17K11982, JP18K15754, JP19K24062, JP19K18989, JP19K10221, JP18K11016, JP20J13034 and JP20H03863	Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Batsis JA, 2018, NAT REV ENDOCRINOL, V14, P513, DOI 10.1038/s41574-018-0062-9; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Giudice J, 2017, CURR OPIN PHARMACOL, V34, P49, DOI 10.1016/j.coph.2017.05.005; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hua N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182430; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Katagiri S, 2016, DIABETES, V65, P2760, DOI 10.2337/db15-1721; Kim OS, 2018, J PERIODONTAL RES, V53, P362, DOI 10.1111/jre.12521; King GL, 2016, DIABETES, V65, P1462, DOI 10.2337/db16-0152; Kitajima Y, 2018, J GASTROENTEROL, V53, P427, DOI 10.1007/s00535-017-1370-x; Kojima T, 1997, J PERIODONTOL, V68, P618, DOI 10.1902/jop.1997.68.7.618; Komazaki R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14260-9; Kudo C, 2012, J DENT RES, V91, P1190, DOI 10.1177/0022034512461796; Lahiri S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aan5662; Lamster IB, 2017, INT DENT J, V67, P67, DOI 10.1111/idj.12264; Li YM, 2019, SAUDI J BIOL SCI, V26, P395, DOI 10.1016/j.sjbs.2018.11.008; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Fernandez-Real JM, 2015, DIABETES CARE, V38, P2169, DOI 10.2337/dc14-3082; Martinez-Herrera M, 2017, MED ORAL PATOL ORAL, V22, pE708, DOI 10.4317/medoral.21786; McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE419, DOI 10.1152/ajpendo.00032.2001; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Page R C, 1998, Ann Periodontol, V3, P108, DOI 10.1902/annals.1998.3.1.108; Pajak B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010234; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Raza GS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05259-3; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Saito T, 1998, NEW ENGL J MED, V339, P482, DOI 10.1056/NEJM199808133390717; Sasaki N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02470; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shadrin IY, 2016, CELL MOL LIFE SCI, V73, P4175, DOI 10.1007/s00018-016-2285-z; Shiba T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30997; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Teramoto T, 2008, J ATHEROSCLER THROMB, V15, P1, DOI 10.5551/jat.E580; Toyoda T, 2011, J BIOL CHEM, V286, P4133, DOI 10.1074/jbc.M110.174938; Udagawa S, 2018, ACTA ODONTOL SCAND, V76, P433, DOI 10.1080/00016357.2018.1426876; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295; Zimowska M, 2017, MUSCLE NERVE, V55, P400, DOI 10.1002/mus.25246; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	57	13	14	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001158R	http://dx.doi.org/10.1096/fj.202001158R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33197074				2022-12-28	WOS:000592668200001
J	Cao, Q; Liu, L; Hu, YG; Jiang, N; Wang, YJ; Chen, JL; Zhou, Q; Guo, RQ				Cao, Quan; Liu, Lian; Hu, Yugang; Jiang, Nan; Wang, Yijia; Chen, Jinling; Zhou, Qing; Guo, Ruiqiang			Irradiation of carotid baroreceptor with low-intensity pulsed ultrasound exerts different metabolic protection in perirenal, epididymal white adipose tissue and interscapular brown adipose tissue of obese rats	FASEB JOURNAL			English	Article						AMP-activated protein kinase; peroxisome proliferator-activated receptor; autonomic nervous system; obesity	SYMPATHETIC ACTIVATION; DEVELOPMENTAL ORIGIN; FAT; ADIPOCYTES; INSULIN; LIPOLYSIS; PROTEIN; HEALTH; RESISTANCE; TARGET	This study was designed to clarify whether the irradiation of carotid baroreceptor (CB) with low-intensity pulsed ultrasound (LIPUS) protects against obesity by rebalancing the autonomic nervous system (ANS). Obesity was induced using a high-fat diet (HFD) for 8 weeks in Sprague-Dawley rats. Irradiation with LIPUS was daily (20 minutes a day) applied to the right CB. In our study, LIPUS significantly ameliorated metabolic disorders in obese rats. LIPUS partly restored norepinephrine (NE) and acetylcholine (ACH) levels in the perirenal white adipose tissue (PWAT), epididymal white adipose tissue (EWAT), interscapular brown adipose tissue (IBAT), and plasma of obese rats. LIPUS partially rectified the dysregulated AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor (PPAR) alpha/gamma pathway in the PWAT, EWAT, and IBAT of obese rats. PPAR gamma and PPAR gamma target genes respond more sensitively to HFD and LIPUS in PWAT and EWAT than in IBAT. NE, ACH, uncoupling protein-1, phosphorylated AMPK, PPAR alpha, and PPAR alpha target genes respond more sensitively to HFD and LIPUS in IBAT than in PWAT and EWAT. Conclusion: LIPUS irradiation of CB exerts different metabolic protection in PWAT, EWAT, and IBAT by rebalancing the ANS and rectifying the AMPK/PPAR alpha/gamma pathway in obese rats.	[Cao, Quan; Hu, Yugang; Jiang, Nan; Wang, Yijia; Chen, Jinling; Zhou, Qing; Guo, Ruiqiang] Wuhan Univ, Renmin Hosp, Dept Ultrasound Imaging, Echo Lab, 238 Jiefang Rd, Wuhan 430060, Peoples R China; [Cao, Quan; Hu, Yugang; Jiang, Nan; Wang, Yijia; Chen, Jinling; Zhou, Qing; Guo, Ruiqiang] Wuhan Univ, Renmin Hosp, Dept Ultrasound Imaging, 3D Printing & AI Lab, Wuhan, Peoples R China; [Liu, Lian] Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zhou, Q; Guo, RQ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Ultrasound Imaging, Echo Lab, 238 Jiefang Rd, Wuhan 430060, Peoples R China.	qingzhou@whu.edu.cn; ruiqiangwhrm@whu.edu.cn			National Natural Science Foundation of China [81971624]; Wuhan Municipal Science and Technology Bureau [2019020701011477]; Fundamental Research Funds for the Central Universities [2042019kf0089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Municipal Science and Technology Bureau; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 81971624, Recipient: Qing Zhou), Wuhan Municipal Science and Technology Bureau (No. 2019020701011477, Recipient: Qing Zhou), and Fundamental Research Funds for the Central Universities (No. 2042019kf0089, Recipient: Nan Jiang)	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Beech DJ, 2019, ARTERIOSCL THROM VAS, V39, P2228, DOI 10.1161/ATVBAHA.119.313348; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Campioli E, 2011, OBESITY, V19, P703, DOI 10.1038/oby.2010.244; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao Q, 2019, J LIPID RES, V60, P1212, DOI [10.1194/jlr.M091256, 10.1194/jlr.m091256]; Chakravarthy MV, 2009, J LIPID RES, V50, P630, DOI 10.1194/jlr.M800379-JLR200; Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002; Chu DT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13093; Chu DT, 2017, HORM METAB RES, V49, P276, DOI 10.1055/s-0043-100384; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Deng JL, 2020, AUTOPHAGY, V16, P451, DOI 10.1080/15548627.2019.1628537; Deshpande SS, 2019, ENDOCRINOLOGY, V160, P220, DOI 10.1210/en.2018-00569; Ding L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2006-0; Chu DT, 2017, BIOCHIMIE, V138, P102, DOI 10.1016/j.biochi.2017.04.017; Chu DT, 2017, J PHYSIOL BIOCHEM, V73, P1, DOI 10.1007/s13105-016-0536-y; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Frayn KN, 2010, ACTA PHYSIOL, V199, P509, DOI 10.1111/j.1748-1716.2010.02128.x; Fucho R, 2017, FASEB J, V31, P1263, DOI 10.1096/fj.201601156R; Gamboa A, 2014, HYPERTENSION, V64, P867, DOI 10.1161/HYPERTENSIONAHA.114.03738; Garretson JT, 2016, MOL METAB, V5, P626, DOI 10.1016/j.molmet.2016.06.013; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Giordano A, 2014, EUR J ENDOCRINOL, V170, pR159, DOI 10.1530/EJE-13-0945; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Granger AJ, 2017, CURR OPIN NEUROBIOL, V45, P85, DOI 10.1016/j.conb.2017.04.007; Greenberg AS, 2011, EMBO J, V30, P4337, DOI 10.1038/emboj.2011.371; Hashimoto M, 2019, FASEB J, V33, P8069, DOI 10.1096/fj.201802147RR; Jura M, 2016, BIOCHIMIE, V124, P124, DOI 10.1016/j.biochi.2015.05.006; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kotzbeck P, 2018, J LIPID RES, V59, P784, DOI 10.1194/jlr.M079665; Lainez NM, 2019, ENDOCRINOLOGY, V160, P2719, DOI 10.1210/en.2019-00487; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Landsberg L, 2012, OBES REV, V13, P97, DOI 10.1111/j.1467-789X.2012.01040.x; Li L, 2019, MOL ASPECTS MED, V68, P60, DOI 10.1016/j.mam.2019.07.005; Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702; Lim K, 2013, HYPERTENSION, V61, P628, DOI 10.1161/HYPERTENSIONAHA.111.00705; Marin-Royo G, 2019, FASEB J, V33, P12060, DOI 10.1096/fj.201900347RR; Messina G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00137; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Qi M, 2017, THERANOSTICS, V7, P4498, DOI 10.7150/thno.17949; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6; Schreiber R, 2015, P NATL ACAD SCI USA, V112, P13850, DOI 10.1073/pnas.1516004112; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Silva AZ, 2018, LIFE SCI, V211, P147, DOI 10.1016/j.lfs.2018.09.027; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Straznicky NE, 2009, DIABETES, V58, P1126, DOI 10.2337/db08-1595; Tabuchi Y, 2007, CANCER LETT, V246, P149, DOI 10.1016/j.canlet.2006.02.011; Thomas D, 2017, METABOLISM, V72, P120, DOI 10.1016/j.metabol.2017.04.005; Toczylowski K, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2060-7; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Vekic J, 2019, METABOLISM, V92, P71, DOI 10.1016/j.metabol.2018.11.005; Victor RG, 2015, NAT REV CARDIOL, V12, P451, DOI 10.1038/nrcardio.2015.96; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang J, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0750-1; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Xiong XQ, 2014, ACTA PHYSIOL, V210, P468, DOI 10.1111/apha.12182; Xue RQ, 2017, J CELL MOL MED, V21, P58, DOI 10.1111/jcmm.12938; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhu YB, 2015, OBESITY, V23, P1014, DOI 10.1002/oby.21062; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	72	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15431	15447		10.1096/fj.202001550R	http://dx.doi.org/10.1096/fj.202001550R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954572				2022-12-28	WOS:000573726700001
J	Martucciello, S; Turturo, MG; Bilio, M; Cioffi, S; Chen, L; Baldini, A; Illingworth, E				Martucciello, Stefania; Turturo, Maria Giuseppina; Bilio, Marchesa; Cioffi, Sara; Chen, Li; Baldini, Antonio; Illingworth, Elizabeth			A dual role forTbx1in cardiac lymphangiogenesis through genetic interaction withVegfr3	FASEB JOURNAL			English	Article						cardiac; genetic interaction; lymphatic vessel; mouse model; Tbx1; Vegfr3	2ND HEART; TBX1; VEGFR3; ANGIOGENESIS; EXPRESSION; GROWTH; CELLS; CRE; ENDOTHELIUM; LYMPHATICS	The transcription factorTBX1is the major gene implicated in 22q11.2 deletion syndrome (22q11.2DS). The complex clinical phenotype includes vascular anomalies and a recent report presented new cases of primary lymphedema in 22q11.2DS patients. We have previously shown that TBX1 is required for systemic lymphatic vessel development in prenatal mice and it is critical for their survival postnatally. Using loss-of-function genetics and transgenesis in the mouse, we show here a strong genetic interaction betweenTbx1andVegfr3in cardiac lymphangiogenesis. Intriguingly, we found that different aspects of the cardiac lymphatic phenotype inTbx1-Vegfr3compound heterozygotes were regulated independently by the two genes, withTbx1primarily regulating vessel numbers andVegfr3vessel morphology. Consistent with this observation,Tbx1(Cre)-activated expression of aVegfr3transgene rescued partially the cardiac lymphatic abnormalities in compound heterozygotes. Through time-controlled genetic experiments, we show thatTbx1is activated and required in cardiac lymphatic endothelial cell (LEC) progenitors between E10.5 and E11.5. Furthermore, we found that it is also required later in development for the growth of the cardiac lymphatics. Finally, our study revealed a differential sensitivity between ventral and dorsal cardiac lymphatics to the effects of alteredTbx1andVegfr3gene dosage, and we show that this likely results from an earlier requirement forTbx1in ventral cardiac LEC progenitors.	[Martucciello, Stefania] IRCCS Neuromed, Pozzilli, Italy; [Martucciello, Stefania; Illingworth, Elizabeth] Univ Salerno, Dept Chem & Biol, Via Giovanni Paolo II 132, I-84084 Fisciano, Italy; [Turturo, Maria Giuseppina; Bilio, Marchesa; Cioffi, Sara; Baldini, Antonio] CNR, Inst Genet & Biophys ABT, Naples, Italy; [Chen, Li] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Baldini, Antonio] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	IRCCS Neuromed; University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Houston System; University of Houston; University of Naples Federico II	Illingworth, E (corresponding author), Univ Salerno, Dept Chem & Biol, Via Giovanni Paolo II 132, I-84084 Fisciano, Italy.	eillingworth@unisa.it	CIOFFI, Sara/GWZ-9079-2022; Baldini, Antonio/M-2355-2015	CIOFFI, Sara/0000-0003-3197-6578; MARTUCCIELLO, STEFANIA/0000-0002-3720-1442; Baldini, Antonio/0000-0002-5330-0256	Fondation Leducq [15CVD01]; Ministero della Salute (Ministry of Health, Italy) [RF-2011-02347197, 20179J2P9J]; Fondation Jerome Lejeune (Jerome Lejeune Foundation) [1685]	Fondation Leducq(Leducq Foundation); Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy); Fondation Jerome Lejeune (Jerome Lejeune Foundation)	Fondation Leducq, Grant/Award Number: 15CVD01; Ministero della Salute (Ministry of Health, Italy), Grant/Award Number: RF-2011-02347197 and 20179J2P9J; Fondation Jerome Lejeune (Jerome Lejeune Foundation), Grant/Award Number: 1685	Alfano D, 2019, HUM MOL GENET, V28, P2295, DOI 10.1093/hmg/ddz058; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Chen L, 2010, J CELL BIOL, V189, P417, DOI 10.1083/jcb.200912037; Cioffi S, 2014, HUM MOL GENET, V23, P78, DOI 10.1093/hmg/ddt400; Connell FC, 2009, HUM GENET, V124, P625, DOI 10.1007/s00439-008-0586-5; Cortes C, 2018, CIRC RES, V122, P142, DOI 10.1161/CIRCRESAHA.117.310838; Diogo R, 2015, NATURE, V520, P466, DOI 10.1038/nature14435; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Ehlers ML, 2014, CELL REP, V8, P1639, DOI 10.1016/j.celrep.2014.08.035; Flaht-Zabost A, 2014, ANAT REC, V297, P1115, DOI 10.1002/ar.22912; Gordon K, 2013, CIRC RES, V112, P956, DOI 10.1161/CIRCRESAHA.113.300350; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Ishikawa Y, 2007, HISTOPATHOLOGY, V51, P345, DOI 10.1111/j.1365-2559.2007.02785.x; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lioux G, 2020, DEV CELL, V52, P350, DOI 10.1016/j.devcel.2019.12.006; Mahadevan A, 2014, DEV CELL, V31, P690, DOI 10.1016/j.devcel.2014.11.002; Mansir T, 1999, GENET COUNSEL, V10, P67; Martinez-Corral I, 2015, CIRC RES, V116, P1649, DOI 10.1161/CIRCRESAHA.116.306170; Maruyama K, 2019, DEV BIOL, V452, P134, DOI 10.1016/j.ydbio.2019.05.002; Megason SG, 2002, DEVELOPMENT, V129, P2087; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Pichol-Thievend C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160184; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Reuter MS, 2019, GENET MED, V21, P1001, DOI 10.1038/s41436-018-0260-9; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stanczuk L, 2015, CELL REP, V10, P1708, DOI 10.1016/j.celrep.2015.02.026; Stone OA, 2019, DEV CELL, V50, P247, DOI 10.1016/j.devcel.2019.04.034; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Theveniau-Ruissy M, 2016, DEV DYNAM, V245, P445, DOI 10.1002/dvdy.24380; Unolt M, 2018, EUR J MED GENET, V61, P411, DOI 10.1016/j.ejmg.2018.02.006; Unolt M, 2018, AM J MED GENET A, V176, P2087, DOI 10.1002/ajmg.a.38662; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Xu HS, 2005, DEVELOPMENT, V132, P4387, DOI 10.1242/dev.02018; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yang Y, 2014, J CLIN INVEST, V124, P888, DOI 10.1172/JCI71609; Zarkada G, 2015, P NATL ACAD SCI USA, V112, P761, DOI 10.1073/pnas.1423278112	44	5	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15062	15079		10.1096/fj.201902202R	http://dx.doi.org/10.1096/fj.201902202R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32951265	hybrid, Green Submitted			2022-12-28	WOS:000573725500001
J	Zhu, YQ; Pan, XS; Du, N; Li, KY; Hu, YM; Wang, LL; Zhang, J; Liu, YY; Zuo, LQ; Meng, XM; Hu, CM; Wu, X; Jin, J; Wu, WY; Chen, XT; Wu, FR; Huang, Y				Zhu, Yueqin; Pan, Xuesheng; Du, Na; Li, Kuayue; Hu, Yamin; Wang, Lili; Zhang, Jin; Liu, Yanyi; Zuo, Longquan; Meng, Xiaoming; Hu, Chengmu; Wu, Xian; Jin, Juan; Wu, Wenyong; Chen, Xiangtao; Wu, Fanrong; Huang, Yan			ASIC1a regulates miR-350/SPRY2 by N-6-methyladenosine to promote liver fibrosis	FASEB JOURNAL			English	Article						ASIC1a; HSC; SPRY2; METTL3; miR-350	SENSING ION CHANNELS; HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; NUCLEAR-RNA; INDUCED ACTIVATION; METHYLATION; EXPRESSION; PROLIFERATION; TRANSDUCTION; MICRORNA	As a reversible scar repair reaction, liver fibrosis can be blocked or even reversed by proper intervention during its formation. Our work suggests that acid-sensitive ion channel 1a (ASIC1a) participates in liver fibrosis and presents a novel mechanism involving m(6)A modification and miR-350/SPRY2. We demonstrated that the expression of ASIC1a was significantly increased in liver tissue of patients with liver fibrosis and animal models of liver fibrosis, as well as PDGF-BB-induced activated HSC-T6. After downregulating the expression of ASIC1a, the degree of liver fibrosis is reduced and HSC activation was inhibited, the level of m(6)A modification and miR-350 expression were also reduced. The results of dual luciferase reporter assay showed that miR-350 can bind to the target gene SPRY2 and inhibit its expression. We also found that METTL3 can regulate the extent of m(6)A modification of pri-miR-350 by binding to DGCR8. In addition, silencing or blocking the expression of ASIC1a can reduce the expression of PI3K/AKT and ERK signaling pathway-related proteins in activated HSCs. Taken together, we demonstrated that ASIC1a regulates the processing of miR-350 through METTL3-dependent m(6)A modification, and mature miR-350 targets SPRY2 and further promotes liver fibrosis through the PI3K/KT and ERK pathways.	[Zhu, Yueqin; Pan, Xuesheng; Du, Na; Li, Kuayue; Hu, Yamin; Wang, Lili; Zhang, Jin; Liu, Yanyi; Meng, Xiaoming; Hu, Chengmu; Wu, Xian; Chen, Xiangtao; Wu, Fanrong; Huang, Yan] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Anhui Prov Lab Inflammatory & Immun Dis, Hefei 230032, Peoples R China; [Zuo, Longquan] Hosp Armed Police Anhui Prov, Dept Pharm, Hefei 230041, Peoples R China; [Jin, Juan] Anhui Med Univ, Sch Basic Med Sci, Dept Pharmacol, Hefei 230032, Peoples R China; [Wu, Wenyong] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei 230022, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Huang, Y (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China.	aydhy@126.com		Huang, Yan/0000-0002-6587-6607	Outstanding youth project of Anhui natural science foundation [1908085J30]; 2019 anhui medical university basic and clinical cooperative research promotion project [2019xkjT015]; School-level Young Talents Supporting Plan [0601037104]; 2018 Young Talents Double Training Project Subsidy [0601037206]	Outstanding youth project of Anhui natural science foundation; 2019 anhui medical university basic and clinical cooperative research promotion project; School-level Young Talents Supporting Plan; 2018 Young Talents Double Training Project Subsidy	Outstanding youth project of Anhui natural science foundation, Grant/Award Number: 1908085J30; 2019 anhui medical university basic and clinical cooperative research promotion project, Grant/Award Number: 2019xkjT015; School-level Young Talents Supporting Plan, Grant/Award Number: 0601037104; 2018 Young Talents Double Training Project Subsidy, Grant/Award Number: 0601037206	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Alexander IE, 1996, HUM GENE THER, V7, P841, DOI 10.1089/hum.1996.7.7-841; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chai S, 2010, J BIOL CHEM, V285, P13002, DOI 10.1074/jbc.M109.086041; Chassagnon IR, 2017, P NATL ACAD SCI USA, V114, P3750, DOI 10.1073/pnas.1614728114; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Chen YZ, 2019, CELL DEATH DIFFER, V26, P1832, DOI 10.1038/s41418-018-0250-0; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dibas A, 2018, CURR EYE RES, V43, P921, DOI 10.1080/02713683.2018.1454478; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao ML, 2012, EMBO MOL MED, V4, P776, DOI 10.1002/emmm.201100944; Ge YZ, 2013, BBA-MOL BASIS DIS, V1832, P1, DOI 10.1016/j.bbadis.2012.09.004; Gregory NS, 2018, NEUROSCIENCE, V386, P166, DOI 10.1016/j.neuroscience.2018.06.033; Han B, 2020, NANOTOXICOLOGY, V14, P1, DOI 10.1080/17435390.2019.1661041; He Y, 2018, CELL PHYSIOL BIOCHEM, V47, P1465, DOI 10.1159/000490839; Hu JF, 2015, CLIN SCI, V129, P305, DOI 10.1042/CS20140012; Huang C, 2010, J PHARM PHARMACOL, V62, P223, DOI 10.1211/jpp.62.02.0010; Huang HL, 2019, NATURE, V567, P414, DOI 10.1038/s41586-019-1016-7; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jin C, 2017, ONCOTARGET, V8, P25977, DOI 10.18632/oncotarget.10774; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Knuckles P, 2017, NAT STRUCT MOL BIOL, V24, P561, DOI 10.1038/nsmb.3419; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu ML, 2017, ONCOTARGET, V8, P8283, DOI 10.18632/oncotarget.14164; Liu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25386-9; Lu QL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10116-0; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420; Pan XY, 2019, THERANOSTICS, V9, P4308, DOI 10.7150/thno.32710; Patel R, 2013, J CLIN INVEST, V123, P1157, DOI 10.1172/JCI63672; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Peng Y, 2014, AM J PHYSIOL-GASTR L, V306, pG253, DOI 10.1152/ajpgi.00471.2012; Pereira BLB, 2015, NUTRIENTS, V7, P9640, DOI 10.3390/nu7115493; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Qu NF, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6638-5; Rivera-Barahona A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06420-8; Samadaian N, 2018, PATHOL RES PRACT, V214, P2018, DOI 10.1016/j.prp.2018.09.019; Sanchez A, 2008, ONCOGENE, V27, P4969, DOI 10.1038/onc.2008.129; Sui J, 2018, CHEM-BIOL INTERACT, V280, P77, DOI 10.1016/j.cbi.2017.12.020; Tao L, 2018, ARCH TOXICOL, V92, P2935, DOI 10.1007/s00204-018-2278-9; Tsay HC, 2019, J HEPATOL, V70, P722, DOI 10.1016/j.jhep.2018.12.016; Wang H, 2015, BIOCHEM BIOPH RES CO, V468, P758, DOI 10.1016/j.bbrc.2015.11.029; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang YH, 2019, TOXICOL LETT, V300, P1, DOI 10.1016/j.toxlet.2018.10.003; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wu FR, 2014, MOL CELL BIOCHEM, V395, P199, DOI 10.1007/s11010-014-2125-0; Wu KM, 2016, CLIN SCI, V130, P1469, DOI 10.1042/CS20160334; Xiao FL, 2018, CELL BIOL INT, V42, P1370, DOI 10.1002/cbin.11022; Xiao S, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0097-8; Xin X, 2014, FRONT BIOSCI-LANDMRK, V19, P1418, DOI 10.2741/4292; Yu H, 2018, J BIOMOL STRUCT DYN, V36, P2558, DOI 10.1080/07391102.2017.1363087; Yu XW, 2015, GLIA, V63, P483, DOI 10.1002/glia.22766; Zhang F, 2014, MOL CELL ENDOCRINOL, V382, P197, DOI 10.1016/j.mce.2013.09.020; Zhang YH, 2017, LAB INVEST, V97, P53, DOI 10.1038/labinvest.2016.127; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zuo LQ, 2019, J CELL MOL MED, V23, P3940, DOI 10.1111/jcmm.14275	68	12	14	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14371	14388		10.1096/fj.202001337R	http://dx.doi.org/10.1096/fj.202001337R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32949431				2022-12-28	WOS:000572425000001
J	Silvestri, E; Senese, R; De Matteis, R; Cioffi, F; Moreno, M; Lanni, A; Gentile, A; Busiello, RA; Salzano, AM; Scaloni, A; de Lange, P; Goglia, F; Lombardi, A				Silvestri, Elena; Senese, Rosalba; De Matteis, Rita; Cioffi, Federica; Moreno, Maria; Lanni, Antonia; Gentile, Alessandra; Busiello, Rosa Anna; Salzano, Anna Maria; Scaloni, Andrea; de Lange, Pieter; Goglia, Fernando; Lombardi, Assunta			Absence of uncoupling protein 3 at thermoneutrality influences brown adipose tissue mitochondrial functionality in mice	FASEB JOURNAL			English	Article						metabolism; oxidative stress; respiratory chain	BLUE NATIVE-PAGE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; SUPEROXIDE-PRODUCTION; RESPIRATORY-CHAIN; SKELETAL-MUSCLE; THYROID-HORMONE; UCP3; THERMOGENESIS; OBESITY; ELECTROPHORESIS	The physiological role played by uncoupling protein 3 (UCP3) in brown adipose tissue (BAT) has not been fully elucidated so far. In the present study, we evaluated the impact of the absence of UCP3 on BAT mitochondrial functionality and morphology. To this purpose, wild type (WT) and UCP3 Knockout (KO) female mice were housed at thermoneutrality (30 degrees C), a condition in which BAT contributes to energy homeostasis independently of its cold-induced thermogenic function. BAT mitochondria from UCP3 KO mice presented a lower ability to oxidize the fatty acids and glycerol-3-phosphate, and an enhanced oxidative stress as revealed by enhanced mitochondrial electron leak, lipid hydroperoxide levels, and induction of antioxidant mitochondrial enzymatic capacity. The absence of UCP3 also influenced the mitochondrial super-molecular protein aggregation, an important feature for fatty acid oxidation rate as well as for adequate cristae organization and mitochondrial shape. Indeed, electron microscopy revealed alterations in mitochondrial morphology in brown adipocytes from KO mice. In the whole, data here reported show that the absence of UCP3 results in a significant alteration of BAT mitochondrial physiology and morphology. These observations could also help to clarify some aspects of the association between metabolic disorders associated with low UCP3 levels, as previously reported in human studies.	[Silvestri, Elena; Cioffi, Federica; Moreno, Maria; Goglia, Fernando] Univ Sannio, Dept Sci & Technol, Via Sanctis, I-82100 Benevento, Italy; [Senese, Rosalba; Lanni, Antonia; de Lange, Pieter] Univ Campania Luigi Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [De Matteis, Rita] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Gentile, Alessandra; Busiello, Rosa Anna; Lombardi, Assunta] Univ Naples Federico II, Dept Biol, Naples, Italy; [Salzano, Anna Maria; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, Naples, Italy	University of Sannio; Universita della Campania Vanvitelli; University of Urbino; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Goglia, F (corresponding author), Univ Sannio, Dept Sci & Technol, Via Sanctis, I-82100 Benevento, Italy.; Lombardi, A (corresponding author), Univ Naples Federico II, Complesso Univ Monte St Angelo, Dept Biol, Edificio 7, I-80126 Naples, Italy.	goglia@unisannio.it; assunta.lombardi@unina.it	de Lange, Pieter/GXA-3052-2022; Salzano, Anna Maria/C-7139-2012	Salzano, Anna Maria/0000-0001-7192-8760; SENESE, Rosalba/0000-0003-1571-0980; MORENO, Maria/0000-0002-6218-5501; Scaloni, Andrea/0000-0001-9362-8515; Silvestri, Elena/0000-0002-0592-9033; GENTILE, ALESSANDRA/0000-0002-5790-8533	University of Sannio Research Grants; University of Urbino Grants; Department of Biology University of Naples Federico II (Ricerca di Base)	University of Sannio Research Grants; University of Urbino Grants; Department of Biology University of Naples Federico II (Ricerca di Base)	This study was funded by University of Sannio Research Grants, University of Urbino Grants and by the Department of Biology University of Naples Federico II (Ricerca di Base)	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Arioli S, 2009, MICROBIOL-SGM, V155, P1953, DOI 10.1099/mic.0.024737-0; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bloor ID, 2014, HORM BEHAV, V66, P95, DOI 10.1016/j.yhbeh.2014.02.007; Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014; BUKOWIEC.LJ, 1974, BIOCHIM BIOPHYS ACTA, V348, P115, DOI 10.1016/0005-2760(74)90097-6; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019; Calderon-Dominguez M, 2016, ADIPOCYTE, V5, P98, DOI 10.1080/21623945.2015.1122857; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965; de Lange P, 2001, ENDOCRINOLOGY, V142, P3414, DOI 10.1210/en.142.8.3414; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; GARRIB A, 1986, J BIOL CHEM, V261, P8042; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Gonzalez-Hurtado E, 2018, MOL METAB, V7, P45, DOI 10.1016/j.molmet.2017.11.004; He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115; HEATH RL, 1976, ANAL BIOCHEM, V76, P184, DOI 10.1016/0003-2697(76)90277-3; Hilse KE, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00747; Hilse KE, 2016, BBA-BIOENERGETICS, V1857, P72, DOI 10.1016/j.bbabio.2015.10.011; Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lombardi A, 2009, J PROTEOMICS, V72, P708, DOI 10.1016/j.jprot.2009.02.007; Lombardi A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080916; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Masand R, 2018, CELL METAB, V27, P616, DOI 10.1016/j.cmet.2018.01.018; McBride S, 2019, ARCH BIOCHEM BIOPHYS, V663, P239, DOI 10.1016/j.abb.2019.01.018; Mills EM, 2004, J MOL MED, V82, P787, DOI 10.1007/s00109-004-0591-7; Mills EM, 2003, NATURE, V426, P403, DOI 10.1038/426403a; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Motloch LJ, 2016, J MEMBRANE BIOL, V249, P577, DOI 10.1007/s00232-016-9913-2; MRAEK T, 2014, BIOCHIM BIOPHYS ACTA, V1837, P98; MRAEK T, 2013, BIOCH BIOPHYS ACTA B, V1827, P401, DOI DOI 10.1016/j.bbabio.2012.11.014; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; Perrino C, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000086; Pohl EE, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00470; Quintana-Cabrera R, 2018, BIOCHEM BIOPH RES CO, V500, P94, DOI 10.1016/j.bbrc.2017.04.088; Rauchova H, 2003, ACTA BIOCHIM POL, V50, P405; Reitman ML, 2018, FEBS LETT, V592, P2098, DOI 10.1002/1873-3468.13070; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Rodriguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200; Salzano AM, 2013, J PROTEOMICS, V94, P240, DOI 10.1016/j.jprot.2013.09.007; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572; Schrauwen P, 2005, ACTA PHYSIOL SCAND, V183, P273, DOI 10.1111/j.1365-201X.2004.01393.x; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Sprague JE, 2004, BIOCHEM PHARMACOL, V68, P1339, DOI 10.1016/j.bcp.2004.03.049; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Valle A, 2007, CELL PHYSIOL BIOCHEM, V19, P195, DOI 10.1159/000099207; Vrbacky M, 2007, BBA-BIOENERGETICS, V1767, P989, DOI 10.1016/j.bbabio.2007.05.002; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	62	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15146	15163		10.1096/fj.202000995R	http://dx.doi.org/10.1096/fj.202000995R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32946628				2022-12-28	WOS:000572282400001
J	Marinello, WP; Mohseni, ZS; Cunningham, SJ; Crute, C; Huang, R; Zhang, JJ; Feng, LP				Marinello, William P.; Mohseni, Zahra S.; Cunningham, Sarah J.; Crute, Christine; Huang, Rong; Zhang, Jun J.; Feng, Liping			Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes	FASEB JOURNAL			English	Article						invasion; PFBS; placenta cytotrophoblast; preeclampsia; proliferation	EPITHELIAL-MESENCHYMAL TRANSITION; POLYFLUOROALKYL SUBSTANCES PFASS; INTRAUTERINE GROWTH RESTRICTION; EXTRAVILLOUS TROPHOBLAST CELLS; ADRENOMEDULLIN MESSENGER-RNA; ACTIVATED PROTEIN-KINASE; PERFLUOROOCTANE SULFONATE; PERFLUORINATED COMPOUNDS; 1ST TRIMESTER; PERFLUOROALKYL ACIDS	We reported that maternal PFBS, an emerging pollutant, exposure is positively associated with preeclampsia which can result from aberrant trophoblasts invasion and subsequent placental ischemia. In this study, we investigated the effects of PFBS on trophoblasts proliferation/invasion and signaling pathways. We exposed a human trophoblast line, HTR8/SVneo, to PFBS. Cell viability, proliferation, and cell cycle were evaluated by the MTS assay, Ki-67 staining, and flow cytometry, respectively. We assessed cell migration and invasion with live-cell imaging-based migration assay and matrigel invasion assay, respectively. Signaling pathways were examined by Western blot, RNA-seq, and qPCR. PFBS exposure interrupted cell proliferation and invasion in a dose-dependent manner. PFBS (100 mu M) did not cause cell death but instead significant cell proliferation without cell cycle disruption. PFBS (10 and 100 mu M) decreased cell migration and invasion, while PFBS (0.1 mu M) significantly increased cell invasion but not migration. Further, RNA-seq analysis identified dysregulated HIF-1 alpha target genes that are relevant to cell proliferation/invasion and preeclampsia, while Western Blot data showed the activation of HIF-1 alpha, but not Notch, ERK1/2, (PI3K)AKT, and P38 pathways. PBFS exposure altered trophoblast cell proliferation/invasion which might be mediated by preeclampsia-related genes, suggesting a possible association between prenatal PFBS exposure and adverse placentation.	[Marinello, William P.; Mohseni, Zahra S.; Crute, Christine; Feng, Liping] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA; [Cunningham, Sarah J.] Duke Univ, Univ Program Genet & Genom, Durham, NC USA; [Crute, Christine] Duke Univ, Nicholas Sch Environm, Integrated Toxicol & Environm Hlth Program, Durham, NC 27708 USA; [Huang, Rong; Zhang, Jun J.; Feng, Liping] Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp, Sch Med, Shanghai, Peoples R China	Duke University; Duke University; Duke University; Shanghai Jiao Tong University	Feng, LP (corresponding author), Duke Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Med Ctr, Box 103208, Durham, NC 27710 USA.	liping.feng@duke.edu	Marinello, William/AAR-8203-2020	Marinello, William/0000-0002-7248-3908	Fogarty International Center of the National Institutes of Health [1K01TW010828-01]; Ministry of Science and Technology of China [2014CB943300]; National Natural Science Foundation of China [81803246]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fogarty International Center of the National Institutes of Health under Award Number 1K01TW010828-01 (PI: Liping Feng) and the Ministry of Science and Technology of China under Award Number 2014CB943300 (PI: Jun J. Zhang). National Natural Science Foundation of China (81803246, PI: Rong Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge Emi Yuan, a summer working student, performed the quantitate PCR to confirm RNA-seq results and Junjiao Song, a visiting scholar, performed Western Blot for HIF-1 alpha.	Al-Ghafra A, 2006, MOL HUM REPROD, V12, P181, DOI 10.1093/molehr/gal016; Albini A, 2016, CANCER RES, V76, P4595, DOI 10.1158/0008-5472.CAN-16-1971; Alexander BT, 2001, HYPERTENSION, V37, P485, DOI 10.1161/01.HYP.37.2.485; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Anin Sheba Anin, 2004, Hum Fertil (Camb), V7, P169, DOI 10.1080/14647270400006911; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Appel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103216; Arimoto-Ishida E, 2009, ENDOCRINOLOGY, V150, P4306, DOI 10.1210/en.2008-1662; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Barrett SL, 2008, PRENATAL DIAG, V28, P28, DOI 10.1002/pd.1898; Bechi N, 2013, TOXICOL IN VITRO, V27, P995, DOI 10.1016/j.tiv.2013.01.013; Behr AC, 2018, TOXICOL LETT, V291, P51, DOI 10.1016/j.toxlet.2018.03.029; Beiswenger TR, 2012, REPROD SCI, V19, P526, DOI 10.1177/1933719111426600; Benskin JP, 2011, ENVIRON SCI TECHNOL, V45, P7188, DOI 10.1021/es2011176; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Boc-Zalewska A, 2011, GINEKOL POL, V82, P585; Boc-Zalewska A, 2011, GINEKOL POL, V82, P178; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Butt CM, 2010, SCI TOTAL ENVIRON, V408, P2936, DOI 10.1016/j.scitotenv.2010.03.015; Campo J, 2016, ENVIRON RES, V147, P503, DOI 10.1016/j.envres.2016.03.010; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Castiglioni S, 2015, J HAZARD MATER, V282, P51, DOI 10.1016/j.jhazmat.2014.06.007; Chakraborty C, 2003, MOL CELL ENDOCRINOL, V201, P63, DOI 10.1016/S0303-7207(02)00431-8; Chen FJ, 2018, ECOTOX ENVIRON SAFE, V158, P223, DOI 10.1016/j.ecoenv.2018.04.032; Chen L, 2012, MOL CELL BIOCHEM, V365, P263, DOI 10.1007/s11010-012-1267-1; Chen T, 2012, REPROD TOXICOL, V33, P538, DOI 10.1016/j.reprotox.2011.03.003; Conder JM, 2008, ENVIRON SCI TECHNOL, V42, P995, DOI 10.1021/es070895g; Corsini E, 2012, TOXICOL APPL PHARM, V258, P248, DOI 10.1016/j.taap.2011.11.004; Crocker IP, 2005, J PATHOL, V206, P476, DOI 10.1002/path.1801; Crosley EJ, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-123; Darakhshan S, 2019, PREGNANCY HYPERTENS, V17, P36, DOI 10.1016/j.preghy.2019.05.001; Darrow LA, 2013, ENVIRON HEALTH PERSP, V121, P1207, DOI 10.1289/ehp.1206372; DaSilva-Arnold SC, 2018, BIOL REPROD, V99, P409, DOI 10.1093/biolre/ioy042; De Villiers CP, 2018, CLIN CHEM LAB MED, V56, P65, DOI 10.1515/cclm-2017-0356; Dikensoy E, 2009, HYPERTENS PREGNANCY, V28, P383, DOI 10.3109/10641950802629634; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duan HL, 2017, CLIN LAB, V63, P921, DOI 10.7754/Clin.Lab.2016.161103; Fedorova L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-15; Feng XJ, 2017, TOXICOL SCI, V155, P409, DOI 10.1093/toxsci/kfw219; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Gebbink WA, 2016, CHEMOSPHERE, V144, P2384, DOI 10.1016/j.chemosphere.2015.10.116; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Giesy JP, 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI 10.1021/es022253t; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Gorrochategui E, 2014, TOXICOL APPL PHARM, V277, P124, DOI 10.1016/j.taap.2014.03.012; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Gratton RJ, 2003, J CLIN ENDOCR METAB, V88, P6048, DOI 10.1210/jc.2003-030323; Grill S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-70; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Gyllenhammar I, 2018, ENVIRON SCI TECHNOL, V52, P7101, DOI 10.1021/acs.est.8b00770; Haddad JJ, 2002, RESP RES, V3, DOI 10.1186/rr190; Haiminen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024182; Hatipoglu OF, 2009, J BIOL CHEM, V284, P16325, DOI 10.1074/jbc.M109.001313; Hiden U, 2018, HISTOCHEM CELL BIOL, V149, P31, DOI 10.1007/s00418-017-1608-y; Highet AR, 2015, EUR J CELL BIOL, V94, P589, DOI 10.1016/j.ejcb.2015.10.004; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; Huang R, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-018-0445-3; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; James JL, 2006, HUM REPROD UPDATE, V12, P137, DOI 10.1093/humupd/dmi043; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Johnson SK, 2009, WORLD J GASTROENTERO, V15, P3355, DOI 10.3748/wjg.15.3355; Jonkman JEN, 2014, CELL ADHES MIGR, V8, P440, DOI 10.4161/cam.36224; Kalem MN, 2018, HYPERTENS PREGNANCY, V37, P9, DOI 10.1080/10641955.2017.1397690; Kannan K, 2005, ARCH ENVIRON CON TOX, V48, P559, DOI 10.1007/s00244-004-0133-x; Karrman A, 2007, ENVIRON HEALTH PERSP, V115, P226, DOI 10.1289/ehp.9491; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Koyama S, 2011, BBA-GEN SUBJECTS, V1810, P836, DOI 10.1016/j.bbagen.2011.06.013; Krantz D, 2004, AM J OBSTET GYNECOL, V191, P1452, DOI 10.1016/j.ajog.2004.05.068; Kraus DM, 2014, REPROD SCI, V21, P63, DOI 10.1177/1933719113488456; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lan X, 2017, ONCOTARGET, V8, P51507, DOI 10.18632/oncotarget.17882; Lash GE, 2007, PLACENTA, V28, P390, DOI 10.1016/j.placenta.2006.06.001; Lau C, 2004, TOXICOL APPL PHARM, V198, P231, DOI 10.1016/j.taap.2003.11.031; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Lenhart PM, 2014, AM J PERINAT, V31, P327, DOI 10.1055/s-0033-1349345; Li HS, 2003, HYPERTENSION, V42, P895, DOI 10.1161/01.HYP.0000095613.41961.6E; Li YN, 2019, ENVIRON INT, V123, P87, DOI 10.1016/j.envint.2018.11.036; Lindstrom AB, 2011, ENVIRON SCI TECHNOL, V45, P8015, DOI 10.1021/es1039425; Liu L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.419; Liu YW, 2018, CELL RES, V28, P819, DOI 10.1038/s41422-018-0066-y; Lou QQ, 2013, ECOTOXICOLOGY, V22, P1133, DOI 10.1007/s10646-013-1100-y; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Miyake H, 2000, CANCER RES, V60, P3058; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naile JE, 2012, CHEMOSPHERE, V86, P270, DOI 10.1016/j.chemosphere.2011.09.044; Nicola C, 2008, ENDOCRINOLOGY, V149, P1243, DOI 10.1210/en.2007-1136; Nishizawa H, 2008, MOL HUM REPROD, V14, P595, DOI 10.1093/molehr/gan054; NOVA A, 1991, AM J OBSTET GYNECOL, V165, P724, DOI 10.1016/0002-9378(91)90317-K; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Parsons JR, 2008, REV ENVIRON CONTAM T, V196, P53, DOI 10.1007/978-0-387-78444-1_2; Pelch KE, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.045; Pihl K, 2008, PRENATAL DIAG, V28, P1131, DOI 10.1002/pd.2141; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Quinete N, 2010, ARCH ENVIRON CON TOX, V59, P20, DOI 10.1007/s00244-009-9451-3; Rahman MF, 2014, WATER RES, V50, P318, DOI 10.1016/j.watres.2013.10.045; Rath G, 2016, J CLIN LAB ANAL, V30, P75, DOI 10.1002/jcla.21819; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Renner R, 2006, ENVIRON SCI TECHNOL, V40, P12, DOI 10.1021/es062612a; Ritter SK, 2010, CHEM ENG NEWS, V88, P12; Russell DL, 2015, MATRIX BIOL, V44-46, P54, DOI 10.1016/j.matbio.2015.03.007; Slotkin TA, 2008, ENVIRON HEALTH PERSP, V116, P716, DOI 10.1289/ehp.11253; Smart B. E., 1994, ORGANOFLUORINE CHEM, P57, DOI DOI 10.1007/978-1-4899-1202-2_3; Smith GCS, 2002, J CLIN ENDOCR METAB, V87, P1762, DOI 10.1210/jc.87.4.1762; Song XF, 2018, ENVIRON INT, V113, P50, DOI 10.1016/j.envint.2018.01.010; Stahl Thorsten, 2011, Environmental Sciences Europe, V23, P38, DOI 10.1186/2190-4715-23-38; Stein CR, 2009, AM J EPIDEMIOL, V170, P837, DOI 10.1093/aje/kwp212; Sun R, 2018, ECOTOX ENVIRON SAFE, V149, P88, DOI 10.1016/j.ecoenv.2017.11.012; Szabo S, 2015, PATHOL ONCOL RES, V21, P659, DOI 10.1007/s12253-014-9872-9; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; Tucker EK, 2018, REPROD TOXICOL, V78, P60, DOI 10.1016/j.reprotox.2018.03.008; Vicovac L, 1996, ACTA ANAT, V156, P202; Wang B, 2017, ENVIRON INT, V102, P207, DOI 10.1016/j.envint.2017.03.003; Wang B, 2016, ENVIRON INT, V97, P7, DOI 10.1016/j.envint.2016.10.008; WANG C, 2018, FRONT PHARMACOL, V9; Wang YW, 2019, ENVIRON SCI POLLUT R, V26, P2691, DOI 10.1007/s11356-018-3686-3; Wang ZY, 2015, ENVIRON INT, V75, P172, DOI 10.1016/j.envint.2014.11.013; Whigham CA, 2019, PREGNANCY HYPERTENS, V16, P16, DOI 10.1016/j.preghy.2019.02.003; Xie SW, 2013, ENVIRON INT, V59, P336, DOI 10.1016/j.envint.2013.06.015; Xie SW, 2013, ENVIRON INT, V52, P1, DOI 10.1016/j.envint.2012.11.004; Xu XL, 2010, AM J PATHOL, V177, P424, DOI 10.2353/ajpath.2010.090512; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang N, 2015, PLACENTA, V36, P575, DOI 10.1016/j.placenta.2015.02.008; Zhang TT, 2018, EXP THER MED, V15, P4615, DOI 10.3892/etm.2018.6027; Zhang W, 2011, ECOTOX ENVIRON SAFE, V74, P1787, DOI 10.1016/j.ecoenv.2011.04.027; Zhao PJ, 2016, SCI TOTAL ENVIRON, V568, P57, DOI 10.1016/j.scitotenv.2016.05.221; Zhao WX, 2017, BIOL OPEN, V6, P1123, DOI 10.1242/bio.025767; Zhu Y, 2016, SCI TOTAL ENVIRON, V559, P166, DOI 10.1016/j.scitotenv.2016.03.187; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51; Zushi Y, 2012, CLEAN TECHNOL ENVIR, V14, P9, DOI 10.1007/s10098-011-0375-z	143	11	11	7	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14182	14199		10.1096/fj.202000716RR	http://dx.doi.org/10.1096/fj.202000716RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901980	Green Accepted			2022-12-28	WOS:000568306900001
J	Nagai, K; Ideguchi, H; Kajikawa, T; Li, XF; Chavakis, T; Cheng, J; Messersmith, PB; Heber-Katz, E; Hajishengallis, G				Nagai, Kosuke; Ideguchi, Hidetaka; Kajikawa, Tetsuhiro; Li, Xiaofei; Chavakis, Triantafyllos; Cheng, Jing; Messersmith, Phillip B.; Heber-Katz, Ellen; Hajishengallis, George			An injectable hydrogel-formulated inhibitor of prolyl-4-hydroxylase promotes T regulatory cell recruitment and enhances alveolar bone regeneration during resolution of experimental periodontitis	FASEB JOURNAL			English	Article						1,4-dihydrophenonthrolin-4-one-3-carboxylic acid; AMD3100; hypoxia-inducible factor 1 alpha; osteogenesis; T regulatory cells	HYPOXIA-INDUCIBLE FACTOR; STEM-CELLS; FACTOR-I; THERAPY; FACTOR-1-ALPHA; RECONSTRUCTION; SPECIALIZATION; IDENTIFICATION; ACTIVATION; CONSENSUS	The hypoxia-inducible factor 1 alpha (HIF-1 alpha) is critically involved in tissue regeneration. Hence, the pharmacological prevention of HIF-1 alpha degradation by prolyl hydroxylase (PHD) under normoxic conditions is emerging as a promising option in regenerative medicine. Using a mouse model of ligature-induced periodontitis and resolution, we tested the ability of an injectable hydrogel-formulated PHD inhibitor, 1,4-dihydrophenonthrolin-4-one-3-carboxylic acid (1,4-DPCA/hydrogel), to promote regeneration of alveolar bone lost owing to experimental periodontitis. Mice injected subcutaneously with 1,4-DPCA/hydrogel at the onset of periodontitis resolution displayed significantly increased gingival HIF-1 alpha protein levels and bone regeneration, as compared to mice treated with vehicle control. The 1,4-DPCA/hydrogel-induced increase in bone regeneration was associated with elevated expression of osteogenic genes, decreased expression of pro-inflammatory cytokine genes, and increased abundance of FOXP3(+)T regulatory (Treg) cells in the periodontal tissue. The enhancing effect of 1,4-DPCA/hydrogel on Treg cell accumulation and bone regeneration was reversed by AMD3100, an antagonist of the chemokine receptor CXCR4 that mediates Treg cell recruitment. In conclusion, the administration of 1,4-DPCA/hydrogel at the onset of periodontitis resolution promotes CXCR4-dependent accumulation of Treg cells and alveolar bone regeneration, suggesting a novel approach for regaining bone lost due to periodontitis.	[Nagai, Kosuke; Ideguchi, Hidetaka; Kajikawa, Tetsuhiro; Li, Xiaofei; Hajishengallis, George] Univ Penn, Lab Innate Immun & Inflammat, Dept Basic & Translat Sci, Sch Dent Med, Philadelphia, PA 19104 USA; [Nagai, Kosuke; Chavakis, Triantafyllos] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med Carl Gustav Carus, Dresden, Germany; [Ideguchi, Hidetaka] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol Periodontal Sci, Okayama, Japan; [Cheng, Jing; Messersmith, Phillip B.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Cheng, Jing; Messersmith, Phillip B.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Cheng, Jing] Alcon, Formulat Grp R&D, Duluth, GA USA; [Heber-Katz, Ellen] Lankenau Inst Med Res, Lab Regenerat Med, Wynnewood, PA USA	University of Pennsylvania; Technische Universitat Dresden; Okayama University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Novartis; Alcon; Lankenau Medical Center; Lankenau Institute for Medical Research	Hajishengallis, G (corresponding author), Univ Penn, Lab Innate Immun & Inflammat, Dept Basic & Translat Sci, Sch Dent Med, Philadelphia, PA 19104 USA.	geoh@upenn.edu	Chavakis, Triantafyllos/ABE-8845-2020; Li, xiaofei/GXF-7187-2022		HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR) [DE026152, DE028561, DE021104]; Deutsche Forschungsgemeinschaft (DFG) [SFB1181]	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	HHS vertical bar NIH vertical bar National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE026152, DE028561 and DE021104; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1181	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200; Banerji B, 2005, CHEM COMMUN, P5438, DOI 10.1039/b510707e; Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x; Benakanakere MR, 2019, APOPTOSIS, V24, P108, DOI 10.1007/s10495-018-01513-9; Brauchle F, 2013, INT DENT J, V63, P306, DOI 10.1111/idj.12042; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chapple ILC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2645; Chen SC, 2006, J PERIODONTAL RES, V41, P547, DOI 10.1111/j.1600-0765.2006.00904.x; Chen SY, 2016, J CELL BIOCHEM, V117, P267, DOI 10.1002/jcb.25283; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Cochran DL, 2015, J PERIODONTOL, V86, pS153, DOI 10.1902/jop.2015.140381; Colombo APV, 2012, J PERIODONTOL, V83, P1279, DOI 10.1902/jop.2012.110566; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Demmer RT, 2010, PERIODONTOL 2000, V53, P28, DOI 10.1111/j.1600-0757.2009.00326.x; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dutzan N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0797; Dzobo K, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/2495848; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Foster B L, 2005, Orthod Craniofac Res, V8, P285, DOI 10.1111/j.1601-6343.2005.00351.x; Frencken JE, 2017, J CLIN PERIODONTOL, V44, pS94, DOI 10.1111/jcpe.12677; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Heber-Katz E, 2018, ADV DRUG DELIVER REV, V129, P254, DOI 10.1016/j.addr.2018.02.006; Heber-Katz E, 2017, TRENDS MOL MED, V23, P1024, DOI 10.1016/j.molmed.2017.08.008; Hong WX, 2014, ADV WOUND CARE, V3, P390, DOI 10.1089/wound.2013.0520; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Kinane DF, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.38; Koivunen P, 2018, TRENDS MOL MED, V24, P1021, DOI 10.1016/j.molmed.2018.10.004; Kourtzelis I, 2019, NAT IMMUNOL, V20, P40, DOI 10.1038/s41590-018-0249-1; Lamont RJ, 2018, NAT REV MICROBIOL, V16, P745, DOI 10.1038/s41579-018-0089-x; Lang NP, 2019, PERIODONTOL 2000, V79, P15, DOI 10.1111/prd.12240; Lei H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00184; Li JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00585; Lin WP, 2017, J ORTHOP TRANSL, V9, P19, DOI 10.1016/j.jot.2017.03.002; Lin Z, 2015, J PERIODONTOL, V86, pS134, DOI 10.1902/jop.2015.130689; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Love RJ, 2013, J BIOMED MATER RES A, V101, P3599, DOI 10.1002/jbm.a.34648; Maekawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9272; Miguel SMS, 2010, J PERIODONTAL RES, V45, P60, DOI 10.1111/j.1600-0765.2009.01201.x; Murakami S, 2017, EMERGING REGENERATIV, P135; Murakami S., 2001, PERIODONTOLOGY, V56, P188; Ng KT, 2011, J PERIODONTOL, V82, P136, DOI 10.1902/jop.2010.100100; Pacios S, 2012, FASEB J, V26, P1423, DOI 10.1096/fj.11-196279; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Roguljic H, 2013, J DENT RES, V92, P709, DOI 10.1177/0022034513493434; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x; Sculean A, 2015, PERIODONTOL 2000, V68, P182, DOI 10.1111/prd.12086; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shin J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5380; Somerman MJ, 1999, J PERIODONTAL RES, V34, P420, DOI 10.1111/j.1600-0765.1999.tb02276.x; Tang LX, 2014, J LEUKOCYTE BIOL, V96, P809, DOI 10.1189/jlb.4MA1213-647RR; Tonetti MS, 2011, J CLIN PERIODONTOL, V38, P114, DOI 10.1111/j.1600-051X.2010.01675.x; Tyagi AM, 2018, IMMUNITY, V49, P1116, DOI 10.1016/j.immuni.2018.10.013; Van Dyke TE, 2015, J DENT RES, V94, P148, DOI 10.1177/0022034514557331; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Yamamoto A, 2019, J CLIN INVEST, V129, P3640, DOI 10.1172/JCI124099; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869; Yuh D, 2020, J BIOL CHEM, V295, P7261, DOI 10.1074/jbc.RA120.013024; Zhang Y., 2015, SCI TRANSL MED, V7, P290; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	68	10	11	7	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13726	13740		10.1096/fj.202001248R	http://dx.doi.org/10.1096/fj.202001248R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32812255	Bronze, Green Accepted			2022-12-28	WOS:000562900300001
J	Zhang, H; Liu, J; Ying, Z; Li, S; Wu, YH; Liu, Q				Zhang, Heng; Liu, Jing; Ying, Zhu; Li, Shuang; Wu, Yihan; Liu, Qun			Toxoplasma gondiiUBL-UBA shuttle proteins contribute to the degradation of ubiquitinylated proteins and are important for synchronous cell division and virulence	FASEB JOURNAL			English	Article						cell division; degradation of ubiquitinylated proteins; retroviral aspartic protease activity; Toxoplasma gondii; UBL-UBA shuttle protein family	CYCLE; DOMAINS; RAD23; BIND; DDI1; INTERACT; RECEPTOR	Toxoplasma gondiiis an obligate intracellular apicomplexan parasite that causes lethal diseases in immunocompromised patients. Ubiquitin-proteasome system (UPS) regulates many cellular processes by degrading ubiquitinylated proteins. The UBL-UBA shuttle protein family, which escorts the ubiquitinylated proteins to the proteasome for degradation, are crucial components of UPS. Here, we identified three UBL-UBA shuttle proteins (TGGT1_304680, DNA damage inducible protein 1, DDI1; TGGT1_295340, UV excision repair protein rad23 protein, RAD23; and TGGT1_223680, ubiquitin family protein, DSK2) localized in the cytoplasm and nucleus ofT gondii. Deletion of shuttle proteins inhibited parasites growth and resulted in accumulation of ubiquitinylated proteins. Cell division of triple-gene knockout strain was asynchronous. In addition, we found that the retroviral aspartic protease activity of the nonclassical shuttle protein DDI1 was important for the virulence ofToxoplasmain mice. These results showed the critical roles of UBL-UBA shuttle proteins in regulating the degradation of ubiquitinylated proteins and cell division ofT gondii.	[Zhang, Heng; Liu, Jing; Ying, Zhu; Li, Shuang; Wu, Yihan; Liu, Qun] China Agr Univ, Natl Anim Protozoa Lab, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Zhang, Heng; Liu, Jing; Ying, Zhu; Li, Shuang; Wu, Yihan; Liu, Qun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol, Minist Agr, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, Q (corresponding author), China Agr Univ, Natl Anim Protozoa Lab, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	qunliu@cau.edu.cn	ZHU, YING/HHC-8921-2022		National Natural Science Foundation of China [81971964, 31730096, 31672544]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81971964, 31730096 and 31672544).	Baptista CG, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007946; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Coffey MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10809; de Monerri NCS, 2015, CELL HOST MICROBE, V18, P621, DOI 10.1016/j.chom.2015.10.014; Derouin F, 2000, ANTIMICROB AGENTS CH, V44, P2575, DOI 10.1128/AAC.44.9.2575-2577.2000; Dhara A, 2017, MBIO, V8, DOI 10.1128/mBio.01846-17; Dhara A, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00085-16; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Francia ME, 2014, NAT REV MICROBIOL, V12, P125, DOI 10.1038/nrmicro3184; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gabriely G, 2008, MOL BIOL CELL, V19, P3625, DOI 10.1091/mbc.E07-05-0462; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ivantsiv Y, 2006, MOL CELL BIOL, V26, P1579, DOI 10.1128/MCB.26.5.1579-1588.2006; Kang Y, 2006, J MOL BIOL, V356, P1027, DOI 10.1016/j.jmb.2005.12.001; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kottemann MC, 2018, MOL CELL, V69, P24, DOI 10.1016/j.molcel.2017.11.035; Krylov DM, 2001, CURR BIOL, V11, pR584, DOI 10.1016/S0960-9822(01)00357-8; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lourido S, 2019, TRENDS PARASITOL, V35, P944, DOI 10.1016/j.pt.2019.07.001; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Munoz C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141526; Naumov A, 2017, MBIO, V8, DOI [10.1128/mBio.00579-17, 10.1128/mbio.00579-17]; Nowicka U, 2015, STRUCTURE, V23, P542, DOI 10.1016/j.str.2015.01.010; Onchieku NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201556; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Periz J, 2017, ELIFE, V6, DOI [10.7554/eLife.24119, 10.7554/elife.24119]; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Svoboda M, 2019, DNA REPAIR, V80, P45, DOI 10.1016/j.dnarep.2019.06.008; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Vaishnava S, 2006, MOL MICROBIOL, V61, P1380, DOI 10.1111/j.1365-2958.2006.05343.x; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111993; White RE, 2011, FASEB J, V25, P1729, DOI 10.1096/fj.10-178947; White RE, 2011, FEBS LETT, V585, P139, DOI 10.1016/j.febslet.2010.11.026; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wilson SI, 1997, BBA-PROTEIN STRUCT M, V1339, P113, DOI 10.1016/S0167-4838(96)00224-5; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang H, 2019, PARASITOL RES, V118, P3001, DOI 10.1007/s00436-019-06449-w	51	6	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13711	13725		10.1096/fj.202000759RR	http://dx.doi.org/10.1096/fj.202000759RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32808330				2022-12-28	WOS:000562546200001
J	Guo, NF; Wen, Y; Wang, C; Kang, LF; Wang, XQ; Liu, XY; Soulika, AM; Liu, BW; Zhao, M; Han, XJ; Lv, P; Xing, LX; Zhang, XH; Shen, HT				Guo, Ningfei; Wen, Yue; Wang, Can; Kang, Lifei; Wang, Xiuqing; Liu, Xiaoyi; Soulika, Athena M.; Liu, Bowei; Zhao, Mei; Han, Xiaojing; Lv, Ping; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao			Lung adenocarcinoma-related TNF-alpha-dependent inflammation upregulates MHC-II on alveolar type II cells through CXCR-2 to contribute to Treg expansion	FASEB JOURNAL			English	Article						alveolar type-II (AT-II) cells; lung adenocarcinoma; lung inflammation; MHC-II; Treg	NECROSIS-FACTOR-ALPHA; T-CELLS; EPITHELIAL-CELLS; ANTIGEN PRESENTATION; TRANSCRIPTION FACTOR; MELANOMA-CELLS; CUTTING EDGE; TUMOR-CELLS; EXPRESSION; CANCER	MHC-II on alveolar type-II (AT-II) cells is associated with immune tolerance in an inflammatory microenvironment. Recently, we found TNF-alpha upregulated MHC-II in AT-II in vitro. In this study, we explored whether TNF-alpha-mediated inflammation upregulates MHC-II on AT-II cells to trigger Treg expansion in inflammation-driven lung adenocarcinoma (IDLA). Using urethane-induced mice IDLA model, we found that IDLA cells mainly arise from AT-II cells, which are the major source of MHC-II. Blocking urethane-induced inflammation by TNF-alpha neutralization inhibited tumorigenesis and reversed MHC-II upregulation on tumor cells of AT-II cellular origin in IDLA. MHC-II-dependent AT-II cells were isolated from IDLA-induced Treg expansion. In human LA samples, we found high expression of MHC-II in tumor cells of AT-II cellular origin, which was correlated with increased Foxp3(+)T cells infiltration as well as CXCR-2 expression. CXCR-2 and MHC-II colocalization was observed in inflamed lung tissue and IDLA cells of AT-II cellular origin. Furthermore, at the pro-IDLA inflammatory stage, TNF-alpha-neutralization or CXCR-2 deficiency inhibited the upregulation of MHC-II on AT-II cells in inflamed lung tissue. Thus, tumor cells of AT-II cellular origin contribute to Treg expansion in an MHC-II-dependent manner in TNF-alpha-mediated IDLA. At the pro-tumor inflammatory stage, TNF-alpha-dependent lung inflammation plays an important role in MHC-II upregulation on AT-II cells.	[Guo, Ningfei; Wen, Yue; Wang, Can; Kang, Lifei; Wang, Xiuqing; Liu, Xiaoyi; Liu, Bowei; Zhao, Mei; Han, Xiaojing; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao] Hebei Med Univ, Lab Pathol, 361 East Zhongshan Rd, Shijiazhuang, Hebei, Peoples R China; [Wang, Can; Zhang, Xianghong] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Kang, Lifei] Hebei Chest Hosp, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Soulika, Athena M.] Univ Calif Davis, Sch Med, Dept Dermatol, Davis, CA 95616 USA; [Lv, Ping] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; University of California System; University of California Davis; Hebei Medical University	Zhang, XH; Shen, HT (corresponding author), Hebei Med Univ, Lab Pathol, 361 East Zhongshan Rd, Shijiazhuang, Hebei, Peoples R China.	zhangxianghong2008@163.com; haitaoshen78@hotmail.com						Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Axelrod ML, 2019, CLIN CANCER RES, V25, P2392, DOI 10.1158/1078-0432.CCR-18-3200; Bernert H, 2003, MOL CARCINOGEN, V38, P117, DOI 10.1002/mc.10151; Caetano MS, 2016, CANCER RES, V76, P3189, DOI 10.1158/0008-5472.CAN-15-2840; Callaway CS, 2019, CANCERS, V11, DOI 10.3390/cancers11121863; Corbiere V, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-15; Costantini F, 2017, CELL SIGNAL, V36, P189, DOI 10.1016/j.cellsig.2017.05.008; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Devalaraja MN, 1999, CANCER RES, V59, P1372; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Forero A, 2016, CANCER IMMUNOL RES, V4, P390, DOI 10.1158/2326-6066.CIR-15-0243; Gameiro SF, 2019, CANCERS, V11, DOI 10.3390/cancers11081129; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Gong L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1229724; Gresser O, 2000, CELL TISSUE RES, V300, P373, DOI 10.1007/s004410000222; Hirota JA, 2013, AM J RESP CELL MOL, V49, P453, DOI 10.1165/rcmb.2012-0512OC; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Janker Florian, 2018, Oncotarget, V9, P30527, DOI 10.18632/oncotarget.25668; Johnson DB, 2018, CLIN CANCER RES, V24, P5250, DOI 10.1158/1078-0432.CCR-18-0309; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Jurewicz MM, 2019, IMMUNOGENETICS, V71, P171, DOI 10.1007/s00251-018-1095-x; Kapur R, 2017, BLOOD, V129, P2557, DOI 10.1182/blood-2016-12-758185; Karabela SP, 2011, NEOPLASIA, V13, P1143, DOI 10.1593/neo.111224; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kitakata H, 2002, CANCER RES, V62, P6682; Kolla V, 2007, AM J RESP CELL MOL, V36, P213, DOI 10.1165/rcmb.2006-0207OC; Kreisel D, 2010, J IMMUNOL, V185, P3809, DOI 10.4049/jimmunol.1000971; Krupnick AS, 2005, J IMMUNOL, V175, P6265, DOI 10.4049/jimmunol.175.10.6265; Lerner CA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2076.00391; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Liu CP, 2015, TOXICOL LETT, V232, P547, DOI 10.1016/j.toxlet.2014.11.002; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Martins I, 2007, EUR J IMMUNOL, V37, P788, DOI 10.1002/eji.200636620; Mason RJ, 2000, AM J PATHOL, V156, P175, DOI 10.1016/S0002-9440(10)64717-7; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Narayan Chandradeo, 2012, J Carcinog, V11, P9, DOI 10.4103/1477-3163.98965; Pedersen MH, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1305531; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Phillips JD, 2015, CANCER IMMUNOL IMMUN, V64, P1185, DOI 10.1007/s00262-015-1725-1; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Ragazzo JL, 2001, P NATL ACAD SCI USA, V98, P241, DOI 10.1073/pnas.011397798; Reimers MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-486; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon BL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00444; Shao PL, 2019, J CELL PHYSIOL, V234, P9194, DOI 10.1002/jcp.27596; Shen HT, 2015, J CELL PHYSIOL, V230, P1199, DOI 10.1002/jcp.24852; Shen HT, 2012, WOUND REPAIR REGEN, V20, P580, DOI 10.1111/j.1524-475X.2012.00812.x; Shi GZ, 2014, EUR J IMMUNOL, V44, P420, DOI 10.1002/eji.201343572; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sjaheim TB, 2013, SCAND J IMMUNOL, V77, P398, DOI 10.1111/sji.12035; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Sun KH, 2016, J CELL MOL MED, V20, P2020, DOI 10.1111/jcmm.12890; Thibodeau J, 2012, ONCOIMMUNOLOGY, V1, P908, DOI 10.4161/onci.21205; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Tomita Y, 2004, INT J CANCER, V112, P927, DOI 10.1002/ijc.20493; Westendorf AM, 2009, GUT, V58, P211, DOI 10.1136/gut.2008.151720; Wu JH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00220; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Zaynagetdinov R, 2012, ONCOGENE, V31, P3164, DOI 10.1038/onc.2011.480	65	3	3	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12197	12213		10.1096/fj.202000166RR	http://dx.doi.org/10.1096/fj.202000166RR		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33000506				2022-12-28	WOS:000556418600001
J	Stachenfeld, N				Stachenfeld, Nina			Introducing a special series, sex as a variable in human research: A systems approach	FASEB JOURNAL			English	Editorial Material									[Stachenfeld, Nina] Yale Sch Med, John B Pierce Lab, Dept Obstet Gynecol & Reprod Sci, 290 Congress Ave, New Haven, CT 06519 USA	Yale University; The John B Pierce Laboratory, Inc	Stachenfeld, N (corresponding author), Yale Sch Med, John B Pierce Lab, Dept Obstet Gynecol & Reprod Sci, 290 Congress Ave, New Haven, CT 06519 USA.	nina.stachenfeld@yale.edu							0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8776	8777		10.1096/fj.202001425	http://dx.doi.org/10.1096/fj.202001425			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32946158				2022-12-28	WOS:000546308400002
J	Hirata, T; Yamamoto, K; Ikeda, K; Arita, M				Hirata, Tsuyoshi; Yamamoto, Kimiko; Ikeda, Kazutaka; Arita, Makoto			Functional lipidomics of vascular endothelial cells in response to laminar shear stress	FASEB JOURNAL			English	Article						endothelial cells; ether lipid; lipidomics; shear stress; VCAM&#8208; 1	PROTEIN-KINASE-C; NITRIC-OXIDE SYNTHASE; AUTOLYSIN ACTIVITY; GENE-EXPRESSION; UP-REGULATION; ETHER LIPIDS; FLOW; ACTIVATION; CAVEOLAE; MECHANOTRANSDUCTION	Laminar shear stress generated by blood flow stimulates endothelial cells and activates signal transduction, which plays an important role in vascular homeostasis. Several lines of evidence indicate that membrane and intracellular lipids are involved in the signal transduction of biomechanical stresses. In this study, we performed global profiling of cellular lipids from human pulmonary artery endothelial cells (HPAEC) exposed to laminar shear stress. A total of 761 species of lipids were successfully annotated, with 198 of these species significantly changed in response to shear stress for 24 hours. Ether-linked lipids containing an alkyl moiety with a medium chain length (C11-C14) were uniquely upregulated, and the administration of their biosynthetic precursor 1-O-dodecyl-rac-glycerol attenuated phorbol 12-myristate 13-acetate (PMA) induced vascular cell adhesion molecule-1 (VCAM-1) expression. Given the pro-inflammatory and atherogenic roles of VCAM-1, our findings suggest that the induction of a specific group of lipids (ie, ether-linked lipids with medium length alkyl side chain) may confer atheroprotective and anti-inflammatory roles to vascular endothelial cells under flow conditions.	[Hirata, Tsuyoshi; Ikeda, Kazutaka; Arita, Makoto] RIKEN, Lab Metabol, Ctr Integrat Med Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Hirata, Tsuyoshi; Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan; [Yamamoto, Kimiko] Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Lab Syst Physiol, Tokyo, Japan; [Ikeda, Kazutaka] Kazusa DNA Res Inst, Lab Biomol Anal, Kisarazu, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan	RIKEN; Yokohama City University; University of Tokyo; Kazusa DNA Research Institute; Keio University	Arita, M (corresponding author), RIKEN, Lab Metabol, Ctr Integrat Med Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	makoto.arita@riken.jp		Arita, Makoto/0000-0001-9902-0463				Ando A, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0324-9; Aoyagi R, 2017, J LIPID RES, V58, P2229, DOI 10.1194/jlr.D077123; Bailey KA., 2017, SCI REP-UK, V7, P1; Balleza D, 2012, CHANNELS, V6, P220, DOI 10.4161/chan.21085; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bergan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075904; Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Chun TH, 1997, HYPERTENSION, V29, P1296, DOI 10.1161/01.HYP.29.6.1296; Conway DE, 2013, J CELL SCI, V126, P5101, DOI 10.1242/jcs.138313; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Czarny M, 2004, AM J PHYSIOL-HEART C, V287, pH1344, DOI 10.1152/ajpheart.00222.2004; Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; DeVerse JS, 2013, AM J PHYSIOL-HEART C, V305, pH1149, DOI 10.1152/ajpheart.00311.2013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorninger F, 2017, FEBS LETT, V591, P2761, DOI 10.1002/1873-3468.12788; Fan WD, 2015, J CELL SCI, V128, P70, DOI 10.1242/jcs.154252; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Ford DA, 1996, FEBS LETT, V394, P99, DOI 10.1016/0014-5793(96)00930-1; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; HALLGREN B, 1962, J LIPID RES, V3, P39; Heo KS, 2014, MOL CELLS, V37, P435, DOI [10.14348/molcells.2014.0078, 10.14348/molcells.2014.0108]; Hermann M, 2006, J CARDIOVASC PHARM, V47, pS21, DOI 10.1097/00005344-200605001-00005; Houck KL, 2008, AM J PHYSIOL-HEART C, V295, pH1657, DOI 10.1152/ajpheart.00141.2008; Iannitti T, 2010, MAR DRUGS, V8, P2267, DOI 10.3390/md8082267; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee J, 2012, ANAL SCI, V28, P801, DOI 10.2116/analsci.28.801; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; LIN HJ, 1976, J LIPID RES, V17, P53; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Mandel H, 1998, BIOCHEM BIOPH RES CO, V250, P369, DOI 10.1006/bbrc.1998.9321; Marigny K, 2002, ACTA PHYSIOL SCAND, V176, P263, DOI 10.1046/j.1365-201X.2002.01037.x; Mun GI, 2012, BIOCHEM BIOPH RES CO, V420, P450, DOI 10.1016/j.bbrc.2012.03.016; Okahara K, 1998, ARTERIOSCL THROM VAS, V18, P1922, DOI 10.1161/01.ATV.18.12.1922; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; ROBINSON M, 1995, BBA-LIPID LIPID MET, V1254, P361, DOI 10.1016/0005-2760(94)00200-I; Rog T, 2016, BBA-BIOMEMBRANES, V1858, P97, DOI 10.1016/j.bbamem.2015.10.023; Russell-Puleri S, 2017, AM J PHYSIOL-HEART C, V312, pH485, DOI 10.1152/ajpheart.00035.2016; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Saemisch M, 2019, AM J PHYSIOL-CELL PH, V316, pC210, DOI 10.1152/ajpcell.00005.2018; SDOUGOS HP, 1984, J FLUID MECH, V138, P379, DOI 10.1017/S0022112084000161; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Styger R, 2002, BBA-MOL CELL BIOL L, V1585, P39, DOI 10.1016/S1388-1981(02)00320-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Tsugawa H, 2020, NAT BIOTECHNOL, V38, P1159, DOI 10.1038/s41587-020-0531-2; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; VED HS, 1984, J BIOL CHEM, V259, P8122; VED HS, 1984, J BIOL CHEM, V259, P8115; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113; WARNE TR, 1995, J BIOL CHEM, V270, P11147, DOI 10.1074/jbc.270.19.11147; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Yamamoto K, 2007, AM J PHYSIOL-HEART C, V293, pH1646, DOI 10.1152/ajpheart.01385.2006; Yamamoto K, 2018, CIRC J, V82, P2691, DOI 10.1253/circj.CJ-18-0052; Yamamoto K, 2015, AM J PHYSIOL-HEART C, V309, pH1178, DOI 10.1152/ajpheart.00241.2015; Yamamoto K, 2013, J CELL SCI, V126, P1227, DOI 10.1242/jcs.119628; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100	70	10	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21301	10.1096/fj.202002144R	http://dx.doi.org/10.1096/fj.202002144R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33421194	hybrid			2022-12-28	WOS:000647789600093
J	Hum, M; Tan, HJ; Yang, YX; Srivastava, S; Teh, M; Lim, YP				Hum, Melissa; Tan, Hock Jin; Yang, Yixuan; Srivastava, Supriya; Teh, Ming; Lim, Yoon Pin			WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway	FASEB JOURNAL			English	Article						cell migration; gastric cancer; Hippo pathway; LATS2; WBP2	PROTEIN-INTERACTION NETWORK; DOMAIN-BINDING PROTEIN-2; YES-ASSOCIATED PROTEIN; WW-DOMAIN; BREAST-CANCER; TYROSINE PHOSPHORYLATION; FAMILY PROTEINS; EMERGING ROLE; E-CADHERIN; PROLIFERATION	Dysregulation of signaling pathways is responsible for many human diseases. The lack of understanding of the molecular etiology of gastric cancer (GC) poses a substantial challenge to the development of effective cancer therapy. To better understand the molecular mechanisms underlying the pathogenesis of GC, which will facilitate the identification and development of effective therapeutic approaches to improve patient outcomes, mass spectrometry-based phosphoproteomics analysis was performed to map the global molecular changes in GC. A total of 530 proteins with altered phosphorylation levels were detected across a panel of 15 normal and GC cell lines. WW domain-binding protein 2 (WBP2) was validated to be upregulated in a subset of GC cell lines. WBP2 is overexpressed in 61% cases of GC compared to non-cancer tissues and high WBP2 expression correlates with poor clinical outcomes. WBP2 was found to be required for GC cell migration but is dispensable for cell growth and proliferation. WBP2 knockdown increased p-LATS2 with a concomitant increase in p-YAP, resulting in the cytoplasmic retention of YAP and ultimately the inhibition of YAP/TEAD activity and downregulation of TEAD target genes--CTGF and CYR61. Importantly, the loss of LATS2 reversed the activation of Hippo pathway caused by WBP2 knockdown, indicating that WBP2 acts through LATS2 to exert its function on the Hippo pathway. Moreover, WBP2 interacted with LATS2 to inhibit its phosphorylation and activity. In conclusion, our study established a pivotal role for WBP2 in the promotion of GC cell migration via a novel mechanism that inactivates the Hippo pathway transducer LATS2.	[Hum, Melissa; Tan, Hock Jin; Yang, Yixuan; Lim, Yoon Pin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD4 01-03D,5 Sci Dr 2, Singapore 117545, Singapore; [Srivastava, Supriya] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Teh, Ming] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Lim, Yoon Pin] Natl Univ Canc Inst, Singapore, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lim, YP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD4 01-03D,5 Sci Dr 2, Singapore 117545, Singapore.	bchlyp@nus.edu.sg	yang, yx/GZM-0464-2022; Srivastava, Supriya/HDJ-9671-2022					Ajani JA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.36; Apicella M, 2017, ONCOTARGET, V8, P57654, DOI 10.18632/oncotarget.14825; Arash EH, 2014, EMBO J, V33, P2997, DOI 10.15252/embj.201490230; Arienti C, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01308; Aylon Y, 2016, GENE DEV, V30, P786, DOI 10.1101/gad.274167.115; Bang YJ, 2010, LANCET, V376, P1302; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Boku N, 2014, GASTRIC CANCER, V17, P1, DOI 10.1007/s10120-013-0252-z; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0376-5; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Chiurillo MA, 2015, WORLD J EXP MED, V5, P84, DOI [10.5493/wjem.v5.i2.84, DOI 10.5493/wjem.v5.i2.84, DOI 10.5493/WJEM.V5.I2.84]; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Deng J, 2015, TUMOR BIOL, V36, P6823, DOI 10.1007/s13277-015-3364-8; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Dillon R, 2011, J PROTEOME RES, V10, P5084, DOI 10.1021/pr200498v; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Furth N, 2017, CELL DEATH DIFFER, V24, P1488, DOI 10.1038/cdd.2017.99; Gao J, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109466; Gogl G, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002146; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hollestelle A, 2013, BREAST CANCER RES TR, V138, P47, DOI 10.1007/s10549-013-2415-3; Hu XB, 2014, PATHOL ONCOL RES, V20, P805, DOI 10.1007/s12253-014-9757-y; Jagannathan R, 2016, MOL CELL BIOL, V36, P2526, DOI 10.1128/MCB.00136-16; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kang W, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0134-0; Kang W, 2016, WORLD J GASTROENTERO, V22, P1279, DOI 10.3748/wjg.v22.i3.1279; Kang W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0323-3; Kawakami H, 2016, GASTRIC CANCER, V19, P687, DOI 10.1007/s10120-015-0585-x; Konstantinou D, 2016, CURR OPIN PHARMACOL, V31, P76, DOI 10.1016/j.coph.2016.09.003; Lee WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27903; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Lim SK, 2016, CANCER RES, V76, P6278, DOI 10.1158/0008-5472.CAN-15-3537; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Lim YP, 2003, MOL CANCER THER, V2, P1369; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Lordick F, 2014, CANCER TREAT REV, V40, P692, DOI 10.1016/j.ctrv.2014.03.002; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Nilsson GMA, 2014, INT J ONCOL, V45, P82, DOI 10.3892/ijo.2014.2424; Nitsch R, 2004, BIOCHEM J, V377, P553, DOI 10.1042/BJ20031233; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sitarz R, 2018, CANCER MANAG RES, V10, P239, DOI 10.2147/CMAR.S149619; Sokolova O, 2017, TOXINS, V9, DOI 10.3390/toxins9040119; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Sun D, 2016, ONCOTARGET, V7, P81062, DOI 10.18632/oncotarget.13188; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Walko G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14744; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yang DY, 2011, J GASTROINTEST ONCOL, V2, P77, DOI 10.3978/j.issn.2078-6891.2010.025; Zhang J, 2012, INT J IMMUNOPATH PH, V25, P583, DOI 10.1177/039463201202500304; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhou GX, 2013, ASIAN PAC J CANCER P, V14, P5199, DOI 10.7314/APJCP.2013.14.9.5199; Zhou YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010138	72	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21290	10.1096/fj.202000393R	http://dx.doi.org/10.1096/fj.202000393R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475198				2022-12-28	WOS:000647789600019
J	Scharinger, K; Maxeiner, S; Schalla, C; Rutten, S; Zenke, M; Sechi, A				Scharinger, Katja; Maxeiner, Sebastian; Schalla, Carmen; Rutten, Stephan; Zenke, Martin; Sechi, Antonio			LSP1-myosin1e bimolecular complex regulates focal adhesion dynamics and cell migration	FASEB JOURNAL			English	Article						Actin cytoskeleton remodeling; focal adhesions; cell motility; macrophages	LYMPHOCYTE-SPECIFIC PROTEIN-1; LEUKOCYTE-SPECIFIC PROTEIN-1; NEUTROPHIL ACTIN DYSFUNCTION; MYOSIN 1E; ENA/VASP PROTEINS; ARP2/3 COMPLEX; NAD 47/89; P50 LSP1; CYTOSKELETON; MOTILITY	Several cytoskeleton-associated proteins and signaling pathways work in concert to regulate actin cytoskeleton remodeling, cell adhesion, and migration. Although the leukocyte-specific protein 1 (LSP1) has been shown to interact with the actin cytoskeleton, its function in the regulation of actin cytoskeleton dynamics is, as yet, not fully understood. We have recently demonstrated that the bimolecular complex between LSP1 and myosin1e controls actin cytoskeleton remodeling during phagocytosis. In this study, we show that LSP1 downregulation severely impairs cell migration, lamellipodia formation, and focal adhesion dynamics in macrophages. Inhibition of the interaction between LSP1 and myosin1e also impairs these processes resulting in poorly motile cells, which are characterized by few and small lamellipodia. Furthermore, cells in which LSP1-myosin1e interaction is inhibited are typically associated with inefficient focal adhesion turnover. Collectively, our findings show that the LSP1-myosin1e bimolecular complex plays a pivotal role in the regulation of actin cytoskeleton remodeling and focal adhesion dynamics required for cell migration.	[Scharinger, Katja; Maxeiner, Sebastian; Schalla, Carmen; Zenke, Martin; Sechi, Antonio] Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany; [Rutten, Stephan] Rhein Westfal TH Aachen, Inst Pathol, Electron Microscopy Facil, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Sechi, A (corresponding author), Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany.	antonio.sechi@rwth-aachen.de	Sechi, Antonio S/A-5595-2009	Sechi, Antonio S/0000-0002-1374-1794				Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; BERSHADSKY AD, 1991, CELL MOTIL CYTOSKEL, V19, P152, DOI 10.1002/cm.970190303; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Carballo E, 1996, J IMMUNOL, V156, P1709; Cervero P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02904-x; Cheng J, 2012, MOL BIOL CELL, V23, P2891, DOI 10.1091/mbc.E11-04-0383; COATES TD, 1991, BLOOD, V78, P1338; Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986; Gamper I, 2016, MOL BIOL CELL, V27, P277, DOI 10.1091/mbc.E15-06-0426; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Gupta P, 2013, BIOL OPEN, V2, P1288, DOI 10.1242/bio.20135827; Hannigan M, 2001, J LEUKOCYTE BIOL, V69, P497; Harrison RE, 2004, J CELL SCI, V117, P2151, DOI 10.1242/jcs.00955; HOWARD T, 1994, BLOOD, V83, P231; Howard TH, 1998, BLOOD, V91, P4786, DOI 10.1182/blood.V91.12.4786.412k25_4786_4795; Huang CK, 1997, J BIOL CHEM, V272, P17, DOI 10.1074/jbc.272.1.17; Hwang SH, 2015, P NATL ACAD SCI USA, V112, pE6535, DOI 10.1073/pnas.1514152112; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; JONGSTRA J, 1988, MOL IMMUNOL, V25, P687, DOI 10.1016/0161-5890(88)90104-6; JONGSTRA J, 1994, MOL IMMUNOL, V31, P1125, DOI 10.1016/0161-5890(94)90026-4; Jongstra-Bilen J, 2000, BLOOD, V96, P1827, DOI 10.1182/blood.V96.5.1827.h8001827_1827_1835; JONGSTRABILEN J, 1990, J IMMUNOL, V144, P1104; KADIYALA RK, 1990, EUR J IMMUNOL, V20, P2417; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KLEIN DP, 1989, MOL CELL BIOL, V9, P3043, DOI 10.1128/MCB.9.7.3043; KLEIN DP, 1990, J IMMUNOL, V145, P2967; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Koral K, 2015, HEPATOLOGY, V61, P537, DOI 10.1002/hep.27444; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lammel U, 2014, DEVELOPMENT, V141, P1366, DOI 10.1242/dev.101352; Li Y, 2000, BLOOD, V96, P1100, DOI 10.1182/blood.V96.3.1100.015k33_1100_1105; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Mathieson PW, 2012, CLIN KIDNEY J, V5, P498, DOI 10.1093/ckj/sfs153; MATSUMOTO N, 1993, J BIOCHEM-TOKYO, V113, P630, DOI 10.1093/oxfordjournals.jbchem.a124094; MATSUMOTO N, 1995, J BIOCHEM-TOKYO, V118, P237, DOI 10.1093/oxfordjournals.jbchem.a124885; MATSUMOTO N, 1995, J BIOCHEM, V117, P222, DOI 10.1093/oxfordjournals.jbchem.a124714; Maxeiner S, 2015, MOL BIOL CELL, V26, P1652, DOI 10.1091/mbc.E14-05-1005; May RC, 1999, CURR BIOL, V9, P759, DOI 10.1016/S0960-9822(99)80337-6; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Miyoshi EK, 2001, LEUKEMIA RES, V25, P57, DOI 10.1016/S0145-2126(00)00079-5; Palker TJ, 1998, HYBRIDOMA, V17, P497, DOI 10.1089/hyb.1998.17.497; Petri B, 2011, BLOOD, V117, P942, DOI 10.1182/blood-2010-02-270561; Prasad A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40648; Prasad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048854; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; Ramaekers FCS, 2004, J PATHOL, V204, P351, DOI 10.1002/path.1665; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Schulze N, 2014, J CELL SCI, V127, P1379, DOI 10.1242/jcs.134627; Sechi A, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600455; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Tanimura S, 2016, J CELL BIOL, V214, P475, DOI 10.1083/jcb.201503123; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wang CJ, 2002, J IMMUNOL, V169, P415, DOI 10.4049/jimmunol.169.1.415; Way M, 1998, FOLIA MICROBIOL, V43, P305, DOI 10.1007/BF02818616; WEHLAND J, 1983, J CELL BIOL, V97, P1467, DOI 10.1083/jcb.97.5.1467; Wong MJ, 2003, BBA-MOL CELL RES, V1642, P17, DOI 10.1016/S0167-4889(03)00082-X; Wu Y, 2007, BIOCHEM BIOPH RES CO, V358, P170, DOI 10.1016/j.bbrc.2007.04.104; Wurflinger T, 2011, J MICROSC-OXFORD, V241, P37, DOI 10.1111/j.1365-2818.2010.03404.x; Zamir E, 2001, J CELL SCI, V114, P3583; Zhang QH, 2000, J IMMUNOL, V165, P2052, DOI 10.4049/jimmunol.165.4.2052; Zhang QH, 2001, CELL MOTIL CYTOSKEL, V49, P179, DOI 10.1002/cm.1031	65	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21268	10.1096/fj.202000740RR	http://dx.doi.org/10.1096/fj.202000740RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33470457	Green Submitted			2022-12-28	WOS:000647789600094
J	Millesi, F; Weiss, T; Mann, A; Haertinger, M; Semmler, L; Supper, P; Pils, D; Naghilou, A; Radtke, C				Millesi, Flavia; Weiss, Tamara; Mann, Anda; Haertinger, Maximilian; Semmler, Lorenz; Supper, Paul; Pils, Dietmar; Naghilou, Aida; Radtke, Christine			Defining the regenerative effects of native spider silk fibers on primary Schwann cells, sensory neurons, and nerve-associated fibroblasts	FASEB JOURNAL			English	Article						live cell imaging; migration; Nephila edulis; peripheral nerve regeneration; proliferation	PERIPHERAL-NERVE; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; WALLERIAN DEGENERATION; GUIDANCE CONDUITS; DRAGLINE SILK; INJURY; TISSUE; PROLIFERATION; REPAIR	The search for a suitable material to promote regeneration after long-distance peripheral nerve defects turned the spotlight on spider silk. Nerve conduits enriched with native spider silk fibers as internal guiding structures previously demonstrated a regenerative outcome similar to autologous nerve grafts in animal studies. Nevertheless, spider silk is a natural material with associated limitations for clinical use. A promising alternative is the production of recombinant silk fibers that should mimic the outstanding properties of their native counterpart. However, in vitro data on the regenerative features that native silk fibers provide for cells involved in nerve regeneration are scarce. Thus, there is a lack of reference parameters to evaluate whether recombinant silk fiber candidates will be eligible for nerve repair in vivo. To gain insight into the regenerative effect of native spider silk, our study aims to define the behavioral response of primary Schwann cells (SCs), nerve-associated fibroblasts (FBs), and dorsal root ganglion (DRG) neurons cultured on native dragline silk from the genus Nephila and on laminin coated dishes. The established multi-color immunostaining panels together with confocal microscopy and live cell imaging enabled the analysis of cell identity, morphology, proliferation, and migration on both substrates in detail. Our findings demonstrated that native spider silk rivals laminin coating as it allowed attachment and proliferation and supported the characteristic behavior of all tested cell types. Axonal out-growth of DRG neurons occurred along longitudinally aligned SCs that formed sustained bundled structures resembling Bungner bands present in regenerating nerves. The migration of SCs along the silk fibers achieved the reported distance of regenerating axons of about 1 mm per day, but lacked directionality. Furthermore, rFBs significantly reduced the velocity of rSCs in co-cultures on silk fibers. In summary, this study (a) reveals features recombinant silk must possess and what modifications or combinations could be useful for enhanced nerve repair and (b) provides assays to evaluate the regenerative performance of silk fibers in vitro before being applied as internal guiding structure in nerve conduits in vivo.	[Millesi, Flavia; Weiss, Tamara; Mann, Anda; Haertinger, Maximilian; Semmler, Lorenz; Supper, Paul; Naghilou, Aida; Radtke, Christine] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Res Lab, Vienna, Austria; [Millesi, Flavia; Weiss, Tamara; Haertinger, Maximilian; Radtke, Christine] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Pils, Dietmar] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Surg, Div Gen Surg, Vienna, Austria; [Radtke, Christine] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Weiss, T (corresponding author), Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Res Lab, Vienna, Austria.	tamara.weiss@meduniwien.ac.at	Supper, Paul/GYD-4248-2022; Radtke, Christine/B-8491-2018	Supper, Paul/0000-0001-9998-262X; Haertinger, Maximilian/0000-0003-2478-6477; Semmler, Lorenz/0000-0003-4732-5227; Millesi, Flavia/0000-0002-5999-1940; Naghilou, Aida/0000-0002-4351-0620; Weiss, Tamara/0000-0001-7046-3412; Radtke, Christine/0000-0001-6877-5038	Medical University of Vienna; Austrian Science Fund (FWF) [P33613]	Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by institutional funding of the Medical University of Vienna and by the Austrian Science Fund (FWF, P33613).	ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; Aigner TB, 2018, ADV MATER, V30, DOI 10.1002/adma.201704636; Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; [Anonymous], 2010, OFF J EUR UNION, VL 276, P33; Arslantunali D, 2014, MED DEVICES-EVID RES, V7, P405, DOI 10.2147/MDER.S59124; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; BARONVANEVERCOOREN A, 1986, DEV NEUROSCI-BASEL, V8, P182, DOI 10.1159/000112252; Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877; Bretz F, 2016, MULTIPLE COMP USING; Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296; Cao TT, 2016, MAT SCI ENG C-MATER, V61, P940, DOI 10.1016/j.msec.2015.12.082; Carvalho CR, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00337; Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6; Choe G, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10090997; Ciaramitaro P, 2010, J PERIPHER NERV SYST, V15, P120, DOI 10.1111/j.1529-8027.2010.00260.x; Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004; Daroff RB, 2016, BRADLEYS NEUROLOGY C, V7th; De Rosa M, 2004, J CELL PHYSIOL, V198, P133, DOI 10.1002/jcp.10397; Di Summa PG, 2018, ANAT REC, V301, P1714, DOI 10.1002/ar.23841; Dinis TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109770; Dun XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119168; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gaudin R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3856262; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Haertinger M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010163; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Hoke A, 2010, EXP NEUROL, V223, P1, DOI 10.1016/j.expneurol.2009.12.001; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Jacobsen MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45653; Jang SY, 2016, GLIA, V64, P730, DOI 10.1002/glia.22957; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jessen KR, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00033; Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009; Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012; Kanno H, 2015, REV NEUROSCIENCE, V26, P121, DOI 10.1515/revneuro-2014-0068; Kaplan HM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5558-4; Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Kuhbier JW, 2011, J BIOMED MATER RES B, V97B, P381, DOI 10.1002/jbm.b.31825; Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032; LALLY KP, 1993, J PEDIATR SURG, V28, P45, DOI 10.1016/S0022-3468(05)80352-5; Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lee SH, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.46; Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346; Ling S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00613-5; Lovati AB, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00427; Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Madhusudanan P, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2019.0505; Magaz A, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800308; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P37; MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004; Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P103; Moore AM, 2011, MUSCLE NERVE, V44, P221, DOI 10.1002/mus.22033; Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3; Muheremu A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/237507; Naghilou A, 2020, MAT SCI ENG C-MATER, V116, DOI 10.1016/j.msec.2020.111219; OBREMSKI VJ, 1993, DEV BIOL, V160, P119, DOI 10.1006/dbio.1993.1291; Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pawar K, 2019, ACS APPL BIO MATER, V2, P4872, DOI 10.1021/acsabm.9b00628; Petzold J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201701427; Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990; Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031; Reimers K, 2015, BIOTECHNOL BIOENG, V112, P2201, DOI 10.1002/bit.25654; Roloff F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906819; Salehi S, 2020, MOLECULES, V25, DOI 10.3390/molecules25030737; Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677; Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42; Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; Sinis N, 2005, J NEUROSURG, V103, P1067, DOI 10.3171/jns.2005.103.6.1067; SOONG HK, 1984, OPHTHALMOLOGY, V91, P479; Sosa I, 2005, EXP NEUROL, V195, P7, DOI 10.1016/j.expneurol.2005.04.016; Steins A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145240; Stoll G, 1999, BRAIN PATHOL, V9, P313; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Sulaiman W, 2013, OCHSNER J, V13, P100; Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370; Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vijayavenkataraman S, 2020, ACTA BIOMATER, V106, P54, DOI 10.1016/j.actbio.2020.02.003; Vollrath F, 2000, J Biotechnol, V74, P67; Wang ML, 2019, CONNECT TISSUE RES, V60, P3, DOI 10.1080/03008207.2018.1489381; Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K; Weiss T, 2018, METHODS MOL BIOL, V1739, P67, DOI 10.1007/978-1-4939-7649-2_5; Weiss T, 2016, GLIA, V64, P2133, DOI 10.1002/glia.23045; Widhe M, 2013, BIOMATERIALS, V34, P8223, DOI 10.1016/j.biomaterials.2013.07.058; Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069; Yang DP, 2008, MOL CELL NEUROSCI, V38, P80, DOI 10.1016/j.mcn.2008.01.017; Yousefi F, 2019, LIFE SCI, V221, P99, DOI 10.1016/j.lfs.2019.01.052; Zhou YZ, 2020, MAT SCI ENG C-MATER, V111, DOI 10.1016/j.msec.2020.110752; Zhu BF, 2015, BIOMACROMOLECULES, V16, P202, DOI 10.1021/bm501403f	104	10	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001447R	http://dx.doi.org/10.1096/fj.202001447R		NOV 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33210360	Green Published, hybrid			2022-12-28	WOS:000592745800001
J	Li, Y; Yong, YL; Yang, ML; Wang, WJ; Qu, XY; Dang, XM; Shang, D; Shao, YP; Liu, JK; Chang, Y				Li, Ying; Yong, Yu-Le; Yang, Menglin; Wang, Weijia; Qu, Xiaoyan; Dang, Xiaomin; Shang, Dong; Shao, Yongping; Liu, Jiankang; Chang, Ying			Fine particulate matter inhibits phagocytosis of macrophages by disturbing autophagy	FASEB JOURNAL			English	Article						ATG2A; ERK1; 2; reactive oxygen species	OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR MACROPHAGES; V-ATPASE; INFLAMMATION; ACIDIFICATION; PARTICLES; PROTEINS; ASTHMA	Mounting evidence from epidemiological and clinical studies has revealed marked correlations between the air pollutant fine particulate matter (FPM) and respiratory diseases. FPM reaches distal airways and deposits in alveolar regions where it can act directly on alveolar macrophages. However, the detailed effect of FPM on the physiological function of alveolar macrophages and the underlying mechanisms remain unclear. In this study, we showed that exposing THP-1-derived macrophages to FPM led to autophagy dysfunction. FPM activated the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway, which promoted the expression of autophagy-related 2A (ATG2A) and reactive oxygen species generation. The overexpression of ATG2A enhanced the synthesis of autophagic membranes, and the excessive production of reactive oxygen species caused autophagy flux inhibition through disrupting the lysosomal activity. More importantly, FPM impaired the phagocytic ability of macrophages on Escherichia coli and apoptotic neutrophils. Finally, we showed that restoring autophagy rescued the impairment of phagocytic ability induced by FPM. In summary, these results reveal the molecular mechanism of autophagy dysfunction caused by FPM and provide a novel approach to resolve the impaired function of macrophages in respiratory diseases induced by FPM.	[Li, Ying; Yang, Menglin; Wang, Weijia; Qu, Xiaoyan; Shao, Yongping; Chang, Ying] Xi An Jiao Tong Univ, Ctr Translat Med, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China; [Li, Ying; Yang, Menglin; Wang, Weijia; Qu, Xiaoyan; Shao, Yongping; Chang, Ying] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Yong, Yu-Le] Fourth Mil Med Univ, Dept Cell Biol, Natl Translat Sci Ctr Mol Med, Xian, Peoples R China; [Dang, Xiaomin; Shang, Dong] Xi'an Jiaotong Univ, Affiliated Hosp 1, Dept Respirat, Xian, Peoples R China; [Liu, Jiankang] Xi'an Jiaotong Univ, Sch Life Sci & Technol, Minist Educ, Ctr Mitochondrial Biol & Med,Key Lab Biomed Infor, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University	Chang, Y (corresponding author), Xi An Jiao Tong Univ, Ctr Translat Med, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.; Chang, Y (corresponding author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China.; Liu, JK (corresponding author), Xi'an Jiaotong Univ, Sch Life Sci & Technol, Minist Educ, Ctr Mitochondrial Biol & Med,Key Lab Biomed Infor, Xian, Peoples R China.	j.liu@mail.xjtu.edu.cn; changying0613@mail.xjtu.edu.cn			National Natural Science Foundation of China [31501044, 31770917, 31570777, 91649106]; National Basic Research Program [2015CB553602]; Natural Science Basic Research Plan in Shaanxi Province of China [2020JM-002]; International Cooperation and Exchange Program of Science and Technology of Shaanxi Province [2020KW-046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Natural Science Basic Research Plan in Shaanxi Province of China; International Cooperation and Exchange Program of Science and Technology of Shaanxi Province	National Natural Science Foundation of China, Grant/Award Number: 31501044, 31770917, 31570777 and 91649106; National Basic Research Program, Grant/Award Number: 2015CB553602; Natural Science Basic Research Plan in Shaanxi Province of China, Grant/Award Number: 2020JM-002; International Cooperation and Exchange Program of Science and Technology of Shaanxi Province, Grant/Award Number: 2020KW-046	Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Almatroodi Saleh A, 2014, Lung Cancer Int, V2014, P721087, DOI 10.1155/2014/721087; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bewley MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163139; Brandstaetter H, 2014, AUTOPHAGY, V10, P2310, DOI 10.4161/15548627.2014.984272; Chu X, 2016, ENVIRON TOXICOL PHAR, V48, P76, DOI 10.1016/j.etap.2016.10.006; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Gong L, 2012, IUBMB LIFE, V64, P740, DOI 10.1002/iub.1070; Guo CL, 2019, EXP THER MED, V17, P3848, DOI 10.3892/etm.2019.7402; Hamanaka RB, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00680; Hiraiwa K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/619523; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Jin M, 2004, AM J RESP CELL MOL, V31, P322, DOI 10.1165/rcmb.2004-0080OC; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708; Lund ME, 2016, J IMMUNOL METHODS, V430, P64, DOI 10.1016/j.jim.2016.01.012; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Maeda S, 2019, ELIFE, V8, DOI 10.7554/eLife.45777; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Miyata R, 2011, TOXICOL APPL PHARM, V257, P209, DOI 10.1016/j.taap.2011.09.007; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Ni L, 2015, FRONT PHYSIOL, V6, DOI [10.3339/fphys.2015.00294, 10.3389/fphys.2015.00294]; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; Palmer A, 2017, SHOCK, V48, P104, DOI 10.1097/SHK.0000000000000813; Pesonen M, 2019, TOXICOL LETT, V305, P1, DOI 10.1016/j.toxlet.2019.01.007; Racanelli AC, 2018, AUTOPHAGY, V14, P221, DOI 10.1080/15548627.2017.1389823; Reiners JJ, 2011, FREE RADICAL BIO MED, V50, P281, DOI 10.1016/j.freeradbiomed.2010.11.006; Repnik Urska, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087106; Repnik U, 2017, J CELL SCI, V130, P3124, DOI 10.1242/jcs.204529; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shin IS, 2015, J PINEAL RES, V58, P50, DOI 10.1111/jpi.12192; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Terman A, 2006, IUBMB LIFE, V58, P531, DOI 10.1080/15216540600904885; Ugland H, 2011, AUTOPHAGY, V7, P1199, DOI 10.4161/auto.7.10.16649; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Wang YH, 2015, INT J CLIN EXP MED, V8, P58; Wei Y, 2018, TOXICOL MECH METHOD, V28, P302, DOI 10.1080/15376516.2017.1410743; Wilson WE, 2002, CHEMOSPHERE, V49, P1009, DOI 10.1016/S0045-6535(02)00270-9; Xie YC, 2015, AUTOPHAGY, V11, P28, DOI 10.4161/15548627.2014.984267; Xu X, 2016, 2016 IEEE 18TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES (HEALTHCOM), P194	52	7	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16716	16735		10.1096/fj.202000657R	http://dx.doi.org/10.1096/fj.202000657R		OCT 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124742	Bronze			2022-12-28	WOS:000589710500001
J	Liu, XQ; Xie, DB; Hua, Y; Zeng, P; Ma, LJ; Zeng, FL				Liu, Xueqin; Xie, Debao; Hua, Yu; Zeng, Pei; Ma, Lujie; Zeng, Fanli			Npa3 interacts with Gpn3 and assembly factor Rba50 for RNA polymerase II biogenesis	FASEB JOURNAL			English	Article						assembly factor; GPN-loop GTPase; Npa3; Rba50; RNA polymerase II	NUCLEAR IMPORT; PROTEIN; ASSOCIATE; GTPASES; EXPORT	RNA polymerase II is one of the most vital macromolecular complexes in eukaryotes and the assembly of such complete enzyme requires many factors. Three members of GPN-loop GTPase family Npa3/Gpn1, Gpn2, and Gpn3 participate in the biogenesis of RNA polymerase II with nonredundant roles. We show here that rapid degradation of each GPN protein in yeast leads to cytoplasmic accumulation of Rpb1 and defects in the assembly of RNA polymerase II, suggesting conserved functions of GPN paralogs for RNA polymerase II biogenesis as in humans. Taking advantage of a multicopy genetic screening, we identifiedGPN3and assembly factorRBA50among others as strong suppressors ofnpa3(ts)mutants. We further demonstrated that Npa3 interacts with Gpn3 and Rba50, similarly human Gpn1 physically interacts with Gpn3 and RPAP1 (human analog of Rba50). Moreover, a mutual dependency of protein levels of Npa3 and Gpn3 was also clearly presented in yeast using an auxin-inducible degron (AID) system. Interestingly, Rpb2, the second largest subunit of RNA polymerase II was determined to be the subunit that interacts with both Gpn1 and Rba50, indicating a close association of Npa3 and Rba50 in Rpb2 subcomplex assembly. Based on these results, we conclude that Npa3 interacts with Gpn3 and Rba50, for RNA polymerase II biogenesis. We therefore propose that multiple factors may coordinate through conserved regulatory mechanisms in the assembly of RNA polymerase complex.	[Liu, Xueqin; Xie, Debao; Zeng, Pei; Ma, Lujie; Zeng, Fanli] Hebei Agr Univ, Coll Life Sci, Baoding 071001, Hebei, Peoples R China; [Liu, Xueqin; Xie, Debao; Zeng, Pei; Ma, Lujie; Zeng, Fanli] State Key Lab North China Crop Improvement & Regu, Baoding, Peoples R China; [Hua, Yu; Zeng, Fanli] Peking Univ, Coll Life Sci, Natl Lab Prot & Plant Gene Res, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Hebei Agricultural University; Peking University	Zeng, FL (corresponding author), Hebei Agr Univ, Coll Life Sci, Baoding 071001, Hebei, Peoples R China.	fanli.zeng@pku.edu.cn			Natural Science Foundation of Hebei Province [C2020204109]; National Natural Science Foundation of China [32070574]; Hebei Provincial Department of Education [BJ2020003]	Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Provincial Department of Education	Natural Science Foundation of Hebei Province, Grant/Award Number: C2020204109; National Natural Science Foundation of China, Grant/Award Number: 32070574; Hebei Provincial Department of Education, Grant/Award Number: BJ2020003	Alonso B, 2013, CELL CYCLE, V12, P463, DOI 10.4161/cc.23367; Barbosa-Camacho AA, 2017, FEBS LETT, V591, P3555, DOI 10.1002/1873-3468.12856; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Calera MR, 2011, BBA-MOL CELL RES, V1813, P1708, DOI 10.1016/j.bbamcr.2011.07.005; Carre C, 2011, MOL CELL BIOL, V31, P3953, DOI 10.1128/MCB.05442-11; Contreras R, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01044; Cristobal-Mondragon GR, 2019, FEBS J, V286, P4797, DOI 10.1111/febs.14996; Forget D, 2013, NUCLEIC ACIDS RES, V41, P6881, DOI 10.1093/nar/gkt455; Forget D, 2010, MOL CELL PROTEOMICS, V9, P2827, DOI 10.1074/mcp.M110.003616; Frischknecht L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44112-7; Guglielmi V, 2015, HISTOPATHOLOGY, V67, P859, DOI 10.1111/his.12715; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lara-Chacon B, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819870823; Lesseur C, 2016, NAT GENET, V48, P1544, DOI 10.1038/ng.3685; Li YX, 2018, PLANT CELL, V30, P466, DOI 10.1105/tpc.17.00380; Mendez-Hernandez LE, 2017, FEBS LETT, V591, P3757, DOI 10.1002/1873-3468.12883; Mendez-Hernandez LE, 2014, FEBS LETT, V588, P3823, DOI 10.1016/j.febslet.2014.08.038; Minaker SW, 2013, GENETICS, V193, P853, DOI 10.1534/genetics.112.148726; Niesser J, 2016, MOL CELL BIOL, V36, P820, DOI 10.1128/MCB.01009-15; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Ren P, 2016, GENES CELLS, V21, P543, DOI 10.1111/gtc.12361; Reyes-Pardo H, 2012, BBA-MOL CELL RES, V1823, P1756, DOI 10.1016/j.bbamcr.2012.07.001; Sapkota Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064896; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Staresincic L, 2011, J BIOL CHEM, V286, P35553, DOI 10.1074/jbc.M111.286161; van Leeuwen J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700042; Wild T, 2012, TRENDS BIOCHEM SCI, V37, P99, DOI 10.1016/j.tibs.2011.12.001; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Zeng FL, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00091-18; Zeng FL, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0394-x	31	6	6	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15547	15558		10.1096/fj.202001523R	http://dx.doi.org/10.1096/fj.202001523R		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32985767				2022-12-28	WOS:000574551900001
J	Mao, XW; Nishiyama, NC; Byrum, SD; Stanbouly, S; Jones, T; Holley, J; Sridharan, V; Boerma, M; Tackett, AJ; Willey, JS; Pecaut, MJ; Delp, MD				Mao, Xiao W.; Nishiyama, Nina C.; Byrum, Stephanie D.; Stanbouly, Seta; Jones, Tamako; Holley, Jacob; Sridharan, Vijayalakshmi; Boerma, Marjan; Tackett, Alan J.; Willey, Jeffrey S.; Pecaut, Michael J.; Delp, Michael D.			Spaceflight induces oxidative damage to blood-brain barrier integrity in a mouse model	FASEB JOURNAL			English	Article						brain tissue; blood-brain barrier; microgravity; neurodegeneration; proteomics; spaceflight	MITOCHONDRIAL DYSFUNCTION; SIMULATED MICROGRAVITY; PROTEIN-ALPHA; STRESS; RADIATION; AQUAPORIN-4; DISRUPTION; CELL; INFLAMMATION; NEUROGENESIS	Many factors contribute to the health risks encountered by astronauts on missions outside Earth's atmosphere. Spaceflight-induced potential adverse neurovascular damage and late neurodegeneration are a chief concern. The goal of the present study was to characterize the effects of spaceflight on oxidative damage in the mouse brain and its impact on blood-brain barrier (BBB) integrity. Ten-week-old male C57BL/6 mice were launched to the International Space Station (ISS) for 35 days as part of Space-X 12 mission. Ground control (GC) mice were maintained on Earth in flight hardware cages. Within 38 +/- 4 hours after returning from the ISS, mice were euthanized and brain tissues were collected for analysis. Quantitative assessment of brain tissue demonstrated that spaceflight caused an up to 2.2-fold increase in apoptosis in the hippocampus compared to the control group. Immunohistochemical analysis of the mouse brain revealed an increased expression of aquaporin4 (AQP4) in the flight hippocampus compared to the controls. There was also a significant increase in the expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) and a decrease in the expression of the BBB-related tight junction protein, Zonula occludens-1 (ZO-1). These results indicate a disturbance of BBB integrity. Quantitative proteomic analysis showed significant alterations in pathways responsible for neurovascular integrity, mitochondrial function, neuronal structure, protein/organelle transport, and metabolism in the brain after spaceflight. Changes in pathways associated with adhesion and molecular remodeling were also documented. These data indicate that long-term spaceflight may have pathological and functional consequences associated with neurovascular damage and late neurodegeneration.	[Mao, Xiao W.; Nishiyama, Nina C.; Stanbouly, Seta; Jones, Tamako; Holley, Jacob; Pecaut, Michael J.] Loma Linda Univ, Div Biomed Engn Sci BMES, Dept Basic Sci, Sch Med & Med Ctr, Loma Linda, CA 92350 USA; [Byrum, Stephanie D.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Byrum, Stephanie D.; Tackett, Alan J.] Arkansas Childrens Res Inst, Little Rock, AR USA; [Sridharan, Vijayalakshmi; Boerma, Marjan] Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Willey, Jeffrey S.] Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC 27101 USA; [Delp, Michael D.] Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA	Loma Linda University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Wake Forest University; State University System of Florida; Florida State University	Mao, XW (corresponding author), Loma Linda Univ, Div Biomed Engn Sci BMES, Dept Basic Sci, Sch Med & Med Ctr, Loma Linda, CA 92350 USA.	xmao@llu.edu	Pecaut, Michael J/P-6481-2015	Pecaut, Michael J/0000-0002-2915-9686; Holley, Jacob/0000-0002-0484-904X	NASA | Ames Research Center [NNX16AC28G]; DH | NIHR | Programme Grants for Applied Research (PGfAR) [P20GM121293]; Loma Linda University	NASA | Ames Research Center(National Aeronautics & Space Administration (NASA)); DH | NIHR | Programme Grants for Applied Research (PGfAR); Loma Linda University	NASA | Ames Research Center, Grant/Award Number: NNX15AB41G; DH | NIHR | Programme Grants for Applied Research (PGfAR), Grant/Award Number: P20GM121293; NASA | Ames Research Center, Grant/Award Number: NNX16AC28G; Loma Linda University	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Anderson CM, 2003, TRENDS NEUROSCI, V26, P340, DOI 10.1016/S0166-2236(03)00141-3; Anzabi M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00019; Armentero MT, 2011, NEUROBIOL DIS, V43, P663, DOI 10.1016/j.nbd.2011.05.017; Balentova S, 2017, NEUROTOXICOLOGY, V60, P70, DOI 10.1016/j.neuro.2017.03.005; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Begum G, 2018, GLIA, V66, P126, DOI 10.1002/glia.23232; Bors L, 2018, BRAIN RES BULL, V139, P269, DOI 10.1016/j.brainresbull.2018.03.001; Carvalho AN, 2017, CURR DRUG TARGETS, V18, P705, DOI 10.2174/1389450117666160401120514; Chen Hai-Long, 2009, Shengli Xuebao, V61, P108; Day JR, 1998, J APPL PHYSIOL, V85, P716, DOI 10.1152/jappl.1998.85.2.716; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Ding GR, 2010, TOXICOL LETT, V196, P154, DOI 10.1016/j.toxlet.2010.04.011; Dominic A, 2015, J THERM SCI ENG APPL, V7, DOI 10.1115/1.4030104; Erdo F, 2017, J CEREBR BLOOD F MET, V37, P4, DOI 10.1177/0271678X16679420; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Goodall EF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123097; Grigor'ev A I, 1996, Hum Physiol, V22, P139; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hattori N, 2003, J NUCL MED, V44, P1709; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; JONES EG, 1970, J ANAT, V106, P507; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kalinowska A, 2006, EUR J NEUROL, V13, P1284, DOI 10.1111/j.1468-1331.2006.01640.x; Kempuraj D, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00054; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Lakin WD, 2007, AVIAT SPACE ENVIR MD, V78, P932, DOI 10.3357/ASEM.2060.2007; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lazarini F, 2012, J NEUROSCI, V32, P3652, DOI 10.1523/JNEUROSCI.6394-11.2012; Lee WY, 2010, J BIOL CHEM, V285, P37953, DOI 10.1074/jbc.M110.180018; Leek J. T., 2019, SURROGATE VARIABLE A; Lehner C, 2011, ANTIOXID REDOX SIGN, V15, P1305, DOI 10.1089/ars.2011.3923; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Lin AL, 2013, J CEREBR BLOOD F MET, V33, P1605, DOI 10.1038/jcbfm.2013.116; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Lonergan PE, 2002, J BIOL CHEM, V277, P20804, DOI 10.1074/jbc.M202387200; Love S, 1999, BRAIN PATHOL, V9, P119; Lowe XR, 2009, RADIAT RES, V171, P53, DOI 10.1667/RR1389.1; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mao XW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44696-0; Mao XW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010007; Mao XW, 2017, RADIAT RES, V188, P392, DOI 10.1667/RR14754.1; Mao XW, 2016, RADIAT RES, V185, P647, DOI 10.1667/RR14267.1; Mao XW, 2010, RADIAT RES, V173, P486, DOI 10.1667/RR1728.1; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nguyen V, 2000, RADIAT RES, V154, P531, DOI 10.1667/0033-7587(2000)154[0531:LEOIRO]2.0.CO;2; Niewiarowska-Sendo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206443; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Pintado C, 2011, J NEUROIMMUNOL, V238, P44, DOI 10.1016/j.jneuroim.2011.06.017; Rao KVR, 2010, GLIA, V58, P1490, DOI 10.1002/glia.21023; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts DR, 2017, NEW ENGL J MED, V377, P1746, DOI 10.1056/NEJMoa1705129; Ryan SM, 2016, NEUROSCI BIOBEHAV R, V61, P121, DOI 10.1016/j.neubiorev.2015.12.004; Sajdel-Sulkowska EV, 2007, ADV SPACE RES, V40, P1414, DOI 10.1016/j.asr.2007.08.004; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Sofronova SI, 2015, J APPL PHYSIOL, V118, P830, DOI 10.1152/japplphysiol.00976.2014; Stein TP, 2002, NUTRITION, V18, P867, DOI 10.1016/S0899-9007(02)00938-3; Stolp HB, 2009, NEUROPATH APPL NEURO, V35, P132, DOI 10.1111/j.1365-2990.2008.01005.x; Stolp HB, 2005, EUR J NEUROSCI, V22, P2805, DOI 10.1111/j.1460-9568.2005.04483.x; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Timms JF, 1999, CURR BIOL, V9, P927, DOI 10.1016/S0960-9822(99)80401-1; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; Vecchione C, 2009, HYPERTENSION, V54, P1028, DOI 10.1161/HYPERTENSIONAHA.109.136572; Wang Y, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101233; Yan BC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00775; Yang Tang-bin, 2003, Space Med Med Eng (Beijing), V16, P455; Yaribeygi H, 2018, CNS NEUROL DISORD-DR, V17, P207, DOI 10.2174/1871527317666180425122557; Zhan H, 1999, Space Med Med Eng (Beijing), V12, P1; Zhang LF, 2018, PHYSIOL REV, V98, P59, DOI 10.1152/physrev.00017.2016; Zhang R, 2012, J PHYSIOL BIOCHEM, V68, P99, DOI 10.1007/s13105-011-0123-1; Zhang YL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2547532; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011; Zorkina YA, 2014, B EXP BIOL MED+, V158, P127, DOI 10.1007/s10517-014-2708-5	80	20	22	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15516	15530		10.1096/fj.202001754R	http://dx.doi.org/10.1096/fj.202001754R		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32981077	Green Accepted, hybrid			2022-12-28	WOS:000574543300001
J	Sunda, F; Arowolo, A				Sunda, Falone; Arowolo, Afolake			A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol	FASEB JOURNAL			English	Review						cannabidiol (CBD); fibrosis; inflammation; reactive oxygen species (ROS)	ACTIVATED RECEPTOR-GAMMA; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; CANNABINOID RECEPTOR; NADPH OXIDASES; MN-SOD; ADENOSINE; GPR55; INHIBITION; CHANNELS; INFLAMMATION	Cannabidiol (CBD) is considered a non-psychoactive, antioxidant, and anti-inflammatory compound derived from the Cannabis sativa plant. There are various reports on the versatile function of CBD, including ameliorating chronic inflammation and fibrosis formation in several tissue types. However, only a hand full of studies have proposed or provided a molecular justification for the beneficial properties of this Phyto-compound. This review focused on the anti-inflammation and anti-fibrotic effects of CBD based on modulating the associated chemokines/cytokines and receptor-mediated pathways. We also highlighted the regulatory impact of CBD on reactive oxygen species (ROS) producing-NADPH oxidase (Nox), and ROS scavenging-superoxide dismutase (SOD) enzymes. Although CBD has a low affinity to Cannabinoid receptors 1 and 2 (CB(1)and CB2), we reported on the activation of these receptors by other CBD analogs, and CBD on non-CBD receptors. CBD downregulates pro-inflammatory and pro-fibrotic chemokines/cytokines by acting as direct or indirect agonists of Adenosine A(2A)/equilibrative nucleoside transporter receptors, Peroxisome proliferator-activated receptor gamma, and Transient receptor potential vanilloid receptors or channels, and as an antagonist of GPR55 receptors. CBD also caused the reduction and enhancement of the ROS producing, Nox and ROS-scavenging, SOD enzyme activities, respectively. This review thus recommends the continued study of CBD's molecular mechanism in treating established and emerging inflammatory and fibrosis-related diseases.	[Sunda, Falone; Arowolo, Afolake] Univ Cape Town, Div Med Biochem & Dermatol, Hair & Skin Res Lab, Cape Town, South Africa; [Sunda, Falone; Arowolo, Afolake] Univ Cape Town, Fac Hlth Sci, Dept Med, Cape Town, South Africa; [Sunda, Falone; Arowolo, Afolake] Univ Cape Town, Groote Schuur Hosp, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Arowolo, A (corresponding author), Univ Cape Town, Groote Schuur Hosp, Div Dermatol, Hair & Skin Res Lab, Old Main Bldg,Anzio Rd, ZA-7925 Cape Town, South Africa.	at.arowolo2@uct.ac.za			National Research Foundation (NRF) [TTK170413227114]	National Research Foundation (NRF)	National Research Foundation (NRF), Grant/Award Number: TTK170413227114	Appendino G, 2008, J NAT PROD, V71, P1427, DOI 10.1021/np8002673; Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Atalay S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010021; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/721608; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bellini A, 2012, MUCOSAL IMMUNOL, V5, P140, DOI 10.1038/mi.2011.60; Bisoyi HK, 2014, NANOSCI TECHNOL, P69, DOI 10.1007/978-3-319-04867-3_3; Boswell-Casteel RC, 2017, NUCLEOS NUCLEOT NUCL, V36, P7, DOI 10.1080/15257770.2016.1210805; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Burstein S, 2015, BIOORGAN MED CHEM, V23, P1377, DOI 10.1016/j.bmc.2015.01.059; Campos AC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00269; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; Chan ESL, 2010, MOD RHEUMATOL, V20, P114, DOI 10.1007/s10165-009-0251-4; Cheng D, 2014, PSYCHOPHARMACOLOGY, V231, P3009, DOI 10.1007/s00213-014-3478-5; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Davidson JM, 2006, DIABETIC FOOT, P59; De Petrocellis L, 2012, ACTA PHYSIOL, V204, P255, DOI 10.1111/j.1748-1716.2011.02338.x; del Rio C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21703; Elbaz M, 2015, MOL ONCOL, V9, P906, DOI 10.1016/j.molonc.2014.12.010; Emerit J, 2006, BIOMED PHARMACOTHER, V60, P1, DOI 10.1016/j.biopha.2005.09.002; Fagundo AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066387; Gallelli CA, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7070093; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Garcia-Arencibia M, 2007, BRAIN RES, V1134, P162, DOI 10.1016/j.brainres.2006.11.063; Gianazza E, 2007, AMINO ACIDS, V33, P51, DOI 10.1007/s00726-006-0410-2; Gui H, 2014, RHEUMATOLOGY, V53, P802, DOI 10.1093/rheumatology/ket447; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Iannotti FA, 2014, ACS CHEM NEUROSCI, V5, P1131, DOI 10.1021/cn5000524; Jarman ER, 2014, AM J RESP CELL MOL, V50, P158, DOI 10.1165/rcmb.2013-0174OC; Koscso B, 2012, J IMMUNOL, V188, P445, DOI 10.4049/jimmunol.1101224; Lanuti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126839; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Lefaix JL, 1996, INT J RADIAT ONCOL, V35, P305, DOI 10.1016/0360-3016(96)00061-2; LeMoine O, 1996, J IMMUNOL, V156, P4408; Liang S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00017; Lin XH, 2011, NEUROGASTROENT MOTIL, V23, P862, DOI 10.1111/j.1365-2982.2011.01742.x; Liou GI, 2008, INVEST OPHTH VIS SCI, V49, P5526, DOI 10.1167/iovs.08-2196; Little JW, 2015, BRAIN, V138, P28, DOI 10.1093/brain/awu330; Luo XZ, 2019, NATURE, V567, P123, DOI 10.1038/s41586-019-0978-9; Mack M, 2018, MATRIX BIOL, V68-69, P106, DOI 10.1016/j.matbio.2017.11.010; Marichal-Cancino BA, 2017, CURR NEUROPHARMACOL, V15, P771, DOI 10.2174/1570159X14666160729155441; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V50, P1368, DOI 10.1016/j.freeradbiomed.2011.02.021; Muller C, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00487; Nabissi M, 2013, CARCINOGENESIS, V34, P48, DOI 10.1093/carcin/bgs328; Nan YM, 2011, SCAND J GASTROENTERO, V46, P358, DOI 10.3109/00365521.2010.525717; O'Sullivan SE, 2016, BRIT J PHARMACOL, V173, P1899, DOI 10.1111/bph.13497; Okada Y, 2015, CORNEA, V34, pS136, DOI 10.1097/ICO.0000000000000602; Paik YH, 2014, ANTIOXID REDOX SIGN, V20, P2854, DOI 10.1089/ars.2013.5619; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; Paunkov A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090353; Pellati F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1691428; PIZZINO G, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/8416763; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Ribeiro A, 2012, EUR J PHARMACOL, V678, P78, DOI 10.1016/j.ejphar.2011.12.043; Richter K, 2016, CELL TISSUE RES, V365, P591, DOI 10.1007/s00441-016-2445-3; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSALES C, 2018, FRONT PHYSIOL, V9; Sahoo S, 2016, CLIN SCI, V130, P317, DOI 10.1042/CS20150087; Sajjadi FG, 1996, J IMMUNOL, V156, P3435; Samanta A, 2018, SUBCELL BIOCHEM, V87, P141, DOI 10.1007/978-981-10-7757-9_6; Samoylenko A, 2013, ANTIOXID REDOX SIGN, V19, P2157, DOI 10.1089/ars.2012.4662; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Schicho R, 2012, CURR OPIN PHARMACOL, V12, P653, DOI 10.1016/j.coph.2012.09.009; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Stanley CP, 2015, CARDIOVASC RES, V107, P568, DOI 10.1093/cvr/cvv179; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Suthahar Navin, 2017, Curr Heart Fail Rep, V14, P235, DOI 10.1007/s11897-017-0343-y; Sylantyev S, 2013, P NATL ACAD SCI USA, V110, P5193, DOI 10.1073/pnas.1211204110; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Ulisse S, 2001, AM J GASTROENTEROL, V96, P2691, DOI 10.1111/j.1572-0241.2001.04139.x; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Velasco G, 2016, CURR ONCOL, V23, pS23, DOI 10.3747/co.23.3080; VUCKOVIC S, 2018, FRONT PHARMACOL, V9; Vuolo F, 2019, EUR J PHARMACOL, V843, P251, DOI 10.1016/j.ejphar.2018.11.029; Wang YA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06219-7; Wang YH, 2004, PLANT SCI, V167, P671, DOI 10.1016/j.plantsci.2004.03.032; Wei W, 2013, J IMMUNOL, V190, P138, DOI 10.4049/jimmunol.1103721; Weiss L, 2008, NEUROPHARMACOLOGY, V54, P244, DOI 10.1016/j.neuropharm.2007.06.029; Yang Yoon Mee, 2015, Curr Pathobiol Rep, V3, P253	88	21	20	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14083	14092		10.1096/fj.202000975R	http://dx.doi.org/10.1096/fj.202000975R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32885502				2022-12-28	WOS:000566829900001
J	Quignon, C; Beymer, M; Gauthier, K; Gauer, F; Simonneaux, V				Quignon, Clarisse; Beymer, Matthew; Gauthier, Karine; Gauer, Francois; Simonneaux, Valerie			Thyroid hormone receptors are required for the melatonin-dependent control of Rfrp gene expression in mice	FASEB JOURNAL			English	Article						deiodinase; neuropeptides; seasonal rhythms; tanycytes; TSH	TYPE-2 DEIODINASE GENE; PARS TUBERALIS; CELL-PROLIFERATION; DJUNGARIAN HAMSTER; BODY-WEIGHT; ALPHA; PHOTOPERIOD; PINEAL; RAT; REPRODUCTION	Mammals adapt to seasons using a neuroendocrine calendar defined by the photoperiodic change in the nighttime melatonin production. Under short photoperiod, melatonin inhibits thepars tuberalisproduction of TSH beta, which, in turn, acts on tanycytes to regulate the deiodinase 2/3 balance resulting in a finely tuned seasonal control of the intra-hypothalamic thyroid hormone T3. Despite the pivotal role of this T3 signaling for synchronizing reproduction with the seasons, T3 cellular targets remain unknown. One candidate is a population of hypothalamic neurons expressingRfrp, the gene encoding the RFRP-3 peptide, thought to be integral for modulating rodent's seasonal reproduction. Here we show that nighttime melatonin supplementation in the drinking water of melatonin-deficient C57BL/6J mice mimics photoperiodic variations in the expression of the genesTshb, Dio2,Dio3, andRfrp, as observed in melatonin-proficient mammals. Notably, we report that this melatonin regulation ofRfrpexpression is no longer observed in mice carrying a global mutation of the T3 receptor, TR alpha, but is conserved in mice with a selective neuronal mutation of TR alpha. In line with this observation, we find that TR alpha is widely expressed in the tanycytes. Altogether, our data demonstrate that the melatonin-driven T3 signal regulates RFRP-3 neurons through non-neuronal, possibly tanycytic, TR alpha.	[Quignon, Clarisse; Beymer, Matthew; Gauer, Francois; Simonneaux, Valerie] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, UPR 3212, Strasbourg, France; [Gauthier, Karine] Univ Lyon, Inst Genom Fonct Lyon, ENS Lyon, INRAE,CNRS, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Simonneaux, V (corresponding author), Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, 8 Allee Gen Rouvillois, F-67000 Strasbourg, France.	simonneaux@inci-cnrs.unistra.fr			Agence Nationale de la Recherche (ANR) [ANR-13-BSV1-001]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-13-BSV1-001	Ancel C, 2012, ENDOCRINOLOGY, V153, P1352, DOI 10.1210/en.2011-1622; Angelopoulou E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00183; Banares S, 2005, GENESIS, V42, P6, DOI 10.1002/gene.20117; Bank JHH, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12487; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Batailler M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24381-4; Bernal J, 2015, NAT REV ENDOCRINOL, V11, P406, DOI 10.1038/nrendo.2015.66; Bockmann J, 1996, ENDOCRINOLOGY, V137, P1804, DOI 10.1210/en.137.5.1804; Bothorel B, 2002, EUR J NEUROSCI, V16, P1090, DOI 10.1046/j.1460-9568.2002.02176.x; BRADLEY DJ, 1989, P NATL ACAD SCI USA, V86, P7250, DOI 10.1073/pnas.86.18.7250; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; CARLSON DJ, 1994, ENDOCRINOLOGY, V135, P1831, DOI 10.1210/en.135.5.1831; Cazarez-Marquez F, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12710; Dardente H, 2003, J NEUROENDOCRINOL, V15, P778, DOI 10.1046/j.1365-2826.2003.01060.x; Dardente H, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12729; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; de Miera CS, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.217687; Dufourny L, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12344; Freeman DA, 2007, AM J PHYSIOL-REG I, V292, pR2368, DOI 10.1152/ajpregu.00713.2006; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.0.CO;2-2; Guadano-Ferraz A, 2003, MOL PSYCHIATR, V8, P30, DOI 10.1038/sj.mp.4001196; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Hazlerigg D, 2014, KNOBIL NEILLS PHYSL, V34, P1575; Hazlerigg DG, 2013, CHRONOBIOL INT, V30, P548, DOI 10.3109/07420528.2012.754450; Helfer G, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12680; Henningsen JB, 2017, ENDOCRINOLOGY, V158, P652, DOI 10.1210/en.2016-1689; Henson JR, 2013, J BIOL RHYTHM, V28, P193, DOI 10.1177/0748730413487974; Herwig A, 2008, OBESITY FACTS, V1, P71, DOI 10.1159/000123428; Huang LY, 1998, J NEUROBIOL, V36, P410, DOI 10.1002/(SICI)1097-4695(19980905)36:3<410::AID-NEU8>3.0.CO;2-Z; Kapoor R, 2015, J NEUROCHEM, V133, P599, DOI 10.1111/jnc.13093; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; KLOSEN P, 1993, J HISTOCHEM CYTOCHEM, V41, P455, DOI 10.1177/41.3.8429209; Klosen P, 2013, FASEB J, V27, P2677, DOI 10.1096/fj.13-229559; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; MAYWOOD ES, 1993, J ENDOCRINOL, V136, P65, DOI 10.1677/joe.0.1360065; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Migaud M, 2011, J BIOL RHYTHM, V26, P486, DOI 10.1177/0748730411420062; Murphy M, 2012, ENDOCRINOLOGY, V153, P101, DOI 10.1210/en.2011-1249; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nishiwaki-Ohkawa T, 2016, J ENDOCRINOL, V229, pR117, DOI 10.1530/JOE-16-0066; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Prevot V, 2018, ENDOCR REV, V39, P333, DOI 10.1210/er.2017-00235; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; REITER RJ, 1980, INT J BIOMETEOROL, V24, P57, DOI 10.1007/BF02245542; Revel FG, 2008, ENDOCRINOLOGY, V149, P902, DOI 10.1210/en.2007-0848; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Revel FG, 2006, CURR BIOL, V16, P1730, DOI 10.1016/j.cub.2006.07.025; Ribelayga C, 2000, AM J PHYSIOL-REG I, V278, pR1339, DOI 10.1152/ajpregu.2000.278.5.R1339; Richard S, 2017, BEHAV BRAIN RES, V321, P18, DOI 10.1016/j.bbr.2016.12.025; ROLLAG MD, 1980, P SOC EXP BIOL MED, V165, P330, DOI 10.3181/00379727-165-40981; Simonneaux V, 2020, EUR J NEUROSCI, V51, P509, DOI 10.1111/ejn.14287; Wallis K, 2010, MOL ENDOCRINOL, V24, P1904, DOI 10.1210/me.2010-0175; Warner A, 2012, J MOL ENDOCRINOL, V49, pR29, DOI 10.1530/JME-12-0068; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; WITTKOWSKI W, 1988, CELL TISSUE RES, V251, P183, DOI 10.1007/BF00215463; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2009, J NEUROSCI, V29, P2885, DOI 10.1523/JNEUROSCI.0145-09.2009; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	61	6	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12072	12082		10.1096/fj.202000961R	http://dx.doi.org/10.1096/fj.202000961R		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32776612	Green Submitted			2022-12-28	WOS:000558417200001
J	Han, SJ; Kim, M; Novitsky, E; D'Agati, V; Lee, HT				Han, Sang Jun; Kim, Mihwa; Novitsky, Ella; D'Agati, Vivette; Lee, H. Thomas			Intestinal TLR9 deficiency exacerbates hepatic IR injury via altered intestinal inflammation and short-chain fatty acid synthesis	FASEB JOURNAL			English	Article						apoptosis; butyrate; inflammation; microbiome; necrosis; neutrophil; propionate; short-chain fatty acid	ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; RENAL ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; DEPENDENT REPRESSION; LIVER ISCHEMIA; RECEPTOR 9; PROTECTS; BUTYRATE; CELLS	Mice deficient in intestinal epithelial TLR9 develop small intestinal Paneth cell hyperplasia and higher Paneth cell IL-17A levels. Since small intestinal Paneth cells and IL-17A play critical roles in hepatic ischemia reperfusion (IR) injury, we tested whether mice lacking intestinal TLR9 have increased hepatic IR injury. Mice lacking intestinal TLR9 had profoundly increased liver injury after hepatic IR compared to WT mice with exacerbated hepatocyte necrosis, apoptosis, neutrophil infiltration, and inflammatory cytokine generation. Moreover, we observed increased small intestinal inflammation and apoptosis after hepatic IR in intestinal TLR9 deficient mice. As a potential explanation for increased hepatic IR injury, fecal short-chain fatty acids butyrate and propionate levels were lower in intestinal TLR9 deficient mice. Suggesting a potential therapy for hepatic IR, exogenous administration of butyrate or propionate protected against hepatic IR injury in intestinal TLR9 deficient mice. Mechanistically, butyrate induced small intestinal IL-10 expression and downregulated the claudin-2 expression. Finally, IL-10 neutralization abolished the protective effects of butyrate against hepatic IR injury. Our studies show intestinal TLR9 deficiency results in exacerbated hepatic IR injury with increased small intestinal apoptosis and inflammation. Furthermore, short-chain fatty acids butyrate and propionate protect against hepatic IR injury and intestinal apoptosis/inflammation in intestinal TLR9 deficient mice.	[Han, Sang Jun; Kim, Mihwa; Novitsky, Ella; Lee, H. Thomas] Columbia Univ, Dept Anesthesiol, Anesthesiol Res Labs, P&S Box 46 PH-5,630 West 168th St, New York, NY 10032 USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University	Han, SJ; Lee, HT (corresponding author), Columbia Univ, Dept Anesthesiol, Anesthesiol Res Labs, P&S Box 46 PH-5,630 West 168th St, New York, NY 10032 USA.	sh3740@cumc.columbia.edu; tl128@columbia.edu			National Research Foundation of Korea (NRF) [NRF-2018R1A6A3A03011633]; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK-109544, DK-115694]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A6A3A03011633; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK-109544 and DK-115694	Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asarat M, 2016, IMMUNOL INVEST, V45, P205, DOI 10.3109/08820139.2015.1122613; Bakar AM, 2012, INT J MOL SCI, V13, P977, DOI 10.3390/ijms13010977; Bakker PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137511; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Bartoszek A, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2019.104604; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bhaskaran N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01995; Callahan Ben J, 2016, F1000Res, V5, P1492; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12.1519, 10.3748/wjg.v17.i12. 1519]; Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen SWC, 2009, TRANSPLANTATION, V87, P1478, DOI 10.1097/TP.0b013e3181a3c691; Dar WA, 2019, LIVER INT, V39, DOI 10.1111/liv.14091; De Vuyst L, 2011, INT J FOOD MICROBIOL, V149, P73, DOI 10.1016/j.ijfoodmicro.2011.03.003; Deng MH, 2018, J IMMUNOL, V200; Foureau DM, 2010, J IMMUNOL, V184, P7022, DOI 10.4049/jimmunol.0901642; Han SJ, 2019, KIDNEY INT, V95, P859, DOI 10.1016/j.kint.2018.10.035; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; Huang H, 2015, HEPATOLOGY, V62, P600, DOI 10.1002/hep.27841; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Kimura I, 2020, PHYSIOL REV, V100, P171, DOI 10.1152/physrev.00041.2018; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Lee HT, 2013, AM J PHYSIOL-GASTR L, V304, pG12, DOI 10.1152/ajpgi.00201.2012; Lee HT, 2012, AM J PHYSIOL-RENAL, V303, pF1216, DOI 10.1152/ajprenal.00220.2012; Lee HT, 2009, LAB INVEST, V89, P196, DOI 10.1038/labinvest.2008.124; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106184; Lu C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000629; Luettig J, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.977176; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; Vergara DM, 2017, NUTR HOSP, V34, P58, DOI 10.20960/nh.1573; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Nastos C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/906965; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Park SW, 2012, J IMMUNOL, V189, P5421, DOI 10.4049/jimmunol.1200581; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Park SW, 2011, KIDNEY INT, V80, P1315, DOI 10.1038/ki.2011.281; Park SW, 2011, HEPATOLOGY, V53, P1662, DOI 10.1002/hep.24253; Park SW, 2009, AM J PHYSIOL-RENAL, V297, pF885, DOI 10.1152/ajprenal.00317.2009; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Qiao YL, 2014, J SURG RES, V187, P653, DOI 10.1016/j.jss.2013.08.028; Qiao YL, 2015, J SURG RES, V197, P324, DOI 10.1016/j.jss.2015.04.031; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rumio C, 2012, J CELL PHYSIOL, V227, P1107, DOI 10.1002/jcp.22830; Salzman NH, 2013, SEMIN IMMUNOL, V25, P334, DOI 10.1016/j.smim.2013.09.006; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Shaker ME, 2016, BIOCHEM PHARMACOL, V112, P90, DOI 10.1016/j.bcp.2016.05.003; Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110; Slone EA, 2012, AM J CLIN EXP IMMUNO, V1, P124; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; TRABER PG, 1991, AM J PHYSIOL, V260, pG895, DOI 10.1152/ajpgi.1991.260.6.G895; Yap S, 2012, AM J PHYSIOL-RENAL, V302, pF1104, DOI 10.1152/ajprenal.00543.2011; Zhang MM, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0500-x; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105	63	4	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12083	12099		10.1096/fj.202000314R	http://dx.doi.org/10.1096/fj.202000314R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738096				2022-12-28	WOS:000558164800001
J	Schetters, STT; Kruijssen, LJW; Crommentuijn, MHW; Kalay, H; den Haan, JMM; van Kooyk, Y				Schetters, Sjoerd T. T.; Kruijssen, Laura J. W.; Crommentuijn, Matheus H. W.; Kalay, Hakan; den Haan, Joke M. M.; van Kooyk, Yvette			Immunological dynamics after subcutaneous immunization with a squalene-based oil-in-water adjuvant	FASEB JOURNAL			English	Article						adaptive immunity; dendritic cell; monocyte; vaccine	INFLAMMATORY DENDRITIC CELLS; ADIPOSE-TISSUE; FUNCTIONAL SPECIALIZATION; MONOCYTE DIFFERENTIATION; VACCINE; MF59; RESPONSES; IMMUNITY; INDUCE; SPECIFICITY	The clinically successful adjuvant MF59 is used in seasonal influenza vaccines, which is proposed to enhance immunity by creating an immune-competent microenvironment in the muscle that allows recruitment of immune cells that drive adaptive immune responses. Here, we examined whether the clinically successful adjuvants MF59/AddaVax could be used for subcutaneous use and how antigen delivery can be synergized with cellular dynamics at the vaccination site. Subcutaneous injection of AddaVax leads to thickening of the skin, characterized by a neutrophil-monocyte recruitment sequence. Skin-infiltrating CCR2(+)Ly6C(high)monocytes showed differentiation to CD11b(+)Ly6C(+)MHCII(+)CD11c(+)CD64(+)monocyte-derived DCs over time in the hypodermal layers of the skin, expressing high levels of CD209a/mDC-SIGN. Surprisingly, skin thickening was accompanied with increased white adipose tissue highly enriched with monocytes. Analysis of the skin-draining lymph nodes revealed early increases in neutrophils and moDCs at 12 hours after injection and later increases in migratory cDC2s. Subcutaneous vaccination with AddaVax enhanced antigen-specific CD8(+)and CD4(+)T cell responses, while moDC targeting using antigen-coupled CD209a antibody additionally boosted humoral responses. Hence, oil-in-water emulsions provide an attractive immune modulatory adjuvants aimed at increasing cellular responses, as well as antibody responses when combined with moDC targeting.	[Schetters, Sjoerd T. T.; Kruijssen, Laura J. W.; Crommentuijn, Matheus H. W.; Kalay, Hakan; den Haan, Joke M. M.; van Kooyk, Yvette] Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Schetters, Sjoerd T. T.; Kruijssen, Laura J. W.; Crommentuijn, Matheus H. W.; Kalay, Hakan; den Haan, Joke M. M.; van Kooyk, Yvette] Vrije Univ Amsterdam, Amsterdam Infect & Immun Inst, Canc Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	van Kooyk, Y (corresponding author), Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	y.vankooyk@amsterdamumc.nl	Schetters, Sjoerd/ABA-5242-2022; den Haan, Joke MM/A-4281-2010	den Haan, Joke MM/0000-0002-4421-6917; Van Kooyk, Yvette/0000-0001-5997-3665	EC \ European Research Council (ERC) [ERC-339977-Glycotreat]; Hersen Tumor Fonds [20180625]; KWF Kankerbestrijding (Dutch Cancer Society) [VU2013-5940, VU2016-10449]	EC \ European Research Council (ERC); Hersen Tumor Fonds; KWF Kankerbestrijding (Dutch Cancer Society)	EC vertical bar European Research Council (ERC), Grant/Award Number: ERC-339977-Glycotreat; Hersen Tumor Fonds, Grant/Award Number: 20180625; KWF Kankerbestrijding (Dutch Cancer Society), Grant/Award Number: VU2013-5940 and VU2016-10449	Belshe RB, 2014, JAMA-J AM MED ASSOC, V312, P1420, DOI 10.1001/jama.2014.12609; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Calabro S, 2013, VACCINE, V31, P3363, DOI 10.1016/j.vaccine.2013.05.007; Caminschi I, 2012, TRENDS IMMUNOL, V33, P71, DOI 10.1016/j.it.2011.10.007; Chakarov S, 2014, EMBO MOL MED, V6, P590, DOI 10.1002/emmm.201403841; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chow KV, 2016, J IMMUNOL, V196, P624, DOI 10.4049/jimmunol.1501202; Cox AR, 2019, ENDOCRINOLOGY, V160, P1645, DOI 10.1210/en.2019-00266; Cruz-Valdez A, 2018, HUM VACC IMMUNOTHER, V14, P386, DOI 10.1080/21645515.2017.1373227; Dalod M, 2014, EMBO J, V33, P1104, DOI 10.1002/embj.201488027; Dyer DP, 2019, IMMUNITY, V50, P378, DOI 10.1016/j.immuni.2019.01.009; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Griffiths KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13894; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6074; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Huber A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02804; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Juge-Aubry CE, 2005, BEST PRACT RES CL EN, V19, P547, DOI 10.1016/j.beem.2005.07.009; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lee HY, 2011, J IMMUNOL, V186, P4347, DOI 10.4049/jimmunol.1002068; Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094; Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; O'Hagan DT, 2015, VACCINE, V33, pB14, DOI 10.1016/j.vaccine.2015.01.088; O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/ERV.12.140, 10.1586/erv.12.140]; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960; Sander J, 2017, IMMUNITY, V47, P1051, DOI 10.1016/j.immuni.2017.11.024; Schetters STT, 2020, CELL MOL IMMUNOL, V17, P415, DOI 10.1038/s41423-019-0298-x; Schetters STT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00990; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schultze JL, 2019, SEMIN CELL DEV BIOL, V86, P15, DOI 10.1016/j.semcdb.2018.02.017; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tang-Huau TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04985-0; Unger WWJ, 2011, CURR OPIN IMMUNOL, V23, P131, DOI 10.1016/j.coi.2010.11.011; Vono M, 2013, P NATL ACAD SCI USA, V110, P21095, DOI 10.1073/pnas.1319784110; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	51	9	9	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12406	12418		10.1096/fj.202000848R	http://dx.doi.org/10.1096/fj.202000848R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33411367	Green Published, hybrid			2022-12-28	WOS:000556097500001
J	Chen, LJ; Hu, B; Han, ZQ; Liu, W; Zhu, JH; Chen, XX; Li, ZP; Zhou, H				Chen, Li-Juan; Hu, Bin; Han, Zhi-Qiang; Liu, Wei; Zhu, Jian-Hua; Chen, Xue-Xing; Li, Zi-Ping; Zhou, Hao			Repression of FBXW7 by HES5 contributes to inactivation of the TGF-beta signaling pathway and alleviation of endometriosis	FASEB JOURNAL			English	Article						endometriosis; F&#8208; box and WD repeat domain containing 7; HES family bHLH transcription factor 5; transforming growth factor beta&#8208; induced factor 1	TUMOR-SUPPRESSOR; MOUSE MODEL; CANCER; PROLIFERATION; EXPRESSION; FIBROSIS; WOMEN	Endometriosis (EMS) is a gynecologic disorder associated with infertility and characterized by the endometrial-type mucosa outside the uterine cavity. Currently available treatment modalities are limited to undesirable effects. Thus, in the present study, we sought to study the pathogenesis mechanism of EMS. For this purpose, the ectopic and eutopic endometrial tissues were resected from 86 patients with EMS and 54 infertile patients without EMS, respectively. The regulatory mechanism among HES family bHLH transcription factor 5 (HES5), transforming growth factor-beta (TGF-beta)-induced factor 1 (TGIF1), F-box, and WD repeat domain containing 7 (FBXW7) was studied by performing co-immunoprecipitation, dual-luciferase reporter gene assay, and chromatin immunoprecipitation, respectively. A mouse model of EMS was established to verify the aforementioned regulatory mechanism in vivo. Upregulation of HES5 and TGIF1, as well as downregulation of FBXW7, was observed in EMS endometrial tissues and human endometrial stromal cells (hESCs), respectively. The overexpression of HES5 was found to suppress the FBXW7 transcription and TGIF1 degradation, resulting in the inactivation of the TGF-beta signaling pathway, as well as inhibition of hESC proliferation and invasion, thereby enhancing apoptosis. Results from a mouse model of EMS showed that the presence of HES5 contributed to the alleviation of EMS. Collectively, we attempted to provide a mechanistic insight into the unrecognized roles of the HES5/FBXW7 in EMS progression.	[Chen, Li-Juan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Hu, Bin] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Han, Zhi-Qiang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Liu, Wei] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Stem Cell Res & Applicat, Wuhan, Peoples R China; [Zhu, Jian-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 1 Hosp, Lab Clin Immunol, Wuhan, Peoples R China; [Chen, Xue-Xing; Li, Zi-Ping; Zhou, Hao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, H (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430022, Peoples R China.	zhouhao@hust.edu.cn						Alotaibi FT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219064; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Buigues A, 2018, BIOL REPROD, V99, P326, DOI 10.1093/biolre/ioy057; Cai JT, 2018, PROTEIN CELL, V9, P754, DOI 10.1007/s13238-017-0486-3; Chen X, 2018, NEOPLASMA, V65, P201, DOI 10.4149/neo_2018_170228N149; Gellersen B, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106724; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Greaves E, 2014, AM J PATHOL, V184, P1930, DOI 10.1016/j.ajpath.2014.03.011; Gu SD, 2017, ONCOL REP, V37, P474, DOI 10.3892/or.2016.5268; Guca E, 2018, NUCLEIC ACIDS RES, V46, P9220, DOI 10.1093/nar/gky680; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Heinen A, 2012, GLIA, V60, P1696, DOI 10.1002/glia.22388; Herreros-Villanueva M, 2019, CLIN CHIM ACTA, V493, P63, DOI 10.1016/j.cca.2019.02.016; Hickey M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1752; Jiang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13735; Kim HS, 2014, BRIT J CANCER, V110, P1878, DOI 10.1038/bjc.2014.29; Kondo N, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201708547; Lupini L, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13137; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Potlog-Nahari C, 2004, FERTIL STERIL, V82, P86, DOI 10.1016/j.fertnstert.2003.11.059; Rutkowski TP, 2016, J CELL SCI, V129, P2145, DOI 10.1242/jcs.181271; Sailo BL, 2019, CANCERS, V11, DOI 10.3390/cancers11020246; Salilew-Wondim D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2513-9; Sancho R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001586; Shi LB, 2017, BIOL REPROD, V97, P873, DOI 10.1093/biolre/iox140; Skrzypczak Jana, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS143; Soni UK, 2019, BIOL REPROD, V100, P917, DOI 10.1093/biolre/ioy242; Su RW, 2015, J CLIN ENDOCR METAB, V100, pE433, DOI 10.1210/jc.2014-3720; Suda K, 2018, CELL REP, V24, P1777, DOI 10.1016/j.celrep.2018.07.037; Tan WZ, 2018, APOPTOSIS, V23, P667, DOI 10.1007/s10495-018-1484-5; Tanaka Y O, 1996, Radiat Med, V14, P111; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Wang Y, 2017, WORLD J GASTROENTERO, V23, P2330, DOI 10.3748/wjg.v23.i13.2330; Xiao GD, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12473; Yeh CH, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0857-2; Yen-Ping J, 2010, FERTIL STERIL, V94, P1078, DOI 10.1016/j.fertnstert.2009.05.001; Yotova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170859; Young VJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106773; Zhou H, 2010, AUTOIMMUNITY, V43, P299, DOI 10.3109/08916930903405875; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	41	5	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e20938	10.1096/fj.202000438RRR	http://dx.doi.org/10.1096/fj.202000438RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496006				2022-12-28	WOS:000647789600095
J	Goshayeshi, L; Taemeh, SY; Dehdilani, N; Nasiri, M; Seno, MMG; Dehghani, H				Goshayeshi, Lena; Taemeh, Sara Yousefi; Dehdilani, Nima; Nasiri, Mohammadreza; Seno, Mohammad M. Ghahramani; Dehghani, Hesam			CRISPR/dCas9-mediated transposition with specificity and efficiency of site-directed genomic insertions	FASEB JOURNAL			English	Article						CRISPR&#8208; associated protein 9; gene insertion; Insertional mutagenesis; piggyBac transposase; transposases	HYPERACTIVE PIGGYBAC TRANSPOSASE; SLEEPING-BEAUTY; GENE-EXPRESSION; IN-VIVO; INTEGRATION; NUCLEASES; LOCUS; MECHANISM; SELECTION; IMPROVES	The ability and efficiency of targeted nucleases to perform sequence replacements or insertions into the genome are limited. This limited efficiency for sequence replacements or insertions can be explained by the dependency on DNA repair pathways, the possibility of cellular toxicity, and unwanted activation of proto-oncogenes. The piggyBac (PB) transposase uses a very efficient enzymatic mechanism to integrate DNA fragments into the genome in a random manner. In this study, we fused an RNA-guided catalytically inactive Cas9 (dCas9) to the PB transposase and used dual sgRNAs to localize this molecule to specific genomic targets. We designed and used a promoter/reporter complementation assay to register and recover cells harboring-specific integrations, where only by complementation upon correct genomic integration, the reporter can be activated. Using an RNA-guided piggyBac transposase and dual sgRNAs, we were able to achieve site-directed integrations in the human ROSA26 safe harbor region in 0.32% of cells. These findings show that the methodology used in this study can be used for targeting genomic regions. An application for this finding could be in cancer cells to insert sequences into specific target regions that are intended to be destroyed, or to place promoter cargos behind the tumor suppressor genes to activate them.	[Goshayeshi, Lena; Taemeh, Sara Yousefi; Dehdilani, Nima; Seno, Mohammad M. Ghahramani; Dehghani, Hesam] Ferdowsi Univ Mashhad, Fac Vet Med, Div Biotechnol, Mashhad, Razavi Khorasan, Iran; [Goshayeshi, Lena; Taemeh, Sara Yousefi; Dehdilani, Nima; Dehghani, Hesam] Ferdowsi Univ Mashhad, Res Inst Biotechnol, Stem Cell Biol & Regenerat Med Res Grp, Mashhad, Razavi Khorasan, Iran; [Nasiri, Mohammadreza] Ferdowsi Univ Mashhad, Res Inst Biotechnol, Recombinant Prot Res Grp, Mashhad, Razavi Khorasan, Iran; [Nasiri, Mohammadreza] Ferdowsi Univ Mashhad, Dept Anim Sci, Mashhad, Razavi Khorasan, Iran; [Seno, Mohammad M. Ghahramani; Dehghani, Hesam] Ferdowsi Univ Mashhad, Fac Vet Med, Dept Basic Sci, Mashhad, Razavi Khorasan, Iran	Ferdowsi University Mashhad; Ferdowsi University Mashhad; Ferdowsi University Mashhad; Ferdowsi University Mashhad; Ferdowsi University Mashhad	Dehghani, H (corresponding author), Ferdowsi Univ Mashhad, Res Inst Biotechnol, Azadi Sq, Mashhad 9177943369, Razavi Khorasan, Iran.	dehghani@um.ac.ir	Dehghani, Hesam/D-1421-2010; Taemeh, Sara Yousefi/ABD-5803-2020	Dehghani, Hesam/0000-0001-6750-0040; 				Bhatt S, 2019, NUCLEIC ACIDS RES, V47, P8126, DOI 10.1093/nar/gkz552; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Chen QJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17128-1; Chen SP, 2019, CRISPR J, V2, P376, DOI 10.1089/crispr.2019.0030; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Matteo M, 2012, EXPERT OPIN BIOL TH, V12, P841, DOI 10.1517/14712598.2012.684875; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Eckermann KN, 2018, INSECT BIOCHEM MOLEC, V98, P16, DOI 10.1016/j.ibmb.2018.04.001; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020514; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gogol-Doring A, 2016, MOL THER, V24, P592, DOI 10.1038/mt.2016.11; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Hew BE, 2019, SYN BIOL, V4, DOI 10.1093/synbio/ysz018; Hickman AB, 2016, CHEM REV, V116, P12758, DOI 10.1021/acs.chemrev.6b00003; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ju HuiMing, 2015, Journal of Food, Agriculture & Environment, V13, P149; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kimura Y, 2019, STEM CELL TRANSL MED, V8, P627, DOI 10.1002/sctm.18-0039; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kovac A, 2020, ELIFE, V9, DOI 10.7554/eLife.53868; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Li MA, 2013, MOL CELL BIOL, V33, P1317, DOI 10.1128/MCB.00670-12; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu X., 2012, TRANSGENIC RES, V81, P165; Luo WT, 2017, NUCLEIC ACIDS RES, V45, P8411, DOI 10.1093/nar/gkx572; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10124; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; Morellet N, 2018, NUCLEIC ACIDS RES, V46, P2660, DOI 10.1093/nar/gky044; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Negoua A, 2013, GENETICA, V141, P369, DOI 10.1007/s10709-013-9736-3; Olsen PA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-35; Ordovas L, 2018, STEM CELL REP, V10, P673, DOI 10.1016/j.stemcr.2018.01.034; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Owens JB, 2013, NUCLEIC ACIDS RES, V41, P9197, DOI 10.1093/nar/gkt677; Owens JB, 2012, NUCLEIC ACIDS RES, V40, P6978, DOI 10.1093/nar/gks309; Palais G, 2009, PHYSIOL GENOMICS, V37, P140, DOI 10.1152/physiolgenomics.90328.2008; Pellenz S, 2019, HUM GENE THER, V30, P814, DOI 10.1089/hum.2018.169; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Wilson MH, 2005, FEBS LETT, V579, P6205, DOI 10.1016/j.febslet.2005.10.004; Woodard LE, 2015, TRENDS BIOTECHNOL, V33, P525, DOI 10.1016/j.tibtech.2015.06.009; Wu M., 2016, SCI REP-UK, V6, P1; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Ye L., 2015, SCI REP-UK, V5, P749; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zare K, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0086-5	65	3	3	6	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21359	10.1096/fj.202001830RR	http://dx.doi.org/10.1096/fj.202001830RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496003				2022-12-28	WOS:000647789600098
J	Heo, JW; No, MH; Cho, J; Choi, Y; Cho, EJ; Park, DH; Kim, TW; Kim, CJ; Seo, DY; Han, J; Jang, YC; Jung, SJ; Kang, JH; Kwak, HB				Heo, Jun-Won; No, Mi-Hyun; Cho, Jinkyung; Choi, Youngju; Cho, Eun-Jeong; Park, Dong-Ho; Kim, Tae-Woon; Kim, Chang-Ju; Seo, Dae Yun; Han, Jin; Jang, Young C.; Jung, Su-Jeen; Kang, Ju-Hee; Kwak, Hyo-Bum			Moderate aerobic exercise training ameliorates impairment of mitochondrial function and dynamics in skeletal muscle of high-fat diet-induced obese mice	FASEB JOURNAL			English	Article						aerobic exercise; insulin resistance; mitochondrial function; mitochondrial dynamics; skeletal muscle	INSULIN-RESISTANCE; OXIDATIVE STRESS; DYSFUNCTION; FIBERS	The purpose of this study is to determine whether moderate aerobic exercise training improves high-fat diet-induced alterations in mitochondrial function and structure in the skeletal muscle. Male 4-week-old C57BL/6 mice were randomly divided into four groups: control (CON), control plus exercise (CON + EX), high-fat diet (HFD), and high-fat diet plus exercise (HFD + EX). After obesity was induced by 20 weeks of 60% HFD, treadmill exercise training was performed at 13-16 m/min, 40-50 min/day, and 6 days/week for 12 weeks. Mitochondrial structure, function, and dynamics, and mitophagy were analyzed in the skeletal muscle fibers from the red gastrocnemius. Exercise training increased mitochondrial number and area and reduced high-fat diet-induced obesity and hyperglycemia. In addition, exercise training attenuated mitochondrial dysfunction in the permeabilized myofibers, indicating that HFD-induced decrease of mitochondrial O-2 respiration and Ca2+ retention capacity and increase of mitochondrial H2O2 emission were attenuated in the HFD + EX group compared to the HFD group. Exercise also ameliorated HFD-induced imbalance of mitochondrial fusion and fission, demonstrating that HFD-induced decrease in fusion protein levels was elevated, and increase in fission protein levels was reduced in the HFD + EX groups compared with the HFD group. Moreover, dysregulation of mitophagy induced by HFD was mitigated in the HFD + EX group, indicating a decrease in PINK1 protein level. Our findings demonstrated that moderate aerobic exercise training mitigated obesity-induced insulin resistance by improving mitochondrial function, and reversed obesity-induced mitochondrial structural damage by improving mitochondrial dynamics and mitophagy, suggesting that moderate aerobic exercise training may play a therapeutic role in protecting the skeletal muscle against mitochondrial impairments and insulin resistance induced by obesity.	[Heo, Jun-Won; Cho, Eun-Jeong; Park, Dong-Ho; Kang, Ju-Hee; Kwak, Hyo-Bum] Inha Univ, Dept Biomed Sci, Program Biomed Sci & Engn, Incheon, South Korea; [Heo, Jun-Won; Cho, Jinkyung; Choi, Youngju; Cho, Eun-Jeong; Park, Dong-Ho; Kang, Ju-Hee; Kwak, Hyo-Bum] Inha Univ, Inst Sports & Arts Convergence, Incheon, South Korea; [No, Mi-Hyun; Park, Dong-Ho; Kwak, Hyo-Bum] Inha Univ, Dept Kinesiol, Incheon, South Korea; [Kim, Tae-Woon; Kim, Chang-Ju] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Seo, Dae Yun; Han, Jin] Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Dept Physiol,Natl Res Lab Mitochondria Signaling, Busan, South Korea; [Jang, Young C.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Jung, Su-Jeen] Seoil Univ, Dept Leisure Sports, Seoul, South Korea; [Kang, Ju-Hee] Inha Univ, Coll Med, Dept Pharmacol, Incheon, South Korea	Inha University; Inha University; Inha University; Kyung Hee University; Inje University; University System of Georgia; Georgia Institute of Technology; Inha University	Kang, JH (corresponding author), Inha Univ, Dept Pharmacol, Dept Biomed Sci, Program Biomed Sci & Engn, 100 Inha Ro, Incheon 22212, South Korea.; Kwak, HB (corresponding author), Inha Univ, Dept Kinesiol, Dept Biomed Sci, Program Biomed Sci & Engn, 100 Inha Ro, Incheon 22212, South Korea.	johykang@inha.ac.kr; kwakhb@inha.ac.kr	Cho, Jinkyung/ABC-8116-2021	Seo, Dae Yun/0000-0002-4377-5792				Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Calonne J, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00119; Campello S, 2014, BBA-BIOENERGETICS, V1837, P451, DOI 10.1016/j.bbabio.2013.11.010; Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Choi JW, 2018, METABOLISM, V78, P43, DOI 10.1016/j.metabol.2017.09.005; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Di Meo S, 2017, J ENDOCRINOL, V233, pR15, DOI 10.1530/JOE-16-0598; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; Fealy CE, 2018, TRANSL RES, V202, P69, DOI 10.1016/j.trsl.2018.07.011; Fealy CE, 2014, J APPL PHYSIOL, V117, P239, DOI 10.1152/japplphysiol.01064.2013; Greene NP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12470; Han DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019739; Heo JW, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102301; Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Jacob S, 2020, CARDIOVASC ENDOCR ME, V9, P1, DOI 10.1097/XCE.0000000000000196; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Lanza IR, 2013, AM J PHYSIOL-ENDOC M, V304, pE1391, DOI 10.1152/ajpendo.00584.2012; Leduc-Gaudet JP, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13548; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lin HY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7514383; Liu RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092810; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Ng M, 2014, LANCET, V384, P746; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Venditti P, 2014, FREE RADICAL RES, V48, P1179, DOI 10.3109/10715762.2014.937341; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Yoo SZ, 2019, J EXERC REHABIL, V15, P512, DOI 10.12965/jer.1938380.190; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zorzano Antonio, 2009, Archives of Physiology and Biochemistry, V115, P1, DOI 10.1080/13813450802676335; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	8	9	5	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21340	10.1096/fj.202002394R	http://dx.doi.org/10.1096/fj.202002394R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33455027	Bronze			2022-12-28	WOS:000647789600040
J	Kou, GN; Li, PY; Hu, YC; Chen, HA; Amoah, AN; Traore, SS; Cui, ZW; Lyu, QJ				Kou, Guangning; Li, Peiyuan; Hu, Youchun; Chen, Huanan; Amoah, Adwoa Nyantakyiwaa; Traore, Stanislav Seydou; Cui, Zhenwei; Lyu, Quanjun			Nobiletin activates thermogenesis of brown and white adipose tissue in high-fat diet-fed C57BL/6 mice by shaping the gut microbiota	FASEB JOURNAL			English	Article						gut microbiome; nobiletin; obesity; short&#8208; chain fatty acids; thermogenesis	INDUCED OBESITY; ADIPOGENESIS; ANGIOGENESIS; POPULATION; METABOLISM; DISEASE; MOUSE	Increasing energy expenditure by activating thermogenesis in brown and beige adipocytes is a critical approach to protect against obesity. Here, we investigated the action and mechanism of a natural polymethoxyflavone on adaptive thermogenesis in high-fat diet-induced obesity mouse model. Nobiletin treatment significantly ameliorated obesity, alleviated the whitening of brown adipose tissue, and promoted browning of white adipose tissue in mice fed a high-fat diet. Gut microbiota analysis and metabolomic profiling revealed that nobiletin treatment resulted in a composition shift in the gut microbiota thereby altering fermentation products acetate levels in the host feces and serum. Further, transplantation of the microbiota from nobiletin-treated mice to microbiota-depleted mice activated brown adipose tissue activity, promoted beige adipocytes formation, and improved high-fat diet-induced obesity. Our results indicate that nobiletin could be used as a dietary therapy to prevent HFD-induced obesity, and provide a potential target-specific gut microbial species-driven mechanism for activating thermogenesis in brown and beige adipocytes.	[Kou, Guangning; Li, Peiyuan; Cui, Zhenwei] Zhengzhou Univ, Ctr Sport Nutr & Hlth, Sch Phys Educ, Zhengzhou, Peoples R China; [Kou, Guangning; Li, Peiyuan; Hu, Youchun; Chen, Huanan; Amoah, Adwoa Nyantakyiwaa; Traore, Stanislav Seydou; Lyu, Quanjun] Zhengzhou Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou 450001, Peoples R China; [Lyu, Quanjun] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Cui, ZW (corresponding author), Zhengzhou Univ, Ctr Sport Nutr & Hlth, Sch Phys Educ, Zhengzhou, Peoples R China.; Lyu, QJ (corresponding author), Zhengzhou Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou 450001, Peoples R China.	cuizw0808@zzu.edu.cn; lqjnutr@zzu.edu.cn						Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005; Chou YC, 2018, J AGR FOOD CHEM, V66, P9697, DOI 10.1021/acs.jafc.8b02719; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Graham C, 2015, NUTR REV, V73, P376, DOI 10.1093/nutrit/nuv004; Hanatani S, 2016, J CLIN BIOCHEM NUTR, V59, P207, DOI 10.3164/jcbn.16-23; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hernandez JB, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8216, 10.1038/ncomms8489]; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Hu JM, 2016, ENDOCRINOLOGY, V157, P1881, DOI 10.1210/en.2015-1944; Jiang RH, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106010; Ke ZL, 2018, J FUNCT FOODS, V47, P28, DOI 10.1016/j.jff.2018.05.032; Kim YJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600889; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Mestdagh R, 2012, J PROTEOME RES, V11, P620, DOI 10.1021/pr200938v; Nakajima A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143380; Nguyen-Ngo C, 2020, CLIN SCI, V134, P571, DOI 10.1042/CS20191099; Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y; Pei L, 2018, BIOMED PHARMACOTHER, V105, P625, DOI 10.1016/j.biopha.2018.06.018; Pi-Sunyer FX, 2002, OBES SURG, V12, p6S, DOI 10.3810/pgm.2009.11.2074; Razaz N, 2020, LANCET DIABETES ENDO, V8, P572, DOI 10.1016/S2213-8587(20)30151-0; Saigusa D, 2011, ANAL BIOANAL CHEM, V400, P3635, DOI 10.1007/s00216-011-5031-2; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Takeda K, 2016, NAT REV IMMUNOL, V16, P206, DOI 10.1038/nri.2016.18; Tomova A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00047; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Vanhoecke BW, 2005, IN VIVO, V19, P103; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Yoshida H, 2019, ARCH BIOCHEM BIOPHYS, V672, DOI 10.1016/j.abb.2019.07.022; Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459RR, 10.1096/fj.201600459rr]; Zeng SL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6208; Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	47	6	6	9	47	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21267	10.1096/fj.202002197R	http://dx.doi.org/10.1096/fj.202002197R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475201				2022-12-28	WOS:000647789600087
J	Lin, YS; Tsai, ML; Hsieh, IC; Wen, MS; Wang, CY				Lin, Yu-Sheng; Tsai, Ming-Lung; Hsieh, I-Chang; Wen, Ming-Shien; Wang, Chao-Yung			Deficiency of circadian gene cryptochromes in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice	FASEB JOURNAL			English	Article						circadian rhythm; cryptochrome; atherosclerosis; LDLR; macrophages	RHYTHM; CHOLESTEROL; METABOLISM	Cryptochromes are photoreceptors that mediate the circadian entrainment by light in plants and animals. They are also involved in magnetic field sensing in some animals. Recent studies suggest that cryptochromes play an essential role in metabolism and cardiovascular disease. However, the tissue-specific function of cryptochromes in atherosclerosis is unknown. We transplanted bone marrow from wild-type (WT) and cryptochrome 1/2 knockout (Cry1/2 KO) mice into irradiated recipient low-density lipoprotein receptor knockout (LDLR-/-) mice and induced atherosclerosis with a high cholesterol diet for 12 weeks. There was a reduction in atherosclerotic plaques and macrophage accumulation in the aorta of LDLR-/- mice that received Cry1/2 KO bone marrow compared to mice that received WT bone marrow. Bone marrow-derived macrophages (BMDMs) from Cry1/2 KO mice exhibited impaired uptake of low-density lipoprotein, and subsequently, impaired foam cell formation. Analysis of macrophage mRNA circadian oscillations revealed that the circadian rhythm of the LDLR mRNAs was lost in Cry1/2 KO BMDMs. Reinstalling the circadian oscillatory LDLR mRNAs using adenovirus into the BMDMs was able to rescue the lipid uptake and foam cell formation function. However, the noncircadian oscillatory LDLR mRNAs exhibited reduced ability to rescue the macrophage functions. These findings indicate that cryptochromes in bone marrow-derived cells are critical mediators of atherosclerosis through regulation of the LDLR mRNA circadian rhythm. Therapeutic measures targeting cryptochromes in the macrophage may have important implications for atherosclerosis.	[Lin, Yu-Sheng] Chang Gung Univ, Chang Gung Mem Hosp, Healthcare Ctr, Coll Med, Taoyuan, Taiwan; [Lin, Yu-Sheng; Tsai, Ming-Lung; Hsieh, I-Chang; Wen, Ming-Shien; Wang, Chao-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taoyuan, Taiwan; [Wang, Chao-Yung] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Wang, Chao-Yung] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Health Research Institutes - Taiwan; National Tsing Hua University	Wang, CY (corresponding author), 5 Fu Hsing St, Taoyuan 333, Taiwan.	cwang@ocean.ag	Wang, Chao-Yung/ABA-6757-2021	Wang, Chao-Yung/0000-0003-1546-7298; Lin, Yu-Sheng/0000-0002-7654-6558				Akashi M, 2017, EBIOMEDICINE, V20, P127, DOI 10.1016/j.ebiom.2017.04.034; Anand SN, 2013, J NEUROSCI, V33, P7145, DOI 10.1523/JNEUROSCI.4950-12.2013; BALASUBRAMANIAM S, 1994, BIOCHEM J, V298, P39, DOI 10.1042/bj2980039; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Cal-Kayitmazbatir S, 2021, FEBS J, V288, P614, DOI 10.1111/febs.15360; Cao Q, 2017, P NATL ACAD SCI USA, V114, P12548, DOI 10.1073/pnas.1619119114; Chang L, 2018, CIRCULATION, V138, P67, DOI 10.1161/CIRCULATIONAHA.117.029972; Chen LH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00071; Chen WD, 2014, BIOCHEM BIOPH RES CO, V451, P408, DOI 10.1016/j.bbrc.2014.07.138; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Douma LG, 2019, AM J PHYSIOL-REG I, V316, pR50, DOI 10.1152/ajpregu.00381.2017; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Getz GS, 2016, ARTERIOSCL THROM VAS, V36, P1734, DOI 10.1161/ATVBAHA.116.306874; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Huo MY, 2017, FASEB J, V31, P1097, DOI 10.1096/fj.201601030R; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Lee YJ, 2012, EXP MOL MED, V44, P642, DOI 10.3858/emm.2012.44.11.073; Lin C., 2019, FASEB J, V33, pLB207; Lutshumba J, 2018, ARTERIOSCL THROM VAS, V38, P1063, DOI 10.1161/ATVBAHA.117.310153; Mansukhani NA, 2017, ARTERY RES, V20, P8, DOI 10.1016/j.artres.2017.08.002; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Pan XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13011; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Petrovsky N, 2003, IMMUNOL CELL BIOL, V81, P137, DOI 10.1046/j.0818-9641.2002.01148.x; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Senoo M, 2000, MOL GENET METAB, V69, P269, DOI 10.1006/mgme.2000.2984; Steffens S, 2017, ARTERIOSCL THROM VAS, V37, P1022, DOI 10.1161/ATVBAHA.117.309374; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wang CY, 2016, BIOCHEM BIOPH RES CO, V478, P935, DOI 10.1016/j.bbrc.2016.08.054; Wang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18874; Wang CY, 2015, BIOCHEM BIOPH RES CO, V464, P826, DOI 10.1016/j.bbrc.2015.07.046; Wang YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155075; Winter C, 2018, CELL METAB, V28, P175, DOI 10.1016/j.cmet.2018.05.002; Yang GR, 2020, ARTERIOSCL THROM VAS, V40, P1523, DOI 10.1161/ATVBAHA.120.314318; Yang L, 2015, INT IMMUNOPHARMACOL, V28, P525, DOI 10.1016/j.intimp.2015.07.001; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	49	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21309	10.1096/fj.202001818RRR	http://dx.doi.org/10.1096/fj.202001818RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423309				2022-12-28	WOS:000647789600045
J	Huang, ZX; Lu, XH; Huang, LL; Zhang, CH; Veldhuis, JD; Cowley, MA; Chen, C				Huang, Zhengxiang; Lu, Xuehan; Huang, Lili; Zhang, Chunhong; Veldhuis, Johannes D.; Cowley, Michael A.; Chen, Chen			Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice	FASEB JOURNAL			English	Article						GH; GHSR; hexarelin; MC4R; obesity	DE-NOVO LIPOGENESIS; GHRELIN RECEPTOR; VISCERAL FAT; PPAR-GAMMA; GH; BASAL; TESAMORELIN; EXPRESSION; ADIPOSITY; PITUITARY	Obese individuals often show low growth hormone (GH) secretion, which leads to reduced lipid mobilization and further fat accumulation. Pharmacological approaches to increase GH levels in obese individuals by GH injection or GH-releasing hormone receptor agonist showed promising effects on fat reduction. However, side effects on glucose metabolism and the heavy costs on making large peptides hindered their clinical application. Here, we tested whether stimulation of endogenous GH secretion by a synthetic GH secretagogue receptor (GHSR) agonist, hexarelin, improved the metabolism in a hyperphagic obese mouse model. Male melanocortin 4 receptor knockout mice (MC4RKO) were pair-fed and received continuous hexarelin (10.56 mu g/day) or vehicle infusion by an osmotic pump for 3-4 weeks. Hexarelin treatment significantly increased the pulsatile GH secretion without detectable alteration on basal GH secretion in MC4RKO mice. The treated mice showed increased lipolysis and lipid oxidation in the adipose tissue, and reduced de novo lipogenesis in the liver, leading to reduced visceral fat mass, reduced triglyceride content in liver, and unchanged circulating free fatty acid levels. Importantly, hexarelin treatment improved the whole-body insulin sensitivity but did not alter glucose tolerance, insulin levels, or insulin-like growth factor 1 (IGF-1) levels. The metabolic effects of hexarelin were likely through the direct action of GH, as indicated by the increased expression level of genes involved in GH signaling pathways in visceral adipose tissues and liver. In conclusion, hexarelin treatment stimulated the pulsatile GH secretion and reduced the fat accumulation in visceral depots and liver in obese MC4RKO mice with improved insulin sensitivity without altered levels of insulin or IGF-1. It provides evidence for managing obesity by enhancing pulsatile GH secretion through activation of GHSR in the pituitary gland.	[Huang, Zhengxiang; Lu, Xuehan; Huang, Lili; Zhang, Chunhong; Chen, Chen] Univ Queensland, Sch Biomed Sci, Bldg 64, St Lucia, Qld, Australia; [Veldhuis, Johannes D.] Mayo Clin, Clin Translat Sci Ctr, Mayo Sch Grad Med Educ, Dept Med,Endocrine Res Unit, Rochester, MN USA; [Cowley, Michael A.] Monash Univ, Dept Physiol, Melbourne, Vic, Australia	University of Queensland; Mayo Clinic; Monash University	Chen, C (corresponding author), Univ Queensland, Sch Biomed Sci, Bldg 64, St Lucia, Qld, Australia.	zhengxiang.huang@uq.net.au; chen.chen@uq.edu.au	chen, chen/GRY-7085-2022; Chen, Chen/B-4284-2010; Huang, Zhengxiang/AAA-8535-2022; CHEN, CHEN/HDM-6657-2022	Chen, Chen/0000-0003-2104-534X; Huang, Zhengxiang/0000-0002-1194-2701; Lu, Xuehan/0000-0002-1248-3180				Berryman DE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081621; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Cersosimo E, 1996, AM J PHYSIOL-ENDOC M, V271, pE123, DOI 10.1152/ajpendo.1996.271.1.E123; Cordoba-Chacon J, 2015, DIABETES, V64, P3093, DOI 10.2337/db15-0370; Dhillon S, 2011, DRUGS, V71, P1071, DOI 10.2165/11202240-000000000-00000; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Faje AT, 2010, J CLIN ENDOCR METAB, V95, P2486, DOI 10.1210/jc.2009-2634; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fourman LT, 2017, AIDS, V31, P2253, DOI [10.1097/QAD.0000000000001614, 10.1097/qad.0000000000001614]; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gravholt CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE848, DOI 10.1152/ajpendo.1999.277.5.E848; Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Huang L, 2012, ENDOCRINOLOGY, V153, P4380, DOI 10.1210/en.2012-1178; Huang ZX, 2020, TRENDS ENDOCRIN MET, V31, P642, DOI 10.1016/j.tem.2020.04.005; Huang ZX, 2020, J ENDOCRINOL, V245, P1, DOI 10.1530/JOE-19-0385; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Hwang DL, 2008, GROWTH HORM IGF RES, V18, P65, DOI 10.1016/j.ghir.2007.07.007; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; Karastergiou K, 2016, OBESITY, V24, P1090, DOI 10.1002/oby.21460; Kurashina T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14041; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Li ZR, 2014, P NATL ACAD SCI USA, V111, P13163, DOI 10.1073/pnas.1411571111; Lin LG, 2016, AGING-US, V8, P178, DOI 10.18632/aging.100888; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Ma XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE422, DOI 10.1152/ajpendo.00576.2011; Marechal L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051529; Mekala KC, 2009, J CLIN ENDOCR METAB, V94, P130, DOI 10.1210/jc.2008-1357; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Roumi M, 2000, DRUG METAB DISPOS, V28, P44; Stanley TL, 2015, GROWTH HORM IGF RES, V25, P59, DOI 10.1016/j.ghir.2014.12.005; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, P150, DOI 10.1210/jc.2010-1587; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Surya S, 2009, J CLIN ENDOCR METAB, V94, P2828, DOI 10.1210/jc.2009-0638; Tan HY, 2016, J PHYSIOL-LONDON, V594, P7309, DOI 10.1113/JP272770; Tsai YS, 2005, TRENDS CARDIOVAS MED, V15, P81, DOI 10.1016/j.tcm.2005.04.002; VANDERSCHUERENLODEWEYCKX M, 1993, HORM RES, V40, P23, DOI 10.1159/000183763; VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; WINER LM, 1990, J CLIN ENDOCR METAB, V70, P1678, DOI 10.1210/jcem-70-6-1678; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002; Zuo LY, 2019, CURR PHARM DESIGN, V25, P3590, DOI 10.2174/1381612825666190920123129	48	4	4	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21269	10.1096/fj.202001924RR	http://dx.doi.org/10.1096/fj.202001924RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368660				2022-12-28	WOS:000605626600037
J	Townsend, LK; Weber, AJ; Day, EA; Shamshoum, H; Shaw, SJ; Perry, CGR; Kemp, BE; Steinberg, GR; Wright, DC				Townsend, Logan K.; Weber, Alyssa J.; Day, Emily A.; Shamshoum, Hesham; Shaw, Simon J.; Perry, Christopher G. R.; Kemp, Bruce E.; Steinberg, Gregory R.; Wright, David C.			AMPK mediates energetic stress-induced liver GDF15	FASEB JOURNAL			English	Article						AMPK; CHOP; energetic stress; ER stress; GDF15; liver	ENDOPLASMIC-RETICULUM STRESS; DIFFERENTIATION FACTOR 15; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; OXIDATIVE-PHOSPHORYLATION; HEPATIC STEATOSIS; HOMEOSTASIS; ACTIVATOR; RECEPTOR; PATHWAY	Growth differentiating factor-15 (GDF15) is an emerging target for the treatment of obesity and metabolic disease partly due to its ability to suppress food intake. GDF15 expression and secretion are thought to be regulated by a cellular integrated stress response, which involves endoplasmic reticulum (ER) stress. AMPK is another cellular stress sensor, but the relationship between AMPK, ER stress, and GDF15 has not been assessed in vivo. Wildtype (WT), AMPK beta 1 deficient (AMPK beta 1(-/-)), and CHOP-/- mice were treated with three distinct AMPK activators; AICAR, which is converted to ZMP mimicking the effects of AMP on the AMPK gamma isoform, R419, which indirectly activates AMPK through inhibition of mitochondrial respiration, or A769662, a direct AMPK activator which binds the AMPK beta 1 isoform ADaM site causing allosteric activation. Following treatments, liver Gdf15, markers of ER-stress, AMPK activity, adenine nucleotides, circulating GDF15, and food intake were assessed. AICAR and R419 caused ER and energetic stress, increased GDF15 expression and secretion, and suppressed food intake. Direct activation of AMPK beta 1 containing complexes by A769662 increased hepatic Gdf15 expression, circulating GDF15, and suppressed food intake, independent of ER stress. The effects of AICAR, R419, and A769662 on GDF15 were attenuated in AMPK beta 1(-/-) mice. AICAR and A769662 increased GDF15 to a similar extent in WT and CHOP-/- mice. Herein, we provide evidence that AMPK plays a role in mediating the induction of GDF15 under conditions of energetic stress in mouse liver in vivo.	[Townsend, Logan K.; Weber, Alyssa J.; Shamshoum, Hesham; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada; [Townsend, Logan K.; Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada; [Townsend, Logan K.; Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Div Endocrinol & Metab, Dept Med, Hamilton, ON, Canada; [Shaw, Simon J.] Rigel Pharmaceut Inc, San Francisco, CA USA; [Perry, Christopher G. R.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst, Dept Med, Melbourne, Vic, Australia; [Kemp, Bruce E.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Fitzroy, Vic, Australia	University of Guelph; McMaster University; McMaster University; York University - Canada; St. Vincent's Institute of Medical Research; University of Melbourne; Australian Catholic University	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca		Wright, David/0000-0003-3867-8901				Banfi S, 2018, P NATL ACAD SCI USA, V115, pE1249, DOI 10.1073/pnas.1717420115; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Bush ND, 2018, J PHARMACOL EXP THER, V365, P526, DOI 10.1124/jpet.118.248393; Campderrs L, 2019, OBESITY, V27, P1606, DOI 10.1002/oby.22584; Choi MJ, 2020, DIABETOLOGIA, V63, P837, DOI 10.1007/s00125-019-05082-7; Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Fiedler M, 2001, DIABETOLOGIA, V44, P2180, DOI 10.1007/s001250100027; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Galic S, 2018, ELIFE, V7, DOI 10.7554/eLife.32656; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gerstein HC, 2017, DIABETES CARE, V40, P280, DOI 10.2337/dc16-1682; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hetz C, 2020, NAT REV MOL CELL BIO, V21, P421, DOI 10.1038/s41580-020-0250-z; Hou WL, 2018, J CELL MOL MED, V22, P1316, DOI 10.1111/jcmm.13432; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Jenkins Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081870; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jung TW, 2018, J BIOL CHEM, V293, P3981, DOI 10.1074/jbc.RA117.000885; Klein MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06003-9; Lee J, 2017, CELL REP, V20, P655, DOI 10.1016/j.celrep.2017.06.080; Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart SM, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa007; Morris EM, 2017, J PHYSIOL-LONDON, V595, P4909, DOI 10.1113/JP274281; Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114; Mottillo EP, 2016, CELL METAB, V24, P118, DOI 10.1016/j.cmet.2016.06.006; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Perry CGR, 2008, APPL PHYSIOL NUTR ME, V33, P1112, DOI 10.1139/H08-097; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Shamshoum H, 2019, FASEB J, V33, P14010, DOI 10.1096/fj.201901820R; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Steneberg P, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99114; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; Townsend LK, 2020, AM J PHYSIOL-ENDOC M, V319, pE1053, DOI 10.1152/ajpendo.00271.2020; Townsend LK, 2019, J LIPID RES, V60, P1236, DOI 10.1194/jlr.M092510; Townsend LK, 2019, FASEB J, V33, P4824, DOI 10.1096/fj.201802048RR; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Whitfield J, 2017, J BIOL CHEM, V292, P16653, DOI 10.1074/jbc.M117.806786; Xiong YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8732; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Yong J, 2019, ELIFE, V8, DOI 10.7554/eLife.49682; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9	65	10	12	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21218	10.1096/fj.202000954R	http://dx.doi.org/10.1096/fj.202000954R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337559				2022-12-28	WOS:000605626600030
J	Yuan, YJ; Ye, Z; Yu, H; Chen, Y; Wang, YW; Zhao, JH; Sun, JF; Xu, LM				Yuan, Ya-Jing; Ye, Zhi; Yu, Hao; Chen, Yang; Wang, Yu-Wen; Zhao, Jun-Hua; Sun, Ji-Feng; Xu, Li-Ming			Shrm4 contributes to autophagy inhibition and neuroprotection following ischemic stroke by mediating GABA(B)receptor activation	FASEB JOURNAL			English	Article						autophagy; baclofen; gamma-aminobutyric acid; gamma-aminobutyric acid receptor; ischemic stroke; middle cerebral artery occlusion; Shrm4	RECEPTOR AGONISTS; GABA; TRANSPORTERS; RECOVERY; PATHWAY; CELLS	Acute ischemic stroke is one of the leading causes of death in developed countries and the most common cause of disability in adults worldwide. Despite advances in the understanding of stroke pathophysiology, therapeutic options remain limited. In this study, we explored the interaction of Shrm4 and the metabotropic gamma-aminobutyric acid (GABA) receptors (GABA(B)) in ischemic stroke. A transient middle cerebral artery occlusion (MCAO) model was induced by filament insertion in Shrm4+/+ and wild-type C57BL/6J mice, followed by reperfusion for up to 7 days. Baclofen was administered was used to activate GABA(B)in vivo during reperfusion. Neurological deficits, motor and memory functions, and infarct volume were determined in the various mouse groups. Furthermore, we also developed an oxygen-glucose deprivation (OGD) cell model in primary neurons to test Shrm4/GABA(B)interactions in vitro. Shrm4 was observed to decrease infarct volume and neuronal cell loss in penumbra, and rescue neurological deficits in MCAO mice. Notably, Shrm4 also increased pole climbing speed, reduced foot faults, and increased escape latency in the Morris water maze test, while reducing neuron autophagy through an interaction with GABA(B)receptors. GABA(B)activation using baclofen further reduced OGD-induced neuron damage in culture and stroke outcomes of MCAO, relative to Shrm4 alone. Taken together, Shrm4-mediated GABA(B)activation confers neuroprotection by reducing neuronal autophagy in acute ischemic stroke.	[Yuan, Ya-Jing] Tianjin Med Univ Canc Inst & Hosp, Dept Anesthesia, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Tianjins Clin Res, Tianjin, Peoples R China; [Ye, Zhi] Ctr South Univ, Affiliated Xiangya Hosp, Dept Anesthesia, Changsha, Peoples R China; [Yu, Hao; Chen, Yang] Tianjin Med Univ Canc Inst & Hosp, Dept Radiotherapy, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, 24 West Huan Hu Rd, Tianjin 300060, Peoples R China; [Wang, Yu-Wen; Zhao, Jun-Hua; Sun, Ji-Feng; Xu, Li-Ming] Tianjin Med Univ, Canc Hosp, Airport Hosp, Dept Radiotherapy, Tianjin, Peoples R China; [Xu, Li-Ming] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp,Key Lab Breast, Key Lab Canc Prevent & Therapy,Tianjins Clin Res, Dept Radiotherapy,Natl Clin Res Ctr Canc,Minist E, Tianjin, Peoples R China	Tianjin Medical University; Central South University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Xu, LM (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Radiotherapy, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, 24 West Huan Hu Rd, Tianjin 300060, Peoples R China.	limingxu2013@yeah.net	Ye, zhi/HGD-4616-2022		National Natural Science Foundation of China [81501140, 81502656]; Tianjin Health Bureau Fund [2012KZ072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Health Bureau Fund	This study was supported by the National Natural Science Foundation of China (No. 81501140 & No.81502656) and Tianjin Health Bureau Fund (2012KZ072).	Asadi H, 2015, INTERN MED J, V45, P798, DOI 10.1111/imj.12652; Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Baudel MASMA, 2017, J NEUROCHEM, V140, P195, DOI 10.1111/jnc.13901; Bishop BM, 2016, ANN PHARMACOTHER, V50, P219, DOI 10.1177/1060028015620199; Bowery NG, 2006, CURR OPIN PHARMACOL, V6, P37, DOI 10.1016/j.coph.2005.10.002; Brohan J, 2017, CNS DRUGS, V31, P845, DOI 10.1007/s40263-017-0463-7; Bush CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147287; Chen K, 2005, BRAIN RES BULL, V67, P310, DOI 10.1016/j.brainresbull.2005.07.004; Dietz ML, 2006, J BIOL CHEM, V281, P20542, DOI 10.1074/jbc.M512463200; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Hodor A, 2014, ANN CLIN TRANSL NEUR, V1, P765, DOI 10.1002/acn3.115; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jiang YJ, 2016, MOL MED REP, V13, P2060, DOI 10.3892/mmr.2016.4773; Khoshnam SE, 2017, NEUROL SCI, V38, P1167, DOI 10.1007/s10072-017-2938-1; Kokinovic B, 2018, J PHYSIOL-LONDON, V596, P1949, DOI 10.1113/JP275690; Li L, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0144219, 10.1371/journal.pone.0150898]; Lie MEK, 2017, ADV NEUROBIOL, V16, P137, DOI 10.1007/978-3-319-55769-4_7; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14474; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Onwuekwe IO, 2012, ANN MED HEALTH SCI R, V2, P186, DOI 10.4103/2141-9248.105669; Shehadah A, 2016, NEUROLOGY, V87, P450, DOI 10.1212/WNL.0000000000002925; Tian RH, 2020, MOL CELL BIOCHEM, V463, P115, DOI 10.1007/s11010-019-03634-4; Wang HB, 2019, RESTOR NEUROL NEUROS, V37, P315, DOI 10.3233/RNN-180827; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Yan HL, 2016, NEUROSCIENCE, V337, P191, DOI 10.1016/j.neuroscience.2016.09.017; Yoder M, 2007, CELL MOTIL CYTOSKEL, V64, P49, DOI 10.1002/cm.20167; Zapata J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14536; Zhang J, 2019, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001928.PUB3; Zhu XQ, 2015, MOL MED REP, V12, P5957, DOI 10.3892/mmr.2015.4207	30	6	7	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15837	15848		10.1096/fj.202000458RR	http://dx.doi.org/10.1096/fj.202000458RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33079458				2022-12-28	WOS:000581626000001
J	Keppley, LJW; Walker, SJ; Gademsey, AN; Smith, JP; Keller, SR; Kester, M; Fox, TE				Keppley, Laura J. W.; Walker, Susan J.; Gademsey, Alexis N.; Smith, Jason P.; Keller, Susanna R.; Kester, Mark; Fox, Todd E.			Nervonic acid limits weight gain in a mouse model of diet-induced obesity	FASEB JOURNAL			English	Article						ceramide; fatty acid oxidation; obesity; omega-9; sphingolipids	FATTY-ACIDS; LIPID-METABOLISM; ADIPOSE-TISSUE; PLASMA; LIVER; PHOSPHOLIPIDS; ADIPOCYTES; CARNITINE; RISK; RATS	Lipid perturbations contribute to detrimental outcomes in obesity. We previously demonstrated that nervonic acid, a C24:1 omega-9 fatty acid, predominantly acylated to sphingolipids, including ceramides, are selectively reduced in a mouse model of obesity. It is currently unknown if deficiency of nervonic acid-sphingolipid metabolites contribute to complications of obesity. Mice were fed a standard diet, a high fat diet, or these diets supplemented isocalorically with nervonic acid. The primary objective was to determine if dietary nervonic acid content alters the metabolic phenotype in mice fed a high fat diet. Furthermore, we investigated if nervonic acid alters markers of impaired fatty acid oxidation in the liver. We observed that a nervonic acid-enriched isocaloric diet reduced weight gain and adiposity in mice fed a high fat diet. The nervonic acid enrichment led to increased C24:1-ceramides and improved several metabolic parameters including blood glucose levels, and insulin and glucose tolerance. Mechanistically, nervonic acid supplementation increased PPAR alpha and PGC1 alpha expression and improved the acylcarnitine profile in liver. These alterations indicate improved energy metabolism through increased beta-oxidation of fatty acids. Taken together, increasing dietary nervonic acid improves metabolic parameters in mice fed a high fat diet. Strategies that prevent deficiency of, or restore, nervonic acid may represent an effective strategy to treat obesity and obesity-related complications.	[Keppley, Laura J. W.; Walker, Susan J.; Gademsey, Alexis N.; Smith, Jason P.; Kester, Mark; Fox, Todd E.] Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,1215 Pinn Hall,POB 800735, Charlottesville, VA 22908 USA; [Keller, Susanna R.] Univ Virginia, Med Endocrinol & Metab, Charlottesville, VA USA; [Fox, Todd E.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Fox, TE (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,1215 Pinn Hall,POB 800735, Charlottesville, VA 22908 USA.	tfox@virginia.edu	Kester, Mark/ABG-4615-2020		University of Virginia; National Institute of Health [EY018336]	University of Virginia; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	University of Virginia; National Institute of Health, Grant/Award Number: EY018336	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anroedh S, 2018, J LIPID RES, V59, P1729, DOI 10.1194/jlr.P081281; Bandet CL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030479; Cazzola R, 2011, J NUTR BIOCHEM, V22, P388, DOI 10.1016/j.jnutbio.2010.03.007; Chaurasia B, 2019, SCIENCE, V365, P386, DOI 10.1126/science.aav3722; Cheng CF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113447; CHRISTOPHERSEN B, 1983, LIPIDS, V18, P137, DOI 10.1007/BF02536108; Delgado GE, 2017, J CLIN LIPIDOL, V11, P126, DOI 10.1016/j.jacl.2016.10.015; DEWAILLY P, 1978, LIPIDS, V13, P301, DOI 10.1007/BF02533676; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Fox TE, 2010, ADV EXP MED BIOL, V688, P206; Giesbertz P, 2015, J LIPID RES, V56, P2029, DOI 10.1194/jlr.D061721; Gosejacob D, 2016, J BIOL CHEM, V291, P6989, DOI 10.1074/jbc.M115.691212; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Hack A, 2006, PEDIATR RES, V60, P93, DOI 10.1203/01.pdr.0000219479.95410.79; Hammad SS, 2017, LIPIDS, V52, P803, DOI 10.1007/s11745-017-4291-9; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; HARDWICK JP, 2009, PPAR RES, V2009, DOI [10.1155/2009/952734, DOI 10.1155/2009/952734]; HULAN HW, 1977, CAN J PHYSIOL PHARM, V55, P258, DOI 10.1139/y77-037; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Karlsson M, 2006, OBESITY, V14, P1931, DOI 10.1038/oby.2006.225; Kojima M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-77; Lambert Johana M., 2018, Advances in Biological Regulation, V70, P19, DOI 10.1016/j.jbior.2018.10.002; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Law BA, 2018, FASEB J, V32, P1403, DOI 10.1096/fj.201700300R; Matsuzaka T, 2020, HEPATOLOGY, V71, P1609, DOI 10.1002/hep.30953; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Mwinyi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175776; Oda E, 2005, INT HEART J, V46, P975, DOI 10.1536/ihj.46.975; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Othman A, 2015, DIABETES, V64, P1035, DOI 10.2337/db14-1325; Palomer X, 2018, TRENDS ENDOCRIN MET, V29, P178, DOI 10.1016/j.tem.2017.11.009; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Pickens CA, 2015, PROSTAG LEUKOTR ESS, V95, P31, DOI 10.1016/j.plefa.2014.12.001; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Yamazaki Y, 2014, J OLEO SCI, V63, P527, DOI 10.5650/jos.ess13226; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004	45	10	10	9	52	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15314	15326		10.1096/fj.202000525R	http://dx.doi.org/10.1096/fj.202000525R		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959931	Green Accepted			2022-12-28	WOS:000573862400001
J	Kurano, M; Tsukamoto, K; Hara, M; Tsuneyama, K; Nishikawa, T; Ikeda, H; Yatomi, Y				Kurano, Makoto; Tsukamoto, Kazuhisa; Hara, Masumi; Tsuneyama, Koichi; Nishikawa, Takako; Ikeda, Hitoshi; Yatomi, Yutaka			Modulation of sphingosine 1-phosphate by hepatobiliary cholesterol handling	FASEB JOURNAL			English	Article						Niemann-Pick C1-like 1 protein; hepatobiliary cholesterol handling; sphingosine 1-phosphate; apolipoprotein M; ceramides; glycero-lysophospholipids; ABCG5; 8	M GENE-EXPRESSION; IN-VIVO; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; LIVER; OVEREXPRESSION; SECRETION; NPC1L1; MICE; SPHINGOLIPIDS	Hepatobiliary cholesterol handling, mediated by Niemann-Pick C1-like 1 protein (NPC1L1) and ABCG5/8, is well-known to contribute to the homeostasis of cholesterol. We attempted to elucidate the impact of hepatobiliary cholesterol handling on the homeostasis of sphingolipids and lysophospholipids, especially sphingosine 1-phosphate (S1P). We induced the overexpression of NPC1L1 or ABCG5/8 in the mouse liver. Hepatic NPC1L1 overexpression increased the plasma and hepatic S1P levels, while it decreased the biliary S1P levels, and all of these changes were inhibited by ezetimibe. The ability of HDL to activate Akt in the endothelial cells was augmented by hepatic NPC1L1 overexpression. NPC1L1-mediated S1P transport was confirmed by both in vitro and in vivo studies conducted using C(17)S1P, an exogenous S1P analog. Upregulation of apolipoprotein M (apoM) was involved in these modulations, although apoM was not necessary for these modulations. Moreover, the increase in the plasma S1P levels also observed in ABCG5/8-overexpressing mice was dependent on the elevation of the plasma apoM levels. In regard to other sphingolipids and lysophospholipids, ceramides were similarly modulated by NPC1L1 to S1P, while other lipids were differently influenced by NPC1L1 or ABCG5/8 from S1P. Hepatobiliary cholesterol handling might also regulate the functional lipids, such as S1P.	[Kurano, Makoto; Nishikawa, Takako; Ikeda, Hitoshi; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Tsukamoto, Kazuhisa] Teikyo Univ, Dept Internal Med, Sch Med, Tokyo, Japan; [Hara, Masumi] Teikyo Univ, Mizonokuchi Hosp, Dept Med 4, Sch Med, Kawasaki, Kanagawa, Japan; [Tsuneyama, Koichi] Tokushima Univ, Inst Biomed Sci, Dept Pathol & Lab Med, Grad Sch, Tokushima, Japan	University of Tokyo; Teikyo University; Teikyo University; Tokushima University	Kurano, M; Yatomi, Y (corresponding author), Univ Tokyo, Dept Clin Lab Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurano-tky@umin.ac.jp; yatoyuta-tky@umin.ac.jp		Tsuneyama, Koichi/0000-0002-0670-9868; Yatomi, Yutaka/0000-0003-1719-4297	Japan Agency for Medical Research and Development (AMED); MSD Life Science Foundation; Public Interest Incorporated Foundation; AMED [15H05906]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MSD Life Science Foundation; Public Interest Incorporated Foundation; AMED	Japan Agency for Medical Research and Development (AMED); MSD Life Science Foundation, Public Interest Incorporated Foundation, Grant/Award Number: N/A; AMED, a Grant-in-Aid for Scientific Research on Innovative Areas, Grant/Award Number: 15H05906	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; ANGELICO M, 1991, GASTROENTEROLOGY, V101, P228, DOI 10.1016/0016-5085(91)90482-Z; Burg N, 2018, ARTHRITIS RHEUMATOL, V70, P1879, DOI 10.1002/art.40558; Cartier A, 2020, P NATL ACAD SCI USA, V117, P3157, DOI 10.1073/pnas.1906246117; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Janiurek MM, 2019, ELIFE, V8, DOI 10.7554/eLife.49405; Kidambi S, 2008, XENOBIOTICA, V38, P1119, DOI [10.1080/00498250802007930, 10.1080/00498250802007930 ]; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kosters A, 2003, J HEPATOL, V38, P710, DOI 10.1016/S0168-8278(03)00093-X; Kramer W, 2000, FEBS LETT, V487, P293, DOI 10.1016/S0014-5793(00)02372-3; Kurano M, 2020, DIABETES, V69, P867, DOI 10.2337/db19-0811; Kurano M, 2019, BIOCHEM J, V476, P3565, DOI 10.1042/BCJ20190498; Kurano M, 2019, FASEB J, V33, P5181, DOI 10.1096/fj.201801748R; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; Kurano M, 2018, BIOCHEM J, V475, P2009, DOI 10.1042/BCJ20180052; Kurano M, 2018, BBA-MOL CELL BIOL L, V1863, P191, DOI 10.1016/j.bbalip.2017.12.004; Kurano M, 2018, J ATHEROSCLER THROMB, V25, P16, DOI 10.5551/jat.RV17010; Kurano M, 2017, ARTERIOSCL THROM VAS, V37, P506, DOI 10.1161/ATVBAHA.116.308692; Kurano M, 2016, BRIT J PHARMACOL, V173, P222, DOI 10.1111/bph.13360; Kurano M, 2015, METABOLISM, V64, P588, DOI 10.1016/j.metabol.2015.01.011; Kurano M, 2015, J BIOL CHEM, V290, P2477, DOI 10.1074/jbc.M114.596445; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Kurano M, 2012, J LIPID RES, V53, P2275, DOI 10.1194/jlr.M026575; Kurano M, 2011, J ATHEROSCLER THROMB, V18, P373, DOI 10.5551/jat.6999; Lorenzatti AJ, 2020, EUR CARDIOL REV, V15, P29, DOI 10.15420/ecr.2019.06; Luo GH, 2005, BBA-MOL CELL BIOL L, V1734, P198, DOI 10.1016/j.bbalip.2005.02.005; Luo GH, 2014, BIOCHEM BIOPH RES CO, V445, P203, DOI 10.1016/j.bbrc.2014.01.170; Magaye RR, 2019, CELL MOL LIFE SCI, V76, P1107, DOI 10.1007/s00018-018-2984-8; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Matanes F, 2019, ADV EXP MED BIOL, V1159, P109, DOI 10.1007/978-3-030-21162-2_7; Mishima Y, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181288; Morita Y, 2019, LIPIDS, V54, P487, DOI 10.1002/lipd.12175; Mosialou I, 2010, J BIOL CHEM, V285, P30719, DOI 10.1074/jbc.M110.131771; Nagahashi M, 2016, J LIPID RES, V57, P1636, DOI 10.1194/jlr.R069286; Nojiri T, 2014, J DIABETES INVEST, V5, P639, DOI 10.1111/jdi.12232; Park WJ, 2020, MOL CELLS, V43, P419, DOI 10.14348/molcells.2020.0054; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Sakai E, 2020, J APPL LAB MED, V5, P656, DOI 10.1093/jalm/jfaa022; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; Wenniger LMD, 2010, DIGEST LIVER DIS, V42, P409, DOI 10.1016/j.dld.2010.03.015; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yatomi Y, 2018, P JPN ACAD B-PHYS, V94, P373, DOI 10.2183/pjab.94.025; Yuyama K, 2014, BBA-MOL CELL BIOL L, V1841, P793, DOI 10.1016/j.bbalip.2013.08.002; Zhang X, 2008, BIOCHEM BIOPH RES CO, V371, P114, DOI 10.1016/j.bbrc.2008.04.017; Zhang XY, 2007, BBA-MOL CELL BIOL L, V1771, P879, DOI 10.1016/j.bbalip.2007.04.020; Zheng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105681	50	4	4	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14655	14670		10.1096/fj.202001397R	http://dx.doi.org/10.1096/fj.202001397R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918529	Bronze			2022-12-28	WOS:000570583500001
J	Sakurai, T; Okuyama, Y; Kobayashi, S; Phung, HT; Asao, A; Kawabe, T; Ndhlovu, LC; Riccardi, C; Kudo, H; Wada, M; Nio, M; So, T; Ishii, N				Sakurai, Tsuyoshi; Okuyama, Yuko; Kobayashi, Shuhei; Phung, Hai The; Asao, Atsuko; Kawabe, Takeshi; Ndhlovu, Lishomwa C.; Riccardi, Carlo; Kudo, Hironori; Wada, Motoshi; Nio, Masaki; So, Takanori; Ishii, Naoto			GITR controls intestinal inflammation by suppressing IL-15-dependent NK cell activity	FASEB JOURNAL			English	Article						inflammatory bowel disease; innate immunity; natural killer cells; TNFRSF	NATURAL-KILLER-CELLS; DEXTRAN SULFATE SODIUM; EXPERIMENTAL COLITIS; BOWEL-DISEASE; PROTEIN LIGAND; LAMINA PROPRIA; RECEPTOR; INNATE; ACTIVATION; EXPRESSION	Glucocorticoid-induced TNFR family related gene (GITR) is a member of the TNFR superfamily that is expressed on cells of the immune system. Although the protective and pathogenic roles of GITR in T cell immunity are well characterized, the role of GITR in innate immunity in the intestinal tissues has not been well clarified. In this study, using a dextran sulfate sodium (DSS)-induced colitis model in mice, we found that GITR-deficiency rendered mice more susceptible to acute intestinal inflammation and that a significantly higher number of activated natural killer (NK) cells was accumulated in the colonic lamina propria ofGitr(-/-)mice as compared to wild-type mice. Additionally,Rag2(-/-)Gitr(-/-)mice, which lack T cells but have NK cells, also displayed more severe colonic inflammation thanRag2(-/-)mice. In contrast, an anti-GITR agonistic antibody significantly alleviated colitis inRag2(-/-)mice. Engagement of GITR inhibited IL-15-mediated activating signaling events in NK cells, which include cell activation and proliferation, and production of cytokines and cytotoxic granules. Taken together, our results provide the first evidence that GITR negatively controls intestinal inflammation through NK cell functions.	[Sakurai, Tsuyoshi; Okuyama, Yuko; Kobayashi, Shuhei; Phung, Hai The; Asao, Atsuko; Kawabe, Takeshi; So, Takanori; Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan; [Sakurai, Tsuyoshi; Kudo, Hironori; Wada, Motoshi; Nio, Masaki] Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Sendai, Miyagi, Japan; [Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Dept Trop Med, Manoa, HI USA; [Riccardi, Carlo] Perugia Univ, Med Sch, Pharmacol Sect, Dept Clin & Expt Med, Perugia, Italy; [So, Takanori] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Lab Mol Cell Biol, Toyama, Japan	Tohoku University; Tohoku University; University of Hawaii System; University of Hawaii Manoa; University of Perugia; University of Toyama	Okuyama, Y; Ishii, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan.	y.okuyama@med.tohoku.ac.jp; ishiin@med.tohoku.ac.jp	So, Takanori/R-6175-2019	So, Takanori/0000-0003-3004-8526; sakurai, tsuyoshi/0000-0001-9242-537X; Riccardi, Carlo/0000-0001-9257-3997	JSPS KAKENHI [16K15508]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Shimon Sakaguchi (Osaka University) and Takeshi Takahashi for the gift of the DTA-1 antibody. We also thank the Biomedical Research Core and the Institute for Animal Experimentation (Tohoku University Graduate School of Medicine) for technical support. This work was supported by JSPS KAKENHI Grant Number 16K15508 (NI).	Azuma M, 2010, CRIT REV IMMUNOL, V30, P547, DOI 10.1615/CritRevImmunol.v30.i6.40; Baltz KM, 2008, BLOOD, V112, P3735, DOI 10.1182/blood-2008-03-143016; Baltz KM, 2007, FASEB J, V21, P2442, DOI 10.1096/fj.06-7724com; Buechele C, 2012, LEUKEMIA, V26, P991, DOI 10.1038/leu.2011.313; Chen S, 2008, EUR J IMMUNOL, V38, P2229, DOI 10.1002/eji.200838167; Clouthier DL, 2014, CYTOKINE GROWTH F R, V25, P91, DOI 10.1016/j.cytogfr.2013.12.003; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fathollahi A, 2018, INFLAMM RES, V67, P727, DOI 10.1007/s00011-018-1162-7; Gotthardt D, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00694; Gu L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/265868; Hall LJ, 2013, MUCOSAL IMMUNOL, V6, P1016, DOI 10.1038/mi.2012.140; Holgersen K, 2015, J CROHNS COLITIS, V9, P492, DOI 10.1093/ecco-jcc/jjv050; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Lee SK, 2006, IMMUNOLOGY, V119, P479, DOI 10.1111/j.1365-2567.2006.02459.x; Liao GX, 2012, GASTROENTEROLOGY, V142, P582, DOI 10.1053/j.gastro.2011.11.031; Liu BY, 2008, J BIOL CHEM, V283, P8202, DOI 10.1074/jbc.M708944200; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Middleton D, 2002, TRANSPL IMMUNOL, V10, P147, DOI 10.1016/S0966-3274(02)00062-X; Motta AC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-93; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Nagashima H, 2018, J ALLERGY CLIN IMMUN, V141, P1939, DOI 10.1016/j.jaci.2018.01.028; Nocentini G, 2009, ADV EXP MED BIOL, V647, P156, DOI 10.1007/978-0-387-89520-8_11; Patel M, 2005, EUR J IMMUNOL, V35, P3581, DOI 10.1002/eji.200535421; Patidar M, 2016, CYTOKINE GROWTH F R, V31, P49, DOI 10.1016/j.cytogfr.2016.06.001; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/171520; Santucci L, 2007, GUT, V56, P52, DOI 10.1136/gut.2006.091181; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schmiedel BJ, 2013, MOL THER, V21, P877, DOI 10.1038/mt.2013.11; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Steel AW, 2011, ALIMENT PHARM THER, V33, P115, DOI 10.1111/j.1365-2036.2010.04499.x; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Tomizawa R, 2011, CLIN EXP IMMUNOL, V165, P141, DOI 10.1111/j.1365-2249.2011.04414.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Waldner MJ, 2010, INFLAMM BOWEL DIS, V16, P559, DOI 10.1002/ibd.21107; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Wang F, 2017, ONCOTARGET, V8, P98945, DOI 10.18632/oncotarget.22132; Wang SJ, 2012, AM J PATHOL, V180, P1059, DOI 10.1016/j.ajpath.2011.11.018; Xu YH, 2008, J NEUROIMMUNOL, V200, P53, DOI 10.1016/j.jneuroim.2008.06.008; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yoshihara K, 2006, GUT, V55, P334, DOI 10.1136/gut.2005.076000	43	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14820	14831		10.1096/fj.202001675R	http://dx.doi.org/10.1096/fj.202001675R		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910505	Bronze			2022-12-28	WOS:000568315200001
J	Li, Q; Jin, RR; Zhang, SH; Sun, XH; Wu, JH				Li, Qian; Jin, Ruiri; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong			Transient receptor potential vanilloid four channels modulate inhibitory inputs through differential regulation of GABA and glycine receptors in rat retinal ganglion cells	FASEB JOURNAL			English	Article						GABA(A)receptor; glycine receptor; inhibitory input; retinal ganglion cell; TRPV4	TRPV4 CHANNELS; CALCIUM HOMEOSTASIS; ACTIVATION; EXPRESSION; APOPTOSIS; NEURONS; LOCALIZATION; TRANSMISSION; EXCITABILITY; PRESSURE	The transient receptor potential vanilloid 4 (TRPV4) channel is widely distributed in the retina. Activation of the TRPV4 channel enhances excitatory signaling from bipolar cells to retinal ganglion cells (RGCs), thereby increasing RGC firing rate and membrane excitability. In this study, we investigated the effect of TRPV4 channel activation on the miniature inhibitory postsynaptic current (mIPSC) in rat RGCs. Our results showed that perfusion with HC-067047, a TRPV4-channel antagonist, significantly reduced the amplitude of RGC mIPSCs. Extracellular application of the TRPV4 channel agonist GSK1016790A (GSK101) enhanced the frequency and amplitude of mIPSCs in ON- and OFF-type RGCs; pre-application of HC-067047 blocked the effect of GSK101 on mIPSCs. Furthermore, TRPV4 channels were able to enhance the frequency and amplitude of glycine receptor (GlyR)-mediated mIPSCs and inhibit the frequency of type A gamma-aminobutyric acid receptor (GABA(A)R)-mediated mIPSCs. Upon intracellular administration or intravitreal injection of GSK101, TRPV4 channel activation reduced the release of presynaptic glycine and enhanced the function and expression of postsynaptic GlyRs; however, it inhibited presynaptic release of GABA, but did not affect postsynaptic GABA(A)Rs. Our study results provide insight regarding the effect of TRPV4 channel activation on RGCs and offer a potential interventional target for retinal diseases involving TRPV4 channels.	[Li, Qian; Sun, Xinghuai; Wu, Jihong] Fudan Univ, Eye Inst, Eye & ENT Hosp, Shanghai, Peoples R China; [Li, Qian; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong] Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China; [Li, Qian; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong] Fudan Univ, NHC Key Lab Myopia, Shanghai, Peoples R China; [Li, Qian; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong] Chinese Acad Med Sci, Key Lab Myopia, Shanghai, Peoples R China; [Jin, Ruiri] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China	Fudan University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Nanchang University	Sun, XH; Wu, JH (corresponding author), Fudan Univ, Coll Med, Inst Eye, Eye & ENT Hosp, 83 Fenyang Rd, Shanghai 200031, Peoples R China.	xhsun@shmu.edu.cn; jihongwu@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [31800872, 81790641, 81770925]; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund) [17YF1401800]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31800872, 81790641 and 81770925; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund), Grant/Award Number: 17YF1401800	Zamarripa DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13621-8; Baratchi S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00006; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Ciura S, 2018, CELL REP, V23, P2245, DOI 10.1016/j.celrep.2018.04.090; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Cui P, 2017, NEUROSCIENCE, V355, P71, DOI 10.1016/j.neuroscience.2017.04.046; DOI M, 1995, J COMP NEUROL, V356, P368, DOI 10.1002/cne.903560305; Dong LD, 2015, J NEUROSCI, V35, P5409, DOI 10.1523/JNEUROSCI.4376-14.2015; Du JL, 2000, J NEUROPHYSIOL, V84, P666, DOI 10.1152/jn.2000.84.2.666; Duan L, 2009, J PHYSIOL-LONDON, V587, P4063, DOI 10.1113/jphysiol.2009.174797; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Gao F, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1576-3; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; GRASSI F, 1992, BRAIN RES, V594, P115, DOI 10.1016/0006-8993(92)91035-D; HAMILL OP, 1992, P NATL ACAD SCI USA, V89, P7462, DOI 10.1073/pnas.89.16.7462; Harmon TC, 2020, J NEUROSCI, V40, P3063, DOI 10.1523/JNEUROSCI.2322-19.2020; Heathcote HR, 2019, BRIT J PHARMACOL, V176, P3297, DOI 10.1111/bph.14762; Hong ZW, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00077; Howell RD, 2016, J PHYSIOL-LONDON, V594, P3651, DOI 10.1113/JP272124; Iuso A, 2016, CHANNELS, V10, P172, DOI 10.1080/19336950.2016.1140956; Jiang LL, 2011, EUR J CELL BIOL, V90, P333, DOI 10.1016/j.ejcb.2010.10.003; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Jung C, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam6558; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Krizaj D, 2016, ADV EXP MED BIOL, V854, P693, DOI 10.1007/978-3-319-17121-0_92; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Li Q, 2020, NEUROPHARMACOLOGY, V170, DOI 10.1016/j.neuropharm.2020.108016; Li Q, 2017, BRAIN STRUCT FUNCT, V222, P813, DOI 10.1007/s00429-016-1248-3; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Lu T, 2008, NEURON, V57, P524, DOI 10.1016/j.neuron.2007.12.010; Lu Y, 2012, NEUROCHEM INT, V61, P649, DOI 10.1016/j.neuint.2012.07.005; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Matsumoto H, 2018, J NEUROSCI, V38, P8745, DOI 10.1523/JNEUROSCI.0897-18.2018; Molchanova SM, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00442; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; PEICHL L, 1989, J COMP NEUROL, V286, P120, DOI 10.1002/cne.902860108; Phuong TTT, 2017, J PHYSIOL-LONDON, V595, P6869, DOI 10.1113/JP275052; Popova E, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/149187; Popova E, 2014, CURR NEUROPHARMACOL, V12, P509, DOI 10.2174/1570159X13999150122165018; Qi MW, 2018, CELL PHYSIOL BIOCHEM, V45, P1084, DOI 10.1159/000487350; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Ryskamp DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30583; Ryskamp DA, 2014, J NEUROSCI, V34, P15689, DOI 10.1523/JNEUROSCI.2540-14.2014; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Scarnati MS, 2018, ELIFE, V7, DOI 10.7554/eLife.36697; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; SHIN DH, 1989, ARCH OPHTHALMOL-CHIC, V107, P1599, DOI 10.1001/archopht.1989.01070020677026; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Son A, 2018, J MOL ENDOCRINOL, V61, P207, DOI 10.1530/JME-18-0051; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Taylor L, 2017, EXP EYE RES, V154, P10, DOI 10.1016/j.exer.2016.11.002; Thou XJ, 2019, J NEUROSCI, V39, P1484, DOI 10.1523/JNEUROSCI.1685-18.2018; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; ULLRICH B, 1994, J PHYSIOL-PARIS, V88, P249, DOI 10.1016/0928-4257(94)90088-4; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Wang XH, 2016, BRAIN STRUCT FUNCT, V221, P301, DOI 10.1007/s00429-014-0908-4; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Yu YC, 2006, J NEUROSCI, V26, P696, DOI 10.1523/JNEUROSCI.3653-05.2006	66	2	2	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14521	14538		10.1096/fj.201902937RR	http://dx.doi.org/10.1096/fj.201902937RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892440				2022-12-28	WOS:000568292300001
J	Wang, W; Wu, JH; Mukherjee, A; He, TH; Wang, XY; Ma, YB; Fang, XJ				Wang, Wei; Wu, Jinhua; Mukherjee, Abir; He, Tianhai; Wang, Xiang-Yang; Ma, Yibao; Fang, Xianjun			Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer	FASEB JOURNAL			English	Article						ADAM17; cytokines; LPA; ovarian cancer; TNF-alpha	GROWTH-FACTOR RECEPTOR; C-REACTIVE PROTEIN; TNF-ALPHA; KAPPA-B; COUPLED RECEPTORS; UP-REGULATION; SERUM-LEVELS; EXPRESSION; RISK; INTERLEUKIN-6	Epithelial ovarian carcinoma tissues express high levels of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory cytokines. The underlying mechanism leading to the abnormal TNF-alpha expression in ovarian cancer remains poorly understood. In the current study, we demonstrated that lysophosphatidic acid (LPA), a lipid mediator present in ascites of ovarian cancer patients, induced expression of TNF-alpha mRNA and release of TNF-alpha protein in ovarian cancer cells. LPA also induced expression of interleukin-1 beta (IL-1 beta) mRNA but no significant increase in IL-1 beta protein was detected. LPA enhanced TNF-alpha mRNA through NF-kappa B-mediated transcriptional activation. Inactivation of ADAM17, a disintegrin and metalloproteinase, with a specific inhibitor TMI-1 or by shRNA knockdown prevented ovarian cancer cells from releasing TNF-alpha protein in response to LPA, indicating that LPA-mediated TNF-alpha production relies on both transcriptional upregulations of the TNF-alpha gene and the activity of ADAM17, the membrane-associated TNF-alpha-converting enzyme. Like many other biological responses to LPA, induction of TNF-alpha by LPA also depended on the transactivation of the epidermal growth factor receptor (EGFR). Interestingly, our results revealed that ADAM17 was also the shedding protease responsible for the transactivation of EGFR by LPA in ovarian cancer cells. To explore the biological outcomes of LPA-induced TNF-alpha, we examined the effects of a TNF-alpha neutralizing antibody and recombinant TNF-alpha soluble receptor on LPA-stimulated expression of pro-tumorigenic cytokines and chemokines overexpressed in ovarian cancer. Blockade of TNF-alpha signaling significantly reduced the production of IL-8, IL-6, and CXCL1, suggesting a hierarchy of mechanisms contributing to the robust expression of the inflammatory mediators in response to LPA in ovarian cancer cells. In contrast, TNF-alpha inhibition did not affect LPA-dependent cell proliferation. Taken together, our results establish that the bioactive lipid LPA drives the expression of TNF-alpha to regulate an inflammatory network in ovarian cancer.	[Wang, Wei; Wu, Jinhua; Mukherjee, Abir; He, Tianhai; Ma, Yibao; Fang, Xianjun] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Wu, Jinhua] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mukherjee, Abir] Univ Chicago, Ctr Integrat Sci, Sect Gynecol Oncol, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Wang, Xiang-Yang] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA	Virginia Commonwealth University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Chicago; Virginia Commonwealth University	Fang, XJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Sanger Hall 2-016,1101 East Marshall St, Richmond, VA 23298 USA.	xianjun.fang@vcuhealth.org			HHS | NIH | National Cancer Institute (NCI) [CA229812, CA16059]; Astar Biotech Research Award; Massey Cancer Center Pilot Research Award	HHS | NIH | National Cancer Institute (NCI); Astar Biotech Research Award; Massey Cancer Center Pilot Research Award	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: CA229812 and CA16059; Astar Biotech Research Award; Massey Cancer Center Pilot Research Award	Bae GH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.203; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Cabron AS, 2018, J IMMUNOL, V201, P3106, DOI 10.4049/jimmunol.1701556; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; CHEN QL, 1995, J BIOL CHEM, V270, P28499, DOI 10.1074/jbc.270.48.28499; Chou CH, 2005, CARCINOGENESIS, V26, P45, DOI 10.1093/carcin/bgh301; Clendenen TV, 2011, CYTOKINE, V56, P769, DOI 10.1016/j.cyto.2011.09.013; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; GADDUCCI A, 1995, GYNECOL ONCOL, V58, P184, DOI 10.1006/gyno.1995.1207; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Gupta M, 2016, HUM PATHOL, V54, P82, DOI 10.1016/j.humpath.2016.03.006; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Hu YL, 2001, J NATL CANCER I, V93, P762, DOI 10.1093/jnci/93.10.762; Kampan NC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01482; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Kwon JH, 2018, BBA-MOL CELL BIOL L, V1863, P1237, DOI 10.1016/j.bbalip.2018.07.015; Lee S. C., 2015, RECEPT CLIN INVEST, V2, pe440; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Li HB, 2005, J BIOL CHEM, V280, P10564, DOI 10.1074/jbc.M412152200; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; LUGER TA, 1990, J INVEST DERMATOL, V95, pS100, DOI 10.1111/1523-1747.ep12874944; Lundin E, 2009, CANCER CAUSE CONTROL, V20, P1151, DOI 10.1007/s10552-009-9330-2; Ma YB, 2019, CANCERS, V11, DOI 10.3390/cancers11010033; McSorley MA, 2007, OBSTET GYNECOL, V109, P933, DOI 10.1097/01.AOG.0000257126.68803.03; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; MORADI MM, 1993, CANCER, V72, P2433, DOI 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L; Mukherjee A, 2015, NEOPLASIA, V17, P723, DOI 10.1016/j.neo.2015.09.003; NAYLOR MS, 1993, J CLIN INVEST, V91, P2194, DOI 10.1172/JCI116446; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Oyesanya RA, 2008, FASEB J, V22, P2639, DOI 10.1096/fj.07-101428; Oyesanya RA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-8; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Piura B, 2014, ANTICANCER RES, V34, P745; Poole EM, 2013, AM J EPIDEMIOL, V178, P1256, DOI 10.1093/aje/kwt098; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pustilnik TB, 1999, CLIN CANCER RES, V5, P3704; Rodland KD, 2008, J BIOL CHEM, V283, P31477, DOI 10.1074/jbc.M800456200; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; Shah BH, 2002, MOL PHARMACOL, V61, P343, DOI 10.1124/mol.61.2.343; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007; Sipak-Szmigiel O, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0320-9; Song YD, 2009, CLIN CANCER RES, V15, P492, DOI 10.1158/1078-0432.CCR-08-1945; Steeland S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051442; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Symowicz J, 2005, CANCER RES, V65, P2234, DOI 10.1158/0008.5472.CAN-04-2781; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Toriola AT, 2011, ANN ONCOL, V22, P1916, DOI 10.1093/annonc/mdq694; Trabert B, 2014, GYNECOL ONCOL, V135, P297, DOI 10.1016/j.ygyno.2014.08.025; Vitonis AF, 2011, OBSTET GYNECOL, V117, P1042, DOI 10.1097/AOG.0b013e318212fcb7; Wang ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010095; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; WU S, 1993, CANCER RES, V53, P1939; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yun CC, 2019, CANCERS, V11, DOI 10.3390/cancers11070958; Zhang YH, 2004, J PHARMACOL EXP THER, V309, P348, DOI 10.1124/jpet.103.059675	77	29	30	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13935	13948		10.1096/fj.202001136R	http://dx.doi.org/10.1096/fj.202001136R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32851734	Green Accepted			2022-12-28	WOS:000565961700001
J	Hoy, JJ; Parra, NS; Park, J; Kuhn, S; Iglesias-Bartolome, R				Hoy, James J.; Salinas Parra, Natalia; Park, Jeannie; Kuhn, Skyler; Iglesias-Bartolome, Ramiro			Protein kinase A inhibitor proteins (PKIs) divert GPCR-G alpha s-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth	FASEB JOURNAL			English	Article						cAMP; GPCR; EPAC; PKA; PKI	ADENYLYL-CYCLASE; REGULATED KINASES; MAP KINASE; CYCLIC-AMP; B-RAF; PKA; RAP1; PHOSPHORYLATION; PATHWAY; FAMILY	The PKA-inhibitor (PKI) family members PKI alpha, PKI beta, and PKI gamma bind with high affinity to PKA and block its kinase activity, modulating the extent, and duration of PKA-mediated signaling events. While PKA is a well-known regulator of physiological and oncogenic events, the role of PKI proteins in these pathways has remained elusive. Here, by measuring activation of the MAPK pathway downstream of GPCR-G alpha s-cAMP signaling, we show that the expression levels of PKI proteins can alter the balance of activation of two major cAMP targets: PKA and EPAC. Our results indicate that PKA maintains repressive control over MAPK signaling as well as a negative feedback on cAMP concentration. Overexpression of PKI and its subsequent repression of PKA dysregulates these signaling pathways, resulting in increased intracellular cAMP, and enhanced activation of EPAC and MAPK. We also find that amplifications ofPKIAare common in prostate cancer and are associated with reduced progression free survival. Depletion ofPKIAin prostate cancer cells leads to reduced migration, increased sensitivity to anoikis and reduced tumor growth. By altering PKA activity PKI can act as a molecular switch, driving GPCR-G alpha s-cAMP signaling toward activation of EPAC-RAP1 and MAPK, ultimately modulating tumor growth.	[Hoy, James J.; Salinas Parra, Natalia; Park, Jeannie; Iglesias-Bartolome, Ramiro] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Room 2050C, Bethesda, MD 20892 USA; [Kuhn, Skyler] NCI, Collaborat Bioinformat Resource, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Iglesias-Bartolome, R (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Room 2050C, Bethesda, MD 20892 USA.	ramiro.iglesias-bartolome@nih.gov	Iglesias-Bartolome, Ramiro/H-4460-2014	Iglesias-Bartolome, Ramiro/0000-0002-0792-1254; Kuhn, Skyler/0000-0003-0606-2125; Salinas Parra, Natalia/0000-0003-3018-2581	HHS \ NIH \ National Cancer Institute (NCI)	HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Cancer Institute (NCI)	ASHBY CD, 1973, J BIOL CHEM, V248, P1255; ASHBY CD, 1972, J BIOL CHEM, V247, P6637; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Belyamani M, 2001, MOL CELL BIOL, V21, P3959, DOI 10.1128/MCB.21.12.3959-3963.2001; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Blanchet E, 2015, CELL REP, V10, P1149, DOI 10.1016/j.celrep.2015.01.046; Bos JL, 2018, COLD SPRING HARB PER, V8, P1; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Chung S, 2009, ONCOGENE, V28, P2849, DOI 10.1038/onc.2009.144; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; de Lecea L, 1998, J NEUROSCI RES, V53, P269, DOI 10.1002/(SICI)1097-4547(19980801)53:3<269::AID-JNR1>3.0.CO;2-8; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gangolli EA, 2000, MOL CELL BIOL, V20, P3442, DOI 10.1128/MCB.20.10.3442-3448.2000; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Iglesias-Bartolome R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8798; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; IWAMI G, 1995, J BIOL CHEM, V270, P12481, DOI 10.1074/jbc.270.21.12481; Jewell JL, 2019, ELIFE, V8, DOI 10.7554/eLife.43038; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lee SR, 2016, CELL REP, V14, P3019, DOI 10.1016/j.celrep.2016.02.077; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Manschwetus JT, 2019, MOLECULES, V24, DOI 10.3390/molecules24081567; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pattabiraman DR, 2016, SCIENCE, V351, P1042, DOI 10.1126/science.aad3680; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Sotomayor-Flores C, 2020, CELL DEATH DIFFER, V27, P2586, DOI 10.1038/s41418-020-0522-3; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Takahashi M, 2017, J BIOL CHEM, V292, P1449, DOI 10.1074/jbc.M116.768986; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tsalkova T, 2012, P NATL ACAD SCI USA, V109, P18613, DOI 10.1073/pnas.1210209109; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wan Y, 1998, J BIOL CHEM, V273, P14533, DOI 10.1074/jbc.273.23.14533; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; WEN W, 1994, J BIOL CHEM, V269, P32214; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896; Zhu YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09344	64	10	10	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13900	13917		10.1096/fj.202001515R	http://dx.doi.org/10.1096/fj.202001515R		AUG 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32830375	Green Accepted, Bronze			2022-12-28	WOS:000564399000001
J	Wang, YH; Chen, T; Pan, ZC; Lin, ZY; Yang, LW; Zou, BA; Yao, WM; Feng, DH; Huangfu, CM; Lin, CY; Wu, GQ; Ling, HY; Liu, G				Wang, Yahong; Chen, Ting; Pan, Zhanchun; Lin, Ziying; Yang, Lawei; Zou, Baoan; Yao, Weimin; Feng, Dehui; Huangfu, Changmei; Lin, Chunyu; Wu, Guiqing; Ling, Huayu; Liu, Gang			8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2/3 and interacting with Smad7	FASEB JOURNAL			English	Article						cell transformation; OGG1; pulmonary fibrosis; Smad2; 3; Smad7	LUNG FIBROSIS; TGF-BETA; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; REPAIR; ACTIVATION; EXPRESSION; DAMAGE	The DNA repair enzyme 8-oxoguanine DNA glycosylase-1 (OGG1) is involved in early embryonic development, as well as in multiple conditions, including cardiac fibrosis, diabetes, and neurodegenerative diseases. But, function of OGG1 in pulmonary fibrosis was not entirely clear. In this study, we identified a novel function of OGG1 in the cell transformation process in pulmonary fibrosis. We demonstrated that OGG1 and Smad7 co-localize and interact in A549 cells. Bleomycin-induced pulmonary fibrosis was established in wild-type (WT) andOgg1(-/-)mice. Upon treatment with transforming growth factor (TGF)-beta 1, increased OGG1 expression was observed in WT mice with pulmonary fibrosis as well as in A549 cells, MRC-5 cells, and primary rat type II alveolar epithelial cells. The increased expression of OGG1 promoted cell migration, while OGG1 depletion decreased migration ability. Expression of the transformation-associated markers vimentin and alpha-smooth muscle actin were also affected by OGG1. We also observed that OGG1 promoted TGF-beta 1-induced cell transformation and activated Smad2/3 by interacting with Smad7. The interaction between OGG1 and the TGF-beta/Smad axis modulates the cell transformation process in lung epithelial cells and fibroblasts. Moreover, we demonstrated thatOgg1deficiency relieved pulmonary fibrosis in bleomycin-treated mice.Ogg1knockout decreased the bleomycin-induced expression of Smad7 and phosphorylation of Smad2/3 in mice. These findings suggest that OGG1 has multiple biological functions in the pathogenesis of pulmonary fibrosis.	[Wang, Yahong; Chen, Ting; Lin, Ziying; Yang, Lawei; Zou, Baoan; Liu, Gang] Guangdong Med Univ, Affiliated Hosp, Clin Res Ctr, Zhanjiang 524001, Peoples R China; [Pan, Zhanchun; Yao, Weimin; Lin, Chunyu; Wu, Guiqing; Ling, Huayu] Guangdong Med Univ, Affiliated Hosp, Dept Resp Med, Zhanjiang, Peoples R China; [Feng, Dehui; Huangfu, Changmei] Guangdong Med Univ, Affiliated Hosp, Elderly Med Ctr, Zhanjiang, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University	Liu, G (corresponding author), Guangdong Med Univ, Affiliated Hosp, Clin Res Ctr, Zhanjiang 524001, Peoples R China.	gangliu11@gdmu.edu.cn	Liu, Gang/M-4073-2014	Liu, Gang/0000-0002-4536-8453	Natural Science Foundation of China [NSFC81570062, NSFC81600049, NSFC81172615]; Guangdong Natural Science Foundation [2016A030313681]; Guangdong Medical Science Foundation [A2017010, A2017027]; Guangdong Medical University Scientific Research Fund [M2016001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Medical Science Foundation; Guangdong Medical University Scientific Research Fund	This work was supported by the Natural Science Foundation of China (Grant Nos. NSFC81570062, NSFC81600049, and NSFC81172615), Guangdong Natural Science Foundation (Grant Nos. 2016A030313681), Guangdong Medical Science Foundation (Grant Nos. A2017010, A2017027), and Guangdong Medical University Scientific Research Fund (Grant Nos. M2016001)	Aguilera-Aguirre L, 2015, FREE RADICAL BIO MED, V89, P20, DOI 10.1016/j.freeradbiomed.2015.07.007; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Cheresh P, 2015, AM J RESP CELL MOL, V52, P25, DOI 10.1165/rcmb.2014-0038OC; Fang XC, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-9; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2012, Proc Am Thorac Soc, V9, P137, DOI 10.1513/pats.201202-017AW; Hoyles RK, 2011, AM J RESP CRIT CARE, V183, P249, DOI 10.1164/rccm.201002-0279OC; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kim SJ, 2015, INT J MOL SCI, V16, P21486, DOI 10.3390/ijms160921486; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Luo JX, 2014, FREE RADICAL BIO MED, V73, P430, DOI 10.1016/j.freeradbiomed.2014.03.030; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Morbini P, 2011, PATHOL RES PRACT, V207, P559, DOI 10.1016/j.prp.2011.06.006; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sheppard Dean, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS21, DOI 10.1513/AnnalsATS.201406-245MG; Shi L, 2016, J CELL MOL MED, V20, P2183, DOI 10.1111/jcmm.12918; Staffolani S, 2015, MUTAGENESIS, V30, P487, DOI 10.1093/mutage/gev007; Tang N, 2014, J CELL MOL MED, V18, P156, DOI 10.1111/jcmm.12178; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Witowski J, 2008, NEPHRON EXP NEPHROL, V108, pE69, DOI 10.1159/000126920; Wuyts WA, 2013, EUR RESPIR J, V41, P1207, DOI 10.1183/09031936.00073012; Yang LW, 2015, EXP MOL PATHOL, V99, P365, DOI 10.1016/j.yexmp.2015.08.005	29	4	4	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13461	13473		10.1096/fj.201901291RRRRR	http://dx.doi.org/10.1096/fj.201901291RRRRR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32808374				2022-12-28	WOS:000562545500001
J	Shi, YY; Cui, XW; Sun, YL; Zhao, Q; Liu, TJ				Shi, Yongyan; Cui, Xuewei; Sun, Yanli; Zhao, Qun; Liu, Tianjing			Intestinal vitamin D receptor signaling ameliorates dextran sulfate sodium-induced colitis by suppressing necroptosis of intestinal epithelial cells	FASEB JOURNAL			English	Article						inflammatory bowel disease; necroptosis; vitamin D receptor	INFLAMMATORY-BOWEL-DISEASE; EXPRESSION; BARRIER; APOPTOSIS; NECROSIS; INJURY; DEATH	Vitamin D status is closely related to inflammatory bowel disease (IBD), but the mechanism has not been fully elucidated. This study explored the effect of intestinal vitamin D signaling on necroptosis and the underlying mechanism in colitis. Serum 25(OH)D levels and the expression of necroptotic proteins were examined in patients with IBD. Colitis was induced in an intestinal-specific hVDR transgenic model, and the gross manifestation, histological integrity, and intestinal barrier function were tested. The findings were further confirmed in vitro. Immunoprecipitation and colocalization were performed to investigate the association between the vitamin D receptor and necroptotic proteins. We found that serum 25(OH)D decreased in patients with IBD, while the expression of necroptotic proteins increased. The intestinal hVDR transgenic model could largely ameliorate the structural destruction, restore barrier dysfunction, and suppress necroptosis caused by DSS. This was probably achieved by binding to RIPK1/3 necrosomes, as we observed decreased RIPK1/3 necrosome formation and increased VDR expression in the cytosol. This study demonstrated an inhibitory effect of the intestinal vitamin D signaling pathway on necroptosis in DSS-induced colitis. The vitamin D receptor shifts from the nucleus to the cytosol to impede the formation of RIPK1/3. Our findings may offer some theoretical basis for a novel treatment of IBD in clinical practice.	[Shi, Yongyan; Cui, Xuewei] China Med Univ, Dept Pediat, Shengjing Hosp, Shenyang, Peoples R China; [Sun, Yanli] China Med Univ, Dept Pediat, Affiliated Hosp 4, Shenyang, Peoples R China; [Zhao, Qun; Liu, Tianjing] China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, TJ (corresponding author), China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China.	tianjing_rat@163.com	Cui, Xuewei/HCH-4622-2022		National Natural Science Foundation of China (NSFC) [81700459, 81801500]; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation) [20180550562]; The 345 Talent Project of Shengjing Hospital [M0275, M0279]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation); The 345 Talent Project of Shengjing Hospital	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81700459 and 81801500; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation), Grant/Award Number: 20180550562; The 345 Talent Project of Shengjing Hospital, Grant/Award Number: M0275 and M0279	APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Caviezel Daniel, 2018, Inflamm Intest Dis, V2, P200, DOI 10.1159/000489010; Chen SW, 2015, TOXICOL LETT, V237, P79, DOI 10.1016/j.toxlet.2015.06.006; Cheng SL, 2016, INTERDISCIP SCI, V8, P65, DOI 10.1007/s12539-015-0106-y; COOPER HS, 1993, LAB INVEST, V69, P238; Du J, 2015, INFLAMM BOWEL DIS, V21, P2495, DOI 10.1097/MIB.0000000000000526; Golan MA, 2015, DIGEST DIS SCI, V60, P1941, DOI 10.1007/s10620-015-3634-8; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hausmann J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091319; Jeong MS, 2014, ANN DERMATOL, V26, P296, DOI 10.5021/ad.2014.26.3.296; Ko KH, 2019, INTEST RES, V17, P70, DOI 10.5217/ir.2018.00022; Li S, 2018, WORLD J CLIN CASES, V6, P745, DOI 10.12998/wjcc.v6.i14.745; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32889; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Liu ZY, 2015, AM J CANCER RES, V5, P3174; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Newton K, 2016, ANNU REV BIOCHEM, V85, P743, DOI 10.1146/annurev-biochem-060815-014830; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Quarni W, 2017, J STEROID BIOCHEM, V173, P157, DOI 10.1016/j.jsbmb.2017.01.024; Sharma D, 2017, IMMUNOL REV, V280, P57, DOI 10.1111/imr.12602; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Tabatabaeizadeh SA, 2018, J RES MED SCI, V23, DOI 10.4103/jrms.JRMS_606_17; Wang F, 2017, ENDOCRINOLOGY, V158, P1951, DOI 10.1210/en.2016-1913; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wu TL, 2019, ANN PALLIAT MED, V8, P483, DOI 10.21037/apm.2019.07.04; Zammit SC, 2018, EUR J GASTROEN HEPAT, V30, P1297, DOI 10.1097/MEG.0000000000001238; Zhang C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1580-7; Zhang J, 2019, MOL IMMUNOL, V107, P132, DOI 10.1016/j.molimm.2019.01.018; Zhao GX, 2019, J CLIN INVEST, V129, P972, DOI 10.1172/JCI122779; Zhu T, 2015, INT J MOL MED, V35, P1213, DOI 10.3892/ijmm.2015.2150	34	7	7	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13494	13506		10.1096/fj.202000143RRR	http://dx.doi.org/10.1096/fj.202000143RRR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32779265	hybrid			2022-12-28	WOS:000558416600001
J	Stone, E; Kiat, H; McLachlan, CS				Stone, Elijah; Kiat, Hosen; McLachlan, Craig S.			Atrial fibrillation in COVID-19: A review of possible mechanisms	FASEB JOURNAL			English	Review						atrial fibrillation; COVID-19; heart; immune system; lung; pathophysiology	AGE-RELATED-CHANGES; HYDROSTATIC-PRESSURE; SUBSTRATE STIFFNESS; HEART-FAILURE; IMMUNE; PERICYTES; ANGIOTENSIN-(1-7); INTERLEUKIN-2; PROPHYLAXIS; PROMOTE	A relationship between COVID-19 infection and an increasing incidence of atrial fibrillation has been observed. However, the underlying pathophysiology as a precipitant to AF has not been reviewed. This paper will consider the possible pathological and immunological AF mechanisms as a result, of COVID-19 infection. We discuss the role myocardial microvascular pericytes expressing the ACE-2 receptor and their potential for an organ-specific cardiac involvement with COVID-19. Dysfunctional microvascular support by pericytes or endothelial cells may increase the propensity for AF via increased myocardial inflammation, fibrosis, increased tissue edema, and interstitial hydrostatic pressure. All of these factors can lead to electrical perturbances at the tissue and cellular level. We also consider the contribution of Angiotensin, pulmonary hypertension, and regulatory T cells as additional contributors to AF during COVID-19 infection. Finally, reference is given to two common drugs, corticosteroids and metformin, in COVID-19 and how they might influence AF incidence.	[Stone, Elijah; Kiat, Hosen; McLachlan, Craig S.] Torrens Univ Australia, Ctr Hlth Futures, Hlth Vert, 5-235 Pyrmont St, Sydney, NSW 2009, Australia; [Kiat, Hosen] Cardiac Hlth Inst, Eastwood, NSW, Australia; [Kiat, Hosen] Macquarie Univ, Australian Sch Adv Med, 2 Technol Pl, Sydney, NSW, Australia	Torrens University Australia; Macquarie University	McLachlan, CS (corresponding author), Torrens Univ Australia, Ctr Hlth Futures, Hlth Vert, 5-235 Pyrmont St, Sydney, NSW 2009, Australia.	reperufsion@hotmail.com	Kiat, Hosen/AEQ-8110-2022	Kiat, Hosen/0000-0002-2899-118X; McLachlan, Craig/0000-0001-9843-8980				Agabiti-Rosei C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197178; Al-Shawabkeh Z, 2017, J SAUDI HEART ASSOC, V29, P23, DOI 10.1016/j.jsha.2016.03.005; Antzelevitch Charles, 2011, Card Electrophysiol Clin, V3, P23, DOI 10.1016/j.ccep.2010.10.012; Avolio E, 2016, VASC PHARMACOL, V86, P53, DOI 10.1016/j.vph.2016.05.009; Belen-Apak FB, 2020, J THROMB THROMBOLYS, V50, P278, DOI 10.1007/s11239-020-02129-0; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Bontekoe J, 2018, CLIN APPL THROMB-HEM, V24, p269S, DOI 10.1177/1076029618808909; Boothe SD, 2016, CELL BIOCHEM BIOPHYS, V74, P527, DOI 10.1007/s12013-016-0758-1; Bouferrache K, 2011, CURR OPIN CRIT CARE, V17, P30, DOI 10.1097/MCC.0b013e328342722b; Chang SH, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0647-9; Chatterjee S, 2015, AM J PHYSIOL-HEART C, V308, pH1451, DOI 10.1152/ajpheart.00105.2015; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078; Colon CM, 2020, JACC-CLIN ELECTROPHY, V6, P1189, DOI 10.1016/j.jacep.2020.05.015; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dongaonkar RM, 2010, CARDIOVASC RES, V87, P331, DOI 10.1093/cvr/cvq145; DOUBT TJ, 1978, J APPL PHYSIOL, V45, P24, DOI 10.1152/jappl.1978.45.1.24; Dumitriu IE, 2018, CARDIOVASC RES, V114, pS124, DOI 10.1093/cvr/cvy060.368; Farazi M, 2014, J LEUKOCYTE BIOL, V96, P245, DOI 10.1189/jlb.1A0114-066R; Farha Samar, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc021; Freestone B, 2005, ANN MED, V37, P365, DOI 10.1080/07853890510037392; Fu GQ, 2013, INT J MOL MED, V31, P423, DOI 10.3892/ijmm.2012.1218; Galandrin S, 2016, HYPERTENSION, V68, P1365, DOI 10.1161/HYPERTENSIONAHA.116.08118; Granger DN, 2010, MICROCIRCULATION, V17, P192, DOI 10.1111/j.1549-8719.2009.00015.x; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106; Hak L, 2009, J INTERF CYTOK RES, V29, P327, DOI 10.1089/jir.2008.0082.2906; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Huang JQ, 2020, HEART LUNG CIRC, V29, pE168, DOI 10.1016/j.hlc.2019.11.004; Inciardi Riccardo M, 2020, Eur Heart J, V41, P1821, DOI 10.1093/eurheartj/ehaa388; Jamilloux Y, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102567; Jansen HJ, 2018, J MOL CELL CARDIOL, V124, P12, DOI 10.1016/j.yjmcc.2018.09.011; Kennedy-Lydon T, 2017, ADV EXP MED BIOL, V1003, P93, DOI 10.1007/978-3-319-57613-8_5; Khanolkar A, 2009, J VIROL, V83, P9258, DOI 10.1128/JVI.00355-09; Laroumanie F, 2014, CIRCULATION, V129, P2111, DOI 10.1161/CIRCULATIONAHA.113.007101; Launey Y, 2019, J INTENSIVE CARE MED, V34, P238, DOI 10.1177/0885066617696847; Lee LL, 2019, ADV EXP MED BIOL, V1122, P187, DOI 10.1007/978-3-030-11093-2_11; Li H, 2020, LANCET, V395, P1517, DOI 10.1016/S0140-6736(20)30920-X; Li J, 2018, HYPERTENSION, V71, P866, DOI 10.1161/HYPERTENSIONAHA.117.10390; Li MJ, 2013, EXP THER MED, V6, P1121, DOI 10.3892/etm.2013.1274; Li X, 2020, J MOL CELL CARDIOL, V140, P10, DOI 10.1016/j.yjmcc.2020.01.012; Li X, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117209; Liu R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97881; Martini E, 2019, CIRCULATION, V140, P2089, DOI 10.1161/CIRCULATIONAHA.119.041694; McKinney CA, 2014, CLIN SCI, V126, P815, DOI 10.1042/CS20130436; McLachlan CS, 2020, CLIN HYPERTENS, V26, DOI 10.1186/s40885-020-00147-x; Moss TJ, 2017, CRIT CARE MED, V45, P790, DOI 10.1097/CCM.0000000000002325; Murray IR, 2017, PHARMACOL THERAPEUT, V171, P65, DOI 10.1016/j.pharmthera.2016.09.005; Naqvi TZ, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.003952; Nattel Stanley, 2017, JACC Clin Electrophysiol, V3, P425, DOI 10.1016/j.jacep.2017.03.002; Nowroozpoor Armin, 2019, Tanaffos, V18, P180; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Pinsky MR, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1440-0; Qiao G, 2017, MOL MED REP, V16, P4143, DOI 10.3892/mmr.2017.7045; Qin XY, 2018, CELL PHYSIOL BIOCHEM, V45, P1366, DOI 10.1159/000487562; Radwan E, 2019, BBA-MOL BASIS DIS, V1865, P403, DOI 10.1016/j.bbadis.2018.10.031; Rai A, 2020, J HYPERTENS, V38, P1878, DOI 10.1097/HJH.0000000000002456; Rizos I, 2007, CYTOKINE, V40, P157, DOI 10.1016/j.cyto.2007.08.013; Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0; Rudemiller NP, 2016, HYPERTENSION, V68, P289, DOI 10.1161/HYPERTENSIONAHA.116.06591; Seecheran R, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620925571; Seguin P, 2010, CRIT CARE, V14, DOI 10.1186/cc9093; Shete A, 2020, INT J INFECT DIS, V96, P348, DOI 10.1016/j.ijid.2020.05.002; Singh R, 2019, PULM MED, V2019, DOI 10.1155/2019/1907807; Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Sulzgruber P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28046-0; Sulzgruber P, 2017, THROMB HAEMOSTASIS, V117, P349, DOI 10.1160/TH16-07-0531; Sun ZW, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0584-z; Sweeney M, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00154; Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Tsapenko MV, 2008, VASC HEALTH RISK MAN, V4, P1043, DOI 10.2147/VHRM.S3998; Ullah Waqas, 2020, JACC Case Rep, V2, P1379, DOI 10.1016/j.jaccas.2020.04.008; van der Hooft CS, 2006, ARCH INTERN MED, V166, P1016, DOI 10.1001/archinte.166.9.1016; Wanamaker B, 2018, ARRHYTH ELECTROPHYSI, V7, P43, DOI 10.15420/aer.2018.3.2; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang M, 2018, CLIN IMMUNOL, V197, P77, DOI 10.1016/j.clim.2018.09.005; Wei ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114895; Xia Y, 2016, INFLAMMATION, V39, P1892, DOI 10.1007/s10753-016-0425-0; XU B, 2020, J INFECTION, V81, pE51, DOI 10.1016/j.jinf.2020.04.012; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yamamura K, 2011, LUPUS, V20, P871, DOI 10.1177/0961203310392429; Yao ZX, 2020, AGING-US, V12, P7639, DOI 10.18632/aging.103101; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Yu CM, 2006, POSTGRAD MED J, V82, P140, DOI 10.1136/pgmj.2005.037515; Zhang LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150806	90	24	24	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11347	11354		10.1096/fj.202001613	http://dx.doi.org/10.1096/fj.202001613		JUL 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33078484				2022-12-28	WOS:000557516900001
J	Zhong, C; Yu, Q; Jia, WT; Yu, X; Yu, DD; Yang, M; Wang, LN; Ling, CQ; Zhu, LQ				Zhong, Chen; Yu, Qin; Jia, Wentao; Yu, Xin; Yu, Dandan; Yang, Ming; Wang, Lina; Ling, Changquan; Zhu, Liqing			Mechanism for enhanced transduction of hematopoietic cells by recombinant adeno-associated virus serotype 6 vectors	FASEB JOURNAL			English	Article						gene delivery; hematopoietic stem; progenitor cells; proteasome inhibitor; reactive oxygen species; shikonin	HIGH-EFFICIENCY TRANSDUCTION; GENE-THERAPY; IN-VITRO; TRANSGENE EXPRESSION; STEM; TRANSPLANTATION; INDUCTION; SHIKONIN; EFFICACY; MOUSE	Hematopoietic gene delivery, such as hematopoietic stem/progenitor cells (HSPCs), is a promising treatment for both inherited and acquired diseases, such as hemophilia. Recently, a combined strategy to achieve more than 90% transduction efficiency was documented using recombinant adeno-associated virus serotype 6 (rAAV6) vectors. However, the mechanisms of enhanced vector transduction efficiency in hematopoietic cells are largely unknown. In this manuscript, we first reported that proteasome inhibitors, which are well-known to facilitate rAAV intracellular trafficking in various cell types, are not effective in hematopoietic cells. From the screening of small molecules derived from traditional Chinese medicine, we demonstrated that shikonin, a potential reactive oxygen species (ROS) generator, significantly increased the in vitro and ex vivo transgene expression mediated by rAAV6 vectors in hematopoietic cells, including human cord blood-derived CD34 + HSPCs. Shikonin mainly targeted vector intracellular trafficking, instead of host cell entry or endonuclear single to double strand vector DNA transition, in a vector serotype-dependent manner. Moreover, a ROS scavenger completely prevented the capability of shikonin to enhance rAAV6 vector-mediated transgene expression. Taken together, these studies expand our understanding of rAAV6-mediated transduction in hematopoietic cells and are informative for improving rAAV6-based treatment of blood diseases.	[Zhong, Chen; Yu, Dandan; Zhu, Liqing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou 325000, Zhejiang, Peoples R China; [Zhong, Chen; Yang, Ming] Fudan Univ, Sch Life Sci, Zhongshan Hosp, State Key Lab Genet Engn, Shanghai, Peoples R China; [Yu, Qin; Ling, Changquan] Shanghai Univ Tradit Chinese Med, Grad Sch, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Jia, Wentao; Yu, Xin; Wang, Lina; Ling, Changquan] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, 168 Changhai Rd, Shanghai 200433, Peoples R China	Wenzhou Medical University; Fudan University; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Zhu, LQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou 325000, Zhejiang, Peoples R China.; Ling, CQ (corresponding author), Shanghai Univ Tradit Chinese Med, Grad Sch, 1200 Cailun Rd, Shanghai 201203, Peoples R China.; Wang, LN; Ling, CQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, 168 Changhai Rd, Shanghai 200433, Peoples R China.	rena1022@163.com; lingchangquan@hotmail.com; wzzhuliqing@126.com			National Natural Science Foundation of China (NSFC) [81430101, 81774244]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81430101 and 81774244	Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Basaiyye SS, 2019, J INTEGR MED-JIM, V17, P221, DOI 10.1016/j.joim.2019.03.004; Brown N, 2017, HUM GENE THER, V28, P450, DOI 10.1089/hum.2017.038; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; de Sio FRS, 2006, BLOOD, V107, P4257, DOI 10.1182/blood-2005-10-4047; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Fleischer T, 2016, J INTEGR MED-JIM, V14, P322, DOI 10.1016/S2095-4964(16)60270-4; Gaudet D, 2016, HUM GENE THER, V27, P916, DOI 10.1089/hum.2015.158; Hoy SM, 2019, DRUGS, V79, P1255, DOI 10.1007/s40265-019-01162-5; Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4; Li M, 2017, BLOOD, V130, P1041, DOI 10.1182/blood-2016-12-755967; Ling C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35495; Ling C, 2014, HUM GENE THER, V25, P1023, DOI 10.1089/hum.2014.099; Lu JM, 2017, CEREB CORTEX, V27, P3842, DOI 10.1093/cercor/bhx082; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Mitchell AM, 2013, J VIROL, V87, P13035, DOI 10.1128/JVI.01826-13; Mitchell AM, 2013, J VIROL, V87, P4571, DOI 10.1128/JVI.03443-12; Monahan PE, 2010, MOL THER, V18, P1907, DOI 10.1038/mt.2010.170; Morgan RA, 2017, CELL STEM CELL, V21, P574, DOI 10.1016/j.stem.2017.10.010; Naldini L, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809958; Nienhuis AW, 2017, MOL THER, V25, P1163, DOI 10.1016/j.ymthe.2017.03.033; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Settharaksa S, 2019, J INTEGR MED-JIM, V17, P351, DOI 10.1016/j.joim.2019.05.003; Smith KA, 2017, REDOX BIOL, V13, P228, DOI 10.1016/j.redox.2017.05.020; Song LJ, 2013, CYTOTHERAPY, V15, P986, DOI 10.1016/j.jcyt.2013.04.003; Song LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058757; Su J, 2015, BIOMATERIALS, V70, P84, DOI 10.1016/j.biomaterials.2015.08.004; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang LN, 2014, J INTEGR MED-JIM, V12, P20, DOI 10.1016/S2095-4964(14)60003-0; Wang RB, 2012, EXPERT OPIN THER PAT, V22, P977, DOI 10.1517/13543776.2012.709237; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Wheeler MD, 2000, HEPATOLOGY, V32, P1050, DOI 10.1053/jhep.2000.19339; Zhang FL, 2011, GENE THER, V18, P128, DOI 10.1038/gt.2010.120; Zheng QY, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100920; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	38	2	2	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12379	12391		10.1096/fj.201902875R	http://dx.doi.org/10.1096/fj.201902875R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32960474				2022-12-28	WOS:000556424300001
J	Kotthoff, M; Bauer, J; Haag, F; Krautwurst, D				Kotthoff, Matthias; Bauer, Julia; Haag, Franziska; Krautwurst, Dietmar			Conserved C-terminal motifs in odorant receptors instruct their cell surface expression and cAMP signaling	FASEB JOURNAL			English	Article						GPCR; helix 8; intracellular transport; luciferase assay; phylogenetic trees	ENDOPLASMIC-RETICULUM RETENTION; KEY FOOD ODORANT; OLFACTORY RECEPTOR; FUNCTIONAL EXPRESSION; INTRACELLULAR RETENTION; HELIX 8; STRUCTURAL DETERMINANTS; BASIC RESIDUES; D1 RECEPTOR; PROTEIN	The highly individual plasma membrane expression and cAMP signaling of odorant receptors have hampered their ligand assignment and functional characterization in test cell systems. Chaperones have been identified to support the cell surface expression of only a portion of odorant receptors, with mechanisms remaining unclear. The presence of amino acid motifs that might be responsible for odorant receptors' individual intracellular retention or cell surface expression, and thus, for cAMP signaling, is under debate: so far, no such protein motifs have been suggested. Here, we demonstrate the existence of highly conserved C-terminal amino acid motifs, which discriminate at least between class-I and class-II odorant receptors, with their numbers of motifs increasing during evolution, by comparing C-terminal protein sequences from 4808 receptors across eight species. Truncation experiments and mutation analysis of C-terminal motifs, largely overlapping with helix 8, revealed single amino acids and their combinations to have differential impact on the cell surface expression and on stimulus-dependent cAMP signaling of odorant receptors in NxG 108CC15 cells. Our results demonstrate class-specific and individual C-terminal motif equipment of odorant receptors, which instruct their functional expression in a test cell system, and in situ may regulate their individual cell surface expression and intracellular cAMP signaling.	[Kotthoff, Matthias] Hamm Lippstadt Univ Appl Sci, Hamm, Germany; [Bauer, Julia; Haag, Franziska; Krautwurst, Dietmar] Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany	Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich	Krautwurst, D (corresponding author), Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany.	d.krautwurst.leibniz-lsb@tum.de		Haag, Franziska/0000-0003-4210-0475				Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bermak JC, 2002, EUR J CELL BIOL, V81, P77, DOI 10.1078/0171-9335-00222; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; Bruno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042023; Bubnell J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141712; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Flensborg M., 2011, CLC MAIN WORKBENCH; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Geithe C., 2015, FLAVOUR SCI, P297; Geithe C, 2017, CELL MOL LIFE SCI, V74, P4209, DOI 10.1007/s00018-017-2576-z; Geithe C, 2017, CHEM SENSES, V42, P181, DOI 10.1093/chemse/bjw117; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Gimelbrant AA, 1999, J NEUROCHEM, V72, P2301, DOI 10.1046/j.1471-4159.1999.0722301.x; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gomez M, 2000, J BIOL CHEM, V275, P29162, DOI 10.1074/jbc.M003630200; Gonzalez-Kristeller DC, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00035; Haag F, 2020, CELL MOL LIFE SCI, V77, P2157, DOI 10.1007/s00018-019-03279-y; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; Hermosilla R, 2001, MOL PHARMACOL, V60, P1031, DOI 10.1124/mol.60.5.1031; HORDE, 2011, HUM OLF REC DAT EXPL; Ikegami K, 2020, P NATL ACAD SCI USA, V117, P2957, DOI 10.1073/pnas.1915520117; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Juhl C, 2012, CELL SIGNAL, V24, P1762, DOI 10.1016/j.cellsig.2012.05.002; Katada S, 2004, J NEUROCHEM, V90, P1453, DOI 10.1111/j.1471-4159.2004.02619.x; Kawasaki T, 2015, FEBS LETT, V589, P1136, DOI 10.1016/j.febslet.2015.03.025; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kling RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067244; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Krautwurst Dietmar, 2013, Methods Mol Biol, V1003, P85, DOI 10.1007/978-1-62703-377-0_6; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Kuwasako K, 2011, PEPTIDES, V32, P144, DOI 10.1016/j.peptides.2010.10.005; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li SJ, 2016, J AM CHEM SOC, V138, P13281, DOI 10.1021/jacs.6b06983; Liu AH, 2003, GENOMICS, V81, P443, DOI 10.1016/S0888-7543(03)00022-3; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Mallouk N, 2002, J MEMBRANE BIOL, V185, P129, DOI 10.1007/s00232-001-0119-9; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; McClintock TS, 2003, NEUROREPORT, V14, P1547, DOI 10.1097/00001756-200308260-00001; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Michelsen K, 2006, TRAFFIC, V7, P903, DOI 10.1111/j.1600-0854.2006.00430.x; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; NCBI, 2011, NAT CTR BIOT INF GEN; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Noe Franziska, 2017, Journal of Biological Methods, V4, pe82, DOI 10.14440/jbm.2017.207; Noe Franziska, 2017, Journal of Biological Methods, V4, pe81, DOI 10.14440/jbm.2017.206; Noe F, 2017, CHEM SENSES, V42, P195, DOI 10.1093/chemse/bjw118; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Okamoto Y, 2013, J BIOL CHEM, V288, P9189, DOI 10.1074/jbc.M112.445817; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park J, 2019, J BIOL CHEM, V294, P4759, DOI 10.1074/jbc.RA118.006173; Peterlin Z, 2014, J GEN PHYSIOL, V143, P527, DOI 10.1085/jgp.201311151; Reisert J, 2010, J GEN PHYSIOL, V136, P529, DOI 10.1085/jgp.201010528; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rodrigues AR, 2017, BBA-MOL CELL RES, V1864, P1217, DOI 10.1016/j.bbamcr.2017.04.004; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Samsonova EV, 2007, PROTEINS, V67, P154, DOI 10.1002/prot.21112; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sato T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111930; Sato-Akuhara N, 2016, J NEUROSCI, V36, P4482, DOI 10.1523/JNEUROSCI.3259-15.2016; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Sester M, 2013, J VIROL, V87, P6104, DOI 10.1128/JVI.03391-12; Sharon D, 2000, GENE, V260, P87, DOI 10.1016/S0378-1119(00)00467-4; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Thielen A, 2005, FEBS LETT, V579, P5227, DOI 10.1016/j.febslet.2005.08.043; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Woo CH, 2015, MOL BIOL CELL, V26, P4280, DOI 10.1091/mbc.E15-06-0361; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Zaarour N, 2012, J BIOL CHEM, V287, P42642, DOI 10.1074/jbc.M112.399162; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang JJ, 2012, MOL CELL NEUROSCI, V51, P79, DOI 10.1016/j.mcn.2012.08.006; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zozulya S, 2001, GENOME BIOL, V2; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	124	2	2	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21274	10.1096/fj.202000182RR	http://dx.doi.org/10.1096/fj.202000182RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33464692				2022-12-28	WOS:000647789600058
J	Li, CZ; Shen, YT; Huang, LW; Liu, CB; Wang, J				Li, Caizhen; Shen, Yanting; Huang, Liuwei; Liu, Chongbin; Wang, Jun			Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence	FASEB JOURNAL			English	Article						acute kidney injury; chronic kidney disease; dasatinib; senescence; senolytics; quercetin	TUBULAR EPITHELIAL-CELLS; DISEASE; PATHOPHYSIOLOGY; STRATEGIES	Acute kidney injury (AKI) is a common clinical problem, and patients who survive AKI have a high risk of chronic kidney disease (CKD). The mechanism of CKD post-AKI, characterized by progressive renal fibrosis, is still unclear. Maladaptive tubular epithelial cells (TECs) after AKI are considered a leading cause of renal fibrosis post-AKI. TECs under maladaptive repair manifest characteristics of senescence. Removing senescent TECs by genetic ablation has been proven effective in reducing renal fibrosis. Senolytics, which eliminate senescent cells by pharmacological intervention, have been studied in a series of degenerative diseases. To our knowledge, the effects of senolytics on renal fibrosis post-AKI have not been verified before. Here, we confirmed renal senescence in the unilateral ischemia/reperfusion injury murine model. Senescent TECs could activate fibroblasts and senolytics specifically induced apoptosis of senescent TECs. Next, we demonstrated that senolytics could reduce renal senescence and ameliorate renal fibrosis in both unilateral renal ischemia/reperfusion injury and multiple-cisplatin-treatment murine models. Our results indicate senescent TECs as a vital factor in renal fibrosis progression, and senolytic therapy might be promising for treating CKD post-AKI.	[Li, Caizhen; Shen, Yanting; Huang, Liuwei; Liu, Chongbin; Wang, Jun] Southern Med Univ, Guangdong Prov Inst Nephrol, State Key Lab Organ Failure Res,Div Nephrol, Natl Clin Res Ctr Kidney Dis,Nanfang Hosp, Guangzhou, Peoples R China	Southern Medical University - China	Wang, J (corresponding author), Nanfang Hosp, Div Nephrol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.	wangjun1975@smu.edu.cn						Andrade L, 2018, CELL TRANSPLANT, V27, P739, DOI 10.1177/0963689717743512; Baisantry A, 2015, J AM SOC NEPHROL, V27, P1; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Cruz FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147005; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DiRocco DP, 2014, AM J PHYSIOL-RENAL, V306, pF379, DOI 10.1152/ajprenal.00475.2013; Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Goligorsky MS, 2020, AM J PATHOL, V190, P1164, DOI 10.1016/j.ajpath.2020.01.016; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366; Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069; Hoste EAJ, 2018, NAT REV NEPHROL, V14, P607, DOI 10.1038/s41581-018-0052-0; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jin H, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125490; Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052; Katagiri D, 2016, KIDNEY INT, V89, P374, DOI 10.1038/ki.2015.327; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim SR, 2020, AM J PHYSIOL-RENAL, V318, pF1167, DOI 10.1152/ajprenal.00535.2019; Kim SR, 2019, TRANSL RES, V213, P112, DOI 10.1016/j.trsl.2019.07.005; Kirkland JL, 2015, EXP GERONTOL, V68, P19, DOI 10.1016/j.exger.2014.10.012; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Le Clef N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152153; Leveque D, 2020, CLIN PHARMACOKINET, V59, P849, DOI 10.1007/s40262-020-00872-4; Li CZ, 2019, FREE RADICAL BIO MED, V130, P512, DOI 10.1016/j.freeradbiomed.2018.11.006; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu J, 2012, TRANSL RES, V159, P454, DOI 10.1016/j.trsl.2011.11.008; Liu T, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118116; Megyesi J, 2001, KIDNEY INT, V60, P2164, DOI 10.1046/j.1523-1755.2001.00044.x; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Ovadya Y, 2018, J CLIN INVEST, V128, P1247, DOI 10.1172/JCI95149; Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950; Qi RC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1157-x; Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Sharp CN, 2018, AM J PHYSIOL-RENAL, V315, pF161, DOI 10.1152/ajprenal.00636.2017; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	48	27	28	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21229	10.1096/fj.202001855RR	http://dx.doi.org/10.1096/fj.202001855RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368613				2022-12-28	WOS:000605626600013
J	Mazzoleni, V; Zimmermann, K; Smirnova, A; Tarassov, I; Prevost, G				Mazzoleni, Viola; Zimmermann, Kiran; Smirnova, Anna; Tarassov, Ivan; Prevost, Gilles			Staphylococcus aureus Panton-Valentine Leukocidin triggers an alternative NETosis process targeting mitochondria	FASEB JOURNAL			English	Article						colocalization; Leukocidin; mitochondria; NETosis; ROS; SK channels	EXTRACELLULAR TRAP FORMATION; GAMMA-HEMOLYSIN; NADPH OXIDASE; HIGH PREVALENCE; C5A RECEPTOR; LEUCOCIDIN; FAMILY; ACTIVATION; TOXIN; CITRULLINATION	Panton-Valentine Leukocidin (PVL) is a bicomponent leukotoxin produced by 3%-10% of clinical Staphylococcus aureus (SA) strains involved in the severity of hospital and community-acquired infections. Although PVL was long known as a pore-forming toxin, recent studies have challenged the formation of a pore at the plasma membrane, while its endocytosis and the exact mode of action remain to be defined. In vitro immunolabeling of human neutrophils shows that Neutrophil Extracellular Traps (NETosis) is triggered by the action of purified PVL, but not by Gamma hemolysin CB (HlgCB), a structurally similar SA leukotoxin. PVL causes the ejection of chromatin fibers (NETs) decorated with antibacterial peptides independently of the NADPH oxidase oxidative burst. Leukotoxin partially colocalizes with mitochondria and enhances the production of reactive oxygen species from these organelles, while showing an increased autophagy, which results unnecessary for NETs ejection. PVL NETosis is elicited through Ca2+-activated SK channels and Myeloperoxidase activity but is abolished by Allopurinol pretreatment of neutrophils. Moreover, massive citrullination of the histone H3 is performed by peptidyl arginine deiminases. Inhibition of this latter enzymes fails to abolish NET extrusion. Unexpectedly, PVL NETosis does not seem to involve Src kinases, which is the main kinase family activated downstream the binding of PVL F subunit to CD45 receptor, while the specific kinase pathway differs from the NADPH oxidase-dependent NETosis. PVL alone causes a different and specific form of NETosis that may rather represent a bacterial strategy conceived to disarm and disrupt the immune response, eventually allowing SA to spread.	[Mazzoleni, Viola; Zimmermann, Kiran; Prevost, Gilles] Univ Strasbourg, Inst Bacteriol, CHRU Strasbourg, ITI InnoVec,Federat Med Translat Strasbourg,UR729, 3 Rue Koeberle, F-67000 Strasbourg, France; [Smirnova, Anna; Tarassov, Ivan] Strasbourg Univ, GMGM, UMR 7156, CNRS, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Prevost, G (corresponding author), Univ Strasbourg, Inst Bacteriol, CHRU Strasbourg, ITI InnoVec,Federat Med Translat Strasbourg,UR729, 3 Rue Koeberle, F-67000 Strasbourg, France.	violamazzoleni1988@gmail.com; prevost@unistra.fr	Mazzoleni, Viola/AGX-5969-2022	Mazzoleni, Viola/0000-0003-2067-3758; Prevost, Gilles/0000-0002-0419-7766; Tarassov, Ivan/0000-0001-8763-6703	Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation (MESRI) [UR7290, UMR7156]; Labex Mitocros, Universite de Strasbourg [UMR7156]	Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation (MESRI); Labex Mitocros, Universite de Strasbourg	Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation (MESRI), Grant/Award Number: UR7290,UMR7156; Labex Mitocros, Universite de Strasbourg, Grant/Award Number: UMR7156	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P3790, DOI 10.1128/JCM.01192-06; Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; Bhattacharya M, 2018, P NATL ACAD SCI USA, V115, P7416, DOI 10.1073/pnas.1721949115; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chessa D, 2015, J INFECT DEV COUNTR, V9, P547, DOI 10.3855/jidc.6923; Cutrona KJ, 2015, FEBS LETT, V589, P3915, DOI 10.1016/j.febslet.2015.11.002; Douda DN, 2014, BLOOD, V123, P597, DOI 10.1182/blood-2013-09-526707; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; FINCKBARBANCON V, 1991, RES MICROBIOL, V142, P75, DOI 10.1016/0923-2508(91)90099-V; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Graves SF, 2012, J LEUKOCYTE BIOL, V92, P361, DOI 10.1189/jlb.1111575; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; ITOH T, 1985, J PHYSIOL-LONDON, V359, P467, DOI 10.1113/jphysiol.1985.sp015597; Jover E, 2013, CELL MICROBIOL, V15, P742, DOI 10.1111/cmi.12069; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; KARWINSKI W, 1993, EUR J SURG, V159, P355; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/eLife.24437, 10.7554/elife.24437]; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03257-z; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41749; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Konig MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00461; Koziel J, 2014, J IMMUNOL, V192, P5363, DOI 10.4049/jimmunol.1303062; Lee WY, 2006, BIOCHEM BIOPH RES CO, V349, P1087, DOI 10.1016/j.bbrc.2006.08.140; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liu XL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20590-z; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Meyer F, 2009, INFECT IMMUN, V77, P266, DOI 10.1128/IAI.00402-08; Miller BF, 1942, SCIENCE, V96, P428, DOI 10.1126/science.96.2497.428; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Nijhuis E, 2002, J LEUKOCYTE BIOL, V71, P115; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Palmer LJ, 2012, CLIN EXP IMMUNOL, V167, P261, DOI 10.1111/j.1365-2249.2011.04518.x; Parker H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00424; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Rebernick R, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0072-y; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rizk A, 2014, NAT PROTOC, V9, P586, DOI 10.1038/nprot.2014.037; Rohrbach AS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00360; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Sohn DH, 2015, ARTHRITIS RHEUMATOL, V67, P2877, DOI 10.1002/art.39283; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Spaan AN, 2015, J IMMUNOL, V195, P1034, DOI 10.4049/jimmunol.1500604; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; SUPERSAC G, 1993, INFECT IMMUN, V61, P580, DOI 10.1128/IAI.61.2.580-587.1993; Tagai C, 2011, PEPTIDES, V32, P2003, DOI 10.1016/j.peptides.2011.09.005; Tawk MY, 2015, CELL MICROBIOL, V17, P1241, DOI 10.1111/cmi.12434; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tromp AT, 2018, NAT MICROBIOL, V3, P708, DOI 10.1038/s41564-018-0159-x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; Vergeade A, 2012, J CARDIOVASC PHARM, V60, P538, DOI 10.1097/FJC.0b013e318271223c; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Werner S, 2002, INFECT IMMUN, V70, P1310, DOI 10.1128/IAI.70.3.1310-1318.2002; Zimmermann-Meisse G, 2017, TOXINS, V9, DOI 10.3390/toxins9010041	72	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.201902981R	http://dx.doi.org/10.1096/fj.201902981R		NOV 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33241563	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000593134300001
J	Wei, ZP; Du, QY; Li, PF; Liu, HC; Xia, MH; Chen, YF; Bi, GY; Tang, ZH; Cheng, X; Lu, YM; He, R; Laurence, A; Wang, J; Huang, L; Li, HB; Yang, XP				Wei, Zhengping; Du, Qiuyang; Li, Pingfei; Liu, Huicheng; Xia, Minghui; Chen, Yufei; Bi, Guoyu; Tang, Zhao-Hui; Cheng, Xiang; Lu, Youming; He, Ran; Laurence, Arian; Wang, Jing; Huang, Liu; Li, Huabin; Yang, Xiang-Ping			Death-associated protein kinase 1 (DAPK1) controls CD8(+) T cell activation, trafficking, and antitumor activity	FASEB JOURNAL			English	Article						Akt; CD8(+) T cells; DAPK1; mTORC1; trafficking	CHEMOKINE RECEPTOR; L-SELECTIN; MIGRATION; MTOR; CCR7; SIGNALS	Appropriate migration of cytotoxic T effector cells into the tumors is crucial for their antitumor function. Despite the controversial role of PI3K-Akt in CD8(+) T cell mTORC1 activation, a link between Akt-mTORC1 signaling and CD8(+) trafficking has been demonstrated. We have recently discovered that TCR-induced calcineurin activates DAPK1, which interacts with TSC2 via its death domain and phosphorylates TSC2 via its kinase domain to mediate mTORC1 activation in CD8(+) T cells. However, whether DAPK1 regulates CD8(+) trafficking into tumors remains unclear. Here, using pharmacological inhibitor and genetic approaches, we found that like rapamycin, inhibition of DAPK1 activity led to enhanced expression of the homing receptors CD62L and CCR7. Deletion of either kinase domain or death domain in the T cell compartment reduced the T cell activation and maintained the expression of CD62L and CCR7. DAPK1-DD-deficient mice were more susceptible to tumor growth and deficiency of DAPK1 activity significantly reduced the migratory ability of CD8(+) into the tumors. These data revealed a crucial role of DAPK1-mTORC1 in mediating CD8(+) trafficking and antitumor function.	[Wei, Zhengping; Du, Qiuyang; Li, Pingfei; Liu, Huicheng; Xia, Minghui; Chen, Yufei; Bi, Guoyu; He, Ran; Wang, Jing; Yang, Xiang-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan, Peoples R China; [Li, Pingfei] Hubei Univ Med, Dept Immunol, Shiyan, Peoples R China; [Tang, Zhao-Hui] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Surg, Wuhan, Peoples R China; [Cheng, Xiang] HUST, Union Hosp, Tongji Med Coll, Inst Cardiol,Lab Cardiovasc Immunol, Wuhan, Peoples R China; [Lu, Youming] Huazhong Univ Sci & Technol, Inst Brain Res, Wuhan, Peoples R China; [Lu, Youming] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Physiol, Wuhan, Peoples R China; [Laurence, Arian] UCL, Hosp NHS Trust, Dept Haematol, London, England; [Huang, Liu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China; [Li, Huabin] Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Huazhong University of Science & Technology; Hubei University of Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of London; University College London; Huazhong University of Science & Technology; Fudan University	Li, HB (corresponding author), Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.; Yang, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Sch, Dept Immunol, Wuhan 430030, Peoples R China.	allergyli@163.com; yangxp@hust.edu.cn	Wu, Jing/GZK-5063-2022; Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022	Yang, Xiang-Ping/0000-0001-9003-1772	National Natural Science Foundation of China (NSFC) [81671539, 31870892, 81725004, 81602104]; Ministry of Science and Technology [81725004, 81602104, 2019YFC1316203]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671539, 31870892, 81725004 and 81602104; Ministry of Science and Technology, Grant/Award Number: 2019YFC1316203, 81725004 and 81602104	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chou TF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11904; Chuang YT, 2008, J IMMUNOL, V180, P3238, DOI 10.4049/jimmunol.180.5.3238; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Galkina E, 2007, EUR J IMMUNOL, V37, P1243, DOI 10.1002/eji.200636481; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hirata T, 2002, J IMMUNOL, V169, P4307, DOI 10.4049/jimmunol.169.8.4307; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Li QS, 2011, IMMUNITY, V34, P541, DOI 10.1016/j.immuni.2011.04.006; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Pei L, 2015, CEREB CORTEX, V25, P4559, DOI 10.1093/cercor/bhv096; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Shu S, 2016, J NEUROSCI, V36, P10843, DOI 10.1523/JNEUROSCI.2258-16.2016; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Wei ZP, 2021, CELL MOL IMMUNOL, V18, P138, DOI 10.1038/s41423-019-0293-2; Weigelin B, 2011, IMMUNOL LETT, V138, P19, DOI 10.1016/j.imlet.2011.02.016; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zou WP, 2018, CELL MOL IMMUNOL, V15, P419, DOI 10.1038/s41423-018-0011-5	33	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.201903067RR	http://dx.doi.org/10.1096/fj.201903067RR		NOV 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33184932				2022-12-28	WOS:000590889200001
J	Curci, L; Brukman, NG; Munoz, MW; Rojo, D; Carvajal, G; Sulzyk, V; Gonzalez, SN; Rubinstein, M; Da Ros, VG; Cuasnicu, PS				Curci, L.; Brukman, N. G.; Weigel Munoz, M.; Rojo, D.; Carvajal, G.; Sulzyk, V.; Gonzalez, S. N.; Rubinstein, M.; Da Ros, V. G.; Cuasnicu, P. S.			Functional redundancy and compensation: Deletion of multiple murineCrispgenes reveals their essential role for male fertility	FASEB JOURNAL			English	Article						development; embryo; fertilization; protein family; sperm	RICH SECRETORY PROTEIN; SPERM-EGG FUSION; EPIDIDYMAL PROTEIN; COMPLEMENTARY SITES; GAMETE FUSION; FERTILIZATION; CRISP; MICE; SPERMATOZOA; MATURATION	Mammalian Cysteine-RIch Secretory Protein (CRISP) family includes four members present in sperm and reported to regulate Ca(2+)channels and fertilization. Based on our previous observations using single knockouts models and suggesting the existence of functional compensation among CRISP proteins, we investigated their relevance for male fertility by generating multipleCrispgene mutants by CRISPR/Cas9 technology. Whereas targeting ofCrisp1andCrisp3yielded subfertile males with early embryo developmental defects, the same deletion in zygotes from fertileCrisp2(-/-).Crisp4(-/-)mice led to the generation of both triple and quadruple knockout mice exhibiting a complete or severe disruption of male fertility due to a combination of sperm transport, fertilization, and embryo developmental defects linked to intracellular Ca(2+)dysregulation. These observations reveal that CRISP proteins are essential for male fertility and organize in functional modules that contribute distinctly to fertility success, bringing insights into the mechanisms underlying functional redundancy/compensation in protein families and emphasizing the importance of generating multiple and not just single knockout which might be masking the true functional relevance of family genes.	[Curci, L.; Brukman, N. G.; Weigel Munoz, M.; Carvajal, G.; Sulzyk, V.; Gonzalez, S. N.; Da Ros, V. G.; Cuasnicu, P. S.] Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina; [Rojo, D.; Rubinstein, M.] Consejo Nacl Invest Cient & Tecn, INGEBI, Inst Invest Ingn Genet & Biol Mol, Buenos Aires, DF, Argentina; [Rubinstein, M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Cuasnicu, PS (corresponding author), Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.	pcuasnicu@gmail.com	Brukman, Nicolas/ABD-4071-2020	Rojo, Daniela/0000-0003-1750-9738; Da Ros, Vanina Gabriela/0000-0003-2367-0042	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2015-149]; MINCyT | Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2015-471]; MINCyT | ANPCyT | Fondo para la Investigacion Cientifica y Tecnologica (FonCyT) [PPL2/08 EBAL]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); MINCyT | Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); MINCyT | ANPCyT | Fondo para la Investigacion Cientifica y Tecnologica (FonCyT)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Grant/Award Number: PIP 2015-149; MINCyT | Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Grant/Award Number: (PICT 2015-471); MINCyT | ANPCyT | Fondo para la Investigacion Cientifica y Tecnologica (FonCyT), Grant/Award Number: PPL2/08 EBAL	Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Brown RL, 1999, P NATL ACAD SCI USA, V96, P754, DOI 10.1073/pnas.96.2.754; Brukman NG, 2016, MOL HUM REPROD, V22, P240, DOI 10.1093/molehr/gaw005; Busso D, 2007, BIOL REPROD, V77, P848, DOI 10.1095/biolreprod.107.061788; Busso D, 2007, BIOL REPROD, V76, P701, DOI 10.1095/biolreprod.106.056770; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; CAMEO MS, 1976, J ENDOCRINOL, V69, P47, DOI 10.1677/joe.0.0690047; Carvajal G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35719-3; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Cohen DJ, 2008, INT J DEV BIOL, V52, P737, DOI 10.1387/ijdb.072538dc; Cohen DJ, 2000, BIOL REPROD, V63, P462, DOI 10.1095/biolreprod63.2.462; Cohen DJ, 2000, MOL REPROD DEV, V56, P180, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;180::AID-MRD9&gt;3.0.CO;2-4; Cohen DJ, 2001, BIOL REPROD, V65, P1000, DOI 10.1095/biolreprod65.4.1000; Conine CC, 2018, DEV CELL, V46, P470, DOI 10.1016/j.devcel.2018.06.024; Da Ros VG, 2008, DEV BIOL, V320, P12, DOI 10.1016/j.ydbio.2008.03.015; Da Ros VG, 2015, ASIAN J ANDROL, V17, P711, DOI 10.4103/1008-682X.155769; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Ellerman DA, 2006, DEV BIOL, V297, P228, DOI 10.1016/j.ydbio.2006.05.013; ERBACH GT, 1994, BIOL REPROD, V50, P1027, DOI 10.1095/biolreprod50.5.1027; Ernesto JI, 2015, J CELL BIOL, V210, P1213, DOI 10.1083/jcb.201412041; Evans J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127480; Fujihara Y, 2019, P NATL ACAD SCI USA, V116, P18498, DOI 10.1073/pnas.1908736116; Fujihara Y, 2018, EXP ANIM TOKYO, V67, P91, DOI 10.1538/expanim.17-0153; Gibbs GM, 2011, P NATL ACAD SCI USA, V108, P7034, DOI 10.1073/pnas.1015935108; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Gomez-Elias MD, 2016, HUM REPROD, V31, P53, DOI 10.1093/humrep/dev287; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Hu JH, 2018, MOL HUM REPROD, V24, P111, DOI 10.1093/molehr/gay001; Hwang JY, 2019, CELL, V177, P1480, DOI 10.1016/j.cell.2019.03.047; Jalkanen J, 2005, BIOL REPROD, V72, P1268, DOI 10.1095/biolreprod.104.035758; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; KOHANE AC, 1980, BIOL REPROD, V23, P737, DOI 10.1095/biolreprod23.4.737; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Krutskikh A, 2012, FASEB J, V26, P4198, DOI 10.1096/fj.12-205211; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim S, 2019, ENDOCRINOLOGY, V160, P915, DOI 10.1210/en.2018-01076; Magdaleno L, 1997, FEBS LETT, V420, P179, DOI 10.1016/S0014-5793(97)01514-7; Maldera JA, 2014, MOL HUM REPROD, V20, P341, DOI 10.1093/molehr/gat092; Mata-Martinez E, 2013, JOVE-J VIS EXP, DOI 10.3791/50344; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; MORRISSETTE J, 1995, BIOPHYS J, V68, P2280, DOI 10.1016/S0006-3495(95)80410-8; Munoz MW, 2018, BIOL REPROD, V99, P373, DOI 10.1093/biolre/ioy048; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Navarrete FA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00262; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; O'Bryan MK, 2001, MOL REPROD DEV, V58, P116, DOI 10.1002/1098-2795(200101)58:1&lt;116::AID-MRD14&gt;3.0.CO;2-8; Okabe M, 2018, BIOL REPROD, V99, P134, DOI 10.1093/biolre/ioy028; Okabe M, 2015, ASIAN J ANDROL, V17, P646, DOI 10.4103/1008-682X.153299; Olesen C, 2001, MOL HUM REPROD, V7, P11, DOI 10.1093/molehr/7.1.11; ORGEBINCRIST MC, 1967, ANN BIOL ANIM BIOCH, V7, P373, DOI 10.1051/rnd:19670403; Paoloni-Giacobino A, 2000, CLIN GENET, V58, P324, DOI 10.1034/j.1399-0004.2000.580411.x; Reddy T, 2008, DEV DYNAM, V237, P3313, DOI 10.1002/dvdy.21738; ROCHWERGER L, 1992, MOL REPROD DEV, V31, P34, DOI 10.1002/mrd.1080310107; ROCHWERGER L, 1992, DEV BIOL, V153, P83, DOI 10.1016/0012-1606(92)90093-V; Sheng J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182345; Toshimori K, 2015, KNOBIL NEILLS PHYSL, V1, P99; Turunen HT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092403; Udby L, 2002, J IMMUNOL METHODS, V263, P43, DOI 10.1016/S0022-1759(02)00033-9; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Munoz MW, 2019, ANDROLOGY-US, V7, P610, DOI 10.1111/andr.12638; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Yamazaki Y, 2002, BIOCHEMISTRY-US, V41, P11331, DOI 10.1021/bi026132h; Yanagimachi R., 1994, P189	68	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15718	15733		10.1096/fj.202001406R	http://dx.doi.org/10.1096/fj.202001406R		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33037689				2022-12-28	WOS:000581163400001
J	Chang, YD; Li, CH; Tsai, CH; Cheng, YW; Kang, JJ; Lee, CC				Chang, Yu-Di; Li, Ching-Hao; Tsai, Chi-Hao; Cheng, Yu-Wen; Kang, Jaw-Jou; Lee, Chen-Chen			Aryl hydrocarbon receptor deficiency enhanced airway inflammation and remodeling in a murine chronic asthma model	FASEB JOURNAL			English	Article						airway remodeling; allergy; aryl hydrocarbon receptor; epithelial-mesenchymal transition	T-CELLS; DIOXIN RECEPTOR; DENDRITIC CELLS; ACTIVATION; EXPRESSION; INDUCTION; GENDER	The aryl hydrocarbon receptor (AhR) is a ligand-dependent-activated transcriptional factor that regulates the metabolism of xenobiotic and endogenous compounds. Recent studies have shown that AhR is a novel master regulator of the mucosal immune system, including lungs and intestine. To elucidate the role of AhR in chronic severe asthma, AhR wild-type and knockout mice (AhR(-/-)) were sensitized and challenged with ovalbumin for 4 weeks. To uncover the underlying mechanisms, inflammatory cells profile and cytokines production were analyzed in bronchial lavage fluid (BALF) and lung tissue. Compared to wild-type mice, AhR(-/-)mice had exacerbated asthma symptoms, including airway inflammation, mucus production, airway hyperresponsiveness, and airway remodeling. BALF monocytes, neutrophils, eosinophils, and lymphocytes were all enhanced in OVA-immunized AhR(-/-)mice. In OVA-immunized AhR(-/-)mice, T helper (Th) 17 cell-specific cytokine IL-17A, as well as airway remodeling factors, including epithelial-mesenchymal transition (EMT) markers and vascular endothelial growth factor (VEGF), were all enhanced in lung tissue. Moreover, human cohort studies showed that AhR gene expression in bronchial epithelial cells decreases in severe asthma patients. Loss of AhR leads to worsening of allergic asthma symptoms, indicating its importance in maintaining normal lung function and mediating disease severity.	[Chang, Yu-Di; Lee, Chen-Chen] China Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan; [Li, Ching-Hao] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan; [Tsai, Chi-Hao; Kang, Jaw-Jou] Natl Yang Min Univ, Sch Pharmaceut Sci, 155,Sect 2,Linong St, Taipei 112, Taiwan; [Cheng, Yu-Wen] Taipei Med Univ, Sch Pharm, Taipei, Taiwan	China Medical University Taiwan; Taipei Medical University; Taipei Medical University	Kang, JJ (corresponding author), Natl Yang Min Univ, Sch Pharmaceut Sci, 155,Sect 2,Linong St, Taipei 112, Taiwan.; Lee, CC (corresponding author), China Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.	jjkang@ym.edu.tw; leechenchen@mail.cmu.edu.tw			China Medical University [CMU108-S-28, CMU108-MF-78, CMU107-S-30, CMU106-S-12]; Ministry of Science, and Technology, Taiwan [MOST 104-2320-B-039-002]; "Drug Development Centre, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	China Medical University(China Medical University); Ministry of Science, and Technology, Taiwan(Ministry of Science and Technology, Taiwan); "Drug Development Centre, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	The work was supported by China Medical University (CMU108-S-28, CMU108-MF-78, CMU107-S-30, and CMU106-S-12), Ministry of Science, and Technology, Taiwan (MOST 104-2320-B-039-002). This work was financially supported by the "Drug Development Centre, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Antczak A, 1997, EUR RESPIR J, V10, P1235, DOI 10.1183/09031936.97.10061235; Bel EH, 2011, THORAX, V66, P910, DOI 10.1136/thx.2010.153643; Bonds RS, 2013, CURR OPIN ALLERGY CL, V13, P92, DOI 10.1097/ACI.0b013e32835a6dd6; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Goettel JA, 2016, CELL REP, V17, P1318, DOI 10.1016/j.celrep.2016.09.082; Goleva E, 2007, J ALLERGY CLIN IMMUN, V120, P1065, DOI 10.1016/j.jaci.2007.07.042; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Haarmann-Stemmann T, 2006, BIOL CHEM, V387, P1195, DOI 10.1515/BC.2006.147; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Jaeger C, 2017, J BIOL RHYTHM, V32, P109, DOI 10.1177/0748730417696786; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kupczyk M, 2012, J INTERN MED, V272, P121, DOI 10.1111/j.1365-2796.2012.02558.x; Laffont S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01069; Larigot Lucie, 2018, Biochim Open, V7, P1, DOI 10.1016/j.biopen.2018.05.001; Lee CC, 2016, CANCER LETT, V376, P211, DOI 10.1016/j.canlet.2016.03.052; Lee CC, 2010, BRIT J PHARMACOL, V161, P1496, DOI 10.1111/j.1476-5381.2010.00972.x; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Modena BD, 2014, AM J RESP CRIT CARE, V190, P1363, DOI 10.1164/rccm.201406-1099OC; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Reddy AT, 2012, JOVE-J VIS EXP, DOI 10.3791/3771; Saleh D, 1998, FASEB J, V12, P929, DOI 10.1096/fasebj.12.11.929; Sathish V, 2015, PHARMACOL THERAPEUT, V150, P94, DOI 10.1016/j.pharmthera.2015.01.007; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Thatcher TH, 2016, IMMUNOLOGY, V147, P41, DOI 10.1111/imm.12540; Voraphani N, 2014, MUCOSAL IMMUNOL, V7, P1175, DOI 10.1038/mi.2014.6; Wang CN, 2019, BRIT J PHARMACOL, V176, P1122, DOI 10.1111/bph.14596; Weng CM, 2018, ALLERGY, V73, P2192, DOI 10.1111/all.13462; Wilson SR, 2013, J PHARMACOL EXP THER, V345, P419, DOI 10.1124/jpet.113.203786; Xu T, 2015, J IMMUNOL, V195, P5539, DOI 10.4049/jimmunol.1501198; Zhang SJ, 2015, TOXICOL APPL PHARM, V286, P92, DOI 10.1016/j.taap.2015.03.023	43	9	9	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15300	15313		10.1096/fj.202001529R	http://dx.doi.org/10.1096/fj.202001529R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959404				2022-12-28	WOS:000573859700001
J	Song, XP; Hu, HL; Zhao, MC; Ma, TW; Gao, L				Song, Xiaopeng; Hu, Hailong; Zhao, Mingchao; Ma, Tianwen; Gao, Li			Prospects of circadian clock in joint cartilage development	FASEB JOURNAL			English	Review						circadian; clock; chondrogenesis; development; pathway	GROWTH-FACTOR 21; PROMOTES OSTEOGENIC DIFFERENTIATION; MESENCHYMAL STEM-CELLS; ORPHAN RECEPTOR-ALPHA; PROTEIN-KINASE-A; REV-ERB-ALPHA; ARTICULAR-CARTILAGE; KNEE-JOINT; GENE-EXPRESSION; SYNOVIAL JOINT	Altering the food intake, exercise, and sleep patterns have a great influence on the homeostasis of the biological clock. This leads to accelerated aging of the articular cartilage, susceptibility to arthropathy and other aspects. Deficiency or overexpression of certain circadian clock-related genes accelerates the cartilage deterioration and leads to phenotypic variation in different joints. The process of joint cartilage development includes the formation of joint site, interzone, joint cavitation, epiphyseal ossification center, and cartilage maturation. The mechanism by which, biological clock regulates the cell-cycle, growth, metabolism, and other biological processes of chondrocytes is poorly understood. Here, we summarized the interaction between biological clock proteins and developmental pathways in chondrogenesis and provided the evidence from other tissues that further predicts the molecular patterns of these protein-protein networks in activation, proliferation, and differentiation. The purpose of this review is to gain deeper understanding of the evolution of cartilage and its irreversibility seen in damage and aging.	[Song, Xiaopeng; Hu, Hailong; Zhao, Mingchao; Ma, Tianwen; Gao, Li] Northeast Agr Univ, Coll Vet Med, Heilongjiang Key Lab Anim & Comparat Med, Harbin 150038, Peoples R China	Northeast Agricultural University - China	Gao, L (corresponding author), Northeast Agr Univ, Coll Vet Med, Heilongjiang Key Lab Anim & Comparat Med, Harbin 150038, Peoples R China.	gaoli43450@163.com		Song, Xiaopeng/0000-0003-4881-3935	National Key Research and Development Program of China [2017YFD0502200]; Applied Technology Research and Development Plan of Heilongjiang, China [GA18B203]	National Key Research and Development Program of China; Applied Technology Research and Development Plan of Heilongjiang, China	The National Key Research and Development Program of China, Grant/Award Number: 2017YFD0502200; Applied Technology Research and Development Plan of Heilongjiang, China, Grant/Award Number: GA18B203	AbuHijleh G, 1997, CLIN ANAT, V10, P183, DOI 10.1002/(SICI)1098-2353(1997)10:3<183::AID-CA4>3.0.CO;2-V; ANDERSEN H, 1961, ACTA ANAT, V46, P279; ANDERSEN H, 1961, AM J ANAT, V108, P111, DOI 10.1002/aja.1001080108; Gorostiza EA, 2013, J NEUROSCI, V33, P687, DOI 10.1523/JNEUROSCI.3448-12.2013; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Bass J, 2013, NAT MED, V19, P1090, DOI 10.1038/nm.3334; Beckwith EJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001733; Berardi S, 2018, MECH DEVELOP, V153, P42, DOI 10.1016/j.mod.2018.08.008; Berenbaum F, 2016, NAT REV RHEUMATOL, V12, P508, DOI 10.1038/nrrheum.2016.93; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bland YS, 1996, ANAT EMBRYOL, V194, P607; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Borjigin J, 1999, J BIOL CHEM, V274, P35012, DOI 10.1074/jbc.274.49.35012; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23; Cai DW, 2018, EUR REV MED PHARMACO, V22, P2572, DOI 10.26355/eurrev_201805_14950; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Carpenter TO, 2010, J CLIN ENDOCR METAB, V95, pE352, DOI 10.1210/jc.2010-0589; Chatterjee S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41059-7; Cheng A, 2016, DIFFERENTIATION, V92, P298, DOI 10.1016/j.diff.2016.03.005; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Chu GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184524; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; CRAIG FM, 1990, J ANAT, V171, P17; Curran KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108266; Curran KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002749; Delezoide AL, 1998, MECH DEVELOP, V77, P19, DOI 10.1016/S0925-4773(98)00133-6; DOLLE P, 1989, EMBO J, V8, P1507, DOI 10.1002/j.1460-2075.1989.tb03535.x; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; Dudek M, 2014, BIOCHEM J, V463, P1, DOI 10.1042/BJ20140700; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Foo JP, 2015, INT J OBESITY, V39, P945, DOI 10.1038/ijo.2014.215; Foo JP, 2013, DIABETES CARE, V36, P935, DOI 10.2337/dc12-0497; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Fu LN, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000201; Fu SQ, 2019, J ENDOCRINOL, V241, P161, DOI 10.1530/JOE-19-0022; Gamer LW, 2018, J BONE MINER RES, V33, P1708, DOI 10.1002/jbmr.3441; GEGOUT P, 1991, LIFE SCI, V49, pPL31, DOI 10.1016/0024-3205(91)90116-S; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Goff DJ, 1997, DEVELOPMENT, V124, P627; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Gossan N, 2015, BIOGERONTOLOGY, V16, P209, DOI 10.1007/s10522-014-9522-3; Green CB, 2001, MECH DEVELOP, V101, P105, DOI 10.1016/S0925-4773(00)00559-1; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He Y, 2015, STEM CELLS DEV, V24, P1194, DOI 10.1089/scd.2014.0437; Hellingman CA, 2010, TISSUE ENG PT A, V16, P545, DOI [10.1089/ten.tea.2008.0551, 10.1089/ten.TEA.2008.0551]; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Hirai T, 2019, BIOCHEM PHARMACOL, V164, P165, DOI 10.1016/j.bcp.2019.04.017; Hirai T, 2019, BIOMED PHARMACOTHER, V109, P503, DOI 10.1016/j.biopha.2018.10.154; Honda KK, 2013, J BIOCHEM, V154, P373, DOI 10.1093/jb/mvt068; Hosaka Y, 2013, P NATL ACAD SCI USA, V110, P1875, DOI 10.1073/pnas.1207458110; Huang ZF, 2020, MOL MED REP, V21, P1590, DOI 10.3892/mmr.2020.10954; Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010; Iimura T, 2012, J BONE MINER METAB, V30, P254, DOI 10.1007/s00774-011-0295-3; Ito MM, 2000, J ANAT, V197, P659, DOI 10.1046/j.1469-7580.2000.19740659.x; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Joeng KS, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.4; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawai M, 2014, J BIOL CHEM, V289, P1457, DOI 10.1074/jbc.M113.500850; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Kremsdorf RA, 2013, J CLIN ENDOCR METAB, V98, P1207, DOI 10.1210/jc.2012-2910; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurio N, 2018, MATRIX BIOL, V67, P15, DOI 10.1016/j.matbio.2018.02.011; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Lecarpentier Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01248; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; Lee P, 2013, J CLIN ENDOCR METAB, V98, pE98, DOI 10.1210/jc.2012-3107; Li ZX, 2007, BIOCHEM BIOPH RES CO, V359, P491, DOI 10.1016/j.bbrc.2007.05.156; Lin FW, 2013, CELL BIOCHEM FUNCT, V31, P166, DOI 10.1002/cbf.2871; Liu SL, 2017, CANCER LETT, V402, P117, DOI 10.1016/j.canlet.2017.05.022; Liu ZY, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3792; Loughlin J, 2011, BRIT J SPORT MED, V45, P278, DOI 10.1136/bjsm.2010.081059; Luo XT, 2018, J CRANIO MAXILL SURG, V46, P1132, DOI 10.1016/j.jcms.2018.04.026; Mahjoub M, 2012, TISSUE CELL, V44, P182, DOI 10.1016/j.tice.2012.03.001; Mao GP, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1004-0; Marbach-Breitruck E, 2019, J HEPATOL, V70, P1192, DOI 10.1016/j.jhep.2019.01.022; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Matsu-ura T, 2016, MOL CELL, V64, P900, DOI 10.1016/j.molcel.2016.10.015; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; MeridaVelasco JA, 1997, ANAT REC, V248, P259, DOI 10.1002/(SICI)1097-0185(199706)248:2<259::AID-AR13>3.0.CO;2-O; MeridaVelasco JA, 1997, ANAT REC, V248, P269, DOI 10.1002/(SICI)1097-0185(199706)248:2<269::AID-AR14>3.0.CO;2-N; Miller AV, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00011; MITROVIC D, 1978, AM J ANAT, V151, P475, DOI 10.1002/aja.1001510403; Miyamoto S, 2010, PATHOBIOLOGY, V77, P28, DOI 10.1159/000272952; Morris JL, 2019, SEMIN ARTHRITIS RHEU, V49, P331, DOI 10.1016/j.semarthrit.2019.03.008; Nam D, 2015, J CELL SCI, V128, P1835, DOI 10.1242/jcs.167643; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Ollitrault D, 2015, TISSUE ENG PART C-ME, V21, P133, DOI [10.1089/ten.TEC.2013.0724, 10.1089/ten.tec.2013.0724]; Ornitz DM, 2017, DEV DYNAM, V246, P291, DOI 10.1002/dvdy.24479; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Parasram K, 2018, STEM CELL REP, V11, P1287, DOI 10.1016/j.stemcr.2018.10.010; Park SC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071684; Pitsillides AA, 2008, DEV DYNAM, V237, P2284, DOI 10.1002/dvdy.21654; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Pruksakorn Dumnoensun, 2015, Journal of the Medical Association of Thailand, V98, P45; Reddi AH, 2003, ANN RHEUM DIS, V62, P73; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Rudnicki JA, 1997, DEV BIOL, V185, P104, DOI 10.1006/dbio.1997.8536; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Samsa WE, 2017, SEMIN CELL DEV BIOL, V62, P3, DOI 10.1016/j.semcdb.2016.07.008; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Sotak M, 2014, ANN MED, V46, P221, DOI 10.3109/07853890.2014.892296; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Su Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001747; Sun SW, 2018, BIOCHEM BIOPH RES CO, V506, P746, DOI 10.1016/j.bbrc.2018.10.134; Suzuki M, 2002, MECH DEVELOP, V118, P241, DOI 10.1016/S0925-4773(02)00257-5; Swanson C, 2017, OSTEOPOROSIS INT, V28, P3205, DOI 10.1007/s00198-017-4162-5; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takarada T, 2012, J BIOL CHEM, V287, P36081, DOI 10.1074/jbc.M112.408963; Tan HY, 2018, J CELL BIOCHEM, V119, P7218, DOI 10.1002/jcb.26888; Tasaki H, 2015, AM J PHYSIOL-CELL PH, V308, pC528, DOI 10.1152/ajpcell.00220.2014; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Tsukamoto-Yamauchi N, 2015, BIOCHEM BIOPH RES CO, V459, P172, DOI 10.1016/j.bbrc.2015.02.100; Usami Y, 2016, LAB INVEST, V96, P186, DOI 10.1038/labinvest.2015.142; Vallee A, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1320-y; Vallee A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070726; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Woronowicz KC, 2018, DEV BIOL, V444, pS219, DOI 10.1016/j.ydbio.2018.05.002; Xiong YP, 2019, ONCOTARGETS THER, V12, P993, DOI 10.2147/OTT.S193024; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang N, 2016, J BIOL RHYTHM, V31, P415, DOI 10.1177/0748730416662748; Yang XM, 2009, J BIOCHEM, V145, P289, DOI 10.1093/jb/mvn167; Yang Y, 1997, DEVELOPMENT, V124, P4393; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Yeung CYC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05183; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Yu SL, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12727; Zhang F, 2017, ONCOL RES, V25, P709, DOI 10.3727/096504016X14772331883976; Zhang L, 2006, DEV BIOL, V299, P221, DOI 10.1016/j.ydbio.2006.07.025; Zhang YK, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.152; Zhou L, 2018, LIFE SCI, V212, P129, DOI 10.1016/j.lfs.2018.09.053; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820; Zhu MJ, 2018, AM J TRANSL RES, V10, P3150; Zhu Z, 2016, IUBMB LIFE, V68, P557, DOI 10.1002/iub.1512	162	2	4	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14120	14135		10.1096/fj.202001597R	http://dx.doi.org/10.1096/fj.202001597R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32946614				2022-12-28	WOS:000572341900001
J	Norris, JM; Simpson, BS; Freeman, A; Kirkham, A; Whitaker, HC; Emberton, M				Norris, Joseph M.; Simpson, Benjamin S.; Freeman, Alex; Kirkham, Alex; Whitaker, Hayley C.; Emberton, Mark			Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis	FASEB JOURNAL			English	Article						conspicuity theory; multiparametric MRI; prostate cancer	PREDICTING BIOCHEMICAL RECURRENCE; MULTI-PARAMETRIC MRI; RADICAL PROSTATECTOMY; TUMOR ANGIOGENESIS; PROGRESSION; ANTIGEN; BIOPSY; EXPRESSION; RISK; ASSOCIATION	Pre-biopsy multiparametric magnetic resonance imaging (mpMRI) has transformed the risk stratification and diagnostic approach for suspected prostate cancer. The majority of clinically significant prostate cancers are visible on pre-biopsy mpMRI, however, there are a subset of significant tumors that are not detected by mpMRI. The radiobiological mechanisms underpinning mpMRI-visibility and invisibility of these cancers remain uncertain. Emerging evidence suggests that mpMRI-visible tumors are enriched with molecular features associated with increased disease aggressivity and poor clinical prognosis, which is supported by short-term endpoints, such as biochemical recurrence following surgery. Furthermore, at the histopathological level, mpMRI-visible tumors appear to exhibit increased architectural and vascular density compared to mpMRI-invisible disease. It seems probable that the genomic, pathological, radiological, and clinical features of mpMRI-visible and mpMRI-invisible prostate cancers are interrelated. Here, we propose a novel cross-disciplinary theory that links genomic and molecular evidence with cellular and histopathological appearances, elucidating both the mpMRI visibility and clinical status of significant prostate cancer.	[Norris, Joseph M.; Simpson, Benjamin S.; Whitaker, Hayley C.; Emberton, Mark] UCL, UCL Div Surg & Intervent Sci, 3rd Floor,Charles Bell House,43-45 Foley St, London W1W 7TS, England; [Norris, Joseph M.; Emberton, Mark] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England; [Freeman, Alex] Univ Coll London Hosp NHS Fdn Trust, Dept Pathol, London, England; [Kirkham, Alex] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Norris, JM (corresponding author), UCL, UCL Div Surg & Intervent Sci, 3rd Floor,Charles Bell House,43-45 Foley St, London W1W 7TS, England.	joseph.norris@ucl.ac.uk			Medical Research Council (MRC) [MR/S00680X/1]; Rosetrees Trust; MRC [MR/S00680X/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Joseph M. Norris is funded by the Medical Research Council (MRC) (Grant Reference: MR/S00680X/1). Benjamin S. Simpson is funded by the Rosetrees Trust	Adamis S, 2014, EJSO-EUR J SURG ONC, V40, P496, DOI 10.1016/j.ejso.2014.02.221; Ahdoot M, 2020, NEW ENGL J MED, V382, P917, DOI 10.1056/NEJMoa1910038; Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Amin A, 2020, J UROLOGY, V203, P910, DOI 10.1097/JU.0000000000000693; Beksac AT, 2018, J UROLOGY, V200, P1241, DOI 10.1016/j.juro.2018.06.041; Bill-Axelson A, 2018, NEW ENGL J MED, V379, P2319, DOI 10.1056/NEJMoa1807801; Bono AV, 2002, PROSTATE CANCER P D, V5, P123, DOI 10.1038/sj.pcan.4500572; Borren A, 2014, ACTA ONCOL, V53, P88, DOI 10.3109/0284186X.2013.837581; Branca G, 2017, ONCOL REV, V11, DOI 10.4081/oncol.2017.317; Chesnut GT, 2020, EUR UROL, V77, P501, DOI 10.1016/j.eururo.2019.12.009; Coffey N, 2015, J MAGN RESON IMAGING, V41, P1639, DOI 10.1002/jmri.24694; Dasgupta P, 2019, BJU INT, V124, P1, DOI 10.1111/bju.14815; De Jaeger K, 1998, INT J RADIAT ONCOL, V42, P717, DOI 10.1016/S0360-3016(98)00323-X; Downes MR, 2016, ACAD RADIOL, V23, P1412, DOI 10.1016/j.acra.2016.07.013; Drost FJH, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012663.pub2; Dulaney CR, 2017, ONCOTARGET, V8, P68038, DOI 10.18632/oncotarget.19145; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattori S, 2014, BJU INT, V113, P741, DOI 10.1111/bju.12329; Hong MKH, 2011, PATHOLOGY, V43, P138, DOI 10.1097/PAT.0b013e3283420155; Houlahan KE, 2019, EUR UROL, V76, P18, DOI 10.1016/j.eururo.2018.12.036; Hricak H, 2003, SEMIN ONCOL, V30, P616, DOI 10.1016/S0093-7754(03)00359-2; Jambor I, 2020, J MAGN RESON IMAGING, V51, P1075, DOI 10.1002/jmri.26928; Johnson DC, 2019, EUR UROL, V75, P712, DOI 10.1016/j.eururo.2018.11.031; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Kesch C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35058-3; Kweldam CF, 2018, TRANSL ANDROL UROL, V7, P145, DOI 10.21037/tau.2017.12.33; Laufer M, 2000, UROLOGY, V55, P309, DOI 10.1016/S0090-4295(99)00465-3; Lavallee LT, 2011, CUAJ-CAN UROL ASSOC, V5, P397, DOI 10.5489/cuaj.11061; Lee JJ, 2015, PROSTATE, V75, P183, DOI 10.1002/pros.22903; Lenkinski RE, 2008, MAGN RESON MATER PHY, V21, P411, DOI 10.1007/s10334-008-0133-3; Li P, 2018, THERANOSTICS, V8, P1752, DOI 10.7150/thno.23180; Li ZP, 2005, WORLD J GASTROENTERO, V11, P1287, DOI 10.3748/wjg.v11.i9.1287; McCann SM, 2016, AM J ROENTGENOL, V206, P559, DOI 10.2214/AJR.15.14967; Melegh Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112676; Meng AX, 2005, RADIOTHER ONCOL, V76, P168, DOI 10.1016/j.radonc.2005.06.025; Ming M, 2012, CANCER LETT, V319, P125, DOI 10.1016/j.canlet.2012.01.003; Miyai K, 2019, MODERN PATHOL, V32, P1536, DOI 10.1038/s41379-019-0292-y; Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8; Norris J, 2020, NPJ CLIM ATMOS SCI, V3, DOI 10.1038/s41612-019-0105-5; Norris JM, 2019, EUR J SURG ONCOL, V45, P2203; Norris JM, 2020, EUR UROL, V78, P163, DOI 10.1016/j.eururo.2020.04.029; Norris JM, 2020, BJU INT, V126, P237, DOI 10.1111/bju.15085; Norris JM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034611; Norris JM, 2020, BJU INT, V125, P340, DOI 10.1111/bju.14919; Park JJ, 2014, AM J ROENTGENOL, V202, pW459, DOI 10.2214/AJR.13.11381; Parry MA, 2019, EUR UROL ONCOL, V2, P1, DOI 10.1016/j.euo.2018.08.005; Petit JH, 2006, CANCER-AM CANCER SOC, V107, P2180, DOI 10.1002/cncr.22243; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Preda A, 2004, J MAGN RESON IMAGING, V20, P865, DOI 10.1002/jmri.20184; Radtke JP, 2015, J UROLOGY, V193, P87, DOI 10.1016/j.juro.2014.07.098; Schieda N, 2014, EUR RADIOL, V24, P1349, DOI 10.1007/s00330-014-3150-9; Shikanov S, 2012, PROSTATE CANCER P D, V15, P106, DOI 10.1038/pcan.2011.55; Stavrinides V, 2020, EUR UROL, V78, P443, DOI 10.1016/j.eururo.2020.03.035; Sun Y, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190373; Switlyk MD, 2019, AM J ROENTGENOL, V212, P1206, DOI 10.2214/AJR.18.20743; Tom MC, 2019, J UROLOGY, V202, P710, DOI 10.1097/JU.0000000000000316; Tonttila PP, 2019, BJU INT, V124, P992, DOI 10.1111/bju.14812; Truong M, 2018, J UROLOGY, V199, P106, DOI 10.1016/j.juro.2017.07.037; Turkbey B, 2009, AM J ROENTGENOL, V193, P304, DOI 10.2214/AJR.09.2869; van Houdt PJ, 2020, J MAGN RESON IMAGING, V51, P1235, DOI 10.1002/jmri.26933; WISE J, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K5290; Yang LJ, 2018, EBIOMEDICINE, V31, P182, DOI 10.1016/j.ebiom.2018.04.019	65	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14150	14159		10.1096/fj.202001466R	http://dx.doi.org/10.1096/fj.202001466R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32920937	Green Published			2022-12-28	WOS:000570733200001
J	Reynolds, WJ; Hanson, PS; Critchley, A; Griffiths, B; Chavan, B; Birch-Machin, MA				Reynolds, Wil J.; Hanson, Peter S.; Critchley, Adam; Griffiths, Ben; Chavan, Bhaven; Birch-Machin, Mark A.			Exposing human primary dermal fibroblasts to particulate matter induces changes associated with skin aging	FASEB JOURNAL			English	Article						aging; oxidative stress; pollution	ARYL-HYDROCARBON RECEPTOR; URBAN AIR-POLLUTION; EXPOSURE; CANCER; RISK; PROLIFERATION; ULTRAVIOLET; EXPRESSION; DISEASES; LUNG	With a large proportion of the world's population living in areas where air quality does not meet current WHO guidelines, combined with the knowledge that pollutants can interact with human skin, it is now of even greater importance that the effects of air pollutant exposure on human skin be investigated. To evaluate the damaging effects of a known component of air pollution (particulate matter) on human primary dermal fibroblasts. These studies were undertaken by exposing primary human dermal fibroblasts to different concentrations of particulate matter and analyzing the effects over time using resazurin reduction assays. Immunofluorescence microscopy was used to determine if particulate matter caused activation of the aryl hydrocarbon receptor, and phosphorylation of histone H2AX, a known marker of double-strand DNA breaks. Dot blotting was also used to analyze expression changes in secreted MMP-1, MMP-3, and TGF beta. Particulate matter was found to dose-dependently increase cellular viability, activate the aryl hydrocarbon receptor, increase double-strand DNA breaks, and increase the expression of MMP-1, MMP-3, and TGF beta. With the potential of air pollutants such as particulate matter to not only modulate the expression of proteins implicated in skin aging, but also affect cells at a genetic level, brings a pressing need for further investigation so protective strategies can be implemented.	[Reynolds, Wil J.; Birch-Machin, Mark A.] Newcastle Univ, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hanson, Peter S.] Newcastle Univ, Translat & Clin Res Inst, Campus Ageing & Vitality, Newcastle Upon Tyne, Tyne & Wear, England; [Critchley, Adam; Griffiths, Ben] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Chavan, Bhaven] Croda Europe Ltd, Snaith, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Birch-Machin, MA (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mark.birch-machin@ncl.ac.uk		Griffiths, Ben/0000-0002-8745-1861	UK Research and Innovation/Biotechnology and Biological Sciences Research Council; BBSRC [2314361] Funding Source: UKRI	UK Research and Innovation/Biotechnology and Biological Sciences Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	UK Research and Innovation/Biotechnology and Biological Sciences Research Council	Afaq F, 2009, J INVEST DERMATOL, V129, P2396, DOI 10.1038/jid.2009.85; Beelen R, 2008, EPIDEMIOLOGY, V19, P702, DOI 10.1097/EDE.0b013e318181b3ca; Bonnier F, 2015, TOXICOL IN VITRO, V29, P124, DOI 10.1016/j.tiv.2014.09.014; Campaner AB, 2006, J INVEST DERMATOL, V126, P1168, DOI 10.1038/sj.jid.5700200; Castano-Vinyals G, 2008, OCCUP ENVIRON MED, V65, P56, DOI 10.1136/oem.2007.034348; Chen X, 2012, TISSUE ENG PT A, V18, P2528, DOI [10.1089/ten.tea.2012.0094, 10.1089/ten.TEA.2012.0094]; Codriansky KA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1356, DOI 10.1111/j.1751-1097.2009.00592.x; de Jesus RM, 2018, J BRAZIL CHEM SOC, V29, P1268, DOI 10.21577/0103-5053.20170223; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; Forecast MD, 2018, ORBIS RES, V1, P178; Hudson L, 2020, FASEB J, V34, P3874, DOI 10.1096/fj.201902351RR; Jin SP, 2018, J DERMATOL SCI, V91, P175, DOI 10.1016/j.jdermsci.2018.04.015; KADUNCE DP, 1991, ANN INTERN MED, V114, P840, DOI 10.7326/0003-4819-114-10-840; Kim KE, 2016, LIFE SCI, V152, P126, DOI 10.1016/j.lfs.2016.03.039; Koohgoli R, 2017, EXP DERMATOL, V26, P384, DOI 10.1111/exd.13257; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; Lademann J, 2005, J INVEST DERM SYMP P, V10, P301, DOI 10.1111/j.1087-0024.2005.10121.x; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Ngoc LTN, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121458; Lee S, 2015, CHEMOSPHERE, V139, P23, DOI 10.1016/j.chemosphere.2015.05.033; Magnani ND, 2016, TOXICOL SCI, V149, P227, DOI 10.1093/toxsci/kfv230; Mancebo SE, 2015, J EUR ACAD DERMATOL, V29, P2326, DOI 10.1111/jdv.13250; MENICHINI E, 1992, SCI TOTAL ENVIRON, V116, P109, DOI 10.1016/0048-9697(92)90368-3; Ono Y, 2013, EXP DERMATOL, V22, P349, DOI 10.1111/exd.12148; Phalen Robert F, 2004, Nonlinearity Biol Toxicol Med, V2, P259, DOI 10.1080/15401420490900245; Piao MJ, 2015, BIOMOL THER, V23, P557, DOI 10.4062/biomolther.2015.054; Pittayapruek P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060868; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Quan, 2016, COSMETICS, V3, P28, DOI [10.3390/cosmetics3030028, DOI 10.3390/COSMETICS3030028]; Rosso James Del, 2016, J Clin Aesthet Dermatol, V9, pS2; Ruchirawat M, 2007, TOXICOL LETT, V168, P200, DOI 10.1016/j.toxlet.2006.09.013; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Sighom JRN, 2017, FUTURE INTERNET, V9, DOI 10.3390/fi9030023; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Takai S, 2003, J PHARMACOL EXP THER, V305, P17, DOI 10.1124/jpet.102.045179; Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004; Valacchi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131097; Vierkotter A, 2010, J INVEST DERMATOL, V130, P2719, DOI 10.1038/jid.2010.204; World Health Organization, 2018, AMB AIR POLL GLOB AS, P131; Xu QF, 2016, CHINESE MED J-PEKING, V129, P2853, DOI 10.4103/0366-6999.194654; Zorin V, 2019, AGING-US, V11, P4536, DOI 10.18632/aging.102067	41	7	7	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14725	14735		10.1096/fj.202001357R	http://dx.doi.org/10.1096/fj.202001357R		SEP 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32915475	hybrid, Green Published			2022-12-28	WOS:000570521700001
J	Koutsogiannaki, S; Bu, WM; Hou, LF; Shibamura-Fujiogi, M; Ishida, H; Ohto, U; Eckenhoff, RG; Yuki, K				Koutsogiannaki, Sophia; Bu, Weiming; Hou, Lifei; Shibamura-Fujiogi, Miho; Ishida, Hanako; Ohto, Umeharu; Eckenhoff, Roderic G.; Yuki, Koichi			The effect of anesthetics on toll like receptor 9	FASEB JOURNAL			English	Article						electrostatic potential; nucleic acid; toll-like receptor; volatile anesthetics	MITOCHONDRIAL-DNA; VOLATILE ANESTHETICS; BINDING-SITE; HUMAN TLR9; ISOFLURANE; CPG; RECOGNITION; SEVOFLURANE; INFLAMMATION; SELECTIVITY	Toll like receptors (TLRs) are critical receptors to respond to danger signals, and their functions are relevant in the perioperative period. We previously reported that volatile anesthetics directly bound to TLR2 and TLR4 and attenuated their functions. Given that TLR9 can respond to mitochondrial DNA, a danger signal that is released upon tissue injury, we examined the role of anesthetics on TLR9 function. Our reporter assay showed that volatile anesthetics isoflurane and sevoflurane increased the activation of TLR9, while propofol attenuated it. TLR9 activation occurs via its dimerization. The dimerization is facilitated by unmethylated cytosine-phosphate-guanine (CpG) DNA as well as DNA containing cytosine at the second position from 5 '-end (5 '-xCx DNA). Our structural analysis using photoactivable anesthetics and rigid docking simulation showed that isoflurane and sevoflurane bound to both TLR9 dimer interface and 5 '-xCx DNA binding site. Propofol bound to the TLR9 antagonist binding site. This is the first illustration that anesthetics can affect the binding of nucleic acids to their receptor. This study sets the foundation for the effect of anesthetics on TLR9 and will pave the way for future studies to determine the significance of such interactions in the clinical setting.	[Koutsogiannaki, Sophia; Hou, Lifei; Shibamura-Fujiogi, Miho; Yuki, Koichi] Boston Childrens Hosp, Cardiac Anesthesia Div, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA; [Koutsogiannaki, Sophia; Hou, Lifei; Shibamura-Fujiogi, Miho; Yuki, Koichi] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; [Koutsogiannaki, Sophia; Hou, Lifei; Shibamura-Fujiogi, Miho; Yuki, Koichi] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; [Ishida, Hanako; Ohto, Umeharu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; University of Tokyo	Yuki, K (corresponding author), Boston Childrens Hosp, Cardiac Anesthesia Div, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu			HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM118277, GM127600]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM118277 and GM127600	Bao WDN, 2016, SCI REP-UK, V6, DOI 10.1038/srep22579; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Carbo C, 2013, J ANESTH, V27, P261, DOI 10.1007/s00540-012-1508-1; Carty M, 2010, CLIN EXP IMMUNOL, V161, P397, DOI 10.1111/j.1365-2249.2010.04196.x; El-Sayed OM, 2016, J VASC SURG, V64, P1450, DOI 10.1016/j.jvs.2015.08.070; Eppensteiner J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127925; Gan L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/587378; Golovkin AS, 2013, ISRN INFLAMM, V2013, P817901, DOI 10.1155/2013/817901; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Ishida H, 2018, FEBS LETT, V592, P2636, DOI 10.1002/1873-3468.13176; Koutsogiannaki S, 2019, FASEB J, V33, P12668, DOI 10.1096/fj.201901360R; Koutsogiannaki S, 2019, J SURG RES, V233, P323, DOI 10.1016/j.jss.2018.07.075; Koutsogiannaki S, 2017, TOXICOL SCI, V156, P402, DOI 10.1093/toxsci/kfw261; Liu JR, 2014, SHOCK, V42, P532, DOI 10.1097/SHK.0000000000000250; Liu RY, 2005, ANESTHESIOLOGY, V102, P799, DOI 10.1097/00000542-200504000-00016; Mitsui Y, 2020, ANESTH ANALG, V131, P631, DOI 10.1213/ANE.0000000000004741; Ohto U, 2018, IMMUNITY, V48, P649, DOI 10.1016/j.immuni.2018.03.013; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Okuno T, 2019, FASEB J, V33, P14528, DOI 10.1096/fj.201901570R; Okuno T, 2017, FASEB J, V31, P1584, DOI 10.1096/fj.201601095R; Pohar J, 2017, J IMMUNOL, V198, P2093, DOI 10.4049/jimmunol.1600757; Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d; Romics L, 2006, ARCH SURG-CHICAGO, V141, P595, DOI 10.1001/archsurg.141.6.595; Sandler N, 2018, HEART LUNG CIRC, V27, P122, DOI 10.1016/j.hlc.2017.02.014; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Tazawa K, 2017, TOXICOL LETT, V266, P23, DOI 10.1016/j.toxlet.2016.12.007; Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3; Yuki Koichi, 2017, Transl Perioper Pain Med, V2, P1; Yuki K, 2016, ANESTH ANALG, V123, P326, DOI 10.1213/ANE.0000000000001403; Yuki K, 2013, ANESTH ANALG, V117, P803, DOI 10.1213/ANE.0b013e3182a00ae0; Yuki K, 2012, FASEB J, V26, P4408, DOI 10.1096/fj.12-212746; Yuki K, 2010, ANESTHESIOLOGY, V113, P600, DOI 10.1097/ALN.0b013e3181e89a77; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zha H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216163; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650	41	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14645	14654		10.1096/fj.202000791RR	http://dx.doi.org/10.1096/fj.202000791RR		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901993	Green Accepted			2022-12-28	WOS:000568304500001
J	Tanaka, M; Sugimoto, K; Fujimoto, T; Xie, KY; Takahashi, T; Akasaka, H; Yasunobe, Y; Takeya, Y; Yamamoto, K; Hirabayashi, T; Fujino, H; Rakugi, H				Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Yasunobe, Yukiko; Takeya, Yasushi; Yamamoto, Koichi; Hirabayashi, Takumi; Fujino, Hidemi; Rakugi, Hiromi			Differential effects of pre-exercise on cancer cachexia-induced muscle atrophy in fast- and slow-twitch muscles	FASEB JOURNAL			English	Article						cancer cachexia; muscle atrophy; pre-exercise; protein degradation; protein synthesis	SKELETAL-MUSCLE; CAPILLARY REGRESSION; TNF-ALPHA; PHYSICAL-ACTIVITY; EXERCISE; EXPRESSION; PROTEIN; BEARING; OXYGEN; HYPOXIA	We hypothesized that pre-exercise may effectively prevent cancer cachexia-induced muscle atrophy in both fast- and slow-twitch muscle types. Additionally, the fast-twitch muscle may be more affected by cancer cachexia than slow-twitch muscle. This study aimed to evaluate the effects of pre-exercise on cancer cachexia-induced atrophy and on atrophy in fast- and slow-twitch muscles. Twelve male Wistar rats were randomly divided into sedentary and exercise groups, and another 24 rats were randomly divided into control, pre-exercise, cancer cachexia induced by intraperitoneal injections of ascites hepatoma AH130 cells, and pre-exercise plus cancer cachexia groups. We analyzed changes in muscle mass and in gene and protein expression levels of major regulators and indicators of muscle protein degradation and synthesis pathways, angiogenic factors, and mitochondrial function in both the plantaris and soleus muscles. Pre-exercise inhibited muscle mass loss, rescued protein synthesis, prevented capillary regression, and suppressed hypoxia in the plantaris and soleus muscles. Pre-exercise inhibited mitochondrial dysfunction differently in fast- and slow-twitch muscles. These results suggested that pre-exercise has the potential to inhibit cancer-cachexia-induced muscle atrophy in both fast- and slow-twitch muscles. Furthermore, the different progressions of cancer-cachexia-induced muscle atrophy in fast- and slow-twitch muscles are related to differences in mitochondrial function.	[Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Yasunobe, Yukiko; Takeya, Yasushi; Yamamoto, Koichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Osaka, Japan; [Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Yasunobe, Yukiko; Takeya, Yasushi; Yamamoto, Koichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Gen Med, Osaka, Japan; [Tanaka, Minoru; Hirabayashi, Takumi; Fujino, Hidemi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo, Japan; [Tanaka, Minoru] Osaka Hlth Sci Univ, Dept Rehabil Sci, Osaka, Japan	Osaka University; Osaka University; Kobe University	Sugimoto, K (corresponding author), Osaka Univ, Grad Sch, Dept Geriatr & Gen Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sugimoto@geriat.med.osaka-u.ac.jp		Yamamoto, Koichi/0000-0003-0107-9315; Takahashi, Toshimasa/0000-0002-5203-155X	JSPS KAKENHI [16K21517, 18H03130]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We appreciate the grant from Grants-in-Aid for Scientific Research (JSPS KAKENHI, grant numbers 16K21517 and 18H03130).	Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5; Baldwin KM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00284; Ballaro R, 2019, CANCERS, V11, DOI 10.3390/cancers11030285; Blomstrand E, 2011, PFLUG ARCH EUR J PHY, V462, P257, DOI 10.1007/s00424-011-0978-6; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Carbo N, 2002, BRIT J CANCER, V86, P1012, DOI 10.1038/sj.bjc.6600167; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Devine RD, 2017, AM J PHYSIOL-HEART C, V312, pH1154, DOI 10.1152/ajpheart.00090.2016; Dun YL, 2015, FOOD FUNCT, V6, P3056, DOI 10.1039/c5fo00533g; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fernandez-Celemin L, 2002, AM J PHYSIOL-ENDOC M, V283, pE1279, DOI 10.1152/ajpendo.00054.2002; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; HANSENSMITH FM, 1992, J APPL PHYSIOL, V73, P776, DOI 10.1152/jappl.1992.73.2.776; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Hirayama Y, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12356; Hirayama Y, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13134; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Hudlicka O, 2011, MLTJ-MUSCLE LIGAMENT, V1, P3; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kim SJ, 1985, J APPL PHYSIOL, V105, P1246; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Kondo H, 2015, MUSCLE NERVE, V51, P391, DOI 10.1002/mus.24316; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lee DH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020431; Lejay A, 2014, INT J BIOCHEM CELL B, V50, P101, DOI 10.1016/j.biocel.2014.02.013; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Llovera M, 1998, MOL CELL ENDOCRINOL, V142, P183, DOI 10.1016/S0303-7207(98)00105-1; Lloyd PG, 2003, AM J PHYSIOL-HEART C, V284, pH1668, DOI 10.1152/ajpheart.00743.2002; Malek MH, 2010, EXP PHYSIOL, V95, P359, DOI 10.1113/expphysiol.2009.050369; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Matsumoto T, 2019, J PHYSIOL SCI, V69, P317, DOI 10.1007/s12576-018-0648-y; Mijwel S, 2018, FASEB J, V32, P5495, DOI 10.1096/fj.201700968R; Milne KJ, 1985, J APPL PHYSIOL, V2002, P561; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Olfert IM, 2016, MICROCIRCULATION, V23, P146, DOI 10.1111/micc.12263; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Park S, 2008, LIFE SCI, V82, P503, DOI 10.1016/j.lfs.2007.12.018; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; Poole David C., 1996, Microcirculation (Philadelphia), V3, P175, DOI 10.3109/10739689609148286; Pottecher J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00579; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Powers SK, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101462; Ramos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131766; Squires RW, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0681-2; SRERE PA, 1963, BIOCHIM BIOPHYS ACTA, V73, P523, DOI 10.1016/0926-6569(63)90146-9; Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323; Tanaka M, 2016, J MUSCULOSKEL NEURON, V16, P152; Tanaka M, 2019, FASEB J, V33, P7852, DOI 10.1096/fj.201802430R; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; Tang K, 2010, J CELL PHYSIOL, V222, P320, DOI 10.1002/jcp.21955; TESSITORE L, 1987, BIOCHEM J, V241, P153, DOI 10.1042/bj2410153; Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77; Turner RR, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010192.pub3; Uchida K, 2016, GEN PHYSIOL BIOPHYS, V35, P425, DOI 10.4149/gpb_2016016; Uchida T, 2018, AM J PHYSIOL-CELL PH, V314, pC721, DOI 10.1152/ajpcell.00184.2017; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Vargas-Ortiz K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112717; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; YANG HT, 1995, CIRC RES, V76, P448, DOI 10.1161/01.RES.76.3.448; Zebrowska A, 2018, ADV CLIN EXP MED, V27, P207, DOI 10.17219/acem/66354; Zwaans BMM, 2014, DIS MODEL MECH, V7, P1023, DOI 10.1242/dmm.016287	71	4	4	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14389	14406		10.1096/fj.202001330R	http://dx.doi.org/10.1096/fj.202001330R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892438				2022-12-28	WOS:000568294100001
J	Si, ZZ; Guan, XJ; Teng, XY; Peng, XX; Wan, ZQ; Li, Q; Chen, GS; Tan, JQ; Li, JQ				Si, Zhongzhou; Guan, Xinjie; Teng, Xiangyun; Peng, Xiaoxia; Wan, Zhengqin; Li, Qiang; Chen, Guangshun; Tan, Jieqiong; Li, Jiequn			Identification of CYP46A1 as a new regulator of lipid metabolism through CRISPR-based whole-genome screening	FASEB JOURNAL			English	Article						genome-scale CRISPR-Cas9 knockout; lipid droplet; nonalcoholic fatty liver disease; transcriptomics	FATTY LIVER-DISEASE; NEGATIVE REGULATOR; DROPLET FORMATION; CELL-LINE; TRANSCRIPTOME; ACCUMULATION; ASSOCIATION; HOMEOSTASIS; STEATOSIS; G6PC2	Abnormal lipid droplet (LD) metabolism causes a variety of disorders, especially to nonalcoholic fatty liver disease (NAFLD). But the mechanism of abnormal aggregation of LD is still not fully elucidated. Here, Genome-wide CRISPR-Cas9 knockout (GeCKO) screening was employed to identify candidate genes regulating LD metabolism in L02 cell. We analyzed simultaneously the transcriptomics of liver tissues of NAFLD to find potential genes involved in pathogenesis of NAFLD. After integration these data, we found that the expression of 43 candidate genes from the GeCKO screening was also decreased in tissues of NAFLD patients. Many of these 43 overlapping genes have been reported to play an important role in the formation of LD. Subsequently, we focused onCYP46A1, one of 43 candidate genes and mitochondria-related genes. We confirmed that the protein expression ofCYP46A1is deceased in tissues of NAFLD patients. Downregulation or overexpression ofCYP46A1affected LD accumulation in vitro. Deficiency ofCYP46A1impaired mitochondrial morphology and function, which may be responsible for the accumulation of LD. In summary, this study explored regulatory factors of LD accumulation at the whole-genome level, and demonstrated thatCYP46A1regulated LD formation involving in NAFLD pathogenesis. It provides new clues for studying the molecular mechanisms of diseases related to abnormal lipid metabolism.	[Si, Zhongzhou; Li, Qiang; Chen, Guangshun; Li, Jiequn] Cent South Univ, Xiangya Hosp 2, Ctr Organ Transplantat, 139 Rennin Rd, Changsha 410011, Hunan, Peoples R China; [Guan, Xinjie; Peng, Xiaoxia; Wan, Zhengqin; Tan, Jieqiong] Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha, Peoples R China; [Teng, Xiangyun] 3G BIOTECK Co Ltd, Changsha, Peoples R China	Central South University; Central South University	Li, JQ (corresponding author), Cent South Univ, Xiangya Hosp 2, Ctr Organ Transplantat, 139 Rennin Rd, Changsha 410011, Hunan, Peoples R China.	leejiequn@csu.edu.cn			Natural Science Foundation of Hunan Province, China [2018JJ2561]; Hunan Province Science and Technology Grant [2019GK5010]; National Natural Science Foundation of China [81102241]	Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Hunan Province Science and Technology Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Hunan Province, China (Grant No. 2018JJ2561), Hunan Province Science and Technology Grant (No. 2019GK5010), and the National Natural Science Foundation of China (Grant No. 81102241)	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; BasuRay S, 2019, P NATL ACAD SCI USA, V116, P9521, DOI 10.1073/pnas.1901974116; Beck A, 2011, DIABETOLOGIA, V54, P2845, DOI 10.1007/s00125-011-2277-3; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Boussicault L, 2016, BRAIN, V139, P953, DOI 10.1093/brain/awv384; Breher-Esch S, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0438-7; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cai M, 2019, J CELL PHYSIOL, V234, P9184, DOI 10.1002/jcp.27595; Cazanave S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17370-6; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; He YQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-575; Huang A, 2020, NAT REV DRUG DISCOV, V19, P23, DOI 10.1038/s41573-019-0046-z; Huang ZJ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00484; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Kim E, 2012, CHEM COMMUN, V48, P2331, DOI 10.1039/c2cc17496k; Kim S, 2014, KOREAN J PHYSIOL PHA, V18, P333, DOI 10.4196/kjpp.2014.18.4.333; Kirpich IA, 2011, J NUTR BIOCHEM, V22, P38, DOI 10.1016/j.jnutbio.2009.11.009; Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koumanov F, 2015, DIABETOLOGIA, V58, P1877, DOI 10.1007/s00125-015-3627-3; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Li SW, 2016, G3-GENES GENOM GENET, V6, P2407, DOI 10.1534/g3.116.030866; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Pang E, 2000, CANCER GENET CYTOGEN, V121, P9, DOI 10.1016/S0165-4608(99)00247-2; Pound LD, 2013, DIABETES, V62, P1547, DOI 10.2337/db12-1067; Rodrigues E, 2019, FRONT CELL NEUROSCI, V13, DOI [10.3389/conf.fncel.2019.01.00030, DOI 10.3389/CONF.FNCEL.2019.01.00030]; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sherif ZA, 2016, DIGEST DIS SCI, V61, P1214, DOI 10.1007/s10620-016-4143-0; Sohle J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031193; Ta MT, 2012, FEBS J, V279, P4231, DOI 10.1111/febs.12015; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whittaker R, 2010, J BIOMOL SCREEN, V15, P798, DOI 10.1177/1087057110374991; Yoon Eugene J, 2006, Int J Med Sci, V3, P53; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	46	4	4	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13776	13791		10.1096/fj.202001067R	http://dx.doi.org/10.1096/fj.202001067R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32816363	Bronze			2022-12-28	WOS:000563238400001
J	Li, XY; Xie, L; Qu, XL; Zhao, BY; Fu, W; Wu, BL; Wu, J				Li, Xinyi; Xie, Li; Qu, Xiangli; Zhao, Bangyi; Fu, Wei; Wu, Beili; Wu, Jian			GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses	FASEB JOURNAL			English	Review						G protein-coupled receptor; innate immunity; metabolic regulation; succinate; SUCNR1	SUCCINATE RECEPTOR GPR91; PROTEIN-COUPLED RECEPTORS; CELLS; ACTIVATION; DISCOVERY; LEADS; GPCRS; DYSFUNCTION; NANOBODIES; FUMARATE	Succinate receptor GPR91 is one of G protein-coupled receptors (GPCRs), and is expressed in a variety of cell types and tissues. Succinate is its natural ligand, and its activation represents that an intrinsic metabolic intermediate exerts a regulatory role on many critical life processes involving pathophysiologic mechanisms, such as innate immunity, inflammation, tissue repair, and oncogenesis. With the illustration of 3-dimensional crystal structure of the receptor and discovery of its antagonists, it is possible to dissect the succinate-GPR91-G protein signaling pathways in different cell types under pathophysiological conditions. Deep understanding of the GPR91-ligand binding mode with various agonists and antagonists would aid in elucidating the molecular basis of a spectrum of chronic illnesses, such as hypertension, diabetes, and their renal and retina complications, metabolic-associated fatty liver diseases, such as nonalcoholic steatohepatitis and its fibrotic progression, inflammatory bowel diseases (Crohn's disease and ulcerative colitis), age-related macular degeneration, rheumatoid arthritis, and progressive behaviors of malignancies. With better delineation of critical regulatory role of the succinate-GPR91 axis in these illnesses, therapeutic intervention may be developed by specifically targeting this signaling pathway with small molecular antagonists or other strategies.	[Li, Xinyi; Xie, Li; Wu, Jian] Fudan Univ, Sch Basic Med Sci, MOE NHC CAMS Key Lab Med Mol Virol, Dept Med Microbiol, Shanghai, Peoples R China; [Qu, Xiangli; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zhuchongzhi Rd, Shanghai 201203, Peoples R China; [Zhao, Bangyi; Fu, Wei] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai, Peoples R China; [Wu, Jian] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China; [Wu, Jian] Fudan Univ, Shanghai Med Coll, Shanghai Inst Liver Dis, Shanghai, Peoples R China; [Qu, Xiangli; Wu, Beili] Univ Chinese Acad Sci, Beijing, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zhuchongzhi Rd, Shanghai 201203, Peoples R China.; Wu, J (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Mol Virol, Dept Med Microbiol, 138 Yixue Yuan Rd,POB 228, Shanghai 200032, Peoples R China.	beiliwu@simm.ac.cn; jian.wu@fudan.edu.cn	Wu, Jian/AAU-5221-2020; li, xin/HHS-9461-2022; li, xinyi/GWZ-8941-2022	Wu, Jian/0000-0001-9933-7364; 	National Natural Science Foundation of China [81572356, 81871997, 31825010]; National Key R&D Program of China [2016YFE0107400]; Shanghai Commission of Science and Technology [16140903700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	The National Natural Science Foundation of China, Grant/Award Number: 81572356, 81871997 and 31825010; National Key R&D Program of China, Grant/Award Number: 2016YFE0107400; Shanghai Commission of Science and Technology, Grant/Award Number: 16140903700	Aguiar CJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0078-2; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Cho EH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00455; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Favret S, 2013, AGING-US, V5, P427, DOI 10.18632/aging.100563; Geubelle P, 2017, BRIT J PHARMACOL, V174, P796, DOI 10.1111/bph.13738; Gilissen J, 2016, PHARMACOL THERAPEUT, V159, P56, DOI 10.1016/j.pharmthera.2016.01.008; Gilissen J, 2015, BIOCHEM PHARMACOL, V98, P381, DOI 10.1016/j.bcp.2015.09.010; Gurevich VV, 2019, CELL MOL LIFE SCI, V76, P4413, DOI 10.1007/s00018-019-03272-5; Gutkind JS, 2018, NAT REV MOL CELL BIO, V19, P615, DOI 10.1038/s41580-018-0041-y; Haffke M, 2019, NATURE, V574, P581, DOI 10.1038/s41586-019-1663-8; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hodge RJ, 2013, CLIN PHARM DRUG DEV, V2, P213, DOI 10.1002/cpdd.34; Hogberg C, 2011, J THROMB HAEMOST, V9, P361, DOI 10.1111/j.1538-7836.2010.04158.x; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Hsu CC, 2016, EXP BIOL MED, V241, P1281, DOI 10.1177/1535370216641787; Hu JY, 2013, EXP EYE RES, V109, P31, DOI 10.1016/j.exer.2013.01.011; Huang YH, 2017, CURR OPIN PHARMACOL, V32, P96, DOI 10.1016/j.coph.2017.02.001; Jakowiecki J, 2020, GPCRS: STRUCTURE, FUNCTION, AND DRUG DISCOVERY, P43, DOI 10.1016/B978-0-12-816228-6.00003-9; Kahsai AW, 2018, CELL RES, V28, P783, DOI 10.1038/s41422-018-0067-x; Kamal FA, 2017, J AM SOC NEPHROL, V28, P197, DOI 10.1681/ASN.2015080852; Keiran N, 2019, NAT IMMUNOL, V20, P581, DOI 10.1038/s41590-019-0372-7; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Laukka T, 2016, J BIOL CHEM, V291, P4256, DOI 10.1074/jbc.M115.688762; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Li M, 2017, BBA-MOL BASIS DIS, V1863, P3202, DOI 10.1016/j.bbadis.2017.09.008; Li Y, 2018, FREE RADICAL BIO MED, V126, P1, DOI 10.1016/j.freeradbiomed.2018.07.009; Li YH, 2016, J BIOL CHEM, V291, P10277, DOI 10.1074/jbc.M115.692244; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Liu XJ, 2020, LIVER INT, V40, P830, DOI 10.1111/liv.14370; Luo J, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0059-6; Macias-Ceja DC, 2019, MUCOSAL IMMUNOL, V12, P178, DOI 10.1038/s41385-018-0087-3; McCreath KJ, 2015, DIABETES, V64, P1154, DOI 10.2337/db14-0346; Mu XM, 2017, ONCOTARGET, V8, P13174, DOI 10.18632/oncotarget.14485; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Pellicciari R, 2009, J MED CHEM, V52, P7958, DOI 10.1021/jm901390p; Raval Z, 2011, J AM COLL CARDIOL, V58, P223, DOI 10.1016/j.jacc.2011.03.026; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Riddy DM, 2018, PHARMACOL REV, V70, P39, DOI 10.1124/pr.117.014373; Robben JH, 2009, KIDNEY INT, V76, P1258, DOI 10.1038/ki.2009.360; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sanchack K, 2018, AM FAM PHYSICIAN, V97, P573; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Saraiva AL, 2018, FASEB J, V32, P6550, DOI 10.1096/fj.201800285; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Schmitt J, 2015, LIVER INT, V35, P1133, DOI 10.1111/liv.12456; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Sundstrom L, 2013, FEBS LETT, V587, P2399, DOI 10.1016/j.febslet.2013.05.067; Sushma, 2019, MOL CELL NEUROSCI, V101, DOI 10.1016/j.mcn.2019.103414; Tang XL, 2012, ACTA PHARMACOL SIN, V33, P363, DOI 10.1038/aps.2011.210; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Trauelsen M, 2017, MOL METAB, V6, P1585, DOI 10.1016/j.molmet.2017.09.005; Tseng PL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21361-6; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Vass M, 2018, TRENDS PHARMACOL SCI, V39, P494, DOI 10.1016/j.tips.2018.02.004; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wentzel JF, 2017, BIOCHIMIE, V135, P28, DOI 10.1016/j.biochi.2017.01.004; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Wu J, 2016, ONCOTARGET, V7, P42762, DOI 10.18632/oncotarget.8641; Yang JW, 2018, DIABETES OBES METAB, V20, P257, DOI 10.1111/dom.13062; Yu XN, 2019, BBA-REV CANCER, V1871, P379, DOI 10.1016/j.bbcan.2019.03.001; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhao J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00058; Zhao T, 2017, ONCOTARGET, V8, P53819, DOI 10.18632/oncotarget.17734	75	9	9	6	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13091	13105		10.1096/fj.202001037R	http://dx.doi.org/10.1096/fj.202001037R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32812686	Bronze			2022-12-28	WOS:000567542800001
J	Diem, K; Fauler, M; Fois, G; Hellmann, A; Winokurow, N; Schumacher, S; Kranz, C; Frick, M				Diem, Kathrin; Fauler, Michael; Fois, Giorgio; Hellmann, Andreas; Winokurow, Natalie; Schumacher, Stefan; Kranz, Christine; Frick, Manfred			Mechanical stretch activates piezo1 in caveolae of alveolar type I cells to trigger ATP release and paracrine stimulation of surfactant secretion from alveolar type II cells	FASEB JOURNAL			English	Article						lung; mechanobiology; piezo-1; purinergic signaling	DEFORMATION-INDUCED INJURY; LUNG EPITHELIAL-CELLS; CA2+ ENTRY; IMMOBILIZATION MATRIX; VESICULAR P2X(4); EXOCYTOSIS; STRAIN; RECEPTORS; POLY(BENZOXAZINE); PATHOPHYSIOLOGY	Secretion of pulmonary surfactant in the alveoli of the lungs is essential to maintain lung function. Stretching of alveoli during lung inflation is the main trigger for surfactant secretion. Yet, the molecular mechanisms how mechanical distension of alveoli results in surfactant secretion are still elusive. The alveolar epithelium consists of alveolar epithelial type I (ATI) and surfactant secreting type II (ATII) cells. ATI, but not ATII cells, express caveolae, small plasma membrane invaginations that can respond to plasma membrane stresses and serve mechanotransductive roles. Within this study, we investigated the role of caveolae as mechanosensors in the alveolus. We generated a human caveolin-1 knockout ATI cell (hAELVi(cav-/-)) using CRISPR/Cas9. Wildtype (hAELVi(wt)) and hAELVi(cav-/-)cells grown on flexible membranes responded to increasing stretch amplitudes with rises in intracellular Ca2+. The response was less frequent and started at higher stretch amplitudes in hAELVi(cav-/-)cells. Stretch-induced Ca2+-signals depended on Ca2+-entry via piezo1 channels, localized within caveolae in hAELVi(wt)and primary ATI cells. Ca2+-entry via piezo1 activated pannexin-1 hemichannels resulting in ATP release from ATI cells. ATP release was reduced in hAELVi(cav-/-)cells. In co-cultures resembling the alveolar epithelium, released ATP stimulated Ca(2+)signals and surfactant secretion from neighboring ATII cells when co-cultured with hAELVi(wt)but not hAELVi(cav-/-)cells. In summary, we propose that caveolae in ATI cells are mechanosensors within alveoli regulating stretch-induced surfactant secretion from ATII cells.	[Diem, Kathrin; Fauler, Michael; Fois, Giorgio; Frick, Manfred] Ulm Univ, Inst Gen Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Hellmann, Andreas; Kranz, Christine] Ulm Univ, Inst Analyt & Bioanalyt Chem, Ulm, Germany; [Winokurow, Natalie; Schumacher, Stefan] Ulm Univ, Inst Mol & Cellular Anat, Ulm, Germany	Ulm University; Ulm University; Ulm University	Frick, M (corresponding author), Ulm Univ, Inst Gen Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	manfred.frick@uni-ulm.de	Frick, Manfred/E-1374-2012; Fois, Giorgio/AAD-5657-2022	Frick, Manfred/0000-0002-4763-1104; Fois, Giorgio/0000-0001-5414-1149	Deutsche Forschungsgemeinschaft [278012962, 251293561, 175083951]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft, Grant/Award Number: 278012962, 251293561 and 175083951	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Andronescu C, 2014, ELECTROCHEM COMMUN, V41, P12, DOI 10.1016/j.elecom.2014.01.015; Arold SP, 2009, AM J PHYSIOL-LUNG C, V296, pL574, DOI 10.1152/ajplung.90454.2008; Ashino Y, 2000, AM J PHYSIOL-LUNG C, V279, pL5, DOI 10.1152/ajplung.2000.279.1.L5; Bachofen H, 2001, COMP BIOCHEM PHYS A, V129, P183, DOI 10.1016/S1095-6433(01)00315-4; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Belete HA, 2010, CELL PHYSIOL BIOCHEM, V25, P71, DOI 10.1159/000272052; Bove PF, 2010, J BIOL CHEM, V285, P34939, DOI 10.1074/jbc.M110.162933; Boyce AKJ, 2015, BIOCHEM J, V470, P319, DOI 10.1042/BJ20141551; Brunello CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30498; Brunschweiger A, 2006, CURR MED CHEM, V13, P289, DOI 10.2174/092986706775476052; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Chiu YH, 2018, J GEN PHYSIOL, V150, P19, DOI 10.1085/jgp.201711888; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; DeLalio LJ, 2019, J BIOL CHEM, V294, P6940, DOI 10.1074/jbc.RA118.006982; DeLalio LJ, 2018, ARTERIOSCL THROM VAS, V38, P2065, DOI 10.1161/ATVBAHA.118.311290; Dietl P, 2004, BIOL NEONATE, V85, P299, DOI 10.1159/000078176; Dietl P, 2001, NEWS PHYSIOL SCI, V16, P239; Dietl P, 2012, CELL CALCIUM, V52, P296, DOI 10.1016/j.ceca.2012.04.010; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Edwards YS, 1999, FEBS LETT, V448, P127, DOI 10.1016/S0014-5793(99)00357-9; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; Fernandez-Rojo MA, 2013, CELL REP, V4, P238, DOI 10.1016/j.celrep.2013.06.017; Fois G, 2018, J GEN PHYSIOL, V150, P277, DOI 10.1085/jgp.201711870; Fois G, 2012, BIOMECH MODEL MECHAN, V11, P959, DOI 10.1007/s10237-011-0365-4; Frick M, 2004, AM J PHYSIOL-LUNG C, V286, pL210, DOI 10.1152/ajplung.00332.2003; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Furuya K, 2016, AM J PHYSIOL-LUNG C, V311, pL956, DOI 10.1152/ajplung.00425.2015; Gehi R, 2011, J BIOL CHEM, V286, P27639, DOI 10.1074/jbc.M111.260711; Gerstmair A, 2009, J APPL PHYSIOL, V107, P613, DOI 10.1152/japplphysiol.00012.2009; Gervasio OL, 2011, J CELL SCI, V124, P3581, DOI 10.1242/jcs.084376; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; Gosens R, 2008, CURR MOL MED, V8, P741, DOI 10.2174/156652408786733720; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Isakson BE, 2003, AM J RESP CELL MOL, V29, P552, DOI 10.1165/rcmb.2002-0281OC; Isakson BE, 2001, AM J PHYSIOL-LUNG C, V280, pL221, DOI 10.1152/ajplung.2001.280.2.L221; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; Knudsen L, 2018, HISTOCHEM CELL BIOL, V150, P661, DOI 10.1007/s00418-018-1747-9; Kuehn A, 2016, ALTEX-ALTERN ANIM EX, V33, P251, DOI 10.14573/altex.1511131; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2011, ADV PHARMACOL, V61, P221, DOI 10.1016/B978-0-12-385526-8.00008-4; LAZAROWSKI ER, 1995, BRIT J PHARMACOL, V116, P1619, DOI 10.1111/j.1476-5381.1995.tb16382.x; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Lopez-Rodriguez E, 2016, AM J PHYSIOL-LUNG C, V310, pL1260, DOI 10.1152/ajplung.00065.2016; Martin C, 1996, EUR RESPIR J, V9, P2479, DOI 10.1183/09031936.96.09122479; Mendoza-Topaz C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205306; Miklavc P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00171; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Miklavc P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010982; Mishra A, 2011, J CELL SCI, V124, P657, DOI 10.1242/jcs.066977; Moreno-Vicente R, 2018, CELL REP, V25, P1622, DOI 10.1016/j.celrep.2018.10.024; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Newman GR, 1999, CELL TISSUE RES, V295, P111, DOI 10.1007/s004410051217; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parton RG, 2018, CURR BIOL, V28, pR402, DOI 10.1016/j.cub.2017.11.075; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Perlman CE, 2007, J APPL PHYSIOL, V103, P1037, DOI 10.1152/japplphysiol.00160.2007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rausch V, 2019, CURR BIOL, V29, P242, DOI 10.1016/j.cub.2018.11.066; Ravasio A, 2011, AM J PHYSIOL-CELL PH, V300, pC1456, DOI 10.1152/ajpcell.00427.2010; Roan E, 2011, AM J PHYSIOL-LUNG C, V301, pL625, DOI 10.1152/ajplung.00105.2011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Steffen L, 2017, AM J PHYSIOL-LUNG C, V313, pL313, DOI 10.1152/ajplung.00033.2017; Tan JJ, 2020, AM J PHYSIOL-LUNG C, V318, pL49, DOI 10.1152/ajplung.00321.2019; Thompson MA, 2014, EXPERT REV RESP MED, V8, P111, DOI 10.1586/17476348.2014.855610; Torday JS, 2002, AM J PHYSIOL-LUNG C, V283, pL130, DOI 10.1152/ajplung.00380.2001; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Waters CM, 2012, COMPR PHYSIOL, V2, P1, DOI 10.1002/cphy.c100090; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; Yamamoto K, 2011, J CELL SCI, V124, P3477, DOI 10.1242/jcs.087221; Ziller C, 2017, CHEMELECTROCHEM, V4, P864, DOI 10.1002/celc.201600765	90	35	35	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12785	12804		10.1096/fj.202000613RRR	http://dx.doi.org/10.1096/fj.202000613RRR		AUG 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744386	hybrid, Green Published			2022-12-28	WOS:000557254400001
J	Liu, J; Li, ML; Kong, LH; Cao, MW; Zhang, ML; Wang, YH; Song, CC; Fang, XT; Chen, H; Zhang, CL				Liu, Jia; Li, MengLu; Kong, LingHao; Cao, MengWen; Zhang, MoLan; Wang, YanHong; Song, ChengChuang; Fang, XingTang; Chen, Hong; Zhang, ChunLei			CircARID1A regulates mouse skeletal muscle regeneration by functioning as a sponge of miR-6368	FASEB JOURNAL			English	Article						circARID1A; miR&#8208; 6368; proliferation and differentiation; regeneration	PROMOTES MYOBLAST PROLIFERATION; CIRCULAR RNAS; DIFFERENTIATION; EXPRESSION; REVEALS; TARGETS; GENES; CELLS; TLR4; MICRORNAS	The noncoding RNAs play important role in growth and development of mammalian skeletal muscle. Recent work has shown that circRNAs are abundant in skeletal muscle tissue, with significant changes in their expression patterns during muscle development and aging. We identified a novel circRNA called circARID1A that is highly expressed in mice skeletal muscle compare to its linear transcript. Experiments shown that circARID1A significantly inhibited the process of C2C12 cell proliferation and promoted its differentiation. Interactions between circRNA and miRNA were screened by miRNA gene chip sequencing. The results indicated that circARID1A can sponge miR-6368, which was further verified by miRNA sensor and other experiments. Besides, miR-6368 is a commonly expressed miRNA that regulates the expression of several target genes including Tlr4. A mouse model of skeletal muscle injury was successfully established to explore the role of circARID1A in skeletal muscle development and regeneration in vivo. Moreover, we found the overexpression of circARID1A significantly promoted the regeneration of skeletal muscle. The results of our study suggest that circARID1A may regulate skeletal muscle cell development and regeneration by sponging miR-6368.	[Liu, Jia; Li, MengLu; Kong, LingHao; Cao, MengWen; Zhang, MoLan; Wang, YanHong; Song, ChengChuang; Fang, XingTang; Chen, Hong; Zhang, ChunLei] Jiangsu Normal Univ, Sch Life Sci, Inst Cellular & Mol Biol, Xuzhou 221116, Jiangsu, Peoples R China	Jiangsu Normal University	Wang, YH; Zhang, CL (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Inst Cellular & Mol Biol, Xuzhou 221116, Jiangsu, Peoples R China.	7096871@163.com; clzhang@jsnu.edu.cn	Wang, Yuan/HHC-1520-2022; Wang, Yu/GZL-9655-2022; wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; wang, yan/GSE-6489-2022					Abdelmohsen K, 2015, AGING-US, V7, P903, DOI 10.18632/aging.100834; Agnieszka RW., 2016, MOL CELL, V58, P1; Cao Y, 2018, ASIAN AUSTRAL J ANIM, V31, P1550, DOI 10.5713/ajas.17.0563; Chen JN, 2018, ONCOTARGET, V9, P1524, DOI 10.18632/oncotarget.23290; Chen XL, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110199; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dudekulay DB, 2016, RNA BIOL, V13, P34, DOI 10.1080/15476286.2015.1128065; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Greco S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113454; Guardiola O, 2017, JOVE-J VIS EXP, V119, pe54515; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Hosokawa T, 2015, J PEDIATR SURG, V50, P1352, DOI 10.1016/j.jpedsurg.2014.12.028; Iotzova-Weiss G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185668; Jakub OW., 2014, CELL REP, V9, P1; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li CY, 2017, ONCOTARGET, V8, P97165, DOI 10.18632/oncotarget.21835; Li H, 2018, J CELL PHYSIOL, V233, P4643, DOI 10.1002/jcp.26230; Li XY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060616; Liu YL, 2016, AM J PHYSIOL-REG I, V311, pR365, DOI 10.1152/ajpregu.00043.2016; Martineau Y, 2013, ONCOGENE, V32, P671, DOI 10.1038/onc.2012.116; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nakajima H., 2014, NEUROPROTECTION REGE, V1, P193; Nicolas FE, 2011, METHODS MOL BIOL, V732, P139, DOI 10.1007/978-1-61779-083-6_11; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ouyang HJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00172; Ouyang HJ, 2018, DNA RES, V25, P71, DOI 10.1093/dnares/dsx039; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Paul JS., 2019, INT J MOL SCI, V20, P5273; Qin XY, 2016, CELL CYCLE, V15, P781, DOI 10.1080/15384101.2016.1151581; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Sikalidis AK., 2013, J AMINO ACIDS, V2013, P864757, DOI DOI 10.1155/2013/864757; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Sun QL, 2008, MOL IMMUNOL, V45, P2929, DOI 10.1016/j.molimm.2008.01.025; Surono A, 1999, HUM MOL GENET, V8, P493, DOI 10.1093/hmg/8.3.493; Tang CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40342; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Wang LS, 2018, J AGR FOOD CHEM, V66, P6308, DOI 10.1021/acs.jafc.8b01753; Wang YH, 2019, INT J BIOL MACROMOL, V121, P1308, DOI 10.1016/j.ijbiomac.2018.09.039; Wei XF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.541; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Xiao YW, 2020, J CELL BIOCHEM, V121, P394, DOI 10.1002/jcb.29194; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yue BL, 2019, INT J BIOCHEM CELL B, V117, DOI 10.1016/j.biocel.2019.105621; Zhang CL, 2016, J DAIRY SCI, V99, P4750, DOI 10.3168/jds.2015-10381; Zhang CL, 2014, J NUTR, V144, P1142, DOI 10.3945/jn.114.192575; Zhang GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02347-2; Zhang PP, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080885; Zhang Y., 2018, BIOMED RES INT, V2018, P1; Zhang Y, 2016, CELL REP, V15, P611, DOI 10.1016/j.celrep.2016.03.058	57	10	10	7	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21324	10.1096/fj.202001992R	http://dx.doi.org/10.1096/fj.202001992R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33421208				2022-12-28	WOS:000647789600075
J	Ganguly, E; Kirschenman, R; Spaans, F; Holody, CD; Phillips, TEJ; Case, CP; Cooke, CLM; Murphy, MP; Lemieux, H; Davidge, ST				Ganguly, Esha; Kirschenman, Raven; Spaans, Floor; Holody, Claudia D.; Phillips, Thomas E. J.; Case, C. Patrick; Cooke, Christy-Lynn M.; Murphy, Michael P.; Lemieux, Helene; Davidge, Sandra T.			Nanoparticle-encapsulated antioxidant improves placental mitochondrial function in a sexually dimorphic manner in a rat model of prenatal hypoxia	FASEB JOURNAL			English	Article						mitochondrial function; nMitoQ; placenta; prenatal hypoxia	INTRAUTERINE GROWTH RESTRICTION; HIGH-FAT DIET; OXIDATIVE STRESS; S-NITROSYLATION; RESPIRATION; FISSION; DRP1; PHOSPHORYLATION; PREECLAMPSIA; ADAPTATIONS	Pregnancy complications associated with prenatal hypoxia lead to increased placental oxidative stress. Previous studies suggest that prenatal hypoxia can reduce mitochondrial respiratory capacity and mitochondrial fusion, which could lead to placental dysfunction and impaired fetal development. We developed a placenta-targeted treatment strategy using a mitochondrial antioxidant, MitoQ, encapsulated into nanoparticles (nMitoQ) to reduce placental oxidative stress and (indirectly) improve fetal outcomes. We hypothesized that, in a rat model of prenatal hypoxia, nMitoQ improves placental mitochondrial function and promotes mitochondrial fusion in both male and female placentae. Pregnant rats were treated with saline or nMitoQ on gestational day (GD) 15 and exposed to normoxia (21% O-2) or hypoxia (11% O-2) from GD15-21. On GD21, male and female placental labyrinth zones were collected for mitochondrial respirometry assessments, mitochondrial content, and markers of mitochondrial biogenesis, fusion and fission. Prenatal hypoxia reduced complex IV activity and fusion in male placentae, while nMitoQ improved complex IV activity in hypoxic male placentae. In female placentae, prenatal hypoxia decreased respiration through the S-pathway (complex II) and increased N-pathway (complex I) respiration, while nMitoQ increased fusion in hypoxic female placentae. No changes in mitochondrial content, biogenesis or fission were found. In conclusion, nMitoQ improved placental mitochondrial function in male and female placentae from fetuses exposed to prenatal hypoxia, which may contribute to improved placental function. However, the mechanisms (ie, changes in mitochondrial respiratory capacity and mitochondrial fusion) were distinct between the sexes. Treatment strategies targeted against placental oxidative stress could improve placental mitochondrial function in complicated pregnancies.	[Ganguly, Esha; Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Ganguly, Esha; Kirschenman, Raven; Spaans, Floor; Cooke, Christy-Lynn M.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynaecol, Edmonton, AB, Canada; [Ganguly, Esha; Kirschenman, Raven; Spaans, Floor; Holody, Claudia D.; Cooke, Christy-Lynn M.; Lemieux, Helene; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Holody, Claudia D.] Univ Alberta, Dept Paediat, Edmonton, AB, Canada; [Holody, Claudia D.] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Phillips, Thomas E. J.] Cardiff Univ, Dementia Res Inst, Cardiff, Wales; [Case, C. Patrick] Univ Bristol, Musculoskeletal Res Unit, Bristol, Avon, England; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Keith Peters Bldg, Cambridge, England; [Lemieux, Helene] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Cardiff University; University of Bristol; University of Cambridge; University of Alberta	Davidge, ST (corresponding author), Univ Alberta, Canada Res Chair Maternal & Perinatal Cardiovasc, 232 HMRC, Edmonton, AB T6G 2S2, Canada.	sandra.davidge@ualberta.ca	Phillips, Thomas/AAJ-5804-2021	Phillips, Thomas/0000-0002-4709-2550; Davidge, Sandra/0000-0002-5559-4905; Holody, Claudia/0000-0003-1479-3809	Canadian Institutes of Health Research [CIHR FS 154313]; Women and Children's Health Research Institute (WCHRI) through Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Natural Sciences and Engineering Research Council of Canada [RGPIN 402636]; Faculty of Medicine & Dentistry 75th Anniversary Awards; WCHRI Graduate Studentship Program; University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute (WCHRI) through Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Faculty of Medicine & Dentistry 75th Anniversary Awards; WCHRI Graduate Studentship Program; University of Alberta(University of Alberta)	This research was funded by grants from the Canadian Institutes of Health Research (CIHR FS 154313) and the Women and Children's Health Research Institute (WCHRI) through the generosity of the Stollery Children's Hospital Foundation and supporters of the Lois Hole Hospital for Women supporting the laboratory of SD. SD is a Canada Research Chair in Maternal and Perinatal Cardiovascular Health and a Distinguished University Professor at the University of Alberta. HL was supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 402636). EG was supported by Faculty of Medicine & Dentistry 75th Anniversary Awards, WCHRI Graduate Studentship Program and Dean's Doctoral Award from the University of Alberta.	Aljunaidy MM, 2018, PHARMACOL RES, V134, P332, DOI 10.1016/j.phrs.2018.05.006; Ausman J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0360-0; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chaudhari HN, 2014, FREE RADICAL RES, V48, P587, DOI 10.3109/10715762.2014.896003; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Colleoni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055194; Fisher JJ, 2020, CLIN EXP PHARMACOL P, V47, P176, DOI 10.1111/1440-1681.13172; Ganguly E, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104836; Ganguly E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00562; Gnaiger E., 2014, MITOCHONDRIAL PATHWA, V4th; Han WH, 2017, INVEST OPHTH VIS SCI, V58, P3826, DOI 10.1167/iovs.17-21929; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Holland O, 2017, PLACENTA, V54, P2, DOI 10.1016/j.placenta.2016.12.012; Holland OJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1190-9; Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144; Jahani-Asl A, 2007, EMBO REP, V8, P912, DOI 10.1038/sj.embor.7401077; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kim H, 2009, MACROMOL BIOSCI, V9, P842, DOI 10.1002/mabi.200800367; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lemieux H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02789-8; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141; Longtine MS, 2011, SEMIN REPROD MED, V29, P187, DOI 10.1055/s-0031-1275515; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, pE14, DOI 10.1152/ajpendo.00332.2012; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nuzzo AM, 2018, AM J PATHOL, V188, P2704, DOI 10.1016/j.ajpath.2018.07.027; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Phillips TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06300-1; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Raijmakers MTM, 2004, HYPERTENSION, V44, P374, DOI 10.1161/01.HYP.0000141085.98320.01; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Schneider J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228710; Sferruzzi-Perri AN, 2019, P NATL ACAD SCI USA, V116, P1621, DOI 10.1073/pnas.1816056116; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Song H, 2019, BIOL REPROD, V100, P208, DOI 10.1093/biolre/ioy167; Vaughan OR, 2016, REPROD DOMEST ANIM, V51, P25, DOI 10.1111/rda.12797; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Vishnyakova PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32410; Wang Y, 2018, ADV SUSTAIN SYST, V2, DOI 10.1002/adsu.201700119; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360; Zhou XB, 2017, EXP CELL RES, V359, P195, DOI 10.1016/j.yexcr.2017.07.029	57	8	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21338	10.1096/fj.202002193R	http://dx.doi.org/10.1096/fj.202002193R		JAN 2021	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33428278				2022-12-28	WOS:000607203800001
J	Wu, Q; Hao, Q; Li, HY; Wang, B; Wang, PN; Jin, XF; Yu, P; Gao, GF; Chang, YZ				Wu, Qiong; Hao, Qian; Li, Haiyan; Wang, Bo; Wang, Peina; Jin, Xiaofang; Yu, Peng; Gao, Guofen; Chang, Yan-Zhong			Brain iron deficiency and affected contextual fear memory in mice with conditional Ferroportin1 ablation in the brain	FASEB JOURNAL			English	Article						brain iron homeostasis; contextual fear; ferroportin1; Nestin&#8208; cre	MITOCHONDRIAL FERRITIN; CELLULAR IRON; HOMEOSTASIS; METABOLISM; EXPRESSION; TRANSPORTER; MACROPHAGES; KIDNEY	Fear memory is a pivotal biological function by which organisms can predict possible danger to avoid or reduce harm. However, dysregulation of fear memory processing may lead to pathological fear or anxiety and produce serious clinical symptoms, such as post-traumatic stress disorder (PTSD). Iron deficiency (ID) is reported to inhibit the initiation of fear memory. In our study, we found that ferroportin1 (FPN1), the only known cellular iron export protein in mammals, and ablation in neurons and astrocytes caused iron deficiency in the cortex and hippocampus. However, little is known about its role in the development of fear memory. Moreover, direct evidence of the role of FPN1, or the related molecular mechanisms of such a role, in balancing brain iron homeostasis, especially in neuronal cells, is lacking. Herein, we deleted Fpn1 in mouse neurons, using Nestin-cre transgenic mice, and explored the impact on neuronal iron recycling and brain iron homeostasis in the cortex and hippocampus. We investigated the response of the mice to contextual fear and found that formation of fear memory was impeded after neuronal FPN1 depletion. We also found that FPN1 ablation in neurons and astrocytes caused an atypical expression of iron metabolism-related proteins in these two regions: decreased expression of DMT1, Ft-H, and Ft-L, and increased TfR1 expression. In addition, the decreased FPN1 in brain microvascular endothelial cells (BMVECs) also shed light on the cause of the decreased iron delivery to the brain through the blood-brain barrier (BBB). Our research highlights the major role played by FPN1 in brain iron homeostasis and identifies a potential target for the treatment of PTSD.	[Wu, Qiong; Hao, Qian; Li, Haiyan; Wang, Bo; Wang, Peina; Jin, Xiaofang; Yu, Peng; Gao, Guofen; Chang, Yan-Zhong] Hebei Normal Univ, Coll Life Sci, Lab Mol Iron Metab, 20 Nanerhuan Eastern Rd, Shijiazhuang 050024, Hebei, Peoples R China; [Wu, Qiong] Hebei Univ Chinese Med, Coll Basic Med, Shijiazhuang, Hebei, Peoples R China; [Wu, Qiong] Hebei Key Lab Chinese Med Res Cardiocerebrovasc D, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei University of Chinese Medicine	Chang, YZ (corresponding author), Hebei Normal Univ, Coll Life Sci, Lab Mol Iron Metab, 20 Nanerhuan Eastern Rd, Shijiazhuang 050024, Hebei, Peoples R China.	yzchang@hebtu.edu.cn	YU, Peng/GRJ-4129-2022; Chang, Yan-Zhong/AAB-5676-2020	Chang, Yan-Zhong/0000-0002-6386-9649	National Natural Science Foundation of China (NSFC) [31520103908, 31471035]; Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation) [H2019423032]; Bureau of Science and Technology of Hebei Province (Hebei Province Science and Technology Bureau) [18962401D]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation); Bureau of Science and Technology of Hebei Province (Hebei Province Science and Technology Bureau)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31520103908 and 31471035; Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation), Grant/Award Number: H2019423032; Bureau of Science and Technology of Hebei Province (Hebei Province Science and Technology Bureau), Grant/Award Number: 18962401D	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Aguirre P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-3; Bastian TW, 2016, DEV NEUROSCI-BASEL, V38, P264, DOI 10.1159/000448514; Batista-Nascimento L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/128647; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Furigo IC, 2018, BRAIN STRUCT FUNCT, V223, P2229, DOI 10.1007/s00429-018-1627-z; Ganz T, 2005, CELL METAB, V1, P155, DOI 10.1016/j.cmet.2005.02.005; Gao GF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00019; Gewirtz JC, 2008, BRAIN RES, V1237, P195, DOI 10.1016/j.brainres.2008.08.079; Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002; Hasan MT, 2019, NEURON, V103, P133, DOI 10.1016/j.neuron.2019.04.029; Heffron DS, 2009, AM J PATHOL, V175, P2586, DOI 10.2353/ajpath.2009.090130; Huckleberry KA, 2018, NEUROPSYCHOPHARMACOL, V43, P2487, DOI 10.1038/s41386-018-0109-6; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Knutson MD, 2019, FREE RADICAL BIO MED, V133, P101, DOI 10.1016/j.freeradbiomed.2018.10.413; Lakhal-Littleton S, 2015, P NATL ACAD SCI USA, V112, P3164, DOI 10.1073/pnas.1422373112; Li X, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071518; Li YP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0740-2; Liao ZH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00396; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Mayr R, 2010, J HEPATOL, V53, P941, DOI 10.1016/j.jhep.2010.05.016; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mobbs D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00055; Mok H, 2004, DEVELOPMENT, V131, P1859, DOI 10.1242/dev.01081; Moos T, 1996, J COMP NEUROL, V375, P675, DOI 10.1002/(SICI)1096-9861(19961125)375:4<675::AID-CNE8>3.0.CO;2-Z; Morales AV, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00096; Mouri A, 2010, HIPPOCAMPUS, V20, P293, DOI 10.1002/hipo.20625; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Qian ZM, 2019, BIOL REV, V94, P1672, DOI 10.1111/brv.12521; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rozeske RR, 2015, GENES BRAIN BEHAV, V14, P22, DOI 10.1111/gbb.12181; Saur L, 2016, NEUROCHEM RES, V41, P892, DOI 10.1007/s11064-015-1770-3; Scott GA, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00407; Sengupta A, 2019, NEURON, V103, P489, DOI 10.1016/j.neuron.2019.05.029; Soler-Cedeno O, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0354-18.2019; Texel SJ, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07554.x; Wang L, 2019, J CELL PHYSIOL, V234, P7600, DOI 10.1002/jcp.27522; Wang SM, 2010, CELL MOL LIFE SCI, V67, P123, DOI 10.1007/s00018-009-0167-3; Wang XQ, 2018, AM J PHYSIOL-RENAL, V315, pF1042, DOI 10.1152/ajprenal.00072.2018; Wenger MJ, 2019, J NUTR, V149, P687, DOI 10.1093/jn/nxy265; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Wu Q, 2019, ANTIOXID REDOX SIGN, V30, P198, DOI 10.1089/ars.2017.7063; Wu WY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.372; You LH, 2015, NEUROSCIENCE, V284, P234, DOI 10.1016/j.neuroscience.2014.09.071; You LH, 2016, BRAIN RES, V1642, P33, DOI 10.1016/j.brainres.2016.03.023; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhang ZZ, 2012, HEPATOLOGY, V56, P961, DOI 10.1002/hep.25746; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; Zohn IE, 2007, BLOOD, V109, P4174, DOI 10.1182/blood-2007-01-066068	63	4	4	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000167RR	http://dx.doi.org/10.1096/fj.202000167RR		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200454				2022-12-28	WOS:000592669300001
J	Edwards, NJ; Hwang, C; Marini, S; Pagani, CA; Spreadborough, PJ; Rowe, CJ; Yu, PE; Mei, AN; Visser, N; Li, SL; Hespe, GE; Huber, AK; Strong, AL; Shelef, MA; Knight, JS; Davis, TA; Levi, B				Edwards, Nicole J.; Hwang, Charles; Marini, Simone; Pagani, Chase A.; Spreadborough, Philip J.; Rowe, Cassie J.; Yu, Pauline; Mei, Annie; Visser, Noelle; Li, Shuli; Hespe, Geoffrey E.; Huber, Amanda K.; Strong, Amy L.; Shelef, Miriam A.; Knight, Jason S.; Davis, Thomas A.; Levi, Benjamin			The role of neutrophil extracellular traps and TLR signaling in skeletal muscle ischemia reperfusion injury	FASEB JOURNAL			English	Article						extracellular signal-regulated kinases (ERK) 1; 2; hydroxychloroquine; inflammation; muscle fibrosis	PEPTIDYLARGININE DEIMINASE INHIBITION; SLE PATIENTS; MYOPATHY; FIBROSIS; PAD4; ACTIVATION; SUFFICIENT; APOPTOSIS; AUTOPHAGY; PATHWAY	Ischemia reperfusion (IR) injury results in devastating skeletal muscle fibrosis. Here, we recapitulate this injury with a mouse model of hindlimb IR injury which leads to skeletal muscle fibrosis. Injury resulted in extensive immune infiltration with robust neutrophil extracellular trap (NET) formation in the skeletal muscle, however, direct targeting of NETs via the peptidylarginine deiminase 4 (PAD4) mechanism was insufficient to reduce muscle fibrosis. Circulating levels of IL-10 and TNF alpha were significantly elevated post injury, indicating toll-like receptor (TLR) signaling may be involved in muscle injury. Administration of hydroxychloroquine (HCQ), a small molecule inhibitor of TLR7/8/9, following injury reduced NET formation, IL-10, and TNF alpha levels and ultimately mitigated muscle fibrosis and improved myofiber regeneration following IR injury. HCQ treatment decreased fibroadipogenic progenitor cell proliferation and partially inhibited ERK1/2 phosphorylation in the injured tissue, suggesting it may act through a combination of TLR7/8/9 and ERK signaling mechanisms. We demonstrate that treatment with FDA-approved HCQ leads to decreased muscle fibrosis and increased myofiber regeneration following IR injury, suggesting short-term HCQ treatment may be a viable treatment to prevent muscle fibrosis in ischemia reperfusion and traumatic extremity injury.	[Edwards, Nicole J.; Hwang, Charles; Marini, Simone; Pagani, Chase A.; Yu, Pauline; Mei, Annie; Visser, Noelle; Li, Shuli; Hespe, Geoffrey E.; Huber, Amanda K.; Strong, Amy L.; Levi, Benjamin] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Spreadborough, Philip J.; Rowe, Cassie J.; Davis, Thomas A.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Shelef, Miriam A.] Univ Wisconsin, Div Rheumatol, Madison, WI USA; [Shelef, Miriam A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Knight, Jason S.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Levi, Benjamin] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levi, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Gen Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Levi, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Organogenesis & Trauma, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	benjamin.levi@UTSouthwestern.edu		Visser, Noelle/0000-0002-9025-6020; Pagani, Chase/0000-0001-9834-2516; Marini, Simone/0000-0002-5704-3533; Edwards, Nicole/0000-0002-2622-1544	Ruth L. Kirschstein Institutional National Research Service Award Postdoctoral fellowship [T32-HD007505]; Howard Hughes Medical Institute Medical Research Fellowship; National Institutes of Health NIAMS [K08 AR065500]; National Institutes of Health (NIH) [R01GM123069, R01AR071379]; American College of Surgeons Clowes Award; US Department of Defense [W81XWH-18-1-0653, OR170174, W81XWH-17-1-0655, OR160105]	Ruth L. Kirschstein Institutional National Research Service Award Postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Clowes Award; US Department of Defense(United States Department of Defense)	NJE was supported by a Ruth L. Kirschstein Institutional National Research Service Award Postdoctoral fellowship (T32-HD007505). CH was supported by a Howard Hughes Medical Institute Medical Research Fellowship. MS was supported by National Institutes of Health NIAMS K08 AR065500. BL was supported or partially supported by National Institutes of Health (NIH) R01GM123069, R01AR071379, American College of Surgeons Clowes Award, US Department of Defense Grants W81XWH-18-1-0653 (OR170174) and W81XWH-17-1-0655 (OR160105).	Agarwal S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02148; Albadawi H, 2016, J VASC SURG, V64, P484, DOI 10.1016/j.jvs.2015.01.031; Allen C, 2012, J IMMUNOL, V189, P381, DOI 10.4049/jimmunol.1200409; Andrikopoulos P, 2019, J AM SOC NEPHROL, V30, P33, DOI 10.1681/ASN.2018020209; AVINAZUBIETA JA, 1995, BRIT J RHEUMATOL, V34, P166; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cai YJ, 2018, BIOMED PHARMACOTHER, V105, P1318, DOI 10.1016/j.biopha.2018.06.091; de Oliveira THC, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01917; Carmona-Rivera C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag3358; Casado E, 2006, ANN RHEUM DIS, V65, P385, DOI 10.1136/ard.2004.023200; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cepika AM, 2012, CELL IMMUNOL, V276, P196, DOI 10.1016/j.cellimm.2012.05.009; Chen YP, 2017, EUR J PHARMACOL, V796, P90, DOI 10.1016/j.ejphar.2016.11.053; Choi DE, 2017, SURGERY, V161, P444, DOI 10.1016/j.surg.2016.07.028; Cholok D, 2017, J TRAUMA ACUTE CARE, V82, P174, DOI 10.1097/TA.0000000000001290; Chowdhury CS, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4579; Collier JB, 2016, J BIOL CHEM, V291, P26850, DOI 10.1074/jbc.M116.754762; Cook KL, 2014, CLIN CANCER RES, V20, P3222, DOI 10.1158/1078-0432.CCR-13-3227; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Feng J, 2017, DRUG DES DEV THER, V11, P1989, DOI 10.2147/DDDT.S136792; Foglia B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112700; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gillani S, 2012, INJURY, V43, P670, DOI 10.1016/j.injury.2011.03.008; Godsell J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34604; Guimaraes-Costa AB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00523; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Honda M, 2013, TRANSPLANTATION, V95, P551, DOI 10.1097/TP.0b013e31827d62b5; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/eLife.24437, 10.7554/elife.24437]; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Khosa S, 2018, NEUROPATHOLOGY, V38, P646, DOI 10.1111/neup.12520; Kim JG, 2009, PHYSIOL MEAS, V30, P529, DOI 10.1088/0967-3334/30/7/001; Kim JY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215299; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Knight JS, 2013, J CLIN INVEST, V123, P2981, DOI 10.1172/JCI67390; Kusunoki Y, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00227; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leffler J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0726-y; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lindau D, 2014, ANN RHEUM DIS, V73, P2199, DOI 10.1136/annrheumdis-2012-203041; Liu L, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12579; Mallavia B, 2020, AM J RESP CELL MOL, V62, P364, DOI 10.1165/rcmb.2019-0140OC; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; McIlroy DJ, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.07.013; Muchir A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-17; Nie M, 2019, CLIN CANCER RES, V25, P1867, DOI 10.1158/1078-0432.CCR-18-1226; Okada M, 2018, SURG TODAY, V48, P1089, DOI 10.1007/s00595-018-1696-x; Oklu R, 2013, J VASC SURG, V58, P1627, DOI 10.1016/j.jvs.2013.02.241; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Patel R, 2012, AM J SURG, V203, P488, DOI 10.1016/j.amjsurg.2011.05.005; Ramser B, 2009, J INVEST DERMATOL, V129, P2419, DOI 10.1038/jid.2009.80; Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266; Sorensen OE, 2016, J CLIN INVEST, V126, P1612, DOI 10.1172/JCI84538; Stepien DM, 2020, J IMMUNOL, V204, P2203, DOI 10.4049/jimmunol.1900814; Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004; Thomas MM, 2014, FASEB J, V28, P2098, DOI 10.1096/fj.13-238972; Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Walters TJ, 2008, APPL PHYSIOL NUTR ME, V33, P272, DOI 10.1139/H07-180; Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017; Willis R, 2012, LUPUS, V21, P830, DOI 10.1177/0961203312437270; Willis VC, 2017, CLIN EXP IMMUNOL, V188, P263, DOI 10.1111/cei.12932; Wong SL, 2018, FASEB J, V32, P6358, DOI 10.1096/fj.201800691R; Wosczyna MN, 2018, DEV CELL, V46, P135, DOI 10.1016/j.devcel.2018.06.018; XU S, 2017, SCI REP UK, V7; Zhang J, 2016, AM J TRANSL RES, V8, P4054; Zhong W, 2009, HEPATOLOGY, V50, P1524, DOI 10.1002/hep.23189; Zhou QL, 2018, EXP CELL RES, V370, P506, DOI 10.1016/j.yexcr.2018.07.016; Zhu BL, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/5701719	80	8	10	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15753	15770		10.1096/fj.202000994RR	http://dx.doi.org/10.1096/fj.202000994RR		OCT 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33089917	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000582261400001
J	Wei, LX; Cao, P; Xu, C; Zhong, HJ; Wang, XK; Bai, MZ; Hu, B; Wang, RZ; Liu, N; Tian, Y; Chen, HJ; Li, JS; Yuan, W				Wei, Leixin; Cao, Peng; Xu, Chen; Zhong, Huajian; Wang, Xiukun; Bai, Meizhu; Hu, Bo; Wang, Ruizhe; Liu, Ning; Tian, Ye; Chen, Huajiang; Li, Jinsong; Yuan, Wen			Chondroitin synthase-3 regulates nucleus pulposus degeneration through actin-induced YAP signaling	FASEB JOURNAL			English	Article						chondroitin sulfate; intervertebral disc degeneration; nucleus pulposus; Yap	INTERVERTEBRAL DISC DEGENERATION; MOLECULAR-CLONING; SULFATE GLUCURONOSYLTRANSFERASE; POLYMERIZING FACTOR; N-ACETYLGALACTOSAMINYLTRANSFERASE; CONTACT INHIBITION; NEEDLE PUNCTURE; MODIFIED MICE; EXPRESSION; CELL	Loss of chondroitin sulfate (CS) has been reported to play a key role during intervertebral disc degeneration (IDD). However, the detailed mechanism of CS and its synthases have not been elucidated. Since CS is mainly synthesized by chondroitin synthases 3 (Chsy3), here, the Chsy3 knockout mice are generated by using CRISPR-Cas9 and semi-cloning technology to study its mechanism during IDD. We find that CS and Chsy3 expression are decreased during IDD both in human and mice nucleus pulposus (NP) tissue, and knockout of Chsy3 shows that spontaneous IDD phenotype resembles that of human samples in theChsy3(-/-)mice. Taking advantage of RNA-Seq data, we confirm increased catabolic and decreased anabolic changes inChsy3(-/-)NP cells. By using bioinformatic analysis and validation, we find that Hippo signaling pathway is significantly downregulated, and the activation of Yap1 is mainly affected inChsy3(-/-)NP cells. Furthermore, functional analyses have shown that Chsy3 could regulate NP cell degeneration by Actin tension mediated activation of Yap1, which is independent of Hippo/Lats signaling. In summary, our findings reveal a novel mechanism that depletion of CS-related Chsy3 can cause spontaneous intervertebral disc degeneration by mediating Yap activation through CS-related actin-tension in NP cells.	[Wei, Leixin; Cao, Peng; Xu, Chen; Zhong, Huajian; Hu, Bo; Wang, Ruizhe; Liu, Ning; Tian, Ye; Chen, Huajiang; Yuan, Wen] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai 200003, Peoples R China; [Wei, Leixin; Wang, Xiukun; Bai, Meizhu; Li, Jinsong] Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Shanghai Key Lab Mol Andr, Shanghai 200031, Peoples R China	Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yuan, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai 200003, Peoples R China.; Li, JS (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Shanghai Key Lab Mol Andr, Shanghai 200031, Peoples R China.	jsli@sibcb.ac.cn; yuanwenspine@smmu.edu.cn	Li, Jin/GYQ-5363-2022; Xu, Chen/AAQ-5514-2020	Xu, Chen/0000-0001-8068-2109; Bai, Meizhu/0000-0001-8208-4073	National Nature Science Foundation of China [82002335, 81972088, 82072471, 81672211, 81871802, 81772376, 81601928, 81702149, 31971109, 31471390]; Shanghai Municipal Commission of Health and Family Planning [17140901500, 18ZR1438900, 20QA1409200, 20184Y0181]; Shanghai Education Development Foundation; Shanghai Municipal Education Commission "Chen Guang" Program [17CG36]; Shanghai "Rising Stars of Medical Talent" Youth Development Program	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning; Shanghai Education Development Foundation; Shanghai Municipal Education Commission "Chen Guang" Program; Shanghai "Rising Stars of Medical Talent" Youth Development Program	National Nature Science Foundation of China, Grant/Award Number: 82002335, 81972088, 82072471, 81672211, 81871802, 81772376, 81601928, 81702149, 31971109 and 31471390; Shanghai Municipal Commission of Health and Family Planning, Grant/Award Number: 17140901500, 18ZR1438900, 20QA1409200 and 20184Y0181; Shanghai Education Development Foundation; Shanghai Municipal Education Commission "Chen Guang" Program, Grant/Award Number: 17CG36; Shanghai "Rising Stars of Medical Talent" Youth Development Program	Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Choi H, 2018, MATRIX BIOL, V70, P102, DOI 10.1016/j.matbio.2018.03.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Gu YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136042; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hu B, 2018, J CELL BIOCHEM, V119, P566, DOI 10.1002/jcb.26215; Hu B, 2017, ONCOTARGET, V8, P49303, DOI 10.18632/oncotarget.17571; Hutton WC, 1997, J SPINAL DISORD, V10, P47; Ishimaru D, 2014, OSTEOARTHR CARTILAGE, V22, P250, DOI 10.1016/j.joca.2013.11.010; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Lei T, 2017, AM J TRANSL RES, V9, P900; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Moreno-Vicente R, 2018, CELL REP, V25, P1622, DOI 10.1016/j.celrep.2018.10.024; Nishiyama H, 1985, Nihon Seikeigeka Gakkai Zasshi, V59, P1119; Ogawa H, 2010, J BIOL CHEM, V285, P34155, DOI 10.1074/jbc.M110.109553; Oichi T, 2018, SPINE, V43, pE557, DOI 10.1097/BRS.0000000000002427; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Sivan SS, 2014, BBA-GEN SUBJECTS, V1840, P3181, DOI 10.1016/j.bbagen.2014.07.013; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; van Meurs JBJ, 2017, OSTEOARTHR CARTILAGE, V25, P181, DOI 10.1016/j.joca.2016.11.011; Wang S, 2014, CELL PROLIFERAT, V47, P381, DOI 10.1111/cpr.12121; Wang WJ, 2015, CLIN CHIM ACTA, V448, P238, DOI 10.1016/j.cca.2015.06.023; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Zhang C, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12492; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhong CQ, 2017, METHODS MOL BIOL, V1498, P121, DOI 10.1007/978-1-4939-6472-7_8; Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005	40	6	6	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16581	16600		10.1096/fj.202001021R	http://dx.doi.org/10.1096/fj.202001021R		OCT 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33089528	hybrid			2022-12-28	WOS:000582261300001
J	Carneros, D; Medina-Gomez, G; Giralt, M; Leon-Camacho, M; Campbell, M; Moreno-Aliaga, MJ; Villarroya, F; Bustos, M				Carneros, David; Medina-Gomez, Gema; Giralt, Marta; Leon-Camacho, Manuel; Campbell, Mark; Moreno-Aliaga, Maria J.; Villarroya, Francesc; Bustos, Matilde			Cardiotrophin-1 contributes to metabolic adaptations through the regulation of lipid metabolism and to the fasting-induced fatty acid mobilization	FASEB JOURNAL			English	Article						adipose tissue; fatty acid mobilization; food restriction; lipids; peroxisome proliferator-activated receptors	ADIPOSE-TISSUE; PPAR-ALPHA; LIPOLYSIS; LIVER; GAMMA; EXPRESSION; GLUCOSE; OBESITY; ACTIVATION; MECHANISMS	It is becoming clear that several human pathologies are caused by altered metabolic adaptations. During liver development, there are physiological changes, from the predominant utilization of glucose (fetal life) to the use of lipids (postnatal life). Fasting is another physiological stress that elicits well-known metabolic adjustments. We have reported the metabolic properties of cardiotrophin-1 (CT-1), a member of the interleukin-6 family of cytokines. Here, we aimed at analyzing the role of CT-1 in response to these metabolic changes. We used different in vivo models. Furthermore, a differential study was carried out with wild-type and CT-1 null mice in fed (ad libitum) and food-restricted conditions. We demonstrated thatCt-1is a metabolic gene induced in the liver via PPAR alpha in response to lipids in mice (neonates- and food-restricted adults). We found thatCt-1mRNA expression in white adipose tissue directly involved PPAR alpha and PPAR gamma. Finally, the physiological role of CT-1 in fasting is confirmed by the impaired food restriction-induced adipose tissue lipid mobilization in CT-1 null mice. Our findings support a previously unrecognized physiological role of CT-1 in metabolic adaptations, through the regulation of lipid metabolism and contributes to fasting-induced free fatty acid mobilization.	[Carneros, David; Bustos, Matilde] Univ Seville, Virgen del Rocio Univ Hosp, CSIC, Inst Biomed Seville IBiS,Area Liver Digest & Infl, Seville, Spain; [Medina-Gomez, Gema] Rey Juan Carlos Univ, Dept Basic Sci Hlth, Area Biochem & Mol Biol, Madrid, Spain; [Giralt, Marta; Villarroya, Francesc] Barcelona Univ, Dept Biochem & Mol Biomed, Barcelona, Spain; [Giralt, Marta; Moreno-Aliaga, Maria J.; Villarroya, Francesc] Inst Hlth Carlos III ISCIII, CIBERobn Physiopathol Obes & Nutr, Madrid, Spain; [Leon-Camacho, Manuel] Inst Grasa, CSIC, Dept Lipid Characterizat & Qual, Seville, Spain; [Campbell, Mark] Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, MRC MDU, Cambridge, England; [Moreno-Aliaga, Maria J.] Univ Navarra, Navarras Hlth Res Inst IdiSNA, Sch Pharm & Nutr, Ctr Nutr Res, Pamplona, Spain; [Moreno-Aliaga, Maria J.] Univ Navarra, Navarras Hlth Res Inst IdiSNA, Sch Pharm & Nutr, Dept Nutr Food Sci & Physiol, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universidad Rey Juan Carlos; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Navarra; University of Navarra	Bustos, M (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla IBIS, Avda Manuel Siurot S-N, Seville 41013, Spain.	mbustos-ibis@us.es	Giralt, Marta/A-4756-2013; Medina-Gomez, Gema/CAF-4668-2022; Medina-Gomez, Gema/CAI-1063-2022; Moreno-Aliaga, Maria J/M-7015-2018	Giralt, Marta/0000-0001-7968-4190; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Moreno-Aliaga, Maria J/0000-0002-2018-6434	Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia) [P18-RT-4775]; Instituto de Salud Carlos III (ISCIII) [IFI 19/00048, PI16/01791]; MINECO/AE/FEDER,UE [PID2019-110587RB-100]	Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); MINECO/AE/FEDER,UE	Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia), Grant/Award Number: P18-RT-4775; Instituto de Salud Carlos III (ISCIII), Grant/Award Number: IFI 19/00048, PI16/01791 and MINECO/AE/FEDER,UE PID2019-110587RB-100	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Carneros D, 2019, FASEB J, V33, P7578, DOI 10.1096/fj.201801563R; Castano D, 2014, J HEPATOL, V60, P1017, DOI 10.1016/j.jhep.2013.12.012; Cron L, 2016, J EXP BIOL, V219, P259, DOI 10.1242/jeb.129213; Enoksson S, 2000, DIABETES, V49, P2149, DOI 10.2337/diabetes.49.12.2149; FERRE P, 1978, PEDIATR RES, V12, P751, DOI 10.1203/00006450-197807000-00002; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Hondares E, 2014, METABOLISM, V63, P312, DOI 10.1016/j.metabol.2013.11.014; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hung HC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17438; Hung HC, 2013, INT J CARDIOL, V169, pE33, DOI 10.1016/j.ijcard.2013.08.112; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Liu ML, 2012, BIOCHIMIE, V94, P2126, DOI 10.1016/j.biochi.2012.01.008; Lopez-Yoldi M, 2015, CYTOKINE GROWTH F R, V26, P523, DOI 10.1016/j.cytogfr.2015.07.009; Lopez-Yoldi M, 2014, J LIPID RES, V55, P2634, DOI 10.1194/jlr.M055335; Malavazos AE, 2008, HYPERTENSION, V51, pE8, DOI 10.1161/HYPERTENSIONAHA.107.105346; Marques JM, 2007, HEPATOLOGY, V45, P639, DOI 10.1002/hep.21508; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; MEHLER MF, 1995, INT J DEV NEUROSCI, V13, P213, DOI 10.1016/0736-5748(94)00060-G; Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4; Montgomery MK, 2019, FASEB J, V33, P13267, DOI 10.1096/fj.201900909RR; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Natal C, 2008, AM J PHYSIOL-ENDOC M, V294, pE52, DOI 10.1152/ajpendo.00506.2007; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Preite NZ, 2016, J ENDOCRINOL, V231, P259, DOI 10.1530/JOE-16-0199; Quehenberger O, 2011, BBA-MOL CELL BIOL L, V1811, P648, DOI 10.1016/j.bbalip.2011.07.006; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; Rodriguez-Cuenca S, 2012, MOL CELL BIOL, V32, P1555, DOI 10.1128/MCB.06154-11; Rogue A, 2014, TOXICOL APPL PHARM, V276, P73, DOI 10.1016/j.taap.2014.02.001; Stephens J, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020024; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vespasiani-Gentilucci U, 2013, ARCH MED SCI, V9, P635, DOI 10.5114/aoms.2013.37272; Viera-Alcaide I, 2007, ANAL CHIM ACTA, V596, P319, DOI 10.1016/j.aca.2007.06.026; Wei D, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2020.117414; Wu JW, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006716; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Wueest S, 2014, AM J PHYSIOL-REG I, V306, pR861, DOI 10.1152/ajpregu.00533.2013; Xia B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007110; Yubero P, 2004, ENDOCRINOLOGY, V145, P4268, DOI 10.1210/en.2004-0099; Zechner R, 2017, NAT REV MOL CELL BIO, V18, P671, DOI 10.1038/nrm.2017.76; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang YX, 2018, P NATL ACAD SCI USA, V115, pE6039, DOI 10.1073/pnas.1806366115	50	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15875	15887		10.1096/fj.202000109R	http://dx.doi.org/10.1096/fj.202000109R		OCT 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047392				2022-12-28	WOS:000581170500001
J	Juge, N; Avci, F; Scott, NE; Creuzenet, C; Valvano, MA				Juge, Nathalie; Avci, Fikri; Scott, Nichollas E.; Creuzenet, Carole; Valvano, Miguel A.			2020 FASEB Science Research Conference on Microbial Glycobiology, July 13-14, 2020	FASEB JOURNAL			English	Article									[Juge, Nathalie] Quadram Inst Biosci, Gut Microbes & Hlth Inst Strateg Programme, Norwich Res Pk, Norwich, Norfolk, England; [Avci, Fikri] Univ Georgia, Ctr Mol Med, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Scott, Nichollas E.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Valvano, Miguel A.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University System of Georgia; University of Georgia; University of Melbourne; Western University (University of Western Ontario); Queens University Belfast	Valvano, MA (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	m.valvano@qub.ac.uk		Avci, Fikri/0000-0002-1902-7532	Chemical Biology (ACS Publications); Society for Glycobiology; Glycom (HOrsholm, Denmark); Journal of Biological Chemistry; VaxNewMo LLC (St. Louis, MO, USA); GLYcoDiag (Orleans, France); Microbiology Society; BBSRC [BBS/E/F/00044452] Funding Source: UKRI	Chemical Biology (ACS Publications); Society for Glycobiology; Glycom (HOrsholm, Denmark); Journal of Biological Chemistry; VaxNewMo LLC (St. Louis, MO, USA); GLYcoDiag (Orleans, France); Microbiology Society; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The FASEB Conference on Microbial Glycobiology received support from the following sponsors: Chemical Biology (ACS Publications), the Society for Glycobiology, Glycom (HOrsholm, Denmark), the Journal of Biological Chemistry, VaxNewMo LLC (St. Louis, MO, USA), GLYcoDiag (Orleans, France), and the Microbiology Society. The Organizing Committee thanks the sponsors for their support. Sponsorship also allowed the committee to provide four awards for the best short talks and poster presentations by junior researchers, which were given to: Andrew Bell (Quadram Institute Bioscience, Norwich, UK), Kelly Lee (University of Nottingham, Nottingham, UK), Sarah Tindall (University of York, York, UK), and Wouter van Bakel (Quadram Institute Bioscience).		0	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14069	14072		10.1096/fj.202002191	http://dx.doi.org/10.1096/fj.202002191		OCT 2020	4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	33031616				2022-12-28	WOS:000576979600001
J	Lane, TE; Segal, BM				Lane, Thomas E.; Segal, Benjamin M.			The 2020 FASEB Science Research Conference on Translational Neuroimmunology: From Mechanisms to Therapeutics, June 29-30, 2020	FASEB JOURNAL			English	Editorial Material									[Lane, Thomas E.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Segal, Benjamin M.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA	University of California System; University of California Irvine; Ohio State University	Lane, TE (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	tlane@uci.edu		Segal, Benjamin/0000-0002-0906-6319	NIH/NIND [1R13 NS116795]	NIH/NIND(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH/NIND, Grant/Award Number: 1R13 NS116795		0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14064	14068		10.1096/fj.202002065	http://dx.doi.org/10.1096/fj.202002065		OCT 2020	5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	33001447	Green Accepted			2022-12-28	WOS:000575398500001
J	Zhang, N; Wang, YL; Zhang, JL; Liu, BB; Deng, XL; Xin, SL; Xu, KS				Zhang, Ning; Wang, Yuli; Zhang, Junli; Liu, Beibei; Deng, Xiaoling; Xin, Shengliang; Xu, Keshu			N-glycosylation of CREBH improves lipid metabolism and attenuates lipotoxicity in NAFLD by modulating PPAR alpha and SCD-1	FASEB JOURNAL			English	Article						cyclic AMP-responsive element-binding protein H; lipid metabolism; lipotoxicity; N-glycosylation; peroxisome proliferator-activated receptor alpha; stearoyl-CoA desaturase-1	FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; BOUND TRANSCRIPTION FACTOR; ELEMENT-BINDING PROTEIN; NONALCOHOLIC STEATOHEPATITIS; LINKED GLYCOSYLATION; GENE-EXPRESSION; ACTIVATION; MECHANISM; CELLS	Introduction: Cyclic adenosine monophosphate (AMP)-responsive element-binding protein H (CREBH), an endoplasmic reticulum-anchored transcription factor essential for lipid metabolism and inflammation in nonalcoholic fatty liver disease (NAFLD), is covalently modified by N-acetylglucosamine. Glycosylation is a ubiquitous type of protein involved in posttranslational modifications, and plays a critical role in various biological processes. However, the mechanism of glycosylated CREBH remains poorly understood in NAFLD. Methods: CREBH glycosylation mutants were obtained by site-mutation methods. After transfection with plasmids, AML-12, LO2, or HepG2 cells were treated with palmitic acid (PA) proteolysis, tunicamycin (Tm), or their combination. Glycosyltransferase V (GnT-V) was used induce hyperglycosylation to further understand the effect of CREBH. In addition, glycosylation mutant mice and hyperglycosylated mice were generated by lentivirus injection to construct two kinds of NAFLD animal models. The expression of NAFLD-related factors was detected to further verify the role of N-linked glycosylation of CREBH in lipid and sterol metabolism, inflammation, and lipotoxicity. Results: N-glycosylation enhanced the ability of CREBH to activate transcription and modulated the production of peroxisome proliferator-activated receptor alpha (PPAR alpha) and stearoyl-CoA desaturase-1 (SCD-1) activity by affecting their promoter-driven transcription activity and protein interactions, leading to reduce lipid deposition and attenuate lipotoxicity. Deglycosylation of CREBH induced by Tm could inhibit the proteolysis of CREBH induced by PA. The addition of unglycosylated CREBH to cells upregulates gene and protein expression of lipogenesis, lipotoxicity, and inflammation, and aggravates liver damage by preventing glycosylation in cells, as well as in mouse models of NAFLD. Furthermore, increased N-glycosylation of CREBH, as achieved by overexpressing GnT-V could significantly improve liver lesion caused by unglycosylation of CREBH. Conclusion: These findings have important implications for the role of CREBH N-glycosylation in proteolytic activation, and they provide the first link between N-glycosylation of CREBH, lipid metabolism, and lipotoxicity processes in the liver by modulating PPAR alpha and SCD-1. These results provide novel insights into the N-glycosylation of CREBH as a therapeutic target for NAFLD.	[Zhang, Ning] Nanchang Univ, Affiliated Ganzhou Hosp, Div Gastroenterol, Ganzhou, Peoples R China; [Wang, Yuli] Nanchang Univ, Affiliated Ganzhou Hosp, Div Oncol, Ganzhou, Peoples R China; [Zhang, Junli; Liu, Beibei; Deng, Xiaoling; Xin, Shengliang; Xu, Keshu] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China	Nanchang University; Nanchang University; Huazhong University of Science & Technology	Xu, KS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China.	xuzoumedmail@126.com	liu, bb/GXA-2527-2022		National Natural Science Foundation of China [81670515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81670515)	Balakrishnan M, 2020, CLIN GASTROENTEROL H, VS1542-3565, P30612; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Carillo S, 2017, METHODS MOL BIOL, V1603, P227, DOI 10.1007/978-1-4939-6972-2_15; Chan CP, 2010, J CELL SCI, V123, P1438, DOI 10.1242/jcs.067819; Chattopadhyay S, 2010, BIOINFORMATION, V4, P448, DOI 10.6026/97320630004448; Chu DT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13093; Cui J, 2018, J PATHOL, V245, P41, DOI 10.1002/path.5054; CZY A, 2009, BIOCHEM BIOPH RES CO, V381, P176; Del Campo JA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030911; Deng XL, 2017, BBA-MOL CELL BIOL L, V1862, P337, DOI 10.1016/j.bbalip.2016.12.007; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dutta D, 2017, BBA-GEN SUBJECTS, V1861, P3096, DOI 10.1016/j.bbagen.2017.08.025; Romero-Ibarguengoitia ME, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193138; Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003; Fan JG, 2009, HEPATOB PANCREAT DIS, V8, P233; Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3; George J, 2018, J HEPATOL, V68, P227, DOI 10.1016/j.jhep.2017.11.016; Guo HB, 2014, J BIOL CHEM, V289, P31534, DOI 10.1074/jbc.M114.602680; Guo XQ, 2017, ANTI-CANCER DRUG, V28, P66, DOI 10.1097/CAD.0000000000000431; Hacker B, 2018, HUM MOL GENET, V27, P1858, DOI 10.1093/hmg/ddy087; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Jin NN, 2018, BIOCHEM BIOPH RES CO, V497, P194, DOI 10.1016/j.bbrc.2018.02.053; Kamada Y, 2016, AM J PHYSIOL-GASTR L, V311, pG859, DOI 10.1152/ajpgi.00231.2016; Kim H, 2019, FASEB J, V33, P7896, DOI 10.1096/fj.201802528R; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Li FY, 2015, BIOINFORMATICS, V31, P1411, DOI 10.1093/bioinformatics/btu852; Li YJ, 2017, HEPATOLOGY, V66, P481, DOI 10.1002/hep.29206; Lloyd KA, 2018, EUR J IMMUNOL, V48, P1030, DOI 10.1002/eji.201747446; Lonardo A, 2017, DIGEST LIVER DIS, V49, P471, DOI 10.1016/j.dld.2017.01.147; Massaro M, 2016, PHARMACOL RES, V107, P125, DOI 10.1016/j.phrs.2016.02.027; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Nakagawa Y, 2014, ENDOCRINOLOGY, V155, P4706, DOI 10.1210/en.2014-1113; Park JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27938; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Petrus P, 2017, INT J OBESITY, V41, P1295, DOI 10.1038/ijo.2017.106; Popeijus HE, 2014, MOL NUTR FOOD RES, V58, P2342, DOI 10.1002/mnfr.201400314; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shigefuku R, 2012, J GASTROENTEROL, V47, P1238, DOI 10.1007/s00535-012-0581-4; Siddique H, 2009, INT J ONCOL, V35, P387, DOI 10.3892/ijo_00000351; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Tong XD, 2015, J NUTR BIOCHEM, V26, P921, DOI 10.1016/j.jnutbio.2015.03.011; Tuong TTK, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10030159; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang M, 2016, MOL MED REP, V13, P1455, DOI 10.3892/mmr.2015.4749; Wang XD, 2018, J MOL CELL CARDIOL, V117, P19, DOI 10.1016/j.yjmcc.2018.02.013; Xu BL, 2017, MED SCI MONITOR, V23, P1363, DOI 10.12659/MSM.900033; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Xue J, 2010, GLYCOBIOLOGY, V20, P905, DOI 10.1093/glycob/cwq048; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077256; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298	61	6	6	6	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15338	15363		10.1096/fj.202000836RR	http://dx.doi.org/10.1096/fj.202000836RR		SEP 2020	26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32996649				2022-12-28	WOS:000574659800001
J	Yashiro, T; Yura, S; Tobita, A; Toyoda, Y; Kasakura, K; Nishiyama, C				Yashiro, Takuya; Yura, Shiori; Tobita, Akari; Toyoda, Yuki; Kasakura, Kazumi; Nishiyama, Chiharu			Pterostilbene reduces colonic inflammation by suppressing dendritic cell activation and promoting regulatory T cell development	FASEB JOURNAL			English	Article						colitis; immunosuppression; pterostilbene; resveratrol	TRANSCRIPTIONAL REGULATION; EXPRESSION; RECEPTOR; KINASE; RESVERATROL; CALCINEURIN; INHIBITORS; SUBSTRATE; DISEASES; COLITIS	Dendritic cells (DCs) and T cells play important roles in immune regulation, and modulating their function is an approach for developing preventive or therapeutic strategies against immune disorders. Herein, the effect of pterostilbene (PSB) (3 ',5 '-dimethoxy-resveratrol)-a resveratrol-related polyphenol found in blueberries-on immune regulation was evaluated. Using an in vitro co-culture system, PSB was found to exert the strongest inhibitory effect among all tested resveratrol derivatives on DC-mediated T cell proliferation; moreover, PSB treatment decreased the Th1 and Th17 populations and increased the regulatory T cell (Treg) population. Upon co-stimulation with anti-CD3 and anti-CD28 antibodies, PSB inhibited CD4(+)T cell proliferation and differentiation into Th1 cells. Additionally, PSB acted on DCs to suppress the lipopolysaccharide-induced transactivation of genes encoding antigen presentation-related molecules and inflammatory cytokines by attenuating the DNA-binding ability of the transcription factor PU.1. Furthermore, PSB promoted DC-mediated Foxp3(+)Treg differentiation, and PU.1 knockdown increased DC-induced Treg activity. Oral administration of PSB alleviated the symptoms of dextran sulfate sodium-induced colitis and decreased tumor necrosis factor-alpha expression in mice. Thus, PSB treatment ameliorates colonic inflammation.	[Yashiro, Takuya; Yura, Shiori; Tobita, Akari; Toyoda, Yuki; Kasakura, Kazumi; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo, Japan	Tokyo University of Science	Yashiro, T (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	tyashiro@rs.tus.ac.jp	Nishiyama, Chiharu/GPW-9372-2022		MEXT; Tokyo Biochemical Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Takeda Science Foundation; Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists) [10792];  [19K05884];  [17K15275]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (CN), Grant-in-Aid for Scientific Research (C) (TY; 19K05884), Grant-in-Aid for Young Scientists (B) (TY; 17K15275), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science), the Tokyo Biochemical Research Foundation (CN), the Tojuro Iijima Foundation for Food Science and Technology (CN and TY), and the Takeda Science Foundation (CN). TY was supported by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #10792)	Chang GM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9872073; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Fonseca-Camarillo G, 2015, INFLAMM BOWEL DIS, V21, P2188, DOI 10.1097/MIB.0000000000000477; Fukai T, 2009, BIOCHEM BIOPH RES CO, V388, P102, DOI 10.1016/j.bbrc.2009.07.126; Gibson DJ, 2013, INFLAMM BOWEL DIS, V19, P2716, DOI 10.1097/MIB.0b013e31829ed7df; Guttman-Yassky E, 2017, CURR OPIN IMMUNOL, V48, P68, DOI 10.1016/j.coi.2017.08.008; Hamdorf M, 2011, STEM CELLS, V29, P297, DOI 10.1002/stem.564; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Inaba K, 2020, J IMMUNOL, V205, P822, DOI 10.4049/jimmunol.1901008; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Kessler Sean P, 2015, Int J Cell Biol, V2015, P745237, DOI 10.1155/2015/745237; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Malaguarnera L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050946; Nunes S, 2018, NUTR RES REV, V31, P85, DOI 10.1017/S095442241700021X; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Palanki MSS, 2002, CURR MED CHEM, V9, P219, DOI 10.2174/0929867023371265; Rimando AM, 2005, J AGR FOOD CHEM, V53, P3403, DOI 10.1021/jf0580364; Ruhlmann A, 1997, IMMUNOBIOLOGY, V198, P192; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; van Panhuys N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00006; Waldner M, 2016, BRIT J CLIN PHARMACO, V82, P1158, DOI 10.1111/bcp.12893; Wang C, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104442; Yao Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23051148; Yashiro T, 2019, FASEB J, V33, P11481, DOI 10.1096/fj.201900379RR; Yashiro T, 2018, J IMMUNOL, V201, P3677, DOI 10.4049/jimmunol.1800492; Yashiro T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34825; Yashiro T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137699; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; Zhang J, 1999, J IMMUNOL, V162, P3819; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	40	11	11	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14810	14819		10.1096/fj.202001502R	http://dx.doi.org/10.1096/fj.202001502R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32964554	hybrid			2022-12-28	WOS:000573907800001
J	Watson, WD; Timm, KN; Lewis, AJ; Miller, JJJ; Emmanuel, Y; Clarke, K; Neubauer, S; Tyler, DJ; Rider, OJ				Watson, William D.; Timm, Kerstin N.; Lewis, Andrew J.; Miller, Jack J. J.; Emmanuel, Yaso; Clarke, Kieran; Neubauer, Stefan; Tyler, Damian J.; Rider, Oliver J.			Nicotinic acid receptor agonists impair myocardial contractility by energy starvation	FASEB JOURNAL			English	Article						cardiac metabolism; nicotinic acid; P-31 MR spectroscopy; hyperpolarized(13)C pyruvate	MAGNETIC-RESONANCE-SPECTROSCOPY; PYRUVATE-DEHYDROGENASE FLUX; REDOX STATE; IN-VIVO; HEART; INSULIN; METABOLISM; MECHANISMS; ACIPIMOX; GPR109A	Nicotinic acid receptor agonists have previously been shown to cause acute reductions in cardiac contractility. We sought to uncover the changes in cardiac metabolism underlying these alterations in function. In nine humans, we recorded cardiac energetics and function before and after a single oral dose of nicotinic acid using cardiac MRI to demonstrate contractile function and Phosphorus-31 (P-31) magnetic resonance spectroscopy to demonstrate myocardial energetics. Nicotinic Acid 400 mg lowered ejection fraction by 4% (64 +/- 8% to 60 +/- 7%,P = .03), and was accompanied by a fall in phosphocreatine/ATP ratio by 0.4 (2.2 +/- 0.4 to 1.8 +/- 0.1,P = .04). In four groups of eight Wistar rats, we used pyruvate dehydrogenase (PDH) flux studies to demonstrate changes in carbohydrate metabolism induced by the nicotinic acid receptor agonist, Acipimox, using hyperpolarized Carbon-13 (C-13) magnetic resonance spectroscopy. In rats which had been starved overnight, Acipimox caused a fall in ejection fraction by 7.8% (67.5 +/- 8.9 to 60 +/- 3.1,P = .03) and a nearly threefold rise in flux through PDH (from 0.182 +/- 0.114 to 0.486 +/- 0.139,P = .002), though this rise did not match pyruvate dehydrogenase flux observed in rats fed carbohydrate rich chow (0.726 +/- 0.201). In fed rats, Acipimox decreased pyruvate dehydrogenase flux (to 0.512 +/- 0.13,P = .04). Concentration of plasma insulin fell by two-thirds in fed rats administered Acipimox (from 1695 +/- 891 ng/L to 550 +/- 222 ng/L,P = .005) in spite of glucose concentrations remaining the same. In conclusion, we demonstrate that nicotinic acid receptor agonists impair cardiac contractility associated with a decline in cardiac energetics and show that the mechanism is likely a combination of reduced fatty acid availability and a failure to upregulate carbohydrate metabolism, essentially starving the heart of fuel.	[Watson, William D.; Lewis, Andrew J.; Miller, Jack J. J.; Neubauer, Stefan; Rider, Oliver J.] Univ Oxford, Dept Cardiovasc Med, Oxford Ctr Clin Magnet Resonance Res, Oxford, England; [Timm, Kerstin N.; Miller, Jack J. J.; Emmanuel, Yaso; Clarke, Kieran; Tyler, Damian J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Miller, Jack J. J.] Univ Oxford, Dept Phys, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Watson, WD (corresponding author), Univ Oxford, Oxford Ctr Clin Magnet Resonance Res, Dept Cardiovasc Med, Radcliffe Dept Med,John Radcliffe Hosp, Oxford OX3 9DU, England.	william.watson@st-annes.ox.ac.uk	Miller, Jack J/AGJ-2547-2022	Miller, Jack J/0000-0002-6258-1299; Neubauer, Stefan/0000-0001-9017-5645	British Heart Foundation [FS FS/16/70/32157, FS/17/48/32907, FS/16/7/31843, FS/19/18/34252]; EPSRC Doctoral Prize Fellowship [EP/M508111/1]; Novo Nordisk Postdoctoral Research Fellowship; University of Oxford; British Heart Foundation; MRC [G0601490] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); EPSRC Doctoral Prize Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Novo Nordisk Postdoctoral Research Fellowship; University of Oxford; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the British Heart Foundation. WW is supported by a British Heart Foundation Clinical Research Training Fellowship (FS/17/48/32907). KNT is supported by a British Heart Foundation Immediate Postdoctoral Basic Science Research Fellowship (FS/16/7/31843). DJT is supported by a British Heart Foundation Senior Fellowship (FS/19/18/34252). OR is supported by a British Heart Foundation Intermediate Fellowship (FS FS/16/70/32157). JJM would like to acknowledge an EPSRC Doctoral Prize Fellowship (ref. EP/M508111/1) and Novo Nordisk Postdoctoral Research Fellowship run in conjunction with the University of Oxford	Abel ED, 2004, FRONT BIOSCI-LANDMRK, V9, P201, DOI 10.2741/1216; Chen LH, 2015, MOL CELL ENDOCRINOL, V404, P56, DOI 10.1016/j.mce.2015.01.029; Donati A, 2004, EXP GERONTOL, V39, P1061, DOI 10.1016/j.exger.2004.03.025; Halbirk M, 2010, AM J PHYSIOL-HEART C, V299, pH1220, DOI 10.1152/ajpheart.00475.2010; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Karwi QG, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00068; KNUUTI MJ, 1995, J MOL CELL CARDIOL, V27, P1359; KNUUTI MJ, 1994, J NUCL MED, V35, P989; Le Page LM, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4099; Le Page LM, 2015, DIABETES, V64, P2735, DOI 10.2337/db14-1560; Lehto HR, 2012, J CLIN ENDOCR METAB, V97, P3277, DOI 10.1210/jc.2012-1219; Lewis AJM, 2016, DIABETES, V65, P3544, DOI 10.2337/db16-0804; Li CW, 1996, NMR BIOMED, V9, P141, DOI 10.1002/(SICI)1099-1492(199606)9:4<141::AID-NBM403>3.0.CO;2-P; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Opie LH, 2009, J AM COLL CARDIOL, V54, P1637, DOI 10.1016/j.jacc.2009.07.024; Purvis LAB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185356; RANDLE PJ, 1963, LANCET, V1, P785; Rider OJ, 2013, EUR HEART J, V34, P292, DOI 10.1093/eurheartj/ehs341; Rider OJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-9; Rodgers CT, 2010, MAGN RESON MED, V63, P881, DOI 10.1002/mrm.22230; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Slart RHJA, 2004, J NUCL MED, V45, P176; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; STONE CK, 1995, J NUCL MED, V36, P996; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Tuunanen H, 2006, CIRCULATION, V114, P2130, DOI 10.1161/CIRCULATIONAHA.106.645184; Tyler DJ, 2009, NMR BIOMED, V22, P405, DOI 10.1002/nbm.1350; van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wang N, 2016, GEN COMP ENDOCR, V237, P98, DOI 10.1016/j.ygcen.2016.08.011; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wolf P, 2016, NUTR METAB CARDIOVAS, V26, P387, DOI 10.1016/j.numecd.2016.03.012; Zafrir B, 2014, CARDIOVASC DRUG THER, V28, P361, DOI 10.1007/s10557-014-6534-9	35	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14878	14891		10.1096/fj.202000084RR	http://dx.doi.org/10.1096/fj.202000084RR		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954525	Green Published, hybrid			2022-12-28	WOS:000572418700001
J	Xylaki, M; Boumpoureka, I; Kokotou, MG; Marras, T; Papadimitriou, G; Kloukina, I; Magrioti, V; Kokotos, G; Vekrellis, K; Emmanouilidou, E				Xylaki, Mary; Boumpoureka, Ioanna; Kokotou, Maroula G.; Marras, Theodoros; Papadimitriou, Georgia; Kloukina, Ismini; Magrioti, Victoria; Kokotos, George; Vekrellis, Kostas; Emmanouilidou, Evangelia			Changes in the cellular fatty acid profile drive the proteasomal degradation of alpha-synuclein and enhance neuronal survival	FASEB JOURNAL			English	Article						alpha-synuclein; arachidonic acid; degradation; oligomers; Parkinson's disease; phospholipase A(2); proteasome	CHAPERONE-MEDIATED AUTOPHAGY; PHOSPHOLIPASE A(2); ARACHIDONIC-ACID; MEMBRANE INTERACTIONS; SNARE COMPLEX; BINDING; MUTANT; TOXICITY; NEURODEGENERATION; OLIGOMERIZATION	Parkinson's disease is biochemically characterized by the deposition of aberrant aggregated alpha-synuclein in the affected neurons. The aggregation properties of alpha-synuclein greatly depend on its affinity to bind cellular membranes via a dynamic interaction with specific lipid moieties. In particular, alpha-synuclein can interact with arachidonic acid (AA), a polyunsaturated fatty acid, in a manner that promotes the formation of alpha-helix enriched assemblies. In a cellular context, AA is released from membrane phospholipids by phospholipase A(2)(PLA(2)). To investigate the impact of PLA(2)activity on alpha-synuclein aggregation, we have applied selective PLA(2)inhibitors to a SH-SY5Y cellular model where the expression of human wild-type alpha-synuclein is correlated with a gradual accumulation of soluble oligomers and subsequent cell death. We have found that pharmacological and genetic inhibition of GIVA cPLA(2)resulted in a dramatic decrease of intracellular oligomeric and monomeric alpha-synuclein significantly promoting cell survival. Our data suggest that alterations in the levels of free fatty acids, and especially AA and adrenic acid, promote the formation of alpha-synuclein conformers which are more susceptible to proteasomal degradation. This mechanism is active only in living cells and is generic since it does not depend on the absolute quantity of alpha-synuclein, the presence of disease-linked point mutations, the expression system or the type of cells. Our findings indicate that the alpha-synuclein-fatty acid interaction can be a critical determinant of the conformation and fate of alpha-synuclein in the cell interior and, as such, cPLA(2)inhibitors could serve to alleviate the intracellular, potentially pathological, alpha-synuclein burden.	[Xylaki, Mary; Boumpoureka, Ioanna; Kloukina, Ismini; Vekrellis, Kostas; Emmanouilidou, Evangelia] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Athens, Greece; [Kokotou, Maroula G.; Magrioti, Victoria; Kokotos, George] Natl & Kapodistrian Univ Athens, Dept Chem, Organ Chem Lab, Athens, Greece; [Marras, Theodoros; Papadimitriou, Georgia; Emmanouilidou, Evangelia] Natl & Kapodistrian Univ Athens, Dept Chem, Biochem Lab, Athens 15784, Greece; [Xylaki, Mary] Univ Med Ctr Goettingen, Dept Expt Neurodegenerat, Ctr Biostruct Imaging Neurodegenerat BIN, G ettingen, Germany	Academy of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Emmanouilidou, E (corresponding author), Natl & Kapodistrian Univ Athens, Dept Chem, Biochem Lab, Athens 15784, Greece.	eemman@chem.uoa.gr	Emmanouilidou, Evangelia/ACP-6562-2022	Xylaki, Mary/0000-0002-7892-8621	General Secretariat for Research and Technology (GSRT); Fondation Sante; Hellenic Foundation of Research and Innovation [1065]; SARG NKUA [16672]	General Secretariat for Research and Technology (GSRT)(Greek Ministry of Development-GSRT); Fondation Sante; Hellenic Foundation of Research and Innovation; SARG NKUA	General Secretariat for Research and Technology (GSRT), Grant/Award Number: COOPERATION II; Fondation Sante; Hellenic Foundation of Research and Innovation, Grant/Award Number: SemiSynPD, No. 1065; SARG NKUA, Grant/Award Number: 16672	Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Alza NP, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00175; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bate C, 2015, BIOMOLECULES, V5, P178, DOI 10.3390/biom5010178; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Calo L, 2016, MOVEMENT DISORD, V31, P169, DOI 10.1002/mds.26479; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Cliffe R, 2019, CELL REP, V26, P2140, DOI 10.1016/j.celrep.2019.01.096; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Corbett Grant T, 2015, Mov Disord, V30, P1870, DOI 10.1002/mds.26361; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Dedaki C, 2019, J MED CHEM, V62, P2916, DOI 10.1021/acs.jmedchem.8b01216; Dehay B, 2016, MOVEMENT DISORD, V31, P882, DOI 10.1002/mds.26568; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Drombosky KW, 2018, NEUROBIOL DIS, V120, P126, DOI 10.1016/j.nbd.2018.08.019; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Galvagnion C, 2017, J PARKINSON DIS, V7, P433, DOI 10.3233/JPD-171103; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Guerrero-Munoz MJ, 2014, NEUROBIOL DIS, V71, P14, DOI 10.1016/j.nbd.2014.08.008; Gustafsson G, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1018-z; Helwig M, 2016, BRAIN, V139, P856, DOI 10.1093/brain/awv376; Hirohata M, 2008, NEUROPHARMACOLOGY, V54, P620, DOI 10.1016/j.neuropharm.2007.11.010; HORROCKS LA, 1989, ANN NY ACAD SCI, V559, P17; Iljina M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33928; Illes-Toth E, 2015, BIOCHEM J, V468, P485, DOI 10.1042/BJ20150159; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kapaki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081654; Karampetsou M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15813-8; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Killinger BA, 2019, NPJ PARKINSONS DIS, V5, DOI 10.1038/s41531-019-0095-3; Kim KH, 2019, TOXINS, V11, DOI 10.3390/toxins11060358; Kokotou MG, 2020, MOLECULES, V25, DOI 10.3390/molecules25071548; Kokotou MG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07330-5; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Magrioti V, 2013, BIOORGAN MED CHEM, V21, P5823, DOI 10.1016/j.bmc.2013.07.010; Malada-Edelstein YF, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0811-z; MASUDA M, 1987, J IMMUNOL METHODS, V96, P225, DOI 10.1016/0022-1759(87)90318-8; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Melachroinou K, 2013, NEUROBIOL AGING, V34, P2853, DOI 10.1016/j.neurobiolaging.2013.06.006; Miki Y, 2017, NEUROSCI LETT, V645, P40, DOI 10.1016/j.neulet.2017.02.027; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohite GM, 2018, BIOCHEMISTRY-US, V57, P5183, DOI 10.1021/acs.biochem.8b00314; Monge P, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040542; Mor DE, 2016, NEUROBIOL DIS, V88, P66, DOI 10.1016/j.nbd.2015.12.018; Mori A, 2019, P NATL ACAD SCI USA, V116, P20689, DOI 10.1073/pnas.1902958116; Nussbaum RL, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024109; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Pham CLL, 2013, BIOSCIENCE REP, V33, P807, DOI 10.1042/BSR20130092; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Schaeffer EL, 2011, PROG NEURO-PSYCHOPH, V35, P1612, DOI 10.1016/j.pnpbp.2011.05.001; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Stefanis L, 2019, J NEUROCHEM, V150, P577, DOI 10.1111/jnc.14704; Tan C, 2016, MOL NEUROBIOL, V53, P3854, DOI 10.1007/s12035-015-9314-z; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Ugalde CL, 2019, J BIOL CHEM, V294, P9016, DOI 10.1074/jbc.REV119.007500; Vekrellis K, 2009, J NEUROCHEM, V109, P1348, DOI 10.1111/j.1471-4159.2009.06054.x; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Xilouri M, 2016, AUTOPHAGY, V12, P2230, DOI 10.1080/15548627.2016.1214777; Ximerakis M, 2014, FASEB J, V28, P3146, DOI 10.1096/fj.13-245852; Ye M, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.49; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007	77	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15123	15145		10.1096/fj.202001344R	http://dx.doi.org/10.1096/fj.202001344R		SEP 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931072				2022-12-28	WOS:000570777700001
J	Yu, S; Galeffi, F; Rodriguiz, RM; Wang, ZR; Shen, YT; Lyu, JJ; Li, R; Bernstock, JD; Johnson, KR; Liu, S; Sheng, HX; Turner, DA; Wetsel, WC; Paschen, W; Yang, W				Yu, Shu; Galeffi, Francesca; Rodriguiz, Ramona M.; Wang, Zhuoran; Shen, Yuntian; Lyu, Jingjun; Li, Ran; Bernstock, Joshua D.; Johnson, Kory R.; Liu, Shuai; Sheng, Huaxin; Turner, Dennis A.; Wetsel, William C.; Paschen, Wulf; Yang, Wei			Small ubiquitin-like modifier 2 (SUMO2) is critical for memory processes in mice	FASEB JOURNAL			English	Article						knockout; LTP; memory impairment; posttranslational modification	LONG-TERM POTENTIATION; SUMOYLATION; LOCALIZATION; MECHANISMS; PLASTICITY; PHYSIOLOGY; ISCHEMIA; PROTEINS; RECOVERY; BEHAVIOR	Small ubiquitin-like modifier (SUMO1-3) conjugation (SUMOylation), a posttranslational modification, modulates almost all major cellular processes. Mounting evidence indicates that SUMOylation plays a crucial role in maintaining and regulating neural function, and importantly its dysfunction is implicated in cognitive impairment in humans. We have previously shown that simultaneously silencing SUMO1-3 expression in neurons negatively affects cognitive function. However, the roles of the individual SUMOs in modulating cognition and the mechanisms that link SUMOylation to cognitive processes remain unknown. To address these questions, in this study, we have focused on SUMO2 and generated a new conditionalSumo2knockout mouse line. We found that conditional deletion ofSumo2predominantly in forebrain neurons resulted in marked impairments in various cognitive tests, including episodic and fear memory. Our data further suggest that these abnormalities are attributable neither to constitutive changes in gene expression nor to alterations in neuronal morphology, but they involve impairment in dynamic SUMOylation processes associated with synaptic plasticity. Finally, we provide evidence that dysfunction on hippocampal-based cognitive tasks was associated with a significant deficit in the maintenance of hippocampal long-term potentiation inSumo2knockout mice. Collectively, these data demonstrate that protein conjugation by SUMO2 is critically involved in cognitive processes.	[Yu, Shu; Wang, Zhuoran; Shen, Yuntian; Lyu, Jingjun; Li, Ran; Liu, Shuai; Sheng, Huaxin; Paschen, Wulf; Yang, Wei] Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094,Res Dr, Durham, NC 27710 USA; [Yu, Shu; Shen, Yuntian] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Yu, Shu; Shen, Yuntian] Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong, Peoples R China; [Galeffi, Francesca; Turner, Dennis A.] Durham VAMC, Res & Surg Serv, Durham, NC USA; [Galeffi, Francesca; Turner, Dennis A.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Galeffi, Francesca; Turner, Dennis A.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Galeffi, Francesca; Turner, Dennis A.] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Dept Psychiat & Behav Sci, Durham, NC USA; [Bernstock, Joshua D.] NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, Bioinformat Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Nantong University; Nantong University; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Duke University	Paschen, W; Yang, W (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094,Res Dr, Durham, NC 27710 USA.	wulf.paschen@duke.edu; wei.yang@duke.edu	Yang, Wei/ABE-2905-2021; Shen, Yuntian/GPX-9670-2022	Liu, Shuai/0000-0002-6069-4900; Bernstock, Joshua/0000-0002-7814-3867	HHS \ NIH\ National Institute of Neurological Disorders and Stroke (NINDS) [NS081299]; American Heart Association (AHA) [16GRNT30270003]	HHS \ NIH\ National Institute of Neurological Disorders and Stroke (NINDS); American Heart Association (AHA)(American Heart Association)	HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: NS081299; American Heart Association (AHA), Grant/Award Number: 16GRNT30270003	Bartley AF, 2015, EUR J NEUROSCI, V41, P1402, DOI 10.1111/ejn.12898; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Chen YC, 2014, J NEUROSCI, V34, P9574, DOI 10.1523/JNEUROSCI.4302-13.2014; Craig TJ, 2012, J BIOL CHEM, V287, P22781, DOI 10.1074/jbc.M112.356337; Daniel JA, 2017, ELIFE, V6, DOI 10.7554/eLife.26338; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Granger AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0136; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Lee L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07190; Liu S, 2016, J CEREBR BLOOD F MET, V36, P393, DOI 10.1177/0271678X15608393; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matsuzaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10730; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nair Rajeevkumar R, 2017, Front Synaptic Neurosci, V9, P8, DOI 10.3389/fnsyn.2017.00008; Nakajima M, 2014, CELL, V159, P295, DOI 10.1016/j.cell.2014.09.020; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Park P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0131; Pogorelov VM, 2017, NEUROPSYCHOPHARMACOL, V42, P2163, DOI 10.1038/npp.2017.52; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Ripamonti S, 2020, J NEUROCHEM, V154, P647, DOI 10.1111/jnc.15008; Sannino S, 2012, LEARN MEMORY, V19, P211, DOI 10.1101/lm.025213.111; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shen YT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009634; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tai DJC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10552; Tai DJC, 2011, EMBO J, V30, P205, DOI 10.1038/emboj.2010.290; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Wang LL, 2014, EMBO REP, V15, P878, DOI 10.15252/embr.201438534; Wang LL, 2014, J PSYCHIATR NEUROSCI, V39, P259, DOI 10.1503/jpn.130148; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yang W, 2014, STROKE, V45, P1115, DOI 10.1161/STROKEAHA.113.004315; Zhang L, 2017, NEUROSCIENCE, V343, P190, DOI 10.1016/j.neuroscience.2016.11.036	46	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14750	14767		10.1096/fj.202000850RR	http://dx.doi.org/10.1096/fj.202000850RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910521	Green Accepted, Bronze			2022-12-28	WOS:000570302000001
J	Chamoun, MN; Sullivan, MJ; Goh, KGK; Acharya, D; Ipe, DS; Katupitiya, L; Gosling, D; Peters, KM; Sweet, MJ; Sester, DP; Schembri, MA; Ulett, GC				Chamoun, Michelle N.; Sullivan, Matthew J.; Goh, Kelvin G. K.; Acharya, Dhruba; Ipe, Deepak S.; Katupitiya, Lahiru; Gosling, Dean; Peters, Kate M.; Sweet, Matthew J.; Sester, David P.; Schembri, Mark A.; Ulett, Glen C.			Restriction of chronicEscherichia coliurinary tract infection depends upon T cell-derived interleukin-17, a deficiency of which predisposes to flagella-driven bacterial persistence	FASEB JOURNAL			English	Article						urinary tract infection; bacterial pathogenesis; innate immunity; Escherichia coli; Gram-negative pathogens	UROPATHOGENIC ESCHERICHIA-COLI; DENDRITIC CELLS; EXPRESSION; BLADDER; INNATE; INFLAMMATION; MICE; COLONIZATION; EPIDEMIOLOGY; ACTIVATION	Urinary tract infections (UTI) frequently progress to chronicity in infected individuals but the mechanisms of pathogenesis underlying chronic UTI are not well understood. We examined the role of interleukin (IL)-17A in UTI because this cytokine promotes innate defense against uropathogenicEscherichia coli(UPEC). Analysis of UPEC persistence and pyelonephritis in mice deficient in IL-17A revealed that UPEC CFT073 caused infection at a rate higher than the multidrug resistant strain EC958.Il17a(-/-)mice exhibited pyelonephritis with kidney bacterial burdens higher than those of wild-type (WT) mice. Synthesis of IL-17A in the bladder reflected a combination of gamma delta-T and T(H)17 cell responses. Analysis of circulating inflammatory mediators at 24h postinoculation identified predictors of progression to chronicity, including IL-6 and monocyte chemoattractant protein-1 (MCP-1). Histological analysis identified infiltrating populations of neutrophils, NK cells, and gamma delta T cells in the bladder, whereas neutrophils predominated in the kidney. Analysis of the contribution of flagella to chronicity using hyper-flagellated andfliC-deficient UPEC in WT andIl17a(-/-)mice revealed that, in a host that is deficient for the production of IL-17A, flagella contribute to bacterial persistence. These findings show a role for IL-17A in defense against chronic UTI and a contribution of flagella to the pathogenesis of infection.	[Chamoun, Michelle N.; Sullivan, Matthew J.; Goh, Kelvin G. K.; Acharya, Dhruba; Ipe, Deepak S.; Katupitiya, Lahiru; Gosling, Dean; Ulett, Glen C.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Med Sci, Parklands, Qld, Australia; [Peters, Kate M.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, IMB Ctr Inflammat & Dis Res, Inst Mol Biosci IMB, Brisbane, Qld, Australia; [Sester, David P.] TRI Flow Cytometry Suite TRIfcs, Translat Res Inst, Woolloongabba, Qld, Australia; [Ipe, Deepak S.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Dent, Parklands, Qld 4222, Australia; [Gosling, Dean] Gold Coast Univ Hosp, Pathol Queensland Gold Coast Lab, 1 Hosp Blvd, Southport, Qld 4215, Australia	Griffith University; University of Queensland; University of Queensland; Griffith University; Gold Coast University Hospital	Ulett, GC (corresponding author), Griffith Univ, Griffith Hlth Ctr, Sch Med Sci, Gold Coast, Qld 4222, Australia.; Ulett, GC (corresponding author), Griffith Univ, Griffith Hlth Ctr, Menzies Hlth Inst Queensland, Gold Coast, Qld 4222, Australia.	g.ulett@griffith.edu.au	Sullivan, Matthew J/C-3857-2009; Sweet, Matthew J/F-2229-2011; Sester, David/GLR-2942-2022; Goh, Kelvin/S-1006-2017	Sullivan, Matthew J/0000-0003-2276-3132; Sweet, Matthew J/0000-0002-0406-8139; Goh, Kelvin/0000-0001-8347-2043	National Health and Medical Research Council (NHMRC) Australia [APP1146820, APP1129273]; NHMRC [APP1107914, GNT1106930]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grants from the National Health and Medical Research Council (NHMRC) Australia (APP1146820 to GCU; and APP1129273 to MJS, MAS, GCU). MJS and MAS are supported by NHMRC Senior Research Fellowships (APP1107914, GNT1106930). We thank Dalia Khalil and Yitian Ding from the flow cytometry core facility at the Translational Research Institute for assistance with acquisition of flow cytometric data, and Steven Hancock for additional experimental assistance.	Acharya D, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00545-19; Acharya D, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00118; Alidjanov JF, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7010006; Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; Carey AJ, 2016, CRIT REV MICROBIOL, V42, P780, DOI 10.3109/1040841X.2015.1028885; Carey AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26836; Carey AJ, 2016, J INFECT DIS, V213, P659, DOI 10.1093/infdis/jiv424; Chamoun MN, 2018, CRIT REV MICROBIOL, V44, P465, DOI [10.1080/1040841x.2018.1426556, 10.1080/1040841X.2018.1426556]; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Cossarizza A, 2019, EUR J IMMUNOL, V49, P1457, DOI 10.1002/eji.201970107; Engel D, 2006, INFECT IMMUN, V74, P6100, DOI 10.1128/IAI.00881-06; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Forde BM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11571-5; Foxman B, 2002, AM J MED, V113, p5S; Hannan TJ, 2014, EBIOMEDICINE, V1, P46, DOI 10.1016/j.ebiom.2014.10.011; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Hu FQ, 2016, INNATE IMMUN-LONDON, V22, P9, DOI 10.1177/1753425915609973; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Kakkanat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16149; Kodner CM, 2010, AM FAM PHYSICIAN, V82, P638; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lane MC, 2007, J BACTERIOL, V189, P5523, DOI 10.1128/JB.00434-07; Leclercq SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29000; Li BR, 2017, AM J PHYSIOL-RENAL, V312, pF43, DOI 10.1152/ajprenal.00471.2016; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Lore NI, 2016, SCI REP-UK, V6, DOI 10.1038/srep25937; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Michaud JE, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1036-0; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mora-Bau G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005044; Murthy AMV, 2018, VIRULENCE, V9, P967, DOI 10.1080/21505594.2018.1465786; Murthy AMV, 2019, FASEB J; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Brien VP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007457; Opal SM, 2019, CRITICAL CARE NEPHRO, P476; Renard J, 2015, INFECT DIS THER, V4, P125, DOI 10.1007/s40121-014-0054-6; Schaale K, 2016, MUCOSAL IMMUNOL, V9, P124, DOI 10.1038/mi.2015.44; Scharff AZ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122998; Schembri MA, 2000, INFECT IMMUN, V68, P2638, DOI 10.1128/IAI.68.5.2638-2646.2000; Schreiber HL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf1283; Schwartz DJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004599; Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Sihra N, 2018, NAT REV UROL, V15, P750, DOI 10.1038/s41585-018-0106-x; Silverman JA, 2013, CURR UROL REP, V14, P448, DOI 10.1007/s11934-013-0354-5; Sivick KE, 2010, J IMMUNOL, V184, P2065, DOI 10.4049/jimmunol.0902386; Sundac L, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw062; Tamadonfar KO, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.BAI-0014-2019; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Tittel AP, 2011, J AM SOC NEPHROL, V22, P1435, DOI 10.1681/ASN.2010101072; Totsika M, 2013, J INFECT DIS, V208, P921, DOI 10.1093/infdis/jit245; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Wagenlehner FME, 2017, CURR OPIN UROL, V27, P133, DOI 10.1097/MOU.0000000000000364; Wolf L, 2016, AM J PHYSIOL-LUNG C, V311, pL1015, DOI 10.1152/ajplung.00158.2016; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Yu L, 2019, ELIFE, V8, DOI 10.7554/eLife.46677	60	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14572	14587		10.1096/fj.202000760R	http://dx.doi.org/10.1096/fj.202000760R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901999	Bronze			2022-12-28	WOS:000568308500001
J	Sang, XY; Xiao, JJ; Liu, Q; Zhu, R; Dai, JJ; Zhang, C; Yu, H; Yang, SJ; Zhang, BF				Sang, Xue-Yu; Xiao, Jing-Jie; Liu, Qing; Zhu, Rui; Dai, Jia-Jia; Zhang, Cheng; Yu, Hong; Yang, Si-Jun; Zhang, Bai-Fang			Regulators of calcineurin 1 deficiency attenuates tubulointerstitial fibrosis through improving mitochondrial fitness	FASEB JOURNAL			English	Article						chronic kidney disease; mitochondrial fragmentation; tubular apoptosis	DYNAMIN-RELATED PROTEIN-1; CHRONIC KIDNEY-DISEASE; MOLECULAR-MECHANISMS; FISSION; RCAN1; INJURY; DISRUPTION; APOPTOSIS; GENE; DEPHOSPHORYLATION	Renal fibrosis is the common pathological process of various chronic kidney diseases (CKD). Recent studies indicate that mitochondrial fragmentation is closely associated with renal fibrosis in CKD. However, the molecular mechanisms leading to mitochondrial fragmentation remain to be elucidated. The present study investigated the role of regulators of calcineurin 1 (RCAN1) in mitochondrial fission and renal interstitial fibrosis using conditional knockout mice in which RCAN1 was genetically deleted in tubular epithelial cells (TECs). TEC-specific deletion of RCAN1 attenuated tubulointerstitial fibrosis and epithelial to mesenchymal transition (EMT)-like phenotype change after unilateral ureteral obstruction (UUO) and ischemia reperfusion injury (IRI) through suppressing TGF-beta 1/Smad3 signaling pathway. TEC-specific deletion of RCAN1 also reduced the tubular apoptosis after UUO by inhibiting cytochrome c/caspase-9 pathway. Ultrastructure analysis revealed a marked decrease in mitochondrial fragmentation in TECs of RCAN1-deficient mice in experimental CKD models. The expression of mitochondrial profission proteins dynamin-related protein 1 (Drp1) and mitochondrial fission factor (Mff) was also downregulated in obstructed kidney of TEC-specific RCAN1-deficient mice. Furthermore, TEC-specific deletion of RCAN1 attenuated the dysfunctional tubular autophagy by regulating PINK1/Parkin-induced mitophagy in CKD. RCAN1 knockdown and knockout similarly improved the mitochondrial quality control in HK-2 cells and primary cultured mouse tubular cells stimulated by TGF-beta 1. Put together, our data indicated that RCAN1 plays an important role in the progression of tubulointerstitial fibrosis through regulating the mitochondrial quality. Therefore, targeting RCAN1 may provide a potential therapeutic approach in CKD.	[Sang, Xue-Yu; Xiao, Jing-Jie; Liu, Qing; Zhu, Rui; Dai, Jia-Jia; Zhang, Cheng; Yu, Hong; Zhang, Bai-Fang] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev Originated Dis, Dept Biochem, Wuhan 430071, Peoples R China; [Yang, Si-Jun] Wuhan Univ, ABSL 3 Lab Ctr Anim Expt, State Key Lab Virol, Sch Med, Wuhan, Peoples R China	Wuhan University; Wuhan University	Zhang, BF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev Originated Dis, Dept Biochem, Wuhan 430071, Peoples R China.; Yang, SJ (corresponding author), Wuhan Univ, ABSL 3 Lab Ctr Anim Expt, State Key Lab Virol, Sch Med, Wuhan, Peoples R China.	zbfwq@whu.edu.cn; zbfwq@whu.edu.cn			National Natural Science Foundation of China [81370819]; Zhongnan Hospital of Wuhan University [ZNLH201907]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhongnan Hospital of Wuhan University	National Natural Science Foundation of China, Grant/Award Number: 81370819; Zhongnan Hospital of Wuhan University ZNLH201907	Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096; Bernhardt A, 2017, KIDNEY INT, V92, P1157, DOI 10.1016/j.kint.2017.03.035; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chen HM, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20192759; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Choi YJ, 2000, KIDNEY INT, V58, P1481, DOI 10.1046/j.1523-1755.2000.00310.x; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Galvan DL, 2019, J CLIN INVEST, V129, P2807, DOI 10.1172/JCI127277; Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jang C, 2011, KOREAN J PHYSIOL PHA, V15, P299, DOI 10.4196/kjpp.2011.15.5.299; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li HL, 2018, KIDNEY INT, V94, P1160, DOI 10.1016/j.kint.2018.07.023; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; McWilliams TG, 2017, CURR OPIN CELL BIOL, V45, P83, DOI 10.1016/j.ceb.2017.03.013; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Parra V, 2018, CIRC RES, V122, pE20, DOI 10.1161/CIRCRESAHA.117.311522; Peiris H, 2018, CLIN EXP PHARMACOL P, V45, P377, DOI 10.1111/1440-1681.12884; Peiris H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006033; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Springer MZ, 2016, J PATHOL, V240, P253, DOI 10.1002/path.4774; Tang CY, 2016, J AM SOC NEPHROL, V27, P1869, DOI 10.1681/ASN.2015111277; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Ucero AC, 2014, INT UROL NEPHROL, V46, P765, DOI 10.1007/s11255-013-0520-1; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wong H, 2015, ACTA NEUROPATHOL, V130, P829, DOI 10.1007/s00401-015-1499-8; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang B, 2018, J AM SOC NEPHROL, V29, P1900, DOI 10.1681/ASN.2017050581; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhan M, 2015, J AM SOC NEPHROL, V26, P1304, DOI 10.1681/ASN.2014050457; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zhou H, 2018, REDOX BIOL, V15, P335, DOI 10.1016/j.redox.2017.12.019	51	6	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14539	14557		10.1096/fj.202000781RRR	http://dx.doi.org/10.1096/fj.202000781RRR		SEP 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32896034	Bronze			2022-12-28	WOS:000568298800001
J	Guillemain, A; Laouarem, Y; Cobret, L; Stefok, D; Chen, WY; Bloch, S; Zahaf, A; Blot, L; Reverchon, F; Normand, T; Decoville, M; Grillon, C; Traiffort, E; Morisset-Lopez, S				Guillemain, Anthony; Laouarem, Yousra; Cobret, Laetitia; Stefok, Dora; Chen, Wanyin; Bloch, Solal; Zahaf, Amina; Blot, Lauren; Reverchon, Flora; Normand, Thierry; Decoville, Martine; Grillon, Catherine; Traiffort, Elisabeth; Morisset-Lopez, Severine			LINGO family receptors are differentially expressed in the mouse brain and form native multimeric complexes	FASEB JOURNAL			English	Article						BRET; LRRIG; nervous system; oligomerization; protein-protein interactions; transmembrane protein	LEUCINE-RICH REPEAT; REGULATES OLIGODENDROCYTE DIFFERENTIATION; NERVOUS-SYSTEM; NOGO RECEPTOR; PROTEIN; HETERODIMERIZATION; HOMODIMERIZATION; REGENERATION; INHIBITION; ACTIVATION	Leucine-rich repeat and immunoglobin-domain containing (LRRIG) proteins that are commonly involved in protein-protein interactions play important roles in nervous system development and maintenance. LINGO-1, one of this family members, is characterized as a negative regulator of neuronal survival, axonal regeneration, and oligodendrocyte precursor cell (OPC) differentiation into mature myelinating oligodendrocytes. Three LINGO-1 homologs named LINGO-2, LINGO-3, and LINGO-4 have been described. However, their relative expression and functions remain unexplored. Here, we show by in situ hybridization and quantitative polymerase chain reaction that the transcripts of LINGO homologs are differentially expressed in the central nervous system. The immunostaining of brain slices confirmed this observation and showed the co-expression of LINGO-1 with its homologs. Using BRET (bioluminescence resonance energy transfer) analysis, we demonstrate that LINGO proteins can physically interact with each of the other ones with comparable affinities and thus form the oligomeric states. Furthermore, co-immunoprecipitation experiments indicate that LINGO proteins form heterocomplexes in both heterologous systems and cortical neurons. Since LINGO-1 is a promising target for the treatment of demyelinating diseases, its ability to form heteromeric complexes reveals a new level of complexity in its functioning and opens the way for new strategies to achieve diverse and nuanced LINGO-1 regulation.	[Guillemain, Anthony; Cobret, Laetitia; Stefok, Dora; Chen, Wanyin; Blot, Lauren; Reverchon, Flora; Normand, Thierry; Decoville, Martine; Grillon, Catherine; Morisset-Lopez, Severine] Univ Orleans, Ctr Biophys Mol, CNRS, UPR 4301, Rue Charles Sadron, F-45071 Orleans 02, France; [Guillemain, Anthony; Cobret, Laetitia; Stefok, Dora; Chen, Wanyin; Blot, Lauren; Reverchon, Flora; Normand, Thierry; Decoville, Martine; Grillon, Catherine; Morisset-Lopez, Severine] INSERM, Rue Charles Sadron, F-45071 Orleans 02, France; [Laouarem, Yousra; Bloch, Solal; Zahaf, Amina; Traiffort, Elisabeth] Paris Saclay Univ, INSERM, U1195, Dis & Hormones Nervous Syst, Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Morisset-Lopez, S (corresponding author), Univ Orleans, Ctr Biophys Mol, CNRS, UPR 4301, Rue Charles Sadron, F-45071 Orleans 02, France.; Morisset-Lopez, S (corresponding author), INSERM, Rue Charles Sadron, F-45071 Orleans 02, France.	severine.morisset-lopez@cnrs-orleans.fr	MORISSET, Séverine/S-7450-2017	MORISSET, Séverine/0000-0002-9930-7824; Reverchon, Flora/0000-0003-1642-4775	Conseil National de la Recherche Scientifique (CNRS); Region Centre Val de Loire	Conseil National de la Recherche Scientifique (CNRS); Region Centre Val de Loire(Region Centre-Val de Loire)	Conseil National de la Recherche Scientifique (CNRS), Grant/Award Number: LINGO Prematuration Program; Region Centre Val de Loire, Grant/Award Number: APR-IR LINGO	Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Aktas O, 2016, CURR OPIN NEUROL, V29, P199, DOI 10.1097/WCO.0000000000000327; Andrews JL, 2015, NEUROSCI BIOBEHAV R, V56, P97, DOI 10.1016/j.neubiorev.2015.06.009; Barrette B, 2007, MOL CELL NEUROSCI, V34, P519, DOI 10.1016/j.mcn.2006.12.004; Cadavid D, 2019, LANCET NEUROL, V18, P845, DOI 10.1016/S1474-4422(19)30137-1; Carim-Todd L, 2003, EUR J NEUROSCI, V18, P3167, DOI 10.1111/j.1460-9568.2003.03003.x; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Cobret L, 2015, BRIT J PHARMACOL, V172, P841, DOI 10.1111/bph.12945; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; El Khamlichi C, 2019, MOLECULES, V24, DOI 10.3390/molecules24030537; Haines BP, 2008, GENE EXPR PATTERNS, V8, P79, DOI 10.1016/j.modgep.2007.10.003; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jepson S, 2012, J BIOL CHEM, V287, P22184, DOI 10.1074/jbc.M112.366179; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lee XH, 2014, MOL CELL NEUROSCI, V60, P36, DOI 10.1016/j.mcn.2014.02.006; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Meabon JS, 2016, MOL CELL NEUROSCI, V70, P1, DOI 10.1016/j.mcn.2015.11.002; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2013, CNS DRUGS, V27, P493, DOI 10.1007/s40263-013-0068-8; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Okafuji T, 2005, GENE EXPR PATTERNS, V6, P57, DOI 10.1016/j.modgep.2005.04.016; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pepinsky RB, 2014, J PHARMACOL EXP THER, V350, P110, DOI 10.1124/jpet.113.211771; Petrillo J, 2019, J NEURO-OPHTHALMOL, V39, P153, DOI 10.1097/WNO.0000000000000697; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shao ZH, 2017, J NEUROSCI, V37, P3127, DOI 10.1523/JNEUROSCI.3722-16.2017; Stein T, 2012, NEUROSCI LETT, V509, P9, DOI 10.1016/j.neulet.2011.11.029; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Zhang ZH, 2013, J BIOL CHEM, V288, P12152, DOI 10.1074/jbc.M112.447771; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200	38	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13641	13653		10.1096/fj.202000826R	http://dx.doi.org/10.1096/fj.202000826R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32862444	Green Submitted			2022-12-28	WOS:000565931500001
J	Bomfim, L; Ramos, I				Bomfim, Larissa; Ramos, Isabela			Deficiency of ULK1/ATG1 in the follicle cells disturbs ER homeostasis and causes defective chorion deposition in the vectorRhodnius prolixus	FASEB JOURNAL			English	Article						choriogenesis; follicle cells; ULK1; ATG1; vector biology	EARLY STEPS; AUTOPHAGY; GUIDELINES; PROTEINS; GENE; ATG9	In insects, synthesis and deposition of the chorion (eggshell) are performed by the professional secretory follicle cells (FCs) that surround the oocytes in the course of oogenesis. Here, we found that ULK1/ATG1, an autophagy-related protein, is highly expressed in the FCs of the Chagas-Disease vectorRhodnius prolixus, and that parental RNAi silencing of ULK1/ATG1 results in oocytes with abnormal chorion ultrastructure and FCs presenting expanded rough ER membranes as well as increased expression of the ER chaperone BiP3, both indicatives of ER stress. Silencing of LC3/ATG8, another essential autophagy protein, did not replicate the ULK1/ATG1 phenotypes, whereas silencing of SEC16A, a known partner of the noncanonical ULK1/ATG1 function in the ER exit sites phenocopied the silencing of ULK1/ATG1. Our findings point to a cooperated function of ULK1/ATG1 and SEC16A in the FCs to complete choriogenesis and provide additional in vivo phenotype-based evidence to the literature of the role of ULK1/ATG1 in the ER in a professional secretory cell.	[Bomfim, Larissa; Ramos, Isabela] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Cidade Univ, BR-21941599 Rio De Janeiro, RJ, Brazil; [Ramos, Isabela] CNPq, INCT EM, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Ramos, I (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Cidade Univ, BR-21941599 Rio De Janeiro, RJ, Brazil.	isabela@bioqmed.ufrj.br	Ramos, Isabela B/N-7091-2017	Ramos, Isabela B/0000-0003-0874-7902; Bomfim, Larissa/0000-0003-0901-3118	JCNE-FAPERJ; CAPES	JCNE-FAPERJ; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the following grants: JCNE-FAPERJ (www.faperj.br/), INCT-EM-CNPq/FAPERJ (http://cnpq.br/), and CAPES (www.capes.gov.br/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED AM, 2006, MICROBES INFECT, V0008, P00308, DOI DOI 10.1016/J.MICINF.2005.06.026; Bomfim L, 2017, EGGSHELL ULTRASTRUCT, P1; BRANDIZZI F, 2013, NAT REV MOL CELL BIO, V0014, P00382, DOI DOI 10.1038/NRM3588; BUSTIN SA, 2009, CLIN CHEM, V0055, P00611, DOI DOI 10.1373/CLINCHEM.2008.112797; FAKHOURI M, 2006, DEV BIOL, V0293, P00127, DOI DOI 10.1016/J.YDBIO.2006.01.028; Gan W, 2017, BMC CELL BIOL, V18, P1; GANLEY IG, 2009, J BIOL CHEM, V0284, P12297, DOI DOI 10.1074/JBC.M900573200; GE L, 2014, CURR OPIN CELL BIOL, V0029, P00018, DOI DOI 10.1016/J.CEB.2014.02.005; GRAEF M, 2013, MOL BIOL CELL, V0024, P02918, DOI DOI 10.1091/MBC.E13-07-0381; HETZ C, 2012, NAT REV MOL CELL BIO, V0013, P00089, DOI DOI 10.1038/NRM3270; Hopwood JA, 2001, J EXPT BIOL, V2780, P2773; HOSOKAWA N, 2009, MOL BIOL CELL, V0020, P01981, DOI DOI 10.1091/MBC.E08-12-1248; HUEBNER E, 1972, J MORPHOL, V0138, P00001; ISHIHARA N, 2001, MOL BIOL CELL, V0012, P03690; JOO JH, 2016, MOL CELL, V0062, P00491, DOI DOI 10.1016/J.MOLCEL.2016.04.020; JUNG CH, 2009, MOL BIOL CELL, V0020, P01992, DOI DOI 10.1091/mbc.E08-12-1249; KARANASIOS E, 2016, NAT COMMUN, V0007, P00001, DOI DOI 10.1038/NCOMMS12420; KLIONSKY DJ, 2016, AUTOPHAGY, V0012, P00001, DOI DOI 10.1080/15548627.2015.1100356; LEE YK, 2016, BMB REP, V0049, P00424, DOI DOI 10.5483/BMBREP.2016.49.8.081; MARI M, 2010, J CELL BIOL, V0190, P01005, DOI DOI 10.1083/JCB.200912089; MEDEIROS MN, 2011, INSECT BIOCHEM MOLEC, V0041, P00823, DOI DOI 10.1016/J.IBMB.2011.06.004; MEDEIROS MN, 2011, INSECT BIOCHEM MOLEC, V0041, P00823, DOI DOI 10.1016/J.IBMB.2011.06.004; MESQUITA RD, 2015, P NATL ACAD SCI USA, V0112, P14936, DOI DOI 10.1073/PNAS.1506226112; NEZIS IP, 2006, DEV GROWTH DIFFER, V0048, P00189, DOI DOI 10.1111/J.1440-169X.2006.00856.X; PAPINSKI D, 2014, MOL CELL, V0053, P00471, DOI DOI 10.1016/J.MOLCEL.2013.12.011; PEREIRA J, 2020, PLOS NEGLECT TROP D, V0014; RIBEIRO JMC, 2014, PLOS NEGLECT TROP D, V0008, P00027, DOI DOI 10.1371/JOURNAL.PNTD.0002594; SONG SL, 2018, J CELL PHYSIOL, V0233, P03867, DOI DOI 10.1002/JCP.26137; SOUID S, 2007, DEV GENES EVOL, V0217, P00159, DOI DOI 10.1007/S00427-006-0124-1; TANG BL, 2017, J CELL PHYSIOL, V0232, P03234, DOI DOI 10.1002/JCP.25842; TOOTLE TL, 2011, PLOS ONE, V0006, DOI DOI 10.1371/JOURNAL.PONE.0019943; UCHIDA K, 2004, J INSECT PHYSIOL, V0050, P00903, DOI DOI 10.1016/J.JINSPHYS.2004.07.002; VELAZQUEZ AFC, 2018, MOL CELL BIOL, V0038; VELENTZAS AD, 2018, SCI REP UK, V0008, P00001, DOI DOI 10.1038/S41598-018-34532-2; VIEIRA PH, 2018, PLOS NEGLECT TROP D, V0012, DOI DOI 10.1371/JOURNAL.PNTD.0006507; WU X, 2008, SEMIN CELL DEV BIOL, V0019, P00271, DOI DOI 10.1016/J.SEMCDB.2008.01.004; YAMAMOTO H, 2012, J CELL BIOL, V0198, P00219, DOI DOI 10.1083/JCB.201202061; YORIMITSU T, 2006, J BIOL CHEM, V0281, P30299, DOI DOI 10.1074/JBC.M607007200	38	5	5	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13561	13572		10.1096/fj.202001396R	http://dx.doi.org/10.1096/fj.202001396R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32844451	Bronze			2022-12-28	WOS:000564885300001
J	Uzawa, H; Kohno, D; Koga, T; Sasaki, T; Fukunaka, A; Okuno, T; Jo-Watanabe, A; Kazuno, S; Miyatsuka, T; Kitamura, T; Fujitani, Y; Watada, H; Saeki, K; Yokomizo, T				Uzawa, Hirotsugu; Kohno, Daisuke; Koga, Tomoaki; Sasaki, Tsutomu; Fukunaka, Ayako; Okuno, Toshiaki; Jo-Watanabe, Airi; Kazuno, Saiko; Miyatsuka, Takeshi; Kitamura, Tadahiro; Fujitani, Yoshio; Watada, Hirotaka; Saeki, Kazuko; Yokomizo, Takehiko			Leukotriene A(4)hydrolase deficiency protects mice from diet-induced obesity by increasing energy expenditure through neuroendocrine axis	FASEB JOURNAL			English	Article						Brown adipocyte; noradrenaline; peptidase; thyroid hormone; uncoupling protein 1	BROWN ADIPOSE-TISSUE; BIFUNCTIONAL ENZYME; INSULIN-RESISTANCE; B-4 RECEPTOR; ACTIVE-SITE; HYDROLASE; AMINOPEPTIDASE; IDENTIFICATION; THERMOGENESIS; LTA(4)H	Obesity is a health problem worldwide, and brown adipose tissue (BAT) is important for energy expenditure. Here, we explored the role of leukotriene A(4)hydrolase (LTA(4)H), a key enzyme in the synthesis of the lipid mediator leukotriene B-4(LTB4), in diet-induced obesity. LTA(4)H-deficient (LTA(4)H-KO) mice fed a high-fat diet (HFD) showed a lean phenotype, and bone-marrow transplantation studies revealed that LTA(4)H-deficiency in non-hematopoietic cells was responsible for this lean phenotype. LTA(4)H-KO mice exhibited greater energy expenditure, but similar food intake and fecal energy loss. LTA(4)H-KO BAT showed higher expression of thermogenesis-related genes. In addition, the plasma thyroid-stimulating hormone and thyroid hormone concentrations, as well as HFD-induced catecholamine secretion, were higher in LTA(4)H-KO mice. In contrast, LTB(4)receptor (BLT1)-deficient mice did not show a lean phenotype, implying that the phenotype of LTA(4)H-KO mice is independent of the LTB4/BLT1 axis. These results indicate that LTA(4)H mediates the diet-induced obesity by reducing catecholamine and thyroid hormone secretion.	[Uzawa, Hirotsugu; Koga, Tomoaki; Okuno, Toshiaki; Jo-Watanabe, Airi; Saeki, Kazuko; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Uzawa, Hirotsugu; Miyatsuka, Takeshi; Watada, Hirotaka] Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan; [Kohno, Daisuke; Sasaki, Tsutomu; Kitamura, Tadahiro] Gunma Univ, Metab Signal Res Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma, Japan; [Koga, Tomoaki] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan; [Sasaki, Tsutomu] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Fukunaka, Ayako; Fujitani, Yoshio] Gunma Univ, Inst Mol & Cellular Regulat, Lab Dev Biol & Metab, Maebashi, Gunma, Japan; [Kazuno, Saiko] Juntendo Univ, Res Support Ctr, Lab Prote & Biomol Sci, Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Gunma University; Kumamoto University; Kyoto University; Gunma University; Juntendo University	Saeki, K (corresponding author), Juntendo Univ, Dept Biochem, Sch Med, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	ksaeki@juntendo.ac.jp		Sasaki, Tsutomu/0000-0001-8041-1915	MEXT \ Japan Society for the Promotion of Science (JSPS) [JP18K06923, JP17K08664, JP19K07357, JP18K15051, JP15H05904, JP15H05897, JP18H02627, JP19KK0199]; Japan Agency for Medical Research and Development (AMED) [JP20gm1210006]; Foundation of Strategic Research Projects in Private Universities from the MEXT [S1311011]; Ono Medical Research Foundation; Takeda Science Foundation; Joint Research Program of the Institute for Molecular and Cellular Regulation, Gunma University; Institute for Environmental; Gender-specific Medicine, Juntendo University	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Foundation of Strategic Research Projects in Private Universities from the MEXT; Ono Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Joint Research Program of the Institute for Molecular and Cellular Regulation, Gunma University; Institute for Environmental; Gender-specific Medicine, Juntendo University	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18K06923, JP17K08664, JP19K07357, JP18K15051, JP15H05904, JP15H05897, JP18H02627 and JP19KK0199; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20gm1210006; Grant-in-Aid from the Foundation of Strategic Research Projects in Private Universities from the MEXT, Grant/Award Number: S1311011; Ono Medical Research Foundation; Takeda Science Foundation; Joint Research Program of the Institute for Molecular and Cellular Regulation, Gunma University; Grant from Institute for Environmental; Gender-specific Medicine, Juntendo University	Akthar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9423; Bianco AC, 2013, LANCET DIABETES ENDO, V1, P250, DOI 10.1016/S2213-8587(13)70069-X; Byrum RS, 1999, J IMMUNOL, V163, P6810; Elias I, 2016, DIABETES, V65, P2139, DOI 10.2337/db16-0040; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FITZPATRICK F, 1983, P NATL ACAD SCI-BIOL, V80, P5425, DOI 10.1073/pnas.80.17.5425; Fujimori K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38453-y; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Haeggstrom JZ, 2018, J CLIN INVEST, V128, P2680, DOI 10.1172/JCI97945; Konig S, 2019, CELL CHEM BIOL, V26, P524, DOI 10.1016/j.chembiol.2019.01.001; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Low CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44449; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Mehrabian M, 2008, DIABETOLOGIA, V51, P978, DOI 10.1007/s00125-008-1002-3; MINAMI M, 1987, J BIOL CHEM, V262, P13873; MINAMI M, 1992, FEBS LETT, V309, P353, DOI 10.1016/0014-5793(92)80806-R; Ohba M, 2018, BIOCHEM BIOPH RES CO, V504, P562, DOI 10.1016/j.bbrc.2018.06.026; OHISHI N, 1990, J BIOL CHEM, V265, P7520; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; ORNING L, 1994, J BIOL CHEM, V269, P11269; Saeki K, 2017, SEMIN IMMUNOL, V33, P30, DOI 10.1016/j.smim.2017.07.010; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; STOCK MJ, 1989, P NUTR SOC, V48, P189, DOI 10.1079/PNS19890029; Stsiapanava A, 2014, P NATL ACAD SCI USA, V111, P4227, DOI 10.1073/pnas.1402136111; Syed I, 2018, CELL METAB, V27, P419, DOI 10.1016/j.cmet.2018.01.001; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; TOH H, 1990, BIOCHEM BIOPH RES CO, V171, P216, DOI 10.1016/0006-291X(90)91379-7; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WETTERHOLM A, 1992, P NATL ACAD SCI USA, V89, P9141, DOI 10.1073/pnas.89.19.9141; Yasui M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136304; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yokomizo T, 2018, J CLIN INVEST, V128, P2691, DOI 10.1172/JCI97946	37	1	1	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13949	13958		10.1096/fj.202001148R	http://dx.doi.org/10.1096/fj.202001148R		AUG 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32844470	Green Submitted, Bronze			2022-12-28	WOS:000564884900001
J	Vara, D; Tarafdar, A; Celikag, M; Patinha, D; Gulacsy, CE; Hounslea, E; Warren, Z; Ferreira, B; Koeners, MP; Caggiano, L; Pula, G				Vara, Dina; Tarafdar, Anuradha; Celikag, Meral; Patinha, Daniela; Gulacsy, Christina E.; Hounslea, Ellie; Warren, Zach; Ferreira, Barbara; Koeners, Maarten P.; Caggiano, Lorenzo; Pula, Giordano			NADPH oxidase 1 is a novel pharmacological target for the development of an antiplatelet drug without bleeding side effects	FASEB JOURNAL			English	Article						free radical; hemostasis; NADPH oxidase; oxidative stress; platelet; redox; thrombosis	PLATELET ACTIVATION; GPVI; COLLAGEN; INHIBITION; MODEL; NOX1; DYSFUNCTION; GKT137831; ROLES	Growing evidence supports a central role of NADPH oxidases (NOXs) in the regulation of platelets, which are circulating cells involved in both hemostasis and thrombosis. Here, the use ofNox1(-/-)andNox1(+/+)mice as experimental models of human responses demonstrated a critical role of NOX1 in collagen-dependent platelet activation and pathological arterial thrombosis, as tested in vivo by carotid occlusion assays. In contrast, NOX1 does not affect platelet responses to thrombin and normal hemostasis, as assayed in tail bleeding experiments. Therefore, as NOX1 inhibitors are likely to have antiplatelet effects without associated bleeding risks, the NOX1-selective inhibitor 2-acetylphenothiazine (2APT) and a series of its derivatives generated to increase inhibitory potency and drug bioavailability were tested. Among the 2APT derivatives, 1-(10H-phenothiazin-2-yl)vinyltert-butyl carbonate (2APT-D6) was selected for its high potency. Both 2APT and 2APT-D6 inhibited collagen-dependent platelet aggregation, adhesion, thrombus formation, superoxide anion generation, and surface activation marker expression, while responses to thrombin or adhesion to fibrinogen were not affected. In vivo administration of 2APT or 2APT-D6 led to the inhibition of mouse platelet aggregation, oxygen radical output, and thrombus formation, and carotid occlusion, while tail hemostasis was unaffected. Differently to in vitro experiments, 2APT-D6 and 2APT displayed similar potency in vivo. In summary, NOX1 inhibition with 2APT or its derivative 2APT-D6 is a viable strategy to control collagen-induced platelet activation and reduce thrombosis without deleterious effects on hemostasis. These compounds should, therefore, be considered for the development of novel antiplatelet drugs to fight cardiovascular diseases in humans.	[Vara, Dina; Tarafdar, Anuradha; Celikag, Meral; Patinha, Daniela; Warren, Zach; Ferreira, Barbara; Koeners, Maarten P.] Univ Exeter, Inst Biomed & Clin Sci, Med Sch, Exeter, Devon, England; [Gulacsy, Christina E.; Hounslea, Ellie; Caggiano, Lorenzo] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England; [Pula, Giordano] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Hamburg, Germany	University of Exeter; University of Bath; University of Hamburg; University Medical Center Hamburg-Eppendorf	Pula, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Hamburg, Germany.	g.pula@uke.de	Pula, Giordano/ABE-8596-2020	Pula, Giordano/0000-0002-7769-1140; Patinha, Daniela/0000-0003-1150-0046	British Heart Foundation (BHF) [FS/14/2/30630, PG/15/40/31522, PG/15/68/31717]; Alzheimer's Research UK (ARUK) [ARUK-PG2017A-3]	British Heart Foundation (BHF)(British Heart Foundation); Alzheimer's Research UK (ARUK)(Alzheimer's Research UK (ARUK))	British Heart Foundation (BHF), Grant/Award Number: FS/14/2/30630, PG/15/40/31522 and PG/15/68/31717; Alzheimer's Research UK (ARUK), Grant/Award Number: ARUK-PG2017A-3; British Heart Foundation (BHF)	Abubaker AA, 2019, PLATELETS, V30, P181, DOI 10.1080/09537104.2017.1392497; Akbar H, 2018, J THROMB HAEMOST, V16, P2083, DOI 10.1111/jth.14240; Akbar H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163227; Anvari E, 2015, FREE RADICAL RES, V49, P1308, DOI 10.3109/10715762.2015.1067697; Bach RD, 1996, J ORG CHEM, V61, P6346, DOI 10.1021/jo960356m; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bonnard T, 2015, JOVE-J VIS EXP, DOI 10.3791/52838; Cammisotto V, 2019, BIOCHEM PHARMACOL, V163, P111, DOI 10.1016/j.bcp.2019.02.016; Carnevale R, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000920; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Dayal S, 2013, CIRCULATION, V127, P1308, DOI 10.1161/CIRCULATIONAHA.112.000966; Delaney MK, 2016, ARTERIOSCL THROM VAS, V36, P846, DOI 10.1161/ATVBAHA.116.307308; El Haouari M, 2019, CURR MED CHEM, V26, P4145, DOI 10.2174/0929867324666171005114456; Florian P, 2017, EUR J CLIN PHARMACOL, V73, P949, DOI 10.1007/s00228-017-2264-9; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Ghasemzadeh M, 2018, THROMB RES, V163, P153, DOI 10.1016/j.thromres.2018.01.048; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Gray SP, 2017, DIABETOLOGIA, V60, P927, DOI 10.1007/s00125-017-4215-5; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Grover SP, 2020, PLATELETS, V31, P432, DOI 10.1080/09537104.2019.1678119; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Jang JY, 2015, FREE RADICAL BIO MED, V89, P842, DOI 10.1016/j.freeradbiomed.2015.10.413; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Jiang P, 2014, DRUG DISCOV TODAY, V19, P1471, DOI 10.1016/j.drudis.2014.06.005; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Kwon G, 2017, ONCOTARGET, V8, P74217, DOI 10.18632/oncotarget.18540; Leppanen J, 2001, J PHARM PHARMACOL, V53, P1489, DOI 10.1211/0022357011778025; Mackman N, 2020, NAT REV DRUG DISCOV, V19, P333, DOI 10.1038/s41573-020-0061-0; Magwenzi S, 2015, BLOOD, V125, P2693, DOI 10.1182/blood-2014-05-574491; Monteiro PF, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-5; Munoz AKM, 2017, THROMB HAEMOSTASIS, V117, P1651, DOI 10.1160/TH16-11-0856; Nagy M, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00099; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rezende F, 2018, REDOX BIOL, V15, P12, DOI 10.1016/j.redox.2017.11.014; Rochat S, 2015, CYTOM PART A, V87A, P32, DOI 10.1002/cyto.a.22567; Sonkar VK, 2019, BLOOD ADV, V3, P1272, DOI 10.1182/bloodadvances.2018025569; Stef G, 2007, PHARMACOL REP, V59, P428; Swan D, 2020, BLOOD REV, V39, DOI 10.1016/j.blre.2019.100619; Teixeira G, 2017, BRIT J PHARMACOL, V174, P1647, DOI 10.1111/bph.13532; Vaezzadeh N, 2014, THROMB HAEMOSTASIS, V112, P412, DOI 10.1160/TH13-11-0919; Vara D, 2014, CURR MOL MED, V14, P1103, DOI 10.2174/1566524014666140603114010; Vara D, 2013, BRIT J PHARMACOL, V168, P212, DOI 10.1111/j.1476-5381.2012.02130.x; Vara D, 2019, HAEMATOLOGICA, V104, P1879, DOI 10.3324/haematol.2018.208819; Violi F, 2014, THROMB HAEMOSTASIS, V111, P817, DOI 10.1160/TH13-10-0818; Voors-Pette C, 2019, ARTERIOSCL THROM VAS, V39, P956, DOI 10.1161/ATVBAHA.118.312314; Walsh TG, 2014, REDOX BIOL, V2, P178, DOI 10.1016/j.redox.2013.12.023; Wang SB, 2015, FREE RADICAL BIO MED, V83, P41, DOI 10.1016/j.freeradbiomed.2015.01.018; Wingler K, 2012, CELL MOL LIFE SCI, V69, P3159, DOI 10.1007/s00018-012-1107-1; Yasuda Hiroshi, 2015, World J Crit Care Med, V4, P40, DOI 10.5492/wjccm.v4.i1.40; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6	52	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13959	13977		10.1096/fj.202001086RRR	http://dx.doi.org/10.1096/fj.202001086RRR		AUG 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32851720				2022-12-28	WOS:000565946400001
J	Zhang, TS; Tian, C; Wu, JR; Zhang, Y; Wang, JH; Kong, QF; Mu, LL; Sun, B; Ai, TH; Wang, Y; Zhao, W; Wang, DD; Li, HL; Wang, GY				Zhang, Tongshuai; Tian, Chao; Wu, Jinrong; Zhang, Yao; Wang, Jinghua; Kong, Qingfei; Mu, Lili; Sun, Bo; Ai, Tianhong; Wang, Yue; Zhao, Wei; Wang, Dandan; Li, Hulun; Wang, Guangyou			MicroRNA-182 exacerbates blood-brain barrier (BBB) disruption by downregulating the mTOR/FOXO1 pathway in cerebral ischemia	FASEB JOURNAL			English	Article						BBB; FOXO1; miR-182; mTOR; TJ proteins	FORKHEAD BOX O1; MIR-182; APOPTOSIS; GROWTH; RAPAMYCIN; PROTECTS; INJURY; CELLS; PROLIFERATION; EXPRESSION	Cerebral ischemia causes damage to the structure and function of the blood-brain barrier (BBB) and alleviating BBB destruction will be of great significance for the treatment and prognosis of ischemic stroke. Recently, microRNAs have been shown to play a critical role in BBB integrity. However, the potential mechanism by which microRNA-182 (miR-182) affects the BBB in ischemic stroke remains unclear. We demonstrated for the first time that cerebral ischemia leads to a significant progressive increase in miR-182 after pMCAO, and bEnd.3 cells are the primary target cells of miR-182. In miR-182 KD transgenic mice, infarct volume, and BBB permeability were attenuated, and tight junction (TJ) proteins increased. Inhibition of miR-182 with an antagomir reduced OGD-induced apoptosis of bEnd.3 cells and the loss of ZO-1 and Occludin. To further explore the mechanism by which miR-182 regulates BBB integrity, we detected the apoptotic proteins Bcl-2/Bax and demonstrated that mTOR and FOXO1 were the targets of miR-182. Inhibition of mTOR/FOXO1 by rapamycin/AS1842856 decreased the ratio of Bcl-2/Bax and exacerbated TJ protein loss. Taken together, inhibition of miR-182 protects BBB integrity by reducing endothelial cell apoptosis through the mTOR/FOXO1 pathway. Thus, miR-182 may be a potential target for the treatment of BBB disruption during cerebral ischemia.	[Zhang, Tongshuai; Tian, Chao; Wu, Jinrong; Zhang, Yao; Wang, Jinghua; Kong, Qingfei; Mu, Lili; Sun, Bo; Ai, Tianhong; Wang, Yue; Zhao, Wei; Li, Hulun; Wang, Guangyou] Harbin Med Univ, Dept Neurobiol, Harbin 150081, Peoples R China; [Zhang, Tongshuai; Li, Hulun; Wang, Guangyou] Harbin Med Univ, Minist Educ, Key Lab Preservat Human Genet Resources & Dis Con, Harbin, Peoples R China; [Tian, Chao] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China; [Wu, Jinrong] Harbin Med Univ, Affiliated Hosp 1, Dept Anaesthesiol, Harbin, Peoples R China; [Wang, Dandan] Harbin Med Univ, Affiliated Hosp 1, Wu Lian De Mem Hosp, Harbin 150000, Peoples R China	Harbin Medical University; Harbin Medical University; Tianjin Medical University; Harbin Medical University; Harbin Medical University	Li, HL; Wang, GY (corresponding author), Harbin Med Univ, Dept Neurobiol, Harbin 150081, Peoples R China.; Wang, DD (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Wu Lian De Mem Hosp, Harbin 150000, Peoples R China.	wangdandan@126.com; lihulun@aliyun.com; wangguangyou@hrbmu.edu.cn	Kong, qingfei/HCI-0643-2022		National Natural Science Foundation of China [31671112, 31371079, 81070943, 31900697]; Natural Science Foundation of Heilongjiang Province of China [QC2017087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	The authors would like to thank Cong Wan for his help in feeding and the breeding techniques of the miR-182 KD transgenic mice. This work was supported by the National Natural Science Foundation of China (31671112, 31371079, 81070943 and 31900697) and the Natural Science Foundation of Heilongjiang Province of China (QC2017087).	Abdullahi W, 2018, AM J PHYSIOL-CELL PH, V315, pC343, DOI 10.1152/ajpcell.00095.2018; Ahmad S, 2019, NEUROMOL MED, V21, P505, DOI 10.1007/s12017-019-08569-z; Bai Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35642; Bertin FR, 2015, J THROMB HAEMOST, V13, P2260, DOI 10.1111/jth.13156; Chang JL, 2017, NAT MED, V23, P450, DOI 10.1038/nm.4309; Chen HJ, 2012, REV NEUROSCIENCE, V23, P279, DOI 10.1515/revneuro-2012-0001; Dharaneeswaran H, 2014, CIRC RES, V115, P238, DOI 10.1161/CIRCRESAHA.115.303227; Diaz A, 2020, J NEUROSCI, V40, P4251, DOI 10.1523/JNEUROSCI.2804-19.2020; Eyileten C, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120249; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fu JH, 2018, EUR REV MED PHARMACO, V22, P351, DOI 10.26355/eurrev_201801_14179; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Gu L, 2008, LEUKEMIA, V22, P2091, DOI 10.1038/leu.2008.204; Huang YN, 2018, THERANOSTICS, V8, P5929, DOI 10.7150/thno.28029; Kiesow K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15007; Kim KM, 2012, J BONE MINER RES, V27, P1669, DOI 10.1002/jbmr.1604; Kim T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat4285; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Li GW, 2018, PROG NEUROBIOL, V163, P59, DOI 10.1016/j.pneurobio.2017.08.002; Li HC, 2018, EUR J PHARMACOL, V831, P20, DOI 10.1016/j.ejphar.2018.05.001; Li L, 2007, BRAIN RES, V1180, P133, DOI 10.1016/j.brainres.2007.08.059; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12495; Lv JJ, 2018, PROG NEUROBIOL, V161, P79, DOI 10.1016/j.pneurobio.2017.12.001; Mahajan SD, 2016, IMMUNOLOGY, V148, P407, DOI 10.1111/imm.12619; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Page S, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0042-1; Petrovic-Djergovic D, 2016, CIRC RES, V119, P142, DOI 10.1161/CIRCRESAHA.116.308022; Sakai N, 1996, BEHAV BRAIN RES, V77, P181, DOI 10.1016/0166-4328(95)00232-4; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Seo HB, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0678-4; Shao ZJ, 2009, J NEUROSCI RES, V87, P2520, DOI 10.1002/jnr.22086; Sifat AE, 2017, AAPS J, V19, P957, DOI 10.1208/s12248-017-0091-7; Song J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.491; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Suzuki R, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00446; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Wallis CJD, 2015, J CANCER, V6, P1295, DOI 10.7150/jca.13176; Wan C, 2019, EUR J IMMUNOL, V49, P2184, DOI 10.1002/eji.201948111; Wan XL, 2006, NEOPLASIA, V8, P394, DOI 10.1593/neo.05820; Wang J, 2018, ASIA PAC POLICY STU, V5, P4, DOI 10.1002/app5.216; Wang Y, 2018, FASEB J, V32, P935, DOI 10.1096/fj.201700139RRR; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Yang CJ, 2019, AM J PHYSIOL-CELL PH, V316, pC135, DOI 10.1152/ajpcell.00136.2018; Yi H, 2017, ARCH BIOCHEM BIOPHYS, V620, P52, DOI 10.1016/j.abb.2016.05.002; Zhang YS, 2018, BIOCHEM CELL BIOL, V96, P646, DOI 10.1139/bcb-2017-0224; Zhao Z, 2017, CELL RES, V27, P849, DOI 10.1038/cr.2017.71; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zuo XK, 2019, EXP NEUROL, V316, P12, DOI 10.1016/j.expneurol.2019.03.017	48	15	15	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13762	13775		10.1096/fj.201903092R	http://dx.doi.org/10.1096/fj.201903092R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32808351	hybrid			2022-12-28	WOS:000562545300001
J	Sehlin, D; Stocki, P; Gustavsson, T; Hultqvist, G; Walsh, FS; Rutkowski, JL; Syvanen, S				Sehlin, Dag; Stocki, Pawel; Gustavsson, Tobias; Hultqvist, Greta; Walsh, Frank S.; Rutkowski, J. Lynn; Syvanen, Stina			Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle	FASEB JOURNAL			English	Article						Alzheimer's disease (AD); amyloid-beta (A beta); antibody; blood-brain barrier (BBB); positron emission tomography (PET); receptor mediated transcytosis	ALZHEIMERS-DISEASE; BARRIER; ANTIBODIES; PENETRATION	Transferrin receptor 1 (TfR1) mediated transcytosis is an attractive strategy to enhance brain uptake of protein drugs, but translation remains a challenge. Here, a single domain shark antibody VNAR fragment (TXB2) with similar affinity to murine and human TfR1 was used to shuttle protein cargo into the brain. TXB2 was fused to a human IgG1 Fc domain (hFc) or to the amyloid-beta (A beta) antibody bapineuzumab (Bapi). TXB2-hFc displayed 20-fold higher brain concentrations compared with a control VNAR-hFc at 18 hours post-injection in wt mice. At the same time point, brain concentrations of Bapi-TXB2 was threefold higher than Bapi. In transgenic mice overexpressing human A beta, the brain-to-blood concentration ratio increased with time due to interaction with intracerebral A beta deposits. The relatively stable threefold difference between Bapi-TXB2 and Bapi was observed for up to 6 days after injection. PET imaging and ex vivo autoradiography revealed more parenchymal distribution of Bapi-TXB2 compared with Bapi. In conclusion, the TXB2 VNAR shuttle markedly increased brain uptake of protein cargo and increased brain concentrations of the A beta binding antibody Bapi.	[Sehlin, Dag; Gustavsson, Tobias; Syvanen, Stina] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, S-75185 Uppsala, Sweden; [Stocki, Pawel; Walsh, Frank S.; Rutkowski, J. Lynn] Ossianix Inc, Gunnels Wood Rd, Stevenage, Herts, England; [Stocki, Pawel; Walsh, Frank S.; Rutkowski, J. Lynn] Ossianix Inc, Philadelphia, PA USA; [Hultqvist, Greta] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Uppsala University; Uppsala University	Sehlin, D (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, S-75185 Uppsala, Sweden.; Stocki, P (corresponding author), Ossianix Inc, Gunnels Wood Rd, Stevenage, Herts, England.	dag.sehlin@pubcare.uu.se; pawel@ossianix.com	Gustavsson, Tobias/AFK-4025-2022; Gustavsson, Tobias/AAG-2820-2022	Sehlin, Dag/0000-0002-9430-3859; Hultqvist, Greta/0000-0002-4136-6792; Syvanen, Stina/0000-0002-8196-4041	Vetenskapsradet (VR) [2018-02715, 2017-02413]; Alzheimerfonden; Hjarnfonden (Swedish Brain Foundation); Torsten Soderbergs Stiftelse (Torsten Soderberg Foundation); Petrus och Augusta Hedlunds Stiftelse (Hedlund Foundation); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Ahlenstiftelsen (Ahlen Foundation); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gun och Bertil Stohnes Stiftelse (Stohnes Stiftelse); Stiftelsen for Gamla Tjanarinnor (Foundation for Old Servants); Stiftelsen Sigurd and Elsa Goljes Minne	Vetenskapsradet (VR)(Swedish Research Council); Alzheimerfonden; Hjarnfonden (Swedish Brain Foundation); Torsten Soderbergs Stiftelse (Torsten Soderberg Foundation); Petrus och Augusta Hedlunds Stiftelse (Hedlund Foundation); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Ahlenstiftelsen (Ahlen Foundation); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gun och Bertil Stohnes Stiftelse (Stohnes Stiftelse); Stiftelsen for Gamla Tjanarinnor (Foundation for Old Servants); Stiftelsen Sigurd and Elsa Goljes Minne	Vetenskapsradet (VR), Grant/Award Number: 2018-02715 and 2017-02413; Alzheimerfonden; Hjarnfonden (Swedish Brain Foundation); Torsten Soderbergs Stiftelse (Torsten Soderberg Foundation); Petrus och Augusta Hedlunds Stiftelse (Hedlund Foundation); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Ahlenstiftelsen (Ahlen Foundation); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gun och Bertil Stohnes Stiftelse (Stohnes Stiftelse); Stiftelsen for Gamla Tjanarinnor (Foundation for Old Servants); Stiftelsen Sigurd and Elsa Goljes Minne	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Clark AJ, 2015, P NATL ACAD SCI USA, V112, P12486, DOI 10.1073/pnas.1517048112; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Gustafsson S, 2018, NEUROPHARMACOLOGY, V143, P1, DOI 10.1016/j.neuropharm.2018.09.001; Hultqvist G, 2017, THERANOSTICS, V7, P308, DOI 10.7150/thno.17155; Johnsen KB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11220-1; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Meier SR, 2018, J NUCL MED, V59, P1885, DOI 10.2967/jnumed.118.213140; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Pardridge WM, 2016, EXPERT OPIN BIOL TH, V16, P1455, DOI 10.1080/14712598.2016.1230195; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sehlin D, 2019, EUR J NUCL MED MOL I, V46, P2848, DOI 10.1007/s00259-019-04426-0; Sehlin D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17358-2; Sehlin D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10759; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Stocki P., 2019, BLOOD BRAIN BARRIER, P1, DOI [10.1101/816900, DOI 10.1101/816900]; Syvanen S, 2018, ALZHEIMERS RES THER, V10, DOI [10.1186/s13195-018-0377-8, 10.1186/S13195-018-0377-8]; Wang E, 2014, NUCL MED COMMUN, V35, P767, DOI 10.1097/MNM.0000000000000117; Webster CI, 2016, FASEB J, V30, P1927, DOI 10.1096/fj.201500078; Wyatt EA, 2019, BIOENG TRANSL MED, V4, P30, DOI 10.1002/btm2.10108; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	31	18	19	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13272	13283		10.1096/fj.202000610RR	http://dx.doi.org/10.1096/fj.202000610RR		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32779267	Green Published, hybrid			2022-12-28	WOS:000558415100001
J	Winnay, JN; Solheim, MH; Sakaguchi, M; Njolstad, PR; Kahn, CR				Winnay, Jonathon N.; Solheim, Marie H.; Sakaguchi, Masaji; Njolstad, Pal R.; Kahn, C. Ronald			Inhibition of the PI 3-kinase pathway disrupts the unfolded protein response and reduces sensitivity to ER stress-dependent apoptosis	FASEB JOURNAL			English	Article						Apoptosis; ER stress; PI 3-kinase; SHORT Syndrome; Unfolded Protein Response	ENDOPLASMIC-RETICULUM STRESS; REGULATORY SUBUNIT; PHOSPHOINOSITIDE 3-KINASE; PIK3R1 MUTATIONS; PARTIAL LIPODYSTROPHY; POSITIVE REGULATION; INSULIN ACTION; SHORT STATURE; P85 ALPHA; P85-ALPHA	Class Ia phosphoinositide 3-kinases (PI3K) are critical mediators of insulin and growth factor action. We have demonstrated that the p85 alpha regulatory subunit of PI3K modulates the unfolded protein response (UPR) by interacting with and regulating the nuclear translocation of XBP-1s, a transcription factor essential for the UPR. We now show that PI3K activity is required for full activation of the UPR. Pharmacological inhibition of PI3K in cells blunts the ER stress-dependent phosphorylation of IRE1 alpha and PERK, decreases induction of ATF4, CHOP, and XBP-1 and upregulates UPR target genes. Cells expressing a human p85 alpha mutant (R649W) previously shown to inhibit PI3K, exhibit decreased activation of IRE1 alpha and PERK and reduced induction of CHOP and ATF4. Pharmacological inhibition of PI3K, overexpression of a mutant of p85 alpha that lacks the ability to interact with the p110 alpha catalytic subunit ( increment p85 alpha) or expression of mutant p85 alpha (R649W) in vivo, decreased UPR-dependent induction of ER stress response genes. Acute tunicamycin treatment of R649W(+/-)mice revealed reduced induction of UPR target genes in adipose tissue, whereas chronic tunicamycin exposure caused sustained increases in UPR target genes in adipose tissue. Finally, R649W(+/-)cells exhibited a dramatic resistance to ER stress-dependent apoptosis. These data suggest that PI3K pathway dysfunction causes ER stress that may drive the pathogenesis of several diseases including Type 2 diabetes and various cancers.	[Winnay, Jonathon N.; Solheim, Marie H.; Sakaguchi, Masaji; Kahn, C. Ronald] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA; [Solheim, Marie H.; Njolstad, Pal R.] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Sakaguchi, Masaji] Kumamoto Univ, Dept Metab Med, Kumamoto, Japan; [Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Winnay, Jonathon N.] Sana Biotechnol, Cambridge, MA USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Bergen; Kumamoto University; University of Bergen; Haukeland University Hospital	Kahn, CR (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, One Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK055545]; EC \ FP7 \ FP7 Ideas: European Research Council (FP7 Ideas) [29357]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); EC \ FP7 \ FP7 Ideas: European Research Council (FP7 Ideas)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01 DK055545; EC vertical bar FP7 vertical bar FP7 Ideas: European Research Council (FP7 Ideas), Grant/Award Number: 29357	AARSKOG D, 1983, AM J MED GENET, V15, P29, DOI 10.1002/ajmg.1320150104; Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Avila M, 2016, CLIN GENET, V89, P501, DOI 10.1111/cge.12688; Barcena C, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-51; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chudasama KK, 2013, AM J HUM GENET, V93, P150, DOI 10.1016/j.ajhg.2013.05.023; Chung BK, 2014, CLIN GENET, V85, P228, DOI 10.1111/cge.12262; Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445; Fruman DA, 2014, NEW ENGL J MED, V370, P1061, DOI 10.1056/NEJMe1400055; Gockeritz E, 2015, INT J CANCER, V137, P2234, DOI 10.1002/ijc.29579; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hawkes CP, 2013, EUR J PEDIATR, V172, P1255, DOI 10.1007/s00431-013-2007-6; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Inukai I, 2001, FEBS LETT, V490, P32, DOI 10.1016/S0014-5793(01)02132-9; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Klatka M, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0362-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LIPSON AH, 1989, J MED GENET, V26, P473, DOI 10.1136/jmg.26.7.473; Lu G, 2013, MOL METAB, V2, P405, DOI 10.1016/j.molmet.2013.07.005; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630; Oakes SA, 2020, AM J PATHOL, V190, P934, DOI 10.1016/j.ajpath.2020.01.010; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Prischi F., 2014, NAT COMMUN, V5, P1; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Ren SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111606; Sakaue H, 1997, MOL ENDOCRINOL, V11, P1552, DOI 10.1210/me.11.10.1552; Solheim MH, 2017, INVEST OPHTH VIS SCI, V58, P3100, DOI 10.1167/iovs.16-21347; Sorge G, 1996, AM J MED GENET, V61, P178, DOI 10.1002/(SICI)1096-8628(19960111)61:2<178::AID-AJMG16>3.0.CO;2-R; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Winnay JN, 2016, J CLIN INVEST, V126, P1401, DOI 10.1172/JCI84005; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	45	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12521	12532		10.1096/fj.202000892R	http://dx.doi.org/10.1096/fj.202000892R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744782				2022-12-28	WOS:000557255100001
J	You, H; Mayer, JU; Johnston, RL; Sivakumaran, H; Ranasinghe, S; Rivera, V; Kondrashova, O; Koufariotis, LT; Du, XF; Driguez, P; French, JD; Waddell, N; Duke, MG; Ittiprasert, W; Mann, VH; Brindley, PJ; Jones, MK; McManus, DP				You, Hong; Mayer, Johannes U.; Johnston, Rebecca L.; Sivakumaran, Haran; Ranasinghe, Shiwanthi; Rivera, Vanessa; Kondrashova, Olga; Koufariotis, Lambros T.; Du, Xiaofeng; Driguez, Patrick; French, Juliet D.; Waddell, Nicola; Duke, Mary G.; Ittiprasert, Wannaporn; Mann, Victoria H.; Brindley, Paul J.; Jones, Malcolm K.; McManus, Donald P.			CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase	FASEB JOURNAL			English	Article						acetylcholinesterase; CRISPR; Cas9; eggs; genome editing; Schistosoma mansoni	END-JOINING PATHWAYS; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; CAENORHABDITIS-ELEGANS; GRANULOMA-FORMATION; CRISPR; GENES; CELLS; ROLES; EGGS	CRISPR/Cas9-mediated genome editing shows cogent potential for the genetic modification of helminth parasites. We report successful gene knock-in (KI) into the genome of the egg of Schistosoma mansoni by combining CRISPR/Cas9 with single-stranded oligodeoxynucleotides (ssODNs). We edited the acetylcholinesterase (AChE) gene of S. mansoni targeting two guide RNAs (gRNAs), X5 and X7, located on exon 5 and exon 7 of Smp_154600, respectively. Eggs recovered from livers of experimentally infected mice were transfected by electroporation with a CRISPR/Cas9-vector encoding gRNA X5 or X7 combining with/ without a ssODN donor. Next generation sequencing analysis of reads of amplicon libraries spanning targeted regions revealed that the major modifications induced by CRISPR/Cas9 in the eggs were generated by homology directed repair (HDR). Furthermore, soluble egg antigen from AChE-edited eggs exhibited markedly reduced AChE activity, indicative that programed Cas9 cleavage mutated the AChE gene. Following injection of AChE-edited schistosome eggs into the tail veins of mice, an significantly enhanced Th2 response involving IL-4, -5, -10, and-13 was detected in lung cells and splenocytes in mice injected with X5-KI eggs in comparison to control mice injected with unmutated eggs. A Th2-predominant response, with increased levels of IL-4, -13, and GATA3, also was induced by X5 KI eggs in small intestine-draining mesenteric lymph node cells when the gene-edited eggs were introduced into the subserosa of the ileum of the mice. These findings confirmed the potential and the utility of CRISPR/Cas9-mediated genome editing for functional genomics in schistosomes.	[You, Hong; Ranasinghe, Shiwanthi; Rivera, Vanessa; Du, Xiaofeng; Duke, Mary G.; Jones, Malcolm K.; McManus, Donald P.] QIMR Berghofer Med Res Inst, Immunol Dept, 300 Herston Rd, Brisbane, Qld 4006, Australia; [Mayer, Johannes U.] Malaghan Inst Med Res, Wellington, New Zealand; [Johnston, Rebecca L.; Sivakumaran, Haran; Kondrashova, Olga; Koufariotis, Lambros T.; French, Juliet D.; Waddell, Nicola] QIMR Berghofer Med Res Inst, Genet & Computat Biol Dept, Brisbane, Qld, Australia; [Rivera, Vanessa] Deakin Univ, Sch Med, Geelong, Vic, Australia; [Driguez, Patrick] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Ittiprasert, Wannaporn; Mann, Victoria H.; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Ittiprasert, Wannaporn; Mann, Victoria H.; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC 20052 USA; [Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	QIMR Berghofer Medical Research Institute; Malaghan Institute; Victoria University Wellington; QIMR Berghofer Medical Research Institute; Deakin University; King Abdullah University of Science & Technology; George Washington University; George Washington University; University of Queensland	You, H; McManus, DP (corresponding author), QIMR Berghofer Med Res Inst, Immunol Dept, 300 Herston Rd, Brisbane, Qld 4006, Australia.	Hong.You@qimrberghofer.edu.au; Don.McManus@qimrberghofer.edu.au	Jones, Malcolm K/A-1097-2009; Johnston, Rebecca L./AAX-7868-2021; You, Hong/AAB-4649-2020; Johnston, Rebecca L./C-7683-2011	Jones, Malcolm K/0000-0002-0035-6141; You, Hong/0000-0002-8790-7793; Johnston, Rebecca L./0000-0001-7503-9514; Kondrashova, Olga/0000-0003-0022-5149; Koufariotis, Lambros/0000-0002-4917-1375; McManus, Donald/0000-0001-6443-1449; Driguez, Patrick/0000-0001-8104-677X; Brindley, Paul J./0000-0003-1765-0002; Sivakumaran, Haran/0000-0002-4691-4989; French, Juliet/0000-0002-9770-0198; Mayer, Johannes U/0000-0001-6225-7803	Wellcome Trust [107475/Z/15/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Almadi MA, 2011, NAT REV GASTRO HEPAT, V8, P455, DOI 10.1038/nrgastro.2011.115; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Anthony BJ, 2012, TRENDS PARASITOL, V28, P572, DOI 10.1016/j.pt.2012.09.005; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Ariyaratne A, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00127-19; Arunsan P, 2019, ELIFE, V8, DOI 10.7554/eLife.41463; Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; BUEDING E, 1972, BRIT J PHARMACOL, V46, P480, DOI 10.1111/j.1476-5381.1972.tb08145.x; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Carson JP, 2018, TRENDS PARASITOL, V34, P524, DOI 10.1016/j.pt.2018.02.005; Chatterjee S, 2004, ACTA TROP, V90, P191, DOI 10.1016/j.actatropica.2003.12.002; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Chu D, 2007, PARASITOLOGY, V134, P1611, DOI 10.1017/S0031182007002946; Chuah C, 2016, INT J PARASITOL, V46, P239, DOI 10.1016/j.ijpara.2015.12.004; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Chuah C, 2013, J LEUKOCYTE BIOL, V94, P353, DOI 10.1189/jlb.1212653; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Costain AH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03042; CRABTREE JE, 1980, PARASITOLOGY, V81, P553, DOI 10.1017/S003118200006193X; Craver MPJ, 2007, MOL BIOCHEM PARASIT, V153, P149, DOI 10.1016/j.molbiopara.2007.02.013; Dalton JP, 1997, PARASITOLOGY, V115, P29, DOI 10.1017/S0031182097001091; DONALD RGK, 1994, MOL BIOCHEM PARASIT, V63, P243, DOI 10.1016/0166-6851(94)90060-4; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; EDUNGBOLA LD, 1979, J PARASITOL, V65, P253, DOI 10.2307/3280158; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gang SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006675; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hagan P, 2004, TRENDS PARASITOL, V20, P92, DOI 10.1016/j.pt.2003.11.010; Hagen J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6375; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Hoffmann KF, 2014, SCIENCE, V346, P168, DOI 10.1126/science.1261139; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ittiprasert W, 2019, ELIFE, V8, DOI 10.7554/eLife.41337; Janssen BD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18442-3; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jones AK, 2002, FASEB J, V16, P441, DOI 10.1096/fj.01-0683fje; Jurberg AD, 2009, DEV GENES EVOL, V219, P219, DOI 10.1007/s00427-009-0285-9; Kaminsky R, 2008, PARASITOL RES, V103, P931, DOI 10.1007/s00436-008-1080-7; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Koslowski N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005595; Lan Z, 2013, BRAIN RES, V1498, P9, DOI 10.1016/j.brainres.2012.12.040; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; LEVISCHAFFER F, 1984, MOL BIOCHEM PARASIT, V13, P283, DOI 10.1016/0166-6851(84)90120-8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lino CA, 2018, DRUG DELIV, V25, P1234, DOI 10.1080/10717544.2018.1474964; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Mayer JU, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15820; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; McVeigh P, 2019, ELIFE, V8, DOI 10.7554/eLife.44382; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; NEILL PJG, 1988, AM J TROP MED HYG, V39, P52, DOI 10.4269/ajtmh.1988.39.52; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Pearson MS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00213; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Pu Zhang FM, 2006, ELECT J BIOL, V2, P11; Ranasinghe SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200433; Ricciardi A, 2015, VACCINE, V33, P346, DOI 10.1016/j.vaccine.2014.11.016; Rinaldi G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002820; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Robertson Alan P., 2007, Invertebrate Neuroscience, V7, P209, DOI 10.1007/s10158-007-0059-x; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Sankaranarayanan G, 2020, BIORXIV; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Team T. A., 2017, CRISPR 101 DESKT RES; Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9; Vaux R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005998; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30227-w; You H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082426; You H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1615-1; You H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003254; You H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009868; You H, 2009, INT J PARASITOL, V39, P1551, DOI 10.1016/j.ijpara.2009.06.006; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065; Zhang WW, 2015, MBIO, V6, DOI 10.1128/mBio.00861-15; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	88	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21205	10.1096/fj.202001745RR	http://dx.doi.org/10.1096/fj.202001745RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337558	Green Published, Green Submitted			2022-12-28	WOS:000605626600007
J	Smith-Cortinez, N; Fagundes, RR; Gomez, V; Kong, DF; de Waart, DR; Heegsma, J; Sydor, S; Olinga, P; de Meijer, VE; Taylor, CT; Bank, R; Paulusma, CC; Faber, KN				Smith-Cortinez, Natalia; Fagundes, Raphael R.; Gomez, Valentina; Kong, Defu; de Waart, Dirk R.; Heegsma, Janette; Sydor, Svenja; Olinga, Peter; de Meijer, Vincent E.; Taylor, Cormac T.; Bank, Ruud; Paulusma, Coen C.; Faber, Klaas Nico			Collagen release by human hepatic stellate cells requires vitamin C and is efficiently blocked by hydroxylase inhibition	FASEB JOURNAL			English	Article						ascorbic acid; vitamin C; collagen&#8208; I; hypoxia; liver fibrosis; myofibroblast	ASCORBIC-ACID 2-PHOSPHATE; PROLYL 4-HYDROXYLASE; GENE-EXPRESSION; LIVER FIBROSIS; EXTRACELLULAR-MATRIX; BILE-ACID; HYPOXIA; PROLIFERATION; ACCUMULATION; PROCOLLAGEN	Liver fibrosis is characterized by the accumulation of extracellular matrix proteins, mainly composed of collagen. Hepatic stellate cells (HSCs) mediate liver fibrosis by secreting collagen. Vitamin C (ascorbic acid) is a cofactor of prolyl-hydroxylases that modify newly synthesized collagen on the route for secretion. Unlike most animals, humans cannot synthesize ascorbic acid and its role in liver fibrosis remains unclear. Here, we determined the effect of ascorbic acid and prolyl-hydroxylase inhibition on collagen production and secretion by human HSCs. Primary human HSCs (p-hHSCs) and the human HSCscell line LX-2 were treated with ascorbic acid, transforming growth factor-beta (TGF beta) and/or the pan-hydroxylase inhibitor dimethyloxalylglycine (DMOG). Expression of collagen-I was analyzed by RT-qPCR (COL1A1), Western blotting, and immunofluorescence microscopy. Collagen secretion was determined in the medium by Western blotting for collagen-I and by HPLC for hydroxyproline concentrations. Expression of solute carrier family 23 members 1 and 2 (SLC23A1/SLC23A2), encoding sodium-dependent vitamin C transporters 1 and 2 (SVCT1/SVCT2) was quantified in healthy and cirrhotic human tissue. In the absence of ascorbic acid, collagen-I accumulated intracellularly in p-hHSCs and LX-2 cells, which was potentiated by TGF beta. Ascorbic acid co-treatment strongly promoted collagen-I excretion and enhanced extracellular hydroxyproline concentrations, without affecting collagen-I (COL1A1) mRNA levels. DMOG inhibited collagen-I release even in the presence of ascorbic acid and suppressed COL1A1 and alpha-smooth muscle actin (alpha SMA/ACTA2) mRNA levels, also under hypoxic conditions. Hepatocytes express both ascorbic acid transporters, while p-hHSCs and LX-2 express the only SVCT2, which is selectively enhanced in cirrhotic livers. Human HSCs rely on ascorbic acid for the efficient secretion of collagen-I, which can be effectively blocked by hydroxylase antagonists, revealing new therapeutic targets to treat liver fibrosis.	[Smith-Cortinez, Natalia; Fagundes, Raphael R.; Kong, Defu; Heegsma, Janette; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatol & Gastroenterol, Groningen, Netherlands; [Gomez, Valentina; de Waart, Dirk R.; Paulusma, Coen C.] Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, Amsterdam Gastroenterol & Metab, Amsterdam UMC, Amsterdam, Netherlands; [Sydor, Svenja] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus, Dept Internal Med, Bochum, Germany; [Olinga, Peter] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [de Meijer, Vincent E.] Univ Groningen, Univ Med Ctr Groningen, Div Hepatopancreatobiliary Surg & Liver Transplan, Dept Surg, Groningen, Netherlands; [Taylor, Cormac T.] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Dublin, Ireland; [Bank, Ruud] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Amsterdam; Ruhr University Bochum; University of Groningen; University of Groningen; University College Dublin; University College Dublin; University of Groningen	Faber, KN (corresponding author), Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	k.n.faber@umcg.nl	Paulusma, Coen/AAR-7943-2021; de Meijer, Vincent Erwin/H-6610-2019; Sydor, Svenja/AAV-9951-2021	de Meijer, Vincent Erwin/0000-0002-7900-5917; Sydor, Svenja/0000-0002-1349-8309; Fagundes, Raphael/0000-0003-1571-0374; Smith Cortinez, Natalia/0000-0003-2170-4157; Gomez Mellado, Valentina Edith/0000-0003-4879-7795; Olinga, Peter/0000-0003-4855-8452	CONICYT through grant Becas Chile	CONICYT through grant Becas Chile	NSC acknowledges support from CONICYT through grant Becas Chile.	Arriazu E, 2014, ANTIOXID REDOX SIGN, V21, P1078, DOI 10.1089/ars.2013.5697; Baiocchini A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151736; Baranyi U, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070721; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bickel M, 1998, HEPATOLOGY, V28, P404, DOI 10.1002/hep.510280217; CHOJKIER M, 1989, J BIOL CHEM, V264, P16957; D'Aniello C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/8936156; FENG J, 1977, IN VITRO CELL DEV B, V13, P91; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103; Hierro C, 2014, EUR J NUTR, V53, P401, DOI 10.1007/s00394-013-0536-4; Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007; Karsdal MA, 2017, ADV DRUG DELIVER REV, V121, P43, DOI 10.1016/j.addr.2017.07.014; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Macias RIR, 2011, BRIT J NUTR, V106, P1814, DOI 10.1017/S0007114511002273; Manns MP, 2013, DTSCH ARZTEBL INT, V110, P83, DOI 10.3238/arztebl.2013.0083; Manresa MC, 2016, AM J PHYSIOL-GASTR L, V311, pG1076, DOI 10.1152/ajpgi.00229.2016; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Nakayama K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133278; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Niimura Yoshihito, 2012, P43; NISHIKIMI M, 1988, ARCH BIOCHEM BIOPHYS, V267, P842, DOI 10.1016/0003-9861(88)90093-8; Padayatty SJ, 2016, ORAL DIS, V22, P463, DOI 10.1111/odi.12446; PALMERINI CA, 1985, J CHROMATOGR, V339, P285, DOI 10.1016/S0378-4347(00)84655-1; Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499; Paternostro C, 2010, WORLD J GASTROENTERO, V16, P281, DOI 10.3748/wjg.v16.i3.281; Pellicoro A, 2007, HEPATOLOGY, V45, P340, DOI 10.1002/hep.21528; Piersma B, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13324; Prathibha P, 2013, REDOX REP, V18, P36, DOI 10.1179/1351000212Y.0000000038; Saeed A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010029; Saeed A, 2017, BBA-MOL CELL BIOL L, V1862, P496, DOI 10.1016/j.bbalip.2017.01.007; Sakaida I, 1996, HEPATOLOGY, V23, P755, DOI 10.1002/hep.510230416; Sakaida I, 1999, J GASTROENTEROL, V34, P376, DOI 10.1007/s005350050277; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; SENOO H, 1994, BIOCHEM BIOPH RES CO, V200, P999, DOI 10.1006/bbrc.1994.1549; Shajari S, 2019, BBA-MOL CELL BIOL L, V1864, P1258, DOI 10.1016/j.bbalip.2019.05.012; Shi YF, 2007, FEBS LETT, V581, P203, DOI 10.1016/j.febslet.2006.12.010; Su M, 2016, AM J TRANSL RES, V8, P2820; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Vasta JD, 2016, BIOCHEMISTRY-US, V55, P3224, DOI 10.1021/acs.biochem.6b00251; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Werner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138655; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]	44	6	7	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001564RR	http://dx.doi.org/10.1096/fj.202001564RR		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33236467	Green Published, hybrid			2022-12-28	WOS:000593293500001
J	Hu, WX; Wu, RR; Gao, CY; Liu, F; Zeng, ZR; Zhu, QF; Chen, JY; Cheng, S; Yu, KX; Qian, Y; Zhao, J; Zhong, SH; Li, QJ; Wang, LH; Liu, XB; Wang, JA				Hu, Wangxing; Wu, Rongrong; Gao, Chenyang; Liu, Feng; Zeng, Zhiru; Zhu, Qifeng; Chen, Jinyong; Cheng, Si; Yu, Kaixiang; Qian, Yi; Zhao, Jing; Zhong, Shuhan; Li, Qingju; Wang, Lihan; Liu, Xianbao; Wang, Jian'an			Knockdown of estrogen-related receptor alpha inhibits valve interstitial cell calcification in vitro by regulating heme oxygenase 1	FASEB JOURNAL			English	Article						calcification; CAVD; ERR&#945; Hmox1; valve interstitial cells	ERR-ALPHA; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; VASCULAR CALCIFICATION; AORTIC-STENOSIS; UP-REGULATION; METABOLISM; EXPRESSION; DISEASE; MECHANISMS	Calcific aortic valve disease (CAVD) is the most common valvular heart disease in adults. The cellular mechanisms of CAVD are still unknown, but accumulating evidence has revealed that osteogenic differentiation of human valve interstitial cells (hVICs) plays an important role in CAVD. Thus, we aimed to investigate the function of estrogen-related receptor alpha (ERR alpha) in the osteogenic differentiation of hVICs. We found that the level of ERR alpha was significantly increased in CAVD samples compared to normal controls. In addition, ERR alpha was significantly upregulated during hVIC osteogenic differentiation in vitro. Gain- and loss-of-function experiments were performed to identify the function of ERR alpha in hVIC calcification in vitro. Inhibition of endogenous ERR alpha attenuated hVIC calcification, whereas overexpression of ERR alpha in hVICs promoted this process. RNA sequencing results suggested that heme oxygenase-1 (Hmox1) was a downstream target of ERR alpha, which was further confirmed by western blotting. Additionally, we also found that downregulation of Hmox1 by shHmox1 efficiently reversed the inhibition of calcification induced by ERR alpha shRNA in hVICs. ChIP-qPCR and luciferase assays indicated that Hmox1 was negatively regulated by ERR alpha. We found that overexpression of Hmox1 or its substrates significantly inhibited hVIC calcification in vitro. In conclusion, we found that knockdown of ERR alpha can inhibit hVIC calcification through upregulating Hmox1 and that ERR alpha and Hmox1 are potential targets for the treatment of CAVD.	[Hu, Wangxing; Wu, Rongrong; Gao, Chenyang; Liu, Feng; Zeng, Zhiru; Zhu, Qifeng; Chen, Jinyong; Cheng, Si; Yu, Kaixiang; Qian, Yi; Zhao, Jing; Zhong, Shuhan; Li, Qingju; Wang, Lihan; Liu, Xianbao; Wang, Jian'an] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou, Peoples R China; [Hu, Wangxing; Wu, Rongrong; Gao, Chenyang; Liu, Feng; Zeng, Zhiru; Zhu, Qifeng; Chen, Jinyong; Cheng, Si; Yu, Kaixiang; Qian, Yi; Zhao, Jing; Zhong, Shuhan; Li, Qingju; Wang, Lihan; Liu, Xianbao; Wang, Jian'an] Key Lab Cardiovasc Dis Zhejiang Prov, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University	Liu, XB; Wang, JA (corresponding author), Key Lab Cardiovasc Dis Zhejiang Prov, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	liuxb@zju.edu.cn; wangjianan111@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81870292, 81622006, 81670261, 81570233, 81770252, 81960083]; National Key R&D Program of China [2019YFA0110400, 2016YFC1301204, 2017YFA0103700]; Key R&D Projects of Zhejiang Province [2015C03028, 2018C03014]; Fundamental Research Funds for the Central Universities [2019XZZX005-4-03]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Key R&D Projects of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870292, 81622006, 81670261, 81570233, 81770252 and 81960083; National Key R&D Program of China, Grant/Award Number: 2019YFA0110400, 2016YFC1301204 and 2017YFA0103700; The Key R&D Projects of Zhejiang Province, Grant/Award Number: 2015C03028 and 2018C03014; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2019XZZX005-4-03	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Alushi B, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00685; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Audet-Walsh E, 2016, CELL REP, V14, P920, DOI 10.1016/j.celrep.2015.12.086; Bolisetty S, 2017, AM J KIDNEY DIS, V69, P531, DOI 10.1053/j.ajkd.2016.10.037; Bonnelye E, 2005, J CLIN ENDOCR METAB, V90, P3115, DOI 10.1210/jc.2004-2168; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; De Bosscher K, 2020, NAT REV ENDOCRINOL, V16, P363, DOI 10.1038/s41574-020-0349-5; Di Pietro C, 2000, FRONT PHARMACOL, V11; Durante W, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090829; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Gaillard S, 2007, MOL ENDOCRINOL, V21, P62, DOI 10.1210/me.2006-0179; Gallet M, 2010, TRENDS ENDOCRIN MET, V21, P637, DOI 10.1016/j.tem.2010.06.008; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Hou YC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072466; Huang T, 2000, STEM CELLS, V35, P411; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Kado DM, 2000, J BONE MINER RES, V15, P1974, DOI 10.1359/jbmr.2000.15.10.1974; Lin TH, 2010, J CELL PHYSIOL, V222, P757, DOI 10.1002/jcp.22008; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007; MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102; Mullican SE, 2013, J MOL ENDOCRINOL, V51, pT115, DOI 10.1530/JME-13-0212; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rajalin AM, 2010, BIOCHEM BIOPH RES CO, V396, P477, DOI 10.1016/j.bbrc.2010.04.120; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Ranhotra HS, 2018, J RECEPT SIG TRANSD, V38, P95, DOI 10.1080/10799893.2018.1456552; Rutkovskiy A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006339; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Sallam T, 2019, CURR OPIN LIPIDOL, V30, P357, DOI 10.1097/MOL.0000000000000632; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shen J, 2018, CIRC RES, V122, P1395, DOI 10.1161/CIRCRESAHA.117.312418; Small A, 2017, ARTERIOSCL THROM VAS, V37, P623, DOI 10.1161/ATVBAHA.116.308615; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wang LJ, 1998, AM J PATHOL, V152, P711; Wang T, 2015, MOL CELL BIOL, V35, P1281, DOI 10.1128/MCB.01156-14; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; Wu BR, 2017, ANNU REV PHYSIOL, V79, P21, DOI 10.1146/annurev-physiol-022516-034001; Xia H, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00206; Yang F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0579-9; Yutzey KE, 2014, ARTERIOSCL THROM VAS, V34, P2387, DOI 10.1161/ATVBAHA.114.302523; Zarjou A, 2009, J AM SOC NEPHROL, V20, P1254, DOI 10.1681/ASN.2008070788	52	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001588RR	http://dx.doi.org/10.1096/fj.202001588RR		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184978				2022-12-28	WOS:000590889600001
J	Miyamoto, Y; Sasaki, M; Miyata, H; Monobe, Y; Nagai, M; Otani, M; Whiley, PAF; Morohoshi, A; Oki, S; Matsuda, J; Akagi, K; Adachi, J; Okabe, M; Ikawa, M; Yoneda, Y; Loveland, KL; Oka, M				Miyamoto, Yoichi; Sasaki, Mitsuho; Miyata, Haruhiko; Monobe, Yoko; Nagai, Masahiro; Otani, Mayumi; Whiley, Penny A. F.; Morohoshi, Akane; Oki, Shinya; Matsuda, Junichiro; Akagi, Ken-ichi; Adachi, Jun; Okabe, Masaru; Ikawa, Masahito; Yoneda, Yoshihiro; Loveland, Kate L.; Oka, Masahiro			Genetic loss of importin alpha 4 causes abnormal sperm morphology and impacts on male fertility in mouse	FASEB JOURNAL			English	Article						axoneme; Kpna; male infertility; nuclear transport; spermiogenesis	NUCLEAR IMPORT; MICE LACKING; NUCLEOCYTOPLASMIC TRANSPORT; CELL FATE; PROTEIN; SPERMIOGENESIS; LOCALIZATION; INHIBITION; CENTROSOME; MANCHETTE	Importin alpha proteins play a central role in the transport of cargo from the cytoplasm to the nucleus. In this study, we observed that male knock-out mice for importin alpha 4, which is encoded by theKpna4gene (Kpna4(-/-)), were subfertile and yielded smaller litter sizes than those of wild-type (WT) males. In contrast, mice lacking the closely related importin alpha 3 (Kpna3(-/-)) were fertile. In vitro fertilization and sperm motility assays demonstrated that sperm fromKpna4(-/-)mice had significantly reduced quality and motility. In addition, acrosome reaction was also impaired inKpna4(-/-)mice. Transmission electron microscopy revealed striking defects, including abnormal head morphology and multiple axoneme structures in the flagella ofKpna4(-/-)mice. A five-fold increase in the frequency of abnormalities inKpna4(-/-)mice compared toWTmice indicates the functional importance of importin alpha 4 in normal sperm development. Moreover, Nesprin-2, which is a component of the linker of nucleus and cytoskeleton complex, was expressed at lower levels in sperm fromKpna4(-/-)mice and was localized with abnormal axonemes, suggesting incorrect formation of the nuclear membrane-cytoskeleton structure during spermiogenesis. Proteomics analysis ofKpna4(-/-)testis showed significantly altered expression of proteins related to sperm formation, which provided evidence that genetic loss of importin alpha 4 perturbed chromatin status. Collectively, these findings indicate that importin alpha 4 is critical for establishing normal sperm morphology in mice, providing new insights into male germ cell development by highlighting the requirement of importin alpha 4 for normal fertility.	[Miyamoto, Yoichi; Otani, Mayumi; Oka, Masahiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Nucl Transport Dynam, 7-6-8 Saito Asagi, Ibaraki, Osaka, Japan; [Sasaki, Mitsuho; Matsuda, Junichiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Anim Models Human Dis, Osaka, Japan; [Miyata, Haruhiko; Morohoshi, Akane; Okabe, Masaru; Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Monobe, Yoko; Akagi, Ken-ichi] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Sect Lab Equipment, Osaka, Japan; [Nagai, Masahiro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Osaka, Japan; [Whiley, Penny A. F.; Loveland, Kate L.] Hudson Inst Med Res, Ctr Reprod Hlth, Clayton, Vic, Australia; [Morohoshi, Akane; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Osaka, Japan; [Oki, Shinya] Kyoto Univ, Grad Sch Med, Dept Drug Discovery Med, Kyoto, Japan; [Adachi, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Proteome Res, Osaka, Japan; [Yoneda, Yoshihiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Osaka, Japan; [Loveland, Kate L.] Monash Univ, Sch Clin Sci, Dept Mol & Translat Sci, Clayton, Vic, Australia	Osaka University; Osaka University; Hudson Institute of Medical Research; Osaka University; Kyoto University; Monash University	Miyamoto, Y; Oka, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Nucl Transport Dynam, 7-6-8 Saito Asagi, Ibaraki, Osaka, Japan.	ymiyamoto@nibiohn.go.jp; moka@nibiohn.go.jp	ikawa, masahito/A-5315-2009; Adachi, Jun/H-2813-2014; Oki, Shinya/J-7662-2019	ikawa, masahito/0000-0001-9859-6217; Adachi, Jun/0000-0003-1220-3246; Oki, Shinya/0000-0002-4767-3259; Miyamoto, Yoichi/0000-0003-4016-1119; AKAGI, Ken-ichi/0000-0002-7051-4598	MEXT | Japan Society for the Promotion of Science (JSPS) [15K07068, 16H04789, 17H03679, 20K06455]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15K07068, 16H04789, 17H03679 and 20K06455	Adachi J, 2016, ANAL CHEM, V88, P7899, DOI 10.1021/acs.analchem.6b01232; Arjomand A, 2014, FASEB J, V28, P3480, DOI 10.1096/fj.13-244913; Baker SA, 2015, J BIOL CHEM, V290, P22485, DOI 10.1074/jbc.M115.658104; Bao JQ, 2011, MOL CELL ENDOCRINOL, V333, P134, DOI 10.1016/j.mce.2010.12.021; Castaneda JM, 2020, BIOL REPROD, V102, P852, DOI 10.1093/biolre/ioz226; Cheng Y, 2007, MOL CELL BIOL, V27, P2582, DOI 10.1128/MCB.01722-06; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fatima S, 2017, BBA-MOL CELL RES, V1864, P546, DOI 10.1016/j.bbamcr.2016.12.017; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Hogarth CA, 2007, DEV DYNAM, V236, P2311, DOI 10.1002/dvdy.21238; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Ito C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50516-2; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P131, DOI 10.1002/mrd.10164; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Loveland KL, 2015, ASIAN J ANDROL, V17, P537, DOI 10.4103/1008-682X.154310; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Miyamoto Y, 2016, J BIOCHEM, V160, P69, DOI 10.1093/jb/mvw036; Miyamoto Y, 2013, BBA-MOL CELL RES, V1833, P731, DOI 10.1016/j.bbamcr.2012.11.005; Miyamoto Y, 2012, BBA-GENE REGUL MECH, V1819, P616, DOI 10.1016/j.bbagrm.2012.01.015; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; Mross C, 2018, NUCLEUS-PHILA, V9, P503, DOI 10.1080/19491034.2018.1523664; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Nagai M, 2011, FEBS LETT, V585, P791, DOI 10.1016/j.febslet.2011.02.002; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Shen CL, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107086; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tarnasky H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-67; Ungricht R, 2017, NAT REV MOL CELL BIO, V18, P229, DOI 10.1038/nrm.2016.153; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Whiley PAF, 2012, INT J ANDROL, V35, P158, DOI 10.1111/j.1365-2605.2011.01202.x; Yamazaki D, 2016, J CELL SCI, V129, P1940, DOI 10.1242/jcs.182220; Yang K, 2018, HISTOCHEM CELL BIOL, V150, P49, DOI 10.1007/s00418-018-1668-7; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Young JC, 2013, BBA-MOL CELL RES, V1833, P2348, DOI 10.1016/j.bbamcr.2013.06.007; Young SAM, 2016, REPRODUCTION, V152, P665, DOI 10.1530/REP-16-0150; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142296	54	7	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16224	16242		10.1096/fj.202000768RR	http://dx.doi.org/10.1096/fj.202000768RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058343				2022-12-28	WOS:000581160300001
J	Wei, YX; Gao, J; Kou, YB; Liu, MN; Meng, LY; Zheng, XP; Xu, SH; Liang, M; Sun, HX; Liu, ZZ; Wang, YG				Wei, Yanxia; Gao, Jing; Kou, Yanbo; Liu, Mengnan; Meng, Liyuan; Zheng, Xingping; Xu, Shihong; Liang, Ming; Sun, Hongxiang; Liu, Zhuanzhuan; Wang, Yugang			The intestinal microbial metabolite desaminotyrosine is an anti-inflammatory molecule that modulates local and systemic immune homeostasis	FASEB JOURNAL			English	Article						desaminotyrosine; flavonoids; microbial metabolite; mucosal barrier; type I IFN	DIET-INDUCED OBESITY; GUT MICROBIOTA; INFLAMMATION; FLAVONOIDS; TRYPTOPHAN	It is considered that intestinal barrier dysfunction and systemic endotoxemia drive obesity and its related complications. However, what causes barrier dysfunction remains to be elucidated. Here, we showed that the gut microbiota from high-fat diet (HFD)-fed mice had impaired ability to degrade dietary flavonoids, and in correspondence, the microbial-derived flavonoid metabolite desaminotyrosine (DAT) was reduced. Supplementation of DAT in the drinking water was able to counter the HFD-induced body fat mass accumulation and body weight increment. This is correlated with the role of DAT in maintaining mucosal immune homeostasis to protect barrier integrity. DAT could attenuate dextran sodium sulfate (DSS)-induced mucosal inflammation in a type I interferon signal-dependent manner. Furthermore, intraperitoneal injection of DAT-protected mice from bacterial endotoxin-induced septic shock. Together, we identified DAT as a gut microbiota-derived anti-inflammatory metabolite that functions to modulate local and systemic immune homeostasis. Our data support the notion of dysbiosis being an important driving force of mucosal barrier dysfunction and systemic metabolic complications.	[Wei, Yanxia; Gao, Jing; Kou, Yanbo; Liu, Mengnan; Meng, Liyuan; Zheng, Xingping; Xu, Shihong; Liang, Ming; Sun, Hongxiang; Liu, Zhuanzhuan; Wang, Yugang] Xuzhou Med Univ, Lab Infect & Immun, Jiangsu Key Lab Immun & Metab, Dept Pathogen Biol & Immunol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University	Wang, YG (corresponding author), Xuzhou Med Univ, Dept Pathogen Biol & Immunol, Tongshan Rd 209, Xuzhou 221004, Jiangsu, Peoples R China.	wangyg@xzhmu.edu.cn		Wang, Yugang/0000-0002-0709-1924	National Natural Science Foundation of China [81770853, 81970730]; Jiangsu Higher Education Institutions [KYLX14-1448]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [16KJB310016]; Xuzhou Medical University [D2016029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province; Xuzhou Medical University	National Natural Science Foundation of China, Grant/Award Number: 81770853 and 81970730; Jiangsu Higher Education Institutions, Grant/Award Number: KYLX14-1448; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, Grant/Award Number: 16KJB310016; Xuzhou Medical University, Grant/Award Number: D2016029	Adams JA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208681; Alsaggar M, 2017, GENE THER, V24, P60, DOI 10.1038/gt.2016.76; Braune A, 2016, GUT MICROBES, V7, P216, DOI 10.1080/19490976.2016.1158395; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Feng XJ, 2016, EBIOMEDICINE, V9, P61, DOI 10.1016/j.ebiom.2016.06.017; George IF, 2009, FEMS MICROBIOL LETT, V296, P159, DOI 10.1111/j.1574-6968.2009.01632.x; Hannibal TD, 2017, DIABETOLOGIA, V60, P2033, DOI 10.1007/s00125-017-4341-0; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kissig M, 2017, EMBO J, V36, P1528, DOI 10.15252/embj.201695588; Krishnan S, 2018, CELL REP, V23, P1099, DOI 10.1016/j.celrep.2018.03.109; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; LAMBERT MA, 1980, J CLIN MICROBIOL, V12, P291, DOI 10.1128/JCM.12.2.291-293.1980; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nieves-Ramirez ME, 2018, MSYSTEMS, V3, DOI [10.1128/mSystems.00007-18, 10.1128/msystems.00007-18]; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rodriguez-Mateos A, 2014, ARCH TOXICOL, V88, P1803, DOI 10.1007/s00204-014-1330-7; Sanmiguel C, 2015, CURR OBES REP, V4, P250, DOI 10.1007/s13679-015-0152-0; Saura-Calixto F, 2010, MOL NUTR FOOD RES, V54, P939, DOI 10.1002/mnfr.200900276; Schoefer L, 2003, APPL ENVIRON MICROB, V69, P5849, DOI 10.1128/AEM.69.10.5849-5854.2003; Selvanantham T, 2016, J IMMUNOL, V197, P4464, DOI 10.4049/jimmunol.1601410; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Tleugabulova MC, 2016, J IMMUNOL, V197, P3959, DOI 10.4049/jimmunol.1601382; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wieser V, 2018, GUT, V67, P157, DOI 10.1136/gutjnl-2016-313155; Winer DA, 2016, CELL METAB, V23, P413, DOI 10.1016/j.cmet.2016.01.003	37	11	11	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16117	16128		10.1096/fj.201902900RR	http://dx.doi.org/10.1096/fj.201902900RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047367				2022-12-28	WOS:000581169400001
J	Lai, SS; Cheng, R; Gao, D; Chen, YG; Deng, C				Lai, Shanshan; Cheng, Ran; Gao, Dan; Chen, Ye-Guang; Deng, Cheng			LGR5 constitutively activates NF-kappa B signaling to regulate the growth of intestinal crypts	FASEB JOURNAL			English	Article						intestinal epithelium; LGR5; LGR4; NF-kappa B pathway; stem cell; apoptosis	PANETH CELL-DIFFERENTIATION; PROTEIN-COUPLED RECEPTORS; R-SPONDIN RECOGNITION; STEM-CELLS; WNT/BETA-CATENIN; COLORECTAL-CANCER; STRUCTURAL BASIS; WNT RECEPTORS; NULL MICE; ENDOCYTOSIS	Mammalian LGR5 and LGR4, markers of adult stem cells, are involved in many physiological functions by enhancing WNT signaling. However, whether LGR5 and LGR4 are coupled to other intracellular signaling pathways to regulate stem cell function remains unknown. Here, we show that LGR5 and LGR4 can constitutively activate NF-kappa B signaling in a ligand-independent manner, which is dependent on their C-termini, but independent of receptor endocytosis. Moreover, the C-termini of LGR5/4 interact with TROY, which is required for activating NF-kappa B signaling. In small intestinal crypt organoids, overexpression of a C-terminal deletion mutant of LGR5 inhibits the growth and bud formation of organoids, whereas overexpression of the R-spondin-binding mutant of LGR5 that is defective for WNT signaling can still promote organoid growth. Our study reveals that NF-kappa B signaling, regulated by LGR5 and LGR4, plays an important role in the survival of colon cancer cells and the growth of intestinal crypts. Our findings also suggest that LGR5/4-induced NF-kappa B signaling and WNT signaling may co-regulate the growth of LGR5(+)adult stem cells and intestinal crypts.	[Lai, Shanshan; Cheng, Ran; Gao, Dan; Deng, Cheng] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, 1 Wenyuan Rd, Nanjing 210023, Peoples R China; [Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing, Peoples R China	Nanjing Normal University; Tsinghua University	Deng, C (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, 1 Wenyuan Rd, Nanjing 210023, Peoples R China.	dengcheng@njnu.edu.cn		deng, cheng/0000-0002-5296-8879	National Key Research and Development Program of China [2018YFD0900602]; National Natural Science Foundation of China [31701234, 31401207]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation from Jiangsu Province [BK20160043, BK20151546, BK20171035, 15KJA180004]; Natural Science Foundation of the Jiangsu Higher Education Institutions [17KJB180006, 19KJB180003]; Jiangsu Distinguished Professor Funding	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation from Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions; Jiangsu Distinguished Professor Funding	National Key Research and Development Program of China, Grant/Award Number: 2018YFD0900602; National Natural Science Foundation of China, Grant/Award Number: 31701234 and 31401207; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation from Jiangsu Province, Grant/Award Number: BK20160043, BK20151546, BK20171035 and 15KJA180004; Natural Science Foundation of the Jiangsu Higher Education Institutions, Grant/Award Number: 17KJB180006 and 19KJB180003; Jiangsu Distinguished Professor Funding	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Carmon KS, 2017, J BIOL CHEM, V292, P14989, DOI 10.1074/jbc.M117.786798; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Ding QR, 2009, CELL RES, V19, P317, DOI 10.1038/cr.2008.299; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Fukuma M, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.10.011; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040842; Ha H, 2009, CURR PROTOC IMMUNOL, V11, p19D; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Hsu HC, 2014, CELL SIGNAL, V26, P2333, DOI 10.1016/j.cellsig.2014.07.004; Hsu HC, 2013, INT J COLORECTAL DIS, V28, P1535, DOI 10.1007/s00384-013-1721-x; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Lauwers E, 2006, BIOCHEM BIOPH RES CO, V351, P21, DOI 10.1016/j.bbrc.2006.09.141; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Li YH, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0051-0; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Mattila SO, 2016, J CELL SCI, V129, P1366, DOI 10.1242/jcs.176115; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nadim WD, 2016, P NATL ACAD SCI USA, V113, P12310, DOI 10.1073/pnas.1600914113; Peng WC, 2013, CELL REP, V3, P1885, DOI 10.1016/j.celrep.2013.06.009; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Qi Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13824; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Snyder JC, 2017, J BIOL CHEM, V292, P7208, DOI 10.1074/jbc.M116.756635; Snyder JC, 2015, J CELL SCI, V128, P1230, DOI 10.1242/jcs.166322; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Thomsen W, 2005, CURR OPIN BIOTECH, V16, P655, DOI 10.1016/j.copbio.2005.10.008; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093608; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu JG, 2015, J BIOL CHEM, V290, P2455, DOI 10.1074/jbc.M114.599134; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Z, 2017, MOL PHARMACOL, V92, P201, DOI 10.1124/mol.116.107839; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	60	8	8	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15605	15620		10.1096/fj.202001329R	http://dx.doi.org/10.1096/fj.202001329R		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	33001511				2022-12-28	WOS:000575398100001
J	Li, J; Yu, TT; Yan, HC; Qiao, YQ; Wang, LC; Zhang, T; Li, Q; Zhou, YH; Liu, DW				Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Qiao, Yi-Qiang; Wang, Lin-Chuan; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei			T cells participate in bone remodeling during the rapid palatal expansion	FASEB JOURNAL			English	Article						bone formation; immunity; orthodontics; osteoclasts	OSTEOCLAST DIFFERENTIATION; MIDPALATAL SUTURE; IFN-GAMMA; RANKL; DESTRUCTION; ALPHA; RUNX2	Palatal expansion has been widely used for the treatment of transverse discrepancy or maxillae hypoplasia, but the biological mechanism of bone formation during this procedure is largely unknown. Osteoclasts, which could be regulated by T cells and other components of the immune system, play a crucial role in force-induced bone remodeling. However, whether T cells participate in the palatal expansion process remains to be determined. In this study, we conducted the tooth borne rapid palatal expansion model on the mouse, and detect whether the helper T cells (Th) and regulatory T cells (Treg) could affect osteoclasts and further bone formation. After bonding open spring palatal expanders for 3-day, 5-day, 7-day, and retention for 28-day, micro-computed tomography scanning, histologic, and immunofluorescence staining were conducted to evaluate how osteoclasts were regulated by T cells during the bone remodeling process. We revealed that the increased osteoclast number was downregulated at the end of the early stage of rapid palatal expansion. Type 1 helper T (Th1) cells and Type 17 helper T (Th17) cells increased initially and promoted osteoclastogenesis. Thereafter, the regulatory T (Treg) cells emerged and maintained a relatively high level at the late stage of the experiment to downregulate the osteoclast number by inhibiting Th1 and Th17 cells, which governed the new bone formation. In conclusion, orchestrated T cells are able to regulate osteoclasts at the early stage of rapid palatal expansion and further facilitate bone formation during retention. This study identifies that T cells participate in the palatal expansion procedure by regulating osteoclasts and implies the potential possibility for clinically modulating T cells to improve the palatal expansion efficacy.	[Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China; [Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei] Natl Clin Res Ctr Oral Dis, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China; [Qiao, Yi-Qiang] Zhengzhou Univ, Affiliated Hosp 1, Dept Stomatol, Zhengzhou, Peoples R China; [Wang, Lin-Chuan] Univ Rochester, Eastman Inst Oral Hlth, Rochester, NY USA	Peking University; Zhengzhou University; University of Rochester	Zhou, YH; Liu, DW (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.	yanhengzhou@vip.163.com; liudawei@bjmu.edu.cn	, 许开源 18362929861 赛德阳光口腔/AFX-1820-2022; Zhou, Yanheng/ABG-5432-2021	Zhou, Yanheng/0000-0002-5610-9967	National Science Foundation of China [81970909, 51903003]; National Natural Science Foundation of China [U1704187]; Natural Science Foundation of Beijing [7192290]; Young Scientists Fund [20110203, 20170109]; Peking University Medicine Seed Fund for Interdisciplinary Research [BMU2018MX007]; Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation [BMU2018PYB009]; Fundamental Research Funds for the Central Universities	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Young Scientists Fund; Peking University Medicine Seed Fund for Interdisciplinary Research; Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Science Foundation of China, Grant/Award Number: 81970909 and 51903003; National Natural Science Foundation of China, Grant/Award Number: U1704187; Natural Science Foundation of Beijing, Grant/Award Number: 7192290; Young Scientists Fund, Grant/Award Number: 20110203 and 20170109; Peking University Medicine Seed Fund for Interdisciplinary Research, Grant/Award Number: BMU2018MX007; Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation, Grant/Award Number: BMU2018PYB009; Fundamental Research Funds for the Central Universities	Adamopoulos IE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2936; Ayon Haro E R, 2011, J Periodontal Res, V46, P361, DOI 10.1111/j.1600-0765.2011.01352.x; Fuhrer RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44959-w; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Hayakawa T, 2015, MOL MED REP, V12, P5879, DOI 10.3892/mmr.2015.4141; He D, 2015, J DENT RES, V94, P1286, DOI 10.1177/0022034515589714; He D, 2015, J DENT RES, V94, P129, DOI 10.1177/0022034514553817; He DQ, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01607-9; HORTON JE, 1972, SCIENCE, V177, P793, DOI 10.1126/science.177.4051.793; Hou B, 2007, BONE, V40, P1483, DOI 10.1016/j.bone.2007.01.019; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kawane T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31853-0; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1, DOI DOI 10.1016/J.AJ0D0.2005.10.007; Li MY, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12697; Li WL, 2020, J CELL PHYSIOL, V235, P5972, DOI 10.1002/jcp.29522; Liu F, 2017, J DENT RES, V96, P694, DOI 10.1177/0022034517690388; Liu SSY, 2011, AM J ORTHOD DENTOFAC, V139, P446, DOI 10.1016/j.ajodo.2009.03.056; Liu SSY, 2010, EUR J ORTHODONT, V32, P371, DOI 10.1093/ejo/cjp103; Liu Y, 2017, J DENT RES, V96, P586, DOI 10.1177/0022034516685527; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Marahleh A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02925; Maruyama T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10526; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; MURRAY JMG, 1971, J DENT RES, V50, P1654, DOI 10.1177/00220345710500065101; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Rody WJ, 2001, AM J ORTHOD DENTOFAC, V120, P477, DOI 10.1067/mod.2001.118623; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shin H, 2019, KOREAN J ORTHOD, V49, P360, DOI 10.4041/kjod.2019.49.6.360; STARNBACH H, 1966, ANGLE ORTHOD, V36, P152; Suzuki N, 2008, INT J MOL MED, V21, P291; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Walsh MC, 2018, NAT REV RHEUMATOL, V14, P146, DOI 10.1038/nrrheum.2017.213; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509; Wu BH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177159; Wu SH, 2012, INT J MED SCI, V9, P801, DOI 10.7150/ijms.4838; Yan Y, 2015, J DENT RES, V94, P1463, DOI 10.1177/0022034515595003; Yu MC, 2018, EMBO REP, V19, P156, DOI 10.15252/embr.201744421; Zaiss MM, 2010, J IMMUNOL, V184, P7238, DOI 10.4049/jimmunol.0903841; Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139	44	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15327	15337		10.1096/fj.202001078R	http://dx.doi.org/10.1096/fj.202001078R		SEP 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32951236				2022-12-28	WOS:000572346100001
J	Ren, HW; Zuo, SK; Hou, YY; Shang, WL; Liu, N; Yin, ZM				Ren, Huiwen; Zuo, Shengkai; Hou, Yayan; Shang, Wenlong; Liu, Na; Yin, Zhuming			Inhibition of alpha 1-adrenoceptor reduces TGF-beta 1-induced epithelial-to-mesenchymal transition and attenuates UUO-induced renal fibrosis in mice	FASEB JOURNAL			English	Article						epithelia-mesenchymal transition; renal fibrosis; sympathetic nerve activity; tamsulosin; transforming growth factor-beta 1; alpha 1-adrenoceptor	PROTEIN-KINASE; ANGIOTENSIN-II; ADENOSINE A(1); KIDNEY; P38; ACTIVATION; CELLS; TRANSDIFFERENTIATION; PHOSPHORYLATION; NOREPINEPHRINE	Renal fibrosis is a common pathological hallmark of chronic kidney disease (CKD). Renal sympathetic nerve activity is elevated in patients and experimental animals with CKD and contributes to renal interstitial fibrosis in obstructive nephropathy. However, the mechanisms underlying sympathetic overactivation in renal fibrosis remain unknown. Norepinephrine (NE), the main sympathetic neurotransmitter, was found to promote TGF-beta 1-induced epithelial-mesenchymal transition (EMT) and fibrotic gene expression in the human renal proximal epithelial cell line HK-2. Using both genetic and pharmacological approaches, we identified that NE binds G alpha q-coupled alpha 1-adrenoceptor (alpha 1-AR) to enhance EMT of HK-2 cells by activating p38/Smad3 signaling. Inhibition of p38 diminished the NE-exaggerated EMT process and increased the fibrotic gene expression in TGF-beta 1-treated HK-2 cells. Moreover, the pharmacological blockade of alpha 1-AR reduced the kidney injury and renal fibrosis in a unilateral ureteral obstruction mouse model by suppressing EMT in the kidneys. Thus, sympathetic overactivation facilitates EMT of renal epithelial cells and fibrosis via the alpha 1-AR/p38/Smad3 signaling pathway, and alpha 1-AR inhibition may be a promising approach toward treating renal fibrosis.	[Ren, Huiwen; Zuo, Shengkai; Hou, Yayan; Shang, Wenlong; Liu, Na] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin Key Lab Inflammat Biol, Tianjin, Peoples R China; [Yin, Zhuming] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Oncoplast Surg, Tianjin, Peoples R China; [Yin, Zhuming] Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Yin, Zhuming] Sino Russian Joint Res Ctr Oncoplast Breast Surg, Tianjin, Peoples R China; [Yin, Zhuming] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Yin, Zhuming] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Yin, Zhuming] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Ren, HW (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	renhuiwen@tmu.edu.cn	Zuo, Shengkai/GVO-9978-2022	Zuo, Shengkai/0000-0003-0040-4470	National Natural Science Foundation of China [81703591, 81703167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81703591 and 81703167)	Bariety J, 2003, NEPHROL DIAL TRANSPL, V18, P1777, DOI 10.1093/ndt/gfg231; Burnstock G, 2017, AUTON NEUROSCI-BASIC, V204, P4, DOI 10.1016/j.autneu.2016.05.007; Chen JH, 2015, AM J TRANSL RES, V7, P1553; Cho BR, 2018, DRUG DES DEV THER, V12, P1855, DOI 10.2147/DDDT.S164049; Das NA, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2019.109506; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Haddad L, 2018, J MATERN-FETAL NEO M, V31, P191, DOI 10.1080/14767058.2017.1280017; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; Ichikawa H, 2013, ANN ANAT, V195, P50, DOI 10.1016/j.aanat.2012.05.004; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kamato D, 2017, CELL MOL LIFE SCI, V74, P1379, DOI 10.1007/s00018-016-2405-9; Kim J, 2015, KIDNEY INT, V87, P350, DOI 10.1038/ki.2014.300; Kim J, 2013, J AM SOC NEPHROL, V24, P229, DOI 10.1681/ASN.2012070678; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P3239, DOI 10.1097/01.ASN.0000098687.01005.A5; Klein JD, 2006, AM J PHYSIOL-RENAL, V291, pF952, DOI 10.1152/ajprenal.00173.2006; Kohno M, 2014, CHEM BIOL, V21, P1522, DOI 10.1016/j.chembiol.2014.09.008; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li QJ, 2018, LIFE SCI, V207, P1, DOI 10.1016/j.lfs.2018.05.003; Lohse MJ, 2015, J MOL MED, V93, P955, DOI 10.1007/s00109-015-1323-x; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Ma TT, 2019, ADV EXP MED BIOL, V1165, P347, DOI 10.1007/978-981-13-8871-2_16; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Nishi EE, 2015, EXP PHYSIOL, V100, P479, DOI 10.1113/expphysiol.2014.079889; Nonogaki K, 2017, NEUROSCI LETT, V638, P35, DOI 10.1016/j.neulet.2016.12.008; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Pereira MMC, 1998, BRIT J PHARMACOL, V125, P697, DOI 10.1038/sj.bjp.0702128; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Puhl SL, 2016, BRIT J PHARMACOL, V173, P88, DOI 10.1111/bph.13339; Robinson AJ, 2001, BRIT J PHARMACOL, V133, P1378, DOI 10.1038/sj.bjp.0704200; Seccia TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003888; Shen N, 2013, KIDNEY INT, V84, P64, DOI 10.1038/ki.2013.82; Shimizu T, 1999, EXP CELL RES, V251, P424, DOI 10.1006/excr.1999.4582; Song S, 2018, J MOL ENDOCRINOL, V61, P101, DOI 10.1530/JME-18-0069; Spencer BH, 2018, PHARMACOLOGY, V102, P17, DOI 10.1159/000488713; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Veelken R, 2008, J AM SOC NEPHROL, V19, P1371, DOI 10.1681/ASN.2007050552; Vongwiwatana A, 2005, AM J TRANSPLANT, V5, P1367, DOI 10.1111/j.1600-6143.2005.00843.x; Wang YY, 2018, DIABETES, V67, P1748, DOI 10.2337/db17-1521; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009; Yan JD, 2009, ACTA PHARMACOL SIN, V30, P994, DOI 10.1038/aps.2009.56; Yan R, 2019, J CELL BIOCHEM, V120, P6998, DOI 10.1002/jcb.27937; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Yoshida S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00008; Yoshinaga T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167848; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zoccali C, 2002, HYPERTENSION, V40, P41, DOI 10.1161/01.HYP.0000022063.50739.60; Zuo SK, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708237	56	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14892	14904		10.1096/fj.202000737RRR	http://dx.doi.org/10.1096/fj.202000737RRR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939891	Bronze			2022-12-28	WOS:000570944300001
J	Salinero, AE; Robison, LS; Gannon, OJ; Riccio, D; Mansour, F; Abi-Ghanem, C; Zuloaga, KL				Salinero, Abigail E.; Robison, Lisa S.; Gannon, Olivia J.; Riccio, David; Mansour, Febronia; Abi-Ghanem, Charly; Zuloaga, Kristen L.			Sex-specific effects of high-fat diet on cognitive impairment in a mouse model of VCID	FASEB JOURNAL			English	Article						cerebral blood flow; diet-induced obesity; prediabetes; sex; vascular contributions to cognitive impairment and dementia	CAROTID-ARTERY OCCLUSION; BLOOD-FLOW; GLUCOSE-TOLERANCE; ALZHEIMER-DISEASE; HORMONE-THERAPY; VISCERAL FAT; OBESITY; ESTROGEN; DEMENTIA; MIDLIFE	Mid-life metabolic disease (ie, obesity, diabetes, and prediabetes) causes vascular dysfunction and is a risk factor for vascular contributions to cognitive impairment and dementia (VCID), particularly in women. Using middle-aged mice, we modeled metabolic disease (obesity/prediabetes) via chronic high-fat (HF) diet and modeled VCID via unilateral common carotid artery occlusion. VCID impaired spatial memory in both sexes, but episodic-like memory in females only. HF diet caused greater weight gain and glucose intolerance in middle-aged females than males. HF diet alone impaired episodic-like memory in both sexes, but spatial memory in females only. Finally, the combination of HF diet and VCID elicited cognitive impairments in all tests, in both sexes. Sex-specific correlations were found between metabolic outcomes and memory. Notably, both visceral fat and the pro-inflammatory cytokine tumor necrosis factor alpha correlated with spatial memory deficits in middle-aged females, but not males. Overall, our data show that HF diet causes greater metabolic impairment and a wider array of cognitive deficits in middle-aged females than males. The combination of HF diet with VCID elicits deficits across multiple cognitive domains in both sexes. Our data are in line with clinical data, which shows that mid-life metabolic disease increases VCID risk, particularly in females.	[Salinero, Abigail E.; Robison, Lisa S.; Gannon, Olivia J.; Riccio, David; Mansour, Febronia; Abi-Ghanem, Charly; Zuloaga, Kristen L.] Albany Med Coll, Dept Neurosci & Expt Therapeut, 47 New Scotland Ave,MC-136, Albany, NY 12208 USA	Albany Medical College	Zuloaga, KL (corresponding author), Albany Med Coll, Dept Neurosci & Expt Therapeut, 47 New Scotland Ave,MC-136, Albany, NY 12208 USA.	zuloagk@amc.edu		Robison, Lisa/0000-0002-5110-9183	American Heart Association (AHA) [16SDG2719001]; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS110749]; HHS \ NIH \ National Institute on Aging (NIA) [R01NS110749]	American Heart Association (AHA)(American Heart Association); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); HHS \ NIH \ National Institute on Aging (NIA)	American Heart Association (AHA), Grant/Award Number: 16SDG2719001; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS110749; HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: R01NS110749	Ahnstedt H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00659; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; CDC, 2017, NAT DIAB STAT REP 20, V2018; Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588; Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339; Cui D, 2019, NEUROREPORT, V30, P441, DOI 10.1097/WNR.0000000000001224; Curb JD, 1999, NEUROLOGY, V52, P971, DOI 10.1212/WNL.52.5.971; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deutsch C, 2009, MICROVASC RES, V78, P100, DOI 10.1016/j.mvr.2009.04.004; Dominguez R, 2018, J STROKE CEREBROVASC, V27, P1743, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.030; Dong S, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1351; Dow CA, 2015, APPL PHYSIOL NUTR ME, V40, P711, DOI 10.1139/apnm-2015-0006; Dybjer E, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0318-3; Dye L, 2017, P NUTR SOC, V76, P443, DOI 10.1017/S0029665117002014; Eringa EC, 2013, REV ENDOCR METAB DIS, V14, P39, DOI 10.1007/s11154-013-9239-7; Gannon OJ, 2019, NEUROCHEM INT, V127, P38, DOI 10.1016/j.neuint.2018.11.014; Geroldi C, 2005, ARCH NEUROL-CHICAGO, V62, P1067, DOI 10.1001/archneur.62.7.1067; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gruzdeva O, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0856-8; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Johnson LA, 2016, EBIOMEDICINE, V3, P26, DOI 10.1016/j.ebiom.2015.12.008; Kaya E, 2008, MATURITAS, V59, P72, DOI 10.1016/j.maturitas.2007.10.004; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim JH, 2017, GLIA, V65, P1471, DOI 10.1002/glia.23174; Kim KW, 2017, INT J OBESITY, V41, P683, DOI 10.1038/ijo.2017.13; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Liang MJ, 2019, J MAGN RESON IMAGING, V49, P1105, DOI 10.1002/jmri.26290; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Lynch CM, 2013, STROKE, V44, P3195, DOI 10.1161/STROKEAHA.113.001366; Marseglia A, 2019, ALZHEIMERS DEMENT, V15, P25, DOI 10.1016/j.jalz.2018.06.3060; Marseglia A, 2018, J GERONTOL A-BIOL, V73, P400, DOI 10.1093/gerona/glx112; Matin N, 2016, AM J PHYSIOL-HEART C, V310, pH1321, DOI 10.1152/ajpheart.00890.2015; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Mikkola TS, 2017, J CLIN ENDOCR METAB, V102, P870, DOI 10.1210/jc.2016-3590; Miller VM, 2017, AM J PHYSIOL-HEART C, V313, pH1013, DOI 10.1152/ajpheart.00383.2017; OHKURA T, 1995, MENOPAUSE, V2, P13; Petrault O, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104536; Pires PW, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12460; Pirimoglu ZM, 2011, CLIMACTERIC, V14, P453, DOI 10.3109/13697137.2010.539723; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Polycarpou A, 2016, AM J PHYSIOL-HEART C, V311, pH972, DOI 10.1152/ajpheart.00197.2016; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Robison LS, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0391-19.2019; Robison LS, 2019, BRAIN RES, V1710, P43, DOI 10.1016/j.brainres.2018.12.030; Rodriguez-Flores M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-2; Ronan L, 2016, NEUROBIOL AGING, V47, P63, DOI 10.1016/j.neurobiolaging.2016.07.010; Rosano GMC, 2007, CLIMACTERIC, V10, P19, DOI 10.1080/13697130601114917; Salinero AE, 2018, INT J OBESITY, V42, P1088, DOI 10.1038/s41366-018-0023-3; Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6; Selvarajah D, 2016, DIABETES VASC DIS RE, V13, P367, DOI 10.1177/1479164116644404; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; Takechi R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00399; Thambisetty M, 2013, NEUROBIOL AGING, V34, P2271, DOI 10.1016/j.neurobiolaging.2013.03.025; Toppala S, 2019, J ALZHEIMERS DIS, V72, P215, DOI 10.3233/JAD-190691; van Bussel FCG, 2016, DIABETES, V65, P2404, DOI 10.2337/db16-0128; Wang LX, 2016, EXP NEUROL, V283, P353, DOI 10.1016/j.expneurol.2016.07.006; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; Xue M, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100944; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Yamashiro K, 2014, EUR J NEUROL, V21, P667, DOI 10.1111/ene.12374; Yoshizaki K, 2008, EXP NEUROL, V210, P585, DOI 10.1016/j.expneurol.2007.12.005; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zhang Y, 2017, ENDOCRINE, V56, P65, DOI 10.1007/s12020-016-1197-x; Zhu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42660; Zuloaga KL, 2016, J CEREBR BLOOD F MET, V36, P1257, DOI 10.1177/0271678X15616400; Zuloaga KL, 2015, TRANSL STROKE RES, V6, P390, DOI 10.1007/s12975-015-0412-z	67	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15108	15122		10.1096/fj.202000085R	http://dx.doi.org/10.1096/fj.202000085R		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939871	Green Accepted, Bronze			2022-12-28	WOS:000571367000001
J	Xia, WZ; Zhu, J; Wang, XY; Tang, YD; Zhou, P; Hou, M; Li, ST				Xia, Wenzheng; Zhu, Jin; Wang, Xueyi; Tang, Yinda; Zhou, Ping; Hou, Meng; Li, Shiting			ANXA1 directs Schwann cells proliferation and migration to accelerate nerve regeneration through the FPR2/AMPK pathway	FASEB JOURNAL			English	Article						AMP-activated protein kinase; exogenous ANXA1; facial nerve injury; formyl peptide receptor 2; Schwann cells	FORMYL PEPTIDE RECEPTOR; ANNEXIN A1; RESOLUTION PHASE; IN-VIVO; INVASION; FPR2; AMPK; MYELINATION; NEUTROPHILS; METASTASIS	Many factors are involved in the process of nerve regeneration. Understanding the mechanisms regarding how these factors promote an efficient remyelination is crucial to deciphering the molecular and cellular processes required to promote nerve repair. Schwann cells (SCs) play a central role in the process of peripheral nerve repair/regeneration. Using a model of facial nerve crush injury and repair, we identified Annexin A1 (ANXA1) as the extracellular trigger of SC proliferation and migration. ANXA1 activated formyl peptide receptor 2 (FPR2) receptors and the downstream adenosine 5 '-monophosphate (AMP)-activated protein kinase (AMPK) signaling cascade, leading to SC proliferation and migration in vitro. SCs lacking FPR2 or AMPK displayed a defect in proliferation and migration. After facial nerve injury (FNI), ANXA1 promoted the proliferation of SCs and nerve regeneration in vivo. Collectively, these data identified the ANXA1/FPR2/AMPK axis as an important pathway in SC proliferation and migration. ANXA1-induced remyelination and SC proliferation promotes FNI regeneration.	[Xia, Wenzheng; Zhu, Jin; Wang, Xueyi; Tang, Yinda; Zhou, Ping; Li, Shiting] Shanghai Jiao Tong Univ, Dept Neurosurg, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China; [Xia, Wenzheng; Zhu, Jin; Wang, Xueyi; Tang, Yinda; Zhou, Ping; Li, Shiting] Shanghai Jiao Tong Univ, Ctr Diag & Treatment Cranial Nerve Dis, Shanghai, Peoples R China; [Hou, Meng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, 2 Fuxue Lane, Wenzhou 325000, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wenzhou Medical University	Li, ST (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China.; Hou, M (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, 2 Fuxue Lane, Wenzhou 325000, Peoples R China.	244517813@qq.com; lishiting@xinhuamed.com.cn	tang, yin/GXZ-6989-2022		National Natural Science Foundation of China (NSFC) [81974186, 81671205, 18XD1402700, YG2017MS68]; Shanghai Jiao Tong University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974186, 81671205, 18XD1402700 and YG2017MS68; Shanghai Jiao Tong University	Aghanoori MR, 2019, MOL METAB, V20, P149, DOI 10.1016/j.molmet.2018.11.008; Beirowski B, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201800075; Beirowski B, 2014, NAT NEUROSCI, V17, P1351, DOI 10.1038/nn.3809; Belvedere R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-961; Buttner R, 2018, AGING CELL, V17, DOI 10.1111/acel.12833; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Chen JL, 2012, CHINESE MED J-PEKING, V125, P1747, DOI 10.3760/cma.j.issn.0366-6999.2012.10.012; Chen KQ, 2014, J BIOL CHEM, V289, P17553, DOI 10.1074/jbc.M113.535674; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Costa MB, 2018, MICROB PATHOGENESIS, V118, P277, DOI 10.1016/j.micpath.2018.03.050; Dalli J, 2012, FASEB J, V26, P387, DOI 10.1096/fj.11-182089; Engstrom M, 2008, LANCET NEUROL, V7, P993, DOI 10.1016/S1474-4422(08)70221-7; Fan WJ, 2019, CELL TRANSPLANT, V28, P723, DOI 10.1177/0963689718817219; Figlia G, 2018, GLIA, V66, P693, DOI 10.1002/glia.23273; Gao DK, 2019, INT J BIOL MACROMOL, V124, P460, DOI 10.1016/j.ijbiomac.2018.10.212; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Han GH, 2017, INT J MOL MED, V39, P357, DOI 10.3892/ijmm.2016.2840; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hou XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03368-7; Jessen K R, 2016, J Physiol, V594, P3521, DOI 10.1113/JP270874; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kano F, 2017, STEM CELLS, V35, P641, DOI 10.1002/stem.2534; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Lee HY, 2013, AM J MED, V126, P336, DOI 10.1016/j.amjmed.2012.08.020; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Li F, 2020, NEUROSCI LETT, V720, DOI 10.1016/j.neulet.2020.134762; Liu SX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101770; Mattsson P, 2001, J COMP NEUROL, V437, P106, DOI 10.1002/cne.1273; McArthur S, 2020, J CLIN INVEST, V130, P1156, DOI 10.1172/JCI124635; McArthur S, 2015, J IMMUNOL, V195, P1139, DOI 10.4049/jimmunol.1500733; Mendes MO, 2019, MOL CELL NEUROSCI, V96, P1, DOI 10.1016/j.mcn.2019.01.003; Moraes LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17622-5; Ohtake Y, 2019, MOL THER, V27, P102, DOI 10.1016/j.ymthe.2018.10.019; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Saez DM, 2019, CELL TRANSPLANT, V28, P1573, DOI 10.1177/0963689719854446; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Senchenkova EY, 2019, CIRCULATION, V140, P319, DOI 10.1161/CIRCULATIONAHA.118.039345; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shan G, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109248; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Sundqvist M, 2019, J IMMUNOL, V203, P3349, DOI 10.4049/jimmunol.1900871; Wang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25946; Xia WZ, 2018, INT J MOL MED, V42, P2175, DOI 10.3892/ijmm.2018.3767; Xia WZ, 2018, INT J MOL MED, V41, P1127, DOI 10.3892/ijmm.2017.3282; Zhu JF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1204-7; ZUB E, 2019, FASEB J, V33, P13998, DOI DOI 10.1096/FJ.201901596R	50	7	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13993	14005		10.1096/fj.202000726RRR	http://dx.doi.org/10.1096/fj.202000726RRR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32856352	hybrid			2022-12-28	WOS:000566008300001
J	Dong, L; Shi, XH; Li, YF; Jiang, X; Wang, YX; Lan, YJ; Wu, HT; Jonas, JB; Wei, WB				Dong, Li; Shi, Xu Han; Li, Yi Fan; Jiang, Xue; Wang, Ya Xing; Lan, Yin Jun; Wu, Hao Tian; Jonas, Jost B.; Wei, Wen Bin			Blockade of epidermal growth factor and its receptor and axial elongation in experimental myopia	FASEB JOURNAL			English	Article						axial length; epidermal growth factor; epidermal growth factor receptor; experimental myopia; myopia; ocular elongation	BRUCHS MEMBRANE THICKNESS; FORM-DEPRIVATION; DOPAMINERGIC AGENTS; CHOROIDAL THICKNESS; RETINAL DOPAMINE; OCULAR GROWTH; TGF-BETA; EXPRESSION; PROGRESSION; DEFOCUS	To examine the influence of epidermal growth factor (EGF) and its receptor (EGFR) on axial ocular elongation, we intraocularly injected an EGF antibody and an EGFR antibody into young guinea pigs with lens-induced axial elongation (myopization). Mean axial elongation was reduced in the eyes injected with the EGF/EGFR-antibody compared with the contralateral control eyes injected with PBS (phosphate-buffered solution) (0.43 +/- 0.13 mm vs 0.53 +/- 0.13 mm;P < .001). The intereye difference in axial length increased (P = .005) as the doses of the EGF antibody and EGFR antibody increased. As a corollary, the thickness of the retina at the posterior pole was dose-dependently increased in the injected eyes compared to the contralateral control eyes. Immunohistochemical staining for EGF and the relative mRNA expression of EGF and EGFR were the highest in eyes not injected with the EGF antibody or EGFR antibody and decreased (P < .05) as the dose of EGF antibody or EGFR antibody increased. In an in vitro study, EGF had a stimulating effect and the EGF antibody had an inhibitory effect on the proliferation and migration of RPE cells. The findings showed that the intravitreal application of an EGF antibody and EGFR antibody is associated with a dose-dependent reduction in lens-induced axial elongation in young guinea pigs. The EGFR family may play a role in axial elongation of the eye and in the development of myopia.	[Dong, Li; Shi, Xu Han; Li, Yi Fan; Jiang, Xue; Lan, Yin Jun; Wu, Hao Tian; Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp,Med Artificial Intelligence, Minist Ind & Informat Technol,Beijing Ophthalmol, Beijing Tongren Eye Ctr,Beijing Key Lab Intraocul, 1 Dong Jiao Min Lane, Beijing 100730, Peoples R China; [Wang, Ya Xing] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Wang, Ya Xing] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany	Capital Medical University; Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp,Med Artificial Intelligence, Minist Ind & Informat Technol,Beijing Ophthalmol, Beijing Tongren Eye Ctr,Beijing Key Lab Intraocul, 1 Dong Jiao Min Lane, Beijing 100730, Peoples R China.	weiwenbintr@163.com	wei, wei/HHR-8613-2022; wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China (NSFC) [81570891]; Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) [7151003]; Beijing Municipal Administration of Hospitals [DFL20150201]; Beijing Municipal Bureau of Health [2014-2-003]; Capital Health Research and Development of Special [2020-1-2052]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; Beijing Municipal Science and Technology Commission [Z181100001818003, Z151100001615052]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation); Beijing Municipal Administration of Hospitals; Beijing Municipal Bureau of Health; Capital Health Research and Development of Special; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570891; Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation), Grant/Award Number: 7151003; Beijing Municipal Administration of Hospitals, Grant/Award Number: DFL20150201; Beijing Municipal Bureau of Health, Grant/Award Number: 2014-2-003; Capital Health Research and Development of Special, Grant/Award Number: 2020-1-2052; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, Grant/Award Number: ZYLX201307; Beijing Municipal Science and Technology Commission, Grant/Award Number: Z181100001818003 and Z151100001615052	Benavente-Perez A, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14524; Berntsen DA, 2013, INVEST OPHTH VIS SCI, V54, P5761, DOI 10.1167/iovs.13-11904; Bikbov MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0567; Burtness B, 2019, LANCET, V394, P1915, DOI 10.1016/S0140-6736(19)32591-7; Chen BY, 2013, GRAEF ARCH CLIN EXP, V251, P1133, DOI 10.1007/s00417-013-2269-8; Chen Z, 2010, PATHOBIOLOGY, V77, P88, DOI 10.1159/000278290; Dong F, 2011, MOL VIS, V17, P2824; Dong L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43212-8; Fang YX, 2018, OPHTHALMOLOGY, V125, P863, DOI 10.1016/j.ophtha.2017.12.005; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Frost MR, 2012, INVEST OPHTH VIS SCI, V53, P322, DOI 10.1167/iovs.11-8354; Gao QY, 2006, GRAEF ARCH CLIN EXP, V244, P1329, DOI 10.1007/s00417-006-0254-1; Guo L, 2014, MOL VIS, V20, P1643; Hasebe S, 2014, INVEST OPHTH VIS SCI, V55, P7177, DOI 10.1167/iovs.12-11462; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jiang LQ, 2014, INVEST OPHTH VIS SCI, V55, P7508, DOI 10.1167/iovs.14-14294; Jiang WJ, 2017, EBIOMEDICINE, V17, P134, DOI 10.1016/j.ebiom.2017.02.021; Jobling AI, 2009, EXP EYE RES, V88, P458, DOI 10.1016/j.exer.2008.10.022; Jonas JB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175120; Jonas JB, 2017, RETINA-J RET VIT DIS, V37, P1428, DOI 10.1097/IAE.0000000000001464; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P1791, DOI 10.1167/iovs.15-18529; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE470, DOI 10.1111/aos.12372; Kimura R, 2013, NEUROENDOCRINOLOGY, V97, P300, DOI 10.1159/000345529; Kopetz S, 2019, NEW ENGL J MED, V381, P1632, DOI 10.1056/NEJMoa1908075; Lan WZ, 2016, EXP EYE RES, V145, P118, DOI 10.1016/j.exer.2015.11.018; Li HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125219; Luo XM, 2017, MOL VIS, V23, P666; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mao JF, 2017, NEUROSCI LETT, V639, P94, DOI 10.1016/j.neulet.2016.12.061; Mao JF, 2016, EXP BIOL MED, V241, P1258, DOI 10.1177/1535370216638773; Mao JF, 2010, OPTOMETRY VISION SCI, V87, P53, DOI 10.1097/OPX.0b013e3181c12b3d; McBrien NA, 2009, MOL VIS, V15, P464; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; Nickla DL, 2010, EXP EYE RES, V91, P715, DOI 10.1016/j.exer.2010.08.021; Ockenga W, 2014, INT J MOL SCI, V15, P21433, DOI 10.3390/ijms151121433; Ostrin LA, 2004, INVEST OPHTH VIS SCI, V45, P3620, DOI 10.1167/iovs.04-0258; Qian LF, 2015, CELL BIOCHEM BIOPHYS, V71, P1373, DOI 10.1007/s12013-014-0359-9; ROHRER B, 1994, EXP EYE RES, V58, P553, DOI 10.1006/exer.1994.1049; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Singh Bhuminder, 2016, F1000Res, V5, DOI 10.12688/f1000research.9025.1; Smith EL, 2010, INVEST OPHTH VIS SCI, V51, P3864, DOI 10.1167/iovs.09-4969; Steindl-Kuscher K, 2011, GRAEF ARCH CLIN EXP, V249, P1195, DOI 10.1007/s00417-011-1673-1; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang XF, 2018, INVEST OPHTH VIS SCI, V59, P2808, DOI 10.1167/iovs.17-22069; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Wollina U, 1998, INT J MOL MED, V2, P725; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yam JC, 2019, OPHTHALMOLOGY, V126, P113, DOI 10.1016/j.ophtha.2018.05.029; Yam JC, 2019, OPHTHALMOLOGY; Yan TT, 2015, INVEST OPHTH VIS SCI, V56, P2475, DOI 10.1167/iovs.13-12361; Yan YN, 2018, OPHTHALMOLOGY, V125, P1253, DOI 10.1016/j.ophtha.2018.01.035; Yoon S, 2013, J BIOL CHEM, V288, P28435, DOI 10.1074/jbc.M113.461202	56	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13654	13670		10.1096/fj.202001095RR	http://dx.doi.org/10.1096/fj.202001095RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32799354				2022-12-28	WOS:000562539400001
J	De Flora, S; Balansky, R; La Maestra, S				De Flora, Silvio; Balansky, Roumen; La Maestra, Sebastiano			Rationale for the use ofN-acetylcysteine in both prevention and adjuvant therapy of COVID-19	FASEB JOURNAL			English	Article						COVID-19; glutathione; inflammation; N-acetyl-L-cysteine; oxidative stress	ACETYL-L-CYSTEINE; N-ACETYLCYSTEINE; VIRUS-REPLICATION; GLUTATHIONE DEPLETION; ANTIOXIDANT ACTION; INFLUENZA-VIRUS; MOUSE MODEL; PATHWAY; INFLAMMATION; IMPROVEMENT	COVID-19 may cause pneumonia, acute respiratory distress syndrome, cardiovascular alterations, and multiple organ failure, which have been ascribed to a cytokine storm, a systemic inflammatory response, and an attack by the immune system. Moreover, an oxidative stress imbalance has been demonstrated to occur in COVID-19 patients.N- Acetyl-L-cysteine (NAC) is a precursor of reduced glutathione (GSH). Due to its tolerability, this pleiotropic drug has been proposed not only as a mucolytic agent, but also as a preventive/therapeutic agent in a variety of disorders involving GSH depletion and oxidative stress. At very high doses, NAC is also used as an antidote against paracetamol intoxication. Thiols block the angiotensin-converting enzyme 2 thereby hampering penetration of SARS-CoV-2 into cells. Based on a broad range of antioxidant and anti-inflammatory mechanisms, which are herein reviewed, the oral administration of NAC is likely to attenuate the risk of developing COVID-19, as it was previously demonstrated for influenza and influenza-like illnesses. Moreover, high-dose intravenous NAC may be expected to play an adjuvant role in the treatment of severe COVID-19 cases and in the control of its lethal complications, also including pulmonary and cardiovascular adverse events.	[De Flora, Silvio; La Maestra, Sebastiano] Univ Genoa, Dept Hlth Sci, Via A Pastore 1, I-16132 Genoa, Italy; [Balansky, Roumen] Natl Oncol Ctr, Sofia, Bulgaria	University of Genoa; National Oncology Center - Bulgaria	De Flora, S (corresponding author), Univ Genoa, Dept Hlth Sci, Via A Pastore 1, I-16132 Genoa, Italy.	sdf@unige.it						Aldini G, 2018, FREE RADICAL RES, V52, P751, DOI 10.1080/10715762.2018.1468564; Amatore D, 2019, FASEB BIOADV, V1, P296, DOI 10.1096/fba.2018-00066; Andreou A, 2020, IN VIVO, V34, P1567, DOI 10.21873/invivo.11946; Arranz L, 2008, FREE RADICAL BIO MED, V45, P1252, DOI 10.1016/j.freeradbiomed.2008.07.014; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Balansky R, 2010, INT J CANCER, V126, P1047, DOI 10.1002/ijc.24942; Bauer Seth R, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc046; Bazzini C, 2013, CELL PHYSIOL BIOCHEM, V32, P129, DOI 10.1159/000356633; Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164; BOESGAARD S, 1993, J PHARMACOL EXP THER, V265, P1239; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Calzetta L, 2018, EXPERT REV RESP MED, V12, P693, DOI 10.1080/17476348.2018.1495562; Cao Min, 2020, medRxiv, DOI 10.1101/2020.03.04.20030395; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Cugno M, 2020, J ALLERGY CLIN IMMUN, V146, P215, DOI 10.1016/j.jaci.2020.05.006; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; DeFlora S, 1997, EUR RESPIR J, V10, P1535, DOI 10.1183/09031936.97.10071535; DiNicolantonio JJ, 2020, MED HYPOTHESES; Ershad M, 2020, STATPEARLS; Fajgenbaum DC, 2020, INFECT DIS THER, V9, P435, DOI 10.1007/s40121-020-00303-8; Garozzo A, 2007, INT J IMMUNOPATH PH, V20, P349, DOI 10.1177/039463200702000215; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Ghezzi P, 2004, INT J IMMUNOPATH PH, V17, P99, DOI 10.1177/039463200401700114; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Gould NS, 2015, TOXICOL SCI, V147, P466, DOI 10.1093/toxsci/kfv143; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Guglielmetti G, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03060-9; Haddad JJ, 2000, CYTOKINES CELL MOL T, V6, P177, DOI 10.1080/mccm.6.4.177.187; Hati S., 2020, IMPACT THOI DISULFID, DOI [10.1101/2020.05.07.083147, DOI 10.1101/2020.05.07.083147]; HO WZ, 1992, AIDS RES HUM RETROV, V8, P1249, DOI 10.1089/aid.1992.8.1249; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hui DSC, 2013, INFLUENZA OTHER RESP, V7, P52, DOI 10.1111/irv.12171; Istituto Superiore di Sanita, 2020, CHAR SARS COV 2 PAT; Izzotti A, 2003, FASEB J, V17, P1127, DOI 10.1096/fj.02-0967fje; Lai K. Y., 2015, Journal of Pulmonary and Respiratory Medicine, V5, P245; Lang JP, 2020, AM HEART J, V226, P29, DOI 10.1016/j.ahj.2020.04.025; Lee MF, 2013, ORAL ONCOL, V49, P129, DOI 10.1016/j.oraloncology.2012.08.003; Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001; Liu M, 1998, CANCER RES, V58, P1723; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Maglakelidze N, 2020, PULM THER, V6, P169, DOI 10.1007/s41030-020-00118-5; Marchetti G, 1999, Cardiologia, V44, P633; Mata M, 2011, BIOCHEM PHARMACOL, V82, P548, DOI 10.1016/j.bcp.2011.05.014; McCarty MF, 2020, PROG CARDIOVASC DIS, V63, P383, DOI 10.1016/j.pcad.2020.02.007; Nasi A, 2020, TOXICOL REP, V7, P768, DOI 10.1016/j.toxrep.2020.06.003; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Ong GJ, 2020, CONTEMP CLIN TRIALS, V90, DOI 10.1016/j.cct.2019.105894; Ortolani O, 2000, SHOCK, V13, P14, DOI 10.1097/00024382-200013010-00003; PACHT ER, 1991, CHEST, V100, P1397, DOI 10.1378/chest.100.5.1397; Palamara AT, 1996, AIDS RES HUM RETROV, V12, P1537, DOI 10.1089/aid.1996.12.1537; Pasupathy S, 2017, CIRCULATION, V136, P894, DOI 10.1161/CIRCULATIONAHA.117.027575; Patel K, 2017, J HEART LUNG TRANSPL, V36, pS371; Poe FL, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109862; Polonikov A, 2020, ACS INFECT DIS, V6, P1558, DOI 10.1021/acsinfecdis.0c00288; Purwanto B, 2020, ACTA MED INDONES, V44, P140; Qi Q, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1042-x; Rangel-Mendez JA, 2020, FUTURE MICROBIOL, V15, P959, DOI 10.2217/fmb-2020-0074; Sadowska AM, 2012, THER ADV RESPIR DIS, V6, P127, DOI 10.1177/1753465812437563; Salamon S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8050111; Soltan-Sharifi MS, 2007, HUM EXP TOXICOL, V26, P697, DOI 10.1177/0960327107083452; Tardiolo G, 2018, MOLECULES, V23, DOI 10.3390/molecules23123305; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V293, pL1156, DOI 10.1152/ajplung.00081.2007; Van Schooten FJ, 2002, CANCER EPIDEM BIOMAR, V11, P167; Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324; Wagener FADTG, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060540; Wang LX, 2020, REDOX BIOL, V31, DOI 10.1016/j.redox.2019.101410; Wrotek S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041393; Zhang RH, 2014, INT IMMUNOPHARMACOL, V22, P1, DOI 10.1016/j.intimp.2014.06.013; Zhao N, 2018, CELL MOL LIFE SCI, V75, P3143, DOI 10.1007/s00018-018-2852-6; Zhou Y, 2018, DRUG DES DEV THER, V12, P4117, DOI 10.2147/DDDT.S179227; Zuin R, 2005, CLIN DRUG INVEST, V25, P401, DOI 10.2165/00044011-200525060-00005	72	85	86	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13185	13193		10.1096/fj.202001807	http://dx.doi.org/10.1096/fj.202001807		AUG 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780893	Green Published			2022-12-28	WOS:000558417100001
J	He, XY; Lin, ZM; Ning, JY; Li, N; Cui, XL; Zhao, BX; Hong, FZ; Miao, JY				He, Xiaoying; Lin, Zhaomin; Ning, Junya; Li, Na; Cui, Xiaoling; Zhao, Baoxiang; Hong, Fanzhen; Miao, Junying			Promoting TTC4 and HSP70 interaction and translocation of annexin A7 to lysosome inhibits apoptosis in vascular endothelial cells	FASEB JOURNAL			English	Article						Akt; Ca(2+)homeostasis; chemical small molecules; GTPase; lysosomal membrane permeabilization	MEMBRANE PERMEABILIZATION; DEATH; MITOCHONDRIAL; PROTEINS; GENE; IDENTIFICATION; SUPPRESSION; METASTASIS; CHAPERONE; THERAPY	We previously demonstrated that Tetraticopeptide 4 (TTC4) inhibited apoptosis in vascular endothelial cells (VEC) deprived of serum and fibroblast growth factor 2 (FGF-2). In this study, we aimed to resolve the mechanism of TTC4 inhibiting VEC apoptosis. TTC4, predicted as a HSP70 co-chaperone protein, may regulate the fate of cells by affecting the activity of HSP70, however, there is no experimental evidence showing the interaction of TTC4 and HSP70. Using Co-immunoprecipitation (Co-IP), we demonstrated that TTC4 interacted with HSP70. If HSP70 was knockdown, TTC4 no longer suppressed apoptosis. Furthermore, we found ABO, an inhibitor of annexin A7 (ANXA7) GTPase, could promote the interaction of TTC4 and HSP70 and the translocation of ANXA7 to lysosome. At the same time, ABO inhibited the interaction of HSP70 and ANXA7. Moreover, Akt, as a downstream effector of HSP70 was upregulated, and ANXA7 translocating to lysosome protected the stability of lysosomal membrane. Here, we discovered a special mechanism by which TTC4 inhibited apoptosis via HSP70 in VECs. On the one hand, increasing TTC4 and HSP70 interaction upregulated Akt that inhibited apoptosis. On the other hand, decreasing HSP70 and ANXA7 interaction promoted the translocation of ANXA7 to lysosome, which inhibited apoptosis through protecting the lysosomal membrane stability.	[He, Xiaoying; Ning, Junya; Li, Na; Cui, Xiaoling; Miao, Junying] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Qingdao, Peoples R China; [Lin, Zhaomin] Shandong Univ, Inst Med Sci, Hosp 2, Jinan, Peoples R China; [Zhao, Baoxiang] Shandong Univ, Sch Chem & Chem Engn, Inst Organ Chem, Jinan, Peoples R China; [Hong, Fanzhen] Shandong Univ, Dept Obstet, Hosp 2, Jinan, Peoples R China; [Miao, Junying] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan, Peoples R China; [Miao, Junying] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Hong, FZ; Miao, JY (corresponding author), Shandong Univ, Inst Dev Biol, Sch Life Sci, Qingdao 266237, Peoples R China.	hongfz@sdu.edu.cn; miaojy@sdu.edu.cn			National Natural Science Foundation of China [31870831, 81601314, 91539105, 31871407, 31741083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31870831, 81601314, 91539105, 31871407 and 31741083	Bruennert D, 2020, J CELL BIOCHEM, V121, P407, DOI 10.1002/jcb.29195; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; Crevel G, 2001, J CELL SCI, V114, P2015; Crevel G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001737; de Castro MAG, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.12; Dmitriev RI, 2009, CELL TISSUE RES, V336, P521, DOI 10.1007/s00441-009-0785-y; Du Y, 2015, BIOMED PHARMACOTHER, V74, P30, DOI 10.1016/j.biopha.2015.06.005; English CA, 2017, J BIOL CHEM, V292, P14765, DOI 10.1074/jbc.M117.789313; Enrich C, 2017, ADV EXP MED BIOL, V981, P351, DOI 10.1007/978-3-319-55858-5_14; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Evans LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140006; Ferrarese R, 2014, J CLIN INVEST, V124, P2861, DOI 10.1172/JCI68836; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Ge D, 2013, APOPTOSIS, V18, P1120, DOI 10.1007/s10495-013-0860-4; Genest O, 2019, J BIOL CHEM, V294, P2109, DOI 10.1074/jbc.REV118.002806; Gorojod RM, 2017, ARCH TOXICOL, V91, P3065, DOI 10.1007/s00204-017-1936-7; Guo CM, 2013, CLIN CHIM ACTA, V423, P83, DOI 10.1016/j.cca.2013.04.018; He XY, 2019, FEBS J, V286, P4937, DOI 10.1111/febs.15038; Huang SY, 2014, INT J BIOCHEM CELL B, V57, P115, DOI 10.1016/j.biocel.2014.10.015; Jiao PF, 2006, BIOORG MED CHEM LETT, V16, P2862, DOI 10.1016/j.bmcl.2006.03.013; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kirilenko A, 2006, BIOCHEMISTRY-US, V45, P4965, DOI 10.1021/bi051629n; Ko SK, 2015, CHEM BIOL, V22, P391, DOI 10.1016/j.chembiol.2015.02.004; Kong FZ, 2016, IN VITRO CELL DEV-AN, V52, P568, DOI 10.1007/s11626-016-0005-5; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Kumar S, 2016, CANCER LETT, V374, P156, DOI 10.1016/j.canlet.2016.01.056; Li H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.317; Li HY, 2013, BBA-MOL CELL RES, V1833, P2092, DOI 10.1016/j.bbamcr.2013.04.015; Liu SQ, 2008, RAPID COMMUN MASS SP, V22, P3172, DOI 10.1002/rcm.3725; Liu SY, 2018, CANCER LETT, V416, P11, DOI 10.1016/j.canlet.2017.12.008; Liu WJ, 2015, AM J PHYSIOL-RENAL, V308, pF639, DOI 10.1152/ajprenal.00383.2014; Marchi S, 2018, CELL CALCIUM, V69, P62, DOI 10.1016/j.ceca.2017.05.003; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Nitika, 2017, TRENDS BIOCHEM SCI, V42, P932, DOI 10.1016/j.tibs.2017.10.002; Park SH, 2018, CELL CHEM BIOL, V25, P1242, DOI 10.1016/j.chembiol.2018.06.010; Park YH, 2017, INT J ONCOL, V51, P573, DOI 10.3892/ijo.2017.4039; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Pislar A, 2015, SEMIN CANCER BIOL, V35, P168, DOI 10.1016/j.semcancer.2015.08.001; Poetsch M, 2000, ONCOGENE, V19, P5817, DOI 10.1038/sj.onc.1203961; POLLARD HB, 1988, P NATL ACAD SCI USA, V85, P2974, DOI 10.1073/pnas.85.9.2974; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rick M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-25; Sahara S, 2010, BIOCHEM BIOPH RES CO, V393, P806, DOI 10.1016/j.bbrc.2010.02.087; Scheffer LL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6646; Seo SU, 2018, ONCOGENE, V37, P5205, DOI 10.1038/s41388-018-0345-6; Serrano-Puebla A, 2016, ANN NY ACAD SCI, V1371, P30, DOI 10.1111/nyas.12966; Sonder SL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43143-4; Song YK, 2020, J CELL BIOCHEM, V121, P1728, DOI 10.1002/jcb.29408; Srinivasan SR, 2018, MOL CANCER RES, V16, P58, DOI 10.1158/1541-7786.MCR-17-0408; Srivastava M, 2007, INT J CANCER, V121, P2628, DOI 10.1002/ijc.23008; Su GF, 1999, GENOMICS, V55, P157, DOI 10.1006/geno.1998.5633; Sun MZ, 2009, PROTEOMICS, V9, P3285, DOI 10.1002/pmic.200701002; Tang YH, 2014, FOOD CHEM TOXICOL, V67, P131, DOI 10.1016/j.fct.2014.02.022; Wang FJ, 2018, TRAFFIC, V19, P918, DOI 10.1111/tra.12613; Wang QQ, 2017, ONCOL LETT, V14, P4729, DOI 10.3892/ol.2017.6757; Wang XX, 2014, INT J ONCOL, V45, P18, DOI 10.3892/ijo.2014.2399; Ye WH, 2017, MOL CELL BIOCHEM, V429, P33, DOI 10.1007/s11010-016-2934-4; Zhao X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04411-3	62	2	2	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12932	12945		10.1096/fj.202000067R	http://dx.doi.org/10.1096/fj.202000067R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33000523				2022-12-28	WOS:000558226000001
J	Silveira, WA; Goncalves, DA; Machado, J; Lautherbach, N; Lustrino, D; Paula-Gomes, S; Pereira, MG; Miyabara, EH; Sandri, M; Kettelhut, IC; Navegantes, LC				Silveira, Wilian A.; Goncalves, Dawit A.; Machado, Juliano; Lautherbach, Natalia; Lustrino, Danilo; Paula-Gomes, Silvia; Pereira, Marcelo G.; Miyabara, Elen H.; Sandri, Marco; Kettelhut, Isis C.; Navegantes, Luiz C.			cAMP-dependent protein kinase inhibits FoxO activity and regulates skeletal muscle plasticity in mice	FASEB JOURNAL			English	Article						adrenergic signaling; protein metabolism; skeletal muscle atrophy; skeletal muscle plasticity; ubiquitin-proteasome system	ACETYLTRANSFERASE ACTIVITY; HEPATIC GLUCONEOGENESIS; ERK1/2 ACTIVATION; UBIQUITIN LIGASES; ATROPHY; PROTEOLYSIS; PGC-1-ALPHA; RECEPTOR; SUPPRESSES; CREB	Although we have shown that catecholamines suppress the activity of the Ubiquitin-Proteasome System (UPS) and atrophy-related genes expression through a cAMP-dependent manner in skeletal muscle from rodents, the underlying mechanisms remain unclear. Here, we report that a single injection of norepinephrine (NE; 1 mg kg(-1); s.c) attenuated the fasting-induced up-regulation of FoxO-target genes in tibialis anterior (TA) muscles by the stimulation of PKA/CREB and Akt/FoxO1 signaling pathways. In addition, muscle-specific activation of PKA by the overexpression of PKA catalytic subunit (PKAcat) suppressed FoxO reporter activity induced by (1) a wild-type; (2) a non-phosphorylatable; (3) a non-phosphorylatable and non-acetylatable forms of FoxO1 and FoxO3; (4) downregulation of FoxO protein content, and probably by (5) PGC-1 alpha up-regulation. Consistently, the overexpression of the PKAcat inhibitor (PKI) up-regulated FoxO activity and the content of Atrogin-1 and MuRF1, as well as induced muscle fiber atrophy, the latter effect being prevented by the overexpression of a dominant negative (d. n.) form of FoxO (d.n.FoxO). The sustained overexpression of PKAcat induced fiber-type transition toward a smaller, slower, and more oxidative phenotype and improved muscle resistance to fatigue. Taken together, our data provide the first evidence that endogenous PKA activity is required to restrain the basal activity of FoxO and physiologically important to maintain skeletal muscle mass.	[Silveira, Wilian A.; Goncalves, Dawit A.; Machado, Juliano; Lautherbach, Natalia; Lustrino, Danilo; Kettelhut, Isis C.; Navegantes, Luiz C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Sao Paulo, Brazil; [Silveira, Wilian A.] Fed Univ Trifingulo Mineiro UFTM, Inst Biol & Nat Sci, Uberaba, Brazil; [Goncalves, Dawit A.; Paula-Gomes, Silvia; Kettelhut, Isis C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem, Sao Paulo, Brazil; [Goncalves, Dawit A.; Paula-Gomes, Silvia; Kettelhut, Isis C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Immunol, Sao Paulo, Brazil; [Goncalves, Dawit A.] Fed Univ Minas Gerais UFMG, Dept Phys Educ, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Goncalves, Dawit A.; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Goncalves, Dawit A.; Sandri, Marco] Venetian Inst Mol Med, Padua, Italy; [Machado, Juliano] Helmholtz Ctr Munich, Inst Diabet & Canc IDC, Neuherberg, Germany; [Pereira, Marcelo G.; Miyabara, Elen H.] Univ Sao Paulo, Dept Anat Inst Biomed Sci, Sao Paulo, Brazil; [Sandri, Marco] Univ Padua, Myol Ctr, Padua, Italy; [Lustrino, Danilo] Univ Fed Sergipe, Dept Physiol, Aracaju, Brazil; [Paula-Gomes, Silvia] Univ Fed Ouro Preto, Inst Exact & Biol Sci, Dept Biol Sci, Ouro Preto, Brazil; [Pereira, Marcelo G.] Univ Sao Paulo, Sch Phys Educ & Sport, Dept Biodynam Human Body Movement, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; University of Padua; Veneto Institute Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universidade de Sao Paulo; University of Padua; Universidade Federal de Sergipe; Universidade Federal de Ouro Preto; Universidade de Sao Paulo	Navegantes, LC (corresponding author), Univ Sao Paulo, Dept Physiol, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil.	navegantes@fmrp.usp.br	Gonçalves, Dawit A/S-3648-2016; Gomes Pereira, Marcelo/D-7324-2015; Lustrino, Danilo/ABC-2635-2021; Miyabara, Elen/E-8143-2012; Kettelhut, Isis do Carmo/I-4839-2012	Gonçalves, Dawit A/0000-0003-2621-3330; Lustrino, Danilo/0000-0001-7118-743X; Miyabara, Elen/0000-0002-2325-9571; Kettelhut, Isis do Carmo/0000-0002-9034-5357; A. Silveira, Wilian/0000-0002-6171-7940; Navegantes, Luiz/0000-0002-9870-9469; Gomes Pereira, Marcelo/0000-0002-6670-8031	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [12/18861-0, 15/21112-7, 12/24524-6, 18/10089-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PNPD20131672, 233261/2014-1, 306624/2015-0]; AFM-Telethon [19524]; Italian Ministry of Education (MiUR) [PRIN 2010/2011]; Foundation Leducq; AIRC [17388]; RISE [645648]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; AFM-Telethon; Italian Ministry of Education (MiUR)(Ministry of Education, Universities and Research (MIUR)); Foundation Leducq; AIRC; RISE	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant/Award Number: 12/18861-0, 15/21112-7, 12/24524-6 and 18/10089-2; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Grant/Award Number: PNPD20131672, 233261/2014-1 and 306624/2015-0; AFM-Telethon, Grant/ Award Number: 19524; Italian Ministry of Education (MiUR), Grant/Award Number: PRIN 2010/2011; Foundation Leducq, AIRC, Grant/Award Number: 17388; RISE, Grant/Award Number: 645648	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Baviera AM, 2007, AM J PHYSIOL-ENDOC M, V292, pE702, DOI 10.1152/ajpendo.00147.2006; Baviera AM, 2010, MOL CELL ENDOCRINOL, V315, P104, DOI 10.1016/j.mce.2009.09.028; Beehler BC, 2006, EXP BIOL MED, V231, P335; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bok J, 2003, J NEUROSCI, V23, P777; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Chen M, 2009, AM J PHYSIOL-CELL PH, V296, pC930, DOI 10.1152/ajpcell.00443.2008; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Goncalves DA, 2019, J CACHEXIA SARCOPENI, V10, P455, DOI 10.1002/jcsm.12395; Goncalves DAP, 2012, AM J PHYSIOL-ENDOC M, V302, pE123, DOI 10.1152/ajpendo.00188.2011; Goncalves DAP, 2009, ENDOCRINOLOGY, V150, P5395, DOI 10.1210/en.2009-0428; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Graca FA, 2013, AM J PHYSIOL-ENDOC M, V305, pE1483, DOI 10.1152/ajpendo.00267.2013; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Harcourt LJ, 2007, NEUROMUSCULAR DISORD, V17, P47, DOI 10.1016/j.nmd.2006.08.012; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Khan MM, 2016, P NATL ACAD SCI USA, V113, P746, DOI 10.1073/pnas.1524272113; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lira EC, 2011, MUSCLE NERVE, V44, P371, DOI 10.1002/mus.22066; Lira EC, 2007, SHOCK, V27, P687, DOI 10.1097/SHK.0b013e31802e43a6; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Mahendra VP, 2019, J FUNCT FOODS, V56, P110, DOI 10.1016/j.jff.2019.02.047; MCELLIGOTT MA, 1987, AM J PHYSIOL, V253, pE370, DOI 10.1152/ajpendo.1987.253.4.E370; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Navegantes LCC, 1999, AM J PHYSIOL-ENDOC M, V277, pE883, DOI 10.1152/ajpendo.1999.277.5.E883; Navegantes LCC, 2000, AM J PHYSIOL-ENDOC M, V279, pE663, DOI 10.1152/ajpendo.2000.279.3.E663; Pereira MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085283; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Ryall JG, 2007, J GERONTOL A-BIOL, V62, P813, DOI 10.1093/gerona/62.8.813; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Silveira WA, 2014, J APPL PHYSIOL, V117, P11, DOI 10.1152/japplphysiol.01055.2013; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; SUGANO T, 1982, J BIOCHEM-TOKYO, V92, P111, DOI 10.1093/oxfordjournals.jbchem.a133907; Voltarelli VA, 2012, SCAND J MED SCI SPOR, V22, pe125, DOI 10.1111/j.1600-0838.2012.01519.x; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Yang JH, 2014, J MOL CELL CARDIOL, V66, P83, DOI 10.1016/j.yjmcc.2013.11.001; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yimlamai T, 2005, J APPL PHYSIOL, V99, P71, DOI 10.1152/japplphysiol.00448.2004; Yuan YA, 2011, MOL CELL BIOCHEM, V348, P77, DOI 10.1007/s11010-010-0640-1; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	63	12	12	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12946	12962		10.1096/fj.201902102RR	http://dx.doi.org/10.1096/fj.201902102RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772437				2022-12-28	WOS:000558817100001
J	Gu, H; Zhou, Y; Yang, JZ; Li, JA; Peng, YX; Zhang, X; Miao, YL; Jiang, W; Bu, GW; Hou, LM; Li, T; Zhang, L; Xia, XL; Ma, ZY; Xiong, YZ; Zuo, B				Gu, Hao; Zhou, Ying; Yang, Jinzeng; Li, Jianan; Peng, Yaxin; Zhang, Xia; Miao, Yiliang; Jiang, Wei; Bu, Guowei; Hou, Liming; Li, Ting; Zhang, Lin; Xia, Xiaoliang; Ma, Zhiyuan; Xiong, Yuanzhu; Zuo, Bo			Targeted overexpression of PPAR gamma in skeletal muscle by random insertion and CRISPR/Cas9 transgenic pig cloning enhances oxidative fiber formation and intramuscular fat deposition	FASEB JOURNAL			English	Article						CRISPR; Cas9; intramuscular fat; muscle fiber types; PPAR&#947; transgenic pigs	ACTIVATED RECEPTOR-GAMMA; MEAT QUALITY TRAITS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ACID-COMPOSITION; IN-VIVO; GENE; EXPRESSION; TRANSCRIPTION; ADIPOGENESIS	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a master regulator of adipogenesis and lipogenesis. To understand its roles in fiber formation and fat deposition in skeletal muscle, we successfully generated muscle-specific overexpression of PPAR gamma in two pig models by random insertion and CRISPR/Cas9 transgenic cloning procedures. The content of intramuscular fat was significantly increased in PPAR gamma pigs while had no changes on lean meat ratio. PPAR gamma could promote adipocyte differentiation by activating adipocyte differentiating regulators such as FABP4 and CCAAT/enhancer-binding protein (C/EBP), along with enhanced expression of LPL, FABP4, and PLIN1 to proceed fat deposition. Proteomics analyses demonstrated that oxidative metabolism of fatty acids and respiratory chain were activated in PPAR gamma pigs, thus, gathered more Ca2+ in PPAR gamma pigs. Raising of Ca2+ could result in increased phosphorylation of CAMKII and p38 MAPK in PPAR gamma pigs, which can stimulate MEF2 and PGC1 alpha to affect fiber type and oxidative capacity. These results support that skeletal muscle-specific overexpression of PPAR gamma can promote oxidative fiber formation and intramuscular fat deposition in pigs.	[Gu, Hao; Zhou, Ying; Li, Jianan; Peng, Yaxin; Zhang, Xia; Miao, Yiliang; Jiang, Wei; Bu, Guowei; Hou, Liming; Li, Ting; Zhang, Lin; Xia, Xiaoliang; Ma, Zhiyuan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Swine Genet & Breeding, Minist Agr & Rural Affairs, Wuhan, Hubei, Peoples R China; [Gu, Hao; Zhou, Ying; Li, Jianan; Peng, Yaxin; Zhang, Xia; Miao, Yiliang; Jiang, Wei; Bu, Guowei; Hou, Liming; Li, Ting; Zhang, Lin; Xia, Xiaoliang; Ma, Zhiyuan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Anim Sci & Technol, Wuhan, Hubei, Peoples R China; [Yang, Jinzeng] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; University of Hawaii System; University of Hawaii Manoa	Zuo, B (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Swine Genet & Breeding, Minist Agr & Rural Affairs, Wuhan, Hubei, Peoples R China.; Zuo, B (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Anim Sci & Technol, Wuhan, Hubei, Peoples R China.	zuobo@mail.hzau.edu.cn	Ma, ZhiYuan/GWN-1061-2022	Peng, YaXin/0000-0002-2795-2648				Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; APPLEBAUMBOWDEN D, 1995, CURR OPIN LIPIDOL, V6, P130, DOI 10.1097/00041433-199506000-00004; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bawa AS, 2013, J FOOD SCI TECH MYS, V50, P1035, DOI 10.1007/s13197-012-0899-1; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brocks L, 1998, MEAT SCI, V50, P411, DOI 10.1016/S0309-1740(98)00053-9; Chan MHS, 2004, FASEB J, V18, P1785, DOI 10.1096/fj.03-1039fje; Chen Z, 2011, GENET MOL BIOL, V34, P56, DOI 10.1590/S1415-47572010005000107; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Cho IC, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008279; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conner AJ, 1999, MUTAT RES-GEN TOX EN, V443, P223, DOI 10.1016/S1383-5742(99)00020-4; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Doshi KB, 2009, DIABETES OBES METAB, V11, P102, DOI 10.1111/j.1463-1326.2008.00908.x; Elzi DJ, 2001, AM J PHYSIOL-CELL PH, V281, pC350; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462; Grindflek E, 1998, BIOCHEM BIOPH RES CO, V249, P713, DOI 10.1006/bbrc.1998.9212; Grindflek E, 2001, MAMM GENOME, V12, P299, DOI 10.1007/s003350010278; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang JL, 2012, TRANSGENIC RES, V21, P1311, DOI 10.1007/s11248-012-9615-1; Huang P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5063; Kahn D, 2021, DIABETOLOGIA, V64, P168, DOI 10.1007/s00125-020-05315-0; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee HY, 2017, DIABETES, V66, P2072, DOI 10.2337/db16-1334; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Liu ZH, 2008, CHINESE SCI BULL, V53, P1035, DOI 10.1007/s11434-008-0168-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loviscach M, 2000, DIABETOLOGIA, V43, P304, DOI 10.1007/s001250050048; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; Metzger K, 2020, IN VITRO CELL DEV-AN, V56, P193, DOI 10.1007/s11626-019-00428-2; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; NEMETH PM, 1984, J HISTOCHEM CYTOCHEM, V32, P1211, DOI 10.1177/32.11.6491255; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Renand G, 2001, MEAT SCI, V59, P49, DOI 10.1016/S0309-1740(01)00051-1; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14253; Savage DB, 2019, J LIPID RES, V60, P1323, DOI 10.1194/jlr.M091942; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Silva WM, 2019, MICROB BIOTECHNOL, V12, P265, DOI 10.1111/1751-7915.13305; Son NH, 2018, J CLIN INVEST, V128, P4329, DOI [10.1172/JCI99315, 10.1172/jci99315]; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Wang YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010011; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wood JD, 2004, MEAT SCI, V67, P651, DOI 10.1016/j.meatsci.2004.01.007; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Ying F, 2016, BIOCHEM BIOPH RES CO, V480, P669, DOI 10.1016/j.bbrc.2016.10.113; Zhang L, 2017, INT J BIOL SCI, V13, P1152, DOI 10.7150/ijbs.20132; Zhou XY, 2016, HUM MUTAT, V37, P110, DOI 10.1002/humu.22913; Zhu M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14718; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003; Zuo EW, 2020, NAT PROTOC, V15, P3009, DOI 10.1038/s41596-020-0361-1	78	8	8	8	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21308	10.1096/fj.202001812RR	http://dx.doi.org/10.1096/fj.202001812RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33481304	Bronze			2022-12-28	WOS:000647789600043
J	Loers, G; Appel, D; Lutz, D; Congiu, L; Kleene, R; Hermans-Borgmeyer, I; Schafer, MKE; Schachner, M				Loers, Gabriele; Appel, Dominik; Lutz, David; Congiu, Ludovica; Kleene, Ralf; Hermans-Borgmeyer, Irm; Schaefer, Michael K. E.; Schachner, Melitta			Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics	FASEB JOURNAL			English	Article						cell adhesion molecule L1; L1 syndrome; neuritogenesis; neuronal cell migration; neuronal survival	ADHESION MOLECULE L1; X-LINKED HYDROCEPHALUS; CELL-ADHESION; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; MISSENSE MUTATION; CORPUS-CALLOSUM; L1CAM; DOMAINS; BINDING	L1 syndrome is a rare developmental disorder characterized by hydrocephalus of varying severity, intellectual deficits, spasticity of the legs, and adducted thumbs. Therapy is limited to symptomatic relief. Numerous gene mutations in the L1 cell adhesion molecule (L1CAM, hereafter abbreviated L1) were identified in L1 syndrome patients, and those affecting the extracellular domain of this transmembrane type 1 glycoprotein show the most severe phenotypes. Previously analyzed rodent models of the L1 syndrome focused on L1-deficient animals or mouse mutants with abrogated cell surface expression of L1, making it difficult to test L1 function-triggering mimetic compounds with potential therapeutic value. To overcome this impasse, we generated a novel L1 syndrome mouse with a mutation of aspartic acid at position 201 in the extracellular part of L1 (p.D201N, hereafter termed L1-201) that displays a cell surface-exposed L1 accessible to the L1 mimetics. Behavioral assessment revealed an increased neurological deficit score and increased locomotor activity in male L1-201 mice carrying the mutation on the X-chromosome. Histological analyses of L1-201 mice showed features of the L1 syndrome, including enlarged ventricles and reduced size of the corpus callosum. Expression levels of L1-201 protein as well as extent of cell surface biotinylation and immunofluorescence labelling of cultured cerebellar neurons were normal. Importantly, treatment of these cultures with the L1 mimetic compounds duloxetine, crotamiton, and trimebutine rescued impaired cell migration and survival as well as neuritogenesis. Altogether, the novel L1 syndrome mouse model provides a first experimental proof-of-principle for the potential therapeutic value of L1 mimetic compounds.	[Loers, Gabriele; Lutz, David; Congiu, Ludovica; Kleene, Ralf; Hermans-Borgmeyer, Irm; Schachner, Melitta] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Appel, Dominik; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Dept Anesthesiol, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy, Mainz, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08554 USA; [Lutz, David] Ruhr Univ Bochum, Abt Ncuroanat & Mol Hirnforsch, Bochum, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Rutgers State University New Brunswick; Ruhr University Bochum	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08554 USA.	schachner@dls.rutgers.edu	Lutz, David/AAX-1607-2021	Lutz, David/0000-0001-9171-4081				APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Behringer R, 2014, MANIPULATING MOUSE E, V4; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Christaller WAA, 2017, CLIN GENET, V91, P115, DOI 10.1111/cge.12763; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Drescher B, 1996, EUR J NEUROSCI, V8, P2467, DOI 10.1111/j.1460-9568.1996.tb01541.x; Finckh U, 2000, AM J MED GENET, V92, P40, DOI 10.1002/(SICI)1096-8628(20000501)92:1<40::AID-AJMG7>3.0.CO;2-R; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; HARPER JR, 1991, J NEUROCHEM, V56, P797, DOI 10.1111/j.1471-4159.1991.tb01994.x; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; Hummel R, 2020, BRIT J PHARMACOL, V177, P5208, DOI 10.1111/bph.15259; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Joseph TP, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00458; JOUET M, 1995, AM J HUM GENET, V56, P1304; KAEPERNICK L, 1994, CLIN GENET, V45, P181; Kanemura Y, 2006, J NEUROSURG, V105, P403, DOI 10.3171/ped.2006.105.5.403; Kataria H, 2016, MOL NEUROBIOL, V53, P4461, DOI 10.1007/s12035-015-9352-6; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Li R, 2018, PHARMACOL BIOCHEM BE, V171, P30, DOI 10.1016/j.pbb.2018.05.013; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2014, J NEUROCHEM, V128, P88, DOI 10.1111/jnc.12408; Lutz D, 2014, J BIOL CHEM, V289, P13503, DOI 10.1074/jbc.M113.530238; Magara F, 2000, NEUROSCI BIOBEHAV R, V24, P45, DOI 10.1016/S0149-7634(99)00051-2; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MARTINI R, 1994, GLIA, V10, P70, DOI 10.1002/glia.440100109; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Michelson P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9096; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Rolf B, 2001, BRAIN RES, V891, P247, DOI 10.1016/S0006-8993(00)03219-4; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Schafer MKE, 2012, CELL TISSUE RES, V349, P39, DOI 10.1007/s00441-012-1345-4; SERVILLE F, 1992, EUR J PEDIATR, V151, P515, DOI 10.1007/BF01957757; Shaw M, 2015, EUR J MED GENET, V58, P364, DOI 10.1016/j.ejmg.2015.04.004; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Sztriha L, 2000, J CHILD NEUROL, V15, P239, DOI 10.1177/088307380001500407; Sztriha L, 2002, PEDIATR NEUROL, V27, P293, DOI 10.1016/S0887-8994(02)00440-X; Tapanes-Castillo A, 2010, NEUROGENETICS, V11, P53, DOI 10.1007/s10048-009-0203-3; Vos YJ, 2010, HUM MUTAT, V31, pE1102, DOI 10.1002/humu.21172; Wei CH, 2012, EXP MOL MED, V44, P413, DOI 10.3858/emm.2012.44.7.050; Xu JP, 2017, DIS MODEL MECH, V10, P1117, DOI 10.1242/dmm.029801; Yoo SW, 2017, J COMP NEUROL, V525, P291, DOI 10.1002/cne.24064	48	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21329	10.1096/fj.202002163R	http://dx.doi.org/10.1096/fj.202002163R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484186	hybrid			2022-12-28	WOS:000647789600002
J	Matta, R; Yousafzai, MS; Murrell, M; Gonzalez, AL				Matta, Rita; Yousafzai, Muhammad Sulaiman; Murrell, Michael; Gonzalez, Anjelica L.			Endothelial cell secreted metalloproteinase-2 enhances neural stem cell N-cadherin expression, clustering, and migration	FASEB JOURNAL			English	Article						cell clustering; cell migration; N&#8208; cadherin; neural stem cell	STREAM; GROWTH; TISSUE; NICHE; NEUROGENESIS; INHIBITION; SCAFFOLDS; QUIESCENT; NEURONS; INJURY	Neuroblasts have a clustered phenotype critical for their unidirectional migration, which in part is dependent on signaling from microvascular endothelial cells (EC) and pericytes (PC). Diffusible signals secreted by vascular cells have been demonstrated to increase survival, proliferation, and differentiation of subventricular zone resident neural stem cells (NSC); however, the signals that promote the necessary initiating step of NSC clustering are undefined. To investigate the role of vascular cells in promoting NSC clustering and directing migration, we created a 3-D hydrogel that mimics the biomechanics, biochemistry, and architectural complexity of brain tissue. We demonstrate that EC, and not PC, have a crucial role in NSC clustering and migration, further verified through microfluidic chamber systems and traction force microscopy. Ablation of the extended NSC aggregate arm halts aggregate movement, suggesting that clustering is a prerequisite for migration. When cultured with EC, NSC clustering occurs and NSC coincidentally increase their expression of N-cadherin, as compared to NSC cultured alone. NSC-presented N-cadherin expression was increased following exposure to EC secreted metalloproteinase-2 (MMP2). We demonstrate that inhibition of MMP2 prevented NSC N-cadherin surface expression and subsequent NSC clustering, even when NSC were in direct contact with EC. Furthermore, with exogenous activation of EGFR, which serves as a downstream activator of N-cadherin cleavage, NSC form clusters. Our results suggest that EC secretion of MMP2 promotes NSC clustering through N-cadherin expression. The insight gained about the mechanisms by which EC promote NSC migration may enhance NSC therapeutic response to sites of injury.	[Matta, Rita; Yousafzai, Muhammad Sulaiman; Murrell, Michael; Gonzalez, Anjelica L.] Yale Univ, Biomed Engn Dept, New Haven, CT USA; [Yousafzai, Muhammad Sulaiman; Murrell, Michael] Yale Univ, Syst Biol Inst, West Haven, CT USA; [Murrell, Michael] Yale Univ, Phys Dept, New Haven, CT USA	Yale University; Yale University; Yale University	Gonzalez, AL (corresponding author), 55 Prospect St, New Haven, CT 06511 USA.	anjelica.gonzalez@yale.edu			NIBIB NIH HHS [R01 EB016629] Funding Source: Medline	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Auler M, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2247; Azevedo PO, 2017, NEUROSCIENCE, V363, P62, DOI 10.1016/j.neuroscience.2017.08.059; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Bressan RB, 2017, DEVELOPMENT, V144, P635, DOI 10.1242/dev.140855; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Conant K, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0827-4; Corbel M, 2001, J PATHOL, V193, P538, DOI 10.1002/path.826; Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]; Rosario LVD, 2020, ANTICANCER RES, V40, P2725, DOI 10.21873/anticanres.14244; Fang TH, 2004, MICROELECTRON J, V35, P595, DOI 10.1016/j.mejo.2004.02.004; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghuman H, 2017, ACTA BIOMATER, V63, P50, DOI 10.1016/j.actbio.2017.09.011; Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775; Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012; HERMAN IM, 1987, TISSUE CELL, V19, P197, DOI 10.1016/0040-8166(87)90005-X; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Klingener M, 2014, J NEUROSCI, V34, P9590, DOI 10.1523/JNEUROSCI.3699-13.2014; Lauridsen HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171386; Leroux A, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00656-0; Marins M, 2009, DEV NEUROBIOL, V69, P715, DOI 10.1002/dneu.20737; Matta R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54167-1; McBride RA, 2003, J MATER CHEM, V13, P1196, DOI 10.1039/b211723c; Miragall F, 1997, CELL TISSUE RES, V287, P243; Pellowe AS, 2017, JOVE-J VIS EXP, DOI 10.3791/56384; Prado AF, 2018, REDOX BIOL, V18, P181, DOI 10.1016/j.redox.2018.07.005; Prontera C, 1999, INT J CANCER, V81, P761, DOI 10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1; Rammensee S, 2017, STEM CELLS, V35, P497, DOI 10.1002/stem.2489; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shin Y, 2014, ADV HEALTHC MATER, V3, P1457, DOI 10.1002/adhm.201300569; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Thomas RC, 2017, ACS BIOMATER SCI ENG, V3, P1451, DOI 10.1021/acsbiomaterials.7b00002; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang PZ, 2013, NEUROSCI LETT, V534, P101, DOI 10.1016/j.neulet.2012.11.018	42	0	0	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21311	10.1096/fj.202002302RR	http://dx.doi.org/10.1096/fj.202002302RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417253				2022-12-28	WOS:000647789600046
J	Ragimbeau, R; El Kebriti, L; Sebti, S; Fourgous, E; Boulahtouf, A; Arena, G; Espert, L; Turtoi, A; Gongora, C; Houede, N; Pattingre, S				Ragimbeau, Romain; El Kebriti, Leila; Sebti, Salwa; Fourgous, Elise; Boulahtouf, Abdelhay; Arena, Giuseppe; Espert, Lucile; Turtoi, Andrei; Gongora, Celine; Houede, Nadine; Pattingre, Sophie			BAG6 promotes PINK1 signaling pathway and is essential for mitophagy	FASEB JOURNAL			English	Article						BAG6; mitophagy; receptor; signaling	QUALITY-CONTROL; PROTEIN; MITOCHONDRIA; PARKIN; DEGRADATION; ELIMINATION; APOPTOSIS; UBIQUITIN; RESOURCE; HUB	Bcl-2-associated athanogen-6 (BAG6) is a nucleocytoplasmic shuttling protein involved in protein quality control. We previously demonstrated that BAG6 is essential for autophagy by regulating the intracellular localization of the acetyltransferase EP300, and thus, modifying accessibility to its substrates (TP53 in the nucleus and autophagy-related proteins in the cytoplasm). Here, we investigated BAG6 localization and function in the cytoplasm. First, we demonstrated that BAG6 is localized in the mitochondria. Specifically, BAG6 is expressed in the mitochondrial matrix under basal conditions, and translocates to the outer mitochondrial membrane after mitochondrial depolarization with carbonyl cyanide m-chlorophenyl hydrazine, a mitochondrial uncoupler that induces mitophagy. In SW480 cells, the deletion of BAG6 expression abrogates its ability to induce mitophagy and PINK1 accumulation. On the reverse, its ectopic expression in LoVo colon cancer cells, which do not express endogenous BAG6, reduces the size of the mitochondria, induces mitophagy, leads to the activation of the PINK1/PARKIN pathway and to the phospho-ubiquitination of mitochondrial proteins. Finally, BAG6 contains two LIR (LC3-interacting Region) domains specifically found in receptors for selective autophagy and responsible for the interaction with LC3 and for autophagosome selectivity. Site-directed mutagenesis showed that BAG6 requires wild-type LIRs domains for its ability to stimulate mitophagy. In conclusion, we propose that BAG6 is a novel mitophagy receptor or adaptor that induces PINK1/PARKIN signaling and mitophagy in a LIR-dependent manner.	[Ragimbeau, Romain; El Kebriti, Leila; Fourgous, Elise; Boulahtouf, Abdelhay; Turtoi, Andrei; Gongora, Celine; Houede, Nadine; Pattingre, Sophie] Univ Montpellier, IRCM, Inst Reg Canc Montpellier, INSERM,U1194, F-34298 Montpellier, France; [El Kebriti, Leila; Houede, Nadine] CHU Nimes, Nimes, France; [Sebti, Salwa] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Sebti, Salwa] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Arena, Giuseppe] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, Belvaux, Luxembourg; [Espert, Lucile] Univ Montpellier, IRIM, UMR 9004, CNRS, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; CHU de Nimes; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Luxembourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Pattingre, S (corresponding author), Univ Montpellier, IRCM, Inst Reg Canc Montpellier, INSERM,U1194, F-34298 Montpellier, France.	sophie.pattingre@inserm.fr	Sebti, Salwa/AAB-3188-2020; Turtoi, Andrei/ABD-1271-2021; Arena, Giuseppe/ABE-8093-2021; Espert, Lucile/ABF-5614-2021	Turtoi, Andrei/0000-0003-3813-6635; Arena, Giuseppe/0000-0003-2398-5503; Sebti, Salwa/0000-0003-4327-1129; FOURGOUS, Elise/0000-0002-3626-250X				Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; De Snoo ML, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2132-x; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Hayashishita M, 2019, FEBS OPEN BIO, V9, P1281, DOI 10.1002/2211-5463.12677; Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032; Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Qu DB, 2015, J BIOL CHEM, V290, P30441, DOI 10.1074/jbc.M115.677815; Rambold AS, 2011, CELL CYCLE, V10, P4032, DOI 10.4161/cc.10.23.18384; Saita S, 2016, GENES CELLS, V21, P408, DOI 10.1111/gtc.12351; Sebti S, 2014, AUTOPHAGY, V10, P1341, DOI 10.4161/auto.28979; Sebti S, 2014, P NATL ACAD SCI USA, V111, P4115, DOI 10.1073/pnas.1313618111; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tahrir FG, 2017, J CELL PHYSIOL, V232, P797, DOI 10.1002/jcp.25476; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Verma M, 2020, J BIOL CHEM, V295, P7865, DOI 10.1074/jbc.RA119.010474; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086276; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Wu W, 2012, J CELL SCI, V125, P4219, DOI 10.1242/jcs.086553; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	39	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21361	10.1096/fj.202000930R	http://dx.doi.org/10.1096/fj.202000930R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33522017	Green Submitted			2022-12-28	WOS:000647789600111
J	Sticco, MJ; Palomino, PAP; Lukacsovich, D; Thompson, BL; Foldy, C; Ressl, S; Martinelli, DC				Sticco, Matthew J.; Pena Palomino, Perla A.; Lukacsovich, David; Thompson, Brianna L.; Foeldy, Csaba; Ressl, Susanne; Martinelli, David C.			C1QL3 promotes cell-cell adhesion by mediating complex formation between ADGRB3/BAI3 and neuronal pentraxins	FASEB JOURNAL			English	Article						CTRP13; NPTXR; NPTX1; synapse; trans&#8208; synaptic	SYNAPSE FORMATION; SECRETED PROTEIN; RECEPTOR BAI3; EXPRESSION; NEUREXIN; NP1; INTEGRATION; TAIPOXIN; DOMAIN; BRAIN	Synapses are the fundamental structural unit by which neurons communicate. An orchestra of proteins regulates diverse synaptic functions, including synapse formation, maintenance, and elimination-synapse homeostasis. Some proteins of the larger C1q super-family are synaptic organizers involved in crucial neuronal processes in various brain regions. C1Q-like (C1QL) proteins bind to the adhesion G protein-coupled receptor B3 (ADGRB3) and act at synapses in a subset of circuits. To investigate the hypothesis that the secreted C1QL proteins mediate tripartite trans-synaptic adhesion complexes, we conducted an in vivo interactome study and identified new binding candidates. We demonstrate that C1QL3 mediates a novel cell-cell adhesion complex involving ADGRB3 and two neuronal pentraxins, NPTX1 and NPTXR. Analysis of single-cell RNA-Seq data from the cerebral cortex shows that C1ql3, Nptx1, and Nptxr are highly co-expressed in the same excitatory neurons. Thus, our results suggest the possibility that in vivo the three co-expressed proteins are presynaptically secreted and form a complex capable of binding to postsynaptically localized ADGRB3, thereby creating a novel trans-synaptic adhesion complex. Identifying new binding partners for C1QL proteins and deciphering their underlying molecular principles will accelerate our understanding of their role in synapse organization.	[Sticco, Matthew J.; Thompson, Brianna L.; Martinelli, David C.] Univ Connecticut Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA; [Pena Palomino, Perla A.; Ressl, Susanne] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA; [Lukacsovich, David; Foeldy, Csaba] Univ Zurich, Fac Med, Brain Res Inst, Lab Neural Connect, Zurich, Switzerland; [Lukacsovich, David; Foeldy, Csaba] Univ Zurich, Fac Sci, Brain Res Inst, Lab Neural Connect, Zurich, Switzerland; [Ressl, Susanne; Martinelli, David C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ressl, Susanne] Univ Texas Austin, Dept Neurosci, 100 E 24TH ST,NHB 4-336, Austin, TX 78712 USA; [Martinelli, David C.] Connecticut Inst Brain & Cognit Sci IBACS, Storrs, CT USA	University of Connecticut; Indiana University System; Indiana University Bloomington; University of Geneva; University of Zurich; University of Zurich; Stanford University; University of Texas System; University of Texas Austin	Martinelli, DC (corresponding author), Univ Connecticut Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.; Ressl, S (corresponding author), Univ Texas Austin, Dept Neurosci, 100 E 24TH ST,NHB 4-336, Austin, TX 78712 USA.	suressl@utexas.edu; martinelli.uchc@gmail.com	Ressl, Susanne/AAT-2517-2021	Foldy, Csaba/0000-0001-8709-8490; Martinelli, David/0000-0002-8318-3986	NIDA NIH HHS [F32 DA031654] Funding Source: Medline; NIH HHS [#UL1TR001108] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aydin H, 2012, JOVE-J VIS EXP, DOI 10.3791/4041; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chew KS, 2017, J BIOL RHYTHM, V32, P222, DOI 10.1177/0748730417704766; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; de Wit J, 2016, NAT REV NEUROSCI, V17, P22, DOI 10.1038/nrn.2015.3; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Elegheert J, 2016, SCIENCE, V353, P295, DOI 10.1126/science.aae0104; Farhy-Tselnicker I, 2017, NEURON, V96, P428, DOI 10.1016/j.neuron.2017.09.053; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Gupta R, 2018, J BIOL CHEM, V293, P18086, DOI 10.1074/jbc.RA118.005403; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Honig B, 2020, CELL, V181, P520, DOI 10.1016/j.cell.2020.04.010; Huang LL, 2021, J NEUROL, V268, P4023, DOI 10.1007/s00415-020-10094-0; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Inforzato A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00407; Jean AHW, 2012, METHODS MOL BIOL, V803, P231, DOI 10.1007/978-1-61779-364-6_16; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; Koch SM, 2010, J NEUROSCI, V30, P5404, DOI 10.1523/JNEUROSCI.4893-09.2010; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Koltes JE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46219-3; Lukacsovich D, 2019, CELL REP, V27, P3752, DOI 10.1016/j.celrep.2019.05.090; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Matsuda K, 2016, NEURON, V90, P752, DOI 10.1016/j.neuron.2016.04.001; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Paxinos G, 2004, COMPACT; Pelkey KA, 2015, NEURON, V85, P1257, DOI 10.1016/j.neuron.2015.02.020; Ressl S, 2015, STRUCTURE, V23, P688, DOI 10.1016/j.str.2015.01.019; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Schaukowitch K, 2017, CELL REP, V18, P1512, DOI 10.1016/j.celrep.2017.01.033; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Ye JJ, 2020, P NATL ACAD SCI USA, V117, P17381, DOI 10.1073/pnas.1922270117; Yuzaki M, 2017, TRENDS NEUROSCI, V40, P138, DOI 10.1016/j.tins.2016.12.004; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	52	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21194	10.1096/fj.202000351RR	http://dx.doi.org/10.1096/fj.202000351RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337553				2022-12-28	WOS:000605626600022
J	Stocki, P; Szary, J; Rasmussen, CLM; Demydchuk, M; Northall, L; Logan, DB; Gauhar, A; Thei, L; Moos, T; Walsh, FS; Rutkowski, JL				Stocki, Pawel; Szary, Jaroslaw; Rasmussen, Charlotte L. M.; Demydchuk, Mykhaylo; Northall, Leandra; Logan, Diana Bahu; Gauhar, Aziz; Thei, Laura; Moos, Torben; Walsh, Frank S.; Rutkowski, J. Lynn			Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1	FASEB JOURNAL			English	Article						blood&#8208; brain barrier (BBB); brain delivery; transcytosis; transferrin receptor 1 (TfR1); variable domain of new antigen receptor (VNAR)	CENTRAL-NERVOUS-SYSTEM; IMMUNOHISTOCHEMICAL LOCALIZATION; MONOCLONAL-ANTIBODIES; PEPTIDE SEQUENCES; NEUROTENSIN; DELIVERY; CROSS; EXPRESSION; STABILITY; BINDING	Transfer across the blood-brain barrier (BBB) remains a significant hurdle for the development of biopharmaceuticals with therapeutic effects within the central nervous system. We established a functional selection method to identify high affinity single domain antibodies to the transferrin receptor 1 (TfR1) with efficient biotherapeutic delivery across the BBB. A synthetic phage display library based on the variable domain of new antigen receptor (VNAR) was used for in vitro selection against recombinant human TfR1 ectodomain (rh-TfR1-ECD) followed by in vivo selection in mouse for brain parenchyma penetrating antibodies. TXB2 VNAR was identified as a high affinity, species cross-reactive VNAR antibody against TfR1-ECD that does not compete with transferrin or ferritin for receptor binding. IV dosing of TXB2 when fused to human Fc domain (TXB2-hFc) at 25 nmol/kg (1.875 mg/kg) in mice resulted in rapid binding to brain capillaries with subsequent transport into the brain parenchyma and specific uptake into TfR1-positive neurons. Likewise, IV dosing of TXB2-hFc fused with neurotensin (TXB2-hFc-NT) at 25 nmol/kg resulted in a rapid and reversible pharmacological response as measured by body temperature reduction. TXB2-hFc did not elicit any acute adverse reactions, bind, or deplete circulating reticulocytes or reduce BBB-expressed endogenous TfR1 in mice. There was no evidence of target-mediated clearance or accumulation in peripheral organs except lung. In conclusion, TXB2 is a high affinity, species cross-reactive, and brain-selective VNAR antibody to TfR1 that rapidly crosses the BBB and exhibits a favorable pharmacokinetic and safety profile and can be readily adapted to carry a wide variety of biotherapeutics from blood to brain.	[Stocki, Pawel; Szary, Jaroslaw; Demydchuk, Mykhaylo; Northall, Leandra; Logan, Diana Bahu; Gauhar, Aziz; Thei, Laura; Walsh, Frank S.; Rutkowski, J. Lynn] Ossianix Inc, Stevenage Biosci Catalyst, Stevenage, Herts, England; [Stocki, Pawel; Szary, Jaroslaw; Demydchuk, Mykhaylo; Northall, Leandra; Logan, Diana Bahu; Gauhar, Aziz; Thei, Laura; Walsh, Frank S.; Rutkowski, J. Lynn] Ossianix Inc, 3675 Market St, Philadelphia, PA 19104 USA; [Rasmussen, Charlotte L. M.; Moos, Torben] Aalborg Univ, Dept Hlth Sci & Technol, Lab Neurobiol, Aalborg, Denmark	Aalborg University	Rutkowski, JL (corresponding author), Ossianix Inc, 3675 Market St, Philadelphia, PA 19104 USA.	rutkowski@ossianix.com		Rasmussen, Charlotte Laurfelt Munch/0000-0001-6535-3729	Lundbeckfonden (Lundbeck Foundation) [R155-2013-14113]	Lundbeckfonden (Lundbeck Foundation)	Lundbeckfonden (Lundbeck Foundation), Grant/Award Number: R155-2013-14113	Boado RJ, 2009, BIOTECHNOL BIOENG, V102, P1251, DOI 10.1002/bit.22135; Chang HY, 2018, MABS-AUSTIN, V10, P843, DOI 10.1080/19420862.2018.1473910; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Daniels-Wells TR, 2016, IMMUNOTHERAPY-UK, V8, P991, DOI 10.2217/imt-2016-0050; Deane R, 2004, J NEUROCHEM, V88, P813, DOI 10.1046/j.1471-4159.2003.02221.x; Demeule M, 2014, J CLIN INVEST, V124, P1199, DOI 10.1172/JCI70647; FRIDEN PM, 1991, P NATL ACAD SCI USA, V88, P4771, DOI 10.1073/pnas.88.11.4771; GHANDOUR MS, 1980, NEUROSCI LETT, V20, P125, DOI 10.1016/0304-3940(80)90133-0; Ghetie V, 2004, CANC DRUG DISC DEV, P475; Griffiths K, 2013, ANTIBODIES, V2, P66, DOI 10.3390/antib2010066; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hanzatian DK, 2018, MABS-AUSTIN, V10, P765, DOI 10.1080/19420862.2018.1465159; Hasler J, 2017, US patent, Patent No. [10,479,990 B2, 10479990]; Hermans E, 1998, PHARMACOL THERAPEUT, V79, P89, DOI 10.1016/S0163-7258(98)00009-6; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Johnsen KB, 2019, PROG NEUROBIOL, V181, DOI 10.1016/j.pneurobio.2019.101665; Kawabata H, 2019, FREE RADICAL BIO MED, V133, P46, DOI 10.1016/j.freeradbiomed.2018.06.037; Kissel K, 1998, HISTOCHEM CELL BIOL, V110, P63, DOI 10.1007/s004180050266; Kolonin MG, 2006, FASEB J, V20, P979, DOI 10.1096/fj.05-5186fje; Lee HJ, 2000, J PHARMACOL EXP THER, V292, P1048; Li JW, 2015, AMINO ACIDS, V47, P401, DOI 10.1007/s00726-014-1874-0; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Manich G, 2013, EUR J PHARM SCI, V49, P556, DOI 10.1016/j.ejps.2013.05.027; Moos T, 1996, J COMP NEUROL, V375, P675, DOI 10.1002/(SICI)1096-9861(19961125)375:4<675::AID-CNE8>3.0.CO;2-Z; Moos T, 2000, CELL MOL NEUROBIOL, V20, P77, DOI 10.1023/A:1006948027674; Moos T, 2001, J NEUROCHEM, V79, P119, DOI 10.1046/j.1471-4159.2001.00541.x; Mustain WC, 2011, CURR OPIN ENDOCRINOL, V18, P75, DOI 10.1097/MED.0b013e3283419052; NEMEROFF CB, 1977, BRAIN RES, V128, P485, DOI 10.1016/0006-8993(77)90173-1; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Pardridge WM, 2018, MOL PHARMACEUT, V15, P5207, DOI 10.1021/acs.molpharmaceut.8b00730; Paris-Robidas S, 2011, MOL PHARMACOL, V80, P32, DOI 10.1124/mol.111.071027; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Popp E, 2007, NEUROPEPTIDES, V41, P349, DOI 10.1016/j.npep.2007.06.002; Sehlin D, 2020, FASEB J, V34, P13272, DOI 10.1096/fj.202000610RR; Smith MW, 2012, PEPTIDES, V38, P172, DOI 10.1016/j.peptides.2012.06.019; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Stocki P, 2019, US patent, Patent No. [US2019175746A1, 2019175746]; Strazielle N, 2016, CURR PHARM DESIGN, V22, P5463, DOI 10.2174/1381612822666160726112115; Stutz CC, 2018, AICHE J, V64, P4229, DOI 10.1002/aic.16360; Sugyo A, 2017, ONCOL REP, V37, P1529, DOI 10.3892/or.2017.5412; Sun JH, 2019, MOL PHARMACEUT, V16, P3534, DOI 10.1021/acs.molpharmaceut.9b00369; Sun YJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00586; Thom G, 2018, MOL PHARMACEUT, V15, P1420, DOI 10.1021/acs.molpharmaceut.7b00937; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Urich E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14104; Wan XM, 2009, PEPTIDES, V30, P343, DOI 10.1016/j.peptides.2008.09.026; Webster CI, 2017, PAIN, V158, P660, DOI 10.1097/j.pain.0000000000000810; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	52	20	22	6	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001787R	http://dx.doi.org/10.1096/fj.202001787R		NOV 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33241587				2022-12-28	WOS:000593133600001
J	Sjoqvist, M; Antfolk, D; Suarez-Rodriguez, F; Sahlgren, C				Sjoqvist, Marika; Antfolk, Daniel; Suarez-Rodriguez, Freddy; Sahlgren, Cecilia			From structural resilience to cell specification - Intermediate filaments as regulators of cell fate	FASEB JOURNAL			English	Review						differentiation; stem cells; cytoskeleton; cell signaling; regeneration	EPITHELIAL-MESENCHYMAL TRANSITION; FIBRILLARY ACIDIC PROTEIN; MICE LACKING VIMENTIN; LAMIN-A; STEM-CELLS; NUCLEAR-MEMBRANE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; HUMAN KERATINOCYTES; ENDOTHELIAL-CELLS; PROGENITOR CELLS	During the last decades intermediate filaments (IFs) have emerged as important regulators of cellular signaling events, ascribing IFs with functions beyond the structural support they provide. The organ and developmental stage-specific expression of IFs regulate cell differentiation within developing or remodeling tissues. Lack of IFs causes perturbed stem cell differentiation in vasculature, intestine, nervous system, and mammary gland, in transgenic mouse models. The aberrant cell fate decisions are caused by deregulation of different stem cell signaling pathways, such as Notch, Wnt, YAP/TAZ, and TGF beta. Mutations in genes coding for IFs cause an array of different diseases, many related to stem cell dysfunction, but the molecular mechanisms remain unresolved. Here, we provide a comprehensive overview of how IFs interact with and regulate the activity, localization and function of different signaling proteins in stem cells, and how the assembly state and PTM profile of IFs may affect these processes. Identifying when, where and how IFs and cell signaling congregate, will expand our understanding of IF-linked stem cell dysfunction during development and disease.	[Sjoqvist, Marika; Antfolk, Daniel; Suarez-Rodriguez, Freddy; Sahlgren, Cecilia] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Tykistokatu 6, Turku 20520, Finland; [Sjoqvist, Marika; Antfolk, Daniel; Suarez-Rodriguez, Freddy; Sahlgren, Cecilia] Abo Akad Univ, Turku Biosci, Turku, Finland; [Sjoqvist, Marika; Antfolk, Daniel; Suarez-Rodriguez, Freddy; Sahlgren, Cecilia] Univ Turku, Turku, Finland; [Sahlgren, Cecilia] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands	Abo Akademi University; Abo Akademi University; University of Turku; Eindhoven University of Technology	Sahlgren, C (corresponding author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, Tykistokatu 6, Turku 20520, Finland.	Cecilia.sahlgren@abo.fi		Sahlgren, Cecilia/0000-0003-3350-4937; Suarez Rodriguez, Freddy/0000-0002-3556-1997; Antfolk, Daniel/0000-0001-9163-3740; Sjoqvist, Marika/0000-0002-8561-4073	ForceMorph project - ERC [771168]; AngstromA CoE BACE; Swedish Cultural Foundation in Finland; K. Albin Johanssons stiftelse	ForceMorph project - ERC; AngstromA CoE BACE; Swedish Cultural Foundation in Finland; K. Albin Johanssons stiftelse	We thank Kai Lan Lin for help with the figures. Images were created using . This work was supported by the ForceMorph project, funded by the ERC, project number 771168 (CS, FSR), by the angstrom A CoE BACE (MS), the Swedish Cultural Foundation in Finland (MS, DA) and by K. Albin Johanssons stiftelse (DA).	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alexander CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008037; Allen EHA, 2016, HUM MOL GENET, V25, P1176, DOI 10.1093/hmg/ddw001; Antfolk D, 2017, P NATL ACAD SCI USA, V114, pE4574, DOI 10.1073/pnas.1703057114; Asghar MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127436; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Battaglia Rachel A, 2018, F1000Res, V7, DOI 10.12688/f1000research.15967.1; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bera M, 2020, NUCLEUS-PHILA, V11, P99, DOI 10.1080/19491034.2020.1769445; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Bermeo S, 2015, J CELL BIOCHEM, V116, P2344, DOI 10.1002/jcb.25185; Bertrand AT, 2014, J CELL SCI, V127, P2873, DOI 10.1242/jcs.144907; BIAMONTI G, 1992, MOL CELL BIOL, V12, P3499, DOI 10.1128/MCB.12.8.3499; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bollong MJ, 2017, P NATL ACAD SCI USA, V114, pE9903, DOI 10.1073/pnas.1716009114; Boraas LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30814; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brodsly NF, 2019, ELIFE, V8, DOI 10.7554/eLife.44745; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Capanni C, 2009, BIOL CELL, V101, P541, DOI 10.1042/BC20080175; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; Cerecedo D, 2013, J CELL BIOCHEM, V114, P2050, DOI 10.1002/jcb.24546; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen M, 2018, MOL NEUROBIOL, V55, P5478, DOI 10.1007/s12035-017-0759-0; Chen Y, 2015, J PATHOL, V237, P343, DOI 10.1002/path.4580; Cheng F, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022046; Cheng F, 2016, P NATL ACAD SCI USA, V113, pE4320, DOI 10.1073/pnas.1519197113; Cho S, 2019, DEV CELL, V49, P920, DOI 10.1016/j.devcel.2019.04.020; Choi HG., 2018, SCI REP-UK, V8, P1; Choi JY, 2018, J BONE MINER RES, V33, P2059, DOI 10.1002/jbmr.3549; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; Cizkova D, 2009, CELLS TISSUES ORGANS, V189, P338, DOI 10.1159/000142161; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cogne B, 2020, EUR J HUM GENET, V28, P1218, DOI 10.1038/s41431-020-0583-2; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; DAHL D, 1981, J NEUROSCI RES, V6, P741, DOI 10.1002/jnr.490060608; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Pascalis C, 2018, J CELL BIOL, V217, P3031, DOI 10.1083/jcb.201801162; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Duarte S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12029-4; DUPREY P, 1995, INT J DEV BIOL, V39, P443; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Escobar-Hoyos LF, 2015, CANCER RES, V75, P3650, DOI 10.1158/0008-5472.CAN-15-0293; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Feng X, 2015, J BIOL CHEM, V290, P22507, DOI 10.1074/jbc.M115.654749; Feng X, 2015, J CELL BIOL, V209, P59, DOI 10.1083/jcb.201408079; Flitney EW, 2009, FASEB J, V23, P2110, DOI 10.1096/fj.08-124453; Fu DJ, 2014, J INVEST DERMATOL, V134, P754, DOI 10.1038/jid.2013.356; FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Gregor M, 2014, FASEB J, V28, P715, DOI 10.1096/fj.13-231829; Gu BN, 2013, CELL STEM CELL, V13, P48, DOI 10.1016/j.stem.2013.04.012; Guo YJ, 2020, ELIFE, V9, DOI 10.7554/eLife.53165; Hagemann TL, 2013, J NEUROSCI, V33, P18698, DOI 10.1523/JNEUROSCI.3693-13.2013; Hiratsuka T, 2020, P NATL ACAD SCI USA, V117, P17796, DOI 10.1073/pnas.2006965117; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Hobbs RP, 2015, NAT GENET, V47, P933, DOI 10.1038/ng.3355; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Ivanovska IL, 2017, MOL BIOL CELL, V28, P2010, DOI 10.1091/mbc.E17-01-0010; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jiang P, 2020, AM J RESP CRIT CARE; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kanugula AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108890; Kaschula CH, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5388-8; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kim J, 2016, J CELL SCI, V129, P2030, DOI 10.1242/jcs.180315; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Ku NO, 2005, GASTROENTEROLOGY, V129, P885, DOI 10.1053/j.gastro.2005.06.065; Kumeta M, 2013, EXP CELL RES, V319, P3226, DOI 10.1016/j.yexcr.2013.07.021; Kwak HI, 2012, ANGIOGENESIS, V15, P287, DOI 10.1007/s10456-012-9262-4; Lahdeniemi IA, 2017, CELL DEATH DIFFER, V24, P984, DOI 10.1038/cdd.2017.28; Langlois B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12024-z; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lasic E, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13399; Lee B, 2017, BBA-MOL CELL RES, V1864, P303, DOI 10.1016/j.bbamcr.2016.11.013; Lessard JC, 2012, J INVEST DERMATOL, V132, P1384, DOI 10.1038/jid.2012.6; Li HJ, 2012, DEV BIOL, V371, P156, DOI 10.1016/j.ydbio.2012.08.023; Lieber JG, 1996, J CELL SCI, V109, P3047; Lim HYG, 2020, NATURE, V585, P404, DOI 10.1038/s41586-020-2647-4; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; LIN F, 1993, J BIOL CHEM, V268, P16321; Lindqvist J, 2017, J CELL SCI, V130, P2833, DOI 10.1242/jcs.202226; Liu CY, 2015, ONCOTARGET, V6, P15966, DOI 10.18632/oncotarget.3862; Liu TG, 2014, J CELL PHYSIOL, V229, P1484, DOI 10.1002/jcp.24590; Liu TG, 2010, AM J PHYSIOL-CELL PH, V299, pC363, DOI 10.1152/ajpcell.00057.2010; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lynch CD, 2013, MOL BIOL CELL, V24, P21, DOI 10.1091/mbc.E12-05-0377; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Matsuyama M, 2013, J BIOL CHEM, V288, P35626, DOI 10.1074/jbc.M113.514737; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Mendez MG, 2014, BIOPHYS J, V107, P314, DOI 10.1016/j.bpj.2014.04.050; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Messica Y, 2017, NANO LETT, V17, P6941, DOI 10.1021/acs.nanolett.7b03358; Miettinen M, 2000, HUM PATHOL, V31, P1062, DOI 10.1053/hupa.2000.9843; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Misiorek JO, 2016, CARCINOGENESIS, V37, P777, DOI 10.1093/carcin/bgw063; Mohseni P, 2011, J NEUROSCI, V31, P11547, DOI 10.1523/JNEUROSCI.4396-10.2011; Na N, 2010, FASEB J, V24, P799, DOI 10.1096/fj.08-128967; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Nakaya Y, 2013, CANCER LETT, V341, P9, DOI 10.1016/j.canlet.2013.02.037; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Noh H, 2016, ONCOTARGET, V7, P72021, DOI 10.18632/oncotarget.12458; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Owens DW, 2004, J CELL SCI, V117, P1989, DOI 10.1242/jcs.01043; Palazzo E, 2015, INT J MOL SCI, V16, P26291, DOI 10.3390/ijms161125948; Pallari HM, 2011, MOL BIOL CELL, V22, P1539, DOI 10.1091/mbc.E10-07-0568; Pallari Hanna-Mari, 2006, Sci STKE, V2006, ppe53, DOI 10.1126/stke.3662006pe53; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; PARRY DAD, 1986, BIOCHEM J, V238, P305, DOI 10.1042/bj2380305; Patteson AE, 2019, J CELL BIOL, V218, P4079, DOI 10.1083/jcb.201902046; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pellegrini C, 2015, ONCOTARGET, V6, P29914, DOI 10.18632/oncotarget.4939; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Petrovsky R, 2018, NUCLEUS-PHILA, V9, P104, DOI 10.1080/19491034.2017.1412028; Peuhu E, 2017, DEVELOPMENT, V144, P4103, DOI 10.1242/dev.154229; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Polacheck WJ, 2017, NATURE, V552, P258, DOI 10.1038/nature24998; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Runembert I, 2002, J CELL SCI, V115, P713; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Sakamoto Y, 2013, J CELL BIOL, V200, P249, DOI 10.1083/jcb.201206010; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schiffers PMH, 2000, ARTERIOSCL THROM VAS, V20, P611, DOI 10.1161/01.ATV.20.3.611; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Sethi S, 2011, AM J TRANSL RES, V3, P90; Seymour PA, 2020, DEV CELL, V52, P731, DOI 10.1016/j.devcel.2020.01.015; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2755, DOI 10.1091/mbc.E08-10-1028; Soady KJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0539-6; Sola-Carvajal A, 2019, J INVEST DERMATOL, V139, P2272, DOI 10.1016/j.jid.2019.05.005; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Steen K, 2020, MOL BIOL CELL, V31, P1103, DOI 10.1091/mbc.E19-10-0565; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Strnad P, 2008, HISTOCHEM CELL BIOL, V129, P735, DOI 10.1007/s00418-008-0431-x; Strnad P, 2011, J CELL SCI, V124, P4221, DOI 10.1242/jcs.089516; Strouhalova K, 2020, CANCERS, V12, DOI 10.3390/cancers12010184; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; Tao GZ, 2007, CLIN GASTROENTEROL H, V5, P857, DOI 10.1016/j.cgh.2007.02.017; Tao GZ, 2003, J CELL SCI, V116, P4629, DOI 10.1242/jcs.00782; Tchorz JS, 2009, HEPATOLOGY, V50, P871, DOI 10.1002/hep.23048; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ting HA, 2019, J IMMUNOL, V202, P1321, DOI 10.4049/jimmunol.1801069; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Toribio-Fernandez R, 2019, J PATHOL, V249, P509, DOI 10.1002/path.5332; Totaro A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15206; Trogden KP, 2018, FASEB J, V32, P2841, DOI 10.1096/fj.201700663R; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Ursitti JA, 2004, J BIOL CHEM, V279, P41830, DOI 10.1074/jbc.M400128200; Vajro P, 2012, CLIN RES HEPATOL GAS, V36, P275, DOI 10.1016/j.clinre.2012.03.019; van Engeland NCA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48218-w; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Vijayaraj Preethi, 2007, Methods Mol Biol, V360, P203; Vijayaraj P, 2010, EUR J CELL BIOL, V89, P299, DOI 10.1016/j.ejcb.2009.10.016; Virtakoivu R, 2015, CANCER RES, V75, P2349, DOI 10.1158/0008-5472.CAN-14-2842; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Walker JL, 2018, MOL BIOL CELL, V29, P1555, DOI 10.1091/mbc.E17-06-0364; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei JC, 2008, ANTICANCER RES, V28, P327; Wiche G, 2015, CURR OPIN CELL BIOL, V32, P21, DOI 10.1016/j.ceb.2014.10.002; Wickstrom SA, 2018, CURR OPIN CELL BIOL, V54, P89, DOI 10.1016/j.ceb.2018.05.003; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2019, BIOL CHEM, V400, P1157, DOI 10.1515/hsz-2019-0170; Wilhelmsson U, 2019, CEREB CORTEX, V29, P4050, DOI 10.1093/cercor/bhy284; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Yang JF, 2011, NAT NEUROSCI, V14, P324, DOI 10.1038/nn.2747; Yoneyama MS, 2014, EUR J CELL BIOL, V93, P157, DOI 10.1016/j.ejcb.2014.03.002; Zahr SK, 2019, CELL DEATH DIFFER, V26, P2495, DOI 10.1038/s41418-019-0411-9; Zamoner A, 2005, LIFE SCI, V77, P3321, DOI 10.1016/j.lfs.2005.05.042; Zamoner A, 2008, STEROIDS, V73, P1400, DOI 10.1016/j.steroids.2008.07.002; Zamoner A, 2006, CELL MOL NEUROBIOL, V26, P209, DOI 10.1007/s10571-006-9027-y; Zanatta L, 2012, BBA-MOL CELL RES, V1823, P1708, DOI 10.1016/j.bbamcr.2012.06.023; ZERLIN M, 1995, J NEUROSCI, V15, P7238; Zha JM, 2019, CELL MOL GASTROENTER, V7, P255, DOI 10.1016/j.jcmgh.2018.09.006; Zhang B, 2019, J PHYSIOL BIOCHEM, V75, P11, DOI 10.1007/s13105-019-00661-z; Zhang JG, 2019, SMALL, V15, DOI 10.1002/smll.201901920; Zhou Q, 2003, MOL BIOL CELL, V14, P2959, DOI 10.1091/mbc.E03-02-0059; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421; Zieman AG, 2019, HUM MOL GENET, V28, P2255, DOI 10.1093/hmg/ddz050	227	4	5	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001627R	http://dx.doi.org/10.1096/fj.202001627R		NOV 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33205514	Green Published, hybrid			2022-12-28	WOS:000592661800001
J	Endo, Y; Baldino, K; Li, B; Zhang, YT; Sakthivel, D; MacArthur, M; Panayi, AC; Kip, P; Spencer, DJ; Jasuja, R; Bagchi, D; Bhasin, S; Nuutila, K; Neppl, RL; Wagers, AJ; Sinha, I				Endo, Yori; Baldino, Kodi; Li, Bin; Zhang, Yuteng; Sakthivel, Dharaniya; MacArthur, Michael; Panayi, Adriana C.; Kip, Peter; Spencer, Daniel J.; Jasuja, Ravi; Bagchi, Debalina; Bhasin, Shalender; Nuutila, Kristo; Neppl, Ronald L.; Wagers, Amy J.; Sinha, Indranil			Loss of ARNT in skeletal muscle limits muscle regeneration in aging	FASEB JOURNAL			English	Article						aging; hypoxia signaling; muscle regeneration	ARYL-HYDROCARBON RECEPTOR; SATELLITE CELLS; STEM-CELLS; HYPOXIA; HOMEOSTASIS	The ability of skeletal muscle to regenerate declines significantly with aging. The expression of aryl hydrocarbon receptor nuclear translocator (ARNT), a critical component of the hypoxia signaling pathway, was less abundant in skeletal muscle of old (23-25 months old) mice. This loss of ARNT was associated with decreased levels of Notch1 intracellular domain (N1ICD) and impaired regenerative response to injury in comparison to young (2-3 months old) mice. Knockdown of ARNT in a primary muscle cell line impaired differentiation in vitro. Skeletal muscle-specific ARNT deletion in young mice resulted in decreased levels of whole muscle N1ICD and limited muscle regeneration. Administration of a systemic hypoxia pathway activator (ML228), which simulates the actions of ARNT, rescued skeletal muscle regeneration in both old and ARNT-deleted mice. These results suggest that the loss of ARNT in skeletal muscle is partially responsible for diminished myogenic potential in aging and activation of hypoxia signaling holds promise for rescuing regenerative activity in old muscle.	[Endo, Yori; Baldino, Kodi; Li, Bin; Zhang, Yuteng; Panayi, Adriana C.; Nuutila, Kristo; Sinha, Indranil] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA; [Li, Bin; Zhang, Yuteng] Southern Med Univ, Nanfang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Peoples R China; [Sakthivel, Dharaniya] Baylor Coll Med, Div Human Genet, Houston, TX 77030 USA; [MacArthur, Michael] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [MacArthur, Michael; Kip, Peter] Brigham & Womens Hosp, Div Vasc & Endovasc Surg, 75 Francis St, Boston, MA 02115 USA; [Spencer, Daniel J.; Jasuja, Ravi; Bhasin, Shalender] Brigham & Womens Hosp, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA; [Bagchi, Debalina; Neppl, Ronald L.] Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA; [Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Wagers, Amy J.] Harvard Stem Cell Inst, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Wagers, Amy J.] Harvard Med Sch, Paul F Glenn Ctr Biol Aging, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Southern Medical University - China; Baylor College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard Medical School	Sinha, I (corresponding author), Brigham & Womens Hosp, Div Plast Surg, 45 Francis St, Boston, MA 02115 USA.	isinha@bwh.harvard.edu	Panayi, Adriana C./AAF-1817-2020; Endo, Yori/AAY-8962-2020; MacArthur, Michael Robert/AAA-3173-2022; Panayi, Adriana/HHT-0513-2022	Panayi, Adriana C./0000-0003-4053-9855; Endo, Yori/0000-0002-9282-8811; MacArthur, Michael Robert/0000-0003-3593-6995; Spencer, Daniel/0000-0003-1547-2935	HHS \ NIH \ National Institute on Aging (NIA) [K76AG059996, P30AG031679]; National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK036836]; Glenn Foundation for Medical Research	HHS \ NIH \ National Institute on Aging (NIA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Glenn Foundation for Medical Research	HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: K76AG059996 and P30AG031679; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: P30 DK036836; Glenn Foundation for Medical Research	Badin PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168457; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929; Chen HL, 2017, EXP THER MED, V13, P861, DOI 10.3892/etm.2017.4049; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DeCarolis NA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025874; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Feige P, 2018, CELL STEM CELL, V23, P653, DOI 10.1016/j.stem.2018.10.006; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Hendrickse P, 2019, J MUSCLE RES CELL M, V40, P127, DOI 10.1007/s10974-019-09520-2; Huang XX, 2018, CURR STEM CELL REP, V4, P149, DOI 10.1007/s40778-018-0127-7; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Liu L, 2018, CELL STEM CELL, V23, P544, DOI 10.1016/j.stem.2018.08.019; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032; Oh J, 2016, AGING-US, V8, P2871, DOI 10.18632/aging.101098; Pawlikowski B, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0067-1; Sacco A, 2015, CELL STEM CELL, V16, P585, DOI 10.1016/j.stem.2015.05.007; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sinha I, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00153; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Theriault JR, 2012, BIOORG MED CHEM LETT, V22, P76, DOI 10.1016/j.bmcl.2011.11.077; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Verma M, 2018, CELL STEM CELL, V23, P530, DOI 10.1016/j.stem.2018.09.007; Xie LW, 2018, J CLIN INVEST, V128, P2339, DOI 10.1172/JCI96208; Yang X, 2017, J BIOL CHEM, V292, P5981, DOI 10.1074/jbc.M116.756312; Yeo EJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0233-3	37	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16086	16104		10.1096/fj.202000761RR	http://dx.doi.org/10.1096/fj.202000761RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33064329	Green Published, hybrid			2022-12-28	WOS:000581154300001
J	Dunham, C; Havlioglu, N; Chamberlain, A; Lake, S; Meyer, G				Dunham, Chelsey; Havlioglu, Necat; Chamberlain, Aaron; Lake, Spencer; Meyer, Gretchen			Adipose stem cells exhibit mechanical memory and reduce fibrotic contracture in a rat elbow injury model	FASEB JOURNAL			English	Article						anterior capsule; mechanical priming; post-traumatic joint contracture; pre-conditioning; range-of-motion	INTRAARTICULAR INJECTION; CARTILAGE DEFECTS; TIBIAL OSTEOTOMY; MOTION LOSS; KNEE; OSTEOARTHRITIS; FIBROSIS; TRANSPLANTATION; MYOFIBROBLAST; STIFFNESS	Fibrosis is driven by a misdirected cell response causing the overproduction of extracellular matrix and tissue dysfunction. Numerous pharmacological strategies have attempted to prevent fibrosis but have attained limited efficacy with some detrimental side effects. While stem cell treatments have provided more encouraging results, they have exhibited high variability and have not always improved tissue function. To enhance stem cell efficacy, we evaluated whether mechanical memory could direct cell response. We hypothesized that mechanically pre-conditioning on a soft matrix (soft priming) will delay adipose-derived stem cell (ASC) transition to a pro-fibrotic phenotype, expanding their regenerative potential, and improving healing in a complex tissue environment. Primary ASCs isolated from rat and human subcutaneous fat exhibited mechanical memory, demonstrated by a delayed cell response to stiffness following two weeks of soft priming including decreased cell area, actin coherency, and extracellular matrix production compared to cells on stiff substrates. Soft primed ASCs injected into our rat model of post-traumatic elbow contracture decreased histological evidence of anterior capsule fibrosis and increased elbow range-of-motion when evaluated by joint mechanics. These findings suggest that exploiting mechanical memory by strategically controlling the culture environment during cell expansion may improve the efficacy of stem cell-based therapies targeting fibrosis.	[Dunham, Chelsey; Lake, Spencer; Meyer, Gretchen] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Havlioglu, Necat] John Cochran VA Med Ctr, Dept Pathol, St Louis, MO USA; [Chamberlain, Aaron; Lake, Spencer; Meyer, Gretchen] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Lake, Spencer] Washington Univ, Dept Mech Engn & Mat Sci, 1 Brookings Dr Campus Box 1185, St Louis, MO 63130 USA; [Lake, Spencer; Meyer, Gretchen] Washington Univ, Ctr Regenerat Med, St Louis, MO 63130 USA; [Meyer, Gretchen] Washington Univ, Program Phys Therapy, 4444 Forest Pk Ave Campus Box 8502, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lake, S (corresponding author), Washington Univ, Dept Mech Engn & Mat Sci, 1 Brookings Dr Campus Box 1185, St Louis, MO 63130 USA.; Meyer, G (corresponding author), Washington Univ, Program Phys Therapy, 4444 Forest Pk Ave Campus Box 8502, St Louis, MO 63130 USA.	lake.s@wustl.edu; meyerg@wustl.edu			Washington University in St. Louis Center of Regenerative Medicine; HHS | National Institutes of Health (NIH) [R01 AR071444]	Washington University in St. Louis Center of Regenerative Medicine; HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Washington University in St. Louis Center of Regenerative Medicine; HHS | National Institutes of Health (NIH), Grant/Award Number: R01 AR071444	Al-Najar M, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0689-6; Alvarez D, 2015, STEM CELLS CLONING, V8, P61, DOI 10.2147/SCCAA.S49801; Anakwe RE, 2011, J BONE JOINT SURG AM, V93A, P1220, DOI 10.2106/JBJS.J.00860; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Barrachina L, 2017, J VET SCI, V18, P39, DOI 10.4142/jvs.2017.18.1.39; Borrelli MR, 2020, STEM CELLS, V38, P382, DOI 10.1002/stem.3115; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Caliari SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21387; Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051; Chow JP, 2016, TISSUE ENG REGEN MED, V13, P701, DOI 10.1007/s13770-016-0018-x; CLARKE SA, 2016, J MOL CELL CARDIOL, V93, P115, DOI DOI 10.1016/j.yjmcc.2015.11.028; Cohen MS, 2007, J SHOULDER ELB SURG, V16, P484, DOI 10.1016/j.jse.2006.06.018; Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026; Degen RM, 2016, ARTHROSCOPY, V32, P2435, DOI 10.1016/j.arthro.2016.04.019; Dunham CL, 2018, CLIN ORTHOP RELAT R, V476, P1878, DOI 10.1097/CORR.0000000000000388; Dunham CL, 2017, J SHOULDER ELB SURG, V26, P611, DOI 10.1016/j.jse.2016.09.059; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Garg K, 2014, J APPL PHYSIOL, V117, P1120, DOI 10.1152/japplphysiol.00689.2014; Gumucio JP, 2013, J APPL PHYSIOL, V115, P539, DOI 10.1152/japplphysiol.00374.2013; Gyorfi AH, 2018, MATRIX BIOL, V68-69, P8, DOI 10.1016/j.matbio.2017.12.016; Heo S. J., 2015, SCI REP, V5, P1, DOI DOI 10.1038/SREP16895; Hildebrand KA, 2004, J ORTHOP RES, V22, P313, DOI 10.1016/j.orthres.2003.08.012; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Isaka Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092532; Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634; Kim YS, 2017, AM J SPORT MED, V45, P2010, DOI 10.1177/0363546517702863; Kocaoglu B, 2010, J BONE JOINT SURG BR, V92B, P889, DOI 10.1302/0301-620X.92B6.23534; Lake SP, 2016, J ORTHOP RES, V34, P354, DOI 10.1002/jor.22981; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li CX, 2017, NAT MATER, V16, P379, DOI [10.1038/nmat4780, 10.1038/NMAT4780]; Li XL, 2019, J ORTHOP RES, V37, P1236, DOI 10.1002/jor.24266; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Loebel C, 2019, NAT MATER, V18, P883, DOI 10.1038/s41563-019-0307-6; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Manka P, 2019, DRUGS, V79, P903, DOI 10.1007/s40265-019-01126-9; McLeod CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38852; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Morrey ME, 2018, J CELL BIOCHEM, V119, P1326, DOI 10.1002/jcb.26256; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Nardone G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15321; Nasrollahi S, 2017, BIOMATERIALS, V146, P146, DOI 10.1016/j.biomaterials.2017.09.012; Papazova DA, 2015, DIS MODEL MECH, V8, P281, DOI 10.1242/dmm.017699; Pers YM, 2016, STEM CELL TRANSL MED, V5, P847, DOI 10.5966/sctm.2015-0245; Schneider P.S., 2017, J HAND SURG AM, V42, pS50; Solovyeva VV, 2014, J PURE APPL MICROBIO, V8, P523; Spees JL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0363-7; Steplewski A, 2017, J ORTHOP RES, V35, P1038, DOI 10.1002/jor.23369; Syed S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187853; Talele NP, 2015, STEM CELL REP, V4, P1016, DOI 10.1016/j.stemcr.2015.05.004; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tse J.R., 2010, CURR PROTOC CELL BIO, V47, pS1; Vangsness CT, 2014, J BONE JOINT SURG AM, V96A, P90, DOI 10.2106/JBJS.M.00058; Vilar JM, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0852-z; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wong KL, 2013, ARTHROSCOPY, V29, P2020, DOI 10.1016/j.arthro.2013.09.074; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xing D, 2018, OSTEOARTHR CARTILAGE, V26, P445, DOI 10.1016/j.joca.2018.01.010; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yang HB, 2016, ACS APPL MATER INTER, V8, P26591, DOI 10.1021/acsami.6b09222; Yukawa H, 2012, BIOMATERIALS, V33, P2177, DOI 10.1016/j.biomaterials.2011.12.009	66	16	16	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12976	12990		10.1096/fj.202001274R	http://dx.doi.org/10.1096/fj.202001274R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33411380	Green Accepted			2022-12-28	WOS:000558224700001
J	Rivera, RR; Lin, ME; Bornhop, EC; Chun, J				Rivera, Richard R.; Lin, Mu-En; Bornhop, Emily C.; Chun, Jerold			Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain	FASEB JOURNAL			English	Article						conditional knockout; LPA; PSNL; Schwann cells; neurons	LYSOPHOSPHATIDIC ACID LPA; MULTIPLE-SCLEROSIS; RECEPTOR GENE; SPINAL-CORD; INJURY; MODEL; ROLES; DISRUPTION; MECHANISMS; MORPHOLOGY	LPA(1)is one of six known receptors (LPA(1-6)) for lysophosphatidic acid (LPA). ConstitutiveLpar1null mutant mice have been instrumental in identifying roles for LPA-LPA(1)signaling in neurobiological processes, brain development, and behavior, as well as modeling human neurological diseases like neuropathic pain. ConstitutiveLpar1null mutant mice are protected from partial sciatic nerve ligation (PSNL)-induced neuropathic pain, however, the cell types that are functionally responsible for mediating this protective effect are unknown. Here, we report the generation of anLpar1(flox/flox)conditional null mutant mouse that allows for cre-mediated conditional deletion, combined with a PSNL pain model.Lpar1(flox/flox)mice were crossed withcretransgenic lines driven by neural gene promoters fornestin(all neural cells),synapsin(neurons), orP0(Schwann cells).CD11b-cretransgenic mice were also used to deleteLpar1in microglia. PSNL-initiated pain responses were reduced following cre-mediatedLpar1deletion with all three neural promoters as well as theCD11bpromoter, supporting involvement of Schwann cells, central and/or peripheral neurons, and microglia in mediating pain. Interestingly, rescue responses were nonidentical, implicating distinct roles forLpar1-expressing cell types. Our results with a newLpar1conditional mouse mutant expand an understanding of LPA(1)signaling in the PSNL model of neuropathic pain.	[Rivera, Richard R.; Bornhop, Emily C.; Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 N Torrey Pines Rd, La Jolla, CA 90237 USA; [Lin, Mu-En] Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Lin, Mu-En] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Lin, Mu-En] RevMAb Biosci, San Francisco, CA USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; University of California System; University of California San Diego	Chun, J (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 N Torrey Pines Rd, La Jolla, CA 90237 USA.	jchun@sbpdiscovery.org			HHS | NIH | National Institute of Mental Health (NIMH) [R01MH051699]; Amira Pharmaceuticals	HHS | NIH | National Institute of Mental Health (NIMH); Amira Pharmaceuticals	HHS | NIH | National Institute of Mental Health (NIMH), Grant/Award Number: R01MH051699; Amira Pharmaceuticals	Anliker B, 2013, GLIA, V61, P2009, DOI 10.1002/glia.22572; Blaho VA, 2018, TRENDS PHARMACOL SCI, V39, P953, DOI 10.1016/j.tips.2018.08.006; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Callaerts-Vegh Z, 2012, GENES BRAIN BEHAV, V11, P1009, DOI 10.1111/j.1601-183X.2012.00840.x; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; Chun J., 2014, LYSOPHOSPHOLIPID REC; Chun J, 2019, ANNU REV PHARMACOL, V59, P149, DOI 10.1146/annurev-pharmtox-010818-021358; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; D'Mello R, 2008, BRIT J ANAESTH, V101, P8, DOI 10.1093/bja/aen088; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Dubin AE, 2010, J NEUROSCI, V30, P7300, DOI 10.1523/JNEUROSCI.6151-09.2010; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fincher J, 2014, DEV NEUROSCI-BASEL, V36, P443, DOI 10.1159/000364858; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Gennero I, 2011, BONE, V49, P395, DOI 10.1016/j.bone.2011.04.018; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lim TKY, 2015, J NEUROSCI, V35, P3346, DOI 10.1523/JNEUROSCI.4040-14.2015; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Lummis NC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2011; Ma L, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-29; Ma L, 2010, J NEUROCHEM, V115, P643, DOI 10.1111/j.1471-4159.2010.06955.x; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Ma L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-64; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; Mirendil H, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.33; Moller T, 2001, J BIOL CHEM, V276, P25946, DOI 10.1074/jbc.M102691200; SCHUMACHER KA, 1979, THROMB HAEMOSTASIS, V42, P631; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Suckau O, 2019, DEV DYNAM, V248, P375, DOI 10.1002/dvdy.23; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Ueda H, 2018, PAIN, V159, P2170, DOI 10.1097/j.pain.0000000000001316; Ueda H, 2017, PAIN, V158, pS55, DOI 10.1097/j.pain.0000000000000813; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	54	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8833	8842		10.1096/fj.202000317R	http://dx.doi.org/10.1096/fj.202000317R		JUN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32929779	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000541772400001
J	Abergel, Z; Shaked, M; Shukla, V; Wu, ZX; Gross, E				Abergel, Zohar; Shaked, Maayan; Shukla, Virendra; Wu, Zheng-Xing; Gross, Einav			The phosphatidylinositol transfer protein PITP-1 facilitates fast recovery of eating behavior after hypoxia in the nematode Caenorhabditis elegans	FASEB JOURNAL			English	Article						C elegans; GLOBIN 5; hypoxia; oxygen sensing neurons; PITP&#8208; 1; PKC&#8208; 1	SOLUBLE GUANYLATE CYCLASES; C-ELEGANS; SYNAPTIC-TRANSMISSION; PHOSPHATIDIC-ACID; NATURAL VARIATION; NERVOUS-SYSTEM; O-2 RESPONSES; OXYGEN; KINASE; NEURONS	Among the fascinating adaptations to limiting oxygen conditions (hypoxia) is the suppression of food intake and weight loss. In humans, this phenomenon is called high-altitude anorexia and is observed in people suffering from acute mountain syndrome. The high-altitude anorexia appears to be conserved in evolution and has been seen in species across the animal kingdom. However, the mechanism underlying the recovery of eating behavior after hypoxia is still not known. Here, we show that the phosphatidylinositol transfer protein PITP-1 is essential for the fast recovery of eating behavior after hypoxia in the nematode Caenorhabditis elegans. Unlike the neuroglobin GLB-5 that accelerates the recovery of eating behavior through its function in the oxygen (O-2)-sensing neurons, PITP-1 appears to act downstream, in neurons that express the mod-1 serotonin receptor. Indeed, pitp-1 mutants display wild-type-like O-2-evoked-calcium responses in the URX O-2-sensing neuron. Intriguingly, loss-of-function of protein kinase C 1 (PKC-1) rescues pitp-1 mutants' recovery after hypoxia. Increased diacylglycerol (DAG), which activates PKC-1, attenuates the recovery of wild-type worms. Together, these data suggest that PITP-1 enables rapid recovery of eating behavior after hypoxia by limiting DAG's availability, thereby limiting PKC activity in mod-1-expressing neurons.	[Abergel, Zohar; Shaked, Maayan; Shukla, Virendra; Gross, Einav] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Fac Med, IMRIC, POB 12271, IL-9112102 Jerusalem, Israel; [Wu, Zheng-Xing] Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ,Inst Biophys & Bi, Wuhan, Peoples R China	Hebrew University of Jerusalem; Huazhong University of Science & Technology	Gross, E (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Fac Med, IMRIC, POB 12271, IL-9112102 Jerusalem, Israel.; Wu, ZX (corresponding author), Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ,Inst Biophys & Bi, Wuhan, Peoples R China.	ibbwuzx@mail.hust.edu.cn; einavg@ekmd.huji.ac.il	Gross, Einav/AAS-7417-2021		European Research Council [281844] Funding Source: Medline; NIH HHS [P40 OD010440] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abergel Z, 2016, J NEUROSCI, V36, P963, DOI 10.1523/JNEUROSCI.3170-15.2016; Alam T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10388; Alberts B, 2008, MOL BIOL CELL; [Anonymous], 2018, WORMATLAS; BRENNER S, 1974, GENETICS, V77, P71; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Cai HH, 2019, J GERONTOL A-BIOL, V74, P1198, DOI 10.1093/gerona/glx206; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; De Henau S, 2016, WORM, V5, DOI DOI 10.1080/21624054.2016.1184390; De Henau S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9782; Farzin M, 2014, J INSECT PHYSIOL, V68, P23, DOI 10.1016/j.jinsphys.2014.06.017; Fenk LA, 2017, P NATL ACAD SCI USA, V114, P4195, DOI 10.1073/pnas.1618934114; Frokjaer-Jensen C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002467; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grabon A, 2019, J LIPID RES, V60, P242, DOI 10.1194/jlr.R089730; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Green MR, 2012, MOL CLONING LAB MANU, V1; Grimm ER, 2011, NUTR REV, V69, P52, DOI 10.1111/j.1753-4887.2010.00361.x; Gross E, 2014, J NEUROSCI, V34, P16726, DOI 10.1523/JNEUROSCI.5368-13.2014; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Hsieh YS, 2005, EUR J NEUROSCI, V22, P715, DOI 10.1111/j.1460-9568.2005.04245.x; Hyde R, 2011, GENES BRAIN BEHAV, V10, P286, DOI 10.1111/j.1601-183X.2010.00667.x; Iwata R, 2011, P NATL ACAD SCI USA, V108, P7589, DOI 10.1073/pnas.1016232108; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kim S, 2013, EMBO REP, V14, P891, DOI 10.1038/embor.2013.113; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; KONNO Y, 1989, J BIOCHEM-TOKYO, V106, P673, DOI 10.1093/oxfordjournals.jbchem.a122915; Kurland M, 2020, J DEV BIOL, V8, DOI 10.3390/jdb8010005; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; Nagashima T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008297; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; Park D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07313-6; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Sun CL, 2014, CELL DEATH DIFFER, V21, P557, DOI 10.1038/cdd.2013.176; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Takeishi A, 2016, NEURON, V90, P235, DOI 10.1016/j.neuron.2016.03.002; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Tilleman L, 2011, IUBMB LIFE, V63, P166, DOI 10.1002/iub.443; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tran A, 2017, ELIFE, V6, DOI [10.7554/eLife.23770, 10.7554/elife.23770]; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Vats P, 2004, HIGH ALT MED BIOL, V5, P90, DOI 10.1089/152702904322963753; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wojtyniak M, 2013, J CELL SCI, V126, P4381, DOI 10.1242/jcs.127274; Zhao YH, 2018, ELIFE, V7, DOI 10.7554/eLife.38675; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	67	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21202	10.1096/fj.202000704R	http://dx.doi.org/10.1096/fj.202000704R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368638	Green Published, hybrid			2022-12-28	WOS:000605626600010
J	Ikeuchi, M; Yuki, R; Saito, Y; Nakayama, Y				Ikeuchi, Masayoshi; Yuki, Ryuzaburo; Saito, Youhei; Nakayama, Yuji			The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner	FASEB JOURNAL			English	Article						bleb; Hippo pathway; LATS2; Merlin; v&#8208; Src	C-SRC; TYROSINE PHOSPHORYLATION; FAMILY KINASES; CELL-MIGRATION; IN-VITRO; F-ACTIN; EXPRESSION; PATHWAY; CANCER; ACTIVATION	When cells with excess DNA, such as tetraploid cells, undergo cell division, it can contribute to cellular transformation via asymmetrical chromosome segregation-generated genetic diversity. Cell cycle progression of tetraploid cells is suppressed by large tumor suppressor 2 (LATS2) kinase-induced inhibitory phosphorylation of the transcriptional coactivator Yes-associated protein (YAP). We recently reported that the oncogene v-Src induces tetraploidy and promotes cell cycle progression of tetraploid cells by suppressing LATS2 activity. We explore here the mechanism by which v-Src suppresses LATS2 activity and the role of LATS2 in v-Src-expressing cells. LATS2 was directly phosphorylated by v-Src and the proto-oncogene c-Src, resulting in decreased LATS2 kinase activity. This kinase-deficient LATS2 accumulated in a YAP transcriptional activity-dependent manner, and knockdown of either LATS2 or the LATS2-binding partner moesin-ezrin-radixin-like protein (Merlin) accelerated v-Src-induced membrane bleb formation. Upon v-Src expression, the interaction of Merlin with LATS2 was increased possibly due to a decrease in Merlin phosphorylation at Ser518, the dephosphorylation of which is required for the open conformation of Merlin and interaction with LATS2. LATS2 was colocalized with Merlin at the plasma membrane in a manner that depends on the Merlin-binding region of LATS2. The bleb formation in v-Src-expressing and LATS2-knockdown cells was rescued by the reexpression of wild-type or kinase-dead LATS2 but not the LATS2 mutant lacking the Merlin-binding region. These results suggest that the kinase-deficient LATS2 plays a role with Merlin at the plasma membrane in the maintenance of cortical rigidity in v-Src-expressing cells, which may cause tumor suppression.	[Ikeuchi, Masayoshi; Yuki, Ryuzaburo; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan; [Ikeuchi, Masayoshi] Japan Soc Promot Sci, DC1, Tokyo, Japan	Kyoto Pharmaceutical University; Japan Society for the Promotion of Science	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp		Saito, Youhei/0000-0002-8545-6925				Aoki K, 2016, P NATL ACAD SCI USA, V113, pE1863, DOI 10.1073/pnas.1600968113; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Brault E, 2001, J CELL SCI, V114, P1901; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Dehm S, 2001, FEBS LETT, V487, P367, DOI 10.1016/S0014-5793(00)02354-1; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fincham VJ, 1999, J CELL SCI, V112, P947; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Guo Feng, 2008, Biotechnol J, V3, P370, DOI 10.1002/biot.200700170; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Honda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38751; Horiuchi M, 2018, J BIOL CHEM, V293, P15524, DOI 10.1074/jbc.RA118.002784; Ikeuchi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060871; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; James MF, 2001, BIOCHEM J, V356, P377, DOI 10.1042/0264-6021:3560377; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kakae K, 2017, CELL SIGNAL, V30, P19, DOI 10.1016/j.cellsig.2016.11.014; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim HB, 2018, BMB REP, V51, P119, DOI 10.5483/BMBRep.2018.51.3.018; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Nakayama Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040811; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Park GS, 2016, ONCOTARGET, V7, P24063, DOI 10.18632/oncotarget.8211; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Rusnak L, 2018, J MOL CELL BIOL, V10, P549, DOI 10.1093/jmcb/mjy061; Sabra H, 2017, J BIOL CHEM, V292, P19179, DOI 10.1074/jbc.M117.808063; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wang TT, 2019, CURR DRUG TARGETS, V20, P1, DOI 10.2174/1389450119666180405094046; Warren JSA, 2018, CANCERS, V10, DOI 10.3390/cancers10040115; Webb BL, 2000, MOL CELL BIOL, V20, P9271, DOI 10.1128/MCB.20.24.9271-9280.2000; Welman A, 2006, NEOPLASIA, V8, P905, DOI 10.1593/neo.06475; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu T, 2015, PROTEIN CELL, V6, P6, DOI 10.1007/s13238-014-0122-4	64	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21242	10.1096/fj.202001909R	http://dx.doi.org/10.1096/fj.202001909R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368671				2022-12-28	WOS:000605626600001
J	Peng, Y; Yue, F; Chen, JJ; Xia, W; Huang, KL; Yang, GS; Kuang, SH				Peng, Ying; Yue, Feng; Chen, Jingjuan; Xia, Wei; Huang, Kuilong; Yang, Gongshe; Kuang, Shihuan			Phosphatase orphan 1 inhibits myoblast proliferation and promotes myogenic differentiation	FASEB JOURNAL			English	Article						mitochondria; MyoG; myogenesis; Phospho1	SKELETAL-MUSCLE; MYOD FAMILY; MECHANISMS; CREATINE; PHOSPHO1; PHOSPHOETHANOLAMINE; PHOSPHOCHOLINE; ACTIVATION; NETWORKS; LEADS	Myogenesis includes sequential stages of progenitor cell proliferation, myogenic commitment and differentiation, myocyte fusion, and myotube maturation. Different stages of myogenesis are orchestrated and regulated by myogenic regulatory factors and various downstream cellular signaling. Here we identify phosphatase orphan 1 (Phospho1) as a new player in myogenesis. During activation, proliferation, and differentiation of quiescent satellite cells, the expression of Phospho1 gradually increases. Overexpression of Phospho1 inhibits myoblast proliferation but promotes their differentiation and fusion. Conversely, knockdown of Phospho1 accelerates myoblast proliferation but impairs myotube formation. Moreover, knockdown of Phospho1 decreases the OXPHO protein levels and mitochondria density, whereas overexpression of Phospho1 upregulates OXPHO protein levels and promotes mitochondrial oxygen consumption. Finally, we show that Phospho1 expression is controlled by myogenin, which binds to the promoter of Phospho1 to regulate its transcription. These results indicate a key role of Phospho1 in regulating myogenic differentiation and mitochondrial function.	[Peng, Ying; Huang, Kuilong; Yang, Gongshe] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Peng, Ying; Yue, Feng; Chen, Jingjuan; Xia, Wei; Huang, Kuilong; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, Hobart & Russell Creighton Hall Anim Sci, W Lafayette, IN 47907 USA; [Xia, Wei] Southwest Minzu Univ, Coll Life Sci & Technol, Chengdu, Peoples R China	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Southwest Minzu University	Yang, GS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.; Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, Hobart & Russell Creighton Hall Anim Sci, W Lafayette, IN 47907 USA.	gsyang@nwafu.edu.cn; skuang@purdue.edu	PENG, YING/AAW-8159-2021		HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR071649]; National Science and Technology Major Project of China [2016ZX08006003]; China Scholarship Council (CSC) [CSC201706300078]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Science and Technology Major Project of China; China Scholarship Council (CSC)(China Scholarship Council)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR071649; National Science and Technology Major Project of China, Grant/Award Number: 2016ZX08006003; China Scholarship Council (CSC), Grant/Award Number: CSC201706300078	Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cheng X, 2018, EXP THER MED, V15, P247, DOI 10.3892/etm.2017.5391; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dayeh T, 2016, EPIGENETICS-US, V11, P482, DOI 10.1080/15592294.2016.1178418; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; Granata F, 2000, BBA-MOL CELL BIOL L, V1483, P334, DOI 10.1016/S1388-1981(99)00186-9; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Houston B, 1999, BBA-MOL CELL RES, V1448, P500, DOI 10.1016/S0167-4889(98)00153-0; Huesa C, 2011, BONE, V48, P1066, DOI 10.1016/j.bone.2011.01.010; Ijuin T, 2012, J BIOL CHEM, V287, P31330, DOI 10.1074/jbc.M112.388785; JANSSON E, 1985, EUR J APPL PHYSIOL O, V54, P207, DOI 10.1007/BF02335931; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; KIM SJ, 1992, J BIOL CHEM, V267, P15140; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Lassche S, 2013, NEUROLOGY, V80, P733, DOI 10.1212/WNL.0b013e318282513b; Li YY, 2018, CANCER LETT, V417, P58, DOI 10.1016/j.canlet.2017.12.015; MacRae VE, 2010, BONE, V46, P1146, DOI 10.1016/j.bone.2009.12.018; Moretti I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12397; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Schiaffino S, 2015, SCAND J MED SCI SPOR, V25, P41, DOI 10.1111/sms.12606; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shan TZ, 2014, STEM CELLS, V32, P2893, DOI 10.1002/stem.1788; Shi H, 2013, J CLIN INVEST, V123, P2064, DOI 10.1172/JCI64375; Stewart AJ, 2003, PROTEIN ENG, V16, P889, DOI 10.1093/protein/gzg126; Sumariwalla VM, 2001, GENESIS, V30, P239, DOI 10.1002/gene.1070; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Yue F, 2016, CELL REP, V17, P2340, DOI 10.1016/j.celrep.2016.11.002	46	1	1	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001672R	http://dx.doi.org/10.1096/fj.202001672R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33140469	Green Accepted			2022-12-28	WOS:000586613000001
J	Nikovics, K; Morin, H; Riccobono, D; Bendahmane, A; Favier, AL				Nikovics, Krisztina; Morin, Halima; Riccobono, Diane; Bendahmane, Abdelhafid; Favier, Anne-Laure			Hybridization-chain-reaction is a relevant method for in situ detection of M2d-like macrophages in a mini-pig model	FASEB JOURNAL			English	Article						adipose tissue-derived stem cells; cytokines and muscle regeneration	MESSENGER-RNA; STEM-CELLS; ANGIOGENESIS; POLARIZATION; GENERATION; ACTIN	Macrophages are a heterogeneous population of cells with an important role in innate immunity and tissue regeneration. Based on in vitro experiments, macrophages have been subdivided into five distinct subtypes named M1, M2a, M2b, M2c, and M2d, depending on the means of their activation and the cell surface markers they display. Whether all subtypes can be detected in vivo is still unclear. The identification of macrophages in vivo in the regenerating muscle could be used as a new diagnostic tool to monitor therapeutic strategies for tissue repair. The use of classical immunolabeling techniques is unable to discriminate between different M2 macrophages and a functional characterization of these macrophages is lacking. Using in situ hybridization coupled with hybridization-chain-reaction detection (HCR), we achieved the identification of M2d-like macrophages within regenerating muscle and applied this technique to understand the role of M2 macrophages in the regeneration of irradiated pig-muscle after adipose tissue stem cell treatment. Our work highlights the limits of immunolabeling and the usefulness of HCR analysis to provide valuable information for macrophage characterization.	[Nikovics, Krisztina; Favier, Anne-Laure] French Armed Forces Biomed Res Inst, Dept Platforms & Technol Res, Imagery Unit, 1,Pl Gen Valerie Andre,BP73, F-91223 Bretigny Sur Orge, France; [Morin, Halima; Bendahmane, Abdelhafid] Univ Evry, Univ Paris Saclay, CNRS, Inst Plant Sci Paris Saclay IPS2,INRAE, Orsay, France; [Riccobono, Diane] French Armed Forces Biomed Res Inst, Dept NRBC Defens, Radiobiol Unit, Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Nikovics, K (corresponding author), French Armed Forces Biomed Res Inst, Dept Platforms & Technol Res, Imagery Unit, 1,Pl Gen Valerie Andre,BP73, F-91223 Bretigny Sur Orge, France.	krisztina.nikovics@intradef.gouv.fr		Bendahmane, Abdelhafid/0000-0003-3246-868X	Delegation Generale de l Armement [PDH2-NRBC-4-NR-4306]	Delegation Generale de l Armement	Delegation Generale de l Armement, Grant/Award Number: PDH2-NRBC-4-NR-4306	Abdelaziz MH, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02251-w; Arora S, 2018, IMMUNOBIOLOGY, V223, P383, DOI 10.1016/j.imbio.2017.11.001; Ballara SC, 1999, INT J EXP PATHOL, V80, P235, DOI 10.1046/j.1365-2613.1999.00129.x; Bonnardel J, 2018, CURR OPIN IMMUNOL, V50, P64, DOI 10.1016/j.coi.2017.12.001; Chistiakov DA, 2017, IMMUNOBIOLOGY, V223, P101, DOI 10.1016/j.imbio.2017.10.005; Choi HMT, 2016, DEVELOPMENT, V143, P3632, DOI 10.1242/dev.140137; Choi HMT, 2014, ACS NANO, V8, P4284, DOI 10.1021/nn405717p; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; GAN FY, 1994, J HISTOTECHNOL, V17, P313, DOI 10.1179/his.1994.17.4.313; Gharib SA, 2019, J ALLERGY CLIN IMMUN, V143, P1536, DOI 10.1016/j.jaci.2018.10.046; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Hou LQ, 2016, AM J PHYSIOL-HEART C, V310, pH455, DOI 10.1152/ajpheart.00726.2015; Huang X, 2018, METHODS MOL BIOL, V1784, P119, DOI 10.1007/978-1-4939-7837-3_12; Jain N, 2019, ANNU REV BIOMED ENG, V21, P267, DOI 10.1146/annurev-bioeng-062117-121224; King A, 2014, ADV WOUND CARE, V3, P614, DOI 10.1089/wound.2013.0497; Lemos DR, 2015, BONE, V80, P19, DOI 10.1016/j.bone.2015.06.013; Linard C, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1051-6; Linard C, 2018, STEM CELL TRANSL MED, V7, P569, DOI 10.1002/sctm.17-0267; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18; Pajarinen J, 2019, BIOMATERIALS, V196, P80, DOI 10.1016/j.biomaterials.2017.12.025; Perandini LA, 2018, FEBS J, V285, P1973, DOI 10.1111/febs.14417; Riccobono D, 2018, HEALTH PHYS, V115, P37, DOI 10.1097/HP.0000000000000822; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Snyder RJ, 2016, WOUND REPAIR REGEN, V24, P613, DOI 10.1111/wrr.12444; Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019; TANEJA KL, 1990, J CELL BIOCHEM, V44, P241, DOI 10.1002/jcb.240440406; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Viniegra A, 2018, J DENT RES, V97, P1160, DOI 10.1177/0022034518777973; Wermuth PJ, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0047-4; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu JJ, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1303-0; Zhao B, 2018, PEERJ, V6, DOI 10.7717/peerj.5400	41	7	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15675	15686		10.1096/fj.202001496R	http://dx.doi.org/10.1096/fj.202001496R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078886				2022-12-28	WOS:000581625700001
J	Egerman, MA; Wong, JS; Runxia, T; Mosoyan, G; Chauhan, K; Reyes-Bahamonde, J; Anandakrishnan, N; Wong, NJ; Bagiella, E; Salem, F; Meliambro, K; Li, H; Azeloglu, EU; Coca, SG; Campbell, KN; Raij, L				Egerman, Marc A.; Wong, Jenny S.; Runxia, Tian; Mosoyan, Gohar; Chauhan, Kinsuk; Reyes-Bahamonde, Joselyn; Anandakrishnan, Nanditha; Wong, Nicholas J.; Bagiella, Emilia; Salem, Fadi; Meliambro, Kristin; Li, Hong; Azeloglu, Evren U.; Coca, Steven G.; Campbell, Kirk N.; Raij, Leopoldo			Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease	FASEB JOURNAL			English	Article						amiloride; edema; eGFR; glomerular; plasminogen; podocytes	URINARY SERINE PROTEASES; FILTRATION-RATE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RENAL OUTCOMES; PROTEINURIA; PLASMIN; ACTIVATION; NEPHRIN; ENAC	Urinary plasminogen/plasmin, or plasmin (ogen) uria, has been demonstrated in proteinuric patients and exposure of cultured podocytes to plasminogen results in injury via oxidative stress pathways. A causative role for plasmin (ogen) as a "second hit" in kidney disease progression has yet to have been demonstrated in vivo. Additionally, association between plasmin (ogen) uria and kidney function in glomerular diseases remains unclear. We performed comparative studies in a puromycin aminonucleoside (PAN) nephropathy rat model treated with amiloride, an inhibitor of plasminogen activation, and measured changes in plasmin (ogen) uria. In a glomerular disease biorepository cohort (n = 128), we measured time-of-biopsy albuminuria, proteinuria, and plasmin (ogen) uria for correlations with kidney outcomes. In cultured human podocytes, plasminogen treatment was associated with decreased focal adhesion marker expression with rescue by amiloride. Increased glomerular plasmin (ogen) was found in PAN rats and focal segmental glomerulosclerosis (FSGS) patients. PAN nephropathy was associated with increases in plasmin (ogen) uria and proteinuria. Amiloride was protective against PAN-induced glomerular injury, reducing CD36 scavenger receptor expression and oxidative stress. In patients, we found associations between plasmin (ogen) uria and edema status as well as eGFR. Our study demonstrates a role for plasmin (ogen)-induced podocyte injury in the PAN nephropathy model, with amiloride having podocyte-protective properties. In one of the largest glomerular disease cohorts to study plasminogen, we validated previous findings while suggesting a potentially novel relationship between plasmin (ogen) uria and estimated glomerular filtration rate (eGFR). Together, these findings suggest a role for plasmin (ogen) in mediating glomerular injury and as a viable targetable biomarker for podocyte-sparing treatments.	[Egerman, Marc A.; Wong, Jenny S.; Mosoyan, Gohar; Chauhan, Kinsuk; Reyes-Bahamonde, Joselyn; Anandakrishnan, Nanditha; Wong, Nicholas J.; Meliambro, Kristin; Azeloglu, Evren U.; Coca, Steven G.; Campbell, Kirk N.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, 1 Gustave Levy Pl,Box 1243, New York, NY 10029 USA; [Runxia, Tian; Raij, Leopoldo] Univ Miami, Miller Sch Med, Dept Med, Katz Family Div Nephrol & Hypertens, 1120 NW 14th St,Suite 809, Miami, FL 33136 USA; [Bagiella, Emilia] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Ctr Biostat, New York, NY 10029 USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Li, Hong] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Azeloglu, Evren U.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of Miami; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai	Campbell, KN (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, 1 Gustave Levy Pl,Box 1243, New York, NY 10029 USA.; Raij, L (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Katz Family Div Nephrol & Hypertens, 1120 NW 14th St,Suite 809, Miami, FL 33136 USA.	kirk.campbell@mssm.edu; lraij@med.miami.edu	Anandakrishnan, Nanditha/AAI-7298-2021; Chauhan, Kinsuk/P-9985-2019	Anandakrishnan, Nanditha/0000-0003-2452-2527; Chauhan, Kinsuk/0000-0002-1198-3562; Li, Hong/0000-0001-5731-5335; Salem, Fadi/0000-0002-2603-2778	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK103022, DK122807, R01DK112258, U01DK10692, R01DK115562, R01DK103022]; HHS | CDC | National Institute for Occupational Safety and Health (NIOSH) [U01OH011326]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01HL85757]; Department of the Army [PR191906P1]; South Florida Veterans Affairs Foundation For Research and Education (SFVAFRE); NIH [NS046593, 1S10OD025047-01]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | CDC | National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Department of the Army; South Florida Veterans Affairs Foundation For Research and Education (SFVAFRE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK103022, DK122807, R01DK112258, U01DK10692, R01DK115562 and R01DK103022; HHS | CDC | National Institute for Occupational Safety and Health (NIOSH), Grant/Award Number: U01OH011326; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL85757; Department of the Army, Grant/Award Number: PR191906P1; South Florida Veterans Affairs Foundation For Research and Education (SFVAFRE); NIH, Grant/Award Number: NS046593 and 1S10OD025047-01	Andersen H, 2015, NEPHROL DIAL TRANSPL, V30, P781, DOI 10.1093/ndt/gfu402; Artunc F, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13249; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; Bello AK, 2011, CLIN J AM SOC NEPHRO, V6, P1418, DOI 10.2215/CJN.09741110; Buhl KB, 2014, J HYPERTENS, V32, P1672, DOI 10.1097/HJH.0000000000000216; Buhl KB, 2012, HYPERTENSION, V60, P1346, DOI 10.1161/HYPERTENSIONAHA.112.198879; Calizo RC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09936-x; Chen JL, 2019, AM J NEPHROL, V50, P92, DOI 10.1159/000501059; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Culleton BF, 2000, AM J MED, V109, P1, DOI 10.1016/S0002-9343(00)00444-7; Currie G, 2014, INT J NEPHROL RENOV, V7, P13, DOI 10.2147/IJNRD.S40522; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Fakhruddin S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8379327; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Fukuda A, 2010, NEPHROLOGY, V15, P321, DOI 10.1111/j.1440-1797.2009.01256.x; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Ge XH, 2020, J AM SOC NEPHROL, V31, P2372, DOI 10.1681/ASN.2019121261; Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; He Chaosheng, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P1654; Hinrichs GR, 2018, AM J PHYSIOL-RENAL, V315, pF151, DOI 10.1152/ajprenal.00545.2017; Inoue T, 2006, HYPERTENS RES, V29, P687, DOI 10.1291/hypres.29.687; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kakizoe Y, 2009, J HYPERTENS, V27, P1679, DOI 10.1097/HJH.0b013e32832c7d23; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kopp JB, 2012, J AM SOC NEPHROL, V23, P1273, DOI 10.1681/ASN.2012060618; Liu H, 2001, AM J PHYSIOL-RENAL, V280, pF88, DOI 10.1152/ajprenal.2001.280.1.F88; Mann JFE, 2004, KIDNEY INT, V66, pS59, DOI 10.1111/j.1523-1755.2004.09215.x; Marshall CB, 2006, KIDNEY INT, V70, P1962, DOI 10.1038/sj.ki.5001965; Matsusaka T, 2011, AM J PHYSIOL-RENAL, V300, pF792, DOI 10.1152/ajprenal.00570.2010; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehrotra R, 2017, J AM SOC NEPHROL, V28, P395, DOI 10.1681/ASN.2016070769; Meilhac O, 2003, FASEB J, V17, P1301, DOI 10.1096/fj.02-0687fje; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Min KJ, 2003, BIOCHEM BIOPH RES CO, V312, P969, DOI 10.1016/j.bbrc.2003.11.010; Morigi M, 2005, AM J PATHOL, V166, P1309, DOI 10.1016/S0002-9440(10)62350-4; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Muroya Y, 2016, CLIN EXP NEPHROL, V20, P862, DOI 10.1007/s10157-016-1253-0; Oxlund CS, 2014, J AM SOC HYPERTENS, V8, P872, DOI 10.1016/j.jash.2014.09.019; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Philippe A, 2008, J AM SOC NEPHROL, V19, P1871, DOI 10.1681/ASN.2008010059; Qin L, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1959-y; Raij L, 2016, AM J PHYSIOL-RENAL, V311, pF1308, DOI 10.1152/ajprenal.00162.2016; Ray EC, 2018, KIDNEY INT REP, V3, P1434, DOI 10.1016/j.ekir.2018.06.007; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Rincon J, 2004, INT J EXP PATHOL, V85, P25, DOI 10.1111/j.0959-9673.2004.0368.x; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schork A, 2016, CLIN J AM SOC NEPHRO, V11, P761, DOI 10.2215/CJN.12261115; Staehr M, 2015, AM J PHYSIOL-RENAL, V309, pF235, DOI 10.1152/ajprenal.00138.2015; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Svenningsen P, 2017, PFLUG ARCH EUR J PHY, V469, P1415, DOI 10.1007/s00424-017-2014-y; Svenningsen P, 2015, PFLUG ARCH EUR J PHY, V467, P531, DOI 10.1007/s00424-014-1661-5; Svenningsen P, 2012, CLIN EXP PHARMACOL P, V39, P117, DOI 10.1111/j.1440-1681.2011.05524.x; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Wickman L, 2013, J AM SOC NEPHROL, V24, P2081, DOI 10.1681/ASN.2013020173; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; Zandi-Nejad K, 2004, KIDNEY INT, V66, pS76, DOI 10.1111/j.1523-1755.2004.09220.x; Zhang B, 2012, NEPHROL DIAL TRANSPL, V27, P1746, DOI 10.1093/ndt/gfr612	67	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16191	16204		10.1096/fj.202000413R	http://dx.doi.org/10.1096/fj.202000413R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070369	Green Submitted, Green Accepted			2022-12-28	WOS:000581164200001
J	Wang, EM; Hu, TH; Huang, CC; Chang, YC; Yang, SM; Huang, ST; Wu, JC; Ma, YL; Chan, HH; Liu, LF; Lu, WB; Kung, ML; Wen, ZH; Wang, JC; Ko, CY; Tsai, WL; Chu, TH; Tai, MH				Wang, E-Ming; Hu, Tsung-Hui; Huang, Chao-Cheng; Chang, Yi-Chen; Yang, Shih-Ming; Huang, Shih-Tsung; Wu, Jian-Ching; Ma, Yi-Ling; Chan, Hoi-Hung; Liu, Li-Feng; Lu, Wen-Bin; Kung, Mei-Lang; Wen, Zhi-Hong; Wang, Jui-Chu; Ko, Chou-Yuan; Tsai, Wei-Lun; Chu, Tian-Huei; Tai, Ming-Hong			Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis	FASEB JOURNAL			English	Article						acute hepatitis; concanavalin A; hepatoma-derived growth factor; neutrophils	NECROSIS-FACTOR-ALPHA; NEUTROPHIL MIGRATION; FACTOR HDGF; TNF-ALPHA; LIVER; INFLAMMATION; CELLS; HEPATOCYTES; EXPRESSION; AUTOPHAGY	Hepatitis is an important health problem worldwide. Novel molecular targets are in demand for detection and management of hepatitis. Hepatoma-derived growth factor (HDGF) has been delineated to participate in hepatic fibrosis and liver carcinogenesis. However, the relationship between hepatitis and HDGF remains unclear. This study aimed to elucidate the role of HDGF during hepatitis using concanavalin A (ConA)-induced hepatitis model. In cultured hepatocytes, ConA treatment-elicited HDGF upregulation at transcriptional level and promoted HDGF secretion while reducing intracellular HDGF protein level and cellular viability. Similarly, mice receiving ConA administration exhibited reduced hepatic HDGF expression and elevated circulating HDGF level, which was positively correlated with serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. By using HDGF knockout (KO) mice, it was found the ConA-evoked cell death was prominently alleviated in KO compared with control. Besides, it was delineated HDGF ablation conferred protection by suppressing the ConA-induced neutrophils recruitment in livers. Above all, the ConA-mediated activation of tumor necrosis factor-alpha (TNF-alpha)/interleukin-1 beta (IL-1 beta)/interleukin-6 (IL-6)/cyclooxygenase-2 (COX-2) inflammatory signaling was significantly abrogated in KO mice. Treatment with recombinant HDGF (rHDGF) dose-dependently stimulated the expression of TNF-alpha/IL-1 beta/IL-6/COX-2 in hepatocytes, further supporting the pro-inflammatory function of HDGF. Finally, application of HDGF antibody not only attenuated the ConA-mediated inflammatory cascade in hepatocytes, but also ameliorated the ConA-induced hepatic necrosis and AST elevation in mice. In summary, HDGF participates in ConA-induced hepatitis via neutrophils recruitment and may constitute a therapeutic target for acute hepatitis.	[Wang, E-Ming; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Wang, E-Ming; Tsai, Wei-Lun] Kaohsiung Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Kaohsiung, Taiwan; [Hu, Tsung-Hui] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol,Dept Internal Med, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Wu, Jian-Ching; Chu, Tian-Huei] Kaohsiung Chang Gung Mem Hosp, Biobank & Tissue Bank, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Wu, Jian-Ching; Wang, Jui-Chu] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Wu, Jian-Ching; Wang, Jui-Chu] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chang, Yi-Chen; Huang, Shih-Tsung; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Chang, Yi-Chen; Huang, Shih-Tsung; Tai, Ming-Hong] Acad Sinica, Kaohsiung, Taiwan; [Yang, Shih-Ming; Lu, Wen-Bin; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan; [Huang, Shih-Tsung] LabTurbo Biotech Corp, Taipei, Taiwan; [Ma, Yi-Ling] Kaohsiung Vet Gen Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chan, Hoi-Hung] Conde S Januario Hosp, Dept Med, Div Gastroenterol, Macau, Peoples R China; [Liu, Li-Feng] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Kung, Mei-Lang] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Ko, Chou-Yuan] Kaohsiung Armed Forces Gen Hosp, Dept Gastroenterol, Kaohsiung, Taiwan; [Chu, Tian-Huei] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, 123 Ta Pei Rd, Kaohsiung 83301, Taiwan; [Tai, Ming-Hong] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung, Taiwan; [Tai, Ming-Hong] Kaohsiung Med Univ, Regenerat Med & Cell Therapy Res Ctr, Kaohsiung, Taiwan	National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Academia Sinica - Taiwan; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; I Shou University; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; Chang Gung Memorial Hospital; National Sun Yat Sen University; Kaohsiung Medical University	Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan.; Chu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med Res, 123 Ta Pei Rd, Kaohsiung 83301, Taiwan.	skbboyz0817@gmail.com; minghongtai@gmail.com		Chu, Tian-Huei/0000-0003-1197-5754	Ministry of Science and Technology, Taiwan [MOST108-2314-B-110-003-MY2]; Kaohsiung Veterans General Hospital, Taiwan [VGHKS100-025, VGHKS109-004]; Chang Gung Medical Foundation [CMRPG8D0642, CMRPG8G0031, CLRPG8I0032]; Kaohsiung Armed Forces General Hospital [108-36, 109-07]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital, Taiwan; Chang Gung Medical Foundation; Kaohsiung Armed Forces General Hospital	This work was supported by grants from Ministry of Science and Technology, Taiwan (MOST108-2314-B-110-003-MY2), Kaohsiung Veterans General Hospital, Taiwan (VGHKS100-025, VGHKS109-004), Chang Gung Medical Foundation (CMRPG8D0642, CMRPG8G0031, CLRPG8I0032), and Kaohsiung Armed Forces General Hospital (108-36,109-07). The authors thank Dr Sebastian Franken (Institute of Physiological Chemistry, University of Bonn, Bonn, Germany) for sharing HDGF KO mice. We thank the Biobank and Tissue Bank, Kaohsiung Chang Gung Memorial Hospital for technical support.	Bandala-Sanchez E, 2018, P NATL ACAD SCI USA, V115, P7783, DOI 10.1073/pnas.1722056115; Barbier L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02014; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Callejas NA, 2000, GASTROENTEROLOGY, V119, P493, DOI 10.1053/gast.2000.9374; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Chen SC, 2015, ONCOTARGET, V6, P16253, DOI 10.18632/oncotarget.3608; Chu TH, 2019, ONCOGENE, V38, P6461, DOI 10.1038/s41388-019-0886-3; Chu TH, 2018, CANCER MED-US, V7, P2567, DOI 10.1002/cam4.1487; Chu TH, 2014, ONCOTARGET, V5, P1475, DOI 10.18632/oncotarget.1745; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Crossin KL, 1997, P NATL ACAD SCI USA, V94, P2687, DOI 10.1073/pnas.94.6.2687; Desjarlais M, 2014, GENE REGUL SYST BIO, V8, P63, DOI 10.4137/GRSB.S13946; DOYLE MV, 1985, BIOCHEM BIOPH RES CO, V130, P768, DOI 10.1016/0006-291X(85)90482-6; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Gallitzendoerfer R, 2008, DEV DYNAM, V237, P1875, DOI 10.1002/dvdy.21589; Giri K, 2016, APOPTOSIS, V21, P329, DOI 10.1007/s10495-015-1200-7; Heneghan MA, 2002, HEPATOLOGY, V35, P7, DOI 10.1053/jhep.2002.30991; Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841; Hsu SS, 2012, J NEURO-ONCOL, V107, P101, DOI 10.1007/s11060-011-0733-z; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Luan JY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00758; Malchow S, 2011, BBA-MOL BASIS DIS, V1812, P290, DOI 10.1016/j.bbadis.2010.11.009; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; NAKAMURA H, 1989, CLIN CHIM ACTA, V183, P273, DOI 10.1016/0009-8981(89)90361-6; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Ray A, 2015, J IMMUNOL, V195, P3071, DOI 10.4049/jimmunol.1500153; Shetty A., 2016, UROL ONCOL, V34, P483; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; SMART SJ, 1994, AM J PHYSIOL, V266, pL238, DOI 10.1152/ajplung.1994.266.3.L238; Sun AM, 2015, CYTOKINE, V72, P31, DOI 10.1016/j.cyto.2014.12.001; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Takano M, 2012, J PERIODONTAL RES, V47, P89, DOI 10.1111/j.1600-0765.2011.01408.x; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Wang CF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/189785; Wei YP, 2020, HEPATOLOGY, V71, P130, DOI 10.1002/hep.30795; Yoon JH, 2011, J PROTEOME RES, V10, P5315, DOI 10.1021/pr200573b; Zhang GR, 2017, TOHOKU J EXP MED, V242, P101, DOI 10.1620/tjem.242.101; Zheng CH, 2018, CELL MOL IMMUNOL, V15, P260, DOI 10.1038/cmi.2016.57; Zhou RR, 2012, EXP MOL PATHOL, V93, P213, DOI 10.1016/j.yexmp.2012.05.006	45	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16163	16178		10.1096/fj.202000511RR	http://dx.doi.org/10.1096/fj.202000511RR		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33063394				2022-12-28	WOS:000581422500001
J	Bai, L; Chang, HM; Zhang, L; Zhu, YM; Leung, PCK				Bai, Long; Chang, Hsun-Ming; Zhang, Liang; Zhu, Yi-Min; Leung, Peter C. K.			BMP2 increases the production of BDNF through the upregulation of proBDNF and furin expression in human granulosa-lutein cells	FASEB JOURNAL			English	Article						ALK; BMP2; BDNF; human granulosa cells; furin; oocyte maturation	BONE MORPHOGENETIC PROTEIN-2; HUMAN OOCYTE MATURATION; EPIDERMAL-GROWTH-FACTOR; NEUROTROPHIC FACTOR; FOLLICULAR-FLUID; GENE-EXPRESSION; RECEPTOR; OVARY; FERTILIZATION; MECHANISMS	Locally produced in human granulosa cells of the developing follicle, bone morphogenetic protein 2 (BMP2) plays a crucial role in the regulation of ovarian folliculogenesis and luteal formation. Brain-derived neurotrophic factor (BDNF) is an intraovarian neurotrophic factor that has been shown to promote oocyte maturation and subsequent fertilization competency. At present, little is known regarding the intracellular regulation, assembly and secretion of endogenous BDNF in human granulosa cells. The aim of this study was to explore the effect of BMP2 on the expression and production of BDNF in human granulosa cells and the molecular mechanisms underlying this effect. An immortalized human granulosa cell line (SVOG) and primary human granulosa-lutein (hGL) cells were utilized as in vitro study models. Our results showed that BMP2 significantly increased the mRNA and secreted levels of BDNF. Additionally, BMP2 upregulated the expression of furin at the transcriptional and translational levels. Knockdown of endogenous furin partially attenuated the BMP2-induced increase in BDNF production, indicating that furin is involved in the maturation process of BDNF. Using pharmacological (kinase receptor inhibitors) and siRNA-mediated inhibition approaches, we demonstrated that BMP2-induced upregulation of BDNF and furin expression is most likely mediated by the activin receptor-like kinase (ALK)2/ALK3-SMAD4 signaling pathway. Notably, analysis using clinical samples revealed that there was a positive correlation between follicular fluid concentrations of BMP2 and those of BDNF. These results indicate that BMP2 increases the production of mature BDNF by upregulating the precursor BDNF and promoting the proteolytic processing of mature BDNF. Finally, we also investigated the effects of BMP2 on ovarian steroidogenesis and the results showed that BMP2 treatment significantly increased the accumulated level of estradiol (by upregulating the expression of FSH receptor and cytochrome P450 aromatase), whereas it decreased the accumulated level of progesterone (by downregulating the expression of LH receptors and steroidogenic acute regulatory protein) in primary hGL cells. Our findings provide a novel paracrine mechanism underlying the regulation of an intraovarian growth factor in human granulosa cells.	[Bai, Long; Zhu, Yi-Min; Leung, Peter C. K.] Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou 310006, Zhejiang, Peoples R China; [Bai, Long; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Zhang, Liang] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Peoples R China	Zhejiang University; University of British Columbia; Zhejiang Academy of Agricultural Sciences	Zhu, YM; Leung, PCK (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou 310006, Zhejiang, Peoples R China.; Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	zhuyim@zju.edu.cn; peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	National Key Research and Development Program of China [2018YFC1003201]; Natural Science Foundation of Zhejiang province, China [LQ20C17000]; CIHR Foundation [143317]	National Key Research and Development Program of China; Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province); CIHR Foundation(Canadian Institutes of Health Research (CIHR))	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1003201; Natural Science Foundation of Zhejiang province, China, Grant/Award Number: LQ20C17000; CIHR Foundation, Grant/Award Number: 143317	Anderson RA, 2010, FERTIL STERIL, V93, P1394, DOI 10.1016/j.fertnstert.2009.04.007; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bai L, 2019, CELL SIGNAL, V53, P201, DOI 10.1016/j.cellsig.2018.10.009; Bai L, 2017, ENDOCRINOLOGY, V158, P3501, DOI 10.1210/en.2017-00436; Bai L, 2017, CELL SIGNAL, V37, P52, DOI 10.1016/j.cellsig.2017.05.017; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Chakraborty P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12664; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chang HM, 2019, HUM REPROD UPDATE, V25, P224, DOI 10.1093/humupd/dmy047; Chang HM, 2017, HUM REPROD UPDATE, V23, P1, DOI 10.1093/humupd/dmw039; Chang HM, 2016, MOL CELL ENDOCRINOL, V422, P9, DOI 10.1016/j.mce.2015.11.009; Chang HM, 2015, J CLIN ENDOCR METAB, V100, pE375, DOI 10.1210/jc.2014-3026; Chang HM, 2014, J CLIN ENDOCR METAB, V99, pE1922, DOI 10.1210/jc.2014-1223; Chen Y, 2015, J NEUROSCI RES, V93, P189, DOI 10.1002/jnr.23455; DISSEN GA, 1995, ENDOCRINOLOGY, V136, P4681, DOI 10.1210/en.136.10.4681; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Gratacos E, 2001, J NEUROCHEM, V79, P747, DOI 10.1046/j.1471-4159.2001.00570.x; Harel S, 2006, MOL HUM REPROD, V12, P357, DOI 10.1093/molehr/gal033; Haugen MJ, 2010, REPRODUCTION, V140, P551, DOI 10.1530/REP-10-0211; Hsieh M, 2009, SEMIN REPROD MED, V27, P52, DOI 10.1055/s-0028-1108010; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kelty BP, 2010, BIOL REPROD, V83, P147, DOI 10.1095/biolreprod.109.079947; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Meng TG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.231; Messinis IE, 2010, ANN NY ACAD SCI, V1205, P5, DOI 10.1111/j.1749-6632.2010.05660.x; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nio-Kobayashi J, 2015, ENDOCRINOLOGY, V156, P1494, DOI 10.1210/en.2014-1704; Paredes A, 2004, DEV BIOL, V267, P430, DOI 10.1016/j.ydbio.2003.12.001; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Rossi RODS, 2016, HISTOL HISTOPATHOL, V31, P339, DOI 10.14670/HH-11-674; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Seifer DB, 2006, AM J OBSTET GYNECOL, V194, P1129, DOI 10.1016/j.ajog.2005.12.022; Seifer DB, 2003, FERTIL STERIL, V79, P451, DOI 10.1016/S0015-0282(02)04669-1; Selvaraju S, 2013, DOMEST ANIM ENDOCRIN, V44, P115, DOI 10.1016/j.domaniend.2012.10.002; Shi J, 2011, AM J REPROD IMMUNOL, V65, P421, DOI 10.1111/j.1600-0897.2010.00917.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; Streiter S, 2016, MOL HUM REPROD, V22, P3, DOI 10.1093/molehr/gav057; Sugiyama R, 2010, HUM CELL, V23, P83, DOI 10.1111/j.1749-0774.2010.00088.x; Takahashi C, 2008, FERTIL STERIL, V89, P586, DOI 10.1016/j.fertnstert.2007.03.080; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; Wang X, 2011, J ASSIST REPROD GEN, V28, P1053, DOI 10.1007/s10815-011-9635-4; Wu YT, 2017, MOL HUM REPROD, V23, P155, DOI 10.1093/molehr/gaw078; Yin JW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010185; Yu Y, 2012, HUM REPROD, V27, P2146, DOI 10.1093/humrep/des099; Zhang XY, 2019, CELL SIGNAL, V55, P109, DOI 10.1016/j.cellsig.2019.01.002; Zhao HJ, 2018, ENDOCRINOLOGY, V159, P2815, DOI 10.1210/en.2018-00301; Zhao P, 2011, HUM REPROD, V26, P695, DOI 10.1093/humrep/deq390	55	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16129	16143		10.1096/fj.202000940R	http://dx.doi.org/10.1096/fj.202000940R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047388				2022-12-28	WOS:000581169300001
J	Buchheim, JI; Ghislin, S; Ouzren, N; Albuisson, E; Vanet, A; Matzel, S; Ponomarev, S; Rykova, M; Chouker, A; Frippiat, JP				Buchheim, Judith-Irina; Ghislin, Stephanie; Ouzren, Nassima; Albuisson, Eliane; Vanet, Anne; Matzel, Sandra; Ponomarev, Sergey; Rykova, Marina; Chouker, Alexander; Frippiat, Jean-Pol			Plasticity of the human IgM repertoire in response to long-term spaceflight	FASEB JOURNAL			English	Article						antibody; cosmonaut; spaceflight; stress; V(D)J recombination	LATENT VIRUSES; STRESS; REACTIVATION; COSMONAUTS; IMMUNITY	Immune dysregulation is among the main adverse outcomes of spaceflight. Despite the crucial role of the antibody repertoire in host protection, the effects of spaceflight on the human antibody repertoire are unknown. Consequently, using high-throughput sequencing, we examined the IgM repertoire of five cosmonauts 25 days before launch, after 64 +/- 11 and 129 +/- 20 days spent on the International Space Station (ISS), and at 1, 7, and 30 days after landing. This is the first study of this kind in humans. Our data revealed that the IgM repertoire of the cosmonauts was different from that of control subjects (n = 4) prior to launch and that two out the five analyzed cosmonauts presented significant changes in their IgM repertoire during the mission. These modifications persisted up to 30 days after landing, likely affected the specificities of IgM binding sites, correlated with changes in the V(D)J recombination process responsible for creating antibody genes, and coincided with a higher stress response. These data confirm that the immune system of approximately half of the astronauts who spent 6 months on the ISS is sensitive to spaceflight conditions, and reveal individual responses indicating that personalized approaches should be implemented during future deep-space exploration missions that will be of unprecedented durations.	[Buchheim, Judith-Irina; Matzel, Sandra; Chouker, Alexander] Hosp Ludwig Maximilians Univ, Dept Anesthesiol, Lab Translat Res Stress & Immun, Munich, Germany; [Ghislin, Stephanie; Ouzren, Nassima; Frippiat, Jean-Pol] Lorraine Univ, Fac Med, Stress Immun Pathogens Lab, EA 7300, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France; [Albuisson, Eliane] Nancy Univ Hosp, Data Management & Stat UMDS, Methodol Unit, DRCI,MPI Dept, Vandoeuvre Les Nancy, France; [Vanet, Anne] Univ Paris, Paris, France; [Vanet, Anne] CNRS, Jacques Monod Inst, Genoinformat Ctr, UMR7592, Paris, France; [Ponomarev, Sergey; Rykova, Marina] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia	University of Munich; Universite de Lorraine; CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Frippiat, JP (corresponding author), Lorraine Univ, Fac Med, Stress Immun Pathogens Lab, EA 7300, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	jean-pol.frippiat@univ-lorraine.fr	Ponomarev, Sergey/AAB-2794-2020	Ponomarev, Sergey/0000-0002-5364-7815; Vanet, Anne/0000-0002-6018-3158	Centre National d'Etudes Spatiales (CNES) [DAR 4800000894, 4800000950, 4800001008]; French Ministry of Higher Education and Research; Universite de Lorraine (UL); French State-Region Project; Deutsches Zentrum fur Luft- und Raumfahrt (DLR) [BMWi 50WB0719, 50WB0919, 50WB1319]; European Space Agency (ESA) [ELIPS 3, ELIPS 4]; Roscosmos; IBMP	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); French Ministry of Higher Education and Research; Universite de Lorraine (UL); French State-Region Project; Deutsches Zentrum fur Luft- und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Space Agency (ESA)(European Space AgencyEuropean Commission); Roscosmos; IBMP	Centre National d'Etudes Spatiales (CNES), Grant/Award Number: DAR 4800000894, 4800000950 and 4800001008; French Ministry of Higher Education and Research; Universite de Lorraine (UL); French State-Region Project Contract; Deutsches Zentrum fur Luft- und Raumfahrt (DLR), Grant/Award Number: BMWi 50WB0719, 50WB0919 and 50WB1319; European Space Agency (ESA), Grant/Award Number: ELIPS 3 and 4 programs; Roscosmos; IBMP, Grant/Award Number: theme 65.1	Agha NH, 2020, J APPL PHYSIOL, V128, P264, DOI 10.1152/japplphysiol.00560.2019; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Buchheim JI, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00085; Campbell JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00648; Chouker A, 2001, J APPL PHYSIOL, V90, P1736, DOI 10.1152/jappl.2001.90.5.1736; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; Crucian BE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01437; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Fonte C, 2019, FASEB J, V33, P896, DOI 10.1096/fj.201800969R; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Globus RK, 2016, J APPL PHYSIOL, V120, P1196, DOI 10.1152/japplphysiol.00997.2015; Gueguinou N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071579; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hong BB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00128; Horie K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44067-9; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kimzey SL, 1977, BIOMEDICAL RESULTS S, P248; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Lange MD, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00345; Ledo A, 2020, BRAIN BEHAV IMMUN, V83, P135, DOI 10.1016/j.bbi.2019.09.024; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Liu LY, 2003, IMMUNOGENETICS, V55, P336, DOI 10.1007/s00251-003-0583-8; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mackworth-Young CG, 2003, CLIN EXP IMMUNOL, V134, P420, DOI 10.1111/j.1365-2249.2003.02319.x; Maki KA, 2020, PHYSIOL GENOMICS, V52, P280, DOI 10.1152/physiolgenomics.00039.2020; Martin V, 2015, ANN NY ACAD SCI, V1362, P153, DOI 10.1111/nyas.12823; Mehta SK, 2014, BRAIN BEHAV IMMUN, V41, P210, DOI 10.1016/j.bbi.2014.05.014; Mehta SK, 2013, CYTOKINE, V61, P205, DOI 10.1016/j.cyto.2012.09.019; Mehta SK, 2007, MICROGRAVITY SCI TEC, V19, P215, DOI 10.1007/BF02919485; Mehta SK, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0015-y; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Novoselova EG, 2015, IMMUNOBIOLOGY, V220, P500, DOI 10.1016/j.imbio.2014.10.021; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rettig TA, 2019, LIFE SCI SPACE RES, V22, P16, DOI 10.1016/j.lssr.2019.06.001; Rettig TA, 2019, FASEB BIOADV, V1, P6, DOI 10.1096/fba.1017; Rettig TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210284; Rettig TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190982; Rettig Trisha A, 2017, Gravit Space Res, V5, P2; Rooney BV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00016; Rykova MP, 2008, ACTA ASTRONAUT, V63, P697, DOI 10.1016/j.actaastro.2008.03.016; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Shearer WT, 2009, J ALLERGY CLIN IMMUN, V123, P900, DOI 10.1016/j.jaci.2008.12.016; Spielmann G, 2019, J APPL PHYSIOL, V126, P469, DOI 10.1152/japplphysiol.00789.2018; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Tascher G, 2019, FASEB J, V33, P3772, DOI 10.1096/fj.201801463R; van Dijk-Hard I, 2002, IMMUNOLOGY, V107, P136, DOI 10.1046/j.1365-2567.2002.01466.x; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Ward C, 2018, LIFE SCI SPACE RES, V16, P63, DOI 10.1016/j.lssr.2017.11.003; Wu GC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13838; Zhang ZX, 2004, IMMUNOL REV, V197, P231, DOI 10.1111/j.0105-2896.2004.0107.x	59	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16144	16162		10.1096/fj.202001403RR	http://dx.doi.org/10.1096/fj.202001403RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047384	Green Submitted			2022-12-28	WOS:000581171300001
J	Brothers, RM; Stephens, BY; Akins, JD; Fadel, PJ				Brothers, R. Matthew; Stephens, Brandi Y.; Akins, John D.; Fadel, Paul J.			Influence of sex on heightened vasoconstrictor mechanisms in the non-Hispanic black population	FASEB JOURNAL			English	Article						cardiovascular disease; hypertension; non-Hispanic black women; vasoconstriction; vascular function	CUTANEOUS MICROVASCULAR FUNCTION; CEREBRAL VASODILATORY CAPACITY; CREATINE-KINASE ACTIVITY; NITRIC-OXIDE SYNTHASE; HIGH BLOOD-PRESSURE; RACIAL-DIFFERENCES; AFRICAN-AMERICANS; ENDOTHELIAL DYSFUNCTION; ETHNIC-DIFFERENCES; GENDER-DIFFERENCES	Cardiovascular disease (CVD) affects individuals of all races and ethnicities; however, its prevalence is highest in non-Hispanic black individuals (BL) relative to other populations. While previous research has provided valuable insight into elevated CVD risk in the BL population, this work has been almost exclusively conducted in men. This is alarming given that BL women suffer from CVD at an equivalent rate to BL men and each has a greater prevalence when compared to all other ethnicities, regardless of sex. The importance of investigating sex differences in mechanisms of cardiovascular function is highlighted by the National Institute of Health requiring sex to be considered as a biological variable in research studies to better our "understanding of key sex influences on health processes and outcomes." The mechanism(s) responsible for the elevated CVD risk in BL women remains unclear and is likely multifactorial. Limited studies in BL women suggest that, while impaired vasodilator capacity is involved, heightened vasoconstrictor tone and/or responsiveness may also contribute. Within this mini-review, we will discuss potential mechanisms of elevated rates of hypertension and other CVDs in BL individuals with a particular focus on young, otherwise healthy, college-aged women. To stimulate academic thought and future research, we will also discuss potential mechanisms for impaired vascular function in BL women, as well as possible divergent mechanisms between BL men and women based on either preliminary data or plausible speculation extending from findings in the existing literature. Last, we will conclude with potential future research directions aimed at better understanding the elevated risk for hypertension and CVD in BL women.	[Brothers, R. Matthew; Stephens, Brandi Y.; Akins, John D.; Fadel, Paul J.] Univ Texas Arlington, Dept Kinesiol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Brothers, RM (corresponding author), Univ Texas Arlington, Dept Kinesiol, Coll Nursing & Hlth Innovat, 500 W Nedderman,MAC 147, Arlington, TX 76019 USA.	matthew.brothers@uta.edu	Akins, John/GVN-2915-2022	Stephens, Brandi/0000-0002-1624-8778; Fadel, Paul/0000-0002-0115-0743	College of Nursing and Health Innovation at University of Texas at Arlington	College of Nursing and Health Innovation at University of Texas at Arlington	The College of Nursing and Health Innovation at University of Texas at Arlington, Grant/Award Number: Start-up funds	Abate NI, 2001, HYPERTENSION, V38, P379, DOI 10.1161/01.HYP.38.3.379; Adefurin A, 2013, HYPERTENSION, V61, P915, DOI 10.1161/HYPERTENSIONAHA.111.00854; Alonso D, 2003, HEART FAIL REV, V8, P107, DOI 10.1023/A:1022155206928; Apple FS, 2003, CLIN CHEM, V49, P1331, DOI 10.1373/49.8.1331; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Barbosa TC, 2018, AM J PHYSIOL-HEART C, V315, pH1316, DOI 10.1152/ajpheart.00387.2018; Barrett-O'Keefe Z, 2013, CLIN SCI, V124, P413, DOI 10.1042/CS20120424; Bourque SL, 2011, AM J PHYSIOL-REG I, V300, pR1288, DOI 10.1152/ajpregu.00397.2010; Brewster LM, 2010, AM J PHYSIOL-HEART C, V299, pH431, DOI 10.1152/ajpheart.00919.2009; Brewster LM, 2006, CIRCULATION, V114, P2034, DOI 10.1161/CIRCULATIONAHA.105.584490; Brewster LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032471; Brothers RM, 2019, AM J PHYSIOL-HEART C, V317, pH777, DOI 10.1152/ajpheart.00126.2019; Brownlow BN, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1098-9; CALHOUN DA, 1993, HYPERTENSION, V22, P801, DOI 10.1161/01.HYP.22.6.801; CALHOUN DA, 1992, AM J MED SCI, V304, P306, DOI 10.1097/00000441-199211000-00008; CALHOUN DA, 1994, J HYPERTENS, V12, P1291; Campia U, 2004, CIRCULATION, V109, P3191, DOI 10.1161/01.CIR.0000130590.24107.D3; Campia U, 2002, J AM COLL CARDIOL, V40, P754, DOI 10.1016/S0735-1097(02)02015-6; Candler WH, 1997, MIL MED, V162, P788, DOI 10.1093/milmed/162.12.788; Cardillo C, 1998, HYPERTENSION, V31, P1235, DOI 10.1161/01.HYP.31.6.1235; Cardillo C, 1999, CIRCULATION, V99, P90, DOI 10.1161/01.CIR.99.1.90; Chen DA, 2009, HYPERTENS RES, V32, P559, DOI 10.1038/hr.2009.59; Choi S, 2014, KIDNEY RES CLIN PRAC, V33, P19, DOI 10.1016/j.krcp.2013.12.001; Christmas KM, 2018, MICROVASC RES, V115, P52, DOI 10.1016/j.mvr.2017.08.005; Clark R, 1999, AM PSYCHOL, V54, P805, DOI 10.1037/0003-066X.54.10.805; Couto GK, 2014, EXP PHYSIOL, V99, P1427, DOI 10.1113/expphysiol.2014.079236; D'Angelo G, 2006, AM J PHYSIOL-HEART C, V290, pH1251, DOI 10.1152/ajpheart.00203.2005; Davern PJ, 2009, HYPERTENSION, V54, P1262, DOI 10.1161/HYPERTENSIONAHA.109.139741; Dawes M, 1997, CIRCULATION, V95, P2293, DOI 10.1161/01.CIR.95.9.2293; De Matteo R, 2006, AM J HYPERTENS, V19, P396, DOI 10.1016/j.amjhyper.2005.09.024; Deo SH, 2015, AM J PHYSIOL-HEART C, V308, pH548, DOI 10.1152/ajpheart.00784.2014; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Dow CA, 2017, EXP PHYSIOL, V102, P1133, DOI 10.1113/EP086454; Drew RC, 2020, AM J PHYSIOL-REG I, V318, pR234, DOI 10.1152/ajpregu.00091.2019; du Plooy CS, 2015, J AMINO ACIDS, V2015, P481517; DuPont JJ, 2011, J APPL PHYSIOL, V111, P1561, DOI 10.1152/japplphysiol.00419.2011; Ergul A, 1999, J CARDIOVASC PHARM, V34, P327, DOI 10.1097/00005344-199909000-00002; Ergul A, 1998, J PHARMACOL EXP THER, V285, P511; Ergul S, 1996, HYPERTENSION, V28, P652, DOI 10.1161/01.HYP.28.4.652; Evans RR, 1996, AM J CARDIOL, V78, P486, DOI 10.1016/S0002-9149(96)00344-X; Feairheller DL, 2011, CTS-CLIN TRANSL SCI, V4, P32, DOI 10.1111/j.1752-8062.2011.00264.x; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Fisher JP, 2009, AUTON NEUROSCI-BASIC, V148, P5, DOI 10.1016/j.autneu.2009.02.003; Fonkoue IT, 2017, J APPL PHYSL 1985; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Freedman RR, 2000, HYPERTENSION, V35, P795, DOI 10.1161/01.HYP.35.3.795; FREEDMAN RR, 1987, CIRC RES, V61, P581, DOI 10.1161/01.RES.61.4.581; Frierson GM, 2013, ETHNIC DIS, V23, P35; Gupta AK, 2010, AM J HYPERTENS, V23, P1023, DOI 10.1038/ajh.2010.105; Harshfield GA, 2002, AM J HYPERTENS, V15, P903, DOI 10.1016/S0895-7061(02)02994-1; Hart EC, 2012, J PHYSIOL-LONDON, V590, P2069, DOI 10.1113/jphysiol.2011.224642; HAYNES WG, 1995, CLIN SCI, V88, P509, DOI 10.1042/cs0880509; Heffernan KS, 2008, AM J PHYSIOL-HEART C, V295, pH2380, DOI 10.1152/ajpheart.00902.2008; Hinds K, 2010, HYPERTENSION, V56, P75, DOI 10.1161/HYPERTENSIONAHA.110.150011; Holowatz LA, 2006, J PHYSIOL-LONDON, V574, P573, DOI 10.1113/jphysiol.2006.108993; Holowatz LA, 2011, J PHYSIOL-LONDON, V589, P4787, DOI 10.1113/jphysiol.2011.212100; Houghton JL, 2002, J AM COLL CARDIOL, V39, P1314, DOI 10.1016/S0735-1097(02)01781-3; Hurr C, 2018, EXP PHYSIOL, V103, P343, DOI 10.1113/EP086776; Hurr C, 2015, EXP PHYSIOL, V100, P1030, DOI 10.1113/EP085269; Hurr C, 2015, EXP PHYSIOL, V100, P35, DOI 10.1113/expphysiol.2014.082362; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Jain S, 2004, BIOL PSYCHOL, V65, P89, DOI 10.1016/S0301-0511(03)00111-X; Jarvis SS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00086; Jeong JH, 2019, J CLIN HYPERTENS, V21, P1191, DOI 10.1111/jch.13625; Johnsen SH, 2011, J HYPERTENS, V29, P36, DOI 10.1097/HJH.0b013e32834068e0; JOHNSON JA, 1995, J CARDIOVASC PHARM, V25, P90, DOI 10.1097/00005344-199501000-00015; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; Karamat FA, 2014, HYPERTENSION, V63, P68, DOI 10.1161/HYPERTENSIONAHA.113.01352; Kitada K, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/731970; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; Lackland DT, 2014, AM J MED SCI, V348, P135, DOI 10.1097/MAJ.0000000000000308; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; Macedo FN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00265; Marinos A, 2017, J AM HEART ASSOC, V6, DOI [10.1161/jaha.117.006971, 10.1161/JAHA.117.006971]; Mata-Greenwood E, 2008, REPROD SCI, V15, P9, DOI 10.1177/1933719107312160; MATURI MF, 1989, J CLIN INVEST, V83, P1217, DOI 10.1172/JCI114004; Mayorov DN, 2003, HYPERTENSION, V41, P1168, DOI 10.1161/01.HYP.0000064574.29317.45; Melikian N, 2007, HYPERTENSION, V49, P873, DOI 10.1161/01.HYP.0000258405.25330.80; Nishida Y, 1998, J HYPERTENS, V16, P1611, DOI 10.1097/00004872-199816110-00007; Nishiyama SK, 2017, J APPL PHYSIOL, V122, P354, DOI 10.1152/japplphysiol.00772.2016; Okada Y, 2016, HYPERTENSION, V67, P951, DOI 10.1161/HYPERTENSIONAHA.115.06700; Okada Y, 2012, HYPERTENSION, V60, P842, DOI 10.1161/HYPERTENSIONAHA.112.195313; Oudman I, 2013, J HYPERTENS, V31, P1025, DOI 10.1097/HJH.0b013e32835f5c29; Patik JC, 2018, AM J PHYSIOL-HEART C, V315, pH1063, DOI 10.1152/ajpheart.00142.2018; Perregaux D, 2000, HYPERTENSION, V36, P866, DOI 10.1161/01.HYP.36.5.866; Ray CA, 1985, J APPL PHYSIOL, V92, P2002; Schmieder RE, 1996, J HYPERTENS, V14, P1201, DOI 10.1097/00004872-199610000-00008; SEEDAT YK, 1989, J HYPERTENS, V7, P515, DOI 10.1097/00004872-198907000-00001; Sherwood A, 2017, J HYPERTENS, V35, P975, DOI 10.1097/HJH.0000000000001266; Stanhewicz AE, 2012, J APPL PHYSIOL, V112, P791, DOI 10.1152/japplphysiol.01257.2011; Stauffer BL, 2010, AM J PHYSIOL-REG I, V298, pR261, DOI 10.1152/ajpregu.00626.2009; Stein CM, 2000, HYPERTENSION, V36, P945, DOI 10.1161/01.HYP.36.6.945; Stephens DP, 2004, AM J PHYSIOL-HEART C, V287, pH1404, DOI 10.1152/ajpheart.00061.2004; Taherzadeh Z, 2016, AM J HYPERTENS, V29, P170, DOI 10.1093/ajh/hpv078; Tawakol A, 2019, J AM COLL CARDIOL, V73, P3243, DOI 10.1016/j.jacc.2019.04.042; Thomas KS, 2006, PSYCHOSOM MED, V68, P692, DOI 10.1097/01.psy.0000238214.80871.e6; Treiber FA, 2002, PSYCHOSOM MED, V64, P707, DOI 10.1097/01.PSY.0000021952.59258.1C; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Vranish JR, 2018, HYPERTENSION, V71, P192, DOI 10.1161/HYPERTENSIONAHA.117.10229; WATKINS LL, 1995, LIFE SCI, V57, P1411, DOI 10.1016/0024-3205(95)02103-P; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; YANG ZH, 1990, CIRCULATION, V82, P188, DOI 10.1161/01.CIR.82.1.188; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619	103	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14073	14082		10.1096/fj.202001405R	http://dx.doi.org/10.1096/fj.202001405R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32949436				2022-12-28	WOS:000572345300001
J	Abid, H; Ryan, ZC; Delmotte, P; Sieck, GC; Lanza, IAR				Abid, Hinnah; Ryan, Zachary C.; Delmotte, Philippe; Sieck, Gary C.; Lanza, Ian R.			Extramyocellular interleukin-6 influences skeletal muscle mitochondrial physiology through canonical JAK/STAT signaling pathways	FASEB JOURNAL			English	Article						interleukin-6; mitochondria; reactive oxygen species; skeletal muscle; STAT3	PERMEABILITY TRANSITION; MOLECULAR-PATTERNS; CYCLOSPORINE-A; STAT3; DYNAMICS; PROTEIN; ROS	Interleukin-6 (IL-6) is a pleiotropic cytokine that has been shown to be produced acutely by skeletal muscle in response to exercise, yet chronically elevated with obesity and aging. The mechanisms by which IL-6 influences skeletal muscle mitochondria acutely and chronically are unclear. To better understand the influence of extramyocellular IL-6 on skeletal muscle mitochondrial physiology, we treated differentiated myotubes with exogenous IL-6 to evaluate the dose- and duration-dependent effects of IL-6 on salient aspects of mitochondrial biology and the role of canonical IL-6 signaling in muscle cells. Acute exposure of myotubes to IL-6 increased the mitochondrial reactive oxygen species (mtROS) production and oxygen consumption rates (JO(2)) in a manner that was dependent on activation of the JAK/STAT pathway. Furthermore, STAT3 activation by IL-6 was partly attenuated by MitoQ, a mitochondrial-targeted antioxidant, suggesting that mtROS potentiates STAT3 signaling in skeletal muscle in response to IL-6 exposure. In concert with effects on mitochondrial physiology, acute IL-6 exposure induced several mitochondrial adaptations, consistent with the stress-induced mitochondrial hyperfusion. Exposure of myotubes to chronically elevated IL-6 further increased mtROS with eventual loss of respiratory capacity. These data provide new evidence supporting the interplay between cytokine signaling and mitochondrial physiology in skeletal muscle.	[Abid, Hinnah; Ryan, Zachary C.; Lanza, Ian R.] Mayo Clin, Coll Med, Div Endocrinol & Metab, 200 First St SW, Rochester, MN 55905 USA; [Delmotte, Philippe; Sieck, Gary C.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Lanza, IAR (corresponding author), Mayo Clin, Coll Med, Div Endocrinol & Metab, 200 First St SW, Rochester, MN 55905 USA.	lanza.ian@mayo.edu						Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Boudina S, 2012, ENDOCRINOLOGY, V153, P2677, DOI 10.1210/en.2011-2147; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Henriquez-Olguin C, 2015, BBA-MOL BASIS DIS, V1852, P1410, DOI 10.1016/j.bbadis.2015.03.012; Jackson MJ, 2011, J PHYSIOL-LONDON, V589, P2139, DOI 10.1113/jphysiol.2011.206623; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Kosmidou I, 2002, AM J RESP CELL MOL, V26, P587, DOI 10.1165/ajrcmb.26.5.4598; Lalia AZ, 2015, DIABETES CARE, V38, P1228, DOI 10.2337/dc14-3101; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Meier JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2588; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407; Nierobisz LS, 2011, COMP BIOCHEM PHYS B, V158, P125, DOI 10.1016/j.cbpb.2010.10.003; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Pedersen BK, 2001, J PHYSIOL-LONDON, V536, P329, DOI 10.1111/j.1469-7793.2001.0329c.xd; Sebastian D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003; Seto DN, 2015, J BIOL CHEM, V290, P19976, DOI 10.1074/jbc.M115.638411; Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Toth A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123583; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V207, P168, DOI 10.1006/bbrc.1995.1168; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wedell-Neergaard AS, 2019, CELL METAB, V29, P844, DOI 10.1016/j.cmet.2018.12.007; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; White JP, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-14; Wilkins HM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00508; Wueest S, 2014, AM J PHYSIOL-REG I, V306, pR861, DOI 10.1152/ajpregu.00533.2013; Yang R, 2016, INT J BIOL SCI, V12, P532, DOI 10.7150/ijbs.15153; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	47	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14458	14472		10.1096/fj.202000965RR	http://dx.doi.org/10.1096/fj.202000965RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32885495				2022-12-28	WOS:000566830200001
J	Engberink, AHOO; Huisman, J; Michel, S; Meijer, JH				Olde Engberink, Anneke H. O.; Huisman, Job; Michel, Stephan; Meijer, Johanna H.			Brief light exposure at dawn and dusk can encode day-length in the neuronal network of the mammalian circadian pacemaker	FASEB JOURNAL			English	Article						GABA; light pollution; plasticity; seasonal; suprachiasmatic nucleus	SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; GABA; CLOCK; RAT; ENTRAINMENT; RHYTHMS; HETEROGENEITY; MECHANISM; NIGHT	The central circadian pacemaker in mammals, the suprachiasmatic nucleus (SCN), is important for daily as well as seasonal rhythms. The SCN encodes seasonal changes in day length by adjusting phase distribution among oscillating neurons thereby shaping the output signal used for adaptation of physiology and behavior. It is well-established that brief light exposure at the beginning and end of the day, also referred to as "skeleton" light pulses, are sufficient to evoke the seasonal behavioral phenotype. However, the effect of skeleton light exposure on SCN network reorganization remains unknown. Therefore, we exposed mice to brief morning and evening light pulses that mark the time of dawn and dusk in a short winter- or a long summer day. Single-cell PER2::LUC recordings, electrophysiological recordings of SCN activity, and measurements of GABA response polarity revealed that skeleton light-regimes affected the SCN network to the same degree as full photoperiod. These results indicate the powerful, yet potentially harmful effects of even relatively short light exposures during the evening or night for nocturnal animals.	[Olde Engberink, Anneke H. O.; Huisman, Job; Michel, Stephan; Meijer, Johanna H.] Leiden Univ, Med Ctr, Dept Cellular & Chem Biol, Lab Neurophysiol, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Meijer, JH (corresponding author), Leiden Univ, Med Ctr, Dept Cellular & Chem Biol, Lab Neurophysiol, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	J.H.Meijer@lumc.nl	Michel, Stephan/ABC-4211-2021		Velux Stiftung [1029]; ERC [834513]	Velux Stiftung; ERC(European Research Council (ERC)European Commission)	We thank Gabriella Lundkvist for providing PER2::LUC knock-in mice and Mayke Tersteeg for her technical assistance and help with animal caretaking. We also thank Ruben Schalk and Tom de Boer for their help with the statistics. This study was supported by funding from Velux Stiftung (project grant 1029 to SM) and by funding from ERC (adv grant 834513 to JHM).	Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Buijink MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168954; Choi HJ, 2008, J NEUROSCI, V28, P5450, DOI 10.1523/JNEUROSCI.5750-07.2008; De Jeu M, 2002, J NEUROPHYSIOL, V87, P834, DOI 10.1152/jn.00241.2001; DeWoskin D, 2015, P NATL ACAD SCI USA, V112, pE3911, DOI 10.1073/pnas.1420753112; Dominoni DM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0015; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Evans JA, 2004, AM J PHYSIOL-REG I, V286, pR539, DOI 10.1152/ajpregu.00456.2003; Evans JA, 2013, NEURON, V80, P973, DOI 10.1016/j.neuron.2013.08.022; Falchi F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600377; Farajnia S, 2014, P NATL ACAD SCI USA, V111, P9627, DOI 10.1073/pnas.1319820111; Hastings MH, 2018, NAT REV NEUROSCI, V19, P453, DOI 10.1038/s41583-018-0026-z; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Irwin RP, 2009, EUR J NEUROSCI, V30, P1462, DOI 10.1111/j.1460-9568.2009.06944.x; Knop E, 2017, NATURE, V548, P206, DOI 10.1038/nature23288; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Michel S, 2013, EUR J NEUROSCI, V37, P964, DOI 10.1111/ejn.12109; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Mrugala M, 2000, AM J PHYSIOL-REG I, V278, pR987, DOI 10.1152/ajpregu.2000.278.4.R987; Myung J, 2015, P NATL ACAD SCI USA, V112, pE3920, DOI 10.1073/pnas.1421200112; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Niepoth N, 2018, J BIOL RHYTHM, V33, P52, DOI 10.1177/0748730417746458; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Quintero JE, 2003, J NEUROSCI, V23, P8070; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Refinetti R, 2004, PHYSIOL BEHAV, V82, P285, DOI 10.1016/j.physbeh.2004.03.015; Refinetti R, 2002, INTEGR PHYS BEH SCI, V37, P114, DOI 10.1007/BF02688824; Rohr KE, 2019, ELIFE, V8, DOI 10.7554/eLife.49578; ROSENWASSER AM, 1983, PHYSIOL BEHAV, V30, P353, DOI 10.1016/0031-9384(83)90138-5; Russart KLG, 2018, J EXP ZOOL PART A, V329, P401, DOI 10.1002/jez.2173; Sanders D, 2018, J EXP ZOOL PART A, V329, P394, DOI 10.1002/jez.2157; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; STEPHAN FK, 1983, PHYSIOL BEHAV, V30, P451, DOI 10.1016/0031-9384(83)90152-X; Sumova A, 2004, PHYSIOL RES, V53, pS167; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; VanderLeest HT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004976; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan L, 2008, EUR J NEUROSCI, V28, P2108, DOI 10.1111/j.1460-9568.2008.06493.x	43	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13685	13695		10.1096/fj.202001133RR	http://dx.doi.org/10.1096/fj.202001133RR		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32869393	hybrid			2022-12-28	WOS:000566831500001
J	He, BX; Wang, X; He, Y; Li, HH; Yang, YH; Shi, ZS; Liu, Q; Wu, MY; Sun, HH; Xie, JT; Zhang, Z; Yu, P; Jiang, JR; Cheng, JP; Yang, JQ; Li, Y; Lin, WJ; Tang, YM; Wang, XC				He, Baixuan; Wang, Xia; He, Yong; Li, Honghong; Yang, Yuhua; Shi, Zhongshan; Liu, Qiang; Wu, Minyi; Sun, Haohui; Xie, Jiatian; Zhang, Zhan; Yu, Pei; Jiang, Jingru; Cheng, Jinping; Yang, Jinqing; Li, Yi; Lin, Wei-Jye; Tang, Yamei; Wang, Xicheng			Gamma ray-induced glial activation and neuronal loss occur before the delayed onset of brain necrosis	FASEB JOURNAL			English	Article						gamma ray; glial activation; inflammatory cytokine; radiation-induced brain necrosis	RADIATION NECROSIS; MICROGLIA; BEVACIZUMAB; INJURY; IRRADIATION; ASTROCYTES; RECEPTOR; NEUROINFLAMMATION; INFLAMMATION; RESPONSES	Radiotherapy is one of the most effective treatments for head and neck tumors. However, delayed radiation-induced brain necrosis (RN) remains a serious issue due to the lack of satisfying prevention and effective treatment. The pathological role of radiation in the delayed onset of brain necrosis is still largely unknown, and the traditional animal model of whole brain irradiation, although being widely used, does not produce reliable and localized brain necrosis mimicking clinical features of RN. In this study, we demonstrated a successful RN mouse model using optimized gamma knife irradiation in male C57BL/6 mice. On the premise that brain necrosis started to appear at 6 weeks postirradiation in our RN model, as confirmed by both MRI and histopathological examinations, we systematically examined different time points before the onset of RN for the histopathological changes and biochemical indicators. Our initial results demonstrated that in the ipsilateral hemisphere of the irradiated brains, a significant decrease in neuronal numbers that occurred at 4 weeks and a sustained increase in TNF-alpha, iNOS, and other inflammatory cytokines beginning at 1-week postirradiation. Changes of cell morphology and cell numbers of both microglia and astrocytes occurred as early as 1-week postirradiation, and intervention by bevacizumab administration resulted in reduced microglia activation and reduction of radiation-induced lesion volume, indicating that chronic glial activation may result in subsequent elevation of inflammatory factors, which led to the delayed onset of neuronal loss and brain necrosis. Since C57BL/6 is the most widely used strain of genetic engineered mouse model, our data provide an invaluable platform for the mechanistic study of RN pathogenesis, identification of potential imaging and biological biomarkers, and the development of therapeutic treatment for the disease.	[He, Baixuan; Li, Honghong; Yang, Yuhua; Shi, Zhongshan; Liu, Qiang; Wu, Minyi; Sun, Haohui; Xie, Jiatian; Zhang, Zhan; Yu, Pei; Jiang, Jingru; Cheng, Jinping; Yang, Jinqing; Li, Yi; Tang, Yamei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, 107 Yanjiangxi Rd, Guangzhou 510120, Peoples R China; [Wang, Xia; Wang, Xicheng] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Dept Oncol, 19 Nonglinzia Rd, Guangzhou 510080, Peoples R China; [He, Yong] Guangzhou Med Univ, Affiliated Hosp 2, Radiotherapeut Dept, Guangzhou, Peoples R China; [Lin, Wei-Jye; Tang, Yamei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China; [Lin, Wei-Jye; Tang, Yamei] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou, Peoples R China; [Lin, Wei-Jye] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou, Peoples R China	Sun Yat Sen University; Guangdong Pharmaceutical University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Tang, YM (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, 107 Yanjiangxi Rd, Guangzhou 510120, Peoples R China.; Wang, XC (corresponding author), Guangdong Pharmaceut Univ, Affiliated Hosp 1, Dept Oncol, 19 Nonglinzia Rd, Guangzhou 510080, Peoples R China.	tangym@mail.sysu.edu.cn; 13902400598@126.com	Liu, Qiang/HHZ-3181-2022; Lin, Wei-Jye/AGW-1054-2022; Shi, Zhongshan/GPW-7675-2022	Lin, Wei-Jye/0000-0002-6057-7325; Shi, Zhongshan/0000-0002-5802-7332; Tang, Yamei/0000-0002-6353-6107	National Natural Science Foundation of China [81925031, 81872549, 81972967, 81820108026]; Guangdong Science and Technology Department [2017B030314026]; National Key R&D Program of China [2017YFC1307500, 2017YFC1307504]; Guangdong Basic and Applied Basic Research Foundation [2019A1515011754]; Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program [2016TQ03R559]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; National Key R&D Program of China; Guangdong Basic and Applied Basic Research Foundation; Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program	This work was supported by grants from the National Natural Science Foundation of China (No. 81925031, No. 81872549, No. 81972967, No. 81820108026), Guangdong Science and Technology Department (2017B030314026), National Key R&D Program of China (2017YFC1307500, 2017YFC1307504), Guangdong Basic and Applied Basic Research Foundation (2019A1515011754), and Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program (2016TQ03R559).	Andrews RN, 2017, RADIAT RES, V187, P599, DOI 10.1667/RR14616.1; Arranz AM, 2019, LANCET NEUROL, V18, P406, DOI 10.1016/S1474-4422(18)30490-3; Ballesteros-Zebadua P, 2012, CNS NEUROL DISORD-DR, V11, P937, DOI 10.2174/1871527311201070937; Bechade C, 2011, MOL CELL NEUROSCI, V46, P762, DOI 10.1016/j.mcn.2011.02.009; Boothe D, 2013, NEURO-ONCOLOGY, V15, P1257, DOI 10.1093/neuonc/not085; Brown WR, 2007, J NEUROL SCI, V257, P67, DOI 10.1016/j.jns.2007.01.014; Chen SH, 2015, GLIA, V63, P118, DOI 10.1002/glia.22738; Chen YP, 2019, LANCET, V394, P64, DOI 10.1016/S0140-6736(19)30956-0; Cheng GW, 2015, CELL BIOCHEM BIOPHYS, V73, P71, DOI 10.1007/s12013-015-0566-z; Cheung MC, 2003, CANCER-AM CANCER SOC, V97, P2019, DOI 10.1002/cncr.11295; Court LE, 2016, TRANSL CANCER RES, V5, P340, DOI 10.21037/tcr.2016.06.17; Ferrer I, 2017, BRAIN PATHOL, V27, P645, DOI 10.1111/bpa.12538; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; GIULIAN D, 1988, J NEUROSCI, V8, P709; Hamasaki K, 2007, CANCER SCI, V98, P1840, DOI 10.1111/j.1349-7006.2007.00641.x; Jenrow KA, 2013, RADIAT RES, V179, P549, DOI 10.1667/RR3026.1; Jeyaretna DS, 2011, J CLIN ONCOL, V29, pE159, DOI 10.1200/JCO.2010.31.4815; Jha MK, 2019, NEUROSCIENTIST, V25, P227, DOI 10.1177/1073858418783959; Jha MK, 2018, PROG NEUROBIOL, V162, P37, DOI 10.1016/j.pneurobio.2017.12.003; Jiang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139596; Jiang XY, 2014, CLIN CANCER RES, V20, P2695, DOI 10.1158/1078-0432.CCR-13-1941; Kirkley KS, 2019, NEUROBIOL DIS, V127, P193, DOI 10.1016/j.nbd.2019.02.020; Lafreniere JD, 2019, CLIN EXP OPHTHALMOL, V47, P638, DOI 10.1111/ceo.13453; Lawrence YR, 2010, INT J RADIAT ONCOL, V76, pS20, DOI 10.1016/j.ijrobp.2009.02.091; LEE AWM, 1988, CANCER-AM CANCER SOC, V61, P1535, DOI 10.1002/1097-0142(19880415)61:8<1535::AID-CNCR2820610809>3.0.CO;2-E; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Li Y, 2018, INT J RADIAT ONCOL, V100, P621, DOI 10.1016/j.ijrobp.2017.11.023; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Luo DD, 2019, PHARMACOL RES, V141, P530, DOI 10.1016/j.phrs.2019.01.027; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Munter MW, 1999, RADIOLOGY, V212, P475; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Ozsoy Z, 2017, J SURG RES, V216, P191, DOI 10.1016/j.jss.2017.05.011; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Unger MS, 2018, ALZHEIMERS DEMENT, V14, P1022, DOI 10.1016/j.jalz.2018.02.017; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Wang YY, 2018, J CELL BIOCHEM, V119, P2298, DOI 10.1002/jcb.26392; Xu YT, 2018, INT J RADIAT ONCOL, V101, P1087, DOI 10.1016/j.ijrobp.2018.04.068; Yang LH, 2017, MOL NEUROBIOL, V54, P1022, DOI 10.1007/s12035-015-9628-x; Yang N, 2016, RADIAT RES, V186, P345, DOI 10.1667/RR14374.1; Yeo HG, 2019, EXP NEUROBIOL, V28, P458, DOI 10.5607/en.2019.28.4.458; Zani IA, 2015, CELLS-BASEL, V4, P178, DOI 10.3390/cells4020178; Zhan J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0731-3; Zhang ZL, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9605265; Zhou K, 2017, SCI REP, V7, P1	49	3	4	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13361	13375		10.1096/fj.202000365RR	http://dx.doi.org/10.1096/fj.202000365RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32851721	hybrid			2022-12-28	WOS:000565962000001
J	Tanida, T; Matsuda, KI; Tanaka, M				Tanida, Takashi; Matsuda, Ken Ichi; Tanaka, Masaki			Novel metabolic system for lactic acid via LRPGC1/ERR gamma signaling pathway	FASEB JOURNAL			English	Article						ERR gamma; lactic acid; LRPGC1; nuclear translocation; TFAM	MITOCHONDRIAL TRANSCRIPTION-FACTOR; RECEPTOR-ALPHA; NUCLEAR IMPORT; ESTROGEN-RECEPTOR; COACTIVATOR PGC-1-ALPHA; INTRANUCLEAR MOBILITY; SODIUM-BICARBONATE; ENERGY-METABOLISM; KEY REGULATOR; LACTATE	Lactic acid (LA) is a byproduct of glycolysis resulting from intense exercise or a metabolic defect in aerobic processes. LA metabolism is essential to prevent lactic acidosis, but the mechanism through which LA regulates its own metabolism is largely unknown. Here, we identified a LA-responsive protein, named LRPGC1, which has a distinct role from PGC1 alpha, a key metabolic regulator, and report that LRPGC1 particularly mediates LA response to activate liver LA metabolism. Following LA stimulation, LRPGC1, but not PGC1 alpha, translocates from the cytoplasm to the nucleus through deactivation of nuclear export signals, interacts with the nuclear receptor ERR gamma, and upregulatesTFAM, which ensures mitochondrial biogenesis. Knockout of PGC1 gene in HepG2 hepatocarcinoma cells decreased the LA consumption andTFAMexpression, which were rescued by LRPGC1 expression, but not by PGC1 alpha. These LRPGC1-induced effects were mediated by ERR gamma, concomitantly with mitochondrial activation. The response element for LRPGC1/ERR gamma signaling pathway was identified inTFAMpromoter. Notably, the survival rate of a mouse model of lactic acidosis was reduced by the liver-targeted silencing ofLrpgc1, while it was significantly ameliorated by the pharmacological activation of ERR gamma. These findings demonstrate LA-responsive transactivation via LRPGC1 that highlight an intrinsic molecular mechanism for LA homeostasis.	[Tanida, Takashi; Matsuda, Ken Ichi; Tanaka, Masaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Anat & Neurobiol, Kyoto, Japan	Kyoto Prefectural University of Medicine	Tanida, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Anat & Neurobiol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	t-tanida@koto.kpu-m.ac.jp		Tanida, Takashi/0000-0002-0864-2433	MEXT | Japan Society for the Promotion of Science (JSPS) [24791116, 26860852, 17K10188, 20K08186]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 24791116, 26860852, 17K10188 and 20K08186	Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5; Beckervordersandforth R, 2017, NEURON, V93, P560, DOI 10.1016/j.neuron.2016.12.017; Bellomo R, 2002, CRIT CARE, V6, P322; Boyd JH, 2008, CURR OPIN CRIT CARE, V14, P379, DOI 10.1097/MCC.0b013e3283069d5c; Chen L, 2019, FASEB J; Choi YS, 2004, ANN NY ACAD SCI, V1011, P69, DOI 10.1196/annals.1293.008; Choi YS, 2002, BBA-GENE STRUCT EXPR, V1574, P200, DOI 10.1016/S0167-4781(01)00361-X; Correia JC, 2015, TRENDS ENDOCRIN MET, V26, P305, DOI 10.1016/j.tem.2015.03.010; CUPP JR, 1991, J BIOL CHEM, V266, P22199; de Groot R, 2011, NETH J MED, V69, P120; del Portal DA, 2010, ACAD EMERG MED, V17, P260, DOI 10.1111/j.1553-2712.2010.00681.x; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Eppenga WL, 2014, DIABETES CARE, V37, P2218, DOI 10.2337/dc13-3023; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Hashimoto T, 2012, J CELL BIOCHEM, V113, P3039, DOI 10.1002/jcb.24182; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; IMAMOTO N, 1992, J CELL BIOL, V119, P1047, DOI 10.1083/jcb.119.5.1047; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; KALIMO H, 1981, J CEREBR BLOOD F MET, V1, P313, DOI 10.1038/jcbfm.1981.35; Kang MH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04244-2; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kitagawa T, 2009, J CLIN ENDOCR METAB, V94, P1288, DOI 10.1210/jc.2008-1053; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Kruse O, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-74; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lamian V, 1996, EXP CELL RES, V228, P84, DOI 10.1006/excr.1996.0302; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Longo DL, 2016, CANCER RES, V76, P6463, DOI 10.1158/0008-5472.CAN-16-0825; Luft FC, 2001, J AM SOC NEPHROL, V12, pS15; Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Matsuda KI, 2018, ACTA HISTOCHEM CYTOC, V51, P129, DOI 10.1267/ahc.18023; Matsuda KI, 2002, MOL ENDOCRINOL, V16, P2215, DOI 10.1210/me.2002-0110; McCommis KS, 2015, BIOCHEM J, V466, P443, DOI 10.1042/BJ20141171; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rachoin JS, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.703; Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319; Romero-Garcia S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01053; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; SESTOFT L, 1982, CLIN PHYSIOL, V2, P51, DOI 10.1111/j.1475-097X.1982.tb00006.x; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Sun SR, 2017, PHYSIOLOGY, V32, P453, DOI 10.1152/physiol.00016.2017; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Tanida T, 2017, BRAIN RES, V1659, P71, DOI 10.1016/j.brainres.2017.01.024; Tanida T, 2015, J BIOL CHEM, V290, P12332, DOI 10.1074/jbc.M114.619098; Thom R, 2014, J BIOL CHEM, V289, P8810, DOI 10.1074/jbc.M114.554394; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893; Wu DM, 2014, AM J NEPHROL, V40, P36, DOI 10.1159/000364783; Wu HJ, 2016, J ENDOCRINOL, V229, pR99, DOI 10.1530/JOE-16-0021; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xia YJ, 2012, J VIRAL HEPATITIS, V19, P509, DOI 10.1111/j.1365-2893.2011.01581.x; Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	81	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13239	13256		10.1096/fj.202000492R	http://dx.doi.org/10.1096/fj.202000492R		AUG 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32851675	Bronze			2022-12-28	WOS:000565961600001
J	Li, J; Guo, Y; Chen, YY; Liu, Q; Chen, Y; Tan, L; Zhang, SH; Gao, ZR; Zhou, YH; Zhang, GY; Feng, YZ				Li, Jun; Guo, Yue; Chen, Ying-Yi; Liu, Qiong; Chen, Yun; Tan, Li; Zhang, Shao-Hui; Gao, Zheng-Rong; Zhou, Ying-Hui; Zhang, Gui-Ying; Feng, Yun-Zhi			miR-124-3p increases in high glucose induced osteocyte-derived exosomes and regulates galectin-3 expression: A possible mechanism in bone remodeling alteration in diabetic periodontitis	FASEB JOURNAL			English	Article						alveolar bone; diabetes mellitus; inflammation; osteoblast; saliva	CELLS; DIFFERENTIATION; OSTEOBLASTS; INVOLVEMENT; ACTIVATION; VESICLES; DISEASE; OBESITY	The mechanisms underlying the two-way relationship between diabetes mellitus (DM) and periodontitis are unclear. We examined a possible effect of galectin-3 (Gal-3), a factor in DM and bone metabolism, on periodontitis with or without DM. Using enzyme-linked immunosorbent assay, we detected saliva Gal-3 in patients with periodontitis, with or without type 2 DM. In animal models, we measured periodontal bone microarchitecture via micro computed tomography, and detected Gal-3, Runt-related transcription factor 2 (Runx2), and interleukin-6 (IL-6) expression in alveolar bone. Applying dual luciferase reporter assay, we explored the target binding of miR-124-3p and Gal-3. We examined osteocyte-derived exosomes with transmission electron microscopy and detected miR-124-3p, Gal-3, and IL-6 expression in exosomes. Saliva Gal-3 was increased in DM compared with controls but decreased in patients with moderate periodontitis and DM compared with those who had moderate periodontitis only. Alveolar bone mass was increased in DM and exacerbated in DM with periodontitis. Gal-3 and Runx2 were both increased in periodontitis and DM compared with controls, but decreased in DM with periodontitis compared with DM alone. MiR-124-3p targeted and inhibited Gal-3 expression in vitro. Osteocytes secreted exosomes carrying miR-124-3p, Gal-3, and IL-6, which were influenced by high glucose. These findings indicate that osteocyte-derived exosomes carrying miR-124-3p may regulate Gal-3 expression of osteoblasts, especially under high-glucose conditions, suggesting a possible mechanism for DM-related alveolar bone pathologies.	[Li, Jun; Guo, Yue; Chen, Ying-Yi; Liu, Qiong; Chen, Yun; Tan, Li; Zhang, Shao-Hui; Gao, Zheng-Rong; Feng, Yun-Zhi] Cent South Univ, Xiangya Hosp 2, Dept Stomatol, Changsha 410011, Hunan, Peoples R China; [Guo, Yue; Zhou, Ying-Hui] Cent South Univ, Xiangya Hosp 2, Dept Endocrinol, Changsha, Peoples R China; [Zhang, Gui-Ying] Cent South Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Peoples R China	Central South University; Central South University; Central South University	Feng, YZ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Stomatol, Changsha 410011, Hunan, Peoples R China.	fengyunzhi001@csu.edu.cn			National Natural Science Foundation of China (NSFC) [81773339, 81800788]; Hunan Provincial Science and Technology Department (HSTD) [2017WK2041, 2018SK52511]; Central South University (CSU) [2014-ZDYZ-1-16]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hunan Provincial Science and Technology Department (HSTD); Central South University (CSU)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81773339 and 81800788; Hunan Provincial Science and Technology Department (HSTD), Grant/Award Number: 2017WK2041 and 2018SK52511; Central South University (CSU), Grant/Award Number: 2014-ZDYZ-1-16	Arad U, 2015, CYTOKINE, V73, P30, DOI 10.1016/j.cyto.2015.01.016; Boileau C, 2008, ANN RHEUM DIS, V67, P175, DOI 10.1136/ard.2006.066514; Bostanci N, 2018, PERIODONTOL 2000, V76, P68, DOI 10.1111/prd.12154; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Chen HB, 2017, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0795-x; Darrow AL, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0230-3; Darrow AL, 2011, PHYSIOL GENOMICS, V43, P1144, DOI 10.1152/physiolgenomics.00035.2011; Demmer RT, 2012, DIABETES CARE, V35, P2036, DOI 10.2337/dc11-2453; Ding GL, 2015, STROKE, V46, P507, DOI 10.1161/STROKEAHA.114.007538; Donath MY, 2019, NAT REV IMMUNOL, V19, P734, DOI 10.1038/s41577-019-0213-9; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Fermin ML, 2016, MOL IMMUNOL, V76, P22, DOI 10.1016/j.molimm.2016.06.005; Guo Y, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/1087017; Guo Y, 2017, DEV GROWTH DIFFER, V59, P94, DOI 10.1111/dgd.12342; Guo Y, 2016, FASEB J, V30, P4214, DOI 10.1096/fj.201600445RR; Han YJ, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0019-6; Iacobini C, 2004, FASEB J, V18, P1773, DOI 10.1096/fj.04-2031fje; Iacobini C, 2018, METABOLISM, V83, P149, DOI 10.1016/j.metabol.2018.02.001; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Ko KI, 2019, DIABETES, V68, P2095, DOI 10.2337/db19-0496; Kukolj T, 2018, J CELL PHYSIOL, V233, P447, DOI 10.1002/jcp.25904; Li L, 2016, CANCER RES, V76, P1770, DOI 10.1158/0008-5472.CAN-15-1625; Li XM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9421019; Liu XL, 2020, HEPATOLOGY, V72, P454, DOI 10.1002/hep.31050; Man XF, 2016, AM J TRANSL RES, V8, P2727; Mazur CM, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0070-y; Mealey BL, 2007, PERIODONTOL 2000, V44, P127, DOI 10.1111/j.1600-0757.2006.00193.x; Men YQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11534-w; Mendonca HR, 2018, BRAIN RES, V1700, P126, DOI 10.1016/j.brainres.2018.07.018; Menini S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9618092; Mercer N, 2004, MOL CELL BIOCHEM, V266, P17, DOI 10.1023/B:MCBI.0000049128.71095.ac; Morrell AE, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0007-x; Nakajima K, 2014, NEOPLASIA, V16, P939, DOI 10.1016/j.neo.2014.09.005; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Prideaux M, 2016, CURR OPIN PHARMACOL, V28, P24, DOI 10.1016/j.coph.2016.02.003; Proctor GB, 2016, PERIODONTOL 2000, V70, P11, DOI 10.1111/prd.12116; Qin YW, 2017, J BIOL CHEM, V292, P11021, DOI 10.1074/jbc.M116.770941; Saremi A, 2005, DIABETES CARE, V28, P27, DOI 10.2337/diacare.28.1.27; Sato M, 2017, BIOMED REP, V6, P223, DOI 10.3892/br.2016.824; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Simon D, 2017, BONE, V105, P35, DOI 10.1016/j.bone.2017.08.013; Solberg LB, 2015, HISTOCHEM CELL BIOL, V143, P195, DOI 10.1007/s00418-014-1272-4; Tang CY, 2017, MOL CELLS, V40, P123, DOI 10.14348/molcells.2017.2228; Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Watanabe K, 2011, J PERIODONTAL RES, V46, P21, DOI 10.1111/j.1600-0765.2010.01304.x; Weigert J, 2010, J CLIN ENDOCR METAB, V95, P1404, DOI 10.1210/jc.2009-1619; Weilner S, 2016, AGING-US, V8, P16, DOI 10.18632/aging.100865; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yu N, 2015, J DENT RES, V94, p194S, DOI 10.1177/0022034515584384; Zhang MR, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12471; Zhang S, 2016, TUMOR BIOL, V37, P11057, DOI 10.1007/s13277-016-4981-6; Zhang X, 2016, J CLIN PATHOL, V69, P1100, DOI 10.1136/jclinpath-2016-203631	56	11	12	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14234	14249		10.1096/fj.202000970RR	http://dx.doi.org/10.1096/fj.202000970RR		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32833280	hybrid			2022-12-28	WOS:000564399400001
J	Ji, QS; Shi, S; Guo, S; Zhan, Y; Zhang, HL; Chen, YF; An, HL				Ji, Qiushuang; Shi, Sai; Guo, Shuai; Zhan, Yong; Zhang, Hailin; Chen, Yafei; An, Hailong			Activation of TMEM16A by natural product canthaxanthin promotes gastrointestinal contraction	FASEB JOURNAL			English	Article						activator; binding site; canthaxanthin; ileal contraction; TMEM16A	CHLORIDE CHANNEL; INTERSTITIAL-CELLS; TRANSMEMBRANE PROTEIN; SWISS-MODEL; CL-CHANNEL; CAJAL; CONTRIBUTES; INHIBITION; EXPRESSION; CFTR	Transmembrane 16A (TMEM16A), also known as anoctamin 1, is the molecular basis of the calcium-activated chloride channels. TMEM16A is present in interstitial cells of Cajal, which are the pacemaker cells that control smooth muscle contraction. TMEM16A is implicated in gastrointestinal disorders. Activation of TMEM16A is believed to promote the gastrointestinal muscle contraction. Here, we report a highly efficient, nontoxic, and selective activator of TMEM16A, canthaxanthin (CX). The study using molecular docking and site-directed mutation revealed that CX-specific binging site in TMEM16A is K769. CX was also found to promote the contraction of smooth muscle cells in gastrointestinal tract through activation of TMEM16A channels, which provides an excellent basis for development of CX as a chemical tool and potential therapeutic for gastrointestinal dysfunction.	[Ji, Qiushuang; Shi, Sai; Guo, Shuai; Zhan, Yong; Chen, Yafei; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Hebei, Peoples R China; [Ji, Qiushuang] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China; [Shi, Sai; Guo, Shuai; Zhan, Yong; An, Hailong] Hebei Univ Technol, Sch Elect Engn, Tianjin, Peoples R China; [Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Key Lab Neural & Vasc Biol, Key Lab Pharmacol & Toxicol New Drug,Minist Educ, Shijiazhuang, Hebei, Peoples R China	Hebei University of Technology; Tianjin University; Hebei University of Technology; Hebei Medical University	Chen, YF; An, HL (corresponding author), Hebei Univ Technol, Inst Biophys, 5340 Xiping Rd, Tianjin 300401, Peoples R China.	chenyafei@hebut.edu.cn; hailong_an@hebut.edu.cn			National Natural Science Foundation of China [11735006, 11175055, 11747610, 31600594, 31400711]; Natural Science Foundation of Hebei Province of China [C2018202302, C2017202208]; Youth Talent Support Program of Hebei Province of China [2013001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Youth Talent Support Program of Hebei Province of China	National Natural Science Foundation of China, Grant/Award Number: 11735006, 11175055, 11747610, 31600594 and 31400711; Natural Science Foundation of Hebei Province of China, Grant/Award Number: C2018202302 and C2017202208; Youth Talent Support Program of Hebei Province of China, Grant/Award Number: 2013001	Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Burris SK, 2015, BRIT J PHARMACOL, V172, P2459, DOI 10.1111/bph.13077; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; Cantrell A, 2003, ARCH BIOCHEM BIOPHYS, V412, P47, DOI 10.1016/S0003-9861(03)00014-6; Cao QH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0499-z; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chai R, 2017, J MEMBRANE BIOL, V250, P483, DOI 10.1007/s00232-017-9975-9; Chang CS, 2013, KAOHSIUNG J MED SCI, V29, P412, DOI 10.1016/j.kjms.2012.12.002; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Drumm BT, 2019, J PHYSIOL-LONDON, V597, P3587, DOI 10.1113/JP278036; Drumm BT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39729-7; Esatbeyoglu T, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600469; Fakhri S, 2019, MOLECULES, V24, DOI 10.3390/molecules24142640; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo S, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104323; Guo S, 2019, J CELL PHYSIOL, V234, P8698, DOI 10.1002/jcp.27529; Guo S, 2017, PFLUG ARCH EUR J PHY, V469, P681, DOI 10.1007/s00424-017-1934-x; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji QS, 2019, J CELL PHYSIOL, V234, P7856, DOI 10.1002/jcp.27865; Jiang Y, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00270; Johnston L, 2008, AM J PHYSIOL-RENAL, V294, pF645, DOI 10.1152/ajprenal.00526.2007; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; Kunzelmann K, 1999, J MEMBRANE BIOL, V168, P1, DOI 10.1007/s002329900492; Liu YN, 2015, PFLUG ARCH EUR J PHY, V467, P1417, DOI 10.1007/s00424-014-1572-5; Mazzone A, 2011, J BIOL CHEM, V286, P13393, DOI 10.1074/jbc.M110.196089; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Oh SJ, 2013, MOL PHARMACOL, V84, P726, DOI 10.1124/mol.113.087502; Ousingsawat J, 2011, CELL PHYSIOL BIOCHEM, V28, P715, DOI 10.1159/000335765; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Sui YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144715; Truong EC, 2017, J MED CHEM, V60, P4626, DOI 10.1021/acs.jmedchem.7b00020; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wang BX, 2015, J MOL CELL CARDIOL, V82, P22, DOI 10.1016/j.yjmcc.2015.02.020; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yao Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038030; Zhang X, 2017, BRIT J PHARMACOL, V174, P2334, DOI 10.1111/bph.13841	51	5	4	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13430	13444		10.1096/fj.202000443RR	http://dx.doi.org/10.1096/fj.202000443RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32812278	Bronze			2022-12-28	WOS:000562900400001
J	Choi, K; Lee, J; Kang, HJ				Choi, Koeul; Lee, Joonhee; Kang, Hyo Jung			Myelination defects in the medial prefrontal cortex of Fkbp5 knockout mice	FASEB JOURNAL			English	Article						Nfasc; PTSD; small RNA&#8208; seq; target prediction	POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER ABNORMALITIES; GLUCOCORTICOID-RECEPTOR; NEUROTROPHIC FACTOR; FEAR EXTINCTION; TRAUMA EXPOSURE; BINDING DOMAIN; NEUROFASCIN; KINESIN; AMYGDALA	The hypothalamic-pituitary-adrenal (HPA) axis plays a principal role in stress response regulation and has been implicated in the etiology of stress-related disorders. The HPA axis regulates the normal synthesis and release of glucocorticoids; dysregulation of the HPA axis causes abnormal responses to stress. FK506-binding protein 5 (FKBP5), a co-chaperone of heat shock protein 90 in the glucocorticoid receptor (GR) molecular complex, is a key GR sensitivity regulator. FKBP5 single nucleotide polymorphisms are associated with dysregulated HPA axis and increased risk of stress-related disorders, including posttraumatic stress disorder (PTSD) and depression. In this study, we profiled the microRNAs (miRNAs) in the medial prefrontal cortex of Fkbp5 knockout (Fkbp5(-/-)) mice and identified the target genes of differentially expressed miRNAs using sequence-based miRNA target prediction. Gene ontology analysis revealed that the differentially expressed miRNAs were involved in nervous system development, regulation of cell migration, and intracellular signal transduction. The validation of the expression of predicted target genes using quantitative polymerase chain reaction revealed that the expression of axon development-related genes, specifically actin-binding LIM protein 1 (Ablim1), lemur tyrosine kinase 2 (Lmtk2), kinesin family member 5c (Kif5c), neurofascin (Nfasc), and ephrin type-A receptor 4 (Epha4), was significantly decreased, while that of brain-derived neurotrophic factor (Bdnf) was significantly increased in the brain of Fkbp5(-/-) mice. These results suggest that axonal development-related genes can serve as potential targets in future studies focused on understanding the pathophysiology of PTSD.	[Choi, Koeul; Lee, Joonhee; Kang, Hyo Jung] Chung Ang Univ, Dept Life Sci, 84 Heukseok Ro, Seoul 06974, South Korea	Chung Ang University	Kang, HJ (corresponding author), Chung Ang Univ, Dept Life Sci, 84 Heukseok Ro, Seoul 06974, South Korea.	hyokang@cau.ac.kr						Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Attwood BK, 2011, NATURE, V473, P372, DOI 10.1038/nature09938; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Bathina S, 2015, ARCH MED SCI, V11, P1164, DOI 10.5114/aoms.2015.56342; Bernard F, 2012, GLIA, V60, P1590, DOI 10.1002/glia.22378; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Boscarino JA, 2012, NEUROPSYCH DIS TREAT, V8, P131, DOI 10.2147/NDT.S29508; Chao LDL, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00333; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Chetty S, 2014, MOL PSYCHIATR, V19, P1275, DOI 10.1038/mp.2013.190; Cheung J, 2015, NEUROBIOL LEARN MEM, V125, P258, DOI 10.1016/j.nlm.2015.09.008; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Cornelis MC, 2010, CURR PSYCHIAT REP, V12, P313, DOI 10.1007/s11920-010-0126-6; Criado-Marrero M, 2017, LEARN MEMORY, V24, P145, DOI 10.1101/lm.043000.116; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Fenster RJ, 2018, NAT REV NEUROSCI, V19, P535, DOI 10.1038/s41583-018-0039-7; Gaali S, 2015, NAT CHEM BIOL, V11, P33, DOI 10.1038/nchembio.1699; Han F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00062; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hoeijmakers L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095796; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Issler O, 2015, NAT REV NEUROSCI, V16, P201, DOI 10.1038/nrn3879; Jones Timmy, 2011, J Am Psychiatr Nurses Assoc, V17, P393, DOI 10.1177/1078390311420564; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kang HJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60334-6; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Koenen KC, 2008, EUR ARCH PSY CLIN N, V258, P82, DOI 10.1007/s00406-007-0787-2; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Kriebel M, 2012, INT J BIOCHEM CELL B, V44, P694, DOI 10.1016/j.biocel.2012.01.012; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Kwon J, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0521-9; Langbroek J, 2019, LECT NOTES ARTIF INT, V11509, P203, DOI 10.1007/978-3-030-20915-5_19; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lemon J., 2006, R R NEWS, V6, P12; Li L, 2016, EBIOMEDICINE, V4, P176, DOI 10.1016/j.ebiom.2016.01.012; Linneberg C, 2015, ASN NEURO, V7, DOI 10.1177/1759091415602859; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Martin CG, 2017, PSYCHIAT RES, V251, P261, DOI 10.1016/j.psychres.2017.01.081; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mehta D, 2011, ARCH GEN PSYCHIAT, V68, P901, DOI 10.1001/archgenpsychiatry.2011.50; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mulder RH, 2017, DEV PSYCHOPATHOL, V29, P491, DOI 10.1017/S095457941700013X; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Nugent AA, 2012, CURR OPIN NEUROBIOL, V22, P837, DOI 10.1016/j.conb.2012.02.006; O'Doherty DCM, 2018, HUM BRAIN MAPP, V39, P1327, DOI 10.1002/hbm.23920; O'Leary JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024840; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oksdath M, 2017, MOL NEUROBIOL, V54, P6085, DOI 10.1007/s12035-016-0144-4; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; R Core Team, 2019, R LANG ENV STAT COMP; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Saha R, 2018, MOL NEUROBIOL, V55, P7317, DOI 10.1007/s12035-018-0930-2; Saha R, 2017, NEUROPSYCHOPHARMACOL, V42, P473, DOI 10.1038/npp.2016.205; Schmidt Ulrike, 2013, Front Psychiatry, V4, P66, DOI 10.3389/fpsyt.2013.00066; Schulte-Herbruggen O, 2006, PSYCHONEUROENDOCRINO, V31, P1266, DOI 10.1016/j.psyneuen.2006.09.008; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Varghese Femina P., 2001, Prim Care Companion J Clin Psychiatry, V3, P151; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Willemsen MH, 2014, J MED GENET, V51, P487, DOI 10.1136/jmedgenet-2013-102182; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Zannas AS, 2016, NEUROPSYCHOPHARMACOL, V41, P261, DOI 10.1038/npp.2015.235; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040; Zhou JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094075; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	82	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21297	10.1096/fj.202001883R	http://dx.doi.org/10.1096/fj.202001883R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33410216	hybrid			2022-12-28	WOS:000647789600009
J	van der Zande, HJP; Gonzalez, MA; de Ruiter, K; Wilbers, RHP; Garcia-Tardon, N; van Huizen, M; van Noort, K; Pelgrom, LR; Lambooij, JM; Zawistowska-Deniziak, A; Otto, F; Ozir-Fazalalikhan, A; van Willigen, D; Welling, M; Poles, J; van Leeuwen, F; Hokke, CH; Schots, A; Yazdanbakhsh, M; Loke, P; Guigas, B				van der Zande, Hendrik J. P.; Gonzalez, Michael A.; de Ruiter, Karin; Wilbers, Ruud H. P.; Garcia-Tardon, Noemi; van Huizen, Mariska; van Noort, Kim; Pelgrom, Leonard R.; Lambooij, Joost M.; Zawistowska-Deniziak, Anna; Otto, Frank; Ozir-Fazalalikhan, Arifa; van Willigen, Danny; Welling, Mick; Poles, Jordan; van Leeuwen, Fijs; Hokke, Cornelis H.; Schots, Arjen; Yazdanbakhsh, Maria; Loke, P'ng; Guigas, Bruno			The helminth glycoprotein omega-1 improves metabolic homeostasis in obese mice through type 2 immunity-independent inhibition of food intake	FASEB JOURNAL			English	Article						helminths; immunometabolism; insulin sensitivity; macrophages; type 2 immunity	SCHISTOSOMA-MANSONI EGGS; INNATE LYMPHOID-CELLS; INSULIN SENSITIVITY; TH2 POLARIZATION; NEUROMEDIN-U; MACROPHAGES; RESISTANCE; DRIVES; IDENTIFICATION; EOSINOPHILS	Type 2 immunity plays an essential role in the maintenance of metabolic homeostasis and its disruption during obesity promotes meta-inflammation and insulin resistance. Infection with the helminth parasite Schistosoma mansoni and treatment with its soluble egg antigens (SEA) induce a type 2 immune response in metabolic organs and improve insulin sensitivity and glucose tolerance in obese mice, yet, a causal relationship remains unproven. Here, we investigated the effects and underlying mechanisms of the T2 ribonuclease omega-1 (omega 1), one of the major S mansoni immunomodulatory glycoproteins, on metabolic homeostasis. We show that treatment of obese mice with plant-produced recombinant omega 1, harboring similar glycan motifs as present on the native molecule, decreased body fat mass, and improved systemic insulin sensitivity and glucose tolerance in a time- and dose-dependent manner. This effect was associated with an increase in white adipose tissue (WAT) type 2 T helper cells, eosinophils, and alternatively activated macrophages, without affecting type 2 innate lymphoid cells. In contrast to SEA, the metabolic effects of omega 1 were still observed in obese STAT6-deficient mice with impaired type 2 immunity, indicating that its metabolic effects are independent of the type 2 immune response. Instead, we found that omega 1 inhibited food intake, without affecting locomotor activity, WAT thermogenic capacity or whole-body energy expenditure, an effect also occurring in leptin receptor-deficient obese and hyperphagic db/db mice. Altogether, we demonstrate that while the helminth glycoprotein omega 1 can induce type 2 immunity, it improves whole-body metabolic homeostasis in obese mice by inhibiting food intake via a STAT6-independent mechanism.	[van der Zande, Hendrik J. P.; de Ruiter, Karin; Garcia-Tardon, Noemi; van Huizen, Mariska; Pelgrom, Leonard R.; Lambooij, Joost M.; Zawistowska-Deniziak, Anna; Otto, Frank; Ozir-Fazalalikhan, Arifa; Hokke, Cornelis H.; Yazdanbakhsh, Maria; Guigas, Bruno] Leiden Univ, Dept Parasitol, Med Ctr, POB 9600,Postal Zone P4-P, NL-2300 RC Leiden, Netherlands; [Gonzalez, Michael A.; Poles, Jordan; Loke, P'ng] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Wilbers, Ruud H. P.; van Noort, Kim; Schots, Arjen] Wageningen Univ & Res, Dept Lab Nematol, Wageningen, Netherlands; [Zawistowska-Deniziak, Anna] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [van Willigen, Danny; Welling, Mick; van Leeuwen, Fijs] Leiden Univ, Dept Radiol, Intervent Mol Imaging Lab, Med Ctr, Leiden, Netherlands; [Loke, P'ng] NIAID, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; New York University; Wageningen University & Research; Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Guigas, B (corresponding author), Leiden Univ, Dept Parasitol, Med Ctr, POB 9600,Postal Zone P4-P, NL-2300 RC Leiden, Netherlands.	b.g.a.guigas@lumc.nl	Pelgrom, Leonard/GVT-0523-2022; van leeuwen, Fijs/AAX-2098-2021; Guigas, Bruno/M-2515-2015; Hokke, Cornelis Hendrik/AAQ-4712-2021; Welling, Mick/A-4582-2012	van leeuwen, Fijs/0000-0002-6844-4025; Guigas, Bruno/0000-0002-8856-5799; Hokke, Cornelis Hendrik/0000-0003-3545-7804; Welling, Mick/0000-0002-2249-5601; Gonzalez, Michael A/0000-0003-2042-6255; Lambooij, Joost Maarten/0000-0002-4853-5843; Zawistowska-Deniziak, Anna/0000-0001-6990-9165; Otto, Frank/0000-0002-8648-2260; van Huizen, Mariska/0000-0002-0561-0049; Pelgrom, Leonard/0000-0002-8422-6810	NHLBI NIH HHS [R01 HL084312] Funding Source: Medline; NIAID NIH HHS [R01 AI133977, R01 AI130945] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdulla MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001368; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; DERUITER K, 2017, PARASITE IMMUNOL, V39; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DUNNE DW, 1981, T ROY SOC TROP MED H, V75, P54, DOI 10.1016/0035-9203(81)90013-4; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Gieseck RL, 2016, IMMUNITY, V45, P145, DOI 10.1016/j.immuni.2016.06.009; Grogan JL, 1996, EUR J IMMUNOL, V26, P1365, DOI 10.1002/eji.1830260628; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Hadju V, 1996, PARASITOLOGY, V113, P497, DOI 10.1017/S0031182000081579; Hams E, 2016, FASEB J, V30, P824, DOI 10.1096/fj.15-277822; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Hart KM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3694; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hensbergen AW, 2019, ACS OMEGA, V4, P12438, DOI 10.1021/acsomega.9b01484; HORBURY SR, 1995, J NEUROENDOCRINOL, V7, P867, DOI 10.1111/j.1365-2826.1995.tb00728.x; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Hussaarts L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00499; Kaiser MMM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005504; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lee CH, 2018, CELL REP, V25, P934, DOI 10.1016/j.celrep.2018.09.070; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Lohmus M, 2012, BIOL LETTERS, V8, P849, DOI 10.1098/rsbl.2012.0385; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Meevissen MHJ, 2010, J PROTEOME RES, V9, P2630, DOI 10.1021/pr100081c; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Okano M, 1999, J IMMUNOL, V163, P6712; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Schneeberger M, 2014, J ENDOCRINOL, V220, pT25, DOI 10.1530/JOE-13-0398; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spa SJ, 2018, THERANOSTICS, V8, P2377, DOI 10.7150/thno.23567; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Thomas A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24618; Valdearcos M, 2017, CELL METAB, V26, P185, DOI 10.1016/j.cmet.2017.05.015; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; van der Zande HJP, 2019, TRENDS PARASITOL, V35, P795, DOI 10.1016/j.pt.2019.07.014; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wilbers RHP, 2017, SCI REP-UK, V7, DOI 10.1038/srep45910; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zinsou JF, 2020, PLOS NEGLECT TROP D, V14, DOI [10.1371/journal.pntd.0008464, 10.1371/journal.pntd.0008464.r001, 10.1371/journal.pntd.0008464.r002, 10.1371/journal.pntd.0008464.r003, 10.1371/journal.pntd.0008464.r004]	58	13	13	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21331	10.1096/fj.202001973R	http://dx.doi.org/10.1096/fj.202001973R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33476078	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000647789600008
J	Berry, BJ; Baldzizhar, A; Nieves, TO; Wojtovich, AP				Berry, Brandon J.; Baldzizhar, Aksana; Nieves, Tyrone O.; Wojtovich, Andrew P.			Neuronal AMPK coordinates mitochondrial energy sensing and hypoxia resistance inC. elegans	FASEB JOURNAL			English	Article						anoxia; metabolism; optogenetics; uncoupling	REPERFUSION INJURY; INNER MEMBRANE; C-ELEGANS; PROTEIN; HEART; CONDUCTANCE; METABOLISM; KINASE; TISSUE; SIGNAL	Organisms adapt to their environment through coordinated changes in mitochondrial function and metabolism. The mitochondrial protonmotive force (PMF) is an electrochemical gradient that powers ATP synthesis and adjusts metabolism to energetic demands via cellular signaling. It is unknown how or where transient PMF changes are sensed and signaled due to the lack of precise spatiotemporal control in vivo. We addressed this by expressing a light-activated proton pump in mitochondria to spatiotemporally "turn off" mitochondrial function through PMF dissipation in tissues with light. We applied our construct-mitochondria-OFF (mtOFF)-to understand how metabolic status impacts hypoxia resistance, a response that relies on mitochondrial function. Activation of mtOFF induced starvation-like behavior mediated by AMP-activated protein kinase (AMPK). We found prophylactic mtOFF activation increased survival following hypoxia, and that protection relied on neuronal AMPK. Our study links spatiotemporal control of mitochondrial PMF to cellular metabolic changes that mediate behavior and stress resistance.	[Berry, Brandon J.; Wojtovich, Andrew P.] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, 575 Elmwood Ave, Rochester, NY 14642 USA; [Baldzizhar, Aksana; Nieves, Tyrone O.; Wojtovich, Andrew P.] Univ Rochester, Med Ctr, Dept Anesthesiol & Perioperat Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Wojtovich, AP (corresponding author), Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, 575 Elmwood Ave, Rochester, NY 14642 USA.	andrew_wojtovich@urmc.rochester.edu	Berry, Brandon/GWQ-5878-2022; Berry, Brandon/ABC-9821-2021	Berry, Brandon/0000-0002-2206-7615	National Institutes of Health [R01 NS092558, R01 NS115906]; American Heart Association Predoctoral Fellowship [18PRE33990054]; NIH Office of Research Infrastructure Programs [P40 OD010440]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	APW is supported by grants from the National Institutes of Health (R01 NS092558, R01 NS115906). BJB is supported by an American Heart Association Predoctoral Fellowship (18PRE33990054). We thank Dr Richard Roy (McGill University) for providing plasmid pMR729. We also thank the Mitochondrial Research & Innovation Group at the University of Rochester Medical Center for helpful discussions and guidance. Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Ahmadi B, 2016, 2016 FOURTH INTERNATIONAL CONFERENCE ON MILLIMETER-WAVE AND TERAHERTZ TECHNOLOGIES (MMWATT), P5, DOI 10.1109/MMWaTT.2016.7869863; Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Bartok A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11646-3; Berry BJ, 2020, EMBO REP, V21, DOI 10.15252/embr.201949113; Berry BJ, 2018, J MOL BIOL, V430, P3873, DOI 10.1016/j.jmb.2018.03.025; Bleasdale EE, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00124; BRENNER S, 1974, GENETICS, V77, P71; Chen X, 2018, METABOLISM, V83, P256, DOI 10.1016/j.metabol.2018.03.004; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; De Magalhaes CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02934-5; Dufayet L, 2020, INT J LEGAL MED, V134, P1003, DOI 10.1007/s00414-020-02268-2; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Ernst P, 2019, BIOPHYS J, V117, P631, DOI 10.1016/j.bpj.2019.06.038; Escorcia W, 2018, JOVE-J VIS EXP, DOI 10.3791/57352; Fagan KA, 2018, CURR BIOL, V28, P902, DOI 10.1016/j.cub.2018.02.029; Goedeke L, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aay0284; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; IMAI Y, 2019, COMMUN BIOL, V2; Iranon NN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008242; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; JUNG DW, 1989, ANAL BIOCHEM, V178, P348, DOI 10.1016/0003-2697(89)90651-9; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Komlodi T, 2018, J BIOENERG BIOMEMBR, V50, P355, DOI 10.1007/s10863-018-9766-8; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Larue BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016790; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Li PA, 2017, J NEUROSCI RES, V95, P2025, DOI 10.1002/jnr.24042; Lim Y, 2019, DEV BIOL, V454, P15, DOI 10.1016/j.ydbio.2019.06.016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McElroy GS, 2017, EXP CELL RES, V356, P217, DOI 10.1016/j.yexcr.2017.03.034; MEISNER H, 1972, BIOCHEMISTRY-US, V11, P949, DOI 10.1021/bi00756a002; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NICHOLLS DG, 1977, EUR J BIOCHEM, V77, P349, DOI 10.1111/j.1432-1033.1977.tb11674.x; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Onukwufor JO, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080285; Otani H, 2004, ANTIOXID REDOX SIGN, V6, P449, DOI 10.1089/152308604322899521; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; Paggio A, 2019, NATURE, V572, P609, DOI 10.1038/s41586-019-1498-3; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Pena S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159989; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Philip NS, 2019, G3-GENES GENOM GENET, V9, P2629, DOI 10.1534/g3.119.400399; Rolland SG, 2019, CELL REP, V28, P1659, DOI 10.1016/j.celrep.2019.07.049; Ryan DA, 2014, CURR BIOL, V24, P2509, DOI 10.1016/j.cub.2014.09.032; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Seager Richard, 2020, Neuronal Signal, V4, pNS20200008, DOI 10.1042/NS20200008; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tkatch T, 2017, P NATL ACAD SCI USA, V114, pE5167, DOI 10.1073/pnas.1703623114; To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032; Trewin AJ, 2019, ANTIOXID REDOX SIGN, V31, P594, DOI 10.1089/ars.2018.7681; Trewin AJ, 2018, FREE RADICAL BIO MED, V128, P157, DOI 10.1016/j.freeradbiomed.2018.02.002; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Velazquez AFC, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00303-18; Wang XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182777; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Wojtovich AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028287; Wolf C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040815; Xie X, 2020, DOSE-RESPONSE, V18, DOI 10.1177/1559325820935329; Yang MY, 2017, J PHOTOCH PHOTOBIO B, V173, P325, DOI 10.1016/j.jphotobiol.2017.06.014; Yin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074011; Yurgel ME, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006409; Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029; Zhang Y, 2019, ELIFE, V8, DOI 10.7554/eLife.49158	77	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16333	16347		10.1096/fj.202001150RR	http://dx.doi.org/10.1096/fj.202001150RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058299	hybrid, Green Published			2022-12-28	WOS:000581159400001
J	Wei, XB; Zhang, LL; Zhang, RJ; Wu, RJ; Si, DY; Ahmad, B; Petitte, JN; Mozdziak, PE; Li, ZX; Guo, HA; Zhang, MY				Wei, Xubiao; Zhang, Lulu; Zhang, Rijun; Wu, Rujuan; Si, Dayong; Ahmad, Baseer; Petitte, James N.; Mozdziak, Paul E.; Li, Zhongxuan; Guo, Henan; Zhang, Manyi			A highly efficient hybrid peptide ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide-receptor interaction	FASEB JOURNAL			English	Article						in silico; NF-kappa B signaling; peptide drug; proinflammatory cytokine; tight junction; Toll-like receptor	CECROPIN A(1-8)-MAGAININ 2(1-12); TIGHT JUNCTION PROTEINS; TOLL-LIKE RECEPTORS; BOWEL-DISEASE; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR-DISEASE; CELL SELECTIVITY; OXIDATIVE STRESS; IMMUNE-RESPONSES; IN-VIVO	Intestinal inflammatory disorders, such as inflammatory bowel disease, are major contributors to mortality and morbidity in humans and animals worldwide. While some native peptides have great potential as therapeutic agents against intestinal inflammation, potential cytotoxicity, anti-inciting action, and suppression of anti-inflammatory activity may limit their development as anti-inflammatory agents. Peptide hybridization is an effective approach for the design and engineering of novel functional peptides because hybrid peptides combine the advantages and benefits of various native peptides. In the present study, a novel hybrid anti-inflammatory peptide that combines the active center of Cecropin A (C) and the core functional region of LL-37 (L) was designed [C-L peptide; C (1-8)-L (17-30)] through in silico analysis to reduce cytotoxicity and improve the anti-inflammatory activity of the parental peptides. The resulting C-L peptide exhibited lower cytotoxicity than either C or L peptides alone. C-L also exerted a protective effect against lipopolysaccharide (LPS)-induced inflammatory responses in RAW264.7 macrophages and in the intestines of a mouse model. The hybrid peptide exhibited increased anti-inflammatory activity compared to the parental peptides. C-L plays a role in protecting intestinal tissue from damage, LPS-induced weight loss, and leukocyte infiltration. In addition, C-L reduces the expression levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), IL-1 beta, and interferon-gamma (IFN-gamma), as well as reduces cell apoptosis. It also reduced mucosal barrier damage caused by LPS. The anti-inflammatory effects of the hybrid peptide were mainly attributed to its LPS-neutralizing activity and antagonizing the activation of LPS-induced Toll-like receptor 4-myeloid differentiation factor 2 (TLR4/MD2). The peptide also affected the TLR4-(nuclear factor kappa B) signaling pathway, modulating the inflammatory response upon LPS stimulation. Collectively, these findings suggest that the newly designed peptide, C-L, could be developed into a novel anti-inflammatory agent for animals or humans.	[Wei, Xubiao; Zhang, Lulu; Zhang, Rijun; Wu, Rujuan; Si, Dayong; Ahmad, Baseer; Li, Zhongxuan; Guo, Henan; Zhang, Manyi] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China; [Petitte, James N.; Mozdziak, Paul E.] North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC USA	China Agricultural University; University of North Carolina; North Carolina State University	Zhang, RJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	rjzhang@cau.edu.cn	zhang, lu/GRO-2969-2022; Ahmad, Baseer/ABG-5769-2021	mozdziak, paul/0000-0002-1575-3123; , Baseer/0000-0002-8177-0271; Petitte, James/0000-0003-2764-6007	National Key Research and Development Program of China [2018YFD0500600]; National Natural Science Foundation of China [31572442, 31272476]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Key Research and Development Program of China (grant number 2018YFD0500600) and National Natural Science Foundation of China (grant numbers 31572442 and 31272476).	Akiyama T, 2014, J INNATE IMMUN, V6, P739, DOI 10.1159/000362789; Anders E, 2018, BIOCHEM BIOPH RES CO, V501, P280, DOI 10.1016/j.bbrc.2018.04.235; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Banerjee S, 2016, MUCOSAL IMMUNOL, V9, P1418, DOI 10.1038/mi.2016.9; Barlow PG, 2006, J LEUKOCYTE BIOL, V80, P509, DOI 10.1189/jlb.1005560; Beaugerie L, 2015, NEW ENGL J MED, V373, P195, DOI 10.1056/NEJMc1505689; Brandenburg K, 2011, APPL MICROBIOL BIOT, V90, P799, DOI 10.1007/s00253-011-3185-7; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Burrin DG, 2005, ENDOCRINOLOGY, V146, P22, DOI 10.1210/en.2004-1119; Chen H, 2014, GUT, V63, P711, DOI 10.1136/gutjnl-2012-303731; Chen X, 2013, BIOCHEM BIOPH RES CO, V433, P532, DOI 10.1016/j.bbrc.2013.03.024; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P484; Choudhary S, 2001, DIGEST DIS SCI, V46, P2222, DOI 10.1023/A:1011975218006; Chubinskiy-Nadezhdin VI, 2013, CELL BIOL INT, V37, P617, DOI 10.1002/cbin.10079; Citi S, 2018, SCIENCE, V359, P1097, DOI 10.1126/science.aat0835; COOPER HS, 1993, LAB INVEST, V69, P238; da Silva VC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124016; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong N, 2014, BIOMATERIALS, V35, P8028, DOI 10.1016/j.biomaterials.2014.06.005; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Foit L, 2016, BIOMATERIALS, V100, P67, DOI 10.1016/j.biomaterials.2016.05.021; Fork C, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0439-4; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gao Y, 2013, J ANIM SCI, V91, P5614, DOI 10.2527/jas.2013-6528; Gibson PR, 2004, GUT, V53, P1724, DOI 10.1136/gut.2004.047092; Goluszko P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.051; Guo ST, 2011, BIOMATERIALS, V32, P4283, DOI 10.1016/j.biomaterials.2011.02.034; Gupta K, 2016, INNATE IMMUN-LONDON, V22, P21, DOI 10.1177/1753425915610643; Han FF, 2015, J IMMUNOL, V194, P1882, DOI 10.4049/jimmunol.1402300; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Heinbockel L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01704; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hering NA, 2009, DIGEST DIS, V27, P450, DOI 10.1159/000233283; Ince C, 2004, CRIT CARE MED, V32, P1963, DOI 10.1097/01.CCM.0000139617.88704.B9; Ishida W, 2016, INVEST OPHTH VIS SCI, V57, P30, DOI [10.1167/ iovs.15-17652, 10.1167/iovs.15-17652]; Jonsson D, 2012, J PERIODONTAL RES, V47, P330, DOI 10.1111/j.1600-0765.2011.01436.x; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Koberlin MS, 2016, CURR OPIN CELL BIOL, V39, P28, DOI 10.1016/j.ceb.2016.01.010; Lee E, 2015, ARCH INSECT BIOCHEM, V88, P31, DOI 10.1002/arch.21193; Lee JH, 2019, J MICROBIOL BIOTECHN, V29, P687, DOI 10.4014/jmb.1809.09031; Li QR, 2009, J CELL MOL MED, V13, P4061, DOI 10.1111/j.1582-4934.2009.00975.x; Li RL, 2012, PLANT CELL, V24, P2105, DOI 10.1105/tpc.112.095695; Li TH, 2017, ACS APPL MATER INTER, V9, P17681, DOI 10.1021/acsami.7b04718; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Liu H, 2020, J DIGEST DIS, V21, P385, DOI 10.1111/1751-2980.12909; Lopes PH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00636; Lopez-Rojas R, 2011, EUR J CLIN MICROBIOL, V30, P1391, DOI 10.1007/s10096-011-1233-y; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma Z, 2015, BIOMATERIALS, V52, P517, DOI 10.1016/j.biomaterials.2015.02.063; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matricon J, 2010, M S-MED SCI, V26, P405, DOI 10.1051/medsci/2010264405; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mu LX, 2017, AMINO ACIDS, V49, P1571, DOI 10.1007/s00726-017-2449-7; Neu J, 2006, SEMIN PERINATOL, V30, P77, DOI 10.1053/j.semperi.2006.02.007; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park EJ, 2010, J PEDIATR GASTR NUTR, V50, P321, DOI 10.1097/MPG.0b013e3181ae2ba0; Park S, 2017, BIOMATERIALS, V126, P49, DOI 10.1016/j.biomaterials.2017.02.023; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pathak AK, 2019, J CHEM THEORY COMPUT, V15, P2706, DOI 10.1021/acs.jctc.9b00005; Pi DA, 2014, J NUTR BIOCHEM, V25, P456, DOI 10.1016/j.jnutbio.2013.12.006; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Qi W, 2004, FASEB J, V18, pA15; Rajasekaran G, 2017, BBA-BIOMEMBRANES, V1859, P722, DOI 10.1016/j.bbamem.2017.01.037; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Saugar JM, 2002, ANTIMICROB AGENTS CH, V46, P875, DOI 10.1128/AAC.46.3.875-878.2002; Scott MG, 1999, INFECT IMMUN, V67, P2005; Segui J, 2005, INFLAMM BOWEL DIS, V11, P872, DOI 10.1097/01.MIB.0000183420.25186.7a; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Senthilkumar B, 2017, J CLUST SCI, V28, P2549, DOI 10.1007/s10876-017-1240-y; Sigman T, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-29; Siti HN, 2015, VASC PHARMACOL, V71, P40, DOI 10.1016/j.vph.2015.03.005; Song YS, 2014, BIOTECHNOL BIOPROC E, V19, P404, DOI 10.1007/s12257-014-0131-4; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stallmach Andreas, 2004, Int J Colorectal Dis, V19, P308, DOI 10.1007/s00384-003-0554-4; Stanbury RM, 1998, BRIT J OPHTHALMOL, V82, P704, DOI 10.1136/bjo.82.6.704; Stein C, 2012, CURR PHARM DESIGN, V18, P6053, DOI 10.2174/138161212803582513; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Sun Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/167572; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Velkov T, 2018, PHARMACOL THERAPEUT, V181, P85, DOI 10.1016/j.pharmthera.2017.07.012; Vieira ELM, 2012, J NUTR BIOCHEM, V23, P430, DOI 10.1016/j.jnutbio.2011.01.007; Ba VAP, 2018, ACS APPL MATER INTER, V10, P17100, DOI 10.1021/acsami.8b04287; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Wang B, 2016, J NUTR, V146, P501, DOI 10.3945/jn.115.224857; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang ZL, 2018, MAR DRUGS, V16, DOI 10.3390/md16020057; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Whitehouse MW, 2005, CURR MED CHEM, V12, P2931, DOI 10.2174/092986705774462879; Wicke C, 2000, ARCH SURG-CHICAGO, V135, P1265, DOI 10.1001/archsurg.135.11.1265; Wu BC, 2017, J IMMUNOL, V199, P3592, DOI 10.4049/jimmunol.1700985; Wu RJ, 2014, MOL BIOL REP, V41, P4163, DOI 10.1007/s11033-013-2900-0; Yu HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11082; Yu HT, 2020, FASEB J, V34, P1018, DOI 10.1096/fj.201901717R; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; Zhang D, 2009, INT J COLORECTAL DIS, V24, P5, DOI 10.1007/s00384-008-0544-7; Zhang YL, 2018, EUR J MED CHEM, V148, P291, DOI 10.1016/j.ejmech.2018.02.008; Zong X, 2016, BIOCHEM PHARMACOL, V104, P74, DOI 10.1016/j.bcp.2016.01.009; Zou DY, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2020.102652	115	3	3	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16049	16072		10.1096/fj.201903263RRR	http://dx.doi.org/10.1096/fj.201903263RRR		OCT 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058296				2022-12-28	WOS:000581158000001
J	Danes, JM; de Abreu, ALP; Kerketta, R; Huang, YP; Palma, FR; Gantner, BN; Mathison, AJ; Urrutia, RA; Bonini, MG				Danes, Jeanne M.; de Abreu, Andre L. P.; Kerketta, Romica; Huang, Yunping; Palma, Flavio R.; Gantner, Benjamin N.; Mathison, Angela J.; Urrutia, Raul A.; Bonini, Marcelo G.			Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer	FASEB JOURNAL			English	Article						arsenic; breast cancer; environmental exposures; estrogen receptor	ESTROGEN-RECEPTOR-ALPHA; EXPRESSION; DATABASE	Inorganic arsenic (iAs/As2O32-) is an environmental toxicant found in watersheds around the world including in densely populated areas. iAs is a class I carcinogen known to target the skin, lungs, bladder, and digestive organs, but its role as a primary breast carcinogen remains controversial. Here, we examined a different possibility: that exposure to iAs promotes the transition of well-differentiated epithelial breast cancer cells characterized by estrogen and progesterone receptor expression (ER+/PR+), to more basal phenotypes characterized by active proliferation, and propensity to metastasis in vivo. Our results indicate two clear phenotypic responses to low-level iAs that depend on the duration of the exposure. Short-term pulses of iAs activate ER signaling, consistent with its reported pseudo-estrogen activity, but longer-term, chronic treatments for over 6 months suppresses both ER and PR expression and signaling. In fact, washout of these chronically exposed cells for up to 1 month failed to fully reverse the transcriptional and phenotypic effects of prolonged treatments, indicating durable changes in cellular physiologic identity. RNA-seq studies found that chronic iAs drives the transition toward more basal phenotypes characterized by impaired hormone receptor signaling despite the conservation of estrogen receptor expression. Because treatments for breast cancer patients are largely designed based on the detection of hormone receptor expression, our results suggest greater scrutiny of ER+ cancers in patients exposed to iAs, because these tumors may spawn more aggressive phenotypes than unexposed ER+ tumors, in particular, basal subtypes that tend to develop therapy resistance and metastasis.	[Danes, Jeanne M.; Huang, Yunping; Palma, Flavio R.; Bonini, Marcelo G.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, 303 E Super St,Suite 7-123, Chicago, IL 60611 USA; [de Abreu, Andre L. P.] Univ Illinois, Dept Med, Chicago, IL USA; [Kerketta, Romica; Mathison, Angela J.; Urrutia, Raul A.] Med Coll Wisconsin, Dept Surg, Gen Sci & Precis Med Ctr GSPMC, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Gantner, Benjamin N.] Med Coll Wisconsin, Dept Med, Div Endocrinol, Milwaukee, WI 53226 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical College of Wisconsin; Medical College of Wisconsin	Bonini, MG (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, 303 E Super St,Suite 7-123, Chicago, IL 60611 USA.	marcelo.bonini@northwestern.edu		Palma, Flavio/0000-0003-4350-2708	HHS | NIH | National Cancer Institute (NCI) [RO1CA216882]; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [RO1ES028149]; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [RO1AI131267]; Advancing a Healthier Wisconsin Endowment; DOD | United States Army | RDECOM | Army Research Office (ARO) [71138LS]	HHS | NIH | National Cancer Institute (NCI); HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); Advancing a Healthier Wisconsin Endowment; DOD | United States Army | RDECOM | Army Research Office (ARO)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: RO1CA216882; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: RO1ES028149; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: RO1AI131267; Advancing a Healthier Wisconsin Endowment; DOD | United States Army | RDECOM | Army Research Office (ARO), Grant/Award Number: 71138LS	Al-Eryani L, 2018, TOXICOL SCI, V162, P645, DOI 10.1093/toxsci/kfx292; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cardoso APF, 2018, TOXICOL SCI, V165, P284, DOI 10.1093/toxsci/kfy128; Carlin DJ, 2016, ENVIRON HEALTH PERSP, V124, P890, DOI 10.1289/ehp.1510209; Chatterjee K, 2018, SOUTH ASIAN J CANCER, V7, P5, DOI 10.4103/sajc.sajc_60_17; Chen GC, 2002, ANTICANCER RES, V22, P633; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; Garcia-Esquinas E, 2013, CANCER EPIDEM BIOMAR, V22, P1944, DOI 10.1158/1055-9965.EPI-13-0234-T; Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011; Hart PC, 2016, ONCOTARGET, V7, P308, DOI 10.18632/oncotarget.5687; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Khanjani N, 2017, REV ENVIRON HEALTH, V32, P267, DOI 10.1515/reveh-2016-0068; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lopez-Carrillo L, 2020, ENVIRON RES, V184, DOI 10.1016/j.envres.2020.109361; Luo M, 2015, CURR PHARM DESIGN, V21, P1301, DOI 10.2174/1381612821666141211120604; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rahman M, 2015, Gulf J Oncolog, V1, P34; Ruiz-Ramos R, 2009, TOXICOL APPL PHARM, V241, P269, DOI 10.1016/j.taap.2009.09.006; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Selmin OI, 2019, INT J ONCOL, V54, P869, DOI 10.3892/ijo.2019.4687; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stoica A, 2000, ENDOCRINOLOGY, V141, P3595, DOI 10.1210/en.141.10.3595; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tang BW, 2015, STEM CELL REP, V4, P155, DOI 10.1016/j.stemcr.2014.11.002; Telli ML, 2011, BREAST CANCER RES TR, V127, P471, DOI 10.1007/s10549-010-1173-8; Xie H, 2014, MUTAT RES-GEN TOX EN, V760, P33, DOI 10.1016/j.mrgentox.2013.11.001; Xu Y, 2014, ARCH TOXICOL, V88, P263, DOI 10.1007/s00204-013-1131-4; Zhang YX, 2019, CHEM-BIOL INTERACT, V310, DOI 10.1016/j.cbi.2019.06.032; Zimmermann MT, 2019, PEERJ, V7, DOI 10.7717/peerj.6994	30	5	5	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16034	16048		10.1096/fj.202001192R	http://dx.doi.org/10.1096/fj.202001192R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047385	Green Accepted			2022-12-28	WOS:000581167800001
J	Patterson, L; Allen, J; Posey, I; Shaw, JJP; Costa-Pinheiro, P; Walker, SJ; Gademsey, A; Wu, XN; Wu, SG; Zachos, NC; Fox, TE; Sears, CL; Kester, M				Patterson, Logan; Allen, Jawara; Posey, Isabella; Shaw, Jeremy Joseph Porter; Costa-Pinheiro, Pedro; Walker, Susan J.; Gademsey, Alexis; Wu, Xinqun; Wu, Shaoguang; Zachos, Nicholas C.; Fox, Todd E.; Sears, Cynthia L.; Kester, Mark			Glucosylceramide production maintains colon integrity in response toBacteroides fragilistoxin-induced colon epithelial cell signaling	FASEB JOURNAL			English	Article						Bacteroides fragilistoxin; glucosylceramides; organoids; permeability; tight junctions	ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; SPHINGOLIPID METABOLISM; TIGHT JUNCTIONS; INTESTINAL PHYSIOLOGY; HUMAN COMMENSAL; CANCER-CELLS; MODEL; ADHERENS; COLITIS; GLYCOSPHINGOLIPIDS	EnterotoxigenicBacteroides fragilis(ETBF) is a commensal bacterium of great importance to human health due to its ability to induce colitis and cause colon tumor formation in mice through the production ofB. fragilistoxin (BFT). The formation of tumors is dependent on a pro-inflammatory signaling cascade, which begins with the disruption of epithelial barrier integrity through cleavage of E-cadherin. Here, we show that BFT increases levels of glucosylceramide, a vital intestinal sphingolipid, both in mice and in colon organoids (colonoids) generated from the distal colons of mice. When colonoids are treated with BFT in the presence of an inhibitor of glucosylceramide synthase (GCS), the enzyme responsible for generating glucosylceramide, colonoids become highly permeable, lose structural integrity, and eventually burst, releasing their contents into the extracellular matrix. By increasing glucosylceramide levels in colonoids via an inhibitor of glucocerebrosidase (GBA, the enzyme that degrades glucosylceramide), colonoid permeability was reduced, and bursting was significantly decreased. In the presence of BFT, pharmacological inhibition of GCS caused levels of tight junction protein 1 (TJP1) to decrease. However, when GBA was inhibited, TJP1 levels remained stable, suggesting that BFT-induced production of glucosylceramide helps to stabilize tight junctions. Taken together, our data demonstrate a glucosylceramide-dependent mechanism by which the colon epithelium responds to BFT.	[Patterson, Logan; Shaw, Jeremy Joseph Porter; Costa-Pinheiro, Pedro] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Allen, Jawara; Wu, Xinqun; Wu, Shaoguang; Zachos, Nicholas C.; Sears, Cynthia L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Posey, Isabella] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Walker, Susan J.; Gademsey, Alexis; Fox, Todd E.; Kester, Mark] Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,Pinn Hall,POB 800735, Charlottesville, VA 22908 USA	University of Virginia; Johns Hopkins University; University of Virginia; University of Virginia	Kester, M (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,Pinn Hall,POB 800735, Charlottesville, VA 22908 USA.	mkester@virginia.edu	Kester, Mark/ABG-4615-2020; Zachos, Nicholas/GWC-7914-2022	Patterson, Logan/0000-0002-4825-0565; Allen, Jawara/0000-0002-6274-0499	Bloomberg Philanthropies; Integrated Physiology and Imaging Cores of the Hopkins Conte Digestive Disease Basic and Translational Research Core Center [NIH DK-089502, S10 OD025244]	Bloomberg Philanthropies; Integrated Physiology and Imaging Cores of the Hopkins Conte Digestive Disease Basic and Translational Research Core Center	This work was supported by Bloomberg Philanthropies (to CLS). The authors also wish to acknowledge the Integrated Physiology and Imaging Cores of the Hopkins Conte Digestive Disease Basic and Translational Research Core Center (NIH DK-089502) for providing growth factor conditioned media for colonoids and use of Olympus FV3000RS confocal microscope (S10 OD025244).	Allen J, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00447-18; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; An DD, 2011, P NATL ACAD SCI USA, V108, P4666, DOI 10.1073/pnas.1001501107; Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Arai K, 2015, J OLEO SCI, V64, P737, DOI 10.5650/jos.ess15005; Beckham TH, 2013, ADV CANCER RES, V117, P1, DOI 10.1016/B978-0-12-394274-6.00001-7; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Campbell HK, 2017, EXP CELL RES, V358, P39, DOI 10.1016/j.yexcr.2017.03.061; Chambers FG, 1997, INFECT IMMUN, V65, P3561, DOI 10.1128/IAI.65.9.3561-3570.1997; Chan JL, 2019, MUCOSAL IMMUNOL, V12, P164, DOI 10.1038/s41385-018-0085-5; Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]; Co JY, 2019, CELL REP, V26, P2509, DOI 10.1016/j.celrep.2019.01.108; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Deng ZB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7956; Duan RD, 2009, PROG LIPID RES, V48, P62, DOI 10.1016/j.plipres.2008.04.003; Franco AA, 2005, INFECT IMMUN, V73, P5273, DOI 10.1128/IAI.73.8.5273-5277.2005; Franco AA, 2002, MOL MICROBIOL, V45, P1067, DOI 10.1046/j.1365-2958.2002.03077.x; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Gouaze V, 2004, MOL CANCER THER, V3, P633; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hadi LA, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3827684; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heaver SL, 2018, CURR OPIN MICROBIOL, V43, P92, DOI 10.1016/j.mib.2017.12.011; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Housseau F, 2010, CELL CYCLE, V9, P3, DOI 10.4161/cc.9.1.10352; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; In J, 2016, CELL MOL GASTROENTER, V2, P48, DOI 10.1016/j.jcmgh.2015.10.001; In JG, 2019, JOVE-J VIS EXP, DOI 10.3791/59357; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Itier JM, 2014, J INHERIT METAB DIS, V37, P1013, DOI 10.1007/s10545-014-9724-5; Jennemann R, 2012, J BIOL CHEM, V287, P32598, DOI 10.1074/jbc.M112.371005; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Landy J, 2016, WORLD J GASTROENTERO, V22, P3117, DOI 10.3748/wjg.v22.i11.3117; Liu LX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67104-4; Machala M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236051; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449; MYERS LL, 1987, AM J VET RES, V48, P774; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schnaar RL, 2017, ESSENTIALS GLYCOBIOL, V3rd, P2015, DOI 10.1101/glycobiology.3e.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sears CL, 2001, TOXICON, V39, P1737, DOI 10.1016/S0041-0101(01)00160-X; Shayman JA, 2006, SPHINGOLIPID BIOL, P83, DOI DOI 10.1007/2F4-431-34200-1_6; Vardi A, 2016, J PATHOL, V239, P496, DOI 10.1002/path.4751; von Gerichten J, 2017, J LIPID RES, V58, P1247, DOI 10.1194/jlr.D076190; Wells CL, 1996, GASTROENTEROLOGY, V110, P1429, DOI 10.1053/gast.1996.v110.pm8613048; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2002, INFECT IMMUN, V70, P2463, DOI 10.1128/IAI.70.5.2463-2471.2002; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995; Zigmond E, 2007, GUT, V56, P82, DOI 10.1136/gut.2006.095497; Zschiebsch K, 2016, J CROHNS COLITIS, V10, P965, DOI 10.1093/ecco-jcc/jjw056	63	12	12	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15922	15945		10.1096/fj.202001669R	http://dx.doi.org/10.1096/fj.202001669R		OCT 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047400	Green Accepted			2022-12-28	WOS:000581170800001
J	Cappellini, A; Mongiorgi, S; Finelli, C; Fazio, A; Ratti, S; Marvi, MV; Curti, A; Salvestrini, V; Pellagatti, A; Billi, AM; Suh, PG; McCubrey, JA; Boultwood, J; Manzoli, L; Cocco, L; Follo, MY				Cappellini, Alessandra; Mongiorgi, Sara; Finelli, Carlo; Fazio, Antonietta; Ratti, Stefano; Marvi, Maria Vittoria; Curti, Antonio; Salvestrini, Valentina; Pellagatti, Andrea; Billi, Anna Maria; Suh, Pann-Ghill; McCubrey, James A.; Boultwood, Jacqueline; Manzoli, Lucia; Cocco, Lucio; Follo, Matilde Y.			Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS)	FASEB JOURNAL			English	Article						deferasirox; inositides; reactive oxygen species	NUCLEAR PI-PLCBETA1; BONE-MARROW; DEFERASIROX; CELLS; ACTIVATION; OVERLOAD; DIFFERENTIATION; AZACITIDINE; INVOLVEMENT; EXPRESSION	MDS are characterized by anemia and transfusion requirements. Transfused patients frequently show iron overload that negatively affects hematopoiesis. Iron chelation therapy can be effective in these MDS cases, but the molecular consequences of this treatment need to be further investigated. That is why we studied the molecular features of iron effect and Deferasirox therapy on PI-PLCbeta1 inositide signaling, using hematopoietic cells and MDS samples. At baseline, MDS patients showing a positive response after iron chelation therapy displayed higher levels of PI-PLCbeta1/Cyclin D3/PKCalpha expression. During treatment, these responder patients, as well as hematopoietic cells treated with FeCl(3)and Deferasirox, showed a specific reduction of PI-PLCbeta1/Cyclin D3/PKCalpha expression, indicating that this signaling pathway is targeted by Deferasirox. The treatment was also able to specifically decrease the production of ROS. This effect correlated with a reduction of IL-1A and IL-2, as well as Akt/mTOR phosphorylation. In contrast, cells exposed only to FeCl(3)and cells from MDS patients refractory to Deferasirox showed a specific increase of ROS and PI-PLCbeta1/Cyclin D3/PKCalpha expression. All in all, our data show that PI-PLCbeta1 signaling is a target for iron-induced oxidative stress and suggest that baseline PI-PLCbeta1 quantification could predict iron chelation therapy response in MDS.	[Cappellini, Alessandra; Mongiorgi, Sara; Fazio, Antonietta; Ratti, Stefano; Marvi, Maria Vittoria; Billi, Anna Maria; Manzoli, Lucia; Cocco, Lucio; Follo, Matilde Y.] Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Via Irnerio 48, I-40126 Bologna, Italy; [Finelli, Carlo; Curti, Antonio; Salvestrini, Valentina] Univ Hosp S Orsola Malpighi, Inst Hematol L & A Seragnoli, Dept Hematol & Oncol, Bologna, Italy; [Pellagatti, Andrea; Boultwood, Jacqueline] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Blood Canc UK Mol Haematol Unit, Oxford, England; [Pellagatti, Andrea; Boultwood, Jacqueline] Oxford BRC Haematol Theme, Oxford, England; [Suh, Pann-Ghill] Korea Brain Res Inst, Daegu, South Korea; [Suh, Pann-Ghill] UNIST, Sch Life Sci, Ulsan, South Korea; [McCubrey, James A.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Oxford; Korea Brain Research Institute (KBRI); Ulsan National Institute of Science & Technology (UNIST); University of North Carolina; East Carolina University	Cocco, L; Follo, MY (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Via Irnerio 48, I-40126 Bologna, Italy.	lucio.cocco@unibo.it; matilde.follo@unibo.it	ratti, stefano/AAC-8714-2022	RATTI, STEFANO/0000-0002-6258-5345; Curti, Antonio/0000-0002-7752-6049; Pellagatti, Andrea/0000-0002-6122-0221	Italian Ministry of Education, University and Research-Research Projects of National Interest; Intesa San Paolo Foundation; Blood Cancer UK [13042]	Italian Ministry of Education, University and Research-Research Projects of National Interest; Intesa San Paolo Foundation; Blood Cancer UK	Italian Ministry of Education, University and Research-Research Projects of National Interest; Intesa San Paolo Foundation; Blood Cancer UK, Grant/Award Number: 13042	Angelucci E, 2014, EUR J HAEMATOL, V92, P527, DOI 10.1111/ejh.12300; Bae J, 2008, J MICROBIOL BIOTECHN, V18, P377; Bowen D, 2003, HAEMATOLOGICA, V88, P1070; Cappellini Maria Domenica, 2007, Ther Clin Risk Manag, V3, P291, DOI 10.2147/tcrm.2007.3.2.291; Casciaro F, 2018, AGING-US, V10, P2911, DOI 10.18632/aging.101599; Cermak J, 2013, LEUKEMIA RES, V37, P1612, DOI 10.1016/j.leukres.2013.07.021; Chan S, 2015, CELL PHYSIOL BIOCHEM, V36, P2063, DOI 10.1159/000430173; Chen YL, 2015, BBA-MOL CELL RES, V1853, P2662, DOI 10.1016/j.bbamcr.2015.07.025; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cocco L, 2015, J LEUKOCYTE BIOL, V98, P769, DOI 10.1189/jlb.2MA1114-541R; Fabiani E, 2019, BRIT J HAEMATOL, V185, P954, DOI 10.1111/bjh.15655; Faenza I, 2005, ANTICANCER RES, V25, P2039; Faenza I, 2003, J CELL PHYSIOL, V195, P446, DOI 10.1002/jcp.10264; Follo MY, 2012, LEUKEMIA, V26, P2474, DOI 10.1038/leu.2012.133; Follo MY, 2012, LEUKEMIA, V26, P943, DOI 10.1038/leu.2011.300; Follo MY, 2011, LEUKEMIA, V25, P271, DOI 10.1038/leu.2010.266; Follo MY, 2019, LEUKEMIA, V33, P2276, DOI 10.1038/s41375-019-0416-x; Follo Matilde Y., 2013, Advances in Biological Regulation, V53, P2, DOI 10.1016/j.jbior.2012.09.009; Follo MY, 2010, J CELL BIOCHEM, V109, P1065, DOI 10.1002/jcb.22483; Forciniti S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062257; Garlanda C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00396; Gattermann N, 2012, HAEMATOL-HEMATOL J, V97, P1364, DOI 10.3324/haematol.2011.048546; Ghoti H, 2010, HAEMATOL-HEMATOL J, V95, P1433, DOI 10.3324/haematol.2010.024992; Gozali MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep27402; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Guida M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/456937; Harmening D, 1983, MODERN BLOOD BANKING; Hartmann J, 2013, LEUKEMIA RES, V37, P327, DOI 10.1016/j.leukres.2012.11.005; Jayavelu AK, 2016, EXP HEMATOL, V44, P1113, DOI 10.1016/j.exphem.2016.08.008; Jimenez-Solas T, 2019, BRIT J HAEMATOL, V187, P93, DOI 10.1111/bjh.16013; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Keune Willem-Jan, 2013, Adv Biol Regul, V53, P179, DOI 10.1016/j.jbior.2013.02.001; Leitch HA, 2019, CRIT REV ONCOL HEMAT, V141, P54, DOI 10.1016/j.critrevonc.2019.06.002; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lo Vasco VR, 2004, LEUKEMIA, V18, P1122, DOI 10.1038/sj.leu.2403368; MANZOLI L, 1995, CANCER RES, V55, P2978; Manzoli L, 2014, MINI-REV MED CHEM, V14, P873, DOI 10.2174/1389557514666141013125936; Messa E, 2010, HAEMATOL-HEMATOL J, V95, P1308, DOI 10.3324/haematol.2009.016824; Mongiorgi S, 2016, EXPERT OPIN THER TAR, V20, P677, DOI 10.1517/14728222.2016.1125885; Mongiorgi S, 2016, CURR PHARM DESIGN, V22, P2345, DOI 10.2174/1381612822666160226132338; NOCKA KH, 1988, CANCER RES, V48, P3571; Nolte F, 2013, ANN HEMATOL, V92, P191, DOI 10.1007/s00277-012-1594-z; Novotna B, 2009, LEUKEMIA RES, V33, P340, DOI 10.1016/j.leukres.2008.07.005; Pellagatti A, 2016, LEUKEMIA, V30, P247, DOI 10.1038/leu.2015.129; Poli A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092080; Poli A, 2018, FASEB J, V32, P681, DOI 10.1096/fj.201700690R; Poli A, 2017, J CELL PHYSIOL, V232, P2550, DOI 10.1002/jcp.25642; Poli A, 2014, BIOCHEM SOC T, V42, P1471, DOI 10.1042/BST20140128; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; Ratti S, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118649; Ratti S, 2019, J LIPID RES, V60, P312, DOI 10.1194/jlr.R089763; Ratti Stefano, 2018, Advances in Biological Regulation, V67, P1, DOI 10.1016/j.jbior.2017.10.008; Ratti S, 2017, J CELL BIOCHEM, V118, P1969, DOI 10.1002/jcb.25894; Saigo Katsuyasu, 2013, J Clin Med Res, V5, P57, DOI 10.4021/jocmr1180w; Silva A, 2011, LEUKEMIA, V25, P960, DOI 10.1038/leu.2011.56; Song MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134235; Suire S, 2019, J LEUKOCYTE BIOL, V106, P815, DOI 10.1002/JLB.2HI0918-359RR; Tataranni T, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1293-y; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Xian J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030697; Zeitz MJ, 2009, J CELL BIOCHEM, V108, P125, DOI 10.1002/jcb.22234; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhu GZ, 2018, CELL IMMUNOL, V328, P9, DOI 10.1016/j.cellimm.2018.02.015; Zuo Y, 2009, CELL RES, V19, P449, DOI 10.1038/cr.2009.19	64	2	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15400	15416		10.1096/fj.202000933RR	http://dx.doi.org/10.1096/fj.202000933RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959428	Green Published, hybrid			2022-12-28	WOS:000573858100001
J	Wang, J; Han, CH; Lu, Z; Ge, PP; Cui, Y; Zhao, DD; Yang, X; Wu, B; Qiang, LH; Zhang, Y; Chai, QY; Lei, ZH; Li, L; Liu, CH; Zhang, LQ				Wang, Jing; Han, Conghui; Lu, Zhe; Ge, Pupu; Cui, Yu; Zhao, Dongdong; Yang, Xi; Wu, Bo; Qiang, Lihua; Zhang, Yong; Chai, Qiyao; Lei, Zehui; Li, Ling; Hua Liu, Cui; Zhang, Lingqiang			Simulated microgravity suppresses MAPK pathway-mediated innate immune response to bacterial infection and induces gut microbiota dysbiosis	FASEB JOURNAL			English	Article						gut microbiota; innate immunity; MAPK pathway; probiotics; simulated microgravity	SPACE; VSLNUMBER-3; SPACEFLIGHT; SYSTEM; HYPERGRAVITY; INTERFERON; PROBIOTICS; JNK	During spaceflight, astronauts are subjected to various physical stressors including microgravity, which could cause immune dysfunction and thus potentially predispose astronauts to infections and illness. However, the mechanisms by which microgravity affects innate immunity remain largely unclear. In this study, we conducted RNA-sequencing analysis to show that simulated microgravity (SMG) suppresses the production of inflammatory cytokines including tumor necrosis factor (TNF) and interleukin-6 (IL-6) as well as the activation of the innate immune signaling pathways including the p38 mitogen-activated protein kinase (MAPK) and the Erk1/2 MAPK pathways in the Enteropathogenic escherichia coli (EPEC)-infected macrophage cells. We then adopted hindlimb-unloading (HU) mice, a model mimicking the microgravity of a spaceflight environment, to demonstrate that microgravity suppresses proinflammatory cytokine-mediated intestinal immunity toCitrobacter rodentiuminfection and induces the disturbance of gut microbiota, both of which phenotypes could be largely corrected by the introduction of VSL#3, a high-concentration probiotic preparation of eight live freeze-dried bacterial species. Taken together, our study provides new insights into microgravity-mediated innate immune suppression and intestinal microbiota disturbance, and suggests that probiotic VSL#3 has great potential as a dietary supplement in protecting individuals from spaceflight mission-associated infections and gut microbiota dysbiosis.	[Wang, Jing; Lu, Zhe; Ge, Pupu; Zhao, Dongdong; Qiang, Lihua; Zhang, Yong; Chai, Qiyao; Lei, Zehui; Hua Liu, Cui] Chinese Acad Sci, Ctr Biosafety Mega Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Han, Conghui; Li, Ling] Southern Med Univ, Sch Publ Hlth, Guangzhou, Peoples R China; [Lu, Zhe; Ge, Pupu; Zhao, Dongdong; Qiang, Lihua; Chai, Qiyao; Lei, Zehui; Hua Liu, Cui] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China; [Cui, Yu; Yang, Xi; Wu, Bo; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci, State Key Lab Prote, Beijing, Peoples R China	Chinese Academy of Sciences; Southern Medical University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, CH (corresponding author), Chinese Acad Sci, Ctr Biosafety Mega Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	liucuihua@im.ac.cn	Zhang, Yong/ABG-3082-2021		National Science and Technology Major Project [2018ZX10101004]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29020000]; Key Program of Logistics Research [BWS17J030]; National Key Research and Development Program of China [2017YFA0505900, 2017YFD0500300]; National Natural Science Foundation of China [81825014, 31830003]	National Science and Technology Major Project; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Program of Logistics Research; National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Science and Technology Major Project, Grant/Award Number: 2018ZX10101004; Strategic Priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDB29020000; Key Program of Logistics Research, Grant/Award Number: BWS17J030; National Key Research and Development Program of China, Grant/Award Number: 2017YFA0505900 and 2017YFD0500300; National Natural Science Foundation of China, Grant/Award Number: 81825014 and 31830003	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bai P, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.917; Benjamin CL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88787; BERRY WD, 1991, J INTERFERON RES, V11, P243, DOI 10.1089/jir.1991.11.243; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Bigley AB, 2019, J APPL PHYSIOL, V126, P842, DOI 10.1152/japplphysiol.00761.2018; Bradley JH, 2017, LIFE SCI SPACE RES, V15, P55, DOI 10.1016/j.lssr.2017.08.002; Candela M, 2015, CRIT REV MICROBIOL, V41, P165, DOI 10.3109/1040841X.2013.813900; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chakraborty N, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-017-0038-4; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Costantini TW, 2009, J SURG RES, V156, P64, DOI 10.1016/j.jss.2009.03.066; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian BE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01437; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Delgado S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020391; Delia P, 2002, AM J GASTROENTEROL, V97, P2150; Dore J, 2017, THERAPIE, V72, P21, DOI 10.1016/j.therap.2016.12.007; Fajardo-Cavazos P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00999; Fonte C, 2019, FASEB J, V33, P896, DOI 10.1096/fj.201800969R; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Gionchetti P, 2005, GASTROENTEROL CLIN N, V34, P499, DOI 10.1016/j.gtc.2005.05.003; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Globus RK, 2016, J APPL PHYSIOL, V120, P1196, DOI 10.1152/japplphysiol.00997.2015; Goto Y, 2016, NAT IMMUNOL, V17, P1244, DOI 10.1038/ni.3587; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Guan CY, 2019, EXP CELL RES, V378, P182, DOI 10.1016/j.yexcr.2019.03.018; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Hammaker D, 2012, ARTHRITIS RHEUM-US, V64, P678, DOI 10.1002/art.33359; Hawkins W R, 1975, Ophthalmic Surg, V6, P66; Jin ML, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00729; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Q, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-1289-4; Long KZ, 2010, INFECT IMMUN, V78, P1221, DOI 10.1128/IAI.00767-09; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Mehta SK, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0015-y; Paulsen K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/538786; Perez-Lopez A, 2016, NAT REV IMMUNOL, V16, P135, DOI 10.1038/nri.2015.17; Pimentel-Nunes P, 2010, EXPERT OPIN THER TAR, V14, P347, DOI 10.1517/14728221003642027; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saei AA, 2012, FUTURE MICROBIOL, V7, P1037, DOI [10.2217/FMB.12.82, 10.2217/fmb.12.82]; Sonnenfeld G, 2005, CURR PHARM BIOTECHNO, V6, P343, DOI 10.2174/1389201054553699; Tackett N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50311-z; TAYLOR GR, 1983, AVIAT SPACE ENVIR MD, V54, pS55; Wieers G, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00454; Xiao ZP, 2018, INT J RETAIL DISTRIB, V46, P2, DOI 10.1108/IJRDM-03-2016-0036; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zechner D, 1998, J BIOL CHEM, V273, P8232, DOI 10.1074/jbc.273.14.8232; Zhuang XN, 2017, CELL MOL IMMUNOL, V14, P237, DOI 10.1038/cmi.2016.52	56	12	13	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14631	14644		10.1096/fj.202001428R	http://dx.doi.org/10.1096/fj.202001428R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918764				2022-12-28	WOS:000570683700001
J	Wang, YF; Singh, AR; Zhao, YY; Du, T; Huang, YT; Wan, XH; Mukhopadhyay, D; Wang, Y; Wang, NP; Zhang, P				Wang, Yinfang; Singh, Angom Ramcharan; Zhao, Yuanyuan; Du, Tao; Huang, Yitong; Wan, Xiaohong; Mukhopadhyay, Debabrata; Wang, Ying; Wang, Nanping; Zhang, Peng			TRIM28 regulates sprouting angiogenesis through VEGFR-DLL4-Notch signaling circuit	FASEB JOURNAL			English	Article						DLL4; sprouting angiogenesis; Tip cell; TRIM28; VEGFR	TIP CELLS; PROTEIN; VEGF; INHIBITION; DLL4; HIF-1-ALPHA; EXPRESSION; DELTA; RBPJ	Sprouting angiogenesis is a highly coordinately process controlled by vascular endothelial growth factor receptor (VEGFR)-Notch signaling. Here we investigated whether Tripartite motif-containing 28 (TRIM28), which is an epigenetic modifier implicated in gene transcription and cell differentiation, is essential to mediate sprouting angiogenesis. We observed that knockdown ofTRIM28ortholog in zebrafish resulted in developmental vascular defect with disorganized and reduced vasculatures. Consistently, TRIM28 knockdown inhibited angiogenic sprouting of cultured endothelial cells (ECs), which exhibited increased mRNA levels of VEGFR1, Delta-like (DLL) 3, and Notch2 but reduced levels of VEGFR2, DLL1, DLL4, Notch1, Notch3, and Notch4.The regulative effects of TRIM28 on these angiogenic factors were partially mediated by hypoxia-inducible factor 1 alpha (HIF-1 alpha) and recombination signal-binding protein for immunoglobulin kappa J region (RBPJ kappa). In vitro DNA-binding assay showed that TRIM28 knockdown increased the association of RBPJ kappa with DNA sequences containing HIF-1 alpha-binding sites. Moreover, the phosphorylation of TRIM28 was controlled by VEGF and Notch1 through a mechanism involving RBPJ kappa-dual-specificity phosphatase (DUSP)-p38 MAPK, indicating a negative feedback mechanism. These findings established TRIM28 as a crucial regulator of VEGFR-Notch signaling circuit through HIF-1 alpha and RBPJ kappa in EC sprouting angiogenesis.	[Wang, Yinfang; Zhao, Yuanyuan; Huang, Yitong; Wan, Xiaohong; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Cent Lab, Putuo Hosp, Shanghai, Peoples R China; [Wang, Yinfang; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovas Med, Shanghai, Peoples R China; [Singh, Angom Ramcharan; Mukhopadhyay, Debabrata; Wang, Ying] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Du, Tao] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China; [Wan, Xiaohong; Zhang, Peng] Anhui Med Univ, Shanghai Putuo Cent Sch Clin Med, Hefei, Peoples R China; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Mayo Clinic; Tongji University; Anhui Medical University; Dalian Medical University	Wang, Y (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA.; Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China.; Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovasc Med, Shanghai, Peoples R China.	wang.ying@mayo.edu; zhangnep@hotmail.com		Wang, Ying/0000-0002-7852-386X; Wang, Nanping/0000-0002-8528-8132	National Natural Science Foundation of China [81770443, 81870327]; NHLBI [HL140411]; American Heart Association [19CDA34700013]; Mayo Clinic CCaTS; Clinical Superior Discipline Development Fund of Shanghai Putuo District [ptkwws201901, 2019ysxk01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Mayo Clinic CCaTS; Clinical Superior Discipline Development Fund of Shanghai Putuo District	This work was supported by the National Natural Science Foundation of China (81770443 to PZ, 81870327 to YFW), NHLBI (#HL140411 to DM), American Heart Association (#19CDA34700013 to YW), and Mayo Clinic CCaTS (Ted and Loretta Rogers Cardiovascular Career Development Award Honoring Hugh C. Smith to YW), Clinical Superior Discipline Development Fund of Shanghai Putuo District(#ptkwws201901 and #2019ysxk01 to PZ).	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Cammas F, 2000, DEVELOPMENT, V127, P2955; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Childs S, 2002, DEVELOPMENT, V129, P973; Chitramuthu BP, 2013, JOVE-J VIS EXP, DOI 10.3791/50644; de Sio FRS, 2012, FASEB J, V26, P4561, DOI 10.1096/fj.12-206177; Diaz-Trelles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12088; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gessler M, 2009, BLOOD, V113, P5375, DOI 10.1182/blood-2009-02-205468; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Ho RXY, 2018, J MOL CELL BIOL, V10, P195, DOI 10.1093/jmcb/mjy002; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; King CA, 2013, J VIROL, V87, P8779, DOI 10.1128/JVI.02976-12; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Layden MJ, 2013, NAT PROTOC, V8, P924, DOI 10.1038/nprot.2013.009; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Li ZB, 2003, EMBO J, V22, P1857, DOI 10.1093/emboj/cdg173; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Moriya J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0180-9; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Rousseaux MWC, 2018, ELIFE, V7, DOI 10.7554/eLife.36768; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Suchting S, 2009, CELL, V137, P988, DOI 10.1016/j.cell.2009.05.024; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trindade A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3171-2; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Wang YF, 2017, FASEB J, V31, P2026, DOI 10.1096/fj.201600988RR; Yang CZ, 2013, J SURG RES, V183, P478, DOI 10.1016/j.jss.2013.01.009; Zhang LM, 2014, J VIROL, V88, P6873, DOI 10.1128/JVI.00283-14; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800	48	6	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14710	14724		10.1096/fj.202000186RRR	http://dx.doi.org/10.1096/fj.202000186RRR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918765				2022-12-28	WOS:000570676900001
J	Ma, L; Tian, MX; Sun, QY; Liu, NN; Dong, JF; Feng, K; Wu, YK; Wang, YX; Wang, GY; Chen, W; Xi, JJ; Kang, JH				Ma, Li; Tian, Meng-Xue; Sun, Qiao-Yi; Liu, Na-Na; Dong, Jian-Feng; Feng, Ke; Wu, Yu-Kang; Wang, Yu-Xi; Wang, Gui-Ying; Chen, Wen; Xi, Jia-Jie; Kang, Jiu-Hong			Fetal growth restriction mice are more likely to exhibit depression-like behaviors due to stress-induced loss of dopaminergic neurons in the VTA	FASEB JOURNAL			English	Article						depression; dopaminergic neurons; environmental stress; fetal growth restriction; memantine	NMDA RECEPTOR ANTAGONISTS; ALZHEIMERS-DISEASE; PARADIGM SHIFT; SEROTONIN; GLUTAMATE; MECHANISM; EXPOSURE; SYSTEM; IMPACT; CONTRIBUTES	Fetal growth restriction (FGR) is a severe perinatal complication that can increase risk for mental illness. To investigate the mechanism by which FGR mice develop mental illness in adulthood, we established the FGR mouse model and the FGR mice did not display obvious depression-like behaviors, but after environmental stress exposure, FGR mice were more likely to exhibit depression-like behaviors than control mice. Moreover, FGR mice had significantly fewer dopaminergic neurons in the ventral tegmental area but no difference in serotoninergic neurons in the dorsal raphe. RNA-seq analysis showed that the downregulated genes in the midbrain of FGR mice were associated with many mental diseases and were especially involved in the regulation of NMDA-selective glutamate receptor (NMDAR) activity. Furthermore, the NMDAR antagonist memantine can relieve the stress-induced depression-like behaviors of FGR mice. In summary, our findings provide a theoretical basis for future research and treatment of FGR-related depression.	[Ma, Li; Tian, Meng-Xue; Sun, Qiao-Yi; Liu, Na-Na; Dong, Jian-Feng; Feng, Ke; Wu, Yu-Kang; Wang, Yu-Xi; Wang, Gui-Ying; Chen, Wen; Xi, Jia-Jie; Kang, Jiu-Hong] Tongji Univ, Clin & Translat Res Ctr, Collaborat Innovat Ctr Brain Sci,Shanghai Key Lab, Sch Life Sci & Technol,Shanghai Matern & Infant H, 1239 Siping Rd, Shanghai 200092, Peoples R China; [Tian, Meng-Xue] Tongji Univ, Tongji Hosp, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol,Inst Translat Res,Shanghai, Shanghai, Peoples R China	Tongji University; Tongji University	Xi, JJ; Kang, JH (corresponding author), Tongji Univ, Clin & Translat Res Ctr, Collaborat Innovat Ctr Brain Sci,Shanghai Key Lab, Sch Life Sci & Technol,Shanghai Matern & Infant H, 1239 Siping Rd, Shanghai 200092, Peoples R China.	jiajiexi_bio@163.com; jhkang@tongji.edu.cn			National Natural Science Foundation of China (NSFC) [81530042, 31571529, 31871495, 31571519]; Ministry of Science and Technology of the People's Republic of China (MOST) [2016YFA0101300]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81530042, 31571529, 31871495 and 31571519; Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2016YFA0101300	Abildgaard A, 2014, ACTA NEUROPSYCHIATR, V26, P8, DOI 10.1017/neu.2013.28; Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bogdanov VB, 2013, BEHAV BRAIN RES, V236, P90, DOI 10.1016/j.bbr.2012.08.004; Bourke CH, 2012, BEHAV BRAIN RES, V227, P270, DOI 10.1016/j.bbr.2011.11.001; Briscoe TA, 2004, AM J OBSTET GYNECOL, V191, P847, DOI 10.1016/j.ajog.2004.01.050; Brown AS, 2008, SCHIZOPHRENIA BULL, V34, P1054, DOI 10.1093/schbul/sbn096; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; CHOI DW, 1988, J NEUROSCI, V8, P185; Denisenko O, 2011, J DEV ORIG HLTH DIS, V2, P124, DOI 10.1017/S2040174410000632; Elsayed M, 2012, BIOL PSYCHIAT, V72, P258, DOI 10.1016/j.biopsych.2012.03.003; Garcia-Garcia AL, 2017, CELL REP, V18, P1144, DOI 10.1016/j.celrep.2017.01.021; Hamon M, 2013, PROG NEURO-PSYCHOPH, V45, P54, DOI 10.1016/j.pnpbp.2013.04.009; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; He XL, 2017, CELL PHYSIOL BIOCHEM, V42, P2281, DOI 10.1159/000480001; He XL, 2016, INT J NANOMED, V11, P4975, DOI 10.2147/IJN.S109088; Hoek HW, 1996, AM J PSYCHIAT, V153, P1637; Hong J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.194; Jastrzebska K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37171; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kale PP, 2013, INDIAN J EXP BIOL, V51, P732; Keiflin R, 2019, CURR BIOL, V29, P93, DOI 10.1016/j.cub.2018.11.050; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Li GP, 2017, STEM CELL REP, V8, P1270, DOI 10.1016/j.stemcr.2017.03.017; Lin F, 2013, PLACENTA, V34, P941, DOI 10.1016/j.placenta.2013.07.007; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Liu D, 2018, PAIN, V159, P175, DOI 10.1097/j.pain.0000000000001083; Liu SB, 2018, MED SCI MONITOR, V24, P7646, DOI 10.12659/MSM.908422; Nardozza LMM, 2012, ARCH GYNECOL OBSTET, V286, P1, DOI 10.1007/s00404-012-2330-6; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Naoi M, 2018, J NEURAL TRANSM, V125, P53, DOI 10.1007/s00702-017-1709-8; Nasihatkon ZS, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/294149; Niciu MJ, 2014, J NEURAL TRANSM, V121, P907, DOI 10.1007/s00702-013-1130-x; Nutt DJ, 2002, INT CLIN PSYCHOPHARM, V17, pS1; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Patton GC, 2004, BRIT J PSYCHIAT, V184, P446, DOI 10.1192/bjp.184.5.446; Qi J, 2016, NAT NEUROSCI, V19, P725, DOI 10.1038/nn.4281; Ramirez S, 2015, NATURE, V522, P335, DOI 10.1038/nature14514; Rollema H, 2000, BIOL PSYCHIAT, V48, P229, DOI 10.1016/S0006-3223(00)00850-7; Root DH, 2014, J NEUROSCI, V34, P13906, DOI 10.1523/JNEUROSCI.2029-14.2014; Sachs BD, 2015, P NATL ACAD SCI USA, V112, P2557, DOI 10.1073/pnas.1416866112; Salam RA, 2014, CURR OPIN CLIN NUTR, V17, P249, DOI 10.1097/MCO.0000000000000051; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Sferruzzi-Perri AN, 2019, P NATL ACAD SCI USA, V116, P1621, DOI 10.1073/pnas.1816056116; Somm E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050131; Stein AD, 2009, EPIDEMIOLOGY, V20, P909, DOI 10.1097/EDE.0b013e3181b5f227; Sullivan GM, 2015, JAMA PSYCHIAT, V72, P169, DOI 10.1001/jamapsychiatry.2014.2406; Takahashi K, 2018, NEUROPHARMACOLOGY, V137, P141, DOI 10.1016/j.neuropharm.2018.04.013; Tan L, 2015, BEHAV BRAIN RES, V279, P274, DOI 10.1016/j.bbr.2014.10.037; Pham TH, 2019, PHARMACOL THERAPEUT, V199, P58, DOI 10.1016/j.pharmthera.2019.02.017; Thwaites SJ, 2013, PHARMACOL BIOCHEM BE, V112, P71, DOI 10.1016/j.pbb.2013.09.016; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; VANROSSUM JM, 1966, ARCH INT PHARMACOD T, V160, P492; Wilkinson ST, 2018, AM J PSYCHIAT, V175, P150, DOI 10.1176/appi.ajp.2017.17040472; Xu D, 2011, ENVIRON TOXICOL PHAR, V32, P356, DOI 10.1016/j.etap.2011.08.003; Yu Q, 2014, MOL PSYCHIATR, V19, P688, DOI 10.1038/mp.2014.10; Zangen A, 2001, PSYCHOPHARMACOLOGY, V155, P434, DOI 10.1007/s002130100746; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069934; Zhou FM, 2005, NEURON, V46, P65, DOI 10.1016/j.neuron.2005.02.010; Zong L, 2017, EXP THER MED, V14, P581, DOI 10.3892/etm.2017.4523	67	0	0	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13257	13271		10.1096/fj.202000534R	http://dx.doi.org/10.1096/fj.202000534R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32860269				2022-12-28	WOS:000566158900001
J	Sinha, S; Dwivedi, N; Woodgett, J; Tao, SX; Howard, C; Fields, TA; Jamadar, A; Rao, R				Sinha, Sonali; Dwivedi, Nidhi; Woodgett, James; Tao, Shixin; Howard, Christianna; Fields, Timothy A.; Jamadar, Abeda; Rao, Reena			Glycogen synthase kinase-3 beta inhibits tubular regeneration in acute kidney injury by a FoxM1-dependent mechanism	FASEB JOURNAL			English	Article						acute kidney injury; cell proliferation; FoxM1; GSK3 beta; ischemia; reperfusion; thiostrepton; tubular regeneration	TRANSCRIPTION FACTOR; TARGETING FOXM1; REPAIR; PROLIFERATION; GSK3-BETA; INVASION; RECEPTOR; KINASE; GROWTH; CELLS	Acute kidney injury (AKI) is characterized by injury to the tubular epithelium that leads to the sudden loss of renal function. Proper tubular regeneration is essential to prevent progression to chronic kidney disease. In this study, we examined the role of FoxM1, a forkhead box family member transcription factor in tubular repair after AKI. Renal FoxM1 expression increased after renal ischemia/reperfusion (I/R)-induced AKI in mouse kidneys. Treatment with thiostrepton, a FoxM1 inhibitor, reduced FoxM1 regulated pro-proliferative factors and cell proliferation in vitro, and tubular regeneration in mouse kidneys after AKI. Glycogen synthase kinase-3 (GSK3) was found to be an upstream regulator of FoxM1 because GSK3 inhibition or renal tubular GSK3 beta gene deletion significantly increased FoxM1 expression, and improved tubular repair and renal function. GSK3 inactivation increased beta-catenin, Cyclin D1, and c-Myc, and reduced cell cycle inhibitors p21 and p27. Importantly, thiostrepton treatment abolished the improved tubular repair in GSK3 beta knockout mice following AKI. These results demonstrate that FoxM1 is important for renal tubular regeneration following AKI and that GSK3 beta suppresses tubular repair by inhibiting FoxM1.	[Sinha, Sonali; Dwivedi, Nidhi; Tao, Shixin; Howard, Christianna; Fields, Timothy A.; Jamadar, Abeda; Rao, Reena] Univ Kansas, Jared Grantham Kidney Inst, Med Ctr, 5040 WHE,3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Woodgett, James] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Woodgett, James] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Fields, Timothy A.] Univ Kansas, Dept Pathol, Med Ctr, Kansas City, KS 66160 USA; [Rao, Reena] Univ Kansas, Dept Internal Med, Med Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Rao, R (corresponding author), Univ Kansas, Jared Grantham Kidney Inst, Med Ctr, 5040 WHE,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	rrao@kumc.edu	Woodgett, Jim/F-1087-2010; DWIVEDI, NIDHI/AAE-8717-2019; Jamadar, Abeda/AAL-4581-2021	Woodgett, Jim/0000-0003-3731-5797; DWIVEDI, NIDHI/0000-0002-7520-5030; Jamadar, Abeda/0000-0002-0887-4613	American Heart Association (AHA) [16GRNT30820009]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK083525]	American Heart Association (AHA)(American Heart Association); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	American Heart Association (AHA), Grant/Award Number: 16GRNT30820009; HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01-DK083525	Abd ElHafeez S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17264-7; Ahmed M, 2012, J CLIN ENDOCR METAB, V97, pE1, DOI 10.1210/jc.2011-1506; Alvarez-Fernandez M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00030; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Bao H, 2012, KIDNEY INT, V81, P662, DOI 10.1038/ki.2011.443; Bao H, 2014, J AM SOC NEPHROL, V25, P488, DOI 10.1681/ASN.2013040350; Chang-Panesso M, 2019, J CLIN INVEST, V129, P5501, DOI 10.1172/JCI125519; Chen JC, 2018, J AM SOC NEPHROL, V29, P2372, DOI 10.1681/ASN.2017121272; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Chen YH, 2016, EMBO J, V35, P668, DOI 10.15252/embj.201592810; Cormier Kevin W, 2017, F1000Res, V6, DOI 10.12688/f1000research.10557.1; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Halasi M, 2013, BIOCHEM PHARMACOL, V85, P644, DOI 10.1016/j.bcp.2012.10.013; He LY, 2017, KIDNEY INT, V92, P1071, DOI 10.1016/j.kint.2017.06.030; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Howard C, 2012, KIDNEY INT, V82, P1000, DOI 10.1038/ki.2012.239; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Inoue Y, 2018, BIOCHEM BIOPH RES CO, V495, P1681, DOI 10.1016/j.bbrc.2017.11.179; Jonker HRA, 2007, NUCLEIC ACIDS RES, V35, P441, DOI 10.1093/nar/gkl1066; Kakade VR, 2016, J MOL CELL BIOL, V8, P464, DOI 10.1093/jmcb/mjw022; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kelleher FC, 2016, ONCOTARGET, V7, P42792, DOI 10.18632/oncotarget.8669; Kongsema M, 2019, ONCOL REP, V42, P953, DOI 10.3892/or.2019.7225; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Li YM, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0347-1; Liao GB, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0266-6; Liu TQ, 2015, FREE RADICAL BIO MED, V81, P170, DOI 10.1016/j.freeradbiomed.2014.10.509; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Merentie M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190981; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Norregaard R, 2015, AM J PHYSIOL-RENAL, V308, pF650, DOI 10.1152/ajprenal.00516.2014; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Patel P, 2017, CURR TOP DEV BIOL, V123, P277, DOI 10.1016/bs.ctdb.2016.11.011; Plotnikov EY, 2013, TOXICOL LETT, V220, P303, DOI 10.1016/j.toxlet.2013.04.023; Rao R, 2010, J AM SOC NEPHROL, V21, P428, DOI 10.1681/ASN.2009060672; Ratliff BB, 2016, ANTIOXID REDOX SIGN, V25, P119, DOI 10.1089/ars.2016.6665; Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511; Sinha S, 2020, ONCOGENE, V39, P1231, DOI 10.1038/s41388-019-1059-0; Sun Y, 2018, J PHARMACOL SCI, V137, P170, DOI 10.1016/j.jphs.2018.05.011; Tao SX, 2015, KIDNEY INT, V87, P1164, DOI 10.1038/ki.2014.427; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang LH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.76; Wang SH, 2016, J BIOL CHEM, V291, P21085, DOI 10.1074/jbc.M116.717892; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Wang Y, 2009, BRIT J PHARMACOL, V157, P1004, DOI 10.1111/j.1476-5381.2009.00284.x; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; Wang ZY, 2010, J AM SOC NEPHROL, V21, P284, DOI 10.1681/ASN.2009080828; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang XP, 2018, AM J TRANSL RES, V10, P629; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yu C, 2015, ONCOL REP, V33, P2402, DOI 10.3892/or.2015.3834; Zhan GW, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-06269-z, 10.1038/s41467-017-02251-3]; Zhao KL, 2014, MOL MED REP, V10, P3185, DOI 10.3892/mmr.2014.2650; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154; Zhou D, 2016, LAB INVEST, V96, P156, DOI 10.1038/labinvest.2015.153; Zu G, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0343-y	57	10	10	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13597	13608		10.1096/fj.202000526RR	http://dx.doi.org/10.1096/fj.202000526RR		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32813289	Green Accepted, Bronze			2022-12-28	WOS:000562900800001
J	Xu, XR; Zhou, XF; Zhang, JY; Li, HJ; Cao, YF; Tan, XH; Zhu, XQ; Yang, J				Xu, Xianrong; Zhou, Xiaofeng; Zhang, Jianyun; Li, Hongjuan; Cao, Yifei; Tan, Xiaohua; Zhu, Xinqiang; Yang, Jun			MicroRNA-191 modulates cisplatin-induced DNA damage response by targeting RCC2	FASEB JOURNAL			English	Article						cisplatin; DNA damage response; miR-191; RCC2	OVARIAN-CANCER CELLS; RESISTANCE; APOPTOSIS; MIR-191; SENSITIVITY; REGULATOR; RADIATION; SURVIVAL; PROTEIN; ARREST	Cisplatin is a first-line chemotherapeutic agent for the treatment of many types of cancer, but the emergence of chemoresistance hinders its application. Thus, a better understanding of cisplatin-induced DNA damage response (DDR) would help to overcome this problem. Previously, we have identified a panel of microRNAs with altered expression after cisplatin treatment in HeLa cells. In the current study, we focused on one of them, miR-191, and investigated its function in cisplatin-induced DDR. We found that overexpression of miR-191 sensitized HeLa cells to the cytotoxic effects of cisplatin, resulted in decreased viable cells. However, overexpression of miR-191 did not cause changes in apoptotic cell ratio but rather induced significant G2/M arrest in HeLa cell treated with cisplatin. Additionally, enhanced cisplatin-induced DNA damage was observed. Through bioinformatic analysis and verified by dual-luciferase assay, it was demonstrated that the chromosome condensation 2 regulator (RCC2) gene is a target for miR-191 regulation. Furthermore, the downregulation of RCC2 by siRNA mimics the effects of miR-191, in which greater DNA damage was observed upon cisplatin treatment. Taken together, our study indicates that miR-191 may be an important player in cisplatin-induced DDR, and it elicits its function, at least partially, through the regulation of RCC2.	[Xu, Xianrong; Zhang, Jianyun; Li, Hongjuan; Cao, Yifei; Tan, Xiaohua; Yang, Jun] Hangzhou Normal Univ, Dept Prevent Med, Sch Med, Hangzhou 311121, Zhejiang, Peoples R China; [Zhou, Xiaofeng] Zhejiang Univ, Affiliated Hosp 2, Dept Radiat Oncol, Sch Med, Hangzhou, Peoples R China; [Zhu, Xinqiang] Zhejiang Univ, Affiliated Hosp 4, Lab Res Ctr, Sch Med, Yiwu 322000, Zhejiang, Peoples R China; [Yang, Jun] Zhejiang Univ, Affiliated Womens Hosp, Zhejiang Prov Ctr Uterine Canc Diag & Therapy Res, Sch Med, Hangzhou, Peoples R China	Hangzhou Normal University; Zhejiang University; Zhejiang University; Zhejiang University	Yang, J (corresponding author), Hangzhou Normal Univ, Dept Prevent Med, Sch Med, Hangzhou 311121, Zhejiang, Peoples R China.; Zhu, XQ (corresponding author), Zhejiang Univ, Affiliated Hosp 4, Lab Res Ctr, Sch Med, Yiwu 322000, Zhejiang, Peoples R China.	zhuxq@zju.edu.cn; gastate@zju.edu.cn		Xu, xianrong/0000-0003-2406-3690	National Natural Science Foundation of China [81602795, 31971138]; Natural Science Foundation of Zhejiang Province [LQ15H260002, LZ19H260001, LY19H260002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	National Natural Science Foundation of China, Grant/Award Number: 81602795 and 31971138; Natural Science Foundation of Zhejiang Province, Grant/Award Number: LQ15H260002, LZ19H260001 and LY19H260002	Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berillo O, 2020, AM J HYPERTENS, V33, P505, DOI 10.1093/ajh/hpaa031; Beyer J, 2010, J CLIN ONCOL, V28, P4906, DOI 10.1200/JCO.2009.26.8128; Blume J, 2019, EUR J IMMUNOL, V49, P121, DOI 10.1002/eji.201847660; Bruun J, 2015, CLIN CANCER RES, V21, P3759, DOI 10.1158/1078-0432.CCR-14-3294; Caravagna G, 2018, NAT METHODS, V15, P707, DOI 10.1038/s41592-018-0108-x; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cataldo A, 2016, ONCOTARGET, V7, P786, DOI 10.18632/oncotarget.6381; CHEN J, 2018, J GENE MED, V20; Chowdhury D, 2013, NAT REV MOL CELL BIO, V14, P181, DOI 10.1038/nrm3523; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Ferreira JA, 2016, DRUG RESIST UPDATE, V24, P34, DOI 10.1016/j.drup.2015.11.003; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Gong SP, 2019, FASEB J, V33, P5350, DOI 10.1096/fj.201801529RR; Guo ZB, 2018, J CELL BIOCHEM, V119, P7032, DOI 10.1002/jcb.26914; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Huang DY, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4831-6; Huang YZ, 2015, TUMOR BIOL, V36, P6095, DOI 10.1007/s13277-015-3290-9; Hubaux R, 2015, INT J CANCER, V137, P2072, DOI 10.1002/ijc.29577; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Li CC, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0148-y; Li H, 2017, HEPATOLOGY, V66, P136, DOI 10.1002/hep.29116; Li JR, 2013, TOXICOL LETT, V220, P267, DOI 10.1016/j.toxlet.2013.04.021; Liang F, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3902-4; Liu H, 2014, TUMOR BIOL, V35, P12157, DOI 10.1007/s13277-014-2521-9; Liu JB, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016193; Lykken EA, 2016, J BIOL CHEM, V291, P23532, DOI 10.1074/jbc.M116.741264; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Nagpal N, 2013, CARCINOGENESIS, V34, P1889, DOI 10.1093/carcin/bgt107; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; Papini D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8678; Patnaik SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009219; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Ray J, 2020, CANCER LETT, V473, P107, DOI 10.1016/j.canlet.2019.12.025; Rocha CRR, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e478s; Sarin N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181081; Selvendiran K, 2007, J BIOL CHEM, V282, P28609, DOI 10.1074/jbc.M703796200; Shi XJ, 2011, ACTA BIOCH BIOPH SIN, V43, P849, DOI 10.1093/abbs/gmr084; Sourisseau T, 2016, CELL CYCLE, V15, P295, DOI 10.1080/15384101.2015.1120918; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Tsuyoshi H, 2017, ONCOTARGET, V8, P99825, DOI 10.18632/oncotarget.21076; Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103; Washington MN, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.208; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Williamson RC, 2014, J CELL SCI, V127, P4292, DOI 10.1242/jcs.154864; Wu N, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3908-y; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yenjerla M, 2013, CELL CYCLE, V12, P837, DOI 10.4161/cc.23821; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang GL, 2012, MUTAT RES-GEN TOX EN, V746, P66, DOI 10.1016/j.mrgentox.2012.03.004; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004	54	5	5	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13573	13585		10.1096/fj.202000945R	http://dx.doi.org/10.1096/fj.202000945R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32803782				2022-12-28	WOS:000562539900001
J	Zannit, HM; Brodt, MD; Silva, MJ				Zannit, Heather M.; Brodt, Michael D.; Silva, Matthew J.			Proliferating osteoblasts are necessary for maximal bone anabolic response to loading in mice	FASEB JOURNAL			English	Article						bone formation; periosteal; thymidine kinase; tibial loading; 3; 6Col1a1	CORTICAL BONE; LINING CELLS; EXPRESSION; LAMELLAR; WOVEN; ADULT	Following mechanical loading, osteoblasts may arise via activation, differentiation, or proliferation to form bone. Our objective was to ablate proliferating osteoblast lineage cells in order to investigate the importance of these cells as a source for loading-induced bone formation. We utilized 3.6Col1a1-tk mice in which replicating osteoblast lineage cells can be ablated in an inducible manner using ganciclovir (GCV). Male and female mice were aged to 5- and 12-months and subjected to 5 days of tibial compression. "Experimental" mice were tk-positive, treated with GCV; "control" mice were either tk-negative treated with GCV, or tk-positive treated with PBS. We confirmed that experimental mice had a decrease in tk-positive cells that arose from proliferation. Next, we assessed bone formation after loading to low (7N) and high (11N) forces and observed that periosteal bone formation rate in experimental mice was reduced by approximately 70% for both forces. Remarkably, woven bone formation induced by high-force loading was blocked in experimental mice. Loading-induced lamellar bone formation was diminished but not prevented in experimental mice. We conclude that osteoblast proliferation induced by mechanical loading is a critical source of bone forming osteoblasts for maximal lamellar formation and is essential for woven bone formation.	[Zannit, Heather M.; Brodt, Michael D.; Silva, Matthew J.] Washington Univ, Musculoskeletal Res Ctr, Dept Biomed Engn, Orthopaed Surg, BJCIH 11th Floor,RM 11617,Campus Box 8233, St Louis, MO 63110 USA	Washington University (WUSTL)	Silva, MJ (corresponding author), Washington Univ, Musculoskeletal Res Ctr, Dept Biomed Engn, Orthopaed Surg, BJCIH 11th Floor,RM 11617,Campus Box 8233, St Louis, MO 63110 USA.	silvam@wustl.edu			HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR047867, AR057235, AR074992, AR060719]; University of Arkansas; Yale University	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); University of Arkansas; Yale University	HHS broken vertical bar NIH broken vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR047867, AR057235, AR074992 and AR060719; University of Arkansas; Yale University	Beck C, 1995, HUM GENE THER, V6, P1525, DOI 10.1089/hum.1995.6.12-1525; Boppart MD, 1998, BONE, V23, P409, DOI 10.1016/S8756-3282(98)00119-7; BORRELLI E, 1988, P NATL ACAD SCI USA, V85, P7572, DOI 10.1073/pnas.85.20.7572; Chermside-Scabbo CJ, 2020, J BONE MINER RES, V35, P1751, DOI 10.1002/jbmr.4031; Chow JWM, 1998, J BONE MINER RES, V13, P1760, DOI 10.1359/jbmr.1998.13.11.1760; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; HEYMAN RA, 1989, P NATL ACAD SCI USA, V86, P2698, DOI 10.1073/pnas.86.8.2698; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Moore ER, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0930-1; Patel TK, 2014, J BIOMECH, V47, P451, DOI 10.1016/j.jbiomech.2013.10.052; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Sun D, 2018, J ORTHOP RES, V36, P682, DOI 10.1002/jor.23727; TURNER CH, 1994, J BONE MINER RES, V9, P87; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; Wang FS, 2003, BONE, V32, P387, DOI 10.1016/S8756-3282(03)00029-2; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Zannit HM, 2019, JBMR PLUS, V3, DOI 10.1002/jbm4.10227	24	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12739	12750		10.1096/fj.202000614R	http://dx.doi.org/10.1096/fj.202000614R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744762	Green Accepted			2022-12-28	WOS:000557255500001
J	Saha, J; Dean, DN; Dhakal, S; Stockmal, KA; Morgan, SE; Dillon, KD; Adamo, MF; Levites, Y; Rangachari, V				Saha, Jhinuk; Dean, Dexter N.; Dhakal, Shailendra; Stockmal, Kelli A.; Morgan, Sarah E.; Dillon, Kristy D.; Adamo, Munir F.; Levites, Yona; Rangachari, Vijayaraghavan			Biophysical characteristics of lipid-induced A beta oligomers correlate to distinctive phenotypes in transgenic mice	FASEB JOURNAL			English	Article						amyloid&#8208; &#946; Alzheimer disease; cerebral amyloid angiopathy; membrane lipids; oligomers; phenotypes	ALZHEIMERS-DISEASE; AMYLOID PEPTIDE(1-40); FIBRIL FORMATION; ENDOGENOUS SEED; ALPHA-SYNUCLEIN; MOUSE MODEL; GANGLIOSIDE; PROTEIN; BRAIN; FORM	Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects cognition and memory. Recent advances have helped identify many clinical sub-types in AD. Mounting evidence point toward structural polymorphism among fibrillar aggregates of amyloid-beta (A beta) to being responsible for the phenotypes and clinical manifestations. In the emerging paradigm of polymorphism and prion-like propagation of aggregates in AD, the role of low molecular weight soluble oligomers, which are long known to be the primary toxic agents, in effecting phenotypes remains inconspicuous. In this study, we present the characterization of three soluble oligomers of A beta 42, namely 14LPOs, 16LPOs, and GM1Os with discreet biophysical and biochemical properties generated using lysophosphatidyl glycerols and GM1 gangliosides. The results indicate that the oligomers share some biophysical similarities but display distinctive differences with GM1Os. Unlike the other two, GM1Os were observed to be complexed with the lipid upon isolation. It also differs mainly in detection by conformation-sensitive dyes and conformation-specific antibodies, temperature and enzymatic stability, and in the ability to propagate morphologically-distinct fibrils. GM1Os also show distinguishable biochemical behavior with pronounced neuronal toxicity. Furthermore, all the oligomers induce cerebral amyloid angiopathy (CAA) and plaque burden in transgenic AD mice, which seems to be a consistent feature among all lipid-derived oligomers, but 16LPOs and GM1Os displayed significantly higher effect than the others. These results establish a correlation between molecular features of A beta 42 oligomers and their distinguishable effects in transgenic AD mice attuned by lipid characteristics, and therefore help bridge the knowledge gap in understanding how oligomer conformers could elicit AD phenotypes.	[Saha, Jhinuk; Dean, Dexter N.; Dhakal, Shailendra; Rangachari, Vijayaraghavan] Univ Southern Mississippi, Sch Math & Nat Sci, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Stockmal, Kelli A.; Morgan, Sarah E.] Univ Southern Mississippi, Sch Polymer Sci & Engn, Hattiesburg, MS 39406 USA; [Dillon, Kristy D.; Adamo, Munir F.; Levites, Yona] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Rangachari, Vijayaraghavan] Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA; [Dean, Dexter N.] NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Southern Mississippi; University of Southern Mississippi; State University System of Florida; University of Florida; University of Southern Mississippi; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rangachari, V (corresponding author), Univ Southern Mississippi, Sch Math & Nat Sci, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Dhakal, Shailendra/ABD-2879-2021	Dhakal, Shailendra/0000-0003-0019-803X; Dean, Dexter N./0000-0002-2279-3393; Morgan, Sarah/0000-0002-8796-9548	NCRR NIH HHS [5P20RR01647-11] Funding Source: Medline; NIA NIH HHS [R56 AG062292] Funding Source: Medline; NIGMS NIH HHS [R01 GM120634, P20 GM103476, 8 P20 GM103476-11] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen NH, 1996, FEBS LETT, V399, P47, DOI 10.1016/S0014-5793(96)01279-3; [Anonymous], 2017, PRION; Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; BUYUKMIHCI N, 1983, EXP NEUROL, V81, P396, DOI 10.1016/0014-4886(83)90271-6; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chemes Lucia B, 2012, Methods Mol Biol, V895, P387, DOI 10.1007/978-1-61779-927-3_22; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cohen ML, 2015, BRAIN, V138, P1009, DOI 10.1093/brain/awv006; Colin J, 2016, BIOCHIMIE, V130, P178, DOI 10.1016/j.biochi.2016.08.014; Condello C, 2018, P NATL ACAD SCI USA, V115, pE782, DOI 10.1073/pnas.1714966115; Couto D, 2016, J AM SOC MASS SPECTR, V27, P1965, DOI 10.1007/s13361-016-1474-1; Creasey RG, 2012, CURR PROTEIN PEPT SC, V13, P232; Das PK, 2017, BIOMACROMOLECULES, V18, P3359, DOI 10.1021/acs.biomac.7b01007; Dean DN, 2018, BIOPHYS J, V114, P539, DOI 10.1016/j.bpj.2017.11.3778; Dean DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40787; Dean DN, 2016, BIOCHEMISTRY-US, V55, P2238, DOI 10.1021/acs.biochem.6b00161; Downey MA, 2019, J AM SOC MASS SPECTR, V30, P85, DOI 10.1007/s13361-018-1975-1; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gu L, 2014, J BIOL CHEM, V289, P27300, DOI 10.1074/jbc.M114.569004; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hou H., 2020, SCI REP-UK, V10, P1; HOWARD AJ, 1989, J ANTIMICROB CHEMOTH, V24, P963, DOI 10.1093/jac/24.6.963; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Jongbloed W, 2015, J ALZHEIMERS DIS, V45, P35, DOI 10.3233/JAD-142136; Ju DD, 1997, J CHROMATOGR A, V779, P195; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kaspersen JD, 2017, BIOPHYS J, V112, P1609, DOI 10.1016/j.bpj.2017.03.013; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; Kiskis J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13489; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111492; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020701, 10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520]; Liberski PP, 2012, FOLIA NEUROPATHOL, V50, P85; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Morgado I, 2015, ADV EXP MED BIOL, V855, P67, DOI 10.1007/978-3-319-17344-3_3; Naudi A, 2015, INT REV NEUROBIOL, V122, P133, DOI 10.1016/bs.irn.2015.05.008; Noel A, 2017, BIOCHIMIE, V137, P158, DOI 10.1016/j.biochi.2017.03.019; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Planchard MS, 2012, ACS CHEM NEUROSCI, V3, P900, DOI 10.1021/cn300030a; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rasmussen J, 2017, P NATL ACAD SCI USA, V114, P13018, DOI 10.1073/pnas.1713215114; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Tettamanti G., 2010, HDB NEUROCHEMISTRY M, P99; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Walker LC, 2016, ANNU REV GENET, V50, P329, DOI 10.1146/annurev-genet-120215-034943; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Xi WH, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5082659; Xu GL, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00911-y; Yanagisawa D, 2011, J ALZHEIMERS DIS, V24, P33, DOI 10.3233/JAD-2011-102100; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yates EA, 2014, BIOCHEMISTRY-US, V53, P7038, DOI 10.1021/bi500792f	74	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21318	10.1096/fj.202002025RR	http://dx.doi.org/10.1096/fj.202002025RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33508158	Green Published, hybrid			2022-12-28	WOS:000647789600061
J	Guo, Y; Wang, QJ; Zhang, KH; Yao, CY; Huang, J; Li, Q; Liu, ZY; Zhang, Y; Shan, CH; Liu, P; Wang, MZ; An, L; Tian, JH; Wu, ZH				Guo, Yao; Wang, Qiang-Jun; Zhang, Ke-Hao; Yao, Chun-Yan; Huang, Jie; Li, Qin; Liu, Zhong-Ying; Zhang, Yu; Shan, Chun-Hua; Liu, Peng; Wang, Mei-Zhi; An, Lei; Tian, Jian-Hui; Wu, Zhong-Hong			Night-restricted feeding improves locomotor activity rhythm and modulates nutrient utilization to accelerate growth in rabbits	FASEB JOURNAL			English	Article						adolescent obesity; circadian rhythm; core body temperature; muscle growth; night&#8208; restricted feeding	MUSCLE INSULIN SENSITIVITY; BODY-TEMPERATURE RHYTHMS; CIRCADIAN CLOCK; SKELETAL-MUSCLE; THYROID-HORMONE; ENERGY-METABOLISM; US CHILDREN; OBESITY; TIME; GENE	An unfavorable lifestyle disrupts the circadian rhythm, leading to metabolic dysfunction in adult humans and animals. Increasing evidence suggests that night-restricted feeding (NRF) can effectively prevent ectopic fat deposition caused by circadian rhythm disruption, and reduce the risk of metabolic diseases. However, previous studies have mainly focused on the prevention of obesity in adults by regulating dietary patterns, whereas limited attention has been paid to the effect of NRF on metabolism during growth and development. Here, we used weaning rabbits as models and found that NRF increased body weight gain without increasing feed intake, and promoted insulin-mediated protein synthesis through the mTOR/S6K pathway and muscle formation by upregulating MYOG. NRF improved the circadian clock, promoted PDH-regulated glycolysis and CPT1B-regulated fatty-acid beta-oxidation, and reduced fat content in the serum and muscles. In addition, NRF-induced body temperature oscillation might be partly responsible for the improvement in the circadian clock and insulin sensitivity. Time-restricted feeding could be used as a nondrug intervention to prevent obesity and accelerate growth in adolescents.	[Guo, Yao; Wang, Qiang-Jun; Zhang, Ke-Hao; Yao, Chun-Yan; Huang, Jie; Li, Qin; Liu, Zhong-Ying; Zhang, Yu; Shan, Chun-Hua; Liu, Peng; Wang, Mei-Zhi; Wu, Zhong-Hong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West, Beijing 100193, Peoples R China; [An, Lei; Tian, Jian-Hui] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Wu, ZH (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West, Beijing 100193, Peoples R China.	wuzhh@cau.edu.cn	An, Lei/GQB-0039-2022	Guo, Yao/0000-0002-4691-5623	National Key Reseach and Development Program of China [2016YFD0500506]; Earmarked fund for China Agriculture Research System for Rabbits [CARS-43-D-1]	National Key Reseach and Development Program of China; Earmarked fund for China Agriculture Research System for Rabbits	National Key Reseach and Development Program of China, Grant/Award Number: 2016YFD0500506; Earmarked fund for China Agriculture Research System for Rabbits, Grant/Award Number: CARS-43-D-1	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; BIANCO AC, 1988, J BIOL CHEM, V263, P18168; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Burgoine T, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0713-1; Chahal H, 2013, PEDIATR OBES, V8, P42, DOI 10.1111/j.2047-6310.2012.00085.x; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chung H, 2016, METABOLISM, V65, P1743, DOI 10.1016/j.metabol.2016.09.006; COMTE B, 1990, METABOLISM, V39, P259, DOI 10.1016/0026-0495(90)90044-D; Denzer C, 2007, INT J OBESITY, V31, P1509, DOI 10.1038/sj.ijo.0803691; Diop SB, 2015, TRENDS ENDOCRIN MET, V26, P618, DOI 10.1016/j.tem.2015.09.009; Dungan CM, 2016, LIPIDS, V51, P905, DOI 10.1007/s11745-016-4168-3; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Francisco V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00640; Gidenne T, 2012, ANIMAL, V6, P1407, DOI 10.1017/S1751731112000389; Guerrot D, 2011, J CLIN ENDOCR METAB, V96, pE929, DOI 10.1210/jc.2010-2337; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Himes JH, 2006, MOL CELL ENDOCRINOL, V254, P13, DOI 10.1016/j.mce.2006.04.013; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ihara T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23115-w; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; James FO, 2007, SLEEP, V30, P1427, DOI 10.1093/sleep/30.11.1427; JILGE B, 1995, PHYSIOL BEHAV, V58, P131, DOI 10.1016/0031-9384(95)00006-5; Kim TW, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/591729; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee J, 2011, ISLETS, V3, P381, DOI 10.4161/isl.3.6.18157; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu J, 2016, ENDOCRINOLOGY, V157, P2259, DOI 10.1210/en.2015-2027; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lubrano C, 2015, ENDOCRINE, V49, P503, DOI 10.1007/s12020-015-0530-0; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Murakami K, 2016, BRIT J NUTR, V115, P1819, DOI 10.1017/S0007114516000854; Neufeld-Cohen A, 2016, P NATL ACAD SCI USA, V113, pE1673, DOI 10.1073/pnas.1519650113; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Pifferi F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/187301; Prendergast BJ, 2015, J BIOL RHYTHM, V30, P543, DOI 10.1177/0748730415609450; Qian JY, 2018, DIABETES OBES METAB, V20, P2481, DOI 10.1111/dom.13391; Ravussin E, 2019, OBESITY, V27, P1244, DOI 10.1002/oby.22518; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Reznick J, 2013, BBA-MOL BASIS DIS, V1832, P228, DOI 10.1016/j.bbadis.2012.08.010; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Salgado-Delgado RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060052; Satoh Y, 2006, AM J PHYSIOL-REG I, V290, pR1276, DOI 10.1152/ajpregu.00775.2005; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheer FAJL, 2005, NEUROSCIENCE, V132, P465, DOI 10.1016/j.neuroscience.2004.12.012; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simonides WS, 1996, J BIOL CHEM, V271, P32048, DOI 10.1074/jbc.271.50.32048; Simonides WS, 2001, BIOSCIENCE REP, V21, P139, DOI 10.1023/A:1013692023449; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sunderram J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-79; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Wang XL, 2018, J INT MED RES, V46, P3765, DOI 10.1177/0300060518779305; Yasumoto Y, 2016, METABOLISM, V65, P714, DOI 10.1016/j.metabol.2016.02.003; Yoda T, 2000, AM J PHYSIOL-REG I, V278, pR134, DOI 10.1152/ajpregu.2000.278.1.R134; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang PP, 2015, BIOCHEM BIOPH RES CO, V463, P102, DOI 10.1016/j.bbrc.2015.05.032; Zhu MF, 2017, ONCOTARGET, V8, P101720, DOI 10.18632/oncotarget.21591	66	1	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001265RR	http://dx.doi.org/10.1096/fj.202001265RR		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33184921				2022-12-28	WOS:000590890200001
J	Wang, LJ; Moore, DC; Huang, JH; Wang, YH; Zhao, H; Yue, JDH; Jackson, CL; Quesenberry, PJ; Cao, WB; Yang, WT				Wang, Lijun; Moore, Douglas C.; Huang, Jiahui; Wang, Yuhong; Zhao, Hu; D-H Yue, Jerry; Jackson, Cynthia L.; Quesenberry, Peter J.; Cao, Weibiao; Yang, Wentian			SHP2 regulates the development of intestinal epithelium by modifying OSTERIX+ crypt stem cell self-renewal and proliferation	FASEB JOURNAL			English	Article						Crypt stem cell; LGR5; OLFM4; Osteoblast; OSTERIX; SHP2; SOX9	CRE-MEDIATED RECOMBINATION; TYROSINE PHOSPHATASE SHP2; TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; SOX9 EXPRESSION; GENE; INFLAMMATION; ACTIVATION; PATHWAY; GROWTH	The protein tyrosine phosphatase SHP2, encoded by PTPN11, is ubiquitously expressed and essential for the development and/or maintenance of multiple tissues and organs. SHP2 is involved in gastrointestinal (GI) epithelium development and homeostasis, but the underlying mechanisms remain elusive. While studying SHP2's role in skeletal development, we made osteoblast-specific SHP2 deficient mice using Osterix (Osx)-Cre as a driver to excise Ptpn11 floxed alleles. Phenotypic characterization of these SHP2 mutants unexpectedly revealed a critical role of SHP2 in GI biology. Mice lacking SHP2 in Osx(+) cells developed a fatal GI pathology with dramatic villus hypoplasia. OSTERIX, an OB-specific zinc finger-containing transcription factor is for the first time found to be expressed in GI crypt cells, and SHP2 expression in the crypt Osx+ cells is critical for self-renewal and proliferation. Further, immunostaining revealed the colocalization of OSTERIX with OLFM4 and LGR5, two bona fide GI stem cell markers, at the crypt cells. Furthermore, OSTERIX expression is found to be associated with GI malignancies. Knockdown of SHP2 expression had no apparent influence on the relative numbers of enterocytes, goblet cells or Paneth cells. Given SHP2's key regulatory role in OB differentiation, our studies suggest that OSTERIX and SHP2 are indispensable for gut homeostasis, analogous to SOX9's dual role as a master regulator of cartilage and an important regulator of crypt stem cell biology. Our findings also provide a foundation for new avenues of inquiry into GI stem cell biology and of OSTERIX's therapeutic and diagnostic potential.	[Wang, Lijun; Moore, Douglas C.; Huang, Jiahui; D-H Yue, Jerry; Yang, Wentian] Brown Univ, Alpert Med Sch, Dept Orthoped, Hoppin St,Coro 402E, Providence, RI 02903 USA; [Wang, Lijun; Moore, Douglas C.; Huang, Jiahui; D-H Yue, Jerry; Jackson, Cynthia L.; Quesenberry, Peter J.; Cao, Weibiao; Yang, Wentian] Rhode Isl Hosp, Hoppin St,Coro 402E, Providence, RI 02903 USA; [Wang, Yuhong; Zhao, Hu] Texas A&M Coll Dent, Dept Comprehens Dent, Dallas, TX USA; [Jackson, Cynthia L.; Cao, Weibiao] Brown Univ, Alpert Med Sch, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Quesenberry, Peter J.] Brown Univ, Alpert Med Sch, Dept Hematol & Oncol, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Yang, WT (corresponding author), Brown Univ, Alpert Med Sch, Dept Orthoped, Hoppin St,Coro 402E, Providence, RI 02903 USA.; Yang, WT (corresponding author), Rhode Isl Hosp, Hoppin St,Coro 402E, Providence, RI 02903 USA.	wyang@lifespan.org	Wang, Yu/GZL-9655-2022		HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [RO1AR066746]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [8P20GM103468, 1P20 GM119943]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: RO1AR066746; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: #8P20GM103468; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: 1P20 GM119943	Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao Y, 2005, CANCER RES, V65, P1124, DOI 10.1158/0008-5472.CAN-04-2128; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2013, CELL, V152, P1198, DOI 10.1016/j.cell.2013.02.030; Coulombe G, 2016, J CELL PHYSIOL, V231, P2529, DOI 10.1002/jcp.25407; Coulombe G, 2013, MOL CELL BIOL, V33, P2275, DOI 10.1128/MCB.00043-13; Dai QS, 2015, ONCOL LETT, V10, P1870, DOI 10.3892/ol.2015.3448; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Fan YY, 2019, METHODS MOL BIOL, V1576, P171, DOI 10.1007/7651_2016_8; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Felber K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144982; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Gagne-Sansfacon J, 2019, J PATHOL, V247, P135, DOI 10.1002/path.5177; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heuberger J, 2014, P NATL ACAD SCI USA, V111, P3472, DOI 10.1073/pnas.1309342111; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jourdan F, 2003, VIRCHOWS ARCH, V443, P115, DOI 10.1007/s00428-003-0833-z; Lanzoni G, 2008, WORLD J GASTROENTERO, V14, P4616, DOI 10.3748/wjg.14.4616; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lowery JW, 2018, PHYSIOL REV, V98, P2431, DOI 10.1152/physrev.00028.2017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Narumi Y, 2009, J CLIN IMMUNOL, V29, P303, DOI 10.1007/s10875-008-9272-6; Neel B. G., 2009, HDB CELL SIGNALING, P771; O'Rourke Kevin P, 2016, Bio Protoc, V6; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Powell AE, 2014, AM J PHYSIOL-GASTR L, V307, pG16, DOI 10.1152/ajpgi.00358.2013; Qi Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13824; Qu S, 2019, J CELL MOL MED, V23, P1116, DOI 10.1111/jcmm.14012; Quante M, 2008, PHYSIOLOGY, V23, P350, DOI 10.1152/physiol.00031.2008; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Roberts DJ, 2000, DEV DYNAM, V219, P109, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1047>3.3.CO;2-Y; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Sukhotnik I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110675; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; Wang LJ, 2018, FASEB J, V32, P875, DOI 10.1096/fj.201700672RR; Xiao P, 2019, J EXP MED, V216, P337, DOI 10.1084/jem.20181198; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092904; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yao B, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1269-3; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107; Zuo CL, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0013-z	72	2	2	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001091R	http://dx.doi.org/10.1096/fj.202001091R		NOV 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33165997				2022-12-28	WOS:000590824300001
J	Boccia, L; Le Foll, C; Lutz, TA				Boccia, Lavinia; Le Foll, Christelle; Lutz, Thomas A.			Noradrenaline signaling in the LPBN mediates amylin's and salmon calcitonin's hypophagic effect in male rats	FASEB JOURNAL			English	Article						6-OHDA; CGRP; CTR; DBH; NA	GENE-RELATED PEPTIDE; SOLITARY TRACT; PARABRACHIAL NUCLEUS; AREA POSTREMA; NORADRENERGIC NEURONS; ENERGY-BALANCE; HORMONE AMYLIN; FOOD-INTAKE; PROJECTIONS; BRAIN	The LPBN (lateral parabrachial nucleus) plays an important role in feeding control. CGRP (calcitonin gene-related peptide) LPBN neurons activation mediates the anorectic effects of different gut-derived peptides, including amylin. Amylin and its long acting analog sCT (salmon calcitonin) exert their anorectic actions primarily by directly activating neurons located in the area postrema (AP). A large proportion of projections from the AP and the adjacent nucleus of the solitary tractNTS to the LPBN, are noradrenergic (NA), and amylin-activated NA(AP) neurons are critical in mediating amylin's hypophagic effects. Here, we determine the functional role of NA(AP) amylin activated neurons to activate CGRP and non-CGRP LPBN neurons. To this end, NA was specifically depleted in the rat LPBN through a stereotaxic microinfusion of 6-OHDA, a neurotoxic agent that destroys NA terminals. While amylin (50 mu g/kg) and sCT (5 mu g/kg) reduced eating in sham-lesioned rats, no reduction in feeding occurred in NA-depleted animals. Further, the amylin-induced c-Fos response in the LPBN and c-Fos/CGRP colocalization were reduced in NA-depleted animals compared to controls. We conclude that AP -> LPBN NA signaling, through the activation of LPBN CGRP neurons, mediates part of amylin's hypophagic effect.	[Boccia, Lavinia; Le Foll, Christelle; Lutz, Thomas A.] Univ Zurich, Inst Vet Physiol, Winterthurerstr 260, CH-8057 Zurich, Switzerland	University of Zurich	Lutz, TA (corresponding author), Univ Zurich, Inst Vet Physiol, Winterthurerstr 260, CH-8057 Zurich, Switzerland.	tomlutz@vetphys.uzh.ch	Le Foll, Christelle/N-4847-2019	Le Foll, Christelle/0000-0002-6677-5488	Swiss National Science Foundation [31003A_156935]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant/Award Number: 31003A_156935	Aristieta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042652; BECKSTEAD RM, 1980, J COMP NEUROL, V190, P259, DOI 10.1002/cne.901900205; Becskei C, 2007, BRAIN RES, V1162, P76, DOI 10.1016/j.brainres.2007.06.016; Braegger FE, 2014, EUR J NEUROSCI, V40, P3055, DOI 10.1111/ejn.12672; BREESE GR, 1970, J PHARMACOL EXP THER, V174, P413; Campos CA, 2016, CELL METAB, V23, P811, DOI 10.1016/j.cmet.2016.04.006; Carter ME, 2015, J NEUROSCI, V35, P4582, DOI 10.1523/JNEUROSCI.3729-14.2015; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; CHANCE WT, 1992, PEPTIDES, V13, P961, DOI 10.1016/0196-9781(92)90057-A; Cheng WW, 2020, CELL METAB, V31, P301, DOI 10.1016/j.cmet.2019.12.012; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Coester B, 2019, NEUROSCIENCE; Coester B, 2020, DIABETES, V69, P1110, DOI 10.2337/db19-0849; DEUTSCH JA, 1981, SCIENCE, V211, P733; Duffy S, 2018, AM J PHYSIOL-REG I, V315, pR856, DOI 10.1152/ajpregu.00179.2018; FREED WJ, 1979, SCIENCE, V206, P850, DOI 10.1126/science.493987; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; HARIK SI, 1984, J NEUROSCI, V4, P699; Hay DL, 2015, PHARMACOL REV, V67, P564, DOI 10.1124/pr.115.010629; HERBERT H, 1990, J COMP NEUROL, V293, P581, DOI 10.1002/cne.902930405; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Hermes SM, 2006, EXP NEUROL, V198, P539, DOI 10.1016/j.expneurol.2005.12.028; Hilton JM, 2000, J ENDOCRINOL, V166, P213, DOI 10.1677/joe.0.1660213; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; KAWAI Y, 1988, BRAIN RES, V459, P369, DOI 10.1016/0006-8993(88)90654-3; Ludvik B, 1997, DIABETIC MED, V14, pS9, DOI 10.1002/(SICI)1096-9136(199706)14:2+<S9::AID-DIA397>3.3.CO;2-4; Lutz TA, 1998, PEPTIDES, V19, P309, DOI 10.1016/S0196-9781(97)00292-1; Lutz Thomas Alexander, 2012, Handb Exp Pharmacol, P231, DOI 10.1007/978-3-642-24716-3_10; Mack C, 2007, AM J PHYSIOL-REG I, V293, pR1855, DOI 10.1152/ajpregu.00297.2007; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mietlicki-Baase EG, 2015, NEUROPSYCHOPHARMACOL, V40, P372, DOI 10.1038/npp.2014.180; MILNER TA, 1986, J NEUROSCI, V6, P2585; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Potes CS, 2010, AM J PHYSIOL-REG I, V299, pR623, DOI 10.1152/ajpregu.00791.2009; Qi T, 2008, MOL PHARMACOL, V74, P1059, DOI 10.1124/mol.108.047142; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; Riediger T, 2004, AM J PHYSIOL-REG I, V286, pR114, DOI 10.1152/ajpregu.00333.2003; Rinaman L, 2007, AM J PHYSIOL-REG I, V293, pR1495, DOI 10.1152/ajpregu.00393.2007; Roman CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11905; Rowland NE, 1997, REGUL PEPTIDES, V71, P171, DOI 10.1016/S0167-0115(97)01034-3; Rushing PA, 2002, PEPTIDES, V23, P985, DOI 10.1016/S0196-9781(02)00022-0; SEXTON PM, 1994, NEUROSCIENCE, V62, P553, DOI 10.1016/0306-4522(94)90388-3; THOENEN H, 1973, ANNU REV PHARMACOL, V13, P169, DOI 10.1146/annurev.pa.13.040173.001125; Wielinga PY, 2007, PHYSIOL BEHAV, V91, P212, DOI 10.1016/j.physbeh.2007.02.012	44	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15448	15461		10.1096/fj.202001456RRR	http://dx.doi.org/10.1096/fj.202001456RRR		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32985027	hybrid			2022-12-28	WOS:000574550900001
J	Sareen, N; Abu-El-Rub, E; Ammar, HI; Yan, WA; Sequiera, GL; ShamsEldeen, AM; Moudgil, M; Dhingra, R; Shokry, HS; Rashed, LA; Kirshenbaum, LA; Dhingra, S				Sareen, Niketa; Abu-El-Rub, Ejlal; Ammar, Hania I.; Yan, Weiang; Sequiera, Glen Lester; ShamsEldeen, Asmaa M.; Moudgil, Meenal; Dhingra, Rimpy; Shokry, Heba S.; Rashed, Laila A.; Kirshenbaum, Lorrie A.; Dhingra, Sanjiv			Hypoxia-induced downregulation of cyclooxygenase 2 leads to the loss of immunoprivilege of allogeneic mesenchymal stem cells	FASEB JOURNAL			English	Article						COP9 signalosome; COX2; CSN5; mesenchymal stem cells; PGE2	T-CELLS; MYOCARDIAL-INFARCTION; DEPENDENT DEGRADATION; CARDIAC REPAIR; INFLAMMATION; DIFFERENTIATION; PROLIFERATION; MECHANISMS; RESOLUTION; EXPRESSION	Allogeneic mesenchymal stem cells (MSCs) from young and healthy donors are reported to hold the potential to treat several immunological and degenerative disorders. However, recent data from animal studies and clinical trials demonstrate that immunogenicity and poor survival of transplanted MSCs impaired the efficacy of cells for regenerative applications. It is reported that initially immunoprivileged under in vitro conditions, MSCs are targeted by the host immune system after transplantation in the ischemic tissues in vivo. We performed in vitro (in MSCs) and in vivo (in the rat model of myocardial infarction [MI]) studies to elucidate the mechanisms responsible for the change in the immunophenotype of MSCs from immunoprivileged to immunogenic under ischemic conditions. We have recently reported that a soluble factor prostaglandin E2 (PGE2) preserves the immunoprivilege of allogeneic MSCs. In the current study, we found that PGE2 levels, which were elevated during normoxia, decreased in MSCs following exposure to hypoxia. Further, we found that proteasome-mediated degradation of cyclooxygenase-2 (COX2, rate-limiting enzyme in PGE2 biosynthesis) in hypoxic MSCs is responsible for PGE2 decrease and loss of immunoprivilege of MSCs. While investigating the mechanisms of COX2 degradation in hypoxic MSCs, we found that in normoxic MSCs, COP9 signalosome subunit 5 (CSN5) binds to COX2 and prevents its degradation by the proteasome. However, exposure to hypoxia leads to a decrease in CSN5 levels and its binding to COX2, rendering COX2 protein susceptible to proteasome-mediated degradation. This subsequently causes PGE2 downregulation and loss of immunoprivilege of MSCs. Maintaining COX2 levels in MSCs preserves immunoprivilege in vitro and improves the survival of transplanted MSCs in a rat model of MI. These data provide novel mechanistic evidence that PGE2 is downregulated in hypoxic MSCs which is responsible for the post-transplantation rejection of allogeneic MSCs. Therefore, our data suggest that the new strategies that target CSN5-COX2 signaling may improve survival and utility of transplanted allogeneic MSCs in the ischemic heart.	[Sareen, Niketa; Abu-El-Rub, Ejlal; Yan, Weiang; Sequiera, Glen Lester; Moudgil, Meenal; Dhingra, Rimpy; Kirshenbaum, Lorrie A.; Dhingra, Sanjiv] Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp,Rady Fac Hlth Sci, Max Rady Coll Med,Albrechtsen Res Ctr, Winnipeg, MB, Canada; [Sareen, Niketa; Abu-El-Rub, Ejlal; Yan, Weiang; Sequiera, Glen Lester; Moudgil, Meenal; Dhingra, Rimpy; Kirshenbaum, Lorrie A.; Dhingra, Sanjiv] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Ammar, Hania I.; ShamsEldeen, Asmaa M.; Shokry, Heba S.; Rashed, Laila A.] Cairo Univ, Dept Physiol & Biochem, Fac Med, Cairo, Egypt	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Egyptian Knowledge Bank (EKB); Cairo University	Dhingra, S (corresponding author), St Boniface Gen Hosp, Inst Cardiovasc Sci, Regenerat Med Program, Res Ctr, R-3028-2,351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	sdhingra@sbrc.ca	Shamseldeen, Asmaa/AAR-2357-2020; Shams, A/HHZ-1192-2022; Dhingra, Sanjiv/D-8766-2014	Shamseldeen, Asmaa/0000-0002-4250-0818; Yan, Weiang/0000-0002-1065-4847; Dhingra, Sanjiv/0000-0002-2664-7633	Gouvernement du Canada; Canadian Institutes of Health Research (CIHR) [MOP142265]	Gouvernement du Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP142265	Abu-El-Rub E, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1359-x; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Ammar HI, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0142-x; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Bagno L, 2018, MOL THER, V26, P1610, DOI 10.1016/j.ymthe.2018.05.009; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Berglund AK, 2017, STEM CELL RES THER, V8, P1; CAI M, 2016, SCI REPORTS, V6, P1, DOI DOI 10.1038/SREP31528; Callige M, 2005, MOL CELL BIOL, V25, P4349, DOI 10.1128/MCB.25.11.4349-4358.2005; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Chen C, 2010, NAT CHEM BIOL, V6, P401, DOI 10.1038/nchembio.375; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Dhingra S, 2013, CIRCULATION, V128, pS69, DOI 10.1161/CIRCULATIONAHA.112.000324; Dhingra S, 2010, TRENDS CARDIOVAS MED, V20, P263, DOI 10.1016/j.tcm.2011.12.002; Ejtehadifar M, 2015, ADV PHARM BULL, V5, P141, DOI 10.15171/apb.2015.021; Gandhi J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00538; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Huang J., 2007, 2007 INT C COMM CIRC, V1, P67; Huang XP, 2016, FASEB J, V30, P3069, DOI 10.1096/fj.201600331R; Isakova IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087238; Kabat M, 2020, STEM CELL TRANSL MED, V9, P17, DOI 10.1002/sctm.19-0202; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Li J, 2018, BIOCHEM BIOPH RES CO, V500, P132, DOI 10.1016/j.bbrc.2018.03.183; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lukomska B, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/9628536; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Murn J, 2008, J EXP MED, V205, P3091, DOI 10.1084/jem.20081163; Natsumeda M, 2017, J AM COLL CARDIOL, V70, P2504, DOI 10.1016/j.jacc.2017.09.036; Neuss H, 2007, J MOL MED-JMM, V85, P961, DOI 10.1007/s00109-007-0197-y; Pacini S, 2017, SEARCH VIVO MSC; Padda J, 2015, CAN J PHYSIOL PHARM, V93, P835, DOI 10.1139/cjpp-2014-0468; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Pezzanite LM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0053-x; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Saravanan S., 2018, SCI REPORTS, V8, P1; Sareen N, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0867-4; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Sequiera GL, 2019, CAN J PHYSIOL PHARM, V97, P536, DOI 10.1139/cjpp-2018-0553; Singh B, 2005, INT J ONCOL, V26, P1393; Sun YQ, 2015, STEM CELLS, V33, P3452, DOI 10.1002/stem.2094; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Uccelli A, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3346-z; Volarevic V, 2018, INT J MED SCI, V15, P36, DOI 10.7150/ijms.21666; Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Yan W, 2019, AM J PHYSIOL-HEART C, V317, pH213, DOI 10.1152/ajpheart.00065.2019; Zhang J, 2012, AM J PHYSIOL-CELL PH, V303, pC115, DOI 10.1152/ajpcell.00326.2011; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	62	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15236	15251		10.1096/fj.202001478R	http://dx.doi.org/10.1096/fj.202001478R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959405				2022-12-28	WOS:000573858900001
J	Wang, XP; Xing, CY; Zhang, JX; Zhou, JH; Li, YC; Yang, HY; Zhang, PF; Zhang, W; Huang, Y; Long, JG; Gao, F; Zhang, X; Li, J				Wang, Xin-Pei; Xing, Chang-Yang; Zhang, Jia-Xin; Zhou, Jia-Heng; Li, Yun-Chu; Yang, Hong-Yan; Zhang, Peng-Fei; Zhang, Wei; Huang, Yin; Long, Jian-Gang; Gao, Feng; Zhang, Xing; Li, Jia			Time-restricted feeding alleviates cardiac dysfunction induced by simulated microgravity via restoring cardiac FGF21 signaling	FASEB JOURNAL			English	Article						cardiac function; FGF21; glucose utilization; microgravity; diet	GLUCOSE-METABOLISM; MOUSE MODEL; BED REST; SPACE; HEART; EXERCISE; ATROPHY; LIVER; RESYNCHRONIZATION; COUNTERMEASURE	Dietary restriction has been well-described to improve health metrics, but whether it could benefit pathophysiological adaptation to extreme environment, for example, microgravity, remains unknown. Here, we investigated the effects of a daily rhythm of fasting and feeding without reducing caloric intake on cardiac function and metabolism against simulated microgravity. Male rats under ad libitum feeding or time-restricted feeding (TRF; food access limited to 8 hours every day) were subjected to hindlimb unloading (HU) to simulate microgravity. HU for 6 weeks led to left ventricular dyssynchrony and declined cardiac function. HU also lowered pyruvate dehydrogenase (PDH) activity and impaired glucose utilization in the heart. All these were largely preserved by TRF. TRF showed no effects on HU-induced loss of cardiac mass, but significantly improved contractile function of cardiomyocytes. Interestingly, TRF raised liver-derived fibroblast growth factor 21 (FGF21) level and enhanced cardiac FGF21 signaling as manifested by upregulation of FGF receptor-1 (FGFR1) expression and its downstream markers in HU rats. In isolated cardiomyocytes, FGF21 treatment improved PDH activity and glucose utilization, consequently enhancing cell contractile function. Finally, both liver-specific knockdown (KD) of FGF21 and cardiac-specific FGFR1 KD abrogated the cardioprotective effects of TRF in HU rats. These data demonstrate that TRF improves cardiac glucose utilization and ameliorates cardiac dysfunction induced by simulated microgravity, at least partially, through restoring cardiac FGF21 signaling, suggesting TRF as a potential countermeasure for cardioprotection in long-term spaceflight.	[Wang, Xin-Pei; Xing, Chang-Yang; Zhang, Jia-Xin; Zhou, Jia-Heng; Li, Yun-Chu; Yang, Hong-Yan; Zhang, Peng-Fei; Gao, Feng; Zhang, Xing; Li, Jia] Fourth Mil Med Univ, Sch Aerosp Med, Xian, Peoples R China; [Xing, Chang-Yang] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Med, Xian, Peoples R China; [Zhang, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian, Peoples R China; [Huang, Yin] China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Nanjing, Peoples R China; [Long, Jian-Gang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Ctr Mitochondrial Biol & Med, Ctr Translat Med, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; China Pharmaceutical University; Xi'an Jiaotong University	Zhang, X (corresponding author), Fourth Mil Med Univ, 169 Changlexi Rd, Xian 710032, Peoples R China.	lbmed@163.com; jiali816@fmmu.edu.cn	Zhang, Xing/ACQ-5035-2022; Xing, Changyang/AAE-2899-2019	Xing, Changyang/0000-0003-1605-8285	National Natural Science Foundation of China (NSFC) [31771265, 81470537, 31871146]; National High Technology Research and Development Program of China [2014AA020542]; Foundation Grants of Fourth Military Medical University [2019RCFCLJ, HYZHXM01001, 2018JSTS15]; National Postdoctoral Program for Innovative Talents [BX20180377]; National Postdoctoral Science Foundation [2019M653965]; Youth Innovation Team of Shaanxi Universities	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Foundation Grants of Fourth Military Medical University; National Postdoctoral Program for Innovative Talents; National Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Team of Shaanxi Universities	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771265, 81470537 and 31871146; National High Technology Research and Development Program of China, Grant/Award Number: 2014AA020542; Foundation Grants of Fourth Military Medical University, Grant/Award Number: 2019RCFCLJ, HYZHXM01001 and 2018JSTS15; National Postdoctoral Program for Innovative Talents, Grant/Award Number: BX20180377; National Postdoctoral Science Foundation Grant, Grant/Award Number: 2019M653965; Youth Innovation Team of Shaanxi Universities	Arbeille P, 2016, AEROSP MED HUM PERF, V87, P449, DOI 10.3357/AMHP.4493.2016; Baskin KK, 2014, EMBO MOL MED, V6, P436, DOI 10.1002/emmm.201303800; Biering-Sorensen T, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005521; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Boucsein A, 2019, FASEB J, V33, P12175, DOI 10.1096/fj.201901004R; BUNGO MW, 1987, J APPL PHYSIOL, V62, P278, DOI 10.1152/jappl.1987.62.1.278; Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chung H, 2016, METABOLISM, V65, P1743, DOI 10.1016/j.metabol.2016.09.006; Coupe M, 2011, AM J PHYSIOL-REG I, V301, pR1748, DOI 10.1152/ajpregu.00234.2011; Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; de Lucia C, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004153; Dong TA, 2020, AM J MED, V133, P901, DOI 10.1016/j.amjmed.2020.03.030; Dorfman TA, 2007, J APPL PHYSIOL, V103, P8, DOI 10.1152/japplphysiol.01162.2006; Feng YF, 2013, CRIT CARE MED, V41, pE74, DOI 10.1097/CCM.0b013e318278b6e7; Fu Q, 2019, CIRCULATION, V140, P729, DOI 10.1161/CIRCULATIONAHA.119.041050; Gabel Kelsey, 2018, Nutr Healthy Aging, V4, P345, DOI 10.3233/NHA-170036; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Geng LL, 2019, CELL REP, V26, P2738, DOI 10.1016/j.celrep.2019.02.014; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; Guo YZ, 2018, CARDIOVASC RES, V114, P979, DOI 10.1093/cvr/cvy052; Hamilton DR, 2011, ECHOCARDIOGR-J CARD, V28, P491, DOI 10.1111/j.1540-8175.2011.01385.x; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hua YF, 2019, ANAL BIOANAL CHEM, V411, P2045, DOI 10.1007/s00216-019-01626-3; Hughson RL, 2012, J APPL PHYSIOL, V112, P719, DOI 10.1152/japplphysiol.01196.2011; Hughson RL, 2018, NAT REV CARDIOL, V15, P167, DOI 10.1038/nrcardio.2017.157; Kirk JA, 2013, CIRC RES, V113, P765, DOI 10.1161/CIRCRESAHA.113.300270; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; LANE HW, 1992, J NUTR, V122, P13, DOI 10.1093/jn/122.1.13; Levine BD, 1996, J APPL PHYSIOL, V81, P686, DOI 10.1152/jappl.1996.81.2.686; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Li TT, 2017, AM J PHYSIOL-ENDOC M, V313, pE577, DOI 10.1152/ajpendo.00014.2017; Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541; Liu H, 2015, LIFE SCI, V121, P1, DOI 10.1016/j.lfs.2014.10.023; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; MANCHESTER JK, 1990, FASEB J, V4, P55, DOI 10.1096/fasebj.4.1.1967237; Marcus KA, 2012, AM J PHYSIOL-HEART C, V302, pH196, DOI 10.1152/ajpheart.00740.2011; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Melkani GC, 2017, J PHYSIOL-LONDON, V595, P3691, DOI 10.1113/JP273094; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Petersen N, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0050-4; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Redondo-Angulo I, 2017, CARDIOVASC RES, V113, P1574, DOI 10.1093/cvr/cvx088; Rohm M, 2018, DIABETES, V67, P1057, DOI 10.2337/db17-1195; Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006; Shi L, 2021, CELL MOL IMMUNOL, V18, P1489, DOI 10.1038/s41423-019-0346-6; Sun J, 2015, ACUPUNCT MED, V33, P381, DOI 10.1136/acupmed-2014-010730; Sutton EF, 2018, CELL METAB, V27, P1212, DOI 10.1016/j.cmet.2018.04.010; Tobin BW, 2002, NUTRITION, V18, P842, DOI 10.1016/S0899-9007(02)00940-1; Wakabayashi H, 2019, MOL IMAGING BIOL, V21, P654, DOI 10.1007/s11307-018-1279-7; Wang Y, 2016, J PROTEOME RES, V15, P29, DOI 10.1021/acs.jproteome.5b00777; Wolff SM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0274-6; Yousefzadeh MJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12706; Yu CM, 2005, J AM COLL CARDIOL, V45, P677, DOI 10.1016/j.jacc.2004.12.003; Zhong GH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00274	62	9	10	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15180	15196		10.1096/fj.202001246RR	http://dx.doi.org/10.1096/fj.202001246RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954538				2022-12-28	WOS:000573726900001
J	Liu, S; Zhao, WJ; Liu, XY; Cheng, LX				Liu, Sheng; Zhao, Wenjing; Liu, Xueyan; Cheng, Lixin			Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target	FASEB JOURNAL			English	Article						atherosclerosis; cardiovascular diseases; gut microbiota; metabolites; metagenome	C-REACTIVE PROTEIN; VASCULAR-DISEASE; NICOTINIC-ACID; FOLIC-ACID; METHANOBREVIBACTER-SMITHII; CARDIOVASCULAR-DISEASE; INTESTINAL MICROBIOTA; WIDE ASSOCIATION; OXIDATIVE STRESS; SERUM METABOLOME	The gut microbiota is associated with cardiovascular diseases, including atherosclerosis. However, the composition, functional capacity, and metabolites of the gut microbiome about atherosclerosis have not been comprehensively studied. Here, we reanalyzed 25 metagenomic stool samples from Sweden and 385 metagenomic stool samples from China using HUMAnN2, PanPhlAn, and MelonnPan to obtain more sufficient information. We found that the samples from atherosclerotic patients in both cohorts were depleted inBacteroides xylanisolvens,Odoribacter splanchnicus,Eubacterium eligens,Roseburia inulinivorans,andRoseburia intestinalis. At the functional level, healthy metagenomes were both enriched in pathways of starch degradation V, glycolysis III (from glucose), CDP-diacylglycerol biosynthesis, and folate transformations.R inulinivoransandR intestinalisare major contributors to starch degradation V, whileE eligensgreatly contribute to the pathway CDP-diacylglycerol biosynthesis, andB xylanisolvensandB uniformiscontribute to folate transformations II. The 11 marker species selected from the Chinese cohort distinguish patients from controls with an area under the receiver operating characteristics curve (AUC) of 0.86. Strain-level microbial analysis revealed a geographically associated adaptation of the strains fromE eligens,B uniformis, andE coli. Two gut microbial metabolites, nicotinic acid and hydrocinnamic acid, had significantly higher predicted abundance in the control samples compared to the patients in the Chinese cohort, and interestinglynicotinic acid is already an effective lipid-lowering drug to reducing cardiovascular risk. Our results indicate intestinal bacteria such asB xylanisolvens,E eligens,andR inulinivoranscould be promising probiotics and potential therapeutic target for atherosclerosis.	[Liu, Sheng; Zhao, Wenjing] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Sch Med, Guangzhou, Peoples R China; [Liu, Sheng; Liu, Xueyan; Cheng, Lixin] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Crit Care Med, Shenzhen, Peoples R China	Sun Yat Sen University; Jinan University	Liu, XY; Cheng, LX (corresponding author), Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Crit Care Med, Shenzhen, Peoples R China.	XYLiu@qq.com; easonlcheng@gmail.com	Cheng, Lixin/I-6191-2019	Cheng, Lixin/0000-0002-9427-383X; Liu, Sheng/0000-0001-5119-0324; Zhao, Wenjing/0000-0003-1706-6324	National Natural Science Foundation of China (NSFC) [31900056]; Health and Family Planning Commission of Shenzhen Municipality [SZXJ2017027]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Shenzhen Municipality	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31900056; Health and Family Planning Commission of Shenzhen Municipality, Grant/Award Number: SZXJ2017027	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Bartolomaeus H, 2019, CIRCULATION, V139, P1407, DOI 10.1161/CIRCULATIONAHA.118.036652; Bennett J.E., 2015, MANDELL DOUGLAS BENN; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Bouter KE, 2017, GASTROENTEROLOGY, V152, P1671, DOI 10.1053/j.gastro.2016.12.048; Brown BG, 2008, AM J CARDIOL, V101, p58B, DOI 10.1016/j.amjcard.2008.02.039; Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149; Cerqueira FM, 2020, TRENDS MICROBIOL, V28, P95, DOI 10.1016/j.tim.2019.09.004; Chassard C, 2008, INT J SYST EVOL MICR, V58, P1008, DOI 10.1099/ijs.0.65504-0; Chung WSF, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix127; Coker OO, 2018, GUT, V67, P1024, DOI 10.1136/gutjnl-2017-314281; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Duncan SH, 2006, INT J SYST EVOL MICR, V56, P2437, DOI 10.1099/ijs.0.64098-0; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Etxeberria U, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500906; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Forstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Grine G, 2017, EUR J CLIN MICROBIOL, V36, P2449, DOI 10.1007/s10096-017-3084-7; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Julius U, 2013, ATHEROSCLEROSIS SUPP, V14, P7, DOI 10.1016/j.atherosclerosissup.2012.10.036; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kasahara K, 2018, NAT MICROBIOL, V3, P1461, DOI 10.1038/s41564-018-0272-x; Kasselman LJ, 2018, ATHEROSCLEROSIS, V271, P203, DOI 10.1016/j.atherosclerosis.2018.02.036; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Li YP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003768; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mallick H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10927-1; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; McOrist AL, 2011, J NUTR, V141, P883, DOI 10.3945/jn.110.128504; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mischke M, 2016, ADV EXP MED BIOL, V902, P33, DOI 10.1007/978-3-319-31248-4_3; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Park J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04632-6; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Santoru ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10034-5; Scholz M, 2016, NAT METHODS, V13, P435, DOI [10.1038/NMETH.3802, 10.1038/nmeth.3802]; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; Skagen K, 2016, ATHEROSCLEROSIS, V247, P64, DOI 10.1016/j.atherosclerosis.2016.01.033; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tso SC, 2013, P NATL ACAD SCI USA, V110, P9728, DOI 10.1073/pnas.1303220110; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Ulsemer P, 2012, APPL ENVIRON MICROB, V78, P528, DOI 10.1128/AEM.06641-11; Visconti A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12476-z; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wald DS, 2006, BMJ-BRIT MED J, V333, P1114, DOI 10.1136/bmj.39000.486701.68; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang CCL, 2016, CIRCULATION, V133, P2459, DOI 10.1161/CIRCULATIONAHA.116.022194; Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83; Wang Y, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00450-19; Wang ZN, 2018, PROTEIN CELL, V9, P416, DOI 10.1007/s13238-018-0549-0; Xu YQ, 2019, J BIOL CHEM, V294, P16740, DOI 10.1074/jbc.RA119.009992; Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7; Zhang L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38216-9; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	87	21	24	5	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14166	14181		10.1096/fj.202000622R	http://dx.doi.org/10.1096/fj.202000622R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939880				2022-12-28	WOS:000570971000001
J	Reithofer, M; Karacs, J; Strobl, J; Kitzmuller, C; Polak, D; Seif, K; Kamalov, M; Becker, CFW; Greiner, G; Schmetterer, K; Stary, G; Bohle, B; Jahn-Schmid, B				Reithofer, Manuel; Karacs, Jasmine; Strobl, Johanna; Kitzmueller, Claudia; Polak, Dominika; Seif, Katharina; Kamalov, Meder; Becker, Christian F. W.; Greiner, Georg; Schmetterer, Klaus; Stary, Georg; Bohle, Barbara; Jahn-Schmid, Beatrice			Alum triggers infiltration of human neutrophils ex vivo and causes lysosomal destabilization and mitochondrial membrane potential-dependent NET-formation	FASEB JOURNAL			English	Article						aluminium hydroxide; vaccine; adjuvant; innate response; neutrophils; NET	EXTRACELLULAR TRAP FORMATION; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; DENDRITIC CELLS; RELEASE; ACTIVATION; IMMUNITY; INJECTION; MECHANISM; ADJUVANTS	Aluminium salts have been used in vaccines for decades. However, the mechanisms underlying their adjuvant effect are still unclear. Neutrophils, the first immune cells at the injection site, can release cellular DNA together with granular material, so-called neutrophil extracellular traps (NETs). In mice, NETs apparently play a role in aluminium hydroxide (alum)-adjuvant immune response to vaccines. Although no experimental data exist, this effect is assumed to be operative also in humans. As a first step to verify this knowledge in humans, we demonstrate that the injection of alum particles into human skin biopsies ex vivo leads to similar tissue infiltration of neutrophils and NET-formation. Moreover, we characterized the mechanism leading to alum-induced NET-release in human neutrophils as rapid, NADPH oxidase-independent process involving charge, phagocytosis, phagolysosomal rupture, Ca2+-flux, hyperpolarization of the mitochondrial membrane, and mitochondrial ROS. Extracellular flow and inhibition experiments suggested that no additional energy from oxidative phosphorylation or glycolysis is required for NET-release. This study suggests a so far unappreciated role for neutrophils in the initial phase of immune responses to alum-containing vaccines in humans and provides novel insights into bioenergetic requirements of NET-formation.	[Reithofer, Manuel; Karacs, Jasmine; Kitzmueller, Claudia; Polak, Dominika; Bohle, Barbara; Jahn-Schmid, Beatrice] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Vienna, Austria; [Strobl, Johanna; Stary, Georg] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Seif, Katharina] Med Univ Vienna, Dept Surg, Vienna, Austria; [Kamalov, Meder; Becker, Christian F. W.] Univ Vienna, Inst Biol Chem, Dept Chem, Vienna, Austria; [Greiner, Georg; Schmetterer, Klaus] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Stary, Georg] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria; [Stary, Georg] CeMM Res Ctr Mol Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Jahn-Schmid, B (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Wahringer Gurtel 18-20,3Q, A-1090 Vienna, Austria.	beatrice.jahn-schmid@meduniwien.ac.at	; Stary, Georg/M-8978-2014	Reithofer, Manuel/0000-0003-2845-1826; Stary, Georg/0000-0003-1746-4250; Strobl, Johanna/0000-0003-3606-2185; Kitzmuller, Claudia/0000-0002-3829-8020	Austrian Science Fund (FWF) [MCCA-W1248, SFB-F4610]; Medical University of Vienna; Austrian Central Bank [17582]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical University of Vienna; Austrian Central Bank	This study was supported by funds of the Austrian Science Fund (FWF; Doctoral Program MCCA-W1248 to BB, BJS, and SFB-F4610 to BB), the Medical University of Vienna, and the Austrian Central Bank to BJS (ONB, Anniversary Fund, Project 17582)	Amini P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05387-y; Amini P, 2016, EUR J IMMUNOL, V46, P178, DOI 10.1002/eji.201545615; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Boeltz S, 2019, CELL DEATH DIFFER, V26, P395, DOI 10.1038/s41418-018-0261-x; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; Calzetti F, 2017, J ALLERGY CLIN IMMUN, V139, P352, DOI 10.1016/j.jaci.2016.06.025; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen KW, 2016, EUR J IMMUNOL, V46, P1004, DOI 10.1002/eji.201545943; Christensen KA, 2002, J CELL SCI, V115, P599; Desai JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17143-1; Desai J, 2016, EUR J IMMUNOL, V46, P223, DOI 10.1002/eji.201545605; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Ghosh M, 2011, FEBS LETT, V585, P623, DOI 10.1016/j.febslet.2010.12.043; Gupta AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097088; Gupta RK, 1996, VACCINE, V14, P1412, DOI 10.1016/S0264-410X(96)00073-4; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; HogenEsch H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00406; HONARPISHEH M, 2017, SCI REP UK, V7; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Johnston CT, 2002, J PHARM SCI, V91, P1702, DOI 10.1002/jps.10166; Kenno S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00879; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/eLife.24437, 10.7554/elife.24437]; Keshari RS, 2012, CYTOM PART A, V81A, P238, DOI 10.1002/cyto.a.21178; Kienhofer D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92920; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lima H, 2013, CELL CYCLE, V12, P1868, DOI 10.4161/cc.24903; Lu FJ, 2013, VACCINE, V31, P3979, DOI 10.1016/j.vaccine.2013.05.107; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Munoz LE, 2019, IMMUNITY, V51, P443, DOI 10.1016/j.immuni.2019.07.002; Munoz LE, 2016, P NATL ACAD SCI USA, V113, pE5856, DOI 10.1073/pnas.1602230113; Neubert E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06263-5; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Rada B, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2896380; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; SCHORN C, 2012, FRONT IMMUNOL, V3; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Stephen J, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0001-5; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00328; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	61	6	6	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					14024	14041		10.1096/fj.202001413R	http://dx.doi.org/10.1096/fj.202001413R		AUG 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32860638	Green Published, hybrid			2022-12-28	WOS:000566158500001
J	Zhuang, F; Bao, H; Shi, Q; Li, J; Jiang, ZL; Wang, YX; Qi, YX				Zhuang, Fei; Bao, Han; Shi, Qian; Li, Jing; Jiang, Zong-Lai; Wang, Yingxiao; Qi, Ying-Xin			Endothelial microparticles induced by cyclic stretch activate Src and modulate cell apoptosis	FASEB JOURNAL			English	Article						apoptosis; cyclic stretch; endothelial microparticles; fluorescence resonance energy transfer; Src	INTERACTING PROTEIN; TETRASPANIN; INCREASES; RECEPTOR	Endothelial microparticles (EMPs) are involved in various cardiovascular pathologies and play remarkable roles in communication between endothelial cells (ECs), which are constantly exposed to mechanical cyclic stretch (CS) following blood pressure. However, the roles of EMPs induced by CS in EC homeostasis are still unclear. Both fluorescence resonance energy transfer (FRET) and western blotting revealed the activation of Src in ECs was significantly increased by 5% CS-induced EMPs. Furthermore, proteomic analysis revealed that the contents were obvious different in the EMPs between 5%- and 15%-group. Based on the bioinformatic analysis, CD151 on EMPs was predicted to activate Src, which was further confirmed by both FRET and western blotting. Moreover, the expression of CD151 on EMPs was significantly increased by 5% CS and involved in the binding of EMPs to ECs. EC apoptosis, which was significantly decreased by 5% CS-derived EMPs, showed obvious increase after pretreatment with Src inhibitor in target ECs. Our present research suggests that mechanical stretch changes the components of EMPs, which in turn modulates EC apoptosis by Src activation. CD151 expressed on CS-induced EMPs may play important roles in EC communication and homeostasis.	[Zhuang, Fei; Bao, Han; Shi, Qian; Jiang, Zong-Lai; Qi, Ying-Xin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, POB 888,800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Li, Jing] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Dept Bioinformat & Biostat, Shanghai, Peoples R China; [Wang, Yingxiao] Univ Calif La Jolla, Dept Bioengn, San Diego, CA 92103 USA; [Qi, Ying-Xin] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China; [Qi, Ying-Xin] Beihang Univ, Beijing Adv Innovat Ctr Biomed Engn, Beijing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California San Diego; Beihang University; Beihang University	Qi, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, POB 888,800 Dongchuan Rd, Shanghai 200240, Peoples R China.; Wang, YX (corresponding author), Univ Calif La Jolla, Dept Bioengn, San Diego, CA 92103 USA.	yiw015@eng.ucsd.edu; qiyx@sjtu.edu.cn			National Natural Science Foundation of China [11625209, 11222223, 11172178]; Innovative research team of high-level local universities in Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative research team of high-level local universities in Shanghai	National Natural Science Foundation of China, Grant/Award Number: 11625209, 11222223 and 11172178; Innovative research team of high-level local universities in Shanghai	Abid H M., 2008, THROMB RES, V121, P865, DOI DOI 10.1016/J.THR0MRES.2007.08.005; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; Arderiu G, 2015, ARTERIOSCL THROM VAS, V35, P348, DOI 10.1161/ATVBAHA.114.303927; Bao H, 2018, FASEB J, V32, P3912, DOI 10.1096/fj.201701073R; Burger D, 2017, DIABETOLOGIA, V60, P1791, DOI 10.1007/s00125-017-4331-2; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Jansen F, 2017, J MOL CELL CARDIOL, V104, P43, DOI 10.1016/j.yjmcc.2016.12.005; Jansen F, 2015, J CELL MOL MED, V19, P2202, DOI 10.1111/jcmm.12607; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Jufri NF, 2015, VASC CELL, V7, DOI 10.1186/s13221-015-0033-z; Kou BJ, 2009, MICROVASC RES, V77, P125, DOI 10.1016/j.mvr.2008.08.001; Kwan HY, 2003, CIRC RES, V92, P286, DOI 10.1161/01.RES.0000054625.24468.08; Lacolley P, 2004, CARDIOVASC RES, V63, P577, DOI 10.1016/j.cardiores.2004.06.017; Letsiou E, 2015, AM J RESP CELL MOL, V52, P193, DOI 10.1165/rcmb.2013-0347OC; Li PC, 2015, MOL MED REP, V11, P1258, DOI 10.3892/mmr.2014.2774; Li Q, 2013, ONCOGENE, V32, P1772, DOI 10.1038/onc.2012.205; Liu B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07008; Liu GQ, 2012, BLOOD, V120, P1942, DOI 10.1182/blood-2011-12-397430; Liu XM, 2003, FEBS LETT, V541, P52, DOI 10.1016/S0014-5793(03)00285-0; Lovren F, 2013, CLIN CHEM, V59, P1166, DOI 10.1373/clinchem.2012.199711; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Nie DM, 2016, AM J PHYSIOL-CELL PH, V310, pC821, DOI 10.1152/ajpcell.00372.2015; Perez-Casal M, 2009, HAEMATOL-HEMATOL J, V94, P387, DOI 10.3324/haematol.13547; Peterson DB, 2008, PROTEOMICS, V8, P2430, DOI 10.1002/pmic.200701029; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Schiro A, 2014, ATHEROSCLEROSIS, V234, P295, DOI 10.1016/j.atherosclerosis.2014.03.019; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Spindel ON, 2014, CIRC RES, V114, P1125, DOI 10.1161/CIRCRESAHA.114.301315; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zhang F, 2011, BLOOD, V118, P4274, DOI 10.1182/blood-2011-03-339531; Zhang F, 2009, CARDIOVASC RES, V83, P7, DOI 10.1093/cvr/cvp080	44	2	3	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13586	13596		10.1096/fj.202000581R	http://dx.doi.org/10.1096/fj.202000581R		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32856783				2022-12-28	WOS:000566045200001
J	Liu, SZ; Wu, D; Sun, X; Fan, Y; Zha, RR; Jalali, A; Teli, M; Sano, T; Siegel, A; Sudo, A; Agarwal, M; Robling, A; Li, BY; Yokota, H				Liu, Shengzhi; Wu, Di; Sun, Xun; Fan, Yao; Zha, Rongrong; Jalali, Aydin; Teli, Meghana; Sano, Tomohiko; Siegel, Amanda; Sudo, Akihiro; Agarwal, Mangilal; Robling, Alexander; Li, Bai-Yan; Yokota, Hiroki			Mechanical stimulations can inhibit local and remote tumor progression by downregulating WISP1	FASEB JOURNAL			English	Article						bone metastasis; breast cancer; cholesterol; urine; TGF beta calcitriol; vitamin D-3; WISP1	BONE-FORMATION; CANCER; EXERCISE; PATHWAYS	Mechanical stimulations can prevent bone loss, but their effects on the tumor-invaded bone or solid tumors are elusive. Here, we evaluated the effect of knee loading, dynamic loads applied to the knee, on metastasized bone and mammary tumors. In a mouse model, tumor cells were inoculated to the mammary fat pad or the proximal tibia. Daily knee loading was then applied and metabolic changes were monitored mainly through urine. Urine samples were also collected from human subjects before and after step aerobics. The result showed that knee loading inhibited tumor progression in the loaded tibia. Notably, it also reduced remotely the growth of mammary tumors. In the urine, an altered level of cholesterol was observed with an increase in calcitriol, which is synthesized from a cholesterol derivative. In urinary proteins, knee loading in mice and step aerobics in humans markedly reduced WNT1-inducible signaling pathway protein 1, WISP1, which leads to poor survival among patients with breast cancer. In the ex vivo breast cancer tissue assay, WISP1 promoted the growth of cancer fragments and upregulated tumor-promoting genes, such as Runx2, MMP9, and Snail. Collectively, the present preclinical and human study demonstrated that mechanical stimulations, such as knee loading and step aerobics, altered urinary metabolism and downregulated WISP1. The study supports the benefit of mechanical stimulations for locally and remotely suppressing tumor progression. It also indicated the role of WISP1 downregulation as a potential mechanism of loading-driven tumor suppression.	[Liu, Shengzhi; Wu, Di; Sun, Xun; Fan, Yao; Zha, Rongrong; Jalali, Aydin; Teli, Meghana; Sano, Tomohiko; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Wu, Di; Sun, Xun; Fan, Yao; Zha, Rongrong; Li, Bai-Yan; Yokota, Hiroki] Harbin Med Univ, Sch Pharm, Dept Pharmacol, Harbin, Peoples R China; [Sano, Tomohiko; Sudo, Akihiro] Mie Univ, Dept Orthoped Surg, Tsu, Mie, Japan; [Siegel, Amanda; Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Integrated Nanosyst Dev Inst, Indianapolis, IN 46202 USA; [Siegel, Amanda] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Mech Engn, Indianapolis, IN 46202 USA; [Robling, Alexander; Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Robling, Alexander; Yokota, Hiroki] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA; [Yokota, Hiroki] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harbin Medical University; Mie University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Yokota, H (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	hyokota@iupui.edu			HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR52144, R01AR053237]; HHS | NIH | National Cancer Institute (NCI) [R03CA238555]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS | NIH | National Cancer Institute (NCI)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR52144 and R01AR053237; HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: R03CA238555	Al-Hendy A, 2016, J CLIN ENDOCR METAB, V101, P1542, DOI 10.1210/jc.2015-3555; Bikle Daniel D, 2014, Adv Exp Med Biol, V810, P282; Coughlin Steven S, 2019, Curr Cancer Rep, V1, P6, DOI 10.25082/CCR.2019.01.002; Coughlin TR, 2017, CURR DRUG TARGETS, V18, P1281, DOI 10.2174/1389450117666161226121650; da Silva PM, 2011, AM J CARDIOVASC DRUG, V11, P93, DOI 10.2165/11591190-000000000-00000; de Boer MC, 2017, CLIN BREAST CANCER, V17, P272, DOI 10.1016/j.clbc.2017.01.006; De Craene B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1521; Deng WT, 2019, J BIOL CHEM, V294, P5261, DOI 10.1074/jbc.RA118.006122; Ewens A, 2005, ANTICANCER RES, V25, P3905; Ferrari N, 2013, J CELL PHYSIOL, V228, P1137, DOI 10.1002/jcp.24285; Friedenreich CM, 2017, J MOL MED, V95, P1029, DOI 10.1007/s00109-017-1558-9; Guo SS, 2020, J SPORT HEALTH SCI, V9, P53, DOI 10.1016/j.jshs.2019.07.004; Holm NJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030310; Kopecka J, 2020, DRUG RESIST UPDATE, V49, DOI 10.1016/j.drup.2019.100670; Liu SZ, 2018, CANCER RES, V78, P3865, DOI 10.1158/0008-5472.CAN-18-0056; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Minami K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45686; Pauli C, 2017, CANCER DISCOV, V7, P462, DOI 10.1158/2159-8290.CD-16-1154; Prabhu AV, 2016, PROG LIPID RES, V64, P138, DOI 10.1016/j.plipres.2016.09.003; Salvador F, 2019, J PATHOL, V249, P6, DOI 10.1002/path.5292; Shim JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085095; Sun HB, 2012, CONNECT TISSUE RES, V53, P180, DOI 10.3109/03008207.2011.628765; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wang LQ, 2019, FASEB J, V33, P13710, DOI 10.1096/fj.201901388R; Wang TJ, 2015, RES NURS HEALTH, V38, P39, DOI 10.1002/nur.21633; Woollam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38920-0; Wu D, 2020, FASEB J, V34, P7578, DOI 10.1096/fj.202000096R; Xu WX, 2015, CELL SIGNAL, V27, P2332, DOI 10.1016/j.cellsig.2015.08.014; Yang S, 2019, FASEB J, V33, P10742, DOI 10.1096/fj.201900306RR; Yousef EM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-609; Zhang P, 2008, BRIT J SPORT MED, V42, P556, DOI 10.1136/bjsm.2007.042556; Zhang P, 2006, J APPL PHYSIOL, V100, P1452, DOI 10.1152/japplphysiol.00997.2005; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020	34	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12847	12859		10.1096/fj.202000713RR	http://dx.doi.org/10.1096/fj.202000713RR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744779	Green Accepted, Green Submitted			2022-12-28	WOS:000557254800001
J	Mytidou, C; Koutsoulidou, A; Katsioloudi, A; Prokopi, M; Kapnisis, K; Michailidou, K; Anayiotos, A; Phylactou, LA				Mytidou, Chrystalla; Koutsoulidou, Andrie; Katsioloudi, Anna; Prokopi, Marianna; Kapnisis, Konstantinos; Michailidou, Kyriaki; Anayiotos, Andreas; Phylactou, Leonidas A.			Muscle-derived exosomes encapsulate myomiRs and are involved in local skeletal muscle tissue communication	FASEB JOURNAL			English	Article						exosomal cross talk; exosomes; myomiRs; skeletal muscle	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MEDIATED DELIVERY; FIBER TYPES; IN-VITRO; MICRORNAS; VESICLES; CELLS; IDENTIFICATION; MICROVESICLES; EXPRESSION	Exosomes are extracellular vesicles that are released from most cell types encapsulating specific molecular cargo. Exosomes serve as mediators of cell-to-cell and tissue-to-tissue communications under normal and pathological conditions. It has been shown that exosomes carrying muscle-specific miRNAs, myomiRs, are secreted from skeletal muscle cells in vitro and are elevated in the blood of muscle disease patients. The aim of this study was to investigate the secretion of exosomes encapsulating the four myomiRs from skeletal muscle tissues and to assess their role in inter-tissue communication between neighboring skeletal muscles in vivo. We demonstrate, for the first time, that isolated, intact skeletal muscle tissues secrete exosomes encapsulating the four myomiRs, miR-1, miR-133a, miR-133b, and miR-206. Notably, we show that the sorting of the four myomiRs within exosomes varies between skeletal muscles of different muscle fiber-type composition. miR-133a and miR-133b downregulation in TA muscles caused a reduction of their levels in neighboring skeletal muscles and in serum exosomes. In conclusion, our results reveal that skeletal muscle-derived exosomes encapsulate the four myomiRs, some of which enter the blood, while a portion is used for the local communication between proximal muscle tissues. These findings provide important evidence regarding novel pathways implicated in skeletal muscle function.	[Mytidou, Chrystalla; Koutsoulidou, Andrie; Phylactou, Leonidas A.] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, POB 23462, CY-1683 Nicosia, Cyprus; [Mytidou, Chrystalla; Koutsoulidou, Andrie; Michailidou, Kyriaki; Phylactou, Leonidas A.] Cyprus Sch Mol Med, Cyprus Inst Neurol & Genet, Nicosia, Cyprus; [Katsioloudi, Anna; Prokopi, Marianna] Theramir Ltd, Limassol, Cyprus; [Prokopi, Marianna; Kapnisis, Konstantinos; Anayiotos, Andreas] Cyprus Univ Technol, Dept Mech Engn & Mat Sci & Engn, Lemesos, Cyprus; [Prokopi, Marianna] German Oncol Ctr, Dept Res & Dev, Limassol, Cyprus; [Michailidou, Kyriaki] Cyprus Inst Neurol & Genet, Biostat Unit, Nicosia, Cyprus	Cyprus University of Technology	Phylactou, LA (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, POB 23462, CY-1683 Nicosia, Cyprus.	laphylac@cing.ac.cy	Kapnisis, Konstantinos/ABG-6186-2020; Anayiotos, Andreas/AFE-8497-2022; Anayiotos, Andreas/AAE-9728-2022	Anayiotos, Andreas/0000-0003-4471-7604; Anayiotos, Andreas/0000-0003-4471-7604; Michailidou, Kyriaki/0000-0001-7065-1237; Phylactou, Leonidas/0000-0002-1377-211X; Kapnisis, Konstantinos/0000-0002-4999-0231				Aoi W, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00039; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Aswad H, 2014, DIABETOLOGIA, V57, P2155, DOI 10.1007/s00125-014-3337-2; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Charoenviriyakul C, 2017, EUR J PHARM SCI, V96, P316, DOI 10.1016/j.ejps.2016.10.009; Chen B, 2017, STEM CELL TRANSL MED, V6, P1753, DOI 10.1002/sctm.16-0477; Chen C, 2017, CANCER LETT, V388, P21, DOI 10.1016/j.canlet.2016.11.027; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; De Gasperi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13105-9; Delcayre A, 2005, EXPERT REV ANTICANC, V5, P537, DOI 10.1586/14737140.5.3.537; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Favier FB, 2015, CELL MOL LIFE SCI, V72, P4681, DOI 10.1007/s00018-015-2025-9; Forterre A, 2014, CELL CYCLE, V13, P78, DOI 10.4161/cc.26808; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001; Ji W., 2018, PLOS ONE, V13, P1; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179, DOI 10.1139/o92-028; Kaewpila S, 2008, CANCER RES, V68, P2781, DOI 10.1158/0008-5472.CAN-07-2635; Katayama M, 2019, DIABETES, V68, P515, DOI 10.2337/db18-0470; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Koutalianos D, 2015, J CELL SCI, V128, P3631, DOI 10.1242/jcs.172288; Koutsoulidou A, 2017, HUM MOL GENET, V26, P3285, DOI 10.1093/hmg/ddx212; Koutsoulidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125341; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li SP, 2018, ACTA PHARMACOL SIN, V39, P542, DOI 10.1038/aps.2017.178; Lima LG, 2018, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS OF EXOSOMES IN CANCER, P175, DOI 10.1016/B978-0-12-812774-2.00010-9; Ma GD, 2015, INT J BIOL SCI, V11, P345, DOI 10.7150/ijbs.10921; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Naseri Z, 2018, INT J NANOMED, V13, P7727, DOI 10.2147/IJN.S182384; Nie YH, 2019, EXP PHYSIOL, V104, P1262, DOI 10.1113/EP087396; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Quattrocelli M, 2015, ADV DRUG DELIVER REV, V88, P37, DOI 10.1016/j.addr.2015.04.011; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rome S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00929; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Ryan MJ, 2008, J GERONTOL A-BIOL, V63, P1015, DOI 10.1093/gerona/63.10.1015; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Steinbichler TB, 2017, SEMIN CANCER BIOL, V44, P170, DOI 10.1016/j.semcancer.2017.02.006; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Zhang D, 2017, AM J PHYSIOL-LUNG C, V312, pL110, DOI 10.1152/ajplung.00423.2016; Zhao L, 2017, CARDIOLOGY, V137, P43, DOI 10.1159/000453544; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	62	16	16	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21279	10.1096/fj.201902468RR	http://dx.doi.org/10.1096/fj.201902468RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484211	hybrid, Green Published			2022-12-28	WOS:000647789600056
J	Wang, CY; Dang, T; Baste, J; Joshi, AA; Bhushan, A				Wang, Chengyao; Thao Dang; Baste, Jasmine; Joshi, Advait Anil; Bhushan, Abhinav			A novel standalone microfluidic device for local control of oxygen tension for intestinal-bacteria interactions	FASEB JOURNAL			English	Article						anaerobe; barrier function; colon; hypoxic intestine; intestine&#8208; bacteria interaction; microfluidics; organ&#8208; on&#8208; chip; oxygen sensor; partitioned oxygen environment	IN-VITRO MODEL; HYPOXIA; CELL; CULTURE; METABOLISM; MICROBIOME; EXPRESSION; RESPONSES	The intestinal environment is unique because it supports the intestinal epithelial cells under a normal oxygen environment and the microbiota under an anoxic environment. Due to importance of understanding the interactions between the epithelium and the microbiota, there is a strong need for developing representative and simple experimental models. Current approaches do not capture the partitioned oxygen environment, require external anaerobic chambers, or are complex. Another major limitation is that with the solutions that can mimic this oxygen environment, the oxygenation level of the epithelial cells is not known, raising the question whether the cells are hypoxic or not. We report standalone microfluidic devices that form a partitioned oxygen environment without the use of an external anaerobic chamber or oxygen scavengers to coculture intestinal epithelial and bacterial cells. By changing the thickness of the device cover, the oxygen tension in the chamber was modulated. We verified the oxygen levels using several tests: microscale oxygen sensitive sensors which were integrated within the devices, immunostaining of Caco-2 cells to determine hypoxia levels, and genetically encoded bacteria to visualize the growth. Collectively, these methods monitored oxygen concentrations in the devices more comprehensively than previous reports and allowed for control of oxygen tension to match the requirements of both intestinal cells and anaerobic bacteria. Our experimental model is supported by the mathematical model that considered diffusion of oxygen into the top chamber. This allowed us to experimentally determine the oxygen consumption rate of the intestinal epithelial cells under perfusion.	[Wang, Chengyao; Thao Dang; Baste, Jasmine; Joshi, Advait Anil; Bhushan, Abhinav] IIT, Dept Biomed Engn, 3255 South Dearborn St,Wishnick Hall Room 224, Chicago, IL 60616 USA	Illinois Institute of Technology	Bhushan, A (corresponding author), IIT, Dept Biomed Engn, 3255 South Dearborn St,Wishnick Hall Room 224, Chicago, IL 60616 USA.	abhushan@iit.edu	Bhushan, Abhinav/AAR-6996-2020	Bhushan, Abhinav/0000-0002-8861-9005; Wang, Chengyao/0000-0002-0362-4498				Aguilera KY., 2014, BIOPROTOC, V4; Ahluwalia A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42113; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Amao Y, 2001, J FLUORINE CHEM, V107, P101, DOI 10.1016/S0022-1139(00)00352-3; Arrieta MC, 2016, CELL HOST MICROBE, V19, P575, DOI 10.1016/j.chom.2016.04.014; Bao BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050860; Beaurivage C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225661; Byron Bird R, 2007, TRANSPORT PHENOMENA, V2nd, DOI DOI 10.1002/AIC.690070245; Chung HH, 2018, LAB CHIP, V18, P1671, DOI 10.1039/c7lc01248a; Chung HH, 2014, LAB CHIP, V14, P2456, DOI 10.1039/c4lc00326h; Decleer M, 2018, TOXINS, V10, DOI 10.3390/toxins10070266; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Duttal D, 2017, CURR OPIN IMMUNOL, V48, P15, DOI 10.1016/j.coi.2017.07.012; Fang KL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23180-1; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14; Gao YD, 2019, LAB CHIP, V19, P306, DOI 10.1039/c8lc00825f; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; Grauso M., 2019, SCI REP-UK, V9, P1; Hegde M, 2014, LAB CHIP, V14, P2033, DOI 10.1039/c4lc00071d; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jalili-Firoozinezhad S, 2019, NAT BIOMED ENG, V3, P520, DOI 10.1038/s41551-019-0397-0; Jenkins J, 2015, ACTA BIOMATER, V16, P126, DOI 10.1016/j.actbio.2015.01.032; Jung SR, 2018, P NATL ACAD SCI USA, V115, pE5706, DOI 10.1073/pnas.1717724115; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Karhausen J, 2003, CELL MOL BIOL, V49, P77; Kaska L, 2016, WORLD J GASTROENTERO, V22, P8698, DOI 10.3748/wjg.v22.i39.8698; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kim R, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab446e; Lei Qi, 2014, Int J Mol Med, V34, P1629, DOI 10.3892/ijmm.2014.1965; Lizier M, 2010, FEMS MICROBIOL LETT, V308, P8, DOI 10.1111/j.1574-6968.2010.01978.x; Loskill P, 2017, LAB CHIP, V17, P1645, DOI 10.1039/c6lc01590e; Markov DA, 2014, BIOMED MICRODEVICES, V16, P91, DOI 10.1007/s10544-013-9808-2; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; Morowitz MJ, 2011, SURG CLIN N AM, V91, P771, DOI 10.1016/j.suc.2011.05.001; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; Oz HS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101085; Page S, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0042-1; Pearce SC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01584; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Place TL, 2017, FREE RADICAL BIO MED, V113, P311, DOI 10.1016/j.freeradbiomed.2017.10.003; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Raleigh JA, 1998, CANCER RES, V58, P3765; Sadaghian Sadabad M., 2015, SCI REP-UK, V5, P1; Samy KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46408-0; Schultz M, 2005, J MICROBIOL METH, V61, P389, DOI 10.1016/j.mimet.2005.01.007; Shah P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11535; SHERIDAN WG, 1990, AM J SURG, V159, P314, DOI 10.1016/S0002-9610(05)81226-7; Shin W, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00013; Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267; Sturrock A, 2018, J IMMUNOL, V201, P3411, DOI 10.4049/jimmunol.1701387; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Thomas PC, 2011, ANAL CHEM, V83, P8821, DOI 10.1021/ac202300g; Thomas PC, 2009, ANAL CHEM, V81, P9239, DOI 10.1021/ac9013379; Tirella A, 2015, J BIOMED NANOTECHNOL, V11, P1451, DOI 10.1166/jbn.2015.2085; Ulluwishewa D, 2015, CELL MICROBIOL, V17, P226, DOI 10.1111/cmi.12360; van Kessel SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08294-y; Wang CY, 2018, ACS BIOMATER SCI ENG, V4, P1377, DOI 10.1021/acsbiomaterials.7b00883; Xu DZ, 1999, J TRAUMA, V46, P280, DOI 10.1097/00005373-199902000-00014; Yeh TS, 2006, SENSOR ACTUAT B-CHEM, V119, P701, DOI 10.1016/j.snb.2006.01.051; Zeitouni N. E., 2016, MOL CELL PEDIAT, V3; Zeitouni NE, 2015, HYPOXIA, V3, P53, DOI 10.2147/HP.S85625; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015	65	7	8	7	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21291	10.1096/fj.202001600RR	http://dx.doi.org/10.1096/fj.202001600RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33506497	Bronze, Green Submitted			2022-12-28	WOS:000647789600017
J	Kimura, AK; Kimura, T				Kimura, Atsuko K.; Kimura, Tomohiro			Phosphatidylserine biosynthesis pathways in lipid homeostasis: Toward resolution of the pending central issue for decades	FASEB JOURNAL			English	Article						feedback regulation; Lenz&#8208; Majewski syndrome; lipid homeostasis; lipid transport; phosphatidylserine; phosphatidylserine synthase	PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; STEROL CARRIER PROTEIN-2; MEMBRANE CONTACT SITES; HAMSTER OVARY CELLS; PHOSPHOLIPID TRANSFER; ENDOPLASMIC-RETICULUM; FUNCTIONAL ROLES; STRUCTURAL BASIS; SECRETORY CARGO	Enzymatic control of lipid homeostasis in the cell is a vital element in the complex organization of life. Phosphatidylserine (PS) is an essential anionic phospholipid of cell membranes, and conducts numerous roles for their structural and functional integrity. In mammalian cells, two distinct enzymes phosphatidylserine synthases-1 (PSS1) and -2 (PSS2) in the mitochondria-associated membrane (MAM) in the ER perform de novo synthesis of PS. It is based on base-exchange reactions of the preexisting dominant phospholipids phosphatidylcholine (PC) and phosphatidylethanolamine (PE). While PSS2 specifically catalyzes the reaction "PE -> PS," whether or not PSS1 is responsible for the same reaction along with the reaction "PC -> PS" remains unsettled despite its fundamental impact on the major stoichiometry. We propose here that a key but the only report that appeared to have put scientists on hold for decades in answering to this issue may be viewed consistently with other available research reports; PSS1 utilizes the two dominant phospholipid classes at a similar intrinsic rate. In this review, we discuss the issue in view of the current information for the enzyme machineries, membrane structure and dynamics, intracellular network of lipid transport, and PS synthesis in health and disease. Resolution of the pending issue is thus critical in advancing our understanding of roles of the essential anionic lipid in biology, health, and disease.	[Kimura, Atsuko K.; Kimura, Tomohiro] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada	McMaster University	Kimura, T (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.	kimurat@mcmaster.ca	Kimura, Tomohiro/AEJ-1621-2022	Kimura, Tomohiro/0000-0002-4192-7852				Aaltonen MJ, 2016, J CELL BIOL, V213, P525, DOI 10.1083/jcb.201602007; Alb JG, 2003, J BIOL CHEM, V278, P33501, DOI 10.1074/jbc.M303591200; Alb JG, 2002, MOL BIOL CELL, V13, P739, DOI 10.1091/mbc.01-09-0457; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Beznoussenko GV, 2014, ELIFE, V3, DOI 10.7554/eLife.02009; BRAHAM RL, 1969, ORAL SURG ORAL MED O, V27, P20, DOI 10.1016/0030-4220(69)90026-7; Carvou N, 2010, J CELL SCI, V123, P1262, DOI 10.1242/jcs.061986; Casler JC, 2019, J CELL BIOL, V218, P1582, DOI 10.1083/jcb.201807195; Choi J, 2018, MOL CELL BIOCHEM, V442, P187, DOI 10.1007/s11010-017-3203-x; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Clark BJ, 2020, MOL CELL ENDOCRINOL, V504, DOI 10.1016/j.mce.2020.110704; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; DEVRIES KJ, 1995, BIOCHEM J, V310, P643, DOI 10.1042/bj3100643; Di Bartolomeo F, 2017, BBA-MOL CELL BIOL L, V1862, P25, DOI 10.1016/j.bbalip.2016.09.007; DICKESON SK, 1989, J BIOL CHEM, V264, P16557; Dickson EJ, 2019, BIOCHEM J, V476, P1, DOI 10.1042/BCJ20180022; Du XM, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201905162; Dunlop MH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00570-z; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Flis VV, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013235; Folch J, 1941, J BIOL CHEM, V139, P973; Fullwood Y, 1999, J BIOL CHEM, V274, P31553, DOI 10.1074/jbc.274.44.31553; Funato K, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.04.013; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gallegos AM, 2001, BIOCHEMISTRY-US, V40, P6493, DOI 10.1021/bi010217l; Galmes R, 2016, EMBO REP, V17, P800, DOI 10.15252/embr.201541108; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Grabon A, 2019, J LIPID RES, V60, P242, DOI 10.1194/jlr.R089730; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; HASEGAWA K, 1989, J BIOL CHEM, V264, P19887; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horibata Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59444-y; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Idevall-Hagren O, 2015, EMBO J, V34, P2291, DOI 10.15252/embj.201591565; Hernandez-Alvarez MI, 2019, CELL, V177, P881, DOI 10.1016/j.cell.2019.04.010; Jackson CL, 2016, DEV CELL, V39, P139, DOI 10.1016/j.devcel.2016.09.030; Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159; Jones SM, 1998, J BIOL CHEM, V273, P10349, DOI 10.1074/jbc.273.17.10349; Kainu V, 2013, BBA-MOL CELL BIOL L, V1831, P429, DOI 10.1016/j.bbalip.2012.11.003; KAMP HH, 1977, BIOCHEMISTRY-US, V16, P1310, DOI 10.1021/bi00626a011; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; Kay JG, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0438-z; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Kimura AK, 2013, J LIPID RES, V54, P214, DOI 10.1194/jlr.M031989; Kimura AK, 2012, FASEB J, V26; Kimura T, 2002, J PHYS CHEM B, V106, P12336, DOI 10.1021/jp021246o; Kimura T, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900348; Kimura T, 2018, BIOCHEMISTRY-US, V57, P2162, DOI 10.1021/acs.biochem.8b00042; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Kodigepalli KM, 2015, FEBS LETT, V589, P3, DOI 10.1016/j.febslet.2014.11.036; Kol MA, 2004, BIOCHEMISTRY-US, V43, P2673, DOI 10.1021/bi036200f; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; KUGE O, 1986, J BIOL CHEM, V261, P5790; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; Kuge O, 1999, J BIOL CHEM, V274, P23844, DOI 10.1074/jbc.274.34.23844; Kuge O, 2003, J BIOL CHEM, V278, P42692, DOI 10.1074/jbc.M307270200; KUGE O, 1991, J BIOL CHEM, V266, P24184; Kuge O, 1997, J BIOL CHEM, V272, P19133, DOI 10.1074/jbc.272.31.19133; KUGE O, 1985, P NATL ACAD SCI USA, V82, P1926, DOI 10.1073/pnas.82.7.1926; Kurokawa K, 2019, J CELL BIOL, V218, P1602, DOI 10.1083/jcb.201807194; Lee M, 2018, BIOCHEM BIOPH RES CO, V496, P1088, DOI 10.1016/j.bbrc.2018.01.138; Lees JA, 2020, CURR OPIN CELL BIOL, V65, P66, DOI 10.1016/j.ceb.2020.02.008; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; LENZ W D, 1974, Birth Defects Original Article Series, V10, P133; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Li H, 2002, BBA-MOL CELL BIOL L, V1580, P67, DOI 10.1016/S1388-1981(01)00191-3; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; McDermott MI, 2016, CHEM PHYS LIPIDS, V200, P42, DOI 10.1016/j.chemphyslip.2016.06.005; Miliara X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09089-x; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; Nissila E, 2012, BBA-MOL CELL BIOL L, V1821, P1472, DOI 10.1016/j.bbalip.2012.08.004; OHASHI M, 1995, NATURE, V377, P544, DOI 10.1038/377544a0; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Orci L, 2000, P NATL ACAD SCI USA, V97, P10400, DOI 10.1073/pnas.190292497; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paul KS, 1998, FEBS LETT, V431, P91, DOI 10.1016/S0014-5793(98)00722-4; Pellett PA, 2013, ELIFE, V2, DOI 10.7554/eLife.01296; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Pradas I, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01165; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Saita S, 2018, EMBO J, V37, DOI 10.15252/embj.201797909; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; Schroeder F, 2007, BBA-MOL CELL BIOL L, V1771, P700, DOI 10.1016/j.bbalip.2007.04.005; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; SLEIGHT RG, 1983, J BIOL CHEM, V258, P9050; Sohn M, 2018, J CELL BIOL, V217, P1797, DOI 10.1083/jcb.201710095; Sohn M, 2016, P NATL ACAD SCI USA, V113, P4314, DOI 10.1073/pnas.1525719113; Sousa SB, 2014, NAT GENET, V46, P70, DOI 10.1038/ng.2829; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Stone SJ, 1998, J BIOL CHEM, V273, P7293, DOI 10.1074/jbc.273.13.7293; Sturbois-Balcerzak B, 2001, J BIOL CHEM, V276, P8205, DOI 10.1074/jbc.M009776200; TANAKA S, 1994, J BIOCHEM-TOKYO, V115, P981, DOI 10.1093/oxfordjournals.jbchem.a124448; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; Tomohiro S, 2009, BIOCHEM J, V418, P421, DOI 10.1042/BJ20081597; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Tsuji T, 2019, P NATL ACAD SCI USA, V116, P13368, DOI 10.1073/pnas.1822025116; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; VANCE JE, 1991, J BIOL CHEM, V266, P8241; VANCE JE, 1991, J BIOL CHEM, V266, P89; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2018, J LIPID RES, V59, P923, DOI 10.1194/jlr.R084004; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Venditti R, 2020, BIOCHEM SOC T, V48, P187, DOI 10.1042/BST20190537; Venditti R, 2019, J CELL BIOL, V218, P1055, DOI 10.1083/jcb.201812020; VOELKER DR, 1986, J BIOL CHEM, V261, P1002; VOELKER DR, 1993, J BIOL CHEM, V268, P7069; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Wong LH, 2019, NAT REV MOL CELL BIO, V20, P85, DOI 10.1038/s41580-018-0071-5; Wu HX, 2018, SCIENCE, V361, pCP15, DOI 10.1126/science.aan5835; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yu HJ, 2016, P NATL ACAD SCI USA, V113, P4362, DOI 10.1073/pnas.1517259113; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]; Zhong SR, 2012, BIOCHEMISTRY-US, V51, P3170, DOI 10.1021/bi300086c	142	9	9	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001802R	http://dx.doi.org/10.1096/fj.202001802R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33205488	Bronze			2022-12-28	WOS:000592661700001
J	Rovini, A; Heslop, K; Hunt, EG; Morris, ME; Fang, DN; Gooz, M; Gerencser, AA; Maldonado, EN				Rovini, Amandine; Heslop, Kareem; Hunt, Elizabeth G.; Morris, Morgan E.; Fang, Diana; Gooz, Monika; Gerencser, Akos A.; Maldonado, Eduardo N.			Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells	FASEB JOURNAL			English	Article						cancer; cell cycle; fibroblasts; HepG2 cells; heterogeneity; mitochondria; mitochondrial membrane potential; plasma membrane potential; TMRM	GLUTAMATE EXCITOTOXICITY; RESPIRATORY IMPAIRMENT; METABOLISM; DYSFUNCTION; APOPTOSIS; STATE	Mitochondrial membrane potential (Delta psi m) is a global indicator of mitochondrial function. Previous reports on heterogeneity of Delta psi m were qualitative or semiquantitative. Here, we quantified intercellular differences in Delta psi m in unsynchronized human cancer cells, cells synchronized in G1, S, and G2, and human fibroblasts. We assessed Delta psi m using a two-pronged microscopy approach to measure relative fluorescence of tetramethylrhodamine methyl ester (TMRM) and absolute values of Delta psi m. We showed that Delta psi m is more heterogeneous in cancer cells compared to fibroblasts, and it is maintained throughout the cell cycle. The effect of chemical inhibition of the respiratory chain and ATP synthesis differed between basal, low and high Delta psi m cells. Overall, our results showed that intercellular heterogeneity of Delta psi m is mainly modulated by intramitochondrial factors, it is independent of the Delta psi m indicator and it is not correlated with intercellular heterogeneity of plasma membrane potential or the phases of the cell cycle.	[Rovini, Amandine; Heslop, Kareem; Hunt, Elizabeth G.; Morris, Morgan E.; Fang, Diana; Gooz, Monika; Maldonado, Eduardo N.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Gerencser, Akos A.] Buck Inst Res Aging & Image Analyst Software, Novato, CA USA; [Maldonado, Eduardo N.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Maldonado, EN (corresponding author), Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	maldona@musc.edu	Maldonado, Eduardo/AAN-3907-2020	Rovini, Amandine/0000-0003-0483-9092; Maldonado, Eduardo/0000-0002-5285-3027; Heslop, Kareem/0000-0002-2618-2530	US National Institutes of Health (NIH) National Cancer Institute (NCI) [RO1 CA184456]; NIH National Institute of General Medical Sciences [P20 GM103542]; NCI [R01CA184456-02]; South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences) [P20 GM103542]	US National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences)	This work was supported, in part, by the US National Institutes of Health (NIH) National Cancer Institute (NCI) Grant RO1 CA184456 and NIH National Institute of General Medical Sciences Grant P20 GM103542 [10] to ENM, and an NCI Administrative Supplement (R01CA184456-02) to MEM. The Cell and Molecular Imaging Shared Resource and the Medical University of South Carolina (MUSC) is supported, in part, by the South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences Grant P20 GM103542)	Begum HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47593-8; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cannino G, 2018, METABOLIC PLASTICITY, V8, DOI 10.3389/fonc.2018.00333; Chakrabarti L, 2019, J IMMUNOL METHODS, V464, P31, DOI 10.1016/j.jim.2018.10.007; Christie CF, 2019, FASEB J, V33, P8186, DOI 10.1096/fj.201802723R; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Connolly NMC, 2018, CELL DEATH DIFFER, V25, P542, DOI 10.1038/s41418-017-0020-4; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Fang D, 2018, ADV CANCER RES, V138, P41, DOI 10.1016/bs.acr.2018.02.002; Gan Z, 2011, AM J PHYSIOL-LUNG C, V300, pL762, DOI 10.1152/ajplung.00334.2010; Gerencser AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159199; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heslop KA, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113728; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Jeon JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.129; Kalucka J, 2015, CELL CYCLE, V14, P3379, DOI 10.1080/15384101.2015.1090068; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Kumagai A, 2016, STEM CELL TRANSL MED, V5, P275, DOI 10.5966/sctm.2015-0145; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Maher MP, 2007, J BIOMOL SCREEN, V12, P656, DOI 10.1177/1087057107302113; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Milani L, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0732; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mizutani S, 2009, CANCER SCI, V100, P1680, DOI 10.1111/j.1349-7006.2009.01238.x; Neagu M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00348; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Salvioli S, 2000, CYTOMETRY, V40, P189, DOI 10.1002/1097-0320(20000701)40:3<189::AID-CYTO3>3.0.CO;2-6; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; Seth S, 2019, CELL REP, V26, P1518, DOI 10.1016/j.celrep.2019.01.048; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward MW, 2000, J NEUROSCI, V20, P7208; WEINHOUSE S, 1976, Z KREBSFORSCH KLIN O, V87, P115; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Wolf DM, 2019, EMBO J, V38, DOI 10.15252/embj.2018101056; Woods DC, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7068567; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	55	6	6	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001693R	http://dx.doi.org/10.1096/fj.202001693R		NOV 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33196122	Green Accepted			2022-12-28	WOS:000592668800001
J	Sominsky, L; Dangel, T; Malik, S; De Luca, SN; Singewald, N; Spencer, SJ				Sominsky, Luba; Dangel, Tamara; Malik, Sajida; De Luca, Simone N.; Singewald, Nicolas; Spencer, Sarah J.			Microglial ablation in rats disrupts the circadian system	FASEB JOURNAL			English	Article						circadian rhythms; clock genes; hippocampus; microglia; temperature	ENDOTOXIN; CLOCK	Microglia, the key neuroimmune cells of the central nervous system, are best known for their function in defending an individual from pathogens and injury. Recent findings, including our own, suggest microglia also have several immune-independent roles, including in regulating satiety, promoting memory, and modifying pain responses. Many of these microglia-associated functions are affected by circadian rhythmicity, thus, varying substantially depending upon the time of day. To gain further insight into this link, we used a Cx3cr1-Dtr transgenic Wistar rat model to acutely deplete microglia and examined if this could lead to a disruption in diurnal temperature, metabolism, and activity measures. We also examined if differences in the physiological rhythms corresponded with changes in the expression of key circadian rhythm-regulating genes and proteins. Our data show that in the absence of microglia there is a pronounced disruption of diurnal rhythms in several domains consistent with a shift toward the inactive phase, in conjunction with changes in circadian rhythm-regulating genes and proteins. These data suggest microglia are involved in the regulation of circadian rhythms and indicate an exciting potential to manipulate these cells to improve disrupted circadian rhythms such as with shift-work or jet-lag.	[Sominsky, Luba; Dangel, Tamara; Malik, Sajida; De Luca, Simone N.; Spencer, Sarah J.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Dangel, Tamara; Singewald, Nicolas] Univ Innsbruck, Inst Pharm, Dept Pharmacol & Toxicol, Innsbruck, Austria; [Dangel, Tamara; Singewald, Nicolas] Univ Innsbruck, CMBI, Innsbruck, Austria; [Spencer, Sarah J.] RMIT Univ, ARC Ctr Excellence Nanoscale Biophoton, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); University of Innsbruck; University of Innsbruck; Royal Melbourne Institute of Technology (RMIT)	Spencer, SJ (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	Sarah.Spencer@rmit.edu.au		Spencer, Sarah/0000-0001-8832-4824; De Luca, Simone/0000-0001-9001-4024; Sominsky, Luba/0000-0002-0674-8824	Department of Health \ National Health and Medical Research Council (NHMRC) [APP1128646]; RMIT University (RMIT); Innsbruck University; Austrian Science Fund FWF [I 3875-B26]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); RMIT University (RMIT); Innsbruck University; Austrian Science Fund FWF(Austrian Science Fund (FWF))	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1128646; RMIT University (RMIT); Innsbruck University; Austrian Science Fund FWF, Grant/Award Number: I 3875-B26	Barrientos RM, 2010, AGING DIS, V1, P212; Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137; Cermakian N, 2014, ARCH IMMUNOL THER EX, V62, P303, DOI 10.1007/s00005-014-0286-x; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Choudhury ME, 2020, GLIA, V68, P44, DOI 10.1002/glia.23698; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; De Luca SN, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12838; De Luca SN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1729-4; De Luca SN, 2019, BRAIN BEHAV IMMUN, V77, P77, DOI 10.1016/j.bbi.2018.12.008; De Luca SN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0578-7; Early JO, 2018, P NATL ACAD SCI USA, V115, pE8460, DOI 10.1073/pnas.1800431115; Fonken LK, 2016, NEUROBIOL AGING, V47, P102, DOI 10.1016/j.neurobiolaging.2016.07.019; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Gaudet AD, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0328-18.2018; Grace PM, 2018, EXP NEUROL, V304, P125, DOI 10.1016/j.expneurol.2018.03.005; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Harbour VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103309; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Hayashi Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02744; Lananna BV, 2018, CELL REP, V25, P1, DOI 10.1016/j.celrep.2018.09.015; Lusk G, 1924, J Physiol, V59, P213; Marpegan L, 2009, CHRONOBIOL INT, V26, P1430, DOI 10.3109/07420520903408358; Martinez-Tapia RJ, 2020, CELL MOL NEUROBIOL, V40, P301, DOI 10.1007/s10571-019-00736-x; Milanova IV, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00424; Mosser EA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48914-7; Okamoto-Uchida Y, 2019, CURR GENOMICS, V20, P332, DOI 10.2174/1389202919666191014094349; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Seillet C, 2020, NAT IMMUNOL, V21, P168, DOI 10.1038/s41590-019-0567-y; Smith BL, 2020, BRAIN BEHAV IMMUN, V84, P80, DOI 10.1016/j.bbi.2019.11.010; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Takayama F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30006; Tuan LH, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104517; Vichaya EG, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01832-2; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Wang DQ, 2019, BEHAV BRAIN RES, V363, P61, DOI 10.1016/j.bbr.2019.01.035; Weil ZM, 2009, NEUROBIOL DIS, V36, P352, DOI 10.1016/j.nbd.2009.07.032; Whitt JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10837; Wilton DK, 2019, ANNU REV NEUROSCI, V42, P107, DOI 10.1146/annurev-neuro-070918-050306; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406	41	17	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001555RR	http://dx.doi.org/10.1096/fj.202001555RR		NOV 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200466				2022-12-28	WOS:000592669700001
J	Akamine, S; Okuzono, S; Yamamoto, H; Setoyama, D; Sagata, N; Ohgidani, M; Kato, TA; Ishitani, T; Kato, H; Masuda, K; Matsushita, Y; Ono, H; Ishizaki, Y; Sanefuji, M; Saitsu, H; Matsumoto, N; Kang, D; Kanba, S; Nakabeppu, Y; Sakai, Y; Ohga, S				Akamine, Satoshi; Okuzono, Sayaka; Yamamoto, Hiroyuki; Setoyama, Daiki; Sagata, Noriaki; Ohgidani, Masahiro; Kato, Takahiro A.; Ishitani, Tohru; Kato, Hiroki; Masuda, Keiji; Matsushita, Yuki; Ono, Hiroaki; Ishizaki, Yoshito; Sanefuji, Masafumi; Saitsu, Hirotomo; Matsumoto, Naomichi; Kang, Dongchon; Kanba, Shigenobu; Nakabeppu, Yusaku; Sakai, Yasunari; Ohga, Shouichi			GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons	FASEB JOURNAL			English	Article						cytoskeleton; developmental and epileptic encephalopathy; G protein subunit alpha O1 (GNAO1); organoid; spectrin alpha; non&#8208; erythrocytic 1 (SPTAN1)	AXON INITIAL SEGMENT; ALPHA-II SPECTRIN; DE-NOVO MUTATIONS; INFANTILE EPILEPTIC ENCEPHALOPATHY; CEREBRAL ORGANOIDS; MOVEMENT-DISORDER; BRAIN-DEVELOPMENT; STEM-CELLS; ANKYRIN-G; ACTIVATION	Developmental and epileptic encephalopathy (DEE) represents a group of neurodevelopmental disorders characterized by infantile-onset intractable seizures and unfavorable prognosis of psychomotor development. To date, hundreds of genes have been linked to the onset of DEE. GNAO1 is a DEE-associated gene encoding the alpha-O1 subunit of guanine nucleotide-binding protein (G alpha(O)). Despite the increasing number of reported children with GNAO1 encephalopathy, the molecular mechanisms underlying their neurodevelopmental phenotypes remain elusive. We herein present that co-immunoprecipitation and mass spectrometry analyses identified another DEE-associated protein, SPTAN1, as an interacting partner of G alpha(O). Silencing of endogenous Gnao1 attenuated the neurite outgrowth and calcium-dependent signaling. Inactivation of GNAO1 in human-induced pluripotent stem cells gave rise to anomalous brain organoids that only weakly expressed SPTAN1 and Ankyrin-G. Furthermore, GNAO1-deficient organoids failed to conduct synchronized firing to adjacent neurons. These data indicate that G alpha(O) and other DEE-associated proteins organize the cytoskeletal remodeling and functional polarity of neurons in the developing brain.	[Akamine, Satoshi; Okuzono, Sayaka; Yamamoto, Hiroyuki; Matsushita, Yuki; Ono, Hiroaki; Ishizaki, Yoshito; Sanefuji, Masafumi; Sakai, Yasunari; Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Setoyama, Daiki; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka, Japan; [Sagata, Noriaki; Ohgidani, Masahiro; Kato, Takahiro A.; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka, Japan; [Ishitani, Tohru] Gunma Univ, Inst Mol & Cellular Regulat, Div Integrated Signaling Syst, Maebashi, Gumma, Japan; [Ishitani, Tohru] Osaka Univ, Div Cellular & Mol Biol, Dept Homeostat Regulat, Res Inst Microbial Dis, Suita, Osaka, Japan; [Kato, Hiroki] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Div Oral Biol Sci, Fukuoka, Japan; [Masuda, Keiji] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Oral Med Children, Fukuoka, Japan; [Saitsu, Hirotomo] Hamamatsu Univ, Dept Biochem, Sch Med, Hamamatsu, Shizuoka, Japan; [Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa, Japan; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Gunma University; Osaka University; Kyushu University; Kyushu University; Hamamatsu University School of Medicine; Yokohama City University; Kyushu University	Sakai, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan.	ysakai22q13@gmail.com	Sanefuji, Masafumi/GRO-5252-2022; Saitsu, Hirotomo/AAM-7131-2021; Nakabeppu, Yusaku/A-8902-2011	Sanefuji, Masafumi/0000-0001-6036-5528; Kato, Hiroki/0000-0002-6529-659X; Nakabeppu, Yusaku/0000-0002-6739-242X	JSPS KAKENHI [JP19K08281, JP17H01539]; AMED [JP19ek0109411, JP19ek0109280, JP19ek0109348, JP18kk020501]; Health and Labour Sciences Research Grant; Ministry of Health, Labour and Welfare of Japan; Life Science Foundation of Japan; Takeda Science Foundation; The Mother and Child Health Foundation; The Japan Epilepsy Research Foundation; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); The Mother and Child Health Foundation; The Japan Epilepsy Research Foundation; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	JSPS KAKENHI, Grant/Award Number: JP19K08281 and JP17H01539; AMED, Grant/Award Number: JP19ek0109411, JP19ek0109280, JP19ek0109348 and JP18kk020501; Health and Labour Sciences Research Grant; Ministry of Health, Labour and Welfare of Japan; Life Science Foundation of Japan; Takeda Science Foundation; The Mother and Child Health Foundation; The Japan Epilepsy Research Foundation; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	Ackermann A, 2019, J ONCOL, V2019, DOI 10.1155/2019/7079604; Akamine Satoshi, 2018, Epilepsia Open, V3, P81, DOI 10.1002/epi4.12085; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007; Baldwin PR, 2016, AUTISM RES, V9, P553, DOI 10.1002/aur.1559; COPPOLA G, 1995, EPILEPSIA, V36, P1017, DOI 10.1111/j.1528-1157.1995.tb00961.x; Danti FR, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000143; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Feng HJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211066; Feng HJ, 2018, NEUROBIOL DIS, V116, P131, DOI 10.1016/j.nbd.2018.05.005; Feng HJ, 2017, NEUROLOGY, V89, P762, DOI 10.1212/WNL.0000000000004262; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Gerald B, 2018, SEMIN PEDIATR NEUROL, V26, P28, DOI 10.1016/j.spen.2017.08.008; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hamdan FF, 2017, AM J HUM GENET, V101, P664, DOI 10.1016/j.ajhg.2017.09.008; Hillenbrand M, 2015, P NATL ACAD SCI USA, V112, pE1181, DOI 10.1073/pnas.1417573112; Huang CYM, 2017, J NEUROSCI, V37, P11311, DOI 10.1523/JNEUROSCI.2112-17.2017; Nguyen HTN, 2019, BIOCHEM BIOPH RES CO, V513, P1048, DOI 10.1016/j.bbrc.2019.04.084; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jiang MS, 2009, NEUROSIGNALS, V17, P23, DOI 10.1159/000186688; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kato H, 2017, CELL STRUCT FUNCT, V42, P105, DOI 10.1247/csf.17012; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; Kurian MA, 2010, BRAIN, V133, P2964, DOI 10.1093/brain/awq238; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lau BYC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221052; Leterrier C, 2016, CURR TOP MEMBR, V77, P185, DOI 10.1016/bs.ctm.2015.10.005; Leterrier C, 2014, SEMIN CELL DEV BIOL, V27, P44, DOI 10.1016/j.semcdb.2013.11.001; LOMBROSO CT, 1990, J CLIN NEUROPHYSIOL, V7, P380, DOI 10.1097/00004691-199007000-00005; Luchtenborg AM, 2014, DEVELOPMENT, V141, P3399, DOI 10.1242/dev.106773; MATSUSHITA Y, 2016, SCI REP UK, V6; McCartney CSE, 2018, BBA-MOL CELL RES, V1865, P221, DOI 10.1016/j.bbamcr.2017.10.013; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Ohkubo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13191; OHTAHARA S, 1987, BRAIN DEV-JPN, V9, P371, DOI 10.1016/S0387-7604(87)80110-9; Pearson TS, 2017, NEUROLOGY, V89, P754, DOI 10.1212/WNL.0000000000004277; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Raucher D, 2001, J CELL SCI, V114, P3759; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sagata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14440-7; Saitsu H, 2016, EUR J HUM GENET, V24, P129, DOI 10.1038/ejhg.2015.92; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Sakaguchi H, 2019, STEM CELL REP, V13, P458, DOI 10.1016/j.stemcr.2019.05.029; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schorling DC, 2017, NEUROPEDIATRICS, V48, P371, DOI 10.1055/s-0037-1603977; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Syrbe S, 2017, BRAIN, V140, P2322, DOI 10.1093/brain/awx195; Takata A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10482-9; Tanaka Y, 2020, CELL REP, V30, P1682, DOI 10.1016/j.celrep.2020.01.038; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tyagarajan SK, 2013, J BIOL CHEM, V288, P9634, DOI 10.1074/jbc.M112.442616; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Wang Y, 2018, J CLIN INVEST, V128, P760, DOI 10.1172/JCI95743; Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou RB, 2019, SCIENCE, V365, P929, DOI 10.1126/science.aaw5937	68	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16601	16621		10.1096/fj.202001113R	http://dx.doi.org/10.1096/fj.202001113R		OCT 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33107105	Green Published, hybrid			2022-12-28	WOS:000586269000001
J	Han, YR; Yun, CC				Han, Yiran; Yun, C. Chris			Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity	FASEB JOURNAL			English	Article						deubiquitinating enzyme; diarrhea; Na+; H+ exchange; ubiquitination	NA+/H+ EXCHANGER NHE3; FUNCTIONAL PROTEOMICS; ACTIVATES P53; TRAFFICKING; TRANSPORT; PROTEIN; PATHOPHYSIOLOGY; INHIBITION; ABSORPTION; MECHANISMS	Na+/H+ exchanger NHE3 of human or primates differs from NHE3 of other animals by having a PY motif, which mediates interaction with the E3 ubiquitin (Ub) ligase Nedd4-2. Ub-conjugation of human NHE3 by Nedd4-2 regulates endocytosis of NHE3 but does not affect its cellular expression. Because Ub-conjugation is a reversible process, the aim of this study is to identify deubiquitinating enzyme (DUB) regulating the post-endosomal fate of human NHE3. Using an activity-based chemical screening, we identified ubiquitin specific protease-7 (USP7) and USP10 that bind NHE3. The roles of DUBs in regulation of NHE3 were studied by determining the effects of silencing of USP7 and USP10. Knockdown of USP7 or USP10 resulted in increased NHE3 ubiquitination and decreased NHE3 expression at the surface membrane and cellular level. The endocytic retrieval of NHE3 was promoted by depletion of USP7 or USP10, with increased association of NHE3 with Rab5a and Rab7. Inhibition of USP7 and USP10 by chemical inhibitors or knockdown had an additive effect on NHE3. In addition, NHE3 half-life was reduced accounting for decreased NHE3 protein abundance. NHE3 is inhibited by protein kinase A. Activation of PKA by forskolin decreased the binding of USP7 and USP10 to NHE3, while increasing ubiquitination of NHE3. Knockdown of USP10 had an additive effect on PKA-dependent inhibition of NHE3. These findings demonstrate that USP7 and USP10 are DUBs that regulate NHE3 ubiquitination and expression, and reveal a new mechanism of NHE3 inhibition involving DUBs.	[Han, Yiran; Yun, C. Chris] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30324 USA; [Han, Yiran; Yun, C. Chris] Atlanta VA Med Ctr, Gastroenterol Res, Decatur, GA USA; [Yun, C. Chris] Emory Univ, Sch Med, Winship Canc Inst, Cell & Mol Biol Res Program, Atlanta, GA USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University	Yun, CC (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30324 USA.	ccyun@emory.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK107719]; U.S. Department of Veterans Affairs (VA) [I01BX004459]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK107719; U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX004459	Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Bhattacharya S, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0012-y; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Cavet ME, 2001, AM J PHYSIOL-CELL PH, V281, pC2039, DOI 10.1152/ajpcell.2001.281.6.C2039; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Di Sole F, 2011, KIDNEY INT, V80, P822, DOI 10.1038/ki.2011.229; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Guo J, 2020, J CELL MOL MED, V24, P4324, DOI 10.1111/jcmm.15093; Gurney MA, 2017, CELL MOL GASTROENTER, V3, P27, DOI 10.1016/j.jcmgh.2016.09.010; He PJ, 2010, J BIOL CHEM, V285, P27869, DOI 10.1074/jbc.M110.133066; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Kee Y, 2016, MOL CELL BIOL, V36, P524, DOI 10.1128/MCB.00847-15; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Maher MM, 1997, GASTROENTEROLOGY, V112, P174, DOI 10.1016/S0016-5085(97)70232-4; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; No YR, 2014, J BIOL CHEM, V289, P18360, DOI 10.1074/jbc.M113.541706; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Sadler JBA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40596-5; Savio MG, 2016, CURR BIOL, V26, P173, DOI 10.1016/j.cub.2015.11.050; Singh V, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218610; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Yoo BK, 2012, AM J PHYSIOL-GASTR L, V303, pG180, DOI 10.1152/ajpgi.00069.2012; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978	44	6	6	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16476	16488		10.1096/fj.202001875R	http://dx.doi.org/10.1096/fj.202001875R		OCT 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33095475	Green Accepted			2022-12-28	WOS:000583914500001
J	Liu, B; Zeng, RH; Guo, TT; Zhang, YZ; Leng, J; Ge, JH; Yu, G; Xu, YN; Zhou, YB				Liu, Bin; Zeng, Ruhui; Guo, Tingting; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Xu, Yineng; Zhou, Yingbi			Differential properties of E prostanoid receptor-3 and thromboxane prostanoid receptor in activation by prostacyclin to evoke vasoconstrictor response in the mouse renal vasculature	FASEB JOURNAL			English	Article						EP3; IP; PGI(2); renal vasoresponse; TP	ENDOTHELIUM-DEPENDENT CONTRACTIONS; PROSTAGLANDIN E-2; NITRIC-OXIDE; HYPERTENSIVE-RATS; ARTERIES; AORTA; CYCLOOXYGENASE-2; ALDOSTERONE; DYSFUNCTION; RELAXATION	Vasomotor reactions of prostacyclin (prostaglandin I-2; PGI(2)) can be collectively modulated by thromboxane prostanoid receptor (TP), E-prostanoid receptor-3 (EP3), and the vasodilator I prostanoid receptor (IP). This study aimed to determine the direct effect of PGI(2)on renal arteries and/or the whole renal vasculature and how each of these receptors is involved. Experiments were performed on vessels or perfused kidneys of wild-type mice and/or mice with deficiency in TP (TP-/-) and/or EP3. Here we show that PGI(2)did not evoke relaxation, but instead resulted in contraction of main renal arteries (from similar to 0.001-0.01 mu M) or reduction of flow in perfused kidneys (from similar to 1 mu M); either of them was reversed into a dilator response in TP-/-/EP3(-/-)counterparts. Also, we found that in renal arteries although it has a lesser effect than TP(-/-)on the maximal contraction to PGI(2)(10 mu M), EP3(-/-)but not TP(-/-)resulted in relaxation to the prostanoid at 0.01-1 mu M. Meanwhile, TP(-/-)only significantly reduced the contractile activity evoked by PGI(2)at >= 0.1 mu M. These results demonstrate that PGI(2)may evoke an overall vasoconstrictor response in the mouse renal vasculature, reflecting activities of TP and EP3 outweighing that of the vasodilator IP. Also, our results suggest that EP3, on which PGI(2)can have a potency similar to that on IP, plays a major role in the vasoconstrictor effect of the prostanoid of low concentrations (<= 1 mu M), while TP, on which PGI(2)has a lower potency but higher efficacy, accounts for a larger part of its maximal contractile activity.	[Liu, Bin; Zeng, Ruhui; Guo, Tingting; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Xu, Yineng; Zhou, Yingbi] Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China; [Zeng, Ruhui] Shantou Univ, Med Coll, Affiliated Hosp 1, Dept Gynecol & Obstet, Shantou, Peoples R China	Shantou University; Shantou University	Zhou, YB (corresponding author), Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	yz_sumc@163.com			National Natural Science Foundation of China (NSFC) [31771272, 81970433, 81770678]; Major Research Program for Universities of Guangdong Province [2017KZDXM037]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Research Program for Universities of Guangdong Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771272, 81970433 and 81770678; the Major Research Program for Universities of Guangdong Province, Grant/Award Number: 2017KZDXM037	Benyahia C, 2013, PROSTAG OTH LIPID M, V107, P48, DOI 10.1016/j.prostaglandins.2013.07.001; Blanco-Rivero J, 2005, HYPERTENSION, V46, P107, DOI 10.1161/01.HYP.0000171479.36880.17; BUNTING S, 1976, PROSTAG OTH LIPID M, V12, P897, DOI 10.1016/0090-6980(76)90125-8; DAI FX, 1992, HYPERTENSION, V19, P795, DOI 10.1161/01.HYP.19.6.795; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; DUSTING GJ, 1977, EUR J PHARMACOL, V45, P301, DOI 10.1016/0014-2999(77)90014-0; Dzeshka MS, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0688-8; Eskildsen MP, 2014, HYPERTENSION, V64, P551, DOI 10.1161/HYPERTENSIONAHA.113.03051; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hu CJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01247; Ihara E, 2000, BRIT J PHARMACOL, V129, P943, DOI 10.1038/sj.bjp.0703141; INSCHO EW, 1990, AM J PHYSIOL, V259, pF157, DOI 10.1152/ajprenal.1990.259.1.F157; Kirkby NS, 2018, HYPERTENSION, V71, P297, DOI 10.1161/HYPERTENSIONAHA.117.09906; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; LEVY JV, 1980, PROSTAG OTH LIPID M, V19, P517, DOI 10.1016/S0090-6980(80)80002-5; LEVY JV, 1978, PROSTAG OTH LIPID M, V16, P93, DOI 10.1016/0090-6980(78)90205-8; Li SS, 2016, CLIN EXP PHARMACOL P, V43, P67, DOI 10.1111/1440-1681.12501; Li Z, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.17; Liu B, 2020, FASEB J, V34, P2568, DOI 10.1096/fj.201901611R; Liu B, 2019, FASEB J, V33, P2451, DOI 10.1096/fj.201801064RR; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136738; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; Liu B, 2012, EXP PHYSIOL, V97, P895, DOI 10.1113/expphysiol.2011.063784; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Liu DL, 2015, AM J PHYSIOL-HEART C, V309, pH804, DOI 10.1152/ajpheart.00150.2015; Longrois D, 2012, EUR J PHARMACOL, V681, P55, DOI 10.1016/j.ejphar.2012.01.041; Luo WH, 2016, EUR J PHARMACOL, V780, P148, DOI 10.1016/j.ejphar.2016.03.043; Meurer M, 2018, PFLUG ARCH EUR J PHY, V470, P1691, DOI 10.1007/s00424-018-2183-3; Michel F, 2008, AM J PHYSIOL-RENAL, V294, pF120, DOI 10.1152/ajprenal.00111.2007; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nasrallah R, 2005, AM J PHYSIOL-RENAL, V289, pF235, DOI 10.1152/ajprenal.00454.2004; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Norel X, 2004, PROSTAG OTH LIPID M, V74, P101, DOI 10.1016/j.prostaglandins.2004.07.003; Norel X, 2004, BRIT J PHARMACOL, V142, P788, DOI 10.1038/sj.bjp.0705843; Rapoport RM, 1996, HYPERTENSION, V28, P64, DOI 10.1161/01.HYP.28.1.64; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SCHOR N, 1981, HYPERTENSION, V3, P81, DOI 10.1161/01.HYP.3.6_Pt_2.II-81; Scotland RS, 2005, CIRCULATION, V111, P796, DOI 10.1161/01.CIR.0000155238.70797.4E; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Vachiery JL, 2011, ADV THER, V28, P251, DOI 10.1007/s12325-011-0005-5; van Rodijnen WF, 2007, AM J PHYSIOL-RENAL, V292, pF1094, DOI 10.1152/ajprenal.00351.2005; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; WILLIAMS SP, 1994, AM J PHYSIOL, V267, pH796, DOI 10.1152/ajpheart.1994.267.2.H796; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Xavier FE, 2008, BRIT J PHARMACOL, V154, P1225, DOI 10.1038/bjp.2008.200; Yu H, 1998, HYPERTENSION, V32, P287, DOI 10.1161/01.HYP.32.2.287; Zhao YJ, 1996, J APPL PHYSIOL, V81, P2595, DOI 10.1152/jappl.1996.81.6.2595; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014	56	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16105	16116		10.1096/fj.202000845RR	http://dx.doi.org/10.1096/fj.202000845RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047360				2022-12-28	WOS:000581168700001
J	Kawai, T; Kayama, K; Tatsumi, S; Akter, S; Miyawaki, N; Okochi, Y; Abe, M; Sakimura, K; Yamamoto, H; Kihara, S; Okamura, Y				Kawai, Takafumi; Kayama, Kento; Tatsumi, Shoki; Akter, Sharmin; Miyawaki, Nana; Okochi, Yoshifumi; Abe, Manabu; Sakimura, Kenji; Yamamoto, Hiroyasu; Kihara, Shinji; Okamura, Yasushi			Regulation of hepatic oxidative stress by voltage-gated proton channels (Hv1/VSOP) in Kupffer cells and its potential relationship with glucose metabolism	FASEB JOURNAL			English	Article						blood glucose; Kupffer cell; voltage-gated proton channels	PHOSPHOENOLPYRUVATE CARBOXYKINASE; SUPEROXIDE-PRODUCTION; LIVER; GLUCONEOGENESIS; INTOLERANCE; VSOP/HV1; ASSAY	Voltage-gated proton channels (Hv1/VSOP), encoded byHvcn1, are important regulator of reactive oxygen species (ROS) production in many types of immune cells. While in vitro studies indicate that Hv1/VSOP regulates ROS production by maintaining pH homeostasis, there are few studies investigating the functional importance of Hv1/VSOP in vivo. In the present study, we first show that Hv1/VSOP is functionally expressed in liver resident macrophage, Kupffer cells, regulating the hepatic oxidative stress in vivo. Our immunocytochemistry and electrophysiology data showed thatHvcn1is specifically expressed in Kupffer cells, but not in hepatocytes. Furthermore,Hvcn1-deficiency drastically altered the hepatic oxidative stress. TheHvcn1-deficient mice showed high blood glucose and serum insulin but normal insulin sensitivity, indicating that these phenotypes were not linked to insulin resistance. Transcriptome analysis indicated that the gene expression ofglycogen phosphorylase (Pygl)andGlucose-6-phosphatase, catalytic subunit (G6pc)were upregulated inHvcn1-deficient liver tissues, and quantitative PCR confirmed the result forPygl. Furthermore, we observed higher amount of glucose-6-phosphate, a key sugar intermediate for glucose inHvcn1-deficient liver than WT, suggesting that glucose production in liver is accelerated inHvcn1-deficient mice. The present study sheds light on the functional importance of Kupffer cells in hepatic oxidative stress and its potential relationship with glucose metabolism.	[Kawai, Takafumi; Kayama, Kento; Tatsumi, Shoki; Akter, Sharmin; Miyawaki, Nana; Okochi, Yoshifumi; Okamura, Yasushi] Osaka Univ, Grad Sch Med & Frontier Biosci, Integrat Physiol, Suita, Osaka, Japan; [Kayama, Kento; Tatsumi, Shoki; Yamamoto, Hiroyasu; Kihara, Shinji] Osaka Univ, Div Hlth Sci, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan; [Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan	Osaka University; Osaka University; Niigata University	Kihara, S (corresponding author), Osaka Univ, Div Hlth Sci, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan.; Okamura, Y (corresponding author), Osaka Univ, Grad Sch Med, Lab Integrat Physiol, Suita, Osaka, Japan.	skihara@sahs.med.osaka-u.ac.jp; vsop1@me.com	Abe, Manabu/A-9221-2008	Akter, Sharmin/0000-0001-6901-3377	MEXT \ Japan Society for the Promotion of Science (JSPS) [12J01957, 15K18575, 21229003, 25253016]; Takeda Medical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24111529, 26111712]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Medical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 12J01957, 15K18575, 21229003 and 25253016; Takeda Medical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 24111529 and 26111712	Aibara D, 2020, ENDOCR J, V67, P9, DOI 10.1507/endocrj.EJ19-0276; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; DeCoursey TE, 2013, PHYSIOL REV, V93, P599, DOI 10.1152/physrev.00011.2012; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Feingold KR, 2012, INNATE IMMUN-LONDON, V18, P231, DOI 10.1177/1753425911398678; HORTON RA, 1994, BIOCHEM J, V299, P735, DOI 10.1042/bj2990735; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jiang Joy X, 2014, Adv Hepatol, V2014; Kawai T, 2018, CHANNELS, V12, P1, DOI 10.1080/19336950.2017.1385684; Kawai T, 2017, J NEUROCHEM, V142, P686, DOI 10.1111/jnc.14106; Kim H, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00048-17; Kimura K, 2016, CELL REP, V14, P2362, DOI 10.1016/j.celrep.2016.02.032; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002; MOTTA PM, 1984, ARCH HISTOL JAPON, V47, P1, DOI 10.1679/aohc.47.1; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Pang HM, 2020, J BIOL CHEM, V295, P3601, DOI 10.1074/jbc.RA119.010489; Petheo GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014081; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Sasaki M, 2013, BIOCHEM J, V450, P295, DOI 10.1042/BJ20121188; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Taylor KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056181; Tu H, 2010, NEUROSCIENCE, V165, P39, DOI 10.1016/j.neuroscience.2009.10.002; WAKE K, 1989, INT REV CYTOL, V118, P173; Wilson LH, 2019, HEPATOL COMMUN, V3, P1544, DOI 10.1002/hep4.1426; WISSE E, 1974, J ULTRA MOL STRUCT R, V46, P393, DOI 10.1016/S0022-5320(74)90064-1; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Xue Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075240; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Yamazaki Tsuyoshi, 2011, Trop Med Health, V39, P41, DOI 10.2149/tmh.2011-08; Ye ZW, 2015, BBA-GEN SUBJECTS, V1850, P1607, DOI 10.1016/j.bbagen.2014.11.010; Yerkovich ST, 2004, INT J BIOCHEM CELL B, V36, P1462, DOI 10.1016/j.biocel.2003.10.022	40	6	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15805	15821		10.1096/fj.202001056RRR	http://dx.doi.org/10.1096/fj.202001056RRR		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33040408				2022-12-28	WOS:000576980100001
J	Pandya, UM; Manzanares, MA; Tellechea, A; Egbuta, C; Daubriac, J; Jimenez-Jaramillo, C; Samra, F; Fredston-Hermann, A; Saadipour, K; Gold, LI				Pandya, Unnati M.; Manzanares, Miguel A.; Tellechea, Ana; Egbuta, Chinaza; Daubriac, Julien; Jimenez-Jaramillo, Couger; Samra, Fares; Fredston-Hermann, Alexa; Saadipour, Khalil; Gold, Leslie, I			Calreticulin exploits TGF-beta for extracellular matrix induction engineering a tissue regenerative process	FASEB JOURNAL			English	Article						calreticulin; chronic wounds; extracellular matrix; integrins; TGF-beta; tissue regeneration	GROWTH-FACTOR-BETA; RECEPTOR-ASSOCIATED PROTEIN; CELL-SURFACE CALRETICULIN; DIFFERENTIAL EXPRESSION; COLLAGEN EXPRESSION; IMMUNE-SYSTEM; WOUND REPAIR; ADHESION; FIBRONECTIN; THROMBOSPONDIN	Topical application of extracellular calreticulin (eCRT), an ER chaperone protein, in animal models enhances wound healing and induces tissue regeneration evidenced by epidermal appendage neogenesis and lack of scarring. In addition to chemoattraction of cells critical to the wound healing process, eCRT induces abundant neo-dermal extracellular matrix (ECM) formation by 3 days post-wounding. The purpose of this study was to determine the mechanisms involved in eCRT induction of ECM. In vitro, eCRT strongly induces collagen I, fibronectin, elastin, alpha-smooth muscle actin in human adult dermal (HDFs) and neonatal fibroblasts (HFFs) mainly via TGF-beta canonical signaling and Smad2/3 activation; RAP, an inhibitor of LRP1 blocked eCRT ECM induction. Conversely, eCRT induction of alpha 5 and beta 1 integrins was not mediated by TGF-beta signaling nor inhibited by RAP. Whereas eCRT strongly induces ECM and integrin alpha 5 proteins in K41 wild-type mouse embryo fibroblasts (MEFs), CRT null MEFs were unresponsive. The data show that eCRT induces the synthesis and release of TGF-beta 3 first via LRP1 or other receptor signaling and later induces ECM proteins via LRP1 signaling subsequently initiating TGF-beta receptor signaling for intracellular CRT (iCRT)-dependent induction of TGF-beta 1 and ECM proteins. In addition, TGF-beta 1 induces 2-3-fold higher level of ECM proteins than eCRT. Whereas eCRT and iCRT converge for ECM induction, we propose that eCRT attenuates TGF-beta-mediated fibrosis/scarring to achieve tissue regeneration.	[Pandya, Unnati M.; Manzanares, Miguel A.; Tellechea, Ana; Egbuta, Chinaza; Daubriac, Julien; Jimenez-Jaramillo, Couger; Samra, Fares; Fredston-Hermann, Alexa; Saadipour, Khalil; Gold, Leslie, I] NYU, Sch Med, Dept Med, Div Translat Med,Langone Hlth, 550 First Ave,MSB 258, New York, NY 10016 USA; [Gold, Leslie, I] NYU, Sch Med, Dept Pathol, Langone Hlth, New York, NY 10016 USA	New York University; New York University	Gold, LI (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med,Langone Hlth, 550 First Ave,MSB 258, New York, NY 10016 USA.	leslie.gold@nyumc.org	Pandya, Unnati/ABG-3968-2020		Calregen, Inc; Tissue Regeneration Sciences, Inc	Calregen, Inc; Tissue Regeneration Sciences, Inc	Calregen, Inc, Grant/Award Number: NA; Tissue Regeneration Sciences, Inc, Grant/Award Number: NA	Apetoh Lionel, 2007, Cancer Genomics & Proteomics, V4, P65; BAKSH S, 1992, PROTEIN EXPRES PURIF, V3, P322, DOI 10.1016/1046-5928(92)90008-K; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Brem H, 2006, PLAST RECONSTR SURG, V117, p193S, DOI 10.1097/01.prs.0000225459.93750.29; Chantre CO, 2018, BIOMATERIALS, V166, P96, DOI 10.1016/j.biomaterials.2018.03.006; Clark RAF, 1996, AM J PATHOL, V148, P1407; Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Distler JHW, 2019, NAT REV RHEUMATOL, V15, P705, DOI 10.1038/s41584-019-0322-7; Duo CC, 2014, INT J MOL SCI, V15, P2916, DOI 10.3390/ijms15022916; Elton CM, 2002, THROMB HAEMOSTASIS, V88, P648, DOI 10.1055/s-0037-1613270; Fadel MP, 2001, J BIOL CHEM, V276, P27083, DOI 10.1074/jbc.M101676200; FLANDERS KC, 1995, J MOL CELL CARDIOL, V27, P805, DOI 10.1016/0022-2828(95)90087-X; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Garg AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00588; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Gold LI, 2014, WOUND REPAIR REGEN, V22, pA42; Gold L, 2015, CELL STRESS CHAPERON, V20, P875, DOI 10.1007/s12192-015-0638-4; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; Greives MR, 2012, WOUND REPAIR REGEN, V20, P715, DOI 10.1111/j.1524-475X.2012.00822.x; Groenendyk J, 2004, MOL CELLS, V17, P383; Groenendyk J, 2019, BBA-GEN SUBJECTS, V1863, P1210, DOI 10.1016/j.bbagen.2019.04.016; Groenendyk J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159682; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105502; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Arias JI, 2018, ARCH DERMATOL RES, V310, P639, DOI 10.1007/s00403-018-1851-7; Ikushima H, 2011, CURR PHARM BIOTECHNO, V12, P2099, DOI 10.2174/138920111798808419; Kaliterna DM, 2019, EXPERT REV CLIN IMMU, V15, P1215, DOI 10.1080/1744666X.2020.1670062; Karimzadeh F, 2017, STEM CELL REP, V8, P1299, DOI 10.1016/j.stemcr.2017.03.018; Kepp O, 2009, CURR OPIN ONCOL, V21, P71, DOI 10.1097/CCO.0b013e32831bc375; Khalil N, 2002, EXP LUNG RES, V28, P233, DOI 10.1080/019021402753570527; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kubo M, 2001, J INVEST DERMATOL, V117, P1369, DOI 10.1046/j.0022-202x.2001.01551.x; Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433; Kypreou KP, 2008, PROTEOMICS, V8, P2407, DOI 10.1002/pmic.200700831; Leask A, 2013, ADV WOUND CARE, V2, P247, DOI 10.1089/wound.2012.0363; Leavitt T, 2016, CELL TISSUE RES, V365, P483, DOI 10.1007/s00441-016-2424-8; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; MASSAGUE J, 1991, CIBA F SYMP, V157, P51; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mori S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137486; Mori Y, 2003, ARTHRITIS RHEUM-US, V48, P1964, DOI 10.1002/art.11157; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Obeid M, 2007, CANCER RES, V67, P7941, DOI 10.1158/0008-5472.CAN-07-1622; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Occleston NL, 2009, EXPERT OPIN INV DRUG, V18, P1231, DOI 10.1517/13543780903130594; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Owusu BY, 2018, J CELL COMMUN SIGNAL, V12, P289, DOI 10.1007/s12079-017-0426-2; Pandya U.M., 2016, J DERMATOL CLIN RES, V4, P1083; Papp S, 2008, EXP CELL RES, V314, P1313, DOI 10.1016/j.yexcr.2008.01.008; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Peidl A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218178; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Peters LR, 2011, J IMMUNOL, V187, P919, DOI 10.4049/jimmunol.1100690; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Raghavan M, 2013, TRENDS IMMUNOL, V34, P13, DOI 10.1016/j.it.2012.08.002; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Ruseska I, 2020, BEILSTEIN J NANOTECH, V11, P101, DOI 10.3762/bjnano.11.10; Schnittert J, 2018, ADV DRUG DELIVER REV, V129, P37, DOI 10.1016/j.addr.2018.01.020; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Sweetwyne MT, 2010, AM J PATHOL, V177, P1710, DOI 10.2353/ajpath.2010.090903; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; Verrecchia F, 2007, RHEUMATOLOGY, V46, P833, DOI 10.1093/rheumatology/kel451; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Verrecchia F, 2006, AUTOIMMUN REV, V5, P563, DOI 10.1016/j.autrev.2006.06.001; Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461; Wordinger RJ, 2014, J OCUL PHARMACOL TH, V30, P154, DOI 10.1089/jop.2013.0220; Wu M, 2007, MATRIX BIOL, V26, P463, DOI 10.1016/j.matbio.2007.02.005; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079975; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Zielins ER, 2015, EXPERT OPIN EMERG DR, V20, P235, DOI 10.1517/14728214.2015.1018176; Zimmerman KA, 2015, J VASC RES, V52, P306, DOI 10.1159/000443884; Zimmerman KA, 2013, J BIOL CHEM, V288, P14584, DOI 10.1074/jbc.M112.447243	103	8	9	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15849	15874		10.1096/fj.202001161R	http://dx.doi.org/10.1096/fj.202001161R		OCT 2020	26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33015849				2022-12-28	WOS:000576520500001
J	Moran, MM; Wilson, BM; Li, J; Engen, PA; Naqib, A; Green, SJ; Virdi, AS; Plaas, A; Forsyth, CB; Keshavarzian, A; Sumner, DR				Moran, Meghan M.; Wilson, Brittany M.; Li, Jun; Engen, Phillip A.; Naqib, Ankur; Green, Stefan J.; Virdi, Amarjit S.; Plaas, Anna; Forsyth, Christopher B.; Keshavarzian, Ali; Sumner, Dale R.			The gut microbiota may be a novel pathogenic mechanism in loosening of orthopedic implants in rats	FASEB JOURNAL			English	Article						bone volume; gut microbiome; implant; implant fixation; orthopedics	PARTICLE-INDUCED OSTEOLYSIS; BONE TURNOVER MARKERS; TOTAL HIP; KNEE ARTHROPLASTY; INFLAMMATORY RESPONSE; COMMENSAL MICROBIOTA; PROBIOTIC REGULATION; UNITED-STATES; MODEL; LIVER	Particles released from implants cause inflammatory bone loss, which is a key factor in aseptic loosening, the most common reason for joint replacement failure. With the anticipated increased incidence of total joint replacement in the next decade, implant failure will continue to burden patients. The gut microbiome is increasingly recognized as an important factor in bone physiology, however, its role in implant loosening is currently unknown. We tested the hypothesis that implant loosening is associated with changes in the gut microbiota in a preclinical model. When the particle challenge caused local joint inflammation, decreased peri-implant bone volume, and decreased implant fixation, the gut microbiota was affected. When the particle challenge did not cause this triad of local effects, the gut microbiota was not affected. Our results suggest that cross-talk between these compartments is a previously unrecognized mechanism of failure following total joint replacement.	[Moran, Meghan M.; Wilson, Brittany M.; Naqib, Ankur; Virdi, Amarjit S.; Sumner, Dale R.] Rush Univ, Med Ctr, Dept Cell & Mol Med, 600 S Paulina St,Suite 507 AAC, Chicago, IL 60612 USA; [Li, Jun; Plaas, Anna] Rush Univ, Rush Med Coll, Dept Internal Med, Div Rheumatol,Med Ctr, Chicago, IL 60612 USA; [Engen, Phillip A.; Naqib, Ankur; Forsyth, Christopher B.; Keshavarzian, Ali] Rush Med Coll, Div Digest Dis & Nutr, Dept Internal Med, Chicago, IL 60612 USA; [Green, Stefan J.] Univ Illinois, Res Resources Ctr, Genome Res Core, Chicago, IL USA	Rush University; Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Moran, MM (corresponding author), Rush Univ, Med Ctr, Dept Cell & Mol Med, 600 S Paulina St,Suite 507 AAC, Chicago, IL 60612 USA.	meghan_moran@rush.edu		Sumner, Dale/0000-0001-9575-3862	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR066562, R21AR075130-01]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR066562 and R21AR075130-01	Akbar M, 2012, J R SOC INTERFACE, V9, P2109, DOI 10.1098/rsif.2012.0006; Anand S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02147; Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Beckmann N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205307; Bellocchi C, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0758-9; Bosch U, 2001, KNEE SURG SPORT TR A, V9, P282, DOI 10.1007/s001670100218; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Britton RA, 2014, J CELL PHYSIOL, V229, P1822, DOI 10.1002/jcp.24636; Burke DG, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0968-8; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Catrina AI, 2016, RHEUMATOLOGY, V55, P391, DOI 10.1093/rheumatology/keu469; Chamaon K, 2019, J BIOMED MATER RES B, V107, P1246, DOI 10.1002/jbm.b.34217; Chan DD, 2015, OSTEOARTHR CARTILAGE, V23, P1879, DOI 10.1016/j.joca.2015.06.021; Cheung AC, 2016, BONE JOINT J, V98B, P6, DOI 10.1302/0301-620X.98B1.36374; Cheuy VA, 2017, J ARTHROPLASTY, V32, P2604, DOI 10.1016/j.arth.2017.02.005; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cobelli N, 2011, NAT REV RHEUMATOL, V7, P600, DOI 10.1038/nrrheum.2011.128; Collins S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090523; Culliford D, 2015, OSTEOARTHR CARTILAGE, V23, P594, DOI 10.1016/j.joca.2014.12.022; Czarnek K, 2015, CENT EUR J IMMUNOL, V40, P236, DOI 10.5114/ceji.2015.52837; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; GLANT TT, 1993, J BONE MINER RES, V8, P1071; GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001; Gur TL, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00005; Guss JD, 2019, OSTEOARTHR CARTILAGE, V27, P129, DOI 10.1016/j.joca.2018.07.020; Guss JD, 2017, J BONE MINER RES, V32, P1343, DOI 10.1002/jbmr.3114; Hallab NJ, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00005; Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182; He ZH, 2010, RESPIROLOGY, V15, P478, DOI 10.1111/j.1440-1843.2010.01709.x; Hernandez CJ, 2017, ADV EXP MED BIOL, V1033, P249, DOI 10.1007/978-3-319-66653-2_12; Hernandez CJ, 2016, J BONE MINER RES, V31, P1638, DOI 10.1002/jbmr.2887; Holloway L, 2007, BRIT J NUTR, V97, P365, DOI 10.1017/S000711450733674X; HUANG GT, 2017, FRONT MICROBIOL, V8; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Inacio MCS, 2017, OSTEOARTHR CARTILAGE, V25, P1797, DOI 10.1016/j.joca.2017.07.022; Inacio MCS, 2017, CLIN ORTHOP RELAT R, V475, P2130, DOI 10.1007/s11999-017-5377-7; Kandahari AM, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.14; Koh A, 2020, MOL CELL, V78, P584, DOI 10.1016/j.molcel.2020.03.005; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liu S, 2012, ARTHRITIS RHEUM-US, V64, P4012, DOI 10.1002/art.37697; Liu SO, 2012, J BIOMED MATER RES A, V100A, P918, DOI 10.1002/jbm.a.34029; Mackos AR, 2017, HORM BEHAV, V88, P70, DOI 10.1016/j.yhbeh.2016.10.006; Matharu D, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9940-0; McCabe L, 2015, CURR OSTEOPOROS REP, V13, P363, DOI 10.1007/s11914-015-0292-x; McCabe LR, 2018, CALCIFIED TISSUE INT, V102, P480, DOI 10.1007/s00223-018-0403-7; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McGinty T, 2018, CURR OPIN HIV AIDS, V13, P28, DOI 10.1097/COH.0000000000000425; Moran MM, 2017, J ORTHOP RES, V35, P2595, DOI 10.1002/jor.23619; Moran MM, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.61; Moucha CS, 2006, JOINT REPLACEMENTS B, P13; Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030; Naqib A, 2018, METHODS MOL BIOL, V1783, P149, DOI 10.1007/978-1-4939-7834-2_7; Nemes S, 2015, ACTA ORTHOP, V86, P426, DOI 10.3109/17453674.2015.1034608; Nemes S, 2014, ACTA ORTHOP, V85, P238, DOI 10.3109/17453674.2014.913224; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan HD, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0719-1; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; R Development Core Team, 2009, R LANG ENV STAT COMP; Richardson JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24931-w; Rios-Arce ND, 2020, BONE, V134, DOI 10.1016/j.bone.2020.115269; Roberfroid MB, 2002, J NUTR, V132, P3599, DOI 10.1093/jn/132.12.3599; Ross RD, 2014, J ORTHOP RES, V32, P967, DOI 10.1002/jor.22607; Rutherford RW, 2018, J ARTHROPLASTY, V33, pS177, DOI 10.1016/j.arth.2018.03.037; Samelko L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160141; Sansone V, 2013, CLIN CASES MINER BON, V10, P34, DOI 10.11138/ccmbm/2013.10.1.034; Schepper JD, 2020, J BONE MINER RES, V35, P801, DOI 10.1002/jbmr.3947; Schepper JD, 2019, J BONE MINER RES, V34, P681, DOI 10.1002/jbmr.3635; Scher JU, 2016, ARTHRITIS RHEUMATOL, V68, P35, DOI 10.1002/art.39259; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scholz-Ahrens KE, 2007, J NUTR, V137, p838S, DOI 10.1093/jn/137.3.838S; Scholz-Ahrens KE, 2001, AM J CLIN NUTR, V73, p459S, DOI 10.1093/ajcn/73.2.459s; Schott EM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95997; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Servick K, 2016, SCIENCE, V353, P741, DOI 10.1126/science.353.6301.741; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Smith RA, 2010, J BIOMED MATER RES A, V93A, P227, DOI 10.1002/jbm.a.32531; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Stephens M, 2018, CELL TISSUE RES, V371, P599, DOI 10.1007/s00441-017-2779-5; Takahara S, 2000, J NUTR, V130, P1792, DOI 10.1093/jn/130.7.1792; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Urban RM, 2004, J ARTHROPLASTY, V19, P94, DOI 10.1016/j.arth.2004.09.013; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Voigt RM, 2016, ALCOHOL CLIN EXP RES, V40, P335, DOI 10.1111/acer.12943; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wan SZ, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00018; Wang ZH, 2017, INT J NANOMED, V12, DOI 10.2147/IJN.S130485; WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005; WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95; WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202; Willert HG, 1996, CLIN ORTHOP RELAT R, P4; Wilson BM, 2020, J ORTHOP RES, V38, P1216, DOI 10.1002/jor.24563; Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202; Xiao L, 2019, J NUTR, V149, P856, DOI 10.1093/jn/nxz006; Yadav Jessica, 2013, Open Orthop J, V7, P605, DOI 10.2174/1874325001307010605; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang WY, 2016, TOXICOL LETT, V258, P192, DOI 10.1016/j.toxlet.2016.07.003; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	106	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14302	14317		10.1096/fj.202001364R	http://dx.doi.org/10.1096/fj.202001364R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931052	Green Accepted, Bronze			2022-12-28	WOS:000570776000001
J	Lu, J; Shen, H; Li, Q; Xiong, FR; Xie, RR; Yuan, MX; Yang, JK				Lu, Jing; Shen, Han; Li, Qi; Xiong, Fengran; Xie, Rongrong; Yuan, Mingxia; Yang, Jin-Kui			KCNH6 protects pancreatic beta-cells from endoplasmic reticulum stress and apoptosis	FASEB JOURNAL			English	Article						apoptosis; endoplasmic reticulum stress; insulin; KCNH6; pancreatic beta-cells	HERG K+ CHANNELS; ER STRESS; ACTIVATION; CALPAIN; CA2+; CALCIUM; TYPE-1; DYSFUNCTION; CASPASE-12; PALMITATE	Adult patients with dysfunction in human ether-a-go-go 2 (hERG2) protein, encoded by KCNH6, present with hypoinsulinemia and hyperglycemia. However, the mechanism of KCNH6 actionin glucose disorders has not been clearly defined. Previous studies identified that sustained endoplasmic reticulum (ER) stress-mediated apoptosis of pancreatic beta-cells and directly contributed to diabetes. In the present study, we showed that Kcnh6 knockout (KO) mice had impaired glucose tolerance mediated by high ER stress levels, and showed increased apoptosis and elevated intracellular calcium levels in pancreatic beta-cells. In contrast, KCNH6 overexpression in islets isolated from C57BL/6J mice attenuated ER stress induced by thapsigargin or palmitic acid. This effect contributed to better preservation of beta-cells, as reflected in increased beta cell survival and enhanced glucose-stimulated insulin secretion. These results were further corroborated by studies evaluating KCNH6 overexpression in KO islets. Similarly, induction of Kcnh6 in KO mice by lentivirus injection improved glucose tolerance by reducing pancreatic ER stress and apoptosis. Our data provide new insights into howKcnh6deficiency causes ER calcium depletion and beta cell dysfunction.	[Lu, Jing; Shen, Han; Li, Qi; Xiong, Fengran; Xie, Rongrong; Yuan, Mingxia; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China; [Shen, Han] Beijing Sijiqing Hosp, Beijing, Peoples R China	Capital Medical University	Yang, JK (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing 100730, Peoples R China.	jkyang@ccmu.edu.cn		Li, Qi/0000-0003-2564-7225	National Natural Science Foundation of China [81561128015, 81800688, 8181930019]; Foundation of Beijing Tongren Hospital, Capital Medical University [TRYY-KYJJ-2016-013]; Beijing Municipal Administration of Hospitals Incubating Program [PX2019006]; National Key R&D Program of China [2017YFC0909600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Beijing Tongren Hospital, Capital Medical University; Beijing Municipal Administration of Hospitals Incubating Program; National Key R&D Program of China	This work was supported by grants from the National Natural Science Foundation of China (81561128015, 81800688, 8181930019), Foundation of Beijing Tongren Hospital, Capital Medical University (TRYY-KYJJ-2016-013), Beijing Municipal Administration of Hospitals Incubating Program (PX2019006) to JL, and the National Key R&D Program of China (2017YFC0909600) to JKY	Babcock JJ, 2013, ACTA PHARMACOL SIN, V34, P329, DOI 10.1038/aps.2013.6; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Cui W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059921; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang CJ, 2010, J BIOL CHEM, V285, P339, DOI 10.1074/jbc.M109.024190; Hylten-Cavallius L, 2017, CIRCULATION, V135, P1705, DOI 10.1161/CIRCULATIONAHA.116.024279; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim JY, 2012, J PHARMACOL SCI, V118, P65, DOI 10.1254/jphs.11072FP; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Nagy G, 2010, TOXICOL APPL PHARM, V243, P96, DOI 10.1016/j.taap.2009.11.017; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Namba T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1386; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Proverbio MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068740; Qiu HY, 2015, J DIABETES RES, V2016, P1; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Shang LS, 2014, DIABETES, V63, P923, DOI 10.2337/db13-0717; Shen N, 2012, EUR J PHARMACOL, V694, P120, DOI 10.1016/j.ejphar.2012.07.052; Shi CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21924; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Wagner M, 2011, CURR OPIN CLIN NUTR, V14, P367, DOI 10.1097/MCO.0b013e32834778d4; Yang JK, 2018, CELL REP, V25, P3800, DOI 10.1016/j.celrep.2018.12.005; Yu C, 2015, J BIOL CHEM, V290, P20687, DOI 10.1074/jbc.M115.654863; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	47	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15015	15028		10.1096/fj.202001218R	http://dx.doi.org/10.1096/fj.202001218R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918525				2022-12-28	WOS:000570676000001
J	Lang, YG; Li, FF; Liu, Q; Xia, ZQ; Ji, ZL; Hu, J; Cheng, YT; Gao, MJ; Sun, F; Shen, BZ; Xie, C; Yi, W; Wu, YL; Yao, J; Cao, ZJ				Lang, Yange; Li, Fangfang; Liu, Qiang; Xia, Zhiqiang; Ji, Zhenglin; Hu, Juan; Cheng, Yuting; Gao, Minjun; Sun, Fang; Shen, Bingzheng; Xie, Chang; Yi, Wei; Wu, Yingliang; Yao, Jing; Cao, Zhijian			The Kv1.3 ion channel acts as a host factor restricting viral entry	FASEB JOURNAL			English	Article						Dengue virus; hepatitis C virus; host factor; Kv1; 3 ion channel; Zika virus	HEPATITIS-C-VIRUS; MITOCHONDRIAL POTASSIUM CHANNEL; ZIKA VIRUS; K+ CHANNEL; FUSION; TARGETS; INNATE; PH	Virus entry into cells is the initial stage of infection and involves multiple steps, and interfering viral entry represents potential antiviral approaches. Ion channels are pore-forming membrane proteins controlling cellular ion homeostasis and regulating many physiological processes, but their roles during viral infection have rarely been explored. Here, the functional Kv1.3 ion channel was found to be expressed in human hepatic cells and tissues. The Kv1.3 was then revealed to restrict HCV entry via inhibiting endosome acidification-mediated viral membrane fusion. The Kv1.3 was also demonstrated to inhibit DENV and ZIKV with an endosome acidification-dependent entry, but have no effect on SeV with a neutral pH penetration. A Kv1.3 antagonist PAP-1 treatment accelerated animal death in ZIKV-infectedIfnar1(-/-)mice. Moreover, Kv1.3-deletion was found to promote weight loss and reduce survival rate in ZIKV-infected Kv1.3(-/-)mice. Altogether, the Kv1.3 ion channel behaves as a host factor restricting viral entry. These findings broaden understanding about ion channel biology.	[Lang, Yange; Li, Fangfang; Xia, Zhiqiang; Ji, Zhenglin; Cheng, Yuting; Gao, Minjun; Sun, Fang; Shen, Bingzheng; Wu, Yingliang; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Qiang; Hu, Juan; Xie, Chang; Yao, Jing] Wuhan Univ, Coll Life Sci, Frontier Sci Ctr Immunol & Metab, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Wuhan 430072, Peoples R China; [Yi, Wei] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Wu, Yingliang; Cao, Zhijian] Wuhan Univ, Biodrug Res Ctr, Wuhan, Peoples R China; [Cao, Zhijian] Wuhan Univ, Ctr Fluorinated Pharmaceut, Hubei Prov Engn & Technol Res, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.; Yao, J (corresponding author), Wuhan Univ, Coll Life Sci, Frontier Sci Ctr Immunol & Metab, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Wuhan 430072, Peoples R China.	jyao@whu.edu.cn; zjcao@whu.edu.cn		Yao, Jing/0000-0003-1844-3988	National Science Fund of China [31872239, 31830031, 81630091, 31929003, 31671209, 31871174, 31601864]; International S&T Cooperation Program of China [S2016G3110]; Hubei Science Fund [2016CFA018, 2017CFA063, 2018CFA016]; Fundamental Research Funds for the Central Universities; Open Research Program of the State Key Laboratory of Virology of China [2020KF002]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China; Hubei Science Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Research Program of the State Key Laboratory of Virology of China	This work was supported by grants from National Science Fund of China (Nos. 31872239, 31830031, 81630091, 31929003, 31671209, 31871174, and 31601864), International S&T Cooperation Program of China (No. S2016G3110), Hubei Science Fund (Nos. 2016CFA018, 2017CFA063, and 2018CFA016), Fundamental Research Funds for the Central Universities, and the Open Research Program of the State Key Laboratory of Virology of China (grant no. 2020KF002)	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Cang CL, 2015, CELL, V162, P1101, DOI 10.1016/j.cell.2015.08.002; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Comes N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00283; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Gruenberg J, 2009, CURR OPIN CELL BIOL, V21, P582, DOI 10.1016/j.ceb.2009.03.008; Hover S, 2017, J GEN VIROL, V98, P345, DOI 10.1099/jgv.0.000712; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Leanza L, 2015, CELL CALCIUM, V58, P131, DOI 10.1016/j.ceca.2014.09.006; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Lu YY, 2013, J BIOL CHEM, V288, P24247, DOI 10.1074/jbc.M113.484253; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Martinez-Marmol R, 2016, CELL MOL LIFE SCI, V73, P1515, DOI 10.1007/s00018-015-2082-0; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Perez-Verdaguer M, 2016, EXPERT OPIN THER TAR, V20, P577, DOI 10.1517/14728222.2016.1112792; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Ujino S, 2016, P NATL ACAD SCI USA, V113, P188, DOI 10.1073/pnas.1506524113; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; Zheng K, 2014, BIOCHEM BIOPH RES CO, V446, P990, DOI 10.1016/j.bbrc.2014.03.050	38	0	0	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000879RR	http://dx.doi.org/10.1096/fj.202000879RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	32910509				2022-12-28	WOS:000570301900001
J	Grant, I; Soria, R; Julian, CG; Vargas, E; Moore, LG; Aiken, CE; Giussani, DA				Grant, I; Soria, R.; Julian, C. G.; Vargas, E.; Moore, L. G.; Aiken, C. E.; Giussani, D. A.			Parental ancestry and risk of early pregnancy loss at high altitude	FASEB JOURNAL			English	Article						high altitude; miscarriage; pregnancy complication; spontaneous abortion	ARTERY BLOOD-FLOW; INTRAUTERINE GROWTH RESTRICTION; BIRTH-WEIGHT; 1ST TRIMESTER; MISCARRIAGE; HYPOXIA; OXYGEN; PREECLAMPSIA; REDUCTIONS; PROTECTION	High altitude pregnancy is associated with increased frequency of low birth weight infants and neonatal complications, the risks of which are higher in women of low-altitude ancestry. Does ancestry also influence the risk of miscarriage (pregnancy loss <20 weeks) in high-altitude pregnancy? To answer this, 5386 women from La Paz, Bolivia (3300-4150 m) with >= 1 live-born infant were identified. Data were extracted from medical records including maternal and paternal ancestry, demographic factors, and reproductive history. The risk of miscarriage by ancestry was assessed using multivariate logistic regression, adjusting for parity, and maternal age. Andean women experienced first live-births younger than Mestizo or European women (21.7 +/- 4.6 vs 23.4 +/- 8.0 vs 24.1 +/- 5.1,P < .001). Andeans experienced more pregnancies per year of reproductive life (P < .001) and had significantly higher ratios of live-births to miscarriages than women of Mestizo or European ancestry (P < .001). Andean women were 24% less likely to have ever experienced a miscarriage compared to European women (OR:0.76; CI:0.62-0.90,P < .001). The woman's partner's ancestry wasn't a significant independent predictor of miscarriage. In conclusion, the risk of miscarriage at high altitude is lower in Andean women. The lack of a paternal ancestry effect suggests underlying mechanisms relate more to differential maternal adaptation in early pregnancy than fetal genetics.	[Grant, I; Aiken, C. E.] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England; [Soria, R.; Vargas, E.] Inst Boliviano Biol Altura, La Paz, Bolivia; [Julian, C. G.] Univ Colorado, Dept Med, Denver, CO USA; [Moore, L. G.] Univ Colorado, Dept Obstet Gynecol, Denver, CO 80202 USA; [Giussani, D. A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; Universidad Mayor de San Andres; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University of Cambridge	Grant, I (corresponding author), Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England.	ig320@cam.ac.uk			Isaac Newton Trust [12.21(a)]; Wellcome Trust ISSF [105602/Z/14/Z]; University of Cambridge Joint Research Grant (CEA); British Heart Foundation [RG/17/8/32924]	Isaac Newton Trust; Wellcome Trust ISSF(Wellcome Trust); University of Cambridge Joint Research Grant (CEA); British Heart Foundation(British Heart Foundation)	Isaac Newton Trust, Grant/Award Number: 12.21(a); Wellcome Trust ISSF, Grant/Award Number: 105602/Z/14/Z; University of Cambridge Joint Research Grant (CEA); British Heart Foundation, Grant/Award Number: RG/17/8/32924	[Anonymous], PAZ BOL METR AR POP; Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014; Bigham AW, 2014, PHYSIOL GENOMICS, V46, P687, DOI 10.1152/physiolgenomics.00063.2014; Brain KL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006552; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Burton GJ, 2017, PLACENTA, V56, P14, DOI 10.1016/j.placenta.2017.01.130; Cindrova-Davies T, 2015, MOL HUM REPROD, V21, P296, DOI 10.1093/molehr/gau105; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Goddijn M, 2000, BEST PRACT RES CL OB, V14, P855, DOI 10.1053/beog.2000.0124; Goldstein M, 2017, J MATERN-FETAL NEO M, V30, P2956, DOI 10.1080/14767058.2016.1269317; GREKSA LP, 1990, AM J HUM BIOL, V2, P603, DOI 10.1002/ajhb.1310020604; Instituto Nacional de Estadistica, CENS DAT; Julian CG, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020150; Julian CG, 2008, AM J PHYSIOL-REG I, V295, pR906, DOI 10.1152/ajpregu.00164.2008; Julian CG, 2012, J MATERN-FETAL NEO M, V25, P1233, DOI 10.3109/14767058.2011.636102; Julian CG, 2009, AM J PHYSIOL-REG I, V296, pR1564, DOI 10.1152/ajpregu.90945.2008; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Kimball Natalie L., 2020, OPEN SECRET HIST UNW, DOI [10.2307/j.ctv10kmc00, DOI 10.2307/J.CTV10KMC00]; Leonard OE, 1948, AM SOCIOL REV, V13, P448, DOI 10.2307/2087239; Mazzucconi MG, 2015, ACTA HAEMATOL-BASEL, V133, P242, DOI 10.1159/000363048; Moore LG, 2001, AM J HUM BIOL, V13, P635, DOI 10.1002/ajhb.1102; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Palmer SK, 1999, AM J OBSTET GYNECOL, V180, P1161, DOI 10.1016/S0002-9378(99)70611-3; Papageorghiou AT, 2018, AM J OBSTET GYNECOL, V218, pS630, DOI 10.1016/j.ajog.2018.01.011; Rodriguez-Larralde A, 2011, AM J PHYS ANTHROPOL, V144, P177, DOI 10.1002/ajpa.21379; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P211, DOI 10.2307/2137904; Simpson JL, 2007, CLIN OBSTET GYNECOL, V50, P10, DOI 10.1097/GRF.0b013e31802f11f6; Soler A, 2017, CYTOGENET GENOME RES, V152, P81, DOI 10.1159/000477707; Soria R, 2013, PEDIATR RES, V74, P633, DOI 10.1038/pr.2013.150; Tashi T, 2017, J MOL MED, V95, P665, DOI 10.1007/s00109-017-1519-3; Vaiman D, 2015, BIOMED J, V38, P11, DOI 10.4103/2319-4170.133777; van Patot MCT, 2011, HIGH ALT MED BIOL, V12, P157, DOI 10.1089/ham.2010.1099; Vargas M, 2007, AM J PHYSIOL-REG I, V293, pR1303, DOI 10.1152/ajpregu.00805.2006; WILCOX AJ, 1993, AM J EPIDEMIOL, V137, P1098, DOI 10.1093/oxfordjournals.aje.a116613; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1; ZAMUDIO S, 1995, J APPL PHYSIOL, V79, P7, DOI 10.1152/jappl.1995.79.1.7; Zhou H, 2016, EUR J OBSTET GYN R B, V206, P57, DOI 10.1016/j.ejogrb.2016.07.514	41	6	6	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13741	13749		10.1096/fj.202001257R	http://dx.doi.org/10.1096/fj.202001257R		AUG 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32856356	hybrid, Green Published			2022-12-28	WOS:000567842000001
J	Yang, SR; Hsu, WH; Wu, CY; Shang, HS; Liu, FC; Chen, A; Hua, KF; Ka, SM				Yang, Shin-Ruen; Hsu, Wan-Han; Wu, Chung-Yao; Shang, Hung-Sheng; Liu, Feng-Cheng; Chen, Ann; Hua, Kuo-Feng; Ka, Shuk-Man			Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-kappa B/NLRP3 inflammasome and sirtuin 1/autophagy axis	FASEB JOURNAL			English	Article						accelerated; severe lupus nephritis; autophagy; honokiol; NLRP3 inflammasome; sirtuin 1	NLRP3 INFLAMMASOME; K+ EFFLUX; ACTIVATION; AUTOPHAGY; ERYTHEMATOSUS; MODEL; GLOMERULONEPHRITIS; NEPHROPATHY; MAGNOLOL; PATHWAYS	Using honokiol (HNK), a major anti-inflammatory bioactive compound inMagnolia officinalis, we show a potent therapeutic outcome against an accelerated, severe form of lupus nephritis (ASLN). The latter may follow infectious insults that act as environmental triggers in the patients. In the current study, an ASLN model in NZB/W F1 mice was treated with HNK by daily gavage after onset of the disease. We show that HNK ameliorated the ASLN by improving renal function, albuminuria, and renal pathology, especially reducing cellular crescents, neutrophil influx, fibrinoid necrosis in glomeruli, and glomerulonephritis activity scores. Meanwhile, HNK differentially regulated T cell functions, reduced serum anti-dsDNA autoantibodies, and inhibited NLRP3 inflammasome activation in the mice. The latter involved: (a) suppressed production of reactive oxygen species and NF-kappa B activation-mediated priming signal of the inflammasome, (b) reduced mitochondrial damage, and (c) enhanced sirtuin 1 (SIRT1)/autophagy axis activation. In conclusion, HNK represents a new drug candidate for acute, severe episodes of LN capable of alleviating renal lesions in ASLN mice by negatively regulating T cell functions and by enhancing SIRT1/autophagy axis-lessened NLRP3 inflammasome activation.	[Yang, Shin-Ruen; Wu, Chung-Yao; Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hsu, Wan-Han; Chen, Ann] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Shang, Hung-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Liu, Feng-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Taipei, Taiwan; [Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, 1,Sec 1,Shen Lung Rd, Ilan 260, Taiwan; [Hua, Kuo-Feng] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Dept Med, 161,Sec 6,Min Quan E Rd, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Ilan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Defense Medical Center	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, 1,Sec 1,Shen Lung Rd, Ilan 260, Taiwan.; Ka, SM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Dept Med, 161,Sec 6,Min Quan E Rd, Taipei, Taiwan.	kuofenghua@niu.edu.tw; shukmanka@gmail.com	Shang, Hung-Sheng/ABD-1918-2021	Yang, Shin-Ruen/0000-0002-9847-4049; Shang, Hung-Sheng/0000-0002-4831-1866	Ministry of Science and Technology (MOST), Taiwan [MOST 109-2327-B-016-001, MOST 109-2314-B-016-034-MY3]; Tri-Service General Hospital (TSGH), Taiwan [TSGH-C107-063, TSGH-D109-090]; National Defense Medical Center, Taipei, Taiwan [MAB-109-028]; Chang Gung Memorial Hospital, Linkou (Linkou Chang Gung Memorial Hospital), Taiwan [CIRPD3B0013, CLRPD190018]	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital (TSGH), Taiwan; National Defense Medical Center, Taipei, Taiwan; Chang Gung Memorial Hospital, Linkou (Linkou Chang Gung Memorial Hospital), Taiwan	Ministry of Science and Technology (MOST), Taiwan, Grant/Award Number: MOST 109-2327-B-016-001 and MOST 109-2314-B-016-034-MY3; Tri-Service General Hospital (TSGH), Taiwan, Grant/Award Number: TSGH-C107-063 and TSGH-D109-090; National Defense Medical Center, Taipei, Taiwan, Grant/Award Number: MAB-109-028; Chang Gung Memorial Hospital, Linkou (Linkou Chang Gung Memorial Hospital), Taiwan, Grant/Award Number: CIRPD3B0013 and CLRPD190018	Akhtar S, 2011, MOL MED, V17, P88, DOI 10.2119/molmed.2010.00080; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Ayyappan P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00658; Benseler SM, 2009, RHEUMATOLOGY, V48, P176, DOI 10.1093/rheumatology/ken445; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; CAVALLO T, 1990, AM J PATHOL, V137, P1549; CAVALLO T, 1990, AM J PATHOL, V137, P971; Chang YP, 2015, J CELL PHYSIOL, V230, P1567, DOI 10.1002/jcp.24903; Chao LK, 2010, J AGR FOOD CHEM, V58, P3472, DOI 10.1021/jf904207m; Chen A, 1998, NEPHRON, V78, P440, DOI 10.1159/000044974; Chen A, 1997, AM J KIDNEY DIS, V30, P693, DOI 10.1016/S0272-6386(97)90495-9; Chiu HW, 2019, SCI REP, V9, P1; Clarke AJ, 2015, ANN RHEUM DIS, V74, P912, DOI 10.1136/annrheumdis-2013-204343; Costantini C, 2010, INT IMMUNOL, V22, P827, DOI 10.1093/intimm/dxq434; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Flanc RS, 2004, AM J KIDNEY DIS, V43, P197, DOI 10.1053/j.ajkd.2003.10.012; Fu R, 2017, ARTHRITIS RHEUMATOL, V69, P1636, DOI 10.1002/art.40155; Fu Y, 2013, INT J MOL SCI, V14, P14105, DOI 10.3390/ijms140714105; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Guo N, 2019, EMERG MICROBES INFEC, V8, P707, DOI 10.1080/22221751.2019.1617643; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; He Q, 2017, INT IMMUNOPHARMACOL, V50, P208, DOI 10.1016/j.intimp.2017.06.029; Huang PP, 2020, INT J MOL MED, V45, P186, DOI 10.3892/ijmm.2019.4393; Illei GG, 2001, ANN INTERN MED, V135, P248, DOI 10.7326/0003-4819-135-4-200108210-00009; Ji YP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16000; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Ka SM, 2007, J AM SOC NEPHROL, V18, P2473, DOI 10.1681/ASN.2006111242; Ka SM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0844-6; Ka SM, 2006, NEPHROL DIAL TRANSPL, V21, P288, DOI 10.1093/ndt/gfi229; Kahlenberg JM, 2014, CURR OPIN RHEUMATOL, V26, P475, DOI 10.1097/BOR.0000000000000088; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199; Ko JH, 2017, ONCOTARGET, V8, P40817, DOI 10.18632/oncotarget.17256; Kronbichler A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/858027; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li CY, 2011, J CELL PHYSIOL, V226, P2338, DOI 10.1002/jcp.22576; Li XZ, 2018, IMMUNOL RES, V66, P521, DOI 10.1007/s12026-018-9012-9; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Lin TJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01951; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Mittal B, 2004, AM J KIDNEY DIS, V44, P1050, DOI 10.1053/j.ajkd.2004.08.027; Molino C, 2009, EUR J INTERN MED, V20, P447, DOI 10.1016/j.ejim.2008.12.018; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Park SH, 2019, J BIOL CHEM, V294, P17951, DOI 10.1074/jbc.RA119.010545; Pillai VB, 2017, ONCOTARGET, V8, P34082, DOI 10.18632/oncotarget.16133; Shin MS, 2013, J IMMUNOL, V190, P1407, DOI 10.4049/jimmunol.1201195; Squires RF, 1999, NEUROCHEM RES, V24, P1593, DOI 10.1023/A:1021116502548; Tsai PY, 2012, ARTHRITIS RHEUM-US, V64, P232, DOI 10.1002/art.33328; Tsai PY, 2011, AM J PHYSIOL-RENAL, V301, pF751, DOI 10.1152/ajprenal.00706.2010; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Tucci M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/457146; Wang LL, 2015, INT J MOL SCI, V16, P25154, DOI 10.3390/ijms161025154; WATANABE K, 1983, PLANTA MED, V49, P103, DOI 10.1055/s-2007-969825; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Whittall-Garcia LP, 2019, LUPUS, V28, P1549, DOI 10.1177/0961203319883936; Wu CY, 2020, J IMMUNOL, V204, P1448, DOI 10.4049/jimmunol.1801610; Yang SR, 2020, KIDNEY INT, V98, P378, DOI 10.1016/j.kint.2020.02.033; Zhang H, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0911-z; Zhao JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1036, DOI 10.1002/art.38993	63	16	16	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13284	13299		10.1096/fj.202001326R	http://dx.doi.org/10.1096/fj.202001326R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32813287	Bronze			2022-12-28	WOS:000562901000001
J	Matyushenko, AM; Nefedova, VV; Shchepkin, DV; Kopylova, GV; Berg, VY; Pivovarova, AV; Kleymenov, SY; Bershitsky, SY; Levitsky, DI				Matyushenko, Alexander M.; Nefedova, Victoria V.; Shchepkin, Daniil, V; Kopylova, Galina, V; Berg, Valentina Y.; Pivovarova, Anastasia, V; Kleymenov, Sergey Y.; Bershitsky, Sergey Y.; Levitsky, Dmitrii, I			Mechanisms of disturbance of the contractile function of slow skeletal muscles induced by myopathic mutations in the tropomyosinTPM3gene	FASEB JOURNAL			English	Article						actin-myosin interaction; Ca2+-regulation of muscle contraction; in vitro motility assay; myopathic mutations; slow skeletal muscles; tropomyosin	2 STABILIZING SUBSTITUTIONS; ALPHA-TROPOMYOSIN; MIDDLE PART; CAUSE GAIN; MYOSIN; ACTIN; TPM3; EXPRESSION; TROPONIN; ISOFORMS	Several congenital myopathies of slow skeletal muscles are associated with mutations in the tropomyosin (Tpm)TPM3gene. Tropomyosin is an actin-binding protein that plays a crucial role in the regulation of muscle contraction. Two Tpm isoforms, gamma (Tpm3.12) and beta (Tpm2.2) are expressed in human slow skeletal muscles forming gamma gamma-homodimers and gamma beta-heterodimers of Tpm molecules. We applied various methods to investigate how myopathy-causing mutations M9R, E151A, and K169E in the Tpm gamma-chain modify the structure-functional properties of Tpm dimers, and how this affects the muscle functioning. The results show that the features of gamma gamma-Tpm and gamma beta-Tpm with substitutions in the Tpm gamma-chain vary significantly. The characteristics of the gamma gamma-Tpm depend on whether these mutations located in only one or both gamma-chains. The mechanism of the development of nemaline myopathy associated with the M9R mutation was revealed. At the molecular level, a cause-and-effect relationship has been established for the development of myopathy by the K169E mutation. Also, we described the structure-functional properties of the Tpm dimers with the E151A mutation, which explain muscle weakness linked to this substitution. The results demonstrate a diversity of the molecular mechanisms of myopathy pathogenesis induced by studied Tpm mutations.	[Matyushenko, Alexander M.; Nefedova, Victoria V.; Pivovarova, Anastasia, V; Kleymenov, Sergey Y.; Levitsky, Dmitrii, I] Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Leninsky Prospect 33, Moscow 119071, Russia; [Shchepkin, Daniil, V; Kopylova, Galina, V; Berg, Valentina Y.; Bershitsky, Sergey Y.] Russian Acad Sci, Ural Branch, Inst Immunol & Physiol, Ekaterinburg, Russia; [Kleymenov, Sergey Y.] Russian Acad Sci, Koltzov Inst Dev Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Levitsky, DI (corresponding author), Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Leninsky Prospect 33, Moscow 119071, Russia.	levitsky@inbi.ras.ru	Shchepkin, Daniil/ABF-1160-2020; Bershitsky, Sergey/AAE-6814-2019; Kopylova, Galina/ABF-2117-2020; Kleymenov, Sergey/R-1195-2018	Kopylova, Galina/0000-0003-2976-2108; Kleymenov, Sergey/0000-0001-5085-0327	Russian Science Foundation [16-14-10199]; Ministry of Science and Higher Education of the Russian Federation [AAAA-A19-119010590010-3, AAAA-A18-118020590135-3]; Russian Science Foundation [19-14-13032] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Science and Higher Education of the Russian Federation; Russian Science Foundation(Russian Science Foundation (RSF))	Russian Science Foundation, Grant/Award Number: Grant 16-14-10199 to D.I.L.; Ministry of Science and Higher Education of the Russian Federation, Grant/Award Number: State Programs AAAA-A19-119010590010-3 to D.I.L. and AAAA-A18-118020590135-3 to S.Y.B.	Akkari PA, 2002, BIOCHEM BIOPH RES CO, V296, P300; Bershitsky SY, 2019, FASEB J, V33, P1963, DOI 10.1096/fj.201800755R; Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308; Corbett MA, 2005, ANN NEUROL, V57, P42, DOI 10.1002/ana.20305; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; Gineste C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109066; Ilkovski B, 2008, J NEUROPATH EXP NEUR, V67, P867, DOI 10.1097/NEN.0b013e318183a44f; Janco M, 2013, J MUSCLE RES CELL M, V34, P177, DOI 10.1007/s10974-013-9353-x; Janco M, 2012, BIOCHEMISTRY-US, V51, P9880, DOI 10.1021/bi301323n; Kalyva A, 2012, BIOCHEMISTRY-US, V51, P6388, DOI 10.1021/bi300340r; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; Lehrer SS, 2014, J MUSCLE RES CELL M, V35, P153, DOI 10.1007/s10974-014-9383-z; Lehrer SS, 2011, J MUSCLE RES CELL M, V32, P203, DOI 10.1007/s10974-011-9263-8; LEHRER SS, 1987, ARCH BIOCHEM BIOPHYS, V256, P1, DOI 10.1016/0003-9861(87)90419-X; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345; Marttila M, 2014, HUM MUTAT, V35, P779, DOI 10.1002/humu.22554; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Matyushenko AM, 2020, BIOCHEMISTRY-MOSCOW+, V85, P20, DOI 10.1134/S0006297920140023; Matyushenko AM, 2020, BIOCHIMIE, V174, P1, DOI 10.1016/j.biochi.2020.03.013; Matyushenko AM, 2018, BIOPHYS CHEM, V243, P1, DOI 10.1016/j.bpc.2018.09.002; Matyushenko AM, 2019, INT J BIOL MACROMOL, V125, P1266, DOI 10.1016/j.ijbiomac.2018.09.105; Matyushenko AM, 2018, FEBS J, V285, P871, DOI 10.1111/febs.14369; Matyushenko AM, 2017, BIOCHEMISTRY-US, V56, P250, DOI 10.1021/acs.biochem.6b00994; Matyushenko AM, 2015, BIOPHYS CHEM, V196, P77, DOI 10.1016/j.bpc.2014.10.001; Matyushenko AM, 2014, FEBS J, V281, P2004, DOI 10.1111/febs.12756; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Memo M, 2013, J MUSCLE RES CELL M, V34, P165, DOI 10.1007/s10974-013-9344-y; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Moraczewska J, 2000, BIOPHYS J, V79, P3217, DOI 10.1016/S0006-3495(00)76554-4; Moraczewska J, 2020, J MUSCLE RES CELL M, V41, P39, DOI 10.1007/s10974-019-09532-y; Nevzorov IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1507, DOI 10.1134/S0006297911130098; Nevzorov IA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209353; Oe M, 2007, MEAT SCI, V75, P558, DOI 10.1016/j.meatsci.2006.09.003; Oe M, 2009, ANIM SCI J, V80, P193, DOI 10.1111/j.1740-0929.2008.00613.x; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Robaszkiewicz K, 2012, BBA-MOL BASIS DIS, V1822, P1562, DOI 10.1016/j.bbadis.2012.06.009; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; Yuen M, 2015, HUM MOL GENET, V24, P6278, DOI 10.1093/hmg/ddv334	44	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13507	13520		10.1096/fj.202001318R	http://dx.doi.org/10.1096/fj.202001318R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32797717				2022-12-28	WOS:000561437500001
J	Sun, JJ; Wang, X; Liu, WF; Ji, P; Shang, AQ; Wu, JL; Zhou, H; Quan, WQ; Yao, YW; Yang, YB; Gu, CZ; Sun, ZJ; Goel, A; Weng, WH; Li, D				Sun, Junjun; Wang, Xuan; Liu, Wenfang; Ji, Ping; Shang, Anquan; Wu, Junlu; Zhou, Hao; Quan, Wenqiang; Yao, Yiwen; Yang, Yibao; Gu, ChenZheng; Sun, Zujun; Goel, Ajay; Weng, Wenhao; Li, Dong			Novel evidence for retinoic acid-induced G (Rig-G) as a tumor suppressor by activating p53 signaling pathway in lung cancer	FASEB JOURNAL			English	Article						epithelial-mesenchymal transition; lung adenocarcinoma; metastasis; p53; prognosis; Rig-G; therapy	EXPRESSION; FAMILY; MEMBER; CELLS	Lung cancer is one of most common malignancies worldwide. We have previously identified retinoic acid-induced gene G (Rig-G) as a tumor suppressor in not only acute promyelocytic leukemia, but also in other solid tumors. However, the clinical significance of Rig-G and the underlying mechanism(s) for its biological function in lung cancer remain largely unexplored. Herein, we first compared the expression of Rig-G between lung cancer (n = 138) and normal tissues (n = 23), from public-available data sets and our patient cohort. We further analyzed the correlation of Rig-G expression with key clinico-pathological features and survival outcomes in a multi-site clinical cohort of 300 lung cancer patients. Functional studies for Rig-G were performed in cell lines, and an animal model to support clinical findings. We found that Rig-G was frequently downregulated in lung cancer tissues and cell lines, and correlated with poor prognosis in lung cancer patients. Overexpression of Rig-G led to significantly reduced cell growth and suppressed migration in A549 and NCI-H1944 cells, accompanied by reduced epithelial-mesenchymal transition. Likewise, restoration of Rig-G in Lewis lung carcinoma cells permitted development of fewer cancer metastases versus controls in an animal model. Gene expression profiling results identified p53 pathway as a key downstream target of Rig-G, and p53 inhibition by pifithrin-alpha caused abrogation of tumor-suppressive effects of Rig-G in lung cancer. In conclusion, we, for the first time, have identified Rig-G as a novel and important tumor suppressor, which may serve as a potential therapeutic target for restoring p53 expression in lung cancer patients.	[Sun, Junjun; Ji, Ping; Shang, Anquan; Wu, Junlu; Quan, Wenqiang; Yao, Yiwen; Yang, Yibao; Gu, ChenZheng; Sun, Zujun; Li, Dong] Tongji Univ, Shanghai Tongji Hosp, Dept Clin Lab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Wang, Xuan] Putuo Peoples Hosp, Dept Pharm, Shanghai, Peoples R China; [Liu, Wenfang; Zhou, Hao] Tongji Univ, Shanghai Tongji Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China; [Goel, Ajay] City Hope Natl Med Ctr, Dept Mol Diagnost & Expt Therapeut, Beckman Res Inst, Comprehens Canc Ctr, Duarte, CA USA; [Weng, Wenhao] Tongji Univ, Yangpu Hosp, Dept Clin Lab, Sch Med, 450 Tenyue Rd, Shanghai 200090, Peoples R China; [Weng, Wenhao] Tongji Univ, Yangpu Hosp, Inst Gastrointestinal Surg & Translat Med, Sch Med, Shanghai, Peoples R China	Tongji University; Tongji University; City of Hope; Beckman Research Institute of City of Hope; Tongji University; Tongji University	Li, D (corresponding author), Tongji Univ, Shanghai Tongji Hosp, Dept Clin Lab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China.; Weng, WH (corresponding author), Tongji Univ, Yangpu Hosp, Dept Clin Lab, Sch Med, 450 Tenyue Rd, Shanghai 200090, Peoples R China.; Goel, A (corresponding author), City Hope Natl Med Ctr, Dept Mol Diagnost & Expt Therapeut, Beckman Res Inst, Comprehens Ctr,Biomed Res Ctr, 1218 S Fifth Ave,Suite 2226, Monrovia, CA 91016 USA.	ajgoel@coh.org; wengwenhao2010@hotmail.com; lidong@tongji.edu.cn	Shang, Anquan/K-7456-2015	Shang, Anquan/0000-0003-2820-1982	National Cancer Institute, National Institutes of Health [R01 CA72851, CA181572, CA184792, CA202797, U01 CA187956]; Baylor Sammons Cancer Center and Foundation; Baylor Scott & White Research Institute; Beckman Research Institute of City of Hope; National Natural Science Foundation of China [81272603, 81472179, 81873975, 81672826, 81874179]; Excellent Academic Leader Training Program of Shanghai Health System [2018BR31]; Clinical Research and Cultivation Project of Shanghai Tongji Hospital [ITJ (ZD) 1803]; Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai [2017YQ044]; Shanghai Pujiang Talent Plan [18PJD047]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Sammons Cancer Center and Foundation; Baylor Scott & White Research Institute; Beckman Research Institute of City of Hope; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Academic Leader Training Program of Shanghai Health System; Clinical Research and Cultivation Project of Shanghai Tongji Hospital; Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai; Shanghai Pujiang Talent Plan	The present work was supported by the grants R01 CA72851, CA181572, CA184792, CA202797, and U01 CA187956 from the National Cancer Institute, National Institutes of Health, pilot grants from the Baylor Sammons Cancer Center and Foundation, funds from the Baylor Scott & White Research Institute and financial support from the Beckman Research Institute of City of Hope, to Ajay Goel. This work was also supported by grants 81272603, 81472179, and 81873975 from National Natural Science Foundation of China, grant 2018BR31 from Excellent Academic Leader Training Program of Shanghai Health System, and grant ITJ (ZD) 1803 from Clinical Research and Cultivation Project of Shanghai Tongji Hospital to Dong Li. In addition, this work was supported by grants 81672826 and 81874179 from the National Natural Science Foundation of China, grant 2017YQ044 from Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai, and grant 18PJD047 from Shanghai Pujiang Talent Plan to Wenhao Weng.	Agustoni F, 2019, CANCER TREAT REV, V72, P15, DOI 10.1016/j.ctrv.2018.08.002; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao MM, 2019, THORAC CANCER, V10, P3, DOI 10.1111/1759-7714.12916; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Gibbons DL, 2014, MOL CANCER RES, V12, P3, DOI 10.1158/1541-7786.MCR-13-0539; Giroux DJ, 2009, J THORAC ONCOL, V4, P679, DOI 10.1097/JTO.0b013e3181a52370; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Ka WH, 2018, BREAST CANCER-TOKYO, V25, P529, DOI 10.1007/s12282-018-0849-5; Kellar A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621324; Kim DW, 2018, TRANSL LUNG CANCER R, V7, P4, DOI 10.21037/tlcr.2017.10.07; Kim HJ, 2004, CANCER RES, V64, P2439, DOI 10.1158/0008-5472.CAN-03-2643; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Li D, 2016, ONCOTARGET, V7, P66032, DOI 10.18632/oncotarget.11797; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Merkel O, 2017, MUTAT RES-REV MUTAT, V773, P1, DOI 10.1016/j.mrrev.2017.02.003; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Shen JJ, 2018, CANCER RES, V78, P359, DOI 10.1158/0008-5472.CAN-17-1805; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Smith BN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020017; Wu SG, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0777-1; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Xu GP, 2013, BIOCHEM BIOPH RES CO, V432, P425, DOI 10.1016/j.bbrc.2013.01.132; Yu M, 1997, P NATL ACAD SCI USA, V94, P7406, DOI 10.1073/pnas.94.14.7406; Zhao KL, 2018, EMBO REP, V19, P305, DOI 10.15252/embr.201744465	25	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11900	11912		10.1096/fj.201903220R	http://dx.doi.org/10.1096/fj.201903220R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32741018	Green Accepted			2022-12-28	WOS:000558168000001
J	Tu, JY; Liu, XL; Jia, HB; Reilly, J; Yu, SS; Cai, C; Liu, F; Lv, YX; Huang, YW; Lu, ZJ; Han, SS; Jiang, T; Shu, XH; Wu, XY; Tang, ZH; Lu, QW; Liu, MG				Tu, Jiayi; Liu, Xiliang; Jia, Haibo; Reilly, James; Yu, Shanshan; Cai, Chen; Liu, Fei; Lv, Yuexia; Huang, Yuwen; Lu, Zhaojing; Han, Shanshan; Jiang, Tao; Shu, Xinhua; Wu, Xiaoyan; Tang, Zhaohui; Lu, Qunwei; Liu, Mugen			The chromatin remodeler Brg1 is required for formation and maintenance of hematopoietic stem cells	FASEB JOURNAL			English	Article						Brg1; chromatin remodeling; epigenetics; hematopoietic stem cells; Klf2a-NO signaling	ATPASE SUBUNIT; SELF-RENEWAL; NITRIC-OXIDE; BONE-MARROW; BLOOD-FLOW; ZEBRAFISH; DIFFERENTIATION; COMPLEXES; MICROENVIRONMENT; INDUCTION	Hematopoietic stem and progenitor cells (HSPCs) have the ability to self-renew and differentiate into various blood cells, thus playing an important role in maintenance of lifelong hematopoiesis. Brahma-related gene 1 (BRG1), which acts as the ATP subunit of mammalian SWI-SNF-related chromatin remodeling complexes, is involved in human acute myeloid leukemia and highly expresses in short-term HSPCs. But its role and regulatory mechanism for HSPC development have not yet been well established. Here, we generated abrg1knockout zebrafish model using TALEN technology. We found that inbrg1(-/-)embryo, the primitive hematopoiesis remained well, while definitive hematopoiesis formation was significantly impaired. The number of hemogenic endothelial cells was decreased, further affecting definitive hematopoiesis with reduced myeloid and lymphoid cells. During embryogenesis, the nitric oxide (NO) microenvironment inbrg1(-/-)embryo was seriously damaged and the reduction of HSPCs could be partially rescued by a NO donor. Chromatin immunoprecipitation (ChIP) assays showed that BRG1 could bind to the promoter ofKLF2and trigger its transcriptional activity of NO synthase. Our findings show that Brg1 promotesklf2aexpression in hemogenic endothelium and highlight a novel mechanism for HSPC formation and maintenance.	[Tu, Jiayi; Liu, Xiliang; Jia, Haibo; Yu, Shanshan; Cai, Chen; Liu, Fei; Lv, Yuexia; Huang, Yuwen; Lu, Zhaojing; Jiang, Tao; Tang, Zhaohui; Lu, Qunwei; Liu, Mugen] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China; [Reilly, James; Shu, Xinhua] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow, Lanark, Scotland; [Han, Shanshan] China Three Gorges Univ, Med Coll, Yichang, Peoples R China; [Wu, Xiaoyan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China	Huazhong University of Science & Technology; Glasgow Caledonian University; China Three Gorges University; Huazhong University of Science & Technology	Lu, QW; Liu, MG (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	luqw@mail.hust.edu.cn; lium@hust.edu.cn	jiang, tao/GWC-7108-2022; Liu, Fei/AAR-6464-2021	Liu, Fei/0000-0002-0310-1072	National Natural Science Foundation of China [81670099, 81870691, 31871260, 81770102, 81670890]; China postdoctoral Science Foundation [2019T120647]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China, Grant/Award Number: 81670099, 81870691, 31871260, 81770102 and 81670890; The China postdoctoral Science Foundation, Grant/Award Number: 2019T120647	Abraham BJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-193; Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; Asada N, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00119; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Buscarlet M, 2014, BLOOD, V123, P1720, DOI 10.1182/blood-2013-02-483495; Choudhuri A, 2017, STEM CELL REP, V8, P1465, DOI 10.1016/j.stemcr.2017.05.018; Choudry FA, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5797521; CIFANI P, 2015, BLOOD, V126; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Carrara RDV, 2018, CLIN TRANSL ONCOL, V20, P542, DOI 10.1007/s12094-017-1751-x; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Fatrai S, 2011, BLOOD, V117, P3320, DOI 10.1182/blood-2010-08-303669; Gebuhr TC, 2003, J EXP MED, V198, P1937, DOI 10.1084/jem.20030714; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Gu QL, 2019, SCIENCE, V363, P1085, DOI 10.1126/science.aav1749; Haladyna JN, 2015, EPIGENOMICS-UK, V7, P301, DOI [10.2217/EPI.14.88, 10.2217/epi.14.88]; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hu XB, 2019, AUTOPHAGY, V15, P453, DOI 10.1080/15548627.2018.1520548; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Jalnapurkar S, 2019, STEM CELLS, V37, P128, DOI 10.1002/stem.2912; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kanz D, 2016, ANN NY ACAD SCI, V1370, P97, DOI 10.1111/nyas.13030; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Koide S, 2015, EXP HEMATOL, V43, pS73, DOI 10.1016/j.exphem.2015.06.164; Konantz M, 2016, EMBO J, V35, P2315, DOI 10.15252/embj.201593454; Lim SE, 2017, EXP HEMATOL, V46, P83, DOI 10.1016/j.exphem.2016.10.002; Liu F, 2017, J BIOL CHEM, V292, P6225, DOI 10.1074/jbc.M116.760314; Liu LL, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0567-7; Lizama CO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8739; Lu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46098; Lucas D, 2017, ADV EXP MED BIOL, V1041, P5, DOI 10.1007/978-3-319-69194-7_2; Michurina T, 2004, MOL THER, V10, P241, DOI 10.1016/j.ymthe.2004.05.030; Moore FE, 2016, J EXP MED, V213, P979, DOI 10.1084/jem.20152013; North TE, 2008, BLOOD, V112, P270; O'Donnell RK, 2016, CANCER RES, V76, P517, DOI 10.1158/0008-5472.CAN-14-3023; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ruzicka L, 2015, GENESIS, V53, P498, DOI 10.1002/dvg.22868; Sarkaria SM, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700190; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Sena JA, 2013, MOL CELL BIOL, V33, P3849, DOI 10.1128/MCB.00731-13; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Theodore LN, 2017, STEM CELL REP, V8, P1226, DOI 10.1016/j.stemcr.2017.03.016; Tiwari A, 2016, STEM CELLS DEV, V25, P1604, DOI 10.1089/scd.2016.0153; Van de Walle I, 2011, BLOOD, V117, P4449, DOI 10.1182/blood-2010-06-290049; Vradii D, 2006, J CELL PHYSIOL, V206, P112, DOI 10.1002/jcp.20432; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; Wei YL, 2014, BLOOD, V124, P1578, DOI 10.1182/blood-2013-11-541391; Witzel M, 2017, NAT GENET, V49, P742, DOI 10.1038/ng.3833; Wolfe RP, 2013, BIOTECHNOL BIOENG, V110, P1231, DOI 10.1002/bit.24782; Wu Q, 2017, EPIGENOMICS-UK, V9, P919, DOI 10.2217/epi-2017-0034; Xue YY, 2017, DEV CELL, V42, P349, DOI 10.1016/j.devcel.2017.07.012; Yu SS, 2019, BLOOD, V133, P805, DOI 10.1182/blood-2018-09-876599; Yu SS, 2017, HUM MOL GENET, V26, P2335, DOI 10.1093/hmg/ddx137; Zhang CX, 2013, BBA-GEN SUBJECTS, V1830, P2370, DOI 10.1016/j.bbagen.2012.06.008; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang YF, 2018, TRENDS CELL BIOL, V28, P976, DOI 10.1016/j.tcb.2018.06.001	59	4	4	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11997	12008		10.1096/fj.201903168RR	http://dx.doi.org/10.1096/fj.201903168RR		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738093				2022-12-28	WOS:000560233000001
J	Zhou, QQ; Shi, YT; Qi, H; Liu, HJ; Wei, NN; Jiang, Y; Wang, KW				Zhou, Qiqi; Shi, Yuntao; Qi, Hang; Liu, Huijie; Wei, Ningning; Jiang, Yong; Wang, KeWei			Identification of two natural coumarin enantiomers for selective inhibition of TRPV2 channels	FASEB JOURNAL			English	Article						brown adipocytes; differentiation; murraxocin; TRPV2 channel	BROWN ADIPOSE-TISSUE; ACTIVATION; DIFFERENTIATION; THERMOGENESIS; EXPRESSION; LIGAND; MICE	Thermosensitive transient receptor potential vanilloid 2 (thermoTRPV2) is a nonselective Ca2+-permeable cation channel broadly expressed, and is implicated in the pathology of diseases such as diabetes and pancreatitis. However, the physiological and pharmacological functions of TRPV2 channels have not been extensively investigated because of the absence of specific modulators. In this study, we report a pair of natural coumarin derivative enantiomers (-)-murraxocin (B304-1) and (+)-murraxocin (B304-2) fromMurraya exoticafor their selective inhibition of TRPV2 channels expressed in HEK293 cells and native TRPV2 currents in differentiated brown adipocytes. Whole-cell patch clamp recordings confirmed the enantiomers B304-1 and B304-2 could selectively inhibit the agonist mediated activation of TRPV2 current with IC(50)values of 22.2 +/- 7.8 mu M and 3.7 +/- 0.7 mu M, respectively. Molecular docking and site-directed mutagenesis revealed a key residue I600 of TRPV2 critical for the binding of the enantiomers. Furthermore, B304-1 and B304-2 significantly reversed TRPV2 agonist-induced inhibition of mouse brown adipocyte differentiation. Taken together, our identification of two natural coumarin enantiomers provides valuable tools and chemical leads for further elucidation of TRPV2 channel function, and pharmacological modulation of thermoTRPV2 in brown adipocytes may represent a new therapeutic strategy for treatment of energy imbalance or metabolic disorders.	[Zhou, Qiqi; Qi, Hang; Liu, Huijie; Wei, Ningning; Wang, KeWei] Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao 266021, Peoples R China; [Shi, Yuntao; Jiang, Yong] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China	Qingdao University; Peking University	Wei, NN; Wang, KW (corresponding author), Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao 266021, Peoples R China.; Jiang, Y (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.	weiningning@qdu.edu.cn; yongjiang@bjmu.edu.cn; wangkw@qdu.edu.cn	Jiang, Yong/C-4026-2016	Jiang, Yong/0000-0002-8450-7786	National Natural Science Foundation of China (NSFC) [81573410]; Ministry of Science and technology China [2018ZX09711001-004-006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81573410; Ministry of Science and technology China, Grant/Award Number: 2018ZX09711001-004-006	Arechaga I, 2001, IUBMB LIFE, V52, P165, DOI 10.1080/15216540152845966; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; BARIK BR, 1987, PHYTOCHEMISTRY, V26, P3319, DOI 10.1016/S0031-9422(00)82496-6; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bishnoi M, 2018, OBES REV, V19, P1269, DOI 10.1111/obr.12703; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao X, 2012, J BIOL CHEM, V287, P25905, DOI 10.1074/jbc.M112.364869; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chai H, 2019, J MED CHEM, V62, P1373, DOI 10.1021/acs.jmedchem.8b01496; Che H, 2014, PFLUG ARCH EUR J PHY, V466, P947, DOI 10.1007/s00424-013-1355-4; Cromer BA, 2008, TOXICON, V51, P163, DOI 10.1016/j.toxicon.2007.10.012; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Darakhshan S, 2015, PHARMACOL RES, V91, P15, DOI 10.1016/j.phrs.2014.10.009; Flockerzi V., 2007, V179, P1; Fricke TC, 2019, P NATL ACAD SCI USA, V116, P24359, DOI 10.1073/pnas.1904332116; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gao W, 2017, METHODS MOL BIOL, V1566, P3, DOI 10.1007/978-1-4939-6820-6_1; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gudermann T, 2005, N-S ARCH PHARMACOL, V371, P241, DOI 10.1007/s00210-005-1029-7; Heler R, 2013, CHANNELS, V7, P74, DOI 10.4161/chan.23453; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Klement G, 2013, BIOPHYS J, V104, P798, DOI 10.1016/j.bpj.2013.01.008; Kojima I, 2014, HANDB EXP PHARMACOL, V222, P247, DOI 10.1007/978-3-642-54215-2_10; Lei L, 2013, J BIOL CHEM, V288, P10427, DOI 10.1074/jbc.M113.457291; Li WQ, 2010, MOLECULES, V15, P5831, DOI 10.3390/molecules15085831; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Munakata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19765-5; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Qin N, 2008, J NEUROSCI, V28, P6231, DOI 10.1523/JNEUROSCI.0504-08.2008; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reddy Narendra L, 2014, BMC Obes, V1, P13, DOI 10.1186/s40608-014-0013-5; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rychkov G., 2007, V179, P23; Sharma R, 2006, PHYTOTHER RES, V20, P607, DOI 10.1002/ptr.1909; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Stokes AJ, 2005, J CELL BIOCHEM, V94, P669, DOI 10.1002/jcb.20331; Stokes AJ, 2004, J EXP MED, V200, P137, DOI 10.1084/jem.20032082; Sugio S, 2017, FASEB J, V31, P1368, DOI 10.1096/fj.201600686RR; Sun WP, 2017, CELL BIOL INT, V41, P908, DOI 10.1002/cbin.10783; Sun WP, 2017, CHANNELS, V11, P94, DOI 10.1080/19336950.2016.1228401; Sun WP, 2016, PFLUG ARCH EUR J PHY, V468, P1527, DOI 10.1007/s00424-016-1846-1; Sun WP, 2016, EMBO REP, V17, P383, DOI 10.15252/embr.201540819; Tang Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0041-2; Tian You-Qing, 2008, Zhongguo Zhong Yao Za Zhi, V33, P339; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Warwick CA, 2019, PAIN, V160, P702, DOI 10.1097/j.pain.0000000000001449; Wei NN, 2016, J BIOL CHEM, V291, P640, DOI 10.1074/jbc.M115.654392; Yang J S, 1983, Yao Xue Xue Bao, V18, P760; Zhang XL, 2018, NAT STRUCT MOL BIOL, V25, P1009, DOI 10.1038/s41594-018-0148-z; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	58	8	9	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12338	12353		10.1096/fj.201901541RRR	http://dx.doi.org/10.1096/fj.201901541RRR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729134	hybrid			2022-12-28	WOS:000556784300001
J	Shao, L; Jiang, GT; Yang, XL; Zeng, ML; Cheng, JJ; Kong, S; Dong, X; Chen, TX; Han, S; Yin, J; Liu, WH; He, XH; He, CJ; Peng, BW				Shao, Lin; Jiang, Guang-tong; Yang, Xing-liang; Zeng, Meng-liu; Cheng, Jing-jing; Kong, Shuo; Dong, Xin; Chen, Tao-xiang; Han, Song; Yin, Jun; Liu, Wan-hong; He, Xiao-hua; He, Chunjiang; Peng, Bi-wen			Silencing of circIgf1r plays a protective role in neuronal injury via regulating astrocyte polarization during epilepsy	FASEB JOURNAL			English	Article						astrocyte; circRNA; epilepsy; neuronal damage	CIRCULAR RNAS; REACTIVE ASTROCYTES; SEIZURE ACTIVITY; ACTIVATION; NEURODEGENERATION; 4-AMINOPYRIDINE; GLUTAMATE; BRAIN; ANTIEPILEPTOGENESIS; INFLAMMATION	Epilepsy is a common brain disorder, repeated seizures of epilepsy may lead to a series of brain pathological changes such as neuronal or glial damage. However, whether circular RNAs are involved in neuronal injury during epilepsy is not fully understood. Here, we screened circIgf1r in the status epilepticus model through circRNA sequencing, and found that it was upregulated after the status epilepticus model through QPCR analysis. Astrocytes polarizing toward neurotoxic A1 phenotype and neurons loss were observed after status epilepticus. Through injecting circIgf1r siRNA into the lateral ventricle, it was found that knocking down circIgf1r in vivo would induce the polarization of astrocytes to phenotype A2 and reduce neuronal loss. The results in vitro further confirmed that inhibiting the expression of circIgf1r in astrocytes could protect neurons by converting reactive astrocytes from A1 to the protective A2. In addition, knocking down circIgf1r in astrocytes could functionally promote astrocyte autophagy and relieve the destruction of 4-AP-induced autophagy flux. In terms of mechanism, circIgf1r promoted the polarization of astrocytes to phenotype A1 by inhibiting autophagy. Taken together, our results reveal circIgf1r may serve as a potential target for the prevention and treatment of neuron damage after epilepsy.	[Shao, Lin; Jiang, Guang-tong; Yang, Xing-liang; Zeng, Meng-liu; Cheng, Jing-jing; Kong, Shuo; Chen, Tao-xiang; He, Chunjiang; Peng, Bi-wen] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Hubei Prov Key Lab Dev Originated Dis, Donghu Rd185, Wuhan 430071, Hubei, Peoples R China; [Dong, Xin; Han, Song; Yin, Jun; He, Xiao-hua] Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan, Peoples R China; [Liu, Wan-hong] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan, Peoples R China; [He, Chunjiang] Huazhong Agr Univ, Coll Biomed & Hlth, Wuhan 430070, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Huazhong Agricultural University	Peng, BW (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Hubei Prov Key Lab Dev Originated Dis, Donghu Rd185, Wuhan 430071, Hubei, Peoples R China.; He, CJ (corresponding author), Huazhong Agr Univ, Coll Biomed & Hlth, Wuhan 430070, Peoples R China.; He, CJ (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Donghu Rd185, Wuhan 430071, Hubei, Peoples R China.	che@whu.edu.cn; pengbiwen@whu.edu.cn	He, Chunjiang/N-4316-2016	He, Chunjiang/0000-0002-4868-331X; /0000-0002-5599-6779; Han, Song/0000-0003-4659-4388				Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Danelon V, 2016, MOL CELL NEUROSCI, V75, P81, DOI 10.1016/j.mcn.2016.07.002; Dube U, 2019, NAT NEUROSCI, V22, P1903, DOI 10.1038/s41593-019-0501-5; Duncan JS, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.9_suppl_5.S15; Erlandsson MC, 2017, BBA-MOL BASIS DIS, V1863, P2158, DOI 10.1016/j.bbadis.2017.06.002; Fang W, 2015, BRAIN RES, V1602, P9, DOI 10.1016/j.brainres.2014.08.030; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Farrell JS, 2017, ADV NEUROBIOL, V15, P317, DOI 10.1007/978-3-319-57193-5_12; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Feng Z, 2020, BIOCHEM BIOPH RES CO, V522, P388, DOI 10.1016/j.bbrc.2019.11.102; Fu HW, 2019, GENE, V716, DOI 10.1016/j.gene.2019.144031; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Gao XY, 2020, J CELL MOL MED, V24, P12980, DOI 10.1111/jcmm.15894; Gong GH, 2018, CELL PHYSIOL BIOCHEM, V51, P1399, DOI 10.1159/000495589; Grimaldi M, 2001, J NEUROSCI, V21, P3135, DOI 10.1523/JNEUROSCI.21-09-03135.2001; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173; Heinemann U, 1999, Adv Neurol, V79, P583; Heuzeroth H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00677; Hiruma H, 2010, J MOL NEUROSCI, V40, P295, DOI 10.1007/s12031-009-9219-2; Holmes GL, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.9_suppl_5.S3; Huang RR, 2017, AUTOPHAGY, V13, P1722, DOI 10.1080/15548627.2017.1356975; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jiang GH, 2015, CLIN SCI, V129, P1047, DOI 10.1042/CS20150312; Jin MM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00378; Kalynchuk LE, 2002, BRAIN RES, V935, P118, DOI 10.1016/S0006-8993(02)02459-9; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Liu JT, 2018, NEUROTHERAPEUTICS, V15, P1093, DOI 10.1007/s13311-018-0653-0; Loewen JL, 2016, J NEUROPATH EXP NEUR, V75, P366, DOI 10.1093/jnen/nlw008; Lu DC, 2021, J NEUROTRAUM, V38, P1193, DOI 10.1089/neu.2011.2114; Lu YJ, 2019, NEUROSCI BULL, V35, P877, DOI 10.1007/s12264-019-00361-0; Luhmann HJ, 2000, EUR J NEUROSCI, V12, P2757, DOI 10.1046/j.1460-9568.2000.00156.x; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Naegele JR, 2007, EPILEPSIA, V48, P107, DOI 10.1111/j.1528-1167.2007.01071.x; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Pitkanen A, 2002, NEUROLOGY, V59, pS27, DOI 10.1212/WNL.59.9_suppl_5.S27; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Shao YY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00249; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; SZENTE M, 1987, BRAIN RES, V413, P368, DOI 10.1016/0006-8993(87)91031-6; TAPIA R, 1982, BRAIN RES, V250, P291, DOI 10.1016/0006-8993(82)90423-1; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Wang HQ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4971; Wang XQ, 2003, J PHARMACOL EXP THER, V305, P502, DOI 10.1124/jpet.102.045013; Wani A, 2019, AUTOPHAGY, V15, P1810, DOI 10.1080/15548627.2019.1596476; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Xu XT, 2019, J CELL PHYSIOL, V234, P904, DOI 10.1002/jcp.26918; Xu ZY, 2020, THORAC CANCER, V11, P875, DOI 10.1111/1759-7714.13329; YAMAGUCHI S, 1992, EPILEPSY RES, V11, P9, DOI 10.1016/0920-1211(92)90016-M; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	69	14	14	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21330	10.1096/fj.202001737RR	http://dx.doi.org/10.1096/fj.202001737RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417289				2022-12-28	WOS:000647789600010
J	Chakraborty, S; Sinha, S; Sengupta, A				Chakraborty, Sayan; Sinha, Sayantani; Sengupta, Amitava			Emerging trends in chromatin remodeler plasticity in mesenchymal stromal cell function	FASEB JOURNAL			English	Review						cell differentiation; chromatin remodeling; epigenetics; gene regulation; hematopoiesis; inflammation; innate immunity; mesenchymal stem cells (MSCs); tumor microenvironment	HEMATOPOIETIC STEM-CELL; PROMOTES OSTEOGENIC DIFFERENTIATION; ESET HISTONE METHYLTRANSFERASE; MAINTAIN SELF-RENEWAL; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; BONE-MARROW; DNA METHYLATION; OSTEOBLAST DIFFERENTIATION; INDOLEAMINE 2,3-DIOXYGENASE	Emerging evidences highlight importance of epigenetic regulation and their integration with transcriptional and cell signaling machinery in determining tissue resident adult pluripotent mesenchymal stem/stromal cell (MSC) activity, lineage commitment, and multicellular development. Histone modifying enzymes and large multi-subunit chromatin remodeling complexes and their cell type-specific plasticity remain the central defining features of gene regulation and establishment of tissue identity. Modulation of transcription factor expression gradient ex vivo and concomitant flexibility of higher order chromatin architecture in response to signaling cues are exciting approaches to regulate MSC activity and tissue rejuvenation. Being an important constituent of the adult bone marrow microenvironment/niche, pathophysiological perturbation in MSC homeostasis also causes impaired hematopoietic stem/progenitor cell function in a non-cell autonomous mechanism. In addition, pluripotent MSCs can function as immune regulatory cells, and they reside at the crossroad of innate and adaptive immune response pathways. Research in the past few years suggest that MSCs/stromal fibroblasts significantly contribute to the establishment of immunosuppressive microenvironment in shaping antitumor immunity. Therefore, it is important to understand mesenchymal stromal epigenome and transcriptional regulation to leverage its applications in regenerative medicine, epigenetic memory-guided trained immunity, immune-metabolic rewiring, and precision immune reprogramming. In this review, we highlight the latest developments and prospects in chromatin biology in determining MSC function in the context of lineage commitment and immunomodulation.	[Chakraborty, Sayan; Sinha, Sayantani; Sengupta, Amitava] CSIR Indian Inst Chem Biol, Stem Cell & Leukemia Lab, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India; [Chakraborty, Sayan; Sinha, Sayantani; Sengupta, Amitava] Translat Res Unit Excellence TRUE, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Sengupta, A (corresponding author), CSIR Indian Inst Chem Biol, Stem Cell & Leukemia Lab, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	amitava.sengupta@iicb.res.in						Ai RZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04310-9; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Alver BH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14648; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76; Azevedo RI, 2020, STEM CELLS, V38, P1007, DOI 10.1002/stem.3185; Backesjo CM, 2009, CELLS TISSUES ORGANS, V189, P93, DOI 10.1159/000151744; Baumgart SJ, 2017, NUCLEIC ACIDS RES, V45, P7722, DOI 10.1093/nar/gkx377; Baylin SB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019505; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bentivegna A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5656701; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Biswas M, 2019, FASEB J, V33, P5268, DOI 10.1096/fj.201801035R; Boila LD, 2018, EXP HEMATOL, V58, P44, DOI 10.1016/j.exphem.2017.10.002; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Breiling A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0016-6; Cakouros D, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-018-0247-4; Camilleri ET, 2018, J BIOL CHEM, V293, P19001, DOI 10.1074/jbc.RA118.003909; Casado JG, 2013, STEM CELL REV REP, V9, P184, DOI 10.1007/s12015-013-9430-y; Chabannes D, 2007, BLOOD, V110, P3691, DOI 10.1182/blood-2007-02-075481; Chang KH, 2014, CELL REP, V9, P2084, DOI 10.1016/j.celrep.2014.11.031; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chatterjee SS, 2018, MOL CANCER RES, V16, P791, DOI 10.1158/1541-7786.MCR-17-0493; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chen X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.537; Chen YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25283; Chinnadurai R, 2014, J IMMUNOL, V192, P1491, DOI 10.4049/jimmunol.1301828; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Davies LC, 2017, STEM CELLS, V35, P766, DOI 10.1002/stem.2509; De Miguel MP, 2012, CURR MOL MED, V12, P574; De Witte SFH, 2018, CYTOTHERAPY, V20, P919, DOI 10.1016/j.jcyt.2018.05.005; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Derecka M, 2020, NAT IMMUNOL, V21, P261, DOI 10.1038/s41590-020-0595-7; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Djurec M, 2018, P NATL ACAD SCI USA, V115, pE1147, DOI 10.1073/pnas.1717802115; Dong R, 2013, EXP CELL RES, V319, P2874, DOI 10.1016/j.yexcr.2013.07.008; Du J, 2013, STEM CELLS, V31, P126, DOI 10.1002/stem.1255; Dudakovic A, 2020, J BIOL CHEM, V295, P7877, DOI 10.1074/jbc.RA119.011685; Dudakovic A, 2018, J BIOL CHEM, V293, P12894, DOI 10.1074/jbc.RA118.002983; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dumitru CA, 2014, FASEB J, V28, P3856, DOI 10.1096/fj.14-250159; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; El Hadidy N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215260; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fielding Claire, 2020, F1000Res, V9, DOI 10.12688/f1000research.22554.1; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Fregni G, 2018, EBIOMEDICINE, V29, P128, DOI 10.1016/j.ebiom.2018.02.017; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gao F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.327; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Giancotti Vincenzo, 2018, Int J Cell Biol, V2018, P3698078, DOI 10.1155/2018/3698078; Gonzalez YIR, 2016, CYTOTHERAPY, V18, P1114, DOI 10.1016/j.jcyt.2016.05.017; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Grandi FC, 2020, TRENDS PHARMACOL SCI, V41, P557, DOI 10.1016/j.tips.2020.05.008; Grandy R, 2011, MOL CELL BIOL, V31, P2997, DOI 10.1128/MCB.05096-11; Greenblatt SM, 2018, CANCER CELL, V34, P888, DOI 10.1016/j.ccell.2018.10.009; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109493; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hong IS, 2014, MUTAT RES-FUND MOL M, V768, P98, DOI 10.1016/j.mrfmmm.2014.01.006; Hota SK, 2016, DEVELOPMENT, V143, P2882, DOI 10.1242/dev.128892; Hu CHD, 2019, STEM CELLS DEV, V28, P933, DOI 10.1089/scd.2019.0059; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Im GI, 2013, EXPERT OPIN BIOL TH, V13, P713, DOI 10.1517/14712598.2013.764410; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Ito T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-47; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jing H, 2017, FASEB J, V31, P4422, DOI 10.1096/fj.201700118R; Jing YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043272; Jung YJ, 2016, CURR STEM CELL RES T, V11, P131, DOI 10.2174/1574888X1102160107171432; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kapoor P, 2014, TRENDS CELL BIOL, V24, P238, DOI 10.1016/j.tcb.2013.10.007; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Nguyen KH, 2015, STEM CELLS, V33, P3028, DOI 10.1002/stem.2064; Khan NM, 2018, PHARMACOL RES, V128, P73, DOI 10.1016/j.phrs.2017.08.007; Khani F, 2017, J CELL BIOCHEM, V118, P1262, DOI 10.1002/jcb.25787; Khosravi M, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0991-1; Khosravi M, 2018, IMMUNOL RES, V66, P207, DOI 10.1007/s12026-017-8973-4; Kim KW, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0948-4; Kim SH, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-019-1531-3; Kornicka K, 2017, J CELL MOL MED, V21, P387, DOI 10.1111/jcmm.12972; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krosl J, 2010, BLOOD, V116, P1678, DOI 10.1182/blood-2010-03-273862; Kumar A, 2011, CELL PROLIFERAT, V44, P128, DOI 10.1111/j.1365-2184.2010.00735.x; Lawson KA, 2013, FEBS LETT, V587, P3961, DOI 10.1016/j.febslet.2013.10.028; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08020; Lee YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106661; Li B, 2018, BONE, V111, P82, DOI 10.1016/j.bone.2018.03.017; Li GJ, 2019, J CELL PHYSIOL, V234, P23485, DOI 10.1002/jcp.28917; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li R, 2018, STEM CELL REP, V10, P166, DOI 10.1016/j.stemcr.2017.11.019; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Lim J, 2017, INT J MOL MED, V40, P739, DOI 10.3892/ijmm.2017.3053; Linares JF, 2017, CELL METAB, V26, P817, DOI 10.1016/j.cmet.2017.09.001; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Liu K, 2017, CARBOHYD POLYM, V175, P721, DOI 10.1016/j.carbpol.2017.08.041; Liu SY, 2015, CELL METAB, V22, P606, DOI 10.1016/j.cmet.2015.08.018; Liu Y, 2011, J BIOL CHEM, V286, P25007, DOI 10.1074/jbc.M110.213108; Loh C, 2019, ANN RHEUM DIS, V78, P1205, DOI 10.1136/annrheumdis-2018-214783; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Ma X, 2019, DIABETES, V68, P871, DOI 10.2337/dbi18-0057; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mashtalir N, 2018, CELL, V175, P1272, DOI 10.1016/j.cell.2018.09.032; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Najar M, 2019, INFLAMM RES, V68, P203, DOI 10.1007/s00011-018-1205-0; Nakahara F, 2019, NAT CELL BIOL, V21, P560, DOI 10.1038/s41556-019-0308-3; Nasef A, 2007, GENE EXPRESSION, V13, P217; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Okuno Y, 2013, DIABETES, V62, P1426, DOI 10.2337/db12-0628; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Ozkul Y, 2016, J CELL PHYSIOL, V231, P2393, DOI 10.1002/jcp.25371; Pan J, 2019, NAT GENET, V51, P618, DOI 10.1038/s41588-019-0363-5; Perez-Campo FM, 2015, CURR GENOMICS, V16, P368, DOI 10.2174/1389202916666150817202559; Philipp D, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1039-2; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pittenger MF, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0083-6; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poggi A, 2005, J IMMUNOL, V175, P6352, DOI 10.4049/jimmunol.175.10.6352; Poggi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00262; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Pure E, 2016, CANCER IMMUNOL RES, V4, P269, DOI 10.1158/2326-6066.CIR-16-0011; Qu P, 2016, STEM CELLS, V34, P1934, DOI 10.1002/stem.2365; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Rauch A, 2019, NAT GENET, V51, P716, DOI 10.1038/s41588-019-0359-1; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Rimando MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37371; Rodova M, 2011, J BONE MINER RES, V26, P1974, DOI 10.1002/jbmr.397; Rojas A, 2015, J BIOL CHEM, V290, P28329, DOI 10.1074/jbc.M115.657825; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Seike M, 2018, GENE DEV, V32, P359, DOI 10.1101/gad.311068.117; Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090; Sengupta A, 2012, BLOOD, V119, P494, DOI 10.1182/blood-2011-06-359232; Sengupta A, 2011, P NATL ACAD SCI USA, V108, P9957, DOI 10.1073/pnas.1103132108; Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122; Shen WC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10197-x; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Shi YF, 2018, NAT REV NEPHROL, V14, P493, DOI 10.1038/s41581-018-0023-5; Siddiqi S, 2010, CURR STEM CELL RES T, V5, P63, DOI 10.2174/157488810790442859; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Singh SA, 2019, ELIFE, V8, DOI 10.7554/eLife.40364; Sinha KM, 2014, J BONE MINER RES, V29, P855, DOI 10.1002/jbmr.2103; Sinha S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107570; Sinha S, 2018, EXP HEMATOL, V62, P39, DOI 10.1016/j.exphem.2018.03.005; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stachecka J, 2020, BIOCHEM BIOPH RES CO, V522, P811, DOI 10.1016/j.bbrc.2019.11.175; Sui BD, 2020, TRENDS CELL BIOL, V30, P97, DOI 10.1016/j.tcb.2019.11.006; Sun FY, 2013, J BONE MINER RES, V28, P1950, DOI 10.1002/jbmr.1932; Sun HL, 2014, STEM CELLS, V32, P1943, DOI 10.1002/stem.1671; Sun J, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0015-x; Sun Z, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-14; Takada I, 2012, PPAR RES, V2012, DOI 10.1155/2012/607141; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Teklemariam T, 2014, BIOCHEM BIOPH RES CO, V452, P753, DOI 10.1016/j.bbrc.2014.08.152; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Teven CM, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/201371; Thaler R, 2011, J BIOL CHEM, V286, P5578, DOI 10.1074/jbc.M110.166181; Tran N, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00341-20; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; van de Peppel J, 2017, STEM CELL REP, V8, P947, DOI 10.1016/j.stemcr.2017.02.018; Vella S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29504-5; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang LJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006522; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wang Y, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0624-1; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xu FH, 2012, J BIOL CHEM, V287, P5033, DOI 10.1074/jbc.M111.279968; Xu X, 2018, BONE RES, V6, DOI 10.1038/s41413-017-0005-4; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yang JP, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/270428; Yang L, 2013, DEV BIOL, V380, P99, DOI 10.1016/j.ydbio.2013.04.031; Yang RL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04464-6; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Yang XS, 2016, MOL ENDOCRINOL, V30, P677, DOI 10.1210/me.2015-1135; Ye L, 2012, CELL STEM CELL, V11, P50, DOI 10.1016/j.stem.2012.04.009; Yin B, 2019, STEM CELLS, V37, P115, DOI 10.1002/stem.2918; Ying J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131816; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yoon DS, 2014, STEM CELLS, V32, P3219, DOI 10.1002/stem.1811; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Yu TT, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2025-z; Yu VWC, 2016, CURR TOP DEV BIOL, V118, P21, DOI 10.1016/bs.ctdb.2016.01.009; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zhang P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10323-z; Zhang P, 2016, STEM CELLS, V34, P2332, DOI 10.1002/stem.2424; Zhang R, 2016, STEM CELLS, V34, P1273, DOI 10.1002/stem.2288; Zhang RP, 2011, J BIOL CHEM, V286, P41083, DOI 10.1074/jbc.M111.258715; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang ZX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64873-w; Zhou CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35924; Zhou CC, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.33; Zhu L, 2013, BIOCHEM BIOPH RES CO, V432, P612, DOI 10.1016/j.bbrc.2013.02.036; Zhu XX, 2016, ONCOTARGET, V7, P63561, DOI 10.18632/oncotarget.11538; Zimmermann JA, 2017, STEM CELL TRANSL MED, V6, P223, DOI 10.5966/sctm.2016-0044	237	5	5	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21234	10.1096/fj.202002232R	http://dx.doi.org/10.1096/fj.202002232R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337557				2022-12-28	WOS:000605626600027
J	Faruqu, FN; Liam-Or, R; Zhou, S; Nip, R; Al-Jamal, KT				Faruqu, Farid N.; Liam-Or, Revadee; Zhou, Shuai; Nip, Rebecca; Al-Jamal, Khuloud T.			Defined serum-free three-dimensional culture of umbilical cord-derived mesenchymal stem cells yields exosomes that promote fibroblast proliferation and migration in vitro	FASEB JOURNAL			English	Article						Aggrewell plates; fibroblasts; platelet lysate; proliferation; wound healing	FETAL BOVINE SERUM; HEPATOCYTE GROWTH-FACTOR; EXTRACELLULAR VESICLES; OSTEOGENIC DIFFERENTIATION; DERMAL FIBROBLASTS; CONDITIONED MEDIUM; SPHEROID CULTURE; STROMAL CELLS; ALTERNATIVES; ANGIOGENESIS	Stem cell-derived exosomes are emerging as novel and clinically relevant cell-free therapeutics for regenerative therapy. This work focused on investigating the stimulation of fibroblasts by exosomes derived from umbilical cord-derived mesenchymal stem cells (ucMSC) in a defined serum-free three-dimensional (3D) culture. 3D culture of ucMSC was carried out in medium supplemented with KnockOut serum replacement (KO-medium) using the Aggrewell system. ucMSC in KO-medium formed spheroids with maintained size and integrity throughout culture. This enabled the isolation of vesicles from ucMSC spheroids in KO-medium with sizes that fall within the exosomal size range and were positive for the expression of canonical exosomal markers CD63, CD9, CD81, Alix, and TSG101. The ucMSC-derived exosomes (Exo(ucMSC)) were shown to significantly increase the migration and proliferation of murine fibroblasts in vitro. To conclude, 3D culture of ucMSC in defined serum-free KO-medium formed viable spheroids which enabled the isolation of Exo(ucMSC) with the potential of accelerating wound healing.	[Faruqu, Farid N.; Liam-Or, Revadee; Zhou, Shuai; Nip, Rebecca; Al-Jamal, Khuloud T.] Kings Coll London, Inst Pharmaceut Sci, Room 5-67,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England	University of London; King's College London	Al-Jamal, KT (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Room 5-67,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	khuloud.al-jamal@kcl.ac.uk	Al-Jamal, Khuloud/ABD-5668-2021; Faruqu, Farid Nazer/AAO-4364-2020	Faruqu, Farid Nazer/0000-0001-5718-0039; AL-JAMAL, KHULOUD/0000-0001-5165-2699	Wellcome Trust [WT103913] Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Bainbridge P, 2013, J WOUND CARE, V22, P407; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blackford SJI, 2019, STEM CELL TRANSL MED, V8, P124, DOI 10.1002/sctm.18-0084; Blak AA, 2011, MOL THER, V19, pS330; Borger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450; Casado-Diaz A, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00146; Cesarz Z, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9176357; Chang YH, 2018, TZU CHI MED J, V30, P71, DOI 10.4103/tcmj.tcmj_23_18; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cooper DR, 2018, ADV WOUND CARE, V7, P299, DOI 10.1089/wound.2017.0775; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Deng MW, 2020, PHOTOCH PHOTOBIO SCI, V19, P406, DOI 10.1039/c9pp00421a; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang S, 2016, STEM CELL TRANSL MED, V5, P1425, DOI 10.5966/sctm.2015-0367; Faruqu FN, 2020, FASEB BIOADV, V2, P419, DOI 10.1096/fba.2020-00025; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haraszti RA, 2018, MOL THER, V26, P2838, DOI 10.1016/j.ymthe.2018.09.015; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; Jarmalaviciute A, 2015, CYTOTHERAPY, V17, P932, DOI 10.1016/j.jcyt.2014.07.013; Kim MS, 2016, NANOMED-NANOTECHNOL, V12, P655, DOI 10.1016/j.nano.2015.10.012; Kusuma GD, 2017, STEM CELLS DEV, V26, P617, DOI 10.1089/scd.2016.0349; Lai RC, 2011, METHODS MOL BIOL, V698, P141, DOI 10.1007/978-1-60761-999-4_11; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lee JH, 2016, BIOMOL THER, V24, P260, DOI 10.4062/biomolther.2015.146; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Li X, 2016, EBIOMEDICINE, V8, P72, DOI 10.1016/j.ebiom.2016.04.030; Li Y, 2015, CELL TISSUE RES, V360, P297, DOI 10.1007/s00441-014-2055-x; Ma J, 2017, STEM CELL TRANSL MED, V6, P51, DOI 10.5966/sctm.2016-0038; Mahaweni NM, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22492; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Marote A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00231; Masamune A, 2018, BIOCHEM BIOPH RES CO, V495, P71, DOI 10.1016/j.bbrc.2017.10.141; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Monguio-Tortajada M, 2017, THERANOSTICS, V7, P270, DOI 10.7150/thno.16154; Mou S, 2009, KAOHSIUNG J MED SCI, V25, P577, DOI 10.1016/S1607-551X(09)70560-1; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Pal R, 2009, J TISSUE ENG REGEN M, V3, P163, DOI 10.1002/term.143; Petrova A, 2020, J INVEST DERMATOL, V140, P121, DOI 10.1016/j.jid.2019.05.031; Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Price P, 1998, EMBRYONIC STEM CELL, Patent No. WO98/30679; Randle WL, 2007, TISSUE ENG, V13, P2957, DOI 10.1089/ten.2007.0072; Ranzato E, 2009, J CELL MOL MED, V13, P2030, DOI 10.1111/j.1582-4934.2008.00467.x; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rauch C, 2011, ALTEX-ALTERN ANIM EX, V28, P305, DOI 10.14573/altex.2011.4.305; Razian G, 2013, JOVE-J VIS EXP, DOI 10.3791/50665; Schievenbusch S, 2009, BIOCHEM BIOPH RES CO, V385, P55, DOI 10.1016/j.bbrc.2009.05.010; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Sherman AB, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0577-3; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Torreggiani E, 2014, EUR CELLS MATER, V28, P137, DOI 10.22203/eCM.v028a11; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Wang JY, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/6091269; Wang L, 2017, MICROCHIM ACTA, V7, P1; Wang LX, 2019, ACS OMEGA, V4, P22638, DOI 10.1021/acsomega.9b03561; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Witzeneder K, 2013, TRANSFUS MED HEMOTH, V40, P417, DOI 10.1159/000356236; Yan LT, 2020, CELL BIOL TOXICOL, V36, P165, DOI 10.1007/s10565-019-09504-5; Yan YM, 2017, MOL THER, V25, P465, DOI 10.1016/j.ymthe.2016.11.019; Yin F, 2019, WORLD J STEM CELLS, V11, P548, DOI 10.4252/wjsc.v11.i8.548; Yin SQ, 2019, AM J TRANSL RES, V11, P1230; Yu A, 2012, J BIOMAT SCI-POLYM E, V23, P1315, DOI 10.1163/092050611X580463; Zhang B, 2015, STEM CELLS, V33, P2158, DOI 10.1002/stem.1771; Zhang J, 2009, J TISSUE ENG REGEN M, V3, P63, DOI 10.1002/term.135; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhao YY, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/761643; Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o; Zhou PP, 2017, BIOCHEM BIOPH RES CO, V491, P323, DOI 10.1016/j.bbrc.2017.07.102; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194	73	9	9	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21206	10.1096/fj.202001768RR	http://dx.doi.org/10.1096/fj.202001768RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368666	Green Published			2022-12-28	WOS:000605626600006
J	Sun, MN; Gao, JL; Meng, T; Liu, SH; Chen, HY; Liu, Q; Xing, XS; Zhao, CY; Luo, Y				Sun, Manni; Gao, Jinlan; Meng, Tao; Liu, Shenghuan; Chen, Haiying; Liu, Qi; Xing, Xuesha; Zhao, Chenyang; Luo, Yang			Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible role in preeclampsia	FASEB JOURNAL			English	Article						CCNG2; Dvl2; RNF123; trophoblast; Wnt; PCP signaling	E3 UBIQUITIN LIGASE; BETA-CATENIN; C-JUN; EXPRESSION; PROTEIN; KINASE; CANCER; PHOSPHORYLATION; PROGRESSION; RESISTANCE	Disruption of extravillous trophoblast (EVT) migration and invasion is considered to be responsible for pathological placentation in preeclampsia (PE). Cyclin G2 (CCNG2) is an atypical cyclin that inhibits cell cycle progression. However, its biological function and underlying molecular mechanism in PE are poorly understood. In this study, clinical data demonstrated that CCNG2 was significantly upregulated in PE placenta and associated with invasive EVT dysfunction. Additionally, Ccng2 knockout led to an attenuation of PE-like symptoms in the PE mouse model produced via treatment with NG-nitro-L-arginine methyl ester (L-NAME). In vitro, CCNG2 inhibited the migration, invasion, and endothelial-like network formation of human trophoblast cell line HTR8/SVneo. Mechanically, CCNG2 suppressed JNK-dependent Wnt/PCP signaling and its downstream indicators including epithelial-to-mesenchymal transition (EMT) markers and matrix metalloproteinases (MMPs) via promoting the polyubiquitination degradation of dishevelled 2 (Dvl2) protein in HTR8/SVneo cells. We also discovered that the E3 ligase Ring finger protein 123 (RNF123), as a novel CCNG2 target among HTR8/SVneo cells, interacted with Dvl2 and participated in CCNG2-induced polyubiquitination degradation of Dvl2. Moreover, we verified that the treatment of HTR8/SVneo cells with RNF123-specific siRNA improved polyubiquitination-induced degradation of Dvl2 and the activity of Wnt/PCP-JNK signaling mediated by CCNG2. Taken together, our results reveal that the CCNG2/RNF123/Dvl2/JNK axis may be involved in the pathogenesis and progression of PE through trophoblastic cell function modulation, thus probably providing us with new therapeutic strategies for PE treatment.	[Sun, Manni; Gao, Jinlan; Liu, Shenghuan; Liu, Qi; Xing, Xuesha; Zhao, Chenyang; Luo, Yang] China Med Univ, Sch Life Sci, Res Ctr Med Genom, Key Lab Med Cell Biol,Minist Educ, Shenyang 110000, Liaoning, Peoples R China; [Meng, Tao; Chen, Haiying] China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang, Peoples R China	China Medical University; China Medical University	Luo, Y (corresponding author), China Med Univ, Sch Life Sci, Res Ctr Med Genom, Key Lab Med Cell Biol,Minist Educ, Shenyang 110000, Liaoning, Peoples R China.	yluo@cmu.edu.cn		sun, manni/0000-0001-5823-6225	Foundation of Liaoning Educational Committee [LZDK201703, JC2019031]; National Natural Science Foundation of China [81871173]	Foundation of Liaoning Educational Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially granted by the Foundation of Liaoning Educational Committee (contract grant numbers: LZDK201703 to Yang Luo and JC2019031 to Jinlan Gao) and the National Natural Science Foundation of China (contract grant numbers: 81871173 to Tao Meng).	Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; [Anonymous], OBSTET GYNECOL, V133, P211; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Burton GJ, 2017, PLACENTA, V56, P14, DOI 10.1016/j.placenta.2017.01.130; Chaturvedi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047558; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Ding XY, 2015, PLACENTA, V36, P1442, DOI 10.1016/j.placenta.2015.10.014; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Fisher RP, 1997, CURR OPIN GENET DEV, V7, P32, DOI 10.1016/S0959-437X(97)80106-2; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao JL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0973-2; Gates KC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174976; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Helmbrecht GD, 1996, AM J OBSTET GYNECOL, V175, P800, DOI 10.1016/S0002-9378(96)80002-0; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kafka A, 2014, CROAT MED J, V55, P459, DOI 10.3325/cmj.2014.55.459; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kasten M, 2001, ONCOGENE, V20, P1832, DOI 10.1038/sj.onc.1204295; Khanna R, 2018, FEBS J, V285, P2243, DOI 10.1111/febs.14477; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Lee HJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08142; Lee H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143107; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Li S, 2019, INT J BIOL SCI, V15, P544, DOI 10.7150/ijbs.30297; Li XJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1741, DOI 10.1159/000485780; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin SS, 2018, CANCERS, V10, DOI 10.3390/cancers10080272; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Monaghan D, 2014, BIOCHEM BIOPH RES CO, V443, P761, DOI 10.1016/j.bbrc.2013.12.041; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motta C, 2015, REPROD DOMEST ANIM, V50, P611, DOI 10.1111/rda.12536; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; Musa J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12071-2; Nadeem U, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119065; Naito Y, 2013, CELL CYCLE, V12, P1773, DOI 10.4161/cc.24878; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Peng B, 2015, ENDOCRINOLOGY, V156, P2269, DOI 10.1210/en.2014-1871; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Roskoski R, 2019, PHARMACOL RES, V139, P471, DOI 10.1016/j.phrs.2018.11.035; Ruan C, 2021, AUTOPHAGY, V17, P1426, DOI 10.1080/15548627.2020.1763019; Salem M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081810; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Sharma M, 2018, CELL SIGNAL, V47, P52, DOI 10.1016/j.cellsig.2018.03.004; Shi XY, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20194513; Shiozawa S, 2009, CELL CYCLE, V8, P1539, DOI 10.4161/cc.8.10.8411; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Thacker G, 2020, J CELL BIOCHEM, V121, P2839, DOI 10.1002/jcb.29516; Ujita M, 2018, PREGNANCY HYPERTENS, V13, P225, DOI 10.1016/j.preghy.2018.06.022; Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vilotic A, 2019, EXCLI J, V18, P1007, DOI 10.17179/excli2019-1630; Wald JH, 2017, ONCOGENE, V36, P5158, DOI 10.1038/onc.2017.126; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Weitzman Jonathan B, 2005, J Biol, V4, P1, DOI 10.1186/jbiol21; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yue LM, 2005, ENDOCRINOLOGY, V146, P2424, DOI 10.1210/en.2004-1605; Zhang DF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00255; Zhao CY, 2020, J CELL MOL MED, V24, P2749, DOI 10.1111/jcmm.14946; Zheng Q, 2018, J CELL BIOCHEM, V119, P6442, DOI 10.1002/jcb.26648; Zimmermann M, 2016, CELL CYCLE, V15, P3278, DOI 10.1080/15384101.2016.1243189; Zuckerwise L, 2016, ONCOTARGET, V7, P38398, DOI 10.18632/oncotarget.9534	80	1	1	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001559RR	http://dx.doi.org/10.1096/fj.202001559RR		NOV 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33205477				2022-12-28	WOS:000592661900001
J	Grisaru-Granovsky, S; Nag, JK; Zakar, L; Rudina, T; Gupta, CL; Maoz, M; Kozlova, D; Bar-Shavit, R				Grisaru-Granovsky, Sorina; Nag, Jeetendra Kumar; Zakar, Liat; Rudina, Tatyana; Gupta, Chhedi Lal; Maoz, Myriam; Kozlova, Daria; Bar-Shavit, Rachel			PAR(1&2) driven placenta EVT invasion act via LRP5/6 as coreceptors	FASEB JOURNAL			English	Article						beta&#8208; catenin; extravilous trophoblasts; G&#8208; protein copupled receptors; placenta; protease&#8208; activated receptors	PROTEASE-ACTIVATED RECEPTOR-2; EXTRAVILLOUS TROPHOBLAST INVASION; SIGNALING PATHWAY; WNT; EXPRESSION; CELL; DIFFERENTIATION; PREECLAMPSIA; ASSOCIATION; RECURRENT	While the involvement of protease-activated receptors (PARs) in the physiological regulation of human placenta development, as in tumor biology, is recognized, the molecular pathway is unknown. We evaluated the impact of PAR(1) and PAR(2) function in cytotrophoblast (CTB) proliferation and invasion in a system of extravillous trophoblast (EVT) organ culture and in human cell-lines. Activation of PAR(1)- and PAR(2)-induced EVT invasion and proliferation, while the shRNA silencing of low-density lipoprotein receptor-related protein 5/6 (LRP5/6) inhibited these processes. PAR(1) and PAR(2) effectively induce beta-catenin stabilization in a manner similar to that shown for the canonical beta-catenin stabilization pathway yet independent of Wnts. Immunoprecipitation analyses and protein-protein docking demonstrated the co-association between either PAR(1) or PAR(2) with LRP5/6 forming an axis of PAR-LRP5/6-Axin. Noticeably, in PAR(1)-PAR(2) heterodimers a dominant role is assigned to PAR(2) over PAR(1) as shown by inhibition of PAR(1)-induced beta-catenin levels, and Dvl nuclear localization. This inhibition takes place either by shRNA silenced hPar2 or in the presence of a TrPAR(2) devoid its cytoplasmic tail. Indeed, TrPAR(2) cannot form the PAR(1)-PAR(2) complex, obstructing thereby the flow of signals downstream. Elucidation of the mechanism of PAR-induced invasion contributes to therapeutic options highlighting key partners in the process.	[Grisaru-Granovsky, Sorina; Zakar, Liat; Kozlova, Daria] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel; [Nag, Jeetendra Kumar; Rudina, Tatyana; Maoz, Myriam; Bar-Shavit, Rachel] Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, POB 12000, IL-91120 Jerusalem, Israel; [Gupta, Chhedi Lal] Agr Res Org, Inst Soil Water & Environm Sci, Volcani Res Ctr, Rishon Leziyyon, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Bar-Shavit, R (corresponding author), Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, POB 12000, IL-91120 Jerusalem, Israel.	Rachelbar@ekmd.huji.ac.il	Gupta, Chhedi Lal/ABH-9176-2020	Gupta, Chhedi Lal/0000-0001-9389-299X	Israel Science Foundation (ISF) [1420/16]	Israel Science Foundation (ISF)(Israel Science Foundation)	Israel Science Foundation (ISF), Grant/Award Number: 1420/16	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Aplin JD, 2000, J REPROD FERTIL, P57; Bao SH, 2013, CLIN EXP IMMUNOL, V172, P437, DOI 10.1111/cei.12066; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Bose P, 2006, PLACENTA, V27, P869, DOI 10.1016/j.placenta.2005.09.007; Bose P, 2004, AM J OBSTET GYNECOL, V191, P2125, DOI 10.1016/j.ajog.2004.05.014; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Fritz R, 2014, INT J DEV BIOL, V58, P261, DOI 10.1387/ijdb.140011da; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grisaru-Granovsky S, 2007, AM J MED GENET A, V143A, P2557, DOI 10.1002/ajmg.a.31985; Grisaru-Granovsky S, 2015, EUR J OBSTET GYN R B, V185, P13, DOI 10.1016/j.ejogrb.2014.11.021; Grisaru-Granovsky S, 2009, J CELL PHYSIOL, V218, P512, DOI 10.1002/jcp.21625; Gu Y, 2012, PLACENTA, V33, P803, DOI 10.1016/j.placenta.2012.06.020; Gupta CL, 2016, BIOTECHNOL APPL BIOC, V63, P441, DOI 10.1002/bab.1377; Haider S, 2016, P NATL ACAD SCI USA, V113, pE7710, DOI 10.1073/pnas.1612335113; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jaber M, 2014, CELL MOL LIFE SCI, V71, P2517, DOI 10.1007/s00018-013-1498-7; Kancharla A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9853; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Lee CQE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162305; Lim KH, 1997, AM J PATHOL, V151, P1809; Nag JK, 2017, ONCOTARGET, V8, P38650, DOI 10.18632/oncotarget.16246; Nicola C, 2005, J CLIN ENDOCR METAB, V90, P4736, DOI 10.1210/jc.2005-0413; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; O'Brien PJ, 2003, AM J PATHOL, V163, P1245, DOI 10.1016/S0002-9440(10)63484-0; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Pollheimer J, 2006, AM J PATHOL, V168, P1134, DOI 10.2353/ajpath.2006.050686; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Sato Y, 2003, DEVELOPMENT, V130, P5519, DOI 10.1242/dev.00729; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Shi XL, 2004, MOL CANCER RES, V2, P395; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Taylor J, 2014, MOL REPROD DEV, V81, P42, DOI 10.1002/mrd.22279; Turm H, 2010, J BIOL CHEM, V285, P15137, DOI 10.1074/jbc.M109.072843; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Westwood M, 2017, PLACENTA, V60, P1, DOI 10.1016/j.placenta.2017.09.009; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Windsperger K, 2017, HUM REPROD, V32, P1208, DOI 10.1093/humrep/dex058; Yin YJ, 2003, ARTERIOSCL THROM VAS, V23, P940, DOI 10.1161/01.ATV.0000066878.27340.22; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang X, 2004, CLIN CANCER RES, V10, P8451, DOI 10.1158/1078-0432.CCR-04-0546; Zhang Z, 2013, REPROD SCI, V20, P981, DOI 10.1177/1933719112472740; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387	57	3	3	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15701	15717		10.1096/fj.202000306R	http://dx.doi.org/10.1096/fj.202000306R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33136328				2022-12-28	WOS:000586612200001
J	Sreekantha, S; Wang, Y; Sakurai, R; Liu, J; Rehan, VK				Sreekantha, Sreevidya; Wang, Ying; Sakurai, Reiko; Liu, Jie; Rehan, Virender K.			Maternal food restriction-induced intrauterine growth restriction in a rat model leads to sex-specific adipogenic programming	FASEB JOURNAL			English	Article						adipocytes; adipogenesis; obesity; preadipocytes; white adipose tissue	METABOLIC SYNDROME; PPAR-GAMMA; OBESITY; CHILDHOOD; DIFFERENTIATION; ASSOCIATION; MORTALITY; RISK; FAT	Intrauterine growth restriction (IUGR) leads to offspring obesity. In a maternal food restriction (MFR) during pregnancy-related IUGR rat model, bone marrow stem cells showed enhanced adipogenic programming; however, the effect of IUGR on white adipose tissue (WAT) progenitors is unknown. Here, by mRNA and functional profiling, we determined sex-specific adipogenic programming of WAT progenitors isolated from pups on the postnatal day (PND) 1 and 21. On PND1, PPAR gamma and Pref-1 expression was significantly downregulated in preadipocytes of both MFR males and females; however, at PND21, preadipocytes of MFR males showed upregulation in these genes. Even following adipogenic induction, both male and female MFR adipocytes exhibited lower PPAR gamma, ADRP, and adiponectin levels at PND1; however, at PND21 MFR male adipocytes showed an upward trend in the expression of these genes. An adipogenesis-specific RT-PCR array showed that male MFR adipocytes were programmed to exhibit stronger adipogenic propensity than females. Last, serum sex hormone and adipocyte estrogen/testosterone receptor expression profiles provide preliminary insights into the possible mechanism underlying sex-specific adipogenic programming in the IUGR offspring. In summary, IUGR programs WAT preadipocytes to greater adipogenic potential in males. Although the altered adipogenic programming following MFR was detectable at PND1, the changes were more pronounced at PND21, suggesting a potential role of postnatal nutrition in facilitating the sex-specific adipogenic programming in the IUGR offspring.	[Sreekantha, Sreevidya; Wang, Ying; Sakurai, Reiko; Liu, Jie; Rehan, Virender K.] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Dept Pediat, 1124 West Carson St, Torrance, CA 90502 USA; [Sreekantha, Sreevidya; Wang, Ying; Sakurai, Reiko; Liu, Jie; Rehan, Virender K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rehan, VK (corresponding author), Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Dept Pediat, 1124 West Carson St, Torrance, CA 90502 USA.	vrehan@lundquist.org			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HD058948, HL151769, HL152915, HL107118, HD071731, HD127237]; Tobacco-Related Disease Research Program (TRDRP) [23RT-0018, 27IP-0050, T29IR0737]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Tobacco-Related Disease Research Program (TRDRP)(University of California System)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HD058948, HL151769, HL152915, HL107118, HD071731 and HD127237; Tobacco-Related Disease Research Program (TRDRP), Grant/Award Number: 23RT-0018, 27IP-0050 and T29IR0737	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; BARKER DJP, 1986, LANCET, V1, P1077; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Cnattingius S, 2012, INT J OBESITY, V36, P1320, DOI 10.1038/ijo.2011.248; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2008, REPROD SCI, V15, P785, DOI 10.1177/1933719108318597; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Garver WS, 2013, GENES NUTR, V8, P271, DOI 10.1007/s12263-013-0339-5; Gong M, 2016, INT J OBESITY, V40, P1768, DOI 10.1038/ijo.2016.157; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; Karadag A, 2009, PEDIATR PULM, V44, P635, DOI 10.1002/ppul.21030; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Malhotra A, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00055; Martin RJ, 1998, P SOC EXP BIOL MED, V219, P200; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; Newell-Fugate AE, 2017, REPRODUCTION, V153, pR133, DOI 10.1530/REP-16-0417; Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Paek DS, 2015, REPROD SCI, V22, P207, DOI 10.1177/1933719114537712; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Puttabyatappa M, 2018, REPROD SCI, V25, P1010, DOI 10.1177/1933719117746767; Rehan VK, 2014, REPROD SCI, V21, P517, DOI 10.1177/1933719113503404; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Tarantal AF, 2014, NUTRIENTS, V6, P1725, DOI 10.3390/nu6041725; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Yee JK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-62; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	35	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16073	16085		10.1096/fj.202000985RR	http://dx.doi.org/10.1096/fj.202000985RR		OCT 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047380	Green Accepted			2022-12-28	WOS:000581168400001
J	Deng, Z; Zheng, LF; Xie, XW; Wei, HK; Peng, J				Deng, Zhao; Zheng, Liufeng; Xie, Xiaowei; Wei, Hongkui; Peng, Jian			GPA peptide enhances Nur77 expression in intestinal epithelial cells to exert a protective effect against DSS-induced colitis	FASEB JOURNAL			English	Article						GPA; inflammation; Nur77; transcriptionally activate; UC	NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; FISH SKIN GELATIN; MICROBIOTA; TRANSCRIPTION; ACTIVATION; GENE	Ulcerative colitis (UC) is a widespread inflammatory bowel disease that causes long-lasting inflammation and ulcers in the colon and rectum. In the inflamed tissue of patients with UC, the tight junctions are disrupted and large amounts of pro-inflammatory cytokines are produced, resulting in immune dysregulation. The expression of Nur77 is significantly reduced in the colon of inflammatory bowel disease, while Nur77 deficiency increases the susceptibility to DSS-induced colitis. Here, we report that Gly-Pro-Ala (GPA) peptide isolated from fish skin gelatin hydrolysate can significantly alleviate intestinal inflammation and damage caused by DSS-induced mice colitis. Besides maintaining the intestinal epithelial barrier, GPA alleviates intestinal inflammation and oxidative stress by inhibiting NF-kappa B activation. Interestingly, GPA binds to the ligand-binding domain of Nur77 and stimulates its autotranscriptional activity to enhance its expression in intestinal epithelial cells. Furthermore, GPA activates the promoter of I kappa B alpha to increase its expression, resulting in the abolishment of the NF-kappa B pathway. In contrast, the inhibitory effects of GPA on colitis are abolished inNur77(-/-)mice. Our results suggest that as a Nur77 modulator, GPA may be applied to the prevention of intestinal inflammation.	[Deng, Zhao; Zheng, Liufeng; Xie, Xiaowei; Wei, Hongkui; Peng, Jian] Huazhong Agr Univ, Dept Anim Nutr & Feed Sci, Coll Anim Sci & Technol, Wuhan 430070, Peoples R China; [Zheng, Liufeng] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Wei, Hongkui; Peng, Jian] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China	Huazhong Agricultural University; Nanchang University	Wei, HK; Peng, J (corresponding author), Huazhong Agr Univ, Dept Anim Nutr & Feed Sci, Coll Anim Sci & Technol, Wuhan 430070, Peoples R China.	weihongkui@mail.hzau.edu.cn; pengjian@mail.hzau.edu.cn	deng, zhao/AAK-6182-2021	deng, zhao/0000-0002-7025-4976	National Natural Science Foundation of China (NSFC) [31972578]; Huebi Agicultural Sciences and Technology Innovation Center [2019ABA081]; Modern Agricultural Industry Technology System [CARS-35]; Basic Scientific Research Operating Expenses of Central Universities [2662017PY017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Huebi Agicultural Sciences and Technology Innovation Center; Modern Agricultural Industry Technology System; Basic Scientific Research Operating Expenses of Central Universities	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31972578; Huebi Agicultural Sciences and Technology Innovation Center, Grant/Award Number: 2019ABA081; The Modern Agricultural Industry Technology System, Grant/Award Number: CARS-35; Basic Scientific Research Operating Expenses of Central Universities, Grant/Award Number: 2662017PY017	Banno A, 2019, AM J PATHOL, V189, P482, DOI 10.1016/j.ajpath.2018.10.002; Bashashati M, 2015, CURR DRUG TARGETS, V16, P199, DOI 10.2174/1389450116666150120104012; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Cha H, 2017, REDOX BIOL, V13, P32, DOI 10.1016/j.redox.2017.05.009; Chami B, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101333; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Crockett EK, 2017, FASEB J; Deng Z, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4964202; Deng Z, 2020, FOOD FUNCT, V11, P414, DOI [10.1039/c9fo02165e, 10.1039/C9FO02165E]; Eisenstein M, 2018, NATURE, V563, pS34, DOI 10.1038/d41586-018-07277-1; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Hamers AAJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133598; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Kang JH, 2017, FOOD FUNCT, V8, P2865, DOI [10.1039/c7fo00576h, 10.1039/C7FO00576H]; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Kurakula K, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02400-2018; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Liu G, 2018, CELL PHYSIOL BIOCHEM, V51, P441, DOI 10.1159/000495240; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Naganuma M, 2018, GASTROENTEROLOGY, V154, P935, DOI 10.1053/j.gastro.2017.11.024; Okamoto H, 2010, ARTHRITIS RHEUM-US, V62, P82, DOI 10.1002/art.25063; Olivera P, 2019, NAT REV GASTRO HEPAT, V16, P312, DOI 10.1038/s41575-019-0102-5; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Plichta DR, 2019, CELL, V178, P1041, DOI 10.1016/j.cell.2019.07.045; Schottelius AJG, 1999, INT J COLORECTAL DIS, V14, P18, DOI 10.1007/s003840050178; Siggers RH, 2011, CELL MOL LIFE SCI, V68, P3623, DOI 10.1007/s00018-011-0821-4; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wada S, 2013, J AGR FOOD CHEM, V61, P8807, DOI 10.1021/jf402515a; Wang LH, 2019, FASEB J, V33, P8935, DOI 10.1096/fj.201802769RR; Wang R, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4703253; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Wu H, 2016, J PATHOL, V238, P457, DOI 10.1002/path.4670; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zhang H, 2015, BBA-MOL BASIS DIS, V1852, P792, DOI 10.1016/j.bbadis.2014.12.023; Zhang M, 2017, FRONT IMMUNOL, V8, P1, DOI 10.3389/fimmu.2017.00942; Zheng LF, 2018, J FUNCT FOODS, V51, P104, DOI 10.1016/j.jff.2018.08.033; Zheng LF, 2018, J AGR FOOD CHEM, V66, P11601, DOI 10.1021/acs.jafc.8b02840	45	8	8	7	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15364	15378		10.1096/fj.202000391RR	http://dx.doi.org/10.1096/fj.202000391RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32978839				2022-12-28	WOS:000574542400001
J	Colson, A; Depoix, CL; Baldin, P; Hubinont, C; Sonveaux, P; Debieve, F				Colson, Arthur; Depoix, Christophe Louis; Baldin, Pamela; Hubinont, Corinne; Sonveaux, Pierre; Debieve, Frederic			Hypoxia-inducible factor 2 alpha impairs human cytotrophoblast syncytialization: New insights into placental dysfunction and fetal growth restriction	FASEB JOURNAL			English	Article						fetal growth retardation; hypoxia; placenta; preeclampsia; trophoblast	TRANSCRIPTION FACTOR; CELL-FUSION; TROPHOBLAST DIFFERENTIATION; OXIDATIVE STRESS; GENE-EXPRESSION; EARLY-ONSET; HIF-ALPHA; SYNCYTIN; OXYGEN; PREGNANCY	Insufficient remodeling of uterine arteries causes pregnancy-related diseases, including fetal growth restriction and preeclampsia. In these situations, reduced maternal blood flow in the placenta is thought to be responsible for the persistence of a low oxygen environment throughout pregnancy. We hypothesized that chronic activation of transcription factors hypoxia-inducible factors (HIFs) actively participates in placental underdevelopment, which impairs fetal growth. The computer-assisted analysis in pathological placentas revealed an increased number of HIF-2 alpha-positive nuclei in the syncytium compared to normal human placentas, while HIF-1 alpha stabilization was unchanged. Specific involvement of HIF-2 alpha was confirmed in primary human cytotrophoblasts rendered deficient forHIF1AorHIF2A. SilencingHIF2Aincreased the expression of main syncytialization markers as well as differentiation and syncytium formation. It also improved placental growth factor bioavailability. None of these changes was seen when silencingHIF1A. Conversely, the experimental induction of HIF-2 alpha expression repressed forskolin-induced differentiation in BeWo choriocarcinoma cells. Our mechanistic insights evidence that transcription factor HIF-2 alpha impairs placental function, thus suggesting its participation in fetal growth restriction and preeclampsia when placentas become chronically hypoxic. Furthermore, it suggests the possibility to develop novel molecular targeting therapies for placental dysfunction.	[Colson, Arthur; Depoix, Christophe Louis; Hubinont, Corinne; Debieve, Frederic] UCLouvain, Inst Expt & Clin Res IREC, Pole Obstet, Brussels, Belgium; [Colson, Arthur; Sonveaux, Pierre] UCLouvain, Inst Expt & Clin Res IREC, Pole Pharmacol & Therapeut, Brussels, Belgium; [Baldin, Pamela] Clin Univ St Luc, Dept Pathol, Brussels, Belgium; [Hubinont, Corinne; Debieve, Frederic] Clin Univ St Luc, Dept Obstet, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Colson, A (corresponding author), Univ Catholique Louvain UCLouvain, Inst Expt & Clin Res IREC, Pole Obstet, Ave Hippocrate 54,4th Floor Box B1-55-03, B-1200 Brussels, Belgium.	arthur.colson@uclouvain.be	Colson, Arthur/ABA-7068-2020	Colson, Arthur/0000-0002-8691-123X; depoix, christophe/0000-0003-2826-3075; Debieve, Frederic/0000-0002-8033-2245	FNRS | Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) [35512061]; Fonds De La Recherche Scientifique -FNRS (FNRS); Fetus For Life Charity; Fondation Louvain (Louvain Foundation)	FNRS | Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fonds De La Recherche Scientifique -FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fetus For Life Charity; Fondation Louvain (Louvain Foundation)	FNRS | Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA), Grant/Award Number: 35512061; Fonds De La Recherche Scientifique -FNRS (FNRS); Fetus For Life Charity; Fondation Louvain (Louvain Foundation)	Albers RE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39426-5; Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Aouache R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051496; Audette MC, 2018, SEMIN FETAL NEONAT M, V23, P119, DOI 10.1016/j.siny.2017.11.004; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Bartoszewski R, 2019, FASEB J, V33, P7929, DOI 10.1096/fj.201802650RR; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brownfoot FC, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.019; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Carnahan MN, 2013, ALCOHOL, V47, P109, DOI 10.1016/j.alcohol.2012.12.003; Chang CW, 2013, MOL HUM REPROD, V19, P745, DOI 10.1093/molehr/gat050; Chau K, 2017, J HUM HYPERTENS, V31, P782, DOI 10.1038/jhh.2017.61; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Colella M, 2018, CURR PEDIATR REV, V14, P212, DOI 10.2174/1573396314666180712114531; Courtney KD, 2018, J CLIN ONCOL, V36, P867, DOI 10.1200/JCO.2017.74.2627; Dai SY, 2004, PATHOL INT, V54, P843, DOI 10.1111/j.1440-1827.2004.01750.x; Debieve F, 2013, MOL REPROD DEV, V80, P774, DOI 10.1002/mrd.22209; Degrelle SA, 2018, METHODS MOL BIOL, V1710, P165, DOI 10.1007/978-1-4939-7498-6_13; Depoix C, 2013, MOL HUM REPROD, V19, P29, DOI 10.1093/molehr/gas042; Depoix CL, 2018, MOL HUM REPROD, V24, P211, DOI 10.1093/molehr/gax069; Depoix CL, 2016, REPROD BIOL, V16, P203, DOI 10.1016/j.repbio.2016.05.001; Deyssenroth MA, 2017, J PERINAT MED, V45, P887, DOI 10.1515/jpm-2017-0064; Dubey R, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12834; Francis JH, 2014, AUST NZ J OBSTET GYN, V54, P354, DOI 10.1111/ajo.12205; Fujii T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12685-w; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Guttmacher AE, 2014, PLACENTA, V35, P303, DOI 10.1016/j.placenta.2014.02.012; Hu CJ, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00378-2019; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jauniaux E, 2016, J GYNECOL OBST BIO R, V45, P775, DOI 10.1016/j.jgyn.2016.02.012; Jauniaux E, 2001, AM J OBSTET GYNECOL, V184, P998, DOI 10.1067/mob.2001.111935; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC; Knerr I, 2002, AM J OBSTET GYNECOL, V186, P210, DOI 10.1067/mob.2002.119636; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Lees C, 2013, ULTRASOUND OBST GYN, V42, P400, DOI 10.1002/uog.13190; Lu XY, 2016, PLACENTA, V39, P45, DOI 10.1016/j.placenta.2016.01.008; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P71; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402; Mole DR, 2002, ADV ENZYME REGUL, V42, P333, DOI 10.1016/S0065-2571(01)00037-1; Newhouse SM, 2007, PLACENTA, V28, P999, DOI 10.1016/j.placenta.2007.04.008; Pawlus MR, 2012, MOL CELL BIOL, V32, P4595, DOI 10.1128/MCB.00724-12; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Rajakumar A, 2001, BIOL REPROD, V64, P499, DOI 10.1093/biolreprod/64.2.499; Ralph GS, 2004, J CEREBR BLOOD F MET, V24, P245, DOI 10.1097/01.WCB.0000110532.48786.46; Salavati N, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01884; Sasagawa T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35745-1; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Sheridan RM, 2012, HUM PATHOL, V43, P1866, DOI 10.1016/j.humpath.2012.01.011; Sibley CP, 2017, J ENDOCRINOL, V234, pR81, DOI 10.1530/JOE-17-0185; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Stepan H, 2015, ULTRASOUND OBST GYN, V45, P241, DOI 10.1002/uog.14799; Stubert J, 2012, J PERINAT MED, V40, P475, DOI 10.1515/jpm-2011-0277; Thame M, 2004, EUR J CLIN NUTR, V58, P894, DOI 10.1038/sj.ejcn.1601909; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vayssiere C, 2015, EUR J OBSTET GYN R B, V193, P10, DOI 10.1016/j.ejogrb.2015.06.021; Wakeland AK, 2017, AM J PATHOL, V187, P767, DOI 10.1016/j.ajpath.2016.11.018; Wang R, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114892; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wich C, 2009, GYNECOL OBSTET INVES, V68, P9, DOI 10.1159/000209396	73	8	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15222	15235		10.1096/fj.202001681R	http://dx.doi.org/10.1096/fj.202001681R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954526				2022-12-28	WOS:000573903500001
J	Sun, X; Zhang, HB; Xie, LH; Qian, C; Ye, YY; Mao, HX; Wang, BY; Zhang, H; Zhang, YZ; He, XZ; Zhang, SZ				Sun, Xiang; Zhang, Hongbo; Xie, Linghai; Qian, Chen; Ye, Yongyi; Mao, Hengxu; Wang, Baoyan; Zhang, Huan; Zhang, Yizhou; He, Xiaozheng; Zhang, Shizhong			Tristetraprolin destabilizes NOX2 mRNA and protects dopaminergic neurons from oxidative damage in Parkinson's disease	FASEB JOURNAL			English	Article						apoptosis; mRNA stability; ROS	UP-REGULATION; EXPRESSION; STRESS; PROTEINS; GLIOMA; MODEL; ACTIVATION; MECHANISMS; REGULATOR; APOPTOSIS	Tristetraprolin (TTP), an RNA-binding protein encoded by the ZFP36 gene, is vital for neural differentiation; however, its involvement in neurodegenerative diseases such as Parkinson's disease (PD) remains unclear. To explore the role of TTP in PD, an in vitro 1-methyl-4-phenylpyridinium (MPP+) cell model and an in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) of PD were used. Transfection of small interfering (si)-TTP RNA upregulated pro-oxidative NOX2 expression and ROS formation, downregulated anti-oxidative GSH and SOD activity(sic)si-TTP upregulated pro-apoptotic cleaved-caspase-3 expression, and downregulated antiapoptotic Bcl-2 expression; while overexpression (OE)-TTP lentivirus caused opposite effects. Through database prediction, luciferase experiment, RNA immunoprecipitation (RIP), and mRNA stability analysis, we evaluated the potential binding sites of TTP to 3 '-untranslated regions (3 '-UTR) of NOX2 mRNA. TTP affected the NOX2 luciferase activity by binding to two sites in the NOX2 3 '-UTR. RIP-qPCR confirmed TTP binding to both sites, with a higher affinity for site-2. In addition, TTP reduced the NOX2 mRNA stability. si-NOX2 and antioxidant N-acetyl cysteine (NAC) reversed si-TTP-induced cell apoptosis. In MPTP-treated mice, TTP expression increased and was co-located with dopaminergic neurons. TTP also inhibited NOX2 and decreased the oxidative stress in vivo. In conclusion, TTP protects against dopaminergic oxidative injury by promoting NOX2 mRNA degradation in the MPP+/MPTP model of PD, suggesting that TTP could be a potential therapeutic target for regulating the oxidative stress in PD.	[Sun, Xiang; Zhang, Hongbo; Xie, Linghai; Qian, Chen; Mao, Hengxu; Wang, Baoyan; Zhang, Huan; He, Xiaozheng; Zhang, Shizhong] Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Natl Key Clin Specialty,Engn Technol Res Ctr, Educ Minist China,Dept Neurosurg,Zhujiang Hosp, 253 Ind Rd, Guangzhou 510282, Peoples R China; [Ye, Yongyi] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Guangzhou, Peoples R China; [Zhang, Yizhou] Tarbut VTorah Community Day Sch, Irvine, CA USA	Southern Medical University - China; Guangzhou Medical University	He, XZ; Zhang, SZ (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Natl Key Clin Specialty,Engn Technol Res Ctr, Educ Minist China,Dept Neurosurg,Zhujiang Hosp, 253 Ind Rd, Guangzhou 510282, Peoples R China.	hxz_smu@163.com; zhangshizhong@smu.edu.cn	毛, 珩旭/GLR-3328-2022		National Natural Science Foundation of China (NSFC) [81671240]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2016A030310384]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671240; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2016A030310384	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Alkallas R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00867-z; Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052; Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Belarbi K, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0225-5; Bollmann F, 2014, J BIOL CHEM, V289, P15653, DOI 10.1074/jbc.M114.566984; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Cargnin F, 2014, J NEUROSCI, V34, P16650, DOI 10.1523/JNEUROSCI.1650-14.2014; Castells-Roca L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148204; Cheng L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1289-z; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Dai WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8576; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Ding XM, 2019, CHEM-BIOL INTERACT, V307, P73, DOI 10.1016/j.cbi.2019.04.017; Eshelman MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50957-9; Frasca D, 2007, J IMMUNOL, V179, P918, DOI 10.4049/jimmunol.179.2.918; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Gordon R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12932; Guhathakurta S, 2017, PROG NEUROBIOL, V154, P21, DOI 10.1016/j.pneurobio.2017.04.004; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jiang LL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0573-z; Joe Y, 2015, AM J PATHOL, V185, P2867, DOI 10.1016/j.ajpath.2015.07.002; Kim YC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00013; Kuchler L, 2014, ANTIOXID REDOX SIGN, V21, P2483, DOI 10.1089/ars.2013.5760; Kuzniewska B, 2016, MOL NEUROBIOL, V53, P1478, DOI 10.1007/s12035-014-9089-7; Vo MT, 2017, ONCOTARGET, V8, P41903, DOI 10.18632/oncotarget.16706; Marchese Domenica, 2017, Nucleic Acids Res, V45, P12888, DOI 10.1093/nar/gkx1048; Matsuo R, 2017, CURR GENET, V63, P895, DOI 10.1007/s00294-017-0689-4; Park A, 2019, ARCH TOXICOL, V93, P1239, DOI 10.1007/s00204-019-02424-7; Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104; Puspita L, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0340-9; Qian C, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111614; Raut GK, 2019, FREE RADICAL BIO MED, V145, P428, DOI 10.1016/j.freeradbiomed.2019.09.020; Ross EA, 2017, ANN RHEUM DIS, V76, P612, DOI 10.1136/annrheumdis-2016-209424; Ryu J, 2015, MOL CELLS, V38, P991, DOI 10.14348/molcells.2015.0197; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Sathe K, 2012, BRAIN, V135, P3336, DOI 10.1093/brain/aws250; Savelieff MG, 2019, CHEM REV, V119, P1221, DOI 10.1021/acs.chemrev.8b00138; Saxena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12398-w; Selmi T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1388-5; Selmi T, 2012, CELL CYCLE, V11, P1977, DOI 10.4161/cc.20309; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Thalmeier A, 2008, INT J NEUROPSYCHOPH, V11, P217, DOI 10.1017/S1461145707007894; Tian FJ, 2018, MOL THER-NUCL ACIDS, V12, P600, DOI 10.1016/j.omtn.2018.07.001; Tseng YT, 2014, PHYTOMEDICINE, V21, P724, DOI 10.1016/j.phymed.2013.11.001; Wang HQ, 2016, BRAIN PATHOL, V26, P167, DOI 10.1111/bpa.12267; Wang QH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00892-y; Wang XL, 2011, AGING CELL, V10, P807, DOI 10.1111/j.1474-9726.2011.00721.x; Yan JQ, 2018, CELL PHYSIOL BIOCHEM, V51, P1957, DOI 10.1159/000495720; Yao LP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1053-4; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0821-5; Yin J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00096; Zawada WM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-129; Zeng B, 2016, INT IMMUNOPHARMACOL, V39, P63, DOI 10.1016/j.intimp.2016.07.001; Zhang DS, 2015, J PHARMACOL SCI, V127, P135, DOI 10.1016/j.jphs.2014.11.012; Zhang H, 2014, J EXP BOT, V65, P5795, DOI 10.1093/jxb/eru313; Zhong JH, 2019, FREE RADICAL BIO MED, V135, P87, DOI 10.1016/j.freeradbiomed.2019.02.027; Zhong JH, 2018, REDOX BIOL, V16, P47, DOI 10.1016/j.redox.2018.02.008	62	6	6	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15047	15061		10.1096/fj.201902967R	http://dx.doi.org/10.1096/fj.201902967R		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954540				2022-12-28	WOS:000573727300001
J	Kim, YW; Kang, Y; Kang, J; Kim, A				Kim, Yea Woon; Kang, Yujin; Kang, Jin; Kim, AeRi			GATA-1-dependent histone H3K27 acetylation mediates erythroid cell-specific chromatin interaction between CTCF sites	FASEB JOURNAL			English	Article						chromatin interaction; CTCF sites; GATA-1; human beta-globin locus	GLOBIN LOCUS; GENOME; TRANSCRIPTION; REVEALS; GENES; ROLES; BRD2; DIMERIZATION; BROMODOMAIN; EXPRESSION	CCCTC-binding factor (CTCF) sites interact with each other in the chromatin environment, establishing chromatin domains. Our previous study showed that interaction between CTCF sites is cell type-specific around the beta-globin locus and is dependent on erythroid-specific activator GATA-1. To find out molecular mechanisms of the cell type-specific interaction, we directly inhibited GATA-1 binding to the beta-globin enhancers by deleting its binding motifs and found that histone H3K27 acetylation (H3K27ac) was decreased at CTCF sites surrounding the beta-globin locus, even though CTCF binding itself was maintained at the sites. Forced H3K27ac by Trichostatin A treatment or CBP/p300 KD affected the interactions between CTCF sites around the beta-globin locus without changes in CTCF binding. Analysis of public ChIA-PET data revealed that H3K27ac is higher at CTCF sites forming short interactions than long interactions. GATA-1 was identified as a representative transcription factor that relates with genes present inside the short interactions in erythroid K562 cells. Depletion of GATA-1-reduced H3K27ac at CTCF sites near erythroid-specific enhancers. These results indicate that H3K27ac at CTCF sites is required for cell type-specific chromatin interactions between them. Tissue-specific activator GATA-1 appears to play a role in H3K27ac at CTCF sites in erythroid cells.	[Kim, Yea Woon; Kang, Yujin; Kang, Jin; Kim, AeRi] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea	Pusan National University	Kim, A (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea.	kimaeri@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1A2B4008947]; Ministry of Education [NRF-2017R1D1A1B03030807]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1A2B4008947) and by the Ministry of Education (NRF-2017R1D1A1B03030807).	Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Brown JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06248-4; Cheung KL, 2017, MOL CELL, V65, P1068, DOI 10.1016/j.molcel.2016.12.022; Chien R, 2011, J BIOL CHEM, V286, P17870, DOI 10.1074/jbc.M110.207365; Despang A, 2019, NAT GENET, V51, P1263, DOI 10.1038/s41588-019-0466-z; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Garcia-Gutierrez P, 2012, J CELL SCI, V125, P3671, DOI 10.1242/jcs.105841; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hanssen LLP, 2017, NAT CELL BIOL, V19, P952, DOI 10.1038/ncb3573; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hsu SC, 2017, MOL CELL, V66, P102, DOI 10.1016/j.molcel.2017.02.027; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kiekhaefer CM, 2002, P NATL ACAD SCI USA, V99, P14309, DOI 10.1073/pnas.212389499; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim YW, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170976; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee DP, 2019, CIRCULATION, V139, P1937, DOI 10.1161/CIRCULATIONAHA.118.036726; Lee J, 2017, CELL REP, V19, P2490, DOI 10.1016/j.celrep.2017.05.072; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Matthews BJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34077; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ren G, 2017, MOL CELL, V67, P1049, DOI 10.1016/j.molcel.2017.08.026; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tanimura N, 2016, EMBO REP, V17, P249, DOI 10.15252/embr.201541465; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Yun WJ, 2014, NUCLEIC ACIDS RES, V42, P4283, DOI 10.1093/nar/gku072; Zhou Y, 2013, BLOOD, V122, P4199, DOI 10.1182/blood-2013-02-483875	46	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14736	14749		10.1096/fj.202001526R	http://dx.doi.org/10.1096/fj.202001526R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32924169	Green Submitted			2022-12-28	WOS:000570665500001
J	Ma, YX; Liu, SS; Jun, HJ; Wang, JE; Fan, XL; Li, GB; Yin, L; Rui, LY; Weinman, SA; Gong, JK; Wu, J				Ma, Yingxu; Liu, Shanshan; Jun, Heejin; Wang, Jine; Fan, Xiaoli; Li, Guobing; Yin, Lei; Rui, Liangyou; Weinman, Steven A.; Gong, Jianke; Wu, Jun			A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control	FASEB JOURNAL			English	Article						diabetic hyperglycemia; glycemic control; liver function; PRMT1 variant 2	NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; ENERGY-METABOLISM; SKELETAL-MUSCLE; METHYLATION; PGC-1-ALPHA; PRMT1; GLUCONEOGENESIS; COACTIVATOR	Appropriate control of hepatic gluconeogenesis is essential for the organismal survival upon prolonged fasting and maintaining systemic homeostasis under metabolic stress. Here, we show protein arginine methyltransferase 1 (PRMT1), a key enzyme that catalyzes the protein arginine methylation process, particularly the isoform encoded byPrmt1variant 2 (PRMT1V2),is critical in regulating gluconeogenesis in the liver. Liver-specific deletion ofPrmt1reduced gluconeogenic capacity in cultured hepatocytes and in the liver.Prmt1v2was expressed at a higher level compared toPrmt1v1in hepatic tissue and cells. Gain-of-function of PRMT1V2 clearly activated the gluconeogenic program in hepatocytes via interactions with PGC1 alpha, a key transcriptional coactivator regulating gluconeogenesis, enhancing its activity via arginine methylation, while no effects of PRMT1V1 were observed. Similar stimulatory effects of PRMT1V2 in controlling gluconeogenesis were observed in human HepG2 cells. PRMT1, specifically PRMT1V2, was stabilized in fasted liver and hepatocytes treated with glucagon, in a PGC1 alpha-dependent manner. PRMT1, particularlyPrmt1v2, was significantly induced in the liver of streptozocin-induced type 1 diabetes and high fat diet-induced type 2 diabetes mouse models and liver-specificPrmt1deficiency drastically ameliorated diabetic hyperglycemia. These findings reveal that PRMT1 modulates gluconeogenesis and mediates glucose homeostasis under physiological and pathological conditions, suggesting that deeper understanding how PRMT1 contributes to the coordinated efforts in glycemic control may ultimately present novel therapeutic strategies that counteracts hyperglycemia in disease settings.	[Ma, Yingxu; Liu, Shanshan; Jun, Heejin; Wang, Jine; Li, Guobing; Gong, Jianke; Wu, Jun] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ma, Yingxu] Cent South Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Peoples R China; [Fan, Xiaoli; Gong, Jianke] Huazhong Univ Sci & Technol, Key Lab Mol Biophys MOE, Int Res Ctr Sensory Biol & Technol MOST, Wuhan, Peoples R China; [Fan, Xiaoli; Gong, Jianke] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan, Peoples R China; [Yin, Lei; Rui, Liangyou; Wu, Jun] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; [Weinman, Steven A.] Univ Kansas, Med Ctr, Ctr Liver, Kansas City, KS 66103 USA	University of Michigan System; University of Michigan; Central South University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Michigan System; University of Michigan; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Wu, J (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Gong, JK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys MOE, Wuhan 430074, Hubei, Peoples R China.	jiankeg@umich.edu; wujunz@umich.edu		Liu, Shanshan/0000-0002-7301-5196	American Diabetes Association (ADA) [1-18-IBS-281]; American Gastroenterological Association (AGA) [AGA2020-21-09]; Chinese Scholarship Council [201806370290, 201908420207]	American Diabetes Association (ADA)(American Diabetes Association); American Gastroenterological Association (AGA); Chinese Scholarship Council(China Scholarship Council)	American Diabetes Association (ADA), Grant/Award Number: 1-18-IBS-281; American Gastroenterological Association (AGA), Grant/Award Number: AGA2020-21-09; Chinese Scholarship Council, Grant/Award Number: 201806370290 and 201908420207	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Besse-Patin A, 2019, P NATL ACAD SCI USA, V116, P4285, DOI 10.1073/pnas.1815150116; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Choi D, 2012, HEPATOLOGY, V56, P1546, DOI 10.1002/hep.25809; Gastaldelli A, 2019, JHEP REP, V1, P312, DOI 10.1016/j.jhepr.2019.07.002; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Hatting M, 2018, ANN NY ACAD SCI, V1411, P21, DOI 10.1111/nyas.13435; Iwasaki H, 2007, BIOCHEM BIOPH RES CO, V364, P1015, DOI 10.1016/j.bbrc.2007.10.113; Jackson MI, 2012, J BIOL CHEM, V287, P36455, DOI 10.1074/jbc.M112.412932; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lai YD, 2017, J CELL SCI, V130, P3578, DOI 10.1242/jcs.206904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu X, 2016, BBA-MOL CELL RES, V1863, P2093, DOI 10.1016/j.bbamcr.2016.05.009; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Priya G, 2018, DIABETES THER, V9, P349, DOI 10.1007/s13300-017-0333-9; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Pyun JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07606-y; Qiao XN, 2019, ENDOCRINOLOGY, V160, P2773, DOI 10.1210/en.2019-00504; Qiu KX, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00260-7; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; SUN Y, 2019, INT J MOL SCI, V20; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tikhanovich I, 2017, J BIOL CHEM, V292, P6882, DOI 10.1074/jbc.M117.778761; Tong X, 2017, DIABETES, V66, P2571, DOI 10.2337/db16-1600; Van Herck MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101072; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Wu JZ, 2015, DIABET METAB SYND OB, V8, P181, DOI 10.2147/DMSO.S82272; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang XP, 2018, CELL PHYSIOL BIOCHEM, V47, P1643, DOI 10.1159/000490983; Zhao J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45585-2; Zhao Jie, 2019, Gene Expression, V19, P137, DOI 10.3727/105221618X15372014086197; Zhao J, 2018, HEPATOLOGY, V67, P1109, DOI 10.1002/hep.29587	45	3	3	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14863	14877		10.1096/fj.202001061R	http://dx.doi.org/10.1096/fj.202001061R		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918517	Green Published			2022-12-28	WOS:000570681500001
J	You, ML; Xia, XB; Li, HB; Wu, JY; Rong, R; Zeng, Z; Xiong, K; Huang, JF; Tang, LS; Lei, HT; Wu, WY; Ji, D				You, Mengling; Xia, Xiaobo; Li, Haibo; Wu, Jiayu; Rong, Rong; Zeng, Zhou; Xiong, Kun; Huang, Jufang; Tang, Luosheng; Lei, Hetian; Wu, Wenyi; Ji, Dan			Normal vitreous promotes angiogenesi via the epidermal growth factor receptor	FASEB JOURNAL			English	Article						Akt; angiogenesis; EGFR; HUVECs; PDR; vitreous	SUPRAMOLECULAR ORGANIZATION; ERBB RECEPTORS; INHIBITION; RETINOPATHY; EXPRESSION; SURVIVAL; CANCER; ACID; DRUG; EGFR	Vitreous, a transparent tissue in our body, contains anti-angiogenesis factors. Our previous work reported that vitreous activates the signaling pathway of epidermal growth factor receptor (EGFR), which plays a critical role in angiogenesis. The aim of this study was to determine the role of EGFR in vitreous-induced angiogenesis-related cellular responses in vitro. Using a pharmacologic and molecular approach, we found that vitreous increased proliferation and migration via EGFR in human umbilical vein endothelial cells (HUVECs). Furthermore, we demonstrated that vitreous promoted tube formation via EGFR in HUVECs. Subsequently, depletion of EGFR using CRISPR/Cas9 and blockage with EGFR inhibitor AG1478 suppressed vitreous-induced Akt activation and cell proliferation, migration, and tube formation in HUVECs. The significance of the angiogenic effect derived from vitreous demonstrates the importance of vitreous in the ocular physiology and the pathobiology of angiogenesis-related ophthalmic diseases, such as proliferative diabetic retinopathy.	[You, Mengling; Xia, Xiaobo; Li, Haibo; Rong, Rong; Zeng, Zhou; Wu, Wenyi; Ji, Dan] Cent South Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China; [You, Mengling; Xia, Xiaobo; Li, Haibo; Rong, Rong; Zeng, Zhou; Wu, Wenyi; Ji, Dan] Hunan Key Lab Ophthalmol, Changsha, Peoples R China; [Wu, Jiayu] Cent South Univ, Sch Life Sci, Changsha, Peoples R China; [Xiong, Kun; Huang, Jufang] Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Peoples R China; [Tang, Luosheng] Cent South Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Peoples R China; [Lei, Hetian] Shenzhen Eye Hosp, Shenzhen Eye Inst, Shenzhen, Peoples R China	Central South University; Central South University; Central South University; Central South University	Wu, WY; Ji, D (corresponding author), Cent South Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China.	15200811001@163.com; 475393400@qq.com	曾, 茁桐/HCI-1998-2022	Ji, Dan/0000-0001-5901-3672; Lei, Hetian/0000-0003-4091-1936; Xia, Xiaobo/0000-0003-1720-7860	National Natural Science Foundation of China [81900893, 81400442]; Science and Technology Plan Project of Hunan Province [2019RS2011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan Project of Hunan Province	This study was supported by the National Natural Science Foundation of China (81900893 to W.-Y.W; 81400442 to DJ) the Science and Technology Plan Project of Hunan Province (2019RS2011 to W.-YW).	ARCINIEGAS A, 1980, OPHTHALMOLOGICA, V180, P207, DOI 10.1159/000308975; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Blackledge G, 2000, PROSTATE CANCER P D, V3, P296, DOI 10.1038/sj.pcan.4500488; Cantor AJ, 2018, P NATL ACAD SCI USA, V115, pE7303, DOI 10.1073/pnas.1803598115; Chen N, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107716; Cheng HW, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0495-3; Cui JY, 2018, LIFE SCI, V192, P293, DOI 10.1016/j.lfs.2017.11.007; Di Y, 2015, INT J MOL MED, V36, P1507, DOI 10.3892/ijmm.2015.2371; Diaz-Rodriguez E, 2005, FEBS LETT, V579, P4020, DOI 10.1016/j.febslet.2005.06.016; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gu QB, 2019, EUR J RADIOL, V118, P32, DOI 10.1016/j.ejrad.2019.06.025; Hammes HP, 2018, DIABETOLOGIA, V61, P29, DOI 10.1007/s00125-017-4435-8; Han HT, 2019, J BIOL CHEM, V294, P15408, DOI 10.1074/jbc.RA119.010130; Ho J, 2017, TRENDS MICROBIOL, V25, P942, DOI 10.1016/j.tim.2017.04.009; JACOBSON B, 1985, EXP EYE RES, V41, P581, DOI 10.1016/0014-4835(85)90031-4; Ju X, 2019, CLIN EXP PHARMACOL P, V46, P75, DOI 10.1111/1440-1681.13029; Kim MN, 2019, CANCER CHEMOTH PHARM, V84, P809, DOI 10.1007/s00280-019-03918-y; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li HL, 2017, EXPERT OPIN INV DRUG, V26, P1103, DOI 10.1080/13543784.2017.1369042; Liu ZP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00551-2; Luo J, 2013, DIABETES, V62, P2613, DOI 10.2337/db12-1093; Peng WJ, 2018, J ETHNOPHARMACOL, V224, P140, DOI 10.1016/j.jep.2018.05.039; Qing L, 2019, DRUG DES DEV THER, V13, P1437, DOI 10.2147/DDDT.S195090; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saraswati S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-82; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Takeuchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091849; Theocharis DA, 2008, CONNECT TISSUE RES, V49, P124, DOI 10.1080/03008200802148496; Wang QZ, 2019, MED SCI MONITOR, V25, P700, DOI 10.12659/MSM.911579; Xu Z, 2017, ONCOTARGET, V8, P32655, DOI 10.18632/oncotarget.15948; Zhang BK, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0400-0; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860	35	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14799	14809		10.1096/fj.201902862RRR	http://dx.doi.org/10.1096/fj.201902862RRR		SEP 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910506	Bronze			2022-12-28	WOS:000568313900001
J	Eldani, M; Luan, Y; Xu, PC; Bargar, T; Kim, SY				Eldani, Maya; Luan, Yi; Xu, Pauline C.; Bargar, Tom; Kim, So-Youn			Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation	FASEB JOURNAL			English	Article						apoptosis; cisplatin; dose; melatonin; ovary	ANTI-MULLERIAN HORMONE; DNA-DAMAGE; QUALITY-CONTROL; INHIBITS INITIATION; MOUSE OOCYTES; MELATONIN; PROTECTS; FERTILITY; GROWTH; CHK2	Chemotherapy directly or indirectly affects organs in a short-term or continuous manner. Endocrine organs are especially sensitive to cancer treatment, leading to concerns among patients regarding their quality of life afterward. Side effects to the ovary include damage to the ovarian reserve, resulting in follicle loss, endocrine hormone deficiency, and infertility. It has been previously demonstrated that continuous treatment with 2 mg/kg cisplatin for 15 days can activate primordial follicles, suggesting that the response in the oocytes of primordial follicles was dependent on cisplatin concentration and administration frequency. However, our results demonstrate that continuous treatment with 2 mg/kg cisplatin for 15 days leads to the same consequence as with the continuous treatment of 5 mg/kg cisplatin: the death of oocytes in primordial follicles without indication of activation. Moreover, animals co-injected with melatonin and cisplatin did not display any significant differences from those treated with cisplatin only contrary to the known results. 6-hydroxymelatonin, a metabolite of melatonin, could not prevent follicle destruction, implying that melatonin does not confer the protection of ovarian follicles, either directly or indirectly. Altogether, our data support that fertoprotectants against cisplatin must target molecules that control cell death pathways in the oocytes of primordial follicles.	[Eldani, Maya; Luan, Yi; Xu, Pauline C.; Kim, So-Youn] Univ Nebraska Med Ctr, Coll Med, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, 985860 Nebraska Med Ctr, Omaha, NE 68198 USA; [Bargar, Tom] Univ Nebraska Med Ctr, Electron Microscopy Core Facil EMCF, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kim, SY (corresponding author), Univ Nebraska Med Ctr, Coll Med, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, 985860 Nebraska Med Ctr, Omaha, NE 68198 USA.	soyoun.kim@unmc.edu		Luan, Yi/0000-0003-1343-816X	National Institute of Child Health and Human Development (NICHD) [R01HD096042-02]	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD096042-02	Barberino RS, 2017, BIOL REPROD, V96, P1244, DOI 10.1093/biolre/iox053; Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671; Bristol-Gould SK, 2006, DEV BIOL, V298, P149, DOI 10.1016/j.ydbio.2006.06.023; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Chemaitilly W, 2019, HORM RES PAEDIAT, V91, P74, DOI 10.1159/000493943; Chen Z, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0519-z; Coutandin D, 2016, ELIFE, V5, DOI 10.7554/eLife.13909; De Araujo JG, 2019, ANTICANCER RES, V39, P2453, DOI 10.21873/anticanres.13364; Deutsch GB, 2011, CELL CYCLE, V10, P1884, DOI 10.4161/cc.10.12.15590; Deutsch GB, 2011, CELL, V144, P566, DOI 10.1016/j.cell.2011.01.013; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Gebauer J, 2019, ENDOCR REV, V40, P711, DOI 10.1210/er.2018-00092; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Haghi-Aminjan H, 2018, J PHARM PHARMACOL, V70, P291, DOI 10.1111/jphp.12855; Jang H, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12432; Jang H, 2016, J PINEAL RES, V60, P336, DOI 10.1111/jpi.12316; Kano M, 2017, P NATL ACAD SCI USA, V114, pE1688, DOI 10.1073/pnas.1620729114; Kehrloesser S, 2018, CELL DEATH DIFFER, V25, P1007, DOI 10.1038/s41418-018-0107-6; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Kerr JB, 2012, NAT MED, V18, P1170, DOI 10.1038/nm.2889; Kim SY, 2013, CELL DEATH DIFFER, V20, P987, DOI 10.1038/cdd.2013.31; Kim So-Youn, 2019, Obstet Gynecol Sci, V62, P382, DOI 10.5468/ogs.2019.62.6.382; Kim SY, 2019, CELL DEATH DIFFER, V26, P502, DOI 10.1038/s41418-018-0151-2; Kim SY, 2016, CANCER RES, V76, P3851, DOI 10.1158/0008-5472.CAN-15-3358; Kim SY, 2015, ENDOCRINOLOGY, V156, P1464, DOI 10.1210/en.2014-1926; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Nguyen QN, 2019, MOL HUM REPROD, V25, P433, DOI 10.1093/molehr/gaz020; Pepin D, 2018, CURR OPIN ENDOCRINOL, V25, P399, DOI 10.1097/MED.0000000000000442; Perse M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1462802; Nguyen QN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0633-7; Roness H, 2019, J ASSIST REPROD GEN, V36, P1793, DOI 10.1007/s10815-019-01507-9; Smart E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19761-9; Sonigo C, 2019, FASEB J, V33, P1278, DOI 10.1096/fj.201801089R; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sun ZY, 2018, AGING-US, V10, P4175, DOI 10.18632/aging.101715; Tuppi M, 2018, NAT STRUCT MOL BIOL, V25, P261, DOI 10.1038/s41594-018-0035-7; VANHENNIK MB, 1987, CANCER RES, V47, P6297; Waguespack SG, 2019, HORM RES PAEDIAT, V91, P104, DOI 10.1159/000495040; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Wang YF, 2018, AGING-US, V10, P463, DOI 10.18632/aging.101405; Zhang L, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12550; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	43	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13885	13899		10.1096/fj.202001461RR	http://dx.doi.org/10.1096/fj.202001461RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32830364	Green Accepted, Bronze			2022-12-28	WOS:000563588500001
J	Yu, QQ; Yang, X; Zhang, C; Zhang, XT; Wang, CY; Chen, L; Liu, XL; Gu, YF; He, XM; Hu, L; Liu, WT; Li, Y				Yu, Qingqing; Yang, Xing; Zhang, Chen; Zhang, Xiaotao; Wang, Chaoyu; Chen, Lu; Liu, Xiaolin; Gu, Yufeng; He, Xueming; Hu, Liang; Liu, Wen-Tao; Li, Yan			AMPK activation by ozone therapy inhibits tissue factor-triggered intestinal ischemia and ameliorates chemotherapeutic enteritis	FASEB JOURNAL			English	Article						AMPK; chemotherapeutic enteritis; ozone; thrombosis; TF	FACTOR PATHWAY INHIBITOR; PACLITAXEL; COLITIS; CELLS; HIF-1-ALPHA; EXPRESSION; MUCOSITIS; PROMOTE; DISEASE; CPT-11	Chemotherapeutic enteritis is a major dose-limiting adverse reaction to chemotherapy, with few effective drugs in clinic. Intestinal ischemic injury plays prominent role in chemotherapeutic enteritis clinically. However, mechanism is not clear. In this article, irinotecan (CPT-11) was used to establish chemotherapeutic enteritis mice model. Western blotting, gelatin zymography, immunohistochemistry (IHC), Laser Doppler flowmetry (LDF) were used to detect the pathogenesis of ischemia-hypoxia injury. CPT-11 increased levels of tissue factor (TF) both in the blood and in intestines, and decreased the intestinal blood flow in mice. Interestingly, the elevation of TF in the blood displayed "double-peak," which was consistent with the intestinal mucosal "double-strike" injury trend. Intestinal microthrombus and mixed thrombus formation were detectable in chemotherapeutic enteritis. Furthermore, ozone therapy relieved chemotherapeutic enteritis in mice. Ozone inhibited TF expression induced by CPT-11 via activating AMPK/SOCS3, and effectively ameliorated the intestinal mucosal injury in mice. Moreover, ozone autotransfusion therapy effectively attenuated chemotherapeutic enteritis and the blood hypercoagulability in patients. For the first time, we proposed that TF-induced thrombotic intestinal ischemic injury is a core trigger pathological mechanism of chemotherapeutic enteritis, and provided a new treatment strategy, ozone therapy, to suppress TF expression and treat chemotherapeutic enteritis.	[Yu, Qingqing; Zhang, Xiaotao; Li, Yan] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Oncol, Jingshi Rd 16766, Jinan 250014, Shandong, Peoples R China; [Yu, Qingqing] Jining 1 Peoples Hosp, Dept Oncol, Jining, Peoples R China; [Yang, Xing; Zhang, Chen; Wang, Chaoyu; Chen, Lu; Gu, Yufeng; Hu, Liang; Liu, Wen-Tao] Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, 101 Longmian Ave, Nanjing 211166, Peoples R China; [Zhang, Xiaotao] Qingdao Cent Hosp, Dept Radiat Oncol, Qingdao, Peoples R China; [Liu, Xiaolin; Li, Yan] Shandong First Med Univ, Shandong Prov Qianfoshan Hosp, Dept Oncol, Hosp 1, Jinan, Peoples R China; [He, Xueming] Nanjing Med Univ, Ctr Clin Res & Translat Med, Affiliated Lianyungang Oriental Hosp, Kangda Coll, Lianyungang, Peoples R China; [Liu, Wen-Tao] Nanjing Med Univ, Inst Translat Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Nanjing Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Nanjing Medical University; Nanjing Medical University	Li, Y (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Oncol, Jingshi Rd 16766, Jinan 250014, Shandong, Peoples R China.; Hu, L (corresponding author), Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, 101 Longmian Ave, Nanjing 211166, Peoples R China.; Liu, WT (corresponding author), Nanjing Med Univ, Inst Translat Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	lianghu@njmu.edu.cn; painresearch@njmu.edu.cn; liyan16766@163.com	Hu, Liang/GLQ-9734-2022; gu, yu/GSD-4507-2022; zhang, xiaotao/AAV-7730-2021; Yu, Qing-Qing/CAG-9050-2022; Liu, Wentao/AAX-7308-2021	zhang, xiaotao/0000-0001-7213-4970; Yu, Qing-Qing/0000-0001-5695-6747; Hu, Liang/0000-0002-0013-7440; Wang, Chaoyu/0000-0001-9224-5061	Major Science and Technology Innovation Project of Shandong Province [2018CXGC1220]; Major Project of "Science and Technology Innovation Fund" of Nanjing Medical University [2017NJMUCX004]; Natural Science Foundation for Young Scientists of Jiangsu province [BK20161033]; Lianyungang 2020 covid-19 emergency science and technology special fund [SF2016]	Major Science and Technology Innovation Project of Shandong Province; Major Project of "Science and Technology Innovation Fund" of Nanjing Medical University; Natural Science Foundation for Young Scientists of Jiangsu province; Lianyungang 2020 covid-19 emergency science and technology special fund	Major Science and Technology Innovation Project of Shandong Province, Grant/Award Number: 2018CXGC1220; Major Project of "Science and Technology Innovation Fund" of Nanjing Medical University, Grant/Award Number: 2017NJMUCX004; Natural Science Foundation for Young Scientists of Jiangsu province, Grant/Award Number: BK20161033; Lianyungang 2020 covid-19 emergency science and technology special fund, Grant/Award Number: SF2016	Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Belaaouaj AA, 2000, J BIOL CHEM, V275, P27123; Bocci V, 2015, DRUG DES DEV THER, V9, P2677, DOI 10.2147/DDDT.S74518; Chang YC, 2017, CANCER LETT, V403, P28, DOI 10.1016/j.canlet.2017.06.001; Chen L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01757; Cunningham AC, 2002, BIOCHEM J, V367, P451, DOI 10.1042/BJ20020696; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Egorina EM, 2011, BLOOD COAGUL FIBRIN, V22, P451, DOI 10.1097/MBC.0b013e328346ef3f; Eliakim R, 2001, DIGEST DIS SCI, V46, P2515, DOI 10.1023/A:1012348525208; Elsayed AG, 2017, CASE REP ONCOL, V10, P689, DOI 10.1159/000479226; Goswami SK, 2010, CURR CARDIOL REV, V6, P265, DOI 10.2174/157340310793566136; Haddad TC, 2006, THROMB RES, V118, P555, DOI 10.1016/j.thromres.2005.10.015; Holz O, 2005, J CLIN PHARMACOL, V45, P498, DOI 10.1177/0091270004273527; Hubner J, 2006, ONKOLOGE, V12, P565; Kunimoto T, 1987, CAN RES, V47, P4; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Lechner D, 2010, ONKOLOGISCHE WELT, V01, P129; Li Q, 2015, TOXICOL APPL PHARM, V289, P133, DOI 10.1016/j.taap.2015.09.025; Li Y, 2015, BRAIN BEHAV IMMUN, V49, P255, DOI 10.1016/j.bbi.2015.06.003; de Jesus CCL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179185; Lu LJ, 2017, J MOL CELL BIOL, V9, P132, DOI 10.1093/jmcb/mjw043; Maggo G, 2014, PATHOL RES PRACT, V210, P606, DOI 10.1016/j.prp.2014.05.005; Mahony R, 2016, CELL MOL LIFE SCI, V73, P3323, DOI 10.1007/s00018-016-2234-x; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; Maroun J A, 2007, Curr Oncol, V14, P13, DOI 10.3747/co.2007.96; McKenna DF, 2013, INT J ORAL MAX IMPL, V28, P1483, DOI 10.11607/jomi.3168; Oe Y, 2016, ARTERIOSCL THROM VAS, V36, P1525, DOI 10.1161/ATVBAHA.116.307883; Paolini A, 2011, ANTICANCER RES, V31, P3727; Paran H, 2007, ISR MED ASSOC J, V9, P488; Peterson DE, 2015, ANN ONCOL, V26, pV139, DOI 10.1093/annonc/mdv202; Silosi I, 2014, ROM J MORPHOL EMBRYO, V55, P1317; Smith NL, 2017, MED GAS RES, V7, P212, DOI 10.4103/2045-9912.215752; Song MS, 2018, MOL MED REP, V17, P2449, DOI 10.3892/mmr.2017.8148; Tashiro M, 2003, AM J GASTROENTEROL, V98, P231; Ucar F, 2013, RENAL FAILURE, V35, P640, DOI 10.3109/0886022X.2013.780530; Van Sebille YZA, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0474-9; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; Wang L, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8721257; Xiong AJ, 2018, TRANSL MED J, V7, P326; Yang Y, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5347804; Yokoyama T, 1997, JPN J CLIN ONCOL, V27, P111, DOI 10.1093/jjco/27.2.111; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu Z, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7083528; ZANKER KS, 1990, CHEMOTHERAPY, V36, P147, DOI 10.1159/000238761; Zhang Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0983-6; Zhe Y, 2016, TUMOR BIOL, V37, P13951, DOI 10.1007/s13277-016-5189-5	47	9	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13005	13021		10.1096/fj.201902717RR	http://dx.doi.org/10.1096/fj.201902717RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32776374	hybrid			2022-12-28	WOS:000558227500001
J	Kiseleva, RY; Glassman, PG; LeForte, KM; Walsh, LR; Villa, CH; Shuvaev, VV; Myerson, JW; Aprelev, PA; Marcos-Contreras, OA; Muzykantov, VR; Greineder, CF				Kiseleva, R. Yu.; Glassman, P. G.; LeForte, K. M.; Walsh, L. R.; Villa, C. H.; Shuvaev, V. V.; Myerson, J. W.; Aprelev, P. A.; Marcos-Contreras, O. A.; Muzykantov, V. R.; Greineder, C. F.			Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo	FASEB JOURNAL			English	Article						cell surface; endothelium; ICAM-1; PECAM-1; targeted drug delivery; thrombomodulin	CELL-ADHESION MOLECULE-1; MONOCLONAL-ANTIBODY; TISSUE DISPOSITION; THROMBOMODULIN; ICAM-1; PHARMACOKINETICS; THERAPEUTICS; MODEL; PECAM; LUNG	Targeted drug delivery to the endothelium has the potential to generate localized therapeutic effects at the blood-tissue interface. For some therapeutic cargoes, it is essential to maintain contact with the bloodstream to exert protective effects. The pharmacokinetics (PK) of endothelial surface-targeted affinity ligands and biotherapeutic cargo remain a largely unexplored area, despite obvious translational implications for this strategy. To bridge this gap, we site-specifically radiolabeled mono- (scFv) and bivalent (mAb) affinity ligands specific for the endothelial cell adhesion molecules, PECAM-1 (CD31) and ICAM-1 (CD54). Radiotracing revealed similar lung biodistribution at 30 minutes post-injection (79.3% +/- 4.2% vs 80.4% +/- 10.6% ID/g for alpha ICAM and 58.9% +/- 3.6% ID/g vs. 47.7% +/- 5.8% ID/g for alpha PECAM mAb vs. scFv), but marked differences in organ residence time, with antibodies demonstrating an order of magnitude greater area under the lung concentration vs. time curve (AUC(inf)1698 +/- 352 vs. 53.3 +/- 7.9 ID/g*hrs for alpha ICAM and 1023 +/- 507 vs. 114 +/- 37 ID/g*hrs for alpha PECAM mAb vs scFv). A physiologically based pharmacokinetic model, fit to and validated using these data, indicated contributions from both superior binding characteristics and prolonged circulation time supporting multiple binding-detachment cycles. We tested the ability of each affinity ligand to deliver a prototypical surface cargo, thrombomodulin (TM), using one-to-one protein conjugates. Bivalent mAb-TM was superior to monovalent scFv-TM in both pulmonary targeting and lung residence time (AUC(inf)141 +/- 3.2 vs 12.4 +/- 4.2 ID/g*hrs for ICAM and 188 +/- 90 vs 34.7 +/- 19.9 ID/g*hrs for PECAM), despite having similar blood PK, indicating that binding strength is more important parameter than the kinetics of binding. To maximize bivalent target engagement, we synthesized an oriented, end-to-end anti-ICAM mAb-TM conjugate and found that this therapeutic had the best lung residence time (AUC(inf)253 +/- 18 ID/g*hrs) of all TM modalities. These observations have implications not only for the delivery of TM, but also potentially all therapeutics targeted to the endothelial surface.	[Kiseleva, R. Yu.; Glassman, P. G.; LeForte, K. M.; Walsh, L. R.; Villa, C. H.; Shuvaev, V. V.; Myerson, J. W.; Aprelev, P. A.; Marcos-Contreras, O. A.; Muzykantov, V. R.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Greineder, C. F.] Univ Michigan, Dept Emergency Med & Pharmacol, North Campus Res Complex,B10-154A, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan	Greineder, CF (corresponding author), Univ Michigan, Dept Emergency Med & Pharmacol, North Campus Res Complex,B10-154A, Ann Arbor, MI 48109 USA.	coling@med.umich.edu		Kiseleva, Raisa/0000-0001-8065-3551	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [K08-HL130430, RO1 HL125462, RO1 HL128398]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K08-HL130430, RO1 HL125462 and RO1 HL128398	Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI 10.1021/bc5004982; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Betts A, 2019, AAPS J, V21, DOI 10.1208/s12248-019-0332-z; Brenner JS, 2018, PULM CIRC, V8, DOI 10.1177/2045893217752329; Brenner Jacob S, 2017, Nanomedicine, V13, P1495, DOI 10.1016/j.nano.2016.12.019; Campagne O, 2018, CLIN CANCER RES, V24, P2631, DOI 10.1158/1078-0432.CCR-17-2265; Chittasupho C, 2009, EUR J PHARM SCI, V37, P141, DOI 10.1016/j.ejps.2009.02.008; Christofidou-Solomidou M, 2003, AM J PHYSIOL-LUNG C, V285, pL283, DOI 10.1152/ajplung.00021.2003; Cilliers C, 2016, AAPS J, V18, P1117, DOI 10.1208/s12248-016-9940-z; DANILOV SM, 1991, LAB INVEST, V64, P118; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; Ding BS, 2005, BLOOD, V106, P4191, DOI 10.1182/blood-2005-05-2002; Drachman JG, 2013, HEMATOL-AM SOC HEMAT, P306, DOI 10.1182/asheducation-2013.1.306; Ferrer MCC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102329; Fuentes RE, 2016, J CLIN INVEST, V126, P483, DOI 10.1172/JCI81470; Gadkar K, 2016, EUR J PHARM BIOPHARM, V101, P53, DOI 10.1016/j.ejpb.2016.01.009; Ghaffarian R, 2016, J CONTROL RELEASE, V238, P221, DOI 10.1016/j.jconrel.2016.07.042; Ghaffarian R, 2014, MOL PHARMACEUT, V11, P4350, DOI 10.1021/mp500409y; Greineder CF, 2018, BIOCONJUGATE CHEM, V29, P56, DOI 10.1021/acs.bioconjchem.7b00592; Greineder CF, 2017, BLOOD ADV, V1, P1452, DOI 10.1182/bloodadvances.2017007229; Greineder CF, 2015, FASEB J, V29, P3483, DOI 10.1096/fj.15-271213; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Greineder CF, 2013, BLOOD, V122, P1565, DOI 10.1182/blood-2013-03-453498; Hayakawa M, 2017, THROMB HAEMOSTASIS, V117, P851, DOI 10.1160/TH16-07-0547; JACOBSON BS, 1992, EUR J CELL BIOL, V58, P296; Khoshnejad M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19784-2; Khot A, 2017, AAPS J, V19, P1715, DOI 10.1208/s12248-017-0131-3; Kiseleva R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169537; Kiseleva R, 2018, DRUG DELIV TRANSL RE, V8, P883, DOI 10.1007/s13346-017-0464-6; Kiseleva RY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20027-7; Lamberti G, 2012, 2012 38 ANN NE BIOEN; Leipold D, 2019, CTS-CLIN TRANSL SCI, V12, P130, DOI 10.1111/cts.12597; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Marcos-Contreras OA, 2019, J CONTROL RELEASE, V301, P54, DOI 10.1016/j.jconrel.2019.03.008; Murciano JC, 2003, NAT BIOTECHNOL, V21, P891, DOI 10.1038/nbt846; Murciano JC, 2003, BLOOD, V101, P3977, DOI 10.1182/blood-2002-09-2853; Muro S, 2006, MOL THER, V13, P135, DOI 10.1016/j.ymthe.2005.07.687; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muro S, 2005, BLOOD, V105, P650, DOI 10.1182/blood-2004-05-1714; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Muzykantov VR., 2013, ISRN VASC MED, V2013, P1, DOI [10.1155/2013/916254, DOI 10.1155/2013/916254]; Myerson JW, 2018, ADV MATER, V30, DOI 10.1002/adma.201802373; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Parhiz H, 2018, J CONTROL RELEASE, V291, P106, DOI 10.1016/j.jconrel.2018.10.015; Roki N, 2019, J CONTROL RELEASE, V305, P41, DOI 10.1016/j.jconrel.2019.05.021; Scherpereel A, 2002, J PHARMACOL EXP THER, V300, P777, DOI 10.1124/jpet.300.3.777; Schmitt C, 2015, J CARDIOVASC PHARM, V65, P611, DOI 10.1097/FJC.0000000000000233; Schneider D, 1998, EUR NEUROL, V40, P78, DOI 10.1159/000007962; Shah DK, 2014, J PHARMACOKINET PHAR, V41, P55, DOI 10.1007/s10928-013-9346-9; Shah DK, 2012, J PHARMACOKINET PHAR, V39, P67, DOI 10.1007/s10928-011-9232-2; Shuvaev VV, 2007, J CONTROL RELEASE, V118, P235, DOI 10.1016/j.jconrel.2006.12.025; Shuvaev VV, 2018, J CONTROL RELEASE, V272, P1, DOI 10.1016/j.jconrel.2017.12.025; Shuvaev VV, 2016, J CONTROL RELEASE, V234, P115, DOI 10.1016/j.jconrel.2016.05.040; Shuvaev VV, 2015, J CONTROL RELEASE, V219, P576, DOI 10.1016/j.jconrel.2015.09.055; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Villa CH, 2016, ADV DRUG DELIVER REV, V106, P88, DOI 10.1016/j.addr.2016.02.007; Wagner NM, 2013, ARTERIOSCL THROM VAS, V33, P1943, DOI 10.1161/ATVBAHA.113.301783; Wang-Lin SX, 2018, MABS-AUSTIN, V10, P1131, DOI 10.1080/19420862.2018.1494478; Zaitsev S, 2012, BLOOD, V119, P4779, DOI 10.1182/blood-2011-12-398149	62	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11577	11593		10.1096/fj.201902515RR	http://dx.doi.org/10.1096/fj.201902515RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738178	Green Accepted, Green Published			2022-12-28	WOS:000558181900001
J	McDonough, W; Aragon, IV; Rich, J; Murphy, JM; Abou Saleh, L; Boyd, A; Koloteva, A; Richter, W				McDonough, Will; Aragon, Ileana V.; Rich, Justin; Murphy, James M.; Abou Saleh, Lina; Boyd, Abigail; Koloteva, Anna; Richter, Wito			PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice	FASEB JOURNAL			English	Article						emesis; gastric retention; nausea; PDE4D; xylazine; ketamine anesthesia	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; AMP-SPECIFIC PHOSPHODIESTERASE; EMETIC ACTION; SPLICE VARIANT; HIGHLY POTENT; MAP KINASE; CROSS-TALK; RAT-BRAIN; ROLIPRAM; IDENTIFICATION	Inhibitors of cAMP-phosphodiesterase 4 (PDE4) exert a number of promising therapeutic benefits, but adverse effects, in particular emesis and nausea, have curbed their clinical utility. Here, we show that PAN-selective inhibition of PDE4, but not inhibition of PDE3, causes a time- and dose-dependent accumulation of chow in the stomachs of mice fed ad libitum without changing the animals' food intake or the weight of their intestines, suggesting that PDE4 inhibition impairs gastric emptying. Indeed, PDE4 inhibition induced gastric retention in an acute model of gastric motility that traces the passage of a food bolus through the stomach over a 30 minutes time period. In humans, abnormal gastric retention of food is known as gastroparesis, a syndrome predominated by nausea (>90% of cases) and vomiting (>80% of cases). We thus explored the abnormal gastric retention induced by PDE4 inhibition in mice under the premise that it may represent a useful correlate of emesis and nausea. Delayed gastric emptying was produced by structurally distinct PAN-PDE4 inhibitors including Rolipram, Piclamilast, Roflumilast, and RS25344, suggesting that it is a class effect. PDE4 inhibitors induced gastric retention at similar or below doses commonly used to induce therapeutic benefits (e.g., 0.04 mg/kg Rolipram), thus mirroring the narrow therapeutic window of PDE4 inhibitors in humans. YM976, a PAN-PDE4 inhibitor that does not efficiently cross the blood-brain barrier, induced gastroparesis only at significantly higher doses (>= 1 mg/kg). This suggests that PDE4 inhibition may act in part through effects on the autonomic nervous system regulation of gastric emptying and that PDE4 inhibitors that are not brain-penetrant may have an improved safety profile. The PDE4 family comprises four subtypes, PDE4A, B, C, and D. Selective ablation of any of these subtypes in mice did not induce gastroparesisper se, nor did it protect from PAN-PDE4 inhibitor-induced gastroparesis, indicating that gastric retention may result from the concurrent inhibition of multiple PDE4s. Thus, potentially, any of the four PDE4 subtypes may be targeted individually for therapeutic benefits without inducing nausea or emesis. Acute gastric retention induced by PDE4 inhibition is alleviated by treatment with the widely used prokinetic Metoclopramide, suggesting a potential of this drug to alleviate the side effects of PDE4 inhibitors. Finally, given that the cause of gastroparesis remains largely idiopathic, our findings open the possibility that a physiologic or pathophysiologic downregulation of PDE4 activity/expression may be causative in a subset of patients.	[McDonough, Will; Aragon, Ileana V.; Rich, Justin; Murphy, James M.; Abou Saleh, Lina; Boyd, Abigail; Koloteva, Anna; Richter, Wito] Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Biochem & Mol Biol, 5851 USA Dr North,MSB2310, Mobile, AL 36688 USA	University of South Alabama	Richter, W (corresponding author), Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Biochem & Mol Biol, 5851 USA Dr North,MSB2310, Mobile, AL 36688 USA.	richter@southalabama.edu		Richter, Wito/0000-0001-5588-9060	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL141473, HL076125, HL066299]; Cystic Fibrosis Foundation (CF Foundation) [RICHTE16GO]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL141473, HL076125 and HL066299; Cystic Fibrosis Foundation (CF Foundation), Grant/Award Number: RICHTE16GO	Abi-Gerges A, 2009, CIRC RES, V105, P784, DOI 10.1161/CIRCRESAHA.109.197947; Aoki M, 2001, J PHARMACOL EXP THER, V298, P1142; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Aspiotis R, 2010, BIOORG MED CHEM LETT, V20, P5502, DOI 10.1016/j.bmcl.2010.07.076; Azam Mohammed Afzal, 2014, Sci Pharm, V82, P453, DOI 10.3797/scipharm.1404-08; Baillie GS, 2019, NAT REV DRUG DISCOV, V18, P770, DOI 10.1038/s41573-019-0033-4; Baillie GS, 2000, BRIT J PHARMACOL, V131, P811, DOI 10.1038/sj.bjp.0703636; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blanchard E, 2014, FASEB J, V28, P791, DOI 10.1096/fj.13-240861; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Bolger G.B., 2007, CYCLIC NUCLEOTIDE PH, P99; Bolger GB, 1996, J BIOL CHEM, V271, P1065, DOI 10.1074/jbc.271.2.1065; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; Cooney JD, 2016, BLOOD, V128, P2886, DOI 10.1182/blood-2016-09-737676; Donnell AF, 2010, BIOORG MED CHEM LETT, V20, P2163, DOI 10.1016/j.bmcl.2010.02.044; Fujita M, 2012, BIOL PSYCHIAT, V72, P548, DOI 10.1016/j.biopsych.2012.04.030; Ghavami Afshin, 2006, Drugs R D, V7, P63, DOI 10.2165/00126839-200607020-00001; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Goto T, 2014, BIOORG MED CHEM LETT, V24, P893, DOI 10.1016/j.bmcl.2013.12.076; Grover M, 2019, GUT, V68, P2238, DOI 10.1136/gutjnl-2019-318712; Hagen TJ, 2014, BIOORG MED CHEM LETT, V24, P4031, DOI 10.1016/j.bmcl.2014.06.002; Hansen RT, 2014, PSYCHOPHARMACOLOGY, V231, P2941, DOI 10.1007/s00213-014-3480-y; Hasler WL, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12091; Hasler WL, 2019, CLIN GASTROENTEROL H, V17, P1285, DOI 10.1016/j.cgh.2018.10.013; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; HEASLIP RJ, 1995, EUR J PHARMACOL, V286, P281, DOI 10.1016/0014-2999(95)00457-2; Henderson DJP, 2014, BRIT J CANCER, V110, P1278, DOI 10.1038/bjc.2014.22; HIKASA Y, 1986, EUR J PHARMACOL, V130, P229, DOI 10.1016/0014-2999(86)90272-4; HIKASA Y, 1992, EUR J PHARMACOL, V229, P241; HIKASA Y, 1989, AM J VET RES, V50, P1348; HIKASA Y, 1992, J PHARMACOL EXP THER, V261, P746; Hirose R, 2007, EUR J PHARMACOL, V573, P93, DOI 10.1016/j.ejphar.2007.06.045; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Houslay MD, 2003, BIOCHEM SOC T, V31, P1186; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang Z, 2001, CURR OPIN CHEM BIOL, V5, P432, DOI 10.1016/S1367-5931(00)00224-6; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; JapundzicZigon N, 1997, PHARMACOL RES, V35, P287, DOI 10.1006/phrs.1997.0133; Jin S.L.C., 2006, CYCLIC NUCLEOTIDE PH, P323; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Kranz M, 2009, BIOORGAN MED CHEM, V17, P5336, DOI 10.1016/j.bmc.2009.03.061; Krishnasamy S, 2018, DIABETES THER, V9, pS1, DOI 10.1007/s13300-018-0454-9; Lamontagne S, 2001, BRAIN RES, V920, P84, DOI 10.1016/S0006-8993(01)03023-2; Lefebvre RA, 2016, EUR J PHARMACOL, V781, P76, DOI 10.1016/j.ejphar.2016.04.003; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Li H, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01048; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Maurice DH, 2011, CURR OPIN PHARMACOL, V11, P656, DOI 10.1016/j.coph.2011.10.009; MCPHEE I, 1995, BIOCHEM J, V310, P965, DOI 10.1042/bj3100965; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Miro X, 2002, SYNAPSE, V45, P259, DOI 10.1002/syn.10100; Molina CE, 2012, J AM COLL CARDIOL, V59, P2182, DOI 10.1016/j.jacc.2012.01.060; Moretto N, 2015, J PHARMACOL EXP THER, V352, P559, DOI 10.1124/jpet.114.220541; Mori F, 2010, J CHEM NEUROANAT, V40, P36, DOI 10.1016/j.jchemneu.2010.03.004; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Nelissen E, 2019, NEUROSCI LETT, V699, P41, DOI 10.1016/j.neulet.2019.01.026; Nio Y, 2017, FASEB J, V31, P5307, DOI 10.1096/fj.201700249R; Omar F, 2019, P NATL ACAD SCI USA, V116, P13320, DOI 10.1073/pnas.1822113116; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Parkman HP, 2016, NEUROGASTROENT MOTIL, V28, P1902, DOI 10.1111/nmo.12893; Parkman HP, 2015, GASTROENTEROL CLIN N, V44, P59, DOI 10.1016/j.gtc.2014.11.015; Pasricha PJ, 2015, GASTROENTEROL CLIN N, V44, P1, DOI 10.1016/j.gtc.2014.11.001; Peng T, 2018, EUR J MED CHEM, V150, P742, DOI 10.1016/j.ejmech.2018.03.046; Polesskaya OO, 2007, BIOL PSYCHIAT, V61, P56, DOI 10.1016/j.biopsych.2006.03.038; Priem E, 2012, NEUROPHARMACOLOGY, V62, P2126, DOI 10.1016/j.neuropharm.2011.12.020; RAEBURN D, 1994, BRIT J PHARMACOL, V113, P1423, DOI 10.1111/j.1476-5381.1994.tb17156.x; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Richter W, 2011, BASIC RES CARDIOL, V106, P249, DOI 10.1007/s00395-010-0138-8; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Robichaud A, 1999, NEUROPHARMACOLOGY, V38, P289, DOI 10.1016/S0028-3908(98)00190-7; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Ryan S, 2018, BRAIN STRUCT FUNCT, V223, P1731, DOI 10.1007/s00429-017-1575-z; Saldou N, 1998, CELL SIGNAL, V10, P427, DOI 10.1016/S0898-6568(97)00169-1; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Schaefer TL, 2012, GENES BRAIN BEHAV, V11, P614, DOI 10.1111/j.1601-183X.2012.00796.x; Schmitz T, 2007, J IMMUNOL, V178, P1115, DOI 10.4049/jimmunol.178.2.1115; Seimetz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129327; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Sisson TH, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13753; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; SOUNESS JE, 1995, BRIT J PHARMACOL, V115, P39; Soykan I, 1998, DIGEST DIS SCI, V43, P2398, DOI 10.1023/A:1026665728213; Srivani P, 2008, CURR PHARM DESIGN, V14, P3854, DOI 10.2174/138161208786898653; Sun JG, 2006, LIFE SCI, V79, P2077, DOI 10.1016/j.lfs.2006.07.001; Suzuki O, 2013, J PHARMACOL SCI, V123, P219, DOI 10.1254/jphs.13103FP; THOMPSON WJ, 1991, PHARMACOL THERAPEUT, V51, P13, DOI 10.1016/0163-7258(91)90039-O; Tiwari S, 2005, BIOCHEM PHARMACOL, V69, P473, DOI 10.1016/j.bcp.2004.10.009; Ukita T, 1999, J MED CHEM, V42, P1088, DOI 10.1021/jm980314l; Wu C, 2016, OBES REV, V17, P429, DOI 10.1111/obr.12385; Yasmeen S, 2019, CELL SIGNAL, V61, P108, DOI 10.1016/j.cellsig.2019.05.011; Zhang HT, 2006, PSYCHOPHARMACOLOGY, V186, P209, DOI 10.1007/s00213-006-0369-4; Zhang KYJ, 2005, EXPERT OPIN THER TAR, V9, P1283, DOI 10.1517/14728222.9.6.1283; Zhao Y, 2003, J PHARMACOL EXP THER, V307, P246, DOI 10.1124/jpet.103.053215; Zhao Y, 2003, J PHARMACOL EXP THER, V305, P565, DOI 10.1124/jpet.102.47407	110	11	11	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12533	12548		10.1096/fj.202001016RR	http://dx.doi.org/10.1096/fj.202001016RR		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738081	Green Accepted			2022-12-28	WOS:000558166500001
J	Theis, T; Kumar, S; Wei, ELN; Nguyen, J; Glynos, V; Paranjape, N; Askarifirouzjaei, H; Khajouienejad, L; Berthiaume, F; Young, W; Schachner, M				Theis, Thomas; Kumar, Suneel; Wei, Elena; Nguyen, Jennifer; Glynos, Vicci; Paranjape, Nikita; Askarifirouzjaei, Hadi; Khajouienejad, Leila; Berthiaume, Francois; Young, Wise; Schachner, Melitta			Myristoylated alanine-rich C-kinase substrate effector domain peptide improves sex-specific recovery and axonal regrowth after spinal cord injury	FASEB JOURNAL			English	Article						myristoylated alanine-rich C-kinase substrate; polysialic acid; regeneration; sex difference; spinal cord injury	ADHESION MOLECULE NCAM; POLYSIALIC ACID; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; CALMODULIN-BINDING; MARCKS DEFICIENCY; PROTEIN; RECEPTOR; EXPRESSION; MEMBRANE	Myristoylated alanine-rich C-kinase substrate (MARCKS) is an intracellular receptor for polysialic acid. MARCKS supports development, synaptic plasticity, and regeneration after injury. MARCKS binds with its functionally essential effector domain (ED) to polysialic acid. A 25-mer peptide comprising the ED of MARCKS stimulates neuritogenesis of primary hippocampal neurons after addition to the culture. This motivated us to investigate whether ED peptide has similar effects in spinal cord injury. ED peptide supported recovery and regrowth of monoaminergic axons in female, but not in male mice. Sex-specific differences in response to ED peptide application also occurred in cultured neurons. In female but not male neurons, the ED peptide enhanced neurite outgrowth that could be suppressed by inhibitors of the estrogen receptors alpha and beta, fibroblast growth factor receptor-1, protein kinase C, and matrix metalloproteinase 2. In addition, we observed female-specific elevation of phosphorylated MARCKS levels after ED peptide treatment. In male neurons, the ED peptide enhanced neuritogenesis in the presence of an androgen receptor inhibitor to the extent seen in ED peptide-treated female neurons. However, inhibition of androgen receptor did not lead to increased phosphorylation of MARCKS. These results provide insights into the functions of a novel compound contributing to gender-dependent regeneration.	[Theis, Thomas; Wei, Elena; Nguyen, Jennifer; Glynos, Vicci; Paranjape, Nikita; Askarifirouzjaei, Hadi; Khajouienejad, Leila; Young, Wise; Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA; [Theis, Thomas; Wei, Elena; Nguyen, Jennifer; Glynos, Vicci; Paranjape, Nikita; Askarifirouzjaei, Hadi; Khajouienejad, Leila; Young, Wise; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA; [Kumar, Suneel; Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08554 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA.; Schachner, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA.	schachner@dls.rutgers.edu	Berthiaume, Francois/ABD-2139-2020; Nguyen, Jennifer/GVS-4347-2022; Theis, Thomas/I-4247-2019; Kumar, Suneel/I-4404-2019	Theis, Thomas/0000-0001-5555-8501; Kumar, Suneel/0000-0003-4829-8654; Wei, Elena/0000-0003-2885-0659; Khajoueinejad, Leila/0000-0002-4269-3082	New Jersey Commission on Spinal Cord Research (NJSCR) [CSCR18ERG015]	New Jersey Commission on Spinal Cord Research (NJSCR)	New Jersey Commission on Spinal Cord Research (NJSCR), Grant/Award Number: CSCR18ERG015	Al-Shboul OA, 2018, BIOMED REP, V8, P283, DOI 10.3892/br.2018.1053; ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; ALLEN LAH, 1995, EMBO J, V14, P1109, DOI 10.1002/j.1460-2075.1995.tb07094.x; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bielecki B, 2016, P NATL ACAD SCI USA, V113, P14829, DOI 10.1073/pnas.1614826113; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; Chan WM, 2013, TRANSL STROKE RES, V4, P447, DOI 10.1007/s12975-012-0249-7; Chen X, 2019, P NATL ACAD SCI USA, V116, P5765, DOI 10.1073/pnas.1814909116; Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1; CRUTCHER KA, 1978, AM J ANAT, V153, P159, DOI 10.1002/aja.1001530110; David S, 2012, INT REV NEUROBIOL, V106, P127, DOI 10.1016/B978-0-12-407178-0.00006-5; Decuypere Jean-Paul, 2011, J Aging Res, V2011, P920178, DOI 10.4061/2011/920178; El Amri M, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0445-1; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; Fargo KN, 2008, HORM BEHAV, V53, P716, DOI 10.1016/j.yhbeh.2008.01.014; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Heller M, 2003, J NEUROCHEM, V84, P557, DOI 10.1046/j.1471-4159.2003.01537.x; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Janas T, 2001, ACTA BIOCHIM POL, V48, P163; Janas T, 2000, EUR BIOPHYS J BIOPHY, V29, P507, DOI 10.1007/s002490000097; Kataria H, 2016, MOL NEUROBIOL, V53, P4461, DOI 10.1007/s12035-015-9352-6; Kawashima T, 2018, NEUROSCI RES, V129, P32, DOI 10.1016/j.neures.2017.07.005; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kleene R, 2019, RESTOR NEUROL NEUROS, V37, P291, DOI 10.3233/RNN-190903; Kleene R, 2010, J BIOL CHEM, V285, P28968, DOI 10.1074/jbc.M110.114876; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Lin HY, 1998, MOL CELL BIOL, V18, P3762, DOI 10.1128/MCB.18.7.3762; LOBAUGH LA, 1990, J BIOL CHEM, V265, P18393; Loers G, 2017, J NEUROCHEM, V142, P392, DOI 10.1111/jnc.14076; Matsumoto A, 1997, BRAIN RES BULL, V44, P539, DOI 10.1016/S0361-9230(97)00240-2; McNamara RK, 1998, J COMP NEUROL, V397, P337; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Namekata K, 2012, GENES CELLS, V17, P688, DOI 10.1111/j.1365-2443.2012.01616.x; Pan HC, 2014, NEUROSCIENCE, V277, P356, DOI 10.1016/j.neuroscience.2014.06.069; Pooley AE, 2015, BRAIN RES, V1624, P19, DOI 10.1016/j.brainres.2015.07.015; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Saini V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26927; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; Swierczynski SL, 1996, DEV BIOL, V179, P135, DOI 10.1006/dbio.1996.0246; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Tajik A, 2020, ANAL BIOCHEM, V600, DOI 10.1016/j.ab.2020.113743; Theis T, 2018, MOL NEUROBIOL, V55, P8203, DOI 10.1007/s12035-018-0953-8; Theis T, 2017, MOL NEUROBIOL, V54, P4659, DOI 10.1007/s12035-016-0007-z; Theis T, 2013, J BIOL CHEM, V288, P6726, DOI 10.1074/jbc.M112.444034; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; VanderHorst VGJM, 2006, J CHEM NEUROANAT, V31, P2, DOI 10.1016/j.jchemneu.2005.08.003; Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b; Westphal N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09468-8; Westphal N, 2016, MOL CELL NEUROSCI, V74, P114, DOI 10.1016/j.mcn.2016.05.003; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Xiao ZF, 2016, SCI CHINA LIFE SCI, V59, P647, DOI 10.1007/s11427-016-5080-z; Yin Y, 2015, WORLD J GASTROENTERO, V21, P4536, DOI 10.3748/wjg.v21.i15.4536; ZANGAR RC, 1995, CARCINOGENESIS, V16, P2593, DOI 10.1093/carcin/16.10.2593; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhu H, 2016, CELL TRANSPLANT, V25, P1925, DOI 10.3727/096368916X691411	72	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12677	12690		10.1096/fj.202000026RR	http://dx.doi.org/10.1096/fj.202000026RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729988				2022-12-28	WOS:000556803600001
J	Kim, YY; Um, JH; Shin, DJ; Jeong, DJ; Hong, YB; Yun, JH				Kim, Young Yeon; Um, Jee-Hyun; Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho			p53-mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells	FASEB JOURNAL			English	Article						cellular senescence; Drp1; mitochondrial dynamics; p53; PKA	GIANT MITOCHONDRIA; ONCOGENIC RAS; LIFE-SPAN; P53; PHOSPHORYLATION; DRP1; TRANSLOCATION; TRANSCRIPTION; INVOLVEMENT; DYSFUNCTION	The tumor suppressor p53 is known as a critical mediator of many cellular processes, including cellular senescence, but its role in mitochondrial dynamics is not fully understood. We have previously shown that p53 regulates mitochondrial dynamics via the PKA-Drp1 pathway to induce cellular senescence. In this study, to further understand the role of p53-dependent regulation of mitochondrial dynamics, the effect of p53 expression on mitochondrial morphology was examined in various cancer cell lines and normal human cells. We found that p53 induced remarkable mitochondrial elongation and cellular senescence in various cancer cells regardless of their p53 status. p53 also induced mitochondrial elongation in various human primary normal cells, suggesting that p53-mediated mitochondrial elongation is a general phenomenon. Moreover, we found that p53 plays an essential role in mitochondrial elongation in H-Ras-induced cellular senescence and in the replicative senescence of normal human cells. Treatment with the MDM-2 antagonist Nutlin-3a also induced mitochondrial elongation through the PKA-Drp1 pathway in IMR90 normal human cells. Furthermore, the inhibition of PKA activity in late-passage normal cells significantly reduced both mitochondrial elongation and cellular senescence, suggesting that the p53-PKA pathway is essential for maintaining the senescence phenotype in normal cells. Together, these results further confirm the direct regulation of mitochondrial dynamics by p53 and the important role of p53-mediated mitochondrial elongation in cellular senescence.	[Kim, Young Yeon; Um, Jee-Hyun; Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho] Dong A Univ, Peripheral Neuropathy Res Ctr, Coll Med, Busan, South Korea; [Kim, Young Yeon; Um, Jee-Hyun; Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho] Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea; [Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho] Dong A Univ, Grad Sch, Dept Translat Biomed Sci, Busan, South Korea	Dong A University; Dong A University; Dong A University	Kim, YY; Yun, JH (corresponding author), Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea.; Kim, YY; Yun, JH (corresponding author), Dong A Univ, Grad Sch, Busan 49201, South Korea.	kyy8191@dau.ac.kr; yunj@dau.ac.kr		Yun, Jeanho/0000-0001-7700-5123				Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711; Chiao YA, 2020, ELIFE, V9, DOI 10.7554/eLife.55513; COLEMAN R, 1987, GERONTOLOGY, V33, P34, DOI 10.1159/000212851; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Kim MA, 2007, EXP MOL MED, V39, P205, DOI 10.1038/emm.2007.23; Kim YY, 2020, FASEB J, V34, P2451, DOI 10.1096/fj.201901747RR; Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MURAKOSHI M, 1985, Tokai Journal of Experimental and Clinical Medicine, V10, P531; Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Saleem A, 2015, AM J PHYSIOL-CELL PH, V308, pC319, DOI 10.1152/ajpcell.00253.2014; SATO T, 1975, ACTA PATHOL JAPON, V25, P403; Sebastian D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Seo KS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00552; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wiley CD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20000-4; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287	46	4	4	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21319	10.1096/fj.202002007R	http://dx.doi.org/10.1096/fj.202002007R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433933				2022-12-28	WOS:000647789600060
J	Wu, YF; Wang, D; Wei, F; Xiong, F; Zhang, SS; Gong, ZJ; Shi, L; Li, XY; Xiang, B; Ma, J; Deng, H; He, Y; Liao, QJ; Zhang, WL; Li, XL; Li, Y; Guo, C; Zeng, ZY; Li, GY; Xiong, W				Wu, Yingfen; Wang, Dan; Wei, Fang; Xiong, Fang; Zhang, Shanshan; Gong, Zhaojian; Shi, Lei; Li, Xiayu; Xiang, Bo; Ma, Jian; Deng, Hao; He, Yi; Liao, Qianjin; Zhang, Wenling; Li, Xiaoling; Li, Yong; Guo, Can; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei			EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1	FASEB JOURNAL			English	Article						cytoskeletal dynamic assembly; EBV&#8208; miR&#8208; BART12; EMT; gastric carcinoma; nasopharyngeal carcinoma; TPPP1	VIRUS-ENCODED MICRORNAS; EPITHELIAL-MESENCHYMAL TRANSITION; COIL KINASE ROCK; NASOPHARYNGEAL CARCINOMA; MICROTUBULE DYNAMICS; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; NAB-PACLITAXEL; METASTASIS; EXPRESSION	Epstein-Barr virus (EBV) infection leads to cancers with an epithelial origin, such as nasopharyngeal cancer and gastric cancer, as well as multiple blood cell-based malignant tumors, such as lymphoma. Interestingly, EBV is also the first virus found to carry genes encoding miRNAs. EBV encodes 25 types of pre-miRNAs which are finally processed into 44 mature miRNAs. Most EBV-encoded miRNAs were found to be involved in the occurrence and development of EBV-related tumors. However, the function of EBV-miR-BART12 remains unclear. The findings of the current study revealed that EBV-miR-BART12 binds to the 3'UTR region of Tubulin Polymerization-Promoting Protein 1 (TPPP1) mRNA and downregulates TPPP1, thereby promoting the invasion and migration of EBV-related cancers, such as nasopharyngeal cancer and gastric cancer. The mechanism underlying this process was found to be the inhibition of TPPP1 by EBV-miRNA-BART12, which, in turn, inhibits the acetylation of alpha-tubulin, and promotes the dynamic assembly of microtubules, remodels the cytoskeleton, and enhances the acetylation of beta-catenin. beta-catenin activates epithelial to mesenchymal transition (EMT). These two processes synergistically promote the invasion and metastasis of tumor cells. To the best of our knowledge, this is the first study to reveal the role of EBV-miRNA-BART12 in the development of EBV-related tumors as well as the mechanism underlying this process, and suggests potential targets and strategies for the treatment of EBV-related tumors.	[Wu, Yingfen; He, Yi; Liao, Qianjin; Li, Xiaoling; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei] Cent South Univ, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Wu, Yingfen; He, Yi; Liao, Qianjin; Li, Xiaoling; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Wang, Dan; Wei, Fang; Xiang, Bo; Ma, Jian; Zhang, Wenling; Li, Xiaoling; Guo, Can; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei] Cent South Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Changsha, Peoples R China; [Xiong, Fang; Zhang, Shanshan] Cent South Univ, Xiangya Hosp, Dept Stomatol, Changsha, Peoples R China; [Gong, Zhaojian; Shi, Lei] Cent South Univ, Xiangya Hosp 2, Dept Oral & Maxillofacial Surg, Changsha, Peoples R China; [Li, Xiayu; Deng, Hao] Cent South Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Peoples R China; [Li, Yong] Baylor Coll Med, Dept Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Baylor College of Medicine	Xiong, W (corresponding author), Cent South Univ, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.; Xiong, W (corresponding author), Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China.	xiongwei@csu.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	Li, Yong/0000-0001-8838-1714	National Natural Science Foundation of China [81772928, 81702907, 81772901, 81803025, 81872278, 81972776]; Overseas Expertise Introduction Project for Discipline Innovation [111-2-12]; Natural Science Foundation of Hunan Province [2018JJ3815, 2018JJ3704, 2018SK21210, 2018SK21211, 2019JJ50354, 2019JJ50872, 2019JJ50778, 2020JJ4125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Overseas Expertise Introduction Project for Discipline Innovation; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	The National Natural Science Foundation of China, Grant/Award Number: 81772928, 81702907, 81772901, 81803025, 81872278 and 81972776; The Overseas Expertise Introduction Project for Discipline Innovation, Grant/Award Number: (111 Project):No. 111-2-12; The Natural Science Foundation of Hunan Province, Grant/Award Number: 2018JJ3815, 2018JJ3704, 2018SK21210, 2018SK21211, 2019JJ50354, 2019JJ50872, 2019JJ50778 and 2020JJ4125	Abdallah MOE, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00316; Ambrosio MR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-12; Asthana J, 2013, J BIOL CHEM, V288, P22516, DOI 10.1074/jbc.M113.489328; Bando H, 2018, EUR J CANCER, V91, P86, DOI 10.1016/j.ejca.2017.11.032; Bang YJ, 2017, LANCET ONCOL, V18, P1637, DOI 10.1016/S1470-2045(17)30682-4; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Bo H, 2019, ONCOL REP, V41, P2431, DOI 10.3892/or.2019.7027; Bu HH, 2014, INT J PHARMACEUT, V471, P206, DOI 10.1016/j.ijpharm.2014.05.039; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Cai LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8353; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Choi SJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061286; Deng XY, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0428-0; Dolcetti R, 2013, SEMIN CANCER BIOL, V23, P441, DOI 10.1016/j.semcancer.2013.07.005; Fan CM, 2021, SCI CHINA LIFE SCI, V64, P534, DOI 10.1007/s11427-019-1735-4; Fan CM, 2019, J CANCER, V10, P3926, DOI 10.7150/jca.31345; Fan CM, 2019, CARCINOGENESIS, V40, P380, DOI 10.1093/carcin/bgy143; Fan CM, 2018, J CANCER, V9, P2852, DOI 10.7150/jca.25460; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; GELMON K, 1994, LANCET, V344, P1267, DOI 10.1016/S0140-6736(94)90754-4; Haakenson J, 2013, INT J MOL SCI, V14, P9514, DOI 10.3390/ijms14059514; He BY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.253; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huh S, 2019, MOLECULES, V24, DOI 10.3390/molecules24213834; Iaconelli J, 2015, ACS CHEM BIOL, V10, P883, DOI 10.1021/cb500838r; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Inokawa Y, 2016, ANTICANCER RES, V36, P4639, DOI 10.21873/anticanres.11014; Jiang XJ, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01709-5; Jung YJ, 2014, J VIROL, V88, P9027, DOI 10.1128/JVI.00721-14; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kim H, 2015, CANCER LETT, V356, P733, DOI 10.1016/j.canlet.2014.10.023; Kinoshita J, 2014, ONCOL REP, V32, P89, DOI 10.3892/or.2014.3210; Kundranda Madappa N, 2015, Drug Des Devel Ther, V9, P3767, DOI 10.2147/DDDT.S88023; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lei T, 2013, INT J CANCER, V133, P79, DOI 10.1002/ijc.28007; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Lian Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0918-9; Liu SL, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5192-x; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Marquitz AR, 2014, J VIROL, V88, P1389, DOI 10.1128/JVI.02662-13; Meng H, 2015, ACS NANO, V9, P3540, DOI 10.1021/acsnano.5b00510; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Miyaushiro S, 2015, INTERNAL MED, V54, P1455, DOI 10.2169/internalmedicine.54.3917; Mo YZ, 2019, J CANCER, V10, P3789, DOI 10.7150/jca.31166; Mo YZ, 2019, J CANCER, V10, P2342, DOI 10.7150/jca.30454; Myachina F, 2017, DEVELOPMENT, V144, P4573, DOI 10.1242/dev.156109; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Nourse JP, 2012, J VIROL METHODS, V184, P46, DOI 10.1016/j.jviromet.2012.05.005; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Oh ST, 2004, VIROLOGY, V320, P330, DOI 10.1016/j.virol.2003.12.005; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Portis T, 2003, BLOOD, V102, P4166, DOI 10.1182/blood-2003-04-1018; Preusser M, 2007, ACTA NEUROPATHOL, V113, P213, DOI 10.1007/s00401-006-0173-6; Qiu J, 2014, P NATL ACAD SCI USA, V111, P11157, DOI 10.1073/pnas.1406136111; Rajesh R, 2011, PLOS ONE, V6; Ren DX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1144-6; Ribeiro J, 2017, CANCER LETT, V404, P37, DOI 10.1016/j.canlet.2017.07.010; Roschewski M, 2012, BEST PRACT RES CL HA, V25, P75, DOI 10.1016/j.beha.2012.01.005; Ross N, 2013, AM J BLOOD RES, V3, P210; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schofield AV, 2013, BIOCHEM BIOPH RES CO, V436, P571, DOI 10.1016/j.bbrc.2013.05.076; Schofield AV, 2013, J BIOL CHEM, V288, P7907, DOI 10.1074/jbc.M112.441048; Schofield AV, 2012, J BIOL CHEM, V287, P43620, DOI 10.1074/jbc.M112.394965; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Shinozaki-Ushiku A, 2015, J VIROL, V89, P5581, DOI 10.1128/JVI.03639-14; Song YL, 2016, ONCOTARGET, V7, P36783, DOI 10.18632/oncotarget.9170; Tang L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0758-7; Tang T, 2020, MOL ONCOL, V14, P2251, DOI 10.1002/1878-0261.12703; Tang YY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0825-x; Tsao SW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0270; Tu CF, 2018, CARCINOGENESIS, V39, P1517, DOI 10.1093/carcin/bgy108; Tu CF, 2017, J VIROL, V91, DOI 10.1128/JVI.00301-17; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WALLIN M, 1995, INT REV CYTOL, V157, P1, DOI 10.1016/S0074-7696(08)62155-5; Wang D, 2020, FASEB J, V34, P8012, DOI 10.1096/fj.202000039RR; Wei F, 2018, BRIT J CANCER, V118, P233, DOI 10.1038/bjc.2017.385; Wen X, 2018, THERANOSTICS, V8, P5676, DOI 10.7150/thno.28538; Worch S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-1; Wu CC, 2019, SCI CHINA LIFE SCI, V62, P640, DOI 10.1007/s11427-018-9461-5; Wu YF, 2019, J CANCER, V10, P2185, DOI 10.7150/jca.30222; Xiao K, 2016, J CANCER, V7, P214, DOI 10.7150/jca.13150; Xiong F, 2019, CHINESE MED J-PEKING, V132, P749, DOI 10.1097/CM9.0000000000000132; Yan QJ, 2015, ONCOTARGET, V6, P41766, DOI 10.18632/oncotarget.6155; Ye YF, 2013, BIOCHEM BIOPH RES CO, V436, P19, DOI 10.1016/j.bbrc.2013.05.008; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zeng ZY, 2014, SCI CHINA LIFE SCI, V57, P315, DOI 10.1007/s11427-013-4577-y; Zhang N, 2013, J BIOL CHEM, V288, P9396, DOI 10.1074/jbc.M112.395913; Zhao J, 2020, CANCER LETT, V477, P131, DOI 10.1016/j.canlet.2020.02.010; Zheng X, 2018, J VIROL, V92, DOI 10.1128/JVI.01022-18; Zhou X, 2017, P NATL ACAD SCI USA, V114, pE10667, DOI 10.1073/pnas.1710506114; Zhu KJ, 2020, CANCER LETT, V492, P11, DOI 10.1016/j.canlet.2020.07.028	93	16	16	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16205	16223		10.1096/fj.202001508R	http://dx.doi.org/10.1096/fj.202001508R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33094864				2022-12-28	WOS:000586258700001
J	Chen, JF; Mishra, R; Yu, YQ; McDonald, JG; Eckert, KM; Gao, L; Mendelson, CR				Chen, Jingfei; Mishra, Ritu; Yu, Yaqin; McDonald, Jeffrey G.; Eckert, Kaitlyn M.; Gao, Lu; Mendelson, Carole R.			Decreased 11 beta-hydroxysteroid dehydrogenase 1 in lungs of steroid receptor coactivator (Src)-1/-2double-deficient fetal mice is caused by impaired glucocorticoid and cytokine signaling	FASEB JOURNAL			English	Article						11 beta-hydroxysteroid dehydrogenase type 1; cytokines; fetal lung development; glucocorticoids; steroid receptor coactivators (SRCs)	NF-KAPPA-B; PROTEIN-A GENE; CYCLIC ADENOSINE 3,5-MONOPHOSPHATE; PLATELET-ACTIVATING-FACTOR; BINDING-PROTEIN; C/EBP-BETA; TRANSCRIPTION FACTORS; TYPE-1 EXPRESSION; TARGETED DISRUPTION; CROSS-TALK	Our previous research revealed that steroid receptor coactivators (Src)-1 and -2 serve a critical cooperative role in production of parturition signals, surfactant protein A and platelet-activating factor, by the developing mouse fetal lung (MFL). To identify the global landscape of genes in MFL affected bySrc-1/-2double-deficiency, we conducted RNA-seq analysis of lungs from 18.5 days post-coitum (dpc)Src-1(-/-)/-2(-/-)(dKO)vs. WT fetuses. One of the genes most highly downregulated (similar to 4.8 fold) inSrc-1/-2dKO fetal lungs encodes 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), which catalyzes conversion of inactive 11-dehydrocorticosterone to the glucocorticoid receptor (GR) ligand, corticosterone. Glucocorticoids were reported to upregulate 11 beta-HSD1 expression in various cell types via induction of C/EBP transcription factors. We observed thatC/ebp alpha andC/ebp beta mRNA and protein were markedly reduced inSrc-1/-2double-deficient (Src-1/-2(d/d)) fetal lungs, compared to WT. Moreover, glucocorticoid induction of11 beta-hsd1,C/ebp alpha and C/ebp beta in cultured MFL epithelial cells was prevented by the SRC family inhibitor, SI-2. Cytokines also contribute to the induction of 11 beta-HSD1. Expression of IL-1 beta and TNF alpha, which dramatically increased toward term in lungs of WT fetuses, was markedly reduced inSrc-1/-2(d/d)fetal lungs. Our collective findings suggest that impaired lung development and surfactant synthesis inSrc-1/-2(d/d)fetuses are likely caused, in part, by decreased GR and cytokine induction of C/EBP and NF-kappa B transcription factors. This results in reduced 11 beta-HSD1 expression and glucocorticoid signaling within the fetal lung, causing a break in the glucocorticoid-induced positive feedforward loop.	[Chen, Jingfei] Cent South Univ, Xiangya Hosp, Dept Obstet & Gynecol, Changsha, Peoples R China; [Chen, Jingfei; Mishra, Ritu; Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Yu, Yaqin; Gao, Lu] Second Mil Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [McDonald, Jeffrey G.; Eckert, Kaitlyn M.] Univ Texas Southwestern Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [McDonald, Jeffrey G.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX USA; [Gao, Lu] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai, Peoples R China; [Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA	Central South University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Naval Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shanghai Jiao Tong University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Gao, L (corresponding author), Second Mil Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	Lu.gao@smmu.edu.cn; carole.mendelson@utsouthwestern.edu			NIH [R01-HL050022, P01HD087150, P01-HL020948]; Burroughs Wellcome Preterm Birth Grant [1019823]; National Natural Science Foundation of China (NSFC) [81771608]; National Key Research and Development Project [2017YFC1001404]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Preterm Birth Grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This work was supported by NIH grants R01-HL050022 (CRM) and P01HD087150 (CRM), Burroughs Wellcome Preterm Birth Grant #1019823 (CRM), NIH Grant P01-HL020948 (JGM), National Natural Science Foundation of China (NSFC) 81771608 (LG), National Key Research and Development Project No. 2017YFC1001404 (LG)	Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; Benlhabib H, 2011, MOL CELL BIOL, V31, P1949, DOI 10.1128/MCB.01063-10; Bird AD, 2015, MOL ENDOCRINOL, V29, P158, DOI 10.1210/me.2014-1362; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Breed DR, 1997, ENDOCRINOLOGY, V138, P5527, DOI 10.1210/en.138.12.5527; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Bry K, 1997, J CLIN INVEST, V99, P2992, DOI 10.1172/JCI119494; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200; COGSWELL JP, 1994, J IMMUNOL, V153, P712; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Esteves CL, 2014, J CLIN ENDOCR METAB, V99, pE160, DOI 10.1210/jc.2013-1708; Esteves CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075874; Frenkel RA, 1996, PROG LIPID RES, V35, P155, DOI 10.1016/0163-7827(96)00002-1; Gao B, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180394; Gao L, 2015, J CLIN INVEST, V125, P2808, DOI 10.1172/JCI78544; Garbrecht MR, 2006, BIOL NEONATE, V89, P109, DOI 10.1159/000088653; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; HOFFMAN DR, 1988, LIPIDS, V23, P96, DOI 10.1007/BF02535287; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hong H, 1999, J BIOL CHEM, V274, P3496, DOI 10.1074/jbc.274.6.3496; Hundertmark S, 2002, HORM METAB RES, V34, P537, DOI 10.1055/s-2002-35424; Hundertmark S, 2002, HORM METAB RES, V34, P545, DOI 10.1055/s-2002-35425; Ignatova ID, 2009, AM J PHYSIOL-ENDOC M, V296, pE367, DOI 10.1152/ajpendo.90531.2008; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Islam KN, 2002, MOL ENDOCRINOL, V16, P1428, DOI 10.1210/me.16.6.1428; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lajoie M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-231; Lee SK, 1999, MOL ENDOCRINOL, V13, P1924, DOI 10.1210/me.13.11.1924; Lee WK, 2020, ENDOCR-RELAT CANCER, V27, P209, DOI 10.1530/ERC-19-0482; LI F, 1995, AM J PHYSIOL-LUNG C, V269, pL241, DOI 10.1152/ajplung.1995.269.2.L241; Li JX, 1998, J BIOL CHEM, V273, P4592, DOI 10.1074/jbc.273.8.4592; Li WJ, 2006, ENDOCRINOLOGY, V147, P2490, DOI 10.1210/en.2005-1626; Liu D, 2008, AM J PHYSIOL-LUNG C, V295, pL264, DOI 10.1152/ajplung.00069.2008; Liu DY, 2009, MOL ENDOCRINOL, V23, P772, DOI 10.1210/me.2008-0282; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Louet JF, 2010, CELL METAB, V12, P606, DOI 10.1016/j.cmet.2010.11.009; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Mendelson CR, 1998, BBA-MOL BASIS DIS, V1408, P132, DOI 10.1016/S0925-4439(98)00063-5; Mishra R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00037-18; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155; Provost PR, 2005, ENDOCRINOLOGY, V146, P2239, DOI 10.1210/en.2005-0077; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; Rosenberg E, 2002, BBA-GENE STRUCT EXPR, V1575, P82, DOI 10.1016/S0167-4781(02)00287-7; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; SALOMON DS, 1979, ENDOCRINOLOGY, V104, P154, DOI 10.1210/endo-104-1-154; SAWAI S, 1993, DEVELOPMENT, V117, P1445; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; SHIMIZU H, 1994, GENE, V149, P305; SMITH BT, 1973, STEROIDS, V22, P515, DOI 10.1016/0039-128X(73)90007-X; Song XZ, 2016, P NATL ACAD SCI USA, V113, P4970, DOI 10.1073/pnas.1604274113; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Stashi E, 2014, TRENDS ENDOCRIN MET, V25, P337, DOI 10.1016/j.tem.2014.05.004; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang YN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9230; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; TORDAY JS, 1976, STEROIDS, V27, P869, DOI 10.1016/0039-128X(76)90145-8; TORDAY JS, 1975, ENDOCRINOLOGY, V96, P1462, DOI 10.1210/endo-96-6-1462; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Winnay JN, 2006, ENDOCRINOLOGY, V147, P1322, DOI 10.1210/en.2005-0751; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; Yang Z, 2009, ENDOCRINE, V36, P404, DOI 10.1007/s12020-009-9245-4; Yang Z, 2009, J CLIN ENDOCR METAB, V94, P306, DOI 10.1210/jc.2008-1534; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Young PP, 1996, AM J PHYSIOL-LUNG C, V271, pL287, DOI 10.1152/ajplung.1996.271.2.L287; Young PP, 1997, MOL ENDOCRINOL, V11, P1082, DOI 10.1210/me.11.8.1082; Zhang ZQ, 2010, J BIOL CHEM, V285, P33092, DOI 10.1074/jbc.M110.130377	86	3	4	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16243	16261		10.1096/fj.202001809R	http://dx.doi.org/10.1096/fj.202001809R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070362	Green Accepted			2022-12-28	WOS:000581166400001
J	Torices, S; Roberts, SA; Park, M; Malhotra, A; Toborek, M				Torices, Silvia; Roberts, Samantha A.; Park, Minseon; Malhotra, Arun; Toborek, Michal			Occludin, caveolin-1, and Alix form a multi-protein complex and regulate HIV-1 infection of brain pericytes	FASEB JOURNAL			English	Article						Alix; blood-brain barrier; caveolin-1; HIV-1; pericytes	CEREBROSPINAL-FLUID; TIGHT JUNCTIONS; EXPRESSION; BINDING; ALIX/AIP1; DISRUPTS; TSG101; HEALTH; DOMAIN; P6	HIV-1 enters the brain by altering properties of the blood-brain barrier (BBB). Recent evidence indicates that among cells of the BBB, pericytes are prone to HIV-1 infection. Occludin (ocln) and caveolin-1 (cav-1) are critical determinants of BBB integrity that can regulate barrier properties of the BBB in response to HIV-1 infection. Additionally, Alix is an early acting endosomal factor involved in HIV-1 budding from the cells. The aim of the present study was to evaluate the role of cav-1, ocln, and Alix in HIV-1 infection of brain pericytes. Our results indicated that cav-1, ocln, and Alix form a multi-protein complex in which they cross-regulate each other's expression. Importantly, the stability of this complex was affected by HIV-1 infection. Modifications of the complex resulted in diminished HIV-1 infection and alterations of the cytokine profile produced by brain pericytes. These results identify a novel mechanism involved in HIV-1 infection contributing to a better understanding of the HIV-1 pathology and the associated neuroinflammatory responses.	[Torices, Silvia; Roberts, Samantha A.; Park, Minseon; Malhotra, Arun; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA	University of Miami	Torices, S; Toborek, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA.	sxt736@med.miami.edu; mtoborek@med.miami.edu			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL126559]; HHS | NIH | National Institute of Mental Health (NIMH) [MH122235, MH072567]; HHS | NIH | National Institute on Drug Abuse (NIDA) [DA039576, DA040537, DA044579, DA047157, DA050528]; American Heart Association (AHA) [20POST35211181]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); HHS | NIH | National Institute of Mental Health (NIMH); HHS | NIH | National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); American Heart Association (AHA)(American Heart Association)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL126559; HHS | NIH | National Institute of Mental Health (NIMH), Grant/Award Number: MH122235 and MH072567; HHS | NIH | National Institute on Drug Abuse (NIDA), Grant/Award Number: DA039576, DA040537, DA044579, DA047157 and DA050528; American Heart Association (AHA), Grant/Award Number: 20POST35211181	Armulik A, 2011, THER DELIV, V2, P419, DOI 10.4155/TDE.11.23; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bertrand L, 2019, BRAIN, V142, P502, DOI 10.1093/brain/awy339; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Bohannon DG, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1463-y; Boneberg EM, 2002, INFLAMM RES, V51, P119, DOI 10.1007/PL00000283; Bordoni V, 2020, CYTOKINE, V125, DOI 10.1016/j.cyto.2019.154839; Castro V, 2018, J CEREBR BLOOD F MET, V38, P317, DOI 10.1177/0271678X17720816; Castro V, 2016, FASEB J, V30, P1234, DOI 10.1096/fj.15-277673; Cho HJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00410; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; Giovannoni G, 1998, J NEUROL SCI, V156, P53, DOI 10.1016/S0022-510X(98)00021-5; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Guerra DAP, 2018, ANGIOGENESIS, V21, P667, DOI 10.1007/s10456-018-9621-x; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hill J, 2014, J NEUROIMMUNE PHARM, V9, P591, DOI 10.1007/s11481-014-9557-x; Huang QY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1387-y; Kamouchi M, 2011, CELL MOL NEUROBIOL, V31, P175, DOI 10.1007/s10571-010-9605-x; Ku PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096950; Lamaze C, 2015, BIOMED J, V38, P367, DOI 10.4103/2319-4170.164229; Lin SS, 2010, J VIROL, V84, P9487, DOI 10.1128/JVI.00763-10; Llano M, 2002, J VIROL, V76, P9152, DOI 10.1128/JVI.76.18.9152-9164.2002; Lynch RD, 2007, EXP CELL RES, V313, P2597, DOI 10.1016/j.yexcr.2007.05.009; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; MCARTHUR JC, 1992, NEUROLOGY, V42, P1707, DOI 10.1212/WNL.42.9.1707; Mergia A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060129; Miller NM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00287; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Nakagawa S, 2012, J CELL MOL MED, V16, P2950, DOI 10.1111/j.1582-4934.2012.01622.x; Nemeth CL, 2015, NEUROSCIENCE, V302, P165, DOI 10.1016/j.neuroscience.2014.09.016; Nusrat A, 2000, J CELL SCI, V113, P1771; Park M, 2012, J CELL MOL MED, V16, P362, DOI 10.1111/j.1582-4934.2011.01320.x; Persidsky Y, 2016, J CEREBR BLOOD F MET, V36, P794, DOI 10.1177/0271678X15606149; Piekna-Przybylska D, 2019, J NEUROVIROL, V25, P114, DOI 10.1007/s13365-018-0693-6; Sa-Pereira I, 2012, MOL NEUROBIOL, V45, P327, DOI 10.1007/s12035-012-8244-2; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sena IFG, 2018, CANCER MED-US, V7, P1232, DOI 10.1002/cam4.1375; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Van Duyne R, 2019, P NATL ACAD SCI USA, V116, P9040, DOI 10.1073/pnas.1820333116; Van Itallie CM, 2012, ANN NY ACAD SCI, V1257, P103, DOI 10.1111/j.1749-6632.2012.06535.x; Wang XM, 2011, J VIROL, V85, P5483, DOI 10.1128/JVI.00254-11; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008; Zou HF, 2011, MECH AGEING DEV, V132, P533, DOI 10.1016/j.mad.2011.11.001; Zou M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3403206	67	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16319	16332		10.1096/fj.202001562R	http://dx.doi.org/10.1096/fj.202001562R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058236	hybrid, Green Published			2022-12-28	WOS:000581161200001
J	Lee, SY; Lee, YY; Choi, JS; Kim, KS; Min, DS; Park, SY; Han, JS				Lee, So Young; Lee, Yun Young; Choi, Jung-Sub; Kim, Kyeong Soo; Min, Do Sik; Park, Shin-Young; Han, Joong-Soo			Nitration of protein phosphatase 2A increases via Epac1/PLC epsilon/CaMKII/HDAC5/iNOS cascade in human endometrial stromal cell decidualization	FASEB JOURNAL			English	Article						decidualization; human endometrial stromal cells; nitration; protein phosphatase 2A	NITRIC-OXIDE SYNTHASE; DEPENDENT ACTIVATION; PHOSPHOLIPASE-C; EPAC PROTEINS; KINASE-II; EXPRESSION; RECEPTOR; ROLES; UTERUS; WOMEN	Decidualization of the endometrial stroma is an essential differentiation process for embryo implantation and maintenance of pregnancy. We previously reported that protein phosphatase 2A (PP2A) acts as a key mediator during cAMP-induced decidualization of human endometrial stromal cells (hESCs). However, the mechanism underlying its activation has remained obscure in hESCs. In the present study, we aimed to reveal the mechanism that induces the nitration of PP2A catalytic subunit (PP2Ac) during cAMP-induced decidualization of hESCs. First, cAMP-induced PP2Ac nitration was significantly repressed using L-NAME, an inhibitor of nitric oxide synthase (NOS). Among several NOS isoforms, only inducible NOS (iNOS) was highly expressed in hESCs, indicating that iNOS directly induces the nitration of PP2Ac. Second, cAMP-induced iNOS expression and PP2Ac nitration were decreased by treatment with TSA, an inhibitor of histone deacetylase 5 (HDAC5). cAMP-induced phosphorylation of CaMKII and HDAC5 was suppressed by treatment with U73122 (an inhibitor of phospholipase C) or transfection of PLC epsilon siRNA. Finally, small G protein Rap1 and its guanine nucleotide exchange factor Epac1 were found to be involved in cAMP-induced PP2A activation. Taken together, our results suggest that PP2Ac nitration during cAMP-induced decidualization of hESCs is induced through the Epac1-Rap1-PLC epsilon-CaMKII-HDAC5-iNOS signaling pathway.	[Lee, So Young; Lee, Yun Young; Han, Joong-Soo] Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Biomed Sci, Seoul, South Korea; [Lee, Yun Young; Park, Shin-Young; Han, Joong-Soo] Hanyang Univ, Coll Med, Biomed Res Inst, Seoul 04763, South Korea; [Lee, Yun Young; Park, Shin-Young; Han, Joong-Soo] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 04763, South Korea; [Choi, Jung-Sub] Hanyang Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Kyeong Soo] Gyeongnam Natl Univ Sci & Technol, Dept Pharmaceut Engn, Jinju, South Korea; [Min, Do Sik] Yonsei Univ, Coll Pharm, Dept Pharm, Incheon, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University; Gyeongnam National University of Science and Technology; Yonsei University	Park, SY; Han, JS (corresponding author), Hanyang Univ, Coll Med, Biomed Res Inst, Seoul 04763, South Korea.; Park, SY; Han, JS (corresponding author), Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 04763, South Korea.	ttokttoki@hanyang.ac.kr; jshan@hanyang.ac.kr	Kim, Kyeong Soo/AAJ-6800-2021; park, shiny/ABY-8695-2022	park, shiny/0000-0002-6073-4634	Korea Health Industry Development Institute (KHIDI) [HI19C0611]; National Research Foundation of Korea (NRF) [NRF-2016R1A2B4015358, 2019R1A2B5B01069443]	Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	Korea Health Industry Development Institute (KHIDI), Grant/Award Number: HI19C0611; National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2016R1A2B4015358 and 2019R1A2B5B01069443	Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Barbieri M, 2009, HUM REPROD, V24, P1818, DOI 10.1093/humrep/dep089; Basu S, 2011, CURR PROTEIN PEPT SC, V12, P3, DOI 10.2174/138920311795659443; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chakravarti Bulbul, 2017, Curr Aging Sci, V10, P246, DOI 10.2174/1874609810666170315112634; Chen YZ, 2020, CANCER RES, V80, P2175, DOI 10.1158/0008-5472.CAN-19-1912; Chen YZ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0930-x; Cockcroft S, 2006, TRENDS BIOCHEM SCI, V31, P4, DOI 10.1016/j.tibs.2005.11.003; da Silva SG, 2019, REV SAUDE PUBL, V53, DOI [10.11606/S1518-8787.2019053000737, 10.11606/s1518-8787.2019053000737]; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deng YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19821; Egom EEA, 2011, AM J PHYSIOL-HEART C, V301, pH1487, DOI 10.1152/ajpheart.01003.2010; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030508; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Hamalainen M, 2008, PULM PHARMACOL THER, V21, P331, DOI 10.1016/j.pupt.2007.08.003; Han SJ, 2015, CELL, V163, P960, DOI 10.1016/j.cell.2015.10.034; Hong K, 2008, J BIOL CHEM, V283, P23129, DOI 10.1074/jbc.M800478200; Hwang JH, 2002, EXP MOL MED, V34, P194, DOI 10.1038/emm.2002.28; Ito M, 2012, J MOL ENDOCRINOL, V49, P193, DOI 10.1530/JME-12-0112; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kawarabayashi Y, 2012, MOL ENDOCRINOL, V26, P846, DOI 10.1210/me.2011-1259; Kusama K, 2013, PLACENTA, V34, P212, DOI 10.1016/j.placenta.2012.12.017; Kusama K, 2014, REPRODUCTION, V147, P897, DOI 10.1530/REP-13-0654; Lee SH, 2018, J ALLERGY CLIN IMMUN, V142, pe1316; Lee SY, 2016, FEBS J, V283, P4163, DOI 10.1111/febs.13914; Lezoualc'h F, 2016, CIRC RES, V118, P881, DOI 10.1161/CIRCRESAHA.115.306529; Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98; Mata-Perez C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01699; McGee SL, 2007, APPL PHYSIOL NUTR ME, V32, P852, DOI 10.1139/H07-082; Miclescu A, 2009, ACTA ANAESTH SCAND, V53, P1107, DOI 10.1111/j.1399-6576.2009.02054.x; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Mohseni J, 2013, GENET MOL BIOL, V36, P299, DOI 10.1590/S1415-47572013000300001; Mori MX, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00022; NATUZZI ES, 1993, BIOCHEM BIOPH RES CO, V194, P1, DOI 10.1006/bbrc.1993.1776; Norman J E, 1996, Rev Reprod, V1, P61, DOI 10.1530/revreprod/1.1.61; Ohama T, 2010, J BIOL CHEM, V285, P8711, DOI 10.1074/jbc.M109.099788; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Pereira L, 2012, J MOL CELL CARDIOL, V52, P283, DOI 10.1016/j.yjmcc.2011.10.016; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rosselli M, 1998, HUM REPROD UPDATE, V4, P3, DOI 10.1093/humupd/4.1.3; Ruiz-Hurtado G, 2013, J MOL CELL CARDIOL, V58, P162, DOI 10.1016/j.yjmcc.2012.11.021; Sakai N, 2003, J BIOL CHEM, V278, P16675, DOI 10.1074/jbc.M211715200; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Su RW, 2015, J CLIN ENDOCR METAB, V100, pE433, DOI 10.1210/jc.2014-3720; Telfer JF, 1997, MOL HUM REPROD, V3, P69, DOI 10.1093/molehr/3.1.69; Thomson AJ, 1997, HUM REPROD, V12, P2546, DOI 10.1093/humrep/12.11.2546; Torrent L, 2012, CURR ALZHEIMER RES, V9, P248, DOI 10.2174/156720512799361682; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wu F, 2009, CARDIOVASC RES, V81, P38, DOI 10.1093/cvr/cvn246; Yoon MS, 2007, BIOL REPROD, V76, P250, DOI 10.1095/biolreprod.106.056226; Zanner R, 2002, AM J PHYSIOL-CELL PH, V282, pC374, DOI 10.1152/ajpcell.00366.2001	59	1	1	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14407	14423		10.1096/fj.202001212R	http://dx.doi.org/10.1096/fj.202001212R		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	33000885	hybrid			2022-12-28	WOS:000575397800001
J	Fujimoto, D; Kuwabara, T; Hata, Y; Umemoto, S; Kanki, T; Nishiguchi, Y; Mizumoto, T; Hayata, M; Kakizoe, Y; Izumi, Y; Takahashi, S; Mukoyama, M				Fujimoto, Daisuke; Kuwabara, Takashige; Hata, Yusuke; Umemoto, Shuro; Kanki, Tomoko; Nishiguchi, Yoshihiko; Mizumoto, Teruhiko; Hayata, Manabu; Kakizoe, Yutaka; Izumi, Yuichiro; Takahashi, Satoru; Mukoyama, Masashi			Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease	FASEB JOURNAL			English	Article						diabetic nephropathy; ERAD; nephrin phosphorylation	ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; EXPRESSION; PHOSPHORYLATION; GLOMERULI; APOPTOSIS; DERLIN-2; LEPTIN; MODEL; MICE	Mesangial lesions and podocyte injury are essential manifestations of the progression of diabetic kidney disease (DKD). Although cross-communication between mesangial cells (MCs) and podocytes has recently been suggested by the results of single-nucleus RNA sequencing analyses, the molecular mechanisms and role in disease progression remain elusive. Our cDNA microarray data of diabetic mouse glomeruli suggested the involvement of endoplasmic reticulum (ER) stress in DKD pathophysiology. In vitro experiments revealed the suppression of the ER-associated degradation (ERAD) pathway and induction of apoptosis in podocytes that were stimulated with the supernatant of MCs cultured in high glucose conditions. In diabetic mice, ERAD inhibition resulted in exacerbated albuminuria, increased apoptosis in podocytes, and reduced nephrin expression associated with the downregulation of ERAD-related biomolecules. Flow cytometry analysis of podocytes isolated from MafB (a transcription factor known to be expressed in macrophages and podocytes)-GFP knock-in mice revealed that ERAD inhibition resulted in decreased nephrin phosphorylation. These findings suggest that an intraglomerular cross talk between MCs and podocytes can inhibit physiological ERAD processes and suppress the phosphorylation of nephrin in podocytes, which thereby lead to podocyte injury under diabetic conditions. Therapeutic intervention of the ERAD pathway through the cross talk between these cells is potentially a novel strategy for DKD.	[Fujimoto, Daisuke; Kuwabara, Takashige; Hata, Yusuke; Umemoto, Shuro; Kanki, Tomoko; Nishiguchi, Yoshihiko; Mizumoto, Teruhiko; Hayata, Manabu; Kakizoe, Yutaka; Izumi, Yuichiro; Mukoyama, Masashi] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Ibaraki, Japan	Kumamoto University; University of Tsukuba	Kuwabara, T; Mukoyama, M (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ktakasea@kumamoto-u.ac.jp; mmuko@kumamoto-u.ac.jp		Kuwabara, Takashige/0000-0003-3507-4328	JSPS KAKENHI [15K09268, 23390225, 17K09706]; Center for Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences [0090909005001011]; Takeda Science Foundation [09700220]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Center for Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by research grants from JSPS KAKENHI (Grant Numbers 15K09268, 23390225, 17K09706), Strategic Grant from Center for Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences (Grant Number 0090909005001011), and Takeda Science Foundation (Grant Number 09700220)	Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Cooper CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203905; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; Dandekar A, 2015, METHODS MOL BIOL, V1292, P205, DOI 10.1007/978-1-4939-2522-3_15; Denhez B, 2015, J BIOL CHEM, V290, P350, DOI 10.1074/jbc.M114.612721; Dimke H, 2015, CURR OPIN NEPHROL HY, V24, P231, DOI 10.1097/MNH.0000000000000117; Drozdova T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.86; Fujii Y, 2006, KIDNEY INT, V69, P1350, DOI 10.1038/sj.ki.5000317; Hassan H, 2016, J AM SOC NEPHROL, V27, P1055, DOI 10.1681/ASN.2015020191; Hata Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59970-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; Inoue T, 2019, KIDNEY INT, V95, P1318, DOI 10.1016/j.kint.2018.11.035; Iwashita Y, 2016, AM J PHYSIOL-RENAL, V310, pF1206, DOI 10.1152/ajprenal.00519.2015; Izumi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184185; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Kuwabara T, 2014, CLIN EXP NEPHROL, V18, P584, DOI 10.1007/s10157-013-0922-5; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Leung JCK, 2018, SEMIN NEPHROL, V38, P485, DOI 10.1016/j.semnephrol.2018.05.018; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Madhusudhan T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7496; Mori KP, 2017, J AM SOC NEPHROL, V28, P278, DOI 10.1681/ASN.2015101168; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; New LA, 2016, J AM SOC NEPHROL, V27, P2422, DOI 10.1681/ASN.2015091048; Nishiyama A, 2005, HYPERTENSION, V45, P710, DOI 10.1161/01.HYP.0000154681.38944.9a; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Ren GH, 2018, AM J PHYSIOL-RENAL, V314, pF471, DOI 10.1152/ajprenal.00691.2016; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sivaskandarajah GA, 2012, DIABETES, V61, P2958, DOI 10.2337/db11-1655; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Suganami T, 2004, FASEB J, V18, P127, DOI 10.1096/fj.04-2183fje; Suganami T, 2001, J AM SOC NEPHROL, V12, P2652, DOI 10.1681/ASN.V12122652; Suyama M, 2018, CLIN EXP NEPHROL, V22, P266, DOI 10.1007/s10157-017-1450-5; Suzaki Y, 2004, KIDNEY INT, V65, P1749, DOI 10.1111/j.1523-1755.2004.00576.x; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wilson PC, 2019, P NATL ACAD SCI USA, V116, P19619, DOI 10.1073/pnas.1908706116; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshimura Y, 2019, J AM SOC NEPHROL, V30, P304, DOI 10.1681/ASN.2018070747	45	8	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15577	15590		10.1096/fj.202000078RR	http://dx.doi.org/10.1096/fj.202000078RR		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32996639	hybrid			2022-12-28	WOS:000574658000001
J	Shapira, G; Shomron, N; Gurwitz, D				Shapira, Guy; Shomron, Noam; Gurwitz, David			Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates	FASEB JOURNAL			English	Article						alpha-1 antitrypsin; COVID-19; rs17580; rs28929474; SERPINA1		Infection rates, severity, and fatalities due to COVID-19, the pandemic mediated by SARS-CoV-2, vary greatly between countries. With few exceptions, these are lower in East and Southeast Asian and Sub-Saharan African countries compared with other regions. Epidemiological differences may reflect differences in border closures, lockdowns, and social distancing measures taken by each county, and by cultural differences, such as common use of face masks in East and Southeast Asian countries. The plasma serine protease inhibitor alpha-1 antitrypsin was suggested to protect from COVID-19 by inhibiting TMPRSS2, a cell surface serine protease essential for the SARS-CoV-2 cell entry. Here, we present evidence that population differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in the COVID-19 epidemiology. Our study compared reported national estimates for the major alpha-1 antitrypsin deficiency alleles PiZ and PiS (SERPINA1rs28929474 and rs17580, respectively) with the Johns Hopkins University Coronavirus Resource Center dataset. We found a significant positive correlation (R = .54,P = 1.98e-6) between the combined frequencies of the alpha-1 antitrypsin PiZ and PiS deficiency alleles in 67 countries and their reported COVID-19 mortality rates. Our observations suggest that alpha-1 antitrypsin deficiency alleles may contribute to national differences in COVID-19 infection, severity, and mortality rates. Population-wide screening for carriers of alpha-1 antitrypsin deficiency alleles should be considered for prioritizing individuals for stricter social distancing measures and for receiving a SARS-CoV-2 vaccine once it becomes available.	[Shapira, Guy; Shomron, Noam; Gurwitz, David] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Shomron, Noam; Gurwitz, David] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Shomron, Noam] Tel Aviv Univ, Edmond J Safra Ctr Bioinformat, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University	Shomron, N; Gurwitz, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	nshomron@tauex.tau.ac.il; gurwitz@tauex.tau.ac.il	; Gurwitz, David/E-7642-2013	Shapira, Guy/0000-0001-9376-4955; Gurwitz, David/0000-0002-9363-1869; Reis, AlessanRSS/0000-0001-8486-7469	Yoran Institute for Human Genome Research at Tel Aviv University; Adelis Foundation	Yoran Institute for Human Genome Research at Tel Aviv University; Adelis Foundation	D. Gurwitz is supported by the Yoran Institute for Human Genome Research at Tel Aviv University. The N. Shomron lab is partially supported by the Adelis Foundation. The authors thank Cindy Cohen for professional editorial assistance.	Azouz Nurit P, 2020, bioRxiv, DOI 10.1101/2020.05.04.077826; Blanco I, 2017, INT J CHRONIC OBSTR, V12, P1683, DOI 10.2147/COPD.S137852; Cirovic B, 2020, CELL HOST MICROBE, V28, P322, DOI 10.1016/j.chom.2020.05.014; de Loyola MB, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2157; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gaye B, 2020, NAT MED, V26, P996, DOI 10.1038/s41591-020-0960-y; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Iwasaki A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012481; Lindley VM, 2021, J AM COLL NUTR, V40, P98, DOI 10.1080/07315724.2020.1740629; McElvaney OJ, 2020, AM J RESP CRIT CARE, V202, P812, DOI 10.1164/rccm.202005-1583OC; Meltzer DO, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19722; Mitchell EL, 2018, CURR PATHOBIOL REP, V6, P97, DOI 10.1007/s40139-018-0164-z; Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z; Pervakova MY, 2020, PULM MED, V2020, DOI 10.1155/2020/9738032; Schuster R, 2020, CELL IMMUNOL, V356, DOI 10.1016/j.cellimm.2020.104177; Vaidyanathan G, 2020, NATURE, V585, P167, DOI 10.1038/d41586-020-02507-x; Vianello A, 2020, ARCH BRONCONEUMOL, V56, P609, DOI [10.1016/j.arbres.2020.05.015, 10.1016/j.arbr.2020.05.011]; Wettstein L, 2020, BIORXIV, P1, DOI [10.1101/2020.07.02.183764, DOI 10.1101/2020.07.02.183764]; Yamamoto M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060629; Yi R, 2004, PROTEOMICS, V4, P3477, DOI 10.1002/pmic.200400897; Yitbarek K, 2020, VACCINE, V38, P6374, DOI 10.1016/j.vaccine.2020.08.018	21	26	26	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14160	14165		10.1096/fj.202002097	http://dx.doi.org/10.1096/fj.202002097		SEP 2020	6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32960480	Green Published, Green Submitted			2022-12-28	WOS:000573862800001
J	Huot, S; Laflamme, C; Fortin, PR; Boilard, E; Pouliot, M				Huot, Sandrine; Laflamme, Cynthia; Fortin, Paul R.; Boilard, Eric; Pouliot, Marc			IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species	FASEB JOURNAL			English	Article						auto-immune diseases; Fc gamma receptors; human; immunecomplexesimmunology; lupusneutrophils; reactive oxygen species; signalling	FC-GAMMA-RIIA; HIGH-AFFINITY RECEPTOR; IMMUNE-COMPLEXES; DIAGNOSTIC MARKER; CD64 EXPRESSION; CROSS-LINKING; ACTIVATION; ADENOSINE; IMPACT; CYCLOOXYGENASE-2	Autoimmune complexes are an important feature of several autoimmune diseases such as lupus, as they contribute to tissue damage through the activation of immune cells. Neutrophils, key players in lupus, interact with immune complexes through Fc gamma receptors (FcgR). Incubation of neutrophils with aggregated-IgGs caused degranulation and increased the surface expression of FcgRI within minutes in a concentration-dependent fashion. After 30 minutes, IgG aggregates (1 mg/mL) upregulated FcgRI by 4.95 +/- 0.45-fold. FcgRI-positive neutrophils reached 67.24% +/- 6.88% on HA-IgGs stimulated neutrophils, from 3.12% +/- 1.62% in non-stimulated cells, ranking IgG-aggregates among the most potent known agonists. FcgRIIa, and possibly FcgRIIIa, appeared to mediate this upregulation. Also, FcgRI-dependent signaling proved necessary for reactive oxygen species (ROS) production in response to IgG-aggregates. Finally, combinations of bacterial materials with aggregates dramatically boosted ROS production. This work suggests FcgRI as an essential component in the response of human neutrophils to immune complexes leading to the production of ROS, which may help explain how neutrophils contribute to tissue damage associated with immune complex-associated diseases, such as lupus.	[Huot, Sandrine; Laflamme, Cynthia; Boilard, Eric; Pouliot, Marc] Univ Laval, CHU Quebec, Fac Med, Ctr Rech,Dept Microbiol & Immunol, 2705 Laurier Blvd,Off T1-49, Quebec City, PQ G1V 4G2, Canada; [Huot, Sandrine; Laflamme, Cynthia; Fortin, Paul R.; Boilard, Eric; Pouliot, Marc] Univ Laval, CHU Quebec, Ctr Rech, Axe Malad Infect & Immunitaires, Quebec City, PQ, Canada; [Fortin, Paul R.] Univ Laval, CHU Quebec, Dept Med, Div Rhumatol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Pouliot, M (corresponding author), Univ Laval, CHU Quebec, Fac Med, Ctr Rech,Dept Microbiol & Immunol, 2705 Laurier Blvd,Off T1-49, Quebec City, PQ G1V 4G2, Canada.	Marc.Pouliot@crchul.ulaval.ca		Fortin, Paul R./0000-0002-7278-2596; Pouliot, Marc/0000-0002-2466-5424	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP220733]	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP220733	Abd-Elhamid Yasser A, 2017, Egypt J Immunol, V24, P67; Ajmani S, 2019, CLIN RHEUMATOL, V38, P997, DOI 10.1007/s10067-018-4334-5; Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Babior B M, 1988, Basic Life Sci, V49, P815; Bengtsson AA, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02221-z; Bonegio RG, 2019, J IMMUNOL, V202, P675, DOI 10.4049/jimmunol.1800300; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; BUCKLE AM, 1989, J IMMUNOL, V143, P2295; Bzowska M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/284759; Cadieux JS, 2005, J CELL SCI, V118, P1437, DOI 10.1242/jcs.01737; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Cloutier N, 2018, P NATL ACAD SCI USA, V115, pE1550, DOI 10.1073/pnas.1720553115; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Eighetany MT, 2004, J CLIN LAB ANAL, V18, P36, DOI 10.1002/jcla.20001; Fiset MT, 2003, BIOCHEMISTRY-US, V42, P10498, DOI 10.1021/bi0300635; Fjaertoft G, 2007, SCAND J INFECT DIS, V39, P525, DOI 10.1080/00365540601113693; Fossati G, 2002, ANN RHEUM DIS, V61, P13, DOI 10.1136/ard.61.1.13; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; GALE R, 1984, ANN RHEUM DIS, V43, P34, DOI 10.1136/ard.43.1.34; Garcia-Garcia E, 2009, J IMMUNOL, V182, P4547, DOI 10.4049/jimmunol.0801468; Giambelluca MS, 2014, FASEB J, V28, P3679, DOI 10.1096/fj.14-251900; Golay J, 2019, BLOOD, V133, P1395, DOI 10.1182/blood-2018-07-864538; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; Hoffmann JJML, 2009, CLIN CHEM LAB MED, V47, P903, DOI 10.1515/CCLM.2009.224; Jonsson F, 2013, J LEUKOCYTE BIOL, V94, P643, DOI 10.1189/jlb.1212623; Johnson JL, 2016, J BIOL CHEM, V291, P25965, DOI 10.1074/jbc.M116.741884; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Khan SQ, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00052; Kikuchi-Taura A, 2015, LUPUS, V24, P1076, DOI 10.1177/0961203315579093; KIMBERLY RP, 1990, J EXP MED, V171, P1239, DOI 10.1084/jem.171.4.1239; Lood C, 2017, J EXP MED, V214, P2103, DOI 10.1084/jem.20161512; Lorenz G, 2015, SEMIN NEPHROL, V35, P410, DOI 10.1016/j.semnephrol.2015.08.003; Marois L, 2011, J BIOL CHEM, V286, P15073, DOI 10.1074/jbc.M110.213660; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Michon JM, 1998, BRIT J HAEMATOL, V100, P550, DOI 10.1046/j.1365-2141.1998.00597.x; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Nguyen GT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00373; Nishi H, 2019, CURR OPIN RHEUMATOL, V31, P193, DOI 10.1097/BOR.0000000000000577; Nishi H, 2017, J CLIN INVEST, V127, P3810, DOI 10.1172/JCI94039; Patel KR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00223; PERUSSIA B, 1983, J EXP MED, V158, P1092, DOI 10.1084/jem.158.4.1092; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Pricop L, 2002, ANTIOXID REDOX SIGN, V4, P85, DOI 10.1089/152308602753625889; Aleman OR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2908034; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; REPP R, 1991, BLOOD, V78, P885, DOI 10.1182/blood.V78.4.885.bloodjournal784885; Rosales C., 2017, FRONT IMMUNOL, V8, P1; Sack U, 2017, CYTOM PART B-CLIN CY, V92, P189, DOI 10.1002/cyto.b.21216; Sandilands GP, 2005, IMMUNOLOGY, V114, P354, DOI 10.1111/j.1365-2567.2004.02114.x; St-Onge M, 2007, BBA-MOL CELL BIOL L, V1771, P1235, DOI 10.1016/j.bbalip.2007.06.002; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Takano K, 2000, INT J HEMATOL, V72, P48; Takei H, 1996, J LEUKOCYTE BIOL, V59, P229, DOI 10.1002/jlb.59.2.229; Tamm A, 1996, J IMMUNOL, V157, P1576; Treffers LW, 2018, FRONT IMMUNOL, V9, P1; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; Turina M, 2005, INFLAMMATION, V29, P55, DOI 10.1007/s10753-006-8970-6; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Wang XL, 2016, J IMMUNOL, V197, P4090, DOI 10.4049/jimmunol.1600051; Wang YJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00829; Warren JS., 2017, ELS, P1, DOI DOI 10.1002/9780470015902.A0002164.PUB3; Yin C, 2018, CELL TISSUE RES, V371, P455, DOI 10.1007/s00441-017-2731-8; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200; Zhang HF, 2018, LIFE SCI, V207, P296, DOI 10.1016/j.lfs.2018.06.015; Zhang YH, 2000, IMMUNITY, V13, P387, DOI 10.1016/S1074-7613(00)00038-8; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P19332, DOI 10.1073/pnas.1008248107; Zivkovic V, 2018, RHEUMATOL INT, V38, P1003, DOI 10.1007/s00296-017-3888-x	69	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15208	15221		10.1096/fj.202001085R	http://dx.doi.org/10.1096/fj.202001085R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32946139	Green Submitted			2022-12-28	WOS:000572282200001
J	Sperber, HS; Togarrati, PP; Raymond, KA; Bouzidi, MS; Gilfanova, R; Gutierrez, AG; Muench, MO; Pillai, SK				Sperber, Hannah S.; Togarrati, Padma Priya; Raymond, Kyle A.; Bouzidi, Mohamed S.; Gilfanova, Renata; Gutierrez, Alan G.; Muench, Marcus O.; Pillai, Satish K.			mu-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies	FASEB JOURNAL			English	Article						antiviral gene therapy; humanized mouse; HIV; HIV latency; latency reversal; shock and kill	HUMAN IMMUNE-SYSTEM; IN-VIVO MODELS; SCID-HU MOUSE; MURINE MODEL; T-CELLS; CEREBROSPINAL-FLUID; HIV-1 INFECTION; TRANSGENIC MICE; MACROPHAGES; HEMATOPOIESIS	A critical barrier to the development of a human immunodeficiency virus (HIV) cure is the lack of a scalable animal model that enables robust evaluation of eradication approaches prior to testing in humans. We established a humanized mouse model of latent HIV infection by transplanting "J-Lat" cells, Jurkat cells harboring a latent HIV provirus encoding an enhanced green fluorescent protein (GFP) reporter, into irradiated adult NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ (NSG) mice. J-Lat cells exhibited successful engraftment in several tissues including spleen, bone barrow, peripheral blood, and lung, in line with the diverse natural tissue tropism of HIV. Administration of tumor necrosis factor (TNF)-alpha, an established HIV latency reversal agent, significantly induced GFP expression in engrafted cells across tissues, reflecting viral reactivation. These data suggest that ourmurinelatency ("mu-Lat") model enables efficient determination of how effectively viral eradication agents, including latency reversal agents, penetrate, and function in diverse anatomical sites harboring HIV in vivo.	[Sperber, Hannah S.; Togarrati, Padma Priya; Raymond, Kyle A.; Bouzidi, Mohamed S.; Gilfanova, Renata; Gutierrez, Alan G.; Muench, Marcus O.; Pillai, Satish K.] Vitalant Res Inst, San Francisco, CA 94118 USA; [Sperber, Hannah S.] Free Univ Berlin, Inst Biochem, Berlin, Germany; [Sperber, Hannah S.; Raymond, Kyle A.; Bouzidi, Mohamed S.; Muench, Marcus O.; Pillai, Satish K.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA	Vitalant; Vitalant Research Institute; Free University of Berlin; University of California System; University of California San Francisco	Pillai, SK (corresponding author), Vitalant Res Inst, San Francisco, CA 94118 USA.	satish.pillai@ucsf.edu	Muench, Marcus O./C-5025-2009	Muench, Marcus O./0000-0001-8946-6605; Sperber, Hannah Sabeth/0000-0002-9638-6555; Raymond, Kyle/0000-0001-8670-2852	National Institutes of Health [R01 AI150449, R01 MH112457]; National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI027763]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USAUniversity of California System)	This study was supported by the National Institutes of Health grants R01 AI150449 (SKP) and R01 MH112457 (SKP), and was additionally supported by a grant from the National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (P30 AI027763). We thank Dr. Roland Schwarzer for valuable input and careful review of the manuscript.	Abdel-Mohsen M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005677; Abreu CM, 2019, MBIO, V10, DOI 10.1128/mBio.01659-19; Alvarez-Carbonell D, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0335-8; Anderson EM, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0448-8; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Barat C, 2018, GLIA, V66, P1363, DOI 10.1002/glia.23310; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beyer AI, 2017, STEM CELLS DEV, V26, P102, DOI 10.1089/scd.2016.0083; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bouchat S, 2016, EMBO MOL MED, V8, P117, DOI 10.15252/emmm.201505557; Bradley T, 2018, CELL REP, V25, P107, DOI 10.1016/j.celrep.2018.09.020; Brogdon J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39032; Castellano P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39898-5; Chen DC, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5173205; Churchill M, 2013, CURR OPIN HIV AIDS, V8, P165, DOI 10.1097/COH.0b013e32835fc601; Dahl V, 2014, J INFECT DIS, V209, P1618, DOI 10.1093/infdis/jit805; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; Dash PK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10366-y; Denton PW, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0807-y; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; Flerin NC, 2019, J VIROL, V93, DOI 10.1128/JVI.02051-18; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Garcia JV, 2016, CURR OPIN VIROL, V19, P56, DOI 10.1016/j.coviro.2016.06.010; Garcia-Mesa Y, 2017, J NEUROVIROL, V23, P47, DOI 10.1007/s13365-016-0499-3; Gray LR, 2016, J NEUROVIROL, V22, P455, DOI 10.1007/s13365-015-0413-4; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hellmuth J, 2015, J VIRUS ERAD, V1, P67; Hoggatt J, 2016, EXP HEMATOL, V44, P132, DOI 10.1016/j.exphem.2015.10.008; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Joseph SB, 2015, J NEUROVIROL, V21, P276, DOI 10.1007/s13365-014-0287-x; Kim KC, 2016, AIDS RES HUM RETROV, V32, P194, DOI [10.1089/AID.2015.0211, 10.1089/aid.2015.0211]; Klase Z, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003997; Krishnakumar V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030252; Kumar N, 2016, CURR OPIN HIV AIDS, V11, P432, DOI 10.1097/COH.0000000000000290; Lai F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110643; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marsden MD, 2015, VIROLOGY, V479, P297, DOI 10.1016/j.virol.2015.01.017; Maung R, 2014, J IMMUNOL, V193, P1895, DOI 10.4049/jimmunol.1302915; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McCune JM, 2019, STEM CELL REP, V13, P777, DOI 10.1016/j.stemcr.2019.10.003; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Nath A, 2011, AIDS, V25, P577, DOI 10.1097/QAD.0b013e3283437d2f; Nixon CC, 2017, J INFECT DIS, V215, pS142, DOI 10.1093/infdis/jiw637; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Persidsky Y, 1996, AM J PATHOL, V149, P1027; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Pitman MC, 2018, LANCET HIV, V5, pE317, DOI 10.1016/S2352-3018(18)30039-0; Planelles V, 2011, CURR HIV RES, V9, P568, DOI 10.2174/157016211798998826; Policicchio BB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00012; Poluektova L, 2004, J IMMUNOL, V172, P7610, DOI 10.4049/jimmunol.172.12.7610; Poluektova LY, 2002, J IMMUNOL, V168, P3941, DOI 10.4049/jimmunol.168.8.3941; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; Rahim MMA, 2009, J VIROL, V83, P11830, DOI 10.1128/JVI.01466-09; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Rochat MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02084-16; Satheesan S, 2018, J VIROL, V92, DOI 10.1128/JVI.02118-17; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schwarzer R, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020188; Seay K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063537; Shytaj IL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002774; SLORDAL L, 1989, EUR J HAEMATOL, V43, P428; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Spivak AM, 2018, ANNU REV MED, V69, P421, DOI 10.1146/annurev-med-052716-031710; Stoszko M, 2016, EBIOMEDICINE, V3, P108, DOI 10.1016/j.ebiom.2015.11.047; Symons J, 2018, CURR OPIN HIV AIDS, V13, P152, DOI 10.1097/COH.0000000000000438; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Telwatte S, 2019, RETROVIROLOGY, V16, DOI 10.1186/s12977-019-0494-x; Telwatte S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007357; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; TYOR WR, 1993, P NATL ACAD SCI USA, V90, P8658, DOI 10.1073/pnas.90.18.8658; Whitney JB, 2018, ADV EXP MED BIOL, V1075, P241, DOI 10.1007/978-981-13-0484-2_10; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; WONG ME, 2019, FRONT IMMUNOL, V10; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012	89	1	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14615	14630		10.1096/fj.202001612RR	http://dx.doi.org/10.1096/fj.202001612RR		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901981	Green Submitted, Green Accepted			2022-12-28	WOS:000568307900001
J	Svard, A; Hammerman, M; Eliasson, P				Svard, Anna; Hammerman, Malin; Eliasson, Pernilla			Elastin levels are higher in healing tendons than in intact tendons and influence tissue compliance	FASEB JOURNAL			English	Article						creep; elastase; elastin; mechanical testing; rupture; tendon	LYSYL OXIDASE; DIGESTION; SHEAR	Elastic fibers containing elastin play an important role in tendon functionality, but the knowledge on presence and function of elastin during tendon healing is limited. The aim of this study was to investigate elastin content and distribution in intact and healing Achilles tendons and to understand how elastin influence the viscoelastic properties of tendons. The right Achilles tendon was completely transected in 81 Sprague-Dawley rats. Elastin content was quantified in intact and healing tendons (7, 14, and 28 days post-surgery) and elastin distribution was visualized by immunohistochemistry at 14 days post-surgery. Degradation of elastin by elastase incubation was used to study the role of elastin on viscoelastic properties. Mechanical testing was either performed as a cyclic test (20x 10 N) or as a creep test. We found significantly higher levels of elastin in healing tendons at all time-points compared to intact tendons (4% in healing tendons 28 days post-surgery vs 2% in intact tendons). The elastin was more widely distributed throughout the extracellular matrix in the healing tendons in contrast to the intact tendon where the distribution was not so pronounced. Elastase incubation reduced the elastin levels by approximately 30% and led to a 40%-50% reduction in creep. This reduction was seen in both intact and healing tendons. Our results show that healing tendons contain more elastin and is more compliable than intact tendons. The role of elastin in tendon healing and tissue compliance indicates a protective role of elastic fibers to prevent re-injuries during early tendon healing. Plain Language Summary Tendons transfer high loads from muscles to bones during locomotion. They are primarily made by the protein collagen, a protein that provide strength to the tissues. Besides collagen, tendons also contain other building blocks such as, for example, elastic fibers. Elastic fibers contain elastin and elastin is important for the extensibility of the tendon. When a tendon is injured and ruptured the tissue heals through scar formation. This scar tissue is different from a normal intact tendon and it is important to understand how the tendons heal. Little is known about the presence and function of elastin during healing of tendon injuries. We have shown, in animal experiments, that healing tendons have higher amounts of elastin compared to intact tendons. The elastin is also spread throughout the tissue. When we reduced the levels of this protein, we discovered altered mechanical properties of the tendon. The healing tendon can normally extend quite a lot, but after elastin removal this extensibility was less obvious. The ability of the healing tissue to extend is probably important to protect the tendon from re-injuries during the first months after rupture. We therefore propose that the tendons heal with a large amount of elastin to prevent re-ruptures during early locomotion.	[Svard, Anna; Eliasson, Pernilla] Linkoping Univ, Fac Hlth Sci, Div Surg Orthoped & Oncol, Dept Biomed & Clin Sci, S-58185 Linkoping, Sweden; [Svard, Anna] Orebro Univ, Med Sci, Cardiovasc Res Ctr CVRC, Sch Med Sci, Orebro, Sweden; [Svard, Anna] Linkoping Univ, Dept Phys Chem & Biol, Div Biophys & Bioengn, Linkoping, Sweden; [Hammerman, Malin] Lund Univ, Dept Biomed Engn, Lund, Sweden	Linkoping University; Orebro University; Linkoping University; Lund University	Eliasson, P (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Surg Orthoped & Oncol, Dept Biomed & Clin Sci, S-58185 Linkoping, Sweden.	pernilla.eliasson@liu.se	Eliasson, Pernilla/AAY-2126-2020	Eliasson, Pernilla/0000-0001-6718-034X	Swedish Research Council [VR2017-00990]; Swedish National Centre for Research in Sports [P2018-0140, P2019-0053]; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Swedish Society of Medicine; Linkoping University [LIO-796831]; Ostergotland Country council [LIO-796831]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Centre for Research in Sports; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Swedish Society of Medicine; Linkoping University; Ostergotland Country council	The Swedish Research Council, Grant/Award Number: VR2017-00990; Swedish National Centre for Research in Sports, Grant/Award Number: P2018-0140,P2019-0053; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Swedish Society of Medicine; Linkoping University and Ostergotland Country council, Grant/Award Number: LIO-796831	Aspenberg P, 2015, MLTJ-MUSCLE LIGAMENT, V5, P151, DOI 10.11138/mltj/2015.5.3.151; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Fang F, 2016, J MECH BEHAV BIOMED, V63, P443, DOI 10.1016/j.jmbbm.2016.06.032; Godinho MSC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09995-4; Grant TM, 2015, ANN BIOMED ENG, V43, P2477, DOI 10.1007/s10439-015-1308-5; Henninger HB, 2015, ACTA BIOMATER, V25, P304, DOI 10.1016/j.actbio.2015.07.011; Henninger HB, 2013, J ORTHOP RES, V31, P1226, DOI 10.1002/jor.22352; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164; Kielty CM, 2002, J CELL SCI, V115, P2817; Kirkendall DT, 1997, SCAND J MED SCI SPOR, V7, P62; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Michalek AJ, 2009, J BIOMECH, V42, P2279, DOI 10.1016/j.jbiomech.2009.06.047; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Nili NF, 2002, CARDIOVASC PATHOL, V11, P272, DOI 10.1016/S1054-8807(02)00119-9; OXLUND H, 1988, J BIOMECH, V21, P213, DOI 10.1016/0021-9290(88)90172-8; PARTRIDGE SM, 1963, NATURE, V197, P1297, DOI 10.1038/1971297a0; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Thorpe CT, 2016, J ANAT, V229, P450, DOI 10.1111/joa.12485; Tran PHT, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14267; UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093; VERED M, 1985, INT J PEPT PROT RES, V25, P76; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	24	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13409	13418		10.1096/fj.202001255R	http://dx.doi.org/10.1096/fj.202001255R		AUG 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32794252	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000561437800001
J	Xu, T; Xu, LL; Meng, PP; Ma, XQ; Yang, XQ; Zhou, YR; Feng, MQ				Xu, Tong; Xu, Lilei; Meng, Panpan; Ma, Xuqian; Yang, Xiaoqing; Zhou, Yaru; Feng, Mingqian			Angptl7 promotes insulin resistance and type 2 diabetes mellitus by multiple mechanisms including SOCS3-mediated IRS1 degradation	FASEB JOURNAL			English	Article						Akt; ERK1; 2; glucose metabolism; hepatocyte; INSR; liver	ANGIOPOIETIN-LIKE 7; GENE-EXPRESSION; SENSITIVITY; OBESITY; FKHR	Angptl7 is a secreted and circulating cytokine that belongs to Angiopoietin-like family. The current knowledge about the function of Angptl7 is still limited, and its biological role is only marginally known, such as in the promotion of angiogenesis and inflammation. Here, we demonstrated that Angptl7 promotes insulin resistance and type 2 diabetes mellitus (T2DM). We found that the circulating Angptl7 levels in T2DM patient and mouse models were significantly elevated. Artificial overexpression of Angptl7 in hepatic cells inhibited glucose uptake and impaired insulin signaling pathway. Furthermore, in vivo overexpression of Angptl7 in experimental healthy mice also caused insulin resistance-like characteristics. Mechanistic studies revealed that Angptl7 can upregulate SOCS3 expression, leading to the IRS1 degradation in proteasome. Furthermore, over-expressed Angptl7 inhibited the phosphorylation of Akt and promoted the phosphorylation of ERK1/2, which was known to be associated with insulin resistance. Taken together, our study provided strong evidence that Angptl7 promotes insulin resistance and T2DM by multiple mechanisms, which made Angptl7 a new potential therapeutic target for treatment of insulin resistance and T2DM.	[Xu, Tong; Meng, Panpan; Ma, Xuqian; Feng, Mingqian] Huazhong Agr Univ, Coll Life Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China; [Xu, Lilei] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China; [Yang, Xiaoqing] Hosp Huazhong Agr Univ, Clin Lab, Wuhan, Peoples R China; [Zhou, Yaru] Hebei Med Univ, Dept Endocrinol, Hosp 3, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China; [Feng, Mingqian] Huazhong Agr Univ, Coll Biomed & Hlth, Wuhan, Peoples R China	Huazhong Agricultural University; Tsinghua University; Hebei Medical University; Huazhong Agricultural University	Feng, MQ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.; Zhou, YR (corresponding author), Hebei Med Univ, Dept Endocrinol, Hosp 3, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China.	Zhouyaru_hc@163.com; Fengmingqian@mail.hzau.edu.cn			National Natural Science Foundation of China [31670943]; Fundamental Research Funds for the Central Universities [2662016PY113, 2662017PY111, 2662019YJ013]; Applied Basic Research Program of Wuhan Science and Technology Bureau [2017060201010195]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Applied Basic Research Program of Wuhan Science and Technology Bureau	The authors would like to thank Dr Bin Gao, Senior Investigator at Laboratory of Liver Diseases, National Institutes of Health, for discussing the project and for reviewing the manuscript. This work was supported by the National Natural Science Foundation of China (31670943), the Fundamental Research Funds for the Central Universities (2662016PY113, 2662017PY111, and 2662019YJ013), the Applied Basic Research Program of Wuhan Science and Technology Bureau (2017060201010195).	Abu-Farha M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173024; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Carbone C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020431; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Diamant JI, 1998, INT OPHTHALMOL CLIN, V38, P197, DOI 10.1097/00004397-199803840-00018; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gusarova V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04611-z; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Inukai K, 2004, BIOCHEM BIOPH RES CO, V317, P1075, DOI 10.1016/j.bbrc.2004.03.151; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Parri M, 2014, ANGIOGENESIS, V17, P881, DOI 10.1007/s10456-014-9435-4; Qian T, 2016, INFLAMMATION, V39, P974, DOI 10.1007/s10753-016-0324-4; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Robciuc MR, 2013, ARTERIOSCL THROM VAS, V33, P1706, DOI 10.1161/ATVBAHA.113.301397; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Serrano-Marco L, 2012, DIABETOLOGIA, V55, P743, DOI 10.1007/s00125-011-2401-4; Serrano-Marco L, 2011, DIABETES, V60, P1990, DOI 10.2337/db10-0704; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu YL, 2019, TOXICOL APPL PHARM, V377, DOI 10.1016/j.taap.2019.114626; Xiao YR, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0102-4	27	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13548	13560		10.1096/fj.202000246RR	http://dx.doi.org/10.1096/fj.202000246RR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32786125				2022-12-28	WOS:000561323100001
J	Boscaro, C; Carotti, M; Albiero, M; Trenti, A; Fadini, GP; Trevisi, L; Sandona, D; Cignarella, A; Bolego, C				Boscaro, Carlotta; Carotti, Marcello; Albiero, Mattia; Trenti, Annalisa; Fadini, Gian Paolo; Trevisi, Lucia; Sandona, Dorianna; Cignarella, Andrea; Bolego, Chiara			Non-genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells	FASEB JOURNAL			English	Article						endothelium; estrogen; GPER; PFKFB3; USP19	BREAST-CANCER-CELLS; GLUCOSE-TRANSPORTER; RECEPTOR GPER; 6-PHOSPHOFRUCTO-2-KINASE; EXPRESSION; ENZYME; PFKFB3; DEGRADATION; METABOLISM; INHIBITOR	Few studies have explored the mechanisms coupling estrogen signals to metabolic demand in endothelial cells. We recently showed that 17 beta-estradiol (E2) triggers angiogenesis via the membrane G-protein coupled estrogen receptor (GPER) and the key glycolytic protein PFKFB3 as a downstream effector. We herein investigated whether estrogenic agents regulate the stability and/or degradation of glycolytic proteins in human umbilical vein endothelial cells (HUVECs). Similarly to E2, the GPER selective agonist G1 rapidly increased PFKFB3 protein amounts, without affecting mRNA levels. In the presence of cycloheximide, E2 and G1 treatment counteracted PFKFB3 degradation over time, whereas E2-induced PFKFB3 stabilization was abolished by the GPER antagonist G15. Inhibitors of selective SCF E3 ubiquitin ligase (SMER-3) and proteasome (MG132) rapidly increased PFKFB3 protein levels. Accordingly, ubiquitin-bound PFKFB3 was lower in E2- or G1-treated HUVECs. Both agents increased deubiquitinase USP19 levels through GPER signaling. Notably, USP 19 siRNA decreased PFKFB3 levels and abolished E2- and G1-mediated HUVEC tubularization. Finally, E2 and G1 treatments rapidly enhanced glucose transporter GLUT1 levels via GPER independent of transcriptional activation. These findings provide new evidence on mechanisms coupling estrogen signals with the glycolytic program in endothelium and unravel the role of USP19 as a target of the pro-angiogenic effect of estrogenic agents.	[Boscaro, Carlotta; Trenti, Annalisa; Trevisi, Lucia; Bolego, Chiara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy; [Carotti, Marcello; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, Padua, Italy; [Albiero, Mattia; Fadini, Gian Paolo; Cignarella, Andrea] Univ Padua, Dept Med, Padua, Italy; [Albiero, Mattia; Fadini, Gian Paolo] Venetian Inst Mol Med, Padua, Italy	University of Padua; University of Padua; University of Padua; Veneto Institute Molecular Medicine	Bolego, C (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy.	chiara.bolego@unipd.it	Albiero, Mattia/AAG-4257-2019	Albiero, Mattia/0000-0003-4142-9738	Universita degli Studi di Padova (University of Padova) [PRID 2018]; Muscular Dystrophy Association (MDA) [577888]	Universita degli Studi di Padova (University of Padova); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	Universita degli Studi di Padova (University of Padova), Grant/Award Number: PRID 2018; Muscular Dystrophy Association (MDA), Grant/Award Number: 577888	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Arao Y, 2018, MOL METAB, V18, P68, DOI 10.1016/j.molmet.2018.09.006; Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Atsumi T, 2002, CANCER RES, V62, P5881; Auslander D, 2018, NAT METHODS, V15, P57, DOI [10.1038/NMETH.4505, 10.1038/nmeth.4505]; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Barton M, 2018, J STEROID BIOCHEM, V176, P4, DOI 10.1016/j.jsbmb.2017.03.021; Bolego C, 2006, BIOCHEM BIOPH RES CO, V339, P188, DOI 10.1016/j.bbrc.2005.11.017; Bolego C, 2006, ARTERIOSCL THROM VAS, V26, P2192, DOI 10.1161/01.ATV.0000242186.93243.25; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Carpentier G, 2012, 4 IMAGEJ US DEV C P, P198; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cignarella A, 2010, TRENDS PHARMACOL SCI, V31, P183, DOI 10.1016/j.tips.2010.01.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; De Francesco EM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122713; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Doddaballapur A, 2015, ARTERIOSCL THROM VAS, V35, P137, DOI 10.1161/ATVBAHA.114.304277; DONOHUE TM, 1983, BIOCHIM BIOPHYS ACTA, V739, P148, DOI 10.1016/0167-4781(83)90024-6; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Feldman RD, 2017, ANNU REV PHARMACOL, V57, P567, DOI 10.1146/annurev-pharmtox-010716-104651; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Ge X, 2015, BIOCHEM BIOPH RES CO, V463, P1115, DOI 10.1016/j.bbrc.2015.06.068; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Guidolin D, 2004, MICROVASC RES, V67, P117, DOI 10.1016/j.mvr.2003.11.002; Heilig C, 2003, AM J PATHOL, V163, P1873, DOI 10.1016/S0002-9440(10)63546-8; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HORWITZ KB, 1980, J BIOL CHEM, V255, P9699; Huang Y, 2012, P NATL ACAD SCI USA, V109, P17478, DOI 10.1073/pnas.1209281109; Imbert-Fernandez Y, 2014, J BIOL CHEM, V289, P9440, DOI 10.1074/jbc.M113.529990; Koo KH, 2015, ONCOTARGET, V6, P21328, DOI 10.18632/oncotarget.4049; LUDBROOK J, 1994, CLIN EXP PHARMACOL P, V21, P673, DOI 10.1111/j.1440-1681.1994.tb02570.x; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; NEEMAN M, 1989, P NATL ACAD SCI USA, V86, P5585, DOI 10.1073/pnas.86.14.5585; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Ogawa M, 2011, J BIOL CHEM, V286, P41455, DOI 10.1074/jbc.M111.276824; Ohno H, 2011, AM J PHYSIOL-CELL PH, V300, pC1047, DOI 10.1152/ajpcell.00416.2010; Pavlides SC, 2013, ENDOCRINOLOGY, V154, P4030, DOI 10.1210/en.2013-1757; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; Qi C, 1999, BIOCHEM BIOPH RES CO, V263, P265, DOI 10.1006/bbrc.1999.1328; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Sharma G, 2018, J STEROID BIOCHEM, V176, P31, DOI 10.1016/j.jsbmb.2017.02.012; Shi J, 1997, AM J PHYSIOL-ENDOC M, V272, pE1016, DOI 10.1152/ajpendo.1997.272.6.E1016; Stangl K, 2010, CARDIOVASC RES, V85, P281, DOI 10.1093/cvr/cvp315; Sudhagar S, 2011, BRIT J CANCER, V105, P953, DOI 10.1038/bjc.2011.349; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Tang MX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14152; Trenti A, 2017, J PHARMACOL EXP THER, V361, P398, DOI 10.1124/jpet.116.238212; Tschugguel W, 2003, J CLIN ENDOCR METAB, V88, P2281, DOI 10.1210/jc.2002-021165; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Xu BB, 2018, CELL REP, V24, P181, DOI 10.1016/j.celrep.2018.06.019; Zeng X, 2012, NAT CHEM BIOL, V8, P383, DOI [10.1038/nchembio.801, 10.1038/NCHEMBIO.801]; Zhang L, 2017, FERTIL STERIL, V107, P439, DOI 10.1016/j.fertnstert.2016.11.008	58	9	9	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12768	12784		10.1096/fj.202001130R	http://dx.doi.org/10.1096/fj.202001130R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32757462				2022-12-28	WOS:000558305600001
J	Marrese, M; Antonovaite, N; Nelemans, BA; Ahmadzada, A; Iannuzzi, D; Smit, TH				Marrese, Marica; Antonovaite, Nelda; Nelemans, Ben K. A.; Ahmadzada, Ariana; Iannuzzi, Davide; Smit, Theodoor H.			In vivo characterization of chick embryo mesoderm by optical coherence tomography-assisted microindentation	FASEB JOURNAL			English	Article						chicken embryos; in vivo mechanical properties; microindentation; optical coherence tomography	SOFT MATTER; CELL; SEGMENTATION; ELONGATION; MECHANICS; STIFFNESS; GRADIENT; CLOCK	Embryos are growing organisms with highly heterogeneous properties in space and time. Understanding the mechanical properties is a crucial prerequisite for the investigation of morphogenesis. During the last 10 years, new techniques have been developed to evaluate the mechanical properties of biological tissues in vivo. To address this need, we employed a new instrument that, via the combination of micro-indentation with Optical Coherence Tomography (OCT), allows us to determine both, the spatial distribution of mechanical properties of chick embryos, and the structural changes in real-time. We report here the stiffness measurements on the live chicken embryo, from the mesenchymal tailbud to the epithelialized somites. The storage modulus of the mesoderm increases from (176 +/- 18) Pa in the tail to (716 +/- 117) Pa in the somitic region (mean +/- SEM, n = 12). The midline has a mean storage modulus of (947 +/- 111) Pa in the caudal (PSM) presomitic mesoderm (mean +/- SEM, n = 12), indicating a stiff rod along the body axis, which thereby mechanically supports the surrounding tissue. The difference in stiffness between midline and presomitic mesoderm decreases as the mesoderm forms somites. This study provides an efficient method for the biomechanical characterization of soft biological tissues in vivo and shows that the mechanical properties strongly relate to different morphological features of the investigated regions.	[Marrese, Marica; Antonovaite, Nelda; Ahmadzada, Ariana; Iannuzzi, Davide] Vrije Univ Amsterdam, Laser LaB Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands; [Nelemans, Ben K. A.; Smit, Theodoor H.] Univ Amsterdam, Dept Orthopaed Surg, Med Ctr, Amsterdam Movement Sci, Amsterdam, Netherlands; [Nelemans, Ben K. A.] Univ Utrecht, Dev Biol, Utrecht, Netherlands; [Smit, Theodoor H.] Univ Amsterdam, Med Ctr, Dept Med Biol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; University of Amsterdam	Marrese, M (corresponding author), Vrije Univ Amsterdam, Laser LaB Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands.; Smit, TH (corresponding author), Univ Amsterdam, Dept Orthopaed Surg, Med Ctr, Amsterdam Movement Sci, Amsterdam, Netherlands.	m.marrese@vu.nl; th.smit@amsterdamumc.nl	Smit, Theodoor/AAX-6657-2020	Smit, Theodoor/0000-0002-8906-7433; Antonovaite, Nelda/0000-0001-9080-0324	European Research Council under the European Union [615170]; ZonMW-VICI grant [918.11.635]	European Research Council under the European Union(European Research Council (ERC)); ZonMW-VICI grant	This work has been financially supported by the European Research Council under the European Union.s Seventh Framework Programme (FP/20072013)/ERC grant agreement no. [615170]. BN was financially supported by ZonMW-VICI grant 918.11.635 to TS.	Agero U, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-19; Antonovaite N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31035-y; BARD JBL, 1988, ROUX ARCH DEV BIOL, V197, P513, DOI 10.1007/BF00385686; Beekmans SV, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0039-1; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Calamari ZT, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800140; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Chavan D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766959; Chavan D, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3516044; CHENEY CM, 1984, J EMBRYOL EXP MORPH, V79, P1; Chevalier NR, 2016, METHODS, V94, P120, DOI 10.1016/j.ymeth.2015.08.001; Corallo D, 2015, CELL MOL LIFE SCI, V72, P2989, DOI 10.1007/s00018-015-1897-z; Damon BJ, 2008, DEV BIOL, V321, P319, DOI 10.1016/j.ydbio.2008.06.018; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Filas BA, 2015, METHODS MOL BIOL, V1189, P3, DOI 10.1007/978-1-4939-1164-6_1; Gjorevski N, 2010, BIRTH DEFECTS RES C, V90, P193, DOI 10.1002/bdrc.20185; Goto Y, 2013, INT J NUMER ANAL MOD, V10, P203; Gruca G, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/9/094033; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Linnaeus, 1758, GALL GALL SUBSP DOM; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mammoto T, 2011, DEV CELL, V21, P758, DOI 10.1016/j.devcel.2011.07.006; Marrese M, 2019, ACTA BIOMATER, V97, P524, DOI 10.1016/j.actbio.2019.07.056; Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Sato Y, 2017, DEVELOPMENT, V144, P281, DOI 10.1242/dev.141259; Schmitz M, 2016, JOVE-J VIS EXP, DOI 10.3791/54636(2016); TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van Hoorn H, 2016, SOFT MATTER, V12, P3066, DOI 10.1039/c6sm00300a; Vuong-Brender TTK, 2017, ELIFE, V6, DOI [10.7554/eLife.23866, 10.17554/eLife.23866, 10.7554/elife.23866]; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211; Zhu M, 2020, P NATL ACAD SCI USA, V117, P4781, DOI 10.1073/pnas.1912656117	37	6	6	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12269	12277		10.1096/fj.202000896R	http://dx.doi.org/10.1096/fj.202000896R		JUL 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33411409	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000554773900001
J	Lee, JY; Tokumoto, M; Satoh, M				Lee, Jin-Yong; Tokumoto, Maki; Satoh, Masahiko			Cadmium toxicity mediated by the inhibition of SLC2A4 expression in human proximal Tubule cells	FASEB JOURNAL			English	Article						ATP; cadmium; glucose; MEF2A transcription factor; proximal tubule	UBE2D FAMILY GENES; DOWN-REGULATION; DNA MICROARRAY; IN-VITRO; BINDING; EXPOSURE; ACCUMULATION; DISRUPTION; EXERCISE; PATHWAY	Cadmium (Cd) is an environmental contaminant that causes renal toxicity. We have previously demonstrated that Cd induces renal toxicity by altering transcriptional activities. In this study, we show that Cd markedly inhibited the activity of transcription factor MEF2A in HK-2 human proximal tubule cells, which generated significant cytotoxicity in the cells. This reduction in the nuclear levels of MEF2A protein may be involved in the Cd-induced inhibition of MEF2A activity. We also demonstrate that one of the glucose transporters, GLUT4, was downregulated not only by Cd treatment but also by MEF2A knockdown. Knockdown of SLC2A4, encoding GLUT4, eliminated both cell viability and Cd toxicity. Cd treatment or SLC2A4 deficiency reduced the cellular concentration of glucose. Therefore, the suppression of SLC2A4 expression, which mediates the reduction in cellular glucose, is involved in Cd toxicity. The Cd toxicity induced by the reduction in GLUT4 may be associated with a reduction of cellular ATP levels in HK-2 cells. The levels of Slc2a4 mRNA in the kidney of mice exposed to Cd for 6 or 12 months were significantly lower than those in the control group. These results demonstrate that Cd exerts its cytotoxicity through the suppression in SLC2A4 expression and the subsequent inhibition of MEF2A transcriptional activity. Cd-induced suppression of SLC2A4 expression also reduces cellular ATP levels, partly by reducing glucose levels. This study suggests that the glucose transporter plays an important role in the renal toxicity of Cd, and provides a crucial breakthrough in our understanding of the mechanism of Cd toxicity.	[Lee, Jin-Yong; Tokumoto, Maki; Satoh, Masahiko] Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Nagoya, Aichi, Japan	Aichi Gakuin University	Satoh, M (corresponding author), Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	masahiko@dpc.agu.ac.jp						Alsahli M, 2017, DIABETES RES CLIN PR, V133, P1, DOI 10.1016/j.diabres.2017.07.033; Chang WQ, 2011, BBA-GEN SUBJECTS, V1810, P569, DOI 10.1016/j.bbagen.2011.02.001; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; Cui X, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113634; Do DT, 2016, CYTOTECHNOLOGY, V68, P2589, DOI 10.1007/s10616-016-9983-0; Fujiwara Y, 2012, BIOL PHARM BULL, V35, P1892, DOI 10.1248/bpb.b212014; Ghezzi C, 2018, DIABETOLOGIA, V61, P2087, DOI 10.1007/s00125-018-4656-5; Gong HJ, 2011, MED SCI SPORT EXER, V43, P1441, DOI 10.1249/MSS.0b013e31820f6093; Guzman J, 2014, DIABETES, V63, P701, DOI 10.2337/db13-0752; Harjutsalo V, 2014, ADV CHRONIC KIDNEY D, V21, P260, DOI 10.1053/j.ackd.2014.03.009; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Houmard JA, 1995, J APPL PHYSIOL, V79, P1936, DOI 10.1152/jappl.1995.79.6.1936; Huff MO, 2016, TOXICOL SCI, V152, P62, DOI 10.1093/toxsci/kfw064; Jarup L, 1998, SCAND J WORK ENV HEA, V24, P240; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; Kothinti RK, 2010, TOXICOL APPL PHARM, V244, P254, DOI 10.1016/j.taap.2009.12.038; Lee JY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17494-9; Lee JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21968; Lee JY, 2015, J TOXICOL SCI, V40, P901, DOI 10.2131/jts.40.901; Lee JY, 2013, J TOXICOL SCI, V38, P959, DOI 10.2131/jts.38.959; Lee JY, 2019, CADMIUM TOXICITY CUR; Lee WK, 2017, ARCH TOXICOL, V91, P3225, DOI 10.1007/s00204-017-1942-9; Luo TW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04555-2; Madugula Kiran, 2019, Oncotarget, V10, P2755, DOI 10.18632/oncotarget.26763; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Nicotera P, 1998, TOXICOL LETT, V103, P139; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pajares M, 2018, AUTOPHAGY, V14, P1310, DOI 10.1080/15548627.2018.1474992; Richardson Marion, 2006, Nurs Times, V102, P28; Roder PV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089977; Sarma SN, 2018, J TOXICOL SCI, V43, P89, DOI 10.2131/jts.43.89; Shinkai Y, 2016, TOXICOL APPL PHARM, V295, P37, DOI 10.1016/j.taap.2016.01.020; Smith JAH, 2008, AM J PHYSIOL-ENDOC M, V295, pE698, DOI 10.1152/ajpendo.00747.2007; Tabatabai NA, 2005, TOXICOLOGY, V207, P369, DOI 10.1016/j.tox.2004.10.007; Tabatabai NM, 2001, TOXICOL APPL PHARM, V177, P163, DOI 10.1006/taap.2001.9321; Thevenod F, 2013, ARCH TOXICOL, V87, P1743, DOI 10.1007/s00204-013-1110-9; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; Tokumoto M, 2014, J TOXICOL SCI, V39, P735, DOI 10.2131/jts.39.735; Tokumoto M, 2013, J TOXICOL SCI, V38, P799; Tokumoto M, 2011, J TOXICOL SCI, V36, P191, DOI 10.2131/jts.36.191; Tokumoto M, 2011, J TOXICOL SCI, V36, P127, DOI 10.2131/jts.36.127; Wang XY, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22011; Watanuki S, 2019, BIOCHEM BIOPH RES CO, V514, P287, DOI 10.1016/j.bbrc.2019.04.123; Wei W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18427-2; Wilmes A, 2011, TOXICOL IN VITRO, V25, P613, DOI 10.1016/j.tiv.2010.12.009; Yue RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050778; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003; Zhang L, 2014, AUTOPHAGY, V10, P1015, DOI 10.4161/auto.28477	53	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21236	10.1096/fj.202001871R	http://dx.doi.org/10.1096/fj.202001871R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337552				2022-12-28	WOS:000605626600025
J	Yan, SM; Wu, G				Yan, Shaomin; Wu, Guang			Spatial and temporal roles of SARS-CoV PLpro-A snapshot	FASEB JOURNAL			English	Review						ISG15; PLpro; p53; SARS&#8208; CoV; SARS&#8208; CoV&#8208; 2; ubiquitin	PAPAIN-LIKE PROTEASE; RESPIRATORY SYNDROME CORONAVIRUS; E3 UBIQUITIN LIGASE; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; UNIQUE DOMAIN; PIRH2; P53; GENOME; POLYMERASE	SARS-CoV and SARS-CoV-2 encode four structural and accessory proteins (spike, envelope, membrane and nucleocapsid proteins) and two polyproteins (pp1a and pp1ab). The polyproteins are further cleaved by 3C-like cysteine protease (3CL(pro)) and papain-like protease (PLpro) into 16 nonstructural proteins (nsps). PLpro is released from nsp3 through autocleavage, and then it cleaves the sites between nsp1/2, between nsp2/3 and between nsp3/4 with recognition motif of LXGG, and the sites in the C-terminus of ubiquitin and of protein interferon-stimulated gene 15 (ISG15) with recognition motif of RLRGG. Alone or together with SARS unique domain (SUD), PLpro can stabilize an E3 ubiquitin ligase, the ring-finger, and CHY zinc-finger domain-containing 1 (RCHY1), through domain interaction, and thus, promote RCHY1 to ubiquitinate its target proteins including p53. However, a dilemma appears in terms of PLpro roles. On the one hand, the ubiquitination of p53 is good for SARS-CoV because the ubiquitinated p53 cannot inhibit SARS-CoV replication. On the other hand, the ubiquitination of NF-kappa B inhibitor (I kappa B alpha), TNF receptor-associated factors (TRAFs), and stimulator of interferon gene (STING), and the ISGylation of targeted proteins are bad for SARS-CoV because these ubiquitination and ISGylation initiate the innate immune response and antiviral state. This mini-review analyzes the dilemma and provides a snapshot on how the viral PLpro smartly manages its roles to avoid its simultaneously contradictory actions, which could shed lights on possible strategies to deal with SARS-CoV-2 infections.	[Yan, Shaomin; Wu, Guang] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Guangxi Biomass Engn Technol Res Ctr, State Key Lab Nonfood Biomass & Enzyme Technol, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China		Wu, G (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Guangxi Biomass Engn Technol Res Ctr, State Key Lab Nonfood Biomass & Enzyme Technol, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China.	hongguanglishibahao@gxas.cn		Yan, Shaomin/0000-0001-7642-3972; Wu, Guang/0000-0003-0775-5759				Al-Obaidi MMJ, 2018, ACTA VIROL, V62, P16, DOI 10.4149/av_2018_102; Baez-Santos YM, 2014, J VIROL, V88, P12511, DOI 10.1128/JVI.01294-14; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Barretto N, 2006, ADV EXP MED BIOL, V581, P37; BREDENBEEK PJ, 1990, NUCLEIC ACIDS RES, V18, P1825, DOI 10.1093/nar/18.7.1825; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; Calistri A, 2014, CELLS-BASEL, V3, P386, DOI 10.3390/cells3020386; Chen S, 2010, PROTEIN CELL, V1, P59, DOI 10.1007/s13238-010-0011-4; Chen XJ, 2014, PROTEIN CELL, V5, P369, DOI 10.1007/s13238-014-0026-3; Cheng SC, 2014, CYTOKINE GROWTH F R, V25, P707, DOI 10.1016/j.cytogfr.2014.06.008; Clasman JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40292; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Duan SS, 2007, EMBO J, V26, P3062, DOI 10.1038/sj.emboj.7601749; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gorbalenya A.E., 1993, SOV SCI REV D, V11, P1; Halaby MJ, 2013, CELL CYCLE, V12, P2733, DOI 10.4161/cc.25785; Han YS, 2005, BIOCHEMISTRY-US, V44, P10349, DOI 10.1021/bi0504761; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HEROLD J, 1993, VIROLOGY, V195, P680, DOI 10.1006/viro.1993.1419; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jung YS, 2013, J INVEST DERMATOL, V133, P1178, DOI 10.1038/jid.2012.466; Jung YS, 2011, J BIOL CHEM, V286, P35388, DOI 10.1074/jbc.M111.261537; Kikkert M, 2020, J INNATE IMMUN, V12, P4, DOI 10.1159/000503030; KIM JC, 1995, VIROLOGY, V208, P1, DOI 10.1006/viro.1995.1123; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li SW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050678; Lin CW, 2004, FEBS LETT, V574, P131, DOI 10.1016/j.febslet.2004.08.017; Lin MH, 2018, ANTIVIR RES, V150, P155, DOI 10.1016/j.antiviral.2017.12.015; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Lindner HA, 2007, ARCH BIOCHEM BIOPHYS, V466, P8, DOI 10.1016/j.abb.2007.07.006; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Ma-Lauer Y, 2016, P NATL ACAD SCI USA, V113, pE5192, DOI 10.1073/pnas.1603435113; Mielech AM, 2014, VIRUS RES, V194, P184, DOI 10.1016/j.virusres.2014.01.025; Muramatsu T, 2016, P NATL ACAD SCI USA, V113, P12997, DOI 10.1073/pnas.1601327113; Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinon JD, 1997, VIROLOGY, V230, P309, DOI 10.1006/viro.1997.8503; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113; Sato Y, 2013, REV MED VIROL, V23, P213, DOI 10.1002/rmv.1738; Sato Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000530; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shan YF, 2004, BIOCHEM BIOPH RES CO, V324, P579, DOI 10.1016/j.bbrc.2004.09.088; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Sulea T, 2005, J VIROL, V79, P4550, DOI 10.1128/JVI.79.7.4550-4551.2005; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Tan J, 2007, BIOCHEM BIOPH RES CO, V364, P877, DOI 10.1016/j.bbrc.2007.10.081; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110; Volk A, 2020, J VIROL, V94, DOI 10.1128/JVI.00178-20; Yuan L, 2015, J BIOL CHEM, V290, P3172, DOI 10.1074/jbc.M114.619890; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853; Ziebuhr J, 2001, J BIOL CHEM, V276, P33220, DOI 10.1074/jbc.M104097200	66	10	11	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21197	10.1096/fj.202002271	http://dx.doi.org/10.1096/fj.202002271			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368679	Green Published			2022-12-28	WOS:000605626600018
J	Yang, LY; Wu, YS; Lin, SH; Dai, BB; Chen, H; Tao, X; Li, GP; Wan, JX; Pan, YB				Yang, Liyan; Wu, Yuansheng; Lin, Songhua; Dai, Binbin; Chen, Hong; Tao, Xuan; Li, Guoping; Wan, Jianxin; Pan, Yangbin			sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1(ser757) signaling pathway	FASEB JOURNAL			English	Article						idiopathic membranous nephropathy; PLA2R; podocyte autophagy; sPLA2&#8208; IB	PHOSPHOLIPASE A(2); P38 MAPK; APOPTOSIS; RECEPTOR; MTOR; ANGIOPOIETIN-1; REGULATOR; RITUXIMAB; DISEASES; CELLS	Secretory phospholipase A2 group IB (sPLA2-IB) and M-type phospholipase A2 receptor (PLA2R) are closely associated with proteinuria in idiopathic membranous nephropathy (IMN). Podocytes constitute an important component of glomerular filtration, and high basal autophagy is indispensable for podocyte function. The current study aimed to analyze the relationship between sPLA2-IB and podocyte autophagy in IMN and determine whether sPLA2-IB mediates abnormal autophagy regulation in podocytes. The serum sPLA2-IB level and podocyte autophagy were detected, and clinical data were collected from IMN patients with different proteinuria levels. Then, the effects of sPLA2-IB on autophagy signaling pathways were evaluated in cultured human podocytes treated with sPLA2-IB, rapamycin, p38 inhibition, and PLA2R-siRNA in vitro. We found that IMN patients with nephrotic-range proteinuria have a significantly higher level of sPLA2-IB and fewer autophagosomes than those with non-nephrotic-range proteinuria. In vitro sPLA2-IB-induced insufficient autophagy in podocytes and promoted podocyte injury via activation of the mTOR/ULK1(ser757) signaling pathway. Moreover, inhibition of p38 MAPK evidently abrogated sPLA2-IB-induced autophagy and the activation of mTOR/ULK1(ser757). Additionally, PLA2R silencing demonstrated that sPLA2-IB-induced abnormal autophagy was also PLA2R-dependent. In conclusion, the results revealed that sPLA2-IB downregulated autophagy and contributed to podocyte injury via PLA2R though activation of the p38MAPK/mTOR/ULK1(ser757) signaling pathway.	[Yang, Liyan; Lin, Songhua; Dai, Binbin; Wan, Jianxin; Pan, Yangbin] Fujian Med Univ, Affiliated Hosp 1, Dept Nephrol, 20th Chazhong Rd, Fuzhou, Fujian, Peoples R China; [Wu, Yuansheng] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Peoples R China; [Chen, Hong; Tao, Xuan; Li, Guoping] Fujian Med Univ, Affiliated Hosp 1, Dept Pathol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University	Wan, JX; Pan, YB (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Nephrol, 20th Chazhong Rd, Fuzhou, Fujian, Peoples R China.	wanjx@263.net; panyb9999@163.com			National Natural Science Foundation of China [81670635]; Family Planning for Young and Middle Aged Talents Training Project [2016-ZQN-36]; Qihang Fund Project of Fujian Medical University [2017XQ2038]; Natural Science Foundation of Fujian Province of China [2019J01441]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Family Planning for Young and Middle Aged Talents Training Project; Qihang Fund Project of Fujian Medical University; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	National Natural Science Foundation of China, Grant/Award Number: 81670635; Family Planning for Young and Middle Aged Talents Training Project, Grant/Award Number: 2016-ZQN-36; Qihang Fund Project of Fujian Medical University, Grant/Award Number: 2017XQ2038; Natural Science Foundation of Fujian Province of China, Grant/Award Number: 2019J01441	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Audzeyenka I, 2017, MOL CELL BIOCHEM, V430, P11, DOI 10.1007/s11010-017-2949-5; Bork T, 2020, AUTOPHAGY, V16, P1932, DOI 10.1080/15548627.2019.1705007; Chen N, 2021, J CELL PHYSIOL, V236, P625, DOI 10.1002/jcp.29890; Couser WG, 2017, CLIN J AM SOC NEPHRO, V12, P983, DOI 10.2215/CJN.11761116; Debiec H, 2016, J AM SOC NEPHROL, V27, P1275, DOI 10.1681/ASN.2015101170; Granata F, 2006, EUR J IMMUNOL, V36, P1938, DOI 10.1002/eji.200535567; Hanasaki K, 2004, BIOL PHARM BULL, V27, P1165, DOI 10.1248/bpb.27.1165; Hanasaki K, 2002, PROSTAG OTH LIPID M, V68-9, P71, DOI 10.1016/S0090-6980(02)00022-9; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hernandez M, 2002, CIRC RES, V90, P38, DOI 10.1161/hh0102.102978; Hollie NI, 2014, ATHEROSCLEROSIS, V234, P377, DOI 10.1016/j.atherosclerosis.2014.03.027; Hu MS, 2017, J CELL MOL MED, V21, P552, DOI 10.1111/jcmm.13001; Jin J, 2017, INT UROL NEPHROL, V49, P1025, DOI 10.1007/s11255-017-1555-5; Kao LY, 2015, J AM SOC NEPHROL, V26, P291, DOI 10.1681/ASN.2013121315; Kawakami T, 2015, J AM SOC NEPHROL, V26, P1040, DOI 10.1681/ASN.2013111202; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051088; Kucharewicz K, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0383-6; Li C, 2020, LIFE SCI, V243, DOI 10.1016/j.lfs.2020.117277; Li WH, 2018, CLIN CHIM ACTA, V482, P178, DOI 10.1016/j.cca.2018.04.009; Liang SK, 2016, INT UROL NEPHROL, V48, P2109, DOI 10.1007/s11255-016-1398-5; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu WJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2002-6; Liu WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07889-z; Lu HJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-156; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Moroni G, 2017, NEPHROL DIAL TRANSPL, V32, P1691, DOI 10.1093/ndt/gfw251; Pan YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06660; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Rheault MN, 2016, J PEDIATR GENET, V5, P15, DOI 10.1055/s-0035-1557109; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1416, DOI 10.1681/ASN.2012020181; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Satchell SC, 2002, J AM SOC NEPHROL, V13, P544, DOI 10.1681/ASN.V132544; Seong Su-Bin, 2019, Cell Physiol Biochem, V53, P747, DOI 10.33594/000000170; Song ZX, 2014, METABOLISM, V63, P1324, DOI 10.1016/j.metabol.2014.06.013; Wang QR, 2016, PHARMACOL RES, V111, P357, DOI 10.1016/j.phrs.2016.06.024; Wang RM, 2018, CELL PHYSIOL BIOCHEM, V45, P899, DOI 10.1159/000487285; Wang YN, 2018, EXP CELL RES, V363, P291, DOI 10.1016/j.yexcr.2018.01.019; Wang YY, 2018, MED SCI MONITOR, V24, P4823, DOI 10.12659/MSM.910868; Wodawek-Potocka I, 2009, REPRODUCTION, V137, P95, DOI 10.1530/REP-08-0209; Wong DWL, 2018, KIDNEY INT, V93, P1367, DOI 10.1016/j.kint.2017.12.017; Wu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063799; Xiao TL, 2014, MOL CELL BIOCHEM, V394, P145, DOI 10.1007/s11010-014-2090-7; Xu J, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12738; Yagami T, 2014, MOL NEUROBIOL, V49, P863, DOI 10.1007/s12035-013-8565-9; Yang MT, 2016, ANTIVIR RES, V133, P223, DOI 10.1016/j.antiviral.2016.08.010; Zhao XC, 2018, J PATHOL, V245, P235, DOI 10.1002/path.5077	51	11	15	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001143R	http://dx.doi.org/10.1096/fj.202001143R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184968				2022-12-28	WOS:000590888400001
J	Zhou, HY; Simion, V; Pierce, JB; Haemmig, S; Chen, AF; Feinberg, MW				Zhou, Haoyang; Simion, Viorel; Pierce, Jacob B.; Haemmig, Stefan; Chen, Alex F.; Feinberg, Mark W.			LncRNA-MAP3K4 regulates vascular inflammation through the p38 MAPK signaling pathway and cis-modulation of MAP3K4	FASEB JOURNAL			English	Article						bidirectional promoter; vascular cells; ChIP&#8208; seq; atherosclerosis; eRNA	ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; LONG NONCODING RNAS; ENDOTHELIAL-CELLS; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; HISTONE MODIFICATIONS; GENE-EXPRESSION; TATA-LESS; GC-RICH	Chronic vascular inflammation plays a key role in the pathogenesis of atherosclerosis. Long non-coding RNAs (lncRNAs) have emerged as essential inflammation regulators. We identify a novel lncRNA termed lncRNA-MAP3K4 that is enriched in the vessel wall and regulates vascular inflammation. In the aortic intima, lncRNA-MAP3K4 expression was reduced by 50% during the progression of atherosclerosis (chronic inflammation) and 70% during endotoxemia (acute inflammation). lncRNA-MAP3K4 knockdown reduced the expression of key inflammatory factors (eg, ICAM-1, E-selectin, MCP-1) in endothelial cells or vascular smooth muscle cells and decreased monocytes adhesion to endothelium, as well as reducing TNF-alpha, IL-1 beta, COX2 expression in macrophages. Mechanistically, lncRNA-MAP3K4 regulates inflammation through the p38 MAPK signaling pathway. lncRNA-MAP3K4 shares a bidirectional promoter with MAP3K4, an upstream regulator of the MAPK signaling pathway, and regulates its transcription in cis. lncRNA-MAP3K4 and MAP3K4 show coordinated expression in response to inflammation in vivo and in vitro. Similar to lncRNA-MAP3K4, MAP3K4 knockdown reduced the expression of inflammatory factors in several different vascular cells. Furthermore, lncRNA-MAP3K4 and MAP3K4 knockdown showed cooperativity in reducing inflammation in endothelial cells. Collectively, these findings unveil the role of a novel lncRNA in vascular inflammation by cis-regulating MAP3K4 via a p38 MAPK pathway.	[Zhou, Haoyang; Simion, Viorel; Pierce, Jacob B.; Haemmig, Stefan; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA; [Zhou, Haoyang; Chen, Alex F.] Cent South Univ, Dept Cardiol, Xiangya Hosp 3, Changsha, Peoples R China; [Pierce, Jacob B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central South University; Northwestern University; Feinberg School of Medicine	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu		Feinberg, Mark/0000-0001-9523-3859; Pierce, Jacob B./0000-0001-9171-1673	American Heart Association (AHA) [20SFRN35200163]; National Institutes of Health (NIH) [HL115141, HL134849, HL148207, HL148355, HL153356]	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	American Heart Association (AHA), Grant/Award Number: 18SFRN33900144; American Heart Association (AHA), Grant/Award Number: 20SFRN35200163; National Institutes of Health (NIH), Grant/Award Number: HL115141, HL134849, HL148207, HL148355 and HL153356	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Al-Salama ZT, 2018, DRUGS, V78, P761, DOI 10.1007/s40265-018-0908-4; Andersen RE, 2019, DEV CELL, V49, P632, DOI 10.1016/j.devcel.2019.04.032; Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Aryal B, 2019, VASC PHARMACOL, V114, P64, DOI 10.1016/j.vph.2018.03.001; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1038/s41569-019-0227-9, 10.1161/CIRCRESAHA.115.306361]; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Blake GJ, 2001, CIRC RES, V89, P763, DOI 10.1161/hh2101.099270; Bornelov S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1485-5; Brown RP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-110; Carlevaro-Fita J, 2019, MOL CELL, V73, P869, DOI 10.1016/j.molcel.2019.02.008; Charron CE, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00188-2017; Chen W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-3; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Decano JL, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0585-2; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02229-1; Elling R, 2018, CELL REP, V25, P1511, DOI 10.1016/j.celrep.2018.10.027; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fatkhullina AR, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1358, DOI 10.1134/S0006297916110134; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Font-Cunill B, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00524; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Gil N, 2020, NAT REV GENET, V21, P102, DOI 10.1038/s41576-019-0184-5; Goebeler M, 1999, BLOOD, V93, P857, DOI 10.1182/blood.V93.3.857.403k03_857_865; Haemmig S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw1868; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hu P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05955-2; Huang LL, 2020, J CELL PHYSIOL, V235, P3815, DOI 10.1002/jcp.29276; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Jangid RK, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4697-7; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kawai Y, 2003, BBA-GENE STRUCT EXPR, V1625, P246, DOI 10.1016/S0167-4781(02)00627-9; Khyzha N, 2019, P NATL ACAD SCI USA, V116, P16410, DOI 10.1073/pnas.1904108116; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lai F, 2020, MOL CELL, V77, P1032, DOI 10.1016/j.molcel.2019.12.029; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lee JS, 2020, MOL CELL, V77, P1044, DOI 10.1016/j.molcel.2019.12.011; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li MN, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00151; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Mahpour A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205608; Maranon DG, 2020, MOL CELL, V77, P932, DOI 10.1016/j.molcel.2020.02.010; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Min W, 1997, J IMMUNOL, V159, P3508; Mobley RJ, 2017, CELL REP, V18, P2387, DOI 10.1016/j.celrep.2017.02.030; Mukherjee S, 2009, J BIOL CHEM, V284, P29391, DOI 10.1074/jbc.M109.005272; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ng YK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-42; Pietersma A, 1997, BIOCHEM BIOPH RES CO, V230, P44, DOI 10.1006/bbrc.1996.5886; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Qvist H, 1998, BIOL CHEM, V379, P75; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; SHIMIZU Y, 1991, J CELL BIOL, V113, P1203, DOI 10.1083/jcb.113.5.1203; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Simion V, 2019, VASC PHARMACOL, V114, P145, DOI 10.1016/j.vph.2018.01.003; Sollome JJ, 2014, CELL SIGNAL, V26, P70, DOI 10.1016/j.cellsig.2013.08.043; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van Gils JM, 2013, ARTERIOSCL THROM VAS, V33, P911, DOI 10.1161/ATVBAHA.112.301155; Verstrepen L, 2014, BIOCHEM PHARMACOL, V92, P519, DOI 10.1016/j.bcp.2014.10.017; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Ward AJ, 2014, NUCLEIC ACIDS RES, V42, P5871, DOI 10.1093/nar/gku184; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yan WS, 2002, SHOCK, V17, P433, DOI 10.1097/00024382-200205000-00016; Yang LX, 2015, HEPATOLOGY, V62, P1804, DOI 10.1002/hep.28149	96	9	10	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001654RR	http://dx.doi.org/10.1096/fj.202001654RR		NOV 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33184917				2022-12-28	WOS:000590887700001
J	Li, B; Zhou, Y; Chen, J; Wang, TT; Li, ZJ; Fu, YL; Zhai, AX; Bi, CL				Li, Bo; Zhou, Yue; Chen, Jing; Wang, Tingting; Li, Zhijuan; Fu, Yili; Zhai, Aixia; Bi, Changlong			Long noncoding RNA H19 acts as a miR-29b sponge to promote wound healing in diabetic foot ulcer	FASEB JOURNAL			English	Article						apoptosis; diabetic foot ulcer; fibrillin 1; long noncoding RNA H19; microRNA&#8208; 29b; proliferation; wound healing	COMPETING ENDOGENOUS RNA; EPITHELIAL-MESENCHYMAL TRANSITION; LNCRNA H19; TARGETING MIR-29B-3P; EXTRACELLULAR-MATRIX; SKIN FIBROBLASTS; BLADDER-CANCER; GASTRIC-CANCER; MOUSE MODEL; FIBRILLIN-1	Aberrant expression of long noncoding RNA (lncRNA) H19 and microRNA (miR)-29b has been implicated in the complications of diabetes mellitus (DM). As a common and important complication of DM, diabetic foot ulcer (DFU) is characterized by high incidence and poor prognosis. Herein, we explored the role of lncRNA H19 in wound healing of DFU. Differentially expressed DM-related lncRNAs were initially screened by microarray data analysis. DFU models were then induced in DM mouse models. The functional role and interaction of lncRNA H19, miR-29b and FBN1 in DFU were subsequently determined by examining the proliferation, migration, and apoptosis of fibroblasts after silencing H19, inhibiting or overexpressing miR-29b and FBN1. According to microarray-based analysis, lncRNA H19 was upregulated in DM. In the ulcerative edge tissues of DFU, high expression of lncRNA H19 and FBN1 and low expression of miR-29b were observed. FBN1 was identified to be a target gene of miR-29b. LncRNA H19 could competitively bind to miR-29b, and then, inhibited its expression, which consequently upregulating FBN1. Silencing of lncRNA H19 led to inhibited proliferation, migration, and enhanced apoptosis of fibroblasts, accompanied by downregulated FBN1 but upregulated miR-29b, which diminished the expression of TGF-beta 1, Smad3, FN, and Col-1 and reduced extracellular matrix accumulation. Altogether, upregulation of lncRNA H19 can elevate the expression of FBN1 through competitively binding to miR-29b, which enhances the proliferation, migration, and inhibits apoptosis of fibroblasts, thus facilitating the wound healing of DFU.	[Li, Bo] Harbin Med Univ, Affiliated Hosp 4, Dept Endocrinol, Harbin, Peoples R China; [Zhou, Yue; Chen, Jing; Wang, Tingting; Li, Zhijuan; Bi, Changlong] Harbin Med Univ, Affiliated Hosp 4, Comprehens Dept 2, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China; [Fu, Yili] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China; [Zhai, Aixia] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Lab Med, 3025 Shennan Middle Rd, Shenzhen 518033, Guangdong, Peoples R China; [Bi, Changlong] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol, Shenzhen, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Institute of Technology; Sun Yat Sen University; Sun Yat Sen University	Bi, CL (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Comprehens Dept 2, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China.; Zhai, AX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 8, Dept Lab Med, 3025 Shennan Middle Rd, Shenzhen 518033, Guangdong, Peoples R China.	aixiazhai@126.com; bichanglongdr@163.com			National Natural Science Foundation of China (NSFC) [81501737,81871562,81800739]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81501737,81871562,81800739	Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Cao TF, 2019, ONCOGENE, V38, P5356, DOI 10.1038/s41388-019-0808-4; Cao W, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0260-5; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Cheng XW, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00263; Christner PJ, 2006, AMINO ACIDS, V30, P445, DOI 10.1007/s00726-005-0265-y; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Galimov A, 2016, STEM CELLS, V34, P768, DOI 10.1002/stem.2281; Guo JR, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0290-6; Handa K, 2018, ARCH ORAL BIOL, V90, P53, DOI 10.1016/j.archoralbio.2018.02.017; Hartner A, 2006, AM J PHYSIOL-RENAL, V290, pF1329, DOI 10.1152/ajprenal.00284.2005; He Y, 2013, BIOCHIMIE, V95, P1355, DOI 10.1016/j.biochi.2013.03.010; Hicks CW, 2016, ANN VASC SURG, V33, P149, DOI 10.1016/j.avsg.2015.11.025; Hua QH, 2016, MUTAGENESIS, V31, P531, DOI 10.1093/mutage/gew018; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Lavery LA, 2012, DIABETES-METAB RES, V28, P60, DOI 10.1002/dmrr.2241; Li JX, 2016, REPROD SCI, V23, P386, DOI 10.1177/1933719115602768; Liu CN, 2018, HEPATOLOGY, V67, P1768, DOI 10.1002/hep.29654; Liu LH, 2019, INT J ONCOL, V54, P929, DOI 10.3892/ijo.2019.4695; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Lu YF, 2017, FASEB J, V31, P954, DOI 10.1096/fj.201600722R; Luo Y, 2015, HYPERTENSION, V65, P414, DOI 10.1161/HYPERTENSIONAHA.114.04600; Lv MX, 2017, BBA-MOL CELL RES, V1864, P1887, DOI 10.1016/j.bbamcr.2017.08.001; Ma XF, 2016, BIOMED PHARMACOTHER, V80, P220, DOI 10.1016/j.biopha.2016.03.020; Merk DR, 2012, CIRC RES, V110, P312, DOI 10.1161/CIRCRESAHA.111.253740; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ramirez HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137133; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Shi RF, 2018, GENE THER, V25, P425, DOI 10.1038/s41434-018-0027-6; Singh KK, 2012, J NEGAT RESULTS BIOM, V11, DOI 10.1186/1477-5751-11-9; Su ZR, 2016, FEBS LETT, V590, P1354, DOI 10.1002/1873-3468.12171; Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816; Tang YJ, 2016, BIOCHEM BIOPH RES CO, V479, P417, DOI 10.1016/j.bbrc.2016.09.028; Tao SC, 2018, DRUG DELIV, V25, P241, DOI 10.1080/10717544.2018.1425774; Teng YJ, 2010, DIABETES OBES METAB, V12, P307, DOI 10.1111/j.1463-1326.2009.01164.x; Thomas A, 2014, CAN J DIABETES, V38, pS61; Wang CJ, 2011, DIABETES RES CLIN PR, V94, P105, DOI 10.1016/j.diabres.2011.06.016; Wang ML, 2018, ASIAN PAC J TROP MED, V11, P245, DOI 10.4103/1995-7645.228441; Yang C, 2015, ONCOTARGET, V6, P15311, DOI 10.18632/oncotarget.3840; Yang DY, 2017, CANCER BIOMARK, V19, P425, DOI 10.3233/CBM-160421; Yoshiba N, 2012, J ENDODONT, V38, P177, DOI 10.1016/j.joen.2011.09.016; Zhang JY, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170036; Zhang XN, 2014, CELL BIOCHEM BIOPHYS, V70, P1105, DOI 10.1007/s12013-014-0029-y; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094	50	16	17	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.201900076RRRRR	http://dx.doi.org/10.1096/fj.201900076RRRRR		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33174326				2022-12-28	WOS:000591080100001
J	Snyder, JM; Zhong, G; Hogarth, C; Huang, WZ; Topping, T; LaFrance, J; Palau, L; Czuba, LC; Griswold, M; Ghiaur, G; Isoherranen, N				Snyder, Jessica M.; Zhong, Guo; Hogarth, Cathryn; Huang, Weize; Topping, Traci; LaFrance, Jeffrey; Palau, Laura; Czuba, Lindsay C.; Griswold, Michael; Ghiaur, Gabriel; Isoherranen, Nina			Knockout of Cyp26a1 and Cyp26b1 during postnatal life causes reduced lifespan, dermatitis, splenomegaly, and systemic inflammation in mice	FASEB JOURNAL			English	Article						cytochrome P450; dermatitis; inflammation; retinoic acid; vitamin A	TRANS-RETINOIC ACID; VITAMIN-A; HUMAN CYTOCHROME-P450; HYDROXYLASES CYP26A1; METABOLISM; CELL; ENZYME; INHIBITION; BIOSYNTHESIS; OSTEOGENESIS	All-trans-retinoic acid (atRA), the active metabolite of vitamin A, is an essential signaling molecule in all chordates. Global knockouts of the atRA clearing enzymes Cyp26a1 or Cyp26b1 are embryonic lethal. In adult rodents, inhibition of Cyp26a1 and Cyp26b1 increases atRA concentrations and signaling. However, postnatal knockout of Cyp26a1 does not cause a severe phenotype. We hypothesized that Cyp26b1 is the main atRA clearing Cyp in postnatal mammals. This hypothesis was tested by generating tamoxifen-inducible knockout mouse models of Cyp26b1 alone or with Cyp26a1. Both mouse models showed dermatitis, blepharitis, and splenomegaly. Histology showed infiltration of inflammatory cells including neutrophils and T lymphocytes into the skin and hyperkeratosis/hyperplasia of the nonglandular stomach. The mice lacking both Cyp26a1 and Cyp26b1 also had a reduced lifespan, failed to gain weight, and showed fat atrophy. There were significant changes in vitamin A homeostasis. Postnatal knockout of Cyp26b1 resulted in increased atRA concentrations in the skin while the postnatal knockout of both Cyp26a1 and Cyp26b1 resulted in increased atRA concentrations in the liver, serum, skin, spleen, and intestines. This study demonstrates the paramount role of Cyp26b1 in regulating retinoid homeostasis in postnatal life.	[Snyder, Jessica M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Zhong, Guo; Huang, Weize; LaFrance, Jeffrey; Czuba, Lindsay C.; Isoherranen, Nina] Univ Washington, Sch Pharm, Dept Pharmaceut, Hlth Sci Bldg,Room H-272M,Box 357610, Seattle, WA 98195 USA; [Hogarth, Cathryn; Topping, Traci; Griswold, Michael] Washington State Univ, Sch Mol Biosci, Pullman, WA USA; [Hogarth, Cathryn] La Trobe Univ, Sch Mol Sci, Dept Pharm & Biomed Sci, Wodonga, Vic, Australia; [Palau, Laura; Ghiaur, Gabriel] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington State University; La Trobe University; Johns Hopkins University	Isoherranen, N (corresponding author), Univ Washington, Sch Pharm, Dept Pharmaceut, Hlth Sci Bldg,Room H-272M,Box 357610, Seattle, WA 98195 USA.	ni2@uw.edu		Huang, Weize/0000-0001-5903-721X; Czuba, Lindsay/0000-0001-9142-5706; Zhong, Guo/0000-0002-6056-9472	NIH [R01 GM111772, T32 DK007247, HD 10808]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grants R01 GM111772 (to JS, CH, and NI), T32 DK007247 (to LC) and HD 10808 (M.G)	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Alonso S, 2017, EXP HEMATOL, V54, P17, DOI 10.1016/j.exphem.2017.07.004; BIESALSKI HK, 1989, TOXICOLOGY, V57, P117, DOI 10.1016/0300-483X(89)90161-3; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hampton AL, 2015, J AM ASSOC LAB ANIM, V54, P487; Hernandez D, 2020, LEUKEMIA, V34, P3077, DOI 10.1038/s41375-020-0790-4; Hogarth CA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129718; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Isoherranen N, 2019, PHARMACOL THERAPEUT, V204, DOI 10.1016/j.pharmthera.2019.107400; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; KRETZSCHMAR R, 1975, ACTA DERM-VENEREOL, V55, P25; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; KURTZ PJ, 1984, TOXICOLOGY, V30, P115, DOI 10.1016/0300-483X(84)90122-7; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Li Yang, 2014, Hepatobiliary Surg Nutr, V3, P126, DOI 10.3978/j.issn.2304-3881.2014.05.04; Minegishi Y, 2014, BIOCHEM BIOPH RES CO, V454, P12, DOI 10.1016/j.bbrc.2014.10.001; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nelson CH, 2013, CURR TOP MED CHEM, V13, P1402; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Nilsson O, 2016, HORM METAB RES, V48, P737, DOI 10.1055/s-0042-114038; Nolte T, 2016, J TOXICOL PATHOL, V29, p1S, DOI 10.1293/tox.29.1S; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Raverdeau M, 2014, J IMMUNOL, V192, P2953, DOI 10.4049/jimmunol.1303245; Renne R, 2009, TOXICOL PATHOL, V37, p5S, DOI 10.1177/0192623309353423; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Senoo H, 2012, ANAT REC, V295, P1660, DOI 10.1002/ar.22555; Slavotinek AM, 2013, HUM MOL GENET, V22, P696, DOI 10.1093/hmg/dds477; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Stevison F, 2017, DRUG METAB DISPOS, V45, P846, DOI 10.1124/dmd.117.075341; Stoppie P, 2000, J PHARMACOL EXP THER, V293, P304; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Thatcher JE, 2010, BIOCHEM PHARMACOL, V80, P903, DOI 10.1016/j.bcp.2010.05.023; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Treuting Piper M, 2015, Curr Protoc Mouse Biol, V5, P223, DOI 10.1002/9780470942390.mo140296; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; WHITE JA, 1994, DEVELOPMENT, V120, P1861; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Zhong G, 2019, J BIOL CHEM, V294, P11166, DOI 10.1074/jbc.RA119.009023	53	6	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15788	15804		10.1096/fj.202001734R	http://dx.doi.org/10.1096/fj.202001734R		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33105029	Green Submitted, Green Accepted			2022-12-28	WOS:000586269500001
J	La, TM; Tachibana, H; Li, SA; Abe, T; Seiriki, S; Nagaoka, H; Takashima, E; Takeda, T; Ogawa, D; Makino, S; Asanuma, K; Watanabe, M; Tian, XF; Ishibe, S; Sakane, A; Sasaki, T; Wada, J; Takei, K; Yamada, H				La, The Mon; Tachibana, Hiromi; Li, Shun-Ai; Abe, Tadashi; Seiriki, Sayaka; Nagaoka, Hikaru; Takashima, Eizo; Takeda, Tetsuya; Ogawa, Daisuke; Makino, Shin-ichi; Asanuma, Katsuhiko; Watanabe, Masami; Tian, Xuefei; Ishibe, Shuta; Sakane, Ayuko; Sasaki, Takuya; Wada, Jun; Takei, Kohji; Yamada, Hiroshi			Dynamin 1 is important for microtubule organization and stabilization in glomerular podocytes	FASEB JOURNAL			English	Article						dynamin; microtubules; podocyte; primary process	MECHANOCHEMICAL ENZYME; CRYSTAL-STRUCTURE; KIDNEY; PROTEIN; PHAGOCYTOSIS; CYTOSKELETON; NOCODAZOLE; HOMOLOGY; TUBULIN; COMPLEX	Dynamin 1 is a neuronal endocytic protein that participates in vesicle formation by scission of invaginated membranes. Dynamin 1 is also expressed in the kidney; however, its physiological significance to this organ remains unknown. Here, we show that dynamin 1 is crucial for microtubule organization and stabilization in glomerular podocytes. By immunofluorescence and immunoelectron microscopy, dynamin 1 was concentrated at microtubules at primary processes in rat podocytes. By immunofluorescence of differentiated mouse podocytes (MPCs), dynamin 1 was often colocalized with microtubule bundles, which radially arranged toward periphery of expanded podocyte. In dynamin 1-depleted MPCs by RNAi, alpha-tubulin showed a dispersed linear filament-like localization, and microtubule bundles were rarely observed. Furthermore, dynamin 1 depletion resulted in the formation of discontinuous, short acetylated alpha-tubulin fragments, and the decrease of microtubule-rich protrusions. Dynamins 1 and 2 double-knockout podocytes showed dispersed acetylated alpha-tubulin and rare protrusions. In vitro, dynamin 1 polymerized around microtubules and cross-linked them into bundles, and increased their resistance to the disassembly-inducing reagents Ca(2+)and podophyllotoxin. In addition, overexpression and depletion of dynamin 1 in MPCs increased and decreased the nocodazole resistance of microtubules, respectively. These results suggest that dynamin 1 supports the microtubule bundle formation and participates in the stabilization of microtubules.	[La, The Mon; Abe, Tadashi; Seiriki, Sayaka; Takeda, Tetsuya; Takei, Kohji; Yamada, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, 2-5-1 Shikata Cho, Okayama 7008558, Japan; [Tachibana, Hiromi; Ogawa, Daisuke; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Li, Shun-Ai; Watanabe, Masami] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Nagaoka, Hikaru; Takashima, Eizo] Ehime Univ, Div Malaria Res, Proteo Sci Ctr, Matsuyama, Ehime, Japan; [Makino, Shin-ichi; Asanuma, Katsuhiko] Chiba Univ, Grad Sch Med, Dept Nephrol, Chiba, Japan; [Tian, Xuefei; Ishibe, Shuta] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06510 USA; [Sakane, Ayuko; Sasaki, Takuya] Tokushima Univ, Grad Sch Med Sci, Dept Biochem, Tokushima, Japan; [Sakane, Ayuko] Inst PostLED Photon, Dept Interdisciplinary Res Med & Photon, Tokushima, Japan	Okayama University; Okayama University; Okayama University; Ehime University; Chiba University; Yale University; Tokushima University	Yamada, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	hiroyama@md.okayama-u.ac.jp	Yamada, Hiroshi/AGZ-4497-2022; WADA, Jun/B-2023-2011; YAMADA, Hiroshi/B-2251-2011	Yamada, Hiroshi/0000-0002-9328-3446; WADA, Jun/0000-0003-1468-5170; YAMADA, Hiroshi/0000-0002-9328-3446; Takei, Kohji/0000-0002-6555-9425; nagaoka, hikaru/0000-0003-2167-1754; Makino, Shin-ichi/0000-0003-0135-0435	MEXT | Japan Society for the Promotion of Science (JSPS) [JP19H03225, JP17K08808, JP19K07084]; Okayama University Central Research Laboratory; Ehime University Proteo-Science Center (PROS)	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Okayama University Central Research Laboratory; Ehime University Proteo-Science Center (PROS)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP19H03225, JP17K08808 and JP19K07084; Okayama University Central Research Laboratory; Ehime University Proteo-Science Center (PROS)	Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Bai XB, 2013, J CELL BIOL, V203, P895, DOI 10.1083/jcb.201308068; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; BONNE D, 1985, J BIOL CHEM, V260, P2819; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Elie A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09964; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Khalil R, 2019, J PATHOL, V247, P177, DOI 10.1002/path.5181; Kobayashi N, 1998, J CELL BIOL, V143, P1961, DOI 10.1083/jcb.143.7.1961; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kurklinsky S, 2011, J NEUROCHEM, V117, P48, DOI 10.1111/j.1471-4159.2011.07169.x; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; NAKATA T, 1993, J CELL SCI, V105, P1; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Prezel E, 2018, MOL BIOL CELL, V29, P154, DOI 10.1091/mbc.E17-06-0429; Schiffer M, 2015, NAT MED, V21, P601, DOI 10.1038/nm.3843; SCHILSTRA MJ, 1989, J BIOL CHEM, V264, P8827; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Sever S, 2018, KIDNEY INT, V93, P1298, DOI 10.1016/j.kint.2017.12.028; Sever S, 2013, TRAFFIC, V14, P1194, DOI 10.1111/tra.12116; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Swiatecka-Urban A, 2013, PEDIATR NEPHROL, V28, P1723, DOI 10.1007/s00467-012-2281-y; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; TAKEMURA R, 1992, J CELL SCI, V103, P953; TAKEMURA R, 1995, MOL BIOL CELL, V6, P981, DOI 10.1091/mbc.6.8.981; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; TORRE E, 1994, J BIOL CHEM, V269, P32411; VASMANT D, 1984, ANAT REC, V210, P17, DOI 10.1002/ar.1092100104; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zhang RH, 2020, NAT CELL BIOL, V22, P674, DOI 10.1038/s41556-020-0519-7; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	43	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16449	16463		10.1096/fj.202001240RR	http://dx.doi.org/10.1096/fj.202001240RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070431	hybrid, Green Published			2022-12-28	WOS:000581167100001
J	Hogh, RI; Moller, SH; Jepsen, SD; Mellergaard, M; Lund, A; Pejtersen, M; Fitzner, E; Andresen, L; Skov, S				Hogh, Rikke Illum; Moller, Sofie Hedlund; Jepsen, Stine Dam; Mellergaard, Maiken; Lund, Astrid; Pejtersen, Mikala; Fitzner, Emil; Andresen, Lars; Skov, Soren			Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells	FASEB JOURNAL			English	Article						cancer; immunometabolism; NKG2D ligands; short-chain fatty acids	DIETARY FIBER; T-CELLS; HISTONE ACETYLTRANSFERASE; GUT MICROBIOTA; PROTEIN; STRESS; ACTIVATION; BUTYRATE; COMPLEX; PHOSPHORYLATION	SCFAs are primarily produced in the colon by bacterial fermentation of nondigestible carbohydrates. Besides providing energy, SCFAs can suppress development of colon cancer. The mechanism, however, remains elusive. Here, we demonstrate that the SCFA propionate upregulates surface expression of the immune stimulatory NKG2D ligands, MICA/B by imposing metabolic changes in dividing cells. Propionate-mediated MICA/B expression did not rely on GPR41/GPR43 receptors but depended on functional mitochondria. By siRNA-directed knockdown, we could further link phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme in gluconeogenesis to propionate regulation of MICA/B expression. Moreover, knockdown of Rictor and specific mTOR inhibitors implicated mTORC2 activity with metabolic changes that control MICA/B expression. SCFAs are precursors to short-chain acyl-CoAs that are used for histone acylation thereby linking the metabolic state to chromatin structure and gene expression. Propionate increased the overall acetylation and propionylation and inhibition of lysine acetyltransferases (KATs) that are responsible for adding acyl-CoAs to histones reduced propionate-mediated MICA/B expression, suggesting that propionate-induced acylation increases MICA/B expression. Notably, propionate upregulated MICA/B surface expression on colon cancer cells in an acylation-dependent manner; however, the impact of mitochondrial metabolism on MICA/B expression was different in colon cancer cells compared with Jurkat cells, suggesting that continuous exposure to propionate in the colon may provide an enhanced capacity to metabolize propionate. Together, our findings support that propionate causes metabolic changes resulting in NKG2D ligand surface expression, which holds potential as an immune activating anticancer therapy.	[Hogh, Rikke Illum; Moller, Sofie Hedlund; Jepsen, Stine Dam; Mellergaard, Maiken; Lund, Astrid; Pejtersen, Mikala; Fitzner, Emil; Andresen, Lars; Skov, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Lab Immunol, Ridebanevej 9, DK-1870 Copenhagen C, Denmark	University of Copenhagen	Skov, S (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Lab Immunol, Ridebanevej 9, DK-1870 Copenhagen C, Denmark.	sosk@sund.ku.dk		Skov, Soren/0000-0003-0732-0026; Jepsen, Stine Dam/0000-0001-5268-7383; Mellergaard, Maiken/0000-0001-5854-1086; Moller, Sofie Hedlund/0000-0002-2268-4277; Andresen, Lars/0000-0002-6362-7973	Danish Council for Independent Research [DFF6111-00499]; Novo Nordisk Foundation [NNF15CC0018346]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Danish Council for Independent Research (DFF6111-00499) and the Novo Nordisk Foundation (NNF15CC0018346)	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ananthakrishnan AN, 2013, GASTROENTEROLOGY, V145, P970, DOI 10.1053/j.gastro.2013.07.050; Andersson AK, 2011, ARTHRITIS RHEUM-US, V63, P2617, DOI 10.1002/art.30460; Andresen L, 2009, J IMMUNOL, V183, P897, DOI 10.4049/jimmunol.0803014; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chekulayev Vladimir, 2015, Biochem Biophys Rep, V4, P111, DOI 10.1016/j.bbrep.2015.08.020; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Dutnall RN, 1998, COLD SPRING HARB SYM, V63, P501, DOI 10.1101/sqb.1998.63.501; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan YY, 2015, AM J PHYSIOL-GASTR L, V309, pG1, DOI 10.1152/ajpgi.00052.2015; Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hansen CHF, 2013, EUR J IMMUNOL, V43, P447, DOI 10.1002/eji.201242462; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Huang WC, 2017, J IMMUNOL, V198, P1172, DOI 10.4049/jimmunol.1601313; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Kaczmarska Z, 2017, NAT CHEM BIOL, V13, P21, DOI [10.1038/NCHEMBIO.2217, 10.1038/nchembio.2217]; Kebede AF, 2017, NAT STRUCT MOL BIOL, V24, P1048, DOI 10.1038/nsmb.3490; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kim Chang H, 2014, Immune Netw, V14, P277, DOI 10.4110/in.2014.14.6.277; Kim K, 2019, MOL MED REP, V20, P1569, DOI 10.3892/mmr.2019.10431; Kobayashi M, 2017, BIOCHEM BIOPH RES CO, V486, P499, DOI 10.1016/j.bbrc.2017.03.071; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Luu M, 2019, EUR J IMMUNOL, V49, P842, DOI 10.1002/eji.201848009; Luu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08711-2; McCarthy MT, 2018, J BIOL CHEM, V293, P3913, DOI 10.1074/jbc.M117.809459; Mellergaard M, 2014, J BIOL CHEM, V289, P20078, DOI 10.1074/jbc.M114.573238; Molfetta R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081677; Molinero LL, 2002, J LEUKOCYTE BIOL, V71, P791; Moloughney JG, 2016, MOL CELL, V63, P811, DOI 10.1016/j.molcel.2016.07.015; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Neitzel C, 2020, CANCERS, V12, DOI 10.3390/cancers12071731; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perry RJ, 2016, J BIOL CHEM, V291, P12161, DOI 10.1074/jbc.M116.720631; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sauer M, 2017, ONCOGENE, V36, P933, DOI 10.1038/onc.2016.259; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Uhlenbrock F, 2014, J IMMUNOL, V193, P1654, DOI 10.4049/jimmunol.1303275; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wongkittichote P, 2017, MOL GENET METAB, V122, P145, DOI 10.1016/j.ymgme.2017.10.002; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Zeng HW, 2014, WORLD J GASTRO ONCOL, V6, P41, DOI 10.4251/wjgo.v6.i2.41; Zhang C, 2009, CANCER IMMUNOL IMMUN, V58, P1275, DOI 10.1007/s00262-008-0645-8	68	11	14	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15531	15546		10.1096/fj.202000162R	http://dx.doi.org/10.1096/fj.202000162R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32996653				2022-12-28	WOS:000574660300001
J	Guo, XZ; Zhang, WP; Wang, C; Zhang, B; Li, R; Zhang, L; Zhao, K; Li, Y; Tian, LL; Li, B; Cheng, HK; Li, LX; Pei, CY; Xu, HW				Guo, Xize; Zhang, Wanping; Wang, Chun; Zhang, Bo; Li, Rui; Zhang, Lie; Zhao, Kai; Li, Yu; Tian, Linlu; Li, Bo; Cheng, Huakun; Li, Lixian; Pei, Chunying; Xu, Hongwei			IRGM promotes the PINK1-mediated mitophagy through the degradation of Mitofilin in SH-SY5Y cells	FASEB JOURNAL			English	Article						IRGM; mitochondria; mitofilin; mitophagy; PINK1	DAMAGED MITOCHONDRIA; PARKIN; MEMBRANE; AUTOPHAGY; PROTEIN; IMMUNITY; RECRUITMENT; APOPTOSIS; COMPLEX	Mitochondria is a double membrane-bound cellular organelle that generates energy to maintain the homeostasis of cells. Immunity-related GTPase M (IRGM) in human locates at the inner membrane of mitochondria and is best known for its role in regulating autophagy against intracellular pathogens. Previous studies have shown that IRGM is crucial for the normal function of mitochondria, yet, the molecular mechanisms underlying IRGM-mediated quality control of mitochondria are still not fully understood. In this study, we showed that knocking-down IRGM inhibits CCCP induced mitophagy in SH-SY5Y cells. Furthermore, we reported that IRGM decreases the stability of Mitofilin (IMMT, MIC60) in the damaged mitochondria. Knocking down Mitofilin rescues the loss of mitophagy that is observed in the IRGM KD cells, suggesting that IRGM regulates mitophagy through the inhibition of Mitofilin. These data together provide molecular insight regarding how IRGM regulates mitophagy to control the quality of mitochondria.	[Guo, Xize; Zhang, Wanping; Wang, Chun; Zhang, Lie; Tian, Linlu; Li, Bo; Pei, Chunying; Xu, Hongwei] Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China; [Zhang, Bo] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 4, Harbin, Peoples R China; [Li, Rui] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Zhao, Kai; Li, Yu; Li, Lixian] Harbin Med Univ, Dept Neurosurg, Affiliate Hosp 1, Harbin, Peoples R China; [Cheng, Huakun] Heilongjiang Prov Hosp, Dept Neurosurg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; University of Pennsylvania; Harbin Medical University	Pei, CY; Xu, HW (corresponding author), Harbin Med Univ, Dept Immunol, Harbin 150081, Peoples R China.	peichunying@hrbmu.edu.cn; hongwei56@hotmail.com	Li, Rui/O-7397-2016	Li, Rui/0000-0002-7210-8358; Xu, Hongwei/0000-0001-5763-3894	National Natural Science Foundation [31371080, 81401286]; Natural Science Foundation of Heilongjiang Province [H2016012]; Youth Science Foundation of Heilongjiang Province [QC2016106]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Youth Science Foundation of Heilongjiang Province	This work was supported by the National Natural Science Foundation Projects under Grant No. 31371080; the National Natural Science Foundation Projects under Grant No. 81401286; the Natural Science Foundation of Heilongjiang Province under Grant No. H2016012; the Youth Science Foundation of Heilongjiang Province under Grant No. QC2016106. We would like to thank Professor Hulun Li for project discussion and technical support.	Akabane S, 2016, MOL CELL, V62, P371, DOI 10.1016/j.molcel.2016.03.037; Bohnert M, 2012, MOL BIOL CELL, V23, P3948, DOI 10.1091/mbc.E12-04-0295; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Ding CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16064; Dong H, 2015, ONCOGENE, V34, P5363, DOI 10.1038/onc.2014.459; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; He SY, 2012, AUTOPHAGY, V8, P1621, DOI 10.4161/auto.21561; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kauffman Megan E, 2016, React Oxyg Species (Apex), V2, P361, DOI 10.20455/ros.2016.865; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Oh CK, 2017, CELL REP, V21, P2171, DOI 10.1016/j.celrep.2017.10.068; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Van Laar VS, 2016, NEUROBIOL DIS, V91, P247, DOI 10.1016/j.nbd.2016.03.015; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wei X, 2015, NEUROTOXICOLOGY, V46, P19, DOI 10.1016/j.neuro.2014.11.007; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Xu HW, 2010, FASEB J, V24, P1583, DOI 10.1096/fj.09-137323; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004; Zhang XN, 2014, AUTOPHAGY, V10, P1801, DOI 10.4161/auto.32136	32	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14768	14779		10.1096/fj.202000943RR	http://dx.doi.org/10.1096/fj.202000943RR		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939830	Bronze			2022-12-28	WOS:000572122500001
J	Park, DH; Park, S; Song, JM; Kang, M; Lee, S; Horak, M; Suh, YH				Park, Da-ha; Park, Sunha; Song, Jae-man; Kang, Minji; Lee, Sanghyeon; Horak, Martin; Suh, Young Ho			N-linked glycosylation of the mGlu7 receptor regulates the forward trafficking and transsynaptic interaction with Elfn1	FASEB JOURNAL			English	Article						degradation; extracellular domain; trafficking; transsynaptic adhesion	METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN GLYCOSYLATION; PKC PHOSPHORYLATION; SURFACE EXPRESSION; LIGAND-BINDING; PICK1; RELEASE; PHYSIOLOGY; DIVERSITY; AFFINITY	Metabotropic glutamate receptor 7 (mGlu7) regulates neurotransmitter release at the presynaptic active zone in the mammalian brain. The regulation of mGlu7 trafficking into and out of the plasma membrane by binding proteins within the C-terminal region of mGlu7 governs the bidirectional synaptic plasticity. However, the functional importance of the extracellular domain of mGlu7 has not yet been characterized. N-glycosylation is an abundant posttranslational modification that plays crucial roles in protein folding and forward trafficking, but the role of N-glycosylation in mGlu7 function remains unknown. In this study, we find that mGlu7 is N-glycosylated at four asparagine residues in heterologous cells and rat cultured neurons. We demonstrate that N-glycosylation is essential for forward transport and surface expression of mGlu7. Deglycosylated mGlu7 is retained in the ER, obstructing expression on the cell surface, and is degraded through the autophagolysosomal degradation pathway. In addition, we identify the binding domain of mGlu7 to Elfn1, a transsynaptic adhesion protein. We find that N-glycosylation of mGlu7 promotes its interaction with Elfn1, thereby enabling proper localization and stable surface expression of mGlu7 at the presynaptic active zone. These findings provide evidence that N-glycans act to modulate the surface expression, stability, and function of mGlu7.	[Park, Da-ha; Park, Sunha; Song, Jae-man; Kang, Minji; Lee, Sanghyeon; Suh, Young Ho] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Neurosci Res Inst,Transplantat Res Inst, Seoul, South Korea; [Horak, Martin] Czech Acad Sci, Inst Physiol, Inst Expt Med, Prague 4, Czech Republic	Seoul National University (SNU); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Room 405 Convergence Res Bldg,103 Daehak Ro, Seoul 03080, South Korea.	suhyho@snu.ac.kr	Suh, Young Ho/AAJ-6405-2021; Horak, Martin/F-9819-2010	Suh, Young Ho/0000-0003-3979-1615; Horak, Martin/0000-0002-4359-051X	Korea Health Industry Development Institute (KHIDI) [HI18C0789]; National Research Foundation of Korea (NRF) [NRF-2018R1A2B6004759, NRF-2017M3C7A1029611, NRF-2020R1A5A1019023]; Czech Science Foundation [18-04329S]	Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Czech Science Foundation(Grant Agency of the Czech Republic)	Korea Health Industry Development Institute (KHIDI), Grant/Award Number: HI18C0789; National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2B6004759, NRF-2017M3C7A1029611 and NRF-2020R1A5A1019023; Czech Science Foundation, Grant/Award Number: 18-04329S	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Andre S, 2009, BIOL CHEM, V390, P557, DOI 10.1515/BC.2009.072; Bertaso F, 2008, NAT NEUROSCI, V11, P940, DOI 10.1038/nn.2142; Bhave G, 2003, J BIOL CHEM, V278, P30294, DOI 10.1074/jbc.M303258200; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; BREWER CF, 1986, J BIOL CHEM, V261, P7306; Cai XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04844-w; Cao Y, 2015, NEURON, V87, P1248, DOI 10.1016/j.neuron.2015.09.002; Chan WY, 2001, MOL CELL NEUROSCI, V17, P577, DOI 10.1006/mcne.2001.0965; Choi JH, 2016, NEUROPHARMACOLOGY, V102, P229, DOI 10.1016/j.neuropharm.2015.11.021; Dev KK, 2001, TRENDS PHARMACOL SCI, V22, P355, DOI 10.1016/S0165-6147(00)01684-9; Dev KK, 2000, J NEUROSCI, V20, P7252; Dolan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080491; Dunn HA, 2019, MOL PSYCHIATR, V24, P1902, DOI 10.1038/s41380-019-0512-3; Dunn HA, 2018, P NATL ACAD SCI USA, V115, P5022, DOI 10.1073/pnas.1722498115; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Fregno I, 2019, CRIT REV BIOCHEM MOL, V54, P153, DOI 10.1080/10409238.2019.1610351; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Garcia-Campos A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004688; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Hanus C, 2016, ELIFE, V5, DOI 10.7554/eLife.20609; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hwang JW, 2018, TRENDS BIOCHEM SCI, V43, P593, DOI 10.1016/j.tibs.2018.06.005; Irani MA, 2017, PROTEINS, V85, P1529, DOI 10.1002/prot.25314; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee SM, 2019, 2019 INTERNATIONAL CONFERENCE ON PLATFORM TECHNOLOGY AND SERVICE (PLATCON), P7; Lichnerova K, 2015, J BIOL CHEM, V290, P18379, DOI 10.1074/jbc.M115.656546; Margraf-Schonfeld S, 2011, J BIOL CHEM, V286, P24142, DOI 10.1074/jbc.M111.225334; Mody N, 1999, NEUROPHARMACOLOGY, V38, P1485, DOI 10.1016/S0028-3908(99)00099-4; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nasrallah C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22729-4; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pelkey KA, 2008, J PHYSIOL-LONDON, V586, P1495, DOI 10.1113/jphysiol.2007.148635; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Robbins MJ, 1999, J NEUROCHEM, V72, P2539, DOI 10.1046/j.1471-4159.1999.0722539.x; Rondard P, 2015, CURR OPIN PHARMACOL, V20, P95, DOI 10.1016/j.coph.2014.12.001; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Selkirk JV, 2002, J NEUROCHEM, V80, P346, DOI 10.1046/j.0022-3042.2001.00704.x; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shimoda A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47760-x; Skrenkova K, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00188; Stachniak TJ, 2019, J NEUROSCI, V39, P4461, DOI 10.1523/JNEUROSCI.2276-18.2019; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Suh YH, 2018, MOL CELL NEUROSCI, V91, P10, DOI 10.1016/j.mcn.2018.03.014; Suh YH, 2013, J BIOL CHEM, V288, P17544, DOI 10.1074/jbc.M112.439513; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Tomioka NH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5501; Tucholski J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094255; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wu D, 2018, P NATL ACAD SCI USA, V115, P8763, DOI 10.1073/pnas.1807439115; Wu XD, 2018, CURR OPIN CELL BIOL, V53, P22, DOI 10.1016/j.ceb.2018.04.004; Zhang CS, 2008, J NEUROSCI, V28, P8604, DOI 10.1523/JNEUROSCI.0628-08.2008; Zhang L, 2016, MABS-AUSTIN, V8, P524, DOI 10.1080/19420862.2016.1149662	64	8	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14977	14996		10.1096/fj.202001544R	http://dx.doi.org/10.1096/fj.202001544R		SEP 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931036				2022-12-28	WOS:000570777800001
J	Seipelt, EM; Tourniaire, F; Couturier, C; Astier, J; Loriod, B; Vachon, H; Puceat, M; Mounien, L; Landrier, JF				Seipelt, Eva M.; Tourniaire, Franck; Couturier, Charlene; Astier, Julien; Loriod, Beatrice; Vachon, Hortense; Puceat, Michel; Mounien, Lourdes; Landrier, Jean-Francois			Prenatal maternal vitamin D deficiency sex-dependently programs adipose tissue metabolism and energy homeostasis in offspring	FASEB JOURNAL			English	Article						adipose tissue; metabolism; maternal vitamin D deficiency; offspring; vitamin D	PREGNANCY; ADIPOCYTES; EXPRESSION; OBESITY; WEIGHT; GROWTH	In utero environment is crucial to ensure normal development of the fetus and to program metabolic health throughout the life. Beside macronutrients, the role of micronutrients, including vitamin D, begins to be explore. The aim of this study was to decipher the impact of maternal vitamin D deficiency (VDD), in normal and high-fat (HF) diet context, on adipose tissue metabolism and energy homeostasis in offspring, considering sex-specific responses. Body weight, energy expenditure, and spontaneous activity was differential impacted in juvenile male and female offspring born from VDD mice. In adulthood, a HF diet combined with maternal VDD disrupted glucose homeostasis and adiposity in male offspring but not in females. Such phenotypes were associated to different transcriptomic profiles in adipose tissue, which could be related to differential modulation of plasma 17 beta-estradiol concentrations. Thus, maternal VDD sex-dependently modulated metabolic fate of the offspring, especially when associated with HF diet in adulthood.	[Seipelt, Eva M.; Tourniaire, Franck; Couturier, Charlene; Astier, Julien; Mounien, Lourdes; Landrier, Jean-Francois] Aix Marseille Univ, INRAE, INSERM, C2VN, Marseille, France; [Seipelt, Eva M.; Puceat, Michel] Aix Marseille Univ, MMG, INSERM, U1251, Marseille, France; [Tourniaire, Franck; Landrier, Jean-Francois] Criblage Biol Marseille, Fac Med Timone, CriBioM, Marseille, France; [Loriod, Beatrice; Vachon, Hortense] Aix Marseille Univ, TGML, TAGC, INSERM, Marseille, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Landrier, JF (corresponding author), Univ Aix Marseille, INSERM, UMR 1260, C2VN,INRAE 1263, 27 Bd Jean Moulin, F-13385 Marseille 05, France.	jean-francois.landrier@univ-amu.fr	PUCEAT, michel/R-6140-2017; Landrier, Jean-Francois/AAH-2757-2019; Inserm U1090, TAGC/ABE-9980-2021	Landrier, Jean-Francois/0000-0002-8690-8014; Mounien, Lourdes/0000-0002-9221-5783	INRAE; INSERM; AMU; Fondation de France; GIS IBiSA; Aix-Marseille Universite;  [ANR-10-INBS-0009-10]	INRAE; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AMU; Fondation de France(Fondation de France); GIS IBiSA; Aix-Marseille Universite; 	The work has been funded by grants from INRAE, INSERM, AMU and the Fondation de France. High throughput sequencing was performed at the TGML Platform, supported by grants from Inserm, GIS IBiSA, Aix-Marseille Universite, and ANR-10-INBS-0009-10	Achkar M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.009; Amraei M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00007; Belenchia AM, 2018, EUR J NUTR, V57, P723, DOI 10.1007/s00394-016-1359-x; Belenchia AM, 2017, J ENDOCRINOL, V234, P301, DOI 10.1530/JOE-17-0015; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Bonnet L, 2019, J STEROID BIOCHEM, V185, P39, DOI 10.1016/j.jsbmb.2018.07.006; Bonnet L, 2018, ENDOCRINOLOGY, V159, P957, DOI 10.1210/en.2017-00650; Borg SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190675; Brown LM, 2010, J STEROID BIOCHEM, V122, P65, DOI 10.1016/j.jsbmb.2009.12.005; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Crozier SR, 2012, AM J CLIN NUTR, V96, P57, DOI 10.3945/ajcn.112.037473; Daraki V, 2018, PEDIATR OBES, V13, P467, DOI 10.1111/ijpo.12267; Derghal A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00181; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; Eyles D.W., 2018, VITAMIN VOL 1 BIOCH, VVolume 1, P563; Fenni S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601083; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Fu L, 2017, PHYSIOL BEHAV, V179, P333, DOI 10.1016/j.physbeh.2017.07.017; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Goyal D, 2019, J ENDOCRINOL, V242, pT105, DOI 10.1530/JOE-19-0009; Hawes JE, 2015, BEHAV BRAIN RES, V286, P192, DOI 10.1016/j.bbr.2015.03.008; Ideraabdullah FY, 2019, J ENDOCRINOL, V241, pR65, DOI 10.1530/JOE-18-0541; Karkeni E, 2018, EPIGENETICS-US, V13, P156, DOI 10.1080/15592294.2016.1276681; Karkeni E, 2015, ENDOCRINOLOGY, V156, P1782, DOI 10.1210/en.2014-1647; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Landrier JF, 2019, J BONE MINER RES, V34, P1383, DOI 10.1002/jbmr.3739; Landrier JF, 2016, P NUTR SOC, V75, P38, DOI 10.1017/S0029665115004164; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcotorchino J, 2014, J NUTR BIOCHEM, V25, P1077, DOI 10.1016/j.jnutbio.2014.05.010; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P1771, DOI 10.1002/mnfr.201200383; Miliku K, 2016, AM J CLIN NUTR, V103, P1514, DOI 10.3945/ajcn.115.123752; Morales E, 2015, INT J OBESITY, V39, P61, DOI 10.1038/ijo.2014.165; Morales E, 2015, EPIDEMIOLOGY, V26, P458, DOI 10.1097/EDE.0000000000000292; Nascimento FAM, 2013, J NUTR SCI VITAMINOL, V59, P367, DOI 10.3177/jnsv.59.367; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Pan P, 2014, DEV PSYCHOBIOL, V56, P12, DOI 10.1002/dev.21086; Reichetzeder C, 2014, KIDNEY BLOOD PRESS R, V39, P315, DOI 10.1159/000355809; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rytter D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164758; Saraf R, 2016, MATERN CHILD NUTR, V12, P647, DOI 10.1111/mcn.12210; Tourniaire F, 2015, J LIPID RES, V56, P1100, DOI 10.1194/jlr.M053652; Turck D, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4587; Wang HP, 2018, J STEROID BIOCHEM, V175, P146, DOI 10.1016/j.jsbmb.2017.09.010; Wen J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18770-4; Zhang HQ, 2014, DIABETOLOGIA, V57, P2165, DOI 10.1007/s00125-014-3316-7	47	6	6	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14905	14919		10.1096/fj.201902924RR	http://dx.doi.org/10.1096/fj.201902924RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32924159	Green Submitted			2022-12-28	WOS:000570667500001
J	Chen, QY; Chen, JC; Wang, CH; Chen, XW; Liu, JF; Zhou, LL; Liu, YH				Chen, Qiyan; Chen, Jiongcheng; Wang, Chunhong; Chen, Xiaowen; Liu, Jiafeng; Zhou, Lili; Liu, Youhua			MicroRNA-466o-3p mediates beta-catenin-induced podocyte injury by targeting Wilms tumor 1	FASEB JOURNAL			English	Article						podocyte; proteinuria; Wilms tumor 1; Wnt; beta-catenin	DOWN-REGULATION; KIDNEY INJURY; WT1; GENE; HEALTH; DYSFUNCTION; INSIGHTS; PATHWAY; BIOLOGY; NEPHROPATHY	Podocytes are highly specialized cells that play an essential role in maintaining the integrity and function of the glomerular filtration barrier. Wilms tumor 1 (WT1) and beta-catenin are two master regulators that play opposing roles in podocyte biology and mutually antagonize each other. However, exactly how beta-catenin inhibits WT1 remains incompletely understood. In this study, we demonstrated the role of miR-466o-3p in mediating beta-catenin-triggered podocyte injury by targeting WT1. The expression of miR-466o-3p was upregulated in cultured podocytes after beta-catenin activation and in glomerular podocytes in adriamycin (ADR) nephropathy, remnant kidney after 5/6 renal ablation, and diabetic kidney disease. Bioinformatics analysis and luciferase reporter assay confirmed that miR-466o-3p directly targeted WT1 mRNA. Furthermore, overexpression of miR-466o-3p downregulated WT1 protein and promoted podocyte injury in vitro. Conversely, inhibition of miR-466o-3p alleviated beta-catenin-induced podocyte dysfunction. In mouse model of ADR nephropathy, overexpression of miR-466o-3p inhibited WT1, aggravated podocytes injury and deteriorated proteinuria. In contrast, inhibition of renal miR-466o-3p by antagomiR, either prior to or after ADR injection, substantially restored WT1, alleviated podocytes injury and reduced renal fibrosis. These studies reveal a critical role for miR-466o-3p, a novel microRNA that has not been characterized previously, in mediating beta-catenin-triggered WT1 inhibition. Our findings also uncover a new pathogenic mechanism by which beta-catenin promotes podocyte injury and proteinuria in glomerular diseases.	[Chen, Qiyan; Chen, Jiongcheng; Wang, Chunhong; Chen, Xiaowen; Liu, Jiafeng; Zhou, Lili; Liu, Youhua] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res,Div Nephrol, Guangzhou, Peoples R China; [Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA	Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.; Zhou, LL (corresponding author), Nanfang Hosp, State Key Lab Organ Failure Res, Natl Clin Res Ctr Kidney Dis, Div Nephrol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.	yhliu@pitt.edu; yhliu@pitt.edu		Liu, Youhua/0000-0002-4740-805X	National Natural Science Foundation of China [81521003, 81770715, 81920108007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81521003, 81770715 and 81920108007	Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Assady S, 2017, J AM SOC NEPHROL, V28, P1707, DOI 10.1681/ASN.2017010027; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Barua M, 2014, KIDNEY INT, V85, P124, DOI 10.1038/ki.2013.354; Chen SQ, 2019, KIDNEY INT, V95, P62, DOI 10.1016/j.kint.2018.08.029; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dong LH, 2015, KIDNEY INT, V88, P684, DOI 10.1038/ki.2015.198; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fan XP, 2012, CELL REPORTS, V2, P52, DOI 10.1016/j.celrep.2012.06.002; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Guo N, 2016, RENAL FAILURE, V38, P989, DOI 10.3109/0886022X.2016.1165119; Hall G, 2015, J AM SOC NEPHROL, V26, P831, DOI 10.1681/ASN.2013101053; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; Jing Zhou, 2015, Cell Signal, V27, P1772, DOI 10.1016/j.cellsig.2015.05.018; Kann M, 2015, J AM SOC NEPHROL, V26, P2097, DOI 10.1681/ASN.2014090940; Karaiskos N, 2018, J AM SOC NEPHROL, V29, P2060, DOI 10.1681/ASN.2018030238; Kaverina NV, 2017, STEM CELL REP, V9, P1152, DOI 10.1016/j.stemcr.2017.08.020; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lefebvre J, 2015, KIDNEY INT, V88, P321, DOI 10.1038/ki.2015.140; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lu YQ, 2017, KIDNEY INT, V92, P1119, DOI 10.1016/j.kint.2017.04.022; Mo HY, 2017, ANTIOXID REDOX SIGN, V27, P345, DOI 10.1089/ars.2016.6758; Morrison AA, 2008, AM J PHYSIOL-RENAL, V295, pF12, DOI 10.1152/ajprenal.00597.2007; Mundel P, 2017, PFLUG ARCH EUR J PHY, V469, P1029, DOI 10.1007/s00424-017-2015-x; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Scholz H, 2005, PHYSIOLOGY, V20, P54, DOI 10.1152/physiol.00048.2004; Tan RJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122399; Tomas NM, 2017, J AM SOC NEPHROL, V28, P3261, DOI 10.1681/ASN.2017010030; Trionfini P, 2017, J AM SOC NEPHROL, V28, P1686, DOI 10.1681/ASN.2016101117; Wan J, 2017, FREE RADICAL BIO MED, V108, P280, DOI 10.1016/j.freeradbiomed.2017.03.012; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Yang XG, 2015, INT J MOL MED, V36, P669, DOI 10.3892/ijmm.2015.2259; Zhou D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130515; Zhou LL, 2019, KIDNEY INT, V95, P830, DOI 10.1016/j.kint.2018.10.032; Zhou LL, 2015, AM J PATHOL, V185, P3211, DOI 10.1016/j.ajpath.2015.08.004; Zhou LL, 2015, NAT REV NEPHROL, V11, P535, DOI 10.1038/nrneph.2015.88; Zhou LL, 2015, J AM SOC NEPHROL, V26, P677, DOI 10.1681/ASN.2013101067; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zuo YY, 2018, NEPHROLOGY, V23, P38, DOI 10.1111/nep.13472	46	4	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14424	14439		10.1096/fj.202000464R	http://dx.doi.org/10.1096/fj.202000464R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32888352				2022-12-28	WOS:000568291000001
J	Jeong, E; Kim, J; Go, M; Lee, SY				Jeong, Eutteum; Kim, Jihee; Go, Miyeon; Lee, Soo Young			Early estrogen-induced gene 1 facilitates osteoclast formation through the inhibition of interferon regulatory factor 8 expression	FASEB JOURNAL			English	Article						bone; bone loss; osteoclast formation; osteoclastogenesis; osteoclasts	TERMINAL DIFFERENTIATION; BONE-RESORPTION; PROTEINS; RECEPTOR; IMMUNE; RANK; OSTEOIMMUNOLOGY; PERIODONTITIS; PLC-GAMMA-2; MECHANISMS	Osteoclast-mediated inflammatory bone resorption is a major cause of many inflammatory bone disorders, including rheumatoid arthritis and periodontitis. However, the mechanisms regulating osteoclast differentiation in inflammatory settings are not well understood. We demonstrate here that early estrogen-induced gene 1 (EEIG1)-deficient mice are protected from inflammatory bone loss as determined with the use of models of lipopolysaccharide (LPS)-induced bone destruction.EEIG1-deficient macrophages markedly decreased RANKL- and TNF alpha-mediated osteoclastogenesis due to the downregulation of the nuclear factor of activated T cells, cytoplasmic 1 (NFATc1), which is an essential transcription factor for osteoclast formation. In contrast, expression of interferon regulatory factor 8 (IRF8), a transcriptional repressor that blocks osteoclast differentiation, is elevated inEEIG1-deficient macrophages relative to wild-type cells. We found that reduced expression of B lymphocyte-induced maturation protein-1 (Blimp1) by siRNA downregulated RANKL-induced EEIG1 levels, whereas overexpression of Blimp1 potentiated EEIG1 levels. Mechanistic studies revealed that EEIG1 forms a complex with Blimp1 to negatively regulate the expression of the anti-osteoclastogenic gene,Irf8. We elucidated a novel mechanism by which EEIG1 restricts IRF8 expression and function, thereby enhancing the osteoclast formation by contributing to Blimp1-mediated IRF8 regulation. Together, these findings identify EEIG1 as a key regulator of osteoclastogenesis and a possible therapeutic target for pathological bone destruction.	[Jeong, Eutteum; Kim, Jihee; Go, Miyeon; Lee, Soo Young] Ewha Womans Univ, Dept Life Sci, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea; [Jeong, Eutteum; Kim, Jihee; Lee, Soo Young] Ewha Womans Univ, Res Ctr Cellular Homeostasis, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea	Ewha Womans University; Ewha Womans University	Lee, SY (corresponding author), Ewha Womans Univ, Dept Life Sci, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.; Lee, SY (corresponding author), Ewha Womans Univ, Res Ctr Cellular Homeostasis, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.	leesy@ewha.ac.kr		Kim, Jihee/0000-0002-4755-3169	National Research Foundation of Korea [2019R1A5A6099645]; Korea Basic Science Institute National Research Facilities & Equipment Center [2019R1A6C1010020]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Basic Science Institute National Research Facilities & Equipment Center	This work was supported by grants from the National Research Foundation of Korea (2019R1A5A6099645) and the Korea Basic Science Institute National Research Facilities & Equipment Center (2019R1A6C1010020). We thank T. Kim and W. Jeong for data analysis and interpretation.	Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Algate K, 2016, J PERIODONTAL RES, V51, P549, DOI 10.1111/jre.12339; Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Boyce BF, 2006, CURR OPIN RHEUMATOL, V18, P427, DOI 10.1097/01.bor.0000231913.32364.32; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Chen ZH, 2015, J BIOL CHEM, V290, P30163, DOI 10.1074/jbc.M115.663518; Choi HK, 2013, CELL RES, V23, P524, DOI 10.1038/cr.2013.33; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kim JH, 2014, CELL DEATH DIFFER, V21, P1613, DOI 10.1038/cdd.2014.71; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Luo G, 2018, MOL MED REP, V17, P6605, DOI 10.3892/mmr.2018.8698; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Schett G, 2011, EUR J CLIN INVEST, V41, P1361, DOI 10.1111/j.1365-2362.2011.02545.x; Shin B, 2014, J BIOL CHEM, V289, P35868, DOI 10.1074/jbc.M114.589614; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	44	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12894	12906		10.1096/fj.202001197R	http://dx.doi.org/10.1096/fj.202001197R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32741026	hybrid			2022-12-28	WOS:000558170100001
J	Yang, Y; Xu, PP; He, P; Shi, FS; Tang, YR; Guan, CY; Zeng, H; Zhou, YS; Song, QJ; Zhou, B; Jiang, S; Shao, CY; Sun, J; Yang, YC; Wang, XD; Song, HH				Yang, Yang; Xu, Pianpian; He, Ping; Shi, Fushan; Tang, Yiran; Guan, Chiyu; Zeng, Huan; Zhou, Yingshan; Song, Quanjiang; Zhou, Bin; Jiang, Sheng; Shao, Chunyan; Sun, Jing; Yang, Yongchun; Wang, Xiaodu; Song, Houhui			Mycobacterial PPE13 activates inflammasome by interacting with the NATCH and LRR domains of NLRP3	FASEB JOURNAL			English	Article						IL-1 beta; mycobacteria; NLRP3 inflammasome; PPE13	POLYMORPHIC TANDEM REPEAT; IL-1-BETA PRODUCTION; AIM2 INFLAMMASOME; SECRETION SYSTEM; TUBERCULOSIS; PROTEIN; INTERLEUKIN-1; INFECTION; INNATE; ESX-5	Pathogenic mycobacteria, such asMycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium marinum,can trigger NLRP3 inflammasome activation leading to maturation and secretion of interleukin 1 beta (IL-1 beta). However, the mycobacterial factors involved in the activation of NLRP3 inflammasome are not fully understood. Here, we identified that the PPE family protein PPE13 was responsible for the induction of IL-1 beta secretion in a NLRP3 inflammasome-dependent manner. We found that the recombinantMycobacterium smegmatisexpressing PPE13 activates NLRP3 inflammasome, thereby inducing caspase-1 cleavage and IL-1 beta secretion in J774A.1, BMDMs, and THP-1 macrophages. To examine whether this inflammasome activation was triggered by PPE13 rather than components ofM. smegmatis, PPE13 was introduced into the aforementioned macrophages by lentivirus as a delivery vector. Similarly, this led to the activation of NLRP3 inflammasome, indicating that PPE13 is a direct activator of NLRP3 cascade. We further demonstrated that the NLRP3 complex activated the inflammasome cascade, and the assembly of this complex was facilitated by PPE13 through interacting with the LRR and NATCH domains of NLRP3. Finally, we found that all PPE13 proteins isolated fromM. tuberculosis,M. bovis,andM. marinumcan activate NLRP3 inflammasome through binding to NLRP3, which requires C-terminal repetitive MPTR domain of PPE13. Thus, we, for the first time, revealed that PPE13 triggers the inflammasome-response by interacting with the MPTR domain of PPE13 and the LRR and NATCH domains of NLRP3. These findings provide a novel perspective on the function of PPE proteins in the immune system during mycobacteria invasion.	[Yang, Yang; Xu, Pianpian; Tang, Yiran; Guan, Chiyu; Zeng, Huan; Zhou, Yingshan; Song, Quanjiang; Zhou, Bin; Jiang, Sheng; Shao, Chunyan; Sun, Jing; Yang, Yongchun; Wang, Xiaodu; Song, Houhui] Zhejiang A&F Univ, Coll Anim Sci & Technol, Coll Vet Med,Zhejiang Prov Engn Lab Anim Hlth Ins, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Hangzhou 311300, Zhejiang, Peoples R China; [He, Ping] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Shi, Fushan] Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou, Peoples R China	Zhejiang A&F University; Chinese Center for Disease Control & Prevention; Zhejiang University	Song, HH (corresponding author), Zhejiang A&F Univ, Coll Anim Sci & Technol, Coll Vet Med,Zhejiang Prov Engn Lab Anim Hlth Ins, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Hangzhou 311300, Zhejiang, Peoples R China.	songhh@zafu.edu.cn		Sun, Jing/0000-0002-3400-1920	National Natural Science Foundation of China [31502034, 31502127, 31602119, 31602062, 31770040, 31802258 31902249, 31972648]; Natural Science Foundation of Zhejiang Province [LQ15C180002, LQ19C180003, LQ20C180002, LZ19C180001]; key Research and Development Program of Zhejiang Province [2019C02043]; ZAFU talents starting program [2014FR069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); key Research and Development Program of Zhejiang Province; ZAFU talents starting program	We thank Prof. Michael Niederweis from University of Alabama at Birmingham for providing the vector pMS2 used in this study. The work was funded by the National Natural Science Foundation of China (Grant Nos. 31502034, 31502127, 31602119, 31602062, 31770040, 31802258 31902249, and 31972648), Natural Science Foundation of Zhejiang Province (Grant Nos. LQ15C180002, LQ19C180003, LQ20C180002, and LZ19C180001), the key Research and Development Program of Zhejiang Province (Grant No. 2019C02043) and ZAFU talents starting program (Grant Nos. 2014FR069).	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Ahmed A, 2015, IUBMB LIFE, V67, P414, DOI 10.1002/iub.1387; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Demangel C, 2004, INFECT IMMUN, V72, P2170, DOI 10.1128/IAI.72.4.2170-2176.2004; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Feng ZH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00116; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; GEYVANPITTIUS NC, 2006, BMC EVOL BIOL, V6; Grover S, 2018, MBIO, V9, DOI 10.1128/mBio.01017-18; HERMANS PWM, 1992, J BACTERIOL, V174, P4157, DOI 10.1128/jb.174.12.4157-4165.1992; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mi YJ, 2017, RES MICROBIOL, V168, P234, DOI 10.1016/j.resmic.2016.06.004; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sayes F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005770; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shah S, 2015, INFECT IMMUN, V83, P4349, DOI 10.1128/IAI.00827-15; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; Shi H., 2015, NUTR CANC, V1, P10, DOI DOI 10.1038/NI.3333; Soldini S, 2011, TUBERCULOSIS, V91, P563, DOI 10.1016/j.tube.2011.08.002; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Su HB, 2018, J BIOL CHEM, V293, P10287, DOI 10.1074/jbc.RA118.001696; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Thi EP, 2013, CELL MICROBIOL, V15, P795, DOI 10.1111/cmi.12073; VANOOSTRUM J, 1991, J STRUCT BIOL, V107, P189; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; World Health Organization, 2018, GLOB TUB REP 2018; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yang Y, 2013, J INFECT DIS, V208, P1849, DOI 10.1093/infdis/jit347; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	54	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12820	12833		10.1096/fj.202000200RR	http://dx.doi.org/10.1096/fj.202000200RR		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738179				2022-12-28	WOS:000558180500001
J	Zong, GN; Jork, N; Hostachy, S; Fiedler, D; Jessen, HJ; Shears, SB; Wang, HC				Zong, Guangning; Jork, Nikolaus; Hostachy, Sarah; Fiedler, Dorothea; Jessen, Henning J.; Shears, Stephen B.; Wang, Huanchen			New structural insights reveal an expanded reaction cycle for inositol pyrophosphate hydrolysis by human DIPP1	FASEB JOURNAL			English	Article						cell&#8208; signaling; Nudix; phosphatase; reaction mechanism	DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE; ADP-RIBOSE PYROPHOSPHATASE; PHOSPHATE; ENZYME; SPECIFICITY; HYDROLASE; MECHANISM; PROTEINS; CAPTURE; ANALOGS	Nudix hydrolases attract considerable attention for their wide range of specialized activities in all domains of life. One particular group of Nudix phosphohydrolases (DIPPs), through their metabolism of diphosphoinositol polyphosphates (PP-InsPs), regulates the actions of these polyphosphates upon bioenergetic homeostasis. In the current study, we describe, at an atomic level, hitherto unknown properties of human DIPP1.We provide X-ray analysis of the catalytic core of DIPP1 in crystals complexed with either natural PP-InsPs, alternative PP-InsP stereoisomers, or non-hydrolysable methylene bisphosphonate analogs ("PCP-InsPs"). The conclusions that we draw from these data are interrogated by studying the impact upon catalytic activity upon mutagenesis of certain key residues. We present a picture of a V-shaped catalytic furrow with overhanging ridges constructed from flexible positively charged side chains; within this cavity, the labile phosphoanhydride bond is appropriately positioned at the catalytic site by an extensive series of interlocking polar contacts which we analogize as "suspension cables." We demonstrate functionality for a triglycine peptide within a beta-strand which represents a non-canonical addition to the standard Nudix catalytic core structure. We describe pre-reaction enzyme/substrate states which we posit to reflect a role for electrostatic steering in substrate capture. Finally, through time-resolved analysis, we uncover a chronological sequence of DIPP1/product post-reaction states, one of which may rationalize a role for InsP(6) as an inhibitor of catalytic activity.	[Zong, Guangning; Shears, Stephen B.; Wang, Huanchen] NIEHS, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Jork, Nikolaus; Jessen, Henning J.] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, Inst Organ Chem, Freiburg, Germany; [Hostachy, Sarah; Fiedler, Dorothea] Leibniz Forschungsinst Mol Pharmakol, Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Freiburg; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wang, HC (corresponding author), NIEHS, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Huanchen.wang@nih.gov	; Jessen, Henning/F-5108-2014	Zong, Guangning/0000-0001-6019-5741; Jessen, Henning/0000-0002-1025-9484; Jork, Nikolaus/0000-0002-3717-443X; Wang, Huanchen/0000-0003-2701-7155	Intramural NIH HHS [Z99 ES999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Caffrey JJ, 2000, J BIOL CHEM, V275, P12730, DOI 10.1074/jbc.275.17.12730; Capolicchio S, 2014, ANGEW CHEM INT EDIT, V53, P9508, DOI 10.1002/anie.201404398; Capolicchio S, 2013, ANGEW CHEM INT EDIT, V52, P6912, DOI 10.1002/anie.201301092; Dollins DE, 2020, P NATL ACAD SCI USA, V117, P9356, DOI 10.1073/pnas.1908875117; Elliott TS, 2012, MEDCHEMCOMM, V3, P735, DOI 10.1039/c2md20079a; ENGEL R, 1977, CHEM REV, V77, P349, DOI 10.1021/cr60307a003; Flohr A, 1999, J MED CHEM, V42, P2633, DOI 10.1021/jm991008q; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Gerasimaite R, 2017, ACS CHEM BIOL, V12, P648, DOI 10.1021/acschembio.7b00026; Hua LV, 2003, BIOCHEM J, V373, P81, DOI 10.1042/BJ20030142; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; Kramer S, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1511; Laussmann T, 2000, EUR J BIOCHEM, V267, P2447, DOI 10.1046/j.1432-1327.2000.01264.x; Leslie NR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-20; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlovic I, 2016, ORG BIOMOL CHEM, V14, P5559, DOI 10.1039/c6ob00094k; Randall Thomas A., 2020, Advances in Biological Regulation, V75, P100674, DOI 10.1016/j.jbior.2019.100674; Riley AM, 2018, MEDCHEMCOMM, V9, DOI [10.1039/c8md00149a, 10.1039/C8MD00149A]; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Shears SB, 2018, J CELL PHYSIOL, V233, P1897, DOI 10.1002/jcp.26017; Singh AN, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-0977-6; Srouji JR, 2017, PROTEINS, V85, P775, DOI 10.1002/prot.25223; Steidle EA, 2016, J BIOL CHEM, V291, P6772, DOI 10.1074/jbc.M116.714907; Thomas MP, 2014, FEBS J, V281, P14, DOI 10.1111/febs.12575; Thorsell AG, 2009, PROTEINS, V77, P242, DOI 10.1002/prot.22489; Tong J, 2015, PROTEINS, V83, P411, DOI 10.1002/prot.24746; Wade RC, 1998, P NATL ACAD SCI USA, V95, P5942, DOI 10.1073/pnas.95.11.5942; Wang HC, 2018, J BIOL CHEM, V293, P6905, DOI 10.1074/jbc.RA117.001670; Wang HC, 2014, CHEM BIOL, V21, P689, DOI 10.1016/j.chembiol.2014.03.009; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; WILCOX RA, 1994, EUR J BIOCHEM, V223, P115, DOI 10.1111/j.1432-1033.1994.tb18972.x; Williams MJ, 2015, MOL ENDOCRINOL, V29, P1303, DOI 10.1210/ME.2015-1077; Wilson MS, 2019, J BIOL CHEM, V294, P11597, DOI 10.1074/jbc.RA119.007848; Winward L, 2020, METHODS MOL BIOL, V2091, P75, DOI 10.1007/978-1-0716-0167-9_6; Winward L, 2010, INT J BIOCHEM CELL B, V42, P1174, DOI 10.1016/j.biocel.2010.04.003; Wu MX, 2014, ANGEW CHEM INT EDIT, V53, P7192, DOI 10.1002/anie.201402905; Yang XN, 1999, J BIOL CHEM, V274, P35434, DOI 10.1074/jbc.274.50.35434; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	44	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21275	10.1096/fj.202001489R	http://dx.doi.org/10.1096/fj.202001489R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475202	Green Accepted			2022-12-28	WOS:000647789600052
J	Liu, Y; Gong, ZZ; Zhou, JF; Yan, JK; Cai, W				Liu, Yang; Gong, Zizhen; Zhou, Jiefei; Yan, Junkai; Cai, Wei			Lin 28A/Occludin axis: An aberrantly activated pathway in intestinal epithelial cells leading to impaired barrier function under total parenteral nutrition	FASEB JOURNAL			English	Article						intestinal barrier function; Lin 28A; Occludin; RNA binding protein; total parenteral nutrition	MOUSE MODEL; MESSENGER-RNA; TRANSLATION; EXPRESSION; ATROPHY; BINDING; DIFFERENTIATION; REGULATOR; APOPTOSIS; OCCLUDIN	Disassembly of tight junctions is a major cause of intestinal barrier dysfunction under total parenteral nutrition (TPN), but the precise mechanisms have not been fully understood. Normally, RNA binding protein Lin 28A is highly restricted to embryonic stem cells and dramatically decreases as differentiation progresses; however, in our preliminary study it was found aberrantly increased in the intestinal epithelial cells of TPN rats, and thus its mechanism of action needs to be addressed. Herein, we report a pivotal role of Lin 28A in the regulation of tight junctions, which induces a sustained translational repression of Occludin, leading to disruption of intestinal barrier function under TPN. Using a rat model of TPN, we found time-dependent upregulation of Lin 28A, negatively correlated with Occludin. Using mouse intestinal organoids and human gut-derived Caco-2 cells as in vitro models, we found that expression of Occludin could be significantly suppressed by ectopic overexpression of Lin 28A. The underlying mechanisms may be partially attributed to translational repression, as the abundance of Occludin transcripts in polysomes was dramatically reduced by Lin 28A (polysomal profiling). Furthermore, Lin 28A was found to directly bind to Occludin mRNA 3 ' untranslated coding region (UTR), thereby repressing the translation of Occludin transcripts through decapping enzyme 1A (DCP1a). Taken together, our findings revealed that Lin 28A/Occludin axis may be a novel mechanism accounting for the development of barrier dysfunction under TPN.	[Liu, Yang; Gong, Zizhen; Zhou, Jiefei; Yan, Junkai; Cai, Wei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai, Peoples R China; [Gong, Zizhen; Zhou, Jiefei; Yan, Junkai; Cai, Wei] Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yan, JK; Cai, W (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai Inst Pediat Res, Xin Hua Hosp,Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	yanjunkai@xinhuamed.com.cn; caiw204@sjtu.edu.cn			Shanghai Municipal Commission of Health and Family [20184Y0337]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [17DZ2272000]; National Natural Science Foundation of China [81630039, 81700787]; Science and Technology Commission of Shanghai Municipality [19495810500]; Foundation of Shanghai Municipal Health Commission [shslczdzk05702, 2019ZB0101]	Shanghai Municipal Commission of Health and Family; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Foundation of Shanghai Municipal Health Commission	Shanghai Municipal Commission of Health and Family, Grant/Award Number: 20184Y0337; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Grant/Award Number: 17DZ2272000; National Natural Science Foundation of China, Grant/Award Number: 81630039 and 81700787; Science and Technology Commission of Shanghai Municipality, Grant/Award Number: 19495810500; Foundation of Shanghai Municipal Health Commission, Grant/Award Number: shslczdzk05702 and 2019ZB0101	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Feng YJ, 2017, CELL MOL GASTROENTER, V3, P447, DOI 10.1016/j.jcmgh.2016.12.005; Feng YJ, 2013, J PHYSIOL-LONDON, V591, P3709, DOI 10.1113/jphysiol.2013.253518; Feng YJ, 2009, J PHYSIOL-LONDON, V587, P641, DOI 10.1113/jphysiol.2008.162719; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Freeman JJ, 2015, FASEB J, V29, P2943, DOI 10.1096/fj.14-269480; Hansraj NZ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12858; Hartman C, 2018, CLIN NUTR, V37, P2418, DOI 10.1016/j.clnu.2018.06.956; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Liu L, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00574-16; Liu L, 2015, MOL BIOL CELL, V26, P1797, DOI 10.1091/mbc.E14-11-1500; Luhur A, 2015, FLY, V9, P173, DOI 10.1080/19336934.2016.1158366; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nagy P, 2017, DEVELOPMENT, V144, P3990, DOI 10.1242/dev.147033; O'Driscoll MC, 2010, AM J HUM GENET, V87, P354, DOI 10.1016/j.ajhg.2010.07.012; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Pereira B, 2013, NUCLEIC ACIDS RES, V41, P3986, DOI 10.1093/nar/gkt087; Pironi L, 2019, CLIN LIVER DIS, V23, P279, DOI 10.1016/j.cld.2018.12.009; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Sun XY, 2008, AM J PHYSIOL-GASTR L, V294, pG139, DOI 10.1152/ajpgi.00386.2007; Takizawa Y, 2013, INT J PHARMACEUT, V450, P31, DOI 10.1016/j.ijpharm.2013.04.026; Wessel Jacqueline, 2017, Adv Pediatr, V64, P253, DOI 10.1016/j.yapd.2017.03.010; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yan JK, 2019, FASEB J, V33, P3378, DOI [10.1096/fj.201801695r, 10.1096/fj.201801695R]; Yan JK, 2018, J CELL MOL MED, V22, P1562, DOI 10.1111/jcmm.13430; Yan JK, 2017, CELL PHYSIOL BIOCHEM, V41, P711, DOI 10.1159/000458430; Yan JK, 2016, CELL PHYSIOL BIOCHEM, V39, P1581, DOI 10.1159/000447860; Yokoyama S, 2008, GENE EXPR PATTERNS, V8, P155, DOI 10.1016/j.gep.2007.11.001; Yu TX, 2016, AM J PHYSIOL-CELL PH, V310, pC54, DOI 10.1152/ajpcell.00112.2015; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhang T, 2019, JPEN-PARENTER ENTER, V43, P96, DOI 10.1002/jpen.1173; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593; Zhu J, 2018, JPEN-PARENTER ENTER, V42, P436, DOI 10.1177/0148607116677048	41	1	1	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001819R	http://dx.doi.org/10.1096/fj.202001819R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200449				2022-12-28	WOS:000592669100001
J	Manalo, JM; Liu, H; Ding, DL; Hicks, J; Sun, H; Salvi, R; Kellems, RE; Pereira, FA; Xia, Y				Manalo, Jeanne M.; Liu, Hong; Ding, Dalian; Hicks, John; Sun, Hong; Salvi, Richard; Kellems, Rodney E.; Pereira, Fred A.; Xia, Yang			Adenosine A2B receptor: A pathogenic factor and a therapeutic target for sensorineural hearing loss	FASEB JOURNAL			English	Article						ADA&#8208; deficiency; adenosine deaminase deficiency; aging; myelination; myelin protein zero	SICKLE-CELL-DISEASE; ELEVATED ADENOSINE; MITOCHONDRIAL-DNA; PERIPHERAL-NERVES; SCIATIC-NERVE; MICE; CONTRIBUTES; HYPOXIA; ATP; DEGENERATION	Over 466 million people worldwide are diagnosed with hearing loss (HL). About 90% of HL cases are sensorineural HL (SNHL) with treatments limited to hearing aids and cochlear implants with no FDA-approved drugs. Intriguingly, ADA-deficient patients have been reported to have bilateral SNHL, however, its underlying cellular and molecular basis remain unknown. We report that Ada(-/-) mice, phenocopying ADA-deficient humans, displayed SNHL. Ada(-/-) mice cochlea with elevated adenosine caused substantial nerve fiber demyelination and mild hair cell loss. ADA enzyme therapy in these mice normalized cochlear adenosine levels, attenuated SNHL, and prevented demyelination. Additionally, ADA enzyme therapy rescued SNHL by restoring nerve fiber structure in Ada(-/-) mice post two-week drug withdrawal. Moreover, elevated cochlear adenosine in untreated mice was associated with enhanced Adora2b gene expression. Preclinically, ADORA2B-specific antagonist treatment in Ada(-/-) mice significantly improved HL, nerve fiber density, and myelin compaction. We also provided genetic evidence that ADORA2B is detrimental for age-related SNHL by impairing cochlear myelination in WT aged mice. Overall, understanding purinergic molecular signaling in SNHL in Ada(-/-) mice allows us to further discover that ADORA2B is also a pathogenic factor underlying aged-related SNHL by impairing cochlear myelination and lowering cochlear adenosine levels or blocking ADORA2B signaling are effective therapies for SNHL.	[Manalo, Jeanne M.; Liu, Hong; Kellems, Rodney E.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, 6431 Fannin,MSB 6-202, Houston, TX 77030 USA; [Manalo, Jeanne M.; Liu, Hong; Kellems, Rodney E.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Ding, Dalian; Salvi, Richard] Univ Buffalo State Univ New York, Dept Commun Disorders & Sci, Buffalo, NY USA; [Hicks, John] Texas Childrens Hosp, Dept Pathol, Houston, TX USA; [Sun, Hong] Cent South Univ, Xiangya Hosp, Otolaryngol Head & Neck Surg, Changsha, Peoples R China; [Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Baylor College of Medicine; Central South University; Baylor College of Medicine	Xia, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, 6431 Fannin,MSB 6-202, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu		Manalo, Jeanne/0000-0001-7289-8102	McGovern Scholar Funds; Bob and Hazel Casey Endowment (REK) of the University of Texas McGovern Medical School	McGovern Scholar Funds; Bob and Hazel Casey Endowment (REK) of the University of Texas McGovern Medical School	We thank Dr Yoshihiro Komatsu and his lab for lending us the cryostat machine and the confocal microscope. This work was supported by McGovern Scholar Funds (YX) and the Bob and Hazel Casey Endowment (REK) of the University of Texas McGovern Medical School.	Abo-Salem OM, 2004, J PHARMACOL EXP THER, V308, P358, DOI 10.1124/jpet.103.056036; Adebiyi MG, 2019, BLOOD ADV, V3, P1347, DOI 10.1182/bloodadvances.2018030619; Albuquerque W, 2004, J PEDIATR-US, V144, P278, DOI 10.1016/j.jpeds.2003.10.055; Arlinger S, 2003, INT J AUDIOL, V42, pS17; BAUMGOLD J, 1992, BIOCHEM PHARMACOL, V43, P889, DOI 10.1016/0006-2952(92)90257-J; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; Blundon JA, 2017, SCIENCE, V356, P1352, DOI 10.1126/science.aaf4612; Bruder ED, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-3; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10762; da Silva JT, 2015, GROWTH FACTORS, V33, P8, DOI 10.3109/08977194.2014.953630; Dai P, 2004, ACTA OTO-LARYNGOL, V124, P130, DOI 10.1080/00016480410016586; Ding DL, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P189, DOI 10.1201/9781420038736.ch13; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Ford MS, 1997, HEARING RES, V105, P130, DOI 10.1016/S0378-5955(96)00204-3; Gratton MA, 1996, HEARING RES, V94, P116, DOI 10.1016/0378-5955(96)00011-1; Hayallah AM, 2002, J MED CHEM, V45, P1500, DOI 10.1021/jm011049y; Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110; Hu X, 2016, CELL REP, V16, P106, DOI 10.1016/j.celrep.2016.05.080; HUNTER KP, 1987, HEARING RES, V30, P207, DOI 10.1016/0378-5955(87)90137-7; Iriyama T, 2015, CIRCULATION, V131, P730, DOI 10.1161/CIRCULATIONAHA.114.013740; Johnson KR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44450; Kamil K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00087; Kobayashi R, 2005, PHARMACOLOGY, V74, P143, DOI 10.1159/000084547; Koupenova Milka, 2013, J Cell Physiol, DOI 10.1002/jcp.24352; Liu H, 2016, CIRCULATION, V134, P405, DOI 10.1161/CIRCULATIONAHA.116.021311; Liu H, 2015, J APPL PHYSIOL, V119, P1173, DOI 10.1152/japplphysiol.00350.2015; Long P, 2018, DEV NEUROBIOL, V78, P80, DOI 10.1002/dneu.22538; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Melcangi RC, 1998, NEUROSCIENCE, V85, P569, DOI 10.1016/S0306-4522(97)00628-3; Melcangi RC, 2000, PROG NEUROBIOL, V60, P291, DOI 10.1016/S0301-0082(99)00028-3; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; MIKAELIAN DO, 1979, LARYNGOSCOPE, V89, P1; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Quarles RH., 2006, BASIC NEUROCHEM MOL, V7, P51; Rangaraju S, 2009, AGING CELL, V8, P178, DOI 10.1111/j.1474-9726.2009.00460.x; Reed JC, 2011, APOPTOSIS PHYSL PATH, P182; Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003; Seidman MD, 2002, OTOLARYNG HEAD NECK, V127, P138, DOI 10.1067/mhn.2002.127627; Shen H., 2018, IET CONTROL THEORY A, V12, P1; Shin SA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215316; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Sun KQ, 2015, BLOOD, V125, P1643, DOI 10.1182/blood-2014-08-595751; Tanaka C, 1996, BRAIN DEV-JPN, V18, P304, DOI 10.1016/0387-7604(96)00014-9; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Vlajkovic SM, 2004, NEUROSCIENCE, V126, P763, DOI 10.1016/j.neuroscience.2004.04.023; Vlajkovic SM, 2007, CELL TISSUE RES, V328, P461, DOI 10.1007/s00441-006-0374-2; Vlajkovic SM, 2009, CURR NEUROPHARMACOL, V7, P246, DOI 10.2174/157015909789152155; Wan GQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14487; Whitmore KV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00314; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29637; Xu XB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00416; Zhang WR, 2013, CIRC RES, V112, P1466, DOI 10.1161/CIRCRESAHA.111.300166; Zhang YJ, 2014, J CLIN INVEST, V124, P2750, DOI 10.1172/JCI74604; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	62	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15771	15787		10.1096/fj.202000939R	http://dx.doi.org/10.1096/fj.202000939R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131093	Bronze			2022-12-28	WOS:000586604700001
J	Prantner, D; Nallar, S; Vogel, SN				Prantner, Daniel; Nallar, Shreeram; Vogel, Stefanie N.			The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways	FASEB JOURNAL			English	Review						toll&#8208; like receptors; inflammation; HMGB1; DAMPs	GLYCATION END-PRODUCTS; NF-KAPPA-B; GROUP BOX 1; ENDOTHELIAL-CELLS; PROINFLAMMATORY ACTIVITY; INFLAMMATORY RESPONSES; MODIFIED ALBUMIN; SPLICE VARIANTS; RECEPTOR RAGE; LUNG INJURY	Although the innate immune receptor protein, Receptor for Advanced Glycation End products (RAGE), has been extensively studied, there has been renewed interest in RAGE for its potential role in sepsis, along with a host of other inflammatory diseases of chronic, noninfectious origin. In contrast to other innate immune receptors, for example, Toll-like receptors (TLRs), that recognize ligands derived from pathogenic organisms that are collectively known as "pathogen-associated molecular patterns" (PAMPs) or host-derived "damage-associated molecular patterns" (DAMPs), RAGE has been shown to recognize a broad collection of DAMPs exclusively. Historically, these DAMPs have been shown to be pro-inflammatory in nature. Early studies indicated that the adaptor molecule, MyD88, might be important for this change. More recent studies have explored further the mechanisms underlying this inflammatory change. Overall, the newer results have shown that there is extensive crosstalk between RAGE and TLRs. The three canonical RAGE ligands, Advanced Glycation End products (AGEs), HMGB1, and S100 proteins, have all been shown to activate both TLRs and RAGE to varying degrees in order to induce inflammation in in vitro models. As with any field that delves deeply into innate signaling, obstacles of reagent purity may be a cause of some of the discrepancies in the literature, and we have found that commercial antibodies that have been widely used exhibit a high degree of nonspecificity. Nonetheless, the weight of published evidence has led us to speculate that RAGE may be physically interacting with TLRs on the cell surface to elicit inflammation via MyD88-dependent signaling.	[Prantner, Daniel; Vogel, Stefanie N.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St,Suite 380, Baltimore, MD 21201 USA; [Nallar, Shreeram] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Vogel, SN (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St,Suite 380, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu			NIH [AI123371, AI125215, S10 OD025101]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: AI123371, AI125215 and S10 OD025101	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Achouiti A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141000; Achouiti A, 2013, CRIT CARE, V17, DOI 10.1186/cc13162; Achouiti A, 2013, J INNATE IMMUN, V5, P603, DOI 10.1159/000348739; Aneja RK, 2008, J LEUKOCYTE BIOL, V84, P1326, DOI 10.1189/jlb.0108030; Bartling B, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129438; Barton DB, 2014, CELL TISSUE RES, V358, P229, DOI 10.1007/s00441-014-1905-x; Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Berge G, 2011, INT J CANCER, V129, P780, DOI 10.1002/ijc.25735; Body-Malapel M, 2019, MUCOSAL IMMUNOL, V12, P468, DOI 10.1038/s41385-018-0119-z; Brenner T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0683-x; Burr SD, 2020, LIFE SCI, V250, DOI 10.1016/j.lfs.2020.117569; Cappelletti C, 2019, FASEB J, V33, P7155, DOI 10.1096/fj.201801577RR; Chakraborty R, 2013, MOL IMMUNOL, V54, P48, DOI 10.1016/j.molimm.2012.10.042; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115828; Chen MC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2432-1; Chen RC, 2016, ONCOTARGET, V7, P61728, DOI 10.18632/oncotarget.11226; Chen XB, 2014, CANCER RES, V74, P7285, DOI 10.1158/0008-5472.CAN-14-1240; Chen YS, 2017, INT J MOL MED, V40, P987, DOI 10.3892/ijmm.2017.3097; Chen YS, 2015, INT J CLIN EXP PATHO, V8, P2288; Coleman LG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195335; Cordone V, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020161; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; Dahlmann M, 2014, ONCOTARGET, V5, P3220, DOI 10.18632/oncotarget.1908; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; del Pozo CH, 2019, CELL REP, V28, P773, DOI 10.1016/j.celrep.2019.06.061; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Ding H, 2015, PULM PHARMACOL THER, V35, P34, DOI 10.1016/j.pupt.2015.10.010; Dragomir AC, 2011, TOXICOL APPL PHARM, V253, P170, DOI 10.1016/j.taap.2011.04.003; Ekanayaka SA, 2018, J OCUL PHARMACOL TH, V34, P659, DOI 10.1089/jop.2018.0073; Evankovich J, 2017, FASEB J, V31, P3894, DOI 10.1096/fj.201700031R; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Gasparotto J, 2018, J BIOL CHEM, V293, P226, DOI 10.1074/jbc.M117.786756; Ge XD, 2018, HEPATOLOGY, V68, P2380, DOI 10.1002/hep.30093; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gong H, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1296-0; Grotterod I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-241; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hatayama K, 2019, J MED VIROL, V91, P361, DOI 10.1002/jmv.25330; He MZ, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0023-8; He Q, 2012, ASIAN PAC J CANCER P, V13, P1365, DOI 10.7314/APJCP.2012.13.4.1365; Hofmann AD, 2015, J PEDIATR SURG, V50, P746, DOI 10.1016/j.jpedsurg.2015.02.024; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Huang CD, 2018, COMMUN CHEM, V1, DOI 10.1038/s42004-018-0050-y; Huang WC, 2012, INFLAMMATION, V35, P350, DOI 10.1007/s10753-011-9325-5; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Humpert PM, 2009, J LEUKOCYTE BIOL, V86, P589, DOI 10.1189/jlb.1008646; Isoda K, 2008, ATHEROSCLEROSIS, V198, P307, DOI 10.1016/j.atherosclerosis.2007.10.035; Jang S, 2017, BIOCHEM BIOPH RES CO, V490, P460, DOI 10.1016/j.bbrc.2017.06.063; Jin X, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/732450; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Katsumi T, 2019, AM J PHYSIOL-CELL PH, V317, pC788, DOI 10.1152/ajpcell.00250.2019; Khan M, 2019, CELLS, V8, P8; Kim TH, 2012, FOOD CHEM TOXICOL, V50, P1118, DOI 10.1016/j.fct.2011.12.004; Kiyota T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1172-y; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27025-9; Li KH, 2016, INT IMMUNOPHARMACOL, V34, P114, DOI 10.1016/j.intimp.2016.01.021; Li PC, 2017, MOL MED REP, V16, P3421, DOI 10.3892/mmr.2017.6978; Li YZ, 2020, INT J MOL MED, V45, P1059, DOI 10.3892/ijmm.2020.4496; Li Z, 2016, CELL DEATH DIFFER, V23, P1428, DOI 10.1038/cdd.2016.21; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Lieuw-a-Fa MLM, 2006, THROMB HAEMOSTASIS, V95, P320, DOI 10.1160/TH05-04-0248; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lin HJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00341; Ling Y, 2011, INT IMMUNOPHARMACOL, V11, P187, DOI 10.1016/j.intimp.2010.11.014; Liu TY, 2019, P NATL ACAD SCI USA, V116, P23254, DOI 10.1073/pnas.1907490116; LO TWC, 1994, J BIOL CHEM, V269, P32299; Luo TT, 2018, ONCOL REP, V39, P2906, DOI 10.3892/or.2018.6353; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Ma WC, 2012, CELL IMMUNOL, V274, P72, DOI 10.1016/j.cellimm.2012.02.001; Marinucci L, 2018, FREE RADICAL BIO MED, V117, P6, DOI 10.1016/j.freeradbiomed.2018.01.017; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Morris-Rosenfeld S, 2011, EUR J CLIN INVEST, V41, P1164, DOI 10.1111/j.1365-2362.2011.02514.x; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ohashi K, 2010, CLIN IMMUNOL, V134, P345, DOI 10.1016/j.clim.2009.10.008; Ohgami N, 2001, ANN NY ACAD SCI, V947, P350; Ohtsu A, 2017, EXP THER MED, V14, P4363, DOI 10.3892/etm.2017.5045; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Patel MC, 2018, MBIO, V9, DOI 10.1128/mBio.00246-18; Peng YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18822; Plante E, 2015, ENDOCRINOLOGY, V156, P1416, DOI 10.1210/en.2014-1718; Prantner D, 2021, J LEUKOCYTE BIOL, V109, P605, DOI 10.1002/JLB.3A0520-745RR; Qiao YX, 2016, DIABETES, V65, P619, DOI 10.2337/db15-1057; Qin QJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-37; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Qiu YY, 2017, MOL CELL ENDOCRINOL, V443, P89, DOI 10.1016/j.mce.2017.01.009; Robinson AB, 2012, AM J PHYSIOL-LUNG C, V302, pL1192, DOI 10.1152/ajplung.00099.2012; Rojas A, 2016, TUMOR BIOL, V37, P3321, DOI 10.1007/s13277-015-3940-y; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Sakaguchi M, 2014, J BIOL CHEM, V289, P23389, DOI 10.1074/jbc.M114.573071; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Sanajou D, 2018, J PHYSIOL BIOCHEM, V74, P467, DOI 10.1007/s13105-018-0640-2; Sanders KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36163-z; Schindler SM, 2018, MOL CELL NEUROSCI, V89, P71, DOI 10.1016/j.mcn.2018.04.005; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; SELL DR, 1990, J CLIN INVEST, V85, P380, DOI 10.1172/JCI114449; Sharma I, 2018, AM J PHYSIOL-RENAL, V314, pF107, DOI 10.1152/ajprenal.00434.2017; Sionov RV, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1624129; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Somensi N, 2017, CELL PHYSIOL BIOCHEM, V42, P2507, DOI 10.1159/000480213; Son M, 2016, BLOOD, V128, P2218, DOI 10.1182/blood-2016-05-719757; Son S, 2017, J BIOL CHEM, V292, P20437, DOI 10.1074/jbc.M117.806307; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Staitieh BS, 2018, AM J MED SCI, V355, P497, DOI 10.1016/j.amjms.2017.12.013; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Sun S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193028; Takahashi HK, 2009, J PHARMACOL EXP THER, V330, P89, DOI 10.1124/jpet.109.150581; Tanaka KA, 2019, ANESTH ANALG, V128, pe53; Tang SG, 2018, J ENDOCRINOL, V238, P47, DOI 10.1530/JOE-17-0681; Tao D, 2019, MOL MED REP, V20, P3719, DOI 10.3892/mmr.2019.10590; Teissier T, 2019, AGING CELL, V18, DOI 10.1111/acel.12850; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Uhle F, 2017, INFLAMM RES, V66, P961, DOI 10.1007/s00011-017-1076-9; Valdes-Ferrer SI, 2013, SHOCK, V40, P492, DOI 10.1097/SHK.0000000000000050; van Zoelen MAD, 2009, VIROLOGY, V391, P265, DOI 10.1016/j.virol.2009.05.032; van Zoelen MAD, 2009, SHOCK, V31, P280, DOI 10.1097/SHK.0b013e318186262d; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang GZ, 2014, EUR J PHARMACOL, V726, P27, DOI 10.1016/j.ejphar.2014.01.030; Wang H, 2018, SHOCK, V50, P472, DOI 10.1097/SHK.0000000000001032; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang JY, 2015, ONCOTARGET, V6, P24075, DOI 10.18632/oncotarget.4373; Wang Y, 2016, MOL MED REP, V14, P5619, DOI 10.3892/mmr.2016.5935; Watanabe M, 2019, BIOTECHNOL APPL BIOC, V67, P265; Wolf L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180092; Wu CH, 2011, J NUTR BIOCHEM, V22, P585, DOI 10.1016/j.jnutbio.2010.05.002; Wu DM, 2018, J CELL MOL MED, V22, P2378, DOI 10.1111/jcmm.13532; Xu YH, 2010, INT IMMUNOPHARMACOL, V10, P1552, DOI 10.1016/j.intimp.2010.09.006; Xu YL, 2010, J BIOL CHEM, V285, P23231, DOI 10.1074/jbc.M110.117457; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Yang DF, 2017, MOL MED REP, V16, P6634, DOI 10.3892/mmr.2017.7446; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0081-6; Yang H, 2015, J EXP MED, V212, P5, DOI 10.1084/jem.20141318; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yu WZ, 2018, MOLECULES, V23, DOI 10.3390/molecules23061447; Zhang F, 2011, J SURG RES, V171, P871, DOI 10.1016/j.jss.2010.04.027; Zhang F, 2009, ANN SURG, V250, P416, DOI [10.1097/SLA.0b013e3e181b41a18, 10.1097/SLA.0b013e3181b41a18]; Zhang JL, 2018, INT J ONCOL, V53, P659, DOI 10.3892/ijo.2018.4420; Zhang XL, 2019, EXP THER MED, V17, P2019, DOI 10.3892/etm.2019.7163; Zhang YH, 2010, INT J MOL MED, V25, P729, DOI 10.3892/ijmm_00000398; Zhong HH, 2020, J IMMUNOL, V205, P767, DOI 10.4049/jimmunol.1900860; Zhou J, 2018, BIOMED RES INT, V650456, P1; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zhou Z, 2008, J BONE MINER RES, V23, P1084, DOI 10.1359/JBMR.080234; Zhou ZE, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4847812; Zhu XM, 2009, ARCH BIOCHEM BIOPHYS, V492, P54, DOI 10.1016/j.abb.2009.09.016	157	23	23	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15659	15674		10.1096/fj.202002136R	http://dx.doi.org/10.1096/fj.202002136R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131091	Green Accepted, Bronze			2022-12-28	WOS:000586600800001
J	Nishihara, H; Gastfriend, BD; Soldati, S; Perriot, S; Mathias, A; Sano, Y; Shimizu, F; Gosselet, F; Kanda, T; Palecek, SP; Du Pasquier, R; Shusta, EV; Engelhardt, B				Nishihara, Hideaki; Gastfriend, Benjamin D.; Soldati, Sasha; Perriot, Sylvain; Mathias, Amandine; Sano, Yasuteru; Shimizu, Fumitaka; Gosselet, Fabien; Kanda, Takashi; Palecek, Sean P.; Du Pasquier, Renaud; Shusta, Eric V.; Engelhardt, Britta			Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions	FASEB JOURNAL			English	Article						blood&#8208; brain barrier; human induced pluripotent stem cells; T&#8208; cell migration; adhesion molecules; VCAM&#8208; 1	MICROVASCULAR ENDOTHELIAL-CELLS; IN-VITRO; RETINOIC ACID; DIFFERENTIATION; TRAFFICKING; PROMOTES; DISEASE; ESTABLISHMENT; PERMEABILITY; ACTIVATION	Human induced pluripotent stem cell (hiPSC)-derived blood-brain barrier (BBB) models established to date lack expression of key adhesion molecules involved in immune cell migration across the BBB in vivo. Here, we introduce the extended endothelial cell culture method (EECM), which differentiates hiPSC-derived endothelial progenitor cells to brain microvascular endothelial cell (BMEC)-like cells with good barrier properties and mature tight junctions. Importantly, EECM-BMEC-like cells exhibited constitutive cell surface expression of ICAM-1, ICAM-2, and E-selectin. Pro-inflammatory cytokine stimulation increased the cell surface expression of ICAM-1 and induced cell surface expression of P-selectin and VCAM-1. Co-culture of EECM-BMEC-like cells with hiPSC-derived smooth muscle-like cells or their conditioned medium further increased the induction of VCAM-1. Functional expression of endothelial ICAM-1 and VCAM-1 was confirmed by T-cell interaction with EECM-BMEC-like cells. Taken together, we introduce the first hiPSC-derived BBB model that displays an adhesion molecule phenotype that is suitable for the study of immune cell interactions.	[Nishihara, Hideaki; Soldati, Sasha; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland; [Gastfriend, Benjamin D.; Palecek, Sean P.; Shusta, Eric V.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA; [Perriot, Sylvain; Mathias, Amandine; Du Pasquier, Renaud] Lausanne Univ Hosp, Neurosci Res Ctr, Lab Neuroimmunol, Lausanne, Switzerland; [Perriot, Sylvain; Mathias, Amandine; Du Pasquier, Renaud] Univ Lausanne, Lausanne, Switzerland; [Sano, Yasuteru; Shimizu, Fumitaka; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi, Japan; [Gosselet, Fabien] Univ Artois, Blood Brain Barrier Lab, Lens, France; [Shusta, Eric V.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA	University of Bern; University of Wisconsin System; University of Wisconsin Madison; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Yamaguchi University; Universite d'Artois; University of Wisconsin System; University of Wisconsin Madison	Engelhardt, B (corresponding author), Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland.; Shusta, EV (corresponding author), Univ Wisconsin, Dept Neurol Surg, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	eshusta@wisc.edu; bengel@tki.unibe.ch	Gosselet, Fabien/U-8427-2019; Nishihara, Hideaki/AAJ-7563-2021	Gosselet, Fabien/0000-0002-0481-5026; Nishihara, Hideaki/0000-0002-2990-835X; Perriot, Sylvain/0000-0002-0337-3262	BangerterRhyner Foundation; Swiss MS Society; ECTRIMS Postdoctoral Research Exchange Fellowship; Uehara Memorial Foundation; JSPS Overseas Research Fellowships; National Institutes of Health [NS103844]; National Science Foundation Graduate Research Fellowship program [1747503]; National Institutes of Health Biotechnology Training Program [T32 GM008349]; Bern Center for Precision Medicine;  [SNF 320030-179531]	BangerterRhyner Foundation; Swiss MS Society; ECTRIMS Postdoctoral Research Exchange Fellowship; Uehara Memorial Foundation(Uehara Memorial Foundation); JSPS Overseas Research Fellowships; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); National Institutes of Health Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bern Center for Precision Medicine; 	This study was funded by the BangerterRhyner Foundation and the Bern Center for Precision Medicine to BE, the Swiss MS Society to BE and RDP, an ECTRIMS Postdoctoral Research Exchange Fellowship, the Uehara Memorial Foundation, and JSPS Overseas Research Fellowships to HN, and National Institutes of Health Grant NS103844 to EVS and SPP. RDP was also supported by a SNF 320030-179531. BDG was supported by the National Science Foundation Graduate Research Fellowship program under grant number 1747503 and the National Institutes of Health Biotechnology Training Program grant T32 GM008349.	Abadier M, 2015, EUR J IMMUNOL, V45, P1043, DOI 10.1002/eji.201445125; Alter A, 2003, J IMMUNOL, V170, P4497, DOI 10.4049/jimmunol.170.9.4497; Alvarez JI, 2015, NEUROBIOL DIS, V74, P14, DOI 10.1016/j.nbd.2014.09.016; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Bao XP, 2016, METHODS MOL BIOL, V1481, P183, DOI 10.1007/978-1-4939-6393-5_17; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; Bonney S, 2016, J NEUROSCI, V36, P7786, DOI 10.1523/JNEUROSCI.3952-15.2016; Boyer-Di Ponio J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084179; Canfield SG, 2017, J NEUROCHEM, V140, P874, DOI 10.1111/jnc.13923; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cayrol R, 2011, METHODS MOL BIOL, V686, P275, DOI 10.1007/978-1-60761-938-3_13; Cecchelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099733; Chang SF, 2014, P NATL ACAD SCI USA, V111, P1855, DOI 10.1073/pnas.1323761111; Clark PA, 2016, MOL PHARMACEUT, V13, P3341, DOI 10.1021/acs.molpharmaceut.6b00441; Coisne C, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-7; DIAS MC, 2019, SCI REP UK, V9; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Engen SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104306; Halaidych OV, 2018, STEM CELL REP, V10, P1642, DOI 10.1016/j.stemcr.2018.03.012; Haruki H, 2013, J NEUROL SCI, V331, P136, DOI 10.1016/j.jns.2013.05.035; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Herich S, 2019, BRAIN, V142, P3411, DOI 10.1093/brain/awz301; Hirase T, 1997, J CELL SCI, V110, P1603; Hollmann EK, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0059-0; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; Larochelle C, 2012, BRAIN, V135, P2906, DOI 10.1093/brain/aws212; Lecuyer MA, 2017, P NATL ACAD SCI USA, V114, pE524, DOI 10.1073/pnas.1614336114; Lian XJ, 2014, STEM CELL REP, V3, P804, DOI 10.1016/j.stemcr.2014.09.005; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lim RG, 2017, CELL REP, V19, P1365, DOI 10.1016/j.celrep.2017.04.021; Linville RM, 2019, BIOMATERIALS, V190, P24, DOI 10.1016/j.biomaterials.2018.10.023; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Luo JY, 1999, BLOOD, V93, P3785, DOI 10.1182/blood.V93.11.3785.411a44_3785_3791; Lyck R, 2017, J CEREBR BLOOD F MET, V37, P2894, DOI 10.1177/0271678X16678639; Malin D, 2014, CLIN CANCER RES, V20, DOI 10.1158/1078-0432.CCR-13-1255; Mizee MR, 2014, ACTA NEUROPATHOL, V128, P691, DOI 10.1007/s00401-014-1335-6; Mossu A, 2019, J CEREBR BLOOD F MET, V39, P395, DOI 10.1177/0271678X18820584; Neal EH, 2019, STEM CELL REP, V12, P1380, DOI 10.1016/j.stemcr.2019.05.008; Nishihara H, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-019-0165-2; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Perriot S, 2018, STEM CELL REP, V11, P1199, DOI 10.1016/j.stemcr.2018.09.015; Pinheiro MAL, 2016, ELIFE, V5, DOI 10.7554/eLife.13149; Pinheiro MAL, 2016, BBA-MOL BASIS DIS, V1862, P461, DOI 10.1016/j.bbadis.2015.10.018; Podjaski C, 2015, BRAIN, V138, P1598, DOI 10.1093/brain/awv092; Praca C, 2019, STEM CELL REP, V13, P599, DOI 10.1016/j.stemcr.2019.08.002; Qian TC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701679; Ribecco-Lutkiewicz M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19522-8; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Shimizu F, 2011, J CELL PHYSIOL, V226, P255, DOI 10.1002/jcp.22337; Stebbins MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7375; Stebbins MJ, 2016, METHODS, V101, P93, DOI 10.1016/j.ymeth.2015.10.016; Steiner O, 2011, J CEREBR BLOOD F MET, V31, P315, DOI 10.1038/jcbfm.2010.96; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Vatine GD, 2019, CELL STEM CELL, V24, P995, DOI 10.1016/j.stem.2019.05.011; Vatine GD, 2017, CELL STEM CELL, V20, P831, DOI 10.1016/j.stem.2017.04.002; Vazao H, 2017, P NATL ACAD SCI USA, V114, pE3022, DOI 10.1073/pnas.1617451114; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wimmer I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00711; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	73	21	21	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16693	16715		10.1096/fj.202001507RR	http://dx.doi.org/10.1096/fj.202001507RR		OCT 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124083	hybrid, Green Published			2022-12-28	WOS:000589710000001
J	Oh, GS; Yoon, J; Kim, G; Kim, GH; Kim, DS; Choi, B; Chang, EJ; Lee, ES; Kim, SW				Oh, Gyun-Sik; Yoon, Jin; Kim, Gukhan; Kim, Geun Hyang; Kim, Dong Seop; Choi, Bongkun; Chang, Eun-Ju; Lee, Eun-Sook; Kim, Seung-Whan			Regulation of adipocyte differentiation by clusterin-mediated Kruppel-like factor 5 stabilization	FASEB JOURNAL			English	Article						adipogenesis; clusterin; ubiquitination	NF-KAPPA-B; TUMOR-SUPPRESSOR; APOLIPOPROTEIN-J; ADIPOGENIC DIFFERENTIATION; DIABETES-MELLITUS; FACTOR KLF5; EXPRESSION; FAT; DEGRADATION; INHIBITION	Clusterin (CLU) is a heterodimeric glycoprotein involved in a range of biological processes. We investigated the function of CLU as a novel regulator of adipogenesis. CLU expression increased during 3T3-L1 preadipocyte differentiation. CLU overexpression promoted adipogenic differentiation of preadipocytes and increased the mRNA levels of adipogenic markers including peroxisome proliferator-activated receptor gamma (Pparg) and CCAAT enhancer-binding protein alpha (Cebpa). Conversely, knockdown of CLU attenuated adipogenesis and reduced transcript levels ofPpargandCebpa. However, the promoter activities of both thePpargand theCebpagene were not affected by alteration of CLU expression on its own. Additionally, the protein level of Kruppel-like factor 5 (KLF5), an upstream transcription factor ofPpargandCebpainvolved in adipogenic differentiation, was upregulated by CLU overexpression, although the mRNA level ofKlf5was not altered by changes in the expression level of CLU. Cycloheximide chase assay showed that the increased level of KLF5 by CLU overexpression was due to decreased degradation of KLF5 protein. Interestingly, CLU increased the stability of KLF5 by decreasing KLF5 ubiquitination. CLU inhibited the interaction between KLF5 and F-box/WD repeat-containing protein 7, which is an E3 ubiquitin ligase that targets KLF5. The adipogenic role of CLU was also addressed in mesenchymal stem cells (MSCs) andClu(-/-)mouse embryonic fibroblasts (MEFs). Furthermore, CLU enhanced KLF5-mediated transcriptional activation of both theCebpaand thePpargpromoter. Taken together, these results suggest that CLU is a novel regulator of adipocyte differentiation by modulating the protein stability of the adipogenic transcription factor KLF5.	[Oh, Gyun-Sik; Yoon, Jin; Kim, Gukhan; Kim, Geun Hyang; Kim, Dong Seop; Lee, Eun-Sook; Kim, Seung-Whan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea; [Oh, Gyun-Sik; Yoon, Jin; Kim, Dong Seop; Lee, Eun-Sook; Kim, Seung-Whan] Univ Ulsan, Biomed Inst Technol, Seoul, South Korea; [Choi, Bongkun; Chang, Eun-Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul, South Korea; [Kim, Gukhan] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Kim, Geun Hyang] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	University of Ulsan; University of Ulsan; University of Ulsan; Asan Medical Center; Cold Spring Harbor Laboratory; Regeneron	Kim, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea.	swkim7@amc.seoul.kr		Kim, Seung-Whan/0000-0001-6983-0481; Kim, Dong Seop/0000-0002-3053-5810	National Research Foundation of Korea (NRF) [NRF-2015R1A2A2A01006403, NRF-2018R1A2B6007013]; Ministry of Health and Welfare (MOHW) [HI15C-0377-020016]; Asan Institute for Life Sciences, Asan Medical Center [2020IL0012]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Health and Welfare (MOHW); Asan Institute for Life Sciences, Asan Medical Center	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2015R1A2A2A01006403 and NRF-2018R1A2B6007013; Ministry of Health and Welfare (MOHW), Grant/Award Number: HI15C-0377-020016; Asan Institute for Life Sciences, Asan Medical Center, Grant/Award Number: 2020IL0012	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Bae CH, 2018, CLIN EXP OTORHINOLAR, V11, P124, DOI 10.21053/ceo.2017.00493; Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bettuzzi S, 2009, ONCOGENE, V28, P4344, DOI 10.1038/onc.2009.286; Bettuzzi S, 2009, ADV CANCER RES, V104, P1, DOI 10.1016/S0065-230X(09)04001-9; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Devauchelle V, 2006, J IMMUNOL, V177, P6471, DOI 10.4049/jimmunol.177.9.6471; Diakiw SM, 2013, IUBMB LIFE, V65, P999, DOI 10.1002/iub.1233; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Essabbani A, 2010, J BIOL CHEM, V285, P4273, DOI 10.1074/jbc.C109.057133; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gao Y, 2015, CURR TOP MED CHEM, V15, P699, DOI 10.2174/1568026615666150302105052; Gil SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2896; Gonzalez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34; Hamam D, 2015, STEM CELLS DEV, V24, P417, DOI 10.1089/scd.2014.0331; Hoofnagle AN, 2010, ARTERIOSCL THROM VAS, V30, P2528, DOI 10.1161/ATVBAHA.110.212894; Ito H, 2004, INT J OBESITY, V28, P242, DOI 10.1038/sj.ijo.0802528; Jang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35884; Kim G, 2011, BIOCHEM BIOPH RES CO, V408, P720, DOI 10.1016/j.bbrc.2011.04.111; Klouckova J, 2016, PHYSIOL RES, V65, P481, DOI 10.33549/physiolres.933121; Kujiraoka T, 2006, J ATHEROSCLER THROMB, V13, P314, DOI 10.5551/jat.13.314; Lechner S, 2013, DIFFERENTIATION, V85, P20, DOI 10.1016/j.diff.2012.11.001; Liu GD, 2018, CELL PHYSIOL BIOCHEM, V45, P1003, DOI 10.1159/000487295; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Liu XF, 2014, INTEGR BIOL-UK, V6, P511, DOI 10.1039/c3ib40265g; Luan Yi, 2014, World J Biol Chem, V5, P216, DOI 10.4331/wjbc.v5.i2.216; Malkki H, 2014, NAT REV NEUROL, V10, P243, DOI [10.1038/nrneurol.2013.250, 10.1038/nrneurol.2014.63, 10.1038/nrneurol.2014.209, 10.1038/nrneurol.2014.61, 10.1038/nrneurol.2014.168, 10.1038/nrneurol.2013.267, 10.1038/nrneurol.2014.21, 10.1038/nrneurol.2014.142]; Oh GS, 2015, BIOCHEM BIOPH RES CO, V465, P501, DOI 10.1016/j.bbrc.2015.08.047; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Park S, 2014, REV ENDOCR METAB DIS, V15, P45, DOI 10.1007/s11154-013-9275-3; Pettersson C, 2011, J INTERN MED, V269, P306, DOI 10.1111/j.1365-2796.2010.02292.x; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Senol-Cosar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10686; Seo HY, 2013, ENDOCRINOLOGY, V154, P1722, DOI 10.1210/en.2012-2009; Shim YJ, 2011, J LEUKOCYTE BIOL, V90, P761, DOI 10.1189/jlb.0311110; Siersbaek R, 2011, COLD SH Q B, V76, P247, DOI 10.1101/sqb.2011.76.010512; Takase O, 2008, KIDNEY INT, V73, P567, DOI 10.1038/sj.ki.5002563; Tellez T, 2016, CURR MED CHEM, V23, P4297, DOI 10.2174/0929867323666161024150540; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2011, MOL CELL BIOL, V31, P1214, DOI 10.1128/MCB.01347-10; Won JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103351; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Xu M, 2015, INT J CLIN EXP MED, V8, P12476; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	51	10	11	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16276	16290		10.1096/fj.202000551RR	http://dx.doi.org/10.1096/fj.202000551RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078455				2022-12-28	WOS:000581557400001
J	Xu, YX; Li, XH; Cheng, Y; Yang, MG; Wang, RR				Xu, Yixin; Li, Xuehan; Cheng, Yan; Yang, Mingan; Wang, Rurong			Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion	FASEB JOURNAL			English	Article						acute lung injury; ferroptosis; lipid peroxidation; reperfusion injury	CELL-DEATH; LIPID-PEROXIDATION; FATTY-ACIDS; INJURY; IRON; IDENTIFICATION; MECHANISM; LUNGS	Lung ischemia-reperfusion (IR) injury is a common clinical pathology associated with high mortality. Ferroptosis, a novel mode of cell death elicited by iron-dependent phospholipid peroxidation, has been implicated in ischemic events. Acyl-CoA synthetase long-chain family member 4 (ACSL4) is one of the main enzymes in pro-ferroptotic lipid metabolism. In this study, the involvement of ferroptotic death in different durations of reperfusion was evaluated by assessing the iron content, malondialdehyde, and glutathione levels, ferroptosis-related protein expression, and mitochondria morphology. The roles of ferroptosis-specific inhibitor, liproxastin-1 (Lip-1), and ACSL4 modulation in a preventive regimen were assessed in vivo and in vitro. The hallmarks of pulmonary function, such as histological lung injury score, wet/dry ratio, and oxygenation index, were evaluated as well. Results showed that lung IR increased the tissue iron content and lipid peroxidation accumulation, along with key protein (GPX4 and ACSL4) expression alteration during reperfusion. Pretreatment with Lip-1 inhibited ferroptosis and ameliorated lung IR-induced injury in animal and cell models. In addition, administering ACSL4 inhibitor rosiglitazone before ischemia diminished the ferroptotic damage in IR-injured lung tissue, consistent with the protective effect of ACSL4 knockdown on lung epithelial cells subjected to hypoxia/reoxygenation. Thus, this study delineated that IR-induced ferroptotic cell death in lung tissue and ACSL4 were correlated with this process. Inhibition of ferroptosis and ACSL4 mitigated the ferroptotic damage in IR-induced lung injury by reducing lipid peroxidation and increasing the glutathione and GPX4 levels.	[Xu, Yixin; Li, Xuehan; Wang, Rurong] Chinese Acad Med Sci, Sichuan Univ, Res Units West China 2018RU12, Dept Anesthesiol,West China Hosp, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China; [Xu, Yixin; Li, Xuehan; Cheng, Yan] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesia & Crit Care Med, Chengdu, Peoples R China; [Yang, Mingan] San Diego State Univ, Sch Publ Hlth, Div Biostat & Epidemiol, San Diego, CA 92182 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Sichuan University; Sichuan University; California State University System; San Diego State University	Wang, RR (corresponding author), Chinese Acad Med Sci, Sichuan Univ, Res Units West China 2018RU12, Dept Anesthesiol,West China Hosp, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China.	wangrurong@scu.edu.cn			Science and Technology Department of Sichuan Province [2017SZ0147]; 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University [2018HXFH029]	Science and Technology Department of Sichuan Province; 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University	Science and Technology Department of Sichuan Province, Grant/Award Number: 2017SZ0147; 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University, Grant/Award Number: 2018HXFH029	Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; AYENE IS, 1993, ARCH BIOCHEM BIOPHYS, V303, P307, DOI 10.1006/abbi.1993.1288; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Dong H, 2020, AGING-US, V12, P12943, DOI 10.18632/aging.103378; Drefs M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8325754; Fischer S, 2000, AM J RESP CRIT CARE, V162, P1932, DOI 10.1164/ajrccm.162.5.9910064; Fischer S, 2000, ANN SURG, V231, P424, DOI 10.1097/00000658-200003000-00016; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Halade GV, 2017, AM J PHYSIOL-HEART C, V313, pH89, DOI 10.1152/ajpheart.00040.2017; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kanou T, 2018, J HEART LUNG TRANSPL, V37, P1261, DOI 10.1016/j.healun.2018.04.005; Laubach VE, 2016, CURR OPIN ORGAN TRAN, V21, P246, DOI 10.1097/MOT.0000000000000304; Li WJ, 2019, J CLIN INVEST, V129, P2293, DOI 10.1172/JCI126428; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Li YC, 2020, CELL DEATH DIFFER, V27, P2635, DOI 10.1038/s41418-020-0528-x; Liu J, 2020, CELL CHEM BIOL, V27, P420, DOI 10.1016/j.chembiol.2020.02.005; Liu XG, 2017, CELL DEATH DIFFER, V24, P683, DOI 10.1038/cdd.2017.1; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Mayr L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15646-6; Muller T, 2017, CELL MOL LIFE SCI, V74, P3631, DOI 10.1007/s00018-017-2547-4; Porteous MK, 2015, CURR OPIN ORGAN TRAN, V20, P506, DOI 10.1097/MOT.0000000000000232; Qayumi A K, 1992, J Invest Surg, V5, P115, DOI 10.3109/08941939209012428; Shologu N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102996; Stammberger U, 2000, ANN THORAC SURG, V69, P1532, DOI 10.1016/S0003-4975(00)01228-5; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Wang MH, 2012, J SURG RES, V173, P153, DOI 10.1016/j.jss.2010.08.053; Wang X, 2019, AM J RESP CELL MOL, V61, P244, DOI 10.1165/rcmb.2018-0207OC; Wei S, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109824; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wu YQ, 2012, INT J MOL MED, V30, P1294, DOI 10.3892/ijmm.2012.1161; Xiong YQ, 2018, BIOCHEM BIOPH RES CO, V506, P578, DOI 10.1016/j.bbrc.2018.10.098; Yamada N, 2020, AM J TRANSPLANT, V20, P1606, DOI 10.1111/ajt.15773; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yoshida M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10991-7; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124; Zhao GC, 1997, AM J RESP CELL MOL, V16, P293, DOI 10.1165/ajrcmb.16.3.9070614; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028	43	43	47	10	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16262	16275		10.1096/fj.202001758R	http://dx.doi.org/10.1096/fj.202001758R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070393				2022-12-28	WOS:000581166200001
J	Sastry, KS; Ibrahim, WN; Chouchane, AI				Sastry, Konduru Seetharama; Ibrahim, Wafa Naim; Chouchane, Aouatef Ismail			Multiple signaling pathways converge on proapoptotic protein BAD to promote survival of melanocytes	FASEB JOURNAL			English	Article						AKT; apoptosis; MAPK; PKA; PKC	GREEN FLUORESCENT PROTEIN; EPIDERMAL-GROWTH-FACTOR; PROSTATE-CANCER CELLS; KINASE-C; MELANOMA-CELLS; APOPTOSIS; INACTIVATION; PHOSPHORYLATION; PROLIFERATION; EXPRESSION	Melanocyte survival is mediated by diverse signaling pathways. However, the molecular mechanisms they use and molecules that they target are incompletely understood. Here, we show that melanocyte survival is mediated by diverse, nonredundant signaling pathways, including ERK1/2, AKT, PKA, and PKC. Each of these pathways is exerting prosurvival effects by phosphorylating the BAD. While Ser112-BAD phosphorylation is regulated by pERK, pPKA and pPKC, Ser136 and Ser155 phosphorylation are exclusively controlled by pAKT and pPKA, respectively. Inhibition of these pathways individually resulted in only modest apoptosis; however, most significant apoptosis, as a result of BAD dephosphorylation, was seen when all pathways were inhibited concurrently. BAD phosphorylation was essential for survival of melanocytes as cells expressing phosphorylation-deficient BAD were not rescued by any of the identified pathway. Furthermore, melanocytes became insensitive to kinase inhibitor-induced apoptosis when BAD expression was knocked down by BAD-shRNA. Overexpression of BAD in melanocytes stimulated faster apoptosis in response to kinase inhibitors. Taken together, our results show that BAD is acting as a convergence point for diverse survival pathways in melanocytes. Understanding the molecular mechanisms of melanocyte survival provides fundamental new insights into physiological mechanisms involved in the development of various melanocyte pathologies such as melanoma and vitiligo.	[Sastry, Konduru Seetharama; Ibrahim, Wafa Naim; Chouchane, Aouatef Ismail] Sidra Med, Dermatol Res Grp, Program Immunol, Precis Med, POB 26999, Doha, Qatar	Sidra Medical & Research Center	Sastry, KS; Chouchane, AI (corresponding author), Sidra Med, Dermatol Res Grp, Program Immunol, Precis Med, POB 26999, Doha, Qatar.	skonduru@sidra.org; achouchane@sidra.org	Sastry, Konduru Seetharama/GQY-6005-2022		Sidra Medicine [001]; Qatar National Library	Sidra Medicine; Qatar National Library(Qatar National Research Fund (QNRF))	Sidra Medicine, Grant/Award Number: 001; Qatar National Library	Abdel-Malek ZA, 2011, MELANOMA DEVELOPMENT: MOLECULAR BIOLOGY, GENETICS AND CLINICAL APPLICATION, P7, DOI 10.1007/978-3-7091-0371-5_2; Chipuk Jerry Edward, 2015, Oncoscience, V2, P729; Choi HR, 2010, OXID MED CELL LONGEV, V3, P219, DOI 10.4161/oxim.3.3.8; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Denning MF, 2012, PIGM CELL MELANOMA R, V25, P466, DOI 10.1111/j.1755-148X.2012.01015.x; Diehl C, 2014, J PIGMENT DISORD, V1, P1; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Eisenmann KM, 2003, CANCER RES, V63, P8330; Fortin M, 2005, METH MOLEC MED, V110, P121; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Jin Y, 2016, NAT GENET, V48, P1418, DOI 10.1038/ng.3680; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kim W, 2010, J RADIAT RES, V51, P285, DOI 10.1269/jrr.09141; Laugier F, 2015, ONCOTARGET, V6, P28120, DOI 10.18632/oncotarget.4866; Lee EF, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1568-3; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Mantovani G, 2008, ONCOGENE, V27, P1834, DOI 10.1038/sj.onc.1210831; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mosenson JA, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12208; Oka M, 2005, CANCER METAST REV, V24, P287, DOI 10.1007/s10555-005-1578-8; Oka M, 2004, J INVEST DERMATOL, V123, P930, DOI 10.1111/j.0022-202X.2004.23454.x; PLETTENBERG A, 1995, AM J PATHOL, V146, P651; Poljsak B, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/135206; Rodriguez CI, 2014, ARCH BIOCHEM BIOPHYS, V563, P22, DOI 10.1016/j.abb.2014.07.003; Sastry KSR, 2014, CELL DEATH DIFFER, V21, P1936, DOI 10.1038/cdd.2014.140; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; Sastry KS, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2841814; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Sosman JA, 2009, CURR ONCOL REP, V11, P405, DOI 10.1007/s11912-009-0054-y; Steff AM, 2001, CYTOMETRY, V45, P237, DOI 10.1002/1097-0320(20011201)45:4<237::AID-CYTO10024>3.0.CO;2-J; SWOPE VB, 1995, EXP CELL RES, V217, P453, DOI 10.1006/excr.1995.1109	36	1	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14602	14614		10.1096/fj.202001260RR	http://dx.doi.org/10.1096/fj.202001260RR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32941657	hybrid			2022-12-28	WOS:000572319500001
J	Hoshikawa, S; Shimizu, K; Watahiki, A; Chiba, M; Saito, K; Wei, WY; Fukumoto, S; Inuzuka, H				Hoshikawa, Seira; Shimizu, Kouhei; Watahiki, Asami; Chiba, Mitsuki; Saito, Kan; Wei, Wenyi; Fukumoto, Satoshi; Inuzuka, Hiroyuki			Phosphorylation-dependent osterix degradation negatively regulates osteoblast differentiation	FASEB JOURNAL			English	Article						Fbw7; p38; ubiquitination	PROTEASOME INHIBITOR; BONE-FORMATION; IN-VIVO; F-BOX; MYELOMA; FBW7; BORTEZOMIB; PROTEIN; PROTEOLYSIS; ACTIVATION	Proteasome inhibitors exert an anabolic effect on bone formation with elevated levels of osteoblast markers. These findings suggest the important role of the proteasomal degradation of osteogenic regulators, while the underlying molecular mechanisms are not fully understood. Here, we report that the proteasome inhibitors bortezomib and ixazomib markedly increased protein levels of the osteoblastic key transcription factor osterix/Sp7 (Osx). Furthermore, we revealed that Osx was targeted by p38 and Fbw7 for proteasomal degradation. Mechanistically, p38-mediated Osx phosphorylation at S73/77 facilitated Fbw7 interaction to trigger subsequent Osx ubiquitination. Consistent with these findings,p38knockdown or pharmacological p38 inhibition resulted in Osx protein stabilization. Treatment with p38 inhibitors following osteogenic stimulation efficiently induced osteoblast differentiation through Osx stabilization. Conversely, pretreatment of p38 inhibitor followed by osteogenic challenge impaired osteoblastogenesis via suppressing Osx expression, suggesting that p38 exerts dual but opposite effects in the regulation of Osx level to fine-tune its activity during osteoblast differentiation. Furthermore,Fbw7-depleted human mesenchymal stem cells and primary mouse calvarial cells resulted in increased osteogenic capacity. Together, our findings unveil the molecular mechanisms underlying the Osx protein stability control and suggest that targeting the Osx degradation pathway could help enhance efficient osteogenesis and bone matrix regeneration.	[Hoshikawa, Seira; Chiba, Mitsuki; Saito, Kan; Fukumoto, Satoshi] Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi, Japan; [Hoshikawa, Seira; Shimizu, Kouhei; Watahiki, Asami; Chiba, Mitsuki; Fukumoto, Satoshi; Inuzuka, Hiroyuki] Tohoku Univ, Grad Sch Dent, Ctr Adv Stem Cell & Regenerat Res, Sendai, Miyagi, Japan; [Wei, Wenyi] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Fukumoto, Satoshi] Kyushu Univ, Dept Pediat Dent, Grad Sch Dent Sci, Fukuoka, Japan	Tohoku University; Tohoku University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University	Fukumoto, S (corresponding author), Tohoku Univ, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Grad Sch Dent,Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.; Inuzuka, H (corresponding author), Tohoku Univ, Grad Sch Dent, Ctr Adv Stem Cell & Regenerat Res, Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	fukumoto@dent.tohoku.ac.jp; hinuzuka@tohoku.ac.jp	Saito, Kan/AFS-5564-2022; Saito, Kan/AAG-3507-2020	Saito, Kan/0000-0002-2151-6204; Saito, Kan/0000-0002-2151-6204; Shimizu, Kouhei/0000-0001-9523-4296; Fukumoto, Satoshi/0000-0002-5046-6891	Japan Society for the Promotion of Science (JSPS) [17H01606, 19H03834, 19J11773]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 17H01606, 19H03834 and 19J11773	Aomatsu E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03652; Artigas N, 2014, J BIOL CHEM, V289, P27105, DOI 10.1074/jbc.M114.576793; Choi YH, 2015, BONE, V75, P201, DOI 10.1016/j.bone.2015.02.026; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fukushima H, 2017, MOL CELL, V68, P645, DOI 10.1016/j.molcel.2017.10.018; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Garcia-Gomez A, 2014, CLIN CANCER RES, V20, P1542, DOI 10.1158/1078-0432.CCR-13-1657; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hojo H, 2016, DEV CELL, V37, P238, DOI 10.1016/j.devcel.2016.04.002; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kitagawa K, 2014, MOL CELL BIOL, V34, P2732, DOI 10.1128/MCB.01549-13; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oyajobi BO, 2007, BRIT J HAEMATOL, V139, P434, DOI 10.1111/j.1365-2141.2007.06829.x; Park JE, 2018, TRANSL RES, V198, P1, DOI 10.1016/j.trsl.2018.03.002; Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Shimizu K, 2018, CELL SIGNAL, V46, P15, DOI 10.1016/j.cellsig.2018.02.009; Shimizu K, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4117; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Terai M, 2005, MOL BIOL CELL, V16, P1491, DOI 10.1091/mbc.e04-07-0652; Thouverey C, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.80; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Xie JM, 2015, J CELL MOL MED, V19, P1814, DOI 10.1111/jcmm.12553; Yumimoto K, 2013, J BIOL CHEM, V288, P28488, DOI 10.1074/jbc.M113.465179	45	5	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14930	14945		10.1096/fj.202001340R	http://dx.doi.org/10.1096/fj.202001340R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931083	Bronze			2022-12-28	WOS:000570776500001
J	He, P; Mann-Collura, O; Fling, J; Edara, N; Hetz, R; Razzaque, MS				He, Ping; Mann-Collura, Olivia; Fling, Jacob; Edara, Naga; Hetz, Rebecca; Razzaque, Mohammed S.			High phosphate actively induces cytotoxicity by rewiring pro-survival and pro-apoptotic signaling networks in HEK293 and HeLa cells	FASEB JOURNAL			English	Article						apoptosis; cytotoxicity; EMT; ER stress; MAPK; phosphate	UNFOLDED PROTEIN RESPONSE; INORGANIC-PHOSPHATE; EXPRESSION; CALCIUM; DIETARY; PATHWAY; DIFFERENTIATION; MOLECULE; MUSCLE; GROWTH	Inorganic phosphate (Pi) is an essential nutrient for human health. Due to the changes in our dietary pattern, dietary Pi overload engenders systemic phosphotoxicity, including excessive Pi-related vascular calcification and chronic tissue injury. The molecular mechanisms of the seemingly distinct phenotypes remain elusive. In this study, we investigated Pi-mediated cellular response in HEK293 and HeLa cells. We found that abnormally high Pi directly mediates diverse cellular toxicity in a dose-dependent manner. Up to 10 mM extracellular Pi promotes cell proliferation by activating AKT signaling cascades and augmenting cell cycle progression. By introducing additional Pi, higher than the concentration of 40 mM, we observed significant cell damage caused by the interwoven Pi-related biological processes. Elevated Pi activates mitogen-activated protein kinase (MAPK) signaling, encompassing extracellular signal-regulated kinase 1/2 (ERK1/2), p38 and Jun amino-terminal kinase (JNK), which consequently potentiates Pi triggered lethal epithelial-mesenchymal transition (EMT). Synergistically, high Pi-caused endoplasmic reticulum (ER) stress also contributes to apparent apoptosis. To counteract, Pi-activated AKT signaling promotes cell survival by activating the mammalian target of rapamycin (mTOR) signaling and blocking ER stress. Pharmacologically or genetically abrogating Pi transport, the impact of high Pi-induced cytotoxicity could be reduced. Taken together, abnormally high extracellular Pi results in a broad spectrum of toxicity by rewiring complicated signaling networks that control cell growth, cell death, and homeostasis.	[He, Ping; Mann-Collura, Olivia; Fling, Jacob; Edara, Naga; Hetz, Rebecca] Lake Erie Coll Ostepath Med, Dept Biochem, 2000 West Grandview Blvd,Room 2-107, Erie, PA 16509 USA; [Razzaque, Mohammed S.] Lake Erie Coll Ostepath Med, Dept Pathol, Erie, PA USA		He, P (corresponding author), Lake Erie Coll Ostepath Med, Dept Biochem, 2000 West Grandview Blvd,Room 2-107, Erie, PA 16509 USA.	phe@lecom.edu	Razzaque, Mohammed S./K-4282-2019	Razzaque, Mohammed S./0000-0003-1115-4550	LECOM internal Seed Grants [COM-18-19]	LECOM internal Seed Grants	LECOM internal Seed Grants, Grant/Award Number: COM-18-19	Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; BEVINGTON A, 1986, CLIN SCI, V71, P729, DOI 10.1042/cs0710729; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Brown RB, 2018, BBA-REV CANCER, V1869, P303, DOI 10.1016/j.bbcan.2018.04.007; Brown RB, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.74; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Camalier CE, 2010, CANCER PREV RES, V3, P359, DOI 10.1158/1940-6207.CAPR-09-0068; Cancela AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036883; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; Conrads KA, 2004, ELECTROPHORESIS, V25, P1342, DOI 10.1002/elps.200405892; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Goodson JM, 2019, J STEROID BIOCHEM, V188, P166, DOI 10.1016/j.jsbmb.2019.01.023; Goodson JM, 2017, J STEROID BIOCHEM, V167, P33, DOI 10.1016/j.jsbmb.2016.10.006; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Jiang Z, 2012, CELL CYCLE, V11, P1118, DOI 10.4161/cc.11.6.19529; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Kalantar-Zadeh K, 2010, CLIN J AM SOC NEPHRO, V5, P519, DOI 10.2215/CJN.06080809; Kanatan M, 2003, J CELL PHYSIOL, V196, P180, DOI 10.1002/jcp.10270; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Kuro-o M, 2014, NEFROLOGIA, V34, P1, DOI 10.3265/Nefrologia.pre2013.Dec.12385; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135582; Lin YM, 2015, MOL CARCINOGEN, V54, P926, DOI 10.1002/mc.22153; Liu L, 2013, EXP HEMATOL, V41, P432, DOI 10.1016/j.exphem.2013.01.004; Mancini FR, 2018, CLIN NUTR, V37, P1625, DOI 10.1016/j.clnu.2017.07.025; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marks J, 2013, CURR OPIN NEPHROL HY, V22, P481, DOI 10.1097/MNH.0b013e3283621310; Michigami T, 2018, PHYSIOL REV, V98, P2317, DOI 10.1152/physrev.00022.2017; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Nishino J, 2017, J CELL BIOCHEM, V118, P1151, DOI 10.1002/jcb.25742; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Rahabi-Layachi H, 2015, J CELL PHYSIOL, V230, P347, DOI 10.1002/jcp.24715; Roussanne MC, 2001, EUR J CLIN INVEST, V31, P610, DOI 10.1046/j.1365-2362.2001.00809.x; Salaun C, 2010, J BIOL CHEM, V285, P34408, DOI 10.1074/jbc.M110.130989; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shen ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150093; Solomon DH, 2007, ACTA PHYSIOL, V190, P119, DOI 10.1111/j.1748-1716.2007.01670.x; Spina A, 2013, BIORESEARCH OPEN ACC, V2, P47, DOI 10.1089/biores.2012.0266; Su J, 2020, NATURE, V577, P566, DOI 10.1038/s41586-019-1897-5; SZCZEPANSKAKONKEL M, 1986, J BIOL CHEM, V261, P6375; TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6; Tan XY, 2016, BIOCHEM BIOPH RES CO, V472, P459, DOI 10.1016/j.bbrc.2016.01.077; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu HY, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00360; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yoshikawa R, 2018, J CLIN BIOCHEM NUTR, V62, P68, DOI 10.3164/jcbn.17-20; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep34597; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang YY, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0836-2	76	11	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000799RR	http://dx.doi.org/10.1096/fj.202000799RR		SEP 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	32892444				2022-12-28	WOS:000568298300001
J	Xu, L; Wu, F; Yang, L; Wang, FF; Zhang, T; Deng, XT; Zhang, XM; Yuan, XL; Yan, Y; Li, YY; Yang, ZP; Yu, DN				Xu, Lei; Wu, Fan; Yang, Lei; Wang, Fangfang; Zhang, Tong; Deng, Xintao; Zhang, Xiumei; Yuan, Xiaoling; Yan, Ying; Li, Yaoyao; Yang, Zhangping; Yu, Duonan			miR-144/451 inhibits c-Myc to promote erythroid differentiation	FASEB JOURNAL			English	Article						anemia; erythropoiesis; enucleation; nuclear condensation	CHROMATIN CONDENSATION; MIR-451 PROTECTS; B-LYMPHOMAS; CELL; EXPRESSION; ERYTHROLEUKEMIA; ENUCLEATION; LOCUS; ERYTHROPOIESIS; CONTRIBUTES	Ablation of miR-144/451 disrupts homeostasis of erythropoiesis. Myc, a protooncogenic protein, is essential for erythroblast proliferation but commits rapid downregulation during erythroid maturation. How erythroblasts orchestrate maturation processes through coding and non-coding genes is largely unknown. In this study, we use miR-144/451 knockout mice as in vivo model, G1E, MEL erythroblast lines and erythroblasts from fresh mouse fetal livers as in vitro systems to demonstrate that targeted depletion of miR-144/451 blocks erythroid nuclear condensation and enucleation. This is due, at least in part, to the continued high expression of Myc in erythroblasts when miR-144/451 is absent. Specifically, miR-144/451 directly inhibits Myc in erythroblasts. Loss of miR-144/451 locus derepresses, and thus, increases the expression of Myc. Sustained high levels of Myc in miR-144/451-depleted erythroblasts blocks erythroid differentiation. Moreover, Myc reversely regulates the expression of miR-144/451, forming a positive miR-144/451-Myc feedback to ensure the complete shutoff of Myc during erythropoiesis. Given that erythroid-specific transcription factor GATA1 activates miR-144/451 and inactivates Myc, our findings indicate that GATA1-miR-144/451-Myc network safeguards normal erythroid differentiation. Our findings also demonstrate that disruption of the miR-144/451-Myc crosstalk causes anemia, suggesting that miR-144/451 might be a potential therapeutic target in red cell diseases.	[Xu, Lei; Wu, Fan; Yang, Lei; Wang, Fangfang; Yan, Ying; Li, Yaoyao; Yu, Duonan] Yangzhou Univ, Inst Translat Med Med Coll, Med Coll, Yangzhou, Jiangsu, Peoples R China; [Xu, Lei; Wu, Fan; Yang, Lei; Wang, Fangfang; Yan, Ying; Li, Yaoyao; Yu, Duonan] Yangzhou Univ, Jiangsu Key Lab Expt & Translat Noncoding RNA Res, Yangzhou, Jiangsu, Peoples R China; [Xu, Lei; Li, Yaoyao; Yu, Duonan] Yangzhou Univ, Cent Lab, Affiliated Hosp, Yangzhou, Jiangsu, Peoples R China; [Zhang, Tong; Deng, Xintao; Zhang, Xiumei; Yu, Duonan] Yangzhou Univ, Xinghua Peoples Hosp, Xinghua, Peoples R China; [Yuan, Xiaoling] Yangzhou Univ, Yangzhou Maternal & Child Care Serv Ctr, Yangzhou, Jiangsu, Peoples R China; [Yang, Zhangping] Yangzhou Univ, Coll Anim Sci & Technol, Dept Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University	Yu, DN (corresponding author), Yangzhou Univ, Med Coll, Jiangsu Key Lab Expt & Translat Noncoding RNA Res, 136 Jiangyang Rd, Yangzhou 225009, Jiangsu, Peoples R China.	dnyu@yzu.edu.cn			National Natural Science Foundation of China (NSFC) [81470277, 81670186, 81870096]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81470277, 81670186 and 81870096	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Ding L, 2018, ONCOGENE, V37, P1293, DOI 10.1038/s41388-017-0055-5; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fang X, 2018, HAEMATOLOGICA, V103, P406, DOI 10.3324/haematol.2017.177394; Figueroa AA, 2018, HAEMATOLOGICA, V103, pE341, DOI 10.3324/haematol.2017.171785; Frojmark AS, 2010, J MOL MED, V88, P39, DOI 10.1007/s00109-009-0558-9; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Hattangadi SM, 2014, BLOOD, V124, P1931, DOI 10.1182/blood-2013-11-537761; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Ji P, 2015, INT REV CEL MOL BIO, V316, P159, DOI 10.1016/bs.ircmb.2015.01.006; Ji P, 2011, TRENDS CELL BIOL, V21, P409, DOI 10.1016/j.tcb.2011.04.003; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mayers S, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-019-0515-9; Ney PA, 2011, CURR OPIN HEMATOL, V18, P152, DOI 10.1097/MOH.0b013e328345213e; Nowak RB, 2017, BLOOD, V130, P1144, DOI 10.1182/blood-2017-05-787051; Pang CJ, 2012, MOL CELL BIOL, V32, P2628, DOI 10.1128/MCB.00104-12; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SKODA RC, 1995, J EXP MED, V181, P1603, DOI 10.1084/jem.181.5.1603; Sui ZH, 2014, BLOOD, V123, P758, DOI 10.1182/blood-2013-03-492710; Wang WC, 2017, ONCOTARGET, V8, P107109, DOI 10.18632/oncotarget.22346; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yu D, 2019, EXRNA, V1, P16, DOI [10.1186/s41544-019-0035-8, DOI 10.1186/S41544-019-0035-8]; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Yu DN, 2005, CANCER RES, V65, P5454, DOI 10.1158/0008-5472.CAN-04-4197; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244; Yu DN, 2007, BLOOD, V109, P4936, DOI 10.1182/blood-2006-10-050294; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218; Zhen R, 2020, BLOOD, V135, P208, DOI 10.1182/blood.2019002165	47	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13194	13210		10.1096/fj.202000941R	http://dx.doi.org/10.1096/fj.202000941R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	33319407	hybrid			2022-12-28	WOS:000562539500001
J	Yoo, JK; Fu, Q				Yoo, Jeung-Ki; Fu, Qi			Impact of sex and age on metabolism, sympathetic activity, and hypertension	FASEB JOURNAL			English	Article						blood pressure; cardiometabolic risk; muscle sympathetic nerve activity; obesity	ADIPOSE-TISSUE; BLOOD-PRESSURE; FAT DISTRIBUTION; NERVOUS-SYSTEM; BODY-FAT; PLASMA NOREPINEPHRINE; ENERGY-EXPENDITURE; NEURAL ACTIVATION; HEART-FAILURE; NORMAL-WEIGHT	In this brief review, we summarize the current knowledge on the complex interplay between metabolism, sympathetic activity and hypertension with a focus on sex differences and changes with age in humans. Evidence suggests that in premenopausal women, sex hormones, particularly estrogen exerts a profound cardioprotective effect which may be associated with favorable metabolic profiles, as well as lower sympathetic activity and blood pressure at rest and any given physiological and environmental stimuli compared with men of a similar age. Along this line, premenopausal women seem to be generally protected from obesity-induced metabolic and cardiovascular complications. However, postmenopausal estrogen deprivation during midlife and older age has a detrimental impact on metabolism, may lead to adipose tissue redistribution from the subcutaneous to abdominal area, and augments sympathetic activity. All these changes could contribute significantly to the higher prevalence of hypertension and greater cardiometabolic risk in older women than older men. It is proposed that obesity-related hypertension has a neurogenic component which is characterized by sympathetic overactivity, but the impact of sex and age remains largely unknown. Understanding sex and age-specific differences in obesity and sympathetic neural control of blood pressure is important in the prevention and/or risk reduction of cardiometabolic disorders for both men and women.	[Yoo, Jeung-Ki; Fu, Qi] Texas Hlth Presbyterian Hosp Dallas, Inst Exercise & Environm Med, 7232 Greenville Ave,Suite 435, Dallas, TX 75231 USA; [Yoo, Jeung-Ki; Fu, Qi] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Fu, Q (corresponding author), Texas Hlth Presbyterian Hosp Dallas, Inst Exercise & Environm Med, 7232 Greenville Ave,Suite 435, Dallas, TX 75231 USA.	QiFu@texashealth.org			National Institutes of Health [R01HL091078, R21HL088184]; American Heart Association [19POST34380615]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This brief review was supported, in part, by the National Institutes of Health (R01HL091078 and R21HL088184) and the American Heart Association Grant-in-Aid (13GRNT16990064) awards. Jeung-Ki Yoo is supported by the American Heart Association post-doctoral fellowship grant (19POST34380615).	Alpert MA, 2014, TRANSL RES, V164, P345, DOI 10.1016/j.trsl.2014.04.010; Alvarenga ME, 2006, PSYCHOSOM MED, V68, P8, DOI 10.1097/01.psy.0000195872.00987.db; Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Badrov MB, 2020, HYPERTENSION, V75, P458, DOI 10.1161/HYPERTENSIONAHA.119.14009; Baker SE, 2018, HYPERTENSION, V72, P1236, DOI 10.1161/HYPERTENSIONAHA.118.11550; BARRETTCONNOR E, 1985, CIRCULATION, V72, P53, DOI 10.1161/01.CIR.72.1.53; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; Benedict CR, 1996, CIRCULATION, V94, P690, DOI 10.1161/01.CIR.94.4.690; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; da Silva AA, 2009, CURR HYPERTENS REP, V11, P206, DOI 10.1007/s11906-009-0036-3; DIBONA GF, 1992, HYPERTENSION, V19, pI28, DOI 10.1161/01.HYP.19.1_Suppl.I28; Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923; Eikelis N, 2004, AM J PHYSIOL-ENDOC M, V286, pE744, DOI 10.1152/ajpendo.00489.2003; Eikelis N, 2003, HYPERTENSION, V41, P1072, DOI 10.1161/01.HYP.0000066289.17754.49; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739; ESLER M, 1995, J CLIN ENDOCR METAB, V80, P435, DOI 10.1210/jc.80.2.435; Esler M, 2000, AM J HYPERTENS, V13, p99S, DOI 10.1016/S0895-7061(00)00225-9; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Esler M, 2018, HYPERTENSION, V71, P22, DOI 10.1161/HYPERTENSIONAHA.117.09790; Fagius J, 1993, Clin Auton Res, V3, P201; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; FRAYN KN, 1992, CLIN SCI, V82, P1, DOI 10.1042/cs0820001; Fryar Cheryl D, 2017, NCHS Data Brief, P1; Fu Q, 2019, J PHYSIOL SCI, V69, P851, DOI 10.1007/s12576-019-00727-z; Fu Q, 2019, ANN NY ACAD SCI, V1454, P31, DOI 10.1111/nyas.14095; Gentile CL, 2007, AM J PHYSIOL-REG I, V292, pR1834, DOI 10.1152/ajpregu.00876.2006; Gerdts E, 2019, NAT MED, V25, P1657, DOI 10.1038/s41591-019-0643-8; Grassi G, 2005, HYPERTENSION, V46, P321, DOI 10.1161/01.HYP.0000174243.39897.6c; Grassi G, 1998, CIRCULATION, V97, P2037, DOI 10.1161/01.CIR.97.20.2037; Grassi G, 2007, HYPERTENSION, V49, P535, DOI 10.1161/01.HYP.0000255983.32896.b9; Grassi G, 2019, HYPERTENSION, V74, P349, DOI 10.1161/HYPERTENSIONAHA.119.12885; Guarino D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00665; Gudbjornsdottir S, 1994, Blood Press, V3, P394, DOI 10.3109/08037059409102293; Gurka MJ, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0024-2; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P2419, DOI 10.1001/jama.2018.7270; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Johnson JA, 2001, AM J PHYSIOL-ENDOC M, V280, pE40, DOI 10.1152/ajpendo.2001.280.1.E40; Jones PP, 2001, CIRCULATION, V104, P2424, DOI 10.1161/hc4501.099308; Joyner MJ, 2016, EXP PHYSIOL, V101, P349, DOI 10.1113/EP085146; Jurimae J, 2009, METABOLISM, V58, P638, DOI 10.1016/j.metabol.2008.12.009; Karabulut A, 2012, GYNECOL ENDOCRINOL, V28, P245, DOI 10.3109/09513590.2011.613971; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Karpe F, 2015, NAT REV ENDOCRINOL, V11, P90, DOI 10.1038/nrendo.2014.185; Kim JK, 2019, AGING CLIN EXP RES, V31, P135, DOI 10.1007/s40520-018-0932-y; KROTKIEWSKI M, 1978, J ENDOCRINOL INVEST, V1, P365, DOI 10.1007/BF03350985; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lambert E, 2007, HYPERTENSION, V50, P862, DOI 10.1161/HYPERTENSIONAHA.107.094649; Lambert E, 2007, J HYPERTENS, V25, P1411, DOI 10.1097/HJH.0b013e3281053af4; LANDSBERG L, 1986, Q J MED, V61, P1081; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lim K, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0750-1; LINDBERG UB, 1990, HORM METAB RES, V22, P345, DOI 10.1055/s-2007-1004917; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Lonnqvist F, 1997, ARTERIOSCL THROM VAS, V17, P1472, DOI 10.1161/01.ATV.17.7.1472; Marinos A, 2017, J AM HEART ASSOC, V6, DOI [10.1161/jaha.117.006971, 10.1161/JAHA.117.006971]; Marques A, 2014, EUR J PUBLIC HEALTH, V28, P295, DOI DOI 10.1093/eurpub/ckx143; Matsukawa T, 1996, J AUTONOM NERV SYST, V60, P209, DOI 10.1016/0165-1838(96)00057-4; Matsukawa T, 1998, AM J PHYSIOL-REG I, V275, pR1600, DOI 10.1152/ajpregu.1998.275.5.R1600; Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730; Narkiewicz K, 1998, CIRCULATION, V98, P772, DOI 10.1161/01.CIR.98.8.772; Narkiewicz K, 2005, HYPERTENSION, V45, P522, DOI 10.1161/01.HYP.0000160318.46725.46; Ng Marie, 2014, Lancet, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nookaew I, 2013, J CLIN ENDOCR METAB, V98, pE370, DOI 10.1210/jc.2012-2764; Okada Y, 2012, HYPERTENSION, V59, P98, DOI 10.1161/HYPERTENSIONAHA.111.176560; Pankevich DE, 2011, SEX DIFFERENCES IMPL, P5; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Ray CA, 2002, J APPL PHYSIOL, V92, P651, DOI 10.1152/japplphysiol.00788.2001; REBUFFESCRIVE M, 1986, METABOLISM, V35, P792, DOI 10.1016/0026-0495(86)90217-9; Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598; Rumantir MS, 1999, J HYPERTENS, V17, P1125, DOI 10.1097/00004872-199917080-00012; Rumantir MS, 2000, HYPERTENSION, V36, P824, DOI 10.1161/01.HYP.36.5.824; Seif MW, 2015, BEST PRACT RES CL OB, V29, P516, DOI 10.1016/j.bpobgyn.2014.10.010; Sharashova E, 2020, EUR HEART J, V41, P1554, DOI 10.1093/eurheartj/ehz234; SHEPHERD JT, 1990, J HYPERTENS, V8, pS15; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Tank J, 2008, J CLIN ENDOCR METAB, V93, P4974, DOI 10.1210/jc.2007-2820; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tooze JA, 2007, AM J CLIN NUTR, V86, P382, DOI 10.1093/ajcn/86.2.382; VALLBO AB, 1979, PHYSIOL REV, V59, P919, DOI 10.1152/physrev.1979.59.4.919; Varlamov Oleg, 2014, Front Endocrinol (Lausanne), V5, P241, DOI 10.3389/fendo.2014.00241; Vaz M, 1997, CIRCULATION, V96, P3423; Vranish JR, 2018, HYPERTENSION, V71, P192, DOI 10.1161/HYPERTENSIONAHA.117.10229; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Xiong XQ, 2014, ACTA PHYSIOL, V210, P468, DOI 10.1111/apha.12182; Zoccali C, 2002, CIRCULATION, V105, P1354, DOI 10.1161/hc1102.105261	95	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11337	11346		10.1096/fj.202001006RR	http://dx.doi.org/10.1096/fj.202001006RR		AUG 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32779294				2022-12-28	WOS:000558379300001
J	Chai, XY; Zhan, JQ; Pan, J; He, MX; Li, B; Wang, J; Ma, HY; Wang, YL; Liu, S				Chai, Xiaoying; Zhan, Jingqiong; Pan, Jing; He, Mengxi; Li, Bo; Wang, Jing; Ma, Hongyan; Wang, Yanlin; Liu, Sen			The rational discovery of multipurpose inhibitors of the ornithine decarboxylase	FASEB JOURNAL			English	Article						inhibitor; negative screening; ornithine decarboxylase; protein-protein interaction; stabilizer	PROTEIN; POLYAMINES; INTERFACES; DOCKING; METABOLISM; MECHANISM	Metabolic reprograming is a hallmark of cancer, and the polyamine metabolic network is dysregulated in many cancers. Ornithine decarboxylase (ODC) is a rate-limiting enzyme for polyamine synthesis in the polyamine metabolic network. In many cancer cells, ODC is over-expressed, so this enzyme has been an attracting anti-cancer drug target. In the catalysis axis (pathway), ODC converts ornithine to putrescine. Meanwhile, ODC's activity is regulated by protein-protein interactions (PPIs), including the ODC-OAZ1-AZIN1 PPI axis and its monomer-dimer equilibrium. Previous studies showed that when ODC's activity is inhibited, the PPIs might counteract the inhibition efficiency. Therefore, we proposed that multipurpose inhibitors that can simultaneously inhibit ODC's activity and perturb the PPIs would be very valuable as drug candidates and molecular tools. To discover multipurpose ODC inhibitors, we established a computational pipeline by combining positive screening and negative screening. We used this pipeline for the forward screening of multipurpose ligands that might inhibit ODC's activity, block ODC-OAZ1 interaction and enhance ODC non-functional dimerization. With a combination of different experimental assays, we identified three multipurpose ODC inhibitors. At last, we showed that one of these inhibitors is a promising drug candidate. This work demonstrated that our computational pipeline is useful for discovering multipurpose ODC inhibitors, and multipurpose inhibitors would be very valuable. Similar with ODC, there are a lot of proteins in human proteome that act as both enzymes and PPI components. Therefore, this work is not only presenting new molecular tools for polyamine study, but also providing potential insights and protocols for discovering multipurpose inhibitors to target more important protein targets.	[Chai, Xiaoying; Pan, Jing; Wang, Jing; Ma, Hongyan; Liu, Sen] Hubei Univ Technol, Natl 111 Ctr Cellular Regulat & Mol Pharmaceut, Key Lab Ind Fermentat, Minist Educ, Wuhan, Peoples R China; [Chai, Xiaoying; Zhan, Jingqiong; Pan, Jing; He, Mengxi; Li, Bo; Wang, Jing; Ma, Hongyan; Wang, Yanlin; Liu, Sen] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotherapy, Peoples Hosp, Yichang, Peoples R China; [Chai, Xiaoying; Liu, Sen] Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Hubei Key Lab Ind Microbiol, Wuhan 430068, Peoples R China; [Zhan, Jingqiong] First Peoples Hosp Yichang, Dept Gynecol & Obstet, Yichang, Peoples R China	Hubei University of Technology; China Three Gorges University; Hubei University of Technology	Liu, S (corresponding author), Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Hubei Key Lab Ind Microbiol, Wuhan 430068, Peoples R China.	senliu.ctgu@gmail.com	Liu, Sen/AAH-8368-2021	Liu, Sen/0000-0001-5182-7241	National Natural Science Foundation of China [31670768, 31971150]; Hubei Provincial Science and Technology Department [2019CFA069]; Wuhan Science and Technology Bureau of China [2018060401011319]; HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics [XBTK-2018008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Science and Technology Department; Wuhan Science and Technology Bureau of China; HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics	S. L. was supported by the grants from National Natural Science Foundation of China (31670768, 31971150), Hubei Provincial Science and Technology Department (2019CFA069), Wuhan Science and Technology Bureau of China (2018060401011319), and the Collaborative Grant-in-Aid of the HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics (XBTK-2018008). The authors thank the generous help from the following persons: Prof. Luhua Lai's lab members, especially Prof. Luhua Lai and Dr Jing Chen (Peking University), for providing us the DOCK-PSCORE suit and kind suggestions, Prof. Gideon Schreiber (Weizmann Institute of Science), for providing us the plasmids for expressing YPET-mODC and CyPET-mOAZ1, and Prof. Nei-Li Chan (National Taiwan University), for providing us the plasmid for expressing hOAZ1.	Ai YB, 2016, J CHEM INF MODEL, V56, P1563, DOI 10.1021/acs.jcim.6b00334; Arruabarrena-Aristorena A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2606; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Buontempo F, 2018, LEUKEMIA, V32, P1, DOI 10.1038/leu.2017.301; Cervelli M, 2014, BREAST CANCER RES TR, V148, P233, DOI 10.1007/s10549-014-3156-7; Chen Q, 2017, BBA-GEN SUBJECTS, V1861, P2535, DOI 10.1016/j.bbagen.2017.08.012; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; Damiani E, 2018, METHODS MOL BIOL, V1694, P469, DOI 10.1007/978-1-4939-7398-9_39; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Dong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep25129; Fahrmann JF, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00276; Gao M, 2012, P NATL ACAD SCI USA, V109, P3784, DOI 10.1073/pnas.1117768109; GRISHIN NV, 1994, PROTEIN SCI, V3, P2455, DOI 10.1002/pro.5560031231; Huang K, 2019, CELL METAB, V30, P1107, DOI 10.1016/j.cmet.2019.09.014; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Khait R, 2012, PROTEIN ENG DES SEL, V25, P681, DOI 10.1093/protein/gzs067; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Levin VA, 2018, CNS ONCOL, V6, P257; Li JK, 2020, BIOCHEM BIOPH RES CO, V524, P123, DOI 10.1016/j.bbrc.2020.01.072; Li JK, 2019, MOLECULES, V24, DOI 10.3390/molecules24183351; Liao CZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10754; Luqman S., 2013, PROTOC EXCH, V10, P1, DOI [10.1038/ protex.2013.045, DOI 10.1038/PROTEX.2013.045, 10.1038/protex.2013.045]; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Paz EA, 2011, ADV CLIN CHEM, V54, P45, DOI 10.1016/B978-0-12-387025-4.00002-9; Qu N, 2003, BIOCHEM J, V375, P465, DOI 10.1042/BJ20030382; Romero P, 2005, GENOME BIOL, V6; Schrodinger, 2010, PYMOL MOL GRAPHICS S; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wei DG, 2008, J MED CHEM, V51, P7882, DOI 10.1021/jm8010096; Wu DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14738; Wu HY, 2015, P NATL ACAD SCI USA, V112, P11229, DOI 10.1073/pnas.1508187112; Zhang Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00248	41	4	6	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12907	12921		10.1096/fj.202001222R	http://dx.doi.org/10.1096/fj.202001222R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32767470				2022-12-28	WOS:000558271700001
J	Gonzalez, YIR; Moyer, AL; LeTexier, NJ; Bratti, AD; Feng, SY; Pena, V; Sun, CS; Pulcastro, H; Liu, T; Iyer, SR; Lovering, RM; O'Rourke, B; Wagner, KR				Gonzalez, Yazmin I. Rovira; Moyer, Adam L.; LeTexier, Nicolas J.; Bratti, August D.; Feng, Siyuan; Pena, Vanessa; Sun, Congshan; Pulcastro, Hannah; Liu, Ting; Iyer, Shama R.; Lovering, Richard M.; O'Rourke, Brian; Wagner, Kathryn R.			Mss51 deletion increases endurance and ameliorates histopathology in the mdx mouse model of Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						endurance; fibrosis; mdx; mitochondrial respiration; Mss51; muscular dystrophy	SKELETAL-MUSCLE; ENERGY-METABOLISM; GENE-EXPRESSION; MEMBRANE; MITOCHONDRIA; DEGENERATION; HYPERTROPHY; MECHANISMS; PROTEOMICS; PATHWAYS	Mitochondrial derangement is an important contributor to the pathophysiology of muscular dystrophies and may be among the earliest cellular deficits. We have previously shown that disruption of Mss51, a mammalian skeletal muscle protein that localizes to the mitochondria, results in enhanced muscle oxygen consumption rate, increased endurance capacity, and improved limb muscle strength in mice with wildtype background. Here, we investigate whether Mss51 deletion in the mdx murine model of Duchenne muscular dystrophy (mdx-Mss51 KO) counteracts the muscle pathology and mitochondrial irregularities observed in mdx mice. We found that mdx-Mss51 KO mice had increased myofiber oxygen consumption rates and an amelioration of muscle histopathology compared to mdx counterparts. This corresponded with greater treadmill endurance and less percent fatigue in muscle physiology, but no improvement in forelimb grip strength or limb muscle force production. These findings suggest that although Mss51 deletion ameliorates the skeletal muscle mitochondrial respiration defects in mdx and improves fatigue resistance in vivo, the lack of improvement in force production suggests that this target alone may be insufficient for a therapeutic effect.	[Gonzalez, Yazmin I. Rovira; Moyer, Adam L.; LeTexier, Nicolas J.; Bratti, August D.; Feng, Siyuan; Pena, Vanessa; Sun, Congshan; Pulcastro, Hannah; Wagner, Kathryn R.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Gonzalez, Yazmin I. Rovira; Moyer, Adam L.] Johns Hopkins Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD USA; [Sun, Congshan; Wagner, Kathryn R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Sun, Congshan; Wagner, Kathryn R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Liu, Ting; O'Rourke, Brian] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Iyer, Shama R.; Lovering, Richard M.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA; [Gonzalez, Yazmin I. Rovira] Shape Therapeut Inc, Dis Biol Div, Seattle, WA USA; [LeTexier, Nicolas J.] Derflan Inc, Bellevue, WA USA; [Bratti, August D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Harvard University	Wagner, KR (corresponding author), Kennedy Krieger Inst, Ctr Genet Muscle Disorders, 707 North Broadway, Baltimore, MD 21205 USA.	wagnerk@kennedykrieger.org		Feng, Siyuan/0000-0003-2374-4769; Rovira Gonzalez, Yazmin/0000-0002-5323-536X	NIAMS, National Institutes of Health (NIH) [R56AR073193] Funding Source: Medline	NIAMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abou-Samra M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0051-9; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; Banks GB, 2010, MUSCLE NERVE, V42, P268, DOI 10.1002/mus.21700; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Buyse GM, 2009, EUR HEART J, V30, P116, DOI 10.1093/eurheartj/ehn406; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARROLL JE, 1985, NEUROLOGY, V35, P96, DOI 10.1212/WNL.35.1.96; Comim CM, 2016, MUSCLE NERVE, V53, P91, DOI 10.1002/mus.24704; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Gaglianone RB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38609-4; Gao QQ, 2015, COMPR PHYSIOL, V5, P1223, DOI 10.1002/cphy.c140048; Garcia-Villegas R, 2017, J BIOL CHEM, V292, P10912, DOI 10.1074/jbc.M116.773077; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Gonzalez YIR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122247; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hughes MC, 2019, J CACHEXIA SARCOPENI, V10, P643, DOI 10.1002/jcsm.12405; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Iyer SR, 2016, METHODS MOL BIOL, V1460, P293, DOI 10.1007/978-1-4939-3810-0_20; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Kyrychenko V, 2015, CELL CALCIUM, V58, P186, DOI 10.1016/j.ceca.2015.04.006; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; LoMauro A, 2015, THER CLIN RISK MANAG, V11, P1475, DOI 10.2147/TCRM.S55889; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Miao YX, 2015, INT J MOL SCI, V16, P7976, DOI 10.3390/ijms16047976; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Moore TM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00690; Moyer Adam L, 2015, J Neuromuscul Dis, V2, P371; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pratt SJP, 2013, J PHYSIOL-LONDON, V591, P559, DOI 10.1113/jphysiol.2012.241679; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270; Rayavarapu S, 2013, MOL CELL PROTEOMICS, V12, P1061, DOI 10.1074/mcp.M112.023127; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Sharma N, 2012, J BIOL CHEM, V287, P30455, DOI 10.1074/jbc.M112.354415; Shkryl VM, 2009, PFLUG ARCH EUR J PHY, V458, P915, DOI 10.1007/s00424-009-0670-2; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Vila MC, 2017, CELL DEATH DIFFER, V24, P330, DOI 10.1038/cdd.2016.127; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Yucel N, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0045-4	55	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21276	10.1096/fj.202002106RR	http://dx.doi.org/10.1096/fj.202002106RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423297				2022-12-28	WOS:000647789600050
J	Hara, T; Saeki, K; Jinnouchi, H; Kazuno, S; Miura, Y; Yokomizo, T				Hara, Takuya; Saeki, Kazuko; Jinnouchi, Hiromi; Kazuno, Saiko; Miura, Yoshiki; Yokomizo, Takehiko			The c-terminal region of BLT2 restricts its localization to the lateral membrane in a LIN7C-dependent manner	FASEB JOURNAL			English	Article						APEX2; barrier; GPCR; LIN7C; trafficking	DARBY CANINE KIDNEY; LEUKOTRIENE B-4 RECEPTOR; PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; BASOLATERAL LOCALIZATION; APICAL SECRETION; BARRIER FUNCTION; DILEUCINE MOTIF; COMPLEX; LIN-7	Leukotriene B-4 receptor type 2 (BLT2) is a G protein-coupled receptor (GPCR) mainly expressed in epithelial cells, where it enhances barrier function. A unique characteristic of BLT2 is its restricted localization to the lateral membrane. However, the molecular mechanism underlying the localization of BLT2 to the lateral membrane and the physiological roles of laterally localized BLT2 are unknown. BLT1 is the most homologous GPCR to BLT2 and localizes to both the apical and lateral membranes. In this study, we generated chimeric receptors of BLT2 and BLT1 as well as deletion mutants of BLT2 to determine the region(s) of BLT2 responsible for its localization. Chimeric receptors containing the C-terminal domain of BLT2 localized only to the lateral membrane, and the C-terminal deletion mutant of BLT2 accumulated at the Golgi apparatus. Furthermore, the middle and C-terminal regions of BLT2 were important for maintaining epithelial barrier function. Proteomics analysis using the chimeric BLT-ascorbate peroxidase 2 biotinylation method showed that some proteins involved in intracellular protein transport, cell-cell junctions, and actin filament binding were located very close to the C-terminal domain of BLT2. Knockdown of lin-7 homolog C (LIN7C), a membrane trafficking protein, led to accumulation of BLT2 in the Golgi apparatus, resulting in diminished epithelial barrier function. These results suggest that the C-terminal region of BLT2 plays an important role in the transport of BLT2 from the Golgi apparatus to the plasma membrane in a LIN7C-dependent manner.	[Hara, Takuya; Saeki, Kazuko; Jinnouchi, Hiromi; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Hara, Takuya] Kowa Co Ltd, Fuji Res Labs, Shizuoka, Japan; [Kazuno, Saiko; Miura, Yoshiki] Juntendo Univ, Res Support Ctr, Lab Prote & Biomol Sci, Grad Sch Med, Tokyo, Japan	Juntendo University; Kowa Company, Ltd.; Juntendo University	Saeki, K (corresponding author), Juntendo Univ, Dept Biochem, Sch Med, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	ksaeki@juntendo.ac.jp	Miura, Yoshiki/U-8875-2019; Yokomizo, Takehiko/P-5673-2016	Miura, Yoshiki/0000-0002-7596-0482; Yokomizo, Takehiko/0000-0002-5219-1553				Alewine C, 2007, AM J PHYSIOL-CELL PH, V293, pC1733, DOI 10.1152/ajpcell.00323.2007; Bachmann A, 2008, EUR J CELL BIOL, V87, P123, DOI 10.1016/j.ejcb.2007.11.002; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chiba T, 2016, EXP DERMATOL, V25, P532, DOI 10.1111/exd.12976; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; de la Fuente-Ortega E, 2015, MOL BIOL CELL, V26, P1728, DOI 10.1091/mbc.E15-01-0047; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Dhitavat J, 2003, J INVEST DERMATOL, V121, P1349, DOI 10.1046/j.1523-1747.2003.12557.x; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; Ishii Y, 2016, FASEB J, V30, P933, DOI 10.1096/fj.15-279653; KITAGAWA Y, 1994, EXP CELL RES, V213, P449, DOI 10.1006/excr.1994.1222; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063; Lozovatsky L, 2009, MOL BIOL CELL, V20, P4489, DOI 10.1091/mbc.E09-04-0280; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Massari S, 2009, TRAFFIC, V10, P246, DOI 10.1111/j.1600-0854.2008.00854.x; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; MONLAUZEUR L, 1995, J BIOL CHEM, V270, P12219, DOI 10.1074/jbc.270.20.12219; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Perego C, 1999, EMBO J, V18, P2384, DOI 10.1093/emboj/18.9.2384; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Saeki K, 2017, SEMIN IMMUNOL, V33, P30, DOI 10.1016/j.smim.2017.07.010; Sandvig K, 2018, HISTOCHEM CELL BIOL, V150, P107, DOI 10.1007/s00418-018-1678-5; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shelly M, 2003, DEV CELL, V5, P475, DOI 10.1016/j.devcel.2003.08.001; Shigematsu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34560; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Straight SW, 2006, J BIOL CHEM, V281, P37738, DOI 10.1074/jbc.M607059200; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; Wang JL, 2018, CIRC RES, V123, P716, DOI 10.1161/CIRCRESAHA.118.311403; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; WILSON PD, 1991, AM J PHYSIOL, V260, pF420, DOI 10.1152/ajprenal.1991.260.3.F420; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421	50	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21364	10.1096/fj.202002640R	http://dx.doi.org/10.1096/fj.202002640R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33481310	Bronze, Green Submitted			2022-12-28	WOS:000647789600109
J	Marquez-Exposito, L; Rodrigues-Diez, RR; Rayego-Mateos, S; Fierro-Fernandez, M; Rodrigues-Diez, R; Orejudo, M; Santos-Sanchez, L; Blanco, EM; Laborda, J; Mezzano, S; Lamas, S; Lavoz, C; Ruiz-Ortega, M				Marquez-Exposito, Laura; Rodrigues-Diez, Raul R.; Rayego-Mateos, Sandra; Fierro-Fernandez, Marta; Rodrigues-Diez, Raquel; Orejudo, Macarena; Santos-Sanchez, Laura; Blanco, Eva Maria; Laborda, Jorge; Mezzano, Sergio; Lamas, Santiago; Lavoz, Carolina; Ruiz-Ortega, Marta			Deletion of delta-like 1 homologue accelerates renal inflammation by modulating the Th17 immune response	FASEB JOURNAL			English	Article						DLK1; inflammation; NOTCH; renal damage; Th17 response	GROWTH-FACTOR; NOTCH LIGAND; CELL-ACTIVATION; KIDNEY; PATHWAY; DLK1; INHIBITOR; INTERLEUKIN-17A; SECUKINUMAB; FIBROSIS	Preclinical studies have demonstrated that activation of the NOTCH pathway plays a key role in the pathogenesis of kidney damage. There is currently no information on the role of the Delta-like homologue 1 (DLK1), a NOTCH inhibitor, in the regulation of renal damage. Here, we investigated the contribution of DLK1 to experimental renal damage and the underlying molecular mechanisms. Using a Dlk1-null mouse model in the experimental renal damage of unilateral ureteral obstruction, we found activation of NOTCH, as shown by increased nuclear translocation of the NOTCH1 intracellular domain, and upregulation of Dlk2/hey-1 expression compared to wild-type (WT) littermates. NOTCH1 over-activation in Dlk1-null injured kidneys was associated with a higher inflammatory response, characterized by infiltration of inflammatory cells, mainly CD4/IL17A + lymphocytes, and activation of the Th17 immune response. Furthermore, pharmacological NOTCH blockade inhibited the transcription factors controlling Th17 differentiation and gene expression of the Th17 effector cytokine IL-17A and other related-inflammatory factors, linked to a diminution of inflammation in the injured kidneys. We propose that the non-canonical NOTCH ligand DLK1 acts as a NOTCH antagonist in renal injury regulating the Th17-mediated inflammatory response.	[Marquez-Exposito, Laura; Rodrigues-Diez, Raul R.; Rayego-Mateos, Sandra; Orejudo, Macarena; Santos-Sanchez, Laura; Ruiz-Ortega, Marta] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Cellular & Mol Biol Renal & Vasc Pathol, Madrid, Spain; [Marquez-Exposito, Laura; Rodrigues-Diez, Raul R.; Orejudo, Macarena; Santos-Sanchez, Laura; Ruiz-Ortega, Marta] Red Invest Renal REDINREN, Madrid, Spain; [Rayego-Mateos, Sandra] Inst Recerca Biomed Lleida IRBLleida, Vasc & Renal Translat Res Grp, Lleida, Spain; [Fierro-Fernandez, Marta; Blanco, Eva Maria; Lamas, Santiago] Ctr Biol Mol Severo Ochoa CSIC UAM, C Nicolas Cabrera 1, Madrid 28049, Spain; [Rodrigues-Diez, Raquel] Univ Autonoma Madrid, Fac Med, Dept Farmacol, Madrid, Spain; [Laborda, Jorge] Univ Castilla La Mancha, Biochem & Mol Biol Branch, Dept Inorgan & Organ Chem & Biochem, Spanish Natl Res Council CSIC, Albacete, Spain; [Mezzano, Sergio; Lavoz, Carolina] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile	Autonomous University of Madrid; Fundacion Jimenez Diaz; Institut de Recerca Biomedica - IRB Lleida; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Universidad Austral de Chile	Fierro-Fernandez, M (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, C Nicolas Cabrera 1, Madrid 28049, Spain.; Ruiz-Ortega, M (corresponding author), IIS Fdn Jimenez Diaz, Cellular & Mol Biol Renal & Vasc Pathol, Avda Reyes Catolicos 2, Madrid 28040, Spain.	mfierro@cbm.csic.es; mruizo@fjd.es	DEL RÍO, MACARENA OREJUDO/AFU-0330-2022; Laborda, Jorge/L-5726-2014	DEL RÍO, MACARENA OREJUDO/0000-0001-7670-1848; Laborda, Jorge/0000-0002-9210-838X; Marquez-Exposito, Laura/0000-0003-4812-1939; Blanco-Ruiz, Eva/0000-0001-5940-1827				Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bonegio R, 2012, EXP CELL RES, V318, P986, DOI 10.1016/j.yexcr.2012.02.036; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chacon MR, 2008, INT J OBESITY, V32, P1122, DOI 10.1038/ijo.2008.40; Cortvrindt C, 2017, PATHOLOGY, V49, P247, DOI 10.1016/j.pathol.2017.01.003; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Djudjaj S, 2012, J PATHOL, V228, P286, DOI 10.1002/path.4076; Sanchez-Nino MD, 2012, J PATHOL, V228, P266, DOI 10.1002/path.4101; Dong XY, 2008, KIDNEY INT, V74, P1294, DOI 10.1038/ki.2008.394; El Machhour F, 2015, J AM SOC NEPHROL, V26, P1561, DOI 10.1681/ASN.2013090968; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukuda D, 2013, CIRC J, V77, P2462, DOI 10.1253/circj.CJ-13-0873; Huang M, 2018, CELL SIGNAL, V51, P139, DOI 10.1016/j.cellsig.2018.08.002; Huang Q, 2019, KOREAN J PHYSIOL PHA, V23, P251, DOI 10.4196/kjpp.2019.23.4.251; Huang SZ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005233; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen CH, 1997, CLIN CHIM ACTA, V268, P1, DOI 10.1016/S0009-8981(97)00152-6; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Kavvadas P, 2018, KIDNEY INT, V94, P126, DOI 10.1016/j.kint.2018.01.031; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kitching AR, 2011, J AM SOC NEPHROL, V22, P235, DOI 10.1681/ASN.2010050536; Kretzler M, 2008, NAT MED, V14, P246, DOI 10.1038/nm0308-246; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Lavoz C, 2019, KIDNEY INT, V95, P1418, DOI 10.1016/j.kint.2018.12.031; Lavoz C, 2018, CLIN SCI, V132, P1097, DOI 10.1042/CS20171553; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Ma L, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1442-6; Marquez-Exposito L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01195; Marquez-Exposito L, 2018, NEFROLOGIA, V38, P466, DOI 10.1016/j.nefro.2017.11.027; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Nueda ML, 2007, J MOL BIOL, V367, P1270, DOI 10.1016/j.jmb.2006.10.020; Nueda ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35252-3; Orejudo M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01015; Peng XG, 2015, J PATHOL, V235, P79, DOI 10.1002/path.4430; Pindjakova J, 2012, KIDNEY INT, V81, P379, DOI 10.1038/ki.2011.348; Puertas-Avendano RA, 2011, J NEUROENDOCRINOL, V23, P849, DOI 10.1111/j.1365-2826.2011.02189.x; Puri RV, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.040642; Quillard T, 2013, INT J MOL SCI, V14, P6863, DOI 10.3390/ijms14046863; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Ramani K, 2016, CLIN IMMUNOL, V162, P31, DOI 10.1016/j.clim.2015.10.009; Rodrigues-Diez R, 2013, LAB INVEST, V93, P812, DOI 10.1038/labinvest.2013.67; Rodriguez P, 2012, CARDIOVASC RES, V93, P232, DOI 10.1093/cvr/cvr296; Rodriguez-Cano MM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092032; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; Ucero AC, 2014, INT UROL NEPHROL, V46, P765, DOI 10.1007/s11255-013-0520-1; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Vijayaraghavan J, 2018, ADV EXP MED BIOL, V1066, P339, DOI 10.1007/978-3-319-89512-3_17; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Xue L, 2011, J SURG RES, V171, P266, DOI 10.1016/j.jss.2009.12.031; Yin XW, 2019, INFLAMM RES, V68, P761, DOI 10.1007/s00011-019-01260-w; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	62	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21213	10.1096/fj.201903131R	http://dx.doi.org/10.1096/fj.201903131R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368614	Green Published			2022-12-28	WOS:000605626600047
J	Zemel, BM; Zhi, LT; Brown, EV; Tymanskyj, SR; Liang, QS; Covarrubias, M				Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel			PKC epsilon associates with the Kv3.4 channel to promote its expression in a kinase activity-dependent manner	FASEB JOURNAL			English	Article						dorsal root ganglia; Kv3; 4; PKC&#949	GATED K+ CHANNELS; POTASSIUM CHANNEL; ION CHANNELS; PHOSPHORYLATION; INACTIVATION; MODULATION; SUBUNITS; DYSREGULATION; NEURONS; STATE	The voltage-gated potassium channel Kv3.4 is a crucial regulator of nociceptive signaling in the dorsal root ganglion (DRG) and the dorsal horn of the spinal cord. Moreover, Kv3.4 dysfunction has been linked to neuropathic pain. Although kinases and phosphatases can directly modulate Kv3.4 gating, the signaling mechanisms regulating the expression and stability of the Kv3.4 protein are generally unknown. We explored a potential role of PKC epsilon and found an unexpected interaction that has a positive effect on Kv3.4 expression. Co-immunoprecipitation studies revealed a physical association between PKC epsilon and Kv3.4 in both heterologous cells and rat DRG neurons. Furthermore, in contrast to the wild-type and constitutively active forms of PKC epsilon, expression of a catalytically inactive form of the enzyme inhibits Kv3.4 expression and membrane localization through a dominant negative effect. Co-expression of Kv3.4 with the wild-type, constitutively active, or catalytically inactive forms of PKC epsilon had no significant effects on Kv3.4 gating. These results suggest that a novel physical interaction of the Kv3.4 channel with functional PKC epsilon primarily determines its stability and localization in DRG neurons. This interaction is akin to those of previously identified accessory ion channel proteins, which could be significant in neural tissues where Kv3.4 regulates electrical signaling.	[Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Dept Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Vickie & Jack Farber Inst Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Zemel, Benjamin M.; Zhi, Lianteng; Brown, Eric V.; Tymanskyj, Stephen R.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Jefferson Coll Life Sci, Philadelphia, PA 19107 USA; [Zemel, Benjamin M.] Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Jefferson University; Jefferson University; Jefferson University; Oregon Health & Science University	Zemel, BM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zemel@ohsu.edu		Tymanskyj, Stephen/0000-0002-6837-0644; Covarrubias, Manuel/0000-0002-0881-4143	NIH HHS [NS090689, NS079855] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Beck EJ, 1998, J GEN PHYSIOL, V112, P71, DOI 10.1085/jgp.112.1.71; Cai SQ, 2006, CELL BIOCHEM BIOPHYS, V46, P91, DOI 10.1385/CBB:46:1:91; Cartwright TA, 2007, BBA-GEN SUBJECTS, V1770, P666, DOI 10.1016/j.bbagen.2006.11.013; Chen Y, 2006, CELL SIGNAL, V18, P215, DOI 10.1016/j.cellsig.2005.04.007; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; Desai R, 2008, J BIOL CHEM, V283, P22283, DOI 10.1074/jbc.M801663200; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kaczmarek LK, 2017, PHYSIOL REV, V97, P1431, DOI 10.1152/physrev.00002.2017; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; Liu PW, 2017, J NEUROSCI, V37, P9705, DOI 10.1523/JNEUROSCI.1703-17.2017; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MORENO H, 1995, J NEUROSCI, V15, P5486; Muqeem T, 2018, J NEUROSCI, V38, P3729, DOI 10.1523/JNEUROSCI.3212-17.2018; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ritter DM, 2015, J NEUROSCI, V35, P1260, DOI 10.1523/JNEUROSCI.1594-14.2015; Ritter DM, 2012, J PHYSIOL-LONDON, V590, P145, DOI 10.1113/jphysiol.2011.218560; Rossie S, 1999, ADV SEC MESS PHOSPH, V33, P23; Rowan MJM, 2017, CELL REP, V18, P2018, DOI 10.1016/j.celrep.2017.01.068; Rowan MJM, 2016, NEURON, V91, P370, DOI 10.1016/j.neuron.2016.05.035; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Song P, 2006, J BIOL CHEM, V281, P15582, DOI 10.1074/jbc.M512866200; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Velasco I, 1998, Neurobiology (Bp), V6, P23; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Zemel BM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00253; Zemel BM, 2017, J NEUROSCI, V37, P8256, DOI 10.1523/JNEUROSCI.0434-17.2017	35	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21241	10.1096/fj.201901877R	http://dx.doi.org/10.1096/fj.201901877R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368632				2022-12-28	WOS:000605626600002
J	Zhang, SL; Xue, L; Liu, XH; Zhang, XJC; Zhou, R; Zhao, H; Shen, CS; Pin, JP; Rondard, P; Liu, JF				Zhang, Shenglan; Xue, Li; Liu, Xuehui; Zhang, Xuejun Cai; Zhou, Rui; Zhao, Han; Shen, Cangsong; Pin, Jean-Philippe; Rondard, Philippe; Liu, Jianfeng			Structural basis for distinct quality control mechanisms of GABA(B)receptor during evolution	FASEB JOURNAL			English	Article						cell surface trafficking; coiled-coil domain; endoplasmic reticulum retention; GPCR	ENDOPLASMIC-RETICULUM RETENTION; GABA(B) RECEPTOR; NMR-SPECTROSCOPY; SURFACE TRAFFICKING; GB2 SUBUNITS; EXPRESSION; DOMAIN; HETERODIMERIZATION; GABA(B)-RECEPTOR; CRYSTALLOGRAPHY	Cell surface trafficking of many G protein-coupled receptors is tightly regulated. Among them, the mandatory heterodimer GABA(B)receptor for the main inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), is a model. In mammals, its cell surface trafficking is highly controlled by an endoplasmic reticulum retention signal in the C-terminal intracellular region of the GB1 subunit that is masked through a coiled-coil interaction with the GB2 subunit. Here, we investigate the molecular basis for the export of its homolog inDrosophila melanogasterthat regulates the circadian rhythm and sleep. In contrast to mammals, the endoplasmic retention signal is carried by GB2, while GB1 reaches the cell surface alone. NMR analysis showed that the coiled-coil domain that controls GABA(B)heterodimer formation is structurally conserved between flies and mammals, despite specific features. These findings show the adaptation of a similar quality control system during evolution for maintaining the subunit composition of a functional heterodimeric receptor.	[Zhang, Shenglan; Xue, Li; Zhou, Rui; Zhao, Han; Shen, Cangsong; Liu, Jianfeng] Huazhong Univ Sci & Technol, Int Res Ctr Sensory Biol & Technol MOST, Key Lab Mol Biophys MOE, Cellular Signaling Lab,Sch Life Sci & Technol, Wuhan, Peoples R China; [Liu, Xuehui] Chinese Acad Sci, Inst Biophys, Core Facil Prot Res, Beijing, Peoples R China; [Zhang, Xuejun Cai] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China; [Zhang, Xuejun Cai] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Pin, Jean-Philippe; Rondard, Philippe] Univ Montpellier, Inst Genom Fonct, CNRS, INSERM, Montpellier, France; [Liu, Jianfeng] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China; [Xue, Li] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurosurg,Ctr Pituitary Tumor, Shanghai, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Shanghai Jiao Tong University	Rondard, P (corresponding author), Univ Montpellier, Inst Genom Fonct, CNRS, INSERM, Montpellier, France.; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Key Lab Mol Biophys MOE, Wuhan 430074, Peoples R China.	philippe.rondard@igf.cnrs.fr; jfliu@mail.hust.edu.cn		XUE, Li/0000-0003-0650-2194	Ministry of Science and Technology of the People's Republic of China (MOST) [2018YFA0507003]; National Natural Science Foundation of China (NSFC) [81720108031, 81872945, 31721002, 31420102909]; Program for Introducing Talents of Discipline to the Universities of the Ministry of Education [B08029]; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Program Hubert Curien (PHC) Cai Yuanpei	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Introducing Talents of Discipline to the Universities of the Ministry of Education; Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Program Hubert Curien (PHC) Cai Yuanpei	Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2018YFA0507003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81720108031, 81872945, 31721002 and 31420102909; Program for Introducing Talents of Discipline to the Universities of the Ministry of Education, Grant/Award Number: B08029; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Program Hubert Curien (PHC) Cai Yuanpei	Agabio R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00140; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; BAX A, 1991, CIBA F SYMP, V161, P108; Blankenburg S, 2015, NEUROPHARMACOLOGY, V88, P134, DOI 10.1016/j.neuropharm.2014.08.022; Boyd GW, 2003, J BIOL CHEM, V278, P27681, DOI 10.1074/jbc.M304938200; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burmakina S, 2014, P NATL ACAD SCI USA, V111, P6958, DOI 10.1073/pnas.1400081111; Calver AR, 2001, J NEUROSCI, V21, P1203; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Comps-Agrar L, 2012, FASEB J, V26, P3430, DOI 10.1096/fj.12-203646; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; Cunningham MR, 2012, J BIOL CHEM, V287, P16656, DOI 10.1074/jbc.M111.315911; Curtis DR, 1998, EXP BRAIN RES, V121, P319, DOI 10.1007/s002210050465; Dalmau J, 2018, NEW ENGL J MED, V378, P840, DOI 10.1056/NEJMra1708712; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Doly S, 2015, TRENDS PHARMACOL SCI, V36, P636, DOI 10.1016/j.tips.2015.06.007; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Gmeiner F, 2013, J EXP BIOL, V216, P3837, DOI 10.1242/jeb.085563; Grieder NC, 2005, GENE EXPR PATTERNS, V6, P11, DOI 10.1016/j.modgep.2005.06.001; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Hasegawa H, 2016, BBA-MOL CELL RES, V1863, P1534, DOI 10.1016/j.bbamcr.2016.04.010; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; Howell RD, 2016, J PHYSIOL-LONDON, V594, P3651, DOI 10.1113/JP272124; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Li CP, 2008, ALCOHOL ALCOHOLISM, V43, P529, DOI 10.1093/alcalc/agn045; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Pagano A, 2001, J NEUROSCI, V21, P1189; Pregitzer P, 2013, INT J BIOL SCI, V9, P707, DOI 10.7150/ijbs.6674; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Sammaraiee Y, 2019, MULT SCLER RELAT DIS, V27, P95, DOI 10.1016/j.msard.2018.10.009; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Shaye H, 2020, NATURE, V584, P298, DOI 10.1038/s41586-020-2408-4; Szabadi E, 2015, J PSYCHOPHARMACOL, V29, P744, DOI 10.1177/0269881115573807; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xue L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10834-5; Yoo Y, 2017, ANN NEUROL, V82, P466, DOI 10.1002/ana.25032	62	2	2	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16348	16363		10.1096/fj.202001355RR	http://dx.doi.org/10.1096/fj.202001355RR		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058267	Green Submitted			2022-12-28	WOS:000581156300001
J	Nicolaisen, TS; Klein, AB; Dmytriyeva, O; Lund, J; Ingerslev, LR; Fritzen, AM; Carl, CS; Lundsgaard, AM; Frost, M; Ma, T; Schjerling, P; Gerhart-Hines, Z; Flamant, F; Gauthier, K; Larsen, S; Richter, EA; Kiens, B; Clemmensen, C				Nicolaisen, Trine S.; Klein, Anders B.; Dmytriyeva, Oksana; Lund, Jens; Ingerslev, Lars R.; Fritzen, Andreas M.; Carl, Christian S.; Lundsgaard, Anne-Marie; Frost, Mikkel; Ma, Tao; Schjerling, Peter; Gerhart-Hines, Zachary; Flamant, Frederic; Gauthier, Karine; Larsen, Steen; Richter, Erik A.; Kiens, Bente; Clemmensen, Christoffer			Thyroid hormone receptor alpha in skeletal muscle is essential for T3-mediated increase in energy expenditure	FASEB JOURNAL			English	Article						energy expenditure; energy metabolism; skeletal muscle; thyroid hormone	BROWN ADIPOSE-TISSUE; THERMOGENESIS; SARCOLIPIN; MICE; TRIIODOTHYRONINE; DETERMINANT; ACTIVATION; EXPRESSION; FAT	Thyroid hormones are important for homeostatic control of energy metabolism and body temperature. Although skeletal muscle is considered a key site for thyroid action, the contribution of thyroid hormone receptor signaling in muscle to whole-body energy metabolism and body temperature has not been resolved. Here, we show that T3-induced increase in energy expenditure requires thyroid hormone receptor alpha 1 (TR alpha(1)) in skeletal muscle, but that T3-mediated elevation in body temperature is achieved in the absence of muscle-TR alpha(1). In slow-twitch soleus muscle, loss-of-function of TR alpha(1)(TR alpha(HSACre)) alters the fiber-type composition toward a more oxidative phenotype. The change in fiber-type composition, however, does not influence the running capacity or motivation to run. RNA-sequencing of soleus muscle from WT mice and TR alpha(HSACre)mice revealed differentiated transcriptional regulation of genes associated with muscle thermogenesis, such as sarcolipin and UCP3, providing molecular clues pertaining to the mechanistic underpinnings of TR alpha(1)-linked control of whole-body metabolic rate. Together, this work establishes a fundamental role for skeletal muscle in T3-stimulated increase in whole-body energy expenditure.	[Nicolaisen, Trine S.; Klein, Anders B.; Dmytriyeva, Oksana; Lund, Jens; Ingerslev, Lars R.; Frost, Mikkel; Ma, Tao; Gerhart-Hines, Zachary; Clemmensen, Christoffer] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Nicolaisen, Trine S.; Fritzen, Andreas M.; Carl, Christian S.; Lundsgaard, Anne-Marie; Richter, Erik A.; Kiens, Bente] Univ Copenhagen, Sect Mol Physiol, Dept Nutr Exercise & Sports, Fac Sci, Copenhagen, Denmark; [Dmytriyeva, Oksana] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Inst Sports Med Copenhagen, Dept Orthoped Surg, Bispebjerg Frederiksberg Hosp, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark; [Flamant, Frederic; Gauthier, Karine] Univ Lyon 1, Inst Genom Fonct Lyon, Univ Lyon, CNRS UMR 5242,INRA USC 1370,Ecole Normale Super L, Lyon, France; [Larsen, Steen] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Xlab,Ctr Hlth Aging, Copenhagen, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Copenhagen	Clemmensen, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	chc@sund.ku.dk	Lund, Jens/AAA-5865-2022; Fritzen, Andreas/D-4103-2015; Larsen, Steen/L-2069-2013; Schjerling, Peter/F-6194-2011; Clemmensen, Christoffer/AAM-3347-2020; Richter, Erik A./N-4189-2014; Kiens, Bente/B-1375-2015	Fritzen, Andreas/0000-0001-8793-9739; Schjerling, Peter/0000-0001-7138-3211; Clemmensen, Christoffer/0000-0003-2456-9667; Klein, Anders Bue/0000-0002-0236-3089; Richter, Erik A./0000-0002-6850-3056; Ingerslev, Lars Roed/0000-0002-4164-7690; Larsen, Steen/0000-0002-5170-4337; Lundsgaard, Anne-Marie/0000-0002-5584-2366; Carl, Christian Strini/0000-0002-9551-5837; Gerhart-Hines, Zachary/0000-0003-2981-4991; Kiens, Bente/0000-0001-5705-5625; Nicolaisen, Trine Sand/0000-0001-5856-6443; Lund, Jens/0000-0003-2338-6033	Novo Nordisk Fonden (NNF) [NNF17SA0031406, NNF17OC0026114, NNF18CC0034900]; Alfred Benzon Foundation; Danish Council for Independent Research [7016-00389A]; Lundbeck Foundation [R2382016-2859]; University of Copenhagen; NNF Center for Basic Metabolic Research [Barres Group, SCOP Platform] Funding Source: researchfish	Novo Nordisk Fonden (NNF); Alfred Benzon Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); University of Copenhagen; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	Novo Nordisk Fonden (NNF), Grant/Award Number: NNF17SA0031406, NNF17OC0026114 and NNF18CC0034900; Alfred Benzon Foundation; Danish Council for Independent Research, Grant/Award Number: 7016-00389A; Lundbeck Foundation, Grant/Award Number: R2382016-2859; University of Copenhagen	ARGOV Z, 1988, J CLIN INVEST, V81, P1695, DOI 10.1172/JCI113508; Bal NC, 2017, J BIOL CHEM, V292, P16616, DOI 10.1074/jbc.M117.790451; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bloise FF, 2018, J ENDOCRINOL, V236, pR57, DOI 10.1530/JOE-16-0611; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Caiozzo VJ, 2000, AM J PHYSIOL-CELL PH, V278, pC709, DOI 10.1152/ajpcell.2000.278.4.C709; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Dittner C, 2019, MOL METAB, V25, P20, DOI 10.1016/j.molmet.2019.05.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Finan B, 2016, CELL, V167, P843, DOI 10.1016/j.cell.2016.09.014; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Johann K, 2019, CELL REP, V27, P3385, DOI 10.1016/j.celrep.2019.05.054; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; Minakhina S, 2020, THYROID, V30, P1193, DOI 10.1089/thy.2019.0763; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Miyabara EH, 2005, CELL TISSUE RES, V321, P233, DOI 10.1007/s00441-005-1119-3; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Salvatore D, 2014, NAT REV ENDOCRINOL, V10, P206, DOI 10.1038/nrendo.2013.238; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; SILVA JE, 1983, NATURE, V305, P712, DOI 10.1038/305712a0; Simonides WS, 2008, THYROID, V18, P205, DOI 10.1089/thy.2007.0256; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Warner A, 2013, P NATL ACAD SCI USA, V110, P16241, DOI 10.1073/pnas.1310300110; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yu FS, 2000, AM J PHYSIOL-REG I, V278, pR1545, DOI 10.1152/ajpregu.2000.278.6.R1545	34	12	12	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15480	15491		10.1096/fj.202001258RR	http://dx.doi.org/10.1096/fj.202001258RR		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32969079	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000574531200001
J	Ma, RH; Serrano, TPO; Davis, J; Prigge, AD; Ridge, KM				Ma, Ruihua; Serrano, Tatiana P. Ortiz; Davis, Jennifer; Prigge, Andrew D.; Ridge, Karen M.			The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease	FASEB JOURNAL			English	Review						AIM2; autoimmune disease; cGAMP; DAMP; pulmonary disease	CYCLIC GMP-AMP; OBSTRUCTIVE PULMONARY-DISEASE; INNATE IMMUNE SENSOR; NEUTROPHIL EXTRACELLULAR TRAPS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AICARDI-GOUTIERES-SYNDROME; MITOCHONDRIAL-DNA; ENDOGENOUS 2ND-MESSENGER; ACTIVATION; DAMAGE	The presence of DNA in the cytosol is usually a sign of microbial infections, which alerts the host innate immune system to mount a defense response. Cyclic GMP-AMP synthase (cGAS) is a critical cytosolic DNA sensor that elicits robust innate immune responses through the production of the second messenger, cyclic GMP-AMP (cGAMP), which binds and activates stimulator of interferon genes (STING). However, cGAS binds to DNA irrespective of DNA sequence, therefore, self-DNA leaked from the nucleus or mitochondria can also serve as a cGAS ligand to activate this pathway and trigger extensive inflammatory responses. Dysregulation of the cGAS-STING pathway is responsible for a broad array of inflammatory and autoimmune diseases. Recently, evidence has shown that self-DNA release and cGAS-STING pathway over-activation can drive lung disease, making this pathway a promising therapeutic target for inflammatory lung disease. Here, we review recent advances on the cGAS-STING pathway governing self-DNA sensing, highlighting its role in pulmonary disease.	[Ma, Ruihua; Serrano, Tatiana P. Ortiz; Davis, Jennifer; Ridge, Karen M.] Northwestern Univ, Div Pulm & Crit Care Med, Dept Med, Feinberg Sch Med, 303 E Super,5-305, Chicago, IL 60611 USA; [Prigge, Andrew D.] Northwestern Univ, Div Crit Care Med, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Prigge, Andrew D.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Ridge, Karen M.] Northwestern Univ, Dept Cell & Dev Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Ma, RH (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Dept Med, Feinberg Sch Med, 303 E Super,5-305, Chicago, IL 60611 USA.	ruihua.ma@northwestern.edu		Prigge, Andrew/0000-0003-4454-5152	David and Christine Cugell Fellowship; Gorter Family Foundation; Stanley Manne Children's Research Institute; Ann & Robert H. Lurie Children's Hosptial of Chicago; NIH [P01HL071643, R01HL128194, P01AG049665]	David and Christine Cugell Fellowship; Gorter Family Foundation; Stanley Manne Children's Research Institute; Ann & Robert H. Lurie Children's Hosptial of Chicago; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	David and Christine Cugell Fellowship; Gorter Family Foundation, the Stanley Manne Children's Research Institute, and the Ann & Robert H. Lurie Children's Hosptial of Chicago; HNIH, Grant/Award Number: P01HL071643, R01HL128194 and P01AG049665	Aarreberg LD, 2019, MOL CELL, V74, P801, DOI 10.1016/j.molcel.2019.02.038; Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Alhede M, 2020, PATHOG DIS, V78, DOI 10.1093/femspd/ftaa018; An J, 2015, J IMMUNOL, V194, P4089, DOI 10.4049/jimmunol.1402793; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Assallum H, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.15; Avriel A, 2016, INT J CHRONIC OBSTR, V11, P3153, DOI 10.2147/COPD.S113256; Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Banoth B, 2018, TRANSL RES, V202, P52, DOI 10.1016/j.trsl.2018.07.014; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Basit A, 2020, EXP MOL MED, V52, P643, DOI 10.1038/s12276-020-0416-y; Benmerzoug S, 2019, CELL REP, V27, P2649, DOI 10.1016/j.celrep.2019.04.110; Benmerzoug S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07425-1; Bennion BG, 2019, J VIROL, V93, DOI 10.1128/JVI.01806-18; Bueno M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218003; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Ceylan E, 2006, RESP MED, V100, P1270, DOI 10.1016/j.rmed.2005.10.011; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Cheng WY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01297; Chung KW, 2019, CELL METAB, V30, P784, DOI 10.1016/j.cmet.2019.08.003; Clarke SLN, 2016, AM J RESP CRIT CARE, V194, P639, DOI 10.1164/rccm.201510-2102LE; Cloonan SM, 2016, J CLIN INVEST, V126, P809, DOI 10.1172/JCI81113; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Daniel C, 2019, NAT REV NEPHROL, V15, P559, DOI 10.1038/s41581-019-0163-2; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Dunphy G, 2018, MOL CELL, V71, P745, DOI 10.1016/j.molcel.2018.07.034; Dwyer M, 2014, J INNATE IMMUN, V6, P765, DOI 10.1159/000363242; El Hassan NO, 2001, PEDIATRICS, V108, P468; Feng SY, 2018, J MOL BIOL, V430, P3068, DOI 10.1016/j.jmb.2018.07.002; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; GIROUD M, 1986, CHILD NERV SYST, V2, P47, DOI 10.1007/BF00274035; da Silva ALG, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0034-z; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Grieves JL, 2015, P NATL ACAD SCI USA, V112, P5117, DOI 10.1073/pnas.1423804112; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Han YL, 2020, J IMMUNOL, V204, P1437, DOI 10.4049/jimmunol.1900869; Hendgen-Cotta UB, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2608187; Hooy RM, 2018, ELIFE, V7, DOI 10.7554/eLife.39984; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu XX, 2019, FEBS J, V286, P4754, DOI 10.1111/febs.15001; Huang LS, 2020, IMMUNITY, V52, P475, DOI 10.1016/j.immuni.2020.02.002; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016394; Kawasaki T, 2019, INT REV CEL MOL BIO, V344, P1, DOI 10.1016/bs.ircmb.2018.08.004; Kenny EF, 2019, EUR J IMMUNOL, V49, P590, DOI 10.1002/eji.201847875; Kerur N, 2018, NAT MED, V24, P50, DOI 10.1038/nm.4450; Keskitalo S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02770; Keyel PA, 2017, DEV BIOL, V429, P1, DOI 10.1016/j.ydbio.2017.06.028; Konig N, 2017, ANN RHEUM DIS, V76, P468, DOI 10.1136/annrheumdis-2016-209841; Konno H, 2018, CELL REP, V23, P1112, DOI 10.1016/j.celrep.2018.03.115; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Lachowicz-Scroggins ME, 2019, AM J RESP CRIT CARE, V199, P1076, DOI 10.1164/rccm.201810-1869OC; Lassig C, 2017, J BIOL CHEM, V292, P9000, DOI 10.1074/jbc.R117.788398; Lama L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08620-4; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu JG, 2015, SCIENCE, V347, DOI 10.1126/science.1258832; Liu T, 2017, CHINESE MED J-PEKING, V130, P730, DOI 10.4103/0366-6999.201608; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Maekawa H, 2019, CELL REP, V29, P1261, DOI 10.1016/j.celrep.2019.09.050; Maluf SW, 2007, MUTAT RES-GEN TOX EN, V626, P180, DOI 10.1016/j.mrgentox.2006.10.002; Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; Martinez-Valle F, 2009, LUPUS, V18, P418, DOI 10.1177/0961203308098189; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Melki I, 2017, J ALLERGY CLIN IMMUN, V140, P543, DOI 10.1016/j.jaci.2016.10.031; Middleton E.A, 2020, BLOOD, DOI [DOI 10.1182/BLOOD.2020007008, 10.1182/blood.2020007008]; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Motani K, 2015, J IMMUNOL, V194, P4914, DOI 10.4049/jimmunol.1402705; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Motwani M, 2019, P NATL ACAD SCI USA, V116, P7941, DOI 10.1073/pnas.1818281116; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Munoz J, 2015, JAMA DERMATOL, V151, P872, DOI 10.1001/jamadermatol.2015.0251; Nakayama H, 2018, BIOCHEM J, V475, P839, DOI 10.1042/BCJ20170714; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nascimento M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51427-y; Ni GX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7119; Ozasa K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02212; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Pastukh VM, 2011, INT J CHRONIC OBSTR, V6, P209, DOI 10.2147/COPD.S15922; Patel S, 2019, GENES IMMUN, V20, P82, DOI 10.1038/s41435-018-0029-9; Pham DL, 2017, CLIN EXP ALLERGY, V47, P57, DOI 10.1111/cea.12859; Piantadosi CA, 2017, ANNU REV PHYSIOL, V79, P495, DOI 10.1146/annurev-physiol-022516-034322; Porto BN, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00311; Pragman Alexa A, 2016, Clin Pulm Med, V23, P57, DOI 10.1097/CPM.0000000000000108; REEVE VE, 1989, IMMUNOL CELL BIOL, V67, P421, DOI 10.1038/icb.1989.59; Rego SL, 2018, AUTOIMMUNITY, V51, P333, DOI 10.1080/08916934.2018.1522305; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Rodriguez-Nuevo A, 2019, CELL STRESS, V3, P195, DOI 10.15698/cst2019.06.190; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Ryu CW, 2017, AM J RESP CRIT CARE, V196, P1571, DOI 10.1164/rccm.201612-2480OC; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sakai T, 2017, J AUTOIMMUN, V81, P13, DOI 10.1016/j.jaut.2017.03.001; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schuliga M, 2020, CLIN SCI, V134, P889, DOI 10.1042/CS20191160; Schuliga M, 2018, J CELL MOL MED, V22, P5847, DOI 10.1111/jcmm.13855; SHAH PI, 1995, EUR RESPIR J, V8, P954; SHAH PL, 1995, RESP MED, V89, P499, DOI 10.1016/0954-6111(95)90126-4; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sureshbabu A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00384; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Tao JL, 2016, IUBMB LIFE, V68, P858, DOI 10.1002/iub.1566; Thomas AS, 2020, OPHTHALMOL RETINA, V4, P115, DOI 10.1016/j.oret.2019.07.014; Toussaint M, 2017, NAT MED, V23, P681, DOI 10.1038/nm.4332; Tuder RM, 2018, ANN AM THORAC SOC, V15, pS227, DOI 10.1513/AnnalsATS.201808-583MG; van der Vliet A, 2018, MOL ASPECTS MED, V63, P59, DOI 10.1016/j.mam.2018.08.001; Volkman HE, 2019, ELIFE, V8, DOI 10.7554/eLife.47491; Wan DS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00615; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wilber A, 2003, CLIN EXP IMMUNOL, V134, P46, DOI 10.1046/j.1365-2249.2003.02267.x; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang Y, 2020, EXUBERANT ELEVATION; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yu YS, 2019, J CLIN INVEST, V129, P546, DOI 10.1172/JCI121842; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao BY, 2019, NATURE, V569, P718, DOI 10.1038/s41586-019-1228-x; Zhao QL, 2018, GASTROENTEROLOGY, V154, P1822, DOI 10.1053/j.gastro.2018.01.065; Zhou RY, 2020, INFECT GENET EVOL, V77, DOI 10.1016/j.meegid.2019.104094; Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999	162	27	27	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13156	13170		10.1096/fj.202001607R	http://dx.doi.org/10.1096/fj.202001607R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32860267	hybrid, Green Accepted			2022-12-28	WOS:000566009500001
J	Miller, TE; Beltran, WFG; Bard, AZ; Gogakos, T; Anahtar, MN; Astudillo, MG; Yang, DN; Thierauf, J; Fisch, AS; Mahowald, GK; Fitzpatrick, MJ; Nardi, V; Feldman, J; Hauser, BM; Caradonna, TM; Marble, HD; Ritterhouse, LL; Turbett, SE; Batten, J; Georgantas, NZ; Alter, G; Schmidt, AG; Harris, JB; Gelfand, JA; Poznansky, MC; Bernstein, BE; Louis, DN; Dighe, A; Charles, RC; Ryan, ET; Branda, JA; Pierce, VM; Murali, MR; Iafrate, AJ; Rosenberg, ES; Lennerz, JK				Miller, Tyler E.; Beltran, Wilfredo F. Garcia; Bard, Adam Z.; Gogakos, Tasos; Anahtar, Melis N.; Astudillo, Michael Gerino; Yang, Diane; Thierauf, Julia; Fisch, Adam S.; Mahowald, Grace K.; Fitzpatrick, Megan J.; Nardi, Valentina; Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Marble, Hetal D.; Ritterhouse, Lauren L.; Turbett, Sara E.; Batten, Julie; Georgantas, Nicholas Zeke; Alter, Galit; Schmidt, Aaron G.; Harris, Jason B.; Gelfand, Jeffrey A.; Poznansky, Mark C.; Bernstein, Bradley E.; Louis, David N.; Dighe, Anand; Charles, Richelle C.; Ryan, Edward T.; Branda, John A.; Pierce, Virginia M.; Murali, Mandakolathur R.; Iafrate, A. John; Rosenberg, Eric S.; Lennerz, Jochen K.			Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital	FASEB JOURNAL			English	Article						biomarker; COVID; qPCR; SARS-CoV-2	CORONAVIRUS; SARS-COV-2	The diagnosis of COVID-19 requires integration of clinical and laboratory data. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic assays play a central role in diagnosis and have fixed technical performance metrics. Interpretation becomes challenging because the clinical sensitivity changes as the virus clears and the immune response emerges. Our goal was to examine the clinical sensitivity of two most common SARS-CoV-2 diagnostic test modalities, polymerase chain reaction (PCR) and serology, over the disease course to provide insight into their clinical interpretation in patients presenting to the hospital. We conducted a single-center, retrospective study. To derive clinical sensitivity of PCR, we identified 209 PCR-positive SARS-CoV-2 patients with multiple PCR test results (624 total PCR tests) and calculated daily sensitivity from date of symptom onset or first positive test. Clinical sensitivity of PCR decreased with days post symptom onset with >90% clinical sensitivity during the first 5 days after symptom onset, 70%-71% from Days 9 to 11, and 30% at Day 21. To calculate daily clinical sensitivity by serology, we utilized 157 PCR-positive patients with a total of 197 specimens tested by enzyme-linked immunosorbent assay for IgM, IgG, and IgA anti-SARS-CoV-2 antibodies. In contrast to PCR, serological sensitivity increased with days post symptom onset with >50% of patients seropositive by at least one antibody isotype after Day 7, >80% after Day 12, and 100% by Day 21. Taken together, PCR and serology are complimentary modalities that require time-dependent interpretation. Superimposition of sensitivities over time indicate that serology can function as a reliable diagnostic aid indicating recent or prior infection.	[Miller, Tyler E.; Beltran, Wilfredo F. Garcia; Bard, Adam Z.; Gogakos, Tasos; Anahtar, Melis N.; Astudillo, Michael Gerino; Yang, Diane; Thierauf, Julia; Fisch, Adam S.; Mahowald, Grace K.; Fitzpatrick, Megan J.; Nardi, Valentina; Marble, Hetal D.; Ritterhouse, Lauren L.; Turbett, Sara E.; Batten, Julie; Georgantas, Nicholas Zeke; Bernstein, Bradley E.; Louis, David N.; Dighe, Anand; Branda, John A.; Pierce, Virginia M.; Murali, Mandakolathur R.; Iafrate, A. John; Rosenberg, Eric S.; Lennerz, Jochen K.] Harvard Med Sch, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Alter, Galit; Schmidt, Aaron G.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Turbett, Sara E.; Gelfand, Jeffrey A.; Poznansky, Mark C.; Charles, Richelle C.; Ryan, Edward T.; Rosenberg, Eric S.] Harvard Med Sch, Div Infect Dis, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Harris, Jason B.; Pierce, Virginia M.] Harvard Med Sch, Div Infect Dis, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Murali, Mandakolathur R.] Harvard Med Sch, Div Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lennerz, JK (corresponding author), Harvard Med Sch, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	jlennerz@partners.org	Dighe, Anand/AAP-9640-2020; Branda, John/ABD-5620-2020	Gogakos, Tasos/0000-0002-4892-8276; Caradonna, Timothy/0000-0001-7138-4441; Pierce, Virginia/0000-0002-3723-1326; Hauser, Blake/0000-0002-0100-1684; Mahowald, Grace/0000-0003-4541-4920; Miller, Tyler E/0000-0002-1269-1895	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [AI146779]; NIH [RO1 CA225655, R01 AI146779]; Centers for Disease Control and Prevention [U01CK000490]; NIGMS [GM007753]	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI146779; NIH, Grant/Award Number: RO1 CA225655 and R01 AI146779; Centers for Disease Control and Prevention, Grant/Award Number: U01CK000490; NIGMS, Grant/Award Number: GM007753	Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bermingham WH, 2020, CLIN MED, V20, P365, DOI 10.7861/clinmed.2020-0170; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cevik M, 2020, CLIN MICROBIOL INFEC, V26, P842, DOI 10.1016/j.cmi.2020.04.023; Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; He YX, 2005, VIROLOGY, V334, P74, DOI 10.1016/j.virol.2005.01.034; Ju B, POTENT HUMAN NEUTRAL; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lu XY, 2020, EMERG INFECT DIS, V26, P1654, DOI 10.3201/eid2608.201246; Nicola M, 2020, INT J SURG, V77, P206, DOI 10.1016/j.ijsu.2020.04.001; Pascarella G, 2020, J INTERN MED, V288, P192, DOI 10.1111/joim.13091; Pulia MS, 2020, ANN MED, V52, P207, DOI 10.1080/07853890.2020.1763449; Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Sun ZH, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1778435; Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Weinstein MC, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2017739; Weissleder R, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc1931; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344	27	72	73	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13877	13884		10.1096/fj.202001700RR	http://dx.doi.org/10.1096/fj.202001700RR		AUG 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32856766	Green Submitted, Green Published			2022-12-28	WOS:000566008900001
J	Widjaja-Adhi, MAK; Silvaroli, JA; Chelstowska, S; Trischman, T; Bederman, I; Sayegh, R; Golczak, M				Widjaja-Adhi, Made Airanthi K.; Silvaroli, Josie A.; Chelstowska, Sylwia; Trischman, Thomas; Bederman, Ilya; Sayegh, Rony; Golczak, Marcin			Deficiency in Acyl-CoA:Wax Alcohol Acyltransferase 2 causes evaporative dry eye disease by abolishing biosynthesis of wax esters	FASEB JOURNAL			English	Article						AWAT2; dry eye disease; MFAT; tear film; wax esters	MULTIFUNCTIONAL O-ACYLTRANSFERASE; MEIBOMIAN GLAND DROPOUT; INTERNATIONAL WORKSHOP; DYSFUNCTION REPORT; MOUSE; IDENTIFICATION; PREVALENCE; MODULATION; PHYSIOLOGY; ANATOMY	Lipids secreted by the meibomian glands (MGs) of the eyelids are essential to the protection of the eye's surface. An altered meibum composition represents the primary cause of evaporative dry eye disease (DED). Despite the critical importance of the meibum, its biosynthetic pathways and the roles of individual lipid components remain understudied. Here, we report that the genetic deletion of Acyl-CoA:wax alcohol acyltransferase 2 (AWAT2) causes the obstruction of MGs and symptoms of evaporative DED in mice. The lipid composition of the meibum isolated fromAwat2(-/-)mice revealed the absence of wax esters, which was accompanied by a compensatory overproduction of cholesteryl esters. The resulting increased viscosity of meibum led to the dilation of the meibomian ducts, and the progressive degeneration of the MGs. Overall, we provide evidence for the main physiological role of AWAT2 and establishAwat2(-/-)mice as a model for DED syndrome that can be used in studies on tear film-oriented therapies.	[Widjaja-Adhi, Made Airanthi K.; Silvaroli, Josie A.; Chelstowska, Sylwia; Trischman, Thomas; Golczak, Marcin] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Bederman, Ilya] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Sayegh, Rony] Case Western Reserve Univ, Sch Med, Dept Ophthalmol, Cleveland, OH 44106 USA; [Golczak, Marcin] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Widjaja-Adhi, MAK; Golczak, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	nkw5@case.edu; mxg149@case.edu		Silvaroli, Josie/0000-0002-4505-3670; Widjaja-Adhi, Made Airanthi K./0000-0002-0589-2605	HHS | NIH | National Eye Institute (NEI) [EY023948, EY011373]	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY023948 and EY011373	Amengual J, 2014, HUM MOL GENET, V23, P5402, DOI 10.1093/hmg/ddu258; Arne JM, 2017, J LIPID RES, V58, P719, DOI 10.1194/jlr.M073692; Baudouin C, 2001, SURV OPHTHALMOL, V45, pS211, DOI 10.1016/S0039-6257(00)00200-9; Blackie CA, 2010, CORNEA, V29, P1333, DOI 10.1097/ICO.0b013e3181d4f366; Bron A J, 2004, Ocul Surf, V2, P149; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; BUTOVICH IA, 2009, METHODS MOL BIOL 1, V579, P221, DOI DOI 10.1007/978-1-60761-322-0_11; Butovich IA, 2019, FASEB J, V33, P10034, DOI 10.1096/fj.201900725R; Butovich IA, 2017, EXP EYE RES, V163, P2, DOI 10.1016/j.exer.2017.06.020; Butovich IA, 2016, BBA-MOL CELL BIOL L, V1861, P538, DOI 10.1016/j.bbalip.2016.03.024; Butovich IA, 2013, EXP EYE RES, V117, P4, DOI 10.1016/j.exer.2013.05.010; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P6881, DOI 10.1167/iovs.12-10516; Butovich IA, 2011, PROG LIPID RES, V50, P278, DOI 10.1016/j.plipres.2011.03.003; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Chen JZ, 2019, CHEM PHYS LIPIDS, V220, P36, DOI 10.1016/j.chemphyslip.2019.01.003; DILLY PN, 1994, ADV EXP MED BIOL, V350, P239; Feng Y, 2014, CURR EYE RES, V39, P965, DOI 10.3109/02713683.2014.891748; Foulks Gary N, 2003, Ocul Surf, V1, P107; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Holmes RS, 2010, COMP BIOCHEM PHYS D, V5, P45, DOI 10.1016/j.cbd.2009.09.004; IYENGAR BTR, 1969, LIPIDS, V4, P28, DOI 10.1007/BF02531790; JESTER JV, 1982, INVEST OPHTH VIS SCI, V22, P660; JESTER JV, 1988, INVEST OPHTH VIS SCI, V29, P1190; Kaercher Thomas, 2008, Dev Ophthalmol, V41, P36, DOI 10.1159/000131069; Kaylor JJ, 2014, P NATL ACAD SCI USA, V111, P7302, DOI 10.1073/pnas.1319142111; Knop E, 2009, OPHTHALMOLOGE, V106, P980, DOI 10.1007/s00347-009-2044-8; Knop E, 2009, OPHTHALMOLOGE, V106, P884, DOI 10.1007/s00347-009-2019-9; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Knop N, 2009, OPHTHALMOLOGE, V106, P872, DOI 10.1007/s00347-009-2006-1; Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a; MAHADEVAN V, 1962, J LIPID RES, V3, P106; Miyamoto M, 2020, ELIFE, V9, DOI 10.7554/eLife.53582; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Ngo W, 2014, OPTOMETRY VISION SCI, V91, P658, DOI 10.1097/OPX.0000000000000279; Pappas A, 2009, DERM-ENDOCRINOL, V1, P72, DOI 10.4161/derm.1.2.7811; SAKAMOTO R, 1993, INVEST OPHTH VIS SCI, V34, P3510; Sassa T, 2018, FASEB J, V32, P2966, DOI 10.1096/fj.201700947R; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schirra F, 2005, INVEST OPHTH VIS SCI, V46, P3666, DOI 10.1167/iovs.05-0426; Schirra F, 2007, CURR EYE RES, V32, P393, DOI 10.1080/02713680701316674; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Sullivan BD, 2006, ARCH OPHTHALMOL-CHIC, V124, P1286, DOI 10.1001/archopht.124.9.1286; Turkish AR, 2009, AM J PHYSIOL-ENDOC M, V297, pE19, DOI 10.1152/ajpendo.90898.2008; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Vincent SD, 2003, GENESIS, V37, P54, DOI 10.1002/gene.10226; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200	50	13	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13792	13808		10.1096/fj.202001191R	http://dx.doi.org/10.1096/fj.202001191R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32851726	Green Accepted, Bronze			2022-12-28	WOS:000565961900001
J	Marchetti, P; Fovez, Q; Germain, N; Khamari, R; Kluza, J				Marchetti, Philippe; Fovez, Quentin; Germain, Nicolas; Khamari, Raeeka; Kluza, Jerome			Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells	FASEB JOURNAL			English	Review						mitochondrial adaptation; mitochondrial dysfunction; mitochondrial flexibility; mitochondrial metabolism; mitochondrial stress; oxygen consumption; respiratory reserve capacity; spare reserve capacity; uncoupling ratio	OXIDATIVE-PHOSPHORYLATION; DRUG-RESISTANCE; METABOLISM CONTRIBUTES; BIOENERGETIC FUNCTION; BCL-2 INHIBITION; RESERVE CAPACITY; PYRUVATE IMPORT; LUNG-CANCER; STRESS; TRANSPORT	Mitochondrial metabolism must constantly adapt to stress conditions in order to maintain bioenergetic levels related to cellular functions. This absence of proper adaptation can be seen in a wide array of conditions, including cancer. Metabolic adaptation calls on mitochondrial function and draws on the mitochondrial reserve to meet increasing needs. Among mitochondrial respiratory parameters, the spare respiratory capacity (SRC) represents a particularly robust functional parameter to evaluate mitochondrial reserve. We provide an overview of potential SRC mechanisms and regulation with a focus on its particular significance in cancer cells.	[Marchetti, Philippe; Fovez, Quentin; Germain, Nicolas; Khamari, Raeeka; Kluza, Jerome] Univ Lille, Inst Rech Canc Lille, INSERM, CHU Lille,UMR9020 UMR S 1277 Canther,CNRS, 1 Pl Verdun, F-59045 Lille, France; [Marchetti, Philippe; Germain, Nicolas] CHU Lille, Banque Tissus, Lille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Marchetti, P (corresponding author), Univ Lille, Inst Rech Canc Lille, INSERM, CHU Lille,UMR9020 UMR S 1277 Canther,CNRS, 1 Pl Verdun, F-59045 Lille, France.	philippe.marchetti@inserm.fr		kluza, jerome/0000-0002-7346-1305; Fovez, Quentin/0000-0003-3051-8022; Germain, Nicolas/0000-0003-0867-3245	Ligue Contre le Cancer [001ARB]; Region Haut de France	Ligue Contre le Cancer(Ligue nationale contre le cancer); Region Haut de France	Ligue Contre le Cancer, Grant/Award Number: 001ARB; Region Haut de France	Agostini M, 2016, CELL DEATH DIFFER, V23, P1502, DOI 10.1038/cdd.2016.36; Amoroso MR, 2017, ADV PROTEIN CHEM STR, V108, P163, DOI 10.1016/bs.apcsb.2017.01.004; [Anonymous], OXIDATIVE MED CELL L; Anso E, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-7; Armstrong JA, 2018, J BIOL CHEM, V293, P8032, DOI 10.1074/jbc.RA118.003200; Bader DA, 2019, NAT METAB, V1, P70, DOI 10.1038/s42255-018-0002-y; Bayot A, 2008, BIOCHIMIE, V90, P260, DOI 10.1016/j.biochi.2007.10.010; Bernard K, 2017, J BIOL CHEM, V292, P3029, DOI 10.1074/jbc.M116.752261; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buckley AM, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010033; Caneba CA, 2012, AM J PHYSIOL-ENDOC M, V303, pE1036, DOI 10.1152/ajpendo.00151.2012; Carbognin E, 2016, EMBO J, V35, P618, DOI 10.15252/embj.201592629; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Chiang CT, 2018, CANCER LETT, V434, P152, DOI 10.1016/j.canlet.2018.07.025; Chowdhury PS, 2018, CANCER IMMUNOL RES, V6, P1375, DOI 10.1158/2326-6066.CIR-18-0095; Chowdhury SKR, 2012, BRAIN, V135, P1751, DOI 10.1093/brain/aws097; Corazao-Rozas P, 2016, ONCOTARGET, V7, P39473, DOI 10.18632/oncotarget.7790; Corazao-Rozas P, 2013, ONCOTARGET, V4, P1986, DOI 10.18632/oncotarget.1420; Costa A, 2019, MATER RES PROC, V14, P1, DOI 10.21741/9781644900413-1; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Czajka A, 2016, REDOX BIOL, V10, P100, DOI 10.1016/j.redox.2016.09.007; Demaria M, 2014, INT J CANCER, V135, P1997, DOI 10.1002/ijc.28767; Denise C, 2015, ONCOTARGET, V6, P41706, DOI 10.18632/oncotarget.5991; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; Dhingra R, 2014, P NATL ACAD SCI USA, V111, pE5537, DOI 10.1073/pnas.1414665111; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Diers AR, 2012, BIOCHEM J, V444, P561, DOI 10.1042/BJ20120294; Divakaruni AS, 2018, CELL METAB, V28, P490, DOI 10.1016/j.cmet.2018.06.001; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Feng LR, 2010, CNS DRUGS, V24, P177, DOI 10.2165/11533740-000000000-00000; Fern R, 2003, J NEUROSCI RES, V71, P759, DOI 10.1002/jnr.10553; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Fiorillo M, 2017, ONCOTARGET, V8, P20309, DOI 10.18632/oncotarget.15852; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Fortini P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.50; Germain N, 2019, INT J MED SCI, V16, P931, DOI 10.7150/ijms.32413; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gong GR, 2003, AM J PHYSIOL-HEART C, V285, pH541, DOI 10.1152/ajpheart.01142.2002; Goo CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045806; Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje; Guieze R, 2019, CANCER CELL, V36, P369, DOI 10.1016/j.ccell.2019.08.005; Mentesana GG, 2014, ARCH MED RES, V45, P237, DOI 10.1016/j.arcmed.2014.03.003; Hemachandra LPMP, 2015, CANCER RES, V75, P4973, DOI 10.1158/0008-5472.CAN-14-3799; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Holley AK, 2013, MITOCHONDRION, V13, P170, DOI 10.1016/j.mito.2012.07.104; Huang A, 2016, CANCER LETT, V377, P149, DOI 10.1016/j.canlet.2016.04.040; James AD, 2015, J BIOL CHEM, V290, P24760, DOI 10.1074/jbc.M115.668707; Jitschin R, 2014, BLOOD, V123, P2663, DOI 10.1182/blood-2013-10-532200; Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x; Jones CL, 2018, CANCER CELL, V34, P724, DOI 10.1016/j.ccell.2018.10.005; Karunanithi S, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-382; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; Kim H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102093; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Le Grand M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45136; Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33667-6; Li C, 2013, FREE RADICAL BIO MED, V60, P29, DOI 10.1016/j.freeradbiomed.2013.01.013; Li CX, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0769-9; Li T, 2019, PROTEIN CELL, V10, P583, DOI 10.1007/s13238-019-0618-z; Li XL, 2017, ONCOTARGET, V8, P46363, DOI 10.18632/oncotarget.18199; Li XR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05086-6; Lopes-Rodrigues V, 2017, SCI REP-UK, V7, DOI 10.1038/srep44541; Malinarich F, 2015, J IMMUNOL, V194, P5174, DOI 10.4049/jimmunol.1303316; Marchetti P, 2018, BBA-GEN SUBJECTS, V1862, P999, DOI 10.1016/j.bbagen.2018.01.018; Marchetti P, 2014, CURR CANCER DRUG TAR, V14, P357, DOI 10.2174/1568009614666140407113124; Marin TL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf7478; Maryanovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8901; Masgras I, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00058; Matassa DS, 2016, CELL DEATH DIFFER, V23, P1542, DOI 10.1038/cdd.2016.39; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Mims J, 2015, RADIAT RES, V183, P291, DOI 10.1667/RR13828.1; Mouradian M, 2015, MOL CARCINOGEN, V54, P810, DOI 10.1002/mc.22151; Nannelli G, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9765027; Nguyen HM, 2016, J NEUROCHEM, V139, P68, DOI 10.1111/jnc.13753; Nguyen QL, 2018, JCI INSIGHT, V2, P1; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nickens KP, 2013, MITOCHONDRION, V13, P662, DOI 10.1016/j.mito.2013.09.005; Oizel K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.13; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Paulus A, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.40; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Pollyea DA, 2018, NAT MED, V24, P1859, DOI 10.1038/s41591-018-0233-1; Prabhu A, 2015, NEURO-ONCOLOGY, V17, P1220, DOI 10.1093/neuonc/nou369; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Rincon M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061656; Sandulache VC, 2011, CANCER, V118, P711; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Sciacovelli M, 2013, CELL METAB, V17, P988, DOI 10.1016/j.cmet.2013.04.019; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shen H, 2015, MOL CANCER THER, V14, P1794, DOI 10.1158/1535-7163.MCT-15-0247; Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408; Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112; Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Takahashi H, 2017, ONCOGENE, V36, P4267, DOI 10.1038/onc.2017.59; Teh JT, 2019, MOL CANCER THER, V18, P693, DOI 10.1158/1535-7163.MCT-18-0766; Trotta AP, 2017, J BIOL CHEM, V292, P11727, DOI 10.1074/jbc.M117.786442; Untereiner AA, 2018, BIOCHEM PHARMACOL, V149, P174, DOI 10.1016/j.bcp.2017.10.007; Valcarcel-Jimenez L, 2017, TRENDS ENDOCRIN MET, V28, P748, DOI 10.1016/j.tem.2017.06.004; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu L, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0217-2; Xie DY, 2016, ONCOTARGET, V7, P11609, DOI 10.18632/oncotarget.7018; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zdralevic Masa, 2018, Advances in Biological Regulation, V68, P55, DOI 10.1016/j.jbior.2017.12.002; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; ZHANG Q, 2016, BLOOD, V128	129	51	51	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13106	13124		10.1096/fj.202000767R	http://dx.doi.org/10.1096/fj.202000767R		AUG 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32808332				2022-12-28	WOS:000563082600001
J	Chen, XW; Liu, WT; Xiao, J; Zhang, Y; Chen, YH; Luo, CW; Huang, QY; Peng, FF; Gong, WQ; Li, ST; He, XY; Zhuang, YY; Wu, N; Liu, YX; Wang, YX; Long, HB				Chen, Xiaowen; Liu, Wenting; Xiao, Jing; Zhang, Ying; Chen, Yihua; Luo, Congwei; Huang, Qianyin; Peng, Fenfen; Gong, Wangqiu; Li, Shuting; He, Xiaoyang; Zhuang, Yiyi; Wu, Na; Liu, Yanxia; Wang, Yuxian; Long, Haibo			FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury	FASEB JOURNAL			English	Article						autophagic degradation; diabetic nephropathy; FOXO3a; oxidative stress; podocyte injury	DIABETIC-NEPHROPATHY; TRANSCRIPTION FACTORS; INDUCED APOPTOSIS; KIDNEY-DISEASE; AUTOPHAGY; PROTECTS; RECEPTOR; PROGRESSION; INHIBITION; DELETION	Podocyte injury is the primary cause of glomerular injury in diabetic nephropathy (DN). Advanced oxidation protein products (AOPPs), the triggers and markers of oxidative stress in DN, have been linked to podocyte damage. However, the underlying mechanism is not yet clear. Here, we investigated the potential role of FOXO3a, a key transcription factor in the response to stress, in mediating AOPPs-induced podocyte injury. We found that FOXO3a expression was increased in the glomeruli of kidney biopsies from patients with DN and it was positively correlated with proteinuria. The serum from patients with DN significantly increased FOXO3a and its downstream genes FasL and Bim, thereby inducing the high level of cleaved caspase3 and the loss of nephrin and podocin expressions in podocytes. Blockade of AOPPs signaling by a neutralizing antibody against the receptor of advanced glycation end products (alpha RAGE) abolished the effect of DN serum on podocytes, confirming the pathogenic role of AOPPs in DN serum. Downregulation of FOXO3a decreased AOPPs-induced podocyte apoptosis and restored the levels of podocyte markers nephrin and podocin, and upregulation of FOXO3a exacerbated these changes in podocytes after AOPPs treatment. Furthermore, FOXO3a specifically activated proapoptotic genes in podocytes only in the presence of AOPPs. Mechanistically, AOPPs increased the FOXO3a protein levels by inhibiting their autophagic degradation in a ROS/mTOR-dependent manner. Moreover AOPPs activated the accumulated FOXO3a by maintaining FOXO3a in the nucleus, and this process was dependent on ROS-mediated AKT signaling deactivation. These studies suggest that FOXO3a plays a critical role in mediating AOPPs-induced podocyte injury and reveal a new mechanistic linkage of oxidative stress, FOXO3a activation and podocyte injury in DN.	[Chen, Xiaowen; Liu, Wenting; Xiao, Jing; Chen, Yihua; Luo, Congwei; Huang, Qianyin; Peng, Fenfen; Gong, Wangqiu; Li, Shuting; He, Xiaoyang; Zhuang, Yiyi; Wu, Na; Long, Haibo] Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Guangzhou 510280, Peoples R China; [Zhang, Ying] Guangzhou Med Univ, Dept Nephrol, Affiliated Hosp 2, Guangzhou, Peoples R China; [Liu, Yanxia] Southern Med Univ, Zhujiang Hosp, Dept Lab Med, Guangzhou 510280, Peoples R China; [Wang, Yuxian] Southern Med Univ, Dept Gerontol, Zhujiang Hosp, Guangzhou 510280, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China; Southern Medical University - China	Long, HB (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Guangzhou 510280, Peoples R China.; Liu, YX (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Lab Med, Guangzhou 510280, Peoples R China.; Wang, YX (corresponding author), Southern Med Univ, Dept Gerontol, Zhujiang Hosp, Guangzhou 510280, Peoples R China.	yanxialiu2015@163.com; 305833465@qq.com; longhb@smu.edu.cn			National Natural Science Foundation of China (NSFC) [81673792, 81600624, 81704134, 81873346, U1801288, 81900607]; China Postdoctoral Science Foundation [2019M663004]; Joint Fund of Basic and Applied Basic Research of Guangdong Province, China [2019A1515110049]; Natural Science Foundation of Guangdong Province, China [2017A030313708, 2019A1515011083, 2020A1515011295]; Science and Technology Planning Project of Guangdong Province, China [2017A020215158]; Science and Technology Planning Project of Guangzhou, China [201707010286]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Joint Fund of Basic and Applied Basic Research of Guangdong Province, China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China; Science and Technology Planning Project of Guangzhou, China	This work was supported by the National Natural Science Foundation of China (NSFC) (no. 81673792, no. 81600624, no. 81704134, no. 81873346, no. U1801288, and no. 81900607), the 66th Batch of China Postdoctoral Science Foundation (no. 2019M663004), the Joint Fund of Basic and Applied Basic Research of Guangdong Province, China (no. 2019A1515110049), the Natural Science Foundation of Guangdong Province, China (no. 2017A030313708, no. 2019A1515011083, and no. 2020A1515011295), Science and Technology Planning Project of Guangdong Province, China (no. 2017A020215158), and Science and Technology Planning Project of Guangzhou, China (no. 201707010286).	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Audesse AJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008097; Bai XY, 2018, FREE RADICAL BIO MED, V118, P71, DOI 10.1016/j.freeradbiomed.2018.02.020; Chang ZS, 2019, AGING CELL, V18, DOI 10.1111/acel.12990; Chuang PY, 2017, AM J PHYSIOL-RENAL, V313, pF621, DOI 10.1152/ajprenal.00255.2017; Conti G, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100675; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; Dong HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00044; Eleftheriadis T, 2018, INT UROL NEPHROL, V50, P179, DOI 10.1007/s11255-017-1733-5; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fitzwalter BE, 2018, DEV CELL, V44, P555, DOI 10.1016/j.devcel.2018.02.014; Fu BB, 2017, BIOCHEM BIOPH RES CO, V486, P198, DOI 10.1016/j.bbrc.2017.03.027; Gao N, 2015, MOL CELL BIOCHEM, V398, P217, DOI 10.1007/s11010-014-2221-1; Gong W, 2016, INT J BIOCHEM CELL B, V78, P75, DOI 10.1016/j.biocel.2016.07.005; Han YC, 2018, REDOX BIOL, V16, P32, DOI 10.1016/j.redox.2018.02.013; Hinz N, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0450-3; Ilatovskaya DV, 2018, J AM SOC NEPHROL, V29, P1917, DOI 10.1681/ASN.2018030280; Jha JC, 2016, ANTIOXID REDOX SIGN, V25, P657, DOI 10.1089/ars.2016.6664; Jha JC, 2016, DIABETOLOGIA, V59, P379, DOI 10.1007/s00125-015-3796-0; Katsoulieris EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158873; Lee CG, 2014, KIDNEY INT, V86, P943, DOI 10.1038/ki.2014.117; Lee SR, 2020, BIOMOL THER, V28, P25, DOI 10.4062/biomolther.2019.188; Lenoir O, 2015, AUTOPHAGY, V11, P1130, DOI 10.1080/15548627.2015.1049799; Li DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132998; Li L, 2019, J CLIN INVEST, V129, P2374, DOI 10.1172/JCI122256; Li L, 2017, J BIOL CHEM, V292, P13774, DOI 10.1074/jbc.M117.791483; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Link W, 2019, METHODS MOL BIOL, V1890, P1, DOI 10.1007/978-1-4939-8900-3_1; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsui T, 2017, DIABETES, V66, P1683, DOI 10.2337/db16-1281; Qi W, 2017, NAT MED, V23, P753, DOI 10.1038/nm.4328; Raij L, 2016, AM J PHYSIOL-RENAL, V311, pF1308, DOI 10.1152/ajprenal.00162.2016; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Song S, 2019, J CELL PHYSIOL, V234, P16485, DOI 10.1002/jcp.28317; Sun JP, 2018, J CELL BIOCHEM, V119, P7166, DOI 10.1002/jcb.26771; Tao GZ, 2013, J BIOL CHEM, V288, P17214, DOI 10.1074/jbc.M112.445965; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Tia N, 2018, GENE, V648, P97, DOI 10.1016/j.gene.2018.01.051; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang F, 2015, AM J OBSTET GYNECOL, V213, P125, DOI 10.1016/j.ajog.2015.01.016; Wang F, 2012, P NATL ACAD SCI USA, V109, P6078, DOI 10.1073/pnas.1119073109; Wang XM, 2014, AM J PHYSIOL-RENAL, V306, pF205, DOI 10.1152/ajprenal.90005.2013; Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; XU LI, 2016, CELL DEATH DIS, V7; Yang DY, 2018, CELL MOL LIFE SCI, V75, P669, DOI 10.1007/s00018-017-2639-1; Ye H, 2014, J DIABETES COMPLICAT, V28, P96, DOI 10.1016/j.jdiacomp.2013.08.006; Yu-Shengyou, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/326986; Zhang SS, 2017, BIOCHEM BIOPH RES CO, V482, P1413, DOI 10.1016/j.bbrc.2016.12.050; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhao XC, 2018, J PATHOL, V245, P235, DOI 10.1002/path.5077; Zhao XY, 2019, SCI TOTAL ENVIRON, V646, P1047, DOI 10.1016/j.scitotenv.2018.07.363; Zhou LL, 2012, KIDNEY INT, V82, P759, DOI 10.1038/ki.2012.184; Zhou LL, 2009, KIDNEY INT, V76, P1148, DOI 10.1038/ki.2009.322; Zhou LL, 2019, KIDNEY INT, V95, P830, DOI 10.1016/j.kint.2018.10.032	55	12	13	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13300	13316		10.1096/fj.202000783R	http://dx.doi.org/10.1096/fj.202000783R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32786113				2022-12-28	WOS:000561322800001
J	Yan, CG; Zhang, LQ; Yang, L; Zhang, Q; Wang, XM				Yan, Chunguang; Zhang, Lanqiu; Yang, Lei; Zhang, Qi; Wang, Ximo			C/EBP gamma is a critical negative regulator of LPS-/IgG immune complex-induced acute lung injury through the downregulation of C/EBP beta-/C/EBP delta-dependent C/EBP transcription activation	FASEB JOURNAL			English	Article						acute lung injury; C/EBP beta; C/EBP gamma; C/EBP delta	BINDING-PROTEIN-BETA; DNA-BINDING; LEUCINE ZIPPER; GENE-EXPRESSION; IL-6; LIPOPOLYSACCHARIDE; HETERODIMERIZATION; OVEREXPRESSION; SPECIFICITY; INDUCTION	Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome are life-threatening diseases. Despite recent advances in intensive care medicine, the mortality is still as high as 50%, which stems from our insufficient understanding of the underlying mechanisms of the diseases. The roles of C/EBP beta and C/EBP delta have been extensively investigated in LPS- and IgG immune complexes-stimulated acute lung injury. However, the effect of C/EBP gamma, belonging to the same family as C/EBP beta and C/EBP delta, on ALI has not been elucidated. Our previous data have shown that during LPS-/IgG immune complexes-induced ALI, the DNA binding activities of C/EBP gamma are obviously reduced. In the present study, we determine whether ALI induced by LPS and IgG immune complexes is affected by C/EBP gamma. We find that adenovirus-mediated C/EBP gamma expression in the lung tissue alleviates LPS-/IgG immune complexes-stimulated acute pulmonary damage through reducing vascular permeability changes and recruitment of neutrophils into alveolar spaces, which might be linked to a decrease in the production of pro-inflammatory mediators, such as TNF-alpha and IL-6. Moreover, our data obtained from macrophages in vitro are consistent with the in vivo results. In terms of mechanisms, C/EBP gamma might inhibit LPS-/IgG immune complexes-mediated inflammation via alleviating C/EBP beta and C/EBP delta transcription activities as reflected by luciferase assays. However, the NF-kappa B-dependent production of pro-inflammatory mediators is not affected by C/EBP gamma. Taken together, C/EBP gamma suppresses LPS- and IgG immune complexes-induced pro-inflammatory mediators' production through the downregulation of C/EBP but not NF-kappa B activation, leading to the subsequent attenuation of ALI. Collectively, our data provide an insight into the critical role of C/EBP gamma in acute lung injury.	[Yan, Chunguang] Southeast Univ, Dept Pathogen Biol & Immunol, Med Sch, Nanjing 210009, Peoples R China; [Yan, Chunguang] Harvard Med Sch, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Zhang, Lanqiu; Yang, Lei; Zhang, Qi] Tianjin Univ, Tianjin Nankai Hosp, Inst Integrated Tradit Chinese & Western Med, Tianjin, Peoples R China; [Wang, Ximo] Tianjin Univ, Tianjin Nankai Hosp, Dept Surg, 6 Changjiang Rd, Tianjin 300100, Peoples R China	Southeast University - China; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tianjin University; Tianjin University	Yan, CG (corresponding author), Southeast Univ, Dept Pathogen Biol & Immunol, Med Sch, Nanjing 210009, Peoples R China.; Wang, XM (corresponding author), Tianjin Univ, Tianjin Nankai Hosp, Dept Surg, 6 Changjiang Rd, Tianjin 300100, Peoples R China.	ycgagcy@163.com; wangximo@126.com	Yan, Chunguang/ABE-5021-2021		National Natural Science Foundation of China [81971858, 31400751]; Natural Science Foundation of Tianjin City [19JCZDJC36200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin)	This project is funded by the National Natural Science Foundation of China (grant numbers 81971858, 31400751), and the Natural Science Foundation of Tianjin City (grant number 19JCZDJC36200).	AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Didon L, 2011, AM J RESP CRIT CARE, V184, P233, DOI 10.1164/rccm.201007-1113OC; Dooher JE, 2011, MOL CANCER RES, V9, P1395, DOI 10.1158/1541-7786.MCR-11-0072; Duitman J, 2012, J INFECT DIS, V206, P1826, DOI 10.1093/infdis/jis615; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao HW, 2004, J IMMUNOL, V172, P7703, DOI 10.4049/jimmunol.172.12.7703; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; He L, 2002, J BIOL CHEM, V277, P43572, DOI 10.1074/jbc.M204535200; Hu B, 2007, J PATHOL, V211, P455, DOI 10.1002/path.2119; Huggins CJ, 2016, MOL CELL BIOL, V36, P693, DOI 10.1128/MCB.00911-15; Huggins CJ, 2013, MOL CELL BIOL, V33, P3242, DOI 10.1128/MCB.01674-12; Kaisho T, 1999, J EXP MED, V190, P1573, DOI 10.1084/jem.190.11.1573; Kardosova M, 2018, HAEMATOLOGICA, V103, pE331, DOI 10.3324/haematol.2017.173781; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lu YB, 2001, J EXP MED, V193, P545, DOI 10.1084/jem.193.4.545; Parkin SE, 2002, J BIOL CHEM, V277, P23563, DOI 10.1074/jbc.M202184200; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Schwartz C, 2000, J VIROL, V74, P65, DOI 10.1128/JVI.74.1.65-73.2000; Thompson LC, 2016, AM J PHYSIOL-LUNG C, V310, pL142, DOI 10.1152/ajplung.00384.2014; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; Wall L, 1996, J BIOL CHEM, V271, P16477, DOI 10.1074/jbc.271.28.16477; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yan CG, 2019, MOL IMMUNOL, V111, P95, DOI 10.1016/j.molimm.2019.04.013; Yan CG, 2018, MOL IMMUNOL, V101, P585, DOI 10.1016/j.molimm.2018.05.004; Yan CG, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9201604; Yan CG, 2013, FASEB J, V27, P2967, DOI 10.1096/fj.12-225797; Yan CG, 2013, AM J PATHOL, V182, P420, DOI 10.1016/j.ajpath.2012.10.013; Yan CG, 2012, J IMMUNOL, V189, P1480, DOI 10.4049/jimmunol.1200877; Yan CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035492; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Zafarana G, 2000, EMBO J, V19, P5856, DOI 10.1093/emboj/19.21.5856; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	38	2	3	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13696	13710		10.1096/fj.202001402R	http://dx.doi.org/10.1096/fj.202001402R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32786052				2022-12-28	WOS:000561322200001
J	Ross, AK; de Almeida, RC; Ramos, YFM; Li, JH; Meulenbelt, I; Guilak, F				Ross, Alison K.; de Almeida, Rodrigo Coutinho; Ramos, Yolande F. M.; Li, Jiehan; Meulenbelt, Ingrid; Guilak, Farshid			The miRNA-mRNA interactome of murine induced pluripotent stem cell-derived chondrocytes in response to inflammatory cytokines	FASEB JOURNAL			English	Article						induced pluripotent stem cell; inflammation; microRNA; RNA-sequencing; tissue engineering	HUMAN ARTICULAR CHONDROCYTES; TISSUE-ENGINEERED CARTILAGE; KNEE OSTEOARTHRITIS; MAMMALIAN MICRORNAS; EXPRESSION; TARGETS; INTERLEUKIN-1; INDUCTION; REDIFFERENTIATION; CHONDROGENESIS	Osteoarthritis (OA) is a degenerative joint disease, and inflammation within an arthritic joint plays a critical role in disease progression. Pro-inflammatory cytokines, specifically IL-1 and TNF-alpha, induce aberrant expression of catabolic and degradative enzymes and inflammatory cytokines in OA and result in a challenging environment for cartilage repair and regeneration. MicroRNAs (miRNAS) are small noncoding RNAs and are important regulatory molecules that act by binding to target messenger RNAs (mRNAs) to reduce protein synthesis and have been implicated in many diseases, including OA. The goal of this study was to understand the mechanisms of miRNA regulation of the transcriptome of tissue-engineered cartilage in response to IL-1 beta and TNF-alpha using an in vitro murine induced pluripotent stem cell (miPSC) model system. We performed miRNA and mRNA sequencing to determine the temporal and dynamic responses of genes to specific inflammatory cytokines as well as miRNAs that are differentially expressed (DE) in response to both cytokines or exclusively to IL-1 beta or TNF-alpha. Through integration of mRNA and miRNA sequencing data, we created networks of miRNA-mRNA interactions which may be controlling the response to inflammatory cytokines. Within the networks, hub miRNAs, miR-29b-3p, miR-17-5p, and miR-20a-5p, were identified. As validation of these findings, we found that delivery of miR-17-5p and miR-20a-5p mimics significantly decreased degradative enzyme activity levels while also decreasing expression of inflammation-related genes in cytokine-treated cells. This study utilized an integrative approach to determine the miRNA interactome controlling the response to inflammatory cytokines and novel mediators of inflammation-driven degradation in tissue-engineered cartilage.	[Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA; [Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Shriners Hosp Children, St Louis, MO USA; [Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO 63110 USA; [de Almeida, Rodrigo Coutinho; Ramos, Yolande F. M.; Meulenbelt, Ingrid] Leiden Univ, Dept Biomed Data Sci, Sect Mol Epidemiol, Med Ctr, Leiden, Netherlands	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Guilak, F (corresponding author), Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA.	guilak@wustl.edu	Meulenbelt, Ingrid/F-4756-2011; Ramos, Yolande F. M./C-3774-2018	Meulenbelt, Ingrid/0000-0001-7786-7081; Ross, Alison/0000-0003-2563-220X; Ramos, Yolande F. M./0000-0003-1459-413X; Li, Jiehan/0000-0002-0528-5303	Nancy Taylor Foundation for Chronic Diseases; Arthritis Foundation; NIH [AG46927, AG15768, AR76820, P30 AR74992, P30 AR073752]; Philip and Sima Needleman Fellowship for Regenerative Medicine from the Washington University Center of Regenerative Medicine; NSF Graduate Research Fellowship Program [DGE-1745038]; Bioinformatics Research Core at the Washington University Center of Regenerative Medicine	Nancy Taylor Foundation for Chronic Diseases; Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip and Sima Needleman Fellowship for Regenerative Medicine from the Washington University Center of Regenerative Medicine; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Bioinformatics Research Core at the Washington University Center of Regenerative Medicine	This study was supported in part by the Nancy Taylor Foundation for Chronic Diseases, the Arthritis Foundation, NIH (AG46927, AG15768, AR76820, P30 AR74992, P30 AR073752), the Philip and Sima Needleman Fellowship for Regenerative Medicine from the Washington University Center of Regenerative Medicine, and the NSF Graduate Research Fellowship Program (DGE-1745038). Funding for this project and technical support was also provided by the Bioinformatics Research Core at the Washington University Center of Regenerative Medicine. We sincerely thank Sara Oswald for editorial assistance and Dr Audrey McAlinden for advice and discussion on this study.	Adkar SS, 2017, TRENDS MOL MED, V23, P917, DOI 10.1016/j.molmed.2017.08.002; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Asahara Hiroshi, 2016, J Bone Metab, V23, P121, DOI 10.11005/jbm.2016.23.3.121; Bai XD, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9450240; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bastiaansen-Jenniskens Y., 2017, CARTILAGE, V2, P81, DOI [10.1007/978-3-319-45803-8_5, DOI 10.1007/978-3-319-45803-8_5]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brunger JM, 2017, STEM CELL REP, V8, P1202, DOI 10.1016/j.stemcr.2017.03.022; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cisternas MG, 2016, ARTHRIT CARE RES, V68, P574, DOI 10.1002/acr.22721; Cong L, 2017, OSTEOARTHR CARTILAGE, V25, P1362, DOI 10.1016/j.joca.2017.03.012; Crowe N, 2016, OSTEOARTHR CARTILAGE, V24, P534, DOI 10.1016/j.joca.2015.10.002; de Almeida RC, 2019, ANN RHEUM DIS, V78, P270, DOI 10.1136/annrheumdis-2018-213882; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fioravanti A, 2009, RHEUMATOL INT, V29, P961, DOI 10.1007/s00296-009-0872-0; Fisch KM, 2018, OSTEOARTHR CARTILAGE, V26, P1531, DOI 10.1016/j.joca.2018.07.012; Furman BD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4591; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Goldring MB, 2015, CURR OPIN PHARMACOL, V22, P51, DOI 10.1016/j.coph.2015.03.004; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Grunke M, 2006, ANN RHEUM DIS, V65, P555, DOI 10.1136/ard.2006.053272; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Haseeb A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15388-4; Hong E, 2013, TISSUE ENG PT A, V19, P1015, DOI [10.1089/ten.tea.2012.0055, 10.1089/ten.TEA.2012.0055]; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kraus VB, 2012, OSTEOARTHR CARTILAGE, V20, P271, DOI 10.1016/j.joca.2011.12.009; Kriegsmann M, 2016, VIRCHOWS ARCH, V469, P93, DOI 10.1007/s00428-016-1939-4; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Le LTT, 2016, J MOL MED, V94, P583, DOI 10.1007/s00109-015-1374-z; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loeser RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054633; Lofgren M, 2018, RES VET SCI, V118, P466, DOI 10.1016/j.rvsc.2018.04.013; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matthews GL, 2011, EXPERT OPIN EMERG DR, V16, P479, DOI 10.1517/14728214.2011.576670; McAlinden A, 2018, J ORTHOP RES, V36, P33, DOI 10.1002/jor.23822; McAlinden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075012; Meng S, 2019, FOOD CHEM X, V1, DOI 10.1016/j.fochx.2019.100004; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Moutos FT, 2016, P NATL ACAD SCI USA, V113, pE4513, DOI 10.1073/pnas.1601639113; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Ousema PH, 2012, BIOMATERIALS, V33, P8967, DOI 10.1016/j.biomaterials.2012.08.045; Philippe L, 2013, ANN RHEUM DIS, V72, P1071, DOI 10.1136/annrheumdis-2012-201654; Philippe L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00070; Ratneswaran A, 2020, CURR OPIN RHEUMATOL, V32, P80, DOI 10.1097/BOR.0000000000000680; Shen J, 2017, CONNECT TISSUE RES, V58, P49, DOI 10.1080/03008207.2016.1208655; Soul J, 2018, ANN RHEUM DIS, V77, P423, DOI 10.1136/annrheumdis-2017-212603; Soyocak A, 2017, GENE, V627, P207, DOI 10.1016/j.gene.2017.06.027; Steinberg J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09335-6; Svala E, 2015, CONNECT TISSUE RES, V56, P315, DOI 10.3109/03008207.2015.1027340; Swingler TE, 2019, CLIN EXP RHEUMATOL, V37, P40; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; van den Berg WB, 1999, CLIN EXP RHEUMATOL, V17, pS105; Vicente R, 2016, NAT REV RHEUMATOL, V12, P211, DOI 10.1038/nrrheum.2015.162; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Willard VP, 2014, ARTHRITIS RHEUMATOL, V66, P3062, DOI 10.1002/art.38780; Wilusz RE, 2008, J ORTHOP RES, V26, P504, DOI 10.1002/jor.20538; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404; Zhang DW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12775	75	9	9	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11546	11561		10.1096/fj.202000889R	http://dx.doi.org/10.1096/fj.202000889R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32767602	Green Accepted, Green Published			2022-12-28	WOS:000558272000001
J	Lin, Y; Zheng, J; Li, Q; Ao, X; Yue, Z				Lin, Yu; Wen-jie, Zheng; Chang-qing, Li; Sheng-xiang, Ao; Yue, Zhou			mir-22-3p/KLF6/MMP14 axis in fibro-adipogenic progenitors regulates fatty infiltration in muscle degeneration	FASEB JOURNAL			English	Article						adipogenesis; FAP; KLF6; mir-22-3p; muscle injury	FIBRO/ADIPOGENIC PROGENITORS; ADIPOCYTE DIFFERENTIATION; TUMOR-SUPPRESSOR; STEM-CELLS; PROMOTES; PATHWAY; PROLIFERATION; INVASION; OBESITY; ACTS	Fibro/adipogenic progenitors (FAPs) are the main cellular source of fatty degeneration in muscle injury; however, the underlying mechanism of FAP adipogenesis in muscle degeneration needs to be further examined. Matrix metalloproteinase 14 (MMP-14) has been reported to induce the adipogenesis of 3T3-L1 preadipocytes, but whether MMP-14 also regulates the differentiation of FAPs remains unclear. To investigate whether and how MMP-14 regulates FAP adipogenesis and fatty infiltration in muscle degeneration, we examined MMP-14 expression in degenerative muscles and tested the effect of MMP-14 on FAP adipogenesis in vitro and in vivo. As expected, MMP-14 enhanced FAP adipogenesis and fatty infiltration in degenerative muscles; moreover, blocking endogenous MMP-14 in injured muscles facilitated muscle repair. Further investigations revealed that Kruppel-like factor 6 (KLF6) was a transcription factor associated with MMP-14 and acted as an "on-off" switch in the differentiation of FAPs into adipocytes or myofibroblasts. Moreover, KLF6 was the target gene of miR-22-3p, which was downregulated during FAP adipogenesis both in vitro and in vivo, and overexpression of miR-22-3p markedly prevented FAP adipogenesis and attenuated fatty degeneration in muscles. Our study revealed that miR-22-3p/KLF6/MMP-14 is a novel pathway in FAP adipogenesis and that inhibiting KLF6 is a potential strategy for the treatment of muscular degenerative diseases.	[Lin, Yu; Wen-jie, Zheng; Chang-qing, Li; Sheng-xiang, Ao; Yue, Zhou] Army Med Univ, Affiliated Xinqiao Hosp 2, Dept Orthopaed, Chongqing 400038, Peoples R China	Army Medical University	Yue, Z (corresponding author), Army Med Univ, Affiliated Xinqiao Hosp 2, Dept Orthopaed, Chongqing 400038, Peoples R China.	happyzhou@vip.163.com			National Natural Science Foundation of China (NSFC) [81672215]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The research reported was supported by the National Natural Science Foundation of China (NSFC, No. 81672215).	Acharya A, 2019, GENE DEV, V33, P1367, DOI 10.1101/gad.328955.119; BOSCO DB, 2017, PLOS ONE, V12, DOI DOI 10.1371/journal.pone.0172925; Chen FF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102101; Chun TH, 2010, DIABETES, V59, P2484, DOI 10.2337/db10-0073; Dai ZY, 2019, FRONT BIOSCI-LANDMRK, V24, P1350, DOI 10.2741/4783; Diniz GP, 2017, CLIN SCI, V131, P2885, DOI 10.1042/CS20171368; Dong JL, 2017, KIDNEY INT, V91, P119, DOI 10.1016/j.kint.2016.07.029; Dong YJ, 2014, FASEB J, V28, P4123, DOI 10.1096/fj.14-254011; Fan Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24183379; Fiore D, 2016, STEM CELL RES, V17, P161, DOI 10.1016/j.scr.2016.06.007; Fiore D, 2016, J CLIN ENDOCR METAB, V101, P1525, DOI 10.1210/jc.2015-4252; He AD, 2017, ONCOTARGET, V8, P87174, DOI 10.18632/oncotarget.19912; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Huang XW, 2019, TOXICOL APPL PHARM, V385, DOI 10.1016/j.taap.2019.114815; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kang X, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0251-0; Kopinke D, 2017, CELL, V170, P340, DOI 10.1016/j.cell.2017.06.035; Kurylowicz A, 2016, INT J OBESITY, V40, P1635, DOI 10.1038/ijo.2016.131; Liu XH, 2016, MLTJ-MUSCLE LIGAMENT, V6, P6, DOI 10.11138/mltj/2016.6.1.006; Ma J, 2014, J CEREBR BLOOD F MET, V34, P1826, DOI 10.1038/jcbfm.2014.152; Masotti A, 2017, PEDIATR OBES, V12, P229, DOI 10.1111/ijpo.12133; Matsuo H, 2015, BIOL PHARM BULL, V38, P1504, DOI 10.1248/bpb.b15-00257; Mueller AA, 2016, NATURE, V540, P276, DOI 10.1038/nature20160; Natarajan A, 2010, CELL CYCLE, V9, P2045, DOI 10.4161/cc.9.11.11854; Perri R, 2012, J DENT RES, V91, P33, DOI 10.1177/0022034511425045; Qi W, 2009, AM J PATHOL, V175, P1858, DOI 10.2353/ajpath.2009.090263; Ri KumChol, 2020, Microrna, V9, P64, DOI 10.2174/2211536608666190314122725; Song CC, 2019, J CELL PHYSIOL, V234, P15742, DOI 10.1002/jcp.28232; Syafruddin SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09116-x; Tian F, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12635; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Yang F, 2018, BIOMED PHARMACOTHER, V97, P616, DOI 10.1016/j.biopha.2017.10.136; Yang HY, 2019, J GASTRIC CANCER, V19, P460, DOI 10.5230/jgc.2019.19.e43; Yao YiKe, 2015, Chinese Journal of Hygienic Insecticides & Equipments, V21, P40; Yu FJ, 2017, J MOL MED, V95, P1191, DOI 10.1007/s00109-017-1586-5; Zhang DW, 2016, ONCOL REP, V36, P3657, DOI 10.3892/or.2016.5190; Zhang S, 2017, EUR REV MED PHARMACO, V21, P4542; Zhu YJ, 2014, ACTA BIOCH BIOPH SIN, V46, P590, DOI 10.1093/abbs/gmu036; Zou XZ, 2017, PULM PHARMACOL THER, V44, P70, DOI 10.1016/j.pupt.2017.03.012	42	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12691	12701		10.1096/fj.202000506R	http://dx.doi.org/10.1096/fj.202000506R		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33000497				2022-12-28	WOS:000556423000001
J	Tedeschi, V; Sisalli, MJ; Petrozziello, T; Canzoniero, LMT; Secondo, A				Tedeschi, Valentina; Sisalli, Maria Jose; Petrozziello, Tiziana; Canzoniero, Lorella Maria Teresa; Secondo, Agnese			Lysosomal calcium is modulated by STIM1/TRPML1 interaction which participates to neuronal survival during ischemic preconditioning	FASEB JOURNAL			English	Article						oxygen and glucose deprivation followed by reoxygenation; ischemic preconditioning; lysosome; ER interplay; neuronal survival; organellar Ca2+ homeostasis; primary cortical neurons; TRPML1	ENDOPLASMIC-RETICULUM; TRP CHANNEL; MOTOR-NEURONS; CA2+ RELEASE; AUTOPHAGY; ACTIVATION; TOXICITY; NCX3; EXOCYTOSIS; CLEARANCE	A robust activity of the lysosomal Ca2+ channel TRPML1 is sufficient to correct cellular defects in neurodegeneration. Importantly, lysosomes are refilled by the endoplasmic reticulum (ER). However, it is unclear how TRPML1 function could be modulated by the ER. Here, we deal with this issue in rat primary cortical neurons exposed to different oxygen conditions affecting neuronal survival. Under normoxic conditions, TRPML1: (1) showed a wide distribution within soma and along neuronal processes; (2) was stimulated by the synthetic agonist ML-SA1 and the analog of its endogenous modulator, PI(3,5)P-2 diC8; (3) its knockdown by siRNA strategy produced an ER Ca2+ accumulation; (4) co-localized and co-immunoprecipitated with the ER-located Ca2+ sensor stromal interacting molecule 1 (STIM1). In cortical neurons lacking STIM1, ML-SA1 and PI(3,5)P-2 diC8 failed to induce Ca2+ release and, more deeply, they induced a negligible Ca2+ passage through the channel in neurons transfected with the genetically encoded Ca2+ indicator GCaMP3-ML1. Moreover, TRPML1/STIM1 interplay changed at low-oxygen conditions: both proteins were downregulated during the ischemic preconditioning (IPC) while during IPC followed by 1 hour of normoxia, at which STIM1 is upregulated, TRPML1 protein was reduced. However, during oxygen and glucose deprivation (OGD) followed by reoxygenation, TRPML1 and STIM1 proteins peaked at 8 hours of reoxygenation, when the proteins were co-immunoprecipitated and reactive oxygen species (ROS) hyperproduction was measured in cortical neurons. This may lead to a persistent TRPML1 Ca2+ release and lysosomal Ca2+ loss. Collectively, we showed a new modulation exerted by STIM1 on TRPML1 activity that may differently intervene during hypoxia to regulate organellar Ca2+ homeostasis.	[Tedeschi, Valentina; Sisalli, Maria Jose; Petrozziello, Tiziana; Secondo, Agnese] Federico II Univ Naples, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Via S Pansini 5, I-80131 Naples, Italy; [Canzoniero, Lorella Maria Teresa] Univ Sannio, Dept Sci & Technol DST, Div Pharmacol, Benevento, Italy	University of Naples Federico II; University of Sannio	Secondo, A (corresponding author), Federico II Univ Naples, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Via S Pansini 5, I-80131 Naples, Italy.	secondo@unina.it	Secondo, Agnese/AAA-3407-2022; Petrozziello, Tiziana/GNM-6238-2022; Sisalli, Maria Josè Sisalli/AAB-8255-2022; Tedeschi, Valentina/GZL-0164-2022	Petrozziello, Tiziana/0000-0002-5487-1667; CANZONIERO, Lorella Maria Teresa/0000-0003-2255-5341; Tedeschi, Valentina/0000-0002-6540-4730				Atakpa P, 2018, CELL REP, V25, P3180, DOI 10.1016/j.celrep.2018.11.064; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Cao Q, 2017, J BIOL CHEM, V292, P8424, DOI 10.1074/jbc.M116.772160; Christensen KA, 2002, J CELL SCI, V115, P599; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Garrity AG, 2016, ELIFE, V5, DOI 10.7554/eLife.15887; Gomez NM, 2018, FASEB J, V32, P782, DOI 10.1096/fj.201700220RR; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hollerhage M, 2019, NEUROPHARMACOLOGY, V149, P13, DOI 10.1016/j.neuropharm.2019.01.023; Hui L, 2015, CELL CALCIUM, V58, P617, DOI 10.1016/j.ceca.2015.10.001; Jiang T, 2014, PHARMACOL RES, V81, P54, DOI 10.1016/j.phrs.2014.02.008; Kahlert S, 2004, CELL CALCIUM, V36, P295, DOI 10.1016/j.ceca.2004.02.009; Kilpatrick Bethan S, 2016, Messenger (Los Angel), V5, P76, DOI 10.1166/msr.2016.1059; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Lee JH, 2015, CELL REP, V12, P1430, DOI 10.1016/j.celrep.2015.07.050; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lopez-Sanjurjo CI, 2013, J CELL SCI, V126, P289, DOI 10.1242/jcs.116103; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; McLeod IX, 2012, IMMUNOL REV, V249, P195, DOI 10.1111/j.1600-065X.2012.01143.x; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Morgan AJ, 2020, CELL CALCIUM, V86, DOI 10.1016/j.ceca.2019.102139; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Petrozziello T, 2017, CELL DEATH DIFFER, V24, P511, DOI 10.1038/cdd.2016.154; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rosato AS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13572-w; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scorziello A, 2013, J CELL SCI, V126, P5566, DOI 10.1242/jcs.129668; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Secondo A, 2019, STROKE, V50, P1240, DOI 10.1161/STROKEAHA.118.024115; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Sirabella R, 2009, STROKE, V40, P922, DOI 10.1161/STROKEAHA.108.531962; Sisalli MJ, 2014, CELL DEATH DIFFER, V21, P1142, DOI 10.1038/cdd.2014.32; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Tedeschi V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46708-5; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Tsunemi T, 2019, J NEUROSCI, V39, P5760, DOI 10.1523/JNEUROSCI.3085-18.2019; Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910; Wang P, 2018, PROG NEUROBIOL, V163, P98, DOI 10.1016/j.pneurobio.2018.01.001; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zhang XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12109	45	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21277	10.1096/fj.202001886R	http://dx.doi.org/10.1096/fj.202001886R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484198	Bronze			2022-12-28	WOS:000647789600049
J	Ziani, W; Shao, JS; Fang, A; Connolly, PJ; Wang, XL; Veazey, RS; Xu, HB				Ziani, Widade; Shao, Jiasheng; Fang, Angela; Connolly, Patrick J.; Wang, Xiaolei; Veazey, Ronald S.; Xu, Huanbin			Mucosal integrin alpha 4 beta 7 blockade fails to reduce the seeding and size of viral reservoirs in SIV-infected rhesus macaques	FASEB JOURNAL			English	Article						&#945; 4&#946; 7; &#945; 4&#946; 1; HIV&#8208; 1; SIV; integrin; viral reservoir	SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; HIV-1 ENVELOPE; LYMPHOCYTE SUBSETS; DUAL ANTAGONIST; ALPHA(4)BETA(7); DNA; ANTIBODY; ACTIVATION; EXPRESSION	Cellular viral reservoirs are rapidly established in tissues upon HIV-1/SIV infection, which persist throughout viral infection, even under long-term antiretroviral therapy (ART). Specific integrins are involved in the homing of cells to gut-associated lymphoid tissues (GALT) and inflamed tissues, which may promote the seeding and dissemination of HIV-1/SIV to these tissue sites. In this study, we investigated the efficacy of prophylactic integrin blockade (alpha 4 beta 7 antibody or alpha 4 beta 7/alpha 4 beta 1 dual antagonist TR-14035) on viral infection, as well as dissemination and seeding of viral reservoirs in systemic and lymphoid compartments post-SIV inoculation. The results showed that blockade of alpha 4 beta 7/alpha 4 beta 1 did not decrease viral infection, replication, or reduce viral reservoir size in tissues of rhesus macaques after SIV infection, as indicated by equivalent levels of plasma viremia and cell-associated SIV RNA/DNA to controls. Surprisingly, TR-14035 administration in acute SIV infection resulted in consistently higher viremia and more rapid disease progression. These findings suggest that integrin blockade alone fails to effectively control viral infection, replication, dissemination, and reservoir establishment in HIV-1/SIV infection. The use of integrin blockade for prevention or/and therapeutic strategies requires further investigation.	[Ziani, Widade; Shao, Jiasheng; Fang, Angela; Connolly, Patrick J.; Wang, Xiaolei; Veazey, Ronald S.; Xu, Huanbin] Tulane Univ, Tulane Natl Primate Res Ctr, Sch Med, Covington, LA USA	Tulane University	Xu, HB (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, 18703 Three Rivers Rd, Covington, LA 70433 USA.	hxu@tulane.edu		Veazey, Ronald/0000-0002-6298-2391	NIAID NIH HHS [R01 AI099795, R01 AI147372] Funding Source: Medline; NICHD NIH HHS [R01 HD099857] Funding Source: Medline; NIDCR NIH HHS [R01 DE025432] Funding Source: Medline; NIH HHS [P51 OD011104] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abbink P, 2019, SCIENCE, V365, P1029, DOI 10.1126/science.aaw8562; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Arrode-Bruses G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005720; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bachmann N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10884-9; Baiula M, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00489; Baxter AE, 2016, CELL HOST MICROBE, V20, P368, DOI 10.1016/j.chom.2016.07.015; Brodin J, 2016, ELIFE, V5, DOI 10.7554/eLife.18889; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Calenda G, 2018, J IMMUNOL, V200, P810, DOI 10.4049/jimmunol.1701150; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; Chand S, 2017, VIROLOGY, V508, P199, DOI 10.1016/j.virol.2017.05.016; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cillo AR, 2018, AIDS, V32, P699, DOI [10.1097/QAD.0000000000001748, 10.1097/qad.0000000000001748]; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Cortijo J, 2006, BRIT J PHARMACOL, V147, P661, DOI 10.1038/sj.bjp.0706658; De Spiegelaere W, 2014, CLIN CHEM, V60, P886, DOI 10.1373/clinchem.2013.219378; DEAN DC, 1993, AM REV RESPIR DIS, V148, pS43, DOI 10.1164/ajrccm/148.6_Pt_2.S43; Deleage C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7116; DeNucci CC, 2010, J IMMUNOL, V184, P2458, DOI 10.4049/jimmunol.0902407; Di Mascio M, 2019, SCIENCE, V365, P1025, DOI 10.1126/science.aav6695; Dubois N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00527; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Guzzo C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam7341; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hong FY, 2016, J CLIN MICROBIOL, V54, P902, DOI 10.1128/JCM.02904-15; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Iwamoto N, 2019, SCIENCE, V365, P1033, DOI 10.1126/science.aaw7765; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kiselinova M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005472; Kostrikis LG, 2002, J VIROL, V76, P10099, DOI 10.1128/JVI.76.20.10099-10108.2002; Lee M, 2016, J MED PRIMATOL, V45, P215, DOI 10.1111/jmp.12244; Lertjuthaporn S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007278; Li H, 2018, EXPERT OPIN THER PAT, V28, P903, DOI 10.1080/13543776.2018.1549227; Li W, 2008, GLYCOBIOLOGY, V18, P114, DOI 10.1093/glycob/cwm107; Ling LJ, 2019, AIDS, V33, pF1, DOI 10.1097/QAD.0000000000002149; Lord JD, 2018, CLIN IMMUNOL, V193, P24, DOI 10.1016/j.clim.2018.05.006; Lu CL, 2018, P NATL ACAD SCI USA, V115, pE11341, DOI 10.1073/pnas.1813512115; Martin-Blondel G, 2015, EUR J IMMUNOL, V45, P3302, DOI 10.1002/eji.201545632; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; Mavigner M, 2016, J VIRUS ERAD, V2, P219; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Nawaz F, 2018, MUCOSAL IMMUNOL, V11, P1342, DOI 10.1038/s41385-018-0044-1; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nishimura Y, 2009, P NATL ACAD SCI USA, V106, P8015, DOI 10.1073/pnas.0903022106; Nolte MA, 2020, BLOOD, V135, P7, DOI 10.1182/blood.2019003336; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Okoye AA, 2018, NAT MED, V24, P1430, DOI 10.1038/s41591-018-0130-7; Pardons M, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007619; Pasternak AO, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0397-2; Pasternak AO, 2016, J VIROL, V90, P1148, DOI 10.1128/JVI.02597-15; Pasternak AO, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-41; Pauls E, 2009, AIDS, V23, P266, DOI 10.1097/QAD.0b013e328320a7f8; Pereira LE, 2009, CELL IMMUNOL, V259, P165, DOI 10.1016/j.cellimm.2009.06.012; Policicchio BB, 2018, J VIROL, V92, DOI 10.1128/JVI.02100-17; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Rouzioux C, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0412-7; Sandborn WJ, 2019, GASTROENTEROLOGY; Santangelo PJ, 2018, MUCOSAL IMMUNOL, V11, P932, DOI 10.1038/mi.2017.112; Sivro A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6354; Sneller MC, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax3447; Tsuda-Tsukimoto M, 2006, PHARM RES-DORDR, V23, P2646, DOI 10.1007/s11095-006-9102-6; Uzzan M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau4711; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wibmer CK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06794-x; Williams MB, 1997, J IMMUNOL, V159, P1746; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Woyciechowski S, 2017, EUR J IMMUNOL, V47, P244, DOI 10.1002/eji.201646722; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Xu HB, 2016, J VIROL, V90, P1578, DOI 10.1128/JVI.02471-15; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927; Zundler S, 2017, INFLAMM BOWEL DIS, V23, P379, DOI 10.1097/MIB.0000000000001029	79	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21282	10.1096/fj.202002235R	http://dx.doi.org/10.1096/fj.202002235R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484474	Green Published, hybrid			2022-12-28	WOS:000647789600082
J	Xiao, L; Han, L; Li, BF; Zhang, MF; Zhou, HZ; Luo, QS; Zhang, XZ; Huang, YH				Xiao, Le; Han, Long; Li, Bufan; Zhang, Manfeng; Zhou, Haizhen; Luo, Qingshan; Zhang, Xinzheng; Huang, Yihua			Structures of the beta-barrel assembly machine recognizing outer membrane protein substrates	FASEB JOURNAL			English	Article						outer membrane protein biogenesis; the BAM&#8208; substrate complex; X&#8208; ray crystallography; Cryo&#8208; EM; &#946; &#8208; signal hypothesis	CARBOXY-TERMINAL PHENYLALANINE; HIGH-RESOLUTION STRUCTURE; CRYSTAL-STRUCTURE; ESSENTIAL COMPONENT; PERIPLASMIC DOMAIN; BAM COMPLEX; BIOGENESIS; INSERTION; TRANSLOCATION; FLEXIBILITY	beta-barrel outer membrane proteins (beta-OMPs) play critical roles in nutrition acquisition, protein import/export, and other fundamental biological processes. The assembly of beta-OMPs in Gram-negative bacteria is mediated by the beta-barrel assembly machinery (BAM) complex, yet its precise mechanism remains elusive. Here, we report two structures of the BAM complex in detergents and in nanodisks, and two crystal structures of the BAM complex with bound substrates. Structural analysis indicates that the membrane compositions surrounding the BAM complex could modulate its overall conformations, indicating low energy barriers between different conformational states and a highly dynamic nature of the BAM complex. Importantly, structures of the BAM complex with bound substrates and the related functional analysis show that the first beta-strand of the BamA beta-barrel (beta 1(BamA)) in the BAM complex is associated with the last but not the first beta-strand of a beta-OMP substrate via antiparallel beta-strand interactions. These observations are consistent with the beta-signal hypothesis during beta-OMP biogenesis, and suggest that the beta 1(BamA) strand in the BAM complex may interact with the last beta-strand of an incoming beta-OMP substrate upon their release from the chaperone-bound state.	[Xiao, Le; Han, Long; Li, Bufan; Zhou, Haizhen; Zhang, Xinzheng; Huang, Yihua] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xiao, Le; Han, Long; Li, Bufan; Zhou, Haizhen; Zhang, Xinzheng; Huang, Yihua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Manfeng] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Genome Anal Lab, Lingnan Guangdong Lab Modern Agr,Minist Agr, Shenzhen, Peoples R China; [Luo, Qingshan] Jinan Univ, Shenzhen Baoan Womens & Childrens Hosp, Shenzhen, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Ministry of Agriculture & Rural Affairs; Jinan University	Huang, YH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	yihuahuang@sun5.ibp.ac.cn	han, long/AHE-5759-2022	han, long/0000-0001-6142-8412				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Bamert RS, 2017, MOL MICROBIOL, V106, P142, DOI 10.1111/mmi.13757; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; deCock H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/jmbi.1997.1069; DeLano WL, 2009, ABSTR PAP AM CHEM S, V238; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Doyle MT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11230-9; Efremov RG, 2017, METHOD ENZYMOL, V594, P1, DOI 10.1016/bs.mie.2017.05.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frauenfeld J, 2016, NAT METHODS, V13, P345, DOI [10.1038/NMETH.3801, 10.1038/nmeth.3801]; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Ge X, 2014, FEBS J, V281, P1226, DOI 10.1111/febs.12701; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hohr AIC, 2018, SCIENCE, V359, P289, DOI 10.1126/science.aah6834; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Jansen KB, 2015, J BIOL CHEM, V290, P2126, DOI 10.1074/jbc.M114.584524; Jiang JH, 2012, INT J MOL SCI, V13, P8038, DOI 10.3390/ijms13078038; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lee J, 2019, ELIFE, V8, DOI 10.7554/eLife.49787; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mallarino LE, 2015, BIOCHEMISTRY-US, V54, P844, DOI 10.1021/bi5011305; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Tomasek D, 2020, NATURE, V583, P473, DOI 10.1038/s41586-020-2370-1; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	62	11	11	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21207	10.1096/fj.202001443RR	http://dx.doi.org/10.1096/fj.202001443RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368572				2022-12-28	WOS:000605626600043
J	Dagar, S; Pushpa, K; Pathak, D; Samaddar, S; Saxena, A; Banerjee, S; Mylavarapu, SVS				Dagar, Sunayana; Pushpa, Kumari; Pathak, Diksha; Samaddar, Sarbani; Saxena, Anjana; Banerjee, Sourav; Mylavarapu, Sivaram V. S.			Nucleolin regulates 14-3-3 zeta mRNA and promotes cofilin phosphorylation to induce tunneling nanotube formation	FASEB JOURNAL			English	Article						cofilin; intercellular communication; mRNA regulation; MSec; RNA&#8208; binding domains	LOCAL TRANSLATION; COMPLEX; STABILIZES; ACTIN; IDENTIFICATION; EXOCYST	Tunneling nanotubes (TNTs) mediate intercellular communication between animal cells in health and disease, but the mechanisms of their biogenesis and function are poorly understood. Here we report that the RNA-binding protein (RBP) nucleolin, which interacts with the known TNT-inducing protein MSec, is essential for TNT formation in mammalian cells. Nucleolin, through its RNA-binding domains (RBDs), binds to and maintains the cytosolic levels of 14-3-3 zeta mRNA, and is, therefore, required for TNT formation. A specific region of the 3 '-untranslated region (UTR) of the 14-3-3 zeta mRNA is likely to be involved in its regulation by nucleolin. Functional complementation experiments suggest that nucleolin and 14-3-3 zeta form a linear signaling axis that promotes the phosphorylation and inactivation of the F-actin depolymerization factor cofilin to induce TNT formation. MSec also similarly inactivates cofilin, but potentiates TNT formation independent of the nucleolin-14-3-3 zeta axis, despite biochemically interacting with both proteins. We show that 14-3-3 zeta and nucleolin are required for the formation of TNTs between primary mouse neurons and astrocytes and in multiple other mammalian cell types. We also report that the Caenorhabditis elegans orthologs of 14-3-3 zeta and MSec regulate the size and architecture of the TNT-like cellular protrusions of the distal tip cell (DTC), the germline stem cell niche in the gonad. Our study demonstrates a novel and potentially conserved mRNA-guided mechanism of TNT formation through the maintenance of cellular 14-3-3 zeta mRNA levels by the RBP nucleolin.	[Dagar, Sunayana; Pushpa, Kumari; Pathak, Diksha; Mylavarapu, Sivaram V. S.] NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, 3rd Milestone Faridabad Gurgaon Expressway, Faridabad 121001, Haryana, India; [Dagar, Sunayana; Mylavarapu, Sivaram V. S.] Kalinga Inst Ind Technol, Bhubaneswar, India; [Samaddar, Sarbani; Banerjee, Sourav] Natl Brain Res Ctr, Manesar, India; [Saxena, Anjana] CUNY Brooklyn Coll, Biol Dept, New York, NY USA; [Saxena, Anjana] CUNY, Grad Ctr, Biol Program, New York, NY USA; [Saxena, Anjana] CUNY, Grad Ctr, Biochem Program, New York, NY USA	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Kalinga Institute of Industrial Technology (KIIT); Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System	Mylavarapu, SVS (corresponding author), NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, 3rd Milestone Faridabad Gurgaon Expressway, Faridabad 121001, Haryana, India.	sivaram@rcb.res.in	Dagar, Sunayana/AAX-5387-2020; Kumari, Pushpa/AAA-4945-2022	Kumari, Pushpa/0000-0002-0230-4177; Samaddar, Sarbani/0000-0002-5564-6402; Dagar, Sunayana/0000-0002-5070-9232	Regional Centre for Biotechnology; DBT India Alliance (India Alliance) [IA/E/13/1/501]; Department of Biotechnology, Ministry of Science and Technology (DBT); Foundation for the National Institutes of Health (FNIH) [NCI [CA175794]]; University Grants Commission (UGC), India	Regional Centre for Biotechnology(Department of Biotechnology (DBT) India); DBT India Alliance (India Alliance); Department of Biotechnology, Ministry of Science and Technology (DBT); Foundation for the National Institutes of Health (FNIH); University Grants Commission (UGC), India(University Grants Commission, India)	Regional Centre for Biotechnology; DBT India Alliance (India Alliance), Grant/Award Number: IA/E/13/1/501; Department of Biotechnology, Ministry of Science and Technology (DBT); Foundation for the National Institutes of Health (FNIH), Grant/Award Number: NCI [CA175794]; University Grants Commission (UGC), India	Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Abounit S, 2016, PRION, V10, P344, DOI 10.1080/19336896.2016.1223003; Abounit S, 2016, EMBO J, V35, P2120, DOI 10.15252/embj.201593411; Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; Austefjord Magnus Wiger, 2014, Commun Integr Biol, V7, pe27934, DOI 10.4161/cib.27934; Bhatt P, 2012, FEBS J, V279, P370, DOI 10.1111/j.1742-4658.2011.08430.x; Boudreau A, 2013, P NATL ACAD SCI USA, V110, pE3937, DOI 10.1073/pnas.1315022110; Brandwein D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102148; BRENNER S, 1974, GENETICS, V77, P71; Byrd DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088372; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Chaudhry U., 2018, ECON MICROBIOL, V14, P631; D'Aloia A, 2018, EXP CELL RES, V362, P349, DOI 10.1016/j.yexcr.2017.11.036; Delage E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39632; Drab M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060626; Dubois F, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2701345; Gerdes HH, 2013, MECH DEVELOP, V130, P381, DOI 10.1016/j.mod.2012.11.006; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gordon A, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700294; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hansraj NZ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12858; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; He KM, 2011, CARDIOVASC RES, V92, P39, DOI 10.1093/cvr/cvr189; Hoja-Lukowicz D, 2009, CANCER IMMUNOL IMMUN, V58, P1471, DOI 10.1007/s00262-009-0705-8; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jansens RJJ, 2020, J VIROL, V94, DOI 10.1128/JVI.02120-19; Jia L, 2016, ONCOGENE, V35, P2040, DOI 10.1038/onc.2015.263; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Kast DJ, 2019, MOL BIOL CELL, V30, P1285, DOI 10.1091/mbc.E18-09-0600; Kast DJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08317-8; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Kimura S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33548; Kimura S, 2013, CELL TISSUE RES, V352, P67, DOI 10.1007/s00441-012-1518-1; Kumar H, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226001; Linden LM, 2017, DEV BIOL, V429, P271, DOI 10.1016/j.ydbio.2017.06.019; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Mardakheh FK, 2015, DEV CELL, V35, P344, DOI 10.1016/j.devcel.2015.10.005; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; Ohno Hiroshi, 2010, Commun Integr Biol, V3, P231; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pergu R, 2019, J BIOL CHEM, V294, P7177, DOI 10.1074/jbc.RA118.005659; Resnik N, 2019, HISTOCHEM CELL BIOL, V152, P311, DOI 10.1007/s00418-019-01806-3; Resnik N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35370-y; Saini M, 2012, GENE, V497, P155, DOI 10.1016/j.gene.2012.01.065; Salvetti A, 2016, J PROTEOME RES, V15, P1659, DOI 10.1021/acs.jproteome.6b00126; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Singh K, 2004, J IMMUNOL, V173, P976, DOI 10.4049/jimmunol.173.2.976; Sisakhtnezhad S, 2015, EUR J CELL BIOL, V94, P429, DOI 10.1016/j.ejcb.2015.06.010; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Sun X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.177; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Wang X, 2012, BBA-BIOMEMBRANES, V1818, P2082, DOI 10.1016/j.bbamem.2011.09.002; Wu DM, 2014, FEBS LETT, V588, P1921, DOI 10.1016/j.febslet.2014.03.047; Xiao S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109858; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang L, 2015, CAN CON EL COMP EN, P31, DOI 10.1109/CCECE.2015.7129155	60	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001152R	http://dx.doi.org/10.1096/fj.202001152R		NOV 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33222276				2022-12-28	WOS:000592925200001
J	Zhao, XG; Li, YH; Zhao, ZW; Du, J				Zhao, Xianguo; Li, Yahong; Zhao, Zhangwu; Du, Juan			Extra sex combs buffers sleep-related stresses through regulating Heat shock proteins	FASEB JOURNAL			English	Article						Drosophila; extra sex comb (ESC); Heat shock proteins (Hsps); sleep	DROSOPHILA; TRANSCRIPTION; TEMPERATURE; DEPRIVATION; HSP70; GENE; EXPRESSION; WAKING; BRAIN	The impact of global warming on the life of the earth is increasingly concerned. Previous studies indicated that temperature changes have a serious impact on insect sleep. Sleep is critical for animals as it has many important physiological functions. It is of great significance to study the regulation mechanism of temperature-induced sleep changes for understanding the impact of global warming on insects. More importantly, understanding how these pressures regulate sleep can provide insights into improving sleep. In this study, we found that extra sex combs (ESC) are a regulatory factor in this process. Our data showed that ESC was an upstream negative regulatory factor of Heat shock proteins (Hsps), and it could regulate sleep in mushroom and ellipsoid of Drosophila. ESC mutation exaggerates the sleep change caused by temperature, while buffering the shortening of life caused by sleep deprivation. These phenotypes can be rescued by Hsps mutants. Therefore, we concluded that the ESC buffers sleep-related stresses through regulating Hsps.	[Zhao, Xianguo; Li, Yahong; Zhao, Zhangwu; Du, Juan] China Agr Univ, Dept Entomol, MOA Key Lab Pest Monitoring & Green Management, Coll Plant Protect, Beijing 100193, Peoples R China	China Agricultural University	Du, J (corresponding author), China Agr Univ, Dept Entomol, MOA Key Lab Pest Monitoring & Green Management, Coll Plant Protect, Beijing 100193, Peoples R China.	dujuan9981@cau.edu.cn		Du, Juan/0000-0002-1850-3613	National Natural Science Foundation of China [31772535, 31572317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31772535 and 31572317	Allwyn P, 2017, EPIGENETICS CHROMATI, V10, P57; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Kidd PB, 2015, P NATL ACAD SCI USA, V112, pE6284, DOI 10.1073/pnas.1511215112; Ly S, 2018, NEUROSCI BIOBEHAV R, V87, P67, DOI 10.1016/j.neubiorev.2018.01.015; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Naidoo N, 2005, J NEUROCHEM, V92, P1150, DOI 10.1111/j.1471-4159.2004.02952.x; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Negre N, 2006, METHOD ENZYMOL, V410, P316, DOI 10.1016/S0076-6879(06)10015-4; Parisky KM, 2016, CURR BIOL, V26, P882, DOI 10.1016/j.cub.2016.02.011; PARSELL DA, 1993, PHILOS T R SOC B, V339, P279, DOI 10.1098/rstb.1993.0026; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Terao A, 2003, NEUROSCIENCE, V116, P187, DOI 10.1016/S0306-4522(02)00695-4; Wada T, 2006, BRAIN RES BULL, V69, P388, DOI 10.1016/j.brainresbull.2006.02.004; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Young JM, 2010, J COMP NEUROL, V518, P1525, DOI 10.1002/cne.22285; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	2	2	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001303RR	http://dx.doi.org/10.1096/fj.202001303RR		NOV 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33220007				2022-12-28	WOS:000592921600001
J	Fan, TY; Qu, RM; Jiang, X; Yang, YC; Sun, B; Huang, XL; Zhou, ZT; Ouyang, J; Zhong, SZ; Dai, JX				Fan, Tingyu; Qu, Rongmei; Jiang, Xin; Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Zhou, Zhitao; Ouyang, Jun; Zhong, Shizhen; Dai, Jingxing			Spatial organization and crosstalk of vimentin and actin stress fibers regulate the osteogenic differentiation of human adipose-derived stem cells	FASEB JOURNAL			English	Article						actin stress fibers; adipose&#8208; derived stem cells (ASCs); osteogenesis; spatial organization; vimentin	SHOCK-PROTEIN 27; INTERMEDIATE-FILAMENTS; BETA-CATENIN; DYNAMICS; PLECTIN; ARCHITECTURE; POLYMERIZATION; LOCALIZATION; CYTOSKELETON; EXPRESSION	Human adipose-derived stem cells (hASCs) are ideal seed cells for tissue engineering due to their multidirectional differentiation potential. Microfilaments, microtubules, and intermediate filaments are responsible for supporting the intracellular space. Vimentin, a type III intermediate filament protein that is specifically expressed in cells of mesenchymal origin, can function as a scaffold and endow cells with tension and shear stress resistance. Actin stress fibers (ASF) act as an important physical device in stress signal transduction, providing stiffness for cells, and promoting osteogenesis. Through direct physical contact, cross-linkers, and spatial interactions, vimentin and actin networks exist as intersecting entities. Spatial interactions occur in the overlapping area of cytoskeleton subsystems, which could affect cell morphology, cell mechanics, and cell fate. However, how does the spatial organization between the cytoskeletal subsystems changed during osteogenesis, especially between vimentin and ASF, is still not understood, and its mechanism effect on cell fate remains unclear. In our study, WB experiment was used to detect the expression changes in Vimentin, ASF, and other proteins. Cells were reconstructed by three-dimensional scanning with fluorescence microscope, and the spatial thickness of vimentin and ASF cytoskeletons and the thickness of the overlapping area between them were calculated, respectively, so as to observe the spatial reorganization of vimentin and ASF in cells. Cytochalasin D (an inhibitor of actin polymerization) and vimentin upregulated/downregulated cells were used to verify the change in the spatial organization between vimentin and ASF and its influence on osteogenesis. Then, heat shock protein 27 (HSP27) was downregulated to illuminate the regulatory mechanisms of spatial organization between vimentin and ASF during osteogenesis. The amounts and the spatial positions of vimentin and actin stress fiber exhibited opposite trends during osteogenesis. Through controlling the anchor sites on the nucleus, intermediate filaments vimentin can reduce the spatial proportion of actin stress fibers, which can be regulated by HSP27. In addition, depolymerization of actin stress fibers lead to lower osteogenic differentiation ability, resulting in osteogenesis and lipogenesis existed simultaneously, that can be resisted by vimentin. Our data indicate that the spatial reorganization of vimentin and actin stress fibers is a key factor in the regulation of the differentiation state of hASCs. And their spatial overlapping area is detrimental to hASCs osteogenesis, providing a new perspective for further exploring the mechanism underlying hASCs osteogenesis.	[Fan, Tingyu; Qu, Rongmei; Jiang, Xin; Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Ouyang, Jun; Zhong, Shizhen; Dai, Jingxing] Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Med Biomech, Guangzhou, Peoples R China; [Fan, Tingyu; Qu, Rongmei; Jiang, Xin; Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Ouyang, Jun; Zhong, Shizhen; Dai, Jingxing] Southern Med Univ, Sch Basic Med Sci, Dept Anat, Guangzhou, Peoples R China; [Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Zhou, Zhitao] Southern Med Univ, Cent Lab, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhong, SZ; Dai, JX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Med Biomech, Guangzhou, Peoples R China.; Zhong, SZ; Dai, JX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Anat, Guangzhou, Peoples R China.	zhszh@smu.edu.cn; daijx@smu.edu.cn	; dai, jingxing/N-8381-2016	qu, rongmei/0000-0002-4994-0613; Ouyang, Jun/0000-0002-8475-3696; dai, jingxing/0000-0002-9339-9174	National Key R&D Program of China [2017YFC1105000]; Sanming Project of Medicine in Shenzhen [SZSM201612019]	National Key R&D Program of China; Sanming Project of Medicine in Shenzhen	This study was financially supported by the National Key R&D Program of China (2017YFC1105000) and Sanming Project of Medicine in Shenzhen (SZSM201612019)	Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Beggs JE, 2015, BIOCHEM J, V467, P63, DOI 10.1042/BJ20141066; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Block J, 2015, BBA-MOL CELL RES, V1853, P3053, DOI 10.1016/j.bbamcr.2015.05.009; Carlier MF, 2017, NAT REV MOL CELL BIO, V18, P389, DOI 10.1038/nrm.2016.172; Castanon MJ, 2013, HISTOCHEM CELL BIOL, V140, P33, DOI 10.1007/s00418-013-1102-0; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Han MKL, 2017, NAT CELL BIOL, V19, P14, DOI 10.1038/ncb3457; HAUS U, 1993, EMBO J, V12, P3763, DOI 10.1002/j.1460-2075.1993.tb06054.x; Havel LS, 2015, ONCOGENE, V34, P1979, DOI 10.1038/onc.2014.123; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hijikata T, 2003, HISTOCHEM CELL BIOL, V119, P109, DOI 10.1007/s00418-003-0496-5; Huber F, 2015, CURR OPIN CELL BIOL, V32, P39, DOI 10.1016/j.ceb.2014.10.005; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jiu Y, 2017, J CELL SCI, V130, P892, DOI 10.1242/jcs.196881; Jiu YM, 2015, CELL REP, V11, P1511, DOI 10.1016/j.celrep.2015.05.008; Kayser J, 2013, BIOPHYS J, V105, P1778, DOI 10.1016/j.bpj.2013.09.007; Ketema M, 2013, MOL BIOL CELL, V24, P2454, DOI 10.1091/mbc.E13-02-0100; Ketema M, 2011, BIOCHEM SOC T, V39, P1719, DOI 10.1042/BST20110669; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; KueperO T, 2007, J BIOL CHEM, V282, P23427, DOI 10.1074/jbc.M701586200; Kumar A, 2016, METHODS APPL FLUORES, V4, DOI [10.1088/2050-6120/4/4044008, 10.1088/2050-6120/4/4/044008]; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lee JS, 2005, EXP MOL MED, V37, P427, DOI 10.1038/emm.2005.53; Leube RE, 2015, CURR OPIN CELL BIOL, V32, P13, DOI 10.1016/j.ceb.2014.09.011; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; Maninova M, 2017, PROTOPLASMA, V254, P1207, DOI 10.1007/s00709-017-1077-0; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Minton K, 2014, NAT REV MOL CELL BIO, V15, P631, DOI 10.1038/nrm3882; Muehlich S, 2017, CELL SIGNAL, V29, P31, DOI 10.1016/j.cellsig.2016.10.002; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Neuhofer W, 1998, KIDNEY INT, V54, pS165, DOI 10.1046/j.1523-1755.1998.06735.x; Perng MD, 1999, J CELL SCI, V112, P2099; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Rosado JA, 2002, CELL SIGNAL, V14, P547, DOI 10.1016/S0898-6568(01)00273-X; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090; Serebryannyy LA, 2017, J CELL SCI, V130, P1717, DOI 10.1242/jcs.199893; Sliogeryte K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101164; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Stavenschi E, 2019, FASEB J, V33, P4178, DOI 10.1096/fj.201801474RR; Tavares S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15237; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tulgren ED, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004481; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wang Y, 2008, MECH DEVELOP, V125, P142, DOI 10.1016/j.mod.2007.09.008; Wang YQ, 2015, EXP CELL RES, V338, P39, DOI 10.1016/j.yexcr.2015.08.002; Wei JC, 2008, ANTICANCER RES, V28, P327; Wiche G, 2015, CURR OPIN CELL BIOL, V32, P21, DOI 10.1016/j.ceb.2014.10.002; Yamazaki S, 2016, HISTOCHEM CELL BIOL, V145, P389, DOI 10.1007/s00418-016-1416-9	57	8	8	9	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000378RR	http://dx.doi.org/10.1096/fj.202000378RR		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33205555				2022-12-28	WOS:000592661500001
J	Ganesan, R; Henkels, KM; Shah, K; De la Rosa, X; Libreros, S; Cheemarla, NR; Serhan, CN; Gomez-Cambronero, J				Ganesan, Ramya; Henkels, Karen M.; Shah, Krushangi; De La Rosa, Xavier; Libreros, Stephania; Cheemarla, Nagarjuna R.; Serhan, Charles N.; Gomez-Cambronero, Julian			D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution	FASEB JOURNAL			English	Article						macrophages; inflammation; resolution; phospholipase D; resolvins D-series; polarization	PHOSPHATIDIC-ACID; MACROPHAGE POLARIZATION; TUMOR-GROWTH; RECEPTOR; CANCER; EXPRESSION; PLD2; IDENTIFICATION; ADHESION; ROLES	A successful acute inflammatory response results in the elimination of infectious agents by neutrophils and monocytes, followed by resolution and repair through tissue-resident and recruited macrophages. Resolvins (D-series and E-series) are pro-resolving lipid mediators involved in resolution and tissue repair, whose intracellular signaling remains of interest. Here, we report that D-series resolvins (RvD1- RvD5) activate phospholipase D (PLD), a ubiquitously expressed membrane lipase enzyme activity in modulating phagocyte functions. The mechanism for PLD-mediated actions of Resolvin-D5 (RvD5) in polarizing macrophages (M1-like toward M2-like) was found to be two-pronged: (a) RvD5 inhibits post-transcriptional modifications, by miRs and 3'exonucleases that process PLD2 mRNA, thus increasing PLD2 expression and activity; and (b) RvD5 enhances PLD2-S6Kinase signaling required for membrane expansion and efferocytosis. In anin vivomodel of second organ reflow injury, we found that RvD5 did not reduce lung neutrophil myeloperoxidase levels in PLD2(-/-)mice compared to WT and PLD1(-/-)mice, confirming a novel role of PLD2 as the isoform in RvD5-mediated resolution processes. These results demonstrate that RvD5-PLD2 are attractive targets for therapeutic interventions in vascular inflammation such as ischemia-reperfusion injury and cardiovascular diseases.	[Ganesan, Ramya; Henkels, Karen M.; Shah, Krushangi; Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH USA; [Ganesan, Ramya; De La Rosa, Xavier; Libreros, Stephania; Serhan, Charles N.; Gomez-Cambronero, Julian] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA; [Ganesan, Ramya; De La Rosa, Xavier; Libreros, Stephania; Serhan, Charles N.; Gomez-Cambronero, Julian] Harvard Med Sch, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA; [Cheemarla, Nagarjuna R.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	University System of Ohio; Wright State University Dayton; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University	Serhan, CN (corresponding author), Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA.; Serhan, CN (corresponding author), Harvard Med Sch, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA.; Ganesan, R (corresponding author), Emory Univ, Sch Med, Dept Med, 1760 Haygood Dr, Atlanta, GA 30322 USA.	ramya.ganesan@emory.edu; cnserhan@zeus.bwh.harvard.edu		Shah, Krushangi N/0000-0002-7908-6462	American Heart Association (AHA) [13GRNT17230097]; National Institutes of Health (NIH) [HL056653-14, P01GM095467]	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	American Heart Association (AHA), Grant/Award Number: 13GRNT17230097; National Institutes of Health (NIH), Grant/Award Number: HL056653-14 and P01GM095467	Abdulnour REE, 2018, J LEUKOCYTE BIOL, V103, P919, DOI 10.1002/JLB.3A0617-252RR; Bashir S, 2016, INFLAMM RES, V65, P1, DOI 10.1007/s00011-015-0874-1; Braga TT, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00602; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Chiang N, 1999, J CLIN INVEST, V104, P309, DOI 10.1172/JCI7016; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dandekar Rishikesh C, 2011, Ann Maxillofac Surg, V1, P150, DOI 10.4103/2231-0746.92782; Fite K, 2016, MOL CELL BIOL, V36, P1078, DOI 10.1128/MCB.00711-15; Fite K, 2016, J BIOL CHEM, V291, P719, DOI 10.1074/jbc.M115.686006; Flak MB, 2020, J CLIN INVEST, V130, P359, DOI 10.1172/JCI131609; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Ganesan R, 2018, J LEUKOCYTE BIOL, V103, P867, DOI 10.1002/JLB.2A1017-407RR; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Gobel K, 2014, EUR J IMMUNOL, V44, P2295, DOI 10.1002/eji.201344107; Gomez-Cambronero J, 2017, METHOD ENZYMOL, V583, P327, DOI 10.1016/bs.mie.2016.09.042; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; Gomez-Cambronero J, 2014, J LEUKOCYTE BIOL, V96, P779, DOI 10.1189/jlb.2VMR0214-120RR; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Gomez-Cambronero J, 2011, CELL SIGNAL, V23, P1885, DOI 10.1016/j.cellsig.2011.06.017; Gomez-Cambronero J, 2010, THESCIENTIFICWORLDJO, V10, P1356, DOI 10.1100/tsw.2010.116; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hatton N, 2015, MOL CELL BIOL, V35, P3131, DOI 10.1128/MCB.00286-15; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2016, ONCOTARGET, V7, P47002, DOI 10.18632/oncotarget.9685; Henkels KM, 2015, FASEB J, V29, P1299, DOI 10.1096/fj.14-260992; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Kang DW, 2014, J BIOL CHEM, V289, P22575, DOI 10.1074/jbc.R114.569822; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Koch T, 2009, J NEUROCHEM, V110, P1288, DOI 10.1111/j.1471-4159.2009.06217.x; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Lee HY, 2004, EXP MOL MED, V36, P135, DOI 10.1038/emm.2004.20; Lee SK, 2015, J EXP MED, V212, P1381, DOI 10.1084/jem.20141813; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Lippestad M, 2018, EXP EYE RES, V173, P64, DOI 10.1016/j.exer.2018.04.015; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahankali M, 2013, J CELL SCI, V126, P1416, DOI 10.1242/jcs.117960; Mahankali M, 2012, J BIOL CHEM, V287, P41417, DOI 10.1074/jbc.M112.383596; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Mancini F, 2015, NEW MICROBIOL, V38, P59; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miller TE, 2017, BIOL OPEN, V6, P176, DOI 10.1242/bio.021261; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Park DW, 2013, BIOCHEM BIOPH RES CO, V430, P933, DOI 10.1016/j.bbrc.2012.11.135; Perkins GD, 2007, THORAX, V62, P36, DOI 10.1136/thx.2006.059410; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Schmid M, 2016, J IMMUNOL, V196, P3429, DOI 10.4049/jimmunol.1501701; Schonberger T, 2014, AM J PATHOL, V184, P2450, DOI 10.1016/j.ajpath.2014.06.005; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Speranza F, 2014, J BIOL CHEM, V289, P28885, DOI 10.1074/jbc.M114.597146; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stegner D, 2013, ARTERIOSCL THROM VAS, V33, P2212, DOI 10.1161/ATVBAHA.113.302030; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	81	7	7	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15888	15906		10.1096/fj.201903025RR	http://dx.doi.org/10.1096/fj.201903025RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047359	Green Accepted			2022-12-28	WOS:000581172200001
J	Tan, RZ; Li, JC; Liu, J; Lei, XY; Zhong, X; Wang, C; Yan, Y; Ye, LYLD; Duan, DDY; Lan, HY; Wang, L				Tan, Rui-zhi; Li, Jian-chun; Liu, Jian; Lei, Xian-ying; Zhong, Xia; Wang, Chen; Yan, Ying; Linda Ye, Lingyu; Darrel Duan, Dayue; Lan, Hui-yao; Wang, Li			BAY61-3606 protects kidney from acute ischemia/reperfusion injury through inhibiting spleen tyrosine kinase and suppressing inflammatory macrophage response	FASEB JOURNAL			English	Article						AKI; BAY61-3606; macrophage; Mincle; Syk	DENDRITIC CELLS; MINCLE; ACTIVATION; NLRP3; SYK; PATHWAYS; DISEASE; REPAIR; ROS; MECHANISMS	Acute kidney injury (AKI) is a highly prevalent clinical syndrome with high mortality and morbidity. Previous studies indicated that inflammation promotes tubular damage and plays a key role in AKI progress. Spleen tyrosine kinase (Syk) has been linked to macrophage-related inflammation in AKI. Up to date, however, no Syk-targeted therapy for AKI has been reported. In this study, we employed both cell model of LPS-induced bone marrow-derived macrophage (BMDM) and mouse model of ischemia/reperfusion injury (IRI)-induced AKI to evaluate the effects of a Syk inhibitor, BAY61-3606 (BAY), on macrophage inflammation in vitro and protection of kidney from AKI in vivo. The expression and secretion of inflammatory cytokines, both in vitro and in vivo, were significantly inhibited even back to normal levels by BAY. The upregulated serum creatinine and blood urea nitrogen levels in the AKI mice were significantly reduced after administration of BAY, implicating a protective effect of BAY on kidneys against IRI. Further analyses from Western blot, immunofluorescence staining and flow cytometry revealed that BAY inhibited the Mincle/Syk/NF-kappa B signaling circuit and reduced the inflammatory response. BAY also inhibited the reactive oxygen species (ROS), which further decreased the formation of inflammasome and suppressed the mature of IL-1 beta and IL-18. Notably, these inhibitory effects of BAY on inflammation and inflammasome in BMDM were significantly reversed by Mincle ligand, trehalose-6,6-dibehenate. In summary, these findings provided compelling evidence that BAY may be an efficient inhibitor of the Mincle/Syk/NF-kappa B signaling circuit and ROS-induced inflammasome, which may help to develop Syk-inhibitors as novel therapeutic agents for AKI.	[Tan, Rui-zhi; Li, Jian-chun; Zhong, Xia; Wang, Chen; Yan, Ying; Wang, Li] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Res Ctr Tradit Chinese Med & Western Med Integrat, 319 Zhongshan Rd, Luzhou 646000, Sichuan, Peoples R China; [Liu, Jian] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Nephrol, Luzhou, Peoples R China; [Lei, Xian-ying] Southwest Med Univ, ICU, Affiliated Hosp, Luzhou, Peoples R China; [Linda Ye, Lingyu; Darrel Duan, Dayue] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Ctr Phen Tradit Chinese Med, Luzhou, Peoples R China; [Lan, Hui-yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Lan, Hui-yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Lan, Hui-yao] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Peoples R China	Southwest Medical University; Southwest Medical University; Southwest Medical University; Southwest Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wang, L (corresponding author), Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Res Ctr Tradit Chinese Med & Western Med Integrat, 319 Zhongshan Rd, Luzhou 646000, Sichuan, Peoples R China.	wangli120@swmu.edu.cn	Lan, Hui Yao/C-9734-2015	Lan, Hui Yao/0000-0003-4283-9755	Luzhou-Southwest Medical University Joint Project [2017LZXNYD-P01, 2018LZXNYD-PT03, 2017LZXNYD-Z03]; Southwest Medical University [2018XYLH-013]; The Scientific Research Program of Health Commission of Sichuan Province [19PJ154, 19PJ152]; The Luzhou Municipal Southwest Medical University Joint Special Grant for the Introduction of High-level Talents; Affiliated Traditional Medicine Hospital [2018XYLH-013]	Luzhou-Southwest Medical University Joint Project; Southwest Medical University; The Scientific Research Program of Health Commission of Sichuan Province; The Luzhou Municipal Southwest Medical University Joint Special Grant for the Introduction of High-level Talents; Affiliated Traditional Medicine Hospital	The Luzhou-Southwest Medical University Joint Project, Grant/Award Number: 2017LZXNYD-P01, 2018LZXNYD-PT03 and 2017LZXNYD-Z03; The Southwest Medical University and Affiliated Traditional Medicine Hospital Joint -key research program, Grant/Award Number: 2018XYLH-013; The Scientific Research Program of Health Commission of Sichuan Province, Grant/Award Number: 19PJ154 and 19PJ152; The Luzhou Municipal Southwest Medical University Joint Special Grant for the Introduction of High-level Talents, Grant/Award Number: Lan HuiYao Team	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Bonavia A, 2018, PEDIATR NEPHROL, V33, P1629, DOI 10.1007/s00467-017-3774-5; Brungs S, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0088-8; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Fan JJ, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/2923072; Fan YN, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01157; Ferenbach DA, 2012, KIDNEY INT, V82, P928, DOI 10.1038/ki.2012.207; Guzzi F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194941; Hennig P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020562; Ho CMK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150339; Hossen MJ, 2015, J ETHNOPHARMACOL, V159, P9, DOI 10.1016/j.jep.2014.10.064; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Hu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056071; Huen SC, 2017, ANNU REV PHYSIOL, V79, P449, DOI 10.1146/annurev-physiol-022516-034219; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Humphreys BD, 2016, J AM SOC NEPHROL, V27, P990, DOI 10.1681/ASN.2015030286; Ishimoto Y, 2016, NEPHROL DIAL TRANSPL, V31, P1062, DOI 10.1093/ndt/gfv317; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047; Kezic A, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6305439; Kim HG, 2018, J ETHNOPHARMACOL, V219, P202, DOI 10.1016/j.jep.2018.03.022; Kim SH, 2016, J ETHNOPHARMACOL, V188, P167, DOI 10.1016/j.jep.2016.05.008; Kim SH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/904142; Kiyotake R, 2015, J BIOL CHEM, V290, P25322, DOI 10.1074/jbc.M115.645234; Kotla S, 2014, FREE RADICAL BIO MED, V76, P147, DOI 10.1016/j.freeradbiomed.2014.08.007; Kumar S, 2018, KIDNEY INT, V93, P27, DOI 10.1016/j.kint.2017.07.030; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lee EJ, 2016, J IMMUNOL, V196, P3148, DOI 10.4049/jimmunol.1502355; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lee WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11322; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Lin YC, 2015, J LEUKOCYTE BIOL, V97, P825, DOI 10.1189/jlb.3HI0814-371RR; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Liu DL, 2020, BIOCHEM PHARMACOL, V175, DOI 10.1016/j.bcp.2020.113863; Lv LL, 2017, KIDNEY INT, V91, P587, DOI 10.1016/j.kint.2016.10.020; Mao H, 2013, CARDIORENAL MED, V3, P178, DOI 10.1159/000353134; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsushita K, 2020, KIDNEY INT, V97, P95, DOI 10.1016/j.kint.2019.06.022; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Menshikh A, 2019, AM J PHYSIOL-RENAL, V317, pF1383, DOI 10.1152/ajprenal.00366.2019; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Okusa MD, 2016, J AM SOC NEPHROL, V27, P44, DOI 10.1681/ASN.2015030233; Pandori WJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007923; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Rangel EB, 2013, STEM CELLS, V31, P1644, DOI 10.1002/stem.1412; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Rogers NM, 2014, NAT REV NEPHROL, V10, P625, DOI 10.1038/nrneph.2014.170; Santana PT, 2016, MICROBES INFECT, V18, P93, DOI 10.1016/j.micinf.2015.10.007; Sato Y, 2018, AM J PHYSIOL-RENAL, V315, pF1501, DOI 10.1152/ajprenal.00195.2018; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Siew ED, 2020, AM J KIDNEY DIS, V75, P204, DOI 10.1053/j.ajkd.2019.05.031; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Tan RZ, 2020, PHYTOTHER RES, V34, P139, DOI 10.1002/ptr.6507; Tan RZ, 2019, PHYTOMEDICINE, V52, P284, DOI 10.1016/j.phymed.2018.09.210; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vaccari JCD, 2015, J NEUROTRAUM, V32, P228, DOI 10.1089/neu.2014.3436; Vinuesa E, 2008, J PATHOL, V214, P104, DOI 10.1002/path.2259; Wang YQ, 2015, KIDNEY INT, V88, P1274, DOI 10.1038/ki.2015.295; Wu SY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00048; Yang D, 2017, IMMUNOL REV, V280, P41, DOI 10.1111/imr.12577; Yang WS, 2012, EXP CELL RES, V318, P1867, DOI 10.1016/j.yexcr.2012.05.016; Yasukawa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4755; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	71	7	7	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15029	15046		10.1096/fj.202000261RRR	http://dx.doi.org/10.1096/fj.202000261RRR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32964547				2022-12-28	WOS:000570776300001
J	Deshpande, P; Flinkman, D; Hong, Y; Goltseva, E; Siino, V; Sun, LH; Peltonen, S; Elo, LL; Kaasinen, V; James, P; Coffey, ET				Deshpande, Prasannakumar; Flinkman, Dani; Hong, Ye; Goltseva, Elena; Siino, Valentina; Sun, Lihua; Peltonen, Sirkku; Elo, Laura L.; Kaasinen, Valtteri; James, Peter; Coffey, Eleanor T.			Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2	FASEB JOURNAL			English	Article						biomarker; cellular mechanism; eEF2; LRRK2; neurodegeneration; Parkinson's disease	ELONGATION FACTOR-II; PHOSPHORYLATION SITES; DOPAMINERGIC-NEURONS; KINASE; TRANSLATION; IDENTIFICATION; MUTATIONS; REGULATOR; BRAIN; GENE	Gain of function LRRK2-G2019S is the most frequent mutation found in familial and sporadic Parkinson's disease. It is expected therefore that understanding the cellular function of LRRK2 will provide insight on the pathological mechanism not only of inherited Parkinson's, but also of sporadic Parkinson's, the more common form. Here, we show that constitutive LRRK2 activity controls nascent protein synthesis in rodent neurons. Specifically, pharmacological inhibition of LRRK2,Lrrk2knockdown orLrrk2knockout, all lead to increased translation. In the rotenone model for sporadic Parkinson's, LRRK2 activity increases, dopaminergic neuron translation decreases, and the neurites atrophy. All are prevented by LRRK2 inhibitors. Moreover, in striatum and substantia nigra of rotenone treated rats, phosphorylation changes are observed on eIF2 alpha-S52(up arrow), eIF2s2-S2(down arrow), and eEF2-T57(up arrow) in directions that signify protein synthesis arrest. Significantly, translation is reduced by 40% in fibroblasts from Parkinson's patients (G2019S and sporadic cases alike) and this is reversed upon LRRK2 inhibitor treatment. In cells from multiple system atrophy patients, translation is unchanged suggesting that repression of translation is specific to Parkinson's disease. These findings indicate that repression of translation is a proximal function of LRRK2 in Parkinson's pathology.	[Deshpande, Prasannakumar; Flinkman, Dani; Hong, Ye; Sun, Lihua; Elo, Laura L.; James, Peter; Coffey, Eleanor T.] Univ Turku, Turku Biosci, Turku, Finland; [Deshpande, Prasannakumar; Flinkman, Dani; Hong, Ye; Sun, Lihua; Elo, Laura L.; James, Peter; Coffey, Eleanor T.] Abo Akad Univ, Turku, Finland; [Flinkman, Dani; Goltseva, Elena; Siino, Valentina; James, Peter] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Peltonen, Sirkku] Univ Turku, Dept Dermatol, Turku, Finland; [Peltonen, Sirkku] Turku Univ Hosp, Turku, Finland; [Kaasinen, Valtteri] Turku Univ Hosp, Div Clin Neurosci, Turku, Finland; [Kaasinen, Valtteri] Univ Turku, Turku, Finland	University of Turku; Abo Akademi University; Lund University; University of Turku; University of Turku; University of Turku; University of Turku	Coffey, ET (corresponding author), Univ Turku, Turku Biosci, Turku, Finland.; Coffey, ET (corresponding author), Abo Akad Univ, Turku, Finland.	eleanor.coffey@bioscience.fi	Peltonen, Sirkku/C-3133-2008; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Kaasinen, Valtteri/O-2086-2016	Peltonen, Sirkku/0000-0003-0990-1430; Kaasinen, Valtteri/0000-0002-3446-7093; Flinkman, Dani/0000-0002-3908-2467; Coffey, Eleanor/0000-0002-9717-5610; Deshpande, Prasannakumar/0000-0002-9965-7859; Sun, Lihua/0000-0002-9931-9497	Business Finland; Michael J. Fox Foundation for Parkinson's Research (MJFF); Abo Akademi University; Turku Graduate School of Biomedical Sciences; MATTI Graduate School; University of Lund	Business Finland; Michael J. Fox Foundation for Parkinson's Research (MJFF); Abo Akademi University; Turku Graduate School of Biomedical Sciences; MATTI Graduate School; University of Lund	Business Finland; Michael J. Fox Foundation for Parkinson's Research (MJFF); Abo Akademi University; Turku Graduate School of Biomedical Sciences; MATTI Graduate School; University of Lund	Alam M, 2004, BEHAV BRAIN RES, V153, P439, DOI 10.1016/j.bbr.2003.12.021; Albanese F, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01352; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Carling PJ, 2020, PROG NEUROBIOL, V187, DOI 10.1016/j.pneurobio.2020.101772; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Di Maio R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5429; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; DOMESICK VB, 1983, NEUROSCIENCE, V8, P743, DOI 10.1016/0306-4522(83)90007-6; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Fell MJ, 2015, J PHARMACOL EXP THER, V355, P397, DOI 10.1124/jpet.115.227587; Gandin V, 2014, TRANSLATION, V2, DOI 10.4161/trla.28109; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gerhard DM, 2016, DRUG DISCOV TODAY, V21, P454, DOI 10.1016/j.drudis.2016.01.016; Gilsbach BK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00032; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; GULLEY RL, 1971, TISSUE CELL, V3, P675, DOI 10.1016/S0040-8166(71)80013-7; Haugarvoll K, 2009, PARKINSONISM RELAT D, V15, pS205, DOI 10.1016/S1353-8020(09)70815-6; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; HOEBEKE J, 1975, LIFE SCI, V17, P591, DOI 10.1016/0024-3205(75)90095-8; Hollos P, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0303-19.2019; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hulihan MM, 2008, LANCET NEUROL, V7, P591, DOI 10.1016/S1474-4422(08)70116-9; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jan A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0554-9; Jellinger KA, 2015, J NEURAL TRANSM, V122, P505, DOI 10.1007/s00702-014-1288-x; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Kearns CM, 1997, J NEUROSCI, V17, P7111; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Langston RG, 2016, BIOCHEM J, V473, P221, DOI 10.1042/BJ20150985; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Lobbestael E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33897; Manzoni C, 2017, ADV NEUROBIOL, V14, P89, DOI 10.1007/978-3-319-49969-7_5; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Mora M, 2015, EUR J HUM GENET, V23, P1116, DOI 10.1038/ejhg.2014.272; Moriya H, 2015, MOL BIOL CELL, V26, P3932, DOI 10.1091/mbc.E15-07-0512; Mutez E, 2014, NEUROBIOL DIS, V63, P165, DOI 10.1016/j.nbd.2013.11.007; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; OVCHINNIKOV LP, 1990, FEBS LETT, V275, P209, DOI 10.1016/0014-5793(90)81473-2; Padzik A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00057; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penney J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12188; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1111/ene.14108, 10.1038/nrdp.2017.13]; Postuma RB, 2018, MOVEMENT DISORD, V33, P1601, DOI 10.1002/mds.27362; PRICE NT, 1991, FEBS LETT, V282, P253, DOI 10.1016/0014-5793(91)80489-P; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Ressa A, 2019, J PROTEOME RES, V18, P576, DOI 10.1021/acs.jproteome.8b00576; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Salvatore MF, 2012, JOVE-J VIS EXP, DOI 10.3791/4171; Sanders LH, 2013, FREE RADICAL BIO MED, V62, P111, DOI 10.1016/j.freeradbiomed.2013.01.003; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Stewart JD, 2015, BIOCHEM J, V467, P217, DOI 10.1042/BJ20141453; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Varidaki A, 2016, MOL MECH DEPRESSION; Vidyadhara DJ, 2019, J NEUROCHEM, V150, P487, DOI 10.1111/jnc.14820; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Younts TJ, 2016, NEURON, V92, P479, DOI 10.1016/j.neuron.2016.09.040; Yu LY, 2008, J NEUROSCI METH, V169, P8, DOI 10.1016/j.jneumeth.2007.11.018; Zhao Y, 2018, BRAIN, V141, P486, DOI 10.1093/brain/awx344; Zhao Y, 2012, MOL CELL NEUROSCI, V49, P300, DOI 10.1016/j.mcn.2011.12.005	88	7	7	6	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14217	14233		10.1096/fj.202001046R	http://dx.doi.org/10.1096/fj.202001046R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32926469	Green Submitted, hybrid			2022-12-28	WOS:000570669800001
J	Hernandez-Perez, M; Kulkarni, A; Samala, N; Sorrell, C; El, K; Haider, I; Aleem, AM; Holman, TR; Rai, G; Tersey, SA; Mirmira, RG; Anderson, RM				Hernandez-Perez, Marimar; Kulkarni, Abhishek; Samala, Niharika; Sorrell, Cody; El, Kimberly; Haider, Isra; Mukhtar Aleem, Ansari; Holman, Theodore R.; Rai, Ganesha; Tersey, Sarah A.; Mirmira, Raghavendra G.; Anderson, Ryan M.			A 12-lipoxygenase-Gpr31 signaling axis is required for pancreatic organogenesis in the zebrafish	FASEB JOURNAL			English	Article						12-lipoxygenase; exocrine tissue; Gpr31; pancreas development; zebrafish; beta cells	OXIDATIVE STRESS; BETA-CELLS; 12/15-LIPOXYGENASE; EXPRESSION; LIPOXYGENASES; STEREOCONTROL; OXYGENATION; INHIBITION; DEFICIENCY; PROTECTS	12-Lipoxygenase (12-LOX) is a key enzyme in arachidonic acid metabolism, and alongside its major product, 12-HETE, plays a key role in promoting inflammatory signaling during diabetes pathogenesis. Although 12-LOX is a proposed therapeutic target to protect pancreatic islets in the setting of diabetes, little is known about the consequences of blocking its enzymatic activity during embryonic development. Here, we have leveraged the strengths of the zebrafish-genetic manipulation and pharmacologic inhibition-to interrogate the role of 12-LOX in pancreatic development. Lipidomics analysis during zebrafish development demonstrated that 12-LOX-generated metabolites of arachidonic acid increase sharply during organogenesis stages, and that this increase is blocked by morpholino-directed depletion of 12-LOX. Furthermore, we found that either depletion or inhibition of 12-LOX impairs both exocrine pancreas growth and unexpectedly, the generation of insulin-producing beta cells. We demonstrate that morpholino-mediated knockdown of GPR31, a purported G-protein-coupled receptor for 12-HETE, largely phenocopies both the depletion and the inhibition of 12-LOX. Moreover, we show that loss of GPR31 impairs pancreatic bud fusion and pancreatic duct morphogenesis. Together, these data provide new insight into the requirement of 12-LOX in pancreatic organogenesis and islet formation, and additionally provide evidence that its effects are mediated via a signaling axis that includes the 12-HETE receptor GPR31.	[Hernandez-Perez, Marimar; Sorrell, Cody; El, Kimberly; Haider, Isra; Tersey, Sarah A.; Mirmira, Raghavendra G.; Anderson, Ryan M.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Pediat, Indianapolis, IN 46202 USA; [Kulkarni, Abhishek; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Samala, Niharika; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mukhtar Aleem, Ansari; Holman, Theodore R.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rai, Ganesha] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Mirmira, Raghavendra G.; Anderson, Ryan M.] Univ Chicago, Dept Med, Kovler Diabet Ctr, 900 E 57th St KCBD 8130, Chicago, IL 60637 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Chicago	Mirmira, RG; Anderson, RM (corresponding author), Univ Chicago, Dept Med, Kovler Diabet Ctr, 900 E 57th St KCBD 8130, Chicago, IL 60637 USA.	rmirmira@uchicago.edu; ryananderson@uchicago.edu	Kulkarni, Abhishek/AAV-4836-2021	Kulkarni, Abhishek/0000-0001-6792-7183	NIH [T32 DK064466, R01 DK105588]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: T32 DK064466 and R01 DK105588	Aleem AM, 2019, BIOCHEMISTRY-US, V58, P848, DOI 10.1021/acs.biochem.8b01167; Amagata T, 2003, J NAT PROD, V66, P230, DOI 10.1021/np020462l; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Brash AR, 1999, ADV EXP MED BIOL, V469, P83; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Cole BK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/851798; Conteh AM, 2019, J BIOL CHEM, V294, P6612, DOI 10.1074/jbc.RA118.007102; Dobrian AD, 2018, PROSTAG OTH LIPID M, V136, P23, DOI 10.1016/j.prostaglandins.2018.03.003; Fehrenbacher N, 2017, J CELL BIOL, V216, P2329, DOI 10.1083/jcb.201609096; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Haas U, 2011, P NATL ACAD SCI USA, V108, P20479, DOI 10.1073/pnas.1117094108; Hennessy E, 2017, DIABETIC MED, V34, P292, DOI 10.1111/dme.13177; Hernandez-Perez M, 2017, DIABETES, V66, P2875, DOI 10.2337/db17-0215; Hesselson D, 2011, CURR BIOL, V21, P712, DOI 10.1016/j.cub.2011.03.041; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Honn KV, 2016, FASEB J, V30, P2360, DOI 10.1096/fj.201500076; Igarashi M, 2015, J NEUROSCI, V35, P6079, DOI 10.1523/JNEUROSCI.4102-14.2015; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Jansen C, 2011, J BIOL CHEM, V286, P37804, DOI 10.1074/jbc.M111.259242; Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100; Kenyon V, 2011, J MED CHEM, V54, P5485, DOI 10.1021/jm2005089; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Lebold KM, 2014, REDOX BIOL, V2, P105, DOI 10.1016/j.redox.2013.12.007; Luci D, 2014, PROBE REPORTS NIH MO; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Mastracci TL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13269; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; Prince VE, 2017, CURR TOP DEV BIOL, V124, P235, DOI 10.1016/bs.ctdb.2016.10.005; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Taylor-Fishwick DA, 2015, DIABETOLOGIA, V58, P549, DOI 10.1007/s00125-014-3452-0; Tersey SA, 2014, MOL CELL BIOL, V34, P3735, DOI 10.1128/MCB.00157-14; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ye LH, 2016, DEV BIOL, V409, P354, DOI 10.1016/j.ydbio.2015.12.003; Ye LH, 2015, DEVELOPMENT, V142, P1407, DOI 10.1242/dev.117911; Zarini S, 2014, PROSTAG OTH LIPID M, V113, P52, DOI 10.1016/j.prostaglandins.2014.08.003; Zhang XJ, 2018, NAT MED, V24, P73, DOI 10.1038/nm.4451	43	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14850	14862		10.1096/fj.201902308RR	http://dx.doi.org/10.1096/fj.201902308RR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918516	Green Accepted			2022-12-28	WOS:000570584600001
J	Che, H; Li, H; Li, Y; Wang, YQ; Yang, ZY; Wang, RL; Wang, LH				Che, Hui; Li, Hui; Li, Yang; Wang, Yue-Qiu; Yang, Zhen-Yu; Wang, Rui-Ling; Wang, Li-Hong			Melatonin exerts neuroprotective effects by inhibiting neuronal pyroptosis and autophagy in STZ-induced diabetic mice	FASEB JOURNAL			English	Article						Melatonin; microRNA-214-3p; neuronal pyroptosis; neuronal autophagy	MECHANISM; CASPASES; FIBROSIS	Diabetes mellitus (DM) patients are at a higher risk of developing brain injury characterized by neuronal death. Melatonin, a hormone produced by the pineal gland, exerts neuroprotective effects against brain damage. However, the effect of melatonin on diabetes-induced brain injury has not been elucidated. This study was to evaluate the role of melatonin against neuronal death in DM and to elucidate the underlying mechanisms. Herein, we found that melatonin administration significantly alleviated the neuronal death in both streptozotocin (STZ)-induced diabetic mice and high glucose (HG)-treated neuronal cells. Melatonin inhibited neuronal pyroptosis and excessive autophagy, as evidenced by decreased levels of NLRP3, cleaved caspase-1, GSDMD-N, IL-1 beta, LC3, Beclin1, and ATG12 both in vivo and in vitro. MicroRNA-214-3p (miR-214-3p) was decreased in DM mice and HG-treated cells, and such a downregulation was corrected by melatonin, which was accompanied by repression of caspase-1 and ATG12. Furthermore, downregulation of miR-214-3p abrogated the anti-pyroptotic and anti-autophagic actions of melatonin in vitro. Our results indicate that melatonin exhibits a neuroprotective effect by inhibiting neuronal pyroptosis and excessive autophagy through modulating the miR-214-3p/caspase-1 and miR-214-3p/ATG12 axes, respectively, and it might be a potential agent for the treatment of brain damage in the setting of DM.	[Che, Hui; Li, Hui; Li, Yang; Wang, Yue-Qiu; Wang, Rui-Ling; Wang, Li-Hong] Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 2, Harbin 150001, Heilongjiang, Peoples R China; [Yang, Zhen-Yu] Harbin Med Univ, Coll Pharm, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Che, H; Wang, LH (corresponding author), Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 2, Harbin 150001, Heilongjiang, Peoples R China.	chehui1203@163.com; chehui1203@163.com			National Natural Science Foundation of China [81600935]; China Postdoctoral Science Foundation [2017M621308]; Natural Science Foundation of Heilongjiang Province [QC2017108]; Science Foundation of the Second Affiliated Hospital of Harbin Medical University [KYBS2015-16]; Graduate research and practice innovation project of Harbin medical university [YJSKYCX2019-47HYD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Science Foundation of the Second Affiliated Hospital of Harbin Medical University; Graduate research and practice innovation project of Harbin medical university	This work was supported by the National Natural Science Foundation of China (81600935), China Postdoctoral Science Foundation (2017M621308), the Natural Science Foundation of Heilongjiang Province (QC2017108), Science Foundation of the Second Affiliated Hospital of Harbin Medical University (KYBS2015-16), and Graduate research and practice innovation project of Harbin medical university (YJSKYCX2019-47HYD).	Avgeris M, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108187; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Annette B, 2017, BBA-MOL BASIS DIS, V1863, P1026, DOI 10.1016/j.bbadis.2017.01.016; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cardinali DP, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00480; Che H, 2020, FASEB J, V34, P5282, DOI 10.1096/fj.201902692R; Che H, 2017, MOL NEUROBIOL, V54, P2595, DOI 10.1007/s12035-016-9856-8; Chen R, 2018, J ALZHEIMERS DIS, V65, P15, DOI 10.3233/JAD-180314; Chen WR, 2020, EXP CELL RES, V389, DOI 10.1016/j.yexcr.2020.111883; Chuang JI, 2016, J PINEAL RES, V61, P230, DOI 10.1111/jpi.12343; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Erukainure OL, 2019, METAB BRAIN DIS, V34, P1385, DOI 10.1007/s11011-019-00444-x; Fang F, 2018, J DIABETES, V10, P625, DOI 10.1111/1753-0407.12646; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Gunata M, 2020, REV NEUROL-FRANCE, V176, P148, DOI 10.1016/j.neurol.2019.07.025; Gurley SB, 2018, DIABETES, V67, P2096, DOI 10.2337/db17-1323; Hoffman WH, 2012, EXP MOL PATHOL, V93, P273, DOI 10.1016/j.yexmp.2011.10.007; Hussain S, 2014, J ALZHEIMERS DIS, V41, P551, DOI 10.3233/JAD-131958; Ismael S, 2020, MOL NEUROBIOL, V57, P2495, DOI 10.1007/s12035-020-01893-7; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kandimalla R, 2017, BBA-MOL BASIS DIS, V1863, P1078, DOI 10.1016/j.bbadis.2016.08.018; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kongsuphol P, 2009, J PINEAL RES, V46, P199, DOI 10.1111/j.1600-079X.2008.00648.x; Lammert CR, 2020, NATURE, V580, P647, DOI 10.1038/s41586-020-2174-3; Li XJ, 2002, J PINEAL RES, V32, P47, DOI 10.1034/j.1600-079x.2002.10831.x; Liu ZG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14676-4; McCarthy R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00616; Milne NT, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.741; Muriach M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/102158; Pourhanifeh MH, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00537-z; Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017; Qi YQ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00243; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Reddy PH, 2018, J ALZHEIMERS DIS, V61, P843, DOI 10.3233/JAD-170512; San-Miguel B, 2015, J PINEAL RES, V59, P151, DOI 10.1111/jpi.12247; Shukla M, 2019, ANN NY ACAD SCI, V1443, P75, DOI 10.1111/nyas.14005; Sun RF, 2019, FASEB J, V33, P5411, DOI 10.1096/fj.201801798RR; Sun YQ, 2019, J CELL PHYSIOL, V234, P231, DOI 10.1002/jcp.26856; Suzumura A, 2020, DIABETES, V69, P724, DOI 10.2337/db19-0550; Wang C, 2020, BRAIN RES, V1742, DOI 10.1016/j.brainres.2020.146863; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002; Wang XB, 2019, BIOCHEM BIOPH RES CO, V519, P402, DOI 10.1016/j.bbrc.2019.09.005; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wang ZV, 2015, CIRCULATION, V131, P771, DOI 10.1161/CIRCULATIONAHA.115.015357; Wrighten SA, 2009, BBA-MOL BASIS DIS, V1792, P444, DOI 10.1016/j.bbadis.2008.10.013; Xie CC, 2016, AUTOPHAGY, V12, P410, DOI 10.1080/15548627.2015.1132134; Yang F, 2018, CELL PHYSIOL BIOCHEM, V50, P1230, DOI 10.1159/000494576; Yang F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1029-4; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Yu ZW, 2020, LIFE SCI, V240, DOI 10.1016/j.lfs.2019.117138; Zhang DP, 2019, J NEUROSCI RES, V97, P645, DOI 10.1002/jnr.24385; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhang YQ, 2016, NEUROTOXICOLOGY, V56, P139, DOI 10.1016/j.neuro.2016.07.004; Zhao NN, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117043	56	23	23	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					14042	14054		10.1096/fj.202001328R	http://dx.doi.org/10.1096/fj.202001328R		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32910484				2022-12-28	WOS:000568309300001
J	Robles-Vera, I; de la Visitacion, N; Toral, M; Sanchez, M; Romero, M; Gomez-Guzman, M; Yang, T; Izquierdo-Garcia, JL; Guerra-Hernandez, E; Ruiz-Cabello, J; Raizada, MK; Perez-Vizcaino, F; Jimenez, R; Duarte, J				Robles-Vera, Inaki; de la Visitacion, Nestor; Toral, Marta; Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Yang, Tao; Izquierdo-Garcia, Jose L.; Guerra-Hernandez, Eduardo; Ruiz-Cabello, Jesus; Raizada, Mohan K.; Perez-Vizcaino, Francisco; Jimenez, Rosario; Duarte, Juan			ProbioticBifidobacterium breveprevents DOCA-salt hypertension	FASEB JOURNAL			English	Article						DOCA-salt hypertension; endothelial dysfunction; gut microbiota; immune system; probiotics	CHAIN FATTY-ACIDS; GUT MICROBIOTA; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; INTESTINAL BARRIER; RECEPTOR 4; BUTYRATE; ACTIVATION; INHIBITION; DYSBIOSIS	Many probiotics that affect gut microbial ecology have been shown to produce beneficial effects on renin-angiotensin-dependent rodent models and human hypertension. We hypothesized thatBifidobacterium breveCECT7263 (BFM) would attenuate hypertension in deoxycorticosterone acetate (DOCA)-salt rats, a renin-independent model of hypertension. Rats were randomly divided into five groups: control, DOCA-salt, treated DOCA-salt-BFM, treated DOCA-salt-butyrate, and treated DOCA-salt-acetate, for 5 weeks. BFM prevented the increase in systolic blood pressure, cardiac weight, and renal damage induced by DOCA-salt. BFM increased acetate-producing bacterial population and gut acetate levels, improved colonic integrity, normalized endotoxemia, plasma trimethylamine (TMA) levels, and restored the Th17 and Treg content in mesenteric lymph nodes and aorta. Furthermore, BFM improved nitric oxide-dependent vasorelaxation induced by acetylcholine in aortic rings and reduced NADPH oxidase activity in DOCA-salt animals. These protective effects were mimicked by acetate, but not by butyrate supplementation. These data demonstrate that BFM induces changes in gut microbiota linked with attenuation of endothelial dysfunction and increase in blood pressure in this low-renin form of hypertension. These beneficial effects seem to be mediated by increased acetate and reduced TMA production by gut microbiota, thus, improving gut integrity and restoring Th17/Tregs polarization and endotoxemia.	[Robles-Vera, Inaki; de la Visitacion, Nestor; Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Jimenez, Rosario; Duarte, Juan] Univ Granada, Dept Pharmacol, Sch Pharm, Granada 18071, Spain; [Robles-Vera, Inaki; de la Visitacion, Nestor; Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Jimenez, Rosario; Duarte, Juan] Univ Granada, Ctr Biomed Res CIBM, Granada, Spain; [Toral, Marta] Ctr Nacl Invest Cardiovasc CHIC, Gene Regulat Cardiovasc Remodeling & Inflammat Gr, Madrid, Spain; [Toral, Marta; Romero, Miguel; Jimenez, Rosario; Duarte, Juan] CIBER Enfermedades Cardiovasc CiberCV, Madrid, Spain; [Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Jimenez, Rosario; Duarte, Juan] Inst Invest Biosanitaria Granada, Granada, Spain; [Yang, Tao] Univ Toledo, Coll Med & Life Sci, Microbiome Consortium, Toledo, OH USA; [Yang, Tao] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Ctr Hypertens & Precis Med, Toledo, OH USA; [Izquierdo-Garcia, Jose L.; Ruiz-Cabello, Jesus] CIC BiomaGUNE, Donostia San Sebastian, Spain; [Guerra-Hernandez, Eduardo] Univ Granada, Dept Nutr & Bromatol, Granada, Spain; [Raizada, Mohan K.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Perez-Vizcaino, Francisco] Univ Complutense Madrid, Fac Med, Dept Farmacol & Toxicol, Madrid, Spain; [Perez-Vizcaino, Francisco] Ciber Enfermedades Resp Ciberes, Madrid, Spain; [Perez-Vizcaino, Francisco] Inst Invest Sanitaria Gregorio Maranon IISGM, Madrid, Spain	University of Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Investigacion Biosanitaria IBS Granada; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; CIC biomaGUNE; University of Granada; State University System of Florida; University of Florida; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Sanchez, M; Duarte, J (corresponding author), Univ Granada, Dept Pharmacol, Sch Pharm, Granada 18071, Spain.	manuelsanchersantos@ugr.es; jmduarte@ugr.es	Sanchez, Manuel/C-4401-2008; Duarte, Juan/AAH-1574-2020; Duarte, Juan/K-6472-2014; Romero, Miguel/K-6053-2014; de la Visitación, Néstor/K-5729-2017; JIMENEZ, ROSARIO/K-9701-2014; Toral, Marta/K-6709-2014; Ruiz-Cabello, Jesus/A-9570-2012; Gómez-Guzmán, M/E-3341-2012; Izquierdo-Garcia, Jose/L-3293-2013; perez, miguel/GXF-5077-2022; Robles Vera, Inaki/K-6355-2017; Perez-Vizcaino, Francisco/A-9735-2011	Sanchez, Manuel/0000-0002-3975-3398; Duarte, Juan/0000-0002-9153-5857; Duarte, Juan/0000-0002-9153-5857; Romero, Miguel/0000-0003-0578-1099; de la Visitación, Néstor/0000-0001-7229-9601; JIMENEZ, ROSARIO/0000-0003-3872-2669; Toral, Marta/0000-0001-5324-8569; Ruiz-Cabello, Jesus/0000-0001-8681-5056; Gómez-Guzmán, M/0000-0003-2452-9286; Izquierdo-Garcia, Jose/0000-0002-7907-3776; Robles Vera, Inaki/0000-0001-6002-9241; Perez-Vizcaino, Francisco/0000-0001-6309-7418	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat) [SAF2017-84894-R]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL102033]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia) [CTS164]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia)	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat), Grant/Award Number: SAF2017-84894-R; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL102033; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia), Grant/Award Number: CTS164	Adnan S, 2017, PHYSIOL GENOMICS, V49, P96, DOI 10.1152/physiolgenomics.00081.2016; Amador CA, 2014, HYPERTENSION, V63, P797, DOI 10.1161/HYPERTENSIONAHA.113.02883; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bartley A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01593; Bartolomaeus H, 2019, CIRCULATION, V139, P1407, DOI 10.1161/CIRCULATIONAHA.118.036652; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; de Montgolfier O, 2019, GEROSCIENCE, V41, P511, DOI 10.1007/s11357-019-00070-6; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Elinav E, 2013, MUCOSAL IMMUNOL, V6, P4, DOI 10.1038/mi.2012.115; Friques AGF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0759-7; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; GAVRAS H, 1975, CIRC RES, V36, P300, DOI 10.1161/01.RES.36.2.300; Gomez-Arango LF, 2016, HYPERTENSION, V68, P974, DOI 10.1161/HYPERTENSIONAHA.116.07910; Gomez-Guzman M, 2015, MOL NUTR FOOD RES, V59, P2326, DOI 10.1002/mnfr.201500290; Grangette C, 2012, GUT, V61, P331, DOI 10.1136/gutjnl-2011-301476; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Huang N, 1997, CYTOKINE, V9, P27, DOI 10.1006/cyto.1996.0132; Izquierdo-Garcia JL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-363; Jaworska K, 2019, CARDIOVASC RES, V115, P1948, DOI 10.1093/cvr/cvz231; Zarzuelo MJ, 2013, CARDIOVASC RES, V99, P622, DOI 10.1093/cvr/cvt152; Juraschek SP, 2015, AM J HYPERTENS, V28, P216, DOI 10.1093/ajh/hpu117; Karbach SH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003698; Khalesi S, 2014, HYPERTENSION, V64, P897, DOI 10.1161/HYPERTENSIONAHA.114.03469; Kim S, 2018, CLIN SCI, V132, P701, DOI [10.1042/CS20180087, 10.1042/cs20180087]; Lewis-Mikhael AM, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104663; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Li M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00533; Li M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00233; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Lim MY, 2019, GEROSCIENCE, V41, P935, DOI 10.1007/s11357-019-00121-y; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Marques FZ, 2018, NAT REV CARDIOL, V15, P20, DOI 10.1038/nrcardio.2017.120; Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]; Mell B, 2015, PHYSIOL GENOMICS, V47, P187, DOI 10.1152/physiolgenomics.00136.2014; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Rath S, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02966; Robles-Vera I, 2020, BRIT J PHARMACOL, V177, P2006, DOI 10.1111/bph.14965; Robles-Vera I, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900616; Robles-Vera I, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800298; Santisteban MM, 2017, CIRC RES, V120, P312, DOI 10.1161/CIRCRESAHA.116.309006; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sharma RK, 2019, CIRC RES, V124, P727, DOI 10.1161/CIRCRESAHA.118.313882; Singh H, 2019, GEROSCIENCE, V41, P907, DOI 10.1007/s11357-019-00098-8; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sun S, 2019, HYPERTENSION, V73, P998, DOI 10.1161/HYPERTENSIONAHA.118.12109; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Toral M, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13285; Toral M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00231; Toral M, 2014, CLIN SCI, V127, P33, DOI 10.1042/CS20130339; Van Deun K, 2008, AVIAN PATHOL, V37, P379, DOI 10.1080/03079450802216603; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Walejko JM, 2018, INT J CARDIOL, V271, P336, DOI 10.1016/j.ijcard.2018.04.074; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Yap WB, 2016, KOREAN J PHYSIOL PHA, V20, P621, DOI 10.4196/kjpp.2016.20.6.621	65	25	25	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13626	13640		10.1096/fj.202001532R	http://dx.doi.org/10.1096/fj.202001532R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780919				2022-12-28	WOS:000558419300001
J	Mu, Q; Wang, H; Tong, L; Fang, QH; Xiang, MQ; Han, LY; Jin, LN; Yang, J; Qian, Z; Ning, G; Zhang, YF; Zhang, ZG				Mu, Qian; Wang, Hui; Tong, Lei; Fang, Qianhua; Xiang, Minqi; Han, Luyu; Jin, Lina; Yang, Jian; Qian, Zhen; Ning, Guang; Zhang, Yifei; Zhang, Zhiguo			Betulinic acid improves nonalcoholic fatty liver disease through YY1/FAS signaling pathway	FASEB JOURNAL			English	Article						betulinic acid; fatty acid synthase; NAFLD; triglyceride; Yin Yang 1	IN-VIVO; SYNTHASE INHIBITORS; X-RECEPTOR; TRANSCRIPTION; YY1; PATHOGENESIS; PROGRESSION; STEATOSIS; LIPOGENESIS; METABOLISM	The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide indicates the urgent need to develop novel and effective treatment strategies. Betulinic acid (BA), a naturally occurring plant-derived pentacyclic triterpenoid, has an outstanding effect in improving metabolism. However, the pharmacological action and mechanism of BA in NAFLD remain unclear. Here, we show that BA-treated high-fat diet mice and methionine-choline deficient diet-fed mice are resistant to hepatic steatosis when compared with vehicle-treated mice. BA alleviates fatty acid synthesis, fibrosis, and inflammation and promotes fatty acid oxidation. Meanwhile, fatty acid synthase (FAS) expression and activity are markedly inhibited with BA treatment both in vitro and in vivo. Moreover, BA inhibits FAS expression through transcriptional suppression of Yin Yang 1 (YY1), leading to retard hepatocytes triglyceride accumulation. Collectively, BA protects hepatocytes from abnormal lipid deposition in NAFLD through YY1/FAS pathway. Our findings establish a novel role of BA in representing a possible therapeutic strategy to reverse NAFLD.	[Mu, Qian; Wang, Hui; Tong, Lei; Fang, Qianhua; Xiang, Minqi; Jin, Lina; Yang, Jian; Ning, Guang; Zhang, Yifei; Zhang, Zhiguo] Shanghai Jiao Tong Univ, Ruijin Hosp,Natl Hlth Commiss PR China,Key Lab En, Shanghai Natl Clin Res Ctr Metab Dis,Shanghai Ins, Sch Med,Shanghai Natl Ctr Translat Med,Dept Endoc, Shanghai, Peoples R China; [Han, Luyu] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai, Peoples R China; [Qian, Zhen] Changchun Univ Chinese Med, Sch Pharm, Dept Pharmacol, Changchun, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Changchun University of Chinese Medicine	Zhang, YF; Zhang, ZG (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrine & Metab Dis, Sch Med,Dept Endocrinol & Metab, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	feifei-a@163.com; zhangzhiguo@outlook.com	Zhang, Yifei/GRO-3001-2022	Yang, Jian/0000-0002-3390-5127	National Key Research and Development Program [2016YFC0901201]; National Natural Science Foundation of China [81570719, 81670797, 81770863]; Shanghai Talent Development Fund [2018091]; Key Laboratory for Endocrine and Metabolic Diseases; Ministry of Science & Technology Innovation Fund [2011YQ030114]; Basic Important Program [10JC141100]; Ministry of Science and Technology [2012ZX09303006-001]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [14SG17]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Talent Development Fund; Key Laboratory for Endocrine and Metabolic Diseases; Ministry of Science & Technology Innovation Fund; Basic Important Program; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation	National Key Research and Development Program, Grant/Award Number: 2016YFC0901201; National Natural Science Foundation of China, Grant/Award Number: 81570719, 81670797 and 81770863; Shanghai Talent Development Fund, Grant/Award Number: 2018091; Key Laboratory for Endocrine and Metabolic Diseases; Ministry of Science & Technology Innovation Fund, Grant/Award Number: 2011YQ030114; Shanghai Talent development fund, Grant/Award Number: 2018091; Basic Important Program, Grant/Award Number: 10JC141100; Ministry of Science and Technology, Grant/Award Number: 2012ZX09303006-001; Shanghai Municipal Education Commission; Shanghai Education Development Foundation, Grant/Award Number: 14SG17	Ajala-Lawal RA, 2020, ARCH PHYSIOL BIOCHEM, V126, P107, DOI 10.1080/13813455.2018.1498901; Angulo P, 2007, NUTR REV, V65, pS57, DOI [10.1111/j.1753-4887.2007.tb00329.x, 10.1301/nr.2007.jun.S57-S63]; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Denechaud PD, 2016, J CLIN INVEST, V126, P137, DOI 10.1172/JCI81542; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Fan HJ, 2016, ONCOL REP, V35, P2651, DOI 10.3892/or.2016.4682; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Gao P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2050; Gu M, 2019, BRIT J PHARMACOL, V176, P847, DOI 10.1111/bph.14570; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Kapur P, 2005, MODERN PATHOL, V18, P1107, DOI 10.1038/modpathol.3800395; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kim KD, 2019, NUTR METAB CARDIOVAS, V29, P409, DOI 10.1016/j.numecd.2018.12.001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kley JT, 2011, BIOORG MED CHEM LETT, V21, P5924, DOI 10.1016/j.bmcl.2011.07.083; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Laavola M, 2016, J NAT PROD, V79, P274, DOI 10.1021/acs.jnatprod.5b00709; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Li YJ, 2019, THERANOSTICS, V9, P7599, DOI 10.7150/thno.34931; Lu Y, 2014, GUT, V63, P170, DOI 10.1136/gutjnl-2012-303150; Rios JL, 2018, PLANTA MED, V84, P8, DOI 10.1055/s-0043-123472; Menendez JA, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.4; Mullen GE, 2015, BIOORG MED CHEM LETT, V25, P4363, DOI 10.1016/j.bmcl.2015.08.087; Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002; Oslob JD, 2013, ACS MED CHEM LETT, V4, P113, DOI 10.1021/ml300335r; Pandey PR, 2012, RECENT PAT ANTI-CANC, V7, P185; Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591; Ratziu V, 2005, J HEPATOL, V42, P12, DOI 10.1016/j.jhep.2004.11.027; Safayhi H, 1997, PLANTA MED, V63, P487, DOI 10.1055/s-2006-957748; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Syed-Abdul MM, 2020, HEPATOLOGY, V72, P103, DOI 10.1002/hep.31000; Verdeguer F, 2016, MOL CELL BIOL, V36, P184, DOI 10.1128/MCB.00722-15; Wan Y, 2013, INT IMMUNOPHARMACOL, V17, P184, DOI 10.1016/j.intimp.2013.06.012; Wong MCS, 2019, NAT REV GASTRO HEPAT, V16, P57, DOI 10.1038/s41575-018-0055-0; Wu SR, 2018, CANCER RES, V78, P4549, DOI 10.1158/0008-5472.CAN-17-4047; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang MJ, 2017, SEMIN LIVER DIS, V37, P363, DOI 10.1055/s-0037-1607451; Zhang ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20848	49	9	9	7	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13033	13048		10.1096/fj.202000546R	http://dx.doi.org/10.1096/fj.202000546R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32777136				2022-12-28	WOS:000558418900001
J	Montesdeoca, N; Lopez, M; Ariza, X; Herrero, L; Makowski, K				Montesdeoca, Nicolas; Lopez, Marta; Ariza, Xavier; Herrero, Laura; Makowski, Kamil			Inhibitors of lipogenic enzymes as a potential therapy against cancer	FASEB JOURNAL			English	Review						cancer drugs; lipid metabolism; lipogenic enzyme inhibitors	FATTY-ACID SYNTHASE; ACETYL-COA CARBOXYLASE; ATP-CITRATE LYASE; MONOACYLGLYCEROL LIPASE MAGL; HIGHLY SELECTIVE INHIBITORS; REDUCES HEPATIC STEATOSIS; DE-NOVO LIPOGENESIS; MONOGLYCERIDE LIPASE; CRYSTAL-STRUCTURE; PROSTATE-CANCER	Cancer cells rely on several metabolic pathways such as lipid metabolism to meet the increase in energy demand, cell division, and growth and successfully adapt to challenging environments. Fatty acid synthesis is therefore commonly enhanced in many cancer cell lines. Thus, relevant efforts are being made by the scientific community to inhibit the enzymes involved in lipid metabolism to disrupt cancer cell proliferation. We review the rapidly expanding body of inhibitors that target lipid metabolism, their side effects, and current status in clinical trials as potential therapeutic approaches against cancer. We focus on their molecular, biochemical and structural properties, selectivity and effectiveness and discuss their potential role as antitumor drugs.	[Montesdeoca, Nicolas; Lopez, Marta; Makowski, Kamil] Yachay Tech Univ, Sch Chem Sci & Engn, Hacienda San Jose S-N, San Miguel De Urcuqui, Ecuador; [Ariza, Xavier] Univ Barcelona, Sch Chem, Dept Inorgan & Organ Chem, Barcelona, Spain; [Ariza, Xavier; Herrero, Laura] Univ Barcelona, Inst Biomed Univ Barcelona IBUB, Barcelona, Spain; [Ariza, Xavier; Herrero, Laura] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Herrero, Laura] Univ Barcelona, Sch Pharm & Food Sci, Dept Biochem & Physiol, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona	Makowski, K (corresponding author), Yachay Tech Univ, Sch Chem Sci & Engn, Hacienda San Jose S-N, San Miguel De Urcuqui, Ecuador.; Herrero, L (corresponding author), Univ Barcelona, Sch Pharm & Food Sci, Dept Biochem & Physiol, E-08028 Barcelona, Spain.	lherrero@ub.edu; kamil.makowski@hotmail.com	Montesdeoca, Nicolas/AAE-5344-2021; Makowski, Kamil/S-9228-2018; Makowski, Kamil/M-8217-2019; Herrero, Laura/ABH-7724-2020	Montesdeoca, Nicolas/0000-0002-9629-1265; Makowski, Kamil/0000-0001-5806-550X; Makowski, Kamil/0000-0001-5806-550X; Herrero, Laura/0000-0003-4244-4673	Ministry of Spain (MINECO) [SAF2017-83813-C31-R]; European Regional Development Fund [ERDF]; Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) [CB06/03/0001]; Government of Catalonia [2017SGR278, 2017SGR474]; Fundacio La Marato de TV3 [201627-30]	Ministry of Spain (MINECO); European Regional Development Fund [ERDF](European Commission); Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Government of Catalonia(Generalitat de Catalunya); Fundacio La Marato de TV3	Ministry of Spain (MINECO), Grant/Award Number: SAF2017-83813-C31-R; European Regional Development Fund [ERDF]; Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Grant/Award Number: CB06/03/0001; Government of Catalonia, Grant/Award Number: 2017SGR278 and 2017SGR474; Fundacio La Marato de TV3, Grant/Award Number: 201627-30	Aaltonen N, 2013, CHEM BIOL, V20, P379, DOI 10.1016/j.chembiol.2013.01.012; AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Aida J, 2018, J MED CHEM, V61, P9205, DOI 10.1021/acs.jmedchem.8b00824; Al-Zoughbi W, 2016, ONCOTARGET, V7, P33832, DOI 10.18632/oncotarget.9418; Alwarawrah Y, 2016, CELL CHEM BIOL, V23, P678, DOI 10.1016/j.chembiol.2016.04.011; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bandyopadhyay S, 2005, ONCOGENE, V24, P5389, DOI 10.1038/sj.onc.1208555; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Bhargava-Shah A, 2016, NANOMEDICINE-UK, V11, P235, DOI 10.2217/nnm.15.193; Bifulco M, 2008, ENDOCR-RELAT CANCER, V15, P391, DOI 10.1677/ERC-07-0258; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Buckley D, 2017, PHARMACOL THERAPEUT, V177, P23, DOI 10.1016/j.pharmthera.2017.02.021; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Chang JW, 2012, CHEM BIOL, V19, P579, DOI 10.1016/j.chembiol.2012.03.009; Chen L, 2019, EXPERT OPIN INV DRUG, V3784, P1; Chen M, 2019, PRECIS CLIN MED, V2, P183, DOI 10.1093/pcmedi/pbz017; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Chonan T, 2009, BIOORG MED CHEM LETT, V19, P6645, DOI 10.1016/j.bmcl.2009.10.012; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Corominas-Faja B, 2014, ONCOTARGET, V5, P8306, DOI 10.18632/oncotarget.2059; Cotte AK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02732-5; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dakeng S, 2012, J CELL BIOCHEM, V113, P49, DOI 10.1002/jcb.23326; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; de Gonzalo-Calvo D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1469-5; Deng H, 2020, ACTA PHARM SIN B, V10, P582, DOI 10.1016/j.apsb.2019.10.006; Deng ZS, 2019, CHEM COMMUN, V55, P4194, DOI 10.1039/c9cc00256a; Falchook G, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-CT153; Fernandez HR, 2018, CELL DEATH DIFFER, V25, P1239, DOI 10.1038/s41418-018-0101-z; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Gao YJ, 2014, CANCER LETT, V349, P15, DOI 10.1016/j.canlet.2014.03.015; GERTH K, 1994, J ANTIBIOT, V47, P23, DOI 10.7164/antibiotics.47.23; Granchi C, 2019, TRENDS PHARMACOL SCI, V40, P364, DOI 10.1016/j.tips.2019.04.008; Granchi C, 2019, J MED CHEM, V62, P1932, DOI 10.1021/acs.jmedchem.8b01483; Granchi C, 2018, EUR J MED CHEM, V157, P1276, DOI 10.1016/j.ejmech.2018.09.001; Granchi C, 2017, EXPERT OPIN THER PAT, V27, P1341, DOI 10.1080/13543776.2018.1389899; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Guais A, 2012, INVEST NEW DRUG, V30, P200, DOI 10.1007/s10637-010-9552-x; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; Harriman G, 2016, P NATL ACAD SCI USA, V113, pE1796, DOI 10.1073/pnas.1520686113; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hill TK, 2016, MOL PHARMACEUT, V13, P720, DOI 10.1021/acs.molpharmaceut.5b00447; Huang C, 2020, CAN MATH BULL, V63, P405, DOI 10.4153/S0008439519000511; Hunsakunachai N, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2568-7; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jayaprakasam B, 2003, CANCER LETT, V189, P11, DOI 10.1016/S0304-3835(02)00497-4; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Jump DB, 2011, BIOCHEM PHARMACOL, V81, P649, DOI 10.1016/j.bcp.2010.12.014; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Karlsson M, 2001, GENE, V272, P11, DOI 10.1016/S0378-1119(01)00559-5; Kim CW, 2017, CELL METAB, V26, P394, DOI 10.1016/j.cmet.2017.07.009; Kinsey SG, 2013, J PHARMACOL EXP THER, V345, P492, DOI 10.1124/jpet.112.201426; Konkel B, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2064; Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Labar G, 2010, CURR MED CHEM, V17, P2588, DOI 10.2174/092986710791859414; Li EQ, 2019, EUR J PHARM SCI, V137, DOI 10.1016/j.ejps.2019.105010; Li JJ, 2007, BIOORG MED CHEM LETT, V17, P3208, DOI 10.1016/j.bmcl.2007.03.017; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Liu XY, 2019, BIOMARK RES, V7, DOI 10.1186/s40364-019-0173-z; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lu TB, 2018, BIOORG MED CHEM LETT, V28, P2159, DOI 10.1016/j.bmcl.2018.05.014; Luo JT, 2017, CANCER LETT, V384, P39, DOI 10.1016/j.canlet.2016.09.020; Lytovchenko O, 2017, BBA-BIOENERGETICS, V1858, P641, DOI 10.1016/j.bbabio.2017.03.006; Ma MY, 2016, MOL MED REP, V13, P2850, DOI 10.3892/mmr.2016.4829; Makowski K, 2019, BIONATURA, V2, DOI [10.21931/RB/CS/2019.02.01.9, DOI 10.21931/RB/CS/2019.02.01.9]; Makowski K, 2017, EUR J MED CHEM, V131, P207, DOI 10.1016/j.ejmech.2017.03.012; Makowski K, 2013, CHIRALITY, V25, P281, DOI 10.1002/chir.22139; Mao JQ, 2003, P NATL ACAD SCI USA, V100, P7515, DOI 10.1073/pnas.1332670100; Marien E, 2016, ONCOTARGET, V7, P12582, DOI 10.18632/oncotarget.7179; Martel PM, 2006, EXP CELL RES, V312, P278, DOI 10.1016/j.yexcr.2005.10.022; Martin MW, 2019, BIOORG MED CHEM LETT, V29, P1001, DOI 10.1016/j.bmcl.2019.02.012; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; McAllister LA, 2018, J MED CHEM, V61, P3008, DOI 10.1021/acs.jmedchem.8b00070; McFadden JM, 2005, J MED CHEM, V48, P946, DOI 10.1021/jm049389h; Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Menendez JA, 2017, EXPERT OPIN THER TAR, V21, P1001, DOI 10.1080/14728222.2017.1381087; Merarchi M, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7030053; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Mizojiri R, 2019, BIOORG MED CHEM LETT, V29, DOI 10.1016/j.bmcl.2019.126749; Mizojiri R, 2018, J MED CHEM, V61, P1098, DOI 10.1021/acs.jmedchem.7b01547; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Muccioli GG, 2008, CHEMBIOCHEM, V9, P2704, DOI 10.1002/cbic.200800428; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Nishiura Y, 2018, BIOORG MED CHEM LETT, V28, P2498, DOI 10.1016/j.bmcl.2018.05.055; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; OLEYNEK JJ, 1995, DRUG DEVELOP RES, V36, P35, DOI 10.1002/ddr.430360106; Oslob JD, 2013, ACS MED CHEM LETT, V4, P113, DOI 10.1021/ml300335r; Pacilli A, 2013, JNCI-J NATL CANCER I, V105, P489, DOI 10.1093/jnci/djt030; Panman W, 2018, J BIOMOL STRUCT DYN, V36, P4114, DOI 10.1080/07391102.2017.1408496; Pasquarelli N, 2015, NEUROPHARMACOLOGY, V91, P148, DOI 10.1016/j.neuropharm.2014.12.001; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Promkan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055732; Qin H, 2014, CELL BIOCHEM BIOPHYS, V70, P33, DOI 10.1007/s12013-014-9899-2; Qu B, 2014, ATMOS CHEM PHYS, V14, P11117, DOI 10.5194/acp-14-11117-2014; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Resh MD, 2013, CURR BIOL, V23, pR431, DOI 10.1016/j.cub.2013.04.024; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Sadowski MC, 2014, ONCOTARGET, V5, P9362, DOI 10.18632/oncotarget.2433; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Scalvini L, 2016, CHEM PHYS LIPIDS, V197, P13, DOI 10.1016/j.chemphyslip.2015.07.011; Schcolnik-Cabrera A, 2018, EXPERT OPIN INV DRUG, V27, P475, DOI 10.1080/13543784.2018.1471132; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Serra D, 2013, ANTIOXID REDOX SIGN, V19, P269, DOI 10.1089/ars.2012.4875; Shaw G, 2013, J UROLOGY, V189, P300; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shimamura K, 2009, J PHARMACOL EXP THER, V330, P249, DOI 10.1124/jpet.109.150854; Singh KB, 2019, MOL CANCER THER, V18, P1800, DOI 10.1158/1535-7163.MCT-19-0046; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Stoiber K, 2018, BRIT J CANCER, V118, P43, DOI 10.1038/bjc.2017.374; Sun TJ, 2010, J BIOL CHEM, V285, P27418, DOI 10.1074/jbc.M109.078667; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Tabrizi MA, 2018, J MED CHEM, V61, P1340, DOI 10.1021/acs.jmedchem.7b01845; Tarui M, 2014, J LIPID RES, V55, P1386, DOI 10.1194/jlr.M049205; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tracz-Gaszewska Z, 2019, CANCERS, V11, DOI 10.3390/cancers11070948; Ventura R, 2015, EBIOMEDICINE, V2, P808, DOI 10.1016/j.ebiom.2015.06.020; Verschueren KHG, 2019, NATURE, V568, P571, DOI 10.1038/s41586-019-1095-5; Vriens K, 2019, NATURE, V566, P403, DOI 10.1038/s41586-019-0904-1; Wang C, 2015, EXPERT REV ANTICANC, V15, P667, DOI 10.1586/14737140.2015.1038246; Wang Chun, 2010, Front Biosci (Schol Ed), V2, P515; Wang JJ, 2019, IEEE HI ASS SYS ENGR, P9, DOI 10.1109/HASE.2019.00012; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Wei J, 2019, NATURE, V568, P566, DOI 10.1038/s41586-019-1094-6; Wei J, 2015, NATURE, V526, P723, DOI 10.1038/nature15375; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xiang W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04999-8; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zadra G, 2019, P NATL ACAD SCI USA, V116, P631, DOI 10.1073/pnas.1808834116; Zagelbaum NK, 2019, CARDIOL REV, V27, P49, DOI 10.1097/CRD.0000000000000218; Zaidi N, 2012, MOL CANCER THER, V11, P1925, DOI 10.1158/1535-7163.MCT-12-0095; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zhang HL, 2004, STRUCTURE, V12, P1683, DOI 10.1016/j.str.2004.07.009; Zhang J., 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP23488; Zhang JS, 2016, PHARM BIOL, V54, P1919, DOI 10.3109/13880209.2015.1113995; Zhang YQ, 2001, J BIOL CHEM, V276, P974, DOI 10.1074/jbc.M005894200; Zhang Z, 2015, HIPPOCAMPUS, V25, P16, DOI 10.1002/hipo.22344; Zhao J, 2017, ONCOL REP, V38, P2105, DOI 10.3892/or.2017.5864; Zhou WB, 2003, CANCER RES, V63, P7330	170	22	22	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11355	11381		10.1096/fj.202000705R	http://dx.doi.org/10.1096/fj.202000705R		AUG 2020	27	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32761847	Green Submitted			2022-12-28	WOS:000558192000001
J	Georgieva, JV; Goulatis, LI; Stutz, CC; Canfield, SG; Song, HW; Gastfriend, BD; Shusta, EV				Georgieva, Julia, V; Goulatis, Loukas, I; Stutz, Charles C.; Canfield, Scott G.; Song, Hannah W.; Gastfriend, Benjamin D.; Shusta, Eric, V			Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS	FASEB JOURNAL			English	Article						antibody-mediated brain drug delivery; blood-brain barrier; nicotinamide adenine dinucleotide	DRUG-DELIVERY; IN-VIVO; ENDOTHELIAL-CELLS; PHAGE; GENERATION; TRANSPORT; BINDING; PERMEABILITY; PENETRATION; MAINTENANCE	Drug delivery across the blood-brain barrier (BBB) remains a significant obstacle for the development of neurological disease therapies. The low penetration of blood-borne therapeutics into the brain can oftentimes be attributed to the restrictive nature of the brain microvascular endothelial cells (BMECs) that comprise the BBB. One strategy beginning to be successfully leveraged is the use of endogenous receptor-mediated transcytosis (RMT) systems as a means to shuttle a targeted therapeutic into the brain. Limitations of known RMT targets and their cognate targeting reagents include brain specificity, brain uptake levels, and off-target effects, driving the search for new and potentially improved brain targeting reagent-RMT pairs. To this end, we deployed human-induced pluripotent stem cell (iPSC)-derived BMEC-like cells as a model BBB substrate on which to mine for new RMT-targeting antibody pairs. A nonimmune, human single-chain variable fragment (scFv) phage display library was screened for binding, internalization, and transcytosis across iPSC-derived BMECs. Lead candidates exhibited binding and internalization into BMECs as well as binding to both human and mouse BBB in brain tissue sections. Antibodies targeted the murine BBB after intravenous administration with one particular clone, 46.1-scFv, exhibiting a 26-fold increase in brain accumulation (8.1 nM). Moreover, clone 46.1-scFv was found to associate with postvascular, parenchymal cells, indicating its successful receptor-mediated transport across the BBB. Such a new BBB targeting ligand could enhance the transport of therapeutic molecules into the brain.	[Georgieva, Julia, V; Goulatis, Loukas, I; Stutz, Charles C.; Canfield, Scott G.; Song, Hannah W.; Gastfriend, Benjamin D.; Shusta, Eric, V] Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA; [Canfield, Scott G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Terre Haute, IN USA; [Shusta, Eric, V] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Indiana University System; University of Wisconsin System; University of Wisconsin Madison	Shusta, EV (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	eshusta@wisc.edu		Canfield, Scott/0000-0003-1328-7365	HHS \ National Institutes of Health (NIH) [NS071513]; DOD | Defense Threat Reduction Agency (DTRA) [HDTRA1-15-1-0012]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD | Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: NS071513; DOD | Defense Threat Reduction Agency (DTRA), Grant/Award Number: HDTRA1-15-1-0012	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Campisi M, 2018, BIOMATERIALS, V180, P117, DOI 10.1016/j.biomaterials.2018.07.014; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Delsing L, 2018, STEM CELLS, V36, P1816, DOI 10.1002/stem.2908; Faley SL, 2019, STEM CELL REP, V12, P474, DOI 10.1016/j.stemcr.2019.01.009; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Goulatis LI, 2017, CURR OPIN STRUC BIOL, V45, P109, DOI 10.1016/j.sbi.2016.12.005; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Hanzatian DK, 2018, MABS-AUSTIN, V10, P765, DOI 10.1080/19420862.2018.1465159; Haqqani AS, 2018, J NEUROCHEM, V146, P735, DOI 10.1111/jnc.14482; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Johnsen BKB, 2019, J CONTROL RELEASE, V295, P237, DOI 10.1016/j.jconrel.2019.01.005; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Jones AR, 2014, BIOTECHNOL J, V9, P664, DOI 10.1002/biot.201300550; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; Kurosawa T, 2018, MOL PHARMACEUT, V15, P5546, DOI 10.1021/acs.molpharmaceut.8b00697; Li JW, 2011, BIOMATERIALS, V32, P4943, DOI 10.1016/j.biomaterials.2011.03.031; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; O'Connell D, 2002, J MOL BIOL, V321, P49, DOI 10.1016/S0022-2836(02)00561-2; Pardridge WM, 2015, EXPERT OPIN DRUG DEL, V12, P207, DOI 10.1517/17425247.2014.952627; PARDRIDGE WM, 1995, PHARMACEUT RES, V12, P807, DOI 10.1023/A:1016244500596; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Park TE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10588-0; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Ribecco-Lutkiewicz M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19522-8; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Stebbins MJ, 2016, METHODS, V101, P93, DOI 10.1016/j.ymeth.2015.10.016; Stephen TL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50781-1; Stutz CC, 2018, AICHE J, V64, P4229, DOI 10.1002/aic.16360; Stutz CC, 2014, CURR PHARM DESIGN, V20, P1564, DOI 10.2174/13816128113199990459; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Umlauf BJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4245; Urich E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14104; Vatine GD, 2017, CELL STEM CELL, V20, P831, DOI 10.1016/j.stem.2017.04.002; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; Wang XX, 2007, NAT METHODS, V4, P143, DOI 10.1038/nmeth993; Wang YI, 2017, BIOTECHNOL BIOENG, V114, P184, DOI 10.1002/bit.26045; Webster CI, 2016, FASEB J, V30, P1927, DOI 10.1096/fj.201500078; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhou Yu, 2009, V525, P145, DOI 10.1007/978-1-59745-554-1_7; Zorniak M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16066-1; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	51	9	9	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12549	12564		10.1096/fj.202000851R	http://dx.doi.org/10.1096/fj.202000851R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32960493	Green Accepted			2022-12-28	WOS:000556911000001
J	Chen, X; Lungova, V; Zhang, HY; Mohanty, C; Kendziorski, C; Thibeault, SL				Chen, Xia; Lungova, Vlasta; Zhang, Haiyan; Mohanty, Chitrasen; Kendziorski, Christina; Thibeault, Susan L.			Novel immortalized human vocal fold epithelial cell line: In vitro tool for mucosal biology	FASEB JOURNAL			English	Article						human vocal fold epithelial cells; immortalization; telomerase; three&#8208; dimensional VF mucosal model	MODEL; MIGRATION; FIBROBLASTS; TELOMERASE; MECHANISMS; SUFFICIENT; SENESCENCE; RESPONSES; GENE	Study of vocal fold (VF) mucosal biology requires essential human vocal fold epithelial cell (hVFE) lines for use in appropriate model systems. We steadily transfected a retroviral construct containing human telomerase reverse transcriptase (hTERT) into primary normal hVFE to establish a continuously replicating hVFE cell line. Immortalized hVFE across passages have cobblestone morphology, express epithelial markers cytokeratin 4, 13 and 14, induced hTERT gene and protein expression, have similar RNAseq profiling, and can continuously grow for more than 8 months. DNA fingerprinting and karyotype analysis demonstrated that immortalized hVFE were consistent with the presence of a single cell line. Validation of the hVFE, in a three-dimensional in vitro VF mucosal construct revealed a multilayered epithelial structure with VF epithelial cell markers. Wound scratch assay revealed higher migration capability of the immortalized hVFE on the surface of collagen-fibronectin and collagen gel containing human vocal fold fibroblasts (hVFF). Collectively, our report demonstrates the first immortalized hVFE from true VFs providing a novel and invaluable tool for the study of epithelial cell-fibroblast interactions that dictate disease and health of this specialized tissue.	[Chen, Xia; Lungova, Vlasta; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, 5103 WIMR,1111 Highland Ave, Madison, WI 53705 USA; [Zhang, Haiyan] Shandong Univ, Shandong Prov ENT Hosp, Cheeloo Coll Med, Dept Otolaryngol Head & Neck Surg, Jinan, Peoples R China; [Mohanty, Chitrasen; Kendziorski, Christina] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Shandong University; University of Wisconsin System; University of Wisconsin Madison	Thibeault, SL (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, 5103 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	thibeault@surgery.wisc.edu		Lungova, Vlasta/0000-0002-5723-3441	NIDCD NIH HHS [R01 DC004336, R01 DC012773] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alvarez J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41102-7; Andrews S., 2010, FASTQC QUALITY CONTR; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen X, 2008, LARYNGOSCOPE, V118, P1700, DOI 10.1097/MLG.0b013e31817aec6c; Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390; Erickson-DiRenzo E, 2019, LARYNGOSCOPE, V129, pE355, DOI 10.1002/lary.27909; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Gregoire L, 2001, CLIN CANCER RES, V7, P4280; Gu YP, 2006, EXP CELL RES, V312, P831, DOI 10.1016/j.yexcr.2005.11.029; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hartman CD, 2016, P NATL ACAD SCI USA, V113, P11190, DOI 10.1073/pnas.1611324113; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Hu PR, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.25; HURLIN PJ, 1991, P NATL ACAD SCI USA, V88, P570, DOI 10.1073/pnas.88.2.570; INOKUCHI S, 1995, BRIT J CANCER, V71, P819, DOI 10.1038/bjc.1995.158; Iversen Nina, 2005, Genet Vaccines Ther, V3, P2, DOI 10.1186/1479-0556-3-2; Karamichos D, 2009, CELL MOTIL CYTOSKEL, V66, P1, DOI 10.1002/cm.20326; Kim CW, 2016, J PHARMACOL TOX MET, V80, P82, DOI 10.1016/j.vascn.2016.05.013; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Leydon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115389; Leydon C, 2013, TISSUE ENG PT A, V19, P2233, DOI [10.1089/ten.tea.2012.0744, 10.1089/ten.TEA.2012.0744]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li NF, 2007, CELL PROLIFERAT, V40, P780, DOI 10.1111/j.1365-2184.2007.00462.x; Ling C., 2015, SCI TRANSL MED, V18, P314; Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Lungova V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12069-w; Lungova V, 2016, METHODS MOL BIOL, V1307, P237, DOI 10.1007/7651_2014_132; Lungova V, 2015, DEV BIOL, V399, P263, DOI 10.1016/j.ydbio.2014.12.037; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Miyazaki K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36646-z; Palencia L, 2015, J SURG RES, V197, P32, DOI 10.1016/j.jss.2015.02.066; Powell J, 2019, LARYNGOSCOPE, V129, P2640, DOI 10.1002/lary.27761; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; SCHOR SL, 1980, J CELL SCI, V41, P159; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Shin HY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205297; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith JL, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0122-6; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xie Y, 2010, TISSUE ENG PART C-ME, V16, P1111, DOI [10.1089/ten.tec.2009.0725, 10.1089/ten.TEC.2009.0725]; Yang G, 2007, CARCINOGENESIS, V28, P174, DOI 10.1093/carcin/bgl115; Yip YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078395	48	2	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21243	10.1096/fj.202001423R	http://dx.doi.org/10.1096/fj.202001423R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33428261	Green Published			2022-12-28	WOS:000647789600108
J	Luo, XH; Yin, JY; Miao, SH; Feng, WQ; Ning, TT; Xu, SM; Huang, SJ; Zhang, S; Liao, YJ; Hao, CB; Wu, BL; Ma, DD				Luo, Xinghong; Yin, Jingyao; Miao, Shenghong; Feng, Weiqing; Ning, Tingting; Xu, Shuaimei; Huang, Shijiang; Zhang, Sheng; Liao, Yunjun; Hao, Chunbo; Wu, Buling; Ma, Dandan			mTORC1 promotes mineralization via p53 pathway	FASEB JOURNAL			English	Article						cell signaling; dentinogenesis; molecular biology; mTORC1; odontoblast; tooth development	PULP STEM-CELLS; ODONTOGENIC DIFFERENTIATION; ODONTOBLAST DIFFERENTIATION; EXPRESSION; GROWTH; SUPPRESSES; PROTEINS; TARGET; TOOTH; MDM2	The objectives of our study were to investigate the roles of mTORC1 in odontoblast proliferation and mineralization and to determine the mechanism by which mTORC1 regulates odontoblast mineralization. In vitro, MDPC23 cells were treated with rapamycin (10 nmol/L) and transfected with a lentivirus for short hairpin (shRNA)-mediated silencing of the tuberous sclerosis complex (shTSC1) to inhibit and activate mTORC1, respectively. CCK8 assays, flow cytometry, Alizarin red S staining, ALP staining, qRT-PCR, and western blot analysis were performed. TSC1-conditional knockout (DMP1-Cre(+); TSC1(f/f), hereafter CKO) mice and littermate control (DMP1-Cre(-); TSC1(f/f), hereafter WT) mice were generated. H&E staining, immunofluorescence, and micro-CT analysis were performed. Transcriptome sequencing analysis was used to screen the mechanism of this process. mTORC1 inactivation decreased the cell proliferation. The qRT-PCR and western blot results showed that mineralization-related genes and proteins were downregulated in mTORC1-inactivated cells. Moreover, mTORC1 overactivation promoted cell proliferation and mineralization-related gene and protein expression. In vivo, the micro-CT results showed that DV/TV and dentin thickness were higher in CKO mice than in controls and H&E staining showed the same results. Mineralization-related proteins expression was upregulated. Transcriptome sequencing analysis revealed that p53 pathway-associated genes were differentially expressed in TSC1-deficient cells. By inhibiting p53 alone or both mTORC1 and p53 with rapamycin and a p53 inhibitor, we elucidated that p53 acts downstream of mTORC1 and that mTORC1 thereby promotes odontoblast mineralization. Taken together, our findings demonstrate that the role of mTORC1 in odontoblast proliferation and mineralization, and confirm that mTORC1 upregulates odontoblast mineralization via the p53 pathway.	[Luo, Xinghong; Yin, Jingyao; Miao, Shenghong; Feng, Weiqing; Wu, Buling] Southern Med Univ, Nanfang Hosp, Dept Stomatol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China; [Luo, Xinghong; Yin, Jingyao; Miao, Shenghong; Feng, Weiqing; Ning, Tingting; Xu, Shuaimei; Wu, Buling] Southern Med Univ, Coll Stomatol, Guangzhou, Peoples R China; [Ning, Tingting; Xu, Shuaimei; Ma, Dandan] Southern Med Univ, Stomatol Hosp, Dept Endodont, Guangzhou, Peoples R China; [Huang, Shijiang; Zhang, Sheng] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou, Peoples R China; [Hao, Chunbo] Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Dept Stomatol, Haikou, Hainan, Peoples R China; [Liao, Yunjun] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Peoples R China; [Ma, Dandan] Univ Maryland, Sch Dent, Dept Adv Oral Sci & Therapeut, Baltimore, MD 21201 USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Hainan Medical University; Southern Medical University - China; University System of Maryland; University of Maryland Baltimore	Ma, DD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Stomatol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.	mdd@smu.edu.cn						Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Chen M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00703; Chen P, 2009, EXP MOL PATHOL, V86, P101, DOI 10.1016/j.yexmp.2009.01.013; Chen Z, 2016, CELL TISSUE RES, V363, P385, DOI 10.1007/s00441-015-2260-2; Choi H, 2016, CELL TISSUE RES, V364, P95, DOI 10.1007/s00441-015-2310-9; Da Pozzo E, 2014, ACS CHEM NEUROSCI, V5, P390, DOI 10.1021/cn4002208; Garg A, 2020, BIOPHYS J, V118, P720, DOI 10.1016/j.bpj.2019.12.015; Hanks CT, 1998, EUR J ORAL SCI, V106, P260, DOI 10.1111/j.1600-0722.1998.tb02185.x; Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442; Hasty P, 2013, CELL CYCLE, V12, P20, DOI 10.4161/cc.22912; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13911-x; Huang B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005426; Huang DL, 2020, STEM CELL REV REP, V16, P41, DOI 10.1007/s12015-019-09940-0; Hur SW, 2015, J DENT RES, V94, P1135, DOI 10.1177/0022034515585125; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kaufman MH, 1997, J ANAT, V191, P57, DOI 10.1046/j.1469-7580.1997.19110057.x; Kim JK, 2011, J ENDODONT, V37, P1081, DOI 10.1016/j.joen.2011.03.034; Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166; Li C, 2018, INT ENDOD J, V51, pe115, DOI 10.1111/iej.12771; Li N, 2019, DENT MATER J, V38, P534, DOI 10.4012/dmj.2018-155; Liao CF, 2019, J CELL PHYSIOL, V234, P20779, DOI 10.1002/jcp.28684; Liu W, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.180262; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Fernandez-Cruz ML, 2011, LIFE SCI, V88, P774, DOI 10.1016/j.lfs.2011.02.019; Ma DD, 2018, J CELL MOL MED, V22, P3442, DOI 10.1111/jcmm.13621; MATSUYAMA T, 1990, CALCIFIED TISSUE INT, V47, P276, DOI 10.1007/BF02555909; Alvarez MMP, 2019, DENT MATER, V35, P606, DOI 10.1016/j.dental.2019.02.008; Shaikh MF, 2016, ANN CLIN LAB SCI, V46, P627; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Tanaka Y, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1077-9; Tao ZH, 2010, BIOCHEMISTRY-US, V49, P8488, DOI 10.1021/bi100673c; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Wang HY, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00075; Wang H, 2019, J CELL PHYSIOL, V234, P12897, DOI 10.1002/jcp.27954; Xie FR, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00250; Yu D, 2019, J CELL PHYSIOL, V234, P1442, DOI 10.1002/jcp.26950; Zhang XY, 2019, J PROTEOMICS, V202, DOI 10.1016/j.jprot.2019.04.014; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zhang Y, 2017, J BONE MINER RES, V32, P1829, DOI 10.1002/jbmr.3172; Zheng H, 2020, J DENT RES, V99, P320, DOI 10.1177/0022034519893672	43	2	2	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21325	10.1096/fj.202002016R	http://dx.doi.org/10.1096/fj.202002016R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33508145	Bronze			2022-12-28	WOS:000647789600073
J	Warner, DR; Warner, JB; Hardesty, JE; Song, YL; Chen, CY; Chen, Z; Kang, JX; McClain, CJ; Kirpich, IA				Warner, Dennis R.; Warner, Jeffrey B.; Hardesty, Josiah E.; Song, Ying L.; Chen, Chi-Yu; Chen, Zoe; Kang, Jing X.; McClain, Craig J.; Kirpich, Irina A.			Beneficial effects of an endogenous enrichment in n3-PUFAs on Wnt signaling are associated with attenuation of alcohol-mediated liver disease in mice	FASEB JOURNAL			English	Article						alcohol&#8208; associated liver disease; n3&#8208; PUFAs; n6; n3&#8208; PUFA ratio; Wnt signaling	TRANSGENIC MICE; NEGATIVE REGULATOR; BETA-CATENIN; CELL-DEATH; INJURY; PROMOTES; ETHANOL; INFLAMMATION; ACID; JNK	Alcohol-associated liver disease (ALD) is a major human health issue for which there are limited treatment options. Experimental evidence suggests that nutrition plays an important role in ALD pathogenesis, and specific dietary fatty acids, for example, n6 or n3-PUFAs, may exacerbate or attenuate ALD, respectively. The purpose of the current study was to determine whether the beneficial effects of n3-PUFA enrichment in ALD were mediated, in part, by improvement in Wnt signaling. Wild-type (WT) and fat-1 transgenic mice (that endogenously convert n6-PUFAs to n3) were fed ethanol (EtOH) for 6 weeks followed by a single LPS challenge. fat-1 mice had less severe liver damage than WT littermates as evidenced by reduced plasma alanine aminotransferase, hepatic steatosis, liver tissue neutrophil infiltration, and pro-inflammatory cytokine expression. WT mice had a greater downregulation of Axin2, a key gene in the Wnt pathway, than fat-1 mice in response to EtOH and LPS. Further, there were significant differences between WT and fat-1 EtOH+LPS-challenged mice in the expression of five additional genes linked to the Wnt signaling pathway, including Apc, Fosl1/Fra-1, Mapk8/Jnk-1, Porcn, and Nkd1. Compared to WT, primary hepatocytes isolated from fat-1 mice exhibited more effective Wnt signaling and were more resistant to EtOH-, palmitic acid-, or TNF alpha-induced cell death. Further, we demonstrated that the n3-PUFA-derived lipid mediators, resolvins D1 and E1, can regulate hepatocyte expression of several Wnt-related genes that were differentially expressed between WT and fat-1 mice. These data demonstrate a novel mechanism by which n3-PUFAs can ameliorate ALD.	[Warner, Dennis R.; Warner, Jeffrey B.; Hardesty, Josiah E.; Song, Ying L.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Dept Med, Div Gastroenterol Hepatol & Nutr, 505 South Hancock St, Louisville, KY 40202 USA; [Warner, Jeffrey B.; Hardesty, Josiah E.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Dept Pharmacol & Toxicol, Sch Med, Louisville, KY 40202 USA; [Chen, Chi-Yu; Chen, Zoe; Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Chen, Chi-Yu; Chen, Zoe; Kang, Jing X.] Harvard Med Sch, Boston, MA 02115 USA; [McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Alcohol Ctr, Sch Med, Louisville, KY 40202 USA; [McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Sch Med, Hepatobiol & Toxicol Ctr, Louisville, KY 40202 USA; [McClain, Craig J.] Robley Rex Vet Med Ctr, Louisville, KY USA	University of Louisville; University of Louisville; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Louisville; University of Louisville	Kirpich, IA (corresponding author), Univ Louisville, Dept Med, Div Gastroenterol Hepatol & Nutr, 505 South Hancock St, Louisville, KY 40202 USA.	i0kirp01@louisville.edu			NIAAA NIH HHS [R01 AA024102, L30 AA027913, U01 AA026936, P50 AA024337, U01 AA026934, R01 AA023681, U01 AA026980, P50AA024337, F31 AA028423, F32 AA027950] Funding Source: Medline; NIEHS NIH HHS [T32 ES011564] Funding Source: Medline; NIGMS NIH HHS [P20 GM113226, P20GM113226] Funding Source: Medline; NIH HHS [1U01AA026926-01] Funding Source: Medline; BLRD VA [I01 BX002996] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BLRD VA		Asai S, 2004, J IMMUNOL, V173, P4669, DOI 10.4049/jimmunol.173.7.4669; Bellentani S, 2001, J HEPATOL, V35, P531, DOI 10.1016/S0168-8278(01)00151-9; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; Diehl AM, 2004, ALCOHOL, V34, P81, DOI 10.1016/j.alcohol.2004.07.010; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gustot T, 2017, J HEPATOL, V67, P1031, DOI 10.1016/j.jhep.2017.06.013; Han MS, 2016, CELL REP, V15, P19, DOI 10.1016/j.celrep.2016.03.008; HERMAN B, 1988, FASEB J, V2, P146, DOI 10.1096/fasebj.2.2.3342967; Huang CK, 2015, J HEPATOL, V63, P191, DOI 10.1016/j.jhep.2015.02.030; Huang LL, 2013, PROSTAG LEUKOTR ESS, V88, P347, DOI 10.1016/j.plefa.2013.02.002; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Isayama F, 2016, AM J PATHOL, V186, P1524, DOI 10.1016/j.ajpath.2016.02.006; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Khadge S, 2018, J NUTR BIOCHEM, V52, P92, DOI 10.1016/j.jnutbio.2017.09.017; Kireva T, 2011, HEPATOLOGY, V53, P1259, DOI 10.1002/hep.24175; Kirpich IA, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010001; Liebig M, 2019, HEPATOBIL SURG NUTR, V8, P447, DOI 10.21037/hbsn.2019.04.03; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063610; Lopez MF, 2018, AM J PHYSIOL-ENDOC M, V315, pE735, DOI 10.1152/ajpendo.00048.2018; Ma J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136496; Nile AH, 2017, P NATL ACAD SCI USA, V114, P4147, DOI 10.1073/pnas.1618293114; Perugorria MJ, 2019, NAT REV GASTRO HEPAT, V16, P121, DOI 10.1038/s41575-018-0075-9; Praetner M, 2018, ARTERIOSCL THROM VAS, V38, P829, DOI 10.1161/ATVBAHA.117.309760; Preziosi M, 2018, HEPATOL COMMUN, V2, P845, DOI 10.1002/hep4.1196; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Schulien I, 2019, CELL DEATH DIFFER, V26, P1688, DOI 10.1038/s41418-018-0239-8; Seitz HK, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0014-7; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shim YR, 2020, EXP MOL MED, V52, P772, DOI 10.1038/s12276-020-0438-5; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Steinhart Z, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146589; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Warner DR, 2019, J LIPID RES, V60, P2034, DOI 10.1194/jlr.RA119000200; Warner DR, 2017, AM J PATHOL, V187, P2232, DOI 10.1016/j.ajpath.2017.06.008; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Zhao LD, 2019, HEPATOLOGY, V69, P2623, DOI 10.1002/hep.30563; Zirnheld K.H., 2019, LIVER RES, V3, P206, DOI [10.1016/j.livres.2019.10.001, DOI 10.1016/J.LIVRES.2019.10.001]	48	5	5	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21377	10.1096/fj.202001202R	http://dx.doi.org/10.1096/fj.202001202R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33481293	Green Accepted, Bronze			2022-12-28	WOS:000647789600083
J	Yan, SM; Wu, G				Yan, Shaomin; Wu, Guang			Is lymphopenia different between SARS and COVID-19 patients?	FASEB JOURNAL			English	Article						COVID-19; lymphopenia; glucocorticoids; apoptosis; SARS-CoV; SARS-CoV-2	ACUTE RESPIRATORY SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; HUMAN CORONAVIRUS NL63; SPIKE PROTEIN; CLINICAL CHARACTERISTICS; MONOCYTE DEACTIVATION; FUNCTIONAL RECEPTOR; IMMUNE-RESPONSE; CATHEPSIN-L; APOPTOSIS	Lymphopenia is commonly observed in SARS and COVID-19 patients although the lymphocyte count is not always below 0.8 x 10(9)/L in all the patients. It is suggested that lymphopenia serves as a useful predictor for prognosis in the patients. It is also hypothesized that lymphopenia is related to glucocorticoids and apoptosis. However, the ordering between lymphopenia and apoptosis appears different between SARS and COVID-19 patients, ie, lymphopenia is prior to apoptosis in SARS patients whereas apoptosis is prior to lymphopenia in COVID-19 patients. This paper attempts to figure out this contradiction through three players, lymphopenia, glucocorticoids, and apoptosis. Although the literature does not provide a solid explanation, the level of glucocorticoids could determine the ordering between lymphopenia and apoptosis because the administration of high doses of glucocorticoids could lead to lymphopenia whereas low doses of glucocorticoids could benefit patients. In the meantime, this paper raises several questions, which need to be answered in order to better understand the whole course of COVID-19.	[Yan, Shaomin; Wu, Guang] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Guangxi Biomass Engn Technol Res Ctr,Guangxi Key, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China		Wu, G (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Guangxi Biomass Engn Technol Res Ctr,Guangxi Key, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China.	hongguanglishibahao@gxas.cn		Wu, Guang/0000-0003-0775-5759; Yan, Shaomin/0000-0001-7642-3972				Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Baraniuk JN, 1997, AM J RESP CRIT CARE, V155, P704, DOI 10.1164/ajrccm.155.2.9032216; Barnes Peter J, 2011, Br J Pharmacol, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cui W, 2003, CLIN INFECT DIS, V37, P857, DOI 10.1086/378587; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Du LY, 2007, BIOCHEM BIOPH RES CO, V359, P174, DOI 10.1016/j.bbrc.2007.05.092; Fathi N, 2020, CELL BIOL INT, V44, P1792, DOI 10.1002/cbin.11403; FAUCI AS, 1976, ANN INTERN MED, V84, P304, DOI 10.7326/0003-4819-84-3-304; FAUCI AS, 1975, IMMUNOLOGY, V28, P669; Fehr AR, 2017, ANNU REV MED, V68, P387, DOI 10.1146/annurev-med-051215-031152; Franks TJ, 2003, HUM PATHOL, V34, P743, DOI 10.1016/S0046-8177(03)00367-8; Girardot T, 2017, APOPTOSIS, V22, P295, DOI 10.1007/s10495-016-1325-3; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Goodman S, 2002, CRIT CARE, V6, P381; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Henry BM, 2020, LANCET RESP MED, V8, pE24, DOI 10.1016/S2213-2600(20)30119-3; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Ho JC, 2003, AM J RESP CRIT CARE, V168, P1449, DOI 10.1164/rccm.200306-766OC; Ho T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010013; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hofmann H, 2006, J VIROL, V80, P8639, DOI 10.1128/JVI.00560-06; Hon KLE, 2003, LANCET, V361, P1701, DOI 10.1016/S0140-6736(03)13364-8; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18; Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12; Kleine-Weber H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34859-w; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lang ZW, 2003, CHINESE MED J-PEKING, V116, P976; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; Lu HY, 2005, WORLD J GASTROENTERO, V11, P2971, DOI 10.3748/wjg.v11.i19.2971; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Ma-Lauer Y, 2016, P NATL ACAD SCI USA, V113, pE5192, DOI 10.1073/pnas.1603435113; MAK JCW, 1995, AM J PHYSIOL-LUNG C, V268, pL41, DOI 10.1152/ajplung.1995.268.1.L41; Maneechotesuwan K, 2008, J ALLERGY CLIN IMMUN, V121, P43, DOI 10.1016/j.jaci.2007.10.011; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Mukerjee R, 2010, CELL CYCLE, V9, P4569, DOI 10.4161/cc.9.22.13836; Munoz-Fontela C, 2011, J IMMUNOL, V187, P6428, DOI 10.4049/jimmunol.1101459; Nelemans T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100961; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Panesar NS, 2008, MED HYPOTHESES, V71, P298, DOI 10.1016/j.mehy.2008.03.019; Panesar NS, 2004, EUR J CLIN INVEST, V34, P382, DOI 10.1111/j.1365-2362.2004.01347.x; Panesar NS, 2003, LANCET, V361, P1985, DOI 10.1016/S0140-6736(03)13557-X; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331; Shieh WJ, 2005, HUM PATHOL, V36, P303, DOI 10.1016/j.humpath.2004.11.006; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Sung JJY, 2004, THORAX, V59, P414, DOI 10.1136/thx.2003.014076; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Weber SU, 2008, CRIT CARE, V12, DOI 10.1186/cc7088; Wheeler DS, 2009, CRIT CARE, V13, DOI 10.1186/cc8162; Wu XD, 2004, CELL RES, V14, P400, DOI 10.1038/sj.cr.7290240; Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363; Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zheng F, 2020, EUR REV MED PHARMACO, V24, P3404, DOI 10.26355/eurrev_202003_20711; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011	87	8	8	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21245	10.1096/fj.202002512	http://dx.doi.org/10.1096/fj.202002512			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33495994	Green Published			2022-12-28	WOS:000647789600106
J	Carino, A; Marchiano, S; Biagioli, M; Scarpelli, P; Bordoni, M; Di Giorgio, C; Roselli, R; Fiorucci, C; Monti, MC; Distrutti, E; Zampella, A; Fiorucci, S				Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Scarpelli, Paolo; Bordoni, Martina; Di Giorgio, Cristina; Roselli, Rosalinda; Fiorucci, Chiara; Monti, Maria Chiara; Distrutti, Eleonora; Zampella, Angela; Fiorucci, Stefano			The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy	FASEB JOURNAL			English	Article						autophagy; bile acids; CREB; FXR; GPBAR1	NUCLEAR RECEPTOR; INTESTINAL MICROBIOTA; TGR5; METABOLISM; IDENTIFICATION; EXPRESSION; STEATOSIS; DISCOVERY; ENDOCRINE; LIGANDS	Autophagy is a highly conserved catabolic process activated by fasting and caloric restriction. FXR, a receptor for primary bile acids, reverses the activity of cAMP-response element binding protein (CREB) on autophagy-related genes (Atg)s and terminates autophagy in the fed state. GPBAR1, a receptor for secondary bile acids, exerts its genomic effects via cAMP-CREB pathway. By genetic and pharmacological approaches, we have obtained evidence that GPBAR1 functions as a positive modulator of autophagy in liver and white adipose tissue (WAT) in fasting. Mechanistically, we found that Gpbar1(-/-) mice lack the expression of Cyp2c70 a gene essential for generation of muricholic acids which are FXR antagonists, and have an FXR-biased bile acid pool. Because FXR represses autophagy, Gpbar1(-/-) mice show a defective regulation of autophagy in fasting. BAR501, a selective GPBAR1 agonist, induces autophagy in fed mice. Defective regulation of autophagy in Gpbar1(-/-) could be reversed by FXR antagonism, while repression of autophagy by feeding was partially abrogated by FXR gene ablation, and FXR activation repressed Atgs in the fast state. BAR501 reversed the negative regulatory effects of feeding and FXR agonism on autophagy and promoted the recruitment of CREB to a CRE on the LC3 promoter. In mice exposed to chronic high caloric intake, GPBAR1 agonism ameliorated insulin sensitivity and induced Atgs expression in the liver and WAT. In summary, GPBAR1 is required for positive regulation of autophagy in fasting and its ligands reverse the repressive effects exerted on liver and WAT autophagy flow by FXR in fed.	[Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Bordoni, Martina; Di Giorgio, Cristina; Fiorucci, Chiara; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Scarpelli, Paolo] Univ eCampus, Novedrate, Italy; [Roselli, Rosalinda; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, Fisciano, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, SC Gastroenterol & Epatol, Perugia, Italy	University of Perugia; Universita Ecampus; University of Naples Federico II; University of Salerno; University of Perugia; Azienda Ospedaliera di Perugia	Fiorucci, S (corresponding author), Univ Perugia, Med Sch, Dept Surg & Biomed Sci, Perugia, Italy.	stefano.fiorucci@unipg.it	Fiorucci, Stefano/I-1251-2012	Carino, Adriana/0000-0003-2341-9528				Allaire M, 2019, J HEPATOL, V70, P985, DOI 10.1016/j.jhep.2019.01.026; Biagioli M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081820; Bunnett NW, 2014, J PHYSIOL-LONDON, V592, P2943, DOI 10.1113/jphysiol.2014.271155; Byun S, 2017, EMBO J, V36, P1755, DOI 10.15252/embj.201695500; Carino A, 2019, FASEB J, V33, P2809, DOI 10.1096/fj.201801373RR; Carino A, 2018, PHARMACOL RES, V131, P17, DOI 10.1016/j.phrs.2018.02.033; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13102-y; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Casaburi I, 2012, CELL CYCLE, V11, P2699, DOI 10.4161/cc.21029; Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x; de Boer JF, 2020, J LIPID RES, V61, P291, DOI 10.1194/jlr.RA119000243; De Marino S, 2019, HANDB EXP PHARMACOL, V256, P137, DOI 10.1007/164_2019_237; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Festa C, 2019, ACS MED CHEM LETT, V10, P504, DOI 10.1021/acsmedchemlett.8b00534; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P3, DOI 10.1007/164_2019_238; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P283, DOI 10.1007/164_2019_227; Fiorucci S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01853; Fiorucci S, 2018, PHARMACOL RES, V134, P289, DOI 10.1016/j.phrs.2018.07.014; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Girolamo F, 2019, MUSCLE NERVE, V60, P315, DOI 10.1002/mus.26608; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo GCL, 2020, J LIPID RES, V61, P269, DOI 10.1194/jlr.C120000621; Hammoutene A, 2020, J HEPATOL, V72, P528, DOI 10.1016/j.jhep.2019.10.028; Holter MM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072124; Jakobi AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14343-8; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang PD, 2015, METHODS, V75, P13, DOI 10.1016/j.ymeth.2014.11.021; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Laing ED, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030260; Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035; Lee Jae Man, 2016, Ann Pediatr Endocrinol Metab, V21, P193, DOI 10.6065/apem.2016.21.4.193; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Levine B, 2015, J CLIN INVEST, V125, P14, DOI 10.1172/JCI73938; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mencarelli A, 2013, DIABETES, V62, P3384, DOI 10.2337/db13-0299; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Renga B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141082; Renga B, 2013, PHARMACOL RES, V77, P1, DOI 10.1016/j.phrs.2013.08.008; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Sepe V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19008; Sepe V, 2014, J MED CHEM, V57, P7687, DOI 10.1021/jm500889f; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Skledar DG, 2019, CHEMOSPHERE, V215, P870, DOI 10.1016/j.chemosphere.2018.10.129; Straniero S, 2020, J LIPID RES, V61, P480, DOI 10.1194/jlr.RA119000307; Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Towers CG, 2016, EBIOMEDICINE, V14, P15, DOI 10.1016/j.ebiom.2016.10.034; Tsuchiya H, 2015, GASTROENTEROLOGY, V148, P1012, DOI 10.1053/j.gastro.2015.01.045; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2013, AUTOPHAGY, V9, P756, DOI 10.4161/auto.23814; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xie C, 2017, DIABETES, V66, P613, DOI 10.2337/db16-0663; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; Zummo FP, 2017, DIABETES, V66, P1272, DOI 10.2337/db16-1009	76	6	7	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21271	10.1096/fj.202001386R	http://dx.doi.org/10.1096/fj.202001386R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368684				2022-12-28	WOS:000605626600023
J	Kwon, SM; Min, S; Jeoun, UW; Sim, MS; Jung, GH; Hong, SM; Jee, BA; Woo, HG; Lee, C; Yoon, G				Kwon, So Mee; Min, Seongki; Jeoun, Un-woo; Sim, Min Seok; Jung, Gu Hyun; Hong, Sun Mi; Jee, Byul A.; Woo, Hyun Goo; Lee, Changhan; Yoon, Gyesoon			Global spliceosome activity regulates entry into cellular senescence	FASEB JOURNAL			English	Article						oxidative stress; replicative senescence; splicing factors; Sp1; splicing variant; transcriptome	TRANSCRIPTION FACTOR SP1; GENE-EXPRESSION; DOWN-REGULATION; RNA; CELLS; P53; INVOLVEMENT; LONGEVITY; REVEALS; PATHWAY	Cellular senescence is a state of permanent growth arrest that can ultimately contribute to aging. Senescence can be induced by various stressors and is associated with a myriad of cellular functions and phenotypic markers. Alternative splicing is emerging as a critical contributor to senescence and aging. However, it is unclear how the composition and function of the spliceosome are involved in senescence. Here, using replicative and oxidative stress-induced senescence models in primary human fibroblasts, we report a common shift in the expression of 58 spliceosomal genes at the pre-senescence stage, prior to the detection of senescence-associated beta-galactosidase (SA-beta-gal) activity. Spliceosomal perturbation, induced by pharmacologic and genetic inhibition of splicesomal genes, triggered cells to enter senescence, suggesting a key role as a gatekeeper. Association analysis of transcription factors based on the 58 splicesomal genes revealed Sp1 as a key regulator of senescence entry. Indeed, Sp1 depletion suppressed the expression of downstream spliceosomal genes (HNRNPA3, SRSF7, and SRSF4) and effectively induced senescence. These results indicate that spliceosomal gene sets, rather than a single spliceosomal gene, regulate the early transition into senescence prior to SA-beta-gal expression. Furthermore, our study provides a spliceosome signature that may be used as an early senescence marker.	[Kwon, So Mee; Min, Seongki; Jeoun, Un-woo; Sim, Min Seok; Jung, Gu Hyun; Hong, Sun Mi; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea; [Kwon, So Mee; Jee, Byul A.; Woo, Hyun Goo] Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Min, Seongki; Jeoun, Un-woo; Sim, Min Seok; Jung, Gu Hyun; Hong, Sun Mi; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biomed Sci Plus BK21, Suwon, South Korea; [Lee, Changhan] USC Leonard Davis Sch Gerontol, Los Angeles, CA USA	Ajou University; Ajou University; Ajou University	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea.	ypeace@ajou.ac.kr	Woo, Hyun Goo/AEJ-7372-2022; Woo, Hyun Goo | 우현구/I-8954-2019	Woo, Hyun Goo/0000-0002-0916-893X; Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Min, Seongki/0000-0001-9621-0739				Alberstein M, 2007, RNA, V13, P1988, DOI 10.1261/rna.492907; An HJ, 2016, MOL CELL BIOCHEM, V414, P201, DOI 10.1007/s11010-016-2672-7; Breig O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059137; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chen J, 2017, CANCER DISCOV, V7, P766, DOI 10.1158/2159-8290.CD-16-0908; Chen WJ, 2015, CURR BIOL, V25, pR181, DOI 10.1016/j.cub.2014.11.059; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Deschenes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646; Effenberger KA, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1381; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789; Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148; Holly AC, 2013, MECH AGEING DEV, V134, P356, DOI 10.1016/j.mad.2013.05.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Blanco FJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00054; Jung HJ, 2017, J BIOL CHEM, V292, P3729, DOI 10.1074/jbc.M116.750539; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim SY, 2012, AGING CELL, V11, P1102, DOI 10.1111/acel.12012; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Latorre E, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0147-7; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maier AB, 2009, AGEING RES REV, V8, P237, DOI 10.1016/j.arr.2009.01.004; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Mazin P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.67; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Oh JE, 2007, BIOCHEM BIOPH RES CO, V353, P86, DOI 10.1016/j.bbrc.2006.11.118; Papasaikas P, 2015, MOL CELL, V57, P7, DOI 10.1016/j.molcel.2014.10.030; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Pont AR, 2012, MOL CELL, V47, P5, DOI 10.1016/j.molcel.2012.04.019; Rodriguez SA, 2016, AGING CELL, V15, P267, DOI 10.1111/acel.12433; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Shimada N, 2009, RNA BIOL, V6, P293, DOI 10.4161/rna.6.3.8497; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Verduci L, 2010, J BIOL CHEM, V285, P39551, DOI 10.1074/jbc.M110.114736; Volk EL, 2009, DIS MODEL MECH, V2, P47, DOI 10.1242/dmm.000992; von Muhlinen N, 2018, ONCOGENE, V37, P2379, DOI 10.1038/s41388-017-0101-3; Walsh CM, 2013, J BIOL CHEM, V288, P2816, DOI 10.1074/jbc.M112.410803; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	50	7	7	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21204	10.1096/fj.202000395RR	http://dx.doi.org/10.1096/fj.202000395RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337569	hybrid			2022-12-28	WOS:000605626600009
J	Goh, Q; Nikolaou, S; Shay-Winkler, K; Emmert, ME; Cornwall, R				Goh, Qingnian; Nikolaou, Sia; Shay-Winkler, Kritton; Emmert, Marianne E.; Cornwall, Roger			Timing of proteasome inhibition as a pharmacologic strategy for prevention of muscle contractures in neonatal brachial plexus injury	FASEB JOURNAL			English	Article						denervation; muscle contracture; muscle length; neonatal brachial plexus injury; proteasome inhibition; protein degradation; sarcomerogenesis	DENERVATED MUSCLE; KAPPA-B; SITES; SHOULDER; GROWTH; PALSY; ACTIVATION; BORTEZOMIB; APOPTOSIS; CELLS	Neonatal brachial plexus injury (NBPI) causes disabling and incurable contractures, or limb stiffness, which result from proteasome-mediated protein degradation impairing the longitudinal growth of neonatally denervated muscles. We recently showed in a mouse model that the 20S proteasome inhibitor, bortezomib, prevents contractures after NBPI. Given that contractures uniquely follow neonatal denervation, the current study tests the hypothesis that proteasome inhibition during a finite window of neonatal development can prevent long-term contracture development. Following neonatal forelimb denervation in P5 mice, we first outlined the minimum period for proteasome inhibition to prevent contractures 4 weeks post-NBPI by treating mice with saline or bortezomib for varying durations between P8 and P32. We then compared the ability of varying durations of longer-term proteasome inhibition to prevent contractures at 8 and 12 weeks post-NBPI. Our findings revealed that proteasome inhibition can be delayed 3-4 days after denervation but is required throughout skeletal growth to prevent contractures long term. Furthermore, proteasome inhibition becomes less effective in preventing contractures beyond the neonatal period. These therapeutic effects are primarily associated with bortezomib-induced attenuation of 20S proteasome beta 1 subunit activity. Our collective results, therefore, demonstrate that temporary neonatal proteasome inhibition is not a viable strategy for preventing contractures long term. Instead, neonatal denervation causes a permanent longitudinal growth deficiency that must be continuously ameliorated during skeletal growth. Additional mechanisms must be explored to minimize the necessary period of proteasome inhibition and reduce the risk of toxicity from long-term treatment.	[Goh, Qingnian; Nikolaou, Sia; Shay-Winkler, Kritton; Cornwall, Roger] Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, 3333 Burnet Ave,MLC 2017, Cincinnati, OH 45229 USA; [Emmert, Marianne E.] Univ Cincinnati, Coll Med, Dept Biomed Sci, Cincinnati, OH USA; [Cornwall, Roger] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Cornwall, Roger] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Cornwall, Roger] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Cornwall, R (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, 3333 Burnet Ave,MLC 2017, Cincinnati, OH 45229 USA.	Roger.Cornwall@cchmc.org	Nikolaou, Sia/AAB-2256-2020	Nikolaou, Sia/0000-0003-2589-6002; Goh, Qingnian/0000-0003-4108-2957; Emmert, Marianne/0000-0003-3173-9812	HHS \ NIH \ National Institute of Child Health and Human Development (NICHD) [R01HD098280-01]; Pediatric Orthopaedic Society of North America (POSNA); Cincinnati Children's Hospital Division of Orthopaedic Surgery; Cincinnati Children's Hospital Junior Cooperative Society	HHS \ NIH \ National Institute of Child Health and Human Development (NICHD); Pediatric Orthopaedic Society of North America (POSNA); Cincinnati Children's Hospital Division of Orthopaedic Surgery; Cincinnati Children's Hospital Junior Cooperative Society	HHS vertical bar NIH vertical bar National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD098280-01; Pediatric Orthopaedic Society of North America (POSNA); Cincinnati Children's Hospital Division of Orthopaedic Surgery; Cincinnati Children's Hospital Junior Cooperative Society	Allouh MZ, 2008, J HISTOCHEM CYTOCHEM, V56, P77, DOI 10.1369/jhc.7A7301.2007; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Besse A, 2019, CELL CHEM BIOL, V26, P340, DOI 10.1016/j.chembiol.2018.11.007; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chauhan D, 2003, APOPTOSIS, V8, P337, DOI 10.1023/A:1024164700094; Citrin R, 2016, EXPERT REV HEMATOL, V9, P873, DOI 10.1080/17474086.2016.1216311; Cohen P, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju006; Crouch DL, 2015, J BONE JOINT SURG AM, V97A, P1264, DOI 10.2106/JBJS.N.01247; Dayanidhi S, 2020, CLIN ORTHOP RELAT R, V478, P886, DOI 10.1097/CORR.0000000000001134; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Eriksson E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt459; Eriksson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050523; Foad SL, 2008, J BONE JOINT SURG AM, V90A, P1258, DOI 10.2106/JBJS.G.00853; Garcia-Lopez A, 2012, J HAND SURG-AM, V37A, P1660, DOI 10.1016/j.jhsa.2012.05.002; Goh Q, 2019, ELIFE, V8, DOI 10.7554/eLife.44876; Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007; Govindan M, 2019, PEDIATR REV, V40, P494, DOI 10.1542/pir.2018-0113; GRIFFIN GE, 1973, ANAT RECORD, V177, P465, DOI 10.1002/ar.1091770311; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Hale HB, 2010, J HAND SURG-AM, V35A, P322, DOI 10.1016/j.jhsa.2009.11.026; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Ho ES, 2015, J HAND THER, V28, P135, DOI 10.1016/j.jht.2014.09.003; Kinney MC, 2017, MUSCLE NERVE, V55, P384, DOI 10.1002/mus.25227; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kubiczkova L, 2014, J CELL MOL MED, V18, P947, DOI 10.1111/jcmm.12279; Kuhn DJ, 2011, CURR CANCER DRUG TAR, V11, P285; Ma L, 2015, ANTI-CANCER AGENT ME, V15, P298, DOI 10.2174/1871520614666141114202606; Mascarenhas VV, 2014, J ORTHOP RES, V32, P1675, DOI 10.1002/jor.22709; Mashima T, 1999, ONCOGENE, V18, P2423, DOI 10.1038/sj.onc.1202558; Menorca RMG, 2013, HAND CLIN, V29, P317, DOI 10.1016/j.hcl.2013.04.002; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Mirabella AC, 2011, CHEM BIOL, V18, P608, DOI 10.1016/j.chembiol.2011.02.015; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Newman CJ, 2006, J PEDIATR ORTHOPED, V26, P647, DOI 10.1097/01.bpo.0000233806.72423.30; Nikolaou S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128454; Nikolaou S, 2015, J HAND SURG-AM, V40, P2007, DOI 10.1016/j.jhsa.2015.07.008; Nikolaou S, 2014, MUSCLE NERVE, V49, P398, DOI 10.1002/mus.23927; Nikolaou S, 2011, J BONE JOINT SURG AM, V93A, P461, DOI 10.2106/JBJS.J.00943; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pedowitz DI, 2007, J SHOULDER ELB SURG, V16, P6, DOI 10.1016/j.jse.2006.04.008; Penna F, 2016, J CACHEXIA SARCOPENI, V7, P345, DOI 10.1002/jcsm.12050; Pondaag W, 2004, DEV MED CHILD NEUROL, V46, P138; Ruoff JM, 2012, DEV MED CHILD NEUROL, V54, P1050, DOI 10.1111/j.1469-8749.2012.04383.x; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Sokolowski JD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-16; Thibaudeau TA, 2019, PHARMACOL REV, V71, P170, DOI 10.1124/pr.117.015370; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; van der Sluijs JA, 2004, J PEDIATR ORTHOP B, V13, P218, DOI 10.1097/00009957-200405000-00015; Weekley H, 2012, J ORTHOP RES, V30, P1335, DOI 10.1002/jor.22061; Wu SF, 2006, ENDOCRINOLOGY, V147, P3761, DOI 10.1210/en.2005-1672; Zaman F, 2008, LEUKEMIA, V22, P883, DOI 10.1038/sj.leu.2404997; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982	56	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002194	http://dx.doi.org/10.1096/fj.202002194		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33236396	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000593294900001
J	Kimball, SR; Davis, TA				Kimball, Scot R.; Davis, Teresa A.			The 2020 FASEB Virtual Science Research Conference on Nutrient Sensing and Metabolic Signaling, August 10-11, 2020	FASEB JOURNAL			English	Editorial Material									[Kimball, Scot R.] Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Davis, Teresa A.] Baylor Coll Med, ARS, USDA, Dept Pediat,Childrens Nutr Res Ctr, 1100 Bates St, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Baylor College of Medicine; United States Department of Agriculture (USDA)	Kimball, SR (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.; Davis, TA (corresponding author), Baylor Coll Med, ARS, USDA, Dept Pediat,Childrens Nutr Res Ctr, 1100 Bates St, Houston, TX 77030 USA.	skimball@psu.edu; tdavis@bcm.edu			 [R13 DK126105]		NIH/NIDDk, Grant/Award Number: R13 DK126105		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15627	15629		10.1096/fj.202002259	http://dx.doi.org/10.1096/fj.202002259		OCT 2020	3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33107626	Bronze, Green Accepted			2022-12-28	WOS:000586268500001
J	Karwelat, D; Schmeck, B; Ringel, M; Benedikter, BJ; Hubner, K; Beinborn, I; Maisner, A; Schulte, LN; Vollmeister, E				Karwelat, Diana; Schmeck, Bernd; Ringel, Marc; Benedikter, Birke J.; Huebner, Kathleen; Beinborn, Isabell; Maisner, Andrea; Schulte, Leon N.; Vollmeister, Evelyn			Influenza virus-mediated suppression of bronchial Chitinase-3-like 1 secretion promotes secondary pneumococcal infection	FASEB JOURNAL			English	Article						air&#8208; liquid interface; apicobasal polarity; post&#8208; viral bacterial infection; Streptococcus pneumoniae	HUMAN CARTILAGE GP-39; STREPTOCOCCUS-PNEUMONIAE; IMMUNE-RESPONSE; E-CADHERIN; PROTEIN; CELLS; BACTERIAL; CHI3L1; YKL-40; PATHOGENESIS	Infections of the lung are among the leading causes of death worldwide. Despite the preactivation of innate defense programs during viral infection, secondary bacterial infection substantially elevates morbidity and mortality rates. Particularly problematic are co-infections with influenza A virus (IAV) and the major bacterial pathogen Streptococcus pneumoniae. However, the molecular processes underlying the severe course of such co-infections are not fully understood. Previously, the absence of secreted glycoprotein Chitinase-3-like 1 (CHI3L1) was shown to increase pneumococcal replication in mice. We therefore hypothesized that an IAV preinfection decreases CHI3L1 levels to promote pneumococcal infection. Indeed, in an air-liquid interface model of primary human bronchial epithelial cells (hBECs), IAV preinfection interfered with apical but not basolateral CHI3L1 release. Confocal time-lapse microscopy revealed that the gradual loss of apical CHI3L1 localization during co-infection with influenza and S. pneumoniae coincided with the disappearance of goblet as well as ciliated cells and increased S. pneumoniae replication. Importantly, extracellular restoration of CHI3L1 levels using recombinant protein significantly reduced bacterial load in influenza preinfected bronchial models. Thus, recombinant CHI3L1 may provide a novel therapeutic means to lower morbidity and mortality associated with post-influenza pneumococcal infections.	[Karwelat, Diana; Schmeck, Bernd; Benedikter, Birke J.; Huebner, Kathleen; Beinborn, Isabell; Schulte, Leon N.; Vollmeister, Evelyn] Univ Giessen & Marburg Lung Ctr, Inst Lung Res, Hesse, Germany; [Karwelat, Diana; Schmeck, Bernd; Benedikter, Birke J.; Huebner, Kathleen; Beinborn, Isabell; Schulte, Leon N.; Vollmeister, Evelyn] Philipps Univ Marburg, German Ctr Lung Res DZL, Hesse, Germany; [Schmeck, Bernd] Philipps Univ Marburg, Dept Pulm & Crit Care Med, Univ Med Ctr Marburg, Univ Giessen & Marburg Lung Ctr, Hesse, Germany; [Schmeck, Bernd; Schulte, Leon N.] German Ctr Lung Res DZL, Marburg, Hesse, Germany; [Schmeck, Bernd] Philipps Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Hesse, Germany; [Ringel, Marc; Maisner, Andrea] Philipps Univ Marburg, Inst Virol, Marburg, Hesse, Germany; [Karwelat, Diana] Bayer AG, Mechanist Toxicol Pharmaceut, Berlin, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Bayer AG	Vollmeister, E (corresponding author), Philipps Univ Marburg, Inst Lung Res, Hans Meerwein Str 2, D-35043 Marburg, Hesse, Germany.	evelyn.vollmeister@uni-marburg.de	Vollmeister, Evelyn/ABA-7940-2021	Vollmeister, Evelyn/0000-0002-0539-7874; Schmeck, Bernd/0000-0002-2767-3606; Schulte, Leon/0000-0001-6814-9344	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) [JPI-AMR-FKZ 01Kl1702, ERACoSysMed2-SysMed-COPDFKZ 031L0140, Med CAPSYSFKZ 01ZX1304E]; Deutsche Forschungsgemeinschaft [SFB/TR-84 TP C01]; Von-Behring-Rontgen-Stiftung [66-LV07]; Hessisches Ministerium fur Wissenschaft und Kunst (LOEWE Medical RNomics) [519/03/00.001-[0003] s]	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Von-Behring-Rontgen-Stiftung; Hessisches Ministerium fur Wissenschaft und Kunst (LOEWE Medical RNomics)	has been funded in part by the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research, JPI-AMR-FKZ 01Kl1702; ERACoSysMed2-SysMed-COPDFKZ 031L0140; e:Med CAPSYSFKZ 01ZX1304E), the Deutsche Forschungsgemeinschaft (SFB/TR-84 TP C01), the Von-Behring-Rontgen-Stiftung (66-LV07), and the Hessisches Ministerium fur Wissenschaft und Kunst (LOEWE Medical RNomics 519/03/00.001-[0003] s) to B. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Areshkov PO, 2012, INT J BIOL SCI, V8, P39, DOI 10.7150/ijbs.8.39; Bhardwaj R, 2015, J IMMUNOL, V194, P2862, DOI 10.4049/jimmunol.1400874; Bohr S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140440; Brekman A, 2014, AM J RESP CELL MOL, V51, P688, DOI 10.1165/rcmb.2013-0363OC; Breyne K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01143; Calbo E, 2010, INT J ANTIMICROB AG, V35, P107, DOI 10.1016/j.ijantimicag.2009.10.002; Cawcutt K, 2017, CURR OPIN CRIT CARE, V23, P385, DOI 10.1097/MCC.0000000000000435; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Ciledag A, 2018, TUBERK TORAK, V66, P273, DOI 10.5578/tt.67319; Coopman P, 2016, CELL MOL LIFE SCI, V73, P3535, DOI 10.1007/s00018-016-2260-8; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Deng JC, 2013, INFLUENZA OTHER RESP, V7, P24, DOI 10.1111/irv.12174; Deutschmann C, 2019, CLIN IMMUNOL, V199, P12, DOI 10.1016/j.clim.2018.12.005; Feldman C, 2011, DRUGS, V71, P131, DOI 10.2165/11585310-000000000-00000; Fikry EM, 2019, BIOMED PHARMACOTHER, V110, P878, DOI 10.1016/j.biopha.2018.12.041; Frasca D, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00071; Fu Y, 2016, CYTOKINE, V86, P10, DOI 10.1016/j.cyto.2016.07.003; Galeas-Pena M, 2019, BIOL CHEM, V400, P443, DOI 10.1515/hsz-2018-0304; Gao N, 2015, INFECT IMMUN, V83, P4154, DOI 10.1128/IAI.00980-15; Gomez JL, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00800-2017; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Hozumi H, 2017, J RHEUMATOL, V44, P1394, DOI 10.3899/jrheum.170373; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Janke BH, 2014, VET PATHOL, V51, P410, DOI 10.1177/0300985813513043; Kang MJ, 2015, AM J RESP CELL MOL, V53, P863, DOI 10.1165/rcmb.2014-0366OC; Kim J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213686; Kim MJ, 2019, ALLERGY, V74, P685, DOI 10.1111/all.13661; Komori M, 2011, PEDIATR RES, V69, P101, DOI 10.1203/PDR.0b013e3182055237; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lai TW, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0338-3; Lee CJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10638; Lee CG, 2010, ALLERGY ASTHMA IMMUN, V2, P20, DOI 10.4168/aair.2010.2.1.20; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lee DH, 2019, MOL THER-NUCL ACIDS, V16, P63, DOI 10.1016/j.omtn.2019.02.007; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lim YK, 2019, DIAGN MICR INFEC DIS, V94, P50, DOI 10.1016/j.diagmicrobio.2018.11.014; Lin HW, 2019, ENDOCR-RELAT CANCER, V26, P73, DOI 10.1530/ERC-18-0300; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; MILLIS AJT, 1986, J CELL PHYSIOL, V127, P366, DOI 10.1002/jcp.1041270304; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mora R, 2002, J VIROL, V76, P3544, DOI 10.1128/JVI.76.7.3544-3553.2002; Nishikawa KC, 2003, EXP CELL RES, V287, P79, DOI 10.1016/S0014-4827(03)00069-7; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; RITCHEY MB, 1976, J VIROL, V18, P738, DOI 10.1128/JVI.18.2.738-744.1976; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmeck B, 2006, AM J PHYSIOL-LUNG C, V290, pL730, DOI 10.1152/ajplung.00271.2005; Stoops EH, 2014, J AM SOC NEPHROL, V25, P1375, DOI 10.1681/ASN.2013080883; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tian PW, 2015, J TRANSL INTERN MED, V3, P89, DOI 10.1515/jtim-2015-0013; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; van Aalst M, 2018, TRAVEL MED INFECT DI, V24, P89, DOI 10.1016/j.tmaid.2018.05.016; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Watanabe Y, 2019, BBA-GEN SUBJECTS, V1863, P1480, DOI 10.1016/j.bbagen.2019.05.012; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wu NH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39668; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929	72	4	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16432	16448		10.1096/fj.201902988RR	http://dx.doi.org/10.1096/fj.201902988RR		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33095949	hybrid			2022-12-28	WOS:000583913000001
J	Wang, H; Lee, JH; Wang, Y; Seo, HS; Wang, JB; Deshane, JS; Ponnazhagan, S				Wang, Hong; Hyoung Lee, Joo; Wang, Yong; Seo, Hwa-seon; Wang, Jianbo; Deshane, Jessy S.; Ponnazhagan, Selvarangan			A conserved aromatic moiety in the ectodomain is a key determinant for structural integrity and protein trafficking of TNFR superfamily	FASEB JOURNAL			English	Article						aromatic moiety; protein trafficking; structural integrity; tumor necrosis factor receptor superfamily	PERIODIC SYNDROME; FOLLICULAR LYMPHOMA; RECEPTOR; MUTATIONS; OSTEOPROTEGERIN; BINDING; GLYCOSYLATION; HETEROGENEITY; ENDOSTATIN; SECRETION	Extracellular trafficking of tumor necrosis factor receptor superfamily (TNFRSF) is tightly regulated, disruption of which triggers various autoinflammatory disorders, including TNF receptor-associated periodic syndrome (TRAPS). Here, we provide thus far unraveled molecular basis of noncysteine mutations in TNFR1 ectodomain where loss of an aromatic moiety in cysteine-rich domain (CRD) 2 results in TRAPS disease-associated phenotype. Our study characterized that a missense mutation on phenylalanine residue located in CRD2 (TNFR1(F60V)) causes a delay in TNFR1 transport to cell membrane, leading to sustained receptor responsiveness and downstream NF-kappa B activation, characteristic of clinical manifestation of a prolonged fever. By creating and characterizing identical mutations on structurally conserved ectodomains of osteoprotegerin (OPG) and decoy receptor 3, other two secreted forms of TNFRSF, we further identified that a conserved aromatic residue at the A1 submodule of CRD2 (A1CRD2) confers structural integrity of ectodomain where aromatic sidechain deletion increases thermal instability, interfering with efficient posttranslational modification and subsequent receptor secretion. Interestingly, our functional analyses indicated that this particular noncysteine mutation is not associated with either protein misfolding or loss of function. Finally, by using a synthetic agonist, we demonstrated gain-of-function of the trafficking defect, suggesting the possibility of rescuing affected pathology in related disorders. Given the structural and topological similarities present in the ectodomains of TNFRSF members, our findings provide mechanistic insights of defects in subcellular trafficking of TNF receptors, reported in various TNFRSF-associated diseases.	[Wang, Hong; Hyoung Lee, Joo; Ponnazhagan, Selvarangan] Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,SHEL 814, Birmingham, AL 35294 USA; [Wang, Yong; Deshane, Jessy S.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Seo, Hwa-seon; Wang, Jianbo] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ponnazhagan, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,SHEL 814, Birmingham, AL 35294 USA.	pons@uab.edu	Lee, Joo Hyoung/A-7713-2017	Lee, Joo Hyoung/0000-0003-4450-3067	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR060948]; HHS \ NIH \ National Cancer Institute (NCI) [CA184770]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL128502]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS \ NIH \ National Cancer Institute (NCI); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR060948; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA184770; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL128502	Aganna E, 2003, ARTHRITIS RHEUM-US, V48, P2632, DOI 10.1002/art.11215; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Byun M, 2013, J EXP MED, V210, P1743, DOI 10.1084/jem.20130592; Cardinale CJ, 2013, GENES IMMUN, V14, P447, DOI 10.1038/gene.2013.43; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Haas SL, 2006, GASTROENTEROLOGY, V130, P172, DOI 10.1053/j.gastro.2005.09.014; Higgs JT, 2015, MOL CANCER RES, V13, P819, DOI 10.1158/1541-7786.MCR-14-0492; Kim YH, 2016, J CELL SCI, V129, P29, DOI 10.1242/jcs.176412; Kimberley FC, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2197; Lachmann HJ, 2014, ANN RHEUM DIS, V73, P2160, DOI 10.1136/annrheumdis-2013-204184; Lee JH, 2017, FASEB J, V31, P1608, DOI 10.1096/fj.201601178R; Lee JH, 2015, P NATL ACAD SCI USA, V112, P1392, DOI 10.1073/pnas.1417660112; Lin WW, 2011, BIOCHEM PHARMACOL, V81, P838, DOI 10.1016/j.bcp.2011.01.011; Lobito AA, 2006, BLOOD, V108, P1320, DOI 10.1182/blood-2005-11-006783; Lobito AA, 2011, TRENDS MOL MED, V17, P494, DOI 10.1016/j.molmed.2011.05.006; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Middleton-Hardie C, 2006, J BONE MINER RES, V21, P438, DOI 10.1359/JBMR.051104; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Nedjai B, 2008, ARTHRITIS RHEUM-US, V58, P273, DOI 10.1002/art.23123; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Schmidt J, 2016, BLOOD, V128, P1101, DOI 10.1182/blood-2016-03-703819; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Skrenkova K, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00188; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turner MD, 2012, BIOSCIENCE REP, V32, P105, DOI 10.1042/BSR20110089; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	34	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15687	15700		10.1096/fj.202000341R	http://dx.doi.org/10.1096/fj.202000341R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047892				2022-12-28	WOS:000581171900001
J	Yuyama, K; Sun, H; Mikami, D; Mioka, T; Mukai, K; Igarashi, Y				Yuyama, Kohei; Sun, Hui; Mikami, Daisuke; Mioka, Tetsuo; Mukai, Katsuyuki; Igarashi, Yasuyuki			Lysosomal-associated transmembrane protein 4B regulates ceramide-induced exosome release	FASEB JOURNAL			English	Article						amyloid-ss; ceramide; exosome; LAPTM4B	ACID CERAMIDASE; AMYLOID-BETA; LAPTM4B; MODEL; PTDINS(4,5)P-2; TRAFFICKING; ACTIVATION; RESISTANCE; VESICLES; ROLES	Exosomes are extracellular vesicles that mediate the transport of intracellular molecules, including neurodegenerative agents. Exogenously administrated ceramides have been implicated in the acceleration of exosome production by neurons; however, the molecular machinery involved in this process is unknown. Here, we found that ceramides, especially those consisting of long fatty acids, were internalized into the endocytic pathway in neuroblastoma SH-SY5Y cells to induce exosome secretion through lysosome-associated protein transmembrane 4B (LAPTM4B). Knockdown of LAPTM4B inhibited the ceramide-mediated increase in exosome release completely. Fluorescence microscopy observations indicated that exogenous ceramides promote the transport of multivesicular bodies to the plasma membranes in a LAPTM4B-dependent manner. Similarly, inhibition of acid ceramidase, which tends to induce intracellular ceramide accumulation, increased exosome production by SH-SY5Y cells in a LAPTM4B-dependent manner. Furthermore, the level of amyloid-ss protein (Ass) was decreased in neuronal cells following treatment with exogenous ceramide or inhibition of acid ceramidase, and this effect was attributed to the LAPTM4B-dependent efflux of Ass-containing exosomes. Overall, these findings reveal the novel machinery involved in exosome secretion regulated by ceramides and LAPTM4B, and may contribute to efforts to ameliorate the cellular accumulation of neurodegenerative agents such as Ass.	[Yuyama, Kohei; Sun, Hui; Mikami, Daisuke; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lipid Biofunct Sect, Sapporo, Hokkaido, Japan; [Mioka, Tetsuo] Hokkaido Univ, Grad Sch Life Sci, Inst Genet Med, Div Mol Interact, Sapporo, Hokkaido, Japan; [Mukai, Katsuyuki] Daicel Corp, R&D Headquarters, Tokyo, Japan	Hokkaido University; Hokkaido University; Daicel Corporation	Yuyama, K (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lipid Biofunct Sect, Kita Ku, Kita 21,Nishi 11, Sapporo, Hokkaido 0010021, Japan.	kyuyama@pharm.hokudai.ac.jp			Industry Creation Departments Funding by Daicel Corporation [8607011, PCS8617001]	Industry Creation Departments Funding by Daicel Corporation	This work was supported by Industry Creation Departments Funding (8607011, PCS8617001) provided by Daicel Corporation to the Lipid Biofunction Section of Hokkaido University	Blom T, 2015, NAT CHEM BIOL, V11, P799, DOI [10.1038/NCHEMBIO.1889, 10.1038/nchembio.1889]; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Dinkins MB, 2015, J ALZHEIMERS DIS, V46, P55, DOI 10.3233/JAD-150088; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hogue DL, 2002, BIOCHEM J, V365, P721, DOI 10.1042/BJ20020205; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huang Y, 2004, EUR J NEUROSCI, V20, P3489, DOI 10.1111/j.1460-9568.2004.03852.x; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li L, 2011, ANAT REC, V294, P1135, DOI 10.1002/ar.21421; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; LOZANO J, 1994, J BIOL CHEM, V269, P19200; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Tan XJ, 2015, J CELL SCI, V128, P4047, DOI 10.1242/jcs.175208; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Thapa N, 2012, CELL ADHES MIGR, V6, P409, DOI 10.4161/cam.21192; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072; Yuyama K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53394-w; Yuyama Kohei, 2016, BioMolecular Concepts, V7, P53, DOI 10.1515/bmc-2015-0033; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zhou KC, 2018, ACS CENTRAL SCI, V4, P548, DOI 10.1021/acscentsci.7b00582	42	9	9	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16022	16033		10.1096/fj.202001599R	http://dx.doi.org/10.1096/fj.202001599R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33090522				2022-12-28	WOS:000581155800001
J	Wang, Q; Banerjee, S; So, C; Qiu, CT; Lam, HIC; Tse, D; Volgyi, B; Pan, F				Wang, Qin; Banerjee, Seema; So, Chunghim; Qiu, Chunting; Lam, Hang-I Christie; Tse, Dennis; Volgyi, Bela; Pan, Feng			Unmasking inhibition prolongs neuronal function in retinal degeneration mouse model	FASEB JOURNAL			English	Article						ganglion cell; inhibition; neurodegenerative disease; retina; vision	GANGLION-CELL SUBTYPES; RETINITIS-PIGMENTOSA; BIPOLAR CELLS; GAP-JUNCTIONS; GLYCINE RECEPTORS; HORIZONTAL CELLS; BETA-SUBUNIT; ROD; ORGANIZATION; SENSITIVITY	All neurodegenerative diseases involve a relatively long period of timeframe from the onset of the disease to complete loss of functions. Extending this timeframe, even at a reduced level of function, would improve the quality of life of patients with these devastating diseases. The retina, as the part of the central nervous system and a frequent site of many distressing neurodegenerative disease, provides an ideal model to investigate the feasibility of extending the functional timeframe through pharmacologic intervention. Retinitis Pigmentosa (RP) is a group of blinding diseases. Although the rate of progression and degree of visual loss varies, there is usually a prolonged time before patients totally lose their photoreceptors and vision. It is believed that inhibitory mechanisms are still intact and may become relatively strong after the gradual loss of photoreceptors in RP patients. Therefore, it is possible that light-evoked responses of retinal ganglion cells and visual information processes in retinal circuits could be "unmasked" by blocking these inhibitory mechanisms restoring some level of visual function. Our results indicate that if the inhibition in the inner retina was unmasked in the retina of the rd10 mouse (the well-characterized RP mimicking, clinically relevant mouse model), the light-evoked responses of many retinal ganglion cells can be induced and restore their normal light sensitivity. GABA A receptor plays a major role in this masking inhibition. ERG b-wave and behavioral tests of spatial vision partly recovered after the application of PTX. Hence, removing retinal inhibition unmasks signalling mediated by surviving cones, thereby restoring some degree of visual function. These results may offer a novel strategy to restore the visual function with the surviving cones in RP patients and other gradual and progressive neurodegenerative diseases.	[Wang, Qin; Banerjee, Seema; So, Chunghim; Qiu, Chunting; Lam, Hang-I Christie; Tse, Dennis; Pan, Feng] Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hong Kong, Peoples R China; [Pan, Feng] Ctr Eye & Vis Res, Hong Kong, Peoples R China; [Volgyi, Bela] Univ Pecs, MTA NAP Retinal Elect Synapses Res Grp, Dept Expt Zool & Neurobiol, Szentagothai Res Ctr, Pecs, Hungary	Hong Kong Polytechnic University; University of Pecs	Pan, F (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hung Hom, Hong Kong, Peoples R China.	feng.a.pan@polyu.edu.hk	Banerjee, Seema/AAF-3540-2022; Banerjee, Seema/AFH-9772-2022; Volgyi, Bela/B-1016-2011	Banerjee, Seema/0000-0002-5158-7062; Banerjee, Seema/0000-0002-5158-7062; Lam, Christie Hang-i/0000-0001-8517-8796; Chung Him, So/0000-0002-7439-5741; Volgyi, Bela/0000-0001-7481-390X; PAN, Feng/0000-0002-5256-4380	Hong Kong Polytechnic University; Hong Kong Research Grants Council (ECS/RGC, Hong Kong, SAR) [25103918, 151060/18M]	Hong Kong Polytechnic University(Hong Kong Polytechnic University); Hong Kong Research Grants Council (ECS/RGC, Hong Kong, SAR)(Hong Kong Research Grants Council)	The study supported by the Hong Kong Polytechnic University grant: G-UACF; UAG4 and University Research Facility in Behavioral and Systems Neuroscience. The study was also supported by a grant from the Hong Kong Research Grants Council (ECS/RGC; 25103918; 151060/18M, Hong Kong, SAR)	Akopian A, 2017, J CLIN INVEST, V127, P2647, DOI 10.1172/JCI91948; [Anonymous], 1988, Arch Ophthalmol, V106, P1518; Arman AC, 2012, J NEUROPHYSIOL, V107, P2649, DOI 10.1152/jn.01202.2011; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Banerjee S, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00124; Barron HC, 2016, NEURON, V90, P191, DOI 10.1016/j.neuron.2016.02.031; Berson EL, 2007, EXP EYE RES, V85, P7, DOI 10.1016/j.exer.2007.03.001; BLOOMFIELD SA, 1982, J COMP NEUROL, V208, P288, DOI 10.1002/cne.902080306; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Campochiaro PA, 2018, PROG RETIN EYE RES, V62, P24, DOI 10.1016/j.preteyeres.2017.08.004; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; Deneve S, 2017, NEURON, V94, P969, DOI 10.1016/j.neuron.2017.05.016; DOSTROVSKY JO, 1976, EXP NEUROL, V52, P480, DOI 10.1016/0014-4886(76)90219-3; Dowling J. E., 2012, RETINA APPROACHABLE; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; Enz R, 1996, J NEUROSCI, V16, P4479; Fahim A, 2018, CURR OPIN PEDIATR, V30, P725, DOI 10.1097/MOP.0000000000000690; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Herrmann R, 2011, NEURON, V72, P101, DOI 10.1016/j.neuron.2011.07.030; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Li L, 2000, J NEUROSCI, V20, P1893; Lin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068084; Majumdar S, 2007, VISUAL NEUROSCI, V24, P471, DOI 10.1017/S0952523807070174; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; O'Brien JJ, 2006, J NEUROSCI, V26, P11624, DOI 10.1523/JNEUROSCI.2296-06.2006; Pan F, 2007, J COMP NEUROL, V500, P815, DOI 10.1002/cne.21127; Pan F, 2016, J PHYSIOL-LONDON, V594, P6679, DOI 10.1113/JP272267; Pan F, 2010, J COMP NEUROL, V518, P911, DOI 10.1002/cne.22254; Payne HL, 2017, ELIFE, V6, DOI 10.7554/eLife.29222; Paz JT, 2015, NAT NEUROSCI, V18, P351, DOI 10.1038/nn.3950; Prado DA, 2020, CURR OPIN OPHTHALMOL, V31, P147, DOI 10.1097/ICU.0000000000000660; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rajan R, 2001, CEREB CORTEX, V11, P171, DOI 10.1093/cercor/11.2.171; Stasheff SF, 2011, J NEUROPHYSIOL, V105, P3002, DOI 10.1152/jn.00704.2010; STAUFFER PL, 1993, J BIOL CHEM, V268, P19769; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tengolics AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51756-y; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P101, DOI 10.1113/jphysiol.1978.sp012295; Toychiev AH, 2013, J NEUROSCI, V33, P13972, DOI 10.1523/JNEUROSCI.2399-13.2013; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Volgyi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069426; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WANG KC, 2014, SCI REP UK, V4; Wang PY, 2005, J NEUROPHYSIOL, V93, P3120, DOI 10.1152/jn.01228.2004; Wiegert JS, 2017, NEURON, V95, P504, DOI 10.1016/j.neuron.2017.06.050; Wood KC, 2017, CURR OPIN NEUROBIOL, V46, P200, DOI 10.1016/j.conb.2017.08.018; Zhang J, 2005, VISUAL NEUROSCI, V22, P535, DOI 10.1017/S0952523805224148; Zheng N, 2010, CEREBELLUM, V9, P56, DOI 10.1007/s12311-009-0140-6	63	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15282	15299		10.1096/fj.202001315RR	http://dx.doi.org/10.1096/fj.202001315RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32985731	Green Accepted			2022-12-28	WOS:000574548600001
J	Zhao, YP; Qiu, W; Liu, JC; Yuan, XL; Mao, WQ; Yin, J; Peng, BW; Liu, WH; Han, S; He, XH				Zhao, Yipeng; Qiu, Wei; Liu, Junchen; Yuan, Xiaolu; Mao, Wenqian; Yin, Jun; Peng, BiWen; Liu, WanHong; Han, Song; He, XiaoHua			Blockade of Kv1.3 potassium channel inhibits CD8(+)T cell-mediated neuroinflammation via PD-1/Blimp-1 signaling	FASEB JOURNAL			English	Article						Blimp-1; CD8(+)T cells; EAE; Kv1; 3 channel; PD-1	T-CELLS; MULTIPLE-SCLEROSIS; BLIMP-1; PD-1; EXPRESSION; TARGET	Kv1.3 potassium channel is considered as a target for the treatment of autoimmune diseases such as multiple sclerosis (MS), since Kv1.3 blockade suppresses memory T cell activation including cytotoxic CD8(+)T cells. However, the underlying signaling pathway related to autoimmune CD8(+)T cell inhibition by Kv1.3 channel in neuroinflammatory diseases remains unclear. We found that ImK, a selective Kv1.3 blocker, reduced auto-reactive CD8(+)T cell infiltration in the spinal cords of experimental autoimmune encephalomyelitis (EAE) rats, an animal model of MS. ImK suppressed transcriptional factor Blimp-1 expression and reduced the cytotoxicity of CD8(+)T cells on neuronal cells. Furthermore, ImK upregulated co-inhibitory molecule PD-1 to inhibit B lymphocyte-induced maturation protein (Blimp-1) in an IL-2 independent way. In addition, PD-1 inhibitor impaired the suppression of ImK on CD8(+)T cells and accelerated EAE progression. Our study demonstrated a novel regulatory mechanism of Kv1.3 blockade on modulating CD8(+)T cell differentiation through PD-1/Blimp-1 signaling. This work expands the understanding of Kv1.3 channel for modulating neuroinflammation.	[Zhao, Yipeng; Liu, Junchen; Yuan, Xiaolu; Mao, Wenqian; Yin, Jun; Han, Song; He, XiaoHua] Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan, Peoples R China; [Zhao, Yipeng; Qiu, Wei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou, Peoples R China; [Peng, BiWen] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Developmentally Originated Dis, Wuhan, Peoples R China; [Liu, WanHong] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Allergy & Immunol, Wuhan, Peoples R China	Wuhan University; Sun Yat Sen University; Wuhan University; Wuhan University	Han, S; He, XH (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan, Peoples R China.	hansong@whu.edu.cn; hexiaohua@whu.edu.cn		/0000-0002-5599-6779	Science and Technology Department of Hubei Province [China] [2017CFA017, 2017CFB698]; Wuhan Municipal Science and Technology Bureau (Wuhan Intellectual Property Bureau) [2019020701011444]; Wuhan University (WHU) [TFLC2018001]	Science and Technology Department of Hubei Province [China]; Wuhan Municipal Science and Technology Bureau (Wuhan Intellectual Property Bureau); Wuhan University (WHU)	Science and Technology Department of Hubei Province [China], Grant/Award Number: 2017CFA017 and 2017CFB698; Wuhan Municipal Science and Technology Bureau (Wuhan Intellectual Property Bureau), Grant/Award Number: 2019020701011444; Wuhan University (WHU), Grant/Award Number: TFLC2018001	Abrahamsson SV, 2013, BRAIN, V136, P2888, DOI 10.1093/brain/awt182; Baecher-Allan C, 2018, NEURON, V97, P742, DOI 10.1016/j.neuron.2018.01.021; Boulet S, 2014, J IMMUNOL, V193, P1847, DOI 10.4049/jimmunol.1302365; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Chandy KG, 2017, CURR OPIN CHEM BIOL, V38, P97, DOI 10.1016/j.cbpa.2017.02.015; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Denic A, 2013, EXPERT OPIN THER TAR, V17, P1053, DOI 10.1517/14728222.2013.815726; Frisullo G, 2008, CYTOKINE, V44, P22, DOI 10.1016/j.cyto.2008.08.007; Gobin SJP, 2001, GLIA, V36, P68, DOI 10.1002/glia.1096; Gocke AR, 2012, J IMMUNOL, V188, P5877, DOI 10.4049/jimmunol.1103095; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2011, TOXICON, V57, P348, DOI 10.1016/j.toxicon.2010.12.015; Hansen Lars Koch, 2014, Dan Med J, V61, pB4946; Hu JZ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0630-7; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kaskow BJ, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029025; Kumar P, 2018, J AUTOIMMUN, V95, P77, DOI 10.1016/j.jaut.2018.08.007; Li Z, 2012, J BIOL CHEM, V287, P29479, DOI 10.1074/jbc.M112.379594; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Park HJ, 2015, J IMMUNOL, V194, P5801, DOI 10.4049/jimmunol.1401936; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Skalniak L, 2017, ONCOTARGET, V8, P72167, DOI 10.18632/oncotarget.20050; Taylor A, 2016, IMMUNITY, V44, P274, DOI 10.1016/j.immuni.2016.01.018; Tintore M, 2019, NAT REV NEUROL, V15, P53, DOI 10.1038/s41582-018-0082-z; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Yuan XL, 2018, CNS NEUROSCI THER, V24, P967, DOI 10.1111/cns.12848; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015	37	3	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15492	15503		10.1096/fj.202000861RR	http://dx.doi.org/10.1096/fj.202000861RR		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32981181	hybrid			2022-12-28	WOS:000574544700001
J	Zhu, H; He, CS; Zhao, HZ; Jiang, WJ; Xu, SB; Li, J; Ma, TT; Huang, C				Zhu, Hong; He, Changsheng; Zhao, Huizi; Jiang, Wenjuan; Xu, Songbing; Li, Jun; Ma, Taotao; Huang, Cheng			Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation	FASEB JOURNAL			English	Article						DNMT1; epigenetic; hepatic stellate cell; liver fibrosis; PTEN; Sennoside A	HEPATIC STELLATE CELLS; DNA METHYLATION; RAT-LIVER; APOPTOSIS; INACTIVATION; FIBROGENESIS; PHOSPHATASE; MECHANISMS; EXPRESSION; CANCER	Hepatic stellate cell (HSC) activation is an essential event during liver fibrogenesis. Phosphatase and tension homolog deleted on chromosome 10 (PTEN) is a negative regulator of this process. DNA methyltransferase 1 (DNMT1), which catalyzes DNA methylation and subsequently leads to the transcriptional repression of PTEN, is selectively induced in myofibroblasts from diseased livers. Sennoside A (SA), a major purgative constituent of senna and the Chinese herb rhubarb, is widely used in China and other Asian countries as an irritant laxative. SA is reported to improve hepatic steatosis. However, the effect and mechanism of SA on liver fibrosis remain largely unknown. We recently identified a novel strategy for protecting liver fibrosis via epigenetic modification by targeting DNMT1. A Surface Plasmon Resonance (SPR) assay first reported that SA could directly bind DNMT1 and inhibit its activity. Administration of SA significantly prevented liver fibrosis, as evidenced by the dramatic downregulation of alpha-smooth muscle actin (alpha-SMA) and type I collagen alpha-1 (Col1 alpha 1) protein levels in a CCl4-induced mouse hepatic fibrosis model and in TGF-beta 1-activated HSC-T6 cells, in vivo and in vitro. SA decreased the expression of Cyclin D1, CDK, and C-myc, indicating that SA may inhibit the activation and proliferation of TGF-beta 1-induced HSC-T6. Moreover, SA significantly promoted the expression of PTEN and remarkably inhibited the expression of p-AKT and p-ERK in vitro. Blocking PTEN or overexpressing DNMT1 could reduce the effect of SA on liver fibrosis. These data suggest that SA directly binds and inhibits the activity and that attenuated DNMT1-mediated PTEN hypermethylation caused the loss of PTEN expression, followed by the inhibition of the AKT and ERK pathways and prevented the development of liver fibrosis. Hence, SA might be employed as a promising natural supplement for liver fibrosis drug therapy.	[Zhu, Hong; He, Changsheng; Zhao, Huizi; Jiang, Wenjuan; Xu, Songbing; Li, Jun; Ma, Taotao; Huang, Cheng] Anhui Med Univ, Anhui Prov Lab Inflammatory & Immun Dis, Anhui Inst Innovat Drugs, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Ma, TT; Huang, C (corresponding author), Anhui Med Univ, Anhui Prov Lab Inflammatory & Immun Dis, Anhui Inst Innovat Drugs, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	mataotao@ahmu.edu.cn; huangcheng@ahmu.edu.cn		Jiang, Wenjuan/0000-0002-8430-556X	National Science Foundation of China [0601011138]; Anhui Provincal Universities Natural Science Foundation [KJ2019A0233]; University Synergy Innovation Progrma of Anhui Province [GXXT-2019045]; National Science Foundation of Anhui Province [2008085MH273]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincal Universities Natural Science Foundation; University Synergy Innovation Progrma of Anhui Province; National Science Foundation of Anhui Province	The National Science Foundation of China, Grant/Award Number: 0601011138; Anhui Provincal Universities Natural Science Foundation, Grant/Award Number: KJ2019A0233; The University Synergy Innovation Progrma of Anhui Province, Grant/Award Number: GXXT-2019045; National Science Foundation of Anhui Province, Grant/Award Number: 2008085MH273	Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Boyanapalli SSS, 2016, PHARMACOL RES, V114, P175, DOI 10.1016/j.phrs.2016.10.021; Butler DE, 2017, ONCOTARGET, V8, P56698, DOI 10.18632/oncotarget.18082; Cao YX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103210; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Choi SB, 2006, LIFE SCI, V78, P934, DOI 10.1016/j.lfs.2005.05.101; Duran A, 2016, CANCER CELL, V30, P595, DOI 10.1016/j.ccell.2016.09.004; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Ferguson LR, 2011, CURR CANCER DRUG TAR, V11, P199; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Giannitrapani L, 2014, WORLD J GASTROENTERO, V20, P7242, DOI 10.3748/wjg.v20.i23.7242; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hong L, 2015, J CELL MOL MED, V19, P2462, DOI 10.1111/jcmm.12636; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ismail Mona H, 2009, Saudi J Gastroenterol, V15, P72, DOI 10.4103/1319-3767.45072; Karvar S, 2020, HEPATOLOGY, V72, P1073, DOI 10.1002/hep.31078; Khomich O, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010024; Kim IH, 2012, EXP MOL MED, V44, P448, DOI 10.3858/emm.2012.44.7.051; Kisseleva T, 2013, CELL CYCLE, V12, P381, DOI 10.4161/cc.23549; Kobayashi M, 2007, BASIC CLIN PHARMACOL, V101, P121, DOI 10.1111/j.1742-7843.2007.00088.x; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Le JM, 2019, ACTA PHARM SIN B, V9, P758, DOI 10.1016/j.apsb.2019.01.014; Le JM, 2018, BIOCHEM BIOPH RES CO, V500, P484, DOI 10.1016/j.bbrc.2018.04.108; Lee JH, 2019, FORENSIC SCI INT, V303, DOI 10.1016/j.forsciint.2019.109932; LENGPESCHLOW E, 1986, J PHARM PHARMACOL, V38, P606, DOI 10.1111/j.2042-7158.1986.tb03089.x; Liu YD, 2020, J CANCER, V11, P488, DOI 10.7150/jca.31422; Massey V, 2017, SEMIN LIVER DIS, V37, P219, DOI 10.1055/s-0037-1605371; Mohammad Amro H, 2019, Oncotarget, V10, P4923, DOI 10.18632/oncotarget.27075; Movassaghi S, 2013, IRAN J BASIC MED SCI, V16, P922; Omar R, 2016, REV PHYSIOL BIOCH P, V172, P1, DOI 10.1007/112_2016_6; Pan XY, 2019, THERANOSTICS, V9, P4308, DOI 10.7150/thno.32710; Pitha-Rowe I, 2009, INVEST OPHTH VIS SCI, V50, P5339, DOI 10.1167/iovs.09-3648; Ramachandran P, 2009, ANN HEPATOL, V8, P283, DOI 10.1016/S1665-2681(19)31740-5; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Sha M, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106157; Sun X, 2013, CELL SIGNAL, V25, P1870, DOI 10.1016/j.cellsig.2013.05.013; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Wu YT, 2017, TOXICOL APPL PHARM, V315, P35, DOI 10.1016/j.taap.2016.12.002; Xiang N, 2008, CARCINOGENESIS, V29, P2175, DOI 10.1093/carcin/bgn179; Xu WT, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0795-2; Yang JA, 2015, ACTA BIOMATER, V12, P174, DOI 10.1016/j.actbio.2014.10.002; Yang JJ, 2013, CELL SIGNAL, V25, P1202, DOI 10.1016/j.cellsig.2013.01.005; Yang Z, 2015, ONCOTARGET, V6, P31916, DOI 10.18632/oncotarget.5577; Yu FJ, 2015, J CELL MOL MED, V19, P2617, DOI 10.1111/jcmm.12655; Zhang A, 2020, BIOCH BIOPHYS RES CO; Zheng JJ, 2014, FEBS J, V281, P88, DOI 10.1111/febs.12574; Zhu XB, 2019, ANN RHEUM DIS, V78, P1420, DOI 10.1136/annrheumdis-2018-214940	52	9	9	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14558	14571		10.1096/fj.202000494RR	http://dx.doi.org/10.1096/fj.202000494RR		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32946656				2022-12-28	WOS:000572281600001
J	Zeng, XX; Niu, YY; Qin, GC; Zhang, DK; Zhou, JY; Chen, LX				Zeng, Xiaoxu; Niu, Yingying; Qin, Guangcheng; Zhang, Dunke; Zhou, Jiying; Chen, Lixue			Deficiency in the function of inhibitory interneurons contributes to glutamate-associated central sensitization through GABABR2-SynCAM1 signaling in chronic migraine rats	FASEB JOURNAL			English	Article						c-Fos; CGRP; glutamate; PAG; PKA	GENE-RELATED PEPTIDE; MECHANICAL HYPERALGESIA; NEUROPATHIC PAIN; RECEPTOR; ACTIVATION; ANTINOCICEPTION; INVOLVEMENT; NOCICEPTION; PATHWAY; MODEL	The occurrence of pain has always been closely related to a break in the balance between excitatory and inhibitory systems, and the internal relationship between these two systems has not been studied in the pathogenesis of chronic migraine (CM). In this study, we explored how inhibitory interneurons specifically modulate the glutamate-induced hyperexcitability in the periaqueductal gray (PAG) of CM rats. The CM model was established by repeated dural infusion of inflammatory soup (IS) in rats. Then, Baclofen, a gamma-aminobutyric acid type B receptor (GABABR) agonist; CGP35348, a GABABR antagonist; H89, a protein kinase A (PKA) inhibitor; and 8-Bromo-cAMP, a PKA agonist, were applied by intraventricular injection to investigate the detailed CM mechanism. Our results showed that GABABR2 mRNA and protein levels were significantly downregulated (P < .01) in the PAG of CM rats. Similarly, gamma-aminobutyric acid (GABA) and its synthetase glutamate decarboxylase 65/67 (GAD65/67) seriously decreased (P < .01), implying a deficit in the function of inhibitory interneurons in the PAG of CM rats. Afterward, the application of Baclofen and H89 alleviated the IS-evoked hyperalgesia and extenuated vesicular glutamate transporter 2 (VGLUT2), glutamate, calcitonin gene-related peptide (CGRP), and c-Fos expression by regulating the GABABR2/PKA/SynCAM1 pathway in the PAG of CM rats, while the application of CGP35348 and 8-Bromo-cAMP exactly exerted the opposite effect. Importantly, CGP35348 induced an elevation of CGRP, and VGLUT2 expression was relieved by H89. These data suggest that the loss in the function of inhibitory interneurons contributes to glutamate-associated central sensitization through the GABABR2/PKA/SynCAM1 pathway in the PAG of CM rats.	[Zeng, Xiaoxu; Niu, Yingying; Qin, Guangcheng; Zhang, Dunke; Chen, Lixue] Chongqing Med Univ, Lab Res Ctr, Affiliated Hosp 1, 1st You Yi Rd, Chongqing 400016, Peoples R China; [Zhou, Jiying] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, LX (corresponding author), Chongqing Med Univ, Lab Res Ctr, Affiliated Hosp 1, 1st You Yi Rd, Chongqing 400016, Peoples R China.	chenlixue@hospital.cqmu.edu.cn			National Natural Science Foundation of China (NSFC) [81671093]; District Science and Technology Projects of Yuzhong Chongqing [20160107]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); District Science and Technology Projects of Yuzhong Chongqing	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671093; District Science and Technology Projects of Yuzhong Chongqing, Grant/Award Number: 20160107	Bagley EE, 2020, NEUROPHARMACOLOGY, V173, DOI 10.1016/j.neuropharm.2020.108131; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Booker SA, 2018, CELL REP, V22, P36, DOI 10.1016/j.celrep.2017.12.021; Booker SA, 2013, J NEUROSCI, V33, P7961, DOI 10.1523/JNEUROSCI.1186-12.2013; Cervo L, 1997, BRAIN RES, V775, P30, DOI 10.1016/S0006-8993(97)00866-4; Chen HS, 2008, PAIN, V135, P31, DOI 10.1016/j.pain.2007.04.040; Dodick DW, 2018, LANCET, V391, P1315, DOI 10.1016/S0140-6736(18)30478-1; Edvinsson L, 2001, CNS DRUGS, V15, P745, DOI 10.2165/00023210-200115100-00001; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Ferrari MD, 2019, LANCET, V394, P1030, DOI 10.1016/S0140-6736(19)31946-4; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Frangaj A, 2018, NEUROPHARMACOLOGY, V136, P68, DOI 10.1016/j.neuropharm.2017.10.011; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gwak YS, 2006, J NEUROTRAUM, V23, P1111, DOI 10.1089/neu.2006.23.1111; Hang LH, 2013, PHARMACOL REP, V65, P710, DOI 10.1016/S1734-1140(13)71049-1; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; He W, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1459-7; Hoy JL, 2009, MOL CELL NEUROSCI, V42, P466, DOI 10.1016/j.mcn.2009.09.010; Huang ZJ, 2012, PAIN, V153, P1426, DOI 10.1016/j.pain.2012.03.025; Ibrahimi K, 2014, MATURITAS, V78, P277, DOI 10.1016/j.maturitas.2014.05.018; Ipponi A, 1999, EUR J PHARMACOL, V368, P205, DOI 10.1016/S0014-2999(99)00034-5; Iyengar S, 2017, PAIN, V158, P543, DOI 10.1097/j.pain.0000000000000831; Jia ZH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04060-6; KEHNE JH, 1987, BRAIN RES, V406, P87, DOI 10.1016/0006-8993(87)90771-2; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kou ZZ, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00025; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Laffray S, 2012, EMBO J, V31, P3239, DOI 10.1038/emboj.2012.161; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lazarus MS, 2015, CEREB CORTEX, V25, P1290, DOI 10.1093/cercor/bht322; Leung LS, 2005, EPILEPSIA, V46, P203, DOI 10.1111/j.0013-9580.2005.35804.x; Liu YQ, 2019, BIOCHEM BIOPH RES CO, V520, P449, DOI 10.1016/j.bbrc.2019.10.044; Long T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1285-3; Mathew NT, 2011, HEADACHE, V51, P84, DOI 10.1111/j.1526-4610.2011.01955.x; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Melo-Carrillo A, 2013, CEPHALALGIA, V33, P1096, DOI 10.1177/0333102413486320; Miletic G, 2002, PAIN, V99, P493, DOI 10.1016/S0304-3959(02)00242-7; Mitsikostas DD, 2011, J HEADACHE PAIN, V12, P411, DOI 10.1007/s10194-011-0352-2; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Romero-Reyes M, 2013, CEPHALALGIA, V33, P566, DOI 10.1177/0333102412472557; Shafizadeh M, 1997, GEN PHARMACOL-VASC S, V28, P611, DOI 10.1016/S0306-3623(96)00241-8; Shao XM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5320641; Silva AP, 2007, FASEB J, V21, P671, DOI 10.1096/fj.06-6163com; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Tajti J, 2015, NEUROPEPTIDES, V52, P19, DOI 10.1016/j.npep.2015.03.006; Vergassola M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00324; Wan D, 2016, EUR J PHARMACOL, V770, P92, DOI 10.1016/j.ejphar.2015.11.056; Wang J, 2020, NEUROSCIENCE, V428, P178, DOI 10.1016/j.neuroscience.2019.12.038; Wang M, 2015, NEUROSCIENCE, V298, P137, DOI 10.1016/j.neuroscience.2015.04.016; Wang XY, 2018, INT CONF SYST INFORM, P19, DOI 10.1109/ICSAI.2018.8599303; Wang ZB, 2005, PAIN, V114, P266, DOI 10.1016/j.pain.2004.12.027; Watson CJ, 2016, PAIN, V157, P2194, DOI 10.1097/j.pain.0000000000000615; Zhang JM, 2002, J NEUROPHYSIOL, V88, P1387, DOI 10.1152/jn.2002.88.3.1387; Zhou HR, 2019, NEUROSCIENCE, V398, P252, DOI 10.1016/j.neuroscience.2018.12.006; Zhou X, 2020, J NEUROCHEM, V155, P370, DOI 10.1111/jnc.14944; Zhu YS, 2019, NEUROPATHOLOGY, V39, P30, DOI 10.1111/neup.12530	61	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14780	14798		10.1096/fj.202001561R	http://dx.doi.org/10.1096/fj.202001561R		SEP 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931071				2022-12-28	WOS:000570777600001
J	Zhan, CS; Chen, J; Chen, J; Zhang, LG; Liu, Y; Du, HX; Wang, H; Zheng, MJ; Yu, ZQ; Chen, XG; Zhang, L; Liang, CZ				Zhan, Chang-Sheng; Chen, Jia; Chen, Jing; Zhang, Li-Gang; Liu, Yi; Du, He-Xi; Wang, Hui; Zheng, Mei-Juan; Yu, Zi-Qiang; Chen, Xian-Guo; Zhang, Li; Liang, Chao-Zhao			CaMK4-dependent phosphorylation of Akt/mTOR underlies Th17 excessive activation in experimental autoimmune prostatitis	FASEB JOURNAL			English	Article						Akt; mTOR signaling; CaMK4; EAP; Th17	PROTEIN-KINASE IV; T-CELLS; T(H)17; DIFFERENTIATION; INFLAMMATION; ENTRY	Chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) is a complicated syndrome characterized by genitourinary pain in the absence of bacterial infection. Th17 cell-driven autoimmunity has been proposed as a cause of CP/CPPS. However, the factors that promote Th17-driven autoimmunity in experimental autoimmune prostatitis (EAP) and the molecular mechanisms are still largely unknown. Here, we showed that Th17 cells were excessively activated, and blockade of IL-17A could effectively ameliorate various symptoms in EAP. Furthermore, we revealed that calcium/calmodulin-dependent kinase (CaMK4), especially Thr(196)p-CaMK4 was increased in the Th17 cells of the EAP group, which were activated by intracellular cytosolic Ca2+. Pharmacologic and genetic inhibition of CaMK4 decreased the proportion of Th17 cells, and the protein and mRNA level of IL-17A, IL-22, and ROR gamma t. The phosphorylation of CaMK4 was dependent on the increase in intracellular cytosolic Ca(2+)concentration in Th17 cells. A mechanistic study demonstrated that inhibition of CaMK4 reduced IL-17A production by decreasing the phosphorylation of Akt-mTOR, which was well accepted to positively regulate Th17 differentiation. Collectively, our results demonstrated that Ca2+-CaMK4-Akt/mTOR-IL-17A axis inhibition may serve as a promising therapeutic strategy for CP/CPPS.	[Zhan, Chang-Sheng; Chen, Jia; Chen, Jing; Zhang, Li-Gang; Liu, Yi; Du, He-Xi; Wang, Hui; Chen, Xian-Guo; Zhang, Li; Liang, Chao-Zhao] Anhui Med Univ, Dept Urol, Affiliated Hosp 1, 218 Jixi Rd, Hefei 230022, Peoples R China; [Zhan, Chang-Sheng; Chen, Jia; Chen, Jing; Zhang, Li-Gang; Liu, Yi; Du, He-Xi; Wang, Hui; Chen, Xian-Guo; Zhang, Li; Liang, Chao-Zhao] Anhui Med Univ, Inst Urol, Hefei, Peoples R China; [Zhan, Chang-Sheng; Liu, Yi; Chen, Xian-Guo; Zhang, Li; Liang, Chao-Zhao] Anhui Med Univ, Anhui Prov Key Lab Genitourinary Dis, Hefei, Peoples R China; [Zheng, Mei-Juan] Anhui Med Univ, Dept Clin Lab, Affiliated Hosp 1, Hefei, Peoples R China; [Yu, Zi-Qiang] Anhui Univ Chinese Med, Dept Urol, Affiliated Hosp 1, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui University of Chinese Medicine	Chen, XG; Zhang, L; Liang, CZ (corresponding author), Anhui Med Univ, Dept Urol, Affiliated Hosp 1, 218 Jixi Rd, Hefei 230022, Peoples R China.	cxg7866186@126.com; lzhang@ahmu.edu.cn; chaozhao@ahmu.edu.cn			National Natural Science Foundation of China (NSFC) [81630019, 81870519, 81470986, 81970597]; Anhui Provincial Natural Science Foundation [2008085QH360]; Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province [2017ZHYX02]; Key Project of Provincial Natural Science Research Project of Anhui Colleges [KJ2019A0278]; Supporting Project for Distinguished Young Scholar of Anhui Colleges [gxyqZD2019018]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province; Key Project of Provincial Natural Science Research Project of Anhui Colleges; Supporting Project for Distinguished Young Scholar of Anhui Colleges	This work was supported by the National Natural Science Foundation of China (NSFC) (No. 81630019, 81870519, 81470986, 81970597), Anhui Provincial Natural Science Foundation (No. 2008085QH360), the Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province (2017ZHYX02), the Key Project of Provincial Natural Science Research Project of Anhui Colleges (KJ2019A0278), and the Supporting Project for Distinguished Young Scholar of Anhui Colleges (gxyqZD2019018).	Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Breser Maria L, 2017, Front Immunol, V8, P898, DOI 10.3389/fimmu.2017.00898; Chen J, 2019, INFLAMMATION, V42, P1705, DOI 10.1007/s10753-019-01030-0; Choi OH, 1996, NATURE, V380, P634; Clemens JQ, 2019, NAT REV UROL, V16, P187, DOI 10.1038/s41585-018-0135-5; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; Crispin JC, 2010, CURR OPIN RHEUMATOL, V22, P499, DOI 10.1097/BOR.0b013e32833c62b0; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Doiron RC, 2019, WORLD J UROL, V37, P1015, DOI 10.1007/s00345-019-02718-6; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Koga T, 2018, MOD RHEUMATOL, V28, P211, DOI 10.1080/14397595.2017.1413964; Koga T, 2016, ARTHRITIS RHEUMATOL, V68, P1981, DOI 10.1002/art.39665; Koga T, 2014, AUTOIMMUNITY, V47, P445, DOI 10.3109/08916934.2014.915954; Koga T, 2014, J CLIN INVEST, V124, P2234, DOI 10.1172/JCI73411; Koga T, 2012, J IMMUNOL, V189, P3490, DOI 10.4049/jimmunol.1201785; Kunihiro I, 2014, ARTHRITIS RHEUM, V63, P523; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lee GR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030730; Li J, 2012, MOL VIS, V18, P2371; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Magistro G, 2016, EUR UROL, V69, P286, DOI 10.1016/j.eururo.2015.08.061; McGinley AM, 2018, J AUTOIMMUN, V87, P97, DOI 10.1016/j.jaut.2018.01.001; Montes M, 2009, CLIN IMMUNOL, V130, P133, DOI 10.1016/j.clim.2008.08.030; Motrich RD, 2016, PAIN, V157, P585, DOI 10.1097/j.pain.0000000000000405; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131085; Murphy SF, 2014, NAT REV UROL, V11, P259, DOI 10.1038/nrurol.2014.63; Nickel JC, 2017, J UROLOGY, V198, P122, DOI 10.1016/j.juro.2017.01.035; Nickel JC, 2013, WORLD J UROL, V31, P709, DOI 10.1007/s00345-013-1121-4; Nohara LL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00234; Penna G, 2007, J IMMUNOL, V179, P1559, DOI 10.4049/jimmunol.179.3.1559; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rees J, 2015, BJU INT, V116, P509, DOI 10.1111/bju.13101; Rivero VE, 1998, J AUTOIMMUN, V11, P603, DOI 10.1006/jaut.1998.0248; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Sari E, 2015, J UROLOGY, V193, P1036, DOI 10.1016/j.juro.2014.09.120; Scalerandi MV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01980; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Zhang LG, 2019, PROSTATE, V79, P1439, DOI 10.1002/pros.23866; Zhang S, 2017, NATURE, V551, P105, DOI 10.1038/nature24283; Zheng MJ, 2016, J IMMUNOL, V196, P4122, DOI 10.4049/jimmunol.1500846	41	9	10	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					14006	14023		10.1096/fj.201902910RRR	http://dx.doi.org/10.1096/fj.201902910RRR		AUG 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32862457	hybrid			2022-12-28	WOS:000565932100001
J	Ren, AJ; Chen, C; Zhang, S; Liu, MN; Wei, CC; Wang, K; Ma, XH; Song, Y; Wang, R; Zhang, H; Chen, YX; Wu, H; Xie, ZF; Zhang, YY; Zhang, WPJ				Ren, An-Jing; Chen, Chao; Zhang, Sha; Liu, Mengna; Wei, Chunchun; Wang, Kai; Ma, Xianhua; Song, Yao; Wang, Rui; Zhang, Hai; Chen, Yu-Xia; Wu, Hong; Xie, Zhifang; Zhang, Youyi; Zhang, Weiping J.			Zbtb20 deficiency causes cardiac contractile dysfunction in mice	FASEB JOURNAL			English	Article						blood pressure; cardiomyocyte; contractility; knockout; mitochondrion; transcription factor	FINGER PROTEIN ZBTB20; BLOOD-PRESSURE; GENE; TRANSCRIPTION; EXPRESSION; CA2+; DIFFERENTIATION; OVEREXPRESSION; MITOCHONDRIA; INDUCTION	The zinc-finger protein ZBTB20 regulates development and metabolism in multiple systems, and is essential for postnatal survival in mice. However, its potential role in the cardiovascular system remains undefined. Here, we demonstrate that ZBTB20 is critically involved in the regulation of cardiac contractility and blood pressure in mice. At the age of 16 days, the relatively healthy Zbtb20-null mice exhibited hypotension without obvious change of heart rate or other evidence for heart failure. Moreover, Zbtb20 deletion led to a marked reduction in heart size, left ventricular wall thickness, and cell size of cardiomyocytes, which was largely proportional to the decreased body growth. Notably, echocardiographic and hemodynamic analyses showed that cardiac contractility was greatly impaired in the absence of ZBTB20. Mechanistically, ZBTB20 deficiency decreased cardiac ATP contents, and compromised the enzyme activity of mitochondrial complex I in heart as well as L-type calcium current density in cardiomyocytes. Furthermore, the developmental activation of some mitochondrial function-related genes was significantly attenuated in Zbtb20-null myocardium, which included Hspb8, Ckmt2, Cox7a1, Tfrc, and Ogdhl. Put together, these results suggest that ZBTB20 plays a crucial role in the regulation of heart development, energy metabolism, and contractility.	[Ren, An-Jing; Zhang, Sha; Liu, Mengna; Wei, Chunchun; Wang, Kai; Ma, Xianhua; Wang, Rui; Zhang, Hai; Chen, Yu-Xia; Zhang, Weiping J.] Naval Med Univ, Dept Pathophysiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Chen, Chao; Song, Yao; Zhang, Youyi] Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100191, Peoples R China; [Zhang, Sha; Wu, Hong] Naval Med Univ, Changhai Hosp, Dept Cardiovasc Dis, Shanghai, Peoples R China; [Xie, Zhifang] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Minist Educ,Sch Med, Shanghai, Peoples R China; [Zhang, Weiping J.] Tianjin Med Univ, Chu Hsien I Mem Hosp, Tianjin Inst Endocrinol, NHC Key Lab Hormones & Dev, Tianjin, Peoples R China	Naval Medical University; Peking University; Naval Medical University; Shanghai Jiao Tong University; Tianjin Medical University	Zhang, WPJ (corresponding author), Naval Med Univ, Dept Pathophysiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.; Zhang, YY (corresponding author), Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100191, Peoples R China.	zhangyy@bjmu.edu.cn; wzhang@smmu.edu.cn	xie, zhifang/HII-4322-2022	xie, zhifang/0000-0002-5846-8381; Wei, Chunchun/0000-0002-1450-3050	National Key Research and Development Project of China [2019YFA0802500]; National Natural Science Foundation of China [31730042, 31471090, 31271221]; Collaborative Innovation Program of Shanghai Municipal Health Commission [2020CXJQ01]	National Key Research and Development Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Program of Shanghai Municipal Health Commission	National Key Research and Development Project of China, Grant/Award Number: 2019YFA0802500; National Natural Science Foundation of China, Grant/Award Number: 31730042, 31471090 and 31271221; Collaborative Innovation Program of Shanghai Municipal Health Commission, Grant/Award Number: 2020CXJQ01	Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; BITTL JA, 1985, J BIOL CHEM, V260, P208; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Cao DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11121; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5279; Chevrier S, 2014, IMMUNOL CELL BIOL, V92, P481, DOI 10.1038/icb.2014.20; Doeppner TR, 2019, MOL NEUROBIOL, V56, P567, DOI 10.1007/s12035-018-1104-y; DUKES ID, 1991, J PHYSIOL-LONDON, V435, P395, DOI 10.1113/jphysiol.1991.sp018516; Eden M, 2016, NAT COMMUN, V7, DOI 10.1315/11317; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; Greene AL, 2000, J BIOL CHEM, V275, P24722, DOI 10.1074/jbc.M001783200; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Huttemann M, 2012, MITOCHONDRION, V12, P294, DOI 10.1016/j.mito.2011.11.002; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Liu G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14824; Liu XG, 2013, P NATL ACAD SCI USA, V110, P11097, DOI 10.1073/pnas.1301257110; Lu ZJ, 2009, CIRCULATION, V120, P318, DOI 10.1161/CIRCULATIONAHA.109.873380; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Marin-Garcia J, 2003, J AM COLL CARDIOL, V41, P2299, DOI 10.1016/S0735-1097(03)00494-7; Marunouchi T, 2014, EUR J PHARMACOL, V730, P140, DOI 10.1016/j.ejphar.2014.02.037; Mitchelmore C, 2002, J BIOL CHEM, V277, P7598, DOI 10.1074/jbc.M110023200; Murthy M, 2017, CELL MOL LIFE SCI, V74, P1261, DOI 10.1007/s00018-016-2402-z; Nagao M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11102; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Oishi S, 2012, J PHARMACOL SCI, V120, P296, DOI 10.1254/jphs.12202FP; Qu ZP, 2016, ELIFE, V5, DOI 10.7554/eLife.17171; Ren AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5984; Rosati B, 2011, J PHYSIOL-LONDON, V589, P3275, DOI 10.1113/jphysiol.2011.210237; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Senyilmaz D, 2015, NATURE, V525, P124, DOI 10.1038/nature14601; Sherrill JD, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99922; Shi JH, 2020, DIABETES, V69, P591, DOI 10.2337/db19-0388; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sutherland APR, 2009, MOL CELL BIOL, V29, P2804, DOI 10.1128/MCB.01667-08; Vites AM, 1996, ANN NY ACAD SCI, V779, P521, DOI 10.1111/j.1749-6632.1996.tb44826.x; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Yousefi K, 2019, J AM COLL CARDIOL, V73, P2705, DOI 10.1016/j.jacc.2019.02.074; Zhang H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0514-0; Zhang WP, 2001, BIOCHEM BIOPH RES CO, V282, P1067, DOI 10.1006/bbrc.2001.4689; Zhang Y, 2012, GASTROENTEROLOGY, V142, P1571, DOI 10.1053/j.gastro.2012.02.043; Zhao SH, 2013, J HYPERTENS, V31, P576, DOI 10.1097/HJH.0b013e32835d6a56; Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849; Zhou GD, 2015, DEVELOPMENT, V142, P385, DOI 10.1242/dev.108530	46	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13862	13876		10.1096/fj.202000160RR	http://dx.doi.org/10.1096/fj.202000160RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32844471	Bronze			2022-12-28	WOS:000564886000001
J	Tserga, E; Moreno-Paublete, R; Sarlus, H; Bjorn, E; Guimaraes, E; Goritz, C; Cederroth, CR; Canlon, B				Tserga, Evangelia; Moreno-Paublete, Rocio; Sarlus, Heela; Bjorn, Erik; Guimaraes, Eduardo; Goritz, Christian; Cederroth, Christopher R.; Canlon, Barbara			Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea	FASEB JOURNAL			English	Article						afferent synapse; circadian; cisplatin ototoxicity; hearing loss; GLAST; PER2; synaptic pairing	GLUTAMATE-ASPARTATE TRANSPORTER; INDUCED HEARING-LOSS; NOISE; GLAST; EXPRESSION; MICE; CHRONOTHERAPY; CHEMOTHERAPY; SENSITIVITY; PROTECTION	The chemotherapeutic agent cisplatin is renowned for its ototoxic effects. While hair cells in the cochlea are established targets of cisplatin, less is known regarding the afferent synapse, which is an essential component in the faithful temporal transmission of sound. The glutamate aspartate transporter (GLAST) shields the auditory synapse from excessive glutamate release, and its loss of function increases the vulnerability to noise, salicylate, and aminoglycosides. Until now, the involvement of GLAST in cisplatin-mediated ototoxicity remains unknown. Here, we test in mice lacking GLAST the effects of a low-dose cisplatin known not to cause any detectable change in hearing thresholds. When administered at nighttime, a mild hearing loss in GLAST KO mice was found but not at daytime, revealing a potential circadian regulation of the vulnerability to cisplatin-mediated ototoxicity. We show that the auditory synapse of GLAST KO mice is more vulnerable to cisplatin administration during the active phase (nighttime) when compared to WT mice and treatment during the inactive phase (daytime). This effect was not related to the abundance of platinum compounds in the cochlea, rather cisplatin had a dose-dependent impact on cochlear clock rhythms only after treatment at nighttime suggesting that cisplatin can modulate the molecular clock. Our findings suggest that the current protocols of cisplatin administration in humans during daytime may cause a yet undetectable damage to the auditory synapse, more so in already damaged ears, and severely impact auditory sensitivity in cancer survivors.	[Tserga, Evangelia; Moreno-Paublete, Rocio; Sarlus, Heela; Canlon, Barbara] Karolinska Inst, Dept Physiol & Pharmacol, Lab Expt Audiol, S-17177 Stockholm, Sweden; [Bjorn, Erik] Umea Univ, Dept Chem, Umea, Sweden; [Guimaraes, Eduardo; Goritz, Christian] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Goritz, Christian] Karolinska Inst, Ming Wai Lau Ctr Reparat Med, Stockholm Node, Stockholm, Sweden; [Cederroth, Christopher R.] Univ Nottingham, Sch Med, Div Clin Neurosci, Hearing Sci, Nottingham, England	Karolinska Institutet; Umea University; Karolinska Institutet; Karolinska Institutet; University of Nottingham	Cederroth, CR; Canlon, B (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Lab Expt Audiol, S-17177 Stockholm, Sweden.	christopher.cederroth@ki.se; Barbara.canlon@ki.se	Göritz, Christian/AAK-5348-2021	Göritz, Christian/0000-0003-0799-766X; Tserga, Evangelia/0000-0002-1428-9816; Cederroth, Christopher/0000-0001-7267-5136; Sarlus, Heela/0000-0001-7880-9828; Canlon, Barbara/0000-0002-4377-5266	Knut and Alice Wallenberg Foundation [KAW2008]; Communication Disorders of the National Institutes of Health [1R56DC016415-01]; Swedish Medical Research Council [2017-01280]; Karolinska Institutet; Tysta Skolan; Horselforskningsfonden; Magnus Bergvalls; European Union	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet); Tysta Skolan; Horselforskningsfonden; Magnus Bergvalls; European Union(European Commission)	Knut and Alice Wallenberg Foundation, Grant/Award Number: #KAW2008; Communication Disorders of the National Institutes of Health, Grant/Award Number: 1R56DC016415-01; Swedish Medical Research Council, Grant/Award Number: 2017-01280; Karolinska Institutet; Tysta Skolan; Horselforskningsfonden; Magnus Bergvalls; European Union's Horizon 2020 research and innovation program	Ahmed S, 2013, BRAIN RES, V1529, P134, DOI 10.1016/j.brainres.2013.06.040; Basinou V, 2017, HEARING RES, V347, P47, DOI 10.1016/j.heares.2016.08.018; Bielefeld EC, 2018, HEARING RES, V370, P16, DOI 10.1016/j.heares.2018.09.004; Breglio AM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01837-1; Cederroth CR, 2019, CELL METAB, V30, P238, DOI 10.1016/j.cmet.2019.06.019; Cederroth CR, 2019, CURR BIOL, V29, P2477, DOI 10.1016/j.cub.2019.06.057; Chirtes F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925485; Dakup Panshak P, 2018, Oncotarget, V9, P14524, DOI 10.18632/oncotarget.24539; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Fernandez KA, 2020, NEUROSCIENCE, V427, P43, DOI 10.1016/j.neuroscience.2019.11.051; Frisina RD, 2016, J CLIN ONCOL, V34, P2712, DOI 10.1200/JCO.2016.66.8822; Furness DN, 2009, NEUROSCIENCE, V162, P1307, DOI 10.1016/j.neuroscience.2009.05.036; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; Greenzang KA, 2018, J CLIN ONCOL, V36, P94, DOI 10.1200/JCO.2017.75.2212; Gurney JG, 2007, PEDIATRICS, V120, pE1229, DOI 10.1542/peds.2007-0178; Hakuba N, 2000, J NEUROSCI, V20, P8750; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hickox AE, 2017, HEARING RES, V349, P164, DOI 10.1016/j.heares.2016.12.010; HRUSHESKY WJM, 1982, CANCER RES, V42, P945; Jin ZH, 2003, TOHOKU J EXP MED, V200, P137, DOI 10.1620/tjem.200.137; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kushner BH, 2006, CANCER-AM CANCER SOC, V107, P417, DOI 10.1002/cncr.22004; Landier W, 2016, CANCER-AM CANCER SOC, V122, P1647, DOI 10.1002/cncr.29779; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; Levi F, 2001, LANCET ONCOL, V2, P307, DOI 10.1016/S1470-2045(00)00326-0; Liberman LD, 2015, JARO-J ASSOC RES OTO, V16, P205, DOI 10.1007/s10162-015-0510-3; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; LIPPMAN AJ, 1973, CANCER CHEMOTH REP 1, V57, P191; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mehraei G, 2016, J NEUROSCI, V36, P3755, DOI 10.1523/JNEUROSCI.4460-15.2016; Meltser I, 2014, CURR BIOL, V24, P658, DOI 10.1016/j.cub.2014.01.047; Moser T, 2016, NAT REV NEUROL, V12, P135, DOI 10.1038/nrneurol.2016.10; Paken J, 2016, J TOXICOL-US, V2016, DOI 10.1155/2016/1809394; Park JS, 2017, CURR BIOL, V27, P2623, DOI 10.1016/j.cub.2017.07.019; Pearson SE, 2019, INT J AUDIOL, V58, P685, DOI 10.1080/14992027.2019.1660918; Poirrier AL, 2010, TOXICOL LETT, V193, P41, DOI 10.1016/j.toxlet.2009.12.003; Puig LS, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00452; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Rybak LP, 2009, TOHOKU J EXP MED, V219, P177, DOI 10.1620/tjem.219.177; Rybak LP, 2005, DRUG DISCOV TODAY, V10, P1313, DOI 10.1016/S1359-6446(05)03552-X; Shaheen LA, 2015, JARO-J ASSOC RES OTO, V16, P727, DOI 10.1007/s10162-015-0539-3; Sheth S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00338; Shimizu Y, 2005, NEUROSCI LETT, V380, P243, DOI 10.1016/j.neulet.2005.01.066; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; SOULBAN G, 1990, CHRONOBIOL INT, V7, P393, DOI 10.3109/07420529009059150; Thomson RS, 2017, LARYNGOSCOPE INVEST, V2, P69, DOI 10.1002/lio2.65; TSERGA E, 2020, PROG BRAIN RES; Tserga E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40138-z; Valero MD, 2018, HEARING RES, V363, P109, DOI 10.1016/j.heares.2018.03.012; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; White-Schwoch T, 2020, JAMA OTOLARYNGOL, V146, P499, DOI 10.1001/jamaoto.2019.4314; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; Yancey A, 2012, PEDIATR BLOOD CANCER, V59, P144, DOI 10.1002/pbc.24138; YONOVITZ A, 1991, ACTA OTO-LARYNGOL, V111, P1006; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yu H, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00158; Zhang SL, 2018, CELL, V173, P130, DOI 10.1016/j.cell.2018.02.017	59	8	9	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13978	13992		10.1096/fj.202001236R	http://dx.doi.org/10.1096/fj.202001236R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32840016	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000564449500001
J	Wu, SM; Feng, PH; Chuang, HC; Ho, SC; Chung, KF; Chen, KY; Wu, GS; Chen, TT; Tseng, CH; Liu, WT; Lee, KY				Wu, Sheng-Ming; Feng, Po-Hao; Chuang, Hsiao-Chi; Ho, Shu-Chuan; Chung, Kian Fan; Chen, Kuan-Yuan; Wu, Guang-Sing; Chen, Tzu-Tao; Tseng, Chien-Hua; Liu, Wen-Te; Lee, Kang-Yun			Impaired lnc-IL7R modulatory mechanism of Toll-like receptors is associated with an exacerbator phenotype of chronic obstructive pulmonary disease	FASEB JOURNAL			English	Article						COPD; exacerbation; inflammation; lnc-IL7R; Toll-like receptor	LONG NONCODING RNA; SYSTEMIC INFLAMMATION; CIGARETTE-SMOKE; COPD	Patients with chronic obstructive pulmonary disease (COPD) are susceptible to bacterial infections, which worsen lung inflammation and contribute to lung function decline and acute exacerbation. Long noncoding (lnc) RNAs are emerging regulators of inflammation with unknown clinical relevance. Herein, we report that levels of the Toll-like receptor (TLR)-related lnc interleukin (IL) 7 receptor (IL7R) were significantly reduced in peripheral blood mononuclear cells from patients with COPD compared with those from normal controls, and the levels were correlated with pulmonary function. Moreover lnc-IL7R levels were reduced in lavaged alveolar macrophages and primary human small airway epithelial cells (HSAEpCs) from patients with COPD. Lnc-IL7R knockdown in primary human macrophages, HSAEpCs, and human pulmonary microvascular endothelial cells (HPMECs) significantly augmented the induction of proinflammatory mediators after TLR2/4 activation. By contrast, lnc-IL7R overexpression attenuated inflammation after TLR2/4 activation. Similar results with lnc-IL7R-mediated inflammation were observed in COPD HSAEpCs. Mechanistically, lnc-IL7R mediated a repressive chromatin state of the proinflammatory gene promoter as a result of decreased acetylation (H3K9ac) and increased methylation (H3K9me3 and H3K27me3). Plasma lnc-IL7R levels were reduced in patients with COPD who experienced more acute exacerbation in the previous year. Notably, patients with lower lnc-IL7R levels in the subsequent year had increased exacerbation risk. Low lnc-IL7R expression in COPD may augment TLR2/4-mediated inflammation and be associated with acute exacerbation.	[Wu, Sheng-Ming; Feng, Po-Hao; Chuang, Hsiao-Chi; Ho, Shu-Chuan; Chen, Kuan-Yuan; Wu, Guang-Sing; Chen, Tzu-Tao; Tseng, Chien-Hua; Liu, Wen-Te; Lee, Kang-Yun] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei, Taiwan; [Wu, Sheng-Ming; Feng, Po-Hao; Chuang, Hsiao-Chi; Chen, Tzu-Tao; Tseng, Chien-Hua; Liu, Wen-Te; Lee, Kang-Yun] Taipei Med Univ, Coll Med, Sch Med, Div Pulm Med,Dept Internal Med, Taipei, Taiwan; [Chuang, Hsiao-Chi; Ho, Shu-Chuan; Liu, Wen-Te] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei, Taiwan; [Chung, Kian Fan] Imperial Coll London, Natl Heart & Lung Inst, Airways Dis, London, England; [Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, London, England; [Chen, Kuan-Yuan; Lee, Kang-Yun] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Tseng, Chien-Hua] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Taipei Medical University; National Taiwan University	Lee, KY (corresponding author), Taipei Med Univ, Sch Med, Dept Internal Med, Div Pulm Med, 250 Wuxing St, Taipei 11031, Taiwan.	lee4949@ms41.hinet.net			Ministry of Science and Technology, Taiwan (MOST) [05-2314-B-038-056-MY3, 107-2314-B-038-114, 108-2314-B-038-111-MY3, 108-2314-B-038-063-MY3]; Ministry of Education of the R.O.C [DP2-108-21121-T04-01, DP2-109-21121-01-T-01]; Taipei Medical University; Shuang Ho Hospital [107F RP-01-3, 108-FRP-04, 109-FRP-03]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Ministry of Education of the R.O.C; Taipei Medical University; Shuang Ho Hospital	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 05-2314-B-038-056-MY3, 107-2314-B-038-114, 108-2314-B-038-111-MY3, and 108-2314-B-038-063-MY3; Ministry of Education of the R.O.C, Grant/Award Number: DP2-108-21121-T04-01 and DP2-109-21121-01-T-01; Taipei Medical University and Shuang Ho Hospital, Grant/Award Number: 106TMU-SHH-18 and 107TMU-SHH-09; Shuang Ho Hospital, Grant/Award Number: 107F RP-01-3, 108-FRP-04, and 109-FRP-03	Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Barnes PJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.76; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Bradford E., 2017, COPD, V18, P180, DOI DOI 10.1186/S12931-017-0662-2; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Buckley CD, 2011, IMMUNOL LETT, V138, P12, DOI 10.1016/j.imlet.2011.02.010; Chen TT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46667; Chowdhury IH, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3427461; Cui HC, 2014, EUR J IMMUNOL, V44, P2085, DOI 10.1002/eji.201344126; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Ding L, 2017, MOL CANCER THER, V16, P1068, DOI 10.1158/1535-7163.MCT-16-0454; Fan YY, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180483; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Geng H, 2016, GENES DIS, V3, P72, DOI 10.1016/j.gendis.2016.01.004; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadjicharalambous MR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02906; Han MK, 2017, LANCET RESP MED, V5, P619, DOI 10.1016/S2213-2600(17)30207-2; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Lee KY, 2012, EUR RESPIR J, V40, P863, DOI 10.1183/09031936.00146811; Liu DS, 2018, INFLAMMATION, V41, P654, DOI 10.1007/s10753-017-0720-4; Massone S, 2011, NEUROBIOL DIS, V41, P308, DOI 10.1016/j.nbd.2010.09.019; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qu XY, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7501851; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Sethi Sanjay, 2004, Proc Am Thorac Soc, V1, P109, DOI 10.1513/pats.2306029; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Tang WX, 2016, INT J CHRONIC OBSTR, V11, P2951, DOI 10.2147/COPD.S109570; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Wan B, 2018, CLIN RESPIR J, V12, P1607, DOI 10.1111/crj.12717; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Ye Z, 2017, MOL MED REP, V15, P1412, DOI 10.3892/mmr.2017.6150; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	48	4	4	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13317	13332		10.1096/fj.202000632R	http://dx.doi.org/10.1096/fj.202000632R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780913				2022-12-28	WOS:000558418600001
J	Jerabkova, K; Liao, YR; Kleiss, C; Fournane, S; Durik, M; Agote-Aran, A; Brino, L; Sedlacek, R; Sumara, I				Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sedlacek, Radislav; Sumara, Izabela			Deubiquitylase UCHL3 regulates bi-orientation and segregation of chromosomes during mitosis	FASEB JOURNAL			English	Article						Aurora B; DUBs; chromosome alignment; chromosome segregation; mitosis	SPINDLE-ASSEMBLY CHECKPOINT; AURORA-B; CENTROMERIC MCAK; CENP-E; UBIQUITIN; KINASE; COMPLEX; ANAPHASE; SITES; LOCALIZATION	Equal segregation of chromosomes during mitosis ensures euploidy of daughter cells. Defects in this process may result in an imbalance in the chromosomal composition and cellular transformation. Proteolytic and non-proteolytic ubiquitylation pathways ensure directionality and fidelity of mitotic progression but specific mitotic functions of deubiquitylating enzymes (DUBs) remain less studied. Here we describe the role of the DUB ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCHL3) in the regulation of chromosome bi-orientation and segregation during mitosis. Downregulation or inhibition of UCHL3 leads to chromosome alignment defects during metaphase. Frequent segregation errors during anaphase are also observed upon inactivation of UCHL3. Mechanistically, UCHL3 interacts with and deubiquitylates Aurora B, the catalytic subunit of chromosome passenger complex (CPC), known to be critically involved in the regulation of chromosome alignment and segregation. UCHL3 does not regulate protein levels of Aurora B or the binding of Aurora B to other CPC subunits. Instead, UCHL3 promotes localization of Aurora B to kinetochores, suggesting its role in the error correction mechanism monitoring bi-orientation of chromosomes during metaphase. Thus, UCHL3 contributes to the regulation of faithful genome segregation and maintenance of euploidy in human cells.	[Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Inst Genet & Biol Mol & Cellulaire IGBMC, Dept Dev & Stem Cells, Illkirch Graffenstaden, France; [Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Ctr Natl Rech Sci UMR 7104, Strasbourg, France; [Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Inst Natl Sante & Rech Med U964, Strasbourg, France; [Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Univ Strasbourg, Strasbourg, France; [Jerabkova, Katerina; Sedlacek, Radislav] Inst Mol Genet CAS, Lab Transgen Models Dis, Vvi, Vestec, Czech Republic; [Jerabkova, Katerina; Sedlacek, Radislav] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Sedlacek, Radislav] Inst Mol Genet CAS, Czech Ctr Phenogen, Vvi, Vestec, Czech Republic; [Brino, Laurent] Ksilink, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Sedlacek, R (corresponding author), Inst Mol Genet CAS, Lab Transgen Models Dis, Vvi, Vestec, Czech Republic.; Sumara, I (corresponding author), Inst Genet & Biol Mol & Cellulaire IGBMC, Illkirch Graffenstaden, France.	radislav.sedlacek@img.cas.cz; sumara@igbmc.fr	; Jerabkova, Katerina/S-3487-2017	Kleiss, Charlotte/0000-0001-7842-8275; Brino, laurent/0000-0002-9036-1461; Sumara, Izabela/0000-0002-5968-3358; Jerabkova, Katerina/0000-0003-4734-6458; LIAO, Yongrong/0000-0001-9053-4900	Agence Nationale de la Recherche (ANR) [ANR-10-LABX-0030-INRT]; Ligue Contre le Cancer; China Scholarship Council (CSC); Czech Academy of Sciences [RVO68378050]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2015040]; CNRS; Fondation ARC pour la recherche sur le cancer; Institut National du Cancer (INCa); USIAS; Programme Federateur Aviesan; INSERM; Sanofi iAward Europe; IGBMC	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); China Scholarship Council (CSC)(China Scholarship Council); Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); USIAS; Programme Federateur Aviesan; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Sanofi iAward Europe; IGBMC	Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-10-LABX-0030-INRT; Ligue Contre le Cancer; China Scholarship Council (CSC); Czech Academy of Sciences, Grant/Award Number: RVO68378050; Ministry of Education, Youth, and Sports of the Czech Republic, Grant/Award Number: LM2015040; IGBMC; CNRS; Fondation ARC pour la recherche sur le cancer; Institut National du Cancer (INCa); USIAS; Programme Federateur Aviesan; INSERM; Sanofi iAward Europe	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Artavanis-Tsakonas K, 2010, J BIOL CHEM, V285, P6857, DOI 10.1074/jbc.M109.072405; Ben-David U, 2020, NAT REV GENET, V21, P44, DOI 10.1038/s41576-019-0171-x; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Dennissen FJA, 2011, FEBS LETT, V585, P2568, DOI 10.1016/j.febslet.2011.06.037; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Ems-McClung SC, 2013, CURR BIOL, V23, P2491, DOI 10.1016/j.cub.2013.10.054; Fournane Sadek, 2012, Genes Cancer, V3, P697, DOI 10.1177/1947601912473477; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Jerabkova K, 2019, SEMIN CELL DEV BIOL, V93, P100, DOI 10.1016/j.semcdb.2018.12.007; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Krenn V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00225; Krupina K, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2016.1271494; Krupina K, 2016, DEV CELL, V36, P63, DOI 10.1016/j.devcel.2015.12.017; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Maerki S, 2010, CELL CYCLE, V9, P2921, DOI 10.4161/cc.9.15.12740; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nishi R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36235-0; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Saurin AT, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00062; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Shrestha RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00209-z; Song ZW, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1628-8; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Sumara I, 2007, CELL CYCLE, V6, P3004, DOI 10.4161/cc.6.24.5068; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Vader G, 2007, MOL BIOL CELL, V18, P4553, DOI 10.1091/mbc.E07-04-0328; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; Wu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08043-7; Zhang MH, 2020, ONCOGENE, V39, P322, DOI 10.1038/s41388-019-0987-z; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086	50	2	2	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12751	12767		10.1096/fj.202000769R	http://dx.doi.org/10.1096/fj.202000769R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738097	Green Published			2022-12-28	WOS:000558165400001
J	Daryadel, A; Ruiz, PA; Gehring, N; Stojanovic, D; Ugrica, M; Bettoni, C; Sabrautzki, S; Pastor-Arroyo, EM; Frey-Wagner, I; Lorenz-Depiereux, B; Strom, TM; de Angelis, MH; Rogler, G; Wagner, CA; Rubio-Aliaga, I				Daryadel, Arezoo; Ruiz, Pedro A.; Gehring, Nicole; Stojanovic, Dragana; Ugrica, Marko; Bettoni, Carla; Sabrautzki, Sibylle; Pastor-Arroyo, Eva-Maria; Frey-Wagner, Isabelle; Lorenz-Depiereux, Bettina; Strom, Tim M.; de Angelis, Martin Hrabe; Rogler, Gerhard; Wagner, Carsten A.; Rubio-Aliaga, Isabel			Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage	FASEB JOURNAL			English	Article						FGF23; Jak; Stat signaling; inflammation; calcitriol; PTH	GROWTH-FACTOR 23; ELEVATED FGF23; EXPRESSION; PHOSPHATE; KIDNEY; TRANSPORT; HYPOPHOSPHATEMIA; MECHANISMS; RESISTANCE; MUTATIONS	Fibroblast growth factor 23 (FGF23) is a main regulator of mineral homeostasis. Low and high circulating FGF23 levels are associated with bone, renal, cardiovascular diseases, and increased mortality. Understanding the factors and signaling pathways affecting FGF23 levels is crucial for the management of these diseases and their complications. Here, we show that activation of the Jak1/Stat3 signaling pathway leads to inflammation in liver and to an increase in hepatic FGF23 synthesis, a key hormone in mineral metabolism. This increased synthesis leads to massive C-terminal FGF23 circulating levels, the inactive C-terminal fragment, and increased intact FGF23 levels, the active form, resulting in imbalanced production and cleavage. Liver inflammation does not lead to activation of the calcineurin-NFAT pathway, and no signs of systemic inflammation could be observed. Despite the increase of active intact FGF23, excessive C-terminal FGF23 levels block the phosphaturic activity of FGF23. Therefore, kidney function and renal alpha Klotho expression are normal and no activation of the MAPK pathway was detected. In addition, activation of the Jak1/Stat3 signaling pathway leads to high calcitriol levels and low parathyroid hormone production. Thus, JAK1 is a central regulator of mineral homeostasis. Moreover, this study also shows that in order to assess the impact of high FGF23 levels on disease and kidney function, the source and the balance in FGF23 production and cleavage are critical.	[Daryadel, Arezoo; Gehring, Nicole; Stojanovic, Dragana; Ugrica, Marko; Bettoni, Carla; Pastor-Arroyo, Eva-Maria; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Univ Zurich UZH, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Daryadel, Arezoo; Gehring, Nicole; Stojanovic, Dragana; Ugrica, Marko; Bettoni, Carla; Pastor-Arroyo, Eva-Maria; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Natl Ctr Competence Res NCCR Kidney CH, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Ruiz, Pedro A.; Frey-Wagner, Isabelle; Rogler, Gerhard] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Sabrautzki, Sibylle; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Inst Expt Genet, German Res Ctr Environm Hlth GmbH, D-85764 Neuherberg, Germany; [Lorenz-Depiereux, Bettina] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Human Genet, Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany	University of Zurich; University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Wagner, CA; Rubio-Aliaga, I (corresponding author), Univ Zurich UZH, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Wagner, CA; Rubio-Aliaga, I (corresponding author), Natl Ctr Competence Res NCCR Kidney CH, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Wagnerca@access.uzh.ch; isabel.rubioaliaga@uzh.ch	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Rubio-Aliaga, Isabel/0000-0003-1051-9511				Bar L, 2019, FEBS LETT, V593, P1879, DOI 10.1002/1873-3468.13494; Bao JF, 2020, J AM SOC NEPHROL, V31, P1423, DOI 10.1681/ASN.2020010081; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; BIBER J, 1983, PFLUG ARCH EUR J PHY, V396, P335, DOI 10.1007/BF01063939; Bienaime F, 2018, J CLIN ENDOCR METAB, V103, P2319, DOI 10.1210/jc.2018-00123; Bon N, 2018, MOL METAB, V11, P197, DOI 10.1016/j.molmet.2018.02.007; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Daryadel A, 2018, PFLUG ARCH EUR J PHY, V470, P1569, DOI 10.1007/s00424-018-2171-7; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Durlacher-Betzer K, 2018, KIDNEY INT, V94, P315, DOI 10.1016/j.kint.2018.02.026; Edmonston D, 2020, NAT REV NEPHROL, V16, P7, DOI 10.1038/s41581-019-0189-5; Egli-Spichtig D, 2019, KIDNEY INT, V96, P890, DOI 10.1016/j.kint.2019.04.009; Flamme I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186979; Gallo LH, 2015, CYTOKINE GROWTH F R, V26, P425, DOI 10.1016/j.cytogfr.2015.03.003; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; HOFFMANN N, 1976, PFLUG ARCH EUR J PHY, V362, P147, DOI 10.1007/BF00583641; Holecki M, 2015, CLIN ENDOCRINOL, V82, P900, DOI 10.1111/cen.12759; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Ito N, 2015, MOL CELL ENDOCRINOL, V399, P208, DOI 10.1016/j.mce.2014.10.007; Johnson K, 2017, J BONE MINER RES, V32, P2062, DOI 10.1002/jbmr.3197; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kuro-o M, 2017, BONE, V100, P4, DOI 10.1016/j.bone.2016.11.013; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Levi M, 2019, NAT REV NEPHROL, V15, P482, DOI 10.1038/s41581-019-0159-y; Li Jiliang, 2013, JAKSTAT, V2, pe23930, DOI 10.4161/jkst.23930; Li Q, 2017, ONCOTARGET, V8, P34687, DOI 10.18632/oncotarget.16670; Masuda Y, 2015, BIOL PHARM BULL, V38, P687, DOI 10.1248/bpb.b14-00276; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; NasrAllah MM, 2013, NEPHRON EXTRA, V3, P106, DOI 10.1159/000356118; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Pastor-Arroyo EM, 2018, KIDNEY INT, V94, P49, DOI 10.1016/j.kint.2018.02.017; Pathak JL, 2016, CALCIFIED TISSUE INT, V98, P596, DOI 10.1007/s00223-016-0116-8; Pathare G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22041-1; Prie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066182; Rabadi S, 2018, AM J PHYSIOL-RENAL, V314, pF132, DOI 10.1152/ajprenal.00081.2017; Richter B, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00189; Roberts MS, 2018, J CLIN INVEST, V128, P5368, DOI 10.1172/JCI122004; Sabrautzki S, 2013, AM J PATHOL, V183, P352, DOI 10.1016/j.ajpath.2013.04.027; Sato H, 2016, INTERNAL MED, V55, P121, DOI 10.2169/internalmedicine.55.5507; Shikida Y, 2018, CALCIFIED TISSUE INT, V103, P455, DOI 10.1007/s00223-018-0440-2; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Silver J, 1999, KIDNEY INT, V56, pS2, DOI 10.1046/j.1523-1755.1999.07310.x; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Toro L, 2018, KIDNEY INT, V93, P1131, DOI 10.1016/j.kint.2017.11.018; Umbach AT, 2015, KIDNEY INT, V87, P728, DOI 10.1038/ki.2014.371; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; Vervloet M, 2019, NAT REV NEPHROL, V15, P109, DOI 10.1038/s41581-018-0087-2; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xu LJ, 2018, J CELL BIOCHEM, V119, P3819, DOI 10.1002/jcb.26332; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	55	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21302	10.1096/fj.202002113R	http://dx.doi.org/10.1096/fj.202002113R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475190	Bronze			2022-12-28	WOS:000647789600092
J	Hirata, H; Xu, XH; Nishioka, K; Matsuhisa, F; Kitajima, S; Kukita, T; Murayama, M; Urano, Y; Miyamoto, H; Mawatari, M; Kukita, A				Hirata, Hirohito; Xu, Xianghe; Nishioka, Kenichi; Matsuhisa, Fumikazu; Kitajima, Shuji; Kukita, Toshio; Murayama, Masatoshi; Urano, Yasuteru; Miyamoto, Hiroshi; Mawatari, Masaaki; Kukita, Akiko			PMEPA1 and NEDD4 control the proton production of osteoclasts by regulating vesicular trafficking	FASEB JOURNAL			English	Article						lysosomal secretion; NEDD4; osteoclast; proton production; V&#8208; ATPase	UBIQUITIN LIGASE NEDD4; VACUOLAR H+-ATPASE; RUFFLED BORDER; MEMBRANE TRAFFICKING; BONE HOMEOSTASIS; OSTEOPETROSIS; EXPRESSION; SECRETION; AUTOPHAGY; TRANSPORT	Osteoclast bone resorption activity is critically regulated to maintain bone homeostasis. Osteoclasts resorb bone by producing protons and acid hydrolase via lysosomal secretion, however, a detailed mechanism remains elusive. PMEPA1 is a vesicular membrane protein, which binds to the NEDD4 family member of ubiquitin ligases. We have previously reported that Pmepa1 is highly expressed in bone resorbing osteoclasts, and regulates bone resorption. Here, we investigated the mechanism of bone resorption regulated by PMEPA1. Mutant mice lacking NEDD4-binding domains of PMEPA1 displayed enhanced bone volume, and reduced bone resorption activity in comparison with those of WT mice. Analysis with pH-sensitive fluorescence probe revealed that proton secretion from osteoclasts significantly decreased in Pmepa1 mutant osteoclasts. Immunofluorescence analysis revealed that PMEPA1 was colocalized with NEDD4, V0A3, and V0D2 subunits of vacuolar ATPase, which regulate the proton production of osteoclasts. In addition, Nedd4 knockdown reduced bone resorption and proton secretion of osteoclasts. Furthermore, Pmepa1 mutation and Nedd4 knockdown altered the cytoplasmic distribution of components of V-ATPase and expression of autophagy-related proteins, suggesting that lysosomal secretion is affected. Collectively, these findings indicate that PMEPA1 controls proton secretion from osteoclasts via NEDD4 by regulating vesicular trafficking, and NEDD4 is an important regulator of bone resorption.	[Hirata, Hirohito; Xu, Xianghe; Murayama, Masatoshi; Miyamoto, Hiroshi; Kukita, Akiko] Saga Univ, Fac Med, Dept Pathol & Microbiol, 5-1-1 Nabeshima, Saga 8498501, Japan; [Hirata, Hirohito; Murayama, Masatoshi; Mawatari, Masaaki] Saga Univ, Fac Med, Dept Orthoped Surg, Saga, Japan; [Xu, Xianghe; Kukita, Toshio] Kyushu Univ, Dept Mol Cell Biol & Oral Anat, Fukuoka, Japan; [Nishioka, Kenichi] Musashimurayama Hosp, Dept Internal Med, Tokyo, Japan; [Matsuhisa, Fumikazu; Kitajima, Shuji] Saga Univ, Analyt Res Ctr Expt Sci, Div Biol Resources & Dev, Saga, Japan; [Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Dept Chem Biol & Mol Imaging, Tokyo, Japan; [Urano, Yasuteru] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Chem & Biol, Tokyo, Japan; [Xu, Xianghe] Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 5, Zhuhai, Peoples R China	Saga University; Saga University; Kyushu University; Saga University; University of Tokyo; University of Tokyo; Sun Yat Sen University	Kukita, A (corresponding author), Saga Univ, Fac Med, Dept Pathol & Microbiol, 5-1-1 Nabeshima, Saga 8498501, Japan.	kukita@cc.saga-u.ac.jp						Bai XL, 2014, CELL SIGNAL, V26, P2030, DOI 10.1016/j.cellsig.2014.06.001; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Cremasco V, 2012, J BONE MINER RES, V27, P2452, DOI 10.1002/jbmr.1701; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Oyarzun JE, 2019, BBA-MOL BASIS DIS, V1865, P1076, DOI 10.1016/j.bbadis.2019.03.009; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Fujiwara T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86330; Funakubo N, 2018, J CELL PHYSIOL, V233, P3105, DOI 10.1002/jcp.26147; Hirvonen Mirkka J, 2013, Bonekey Rep, V2, P306, DOI 10.1038/bonekey.2013.40; Huang X, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2142-8; Itoh S, 2018, J BIOCHEM, V164, P195, DOI 10.1093/jb/mvy059; Jeon SA, 2018, BONE, V116, P248, DOI 10.1016/j.bone.2018.08.012; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kukita A, 2011, ARTHRITIS RHEUM-US, V63, P2744, DOI 10.1002/art.30455; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Lin Q, 2017, J CELL SCI, V130, P3839, DOI 10.1242/jcs.207068; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Luo SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42668; Luo SH, 2016, INT J BIOCHEM CELL B, V76, P98, DOI 10.1016/j.biocel.2016.05.004; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; Matsumoto N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24918-7; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mulari M, 2003, MICROSC RES TECHNIQ, V61, P496, DOI 10.1002/jemt.10371; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; Ohmae S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep41710; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Palokangas H, 1997, J CELL SCI, V110, P1767; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pei G, 2017, AUTOPHAGY, V13, P2041, DOI 10.1080/15548627.2017.1376160; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shiratori T, 2018, J IMMUNOL, V200, P218, DOI 10.4049/jimmunol.1602035; Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935; Sun AQ, 2017, AUTOPHAGY, V13, P522, DOI 10.1080/15548627.2016.1268301; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Willett R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01871-z; Wiszniak S, 2016, DEV BIOL, V410, P98, DOI 10.1016/j.ydbio.2015.12.001; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xu XH, 2019, FASEB J, V33, P4365, DOI 10.1096/fj.201801573R; Xu Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14570; Yu J, 2019, BONE, V127, P376, DOI 10.1016/j.bone.2019.07.009; Zhao HB, 2012, TRAFFIC, V13, P1307, DOI 10.1111/j.1600-0854.2012.01395.x; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201	51	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21281	10.1096/fj.202001795R	http://dx.doi.org/10.1096/fj.202001795R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484199	Bronze			2022-12-28	WOS:000647789600079
J	Nishinaka, A; Nakamura, S; Tanaka, M; Masuda, T; Inoue, Y; Yamamoto, T; Imai, T; Hidaka, Y; Shimazawa, M; Hara, H				Nishinaka, Anri; Nakamura, Shinsuke; Tanaka, Miruto; Masuda, Tomomi; Inoue, Yuki; Yamamoto, Takumi; Imai, Takahiko; Hidaka, Yae; Shimazawa, Masamitsu; Hara, Hideaki			Excess adiponectin in eyes with progressive ocular vascular diseases	FASEB JOURNAL			English	Article						adiponectin; edema; ischemia; retina; vascular disease	RETINAL VEIN OCCLUSION; ENDOTHELIAL GROWTH-FACTOR; DIABETIC MACULAR EDEMA; INSULIN-RESISTANCE; PROTEIN-KINASE; RETINOPATHY; VEGF; ADIPOSE; RANIBIZUMAB; ASSOCIATION	Anti-vascular endothelial growth factor (VEGF) therapies are now the first-line treatment for many ocular diseases, but some patients are non-responders to these therapies. The purpose of this study was to determine whether the level of adiponectin increased the pathogenesis of retinal edema and neovascularization in the retina of progressive ocular vascular diseases. We examined the role played by adiponectin in two types of cells and animal models which are retinal vein occlusion (RVO) and oxygen-induced retinopathy (OIR) mice. Our results showed that an injection of anti-adiponectin antibody ameliorated the retinal edema and ischemia through the depression of the expression level of VEGF-related factors and tight junction-related proteins in the retina of RVO mice. The intravitreal injection of anti-adiponectin antibody also decreased the degree of retinal neovascularization in an OIR mice. In addition, exposure of human retinal microvascular endothelial cells and human brain microvascular pericytes in culture to adiponectin increased both the vascular permeability and neovascularization through the increase of inflammatory factor and the dropout of the pericytes. These findings indicate that adiponectin plays a critical role in retinal edema and neovascularization, and adiponectin is a potential therapeutic target for the treatment of diabetic macular edema, proliferative diabetic retinopathy, and RVO.	[Nishinaka, Anri; Nakamura, Shinsuke; Tanaka, Miruto; Masuda, Tomomi; Inoue, Yuki; Yamamoto, Takumi; Imai, Takahiko; Hidaka, Yae; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan	Gifu Pharmaceutical University	Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	hidehara@gifu-pu.ac.jp	Imai, Takahiko/ABF-6143-2020	Imai, Takahiko/0000-0002-4422-2946; Hara, Hideaki/0000-0003-2046-9001				Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Dai Y, 2013, J GERONTOL A-BIOL, V68, P117, DOI 10.1093/gerona/gls131; Ebneter A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119046; Ebrahimi-Mamaeghani M, 2015, VASC HEALTH RISK MAN, V11, P55, DOI 10.2147/VHRM.S48753; Fu ZJ, 2017, INVEST OPHTH VIS SCI, V58, P3862, DOI 10.1167/iovs.17-21796; Fu ZJ, 2015, AM J CLIN NUTR, V101, P879, DOI 10.3945/ajcn.114.099291; Fuma S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43509; Guenther M, 2014, TRANSL RES, V164, P270, DOI 10.1016/j.trsl.2014.04.008; Gupta A, 2015, OMICS, V19, P733, DOI 10.1089/omi.2015.0128; Higuchi A, 2010, ARTERIOSCL THROM VAS, V30, P46, DOI 10.1161/ATVBAHA.109.198465; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hu XM, 2017, CIRC RES, V120, P449, DOI 10.1161/CIRCRESAHA.116.308427; Inoue Y, 2018, ARTERIOSCL THROM VAS, V38, P174, DOI 10.1161/ATVBAHA.117.310337; Isola V, 2013, CLIN OPHTHALMOL, V7, P455, DOI 10.2147/OPTH.S30156; Kato K, 2008, CLIN ENDOCRINOL, V68, P442, DOI 10.1111/j.1365-2265.2007.03063.x; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Khayat M, 2017, INVEST OPHTH VIS SCI, V58, P6175, DOI 10.1167/iovs.17-22788; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kuo JZ, 2015, J CLIN ENDOCR METAB, V100, P3348, DOI 10.1210/jc.2015-1221; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mao DN, 2012, CURR EYE RES, V37, P803, DOI 10.3109/02713683.2012.676700; Masuda T, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20539; Mouquet F, 2009, EUR HEART J, V30, P840, DOI 10.1093/eurheartj/ehn569; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060517; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Nishiguchi KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013493; Nishinaka A, 2018, INVEST OPHTH VIS SCI, V59, P4701, DOI 10.1167/iovs.18-23994; Ogura S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90905; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Osaadon P, 2014, EYE, V28, P510, DOI 10.1038/eye.2014.13; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; PEER J, 1995, LAB INVEST, V72, P638; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Rodriguez AJ, 2016, J DIABETES COMPLICAT, V30, P357, DOI 10.1016/j.jdiacomp.2015.11.004; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Spyridopoulos I, 2002, ARTERIOSCL THROM VAS, V22, P901, DOI 10.1161/01.ATV.0000020006.89055.11; Srinivasan V., 2013, INT J PHARM BIO SCI, V4, pB993; Stefanini FR, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/632307; Takagi T, 2017, J CEREBR BLOOD F MET, V37, P123, DOI 10.1177/0271678X15621499; Tanabe H, 2015, NATURE, V520, P312, DOI 10.1038/nature14301; Thach AB, 2014, OPHTHALMOLOGY, V121, P1059, DOI 10.1016/j.ophtha.2013.11.022; Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463; Tsurumi Y, 1997, NAT MED, V3, P879, DOI 10.1038/nm0897-879; van Stijn CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086404; Xie J, 2017, JAMA OPHTHALMOL, V135, P586, DOI 10.1001/jamaophthalmol.2017.0988; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhao Yue, 2018, Drugs Context, V7, P212532, DOI 10.7573/dic.212532	69	8	8	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21313	10.1096/fj.202001740RR	http://dx.doi.org/10.1096/fj.202001740RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484194	Bronze			2022-12-28	WOS:000647789600055
J	Zhang, RF; Zhao, XG; Du, J; Wei, LY; Zhao, ZW				Zhang, Ruifeng; Zhao, Xianguo; Du, Juan; Wei, Liya; Zhao, Zhangwu			Regulatory mechanism of daily sleep by miR-276a	FASEB JOURNAL			English	Article						Drosophila melanogaster; clock; miR&#8208; 276a; NPFR1; sleep; tim	DROSOPHILA; DOPAMINE; IDENTIFICATION; HOMEOSTASIS; MODULATION; OCTOPAMINE; AROUSAL; STRESS; REST	MiRNAs have attracted more attention in recent years as regulators of sleep and circadian rhythms after their roles in circadian rhythm and sleep were discovered. In this study, we explored the roles of the miR-276a on daily sleep in Drosophila melanogaster, and found a regulatory cycle for the miR-276a pathway, in which miR-276a, regulated by the core CLOCK/CYCLE (CLK/CYC) transcription factor upstream, regulates sleep via suppressing targets TIM and NPFR1. (a) Loss of miR-276a function makes the flies sleep more during both daytime and nighttime, while flies with gain of miR-276a function sleep less; (b) MiR-276a is widely expressed in the mushroom body (MB), the pars intercerebralis (PI) and some clock neurons lateral dorsal neurons (LNds), in which tim neurons is important for sleep regulation; (c) MiR-276a promoter is identified to locate in the 8th fragment (aFrag8) of the pre-miR-276a, and this fragment is directly activated and regulated by CLK/CYC; (4) MiR-276a is rhythmically oscillating in heads of the wild-type w(1118), but this oscillation disappears in the loss of function mutant clk(jrk); (5) The neuropeptide F receptor 1 (npfr1) was found to be a downstream target of miR-276a. These results clarify that the miR-276a is a very important factor for sleep regulation.	[Zhang, Ruifeng; Zhao, Xianguo; Du, Juan; Zhao, Zhangwu] China Agr Univ, Dept Entomol, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China; [Wei, Liya] Hebei Univ, Coll Life Sci, Baoding, Peoples R China	China Agricultural University; Hebei University	Zhao, ZW (corresponding author), China Agr Univ, Dept Entomol, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China.	zhaozw@cau.edu.cn						Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Brancati G, 2018, NUCLEIC ACIDS RES, V46, P3259, DOI 10.1093/nar/gky201; Broughton JP, 2016, MOL CELL, V64, P320, DOI 10.1016/j.molcel.2016.09.004; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Chen X, 2016, P NATL ACAD SCI USA, V113, pE2965, DOI 10.1073/pnas.1605837113; Chen YW, 2014, DEV CELL, V31, P784, DOI 10.1016/j.devcel.2014.11.029; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; Cirelli C, 2006, P NATL ACAD SCI USA, V103, P13901, DOI 10.1073/pnas.0606652103; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Guo F, 2011, SLEEP, V34, P273, DOI 10.1093/sleep/34.3.273; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; He CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074237; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ishimoto H, 2010, GENETICS, V185, P269, DOI 10.1534/genetics.110.114587; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kadener S, 2009, RNA, V15, P537, DOI 10.1261/rna.1319309; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Li WH, 2013, J NEUROSCI, V33, P5821, DOI 10.1523/JNEUROSCI.4004-12.2013; Nian XG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080923; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Vodala S, 2012, CELL METAB, V16, P601, DOI 10.1016/j.cmet.2012.10.002; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	42	1	1	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21222	10.1096/fj.202001220R	http://dx.doi.org/10.1096/fj.202001220R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33337563				2022-12-28	WOS:000605626600039
J	Gomez-Perosanz, M; Sanchez-Trincado, JL; Fernandez-Arquero, M; Sidney, J; Sette, A; Lafuente, EM; Reche, PA				Gomez-Perosanz, Marta; Sanchez-Trincado, Jose L.; Fernandez-Arquero, Miguel; Sidney, John; Sette, Alessandro; Lafuente, Esther M.; Reche, Pedro A.			Human rhinovirus-specific CD8 T cell responses target conserved and unusual epitopes	FASEB JOURNAL			English	Article						CD8&#8208; positive T&#8208; lymphocytes; epitopes; peptides; rhinovirus	COMPLEX CLASS-I; SEQUENCE VARIABILITY ANALYSIS; CAPSID PROTEIN; MHC MOLECULES; BINDING; PREDICTION; INFECTION; PEPTIDES; ASTHMA; IDENTIFICATION	Human Rhinovirus (HRV) is a major cause of common cold, bronchiolitis, and exacerbations of chronic pulmonary diseases such as asthma. CD8 T cell responses likely play an important role in the control of HRV infection but, surprisingly, HRV-specific CD8 T cell epitopes remain yet to be identified. Here, we approached the discovery and characterization of conserved HRV-specific CD8 T cell epitopes from species A (HRV A) and C (HRV C), the most frequent subtypes in the clinics of various pulmonary diseases. We found IFN gamma-ELISPOT positive responses to 23 conserved HRV-specific peptides on peripheral blood mononuclear cells (PBMCs) from 14 HLA I typed subjects. Peptide-specific IFN gamma production by CD8 T cells and binding to the relevant HLA I were confirmed for six HRV A-specific and three HRV C-specific CD8 T cell epitopes. In addition, we validated A*02:01-restricted epitopes by DimerX staining and found out that these peptides mediated cytotoxicity. All these A*02:01-restricted epitopes were 9-mers but, interestingly, we also identified and validated an unusually long 16-mer epitope peptide restricted by A*02:01, HRVC1791-1806 (GLEPLDLNTSAGFPYV). HRV-specific CD8 T cell epitopes describe here are expected to elicit CD8 T cell responses in up to 87% of the population and could be key for developing an HRV vaccine.	[Gomez-Perosanz, Marta; Sanchez-Trincado, Jose L.; Lafuente, Esther M.; Reche, Pedro A.] Univ Complutense Madrid, Sch Med, Dept Immunol, Pza Ramon y Cajal S-N, Madrid 28040, Spain; [Fernandez-Arquero, Miguel] San Carlos Univ Hosp, Immunol Serv, Madrid, Spain; [Sidney, John; Sette, Alessandro] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA USA	Complutense University of Madrid; Hospital Clinico San Carlos; La Jolla Institute for Immunology	Reche, PA (corresponding author), Univ Complutense Madrid, Sch Med, Dept Immunol, Pza Ramon y Cajal S-N, Madrid 28040, Spain.	parecheg@med.ucm.es	Reche, Pedro A/B-1881-2013; Sette, Alessandro/AFO-8916-2022; Lafuente, Esther M/K-5684-2014	Reche, Pedro A/0000-0003-3966-5838; Gomez-Perosanz, Marta/0000-0002-2411-4358; Lafuente, Esther M/0000-0001-8466-1022	Ministerio de Economia y Competitividad (MINECO) [BIO2014:54164-R]	Ministerio de Economia y Competitividad (MINECO)	Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: BIO2014:54164-R	Alonso-Padilla J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9363750; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; BARCLAY WS, 1989, EPIDEMIOL INFECT, V103, P659, DOI 10.1017/S095026880003106X; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Chen WJ, 2015, J CLIN VIROL, V64, P74, DOI 10.1016/j.jcv.2015.01.007; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Diez-Rivero CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043674; Eckels DD, 1999, INT IMMUNOL, V11, P577, DOI 10.1093/intimm/11.4.577; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Gaido CM, 2018, IMMUN INFLAMM DIS, V6, P143, DOI 10.1002/iid3.206; Gaido CM, 2016, J VIROL, V90, P10459, DOI 10.1128/JVI.01701-16; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Gern JE, 1997, J INFECT DIS, V175, P1108, DOI 10.1086/516449; Glanville N, 2015, CURR OPIN VIROL, V11, P83, DOI 10.1016/j.coviro.2015.03.004; Glanville N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003669; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Guo HL, 2008, VIRAL IMMUNOL, V21, P61, DOI 10.1089/vim.2007.0082; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Li XAC, 2010, CURR OPIN ORGAN TRAN, V15, P499, DOI 10.1097/MOT.0b013e32833bfb33; Makris S., 2018, F1000RES, V7, pF1000; Malm M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01570; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; McLean Gary R, 2014, J Vaccines Immun, V2, P16; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; Molero-Abraham M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/601943; Muehling LM, 2016, J IMMUNOL, V197, P3214, DOI 10.4049/jimmunol.1600663; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Reche Pedro A, 2006, Med Immunol, V5, P1, DOI 10.1186/1476-9433-5-1; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Rossmann MG, 2000, VIROLOGY, V269, P239, DOI 10.1006/viro.2000.0258; Sanchez-Trincado JL, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2680160; Schmidt ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00678; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Steinke JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115271; Stewart JJ, 1997, MOL IMMUNOL, V34, P1067, DOI 10.1016/S0161-5890(97)00130-2; Stone CA, 2016, CLIN VACCINE IMMUNOL, V23, P6, DOI 10.1128/CVI.00414-15; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Wang H, 2018, ONCOL LETT, V16, P2003, DOI 10.3892/ol.2018.8875; Webb BSA, 2014, BIOINFORMATICS, P5; Zhou MH, 2006, J IMMUNOL, V177, P2138, DOI 10.4049/jimmunol.177.4.2138	51	3	4	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202002165R	http://dx.doi.org/10.1096/fj.202002165R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33230881	hybrid, Green Published			2022-12-28	WOS:000593293200001
J	Liu, WG; Feng, M; Jayasuriya, CT; Peng, H; Zhang, L; Guan, YJ; Froehlich, JA; Terek, RM; Chen, Q				Liu, Wenguang; Feng, Meng; Jayasuriya, Chathuraka T.; Peng, Hang; Zhang, Long; Guan, Yingjie; Froehlich, John A.; Terek, Richard M.; Chen, Qian			Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling	FASEB JOURNAL			English	Article						cartilage; mesenchymal stem cells; osteoarthritis; TGF&#8208; beta	MESENCHYMAL PROGENITOR CELLS; ARTICULAR CHONDROCYTES; STEM-CELLS; DIFFERENTIATION; INHIBITION; EXPRESSION; GENE	Human osteoarthritis cartilage contains chondrocytes (OAC) and mesenchymal stromal cells (OA-MSC). Here, we found that TGF-beta had different effects on OA-MSC and OAC, and revealed its lateral signaling mechanism in OA. RNAseq analysis indicated that OA-MSC expressed the same level of Bone Morphogenetic Protein (BMP) Receptor-1A as OAC but only 1/12 of Transforming Growth Factor beta (TGF-beta) Receptor-1. While TGF-beta specifically activated SMAD2 in OAC, it also activated BMP signaling-associated SMAD1 in OA-MSC. While TGF-beta stimulated chondrogenesis in OAC, it induced hypertrophy, mineralization, and MMP-13 in OA-MSC. Inhibiting TGF-beta R1 suppressed MMP-13 in OA-MSC but stimulated it in OAC. In contrast, by specifically targeting BMPR1A/ACVR1 in both cell types, LDN193189 inhibits cartilage degeneration through suppressing hypertrophy and MMP-13 in a mouse osteoarthritis model. Thus, LDN193189, a drug under development to inhibit constitutive BMP signaling during heterotopic ossification, may be re-purposed for OA treatment.	[Liu, Wenguang; Peng, Hang; Zhang, Long] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian, Peoples R China; [Liu, Wenguang; Feng, Meng; Jayasuriya, Chathuraka T.; Zhang, Long; Guan, Yingjie; Froehlich, John A.; Terek, Richard M.; Chen, Qian] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Orthoped, 1 Hoppin St,Suite 402A, Providence, RI 02903 USA; [Feng, Meng] Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 1, Xian, Peoples R China	Xi'an Jiaotong University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Xi'an Jiaotong University	Chen, Q (corresponding author), Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Orthoped, 1 Hoppin St,Suite 402A, Providence, RI 02903 USA.	Qian_Chen@Brown.edu	zhang, long/AAW-8390-2021	zhang, long/0000-0003-0091-6695	NIH [P30GM122732, 1R61AR076807-01, R01 CA166089]; China Scholarship Council [201606280090]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council)	The authors gratefully acknowledge financial support from NIH (P30GM122732, 1R61AR076807-01) to Q.C, (R01 CA166089) to R.M.T, and China Scholarship Council (201606280090) to W.L.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; BUYSE G, 1995, EUR J PEDIATR, V154, P694, DOI 10.1007/BF02276711; Byfield SD, 2004, TRENDS CELL BIOL, V14, P107; Chen CG, 2014, ARTHRITIS RHEUM, V64, P3278; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Fan Z, 2004, CLIN EXP RHEUMATOL, V22, P103; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Harradine KA, 2006, ANN MED, V38, P403, DOI 10.1080/07853890600919911; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; Hu N, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1949-0; Jayasuriya CT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25395-8; Lane NE, 2017, OSTEOARTHR CARTILAGE, V25, P209, DOI 10.1016/j.joca.2016.09.025; Li J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3887; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Padilha EC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00234; Pignolo RJ, 2013, PEDIATR ENDOCR REV P, V10, P437; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Wang TY, 2016, ANN RHEUM DIS, V75, pE72, DOI 10.1136/annrheumdis-2016-210312; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	34	12	12	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16552	16566		10.1096/fj.202001448R	http://dx.doi.org/10.1096/fj.202001448R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33118211	Green Accepted			2022-12-28	WOS:000586840600001
J	Chan, WWR; Li, W; Chang, RCC; Lau, KF				Chan, Wai Wa Ray; Li, Wen; Chang, Raymond Chuen Chung; Lau, Kwok-Fai			ARF6-Rac1 signaling-mediated neurite outgrowth is potentiated by the neuronal adaptor FE65 through orchestrating ARF6 and ELMO1	FASEB JOURNAL			English	Article						ADP ribosylation factor 6; amyloid-beta A4 precursor protein-binding family B member 1; engulfment and cell motility protein 1; neurite outgrowth; plasma membrane targeting; Ras-related C3 botulinum toxin substrate 1	AMYLOID PRECURSOR PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; RHO GTPASES; DOWNSTREAM ACTIVATION; DEPENDENT REGULATION; PHOSPHORYLATION; INTERACTS; MEMBRANE; COMPLEX; BINDING	Ras-related C3 botulinum toxin substrate 1 (Rac1) is a member of the Rho family of GTPases that functions as a molecular switch to regulate many important cellular events including actin cytoskeleton remodeling during neurite outgrowth. Engulfment and cell motility 1 (ELMO1)-dedicator of cytokinesis 1 (DOCK180) is a bipartite guanine nucleotide exchange factor (GEF) complex that has been reported to activate Rac1 on the plasma membrane (PM). Emerging evidence suggests that the small GTPase ADP ribosylation factor 6 (ARF6) activates Rac1 via the ELMO1/DOCK180 complex. However, the exact mechanism by which ARF6 triggers ELMO1/DOCK180-mediated Rac1 signaling remains unclear. Here, we report that the neuronal scaffold protein FE65 serves as a functional link between ARF6 and ELMO1, allowing the formation of a multimeric signaling complex. Interfering with formation of this complex by transfecting either FE65-binding-defective mutants or FE65 siRNA attenuates both ARF6-ELMO1-mediated Rac1 activation and neurite elongation. Notably, the PM trafficking of ELMO1 is markedly decreased in cells with suppressed expression of either FE65 or ARF6. Likewise, this process is attenuated in the FE65-binding-defective mutants transfected cells. Moreover, overexpression of FE65 increases the amount of ELMO1 in the recycling endosome, an organelle responsible for returning proteins to the PM, whereas knockout of FE65 shows opposite effect. Together, our data indicates that FE65 potentiates ARF6-Rac1 signaling by orchestrating ARF6 and ELMO1 to promote the PM trafficking of ELMO1 via the endosomal recycling pathway, and thus, promotes Rac1-mediated neurite outgrowth.	[Chan, Wai Wa Ray; Li, Wen; Lau, Kwok-Fai] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Hong Kong, Peoples R China; [Li, Wen] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Lab Biomed Opt & Mol Imaging, Shenzhen, Peoples R China; [Chang, Raymond Chuen Chung] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Lab Neurodegenerat Dis, Hong Kong, Peoples R China; [Chang, Raymond Chuen Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Hong Kong; University of Hong Kong	Lau, KF (corresponding author), Fac Sci, Sch Life Sci, Shatin, H, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk	LI, WEN/Y-6659-2018	Lau, Kwok-Fai/0000-0002-0193-1152	Research Grants Council, University Grants Committee (RGC, UGC); CUHK direct grant scheme; United College endowment fund; TUYF charitable Trust	Research Grants Council, University Grants Committee (RGC, UGC); CUHK direct grant scheme; United College endowment fund; TUYF charitable Trust	Research Grants Council, University Grants Committee (RGC, UGC); CUHK direct grant scheme; United College endowment fund; TUYF charitable Trust	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bustelo Xose R, 2012, Small GTPases, V3, P60, DOI 10.4161/sgtp.19111; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang LC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15734-7; Chau DDL, 2019, FASEB J, V33, P12019, DOI 10.1096/fj.201802825RR; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Chow WNV, 2015, CELL MOL BIOL LETT, V20, P66, DOI 10.1515/cmble-2015-0002; Chow WNV, 2012, BIOCHEM J, V443, P681, DOI 10.1042/BJ20112175; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cool BH, 2010, J NEUROCHEM, V112, P410, DOI 10.1111/j.1471-4159.2009.06456.x; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Araujo Mariana E G, 2015, Cold Spring Harb Protoc, V2015, P1009, DOI 10.1101/pdb.prot083436; de Araujo Mariana E G, 2015, Cold Spring Harb Protoc, V2015, P1013, DOI 10.1101/pdb.prot083444; DeNardo BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082513; Denton K, 2018, HUM MOL GENET, V27, P2517, DOI 10.1093/hmg/ddy156; Deyts C, 2016, ELIFE, V5, DOI 10.7554/eLife.15645; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dumanis SB, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-9; Eades G, 2015, MOL CANCER RES, V13, P330, DOI 10.1158/1541-7786.MCR-14-0251; Fukaya M, 2014, J NEUROCHEM, V129, P21, DOI 10.1111/jnc.12524; Goldenring JR, 2015, CURR OPIN CELL BIOL, V35, P117, DOI 10.1016/j.ceb.2015.04.018; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Nguyen HTN, 2018, BIOCHEM BIOPHYS REP, V16, P24, DOI 10.1016/j.bbrep.2018.09.004; Jang DJ, 2017, NEUROBIOL LEARN MEM, V138, P31, DOI 10.1016/j.nlm.2016.06.017; Kesavapany S, 2002, NEUROSCIENCE, V115, P951, DOI 10.1016/S0306-4522(02)00422-0; Kim H, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-019-0543-3; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12334-2; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li W, 2018, J BIOL CHEM, V293, P7674, DOI 10.1074/jbc.RA117.000505; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Makino Y, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0113-y; Marei Hadir, 2017, Small GTPases, V8, P139, DOI 10.1080/21541248.2016.1211398; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; Mauldin JP, 2013, CURR BIOL, V23, P162, DOI 10.1016/j.cub.2012.11.049; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mikdache A, 2020, CELL MOL LIFE SCI, V77, P161, DOI 10.1007/s00018-019-03167-5; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Minopoli G, 2012, IUBMB LIFE, V64, P936, DOI 10.1002/iub.1094; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Perez RG, 1997, J NEUROSCI, V17, P9407; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Radhakrishna H, 1999, J CELL SCI, V112, P855; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebelo S, 2013, J ALZHEIMERS DIS, V35, P761, DOI 10.3233/JAD-130095; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sun YF, 2014, J BIOL CHEM, V289, P12217, DOI 10.1074/jbc.M113.526194; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Torii T, 2014, J BIOL CHEM, V289, P33887, DOI 10.1074/jbc.M114.575787; Torii T, 2012, CELL SIGNAL, V24, P1872, DOI 10.1016/j.cellsig.2012.05.016; Wang YH, 2016, J CANCER, V7, P973, DOI 10.7150/jca.15118; Yamashita S, 2016, EPILEPSIA, V57, pE81, DOI 10.1111/epi.13338; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15	72	7	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16397	16413		10.1096/fj.202001703R	http://dx.doi.org/10.1096/fj.202001703R		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047393				2022-12-28	WOS:000581170200001
J	Struk, T; Nair, V; Eichinger, F; Kretzler, M; Wedlich-Soldner, R; Bayraktar, S; Pavenstadt, H				Struk, Thaddaeus; Nair, Viji; Eichinger, Felix; Kretzler, Matthias; Wedlich-Soeldner, Roland; Bayraktar, Samet; Pavenstaedt, Hermann			Transcriptome analysis of primary podocytes reveals novel calcium regulated regulatory networks	FASEB JOURNAL			English	Article						CaAR; mTOR; Nephroseq; pathway analysis; RNA-sequencing	GLOMERULAR INJURY; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; EXPRESSION; ACTIVATION; CYTOSKELETON; PROTEINURIA; PATHWAY; MTOR; ASSOCIATION	Podocytes are pivotal in establishing the selective permeability of the glomerular filtration barrier. Recently, we showed that an increase of the intracellular calcium ion concentration [Ca2+] causes a rapid and transient actin reset (CaAR) measurable through live imaging microscopy using lifeact-mCherry as an actin dye in different cell types including the podocyte. This and other studies show the critical role [Ca2+] and the actin cytoskeleton play in podocyte homeostasis. To further investigate the role of [Ca2+] and the actin cytoskeleton in podocytes, we used a double fluorescent reporter mouse model to establish a primary podocyte culture system. We treated these podocytes temporarily with a Calcium Ionophore and facultatively with Latrunculin A, an inhibitor of actin polymerization. Unbiased genome wide transcriptional analysis identified a transcriptional response in podocytes to elevated [Ca2+] levels, affecting mRNA levels of PDGF-BB, RICTOR, and MIR17HG as mediators of Ca2+-signaling. Comparison of the ex vivo transcriptional response from the primary podocyte culture with glomerular transcripts across a wide spectrum of CKD disease confirmed co-regulation of transcript sets, establishing the disease relevance of the model system. Our findings demonstrate novel [Ca2+] regulated gene networks in podocytes deepening our understanding of podocyte biology and disease.	[Struk, Thaddaeus; Bayraktar, Samet; Pavenstaedt, Hermann] Univ Munster, Dept Med, Munster, Germany; [Nair, Viji; Eichinger, Felix; Kretzler, Matthias] Univ Michigan, Michigan Kidney Translat Med Core, Ann Arbor, MI 48109 USA; [Kretzler, Matthias] Univ Michigan, Dept Nephrol, Internal Med, Ann Arbor, MI 48109 USA; [Wedlich-Soeldner, Roland] Inst Cell Dynam & Imaging, Munster, Germany	University of Munster; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pavenstadt, H (corresponding author), Univ Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.	Hermann.Pavenstaedt@ukmuenster.de			NIH/NIDDK [2P30-DK-081943];  [SFB1009B10]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); 	SFB1009B10; NIH/NIDDK, Grant/Award Number: 2P30-DK-081943; Core	Basu P, 2010, BIOMASS GASIFICATION AND PYROLYSIS: PRACTICAL DESIGN AND THEORY, P1, DOI 10.1016/B978-0-12-374988-8.00001-5; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Boehlke C, 2014, AM J KIDNEY DIS, V64, P452, DOI 10.1053/j.ajkd.2014.04.030; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Burford JL, 2014, J CLIN INVEST, V124, P2050, DOI 10.1172/JCI71702; Choi SY, 2010, ULTRASTRUCT PATHOL, V34, P195, DOI 10.3109/01913121003648402; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eid S, 2016, ANTIOXID REDOX SIGN, V25, P703, DOI 10.1089/ars.2015.6562; Fujiwara I, 2018, CURR BIOL, V28, P3183, DOI 10.1016/j.cub.2018.07.082; Garg P, 2018, AM J NEPHROL, V47, P3, DOI 10.1159/000481633; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Grahammer F, 2014, NEPHROL DIAL TRANSPL, V29, pI9, DOI 10.1093/ndt/gft491; Granado D, 2017, J AM SOC NEPHROL, V28, P3226, DOI 10.1681/ASN.2016111220; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; Han TS, 2006, LUPUS, V15, P71, DOI 10.1191/0961203306lu2264oa; Harder JL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122697; Henger A, 1997, KIDNEY INT, V52, P687, DOI 10.1038/ki.1997.383; Henique C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01885-7; Ilatovskaya DV, 2018, J AM SOC NEPHROL, V29, P1917, DOI 10.1681/ASN.2018030280; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiang CS, 2019, BRIT J HAEMATOL, V185, P616, DOI 10.1111/bjh.15591; Ju WJ, 2012, TRANSL RES, V159, P290, DOI 10.1016/j.trsl.2012.01.020; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; Karaiskos N, 2018, J AM SOC NEPHROL, V29, P2060, DOI 10.1681/ASN.2018030238; Keir LS, 2015, NEPHRON, V129, P128, DOI 10.1159/000369816; Kohn S, 2002, ULTRASTRUCT PATHOL, V26, P371, DOI 10.1080/01913120290104683; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01433; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neild GH, 2017, PEDIATR NEPHROL, V32, P243, DOI 10.1007/s00467-016-3383-8; Nozaki Y, 2012, KIDNEY INT, V82, P892, DOI 10.1038/ki.2012.226; Perez-Hernandez J, 2018, J HYPERTENS, V36, P1712, DOI 10.1097/HJH.0000000000001747; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; REED PW, 1972, J BIOL CHEM, V247, P6970; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rinschen MM, 2018, CELL REP, V23, P2495, DOI 10.1016/j.celrep.2018.04.059; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schiessl IM, 2018, J AM SOC NEPHROL, V29, P1383, DOI 10.1681/ASN.2017101069; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Smeets B, 2016, ISOLATION PRIMARY CU, P3; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Takemura T, 1996, J PATHOL, V178, P343, DOI 10.1002/(SICI)1096-9896(199603)178:3<343::AID-PATH481>3.0.CO;2-H; van Roeyen CRC, 2011, KIDNEY INT, V80, P1292, DOI 10.1038/ki.2011.278; Vassiliadis J, 2011, J AM SOC NEPHROL, V22, P1453, DOI 10.1681/ASN.2010080878; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Walentek P, 2016, ELIFE, V5, DOI 10.7554/eLife.17557; Wingett Steven W, 2018, F1000Res, V7, P1338, DOI 10.12688/f1000research.15931.2; Zhang HT, 2016, CELL PHYSIOL BIOCHEM, V40, P1079, DOI 10.1159/000453163	57	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14490	14506		10.1096/fj.201902493RR	http://dx.doi.org/10.1096/fj.201902493RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931033	hybrid			2022-12-28	WOS:000570777400001
J	Liu, HW; Chen, Q; Lu, D; Pang, X; Yin, SS; Wang, KL; Wang, R; Yang, SS; Zhang, Y; Qiu, YL; Wang, T; Yu, HY				Liu, Hongwei; Chen, Qian; Lu, Di; Pang, Xu; Yin, Shuangshuang; Wang, Kailong; Wang, Rui; Yang, Shenshen; Zhang, Yi; Qiu, Yuling; Wang, Tao; Yu, Haiyang			HTBPI, an active phenanthroindolizidine alkaloid, inhibits liver tumorigenesis by targeting Akt	FASEB JOURNAL			English	Article						an active phenanthroindolizidine alkaloid; HTBPI; liver tumorigenesis; p-Akt (Thr 308)	PROMOTES AUTOPHAGY; CELLS; CARCINOMA; APOPTOSIS; PATHWAYS; AXIS	Akt, a crucial protein involved in a variety of signaling pathways in cancer, acts as an important regulator of survival in hepatocellular carcinoma (HCC), and provides curative option for the related drugs development. We have found an active phenanthroindolizidine alkaloid, (13aR,14R)-9,11,12,13,13a,14-hexahydro-3,6,7-trimethoxydibenzo[f,h]pyrrolo[1,2-b]isoquinolin-14-ol (HTBPI), is a promising Akt inhibitor effective in the suppression of HCC cells proliferation through stimulating apoptotic and autophagic capability in vivo and in vitro. Treatment of HTBPI combined with a classical autophagy-lysosomal inhibitor (bafilomycin A1), could enhance stimulation effects of apoptosis on HCC cell lines. In addition, we confirmed HTBPI targeting Akt, occupied the kinase binding domain (Thr 308) of Akt to inactivate its function by CETSA and DARTS assay. In contrast, ectopic Akt-induced overexpression significantly abrogated inhibitory effects of HTBPI on cell viability and proliferation. Furthermore, high p-Akt (Thr 308) expression is collated with liver tumor formation and poor survival in HCC patients. In conclusions, HTBPI impeded HCC progress through regulation of apoptosis and autophagy machineryviainteraction with p-Akt (Thr 308). This may provide potential molecular candidate by targeting Akt for the therapy of HCC patients.	[Liu, Hongwei; Chen, Qian; Pang, Xu; Yin, Shuangshuang; Wang, Kailong; Wang, Rui; Yang, Shenshen; Zhang, Yi; Wang, Tao; Yu, Haiyang] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 301617, Peoples R China; [Lu, Di] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg,Dept Gen Surg, Hangzhou, Peoples R China; [Qiu, Yuling] Tianjin Med Univ, Sch Pharm, Tianjin 300070, Peoples R China	Tianjin University of Traditional Chinese Medicine; Zhejiang University; Tianjin Medical University	Wang, T; Yu, HY (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 301617, Peoples R China.; Qiu, YL (corresponding author), Tianjin Med Univ, Sch Pharm, Tianjin 300070, Peoples R China.	qiuyuling@tmu.edu.cn; wangtao@tjutcm.edu.cn; hyyu@tjutcm.edu.cn			National Natural Science Foundation of China [81873089, 81603253, 81973570]; Important Drug Development Fund, Ministry of Science and Technology of China [2018ZX09735-002, 2018ZX092011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important Drug Development Fund, Ministry of Science and Technology of China	This work was supported by grants from National Natural Science Foundation of China (Nos. 81873089 and 81603253 to H. Yu, No. 81973570 to Y. Qiu), Important Drug Development Fund, Ministry of Science and Technology of China (2018ZX09735-002 to T. Wang, No. 2018ZX092011 to Z. Li).	Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7; Bishnupuri KS, 2019, CANCER RES, V79, P1138, DOI 10.1158/0008-5472.CAN-18-0668; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen Q, 2018, GUT, V67, P2006, DOI 10.1136/gutjnl-2018-315983; Chen Q, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020096; Chen RC, 2018, HEPATOLOGY, V67, P1823, DOI 10.1002/hep.29663; Dai S, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00960; Efe EY, 2017, CANCER LETT, V410, P139, DOI 10.1016/j.canlet.2017.09.011; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo JP, 2019, NAT CELL BIOL, V21, P226, DOI 10.1038/s41556-018-0261-6; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Jiao L, 2018, AUTOPHAGY, V14, P671, DOI 10.1080/15548627.2017.1381804; Lahiri V, 2019, CELL METAB, V29, P803, DOI 10.1016/j.cmet.2019.03.003; Laurence AB, 2019, SEMIN CANCER BIOL; Li Y. F., 2012, NPG ASIA MATER, V4, pe30; Liu CY, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109543; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Meng J, 2019, THERANOSTICS, V9, P573, DOI 10.7150/thno.27654; Peng SL, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1073-4; Poillet-Perez L, 2019, GENE DEV, V33, P610, DOI 10.1101/gad.325514.119; Spradlin JN, 2019, NAT CHEM BIOL, V15, P747, DOI 10.1038/s41589-019-0304-8; Su ZY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0321-5; Szymonowicz K, 2018, CANCERS, V10, DOI 10.3390/cancers10030078; Toh TB, 2020, J HEPATOL, V72, P104, DOI 10.1016/j.jhep.2019.08.035; Toledo M, 2018, CELL METAB, V28, P268, DOI 10.1016/j.cmet.2018.05.023; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Wang GH, 2019, NAT CELL BIOL, V21, P214, DOI 10.1038/s41556-018-0266-1; Wang HX, 2018, THERANOSTICS, V8, P3949, DOI 10.7150/thno.26161; WANG Qiang, 2016, J INTERATION TECHNOL, V2, P1, DOI DOI 10.1016/j.sandf.2016.02.001; Wu S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00881; Xiang JY, 2019, GASTROENTEROLOGY, VS0016-5085; Yang H, 2019, AUTOPHAGY, V15, P1671, DOI 10.1080/15548627.2019.1634445; Yeh PS, 2016, CANCER LETT, V370, P66, DOI 10.1016/j.canlet.2015.08.030; Yin SS, 2019, INT J CANCER, V145, P3334, DOI 10.1002/ijc.32395; Yoshikawa Y, 2017, CANCER LETT, V410, P82, DOI 10.1016/j.canlet.2017.09.017; Yu HY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0660-4; Yu HY, 2017, MOL CANCER THER, V16, P2711, DOI 10.1158/1535-7163.MCT-17-0498; Zhang Y, 2013, J HEPATOL, V59, P1255, DOI 10.1016/j.jhep.2013.07.009; Zhou CF, 2020, AUTOPHAGY, V16, P1786, DOI 10.1080/15548627.2019.1687212; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	42	5	5	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12255	12268		10.1096/fj.202000254R	http://dx.doi.org/10.1096/fj.202000254R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33411355				2022-12-28	WOS:000556097200001
J	Goetz, TG; Becker, JB; Mazure, CM				Goetz, Teddy G.; Becker, Jill B.; Mazure, Carolyn M.			Women, opioid use and addiction	FASEB JOURNAL			English	Article						addiction medicine; opioid&#8208; related disorders; sex characteristics	NEONATAL ABSTINENCE SYNDROME; SEX-DIFFERENCES; UNITED-STATES; SUBSTANCE USE; GENDER-DIFFERENCES; DRUG-USE; CHRONIC PAIN; BUPRENORPHINE TREATMENT; NATIONAL-SURVEY; PREGNANT-WOMEN	In the midst of the current coronavirus pandemic, the United States continues to struggle with an ongoing opioid epidemic, initially fueled by widespread prescribing of opioid medications during the 1990s. The primary reason for prescribing opioids is to treat pain. Women have more acute and chronic pain and have been prescribed these drugs in significantly greater numbers than men. Comparison of women and men with chronic pain also shows that women receive the majority of prescription opioids, and the use of these prescribed medications became the major pathway to misuse and addiction for women. Yet, recognition of the extent of women's exposure to opioids and the attendant consequences has been limited. Attempts to stem the overall tide of the epidemic focused on reducing the availability of prescription opioids. However, as these medications became more difficult to obtain and treatment opportunities were limited, many turned to other synthetic opioids, such as heroin and fentanyl. Thus, the public health crisis of opioid addiction has endured. This paper highlights the importance of understanding differences among women and men in opioid use and its biological and psychosocial effects to advance the gender-based treatment approaches and effective public health policy.	[Goetz, Teddy G.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Becker, Jill B.] Univ Michigan, Biopsychol Area Chair, Ann Arbor, MI 48109 USA; [Mazure, Carolyn M.] Yale Univ, Sch Med, Dept Psychiat, Womens Hlth Res Yale, 135 Coll St,Suite 220, New Haven, CT 06510 USA	Columbia University; University of Michigan System; University of Michigan; Yale University	Mazure, CM (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Womens Hlth Res Yale, 135 Coll St,Suite 220, New Haven, CT 06510 USA.	Carolyn.Mazure@yale.edu		Goetz, Teddy/0000-0002-1138-6602				Ailes Elizabeth C, 2015, MMWR Morb Mortal Wkly Rep, V64, P37; Alderks C.E., 2017, CBHSQ REPORT, P2013; Alexander MJ, 2018, EPIDEMIOLOGY, V29, P707, DOI [10.1097/EDE.0000000000000858, 10.1097/ede.0000000000000858]; Algren DA, 2013, J MED TOXICOL, V9, P106, DOI 10.1007/s13181-012-0285-4; Ashrafioun L, 2017, J PSYCHIATR RES, V92, P1, DOI 10.1016/j.jpsychires.2017.03.011; Averitt DL, 2019, NEUROPSYCHOPHARMACOL, V44, P155, DOI 10.1038/s41386-018-0127-4; Back SE, 2011, AM J DRUG ALCOHOL AB, V37, P313, DOI 10.3109/00952990.2011.596982; Back SE, 2010, ADDICT BEHAV, V35, P1001, DOI 10.1016/j.addbeh.2010.06.018; Barger BT, 2021, SUBST ABUS, V42, P104, DOI 10.1080/08897077.2019.1702610; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Bawor M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0038-6; Becker JB, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-018-0215-5; Becker JB, 2019, NEUROPSYCHOPHARMACOL, V44, P166, DOI 10.1038/s41386-018-0125-6; Becker JB, 2016, ADDICT BIOL, V21, P1052, DOI 10.1111/adb.12383; Becker JB, 2016, PHARMACOL REV, V68, P242, DOI 10.1124/pr.115.011163; Becker WC, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3115; Buchting FO, 2017, AM J PREV MED, V53, pE1, DOI 10.1016/j.amepre.2016.11.022; Carroll ME, 2002, PSYCHOPHARMACOLOGY, V161, P304, DOI 10.1007/s00213-002-1030-5; Center for Behavioral Health Statistics and Quality, 2018, NATL SURVEY DRUG USE, P948; Centers for Disease Control and Prevention, HEALTHC COST UT PROJ; Choo RE, 2004, DRUG ALCOHOL DEPEN, V75, P253, DOI 10.1016/j.drugalcdep.2004.03.012; Ciccarone D, 2017, INT J DRUG POLICY, V46, P107, DOI 10.1016/j.drugpo.2017.06.010; Cicero TJ, 2017, ADDICT BEHAV, V74, P63, DOI 10.1016/j.addbeh.2017.05.030; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Cicero TJ, 2009, PAIN, V144, P20, DOI 10.1016/j.pain.2009.01.026; Cochran SD, 2004, ADDICTION, V99, P989, DOI 10.1111/j.1360-0443.2004.00759.x; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Dale R, 2016, MED CLIN N AM, V100, P55, DOI 10.1016/j.mcna.2015.08.012; Debelak K, 2013, AM J ADDICTION, V22, P252, DOI 10.1111/j.1521-0391.2012.12005.x; Doyle HH, 2017, J NEUROSCI, V37, P3202, DOI 10.1523/JNEUROSCI.2906-16.2017; Falletta L, 2018, CHILD ABUSE NEGLECT, V79, P125, DOI 10.1016/j.chiabu.2018.01.026; Fausto-Sterling A., 2012, SEXGENDER BIOL SOCIA, DOI 10.4324/9780203127971; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fitzsimons HE, 2007, J SUBST ABUSE TREAT, V32, P19, DOI 10.1016/j.jsat.2006.06.015; Floyd CN, 2018, BRIT J CLIN PHARMACO, V84, P813, DOI 10.1111/bcp.13346; Fuentes M, 2007, J NATL MED ASSOC, V99, P1160; Giovino GA, 2002, ONCOGENE, V21, P7326, DOI 10.1038/sj.onc.1205808; Gonzalez CA, 2017, J PRIM PREV, V38, P419, DOI 10.1007/s10935-017-0469-4; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Green CR, 2003, J PAIN, V4, P176, DOI 10.1016/S1526-5900(02)65013-8; Greenfield SF, 2007, DRUG ALCOHOL DEPEN, V86, P1, DOI 10.1016/j.drugalcdep.2006.05.012; Guttmacher Institute, SUBSTANCE USE PREGNA; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Hales CM., 2020, NCHS DATE BRIEF NUMB; Harrison JM, 2018, AM J PUBLIC HEALTH, V108, P788, DOI 10.2105/AJPH.2018.304349; Hedegaard Holly, 2017, NCHS Data Brief, P1; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Herbeck DM, 2016, J ADDICT DIS, V35, P305, DOI 10.1080/10550887.2016.1189659; Hirschtritt Matthew E, 2018, Prev Med Rep, V9, P49, DOI 10.1016/j.pmedr.2017.12.010; Humphreys K, 2017, LANCET, V390, P437, DOI 10.1016/S0140-6736(17)31918-9; Hutcheson DM, 2001, PSYCHOPHARMACOLOGY, V153, P464, DOI 10.1007/s002130000635; Hwang CS, 2016, AM J PREV MED, V51, P151, DOI 10.1016/j.amepre.2016.02.014; Johnson RE, 2003, DRUG ALCOHOL DEPEN, V70, pS87, DOI 10.1016/S0376-8716(03)00062-0; Johnson RE, 2001, DRUG ALCOHOL DEPEN, V63, P97, DOI 10.1016/S0376-8716(00)00194-0; Jones Emlyn S, 2007, Subst Abus, V28, P3, DOI 10.1300/J465v28n02_02; Jones HE, 2005, DRUG ALCOHOL DEPEN, V79, P1, DOI 10.1016/j.drugalcdep.2004.11.013; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Jones HE, 2012, ADDICTION, V107, P5, DOI 10.1111/j.1360-0443.2012.04035.x; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kandall SR., 1998, NIH PUBLICATION, P53; Kandall SR., 1998, NIH PUBLICATION, P33; Kandall SR, 2010, J ADDICT DIS, V29, P117, DOI 10.1080/10550881003684491; Kecojevic A, 2012, ADDICT BEHAV, V37, P1289, DOI 10.1016/j.addbeh.2012.06.006; Kennedy PJ, PRESIDENTS COMMISSIO; Kidd Jeremy D, 2018, Curr Addict Rep, V5, P158, DOI 10.1007/s40429-018-0196-9; Kolodny A, 2017, JAMA-J AM MED ASSOC, V318, P1537, DOI 10.1001/jama.2017.14567; Kuhn C, 2015, PHARMACOL THERAPEUT, V153, P55, DOI 10.1016/j.pharmthera.2015.06.003; Lagisetty PA, 2019, JAMA PSYCHIAT, V76, P979, DOI 10.1001/jamapsychiatry.2019.0876; Levy B, 2015, AM J PREV MED, V49, P409, DOI 10.1016/j.amepre.2015.02.020; Ling S, 2019, DRUG ALCOHOL DEPEN, V197, P168, DOI 10.1016/j.drugalcdep.2019.02.007; Lynch WJ, 1999, PSYCHOPHARMACOLOGY, V144, P77, DOI 10.1007/s002130050979; MacLean RR, 2019, ADDICT BEHAV, V98, DOI 10.1016/j.addbeh.2019.05.034; Manhapra A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1947; Marsh JC, 2018, J SUBST ABUSE TREAT, V87, P79, DOI 10.1016/j.jsat.2018.01.001; Martin CE, 2015, J SUBST ABUSE TREAT, V48, P37, DOI 10.1016/j.jsat.2014.07.007; Mazure CM, 2018, LANCET, V392, P9, DOI 10.1016/S0140-6736(18)31203-0; Mazure CM, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0068-8; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; McHugh RK, 2020, J BEHAV MED, V43, P623, DOI 10.1007/s10865-019-00086-5; McHugh RK, 2018, CLIN PSYCHOL REV, V66, P12, DOI 10.1016/j.cpr.2017.10.012; McHugh RK, 2013, J SUBST ABUSE TREAT, V45, P38, DOI 10.1016/j.jsat.2012.12.007; Mckee SA, 2016, NICOTINE TOB RES, V18, P1002, DOI 10.1093/ntr/ntv207; Meints SM, 2018, J PAIN, V19, P1461, DOI 10.1016/j.jpain.2018.07.001; Meyer JP, 2019, DRUG ALCOHOL DEPEN, V197, P158, DOI 10.1016/j.drugalcdep.2019.01.017; Miller TR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0607; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Moore BA, 2016, J SUBST ABUSE TREAT, V71, P54, DOI 10.1016/j.jsat.2016.08.016; Moran LM, 2018, AM J DRUG ALCOHOL AB, V44, P512, DOI 10.1080/00952990.2018.1454934; National Academies of Sciences: Engineering and Medicine, 2019, MED OP US DIS SAV LI, DOI [10.17226/25310, DOI 10.17226/25310, DOI 10.1016/j.drugpo.2020.102704]; National Academy of Medicine, PRIORITIES STRATEGIE; National Academy of Medicine, RESOURCES ADDICTION; Ndao-Brumblay S Khady, 2005, J Natl Med Assoc, V97, P1369; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Nicholson HL, 2019, SUBST USE MISUSE, V54, P639, DOI 10.1080/10826084.2018.1531427; Nicholson HL, 2018, DRUG ALCOHOL DEPEN, V186, P264, DOI 10.1016/j.drugalcdep.2017.12.006; Niv N, 2007, DRUG ALCOHOL DEPEN, V87, P194, DOI 10.1016/j.drugalcdep.2006.08.017; Pallatino C, 2021, SUBST ABUS, V42, P197, DOI 10.1080/08897077.2019.1671296; Panchal N., IMPLICATIONS COVID 1; Pardue M.L, 2001, EXPLORING BIOLOGICAL; Peterson AB, 2016, MMWR-MORBID MORTAL W, V65, P844, DOI 10.15585/mmwr.mm6533a3; Roos CR, 2020, PSYCHOL ADDICT BEHAV, V34, P660, DOI 10.1037/adb0000581; Rose ME, 2018, PAIN MED, V19, P793, DOI 10.1093/pm/pnx048; Roth ME, 2002, PHARMACOL BIOCHEM BE, V72, P313, DOI 10.1016/S0091-3057(01)00777-8; Scambler G, 2009, SOCIOL HEALTH ILL, V31, P441, DOI 10.1111/j.1467-9566.2009.01161.x; Schieber LZ, 2020, MMWR-MORBID MORTAL W, V69, P298, DOI 10.15585/mmwr.mm6911a5; Schuler MS, 2018, DRUG ALCOHOL DEPEN, V189, P139, DOI 10.1016/j.drugalcdep.2018.05.008; SKINNER WF, 1994, AM J PUBLIC HEALTH, V84, P1307, DOI 10.2105/AJPH.84.8.1307; Soelberg CD, 2017, ANESTH ANALG, V125, P1675, DOI 10.1213/ANE.0000000000002403; Sorge RE, 2017, J NEUROSCI RES, V95, P1271, DOI 10.1002/jnr.23841; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Sumner SA, 2016, PREHOSP EMERG CARE, V20, P220, DOI 10.3109/10903127.2015.1076096; Tetrault JM, 2018, ANN INTERN MED, V168, P73, DOI 10.7326/M17-2854; Townsend EA, 2019, NEUROPSYCHOPHARMACOL, V44, P2022, DOI 10.1038/s41386-019-0356-1; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wetherington CL, 2007, EXP CLIN PSYCHOPHARM, V15, P411, DOI 10.1037/1064-1297.15.5.411; Yoest KE, 2019, BRIT J PHARMACOL, V176, P4136, DOI 10.1111/bph.14531; Yoest KE, 2018, HORM BEHAV, V104, P119, DOI 10.1016/j.yhbeh.2018.04.002; Yu XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13839-2; Zedler BK, 2016, ADDICTION, V111, P2115, DOI 10.1111/add.13462; Zelaya CE., 2020, CHRONIC PAIN HIGH IM, V390, P1	122	7	7	6	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21303	10.1096/fj.202002125R	http://dx.doi.org/10.1096/fj.202002125R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433026	Green Published			2022-12-28	WOS:000647789600091
J	Petkevicius, K; Bidault, G; Virtue, S; Jenkins, B; van Dierendonck, XAMH; Dugourd, A; Saez-Rodriguez, J; Stienstra, R; Koulman, A; Vidal-Puig, A				Petkevicius, Kasparas; Bidault, Guillaume; Virtue, Sam; Jenkins, Benjamin; van Dierendonck, Xanthe A. M. H.; Dugourd, Aurelien; Saez-Rodriguez, Julio; Stienstra, Rinke; Koulman, Albert; Vidal-Puig, Antonio			Norepinephrine promotes triglyceride storage in macrophages via beta2-adrenergic receptor activation	FASEB JOURNAL			English	Article						adrb2; dgat1; hilpda; immunometabolism; lipid	ADIPOSE-TISSUE MACROPHAGES; FATTY-ACID OXIDATION; LIPID-ACCUMULATION; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; METABOLISM; EXPRESSION; PROTEIN; HEART; INFLAMMATION	Tissue-resident macrophages are required for homeostasis, but also contribute to tissue dysfunction in pathophysiological states. The sympathetic neurotransmitter norepinephrine (NE) induces an anti-inflammatory and tissue-reparative phenotype in macrophages. As NE has a well-established role in promoting triglyceride lipolysis in adipocytes, and macrophages accumulate triglyceride droplets in various physiological and disease states, we investigated the effect of NE on primary mouse bone marrow-derived macrophage triglyceride metabolism. Surprisingly, our data show that in contrast to the canonical role of NE in stimulating lipolysis, NE acting via beta2-adrenergic receptors (B2ARs) in macrophages promotes extracellular fatty acid uptake and their storage as triglycerides and reduces free fatty acid release from triglyceride-laden macrophages. We demonstrate that these responses are mediated by a B2AR activation-dependent increase in Hilpda and Dgat1 gene expression and activity. We further show that B2AR activation favors the storage of extracellular polyunsaturated fatty acids. Finally, we present evidence that macrophages isolated from hearts after myocardial injury, for which survival critically depends on leukocyte B2ARs, have a transcriptional signature indicative of a transient triglyceride accumulation. Overall, we describe a novel and unexpected role of NE in promoting triglyceride storage in macrophages that could have potential implications in multiple diseases.	[Petkevicius, Kasparas; Bidault, Guillaume; Virtue, Sam; Jenkins, Benjamin; Koulman, Albert; Vidal-Puig, Antonio] Univ Cambridge, MDU MRC, Inst Metab Sci, Metab Res Labs, Cambridge, England; [van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands; [van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Dugourd, Aurelien; Saez-Rodriguez, Julio] Rhein Westfal TH Aachen, Fac Med, Joint Res Ctr Computat Biomed, Aachen, Germany; [Dugourd, Aurelien; Saez-Rodriguez, Julio] Heidelberg Univ, Fac Med, Inst Computat Biomed, Heidelberg, Germany; [Dugourd, Aurelien; Saez-Rodriguez, Julio] Heidelberg Univ, Heidelberg Univ Hosp, Heidelberg, Germany; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Hinxton, England; [Petkevicius, Kasparas; Bidault, Guillaume; Virtue, Sam; Jenkins, Benjamin; Koulman, Albert; Vidal-Puig, Antonio] AstraZeneca BioPharmaceut R&D, IMED Biotech Unit, Metab Biosci Cardiovasc Renal & Metab, Gothenburg, Sweden	University of Cambridge; Wageningen University & Research; Radboud University Nijmegen; RWTH Aachen University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Wellcome Trust Sanger Institute	Petkevicius, K; Vidal-Puig, A (corresponding author), Univ Cambridge, MDU MRC, Inst Metab Sci, Metab Res Labs, Cambridge, England.	kasparas.petkevicius@gmail.com; ajv22@medschl.cam.ac.uk	Koulman, Albert/B-2967-2009; Saez-Rodriguez, Julio/H-7114-2019; Dugourd, Aurelien/AGI-0197-2022	Koulman, Albert/0000-0001-9998-051X; Saez-Rodriguez, Julio/0000-0002-8552-8976; van Dierendonck, Xanthe/0000-0002-9855-8701	Biotechnology and Biological Sciences Research Council [BB/P028195/1, BB/M027252/2] Funding Source: Medline; British Heart Foundation [RG/18/7/33636, RG/12/13/29853] Funding Source: Medline; Medical Research Council [G0400192, MC_UU_12012/5, G0802051, MC_UU_00014/5, MC_UU_00014/2, MC_UU_12012/2] Funding Source: Medline; Wellcome Trust [102354/Z/13/Z] Funding Source: Medline; BBSRC [BB/P028195/1, BB/M027252/2] Funding Source: UKRI; MRC [MC_UU_00014/2, MC_UU_00014/5, MC_UU_12012/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Batista-Gonzalez A, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02993; Biswas S.K., 2014, MACROPHAGES BIOL ROL; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Caspar-Bauguil S., 2015, DIABETOLOGIA, V58, P1; Castoldi A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17881-3; Chitraju C, 2017, CELL METAB, V26, P407, DOI 10.1016/j.cmet.2017.07.012; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Das KMP, 2018, J LIPID RES, V59, P531, DOI 10.1194/jlr.M082388; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-019-0363-8, 10.1038/s41590-018-0272-2]; Esler M, 2002, AM J PHYSIOL-REG I, V282, pR909, DOI 10.1152/ajpregu.00335.2001; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524; Greer MS, 2014, LIPIDS, V49, P831, DOI 10.1007/s11745-014-3921-8; Grisanti LA, 2016, P NATL ACAD SCI USA, V113, P15126, DOI 10.1073/pnas.1611023114; Grisanti LA, 2016, CIRCULATION, V134, P153, DOI 10.1161/CIRCULATIONAHA.116.022304; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Jain M, 2014, AM J PHYSIOL-ENDOC M, V306, pE854, DOI 10.1152/ajpendo.00371.2013; Jaisinghani N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01490; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Kintscher U, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100001; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu C, 2019, IMMUNITY, V51, P381, DOI 10.1016/j.immuni.2019.06.017; Lu MF, 2014, J IMMUNOL, V193, P1392, DOI 10.4049/jimmunol.1400886; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Maier A, 2017, FASEB J, V31, P4971, DOI 10.1096/fj.201700235R; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; Medina CB, 2020, NATURE, V580, P130, DOI 10.1038/s41586-020-2121-3; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; Odegaard JI, 2013, CELL METAB, V18, P767, DOI 10.1016/j.cmet.2013.11.011; Parajuli N, 2018, AM J PHYSIOL-HEART C, V315, pH879, DOI 10.1152/ajpheart.00308.2018; Petkevicius K, 2019, ROLE MACROPHAGE INTR, DOI [10.17863/CAM.32789, DOI 10.17863/CAM.32789]; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Rader DJ, 2005, CELL METAB, V1, P223, DOI 10.1016/j.cmet.2005.03.005; Rizzo G., 2020, SINGLE CELL TRANSCRI; Rosas-Ballina M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00131; Schulze RJ, 2017, BBA-MOL CELL BIOL L, V1862, P1178, DOI 10.1016/j.bbalip.2017.06.008; Shi Y, 2016, EXP GERONTOL, V78, P32, DOI 10.1016/j.exger.2016.03.005; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Tang LJ, 2015, ENDOCRINOLOGY, V156, P3680, DOI 10.1210/EN.2015-1096; van Dierendonck XAMH, 2020, CELL REP, V30, P1811, DOI 10.1016/j.celrep.2020.01.046; Walter W, 2018, CELL REP, V23, P622, DOI 10.1016/j.celrep.2018.03.029; Willemze RA, 2019, MOL MED, V25, DOI 10.1186/s10020-018-0068-8; Wu H, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910698; Wu L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01313; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09277-9	62	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21266	10.1096/fj.202001101R	http://dx.doi.org/10.1096/fj.202001101R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484195	Green Published, hybrid			2022-12-28	WOS:000647789600088
J	Weng, YC; Huang, YT; Chiang, IC; Tsai, PJ; Su, YW; Chou, WH				Weng, Yi-Chinn; Huang, Yu-Ting; Chiang, I-Chen; Tsai, Pei-Ju; Su, Yu-Wen; Chou, Wen-Hai			Lipocalin-2 mediates the rejection of neural transplants	FASEB JOURNAL			English	Article						graft; Lipocalin&#8208; 2; neuroinflammation; neutrophil gelatinase&#8208; associated lipocalin; rejection; transplantation	GELATINASE-ASSOCIATED LIPOCALIN; INTRACEREBRAL TRANSPLANTATION; CELL TRANSPLANTATION; IRON HOMEOSTASIS; UP-REGULATION; ASTROCYTES; SURVIVAL; MODEL; RECOGNITION; GENERATION	Lipocalin-2 (LCN2) has been implicated in promoting apoptosis and neuroinflammation in neurological disorders; however, its role in neural transplantation remains unknown. In this study, we cultured and differentiated Lund human mesencephalic (LUHMES) cells into human dopaminergic-like neurons and found that LCN2 mRNA was progressively induced in mouse brain after the intrastriatal transplantation of human dopaminergic-like neurons. The induction of LCN2 protein was detected in a subset of astrocytes and neutrophils infiltrating the core of the engrafted sites, but not in neurons and microglia. LCN2-immunoreactive astrocytes within the engrafted sites expressed lower levels of A1 and A2 astrocytic markers. Recruitment of microglia, neutrophils, and monocytes after transplantation was attenuated in LCN2 deficiency mice. The expression of M2 microglial markers was significantly elevated and survival of engrafted neurons was markedly improved after transplantation in LCN2 deficiency mice. Brain type organic cation transporter (BOCT), the cell surface receptor for LCN2, was induced in dopaminergic-like neurons after differentiation, and treatment with recombinant LCN2 protein directly induced apoptosis in dopaminergic-like neurons in a dose-dependent manner. Our results, therefore, suggested that LCN2 is a neurotoxic factor for the engrafted neurons and a modulator of neuroinflammation. LCN2 inhibition may be useful in reducing rejection after neural transplantation.	[Weng, Yi-Chinn; Huang, Yu-Ting; Chiang, I-Chen; Chou, Wen-Hai] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Tsai, Pei-Ju; Su, Yu-Wen] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Chou, WH (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	wenhaichou@nhri.edu.tw	Chou, Wen-Hai/H-1970-2016	Chou, Wen-Hai/0000-0002-7899-1129				Bonnamain V, 2012, FRONT CELL NEUROSCI, V6; Caines AE, 2005, J HEART LUNG TRANSPL, V24, P486, DOI 10.1016/j.healun.2004.02.009; Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Vocht N, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt312; De Vocht N, 2013, IMMUNOBIOLOGY, V218, P696, DOI 10.1016/j.imbio.2012.08.266; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dunnett SB, 1998, EXP NEUROL, V154, P31, DOI 10.1006/exnr.1998.6926; Enderby C, 2015, AM J MANAG CARE, V21, pS12; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Hare DJ, 2015, NAT REV NEUROL, V11, P536, DOI 10.1038/nrneurol.2015.100; Hoornaert CJ, 2017, STEM CELL TRANSL MED, V6, P1434, DOI 10.1002/sctm.16-0434; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Kim BW, 2016, J NEUROSCI, V36, P5608, DOI 10.1523/JNEUROSCI.4261-15.2016; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; Kowdley KV, 2005, GASTROENTEROLOGY, V129, P494, DOI 10.1053/j.gastro.2005.05.004; Kumar V, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0479-z; Le Blon D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0756-7; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Matejuk A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01416; Mudge DW, 2004, TRANSPLANTATION, V77, P206, DOI 10.1097/01.TP.0000100446.44001.00; Ndayisaba A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00180; Parmar T, 2018, J IMMUNOL, V200, P3128, DOI 10.4049/jimmunol.1701573; Piquet AL, 2012, BRAIN RES BULL, V88, P320, DOI 10.1016/j.brainresbull.2012.03.001; Posel C, 2016, JOVE-J VIS EXP, DOI 10.3791/53658; Praet J, 2015, CELL TRANSPLANT, V24, P1481, DOI 10.3727/096368914X682800; Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920; Resch T, 2017, J HEART LUNG TRANSPL, V36, P732, DOI 10.1016/j.healun.2017.03.004; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Sandmeier P, 2005, CHEST, V128, P1379, DOI 10.1378/chest.128.3.1379; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Smirnova L, 2016, ARCH TOXICOL, V90, P2725, DOI 10.1007/s00204-015-1637-z; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Tomov N, 2020, NEURAL REGEN RES, V15, P1173, DOI 10.4103/1673-5374.270296; Wang GN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176253; Wang G, 2015, J CELL MOL MED, V19, P1637, DOI 10.1111/jcmm.12538; Xiao X, 2017, ANNU REV NUTR, V37, P103, DOI 10.1146/annurev-nutr-071816-064559; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	47	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21317	10.1096/fj.202001018R	http://dx.doi.org/10.1096/fj.202001018R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33421207	hybrid			2022-12-28	WOS:000647789600062
J	Zhang, XW; Sakamoto, W; Canals, D; Ishibashi, M; Matsuda, M; Nishida, K; Toyoshima, M; Shigeta, S; Taniguchi, M; Senkal, CE; Okazaki, T; Yaegashi, N; Hannun, YA; Nabe, T; Kitatani, K				Zhang, Xuewei; Sakamoto, Wataru; Canals, Daniel; Ishibashi, Masumi; Matsuda, Masaya; Nishida, Kentaro; Toyoshima, Masafumi; Shigeta, Shogo; Taniguchi, Makoto; Senkal, Can E.; Okazaki, Toshiro; Yaegashi, Nobuo; Hannun, Yusuf A.; Nabe, Takeshi; Kitatani, Kazuyuki			Ceramide synthase 2-C-24:1-ceramide axis limits the metastatic potential of ovarian cancer cells	FASEB JOURNAL			English	Article						cell motility; ceramide; metastasis; sphingolipids; sphingolipid metabolism	SPHINGOLIPID METABOLISM; V-ATPASE; EXPRESSION; PATHWAY; BIOSYNTHESIS; LOCALIZATION; PROGNOSIS; MECHANISM; MOTILITY; INVASION	Regulation of sphingolipid metabolism plays a role in cellular homeostasis, and dysregulation of these pathways is involved in cancer progression. Previously, our reports identified ceramide as an anti-metastatic lipid. In the present study, we investigated the biochemical alterations in ceramide-centered metabolism of sphingolipids that were associated with metastatic potential. We established metastasis-prone sublines of SKOV3 ovarian cancer cells using an in vivo selection method. These cells showed decreases in ceramide levels and ceramide synthase (CerS) 2 expression. Moreover, CerS2 downregulation in ovarian cancer cells promoted metastasis in vivo and potentiated cell motility and invasiveness. Moreover, CerS2 knock-in suppressed the formation of lamellipodia required for cell motility in this cell line. In order to define specific roles of ceramide species in cell motility controlled by CerS2, the effect of exogenous long- and very long-chain ceramide species on the formation of lamellipodia was evaluated. Treatment with distinct ceramides increased cellular ceramides and had inhibitory effects on the formation of lamellipodia. Interestingly, blocking the recycling pathway of ceramides by a CerS inhibitor was ineffective in the suppression of exogenous C-24:1-ceramide for the formation of lamellipodia. These results suggested that C-24:1-ceramide, a CerS2 metabolite, predominantly suppresses the formation of lamellipodia without the requirement for deacylation/reacylation. Moreover, knockdown of neutral ceramidase suppressed the formation of lamellipodia concomitant with upregulation of C-24:1-ceramide. Collectively, the CerS2-C-24:1-ceramide axis, which may be countered by neutral ceramidase, is suggested to limit cell motility and metastatic potential. These findings may provide insights that lead to further development of ceramide-based therapy and biomarkers for metastatic ovarian cancer.	[Zhang, Xuewei; Ishibashi, Masumi; Toyoshima, Masafumi; Shigeta, Shogo; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan; [Sakamoto, Wataru; Canals, Daniel; Hannun, Yusuf A.] Stony Brook Canc Ctr, Dept Med, Stony Brook, NY USA; [Matsuda, Masaya; Nabe, Takeshi; Kitatani, Kazuyuki] Setsunan Univ, Lab Immunopharmacol, Osaka, Japan; [Nishida, Kentaro] Setsunan Univ, Fac Pharmaceut Sci, Dept Integrat Pharmaceut Sci, Osaka, Japan; [Taniguchi, Makoto; Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Kanazawa, Ishikawa, Japan; [Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Kanazawa, Ishikawa, Japan; [Senkal, Can E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA	Tohoku University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Setsunan University; Setsunan University; Kanazawa Medical University; Kanazawa Medical University; Virginia Commonwealth University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kitatani, K (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Lab Immunopharmacol, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	kazuyuki.kitatani@pharm.setsunan.ac.jp	Kitatani, Kazuyuki/H-7100-2019; Taniguchi, Makoto/L-5757-2019; Canals, Daniel/AAW-1998-2021	Kitatani, Kazuyuki/0000-0002-8516-6135; Taniguchi, Makoto/0000-0001-5920-8285; Canals, Daniel/0000-0002-9293-5123; Nishida, Kentaro/0000-0001-8597-4848; Ishibashi, Masumi/0000-0003-4112-8716; Matsuda, Masaya/0000-0001-6498-8335	Japan Society for the Promotion of Science (JSPS) [16K11125] Funding Source: Medline; NCI NIH HHS [P01 CA097132, R01 CA218678] Funding Source: Medline	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Barth BM, 2011, ANTI-CANCER AGENT ME, V11, P911; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Canals D, 2020, FASEB J, V34, P7610, DOI 10.1096/fj.202000205R; Coant Nicolas, 2019, Advances in Biological Regulation, V71, P141, DOI 10.1016/j.jbior.2018.10.005; Coant Nicolas, 2017, Advances in Biological Regulation, V63, P122, DOI 10.1016/j.jbior.2016.10.002; Dimchev G, 2020, J CELL SCI, V133, DOI 10.1242/jcs.239020; Edmond V, 2015, ONCOGENE, V34, P996, DOI 10.1038/onc.2014.55; Fan S, 2013, ONCOGENE, V32, P1682, DOI 10.1038/onc.2012.183; Fan SH, 2015, J CELL BIOCHEM, V116, P502, DOI 10.1002/jcb.24978; Gulluni F, 2019, TRENDS CELL BIOL, V29, P339, DOI 10.1016/j.tcb.2019.01.001; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; Ito M, 2014, BBA-MOL CELL BIOL L, V1841, P682, DOI 10.1016/j.bbalip.2013.09.008; Kester M, 2003, PHARMACOL RES, V47, P365, DOI 10.1016/S1043-6618(03)00048-3; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Kim MH, 2018, ONCOL REP, V40, P2977, DOI 10.3892/or.2018.6689; Kitatani K, 2016, ONCOGENE, V35, P2801, DOI 10.1038/onc.2015.330; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Koshkaryev A, 2012, CANCER BIOL THER, V13, P50, DOI 10.4161/cbt.13.1.18871; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lu P, 2019, CANCER BIOL THER, V20, P922, DOI 10.1080/15384047.2019.1579962; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Ogiso H, 2014, METABOLITES, V4, P98, DOI 10.3390/metabo4010098; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Pan H, 2001, GENOMICS, V77, P58, DOI 10.1006/geno.2001.6614; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sheng N, 2019, J CELL PHYSIOL, V234, P13001, DOI 10.1002/jcp.27970; Shi YN, 2020, AM J TRANSL RES, V12, P5924; Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15; Stepanovska B, 2020, PHARMACOL RES, V154, DOI 10.1016/j.phrs.2019.02.009; Stiban J, 2015, BBA-BIOMEMBRANES, V1848, P561, DOI 10.1016/j.bbamem.2014.11.018; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Vlerken LE, 2007, CANCER RES, V67, P4843, DOI 10.1158/0008-5472.CAN-06-1648; Waters RJ, 2012, METHOD ENZYMOL, V508, P89, DOI 10.1016/B978-0-12-391860-4.00005-7; Wells A, 2013, TRENDS PHARMACOL SCI, V34, P283, DOI 10.1016/j.tips.2013.03.001; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zhang XW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030627; Zhang XW, 2018, MOL CANCER THER, V17, P50, DOI 10.1158/1535-7163.MCT-17-0173; Zhang Y., 2020, Hepatology.	56	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21287	10.1096/fj.202001504RR	http://dx.doi.org/10.1096/fj.202001504RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423335	Green Accepted			2022-12-28	WOS:000647789600070
J	Zhen, CL; Liu, HX; Gao, L; Tong, YY; He, CY				Zhen, Changlin; Liu, Hongxia; Gao, Li; Tong, Yuanyuan; He, Chaoyong			Signal transducer and transcriptional activation 1 protects against pressure overload-induced cardiac hypertrophy	FASEB JOURNAL			English	Article						Drp1; heart function; Stat1; UCP2	DYNAMIN-RELATED PROTEIN-1; SMOOTH-MUSCLE-CELLS; MITOCHONDRIAL FISSION; THERAPEUTIC TARGETS; ENERGY-METABOLISM; INTERFERON-GAMMA; HEART; FUSION; INFLAMMATION; STAT3	Signal transducers and transcriptional activation 1 (Stat1) is a member of the STATs family, and its role in various biological responses, including cell proliferation, differentiation, migration, apoptosis, and immune regulation has been extensively studied. We aimed to investigate its role in pathological cardiac hypertrophy, which is currently poorly understood. Experiments using H9C2 cardiomyocytes, Stat1, and IfngR cardiomyocyte-specific knockout mice revealed that Stat1 had a protective effect on cardiac hypertrophy. Using transverse aortic constriction (TAC)-induced cardiac hypertrophy in mice, we analyzed the degree of hypertrophy using echocardiography, pathology, and at the molecular level. Mice lacking Stat1 had more pronounced cardiac hypertrophy and fibrosis than wild-type TAC mice. Analysis of the molecular mechanisms suggested that Stat1 downregulated the mRNA levels of hypertrophy and fibrosis markers to inhibit cardiac hypertrophy, and promotes mitochondrial fission through the Ucp2/P-Drp1 pathway, enhancing mitochondrial function, and increasing compensatory myocardial ATP production in the compensatory phase for cardiac hypertrophy inhibition. Overall, this comprehensive analysis revealed that Stat1 inhibits cardiac hypertrophy by downregulating hypertrophic and fibrotic marker genes and enhancing the mitochondrial function to enhance cardiomyocyte function through the Ucp2/P-Drp1 signaling pathway.	[Zhen, Changlin; Liu, Hongxia; Gao, Li; Tong, Yuanyuan; He, Chaoyong] China Pharmaceut Univ, Dept Pharmacol, State Key Lab Nat Med, Nanjing 210009, Peoples R China	China Pharmaceutical University	He, CY (corresponding author), China Pharmaceut Univ, Dept Pharmacol, State Key Lab Nat Med, Nanjing 210009, Peoples R China.	chaoyonghe@cpu.edu.cn						Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Azevedo PS, 2013, CARDIOL REV, V21, P135, DOI 10.1097/CRD.0b013e318274956d; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Chatham JC, 2012, CIRC RES, V111, P666, DOI 10.1161/CIRCRESAHA.112.277392; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Ding MG, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12491; FAGARD R H, 1992, Cardiology Clinics, V10, P241; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Grayfer L, 2009, DEV COMP IMMUNOL, V33, P235, DOI 10.1016/j.dci.2008.09.001; Hall AR, 2014, BRIT J PHARMACOL, V171, P1890, DOI 10.1111/bph.12516; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; Hasan P, 2018, J MOL CELL CARDIOL, V121, P103, DOI 10.1016/j.yjmcc.2018.07.004; He CY, 2017, GENE DEV, V31, P1666, DOI 10.1101/gad.300384.117; He CY, 2015, DIABETES, V64, P4285, DOI 10.2337/db15-0107; He CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8770; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jiang DS, 2014, HYPERTENSION, V64, P77, DOI 10.1161/HYPERTENSIONAHA.114.03229; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Kimura A, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008145; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lackner LL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-35; Lemieux H, 2009, J BIOENERG BIOMEMBR, V41, P99, DOI 10.1007/s10863-009-9211-0; Levick S, 2014, HEART FAIL REV, V19, P227, DOI 10.1007/s10741-013-9393-8; Liu MY, 2016, HYPERTENSION, V68, P1245, DOI 10.1161/HYPERTENSIONAHA.116.07974; Liu YY, 2008, J IMMUNOL, V180, P7349, DOI 10.4049/jimmunol.180.11.7349; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Ong SB, 2015, EUR J PHARMACOL, V763, P104, DOI 10.1016/j.ejphar.2015.04.056; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Quan NH, 2018, J MOL CELL CARDIOL, V115, P170, DOI 10.1016/j.yjmcc.2018.01.005; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tian XY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01060; Toda C, 2016, CELL, V164, P872, DOI 10.1016/j.cell.2016.02.010; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Vasquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301; VESELY DL, 1994, CIRCULATION, V90, P1129, DOI 10.1161/01.CIR.90.3.1129; Wan CK, 2015, P NATL ACAD SCI USA, V112, P9394, DOI 10.1073/pnas.1511711112; Wang H, 2019, JOULE, V3, P53, DOI 10.1016/j.joule.2018.10.012; Wang Y, 2018, REDOX BIOL, V17, P25, DOI 10.1016/j.redox.2018.04.009; Yu TT, 2017, J MOL CELL BIOL, V9, P144, DOI 10.1093/jmcb/mjw042; Yuan LY, 2018, J CELL MOL MED, V22, P4292, DOI 10.1111/jcmm.13713; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang HL, 2017, CARDIOVASC RES, V113, P160, DOI 10.1093/cvr/cvw212; Zhao L, 2016, CIRC RES, V118, P1918, DOI 10.1161/CIRCRESAHA.116.308688; Zhao LL, 2017, INT IMMUNOPHARMACOL, V48, P102, DOI 10.1016/j.intimp.2017.05.002	60	3	4	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21240	10.1096/fj.202000325RRR	http://dx.doi.org/10.1096/fj.202000325RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33377257				2022-12-28	WOS:000605626600003
J	Marquardt, RM; Kim, TH; Yoo, JY; Teasley, HE; Fazleabas, AT; Young, SL; Lessey, BA; Arora, R; Jeong, JW				Marquardt, Ryan M.; Kim, Tae Hoon; Yoo, Jung-Yoon; Teasley, Hanna E.; Fazleabas, Asgerally T.; Young, Steven L.; Lessey, Bruce A.; Arora, Ripla; Jeong, Jae-Wook			Endometrial epithelial ARID1A is critical for uterine gland function in early pregnancy establishment	FASEB JOURNAL			English	Article						ARID1A; endometrium; endometriosis; FOXA2; infertility	CANCER-ASSOCIATED MUTATIONS; LEUKEMIA INHIBITORY FACTOR; PROGESTERONE-RECEPTOR; IMPLANTATION; CELL; FOXA2; EXPRESSION; EMBRYO; BLASTOCYST; PATHWAY	Though endometriosis and infertility are clearly associated, the pathophysiological mechanism remains unclear. Previous work has linked endometrial ARID1A loss to endometriosis-related endometrial non-receptivity. Here, we show in mice that ARID1A binds and regulates transcription of the Foxa2 gene required for endometrial gland function. Uterine-specific deletion of Arid1a compromises gland development and diminishes Foxa2 and Lif expression. Deletion of Arid1a with Ltf-iCre in the adult mouse endometrial epithelium preserves the gland development while still compromising the gland function. Mice lacking endometrial epithelial Arid1a are severely sub-fertile due to defects in implantation, decidualization, and endometrial receptivity from disruption of the LIF-STAT3-EGR1 pathway. FOXA2 is also reduced in the endometrium of women with endometriosis in correlation with diminished ARID1A, and both ARID1A and FOXA2 are reduced in nonhuman primates induced with endometriosis. Our findings describe a role for ARID1A in the endometrial epithelium supporting early pregnancy establishment through the maintenance of gland function.	[Marquardt, Ryan M.; Kim, Tae Hoon; Teasley, Hanna E.; Fazleabas, Asgerally T.; Arora, Ripla; Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA; [Marquardt, Ryan M.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Yoo, Jung-Yoon] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea; [Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Lessey, Bruce A.] Wake Forest Baptist Hlth, Dept Obstet & Gynecol, Winston Salem, NC USA; [Arora, Ripla] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Yonsei University; Yonsei University Health System; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center; Michigan State University	Jeong, JW (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Arora, R (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Inst Quantitat Hlth Sci & Engn, 775 Woodlot Dr, E Lansing, MI 48824 USA.	ripla@msu.edu; jeongj@msu.edu	Marquardt, Ryan M./GVT-6872-2022; Young, Steven/G-2304-2014	Marquardt, Ryan M./0000-0002-6597-4506; Yoo, Jung-Yoon/0000-0001-9366-3863; Young, Steven/0000-0002-5205-4495; Jeong, Jae-Wook/0000-0002-5368-6478	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD084478]; HHS \ NIH [F31HD101207, T32HD087166]; March of Dimes [FY20-209]	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS \ NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes)	HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD084478; HHS vertical bar NIH, Grant/Award Number: F31HD101207 and T32HD087166; March of Dimes, Grant/Award Number: FY20-209	Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; Arora R, 2016, DEVELOPMENT, V143, P4749, DOI 10.1242/dev.144386; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chene G, 2015, INT J GYNECOL OBSTET, V130, P27, DOI 10.1016/j.ijgo.2015.02.021; Daikoku T, 2014, ENDOCRINOLOGY, V155, P2718, DOI 10.1210/en.2014-1265; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Fazleabas AT, 2006, METH MOLEC MED, V121, P95; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Hantak AM, 2014, INT J DEV BIOL, V58, P139, DOI 10.1387/ijdb.130348mb; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; Kelleher AM, 2019, ENDOCR REV, V40, P1424, DOI 10.1210/er.2018-00281; Kelleher AM, 2019, FASEB J, V33, P8543, DOI 10.1096/fj.201900013R; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kim HR, 2018, FASEB J, V32, P1184, DOI 10.1096/fj.201700854RR; Kim TH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005537; Kovacic B, 2014, HAEMATOLOGICA, V99, P1006, DOI 10.3324/haematol.2013.097154; Kumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089742; Kumar R, 2011, J REPROD IMMUNOL, V92, P88, DOI 10.1016/j.jri.2011.06.103; Lac V, 2019, J PATHOL, V249, P173, DOI 10.1002/path.5314; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Liang XH, 2014, J BIOL CHEM, V289, P23534, DOI 10.1074/jbc.M114.588897; Lin AP, 2018, REPROD BIOMED ONLINE, V36, P181, DOI 10.1016/j.rbmo.2017.11.001; Marquardt RM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153822; Mathur R, 2018, PHARMACOL THERAPEUT, V190, P15, DOI 10.1016/j.pharmthera.2018.05.001; Neff R, 2018, INT J CANCER, V143, P2955, DOI 10.1002/ijc.31784; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Raab JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005748; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Suda K, 2018, CELL REP, V24, P1777, DOI 10.1016/j.celrep.2018.07.037; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Vasquez YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007787; Wang XY, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.133637; Wang XJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03504-5; Wetendorf M, 2014, INT J DEV BIOL, V58, P95, DOI 10.1387/ijdb.140069mw; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Yang H, 2015, REPROD SCI, V22, P1060, DOI 10.1177/1933719115592709; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	48	6	6	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002178R	http://dx.doi.org/10.1096/fj.202002178R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33222288	Green Submitted, Green Accepted			2022-12-28	WOS:000592921900001
J	Yue, YY; Zhang, C; Zhao, XY; Liu, SS; Lv, XT; Zhang, ST; Yang, JM; Chen, LM; Duan, HQ; Zhang, YY; Yao, Z; Niu, WY				Yue, Yingying; Zhang, Chang; Zhao, Xiaoyun; Liu, Sasa; Lv, Xiaoting; Zhang, Shitian; Yang, Jianming; Chen, Liming; Duan, Hongquan; Zhang, Youyi; Yao, Zhi; Niu, Wenyan			Tiam1 mediates Rac1 activation and contraction-induced glucose uptake in skeletal muscle cells	FASEB JOURNAL			English	Article						AMPK; glucose uptake; muscle contraction; Rac1; Tiam1	ISLET FUNCTION; G-PROTEINS; INSULIN; AMP; IDENTIFICATION; REGULATOR; KNOCKOUT; MUTATION; TBC1D1; GEF	Contraction-stimulated glucose uptake in skeletal muscle requires Rac1, but the molecular mechanism of its activation is not fully understood. Treadmill running was applied to induce C57BL/6 mouse hind limb skeletal muscle contraction in vivo and electrical pulse stimulation contracted C2C12 myotube cultures in vitro. The protein levels or activities of AMPK or the Rac1-specific GEF, Tiam1, were manipulated by activators, inhibitors, siRNA-mediated knockdown, and adenovirus-mediated expression. Activated Rac1 was detected by a pull-down assay and immunoblotting. Glucose uptake was measured using the 2-NBD-glucose fluorescent analog. Electrical pulse stimulated contraction or treadmill exercise upregulated the expression of Tiam1 in skeletal muscle in an AMPK-dependent manner. Axin1 siRNA-mediated knockdown diminished AMPK activation and upregulation of Tiam1 protein expression by contraction. Tiam1 siRNA-mediated knockdown diminished contraction-induced Rac1 activation, GLUT4 translocation, and glucose uptake. Contraction increased Tiam1 gene expression and serine phosphorylation of Tiam1 protein via AMPK. These findings suggest Tiam1 is part of an AMPK-Tiam1-Rac1 signaling pathway that mediates contraction-stimulated glucose uptake in skeletal muscle cells and tissue.	[Yue, Yingying; Zhang, Chang; Zhao, Xiaoyun; Liu, Sasa; Lv, Xiaoting; Zhang, Shitian; Yang, Jianming; Chen, Liming; Duan, Hongquan; Yao, Zhi; Niu, Wenyan] Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Dept Immunol, Minist Educ, Tianjin 300070, Peoples R China; [Yue, Yingying; Zhang, Chang; Zhao, Xiaoyun; Liu, Sasa; Lv, Xiaoting; Zhang, Shitian; Yang, Jianming; Chen, Liming; Duan, Hongquan; Yao, Zhi; Niu, Wenyan] Tianjin Med Univ, NHC Key Lab Hormones & Dev, Tianjin, Peoples R China; [Yue, Yingying; Zhang, Chang; Zhao, Xiaoyun; Liu, Sasa; Lv, Xiaoting; Zhang, Shitian; Yang, Jianming; Chen, Liming; Duan, Hongquan; Yao, Zhi; Niu, Wenyan] Tianjin Med Univ, Chu Hsien I Mem Hosp, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Yue, Yingying; Zhang, Chang; Zhao, Xiaoyun; Liu, Sasa; Lv, Xiaoting; Zhang, Shitian; Yang, Jianming; Chen, Liming; Duan, Hongquan; Yao, Zhi; Niu, Wenyan] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Yue, Yingying; Zhang, Chang; Zhao, Xiaoyun; Liu, Sasa; Lv, Xiaoting; Zhang, Shitian; Yang, Jianming; Chen, Liming; Duan, Hongquan; Yao, Zhi; Niu, Wenyan] Tianjin Med Univ, Gen Hosp, Dept Pharm, Tianjin, Peoples R China; [Lv, Xiaoting] Cangzhou Peoples Hosp, Clin Lab, Cangzhou, Peoples R China; [Zhang, Youyi] Peking Univ Third Hosp, Inst Vasc Med, Beijing, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Niu, WY (corresponding author), Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Dept Immunol, Minist Educ, Tianjin 300070, Peoples R China.	wniu@tmu.edu.cn			National Natural Science Foundation of China [81670731, 81870547, 81170740, 81161120545]; Tianjin Municipal Science and Technology Commission [15JCZDJC35500]; Tianjin Municipal Education Commission [2019ZD028]; Tianjin Health and Family Planning Commission [15KG102]; Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital [608]; Tianjin Research Innovation Project for Postgraduate Students [2019YJSB101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; Tianjin Municipal Education Commission; Tianjin Health and Family Planning Commission; Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital; Tianjin Research Innovation Project for Postgraduate Students	This work was supported by grants from National Natural Science Foundation of China (#81670731, #81870547, #81170740, and #81161120545), the Tianjin Municipal Science and Technology Commission (#15JCZDJC35500), Tianjin Municipal Education Commission (#2019ZD028), and the Tianjin Health and Family Planning Commission (#15KG102) to W Niu. J Yang was supported by Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital (#608). Y Yue was supported by Tianjin Research Innovation Project for Postgraduate Students (#2019YJSB101)	Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Chadt A, 2015, DIABETES, V64, P746, DOI 10.2337/db14-0368; Chen QL, 2017, DIABETOLOGIA, V60, P336, DOI 10.1007/s00125-016-4151-9; Chen Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08004-0; Dokas J, 2013, ENDOCRINOLOGY, V154, P3502, DOI 10.1210/en.2012-2147; Ducommun S, 2012, AM J PHYSIOL-ENDOC M, V302, pE1036, DOI 10.1152/ajpendo.00379.2011; FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Henriquez-Olguin C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12523-9; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kowluru A, 2003, AM J PHYSIOL-ENDOC M, V285, pE669, DOI 10.1152/ajpendo.00196.2003; Kowluru A, 2017, DIABETES OBES METAB, V19, P63, DOI 10.1111/dom.13011; Kowluru A, 2017, BIOCHEM PHARMACOL, V132, P9, DOI 10.1016/j.bcp.2017.02.007; Li Z, 2018, AM J PHYSIOL-ENDOC M, V314, pE478, DOI 10.1152/ajpendo.00103.2017; Magliozzi R, 2014, J BIOL CHEM, V289, P27400, DOI 10.1074/jbc.M114.575571; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Niu WY, 2011, J CELL PHYSIOL, V226, P173, DOI 10.1002/jcp.22320; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; Payapilly A, 2018, CURR OPIN CELL BIOL, V54, P50, DOI 10.1016/j.ceb.2018.04.009; Polzik E V, 1989, Med Lav, V80, P363; Polzik EV, 1989, MED LAV, V80, P369; Sylow L, 2016, J PHYSIOL-LONDON, V594, P4997, DOI 10.1113/JP272039; Sylow L, 2014, EXP PHYSIOL, V99, P1574, DOI 10.1113/expphysiol.2014.079194; Sylow L, 2013, DIABETES, V62, P1139, DOI 10.2337/db12-0491; Takenaka N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155292; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; You GY, 2013, CELL SIGNAL, V25, P2558, DOI 10.1016/j.cellsig.2013.08.018; Yuan HR, 2017, FEBS LETT, V591, P97, DOI 10.1002/1873-3468.12516; Yue YY, 2020, AM J PHYSIOL-ENDOC M, V318, pE330, DOI 10.1152/ajpendo.00272.2019; Zhang CS, 2018, METHODS MOL BIOL, V1732, P393, DOI 10.1007/978-1-4939-7598-3_25; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005	34	5	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001312R	http://dx.doi.org/10.1096/fj.202001312R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33225507				2022-12-28	WOS:000592368700001
J	Zhu, SD; Zhu, Y; Li, H; Wang, QW; Wang, KS; Baska, K; Zhang, DZ				Zhu, Shudong; Zhu, Yan; Li, Hao; Wang, Qiuwen; Wang, Kuansong; Baska, Katelynn; Zhang, Dianzheng			Long-term consumption of recycled cooking oil induces cell death and tissue damage	FASEB JOURNAL			English	Article						apoptosis; C57 mice; DNA damage; recycled cooking oil; toxicity	DNA-DAMAGE	Recycled cooking oil (RCO) is widely used in many small restaurants. However, the health risk posed by long-term consumption of RCO is unclear. In this study, C57 mice were treated with RCO for 34 weeks. Organ coefficients of the liver, stomach, and kidney were found to be decreased. H&E staining revealed overt lesions in the pancreas, liver, kidney, esophagus, duodenum, and ileum of RCO-treated mice. Immunohistochemistry showed significant DNA damage in the duodenum and ileum and apoptosis in the lungs of the RCO-treated mice. Immunoblotting showed elevated levels of gamma-H2AX, Bcl-2/Bax, TNF alpha, cleaved Caspase-3 and poly ADP-ribose polymerase (PARP). Increased levels of lactate dehydrogenase (LDH) and decreased levels of succinate dehydrogenase (SDH) were also detected. These findings suggest that long-term consumption of RCO produces various toxicities in mice with important implications for humans. DNA damage followed by mitochondria-associated apoptosis, and necrosis is likely to contribute to the toxicities.	[Zhu, Shudong; Zhu, Yan] Nantong Univ, Sch Med, 19 Qixiu Rd, Nantong, Jiangsu, Peoples R China; [Zhu, Shudong; Li, Hao; Wang, Qiuwen] Cent South Univ, Sch Life Sci, Dept Biochem & Mol Biol, Changsha, Peoples R China; [Zhu, Yan] Xuzhou Hlth Res Inst Co Ltd, Xuzhou, Jiangsu, Peoples R China; [Wang, Kuansong] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Peoples R China; [Baska, Katelynn; Zhang, Dianzheng] Philadelphia Coll Osteopath Med, Dept Biomed Sci, Philadelphia, PA USA	Nantong University; Central South University; Central South University	Zhu, SD (corresponding author), Nantong Univ, Sch Med, 19 Qixiu Rd, Nantong, Jiangsu, Peoples R China.	1125537080@qq.com		Zhu, Shudong/0000-0001-8605-3354	HNBRJH program; NTU startup grant	HNBRJH program; NTU startup grant(Nanyang Technological University)	This study was funded by HNBRJH program and NTU startup grant (to SZ).	[Anonymous], 2014, NY TIMES; Bassil K L, 2007, Can Fam Physician, V53, P1704; Bhardwaj S, 2016, FOOD CHEM, V212, P663, DOI 10.1016/j.foodchem.2016.06.021; CAO WM, 2011, GRAIN SCI TECHNOLOGY, V36, P41; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dsouza Herman S, 2002, Indian J Clin Biochem, V17, P9, DOI 10.1007/BF02867934; Guchi E., 2015, J APPL ENV MICROBIOL, V3, P11, DOI DOI 10.12691/JAEM-3-1-3; Jurewicz J, 2008, INT J OCCUP MED ENV, V21, P121, DOI 10.2478/v10001-008-0014-z; Kucukcakan Basak, 2015, Open Access Maced J Med Sci, V3, P363, DOI 10.3889/oamjms.2015.032; Li J, 2017, GLOB HEALTH PROMOT, V24, P75, DOI 10.1177/1757975915623733; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Point Carbon, 2012, CDM JI MONITOR, V9, P1, DOI DOI 10.1186/1742-9994-9-34; Port CM, 2011, ESSENTIALS PATHOPHYS; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944	14	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000825R	http://dx.doi.org/10.1096/fj.202000825R		NOV 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33210326				2022-12-28	WOS:000592746200001
J	Uebbing, S; Kreiss, M; Scholl, F; Hafner, AK; Surun, D; Garscha, U; Werz, O; Basavarajappa, D; Samuelsson, B; Radmark, O; Suess, B; Steinhilber, D				Uebbing, Stella; Kreiss, Marius; Scholl, Friederike; Haefner, Ann-Kathrin; Sueruen, Duran; Garscha, Ulrike; Werz, Oliver; Basavarajappa, Devaraj; Samuelsson, Bengt; Radmark, Olof; Suess, Beatrix; Steinhilber, Dieter			Modulation of microRNA processing by 5-lipoxygenase	FASEB JOURNAL			English	Article						cancer; Dicer; inflammation; leukotriene; miRNA; 5&#8208; lipoxygenase	HUMAN DICER; RNA-BINDING; CELLS; EXPRESSION; TARGET; GENE; IDENTIFICATION; BIOGENESIS; PROTEINS; MIRNAS	The miRNA biogenesis is tightly regulated to avoid dysfunction and consequent disease development. Here, we describe modulation of miRNA processing as a novel noncanonical function of the 5-lipoxygenase (5-LO) enzyme in monocytic cells. In differentiated Mono Mac 6 (MM6) cells, we found an in situ interaction of 5-LO with Dicer, a key enzyme in miRNA biogenesis. RNA sequencing of small noncoding RNAs revealed a functional impact, knockout of 5-LO altered the expression profile of several miRNAs. Effects of 5-LO could be observed at two levels. qPCR analyses thus indicated that (a) 5-LO promotes the transcription of the evolutionarily conserved miR-99b/let-7e/miR-125a cluster and (b) the 5-LO-Dicer interaction downregulates the processing of pre-let-7e, resulting in an increase in miR-125a and miR-99b levels by 5-LO without concomitant changes in let-7e levels in differentiated MM6 cells. Our observations suggest that 5-LO regulates the miRNA profile by modulating the Dicer-mediated processing of distinct pre-miRNAs. 5-LO inhibits the formation of let-7e which is a well-known inducer of cell differentiation, but promotes the generation of miR-99b and miR-125a known to induce cell proliferation and the maintenance of leukemic stem cell functions.	[Uebbing, Stella; Scholl, Friederike; Suess, Beatrix] Tech Univ, Dept Biol, Darmstadt, Germany; [Uebbing, Stella; Kreiss, Marius; Scholl, Friederike; Haefner, Ann-Kathrin; Steinhilber, Dieter] Goethe Univ, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany; [Uebbing, Stella; Scholl, Friederike; Basavarajappa, Devaraj; Samuelsson, Bengt; Radmark, Olof] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Sueruen, Duran] Tech Univ Dresden, UCC, Med Fac Carl Gustav Carus, Med Syst Biol, Dresden, Germany; [Garscha, Ulrike; Werz, Oliver] Friedrich Schiller Univ, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany	Technical University of Darmstadt; Goethe University Frankfurt; Karolinska Institutet; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena	Steinhilber, D (corresponding author), Goethe Univ, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany.	steinhilber@em.uni-frankfurt.de	Garscha, Ulrike/G-3559-2018	Garscha, Ulrike/0000-0002-3645-7833	Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg) [A187]; Deutsche Forschungsgemeinschaft [SFB 1039, TP A02]; Fraunhofer ITMP; Karolinska Institute	Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fraunhofer ITMP; Karolinska Institute(Karolinska Institutet)	Work of the authors was supported by the Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg, A187), the Deutsche Forschungsgemeinschaft (SFB 1039, TP A02) and Fraunhofer ITMP, and by the Karolinska Institute. The authors thank Sven George for technical assistance and purification of recombinant wild-type 5-LO.	Basavarajappa D, 2020, P NATL ACAD SCI USA, V117, P8573, DOI 10.1073/pnas.1916249117; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Brand S, 2018, CELL CHEM BIOL, V25, P1095, DOI 10.1016/j.chembiol.2018.05.016; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Chen ZH, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113223; Curtale G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02037; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; DeKelver RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003765; Dincbas-Renqvist V, 2009, BBA-GENE REGUL MECH, V1789, P99, DOI 10.1016/j.bbagrm.2008.10.002; Fontemaggi G, 2015, RNA BIOL, V12, P690, DOI 10.1080/15476286.2015.1044194; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gilbert B, 2015, BBA-GENE REGUL MECH, V1849, P1003, DOI 10.1016/j.bbagrm.2015.06.004; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hafner AK, 2019, PROSTAG OTH LIPID M, V142, P24, DOI 10.1016/j.prostaglandins.2019.03.003; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hildebrand D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01224; Khalaj M, 2017, J EXP MED, V214, P2453, DOI 10.1084/jem.20161595; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kretschmer SBM, 2016, FUTURE MED CHEM, V8, P149, DOI 10.4155/fmc.15.174; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Liu ZM, 2018, CELL, V173, P1191, DOI 10.1016/j.cell.2018.03.080; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; Michlewski G, 2019, RNA, V25, P1, DOI 10.1261/rna.068692.118; Mueller S, 2013, BIOINFORMATICS, V29, P2651, DOI 10.1093/bioinformatics/btt457; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Provost P, 1999, P NATL ACAD SCI USA, V96, P1881, DOI 10.1073/pnas.96.5.1881; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Roos J, 2014, CANCER RES, V74, P5244, DOI 10.1158/0008-5472.CAN-13-3012; Saul MJ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00824; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Steinhilber D, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00143; Surun D, 2018, MOL THER-NUCL ACIDS, V10, P1, DOI 10.1016/j.omtn.2017.11.001; Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Witwer KW, 2016, RNA BIOL, V13, P1103, DOI 10.1080/15476286.2016.1236172; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	50	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002108R	http://dx.doi.org/10.1096/fj.202002108R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33205517	Green Published, hybrid			2022-12-28	WOS:000592661600001
J	Arora, K; Liyanage, P; Zhong, Q; Naren, AP				Arora, Kavisha; Liyanage, Pramodha; Zhong, Qing; Naren, Anjaparavanda P.			A SNARE protein Syntaxin 17 captures CFTR to potentiate autophagosomal clearance under stress	FASEB JOURNAL			English	Article						autophagy; cystic fibrosis; cystic fibrosis transmembrane conductance regulator; SNARE proteins; lysosomal clearance	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; THERAPEUTIC TARGET; CHLORIDE CHANNELS; ACIDIFICATION; MECHANISMS; DYNAMICS; DIARRHEA; FUSION	Autophagy, a cellular stress response to starvation and bacterial infection, is executed by double-membrane-bound organelles called autophagosomes. Autophagosomes transfer cytosolic material to acidified lysosomes for degradation following soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE)-dependent fusion processes. Many of the autophagy-related disorders stem from defective end-step proteolysis inside lysosomes. The role of epithelial cystic fibrosis (CF) transmembrane conductance regulator (CFTR) chloride channel has been argued to be critical for efficient lysosomal clearance; however, its context to autophagic clearance and the underlying mechanism is poorly defined. Here, we report that syntaxin17 (Stx17), an autophagic SNARE protein interacts with CFTR under nutritional stress and bacterial infection and incorporates it into mature autophagosomes to mediate an efficient lysosomal clearance. Lack of CFTR function and Stx17 and loss of CFTR-Stx17 interaction impairs bacterial clearance. We discover a specialized role of the Stx17-CFTR protein complex that is critical to prevent defective autophagy as has been the reported scenario in CF airway epithelial cells, infectious diseases, and lysosomal clearance disorders.	[Arora, Kavisha; Liyanage, Pramodha; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, 3333 Burnet Ave MLC 2021, Cincinnati, OH 45229 USA; [Zhong, Qing] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX USA	Cincinnati Children's Hospital Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Naren, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, 3333 Burnet Ave MLC 2021, Cincinnati, OH 45229 USA.	anaren@cchmc.org	Liyanage, Pramodha/ABE-9075-2020; Zhong, Qing/GLT-4858-2022	Zhong, Qing/0000-0001-6979-955X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart and Lung Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart and Lung Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart and Lung Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	Arora K, 2015, AM J PATHOL, V185, P2790, DOI 10.1016/j.ajpath.2015.06.007; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Barnaby R, 2018, AM J PHYSIOL-LUNG C, V314, pL432, DOI 10.1152/ajplung.00461.2017; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Bonfield TL, 2015, AM J RESP CRIT CARE, V192, P1406, DOI 10.1164/rccm.201509-1811ED; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Cui GY, 2019, DEV CELL, V51, P421, DOI 10.1016/j.devcel.2019.09.017; Davies Jane C, 2002, Paediatr Respir Rev, V3, P128, DOI 10.1016/S1526-0550(02)00003-3; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Festa BP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02536-7; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Garai P, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007812; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Haggie PM, 2009, J BIOL CHEM, V284, P7681, DOI 10.1074/jbc.M809161200; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Itakura E, 2013, AUTOPHAGY, V9, P917, DOI 10.4161/auto.24109; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Junkins RD, 2014, AUTOPHAGY, V10, P538, DOI 10.4161/auto.27750; Junkins RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072263; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL591, DOI 10.1152/ajplung.00335.2013; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Luo LJ, 2018, FISH SHELLFISH IMMUN, V83, P416, DOI 10.1016/j.fsi.2018.09.016; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Royle SJ, 2013, NAT REV MOL CELL BIO, V14, P592, DOI 10.1038/nrm3641; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Shrestha CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186169; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573	55	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.201903210R	http://dx.doi.org/10.1096/fj.201903210R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33191543	Green Accepted			2022-12-28	WOS:000592667900001
J	Serricchio, M; Hierro-Yap, C; Schadeli, D; Ben Hamidane, H; Hemphill, A; Graumann, J; Zikova, A; Butikofer, P				Serricchio, Mauro; Hierro-Yap, Carolina; Schadeli, David; Ben Hamidane, Hisham; Hemphill, Andrew; Graumann, Johannes; Zikova, Alena; Butikofer, Peter			Depletion of cardiolipin induces major changes in energy metabolism in Trypanosoma brucei bloodstream forms	FASEB JOURNAL			English	Article						ATP synthase; cardiolipin; electron transport chain; mitochondria; protein complexes; trypanosomes	ADP/ATP CARRIER PROTEIN; ESCHERICHIA-COLI; ATP SYNTHASE; HEART-MITOCHONDRIA; BARTH-SYNDROME; CYTOCHROME-C; CELL-CULTURE; COMPLEX; GROWTH; EXPRESSION	The mitochondrial inner membrane glycerophospholipid cardiolipin (CL) associates with mitochondrial proteins to regulate their activities and facilitate protein complex and supercomplex formation. Loss of CL leads to destabilized respiratory complexes and mitochondrial dysfunction. The role of CL in an organism lacking a conventional electron transport chain (ETC) has not been elucidated. Trypanosoma brucei bloodstream forms use an unconventional ETC composed of glycerol-3-phosphate dehydrogenase and alternative oxidase (AOX), while the mitochondrial membrane potential (Delta psi m) is generated by the hydrolytic action of the FoF1-ATP synthase (aka FoF1-ATPase). We now report that the inducible depletion of cardiolipin synthase (TbCls) is essential for survival of T brucei bloodstream forms. Loss of CL caused a rapid drop in ATP levels and a decline in the Delta psi m. Unbiased proteomic analyses revealed a reduction in the levels of many mitochondrial proteins, most notably of FoF1-ATPase subunits and AOX, resulting in a strong decline of glycerol-3-phosphate-stimulated oxygen consumption. The changes in cellular respiration preceded the observed decrease in FoF1-ATPase stability, suggesting that the AOX-mediated ETC is the first pathway responding to the decline in CL. Select proteins and pathways involved in glucose and amino acid metabolism were upregulated to counteract the CL depletion-induced drop in cellular ATP.	[Serricchio, Mauro; Schadeli, David; Butikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland; [Hierro-Yap, Carolina; Zikova, Alena] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Hierro-Yap, Carolina; Zikova, Alena] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Schadeli, David] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Ben Hamidane, Hisham; Graumann, Johannes] Weill Cornell Med Qatar, Doha, Qatar; [Hemphill, Andrew] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Graumann, Johannes] Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany	University of Bern; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Bern; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Bern; Max Planck Society	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.; Zikova, A (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.	azikova@paru.cas.cz; peter.buetikofer@ibmm.unibe.ch	Zikova, Alena/G-7855-2014	Zikova, Alena/0000-0002-8686-0225; Hemphill, Andrew/0000-0002-0622-2128; Serricchio, Mauro/0000-0002-7094-9807	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF) [169355]; Czech Science Foundation [18-17529S]; ERD fund [CZ.02.1.01/0.0/0.0/1 6_019/0000759]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF); Czech Science Foundation(Grant Agency of the Czech Republic); ERD fund	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 169355; Czech Science Foundation, Grant/Award Number: 18-17529S; ERD fund, Grant/Award Number: CZ.02.1.01/0.0/0.0/1 6_019/0000759	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Baker N, 2015, P NATL ACAD SCI USA, V112, P9112, DOI 10.1073/pnas.1505411112; Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; BELEZNAI Z, 1989, BIOCHEM BIOPH RES CO, V159, P132, DOI 10.1016/0006-291X(89)92414-5; Beltran-Heredia E, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0471-x; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Cade WT, 2013, J INHERIT METAB DIS, V36, P91, DOI 10.1007/s10545-012-9486-x; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Cirovic O, 2014, METHODS MOL BIOL, V1188, P47, DOI 10.1007/978-1-4939-1142-4_4; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Gahura O, 2018, FEBS J, V285, P614, DOI 10.1111/febs.14364; Gloaguen Y, 2017, BIOINFORMATICS, V33, P4007, DOI 10.1093/bioinformatics/btx499; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Intlekofer AM, 2017, NAT CHEM BIOL, V13, P494, DOI [10.1038/NCHEMBIO.2307, 10.1038/nchembio.2307]; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; Johnston K, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181601; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kovarova J, 2016, TRENDS PARASITOL, V32, P622, DOI 10.1016/j.pt.2016.04.010; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Li YR, 2019, J BIOL CHEM, V294, P11568, DOI 10.1074/jbc.RA119.009037; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Muhleip A, 2019, ELIFE, V8, DOI 10.7554/eLife.51179; Nejad LD, 2018, MOL MICROBIOL, V109, P105, DOI 10.1111/mmi.13976; NISHIJIMA S, 1988, J BACTERIOL, V170, P775, DOI 10.1128/jb.170.2.775-780.1988; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P29, DOI 10.1111/j.1432-1033.1977.tb11567.x; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Paradies G, 1997, BBA-MOL BASIS DIS, V1362, P193, DOI 10.1016/S0925-4439(97)00075-6; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Raemy E, 2016, CELL DEATH DIFFER, V23, P1165, DOI 10.1038/cdd.2015.166; Raja V, 2019, BBA-MOL CELL BIOL L, V1864, P654, DOI 10.1016/j.bbalip.2019.02.001; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Santucci R, 2019, INT J BIOL MACROMOL, V136, P1237, DOI 10.1016/j.ijbiomac.2019.06.180; Schadeli D, 2019, FASEB J, V33, P13161, DOI 10.1096/fj.201901184RR; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shah TD, 2011, MOL BIOCHEM PARASIT, V179, P100, DOI 10.1016/j.molbiopara.2011.07.001; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Smith Terry K, 2017, F1000Res, V6, DOI 10.12688/f1000research.10342.2; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; Zikova A, 2016, MOL BIOCHEM PARASIT, V209, P46, DOI 10.1016/j.molbiopara.2016.02.007	77	8	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001579RR	http://dx.doi.org/10.1096/fj.202001579RR		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184899				2022-12-28	WOS:000590888700001
J	Yamamoto, A; Morioki, H; Nakae, T; Miyake, Y; Harada, T; Noda, S; Mitsuoka, S; Matsumoto, K; Tomimatsu, M; Kanemoto, S; Tanaka, S; Maeda, M; Conway, SJ; Imaizumi, K; Fujio, Y; Obana, M				Yamamoto, Ayaha; Morioki, Hitomi; Nakae, Takafumi; Miyake, Yoshiaki; Harada, Takeo; Noda, Shunsuke; Mitsuoka, Sayuri; Matsumoto, Kotaro; Tomimatsu, Masashi; Kanemoto, Soshi; Tanaka, Shota; Maeda, Makiko; Conway, Simon J.; Imaizumi, Kazunori; Fujio, Yasushi; Obana, Masanori			Transcription factor old astrocyte specifically induced substance is a novel regulator of kidney fibrosis	FASEB JOURNAL			English	Article						chronic kidney disease; fibrosis; myofibroblast; transcription regulation	RENAL FIBROBLAST ACTIVATION; EXPRESSION; OASIS; MYOFIBROBLASTS; OASIS/CREB3L1; METASTASIS; TRANSDUCER; MECHANISMS; INHIBITION; MIGRATION	Prevention of kidney fibrosis is an essential requisite for effective therapy in preventing chronic kidney disease (CKD). Here, we identify Old astrocyte specifically induced substance (OASIS)/cAMP responsive element-binding protein 3-like 1 (CREB3l1), a CREB/ATF family transcription factor, as a candidate profibrotic gene that drives the final common pathological step along the fibrotic pathway in CKD. Although microarray data from diseased patient kidneys and fibrotic mouse model kidneys both exhibit OASIS/Creb3l1 upregulation, the pathophysiological roles of OASIS in CKD remains unknown. Immunohistochemistry revealed that OASIS protein was overexpressed in human fibrotic kidney compared with normal kidney. Moreover, OASIS was upregulated in murine fibrotic kidneys, following unilateral ureteral obstruction (UUO), resulting in an increase in the number of OASIS-expressing pathological myofibroblasts. In vitro assays revealed exogenous TGF-beta 1 increased OASIS expression coincident with fibroblast-to-myofibroblast transition and OASIS contributed to TGF-beta 1-mediated myofibroblast migration and increased proliferation. Significantly, in vivo kidney fibrosis induced via UUO or ischemia/reperfusion injury was ameliorated by systemic genetic knockout of OASIS, accompanied by reduced myofibroblast proliferation. Microarrays revealed that the transmembrane glycoprotein Bone marrow stromal antigen 2 (Bst2) expression was reduced in OASIS knockout myofibroblasts. Interestingly, a systemic anti-Bst2 blocking antibody approach attenuated kidney fibrosis in normal mice but not in OASIS knockout mice after UUO, signifying Bst2 functions downstream of OASIS. Finally, myofibroblast-restricted OASIS conditional knockouts resulted in resistance to kidney fibrosis. Taken together, OASIS in myofibroblasts promotes kidney fibrosis, at least in part, via increased Bst2 expression. Thus, we have identified and demonstrated that OASIS signaling is a novel regulator of kidney fibrosis.	[Yamamoto, Ayaha; Morioki, Hitomi; Nakae, Takafumi; Miyake, Yoshiaki; Harada, Takeo; Noda, Shunsuke; Mitsuoka, Sayuri; Matsumoto, Kotaro; Tomimatsu, Masashi; Tanaka, Shota; Fujio, Yasushi; Obana, Masanori] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Sci & Biomed, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan; [Kanemoto, Soshi] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Asahikawa, Hokkaido, Japan; [Maeda, Makiko; Fujio, Yasushi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Pharmacol & Therapeut, Suita, Osaka, Japan; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Imaizumi, Kazunori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan; [Fujio, Yasushi; Obana, Masanori] Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan; [Obana, Masanori] Osaka Univ, Inst Radiat Sci, Radioisotope Res Ctr, Suita, Osaka, Japan	Osaka University; Asahikawa Medical College; Osaka University; Indiana University System; Indiana University Bloomington; Hiroshima University; Osaka University; Osaka University	Obana, M (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Sci & Biomed, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.; Obana, M (corresponding author), Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan.	obana@phs.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017	Fujio, Yasushi/0000-0003-0828-2930	MEXT \ Japan Society for the Promotion of Science (JSPS) [18K15027, 18H02603, 18K19545]; HHS <INF>\</INF> National Institutes of Health (NIH) [R01 HL148165]; Takeda Science Foundation; Japanese Association of Dialysis Physicians (JAPD); Japan Agency for Medical Research and Development (AMED) [JP20am0101084]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); HHS <INF>\</INF> National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Association of Dialysis Physicians (JAPD); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18K15027, 18H02603 and 18K19545; HHS | National Institutes of Health (NIH), Grant/Award Number: R01 HL148165; Takeda Science Foundation; Japanese Association of Dialysis Physicians (JAPD); Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20am010104	Abulizi P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00902-5; [Anonymous], 2014, PLOS ONE; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bego MG, 2012, J VIROL, V86, P3513, DOI 10.1128/JVI.06971-11; Carthy JM, 2015, J CELL PHYSIOL, V230, P3084, DOI 10.1002/jcp.25049; Chiang CK, 2011, MOL MED, V17, P1295, DOI 10.2119/molmed.2011.00131; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Cui M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16455; Deng H, 2019, SCI REP, V9, P1; Di J, 2014, CELL PHYSIOL BIOCHEM, V34, P1063, DOI 10.1159/000366321; Eddy AA, 2013, NAT MED, V19, P964, DOI 10.1038/nm.3299; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Feng YX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01052-y; Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; GOTO T, 1994, BLOOD, V84, P1922; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Gu GP, 2012, J CELL BIOCHEM, V113, P1013, DOI 10.1002/jcb.23433; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Imaeda A, 2019, BIOCHEM BIOPH RES CO, V510, P149, DOI 10.1016/j.bbrc.2019.01.070; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kanemoto S, 2015, J CELL SCI, V128, P4353, DOI 10.1242/jcs.176057; Kanno Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05967; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kim JY, 2018, CELL, V175, P133, DOI 10.1016/j.cell.2018.08.020; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Lindahl K, 2018, BONE, V114, P268, DOI 10.1016/j.bone.2018.06.019; Liu WY, 2018, BIOTECHNOL LETT, V40, P1015, DOI 10.1007/s10529-018-2562-z; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mellor P, 2013, MOL CELL BIOL, V33, P4985, DOI 10.1128/MCB.00959-13; Moll S, 2014, EXPERT OPIN DRUG DIS, V9, P1471, DOI 10.1517/17460441.2014.956075; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Rose M, 2014, EPIGENETICS-US, V9, P1626, DOI 10.4161/15592294.2014.988052; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Suchanski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184970; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Vellanki RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054060; Vellanki RN, 2010, ENDOCRINOLOGY, V151, P4146, DOI 10.1210/en.2010-0137; Wang HJ, 2017, J PHARMACOL SCI, V133, P203, DOI 10.1016/j.jphs.2016.12.005; Ward AK, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0672-x; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25272	54	9	9	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001820R	http://dx.doi.org/10.1096/fj.202001820R		NOV 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33150680	Green Published, hybrid			2022-12-28	WOS:000589711000001
J	Cubillos-Zapata, C; Martinez-Garcia, MA; Diaz-Garcia, E; Toledano, V; Campos-Rodriguez, F; Sanchez-de-la-Torre, M; Nagore, E; Martorell-Calatayud, A; Blasco, LH; Pastor, E; Abad-Capa, J; Montserrat, JM; Cabriada-Nuno, V; Cano-Pumarega, I; Corral-Penafiel, J; Arias, E; Mediano, O; Somoza-Gonzalez, M; Dalmau-Arias, J; Almendros, I; Farre, R; Lopez-Collazo, E; Gozal, D; Garcia-Rio, F				Cubillos-Zapata, Carolina; Martinez-Garcia, Miguel Angel; Diaz-Garcia, Elena; Toledano, Victor; Campos-Rodriguez, Francisco; Sanchez-de-la-Torre, Manuel; Nagore, Eduardo; Martorell-Calatayud, Antonio; Hernandez Blasco, Luis; Pastor, Esther; Abad-Capa, Jorge; Montserrat, Josep Maria; Cabriada-Nuno, Valentin; Cano-Pumarega, Irene; Corral-Penafiel, Jaime; Arias, Eva; Mediano, Olga; Somoza-Gonzalez, Maria; Dalmau-Arias, Joan; Almendros, Isaac; Farre, Ramon; Lopez-Collazo, Eduardo; Gozal, David; Garcia-Rio, Francisco		Spanish Sleep Network	Proangiogenic factor midkine is increased in melanoma patients with sleep apnea and induces tumor cell proliferation	FASEB JOURNAL			English	Article						aggressiveness; intermittent hypoxia; lymphangiogenesis; melanoma; sleep apnea	INTERMITTENT HYPOXIA; GROWTH-FACTOR; MOUSE MODEL; CANCER; ACTIVATION; VEGF; ASSOCIATION; EXPRESSION; APOPTOSIS; PROTEIN	Midkine (MDK) might mediate the proangiogenic effect of intermittent hypoxia (IH) in patients with obstructive sleep apnea (OSA) and cutaneous melanoma (CM). We compare circulating MDK in CM patients with and without OSA, and their relationship with tumor aggressiveness, while exploring in vitro effects of soluble MDK on human lymphatic endothelial (HLEC) and melanoma cell proliferation. In 360 CM patients, sleep studies and MDK serum level measurements were performed. The effect of MDK on cell proliferation was assessed using HLEC and melanoma cell lines with patient sera under both normoxia and IH. MDK levels were higher in severe OSA compared to mild OSA or non-OSA patients, whereas no differences in VEGF levels emerged. In OSA patients, MDK levels correlated with nocturnal hypoxemia and CM mitotic rate. In vitro, MDK promotes HLEC proliferation under IH conditions. Moreover, cultures of the human melanoma cell line C81-61 with sera from patients with the highest MDK levels promoted tumor cell proliferation, which was attenuated after the addition of MDK antibody. These responses were enhanced by IH exposures. In conclusion, in CM patients, OSA severity is associated with higher MDK levels, which, appear to enhance both the lymphangiogenesis as the intrinsic aggressiveness of CM tumor cells.	[Cubillos-Zapata, Carolina; Diaz-Garcia, Elena; Garcia-Rio, Francisco] Hosp Univ La Paz IdiPAZ, Grp Enfermedades Resp, Serv Neumol, Madrid, Spain; [Cubillos-Zapata, Carolina; Diaz-Garcia, Elena; Toledano, Victor; Campos-Rodriguez, Francisco; Sanchez-de-la-Torre, Manuel; Abad-Capa, Jorge; Montserrat, Josep Maria; Corral-Penafiel, Jaime; Mediano, Olga; Almendros, Isaac; Farre, Ramon; Lopez-Collazo, Eduardo; Garcia-Rio, Francisco] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Martinez-Garcia, Miguel Angel] Hosp Univ & Politecn La Fe, Resp Dept, Valencia, Spain; [Toledano, Victor; Lopez-Collazo, Eduardo] TumorImmunol Lab IdiPAZ, Madrid, Spain; [Sanchez-de-la-Torre, Manuel; Lopez-Collazo, Eduardo] Hosp Univ Arnau Vilanova & Santa Maria, IRBLleida, Grp Precis Med Chron Dis, Lleida, Spain; [Nagore, Eduardo] Inst Valenciano Oncol, Dermatol Dept, Valencia, Spain; [Martorell-Calatayud, Antonio] Hosp Manises, Dermatol Dept, Valencia, Spain; [Hernandez Blasco, Luis] Hosp Gen Univ Alicante, ISABIAL, Resp Dept, Alicante, Spain; [Hernandez Blasco, Luis] Univ Miguel Hernandez, Dept Med Clin, Elche, Spain; [Pastor, Esther] Hosp San Juan Alicante, Resp Dept, Alicante, Spain; [Abad-Capa, Jorge] Hosp Badalona Germans Trias & Pujol, Ctr Invest Biomed, Resp Dept, Madrid, Spain; [Montserrat, Josep Maria] Hosp Clin IDIBAPS, Resp Dept, Barcelona, Spain; [Cabriada-Nuno, Valentin] Hosp Univ Cruces, Resp Dept, Bilbao, Spain; [Cano-Pumarega, Irene; Corral-Penafiel, Jaime] Hosp Univ Ramon & Cajal, Resp Dept, Madrid, Spain; [Corral-Penafiel, Jaime] Hosp Univ S Pedro Alcantara, Resp Dept, Caceres, Spain; [Arias, Eva] Hosp 12 Octubre, Resp Dept, Madrid, Spain; [Mediano, Olga] Hosp Univ Guadalajara, Resp Dept, Guadalajara, Spain; [Somoza-Gonzalez, Maria] Hosp Consorcio Terrassa, Pneumol Dept, Barcelona, Spain; [Dalmau-Arias, Joan] Hosp Santa Creu & Sant Pau, Dermatol Dept, Barcelona, Spain; [Almendros, Isaac; Farre, Ramon] Univ Barcelona, Fac Med & Ciencies Salut, Unitat Biofis & Bioengn, Barcelona, Spain; [Almendros, Isaac; Farre, Ramon] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Gozal, David] Univ Missouri, Sch Med, Dept Child Hlth, Columbiaville, MI USA; [Garcia-Rio, Francisco] Univ Autonoma Madrid, Fac Med, Madrid, Spain	Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitari i Politecnic La Fe; University Hospital Arnau de Vilanova; Instituto Valenciano De Oncologia; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); Universidad Miguel Hernandez de Elche; Hospital Germans Trias i Pujol; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitario Cruces; Hospital Universitario Ramon y Cajal; Hospital Universitario 12 de Octubre; Hospital of Santa Creu i Sant Pau; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Missouri System; University of Missouri Columbia; Autonomous University of Madrid	Garcia-Rio, F (corresponding author), Hosp Univ La Paz, IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain.	fgr01m@gmail.com	Mediano, Olga/AAZ-2784-2021; Barbé, Ferran/A-5988-2010; Gozal, David/ABH-3805-2020; Zapata, Carolina Cubillos/H-3058-2017; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Lopez-Collazo, Eduardo/U-6634-2018; Farre, Ramon/L-2664-2017	Mediano, Olga/0000-0001-7824-1523; Barbé, Ferran/0000-0002-2340-8928; Zapata, Carolina Cubillos/0000-0002-1948-4514; Martinez-Garcia, Miguel Angel/0000-0002-7321-1891; Lopez-Collazo, Eduardo/0000-0003-1957-877X; Martorell, Antonio/0000-0003-1378-1590; Cano-Pumarega, Irene/0000-0003-1543-7187; Diaz Garcia, Elena/0000-0002-4549-0678; Farre, Ramon/0000-0002-9084-7824; Nagore, Eduardo/0000-0003-3433-8707	Fondo de Investigacion SanitariaFondos FEDER [PI13/01512, PI16/00201, PI14/01234, PIE15/00065, PI16/01772]; National Institutes of Health (NIH) [HL130984, HL140548]	Fondo de Investigacion SanitariaFondos FEDER; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Fondo de Investigacion SanitariaFondos FEDER, Grant/Award Number: PI13/01512, PI16/00201, PI14/01234, PIE15/00065 and PI16/01772; HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: HL130984 and HL140548	Almendros I, 2012, EUR RESPIR J, V39, P215, DOI 10.1183/09031936.00185110; Almendros I, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00272; Almendros I, 2014, AM J RESP CRIT CARE, V189, P593, DOI 10.1164/rccm.201310-1830OC; Martinez-Garcia MA, 2019, AM J RESP CRIT CARE, V200, P1345, DOI 10.1164/rccm.201903-0577PP; Martinez-Garcia MA, 2018, CHEST, V154, P1348, DOI 10.1016/j.chest.2018.07.015; Martinez-Garcia MA, 2017, MELANOMA RES, V27, P558, DOI 10.1097/CMR.0000000000000393; Martinez-Garcia MA, 2016, CHEST, V150, P451, DOI 10.1016/j.chest.2016.04.029; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Cubillos-Zapata C, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01298-2018; Cubillos-Zapata C, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7373921; Cubillos-Zapata C, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00833-2017; Dimitriou F, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0732-8; GARVER RI, 1994, CANCER, V74, P1584, DOI 10.1002/1097-0142(19940901)74:5<1584::AID-CNCR2820740514>3.0.CO;2-V; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Gozal D, 2002, SLEEP, V25, P59, DOI 10.1093/sleep/25.1.59; Gozal D, 2017, AM J RESP CELL MOL, V56, P477, DOI 10.1165/rcmb.2016-0243OC; Gozal D, 2016, SLEEP, V39, P1493, DOI 10.5665/sleep.6004; Gozal D, 2015, CHEST, V148, P1140, DOI 10.1378/chest.15-0634; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018936; Hernandez-Jimenez E, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02456-2016; Ikematsu S, 2008, CANCER SCI, V99, P2070, DOI 10.1111/j.1349-7006.2008.00957.x; Itzhaki O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057160; Kerzerho J, 2010, J IMMUNOL, V185, P418, DOI 10.4049/jimmunol.0901014; Krzystek-Korpacka M, 2007, CLIN BIOCHEM, V40, P1353, DOI 10.1016/j.clinbiochem.2007.07.013; Lee SH, 2012, J CELL PHYSIOL, V227, P1731, DOI 10.1002/jcp.22897; Li L, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0727-x; Lloberes P, 2011, ARCH BRONCONEUMOL, V47, P143, DOI 10.1016/j.arbres.2011.01.001; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1661, DOI 10.1183/09031936.00115413; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Muramatsu H, 1996, J BIOCHEM-TOKYO, V119, P1171; Nakamura E, 1998, GENES CELLS, V3, P811, DOI 10.1046/j.1365-2443.1998.00231.x; Olmeda D, 2017, NATURE, V546, P676, DOI 10.1038/nature22977; Owada K, 1999, J NEUROCHEM, V73, P2084; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Reynolds PR, 2004, J BIOL CHEM, V279, P37124, DOI 10.1074/jbc.M405254200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ryan Silke, 2008, Archives of Physiology and Biochemistry, V114, P261, DOI [10.1080/13813450802307337, 10.1080/13813450802307337 ]; Santamaria-Martos F, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01885-2017; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Takei Y, 2001, CANCER RES, V61, P8486; TOMOMURA M, 1990, J BIOL CHEM, V265, P10765; Wang QL, 2007, J BIOMED SCI, V14, P783, DOI 10.1007/s11373-007-9192-0; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; You ZB, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-6; Zimna A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/549412	46	6	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16179	16190		10.1096/fj.202001247RR	http://dx.doi.org/10.1096/fj.202001247RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058223				2022-12-28	WOS:000581157200001
J	Li, H; Chang, HM; Shi, ZD; Leung, PCK				Li, Hui; Chang, Hsun-Ming; Shi, Zhendan; Leung, Peter C. K.			The p38 signaling pathway mediates the TGF-beta 1-induced increase in type I collagen deposition in human granulosa cells	FASEB JOURNAL			English	Article						ALK5; human granulosa cell; p38; TGF-beta 1; Type I collagen	GROWTH-FACTOR-BETA; FOLLICLE-STIMULATING-HORMONE; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; PROGESTERONE PRODUCTION; GENE-EXPRESSION; CONNEXIN43 EXPRESSION; OVARIAN TISSUE; CORPUS-LUTEUM	Type I collagen, which is mainly composed of collagen type I alpha 1 chain (COL1A1), is the most abundant extracellular matrix (ECM) protein in the mammalian ovary; and the cyclical remodeling of the ECM plays an essential role in the regulation of corpus luteum formation. Our previous studies have demonstrated that TGF-beta 1 is a potent inhibitor of luteinization in human granulosa-lutein (hGL) cells. Whether TGF-beta 1 can regulate the expression of COL1A1 during the luteal phase remains to be elucidated. The aim of this study was to investigate the effect of TGF-beta 1 on the regulation of COL1A1 expression and the underlying molecular mechanisms using an immortalized hGL cell line (SVOG cells) and primary hGL cells (obtained from 20 consenting patients undergoing IVF treatment). The results showed that TGF-beta 1 significantly upregulated the expression of COL1A1. Using inhibition approaches, including pharmacological inhibition (a specific p38 inhibitor, SB203580, and a specific ERK1/2 inhibitor, U0126) and specific siRNA-mediated knockdown inhibition, we demonstrated that TGF-beta 1 promoted the expression and production of COL1A1 in hGL cells, most likely via the ALK5-mediated p38 signaling pathway. Our findings provide insights into the molecular mechanisms by which TGF-beta 1 promotes the deposition of type I collagen during the late follicular phase in humans.	[Li, Hui; Shi, Zhendan] Jiangsu Acad Agr Sci, Jiangsu Key Lab Food Qual & Safety, Minist Sci & Technol, State Key Lab Cultivat Base, Nanjing, Peoples R China; [Li, Hui; Shi, Zhendan] Jiangsu Acad Agr Sci, Inst Anim Sci, Key Lab Anim Breeding & Reprod, Nanjing, Peoples R China; [Li, Hui; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp, Dept Obstet & Gynaecol, Res Inst, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada	Jiangsu Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; BC Childrens Hospital; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp, Dept Obstet & Gynaecol, Res Inst, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca	Shi, Zhendan/AAA-4889-2021	Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research Foundation Scheme Grant [143317]	Canadian Institutes of Health Research Foundation Scheme Grant(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research Foundation Scheme Grant (#143317) to PCKL	Akhmanova M, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/167025; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bagavandoss P, 2014, ACTA HISTOCHEM, V116, P1125, DOI 10.1016/j.acthis.2014.05.007; Bai L, 2018, MOL CELL ENDOCRINOL, V461, P89, DOI 10.1016/j.mce.2017.08.018; Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1; Casey OM, 2005, THERIOGENOLOGY, V64, P1963, DOI 10.1016/j.theriogenology.2005.04.015; Chang HM, 2017, HUM REPROD UPDATE, V23, P1, DOI 10.1093/humupd/dmw039; Chang HM, 2016, FERTIL STERIL, V105, P520, DOI 10.1016/j.fertnstert.2015.10.034; Chang HM, 2013, FERTIL STERIL, V100, P585, DOI 10.1016/j.fertnstert.2013.04.019; Chang SW, 2012, BIOPHYS J, V102, P640, DOI 10.1016/j.bpj.2011.11.3999; CHEGINI N, 1992, ENDOCRINOLOGY, V130, P1707, DOI 10.1210/en.130.3.1707; Chen YC, 2015, HUM REPROD, V30, P2190, DOI 10.1093/humrep/dev175; Cheng JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117940; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; Fang LL, 2014, J CLIN ENDOCR METAB, V99, pE1217, DOI 10.1210/jc.2013-4100; Fang LL, 2014, J CLIN ENDOCR METAB, V99, pE2234, DOI 10.1210/jc.2014-1930; Fang Y, 2016, REPRODUCTION, V152, P205, DOI 10.1530/REP-16-0144; Favero PF, 2019, BIOCHEM BIOPH RES CO, V516, P888, DOI 10.1016/j.bbrc.2019.06.002; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fried G, 1998, HUM REPROD, V13, P656, DOI 10.1093/humrep/13.3.656; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; He T, 2015, CELL PHYSIOL BIOCHEM, V37, P666, DOI 10.1159/000430385; HIRSCH B, 1993, ENDOCRINOLOGY, V133, P2761, DOI 10.1210/en.133.6.2761; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; Huet C, 2001, J ENDOCRINOL, V169, P347, DOI 10.1677/joe.0.1690347; Irani M, 2015, J CLIN ENDOCR METAB, V100, P4307, DOI 10.1210/jc.2015-2580; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; KRIEGLSTEIN K, 1995, INT J DEV NEUROSCI, V13, P301, DOI 10.1016/0736-5748(94)00062-8; Kristensen SG, 2014, MOL HUM REPROD, V20, P293, DOI 10.1093/molehr/gat089; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Li H, 2018, ENDOCRINOLOGY, V159, P1644, DOI 10.1210/en.2017-03127; Liao JH, 2001, CELL RES, V11, P89, DOI 10.1038/sj.cr.7290072; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Lind AK, 2006, ACTA OBSTET GYN SCAN, V85, P1476, DOI 10.1080/00016340601033741; Liu MM, 2015, CLIN ENDOCRINOL, V83, P913, DOI 10.1111/cen.12951; Liu SX, 2018, ELIFE, V7, DOI 10.7554/eLife.26947; Maroni D, 2011, J CELL SCI, V124, P2501, DOI 10.1242/jcs.084558; MORALES TI, 1983, BIOCHIM BIOPHYS ACTA, V756, P119, DOI 10.1016/0304-4165(83)90031-4; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Pahar B, 2015, CLIN IMMUNOL, V158, P8, DOI 10.1016/j.clim.2015.03.001; Pangas SA, 2006, MOL ENDOCRINOL, V20, P1406, DOI 10.1210/me.2005-0462; Raja-Khan N, 2014, REPROD SCI, V21, P20, DOI 10.1177/1933719113485294; Raja-Khan N, 2010, FERTIL STERIL, V94, P2916, DOI 10.1016/j.fertnstert.2010.05.047; REICH R, 1991, ENDOCRINOLOGY, V129, P1869, DOI 10.1210/endo-129-4-1869; Rodgers RJ, 1999, J REPROD FERTIL, P343; Rodriguez-Garcia A, 2017, FEBS J, V284, P3437, DOI 10.1111/febs.14201; Roy SK, 1998, MOL HUM REPROD, V4, P207, DOI 10.1093/molehr/4.3.207; Seki T, 2006, LAB INVEST, V86, P116, DOI 10.1038/labinvest.3700376; Smith MF, 2002, MOL CELL ENDOCRINOL, V191, P45, DOI 10.1016/S0303-7207(02)00054-0; Tal R, 2013, FERTIL STERIL, V100, P538, DOI 10.1016/j.fertnstert.2013.04.022; Vonnahme KA, 2006, REPRODUCTION, V131, P1115, DOI 10.1530/rep.1.01062; Wang X, 2000, ARCH BIOCHEM BIOPHYS, V376, P117, DOI 10.1006/abbi.1999.1688; Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818; Wu YT, 2017, MOL HUM REPROD, V23, P155, DOI 10.1093/molehr/gaw078; Yang YX, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.340.5470; Zhang Y., 2017, WILEY INTERDISCIP RE, V9, pe1420; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng XF, 2009, REPRODUCTION, V137, P969, DOI 10.1530/REP-08-0365	62	3	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15591	15604		10.1096/fj.202001377R	http://dx.doi.org/10.1096/fj.202001377R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32996643				2022-12-28	WOS:000574658800001
J	Li, F; Xu, RJ; Lin, CL; Low, BE; Cai, L; Li, S; Ji, P; Huang, LQ; Wiles, MV; Hannun, YA; Obeid, LM; Chen, Y; Mao, CG				Li, Fang; Xu, Ruijuan; Lin, Chih-Li; Low, Benjamin E.; Cai, Louise; Li, Sally; Ji, Ping; Huang, Liqun; Wiles, Michael V.; Hannun, Yusuf A.; Obeid, Lina M.; Chen, Ye; Mao, Cungui			Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice	FASEB JOURNAL			English	Article						ACER2; ceramidase; placenta; sphingosine; sphingosine-1-phosphate; vasculature	PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; SPHINGOLIPID METABOLISM; CELL-PROLIFERATION; SPHINGOSINE-1-PHOSPHATE; EDG-1; ANGIOGENESIS; INVOLVEMENT; INHIBITION; EXPRESSION	Sphingolipids have been implicated in mammalian placental development and function, but their regulation in the placenta remains unclear. Herein we report that alkaline ceramidase 2 (ACER2) plays a key role in sustaining the integrity of the placental vasculature by regulating the homeostasis of sphingolipids in mice. The mouse alkaline ceramidase 2 gene (Acer2) is highly expressed in the placenta between embryonic day (E) 9.5 and E12.5.Acer2deficiency in both the mother and fetus decreases the placental levels of sphingolipids, including sphingoid bases (sphingosine and dihydrosphingosine) and sphingoid base-1-phosphates (sphingosine-1-phosphate and dihydrosphingosine-1-phosphate) and results in thein uterodeath of approximate to 50% of embryos at E12.5 whereasAcer2deficiency in either the mother or fetus has no such effects.Acer2deficiency causes hemorrhages from the maternal vasculature in the junctional and/or labyrinthine zones in E12.5 placentas. Moreover, hemorrhagic but not non-hemorrhagicAcer2-deficient placentas exhibit an expansion of parietal trophoblast giant cells with a concomitant decrease in the area of the fetal blood vessel network in the labyrinthine zone, suggesting thatAcer2deficiency results in embryonic lethality due to the atrophy of the fetal blood vessel network in the placenta. Taken together, these results suggest that ACER2 sustains the integrity of the placental vasculature by controlling the homeostasis of sphingolipids in mice.	[Li, Fang; Xu, Ruijuan; Lin, Chih-Li; Ji, Ping; Huang, Liqun; Hannun, Yusuf A.; Obeid, Lina M.; Mao, Cungui] SUNY Stony Brook, Dept Med, 9M0834,MART Bldg, Stony Brook, NY 11794 USA; [Li, Fang; Xu, Ruijuan; Lin, Chih-Li; Cai, Louise; Li, Sally; Hannun, Yusuf A.; Obeid, Lina M.; Mao, Cungui] SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA; [Li, Fang; Chen, Ye] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Dept Gastroenterol,State Key Lab Organ Failure Re, 1838 North Guangzhou Rd, Guangzhou 510515, Guangdong, Peoples R China; [Low, Benjamin E.; Wiles, Michael V.] Jackson Lab, Technol Evaluat & Dev, 600 Main St, Bar Harbor, ME 04609 USA; [Obeid, Lina M.] Ralph H Johnson Vet Adm Hosp, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Southern Medical University - China; Jackson Laboratory; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), SUNY Stony Brook, Dept Med, 9M0834,MART Bldg, Stony Brook, NY 11794 USA.; Chen, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Dept Gastroenterol,State Key Lab Organ Failure Re, 1838 North Guangzhou Rd, Guangzhou 510515, Guangdong, Peoples R China.	yechen@smu.edu.cn; cungui.mao@stonybrook.edu	xu, rui/GRX-5734-2022	wiles, michael/0000-0002-3620-8386	National Institutes of Health [R01CA163825, P01CA097132]; National Natural Science Foundation of China [81770529]; Guangdong Gastrointestinal Disease Research Center [2017B020209003]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Gastrointestinal Disease Research Center	National Institutes of Health, Grant/Award Number: R01CA163825 and P01CA097132; National Natural Science Foundation of China, Grant/Award Number: 81770529; The Guangdong Gastrointestinal Disease Research Center, Grant/Award Number: 2017B020209003	Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Ben Shoham A, 2012, DEVELOPMENT, V139, P3859, DOI 10.1242/dev.078550; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Chauvin S, 2015, J CLIN ENDOCR METAB, V100, pE986, DOI 10.1210/jc.2015-1288; Clay H, 2016, DEV BIOL, V418, P157, DOI 10.1016/j.ydbio.2016.06.024; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Coant Nicolas, 2017, Advances in Biological Regulation, V63, P122, DOI 10.1016/j.jbior.2016.10.002; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Del Gaudio I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031019; Del Gaudio I, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158632; Ding NZ, 2018, THERIOGENOLOGY, V106, P227, DOI 10.1016/j.theriogenology.2017.09.036; Edsall LC, 1997, J NEUROSCI, V17, P6952; Hemberger M, 2020, NAT REV GENET, V21, P27, DOI 10.1038/s41576-019-0169-4; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Ko P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21564; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li F, 2018, FASEB J, V32; Li F, 2018, FASEB J, V32, P3058, DOI 10.1096/fj.201700445RR; Lin CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118473; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Mizugishi K, 2015, J BIOL CHEM, V290, P2053, DOI 10.1074/jbc.M114.628867; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Park SW, 2010, LAB INVEST, V90, P1209, DOI 10.1038/labinvest.2010.102; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005591; Westwood M, 2017, PLACENTA, V60, P1, DOI 10.1016/j.placenta.2017.09.009; Wiltshire R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19814; Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Xu RJ, 2018, CELL DEATH DIFFER, V25, P841, DOI 10.1038/s41418-017-0018-y; Xu RJ, 2016, ONCOTARGET, V7, P18440, DOI 10.18632/oncotarget.7825; Xu RJ, 2010, FASEB J, V24, P2507, DOI 10.1096/fj.09-153635; Yang WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106725; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	51	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15252	15268		10.1096/fj.202001104R	http://dx.doi.org/10.1096/fj.202001104R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959379	Green Accepted			2022-12-28	WOS:000573861600001
J	Manti, M; Pui, HP; Edstrom, S; Risal, S; Lu, HJ; Lindgren, E; Ohlsson, C; Jerlhag, E; Benrick, A; Deng, QL; Stener-Victorin, E				Manti, Maria; Pui, Han-Pin; Edstrom, Sonja; Risal, Sanjiv; Lu, Haojiang; Lindgren, Eva; Ohlsson, Claes; Jerlhag, Elisabet; Benrick, Anna; Deng, Qiaolin; Stener-Victorin, Elisabet			Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice	FASEB JOURNAL			English	Article						adipose tissue; imprinting; polycystic ovary syndrome; sex steroids; sympathetic activity	POLYCYSTIC-OVARY; BIRTH-WEIGHT; FOLLICULAR DEVELOPMENT; TRANSGENIC MICE; ADIPOSE-TISSUE; MOUSE; GENE; OBESITY; RISK; FOLLICULOGENESIS	Nerve growth factor (NGF) is critical for the development and maintenance of the peripheral sympathetic neurons. NGF is also involved in the ovarian sympathetic innervation and in the development and maintenance of folliculogenesis. Women with the endocrine disorder, polycystic ovary syndrome (PCOS), have an increased sympathetic nerve activity and increased ovarian NGF levels. The role of ovarian NGF excess in the PCOS pathophysiology and in the PCOS-related features is unclear. Here, using transgenic mice overexpressesing NGF in the ovarian theca cells (17NF mice), we assessed the female embryonic development, and the reproductive and metabolic profile in adult females. Ovarian NGF excess caused growth restriction in the female fetuses, and a delayed gonocyte and primary oocyte maturation. In adulthood, the 17NF mice displayed irregular estrous cycles and altered ovarian expression of steroidogenic and epigenetic markers. They also exhibited an increased sympathetic output with increased circulating dopamine, and metabolic dysfunction reflected by aberrant adipose tissue morphology and function, impaired glucose metabolism, decreased energy expenditure, and hepatic steatosis. These findings indicate that ovarian NGF excess leads to adverse fetal development and to reproductive and metabolic complications in adulthood, mirroring common features of PCOS. This work provides evidence that NGF excess may be implicated in the PCOS pathophysiology.	[Manti, Maria; Pui, Han-Pin; Edstrom, Sonja; Risal, Sanjiv; Lu, Haojiang; Lindgren, Eva; Deng, Qiaolin; Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, Biomedicum B5, S-17177 Stockholm, Sweden; [Pui, Han-Pin; Deng, Qiaolin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Inst Med,Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden; [Benrick, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Gothenburg, Sweden; [Benrick, Anna] Univ Skovde, Sch Hlth & Educ, Skovde, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Skovde	Deng, QL; Stener-Victorin, E (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Biomedicum B5, S-17177 Stockholm, Sweden.	qiaolin.deng@ki.se; elisabet.stener-victorin@ki.se	Ohlsson, Claes/AGP-3544-2022; Ohlsson, Claes/HIR-6959-2022; Risal, Sanjiv/K-9883-2017	Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805; Pui, Han-Pin/0000-0003-4099-0478; Manti, Maria/0000-0003-4370-4780; Risal, Sanjiv/0000-0003-1723-5431; Lu, Haojiang/0000-0001-9051-0140; Deng, Qiaolin/0000-0001-5934-7816	Swedish Medical Research Council [2014-2775, 2018-02435 ESV, 2014-2870 QD, 2018-02557]; Novo Nordisk Foundation [NNF17OC0026724, NNF18OC0033992, NNF19OC0056647]; SRP in Diabetes at Karolinska Institutet; Adlerbertska Research Foundation; Karolinska Institutet KID; Swedish Association of Medical Research (SSMF); Ake Wiberg Foundation; Stockholm County Council; Karolinska Institutet; Novo Nordisk Fonden [NNF13OC0005785, NNF19OC0055250, NNF18OC0033898, NNF14OC0010513] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); SRP in Diabetes at Karolinska Institutet; Adlerbertska Research Foundation; Karolinska Institutet KID(Karolinska Institutet); Swedish Association of Medical Research (SSMF); Ake Wiberg Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by the Swedish Medical Research Council (Project No. 2014-2775, 2018-02435 ESV; 2014-2870 QD; 2018-02557), the Novo Nordisk Foundation (NNF17OC0026724, NNF18OC0033992, and NNF19OC0056647 ESV), the SRP in Diabetes at Karolinska Institutet to ESV; Adlerbertska Research Foundation to ESV; Karolinska Institutet KID funding to ESV and QD; the Swedish Association of Medical Research (SSMF) and the Ake Wiberg Foundation to QD; the Regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet to ESV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Blaszkiewicz M, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010010; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Broholm C, 2016, DIABETOLOGIA, V59, P2664, DOI 10.1007/s00125-016-4099-9; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Chaves RN, 2013, ZYGOTE, V21, P187, DOI 10.1017/S0967199412000111; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Davis BM, 1997, J COMP NEUROL, V387, P489, DOI 10.1002/(SICI)1096-9861(19971103)387:4<489::AID-CNE2>3.0.CO;2-Z; Dissen GA, 2001, ENDOCRINOLOGY, V142, P2078, DOI 10.1210/en.142.5.2078; Dissen GA, 2000, ENDOCRINOLOGY, V141, P1073, DOI 10.1210/en.141.3.1073; Dissen GA, 2009, ENDOCRINOLOGY, V150, P2906, DOI 10.1210/en.2008-1575; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Ek I, 2002, DIABETES, V51, P484, DOI 10.2337/diabetes.51.2.484; Flaa A, 2008, METABOLISM, V57, P1422, DOI 10.1016/j.metabol.2008.05.012; Fornes R, 2019, INT J OBESITY, V43, P2176, DOI 10.1038/s41366-018-0314-8; Furukawa S, 2013, EXP TOXICOL PATHOL, V65, P695, DOI 10.1016/j.etp.2012.09.002; Garcia-Rudaz C, 1998, CLIN ENDOCRINOL, V49, P221, DOI 10.1046/j.1365-2265.1998.00511.x; Garcia-Rudaz C, 2011, REPRODUCTION, V142, P319, DOI 10.1530/REP-11-0134; Glintborg D, 2018, J CLIN ENDOCR METAB, V103, P3819, DOI 10.1210/jc.2018-00889; Guarino D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00665; Han LS, 2018, NAT GENET, V50, P432, DOI 10.1038/s41588-018-0055-6; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Heider U, 2001, FERTIL STERIL, V75, P1141, DOI 10.1016/S0015-0282(01)01805-2; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Hoyle GW, 1998, AM J RESP CELL MOL, V18, P149, DOI 10.1165/ajrcmb.18.2.2803m; HSIEH ACL, 1957, AM J PHYSIOL, V190, P243, DOI 10.1152/ajplegacy.1957.190.2.243; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Iresjo BM, 2019, GENES NUTR, V14, DOI 10.1186/s12263-019-0652-8; Kitsiou-Tzeli S, 2017, CURR OPIN ENDOCRINOL, V24, P43, DOI 10.1097/MED.0000000000000305; Lambert EA, 2015, CLIN ENDOCRINOL, V83, P812, DOI 10.1111/cen.12803; LARA HE, 1990, ENDOCRINOLOGY, V126, P357, DOI 10.1210/endo-126-1-357; Lara HE, 2000, ENDOCRINOLOGY, V141, P1059, DOI 10.1210/en.141.3.1059; LARA HE, 1990, ENDOCRINOLOGY, V126, P364, DOI 10.1210/endo-126-1-364; LARA HE, 1993, ENDOCRINOLOGY, V133, P2690, DOI 10.1210/en.133.6.2690; Large V, 1998, DIABETES METAB, V24, P409; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Makieva S, 2014, HUM REPROD UPDATE, V20, P542, DOI 10.1093/humupd/dmu008; Maliqueo M, 2015, HUM REPROD, V30, P692, DOI 10.1093/humrep/deu351; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Musali N, 2016, GYNECOL ENDOCRINOL, V32, P460, DOI 10.3109/09513590.2015.1130808; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Newell-Fugate AE, 2017, REPRODUCTION, V153, pR133, DOI 10.1530/REP-16-0417; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Ollila MM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033780; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Sanchez F, 2012, BBA-MOL BASIS DIS, V1822, P1896, DOI 10.1016/j.bbadis.2012.05.013; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Shorakae S, 2018, CLIN ENDOCRINOL, V89, P628, DOI 10.1111/cen.13808; Sir-Petermann T, 2005, HUM REPROD, V20, P2122, DOI 10.1093/humrep/dei009; Spritzer PM, 2015, REPRODUCTION, V149, pR219, DOI 10.1530/REP-14-0435; Sverrisdottir YB, 2008, AM J PHYSIOL-ENDOC M, V294, pE576, DOI 10.1152/ajpendo.00725.2007; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; van Deutekom AW, 2016, INT J EPIDEMIOL, V45, P1079, DOI 10.1093/ije/dyw236; Veilleux A, 2009, CLIN LIPIDOL, V4, P367, DOI 10.2217/CLP.09.16; Wang YJ, 2015, DEVELOPMENT, V142, P343, DOI 10.1242/dev.112755; Wilson JL, 2014, ENDOCRINOLOGY, V155, P4494, DOI 10.1210/en.2014-1368; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wulsin LR, 2015, J CLIN ENDOCR METAB, V100, P2443, DOI 10.1210/jc.2015-1748; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709	72	4	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14440	14457		10.1096/fj.202001060R	http://dx.doi.org/10.1096/fj.202001060R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892421	Green Published, hybrid			2022-12-28	WOS:000568293000001
J	Goetzl, EJ				Goetzl, Edward J.			Advancing medicine for Alzheimer's disease: A plasma neural exosome platform	FASEB JOURNAL			English	Article						beta-amyloid peptides; amyloid microangiopathy; cellular prion protein; extracellular vesicles; phospho-tau species; synaptogyrin-3	SYNAPTIC PROTEINS; NEURONAL EXOSOMES; BLOOD EXOSOMES; OLIGOMERS; PROGRESSION; THERAPIES; TRIALS; BETA; TAU	Enrichment of neurally derived extracellular vesicles of several cell-types from plasma for protein quantification longitudinally in living patients with Alzheimer's disease has permitted the development of a tentative temporal framework of initiating events, progression mechanisms, and amplification processes. Interactions of beta-amyloid peptides with an elevated level of their normal prion protein dendritic receptor and of phospho-tau species with their synaptogyrin-3 synaptic vesicle receptor replace excessive production and accumulation of neuropathic proteins as the major initiating events. Synaptic dysfunction and microvascular angiopathy are confirmed as early progression mechanisms of decreased neuronal network connectivity, hypoxia, altered blood-brain barrier, and neurocellular degeneration. Neurally derived extracellular vesicle protein abnormalities also reveal a range of later amplification processes that encompasses insulin resistance, lysosomal defects, decreased survival factors, increased reactive oxygen species, and excessive neuroinflammation. New potential therapeutic targets also are suggested as well as the likely timing of their pathogenic engagement.	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA USA; [Goetzl, Edward J.] Geriatr Res Ctr, Campus Jewish Living, San Francisco, CA USA	University of California System; University of California San Francisco	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu						Abner EL, 2020, FASEB J, V34, P5967, DOI 10.1096/fj.202000034R; Anderson RM, 2017, LANCET, V390, P2327, DOI 10.1016/S0140-6736(17)32399-1; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189; Castle AR, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00019; Charidimou A, 2017, BRAIN, V140, P1829, DOI 10.1093/brain/awx047; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Cohen SH, 2018, J ALZHEIMERS DIS PAR, V8, DOI 10.4172/2161-0460.1000450; Cox TO, 2019, ANN CLIN TRANSL NEUR, V6, P554, DOI 10.1002/acn3.730; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Freeze WM, 2019, STROKE, V50, P328, DOI 10.1161/STROKEAHA.118.023788; Goetzl EJ, 2020, J NEUROTRAUM, V37, P382, DOI 10.1089/neu.2019.6711; Goetzl EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00452; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2018, FASEB J, V32, P888, DOI 10.1096/fj.201700731R; Goetzl EJ, 2017, FASEB J, V31, P3689, DOI 10.1096/fj.201700149; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Hornung S, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00038; Jarosz-Griffiths HH, 2019, J BIOL CHEM, V294, P7085, DOI 10.1074/jbc.RA118.005364; Kapogiannis D, 2019, JAMA NEUROL, V76, P1340, DOI 10.1001/jamaneurol.2019.2462; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Kim HJ, 2015, NEUROLOGY, V85, P63, DOI 10.1212/WNL.0000000000001705; Leuzy A, 2020, JAMA NEUROL, V77, P955, DOI 10.1001/jamaneurol.2020.0989; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nortley R, 2019, SCIENCE, V365, P250, DOI 10.1126/science.aav9518; Ower AK, 2018, EUR J EPIDEMIOL, V33, P657, DOI 10.1007/s10654-017-0326-z; Porter T, 2018, J ALZHEIMERS DIS, V66, P1193, DOI 10.3233/JAD-180713; Schelle J, 2019, ANN NEUROL, V86, P561, DOI 10.1002/ana.25562; Schott JM, 2019, LANCET, V393, P29, DOI 10.1016/S0140-6736(18)31896-8; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Smith EE, 2018, J NEUROCHEM, V144, P651, DOI 10.1111/jnc.14157; Smith LM, 2019, J BIOL CHEM, V294, P6042, DOI 10.1074/jbc.RA118.006252; Tai HC, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0146-2; Uemura MT, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00080; Ulbrich S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197659; Wu B, 2017, ELIFE, V6, DOI 10.7554/eLife.23473; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Zhou LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15295	46	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13079	13084		10.1096/fj.202001655	http://dx.doi.org/10.1096/fj.202001655		AUG 2020	6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32856798				2022-12-28	WOS:000566009100001
J	Bartman, CM; Schiliro, M; Helan, M; Prakash, YS; Linden, D; Pabelick, C				Bartman, Colleen M.; Schiliro, Marta; Helan, Martin; Prakash, Y. S.; Linden, David; Pabelick, Christina			Hydrogen sulfide, oxygen, and calcium regulation in developing human airway smooth muscle	FASEB JOURNAL			English	Article						calcium; contractility; fetal airway; oxygen; prematurity	CYSTATHIONINE BETA-SYNTHASE; PHYSIOLOGICAL ROLES; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; PRETERM INFANTS; GAMMA-LYASE; HYPEROXIA; METABOLISM; H2S; SULFHYDRATION	Preterm infants can develop airway hyperreactivity and impaired bronchodilation following supplemental O-2(hyperoxia) in early life, making it important to understand mechanisms of hyperoxia effects. Endogenous hydrogen sulfide (H2S) has anti-inflammatory and vasodilatory effects with oxidative stress. There is little understanding of H2S signaling in developing airways. We hypothesized that the endogenous H2S system is detrimentally influenced by O(2)and conversely H2S signaling pathways can be leveraged to attenuate deleterious effects of O-2. Using human fetal airway smooth muscle (fASM) cells, we investigated baseline expression of endogenous H2S machinery, and effects of exogenous H2S donors NaHS and GYY4137 in the context of moderate hyperoxia, with intracellular calcium regulation as a readout of contractility. Biochemical pathways for endogenous H2S generation and catabolism are present in fASM, and are differentially sensitive to O(2)toward overall reduction in H2S levels. H2S donors have downstream effects of reducing [Ca2+](i)responses to bronchoconstrictor agonist via blunted plasma membrane Ca(2+)influx: effects blocked by O-2. However, such detrimental O(2)effects are targetable by exogenous H2S donors such as NaHS and GYY4137. These data provide novel information regarding the potential for H2S to act as a bronchodilator in developing airways in the context of oxygen exposure.	[Bartman, Colleen M.; Schiliro, Marta; Helan, Martin; Prakash, Y. S.; Pabelick, Christina] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Prakash, Y. S.; Linden, David; Pabelick, Christina] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Helan, Martin] Masaryk Univ, Dept Anesthesiol & Intens Care, Brno, Czech Republic; [Helan, Martin] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic	Mayo Clinic; Mayo Clinic; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Pabelick, C (corresponding author), Mayo Clin, Dept Anesthesiol & Perioperat Med, 4-184 W Jos SMH, Rochester, MN 55905 USA.	pabelick.christina@mayo.edu	Helan, Martin/A-4159-2018	Helan, Martin/0000-0002-9021-4947; Prakash, Y S/0000-0002-2968-224X; Bartman, Colleen/0000-0002-3624-669X	Mayo Clinic Center for Biomedical Discovery; American Heart Association [20POST35210002]; Ministry of Education, Youth and Sports of the Czech Republic [LQ1605]; NIH [T32 HL105355, R01 HL056470, R01 HL 13840, 2]	Mayo Clinic Center for Biomedical Discovery; American Heart Association(American Heart Association); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Mayo Clinic Center for Biomedical Discovery (Pabelick, Linden); American Heart Association, Grant/Award Number: 20POST35210002; Ministry of Education, Youth and Sports of the Czech Republic, Grant/Award Number: LQ1605, NPU II; NIH, Grant/Award Number: T32 HL105355, R01 HL056470, R01 HL 13840 and 2	Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; Ali NKM, 2012, NEONATOLOGY, V101, P106, DOI 10.1159/000329540; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Bazhanov N, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050249; Bazhanov N, 2017, AM J RESP CELL MOL, V57, P403, DOI 10.1165/rcmb.2017-0114TR; Britt RD, 2015, AM J PHYSIOL-LUNG C, V309, pL537, DOI 10.1152/ajplung.00232.2015; Britt RD, 2015, J CELL PHYSIOL, V230, P1189, DOI 10.1002/jcp.24814; Britt RD, 2013, EXPERT REV RESP MED, V7, P515, DOI 10.1586/17476348.2013.838020; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Cacanyiova S, 2016, PHYSIOL RES, V65, pS273, DOI 10.33549/physiolres.933438; Chen YH, 2009, CYTOKINE, V45, P117, DOI 10.1016/j.cyto.2008.11.009; Cherian S, 2014, PAEDIATR RESPIR REV, V15, P135, DOI 10.1016/j.prrv.2012.12.003; Cole FS, 2011, PEDIATRICS, V127, P363, DOI 10.1542/peds.2010-3507; Dongo E, 2018, NITRIC OXIDE-BIOL CH, V81, P75, DOI 10.1016/j.niox.2017.10.010; Dunn WR, 2016, PHARMACOL THERAPEUT, V158, P101, DOI 10.1016/j.pharmthera.2015.12.007; Edwards MO, 2015, J ALLERGY CLIN IMMUN, V136, P581, DOI 10.1016/j.jaci.2015.05.005; Faksh A, 2016, PEDIATR RES, V79, P391, DOI 10.1038/pr.2015.232; Faller S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176649; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Farrow KN, 2012, ANTIOXID REDOX SIGN, V17, P460, DOI 10.1089/ars.2011.4184; Filipovic MR, 2015, HANDB EXP PHARMACOL, V230, P29, DOI 10.1007/978-3-319-18144-8_2; Freeman MR, 2017, AM J PHYSIOL-LUNG C, V313, pL360, DOI 10.1152/ajplung.00580.2016; Gheibi S, 2018, BIOCHEM PHARMACOL, V149, P42, DOI 10.1016/j.bcp.2018.01.017; Guan RJ, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2019.105979; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hartman WR, 2012, AM J PHYSIOL-LUNG C, V303, pL711, DOI 10.1152/ajplung.00037.2012; Hilgendorff A, 2008, PEDIATR CRIT CARE ME, V9, P629, DOI 10.1097/PCC.0b013e31818d17c8; Hong J, 2018, PATHOL RES PRACT, V214, P1804, DOI 10.1016/j.prp.2018.08.008; Hu H, 2008, NEUROSCIENCE, V156, P1074, DOI 10.1016/j.neuroscience.2008.08.025; Islam JY, 2015, AM J RESP CRIT CARE, V192, P134, DOI 10.1164/rccm.201412-2142PP; Ivanciuc T, 2016, AM J RESP CELL MOL, V55, P684, DOI 10.1165/rcmb.2015-0385OC; Jackson-Weaver O, 2013, AM J PHYSIOL-HEART C, V304, pH1446, DOI 10.1152/ajpheart.00506.2012; Kanagy NL, 2017, AM J PHYSIOL-CELL PH, V312, pC537, DOI 10.1152/ajpcell.00329.2016; Kandil S, 2010, NEUROCHEM INT, V56, P611, DOI 10.1016/j.neuint.2010.01.004; Kimura H, 2015, HANDB EXP PHARMACOL, V230, P61, DOI 10.1007/978-3-319-18144-8_3; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; Kiss L, 2008, LIFE SCI, V83, P589, DOI 10.1016/j.lfs.2008.08.006; Kotecha S, 2018, PEDIAT ALLERG IMM-UK, V29, P715, DOI 10.1111/pai.12957; Lavoie PM, 2010, CURR OPIN PEDIATR, V22, P134, DOI 10.1097/MOP.0b013e328336eb85; Li HD, 2013, EUR J APPL PHYSIOL, V113, P1555, DOI 10.1007/s00421-012-2584-5; Li H, 2015, J VIROL, V89, P5557, DOI 10.1128/JVI.00264-15; Li H, 2014, NEUROREPORT, V25, P358, DOI 10.1097/WNR.0000000000000090; Li N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6492469; Lin F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00675; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Linden DR, 2014, ANTIOXID REDOX SIGN, V20, P818, DOI 10.1089/ars.2013.5312; Liu CX, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2070971; Liu WL, 2013, CHINESE MED J-PEKING, V126, P494, DOI 10.3760/cma.j.issn.0366-6999.20120809; Lu AZ, 2019, PFLUG ARCH EUR J PHY, V471, P1551, DOI 10.1007/s00424-019-02325-9; Madurga A, 2015, AM J PHYSIOL-LUNG C, V309, pL710, DOI 10.1152/ajplung.00134.2015; Madurga A, 2014, AM J PHYSIOL-LUNG C, V306, pL684, DOI 10.1152/ajplung.00361.2013; Martelli A, 2013, PHARMACOL RES, V70, P27, DOI 10.1016/j.phrs.2012.12.005; Martin RJ, 2013, J PEDIATR-US, V162, P443, DOI 10.1016/j.jpeds.2012.11.028; Murphy B, 2019, FASEB J, V33, P13098, DOI 10.1096/fj.201901304R; Musharaf I, 2018, PULM PHARMACOL THER, V48, P195, DOI 10.1016/j.pupt.2017.12.003; Nagao M, 2011, J GASTROINTEST SURG, V15, P12, DOI 10.1007/s11605-010-1306-8; Niu WN, 2015, ANTIOXID REDOX SIGN, V22, P350, DOI 10.1089/ars.2014.5891; O'Reilly M, 2014, NEONATOLOGY, V105, P39, DOI 10.1159/000355641; Olson KR, 2016, PHYSIOLOGY, V31, P60, DOI 10.1152/physiol.00024.2015; Olson KR, 2010, AM J PHYSIOL-REG I, V298, pR51, DOI 10.1152/ajpregu.00576.2009; Onugha H, 2015, NEONATOLOGY, V108, P65, DOI 10.1159/000380758; Pandya HC, 2006, BIOL NEONATE, V89, P211, DOI 10.1159/000089497; Parikh P, 2019, AM J RESP CELL MOL, V61, P51, DOI 10.1165/rcmb.2018-0176OC; Perry MM, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0788-x; Prakash YS, 2017, AM J RESP CRIT CARE, V195, P247, DOI 10.1164/rccm.201611-2248ST; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Sbodio JI, 2018, P NATL ACAD SCI USA, V115, P780, DOI 10.1073/pnas.1717877115; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singha S, 2015, ANAL CHEM, V87, P1188, DOI 10.1021/ac503806w; Strange K, 2007, CELL CALCIUM, V42, P193, DOI 10.1016/j.ceca.2007.02.007; Strege PR, 2011, AM J PHYSIOL-GASTR L, V300, pG1105, DOI 10.1152/ajpgi.00556.2010; Sun Y, 2017, ONCOTARGET, V8, P31888, DOI 10.18632/oncotarget.16649; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2017, PHARMACOL REV, V69, P497, DOI 10.1124/pr.117.014050; VINA J, 1995, AM J CLIN NUTR, V61, P1067, DOI 10.1093/ajcn/61.5.1067; Vogel ER, 2017, PEDIATR RES, V81, P376, DOI 10.1038/pr.2016.218; Vogel ER, 2015, CAN J PHYSIOL PHARM, V93, P119, DOI 10.1139/cjpp-2014-0387; Vohra PK, 2013, BBA-MOL CELL RES, V1833, P2953, DOI 10.1016/j.bbamcr.2013.07.019; Wang H, 2014, AM J PHYSIOL-LUNG C, V307, pL295, DOI 10.1152/ajplung.00208.2013; Zhang GS, 2013, AM J PATHOL, V182, P1188, DOI 10.1016/j.ajpath.2012.12.008; Zhang J, 2014, RESPIROLOGY, V19, P1165, DOI 10.1111/resp.12372; Zhou YY, 2013, CHEM COMMUN, V49, P11782, DOI 10.1039/c3cc46719h; Zimmermann KK, 2018, INFLAMMATION, V41, P249, DOI 10.1007/s10753-017-0684-4; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65	91	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12991	13004		10.1096/fj.202001180R	http://dx.doi.org/10.1096/fj.202001180R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32777143	Green Accepted			2022-12-28	WOS:000558418100001
J	Queen, D; Shen, Y; Trager, MH; Lopez, AT; Samie, FH; Lewin, JM; Niedt, GW; Geskin, LJ; Liu, L				Queen, Dawn; Shen, Yao; Trager, Megan H.; Lopez, Adriana T.; Samie, Faramarz H.; Lewin, Jesse M.; Niedt, George W.; Geskin, Larisa J.; Liu, Liang			UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes	FASEB JOURNAL			English	Article						actinic keratosis; squamous cell carcinoma; ultraviolet radiation	SKIN-CANCER; KERATINOCYTE; EPIDEMIOLOGY; PATHOGENESIS; PROGRESSION; RESPONSES; HISTORY; TUMOR; P53	Currently, there is no sensitive molecular test for identifying transformation-prone actinic keratoses (AKs) and aggressive squamous cell carcinoma (SCC) subtypes. Biomarker-based molecular testing represents a promising tool for risk stratifying these lesions. We evaluated the utility of a panel of ultraviolet (UV) radiation-biomarker genes in distinguishing between benign and transformation-prone AKs and SCCs. The expression of the UV-biomarker genes in 31 SCC and normal skin (NS) pairs and 10 AK/NS pairs was quantified using the NanoString nCounter system. Biomarker testing models were built using logistic regression models with leave-one-out cross validation in the training set. The best model to classify AKs versus SCCs (area under curve (AUC) 0.814, precision score 0.833, recall 0.714) was constructed using a top-ranked set of 13 UV-biomarker genes. Another model based on a 15-gene panel was developed to differentiate histologically concerning from less concerning SCCs (AUC 1, precision score 1, recall 0.714). Finally, 12 of the UV-biomarker genes were differentially expressed between AKs and SCCs, while 10 genes were uniquely expressed in the more concerning SCCs. UV-biomarker gene subsets demonstrate dynamic utility as molecular tools to classify and risk stratify AK and SCC lesions, which will complement histopathologic diagnosis to guide treatment of high-risk patients.	[Queen, Dawn] Lankenau Med Ctr, Dept Med, Philadelphia, PA USA; [Shen, Yao] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY USA; [Trager, Megan H.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Lopez, Adriana T.] NYU, Dept Dermatol, New York, NY 10016 USA; [Samie, Faramarz H.; Lewin, Jesse M.; Geskin, Larisa J.; Liu, Liang] Columbia Univ, Dept Dermatol, Irving Med Ctr, New York, NY 10027 USA; [Niedt, George W.] Columbia Univ, Dept Pathol, Irving Med Ctr, New York, NY USA; [Liu, Liang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Lankenau Medical Center; Columbia University; NewYork-Presbyterian Hospital; Columbia University; New York University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; University of Minnesota System	Liu, L (corresponding author), Univ Minnesota, Hormel Inst, Austin, MN 55912 USA.	LIU00965@umn.edu			NIH/NIAMS [K01AR064315]; Prevent Cancer Foundation; Columbia University Herbert Irving Comprehensive Cancer Center [P30 CA013696]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Prevent Cancer Foundation; Columbia University Herbert Irving Comprehensive Cancer Center	Funding through NIH/NIAMS grant K01AR064315; the Prevent Cancer Foundation research award; the Columbia University Herbert Irving Comprehensive Cancer Center (P30 CA013696)	Bolshakov S, 2003, CLIN CANCER RES, V9, P228; Carli P, 2004, MELANOMA RES, V14, P403, DOI 10.1097/00008390-200410000-00011; Chitsazzadeh V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12601; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; Dawes JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093338; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; Elmets CA, 2014, J INVEST DERMATOL, V134, P2497, DOI 10.1038/jid.2014.192; Feldman SR, 2011, CUTIS, V87, P201; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Holmes C, 2007, AUSTRALAS J DERMATOL, V48, P67, DOI 10.1111/j.1440-0960.2007.00339.x; Karaa A, 2007, INT J DERMATOL, V46, P671, DOI 10.1111/j.1365-4632.2007.03260.x; Karia PS, 2014, J CLIN ONCOL, V32, P327, DOI 10.1200/JCO.2012.48.5326; Karia PS, 2013, J AM ACAD DERMATOL, V68, P957, DOI 10.1016/j.jaad.2012.11.037; Lebwohl M, 2003, BRIT J DERMATOL, V149, P31, DOI 10.1046/j.0366-077X.2003.05621.x; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Lohmann CM, 2001, ADV ANAT PATHOL, V8, P27, DOI 10.1097/00125480-200101000-00005; Marks R, 1997, J AM ACAD DERMATOL, V36, P721, DOI 10.1016/S0190-9622(97)80324-6; Mullen JT, 2006, ANN SURG ONCOL, V13, P902, DOI 10.1245/ASO.2006.07.022; Osborne JE, 2003, BRIT J DERMATOL, V148, P252, DOI 10.1046/j.1365-2133.2003.05154.x; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Rossi R, 2007, INT J DERMATOL, V46, P895, DOI 10.1111/j.1365-4632.2007.03166.x; Schmults CD, 2013, JAMA DERMATOL, V149, P541, DOI 10.1001/jamadermatol.2013.2139; Shen Y, 2019, CARCINOGENESIS, V40, P687, DOI 10.1093/carcin/bgy168; Shen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163054; Shulstad RM, 2010, J DERMAT NURSES ASSO, V2, P12, DOI 10.1097/JDN.0b013e3181cb5165; Skvara H, 2005, ARCH DERMATOL, V141, P155, DOI 10.1001/archderm.141.2.155; Stern RS, 2010, ARCH DERMATOL, V146, P279, DOI 10.1001/archdermatol.2010.4; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	31	2	2	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13022	13032		10.1096/fj.202001412R	http://dx.doi.org/10.1096/fj.202001412R		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32776588	Green Accepted			2022-12-28	WOS:000558416300001
J	Geleta, B; Park, KC; Jansson, PJ; Sahni, S; Maleki, S; Xu, ZH; Murakami, T; Pajic, M; Apte, MV; Richardson, D; Kovacevic, Z				Geleta, Bekesho; Park, Kyung Chan; Jansson, Patric J.; Sahni, Sumit; Maleki, Sanaz; Xu, Zhihong; Murakami, Takashi; Pajic, Marina; Apte, Minoti, V; Richardson, Des R.; Kovacevic, Zaklina			Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma	FASEB JOURNAL			English	Article						DpC; NDRG1; pancreatic cancer; stellate cells; stroma	HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS SUPPRESSOR NDRG1; C-MET EXPRESSION; IRON CHELATORS; REGULATED GENE-1; STELLATE CELLS; ANTIPROLIFERATIVE ACTIVITY; FACTOR RECEPTOR; UP-REGULATION	Pancreatic cancer (PaCa) is characterized by dense stroma that hinders treatment efficacy, with pancreatic stellate cells (PSCs) being a major contributor to this stromal barrier and PaCa progression. Activated PSCs release hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-1) that induce PaCa proliferation, metastasis and resistance to chemotherapy. We demonstrate for the first time that the metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), is a potent inhibitor of the PaCa-PSC cross-talk, leading to inhibition of HGF and IGF-1 signaling. NDRG1 also potently reduced the key driver of PaCa metastasis, namely GLI1, leading to reduced PSC-mediated cell migration. The novel clinically trialed anticancer agent, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), which upregulates NDRG1, potently de-sensitized PaCa cells to ligands secreted by activated PSCs. DpC and NDRG1 also inhibited the PaCa-mediated activation of PSCs via inhibition of sonic hedgehog (SHH) signaling. In vivo, DpC markedly reduced PaCa tumor growth and metastasis more avidly than the standard chemotherapy for this disease, gemcitabine. Uniquely, DpC was selectively cytotoxic against PaCa cells, while "re-programming" PSCs to an inactive state, decreasing collagen deposition and desmoplasia. Thus, targeting NDRG1 can effectively break the oncogenic cycle of PaCa-PSC bi-directional cross-talk to overcome PaCa desmoplasia and improve therapeutic outcomes.	[Geleta, Bekesho; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Canc Metastasis & Tumour Microenvironm Program, Sydney, NSW 2006, Australia; [Geleta, Bekesho; Park, Kyung Chan; Jansson, Patric J.; Sahni, Sumit; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW, Australia; [Jansson, Patric J.] Univ Sydney, Dept Pathol, Canc Drug Resistance Program, Sydney, NSW, Australia; [Sahni, Sumit] Univ Sydney, Kolling Inst Med Res, Bill Walsh Translat Canc Res Lab, Sydney, NSW, Australia; [Maleki, Sanaz] Univ Sydney, Sch Med Sci, Dept Pathol, Histopathol Lab, Sydney, NSW, Australia; [Xu, Zhihong; Apte, Minoti, V] UNSW Sydney, South Western Sydney Clin Sch, Pancreat Res Grp, Sydney, NSW, Australia; [Xu, Zhihong; Apte, Minoti, V] Ingham Inst Appl Med Res, Sydney, NSW, Australia; [Murakami, Takashi] Saitama Med Univ, Fac Med, Moroyama, Saitama, Japan; [Pajic, Marina] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Pajic, Marina] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Richardson, Des R.] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi, Japan; [Richardson, Des R.] Griffith Univ, Ctr Canc Cell Biol & Drug Discovery, Griffith Inst Drug Discovery, Nathan, Qld, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Saitama Medical University; Garvan Institute of Medical Research; University of New South Wales Sydney; Nagoya University; Griffith University	Kovacevic, Z (corresponding author), Univ Sydney, Dept Pathol, Canc Metastasis & Tumour Microenvironm Program, Sydney, NSW 2006, Australia.; Richardson, D (corresponding author), Griffith Univ, Ctr Canc Cell Biol & Drug Discovery, Griffith Inst Drug Discovery, Brisbane, Qld 4611, Australia.	d.richardson@griffith.edu.au; zaklina.kovacevic@sydney.edu.au	Kovacevic, Zaklina/ABD-9581-2021; Geleta, Bekesho/AAC-5785-2022; Jansson, Patric/AAC-4221-2022	Kovacevic, Zaklina/0000-0002-4742-4690; Jansson, Patric/0000-0002-9322-653X; Wendimu, Bekesho Geleta/0000-0002-4546-9692; Pajic, Marina/0000-0002-3871-3829; Richardson, Des/0000-0002-5506-3274; Xu, Zhihong/0000-0001-8445-1076				Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bai YY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002996; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chou A, 2018, GUT, V67, P2142, DOI 10.1136/gutjnl-2017-315144; Cros J., 2016, PANCREATOLOGY, V16, pS27; Cuneo KC, 2018, INT J RADIAT ONCOL, V100, P490, DOI 10.1016/j.ijrobp.2017.10.030; DIRENZO MF, 1995, CANCER RES, V55, P1129; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Fafalios A, 2011, NAT MED, V17, P1577, DOI 10.1038/nm.2531; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Fujita H, 2010, PANCREAS, V39, P1254, DOI 10.1097/MPA.0b013e3181dbf647; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Haqq J, 2014, EUR J CANCER, V50, P2570, DOI 10.1016/j.ejca.2014.06.021; Hirakawa T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159912; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Ireland L, 2016, CANCER RES, V76, P6851, DOI 10.1158/0008-5472.CAN-16-1201; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Kalinowski DS, 2007, J MED CHEM, V50, P6212, DOI 10.1021/jm070839q; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kasai K, 2016, PATHOL INT, V66, P653, DOI 10.1111/pin.12476; Kiehne K, 1997, PANCREAS, V15, P35, DOI 10.1097/00006676-199707000-00005; Kim JH, 2017, ONCOTARGET, V8, P73098, DOI 10.18632/oncotarget.20392; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee JE, 2015, GENET MOL BIOL, V38, P527, DOI 10.1590/S1415-475738420150028; Li XQ, 2014, CLIN CANCER RES, V20, P4326, DOI 10.1158/1078-0432.CCR-13-3426; Li YH, 2015, CELL REP, V12, P599, DOI 10.1016/j.celrep.2015.06.054; Lim SC, 2020, FASEB J, V34, P11511, DOI 10.1096/fj.201903167R; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; Nair PN, 2001, ONCOGENE, V20, P8203, DOI 10.1038/sj.onc.1205044; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Pant S, 2014, ANN ONCOL, V25, P1416, DOI 10.1093/annonc/mdu157; Papaconstantinou J, 2015, ONCOTARGET, V6, P35315, DOI 10.18632/oncotarget.6112; Park KC, 2020, J BIOL CHEM, V295, P481, DOI 10.1074/jbc.RA119.011341; Patel MB, 2014, CARCINOGENESIS, V35, P1891, DOI 10.1093/carcin/bgu122; Pothula SP, 2017, ONCOTARGET, V8, P76722, DOI 10.18632/oncotarget.20822; Pothula SP, 2016, BRIT J CANCER, V114, P269, DOI 10.1038/bjc.2015.478; Procacci P, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100158; Rajbhandari N, 2017, CELL REP, V18, P2243, DOI 10.1016/j.celrep.2017.02.013; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; RICHARDSON D, 1994, CANCER RES, V54, P685; Rucki AA, 2017, MOL CANCER THER, V16, P2399, DOI 10.1158/1535-7163.MCT-16-0452; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Suarez-Causado A, 2015, BBA-MOL CELL RES, V1853, P2453, DOI 10.1016/j.bbamcr.2015.05.017; Subramani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097016; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	62	16	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21347	10.1096/fj.202002279R	http://dx.doi.org/10.1096/fj.202002279R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484481				2022-12-28	WOS:000647789600037
J	Wang, XT; Li, XL; Li, J; Zhai, LD; Liu, DQ; Abdurahman, A; Zhang, YF; Yokota, H; Zhang, P				Wang, Xuetong; Li, Xinle; Li, Jie; Zhai, Lidong; Liu, Daquan; Abdurahman, Abdusami; Zhang, Yifan; Yokota, Hiroki; Zhang, Ping			Mechanical loading stimulates bone angiogenesis through enhancing type H vessel formation and downregulating exosomal miR-214-3p from bone marrow-derived mesenchymal stem cells	FASEB JOURNAL			English	Article						knee loading; MiRNA; osteoporosis; type H vessels; vessel remodeling	OSTEOPOROTIC FRACTURE; FEMORAL-HEAD; OSTEONECROSIS; DIFFERENTIATION; OSTEOGENESIS; REGENERATION; MICRORNAS; MODEL	Exosomes are important transporters of miRNAs, which play varying roles in the healing of the bone fracture. Angiogenesis is one of such critical events in bone healing, and we previously reported the stimulatory effect of mechanical loading in vessel remodeling. Focusing on type H vessels and exosomal miR-214-3p, this study examined the mechanism of loading-driven angiogenesis. MiRNA sequencing and qRT-PCR revealed that miR-214-3p was increased in the exosomes of the bone-losing ovariectomized (OVX) mice, while it was significantly decreased by knee loading. Furthermore, compared to the OVX group, exosomes, derived from the loading group, promoted the angiogenesis of endothelial cells. In contrast, exosomes, which were transfected with miR-214-3p, decreased the angiogenic potential. Notably, knee loading significantly improved the microvascular volume, type H vessel formation, and bone mineral density and contents, as well as BV/TV, Tb.Th, Tb.N, and Tb.Sp. In cell cultures, the overexpression of miR-214-3p in endothelial cells reduced the tube formation and cell migration. Collectively, this study demonstrates that knee loading promotes angiogenesis by enhancing the formation of type H vessels and downregulating exosomal miR-214-3p.	[Wang, Xuetong; Li, Xinle; Li, Jie; Zhai, Lidong; Liu, Daquan; Abdurahman, Abdusami; Zhang, Yifan; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin, Peoples R China; [Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Metab Dis, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Spine & Spinal Cord, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Tianjin Medical University	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin, Peoples R China.	pizhang@tmu.edu.cn			National Natural Science Foundation of China [81772405, 81572100, 81601863, 31871212]; Natural Science Foundation of Tianjin [18JCQNJC82200]; NIH [AR052144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Natural Science Foundation of China, Grant/Award Number: 81772405, 81572100, 81601863 and 31871212; Natural Science Foundation of Tianjin, Grant/Award Number: 18JCQNJC82200; NIH, Grant/Award Number: AR052144	Behera Jyotirmaya, 2018, Oncoscience, V5, P181, DOI 10.18632/oncoscience.421; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; Ding JN, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9742765; Filipowska J, 2017, ANGIOGENESIS, V20, P291, DOI 10.1007/s10456-017-9541-1; Fishman A, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1495-0; Fu R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14076-3; Hatori K, 2015, OSTEOPOROSIS INT, V26, P303, DOI 10.1007/s00198-014-2857-4; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Huang JH, 2020, NEUROSCIENCE, V424, P133, DOI 10.1016/j.neuroscience.2019.10.043; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Huang L, 2018, BIOMATERIALS, V182, P58, DOI 10.1016/j.biomaterials.2018.07.046; Ji G, 2019, BONE JOINT J, V101B, P108, DOI 10.1302/0301-620X.101B7.BJJ-2018-1473.R1; Jing D, 2016, J BONE MINER RES, V31, P1713, DOI 10.1002/jbmr.2837; Kusumbe AP, 2015, NAT PROTOC, V10, P1904, DOI 10.1038/nprot.2015.125; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2159-z; Li WD, 2018, STEM CELLS, V36, P1863, DOI 10.1002/stem.2904; Li XL, 2019, FASEB J, V33, P8913, DOI 10.1096/fj.201802711R; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Liu DQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05488-6; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Liu M, 2018, J DENT RES, V97, P859, DOI 10.1177/0022034518764411; Liu XL, 2017, INT J BIOL SCI, V13, P232, DOI 10.7150/ijbs.16951; Lombardo G, 2018, ONCOGENE, V37, P1175, DOI 10.1038/s41388-017-0034-x; Ma T, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/3290372; Peng Y, 2020, THERANOSTICS, V10, P426, DOI 10.7150/thno.34126; Qi X, 2016, INT J BIOL SCI, V12, P836, DOI 10.7150/ijbs.14809; Qi YX, 2018, ADV EXP MED BIOL, V1097, P69, DOI 10.1007/978-3-319-96445-4_4; Qin YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050712; Ren H, 2019, BONE, V120, P371, DOI 10.1016/j.bone.2018.11.013; Santos TS, 2015, J CELL BIOCHEM, V116, P2896, DOI 10.1002/jcb.25237; Saran U, 2014, ARCH BIOCHEM BIOPHYS, V561, P109, DOI 10.1016/j.abb.2014.07.006; Shang S, 2019, CANCER MED-US, V8, P7728, DOI 10.1002/cam4.2633; Sundh D, 2018, J BONE MINER RES, V33, P1242, DOI 10.1002/jbmr.3431; Teng JW, 2018, EUR REV MED PHARMACO, V22, P17, DOI 10.26355/eurrev_201801_14095; Tian GE, 2019, WORLD J STEM CELLS, V11, P1104, DOI 10.4252/wjsc.v11.i12.1104; Tian XT, 2018, EXP THER MED, V16, P595, DOI 10.3892/etm.2018.6252; van der Eerden BCJ, 2014, ARCH BIOCHEM BIOPHYS, V561, P46, DOI 10.1016/j.abb.2014.04.016; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; Wang B, 2019, J CELL PHYSIOL, V234, P10602, DOI 10.1002/jcp.27735; Wang CD, 2017, EXP CELL RES, V352, P346, DOI 10.1016/j.yexcr.2017.02.021; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wei FY, 2016, EUR CELLS MATER, V31, P341, DOI 10.22203/eCM.v031a22; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Xie Y, 2017, J CELL MOL MED, V21, P1033, DOI 10.1111/jcmm.13039; Yamasaki Y, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0613-3; Yang S, 2019, FASEB J, V33, P10742, DOI 10.1096/fj.201900306RR; Zhang P, 2007, J BONE MINER RES, V22, P1979, DOI 10.1359/JBMR.070803; Zhang P, 2012, J BONE MINER METAB, V30, P31, DOI 10.1007/s00774-011-0292-6; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhang P, 2009, EXERC SPORT SCI REV, V37, P52, DOI 10.1097/JES.0b013e31819121c6; Zheng WW, 2020, FASEB J, V34, P3399, DOI 10.1096/fj.201902117R; Zheng WW, 2019, FASEB J, V33, P4077, DOI 10.1096/fj.201801851R; Zhou LG, 2019, EUR REV MED PHARMACO, V23, P449, DOI 10.26355/eurrev_201901_16854	55	21	25	3	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001080RR	http://dx.doi.org/10.1096/fj.202001080RR		NOV 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33161580	Green Accepted			2022-12-28	WOS:000590916700001
J	Zafarullah, M; Palczewski, G; Rivera, SM; Hessl, DR; Tassone, F				Zafarullah, Marwa; Palczewski, Grzegorz; Rivera, Susan M.; Hessl, David R.; Tassone, Flora			Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)	FASEB JOURNAL			English	Article						fatty acids; fragile X-associated tremor/ataxia syndrome; FMR1; molecular biomarkers; metabolomic	MITOCHONDRIAL DYSFUNCTION; KYNURENINE PATHWAY; EXPANDED ALLELES; ALZHEIMERS; CERAMIDE; NEURODEGENERATION; BRAIN; LACTOSYLCERAMIDE; IDENTIFICATION; APOPTOSIS	Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder associated with the FMR1 premutation. It is currently unknown when, and if, individual premutation carriers will develop FXTAS. Thus, with the aim of identifying biomarkers for early diagnosis, development, and progression of FXTAS, we performed global metabolomic profiling of premutation carriers (PM) who, as part of an ongoing longitudinal study, emerged into two distinct categories: those who developed symptoms of FXTAS (converters, CON) at subsequent visits and those who did not (non-converters, NCON) and we compared to age-matched healthy controls (HC). We assessed CGG repeat allele size by Southern Blot and PCR analysis. Metabolomic profile was obtained by ultra-performance liquid chromatography, accurate mass spectrometer, and an Orbitrap mass analyzer. In this study we found 47 metabolites were significantly dysregulated between HC and the premutation groups (PM). Importantly, we identified 24 metabolites that showed significant changes in expression in the CON as compared to the NCON both at V1 and V2, and 70 metabolites in CON as compared to NCON but only at V2. These findings suggest the potential role of the identified metabolites as biomarkers for early diagnosis and for FXTAS disease progression, respectively. Interestingly, the majority of the identified metabolites were lipids, followed by amino acids. To our knowledge, this the first report of longitudinal metabolic profiling and identification of unique biomarkers of FXTAS. The lipid metabolism and specifically the sub pathways involved in mitochondrial bioenergetics, as observed in other neurodegenerative disorders, are significantly altered in FXTAS.	[Zafarullah, Marwa; Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Palczewski, Grzegorz] Metabolon, Morrisville, NC USA; [Rivera, Susan M.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Rivera, Susan M.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Rivera, Susan M.; Hessl, David R.; Tassone, Flora] Univ Calif Davis, MIND Inst, Med Ctr, 2825 50th St,Room 2460, Sacramento, CA 95817 USA; [Hessl, David R.] Univ Calif Davis, Dept Psychiat & Behav Sci, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis; Metabolon; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tassone, F (corresponding author), Univ Calif Davis, MIND Inst, Med Ctr, 2825 50th St,Room 2460, Sacramento, CA 95817 USA.	ftassone@ucdavis.edu		Zafarullah, Marwa/0000-0003-1856-0535	HHS | National Institutes of Health (NIH) [RO1NS110100-11, RO1MH078041]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: RO1NS110100-11 and RO1MH078041	Adachi Y, 2018, INT J GERONTOL, V12, P290, DOI 10.1016/j.ijge.2018.03.003; Bacalman S, 2006, J CLIN PSYCHIAT, V67, P87, DOI 10.4088/JCP.v67n0112; Basavarajappa BS, 2017, J NEUROCHEM, V142, P624, DOI 10.1111/jnc.14098; BLESA J, 2015, FRONT NEUROANAT, V0009; Cenini G, 2020, OXIDATIVE MED CELLUL, V2020, P1; Checa A, 2015, MULT SCLER J, V21, P1271, DOI 10.1177/1352458514561908; CHENG D, 2011, PLOS ONE, V6; Corso G, 2017, DEMENT GER COGN D EX, V7, P143, DOI 10.1159/000466688; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Eker A, 2016, NOROPSIKIYATRI ARS, V53, P92, DOI 10.5152/npa.2015.10011; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Figura M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191670; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Filippov V, 2012, J ALZHEIMERS DIS, V29, P537, DOI 10.3233/JAD-2011-111202; Giulivi C, 2016, BIOCHEM J, V473, P3871, DOI 10.1042/BCJ20160585; Giulivi C, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00071; Gong YG, 2015, J PHARMACEUT BIOMED, V115, P174, DOI 10.1016/j.jpba.2015.07.007; Graham SF, 2016, J PROTEOME RES, V15, P1592, DOI 10.1021/acs.jproteome.6b00049; Greco CM, 2008, ARCH NEUROL, V65; Gu QQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34662-7; Hagerman RJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00564; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; Hagerman RJ, 2016, NAT REV NEUROL, V12, P403, DOI 10.1038/nrneurol.2016.82; Havelund JF, 2017, METABOLITES, V7, DOI 10.3390/metabo7030042; Heemels MT, 2016, NATURE, V539, P179, DOI 10.1038/539179a; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Kong HE, 2019, HUM MOL GENET, V28, P980, DOI 10.1093/hmg/ddy410; Lahiri DK, 2010, EXP GERONTOL, V45, P291, DOI 10.1016/j.exger.2010.01.001; Lin CN, 2019, ANN CLIN TRANSL NEUR, V6, P537, DOI 10.1002/acn3.726; Maddison DC, 2015, SEMIN CELL DEV BIOL, V40, P134, DOI 10.1016/j.semcdb.2015.03.002; Majlath Z, 2015, TARGET BROADLY PATHO, P193; Makrecka-Kuka M, 2017, SCI REP, V7, P1; Mashhadi Akbar Boojar M., 2018, EGYPT J BASIC APPL S, V5, P237, DOI [10.1016/j.ejbas.2018.10.003, DOI 10.1016/J.EJBAS.2018.10.003]; Mielke MM, 2010, NEUROMOL MED, V12, P331, DOI 10.1007/s12017-010-8121-y; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; Napoli E, 2019, MOL NEUROBIOL, V56, P3702, DOI 10.1007/s12035-018-1330-3; Napoli E, 2016, FASEB J, V30, P3334, DOI 10.1096/fj.201600315R; Novgorodov SA, 2016, J LIPID RES, V57, P546, DOI 10.1194/jlr.M060061; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; Peng B, 2015, PROTEIN CELL, V6, P628, DOI 10.1007/s13238-015-0185-x; Piccinini M, 2010, MOL NEUROBIOL, V41, P314, DOI 10.1007/s12035-009-8096-6; Schroeder MA, 2012, CIRC-CARDIOVASC IMAG, V5, P201, DOI 10.1161/CIRCIMAGING.111.969451; Schulz H, 2004, ENCY BIOL CHEM, V1, P90; Shamim A., 2018, CLIN NUTR EXP, V20, P1, DOI [10.1016/j.yclnex.2018.05.001, DOI 10.1016/J.YCLNEX.2018.05.001]; Shao YP, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0304-2; Shelton AL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00379; Skene DJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43030; Socha E, 2019, AMINO ACIDS, V51, P367, DOI 10.1007/s00726-019-02705-6; Song G, 2016, MOL MED, V22, P548, DOI 10.2119/molmed.2016.00122; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Tassone F, 2012, GENOME MED, V4, DOI 10.1186/gm401; Van Assche R, 2015, METABOLOMICS, V11, P477, DOI 10.1007/s11306-014-0711-5; Wang G, 2008, GLIA, V56, P449, DOI 10.1002/glia.20626; Wood PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191815; Xu Q, 2006, FUTURE LIPIDOL, V1, P441, DOI 10.2217/17460875.1.4.441; Yadav RS, 2014, MOL NEUROBIOL, V50, P168, DOI 10.1007/s12035-014-8661-5; Zafarullah M, 2019, METHODS MOL BIOL, V1942, P173, DOI 10.1007/978-1-4939-9080-1_15; Zhao HY, 2018, J CHROMATOGR B, V1081, P105, DOI 10.1016/j.jchromb.2018.01.025	65	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16676	16692		10.1096/fj.202001880R	http://dx.doi.org/10.1096/fj.202001880R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131090	Green Published, hybrid			2022-12-28	WOS:000586602600001
J	Hansen, KUI; Siegerist, F; Daniel, S; Schindler, M; Iervolino, A; Blumenthal, A; Daniel, C; Amann, K; Zhou, WB; Endlich, K; Endlich, N				Hansen, Kerrin Ursula Ingeborg; Siegerist, Florian; Daniel, Sophie; Schindler, Maximilian; Iervolino, Anna; Blumenthal, Antje; Daniel, Christoph; Amann, Kerstin; Zhou, Weibin; Endlich, Karlhans; Endlich, Nicole			Prolonged podocyte depletion in larval zebrafish resembles mammalian focal and segmental glomerulosclerosis	FASEB JOURNAL			English	Article						FSGS; glomerulus; podocyte injury; zebrafish model organism	PARIETAL EPITHELIAL-CELL; MECHANICAL FORCES; INJURY; REGENERATION; PROTEINURIA; REVEALS; DISEASE; HEART; MODEL	Focal and segmental glomerulosclerosis (FSGS) is a histological pattern frequently found in patients with nephrotic syndrome that often progress to end-stage kidney disease. The initial step in development of this histologically defined entity is injury and ultimately depletion of podocytes, highly arborized interdigitating cells on the glomerular capillaries with important function for the glomerular filtration barrier. Since there are still no causal therapeutic options, animal models are needed to develop new treatment strategies. Here, we present an FSGS-like model in zebrafish larvae, an eligible vertebrate model for kidney research. In a transgenic zebrafish strain, podocytes were depleted, and the glomerular response was investigated by histological and morphometrical analysis combined with immunofluorescence staining and ultrastructural analysis by transmission electron microscopy. By intravenous injection of fluorescent high-molecular weight dextran, we confirmed leakage of the size selective filtration barrier. Additionally, we observed severe podocyte foot process effacement of remaining podocytes, activation of proximal tubule-like parietal epithelial cells identified by ultrastructural cytomorphology, and expression of proximal tubule markers. These activated cells deposited extracellular matrix on the glomerular tuft which are all hallmarks of FSGS. Our findings indicate that glomerular response to podocyte depletion in larval zebrafish resembles human FSGS in several important characteristics. Therefore, this model will help to investigate the disease development and the effects of potential drugs in a living organism.	[Hansen, Kerrin Ursula Ingeborg; Siegerist, Florian; Daniel, Sophie; Schindler, Maximilian; Iervolino, Anna; Blumenthal, Antje; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Cell Biol, Friedrich Loeffler Str 23c, D-17487 Greifswald, Germany; [Iervolino, Anna] Biogem Res Inst Gaetano Salvatore, Ariano Irpino, Italy; [Daniel, Christoph; Amann, Kerstin] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Erlangen, Germany; [Zhou, Weibin] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	Greifswald Medical School; University of Erlangen Nuremberg; Icahn School of Medicine at Mount Sinai	Endlich, N (corresponding author), Univ Med Greifswald, Inst Anat & Cell Biol, Friedrich Loeffler Str 23c, D-17487 Greifswald, Germany.	nicole.endlich@uni-greifswald.de	Siegerist, Florian/GLT-5780-2022; Daniel, Christoph/AAK-2136-2021	Siegerist, Florian/0000-0003-1629-4982; Schindler, Maximilian/0000-0001-8549-510X; Iervolino, Anna/0000-0003-0450-9587; Endlich, Karlhans/0000-0001-6052-6061	Bundesministerium fur Bildung und Forschung (BMBF) [01GM1518B]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: 01GM1518B	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Dijkman H, 2005, KIDNEY INT, V68, P1562, DOI 10.1111/j.1523-1755.2005.00568.x; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Endlich K, 2017, PFLUG ARCH EUR J PHY, V469, P937, DOI 10.1007/s00424-017-2025-8; Eng DG, 2015, KIDNEY INT, V88, P999, DOI 10.1038/ki.2015.152; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Holderied A, 2015, LAB INVEST, V95, P273, DOI 10.1038/labinvest.2014.160; Kato Y, 2020, TOXICOL SCI, V174, P241, DOI 10.1093/toxsci/kfaa009; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; KNOX RJ, 1988, BIOCHEM PHARMACOL, V37, P4661, DOI 10.1016/0006-2952(88)90335-8; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Kriz W, 1999, CURR OPIN NEPHROL HY, V8, P489, DOI 10.1097/00041552-199907000-00014; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Kriz W, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00207; Kuppe C, 2019, KIDNEY INT, V96, P80, DOI 10.1016/j.kint.2019.01.037; Kuppe C, 2015, KIDNEY INT, V88, P990, DOI 10.1038/ki.2015.116; Macary G, 2010, VIRCHOWS ARCH, V456, P325, DOI 10.1007/s00428-009-0840-9; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; McKee Robert A, 2015, Curr Pathobiol Rep, V3, P171; Miceli R, 2014, CELL DEV BIOL, V3, P1; Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012; Neal CR, 2005, J AM SOC NEPHROL, V16, P1223, DOI 10.1681/ASN.2004100822; Ohtaka A, 2002, AM J KIDNEY DIS, V39, P475, DOI 10.1053/ajkd.2002.31391; Pandey G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061290; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Romoli S, 2018, KIDNEY INT, V94, P1111, DOI 10.1016/j.kint.2018.08.013; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Siegerist F, 2017, ACTA PHYSIOL, V220, P167, DOI 10.1111/apha.12754; Siegerist F, 2017, SCI REP-UK, V7, DOI 10.1038/srep43655; Smeets B, 2004, J AM SOC NEPHROL, V15, P928, DOI 10.1097/01.ASN.0000120559.09189.82; Steenbergen PJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051269; Sun H, 2014, EBIOMEDICINE, V1, P107, DOI 10.1016/j.ebiom.2014.11.009; Suzuki T, 2009, AM J PATHOL, V174, P1675, DOI 10.2353/ajpath.2009.080789; Westhoff JH, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00583; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Yin CY, 2012, HEPATOLOGY, V56, P1958, DOI 10.1002/hep.25757; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776	44	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15961	15974		10.1096/fj.202000724R	http://dx.doi.org/10.1096/fj.202000724R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070374	Green Submitted, hybrid			2022-12-28	WOS:000581165100001
J	Olivero, CE; Dimitrova, N				Olivero, Christiane E.; Dimitrova, Nadya			Identification and characterization of functional long noncoding RNAs in cancer	FASEB JOURNAL			English	Article						cancer; function; GEMMs; identification; lncRNA	GENOME-WIDE ASSOCIATION; PROSTATE-SPECIFIC GENE; CELL-PROLIFERATION; PROGNOSTIC-FACTOR; LNCRNA MALAT1; EXPRESSION; LANDSCAPE; MYC; P53; LOCUS	Long noncoding RNAs (lncRNAs) have emerged as key regulators in a variety of cellular processes that influence disease states. In particular, many lncRNAs are genetically or epigenetically deregulated in cancer. However, whether lncRNA alterations are passengers acquired during cancer progression or can act as tumorigenic drivers is a topic of ongoing investigation. In this review, we examine the current methodologies underlying the identification of cancer-associated lncRNAs and highlight important considerations for evaluating their biological significance as cancer drivers.	[Olivero, Christiane E.; Dimitrova, Nadya] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Yale University	Dimitrova, N (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	nadya.dimitrova@yale.edu			Pew-Stewart Foundation for Cancer Research; National Cancer Institute [R37 CA230580]	Pew-Stewart Foundation for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to Lauren Winkler, Elena Martinez, and Giuseppe Militello for insightful comments. ND and CO are supported by grants from the Pew-Stewart Foundation for Cancer Research and from the National Cancer Institute (R37 CA230580). Figures were created with BioRender.com.	Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Amandio AR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006232; Amodio N, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0606-4; Arun G, 2019, RNA BIOL, V16, P860, DOI 10.1080/15476286.2019.1592072; Arun G, 2018, TRENDS MOL MED, V24, P257, DOI 10.1016/j.molmed.2018.01.001; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bertucci F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037943; Bester AC, 2018, CELL, V173, P649, DOI 10.1016/j.cell.2018.03.052; Blume CJ, 2015, LEUKEMIA, V29, P2015, DOI 10.1038/leu.2015.119; Botti G, 2018, CURR DRUG TARGETS, V19, P1220, DOI 10.2174/1389450118666170622091940; Brockdorff N, 2020, GENE DEV, V34, P733, DOI 10.1101/gad.337196.120; Cao LM, 2017, ELIFE, V6, DOI 10.7554/eLife.30433; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chaudhary R, 2017, ELIFE, V6, DOI 10.7554/eLife.23244; Chen X, 2017, CELL PHYSIOL BIOCHEM, V41, P1424, DOI 10.1159/000468005; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Colombo T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304208; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Diermeier SD, 2016, CELL REP, V17, P261, DOI 10.1016/j.celrep.2016.08.081; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dong XY, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/6723487; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao P, 2018, CELL, V174, P576, DOI 10.1016/j.cell.2018.06.003; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Ge YG, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/6807452; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Graham Lloyd D, 2011, Genes Cancer, V2, P829, DOI 10.1177/1947601911431081; GRAHAM M, 1985, NATURE, V314, P740, DOI 10.1038/314740a0; Grisanzio Chiara, 2010, Genes Cancer, V1, P555, DOI 10.1177/1947601910381380; Groff AF, 2016, CELL REP, V16, P2178, DOI 10.1016/j.celrep.2016.07.050; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashemi M, 2019, J GENET, V98, DOI 10.1007/s12041-019-1126-x; Hibi K, 1996, CANCER RES, V56, P480; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hosono Y, 2017, CELL, V171, P1559, DOI 10.1016/j.cell.2017.11.040; Hu WL, 2018, NAT CELL BIOL, V20, P492, DOI 10.1038/s41556-018-0066-7; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Hu Y, 2014, CANCER RES, V74, P6890, DOI 10.1158/0008-5472.CAN-14-0686; Hua JT, 2018, CELL, V174, P564, DOI 10.1016/j.cell.2018.06.014; Huang D, 2018, NAT IMMUNOL, V19, P1112, DOI 10.1038/s41590-018-0207-y; Huang X, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180365; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Idogawa M, 2017, INT J CANCER, V140, P2785, DOI 10.1002/ijc.30689; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jadaliha M, 2016, ONCOTARGET, V7, P40418, DOI 10.18632/oncotarget.9622; Jain AK, 2016, MOL CELL, V64, P967, DOI 10.1016/j.molcel.2016.10.039; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang H, 2018, CANCER LETT, V425, P78, DOI 10.1016/j.canlet.2018.03.038; Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawakami T, 2003, J UROLOGY, V169, P1546, DOI 10.1097/01.ju.0000044927.23323.5a; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Khorshidi HR, 2017, CELL J, V19, P72, DOI 10.22074/cellj.2017.4496; Kim J, 2018, NAT GENET, V50, P1705, DOI 10.1038/s41588-018-0252-3; Kim T, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju505; Kim T, 2014, P NATL ACAD SCI USA, V111, P4173, DOI 10.1073/pnas.1400350111; KONDO M, 1995, ONCOGENE, V10, P1193; Kong YH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00405; Lai F, 2020, MOL CELL, V77, P1032, DOI 10.1016/j.molcel.2019.12.029; Lee JS, 2020, MOL CELL, V77, P1044, DOI 10.1016/j.molcel.2019.12.011; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Li L, 2018, NUCLEIC ACIDS RES, V46, P4213, DOI 10.1093/nar/gky087; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li XL, 2017, CELL REP, V20, P2408, DOI 10.1016/j.celrep.2017.08.041; Lieberman J, 2018, NAT STRUCT MOL BIOL, V25, P357, DOI [10.1038/S41594-018-0054-4, 10.1038/s41594-018-0054-4]; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu SJ, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01995-4; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu YQ, 2018, CANCER RES, V78, P64, DOI 10.1158/0008-5472.CAN-17-0815; Marin-Bejar O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1331-y; Marin-Bejar O, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r104; Meijer D, 2006, MOL CANCER RES, V4, P379, DOI 10.1158/1541-7786.MCR-05-0156; Mello SS, 2017, GENE DEV, V31, P1095, DOI 10.1101/gad.284661.116; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Nissan A, 2012, INT J CANCER, V130, P1598, DOI 10.1002/ijc.26170; Olivero CE, 2020, MOL CELL, V77, P761, DOI 10.1016/j.molcel.2019.12.014; Pandey GK, 2014, CANCER CELL, V26, P722, DOI 10.1016/j.ccell.2014.09.014; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Petrovics G, 2004, ONCOGENE, V23, P605, DOI 10.1038/sj.onc.1207069; Porter JR, 2017, MOL CELL, V67, P1013, DOI 10.1016/j.molcel.2017.07.028; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qian XY, 2019, TRENDS BIOCHEM SCI, V44, P33, DOI 10.1016/j.tibs.2018.09.012; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sahakyan A, 2018, TRENDS CELL BIOL, V28, P999, DOI 10.1016/j.tcb.2018.05.005; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schmitt AM, 2016, NAT GENET, V48, P1370, DOI 10.1038/ng.3673; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Sharma S, 2020, MBIO, V11, DOI 10.1128/mBio.01190-20; Shen LB, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0034-x; Shima H, 2018, BREAST CANCER RES TR, V170, P507, DOI 10.1007/s10549-018-4793-z; Sirchia SM, 2005, CANCER RES, V65, P2139, DOI 10.1158/0008-5472.CAN-04-3465; Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216; Sun YT, 2019, CANCERS, V11, DOI 10.3390/cancers11020216; Swerdlow AJ, 2005, J NATL CANCER I, V97, P1204, DOI 10.1093/jnci/dji240; Szafron LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127475; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Vendramin R, 2018, NAT STRUCT MOL BIOL, V25, P1035, DOI 10.1038/s41594-018-0143-4; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Volders Pieter-Jan, 2018, Non-Coding RNA, V4, P21, DOI 10.3390/ncrna4030021; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang ZH, 2018, CANCER CELL, V33, P706, DOI 10.1016/j.ccell.2018.03.006; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wu CL, 2015, J BIOL CHEM, V290, P30175, DOI 10.1074/jbc.M115.661785; Wu LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31716; Wu WJ, 2013, GASTROENTEROLOGY, V144, P956, DOI 10.1053/j.gastro.2013.01.019; Xing F, 2018, CANCER RES, V78, P4316, DOI 10.1158/0008-5472.CAN-18-1102; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang C, 2017, ONCOTARGET, V8, P2672, DOI 10.18632/oncotarget.13737; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang DM, 2017, CANCER RES, V77, P3745, DOI 10.1158/0008-5472.CAN-16-1768; Zhang J, 2015, INT J CLIN EXP MED, V8, P5499; Zhang ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06862-2; Zhang TJ, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0486-z; Zhang XN, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035700, 10.1371/journal.pone.0035991]; Zhang YJ, 2018, NAT GENET, V50, P814, DOI 10.1038/s41588-018-0120-1; Zhao XW, 2016, ENVIRON MOL MUTAGEN, V57, P508, DOI 10.1002/em.22031; Zhou CC, 2016, HEPATOLOGY, V63, P850, DOI 10.1002/hep.28393; Zhou Y, 2017, CANCER GENE THER, V24, P317, DOI 10.1038/cgt.2017.20; Zhu PP, 2018, NAT CELL BIOL, V20, P1134, DOI 10.1038/s41556-018-0194-0; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	169	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15630	15646		10.1096/fj.202001951R	http://dx.doi.org/10.1096/fj.202001951R		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058262	hybrid, Green Published			2022-12-28	WOS:000581158500001
J	Luo, H; Chen, B; Weng, B; Tang, XW; Chen, Y; Yang, AQ; Chu, D; Zeng, XY; Ran, ML				Luo, Hui; Chen, Bin; Weng, Bo; Tang, Xiangwei; Chen, Yao; Yang, Anqi; Chu, Dan; Zeng, Xinyu; Ran, Maoliang			miR-130a promotes immature porcine Sertoli cell growth by activating SMAD5 through the TGF-beta-PI3K/AKT signaling pathway	FASEB JOURNAL			English	Article						miR-130a; PI3K; AKT signaling pathway; porcine Sertoli cells; proliferation; SMAD5; TGF-beta	TGF-BETA SUPERFAMILY; LONG NONCODING RNAS; INHIBITS PROLIFERATION; PI3K/AKT PATHWAY; MICRORNAS; IDENTIFICATION; EXPRESSION; CROSSTALK; APOPTOSIS; REVEALS	Sertoli cells play vital roles in normal spermatogenesis, and microRNAs (miRNAs) participate in regulating Sertoli cell development. However, the functions and mechanisms of action of most identified miRNAs in porcine Sertoli cells remain largely unknown. Herein, we primarily explored the regulatory roles of miR-130a in immature porcine Sertoli cells using EdU-based high-content screening assay. The results demonstrated that 27 miRNAs have potential roles in the promotion of immature porcine Sertoli cell proliferation, and miR-130a was identified as a promising candidate. miR-130a promoted cell cycle progression and cell proliferation, whereas it impeded cell apoptosis in immature porcine Sertoli cells. It also contributed to Sertoli cell proliferation and testis development in vivo. A TMT-based proteomics approach revealed that miR-130a regulated the expression of 91 proteins and multiple pathways, including the TGF-beta and PI3K/AKT signaling. miR-130a did not directly target the 3 '-UTR ofSMAD5; however, it increased SMAD5 phosphorylation. Moreover, miR-130a enhanced TGF-beta signaling by activating SMAD5 protein, and TGF-beta signaling further activated the PI3K/AKT signaling pathway to promote cell proliferation and inhibit cell apoptosis in porcine immature Sertoli cells. Collectively, miR-130a promoted immature porcine Sertoli cell growth by activating SMAD5 through the TGF-beta-PI3K/AKT signaling pathway. This study, therefore, provides novel insights into the effects of miR-130a on porcine spermatogenesis through the regulation of immature Sertoli cell proliferation and apoptosis.	[Luo, Hui; Chen, Bin; Weng, Bo; Tang, Xiangwei; Chen, Yao; Yang, Anqi; Chu, Dan; Zeng, Xinyu; Ran, Maoliang] Hunan Agr Univ, Hunan Prov Key Lab Genet Improvement Domest Anim, Coll Anim Sci & Technol, Changsha 410128, Hunan, Peoples R China	Hunan Agricultural University	Chen, B; Ran, ML (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Genet Improvement Domest Anim, Coll Anim Sci & Technol, Changsha 410128, Hunan, Peoples R China.	chenbin7586@hunau.edu.cn; ranmaoliang0903@126.com			Hunan Provincial Natural Science Foundation of China [2018JJ3219, 2018JJ2176, 2020JJ4348]; Scientific Research Fund of the Hunan Provincial Education Department [18B093]; Science and Technology Project of Changsha City [kq1901032]; earmarked fund for the China Agriculture Research System [CARS-36]	Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Scientific Research Fund of the Hunan Provincial Education Department(Hunan Provincial Education Department); Science and Technology Project of Changsha City; earmarked fund for the China Agriculture Research System	This work was financially supported by the Hunan Provincial Natural Science Foundation of China (2018JJ3219, 2018JJ2176, and 2020JJ4348), a project supported by the Scientific Research Fund of the Hunan Provincial Education Department (18B093), a Science and Technology Project of Changsha City (kq1901032), and the earmarked fund for the China Agriculture Research System (CARS-36)	Fan YS, 2012, MOL BIOL REP, V39, P4727, DOI 10.1007/s11033-011-1265-5; Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165; Gao H, 2020, REPRODUCTION, V159, P145, DOI 10.1530/REP-19-0303; Griswold MD, 2018, BIOL REPROD, V99, P87, DOI 10.1093/biolre/ioy027; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Hu PD, 2017, CELL CYCLE, V16, P2290, DOI 10.1080/15384101.2017.1380130; Huang Sha, 2018, Acta Veterinaria et Zootechnica Sinica, V49, P701; Hurtado A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197685; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Jiao ZJ, 2015, ENDOCRINOLOGY, V156, P4059, DOI 10.1210/en.2014-1982; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Liu DW, 2018, CELL CYCLE, V17, P2484, DOI 10.1080/15384101.2018.1542901; Liu WT, 2017, ONCOGENE, V36, P2715, DOI 10.1038/onc.2016.424; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Luo ZY, 2018, THERIOGENOLOGY, V117, P61, DOI 10.1016/j.theriogenology.2017.06.023; Luo ZG, 2015, J ASSIST REPROD GEN, V32, P451, DOI 10.1007/s10815-014-0406-x; Ma CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32783; Ma CP, 2016, IN VITRO CELL DEV-AN, V52, P427, DOI 10.1007/s11626-015-9994-8; MULLANEY BP, 1993, MOL ENDOCRINOL, V7, P67, DOI 10.1210/me.7.1.67; Nascimento AR, 2016, REPRODUCTION, V152, P613, DOI 10.1530/REP-16-0330; Ni FD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1782-z; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Ran ML, 2019, J INTEGR AGR, V18, P449, DOI [10.1016/S2095-3119(19)62612-2, 10.1016/s2095-3119(19)62612-2]; Ran ML, 2018, REPROD DOMEST ANIM, V53, P1375, DOI 10.1111/rda.13254; Ran ML, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136911; Ran ML, 2015, RSC ADV, V5, P63439, DOI 10.1039/c5ra07488f; SAUL MJ, 2019, FRONT PHARMACOL, V10; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Sun Y, 2015, THERIOGENOLOGY, V83, P86, DOI 10.1016/j.theriogenology.2014.08.003; Suwanabol PA, 2012, AM J PHYSIOL-HEART C, V302, pH2211, DOI 10.1152/ajpheart.00966.2011; Suzuki HI, 2017, CELL, V168, P1000, DOI 10.1016/j.cell.2017.02.015; Wang WC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010146; Wang YA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0390-7; Wang Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.10; Wang YM, 2020, EXP THER MED, V19, P2119, DOI 10.3892/etm.2020.8415; Wei HJ, 2017, CANCER RES, V77, P6168, DOI 10.1158/0008-5472.CAN-17-0530; Weng B, 2017, GENOMICS, V109, P446, DOI 10.1016/j.ygeno.2017.07.001; Weng B, 2017, GENES GENOM, V39, P1047, DOI 10.1007/s13258-017-0573-0; Wu SW, 2020, TRENDS MOL MED, V26, P215, DOI 10.1016/j.molmed.2019.09.006; Wu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04166-x; Xiao M, 2017, RNA BIOL, V14, P1326, DOI 10.1080/15476286.2015.1112487; Xu XY, 2018, THERIOGENOLOGY, V119, P105, DOI 10.1016/j.theriogenology.2018.06.026; Yang C, 2019, MOL THER-NUCL ACIDS, V14, P1, DOI 10.1016/j.omtn.2018.10.012; Yang WR, 2017, REPROD SCI, V24, P57, DOI 10.1177/1933719116649696; Yao CC, 2016, ONCOTARGET, V7, P2201, DOI 10.18632/oncotarget.6876; Young JC, 2015, SEMIN CELL DEV BIOL, V45, P94, DOI 10.1016/j.semcdb.2015.10.029; Zhang CY, 2019, EUR REV MED PHARMACO, V23, P4890, DOI 10.26355/eurrev_201906_18077; Zhang SX, 2019, DNA CELL BIOL, V38, P41, DOI 10.1089/dna.2018.4387; Zhang ZD, 2019, MOL MED REP, V19, P3505, DOI 10.3892/mmr.2019.10051	50	13	14	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15164	15179		10.1096/fj.202001384R	http://dx.doi.org/10.1096/fj.202001384R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918760	hybrid			2022-12-28	WOS:000570680300001
J	Kang, JJ; Fung, ML; Zhang, K; Lam, CS; Wu, SX; Huang, XF; Yang, SJ; Wong-Riley, MTT; Liu, YY				Kang, Jun-Jun; Fung, Man-Lung; Zhang, Kun; Lam, Chun-Sing; Wu, Sheng-Xi; Huang, Xiao-Feng; Yang, Shou-Jing; Wong-Riley, Margaret T. T.; Liu, Ying-Ying			Chronic intermittent hypoxia alters the dendritic mitochondrial structure and activity in the pre-Botzinger complex of rats	FASEB JOURNAL			English	Article						intermittent hypoxia; neuroplasticity; postsynaptic; respiration; ultrastructure.chronic	CYTOCHROME-OXIDASE; AXONS; PLASTICITY; NEURONS; CRISTAE; NEUROPLASTICITY; HYPERTENSION; MOVEMENT; MOTILITY; NETWORK	Mitochondrial bioenergetics is dynamically coupled with neuronal activities, which are altered by hypoxia-induced respiratory neuroplasticity. Here we report structural features of postsynaptic mitochondria in the pre-Botzinger complex (pre-BotC) of rats treated with chronic intermittent hypoxia (CIH) simulating a severe condition of obstructive sleep apnea. The subcellular changes in dendritic mitochondria and histochemistry of cytochrome c oxidase (CO) activity were examined in pre-BotC neurons localized by immunoreactivity of neurokinin 1 receptors. Assays of mitochondrial electron transport chain (ETC) complex I, IV, V activities, and membrane potential were performed in the ventrolateral medulla containing the pre-BotC region. We found significant decreases in the mean length and area of dendritic mitochondria in the pre-BotC of CIH rats, when compared to the normoxic control and hypoxic group with daily acute intermittent hypoxia (dAIH) that evokes robust synaptic plasticity. Notably, these morphological alterations were mainly observed in the mitochondria in close proximity to the synapses. In addition, the proportion of mitochondria presented with enlarged compartments and filamentous cytoskeletal elements in the CIH group was less than the control and dAIH groups. Intriguingly, these distinct characteristics of structural adaptability were observed in the mitochondria within spatially restricted dendritic spines. Furthermore, the proportion of moderately to darkly CO-reactive mitochondria was reduced in the CIH group, indicating reduced mitochondrial activity. Consistently, mitochondrial ETC enzyme activities and membrane potential were lowered in the CIH group. These findings suggest that hypoxia-induced respiratory plasticity was characterized by spatially confined mitochondrial alterations within postsynaptic spines in the pre-BotC neurons. In contrast to the robust plasticity evoked by dAIH preconditioning, a severe CIH challenge may weaken the local mitochondrial bioenergetics that the fuel postsynaptic activities of the respiratory motor drive.	[Kang, Jun-Jun; Zhang, Kun; Wu, Sheng-Xi; Liu, Ying-Ying] Fourth Mil Med Univ, Dept Neurobiol, 169 Chang Le Xi Rd, Xian 710032, Peoples R China; [Fung, Man-Lung; Lam, Chun-Sing] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Huang, Xiao-Feng; Yang, Shou-Jing] Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian, Peoples R China; [Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Air Force Military Medical University; University of Hong Kong; Air Force Military Medical University; Medical College of Wisconsin	Liu, YY (corresponding author), Fourth Mil Med Univ, Dept Neurobiol, 169 Chang Le Xi Rd, Xian 710032, Peoples R China.	yingyliu@fmmu.edu.cn	Wong-Riley, Margaret/AGM-6202-2022	Yang, Shou Jing/0000-0002-4662-4914	Natural Science Foundation of China [31171102, 31471097, 31971055, 81601056]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (grants: 31171102, 31471097, 31971055, 81601056). We thank Mr Lo YM for his technical assistance.	Barnett WH, 2017, EXP NEUROL, V287, P153, DOI 10.1016/j.expneurol.2016.05.036; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chopra S, 2016, AM J RESP CELL MOL, V54, P299, DOI 10.1165/rcmb.2015-0218TR; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cserep C, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0390-17.2018; Dale EA, 2014, PHYSIOLOGY, V29, P39, DOI 10.1152/physiol.00012.2013; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Del Rio R, 2016, HYPERTENSION, V68, P436, DOI 10.1161/HYPERTENSIONAHA.116.07255; Dougherty BJ, 2018, RESP PHYSIOL NEUROBI, V256, P50, DOI 10.1016/j.resp.2017.05.004; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Fischer TD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006169; Fu ZX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00043-3; Garcia AJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00571; Garcia AJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00004; Giachin G, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00043; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; HEVNER RF, 1989, J NEUROSCI, V9, P3884; Jayashankar V, 2016, CURR OPIN CELL BIOL, V38, P45, DOI 10.1016/j.ceb.2016.02.006; Kang JJ, 2019, EXP NEUROL, V313, P124, DOI 10.1016/j.expneurol.2018.12.008; Kang JJ, 2017, EXP NEUROL, V287, P165, DOI 10.1016/j.expneurol.2016.05.035; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Koizumi H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0081-16.2016; Lam CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117990; Lee A, 2018, CURR OPIN PHYSIOL, V3, P82, DOI 10.1016/j.cophys.2018.03.009; Lewis TL, 2016, CURR BIOL, V26, P2602, DOI 10.1016/j.cub.2016.07.064; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Liu YY, 2001, J APPL PHYSIOL, V90, P685, DOI 10.1152/jappl.2001.90.2.685; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Mitchell GS, 2003, J APPL PHYSIOL, V94, P358, DOI 10.1152/japplphysiol.00523.2002; Mitchell GS, 2001, J APPL PHYSIOL, V90, P2466, DOI 10.1152/jappl.2001.90.6.2466; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Overly CC, 1996, J CELL SCI, V109, P971; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Popov V, 2005, J COMP NEUROL, V492, P50, DOI 10.1002/cne.20682; Rangaraju V, 2019, CELL, V176, P73, DOI 10.1016/j.cell.2018.12.013; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rintoul GL, 2010, BBA-MOL BASIS DIS, V1802, P143, DOI 10.1016/j.bbadis.2009.09.005; Rowland KC, 2000, J NEUROSCI, V20, P9135; Semenza GL, 2015, J APPL PHYSIOL, V119, P1152, DOI 10.1152/japplphysiol.00162.2015; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Smith HL, 2016, ELIFE, V5, DOI 10.7554/eLife.15275; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SOKOLOFF L, 1992, PROG BRAIN RES, V94, P19; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Wagner OI, 2003, J NEUROSCI, V23, P9046; Wei XY, 2010, NEUROSCIENCE, V168, P61, DOI 10.1016/j.neuroscience.2010.03.023; Wilkerson JER, 2018, RESP PHYSIOL NEUROBI, V256, P15, DOI 10.1016/j.resp.2017.10.005; Wong-Riley MTT, 2012, ADV EXP MED BIOL, V748, P283, DOI 10.1007/978-1-4614-3573-0_12; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1989, VISUAL NEUROSCI, V2, P483, DOI 10.1017/S0952523800012384; Xing T, 2013, CLIN EXP PHARMACOL P, V40, P602, DOI 10.1111/1440-1681.12129; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027	59	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14588	14601		10.1096/fj.201902141R	http://dx.doi.org/10.1096/fj.201902141R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910512	Bronze			2022-12-28	WOS:000568310700001
J	Uil, M; Butter, LM; Claessen, N; Larsen, PW; Florquin, S; Roelofs, JJTH				Uil, Melissa; Butter, Loes M.; Claessen, Nike; Larsen, Per W.; Florquin, Sandrine; Roelofs, Joris J. T. H.			Platelet inhibition by ticagrelor is protective against diabetic nephropathy in mice	FASEB JOURNAL			English	Article						diabetes; diabetic kidney disease; endothelium; platelets	CORONARY-ARTERY-DISEASE; FUNCTION PROFILES; CLOPIDOGREL; DYSFUNCTION; MANAGEMENT; MELLITUS; ASPIRIN; P2Y12; HEART	Diabetic nephropathy (DN) is a major complication of diabetes and is associated with high risk for cardiovascular mortality, which is partially related to elevated platelet activity. Platelets are also active players in inflammation and fibrosis. In this study, we examine the effect of ticagrelor-induced platelet inhibition on the development of DN. DN was induced by unilateral nephrectomy followed by streptozotocin injections for 5 days. Mice received ticagrelor (300 mg/kg) or vehicle every other day, for 16 weeks. Experimental groups: non-diabetic control, diabetic control, non-diabetic ticagrelor, and diabetic ticagrelor. Ticagrelor treatment in diabetic mice lowered urinary albumin excretion, it prevented diabetes-induced mesangial matrix expansion, podocyte effacement, and glomerular endothelial cell injury, which includes loss of endothelial fenestrations, ICAM-1 expression, and PECAM expression. In addition, ticagrelor treatment prevented collagen IV deposition and macrophage infiltration in the tubulointerstitium and these diabetic mice showed lower systemic and tubular inflammation and tubular apoptosis. This tubular protection is likely to be a result of protection to the glomerular endothelium by ticagrelor, which reduces albuminuria and albumin toxicity to the tubules and reduced tubular and interstitial inflammation and fibrosis. In conclusion, ticagrelor-induced platelet inhibition protects against renal injury in diabetic mice, likely by protecting the glomerular endothelial cells.	[Uil, Melissa; Butter, Loes M.; Claessen, Nike; Larsen, Per W.; Florquin, Sandrine; Roelofs, Joris J. T. H.] Univ Amsterdam, Locat AMC, Amsterdam UMC, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam	Roelofs, JJTH (corresponding author), Univ Amsterdam, Locat AMC, Amsterdam UMC, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.roelofs@amsterdamumc.nl			ZonMw (Netherlands Organisation for Health Research and Development) [40-00703-97-12480]	ZonMw (Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development)	ZonMw (Netherlands Organisation for Health Research and Development), Grant/Award Number: 40-00703-97-12480	Alemayehu M, 2017, J AM COLL CARDIOL, V69, P2246, DOI 10.1016/j.jacc.2017.02.048; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Angiolillo DJ, 2006, AM J CARDIOL, V97, P38, DOI 10.1016/i.amicard.2005.07.106; Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Angiolillo DJ, 2006, J AM COLL CARDIOL, V48, P298, DOI 10.1016/j.jacc.2006.03.038; [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS3, DOI 10.2337/dc10-S003; Armstrong D, 2014, J CARDIOVASC PHARM T, V19, P209, DOI 10.1177/1074248413511693; Campo G, 2017, THROMB HAEMOSTASIS, V117, P1208, DOI 10.1160/TH16-12-0973; Ganbaatar B, 2018, ATHEROSCLEROSIS, V275, P124, DOI 10.1016/j.atherosclerosis.2018.05.053; Gurbel PA, 2010, CIRCULATION, V121, P1188, DOI 10.1161/CIRCULATIONAHA.109.919456; Jiang ZX, 2018, CAN J CARDIOL, V34, P1606, DOI 10.1016/j.cjca.2018.08.024; Kim HK, 2017, INT J CARDIOL, V240, P326, DOI 10.1016/j.ijcard.2017.04.108; Ma KL, 2019, INT UROL NEPHROL, V51, P551, DOI 10.1007/s11255-018-2059-7; Makino Hisashi, 2003, Clin Exp Nephrol, V7, P33, DOI 10.1007/s101570300004; Michelson AD, 2013, PLATELETS, P733; Michelson AD, 2013, PLATELETS, P295; Mudaliar S, 2004, J CLIN PHARMACOL, V44, P414, DOI 10.1177/0091270004263045; Najafian B., 2019, DIABETIC NEPHROPATHY, V1st, P113; Ntelis K, 2017, SEMIN ARTHRITIS RHEU, V47, P409, DOI 10.1016/j.semarthrit.2017.05.004; Volpe CMO, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0135-z; Rennert L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01589; Roelofs J.J., 2019, DIABETIC NEPHROPATHY, P277; Rossing P., 2019, DIABETIC NEPHROPATHY, P21; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Shanker G, 2006, J THROMB THROMBOLYS, V22, P213, DOI 10.1007/s11239-006-9033-4; Siasos G, 2019, HELL J CARDIOL, V59, P344, DOI 10.1016/j.hjc.2018.06.016; Storey RF, 2010, J AM COLL CARDIOL, V56, P1456, DOI 10.1016/j.jacc.2010.03.100; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Torngren K, 2013, CARDIOLOGY, V124, P252, DOI 10.1159/000347122; Uil M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23839-9; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Ye YM, 2015, ARTERIOSCL THROM VAS, V35, P1805, DOI 10.1161/ATVBAHA.115.305655; Zafrani L, 2015, AM J KIDNEY DIS, V66, P1083, DOI 10.1053/j.ajkd.2015.06.019	34	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13750	13761		10.1096/fj.202000897R	http://dx.doi.org/10.1096/fj.202000897R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32856376	hybrid			2022-12-28	WOS:000566008000001
J	Boff, D; Oliveira, VLS; Queiroz, CM; Galvao, I; Batista, NV; Gouwy, M; Menezes, GB; Cunha, TM; Verri, WA; Proost, P; Teixeira, MM; Amaral, FA				Boff, Daiane; Soares Oliveira, Vivian Louise; Queiroz Junior, Celso M.; Galvao, Izabela; Batista, Nathalia Vieira; Gouwy, Mieke; Menezes, Gustavo Batista; Cunha, Thiago Mattar; Verri Junior, Waldiceu Aparecido; Proost, Paul; Teixeira, Mauro Martins; Amaral, Flavio Almeida			Lipoxin A(4)impairs effective bacterial control and potentiates joint inflammation and damage caused byStaphylococcus aureusinfection	FASEB JOURNAL			English	Article						5-lipoxygenase; arthritis; inflammation	STAPHYLOCOCCUS-AUREUS; SEPTIC ARTHRITIS; LIPID MEDIATORS; DENDRITIC CELLS; RECEPTOR; RESOLUTION; SERUM; IDENTIFICATION; LEUKOTRIENES; NEUTROPHILS	Staphylococcus aureusis the main cause of septic arthritis in humans, a disease associated with high morbidity and mortality. Inflammation triggered in response to infection is fundamental to control bacterial growth but may cause permanent tissue damage. Here, we evaluated the role of Lipoxin A(4)(LXA(4)) inS aureus-induced arthritis in mice. Septic arthritis was induced byS aureusinjection into tibiofemoral joints. At different time points, we evaluated cell recruitment and bacterial load in the joint, the production of pro-inflammatory molecules, and LXA(4)in inflamed tissue and analyzed joint damage and dysfunction. LXA(4)was investigated using genetically modified mice or by pharmacological blockade of its synthesis and receptor. CD11c(+)cells were evaluated in lymph nodes by confocal microscopy and flow cytometry and dendritic cell chemotaxis using the Boyden chamber. Absence or pharmacological blockade of 5-lipoxygenase (5-LO) reduced joint inflammation and dysfunction and was associated with better control of infection at 4 to 7 days after the infection. There was an increase in LXA(4)in joints of S aureus-infected mice and administration of LXA(4)reversed the phenotype in 5-LO(-/-)mice. Blockade or absence of the LXA(4)receptor FPR2 has a phenotype similar to 5-LO(-/-)mice. Mechanistically, LXA(4)appeared to control migration and function of dendritic cells, cells shown to be crucial for adequate protective responses in the model. Thus, after the first days of infection when symptoms become evident therapies that inhibit LXA(4)synthesis or action could be useful for treatment ofS aureus-induced arthritis.	[Boff, Daiane; Soares Oliveira, Vivian Louise; Galvao, Izabela; Batista, Nathalia Vieira; Teixeira, Mauro Martins; Amaral, Flavio Almeida] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Immunopharmacol, Belo Horizonte, MG, Brazil; [Boff, Daiane; Gouwy, Mieke; Proost, Paul] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Mol Immunol, Leuven, Belgium; [Queiroz Junior, Celso M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morphol, Belo Horizonte, MG, Brazil; [Menezes, Gustavo Batista] Univ Fed Minas Gerais, Ctr Biol Gastrointestinal, Dept Morfol, Belo Horizonte, MG, Brazil; [Cunha, Thiago Mattar] Univ Sao Paulo, Ctr Res Inflammatory Dis, Fac Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Verri Junior, Waldiceu Aparecido] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Pathol Sci, Londrina, Parana, Brazil	Universidade Federal de Minas Gerais; KU Leuven; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Estadual de Londrina	Amaral, FA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Av Antonio Carlos 6627,Bloco O 4,Sala 202, Belo Horizonte, MG, Brazil.	famaral@icb.ufmg.br	Menezes, Gustavo B/B-3350-2013; WA, Verri/I-1330-2013; Cunha, Thiago M/B-7729-2012; Teixeira, Mauro M/A-4587-2008; Boff, Daiane/AAU-2149-2021; Proost, Paul/V-3052-2017; Gouwy, Mieke/I-4642-2018	WA, Verri/0000-0003-2756-9283; Cunha, Thiago M/0000-0003-1084-0065; Teixeira, Mauro M/0000-0002-6944-3008; Proost, Paul/0000-0002-0133-5545; Boff, Daiane/0000-0001-8127-916X; Soares de Oliveira, Vivian Louise/0000-0002-1798-5171; Gouwy, Mieke/0000-0002-4035-4810	MCTI \Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ 03072-15]; National Institute of Science and Technology in Dengue and Host-Microorganism Interaction-INCT Dengue [CNPq 465425/2014-3]; FAPEMIG [APQ03606-17]; Programa de Apoio a Grupos de Excelencia (PRONEX) grant by SETI/Araucaria Foundation; MCTI/ CNPq; Parana State Government [014/2017, 46.843, CNPq 427946/20182]; Fund for Scientific Research of Flanders; KU Leuven [C16/17/010]	MCTI \Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Institute of Science and Technology in Dengue and Host-Microorganism Interaction-INCT Dengue; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa de Apoio a Grupos de Excelencia (PRONEX) grant by SETI/Araucaria Foundation; MCTI/ CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Parana State Government; Fund for Scientific Research of Flanders(FWO); KU Leuven(KU Leuven)	MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Grant/Award Number: APQ 03072-15; National Institute of Science and Technology in Dengue and Host-Microorganism Interaction-INCT Dengue, Grant/Award Number: CNPq 465425/2014-3 and FAPEMIG APQ03606-17; Programa de Apoio a Grupos de Excelencia (PRONEX) grant supported by SETI/Araucaria Foundation and MCTI/ CNPq and Parana State Government (agreement 014/2017, protocol 46.843), Grant/Award Number: CNPq 427946/20182:; Fund for Scientific Research of Flanders, and C1 funding (C16/17/010) of the KU Leuven	Ackermann JA, 2017, BBA-MOL CELL BIOL L, V1862, P371, DOI 10.1016/j.bbalip.2016.07.014; Balderia PG, 2015, JCR-J CLIN RHEUMATOL, V21, P196, DOI 10.1097/RHU.0000000000000249; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Bekeredjian-Ding I, 2017, CURR TOP MICROBIOL, V409, P385, DOI 10.1007/82_2015_5004; Bena S, 2012, J BIOL CHEM, V287, P24690, DOI 10.1074/jbc.M112.377101; Blaho VA, 2011, J IMMUNOL, V186, P3076, DOI 10.4049/jimmunol.1003473; Boff D, 2018, EUR J IMMUNOL, V48, P454, DOI 10.1002/eji.201747198; Broker BM, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010031; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Coelho FM, 2008, ARTHRITIS RHEUM-US, V58, P2329, DOI 10.1002/art.23622; Colavite PM, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-19; De Buck M, 2016, CYTOKINE GROWTH F R, V30, P55, DOI 10.1016/j.cytogfr.2015.12.010; De Buck M, 2013, BIOCHEM PHARMACOL, V85, P789, DOI 10.1016/j.bcp.2012.11.027; Dey S, 2015, J INFLAMM RES, V8, P29, DOI 10.2147/JIR.S76045; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Garcia-De La Torre I, 2009, RHEUM DIS CLIN N AM, V35, P63, DOI 10.1016/j.rdc.2009.03.001; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; HENDERSON WR, 1994, ANN INTERN MED, V121, P684, DOI 10.7326/0003-4819-121-9-199411010-00010; Henningsson L, 2010, INFECT IMMUN, V78, P3783, DOI 10.1128/IAI.00385-10; Kennedy N, 2015, J RHEUMATOL, V42, P2392, DOI 10.3899/jrheum.150434; Khan FY, 2013, CLIN RHEUMATOL, V32, P969, DOI 10.1007/s10067-013-2211-9; Kobayashi D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09113-4; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; McGovern NN, 2011, J IMMUNOL, V186, P453, DOI 10.4049/jimmunol.1002213; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Mullen LM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0645-y; Peters-Golden M, 2001, FEBS LETT, V487, P323, DOI 10.1016/S0014-5793(00)02374-7; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Pizzolla A, 2012, J IMMUNOL, V188, P5003, DOI 10.4049/jimmunol.1103430; Proost P, 2003, EUR J IMMUNOL, V33, P3146, DOI 10.1002/eji.200324136; Queiroz CM, 2011, J IMMUNOL, V187, P3821, DOI 10.4049/jimmunol.1101195; Ross JJ, 2017, INFECT DIS CLIN N AM, V31, P203, DOI 10.1016/j.idc.2017.01.001; Sachs D, 2011, BRIT J PHARMACOL, V162, P72, DOI 10.1111/j.1476-5381.2010.00895.x; Santos PC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002390; Schindler D, 2012, AM J PATHOL, V181, P1327, DOI 10.1016/j.ajpath.2012.06.039; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Secatto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031701; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Sharba S, 2019, VIRULENCE, V10, P610, DOI 10.1080/21505594.2019.1635417; Singel KL, 2016, CLIN SCI, V130, P479, DOI 10.1042/CS20150660; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Weiss E, 2018, FASEB J, V32, P26, DOI 10.1096/fj.201700441R; Winkler JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18972; Zhang Y, 2017, J LIPID RES, V58, P494, DOI 10.1194/jlr.M068882	52	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11498	11510		10.1096/fj.201802830RR	http://dx.doi.org/10.1096/fj.201802830RR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32741032				2022-12-28	WOS:000558169200001
J	Jiao, LY; Zheng, MG; Duan, JH; Wu, T; Li, Z; Liu, L; Xiang, XH; Tang, XL; He, JY; Li, XJ; Zhang, GF; Ding, JH; Cai, HB; Lin, X				Jiao, Luyan; Zheng, Meige; Duan, Jinhai; Wu, Ting; Li, Zhao; Liu, Lin; Xiang, Xianhong; Tang, Xiaolu; He, Jinyang; Li, Xingjian; Zhang, Guofeng; Ding, Jinhui; Cai, Huaibin; Lin, Xian			Tau knockout exacerbates degeneration of parvalbumin-positive neurons in substantia nigra pars reticulata in Parkinson's disease-related alpha-synuclein A53T mice	FASEB JOURNAL			English	Article						neurodegeneration; parvalbumin; SNR; synuclein	VENTRAL TEGMENTAL AREA; PROTEIN 1A MAP1A; DOPAMINERGIC-NEURONS; ORGANIZATION; EXPRESSION; PHOSPHORYLATION; DEGRADATION; MATURATION; MUTATIONS; DEFICITS	alpha-Synuclein (alpha-syn)-induced neurotoxicity has been generally accepted as a key step in the pathogenesis of Parkinson's disease (PD). Microtubule-associated protein tau, which is considered second only to alpha-syn, has been repeatedly linked with PD in association studies. However, the underlying interaction between these two PD-related proteins in vivo remains unclear. To investigate how the expression of tau affects alpha-syn-induced neurodegeneration in vivo, we generated triple transgenic mice that overexpressed alpha-syn A53T mutation in the midbrain dopaminergic neurons (mDANs) with different expression levels of tau. Here, we found that tau had no significant effect on the A53T alpha-syn-mediated mDANs degeneration. However, tau knockout could modestly promote the formation of alpha-syn aggregates, accelerate the severe and progressive degeneration of parvalbumin-positive (PV+) neurons in substantia nigra pars reticulata (SNR), accompanied with anxiety-like behavior in aged PD-related alpha-syn A53T mice. The mechanisms may be associated with A53T alpha-syn-mediated specifically successive impairment of N-methyl-d-aspartate receptor subunit 2B (NR2B), postsynaptic density-95 (PSD-95) and microtubule-associated protein 1A (MAP1A) in PV(+)neurons. Our study indicates that MAP1A may play a beneficial role in preserving the survival of PV(+)neurons, and that inhibition of the impairment of NR2B/PSD-95/MAP1A pathway, may be a novel and preferential option to ameliorate alpha-syn-induced neurodegeneration.	[Jiao, Luyan; Wu, Ting; Li, Zhao; Liu, Lin; Li, Xingjian; Zhang, Guofeng; Lin, Xian] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou, Peoples R China; [Jiao, Luyan; Wu, Ting; Li, Zhao; Liu, Lin; Li, Xingjian; Zhang, Guofeng; Lin, Xian] Sun Yat Sen Univ, Dept Anat, Zhongshan Sch Med, Guangzhou, Peoples R China; [Zheng, Meige] Anhui Med Univ, Dept Orthopaed, Hosp 2, Hefei, Peoples R China; [Duan, Jinhai] Guangdong Acad Med Sci, Guangdong Inst Geriatr, Dept Neurol, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China; [Xiang, Xianhong] Sun Yat Sen Univ, Dept Intervent Radiol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Tang, Xiaolu] Gannan Med Univ, Coll Basic Med, Dept Human Anat, Univ Pk Rongjiang New Dist, Ganzhou, Peoples R China; [He, Jinyang] Guangzhou Univ Chinese Med, Trop Med Inst, Guangzhou, Peoples R China; [Ding, Jinhui] NIA, Bioinformat Core, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Cai, Huaibin] NIA, Transgen Sect, Lab Neurogenet, NIH, Bethesda, MD 20892 USA	Sun Yat Sen University; Sun Yat Sen University; Anhui Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University; Gannan Medical University; Guangzhou University of Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lin, X (corresponding author), Sun Yat Sen Univ, Dept Anat, 74,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Lin, X (corresponding author), Sun Yat Sen Univ, Res Ctr Neurobiol, Zhongshan Sch Med, 74,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	linxian3@mail.sysu.edu.cn	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	National Natural Science Foundation of China Grants (NSFC) [31271555, 81171211]; Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) [2016A050502009, 7300973, S2012010009108, 2020A1515010318]; State Education Ministry of China [2012-1707]; Guangzhou Municipal Science and Technology Project [201904010066]	National Natural Science Foundation of China Grants (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province); State Education Ministry of China(Ministry of Education, China); Guangzhou Municipal Science and Technology Project	National Natural Science Foundation of China Grants (NSFC), Grant/Award Number: 31271555 and 81171211; Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province), Grant/Award Number: 2016A050502009, 7300973, S2012010009108 and 2020A1515010318; State Education Ministry of China, Grant/Award Number: 2012-1707; Guangzhou Municipal Science and Technology Project, Grant/Award Number: 201904010066	Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Clemmensen C, 2012, CELL MOL NEUROBIOL, V32, P561, DOI 10.1007/s10571-011-9796-9; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dawson HN, 2001, J CELL SCI, V114, P1179; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Fu YH, 2012, BRAIN STRUCT FUNCT, V217, P591, DOI 10.1007/s00429-011-0349-2; GOETZ CG, 1993, NEUROLOGY, V43, P1; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hardman CD, 1996, NEURODEGENERATION, V5, P49; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Liang D, 2016, BEHAV BRAIN RES, V296, P134, DOI 10.1016/j.bbr.2015.08.033; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu Y, 2015, J NEUROSCI, V35, P4587, DOI 10.1523/JNEUROSCI.2757-14.2015; McRitchie DA, 1996, J COMP NEUROL, V364, P121, DOI 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Navarria L, 2015, NEUROCHEM INT, V85-86, P14, DOI 10.1016/j.neuint.2015.03.008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nevet A, 2004, J NEUROPHYSIOL, V92, P1973, DOI 10.1152/jn.01036.2003; Paxinos GAFK, 2008, MOUSE BRAIN STEREOTA, P18; Powell SB, 2012, NEUROPHARMACOLOGY, V62, P1322, DOI 10.1016/j.neuropharm.2011.01.049; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takei Y, 2015, J NEUROSCI, V35, P15539, DOI 10.1523/JNEUROSCI.2671-15.2015; Tang XL, 2018, NEUROSCIENCE, V373, P52, DOI 10.1016/j.neuroscience.2018.01.002; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Zheng MG, 2017, FASEB J, V31, P3349, DOI 10.1096/fj.201601303R; Zhou FM, 2011, NEUROSCIENCE, V198, P69, DOI 10.1016/j.neuroscience.2011.07.061; Zhou FW, 2009, J NEUROSCI, V29, P10424, DOI 10.1523/JNEUROSCI.4402-08.2009	39	2	2	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12239	12254		10.1096/fj.202000017RR	http://dx.doi.org/10.1096/fj.202000017RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33000527	Green Accepted			2022-12-28	WOS:000556802500001
J	Rosa, HS; Ajaz, S; Gnudi, L; Malik, AN				Rosa, Hannah S.; Ajaz, Saima; Gnudi, Luigi; Malik, Afshan N.			A case for measuring both cellular and cell-free mitochondrial DNA as a disease biomarker in human blood	FASEB JOURNAL			English	Article						absolute quantification; circulating nucleic acids; inflammation; mitochondria; qPCR	COPY NUMBER; POTENTIAL BIOMARKER; PLASMA; ASSOCIATION; DAMAGE; RISK; PCR	Circulating mitochondrial DNA (mtDNA), widely studied as a disease biomarker, comprises of mtDNA located within mitochondria, indicative of mitochondrial function, and cell-free (cf) mtDNA linked to inflammation. The purpose of this study was to determine the ranges of, and relationship between, cellular and cf mtDNA in human blood. Whole blood from 23 controls (HC) and 20 patients with diabetes was separated into peripheral blood mononuclear cells (PBMCs), plasma, and serum. Total DNA was isolated and mtDNA copy numbers were determined using absolute quantification. Cellular mtDNA content in PBMCs was higher than in peripheral blood and a surprisingly high level of cf mtDNA was present in serum and plasma of HC, with no direct relationship between cellular and cf mtDNA content within individuals. Diabetes patients had similar levels of cellular mtDNA compared to healthy participants but a significantly higher cf mtDNA content. Furthermore, only in patients with diabetes, we observed a correlation between whole blood and plasma mtDNA levels, indicating that the relationship between cellular and cf mtDNA content is affected by disease status. In conclusion, when evaluating mtDNA in human blood as a biomarker of mitochondrial dysfunction, it is important to measure both cellular and cf mtDNA.	[Rosa, Hannah S.; Ajaz, Saima; Malik, Afshan N.] Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Dept Diabet, 2nd Floor Hodgkin Bldg,Guys Campus, London SE1 1UL, England; [Gnudi, Luigi; Malik, Afshan N.] Kings Coll London, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, London, England	University of London; King's College London; University of London; King's College London	Malik, AN (corresponding author), Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Dept Diabet, 2nd Floor Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	afshan.malik@kcl.ac.uk		Rosa, Hannah/0000-0003-4624-752X; Ajaz, Saima/0000-0002-1089-1949	European Foundation for the Study of Diabetes (EFSD)	European Foundation for the Study of Diabetes (EFSD)	\European Foundation for the Study of Diabetes (EFSD)	Afrifa J, 2019, MITOCHONDRION, V47, P238, DOI 10.1016/j.mito.2018.12.003; Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arshad O, 2018, JAIDS-J ACQ IMM DEF, V78, P111, DOI 10.1097/QAI.0000000000001650; Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3; Bae JH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040328; Bianco Angelica, 2018, BMC Res Notes, V11, P911, DOI 10.1186/s13104-018-4025-y; Biro O, 2018, BIOMARK MED, V12, P891, DOI 10.2217/bmm-2017-0386; Boyapati RK, 2018, INFLAMM BOWEL DIS, V24, P2113, DOI 10.1093/ibd/izy095; Cao HD, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3131; Cao HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113179; Casula M, 2005, J INFECT DIS, V192, P1794, DOI 10.1086/497140; Canizales YGC, 2018, IRAN J IMMUNOL, V15, P142, DOI IJIv15i2A7; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Cicchillitti L, 2017, ONCOTARGET, V8, DOI [10.18632/oncotar-get.v8i70, DOI 10.18632/ONCOTAR-GET.V8I70]; Cossarizza A, 2003, CURR OPIN INFECT DIS, V16, P5, DOI 10.1097/00001432-200302000-00002; Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002; Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR; Dai Z, 2015, CURR MOL MED, V15, P975, DOI 10.2174/1566524016666151123114401; Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262; Harrington JS, 2019, CHEST, V156, P1120, DOI 10.1016/j.chest.2019.07.014; Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Knez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181036; Kumar M, 2017, CLIN THER, V39, pe68, DOI DOI 10.1177/1010428317736643; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lei L, 2017, J HUM HYPERTENS, V31, P585, DOI 10.1038/jhh.2017.30; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Liu J, 2015, CLIN LAB, V61, P661, DOI 10.7754/Clin.Lab.2014.141132; Longchamps R.J., 2019, EVALUATION MITOCHOND; Lowes H, 2019, MITOCHONDRION, V46, P307, DOI 10.1016/j.mito.2018.07.008; Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067; Malik AN, 2018, MITOCHONDRIAL BIOL E, P297; McCarthy CG, 2015, CARDIOVASC RES, V107, P119, DOI 10.1093/cvr/cvv137; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Picard M, 2018, BIOL PSYCHIAT, V84, P9, DOI 10.1016/j.biopsych.2018.01.012; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515; Qin CY, 2017, ANATOL J CARDIOL, V17, P224, DOI 10.14744/AnatolJCardiol.2016.7209; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Rykova E, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1295-z; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Silzer T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213527; Stertz L, 2015, ACTA PSYCHIAT SCAND, V132, P211, DOI 10.1111/acps.12417; Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3; Tripathi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26749; Udomsinprasert W, 2019, MITOCHONDRION, V47, P1, DOI 10.1016/j.mito.2019.04.006; Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008; Workalemahu T, 2017, J MATERN-FETAL NEO M, V30, P2433, DOI 10.1080/14767058.2016.1252747; Yang Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212808; Zhang RY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36097; Zhong F, 2019, TRENDS IMMUNOL, V40, P1120, DOI 10.1016/j.it.2019.10.008	56	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12278	12288		10.1096/fj.202000959RR	http://dx.doi.org/10.1096/fj.202000959RR		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729179	hybrid			2022-12-28	WOS:000556784700001
J	Vallabhajosyula, S; Ponamgi, SP; Shrivastava, S; Sundaragiri, PR; Miller, VM				Vallabhajosyula, Saraschandra; Ponamgi, Shiva P.; Shrivastava, Sanskriti; Sundaragiri, Pranathi R.; Miller, Virginia M.			Reporting of sex as a variable in cardiovascular studies using cultured cells: A systematic review	FASEB JOURNAL			English	Review						cardiology; cells; culture; endothelium; myocyte; sex; vascular smooth muscle	SMOOTH-MUSCLE-CELLS; ACUTE MYOCARDIAL-INFARCTION; IN-HOSPITAL OUTCOMES; INFECTIVE ENDOCARDITIS; HEART-FAILURE; SEPSIS; PROLIFERATION; MICROVESICLES; DYSFUNCTION; EXPRESSION	Reporting the sex of biological material is critical for transparency and reproducibility in science. This study examined the reporting of the sex of cells used in cardiovascular studies. Articles from 16 cardiovascular journals that publish peer-reviewed studies in cardiovascular physiology and pharmacology in the year 2018 were systematically reviewed using terms "cultured" and "cells." Data were collected on the sex of cells, the species from which the cells were isolated, and the type of cells, and summarized as a systematic review. Sex was reported in 88 (38.6%) of the 228 studies meeting inclusion criteria. Reporting rates varied withCirculation, Cardiovascular ResearchandAmerican Journal of Physiology: Heart and Circulatory Physiologyhaving the highest rates of sex reporting (>50%). A majority of the studies used cells from male (54.5%) or both male and female animals (32.9%). Humans (31.8%), rats (20.4%), and mice (43.8%) were the most common sources for cells. Cardiac myocytes were the most commonly used cell type (37.0%). Overall reporting of sex of experimental material remains below 50% and is inconsistent among journals. Sex chromosomes in cells have the potential to affect protein expression and molecular signaling pathways and should be consistently reported.	[Vallabhajosyula, Saraschandra; Shrivastava, Sanskriti] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA; [Vallabhajosyula, Saraschandra] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN USA; [Vallabhajosyula, Saraschandra] Mayo Clin, Ctr Clin & Translat Sci, Grad Sch Biomed Sci, Rochester, MN USA; [Ponamgi, Shiva P.; Sundaragiri, Pranathi R.] Mayo Clin, Div Hosp Internal Med, Dept Med, Rochester, MN USA; [Miller, Virginia M.] Mayo Clin, Dept Surg, 200 First St SW, Rochester, MN 55905 USA; [Miller, Virginia M.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Miller, VM (corresponding author), Mayo Clin, Dept Surg, 200 First St SW, Rochester, MN 55905 USA.	Miller.Virginia@mayo.edu	Vallabhajosyula, Saraschandra/I-9707-2019	Vallabhajosyula, Saraschandra/0000-0002-1631-8238	NCATS NIH HHS [UL1 TR000135] Funding Source: Medline; NIA NIH HHS [U54 AG044170] Funding Source: Medline; NICHD NIH HHS [K12 HD065987] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Antoniucci D, 2001, ENDOTHELIUM-J ENDOTH, V8, P137, DOI 10.3109/10623320109165322; Bacakova L, 2001, HISTOL HISTOPATHOL, V16, P675, DOI 10.14670/HH-16.675; Beale AL, 2018, CIRCULATION, V138, P198, DOI 10.1161/CIRCULATIONAHA.118.034271; Cheungpasitporn W, 2020, HOSP PRACT, V1995, P1; Clayton JA, 2018, PHYSIOL BEHAV, V187, P2, DOI 10.1016/j.physbeh.2017.08.012; Egbe AC, 2019, INT J CARDIOL, V297, P49, DOI 10.1016/j.ijcard.2019.09.001; Egbe AC, 2020, INT J CARDIOL, V299, P136, DOI 10.1016/j.ijcard.2019.07.063; Egbe AC, 2019, CAN J CARDIOL, V35, P721, DOI 10.1016/j.cjca.2019.02.006; Egbe AC, 2019, AM J CARDIOL, V123, P1999, DOI 10.1016/j.amjcard.2019.03.010; Faubion SS, 2019, MENOPAUSE, V26, P1425, DOI 10.1097/GME.0000000000001412; Greiten LE, 2014, J CARDIOVASC TRANSL, V7, P139, DOI 10.1007/s12265-013-9514-8; Gustafson CM, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0028-8; Hayes SN, 2018, CIRCULATION, V137, pE523, DOI 10.1161/CIR.0000000000000564; Hunter LW, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0241-y; Jayachandran M, 2004, J APPL PHYSIOL, V97, P1445, DOI 10.1152/japplphysiol.01074.2003; Jayachandran M, 2003, PLATELETS, V14, P75, DOI 10.1080/0953710031000080562; Jentzer JC, 2018, CHEST, V154, P416, DOI 10.1016/j.chest.2017.12.021; Kaewput W, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020455; Kararigas G, 2012, J AM COLL CARDIOL, V59, P410, DOI 10.1016/j.jacc.2011.09.054; Kotecha AA, 2018, J INTENSIVE CARE MED, p885066618768180; Kotecha A, 2018, J CRIT CARE, V43, P122, DOI 10.1016/j.jcrc.2017.08.044; Lee SK, 2018, BMB REP, V51, P167, DOI 10.5483/BMBRep.2018.51.4.034; Loukotova J, 1998, PHYSIOL RES, V47, P501; McCullough LD, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0015-5; Miller LR, 2017, FASEB J, V31, P29, DOI 10.1096/fj.201600781R; Miller VM, 2015, J WOMENS HEALTH, V24, P969, DOI 10.1089/jwh.2015.5498; Miller Virginia M, 2013, Minn Med, V96, P46; Miller VM, 2012, AM J PHYSIOL-CELL PH, V302, pC1269, DOI 10.1152/ajpcell.00073.2012; Miller Virginia M, 2011, Biol Sex Differ, V2, P14, DOI 10.1186/2042-6410-2-14; Pandompatam Govind, 2019, Rev. bras. ter. intensiva, V31, P368, DOI [10.5935/0103-507x.20190060, 10.5935/0103-507X.20190060]; Poterucha JT, 2019, CONGENIT HEART DIS, V14, P193, DOI 10.1111/chd.12717; Rayes HA, 2020, CLIN RES CARDIOL, V109, P616, DOI 10.1007/s00392-019-01549-0; Sakhuja A, 2017, RESUSCITATION, V121, P84, DOI 10.1016/j.resuscitation.2017.10.010; Shufelt CL, 2018, ADV EXP MED BIOL, V1065, P433, DOI 10.1007/978-3-319-77932-4_27; Snipelisky D, 2017, AM J CARDIOL, V119, P1008, DOI 10.1016/j.amjcard.2016.11.060; Subramaniam AV, 2019, CARDIOL THER, V8, P211, DOI 10.1007/s40119-019-00152-8; Taylor K Efua, 2011, Biol Sex Differ, V2, P11, DOI 10.1186/2042-6410-2-11; THONGPRAYOON C, 2020, MEDICINA LITHUANIA, V0056, DOI DOI 10.3390/MEDICINA56030103; Thongprayoon C, 2020, HOSP PRACT, V48, P75, DOI 10.1080/21548331.2020.1729621; TRAVO P, 1980, BLOOD VESSELS, V17, P110; Vallabhajosyula S, 2018, ANAESTH INTENS CARE, V46, P13, DOI 10.1177/0310057X1804600104; Vallabhajosyula Saarwaani, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P50, DOI 10.1016/j.mayocpiqo.2019.10.008; Vallabhajosyula S, 2019, AGING-US, V11, P4774, DOI 10.18632/aging.102104; Vallabhajosyula S, 2020, INT J CARDIOL, V310, P9, DOI 10.1016/j.ijcard.2020.02.033; Vallabhajosyula S, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.119.006661; Vallabhajosyula S, 2020, ASAIO J, V66, P980, DOI 10.1097/MAT.0000000000001125; Vallabhajosyula S, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.119.005929; Vallabhajosyula S, 2020, RESUSCITATION, V148, P242, DOI 10.1016/j.resuscitation.2019.11.007; Vallabhajosyula S, 2021, EUROINTERVENTION, V16, pE1254, DOI 10.4244/EIJ-D-19-00226; Vallabhajosyula S, 2020, CATHETER CARDIO INTE, V96, pE59, DOI 10.1002/ccd.28543; Vallabhajosyula S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222894; Vallabhajosyula S, 2019, IJC HEART VASC, V24, DOI 10.1016/j.ijcha.2019.100414; Vallabhajosyula S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0571-2; Vallabhajosyula S, 2020, ASAIO J, V66, P497, DOI 10.1097/MAT.0000000000001039; Vallabhajosyula S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.011954; Vallabhajosyula S, 2019, ANN INTERN MED, V171, pJC4, DOI 10.7326/ACPJ201907160-004; Vallabhajosyula S, 2019, ESC HEART FAIL, V6, P874, DOI 10.1002/ehf2.12482; Vallabhajosyula S, 2019, AM J CARDIOL, V124, P491, DOI 10.1016/j.amjcard.2019.05.038; Vallabhajosyula S, 2019, JACC-HEART FAIL, V7, P469, DOI 10.1016/j.jchf.2018.12.007; Vallabhajosyula S, 2019, J AM COLL CARDIOL, V73, P1781, DOI 10.1016/j.jacc.2019.01.053; Vallabhajosyula S, 2019, INT J CARDIOL, V285, P6, DOI 10.1016/j.ijcard.2019.03.008; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010193; Vallabhajosyula S, 2019, J CRIT CARE, V50, P201, DOI 10.1016/j.jcrc.2018.12.008; Vallabhajosyula S, 2019, AM J CARDIOL, V123, P489, DOI 10.1016/j.amjcard.2018.10.029; Vallabhajosyula S, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0459-6; Vallabhajosyula S, 2018, J INTENSIVE CARE MED, V33, P680, DOI 10.1177/0885066616684774; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009160; Vallabhajosyula S, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006930; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009608; Vallabhajosyula S, 2019, J INTENSIVE CARE MED, V34, P87, DOI 10.1177/0885066618761750; Vallabhajosyula S, 2018, J INTENSIVE CARE MED, V33, P635, DOI 10.1177/0885066616682232; Vallabhajosyula S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190965; Vallabhajosyula S, 2018, SHOCK, V49, P144, DOI 10.1097/SHK.0000000000000952; Vallabhajosyula S, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005930; Vallabhajosyula S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0319-9; Vallabhajosyula S, 2017, J CRIT CARE, V37, P189, DOI 10.1016/j.jcrc.2016.09.025; Vallabhajosyula S, 2016, COPD, V13, P712, DOI 10.1080/15412555.2016.1195349; Vallabhajosyula S, 2016, INDIAN J CRIT CARE M, V20, P597, DOI 10.4103/0972-5229.192051; Vallabhajosyula S, 2016, J GLOB INFECT DIS, V8, P124, DOI 10.4103/0974-777X.188598; Ventura-Clapier R, 2017, CARDIOVASC RES, V113, P711, DOI 10.1093/cvr/cvx066; Wald C, 2010, SCIENCE, V327, P1571, DOI 10.1126/science.327.5973.1571; Wang XF, 1997, AM J PHYSIOL-HEART C, V273, pH1962, DOI 10.1152/ajpheart.1997.273.4.H1962; Winham SJ, 2015, ATHEROSCLEROSIS, V241, P219, DOI 10.1016/j.atherosclerosis.2015.03.021; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	84	8	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8778	8786		10.1096/fj.202000122R	http://dx.doi.org/10.1096/fj.202000122R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32946179	Green Published, hybrid			2022-12-28	WOS:000546308400003
J	D'Amico, D; Gammazza, AM; Macaluso, F; Paladino, L; Scalia, F; Spinoso, G; Dimauro, I; Caporossi, D; Cappello, F; Di Felice, V; Barone, R				D'Amico, Daniela; Gammazza, Antonella Marino; Macaluso, Filippo; Paladino, Letizia; Scalia, Federica; Spinoso, Giulio; Dimauro, Ivan; Caporossi, Daniela; Cappello, Francesco; Di Felice, Valentina; Barone, Rosario			Sex-based differences after a single bout of exercise on PGC1 alpha isoforms in skeletal muscle: A pilot study	FASEB JOURNAL			English	Article						heat shock protein 60; interleukin 6; Myosin Heavy Chain; physical exercise; skeletal muscle	RECEPTOR-GAMMA COACTIVATOR-1; MESSENGER-RNA; EXPRESSION; STRENGTH; PROTEIN; ALPHA; RESISTANCE; RESPONSES; FIBERS; CELLS	To date, there are limited and incomplete data on possible sex-based differences in fiber-types of skeletal muscle and their response to physical exercise. Adult healthy male and female mice completed a single bout of endurance exercise to examine the sex-based differences of the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1 alpha), heat shock protein 60 (Hsp60), interleukin 6 (IL-6) expression, as well as the Myosin Heavy Chain (MHC) fiber-type distribution in soleus and extensor digitorum longus (EDL) muscles. Our results showed for the first time that in male soleus, a muscle rich of type IIa fibers, endurance exercise activates specifically genes involved in mitochondrial biogenesis such as PGC1 alpha 1 isoform, Hsp60 and IL-6, whereas the expression of PGC1 alpha 2 and alpha 3 was significantly upregulated in EDL muscle, a fast-twitch skeletal muscle, independently from the gender. Moreover, we found that the acute response of different PGC1 alpha isoforms was muscle and gender dependent. These findings add a new piece to the huge puzzle of muscle response to physical exercise. Given the importance of these genes in the physiological response of the muscle to exercise, we strongly believe that our data could support future research studies to personalize a specific and sex-based exercise training protocol.	[D'Amico, Daniela; Gammazza, Antonella Marino; Paladino, Letizia; Scalia, Federica; Spinoso, Giulio; Cappello, Francesco; Di Felice, Valentina; Barone, Rosario] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Palermo, Italy; [D'Amico, Daniela; Scalia, Federica; Cappello, Francesco] Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA; [Macaluso, Filippo; Scalia, Federica; Cappello, Francesco] eCampus Univ, SMART Engn Solut & Technol Res Ctr, Novedrate, Italy; [Macaluso, Filippo; Scalia, Federica; Cappello, Francesco] Euromediterranean Inst Sci & Technol IEMEST, Palermo, Italy; [Dimauro, Ivan; Caporossi, Daniela] Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy	University of Palermo; University of Texas System; University of Texas Medical Branch Galveston; Universita Ecampus; Foro Italico University of Rome	Barone, R (corresponding author), Dept Biomed Neurosci & Adv Diagnost BiND, Human Anat Sect, Via Vespro 129, I-90127 Palermo, Italy.	rusbarone@hotmail.it	Di Felice, Valentina/AAG-3740-2021; barone, rosario/ABA-6758-2021; Dimauro, Ivan/AAG-1178-2019; Caporossi, Daniela/D-7434-2011; Cappello, Francesco/F-9153-2012	Di Felice, Valentina/0000-0002-4132-1260; Dimauro, Ivan/0000-0003-0577-3144; Caporossi, Daniela/0000-0001-9628-0665; barone, rosario/0000-0002-8240-1240; Scalia, Federica/0000-0001-9948-9712; D'Amico, Daniela/0000-0002-8630-304X; Marino Gammazza, Antonella/0000-0002-1683-3803; Macaluso, Filippo/0000-0001-5109-2070; Cappello, Francesco/0000-0001-9288-1148				Antonioni A, 2020, FREE RADICAL BIO MED, V152, P301, DOI 10.1016/j.freeradbiomed.2020.03.013; Barone R, 2009, SCAND J MED SCI SPOR, V19, P782, DOI 10.1111/j.1600-0838.2008.00863.x; Barone R, 2017, J CELL MOL MED, V21, P1636, DOI 10.1111/jcmm.13092; Barone R, 2017, J CELL PHYSIOL, V232, P1086, DOI 10.1002/jcp.25511; Barone R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19781; Barone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079686; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Di Felice V, 2015, J TISSUE ENG REGEN M, V9, pE51, DOI 10.1002/term.1739; Dimauro I, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101183; Dimauro I, 2016, FREE RADICAL BIO MED, V98, P46, DOI 10.1016/j.freeradbiomed.2016.03.028; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Gammazza AM, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120224; Gidlund EK, 2015, J APPL PHYSIOL, V119, P374, DOI 10.1152/japplphysiol.01000.2014; Gouspillou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103044; Haizlip KM, 2015, PHYSIOLOGY, V30, P30, DOI 10.1152/physiol.00024.2014; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hiscock N, 2004, FASEB J, V18, P992, DOI 10.1096/fj.03-1259fje; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hyzewicz Janek, 2015, J Neuromuscul Dis, V2, P325; Jeon Y, 2019, J EXERC REHABIL, V15, P537, DOI 10.12965/jer.1938336.168; Jia WH, 2019, BIOCHEM BIOPH RES CO, V514, P407, DOI 10.1016/j.bbrc.2019.04.155; Khassaf M, 2001, J APPL PHYSIOL, V90, P1031, DOI 10.1152/jappl.2001.90.3.1031; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Larsson L, 1997, ACTA PHYSIOL SCAND, V159, P81, DOI 10.1046/j.1365-201X.1997.559328000.x; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37, DOI 10.1113/jphysiol.1983.sp014658; MAUGHAN RJ, 1986, EUR J APPL PHYSIOL, V55, P395, DOI 10.1007/BF00422739; Mendham AE, 2016, J APPL PHYSIOL, V121, P1326, DOI 10.1152/japplphysiol.00289.2016; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Ryu S, 2006, CELL CYCLE, V5, P1140, DOI 10.4161/cc.5.11.2779; SALE DG, 1987, J APPL PHYSIOL, V62, P1786, DOI 10.1152/jappl.1987.62.5.1786; Samelman TR, 2000, EXP PHYSIOL, V85, P97, DOI 10.1111/j.1469-445X.2000.01894.x; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 2018, FEBS J, V285, P3688, DOI 10.1111/febs.14502; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shu JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183118; Silvennoinen M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12563; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Waters RE, 2004, AM J PHYSIOL-CELL PH, V287, pC1342, DOI 10.1152/ajpcell.00247.2004; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Weiss A, 1999, J MOL BIOL, V290, P61, DOI 10.1006/jmbi.1999.2865; Wen XY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/402175; Ydfors M, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.140	58	8	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21328	10.1096/fj.202002173R	http://dx.doi.org/10.1096/fj.202002173R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433932				2022-12-28	WOS:000647789600003
J	Duran-Guell, M; Flores-Costa, R; Casulleras, M; Lopez-Vicario, C; Titos, E; Diaz, A; Alcaraz-Quiles, J; Horrillo, R; Costa, M; Fernandez, J; Arroyo, V; Claria, J				Duran-Guell, Marta; Flores-Costa, Roger; Casulleras, Mireia; Lopez-Vicario, Cristina; Titos, Esther; Diaz, Alba; Alcaraz-Quiles, Jose; Horrillo, Raquel; Costa, Montserrat; Fernandez, Javier; Arroyo, Vicente; Claria, Joan			Albumin protects the liver from tumor necrosis factor alpha-induced immunopathology	FASEB JOURNAL			English	Article						albumin; cytokine&#8208; induced tissue injury; liver cells; liver injury; mitochondrial damage	HUMAN SERUM-ALBUMIN; MITOCHONDRIAL RELEASE; HEPATOCYTE APOPTOSIS; RECEPTOR; PATHWAY; MODEL; MICE	Besides its oncotic power, albumin exerts pleiotropic actions, including binding, transport, and detoxification of endogenous and exogenous molecules, antioxidant activity, and modulation of immune and inflammatory responses. In particular, recent studies have demonstrated that albumin reduces leukocyte cytokine production. Here, we investigated whether albumin also has the ability to protect tissues from the damaging actions of these inflammatory mediators. We circumscribed our investigation to tumor necrosis factor (TNF) alpha, which exemplifies the connection between immunity and tissue injury. In vivo experiments in analbuminemic mice showed that these mice exhibit a more pronounced response to a model of TNF alpha-mediated liver injury induced by the administration of lipopolysaccharide (LPS) and D-galactosamine (D-gal). A tissue protective action against LPS/D-gal liver injury was also observed during the administration of human albumin to humanized mice expressing the human genes for albumin and neonatal Fc receptor (hAlb(+/+)/hFcRn(+/+)) with preestablished carbon tetrachloride (CCl4)-induced early cirrhosis. The cytoprotective actions of albumin against TNF alpha-induced injury were confirmed ex vivo, in precision-cut liver slices, and in vitro, in primary hepatocytes in culture. Albumin protective actions were independent of its scavenging properties and were reproduced by recombinant human albumin expressed in Oryza sativa. Albumin cytoprotection against TNF alpha injury was related to inhibition of lysosomal cathepsin B leakage accompanied by reductions in mitochondrial cytochrome c release and caspase-3 activity. These data provide evidence that in addition to reducing cytokines, the albumin molecule also has the ability to protect tissues against inflammatory injury.	[Duran-Guell, Marta; Flores-Costa, Roger; Casulleras, Mireia; Lopez-Vicario, Cristina; Fernandez, Javier; Arroyo, Vicente; Claria, Joan] European Fdn Study Chron Liver Failure EF Clif &, Barcelona, Spain; [Duran-Guell, Marta; Flores-Costa, Roger; Casulleras, Mireia; Lopez-Vicario, Cristina; Titos, Esther; Alcaraz-Quiles, Jose; Claria, Joan] CIBERehd, Biochem & Mol Genet Serv, Hosp Clin IDIBAPS, Barcelona, Spain; [Titos, Esther; Claria, Joan] Univ Barcelona, Dept Biomed Sci, Barcelona, Spain; [Diaz, Alba] Hosp Clin Barcelona, Pathol Serv, Barcelona, Spain; [Horrillo, Raquel; Costa, Montserrat] Grifols, Biosci Res Grp, Barcelona, Spain; [Fernandez, Javier] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Grifols; University of Barcelona; Hospital Clinic de Barcelona	Claria, J (corresponding author), Hosp Clin IDIBAPS, Barcelona 08036, Spain.	jclaria@clinic.cat	Arroyo, Vicente/F-9189-2015	Arroyo, Vicente/0000-0002-2728-1848; Lopez-Vicario, Cristina/0000-0002-6609-8501; TITOS, ESTHER/0000-0002-2543-2243; Duran, Marta/0000-0002-3265-395X; Casulleras, Mireia/0000-0002-2899-5826				Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Barbaro B, 2008, ARTIF CELL BLOOD SUB, V36, P74, DOI 10.1080/10731190701857819; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Carl DE, 2016, LIVER INT, V36, P865, DOI 10.1111/liv.13023; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Casulleras M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax5135; CORTESE JD, 1993, BIOCHIM BIOPHYS ACTA, V1142, P194, DOI 10.1016/0005-2728(93)90102-L; Ellmerer M, 2000, AM J PHYSIOL-ENDOC M, V278, pE352, DOI 10.1152/ajpendo.2000.278.2.E352; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Gallego-Sandin S, 2005, EUR J PHARMACOL, V520, P1, DOI 10.1016/j.ejphar.2005.06.044; Gatta A, 2012, INTERN EMERG MED, V7, pS193, DOI 10.1007/s11739-012-0802-0; Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Jones DT, 2003, BLOOD, V101, P3174, DOI 10.1182/blood-2002-07-2143; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; LEIST M, 1994, J IMMUNOL, V153, P1778; Leist M, 1997, GASTROENTEROLOGY, V112, P923, DOI 10.1053/gast.1997.v112.pm9041255; Levitt DG, 2016, INT J GEN MED, V9, P229, DOI 10.2147/IJGM.S102819; Liu SY, 2012, APOPTOSIS, V17, P1156, DOI 10.1007/s10495-012-0758-6; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Marshall JS, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0278-1; Moran-Salvador E, 2013, J HEPATOL, V59, P1045, DOI 10.1016/j.jhep.2013.06.023; Moriyama T, 2017, J CELL PHYSIOL, V232, P3565, DOI 10.1002/jcp.25817; Pyzik M, 2017, P NATL ACAD SCI USA, V114, pE2862, DOI 10.1073/pnas.1618291114; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rius B, 2017, FASEB J, V31, P5384, DOI 10.1096/fj.201700394R; Schmidt EGW, 2017, J BIOL CHEM, V292, P13312, DOI 10.1074/jbc.M117.794248; Scholten D, 2015, LAB ANIM-UK, V49, P4, DOI 10.1177/0023677215571192; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Zhang WJ, 2002, CARDIOVASC RES, V55, P820, DOI 10.1016/S0008-6363(02)00492-3; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056; Zoellner H, 1996, J CELL SCI, V109, P2571	38	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21365	10.1096/fj.202001615RRR	http://dx.doi.org/10.1096/fj.202001615RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496031				2022-12-28	WOS:000647789600107
J	Goetzl, EJ; Srihari, VH; Guloksuz, S; Ferrara, M; Tek, C; Heninger, GR				Goetzl, Edward J.; Srihari, Vinod H.; Guloksuz, Sinan; Ferrara, Maria; Tek, Cenk; Heninger, George R.			Neural cell-derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis	FASEB JOURNAL			English	Article						ATP synthase; cyclophilin D; humanin; mitofusin 2; MOTS&#8208; c; schizophrenia	PEPTIDE HUMANIN; EMERGING ROLE; DYSFUNCTION; APOPTOSIS; TRANSPORT; SURVIVAL; AGE	Neuroprotective and other functional proteins of mitochondria were quantified in extracts of plasma neural-derived exosomes from ten first-episode psychosis (FP) patients and ten matched psychiatrically normal controls (ctls). Astrocyte-derived extracellular vesicles (ADEVs) and neuron-derived extracellular vesicles (NDEVs) were immunoabsorbed separately from physically precipitated plasma total EVs. Extracted mitochondrial ATP synthase was specifically immunofixed to plastic wells for quantification of catalytic activity based on conversion of NADH to NAD(+). Other extracted mitochondrial functional proteins were quantified by ELISAs. All protein levels were normalized with EV content of the CD81 exosome marker. FP patient ADEV level but not NDEV level of mitochondrial ATP synthase activity was significantly lower than that of ctls. FP patient ADEV and NDEV levels of the functionally critical mitochondrial proteins mitofusin 2 and cyclophilin D, but not of transcription factor A of mitochondria, and of the mitochondrial short open-reading frame neuroprotective and metabolic regulatory peptides humanin and MOTS-c were significantly lower than those of ctls. In contrast, FP patient NDEV, but not ADEV, level of the mitochondrial-tethering protein syntaphilin, but not of myosin VI, was significantly higher than that of ctls. The distinctively different neural levels of some mitochondrial proteins in FP patients than ctls now should be correlated with diverse clinical characteristics. Drugs that increase depressed levels of proteins and mimetics of deficient short open-reading frame peptides may be of therapeutic value in early phases of schizophrenia.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, Med Ctr, San Francisco, CA 94143 USA; [Goetzl, Edward J.] Campus Jewish Living, San Francisco, CA USA; [Srihari, Vinod H.; Guloksuz, Sinan; Ferrara, Maria; Tek, Cenk; Heninger, George R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Guloksuz, Sinan] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Med Ctr, Maastricht, Netherlands	University of California System; University of California San Francisco; Yale University; Maastricht University	Goetzl, EJ (corresponding author), UCSF, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94143 USA.	edward.goetzl@ucsf.edu	Ferrara, Maria/AHE-21602-2022; Srihari, Vinod/B-9040-2018	Ferrara, Maria/0000-0003-2143-1101; Srihari, Vinod/0000-0003-1556-2332; Guloksuz, Sinan/0000-0002-6626-1874	NIMH NIH HHS [R01 MH103831] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adav SS, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0430-y; Amanakis G, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00595; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943; Zarate SC, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00123; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Flippo KH, 2017, SCHIZOPHR RES, V187, P26, DOI 10.1016/j.schres.2017.05.003; Goetzl EJ, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01046-3; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Goldsmith David R, 2018, Focus (Am Psychiatr Publ), V16, P153, DOI 10.1176/appi.focus.20170046; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Ho NF, 2017, MOL PSYCHIATR, V22, P142, DOI 10.1038/mp.2016.4; Hornung S, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00038; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Kang I, 2018, FEBS LETT, V592, P793, DOI 10.1002/1873-3468.12989; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Li SN, 2020, NAT METAB, V2, P1077, DOI 10.1038/s42255-020-00289-0; Lin MY, 2017, NEURON, V94, P595, DOI 10.1016/j.neuron.2017.04.004; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Ni P., 2019, MOL PSYCHIATR; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Perkovic MN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040733; Rollins Brandi L, 2018, Mol Neuropsychiatry, V3, P157, DOI 10.1159/000484348; Garcia-Gutierrez MS, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00432; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Srihari VH, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0335-3; Yen K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32616-7; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203	34	10	12	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21339	10.1096/fj.202002519R	http://dx.doi.org/10.1096/fj.202002519R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33454965				2022-12-28	WOS:000647789600028
J	Jiang, LG; Yuan, C; Huang, MD				Jiang, Longguang; Yuan, Cai; Huang, Mingdong			A general strategy to inhibit serine protease by targeting its autolysis loop	FASEB JOURNAL			English	Review						serine proteases; autolysis loop; allosteric site; inhibition; inhibitors; antibodies	COAGULATION-FACTOR; EXTRACELLULAR PROTEASES; STRUCTURAL BASIS; CATALYTIC TRIAD; ACTIVE-SITE; FACTOR VIIA; FACTOR-XI; MECHANISM; ANTIBODIES; DOMAIN	Serine proteases are a large family of enzymes critical for multiple physiological processes, and proven diagnostic and therapeutic targets in several clinical indications. The high similarity of active sites among different serine proteases posts a challenge to reach high selectivity for inhibitors of serine proteases targeting at the active site. Here, we demonstrated that one particular surface loop on serine proteases (autolysis loop) can be used to regulate their catalytic activity, through surveying the recent works including ours, and such an approach can reach high specificity. The autolysis loop is highly variable among different serine proteases, explaining the high specificity of inhibitors targeting the autolysis loop. We also outline the structural origin that links the perturbation of the autolysis loop and the inhibition of protease activity. Thus, the autolysis loop appears to be a highly sensitive allosteric site and can be used as a general handle to develop pharmacological agents to intervene with the activities of serine proteases in, eg, blood coagulation.	[Jiang, Longguang; Huang, Mingdong] Fuzhou Univ, Coll Chem, Fuzhou 350116, Fujian, Peoples R China; [Jiang, Longguang] Fuzhou Univ, Fujian Key Lab Marine Enzyme Engn, Fuzhou, Peoples R China; [Yuan, Cai] Fuzhou Univ, Coll Biol Sci & Engn, Fuzhou 350116, Fujian, Peoples R China	Fuzhou University; Fuzhou University; Fuzhou University	Huang, MD (corresponding author), Fuzhou Univ, Coll Chem, Fuzhou 350116, Fujian, Peoples R China.; Yuan, C (corresponding author), Fuzhou Univ, Coll Biol Sci & Engn, Fuzhou 350116, Fujian, Peoples R China.	cyuan@fzu.edu.cn; hmd_lab@fzu.edu.cn		Jiang, Longguang/0000-0002-4734-3778				Andersen LM, 2012, J BIOL CHEM, V287, P8994, DOI 10.1074/jbc.M111.312330; Bannas P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01603; Basu K, 2019, CURR OPIN BIOTECH, V60, P153, DOI 10.1016/j.copbio.2019.01.012; Blouse GE, 2009, J BIOL CHEM, V284, P4647, DOI 10.1074/jbc.M804922200; Botkjaer KA, 2011, BIOCHEM J, V438, P39, DOI 10.1042/BJ20110129; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Craik CS, 2011, BIOCHEM J, V435, P1, DOI 10.1042/BJ20100965; Cudic M, 2009, CURR PROTEIN PEPT SC, V10, P297, DOI 10.2174/138920309788922207; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Farady CJ, 2008, J MOL BIOL, V380, P351, DOI 10.1016/j.jmb.2008.05.009; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Gailani D, 2016, ARTERIOSCL THROM VAS, V36, P1316, DOI 10.1161/ATVBAHA.116.306925; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jiang LG, 2011, CHINESE J STRUC CHEM, V30, P1021; Jiang LG, 2013, BIOCHEM J, V449, P161, DOI 10.1042/BJ20121132; Koch AW, 2019, BLOOD, V133, P1507, DOI 10.1182/blood-2018-10-880849; Kolev K, 2016, BRIT J HAEMATOL, V175, P12, DOI 10.1111/bjh.14255; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Kromann-Hansen T, 2016, J BIOL CHEM, V291, P15156, DOI 10.1074/jbc.M116.732503; Lopez T, 2019, P NATL ACAD SCI USA, V116, P16314, DOI 10.1073/pnas.1903330116; Mathur A, 1997, J BIOL CHEM, V272, P23418, DOI 10.1074/jbc.272.37.23418; McKee DL, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104859; Merski M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.487; Negrier C, 2019, BLOOD REV, V38, DOI 10.1016/j.blre.2019.05.006; Ngo JCK, 2011, CURR DRUG TARGETS, V12, P1729; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pengo V, 2018, BLOOD, V132, P1365, DOI 10.1182/blood-2018-04-848333; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qiu XY, 1996, NATURE, V383, P275, DOI 10.1038/383275a0; Qureshi SH, 2008, BIOPHYS CHEM, V134, P239, DOI 10.1016/j.bpc.2008.02.012; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; ROBBINS KC, 1978, MOL CELL BIOCHEM, V20, P149; Saha N, 2019, CANCER LETT, V467, P50, DOI 10.1016/j.canlet.2019.10.003; Schaefer M, 2019, J MOL BIOL, V431, P4817, DOI 10.1016/j.jmb.2019.09.008; Schiebel J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05769-2; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shapiro MD, 2018, CIRC RES, V122, P1420, DOI 10.1161/CIRCRESAHA.118.311227; Shieh HS, 1996, NATURE, V383, P279, DOI 10.1038/383279a0; Singh N, 2014, FEBS J, V281, P2456, DOI 10.1111/febs.12799; Soualmia F, 2018, EXPERT OPIN THER PAT, V28, P93, DOI 10.1080/13543776.2018.1406478; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Tashiro Y, 2012, BLOOD, V119, P6382, DOI 10.1182/blood-2011-12-399659; ten Cate H, 2017, THROMB HAEMOSTASIS, V117, P1265, DOI 10.1160/TH17-02-0079; Thomas D, 2019, RES PRACT THROMB HAE, V3, P242, DOI 10.1002/rth2.12186; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Walker B, 2001, CELL MOL LIFE SCI, V58, P596, DOI 10.1007/PL00000884; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Xie X, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01232; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	63	9	9	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21259	10.1096/fj.202002139RR	http://dx.doi.org/10.1096/fj.202002139RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417271				2022-12-28	WOS:000647789600084
J	Li, EK; Ajuwon, KM				Li, Enkai; Ajuwon, Kolapo M.			Mechanism of endocytic regulation of intestinal tight junction remodeling during nutrient starvation in jejunal IPEC-J2 cells	FASEB JOURNAL			English	Article						endocytosis; lysosome; nutrient starvation; proteasome; tight junction	BARRIER FUNCTION; CLAUDIN-2 PROTEIN; AUTOPHAGY; DEGRADATION; INTERNALIZATION; INHIBITION	Intestinal epithelial cells are tightly bound by tight junction proteins (TJP) which are dynamic and sensitive to environmental stress. However, the role of the endocytic pathway in the regulation of TJP abundance and tight junction integrity during nutrient stress is poorly understood. Therefore, this study was conducted to investigate the regulation of TJP abundance during nutrient starvation and the role of the endocytic mechanism in this process. IPEC-J2 cells were subjected to nutrient starvation in Krebs-Ringer bicarbonate buffer (KRB) and abundance of TJP, an indication of tight junction remodeling, was characterized with RT-PCR, western blotting and immunofluorescence. Abundance of TJP was dynamically regulated by nutrient starvation. The protein levels of claudin-1, 3, and 4 were initially downregulated within the first 6 hours of starvation, and then, increased thereafter (P < .01). However, there was no change in occludin and ZO-1. Lysosome and proteasome inhibitors were used to determine the contribution of these protein degradation pathways to the TJP remodeling. Short-term starvation-induced degradation of claudin-1, 3, and 4 was found to be lysosome dependent. Specifically, the downregulation of claudin-3 and 4 was via a dynamin-dependent, but clathrin and caveolae independent, endocytic pathway and this downregulation was partly reversed by amino acids supplementation. Interestingly, the re-synthesis of TJP with prolonged starvation partly depended on proteasome function. Collectively, this study, for the first time, elucidated a major role for dynamin-dependent endocytosis of claudin-3 and 4 during nutrient stress in intestinal epithelial cells. Therefore, transient endocytosis inhibition may be a potential mechanism for preserving tight junction integrity and function in metabolic or pathological states such as inflammatory bowel disease that involves destruction of intestinal epithelial TJP.	[Li, Enkai; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, 270 S Russell St, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, 270 S Russell St, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu						Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brooks P. H., 2001, The weaner pig: nutrition and management. Proceedings of a British Society of Animal Science Occasional Meeting, University of Nottingham, UK, September 2000, P153, DOI 10.1079/9780851995328.0153; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; Choi HS, 2009, J MED FOOD, V12, P37, DOI 10.1089/jmf.2007.0613; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Dennis AP, 2005, J STEROID BIOCHEM, V94, P337, DOI 10.1016/j.jsbmb.2004.11.009; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Flores-Maldonado C, 2017, LYSOSOMES ASS DIS ME, P93; Hammer AM, 2015, ALCOHOL RES-CURR REV, V37, P209; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Ji MM, 2016, BIOCHEM BIOPH RES CO, V479, P690, DOI 10.1016/j.bbrc.2016.09.151; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Lenaerts K, 2006, J PROTEOME RES, V5, P2113, DOI 10.1021/pr060183+; Liu J, 2016, MOL NEUROBIOL, V53, P5935, DOI 10.1007/s12035-015-9504-8; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mandel I, 2012, J CELL BIOCHEM, V113, P2415, DOI 10.1002/jcb.24118; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marques C, 2004, FASEB J, V18, P1424, DOI 10.1096/fj.04-1743fje; Mueller M, 2015, ELIFE, V4, DOI 10.7554/eLife.07736; Nighot PK, 2015, J BIOL CHEM, V290, P7234, DOI 10.1074/jbc.M114.597492; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Spreeuwenberg MAM, 2001, J NUTR, V131, P1520, DOI 10.1093/jn/131.5.1520; Takei K, 2005, J BIOCHEM, V137, P243, DOI 10.1093/jb/mvi052; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang B, 2016, J NUTR, V146, P501, DOI 10.3945/jn.115.224857; Wang H, 2015, J NUTR, V145, P25, DOI 10.3945/jn.114.202515; Wen W, 2017, CANC CELL RES, V14, P346; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; Yan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179586; Yu D, 2008, BBA-BIOMEMBRANES, V1778, P709, DOI 10.1016/j.bbamem.2007.07.027; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	41	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21356	10.1096/fj.202002098R	http://dx.doi.org/10.1096/fj.202002098R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484473	Bronze			2022-12-28	WOS:000647789600101
J	Wagner, PM; Prucca, CG; Velazquez, FN; Alderete, LGS; Caputto, BL; Guido, ME				Wagner, Paula M.; Prucca, Cesar G.; Velazquez, Fabiola N.; Sosa Alderete, Lucas G.; Caputto, Beatriz L.; Guido, Mario E.			Temporal regulation of tumor growth in nocturnal mammals: In vivo studies and chemotherapeutical potential	FASEB JOURNAL			English	Article						Bortezomib; cancer chronotherapy; circadian clock; light; dark differences; tumor growth	CLOCK GENE BMAL1; CELL-CYCLE PROGRESSION; CIRCADIAN CLOCK; DNA-DAMAGE; DEREGULATED EXPRESSION; PANCREATIC-CANCER; PROSTATE-CANCER; DAILY RHYTHMS; PER1; GLIOBLASTOMA	Tumors of the nervous system including glioblastoma multiforme (GBM) are the most frequent and aggressive form of brain tumors; however, little is known about the impact of the circadian timing system on the formation, growth, and treatment of these tumors. We investigated day/night differences in tumor growth after injection of A530 glioma cells isolated from malignant peripheral nerve sheath tumor (MPNSTs) of NPcis (Trp53(+/-); Nf1(+/-)) mice. Synchronized A530 cell cultures expressing typical glial markers were injected at the beginning of the day or night into the sciatic nerve zone of C57BL/6 mice subject to a 12:12 hours light/dark (LD) cycle or after being released to constant darkness (DD). Tumors generated in animals injected early at night in the LD cycle or in DD showed higher growth rates than in animals injected diurnally. No differences were found when animals were injected at the same time with cultures synchronized 12 hours apart. Similar experiments performed with B16 melanoma cells showed higher tumor growth rates in animals injected at the beginning of the night compared to those injected in the daytime. A higher tumor growth rate than that in controls was observed when mice were injected with knocked-down clock gene Bmal1 cells. Finally, when we compared day/night administration of different doses of the proteasome inhibitor Bortezomib (0.5-1.5 mg/kg) in tumor-bearing animals, we found that low-dose chemotherapy displayed higher efficacy when administered at night. Results suggest the existence of a precise temporal control of tumor growth and of drug efficacy in which the host state and susceptibility are critical.	[Wagner, Paula M.; Prucca, Cesar G.; Caputto, Beatriz L.; Guido, Mario E.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, Cordoba, Argentina; [Wagner, Paula M.; Prucca, Cesar G.; Caputto, Beatriz L.; Guido, Mario E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina; [Velazquez, Fabiola N.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Velazquez, Fabiola N.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Sosa Alderete, Lucas G.] Univ Nacl Rio Cuarto, UNRC CONICET, Inst Biotecnol Ambiental & Salud INBIAS, Fac Ciencias Exactas Fisicoquim & Nat, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional Rio Cuarto	Guido, ME (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET Dept Quim Biol Ranwel Caputto, Haya Torre S-N,Ciudad Univ, RA-5000 Cordoba, Argentina.	mguido@fcci.unc.edu.ar	Prucca, César Germán/AAC-4630-2021	Prucca, César Germán/0000-0003-4165-4660				Acosta-Rodriguez VA, 2013, J LIPID RES, V54, P1798, DOI 10.1194/jlr.M034264; Antoch MP, 2013, CELL CYCLE, V12, P3673, DOI 10.4161/cc.26614; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Benzekry S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003800; Bjarnason G A, 2000, Prog Cell Cycle Res, V4, P193; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Bollinger T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13984; Cao Q, 2009, CANCER RES, V69, P7619, DOI 10.1158/0008-5472.CAN-08-4199; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Chu LW, 2008, PROSTATE CANCER P D, V11, P342, DOI 10.1038/sj.pcan.4501024; COLLINS VP, 1956, AMER J ROENTGENOL RA, V76, P988; Comba A, 2019, MOL NEUROBIOL, V56, P1653, DOI 10.1007/s12035-018-1182-x; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dai HJ, 2011, BREAST CANCER RES TR, V127, P531, DOI 10.1007/s10549-010-1231-2; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; Garbarino-Pico E, 2004, J BIOL CHEM, V279, P51172, DOI 10.1074/jbc.M309248200; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Gorne LD, 2015, CHRONOBIOL INT, V32, P11, DOI 10.3109/07420528.2014.949734; Grechez-Cassiau A, 2015, CHRONOBIOL INT, V32, P774, DOI 10.3109/07420528.2015.1046601; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gu X, 2012, CELL DEATH DIFFER, V19, P397, DOI 10.1038/cdd.2011.103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hsu CM, 2012, TUMOR BIOL, V33, P149, DOI 10.1007/s13277-011-0258-2; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Huang XL, 2011, J INT MED RES, V39, P2061, DOI 10.1177/147323001103900601; Jiang WL, 2016, CANCER LETT, V371, P314, DOI 10.1016/j.canlet.2015.12.002; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Jung-Hynes B, 2010, J PINEAL RES, V49, P60, DOI 10.1111/j.1600-079X.2010.00767.x; Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232; Lahti T, 2012, ANN MED, V44, P847, DOI 10.3109/07853890.2012.727018; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Lenting K, 2017, ACTA NEUROPATHOL, V133, P263, DOI 10.1007/s00401-017-1671-4; Lin YM, 2008, MOL CARCINOGEN, V47, P925, DOI 10.1002/mc.20446; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Masri S, 2018, NAT MED, V24, P1795, DOI 10.1038/s41591-018-0271-8; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mehrara E, 2009, ACTA ONCOL, V48, P591, DOI 10.1080/02841860802616736; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Niu ZF, 2015, ONCOTARGET, V6, P9951, DOI 10.18632/oncotarget.3179; Oda A, 2009, ANTICANCER RES, V29, P1201; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Pogue-Geile KL, 2006, CANCER LETT, V243, P55, DOI 10.1016/j.canlet.2005.11.049; Puram RV, 2016, CORE CIRCADIAN CLOCK; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Razorenova OV, 2012, CELL CYCLE, V11, P213, DOI 10.4161/cc.11.2.18786; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Rijo-Ferreira F, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0704-0; Rios-Doria J, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000416; Sarma HD, 2011, CURR RADIOPHARM, V4, P150, DOI 10.2174/1874471011104020150; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Slat EA, 2017, J BIOL RHYTHM, V32, P121, DOI 10.1177/0748730417696788; Spyra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021099; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Stylli SS, 2015, J CLIN NEUROSCI, V22, P619, DOI 10.1016/j.jocn.2014.10.013; Sulli G, 2019, TRENDS CANCER, V5, P475, DOI 10.1016/j.trecan.2019.07.002; Sun CM, 2010, PATHOL ONCOL RES, V16, P403, DOI 10.1007/s12253-009-9227-0; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; Taniguchi H, 2009, CANCER RES, V69, P8447, DOI 10.1158/0008-5472.CAN-09-0551; Vlachostergios PJ, 2013, CELL MOL NEUROBIOL, V33, P313, DOI 10.1007/s10571-013-9910-2; Wagner PM, 2019, ASN NEURO, V11, DOI 10.1177/1759091419892713; Wagner PM, 2019, MOL NEUROBIOL, V56, P1276, DOI 10.1007/s12035-018-1152-3; Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595; Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Xia HC, 2010, CAN J NEUROL SCI, V37, P365, DOI 10.1017/S031716710001026X; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115; Zhou F, 2012, CANCER-AM CANCER SOC, V118, P937, DOI 10.1002/cncr.26348; Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648	90	9	9	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21231	10.1096/fj.202001753R	http://dx.doi.org/10.1096/fj.202001753R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33428275				2022-12-28	WOS:000647789600097
J	Wan, SF; Wan, SK; Jiao, XJ; Cao, HX; Gu, Y; Yan, L; Zheng, Y; Niu, PY; Shao, FM				Wan, Shengfeng; Wan, Shengkai; Jiao, Xiaojing; Cao, Huixia; Gu, Yue; Yan, Lei; Zheng, Yan; Niu, Peiyuan; Shao, Fengmin			Advances in understanding the innate immune-associated diabetic kidney disease	FASEB JOURNAL			English	Review						diabetic kidney disease; innate immunity; therapy	NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NLRP3 INFLAMMASOME ACTIVATION; URINARY ALBUMIN EXCRETION; TOLL-LIKE RECEPTORS; SGLT2 INHIBITORS; TNF-ALPHA; COMPLEMENT ACTIVATION; TUBULAR INFLAMMATION	Millions of human deaths occur annually due to chronic kidney disease, caused by diabetic kidney disease (DKD). Despite having effective drugs controlling the hyperglycemia and high blood pressure, the incidence of DKD is increasing, which indicates the need for the development of novel therapies to control DKD. In this article, we discussed the recent advancements in the basic innate immune mechanisms in renal tissues triggered under the diabetes environment, leading to the pathogenesis and progression of DKD. We also summarized the currently available innate immune molecules-targeting therapies tested against DKD in clinical and preclinical settings, and highlighted additional drug targets that could potentially be employed for the treatment of DKD. The improved understanding of the disease pathogenesis may open avenues for the development of novel therapies to rein in DKD, which consequently, can reduce morbidity and mortality in humans in the future.	[Wan, Shengfeng; Jiao, Xiaojing; Cao, Huixia; Gu, Yue; Yan, Lei; Zheng, Yan; Niu, Peiyuan; Shao, Fengmin] Zhengzhou Univ, Dept Nephrol, Henan Prov Key Lab Kidney Dis & Immunol, Henan Prov Peoples Hosp,Peoples Hosp, Zhengzhou 450003, Peoples R China; [Wan, Shengkai] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Operat Management, Peoples Hosp, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Shao, FM (corresponding author), Zhengzhou Univ, Dept Nephrol, Henan Prov Key Lab Kidney Dis & Immunol, Henan Prov Peoples Hosp,Peoples Hosp, Zhengzhou 450003, Peoples R China.	shaofm126@126.com						Al-Rubeaan K, 2019, BIOMARK MED, V13, P467, DOI 10.2217/bmm-2018-0359; Anders HJ, 2016, J AM SOC NEPHROL, V27, P2564, DOI 10.1681/ASN.2016020177; Jigheh ZA, 2020, INDIAN J CLIN BIOCHE, V35, P109, DOI 10.1007/s12291-018-0790-6; Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Borgohain MP, 2017, BASIC CLIN PHARMACOL, V120, P442, DOI 10.1111/bcpt.12718; Bousoik E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00287; Brosius FC, 2016, DIABETOLOGIA, V59, P1624, DOI 10.1007/s00125-016-4021-5; Brosius FC, 2015, CURR OPIN NEPHROL HY, V24, P88, DOI 10.1097/MNH.0000000000000079; Bus P, 2018, KIDNEY INT REP, V3, P302, DOI 10.1016/j.ekir.2017.10.005; Calle P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082806; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chang TT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093172; Chen B, 2019, J CELL PHYSIOL, V234, P21249, DOI 10.1002/jcp.28730; Chen KH, 2019, FASEB J, V33, P4571, DOI 10.1096/fj.201801749RRR; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Corredor Z, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56695-2; Cucak H, 2015, INT IMMUNOPHARMACOL, V25, P30, DOI 10.1016/j.intimp.2015.01.003; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P687, DOI 10.1016/S2213-8587(15)00261-2; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Dekkers CCJ, 2018, DIABETES OBES METAB, V20, P1988, DOI 10.1111/dom.13301; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Donate-Correa J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020458; Donate-Correa J, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/948417; Donate-Correa J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030287; Du PC, 2013, KIDNEY INT, V84, P265, DOI 10.1038/ki.2013.113; Fan JJ, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/2923072; Fearn A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.233; Feng H, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6973175; Feng YY, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400183; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Flyvbjerg A, 2017, NAT REV NEPHROL, V13, P311, DOI 10.1038/nrneph.2017.31; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Fu Y, 2017, MED SCI MONITOR, V23, P3878, DOI 10.12659/MSM.903269; Fujita T, 1999, NEPHRON, V81, P208, DOI 10.1159/000045278; Gale JD, 2018, KIDNEY INT REP, V3, P1316, DOI 10.1016/j.ekir.2018.07.010; Garcia-Garcia PM, 2014, WORLD J DIABETES, V5, P431, DOI 10.4239/wjd.v5.i4.431; Gembardt F, 2014, AM J PHYSIOL-RENAL, V307, pF317, DOI 10.1152/ajprenal.00145.2014; Gu HF, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00507; Gu Harvest F, 2012, Front Endocrinol (Lausanne), V3, P179, DOI 10.3389/fendo.2012.00179; Gupta S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07230-8; Harjunpaa H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01078; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Heerspink HJL, 2019, DIABETOLOGIA, V62, P1154, DOI 10.1007/s00125-019-4859-4; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; Hsia DS, 2017, CURR OPIN ENDOCRINOL, V24, P73, DOI 10.1097/MED.0000000000000311; Inoue MK, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0454-6; International Diabetes Federation, 2019, IDF DIABETES ATLAS; Jheng HF, 2015, DIS MODEL MECH, V8, P1311, DOI 10.1242/dmm.019398; Ji TT, 2019, J CELL PHYSIOL, V234, P6633, DOI 10.1002/jcp.27412; Jialal I, 2014, J DIABETES COMPLICAT, V28, P755, DOI 10.1016/j.jdiacomp.2014.07.003; Kalantarinia K, 2003, KIDNEY INT, V64, P1208, DOI 10.1046/j.1523-1755.2003.00237.x; Kanduri SR, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092723; Karimi Z, 2018, DIABETES METAB SYND, V12, P365, DOI 10.1016/j.dsx.2017.12.028; Kawanami D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051083; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Kim YK, 2016, YONSEI MED J, V57, P5, DOI 10.3349/ymj.2016.57.1.5; Kopel J, 2019, WORLD J DIABETES, V10, P269, DOI 10.4239/wjd.v10.i5.269; Lavoz C, 2019, KIDNEY INT, V95, P1418, DOI 10.1016/j.kint.2018.12.031; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Li L, 2015, METABOLISM, V64, P597, DOI 10.1016/j.metabol.2015.01.014; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113639; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Lin M, 2013, KIDNEY INT, V83, P887, DOI 10.1038/ki.2013.11; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Liu JJ, 2015, J DIABETES COMPLICAT, V29, P707, DOI 10.1016/j.jdiacomp.2015.02.011; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Lu TC, 2009, KIDNEY INT, V76, P63, DOI 10.1038/ki.2009.98; Luan PP, 2018, FASEB J, V32, P1070, DOI 10.1096/fj.201700511RR; Lupfer CR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00923; Ma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097985; Ma J, 2014, INT J CLIN EXP PATHO, V7, P481; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Marko L, 2016, J AM SOC NEPHROL, V27, P2658, DOI 10.1681/ASN.2015070748; Meldrum KK, 2012, J BIOL CHEM, V287, P40391, DOI 10.1074/jbc.M112.402420; Menne J, 2017, NEPHROL DIAL TRANSPL, V32, P307, DOI 10.1093/ndt/gfv459; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Moriwaki Y, 2007, ACTA DIABETOL, V44, P215, DOI 10.1007/s00592-007-0007-6; Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Okada R, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-2; Ortiz-Munoz G, 2010, J AM SOC NEPHROL, V21, P763, DOI 10.1681/ASN.2009060625; Pan CG, 1996, J INVEST MED, V44, P375; Panchapakesan U, 2018, CURR OPIN NEPHROL HY, V27, P30, DOI 10.1097/MNH.0000000000000377; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Qiu YY, 2016, PHARMACOL RES, V114, P251, DOI 10.1016/j.phrs.2016.11.004; Reis ES, 2019, NAT REV IMMUNOL, V19, P503, DOI 10.1038/s41577-019-0168-x; Ruiz-Ortega M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030813; Ruszkowska-Ciastek B, 2015, J ZHEJIANG UNIV-SC B, V16, P355, DOI 10.1631/jzus.B1400218; Sagoo MK, 2020, METHODS MOL BIOL, V2067, P3, DOI 10.1007/978-1-4939-9841-8_1; Sanz AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008955; Shahzad K, 2016, J AM SOC NEPHROL, V27, P2270, DOI 10.1681/ASN.2015060676; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shang J, 2017, BIOCHEM BIOPH RES CO, V484, P435, DOI 10.1016/j.bbrc.2017.01.155; Shi YH, 2010, AM J NEPHROL, V31, P380, DOI 10.1159/000286559; Sircar M, 2018, AM J PATHOL, V188, P2147, DOI 10.1016/j.ajpath.2018.06.018; Song N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00815; Song S, 2018, J MOL ENDOCRINOL, V61, P101, DOI 10.1530/JME-18-0069; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Sun HB, 2015, INFLAMMATION, V38, P1739, DOI 10.1007/s10753-015-0151-z; Sun L, 2015, KIDNEY INT, V88, P662, DOI 10.1038/ki.2015.250; Sun ZJ, 2019, DIABETES METAB, V45, P363, DOI 10.1016/j.diabet.2018.08.011; Tahara A, 2018, EUR J PHARMACOL, V830, P68, DOI 10.1016/j.ejphar.2018.04.024; Tang L, 2017, AM J PHYSIOL-ENDOC M, V313, pE563, DOI 10.1152/ajpendo.00086.2017; Tang SCW, 2020, NAT REV NEPHROL, V16, P206, DOI 10.1038/s41581-019-0234-4; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Tong F, 2017, INT J NANOMED, V12, P7799, DOI 10.2147/IJN.S146978; Tziastoudi M, 2020, CLIN KIDNEY J, V13, P768, DOI 10.1093/ckj/sfaa077; Vaisar T, 2018, DIABETES CARE, V41, P2361, DOI 10.2337/dc18-0699; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Wada J, 2016, NAT REV NEPHROL, V12, P13, DOI 10.1038/nrneph.2015.175; Wang L, 2020, MOL ASPECTS MED, V76, DOI 10.1016/j.mam.2020.100889; Wang X, 2017, DIABETES, V66, P494, DOI 10.2337/db16-0773; Wang X, 2020, MED RES REV, V40, P2466, DOI 10.1002/med.21711; Wei L, 2018, KIDNEY DIS-BASEL, V4, P226, DOI 10.1159/000492633; Willows J, 2020, CLIN MED, V20, P156, DOI 10.7861/clinmed.2019-0452; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Wu M, 2018, MOL CELL ENDOCRINOL, V478, P115, DOI 10.1016/j.mce.2018.08.002; Xie FJ, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/4126913; Xu Tao, 2018, Int J Physiol Pathophysiol Pharmacol, V10, P1; Yahya Mohd Jokha, 2019, Int J Chronic Dis, V2019, P2053015, DOI 10.1155/2019/2053015; Yamakawa I, 2011, AM J PHYSIOL-ENDOC M, V301, pE844, DOI 10.1152/ajpendo.00029.2011; Yang S, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104678; Yao D, 2018, MOL MED REP, V18, P3625, DOI 10.3892/mmr.2018.9393; Yiu WH, 2018, NEPHROL DIAL TRANSPL, V33, P1323, DOI 10.1093/ndt/gfx336; You HN, 2013, AM J PHYSIOL-RENAL, V305, pF1719, DOI 10.1152/ajprenal.00141.2013; Yuan F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164135; Yuan YJ, 2020, STEM CELLS, V38, P639, DOI 10.1002/stem.3144; Zeng HX, 2020, INFLAMM RES, V69, P1215, DOI 10.1007/s00011-020-01411-4; Zhang CX, 2019, DIABETES METAB SYNDR, V12, P1297, DOI 10.2147/DMSO.S199802; Zhang XL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221991; Zheng JM, 2019, J DIABETES INVEST, V10, P738, DOI 10.1111/jdi.12934; Zipfel PF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02166	140	3	3	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21367	10.1096/fj.202002334R	http://dx.doi.org/10.1096/fj.202002334R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33508160	hybrid			2022-12-28	WOS:000647789600110
J	Tabak, S; Hadad, U; Schreiber-Avissar, S; Beit-Yannai, E				Tabak, Saray; Hadad, Uzi; Schreiber-Avissar, Sofia; Beit-Yannai, Elie			Non-pigmented ciliary epithelium derived extracellular vesicles uptake mechanism by the trabecular meshwork	FASEB JOURNAL			English	Article						endocytosis; extracellular vesicles; non&#8208; pigmented ciliary epithelium; phagocytosis; trabecular meshwork; Wnt&#8208; TGF&#946; 2	RECEPTOR-MEDIATED ENDOCYTOSIS; DEPENDENT ENDOCYTOSIS; POLYETHYLENE-GLYCOL; EXOSOME UPTAKE; IN-VITRO; GLAUCOMA; CELLS; DELIVERY; TEMPERATURE; SECRETION	Consistent with increasing findings, extracellular vesicles (EVs), consider as a major constituents of the aqueous humor, have a role as signaling mediators in glaucoma. Following secretion, EVs hold immense promise for utilization as bio-therapeutics and drug delivery vehicles due to their nature as biological nanoparticles that facilitate intercellular molecular transport. Yet, the specific pathway utilizing for transferring signals by EVs in the ocular drainage system is not fully understood. Hence, the objective of this study was to examine internalization mechanisms by which Non-Pigmented Ciliary Epithelium (NPCE)-derived EVs deliver their signals to the Trabecular Meshwork (TM) cells. EVs were isolated and size and concentration were determined. Internalization study of treated EVs with Proteinase-K to achieve removal of surface membrane proteins on EVs was conducted. Energy dependent uptake mechanism was examined under various temperatures. Using uptake inhibitors endocytosis, phagocytosis, and Wnt-TGF beta 2 signaling were investigated. TM cells exposed to NPCE EVs demonstrate a significant decrease in the levels of two proteins in two Wnt-TGFb2 signaling proteins levels: p-GSK3 beta and beta-catenin. A significant decrease in the uptake by TM cells of Proteinase-K-treated EVs was found, followed by attenuation of the Wnt-TGF beta 2 proteins expression. Energy dependent uptake revealed a significant decrease in EVs internalization. The exposure of TM cells to endocytosis uptake inhibitors abolished the decrease of the Wnt-TGF beta 2 proteins levels. Exposure to phagocytosis uptake inhibitor resulted in a partial inhibition of NPCE EVs effect in TM cells. The attenuation of proteins expression levels following uptake inhibitors treatment or EVs membrane proteins removal indicates that Wnt-TGF beta 2 signaling in TM cells is mediated through NPCE EVs surface proteins in an active manner that involves endocytosis-dependent routes.	[Tabak, Saray; Schreiber-Avissar, Sofia; Beit-Yannai, Elie] Ben Gurion Univ Negev, Clin Biochem & Pharmacol Dept, POB 653, IL-84105 Beer Sheva, Israel; [Hadad, Uzi] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel	Ben Gurion University	Beit-Yannai, E (corresponding author), Ben Gurion Univ Negev, Clin Biochem & Pharmacol Dept, POB 653, IL-84105 Beer Sheva, Israel.	bye@bgu.ac.il		Beit-Yannai, Elie/0000-0001-9347-822X	Israel Science Foundation (ISF) [1545/20]	Israel Science Foundation (ISF)(Israel Science Foundation)	Israel Science Foundation (ISF), Grant/Award Number: 1545/20	Abu-Hassan Diala W, 2014, J Ocul Biol, V2; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caponnetto F, 2017, NANOMED-NANOTECHNOL, V13, P1011, DOI 10.1016/j.nano.2016.12.009; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Cesi G, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0136-z; Chen CC, 2016, CELL MOL BIOENG, V9, P509, DOI 10.1007/s12195-016-0458-3; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Chowdhury UR, 2015, INVEST OPHTH VIS SCI, V56, P2993, DOI 10.1167/iovs.15-16744; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; de Jong OG, 2016, J CELL MOL MED, V20, P342, DOI 10.1111/jcmm.12730; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; GOLDENTHAL KL, 1984, EXP CELL RES, V152, P558, DOI 10.1016/0014-4827(84)90658-X; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; He ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23262-0; Holder B, 2016, TRAFFIC, V17, P168, DOI 10.1111/tra.12352; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Klingeborn M, 2017, PROG RETIN EYE RES, V59, P158, DOI 10.1016/j.preteyeres.2017.04.004; Lee HM, 2010, BIOCHEM BIOPH RES CO, V397, P251, DOI 10.1016/j.bbrc.2010.05.094; Lerner N, 2020, J CELL MOL MED, V24, P4646, DOI 10.1111/jcmm.15129; Lerner N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171153; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Ludwig AK, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1528109; Lv CY, 2018, INT UROL NEPHROL, V50, P973, DOI 10.1007/s11255-017-1779-4; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186; McQuate A, 2017, CELL REP, V21, P60, DOI 10.1016/j.celrep.2017.09.023; Menck K, 2013, ONCOTARGET, V4, P2057, DOI 10.18632/oncotarget.1336; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nagai N, 2019, INT J NANOMED, V14, P1213, DOI 10.2147/IJN.S196681; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Ofir-Birin Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01011; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Quigley HA, 2016, ANNU REV VIS SCI, V2, P235, DOI 10.1146/annurev-vision-111815-114417; Ramteke A, 2015, MOL CARCINOGEN, V54, P554, DOI 10.1002/mc.22124; Resende FA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-203; Rider MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23978; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; SAID HM, 1994, AM J PHYSIOL, V266, pG15, DOI 10.1152/ajpgi.1994.266.1.G15; Schmidl D, 2015, J OCUL PHARMACOL TH, V31, P63, DOI 10.1089/jop.2014.0067; Stamer WD, 2011, J PROTEOMICS, V74, P796, DOI 10.1016/j.jprot.2011.02.024; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tabak S, 2018, J CELL MOL MED, V22, P1992, DOI 10.1111/jcmm.13505; Tham YC, 2018, BRIT J OPHTHALMOL, V102, P1402, DOI 10.1136/bjophthalmol-2017-311359; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Weng YJ, 2016, ANALYST, V141, P4640, DOI 10.1039/c6an00892e; Xue W, 2007, INVEST OPHTH VIS SCI, V48, P3184, DOI 10.1167/iovs.06-1403; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	62	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002040R	http://dx.doi.org/10.1096/fj.202002040R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200492				2022-12-28	WOS:000592668900001
J	Zheng, JY; Ding, JX; Liao, MY; Qiu, ZH; Yuan, QC; Mai, WQ; Dai, Y; Zhang, HR; Wu, HL; Wang, YX; Liao, YH; Chen, X; Cheng, X				Zheng, Jiayu; Ding, Jiaxing; Liao, Mengyang; Qiu, Zhihua; Yuan, Qingchen; Mai, Wuqian; Dai, Yong; Zhang, Hongrong; Wu, Hailang; Wang, Yingxuan; Liao, Yuhua; Chen, Xiao; Cheng, Xiang			Immunotherapy against angiotensin II receptor ameliorated insulin resistance in a leptin receptor-dependent manner	FASEB JOURNAL			English	Article						angiotensin II type 1 receptor; immunotherapy; insulin resistance; leptin receptor; skeletal muscle	METABOLIC SYNDROME; SKELETAL-MUSCLE; AT(1) RECEPTORS; OBESITY; HYPERTENSION; CELLS; VALSARTAN; MICE	The angiotensin II type 1 receptor (AT1R) signaling pathway is reported to modulate glucose metabolism. Targeting AT1R, our group invented ATRQ beta-001 vaccine, a novel immunotherapeutic strategy to block the activation of AT1R. Here, we evaluated the therapeutic efficacy of ATRQ beta-001 vaccine in insulin resistance, and investigated the mechanism. Our results showed that ATRQ beta-001 vaccine and specific monoclonal antibody against epitope ATR-001 (McAb-ATR) decreased fasting serum insulin concentration and improved glucose and insulin tolerance in ob/ob mice. These beneficial effects were verified in high-fat diet-induced obese mice. McAb-ATR activated insulin signaling in skeletal muscle and insulin-resistant C2C12 myotubes without affecting liver or white adipose tissue of ob/ob mice. Mechanistically, the favorable impact of McAb-ATR on insulin resistance was abolished in db/db mice and in C2C12 myotubes with leptin receptor knockdown. AT1R knockdown also eradicated the effects of McAb-ATR in C2C12 myotubes. Furthermore, McAb-ATR treatment was able to activate the leptin receptor-mediated JAK2/STAT3 signaling in skeletal muscle of ob/ob mice and C2C12 myotubes. Additionally, angiotensin II downregulated the leptin signaling in skeletal muscle of ob/ob and diet-induced obese mice. We demonstrated that ATRQ beta-001 vaccine and McAb-ATR improved whole-body insulin resistance and regulated glucose metabolism in skeletal muscle in a leptin receptor-dependent manner. Our data suggest that immunotherapy targeting AT1R is a novel strategy for treating insulin resistance.	[Zheng, Jiayu; Ding, Jiaxing; Liao, Mengyang; Qiu, Zhihua; Yuan, Qingchen; Mai, Wuqian; Dai, Yong; Zhang, Hongrong; Wu, Hailang; Wang, Yingxuan; Liao, Yuhua; Chen, Xiao; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430022, Hubei, Peoples R China; [Zheng, Jiayu; Ding, Jiaxing; Liao, Mengyang; Qiu, Zhihua; Yuan, Qingchen; Mai, Wuqian; Dai, Yong; Zhang, Hongrong; Wu, Hailang; Wang, Yingxuan; Liao, Yuhua; Chen, Xiao; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Mol Biol Targeted Therapies,Minist Educ, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, X; Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430022, Hubei, Peoples R China.	skycreeper@126.com; nathancx@hust.edu.cn			National Natural Science Foundation of China (NSFC) [81974106, 91439207, 81670461]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974106, 91439207 and 81670461	Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Chen X, 2013, HYPERTENSION, V61, P408, DOI 10.1161/HYPERTENSIONAHA.112.201020; Claflin KE, 2017, J CLIN INVEST, V127, P1414, DOI 10.1172/JCI88641; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; D'souza AM, 2017, MOL METAB, V6, P1052, DOI 10.1016/j.molmet.2017.04.011; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Denroche HC, 2012, J DIABETES INVEST, V3, P115, DOI 10.1111/j.2040-1124.2012.00203.x; German JP, 2010, DIABETES, V59, P1626, DOI 10.2337/db09-1918; Hall JE, 2019, NAT REV NEPHROL, V15, P367, DOI 10.1038/s41581-019-0145-4; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Haywood NJ, 2017, DIABETES, V66, P287, DOI 10.2337/db16-0997; He HB, 2010, HYPERTENSION, V55, P869, DOI 10.1161/HYPERTENSIONAHA.109.143958; Hilzendeger AM, 2010, J MOL MED, V88, P899, DOI 10.1007/s00109-010-0649-7; Huynh FK, 2010, DIABETES, V59, P3032, DOI 10.2337/db10-0074; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Knowles JW, 2016, J AM COLL CARDIOL, V67, P1656, DOI 10.1016/j.jacc.2015.12.065; Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645; Koo YD, 2019, METABOLISM, V95, P27, DOI 10.1016/j.metabol.2019.03.004; Li H, 2016, HYPERTENSION, V68, P478, DOI 10.1161/HYPERTENSIONAHA.116.07008; Li L, 2013, DIABETES, V62, P762, DOI 10.2337/db12-0570; Luther JM, 2011, TRENDS PHARMACOL SCI, V32, P734, DOI 10.1016/j.tips.2011.07.006; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moon HS, 2013, ENDOCR REV, V34, P377, DOI 10.1210/er.2012-1053; Muller-Fielitz H, 2015, BRIT J PHARMACOL, V172, P857, DOI 10.1111/bph.12949; Muller-Fielitz H, 2014, BRIT J PHARMACOL, V171, P746, DOI 10.1111/bph.12510; Nozhenko Y, 2015, CELL PHYSIOL BIOCHEM, V35, P92, DOI 10.1159/000369678; Roman EAFR, 2010, MOL CELL ENDOCRINOL, V314, P62, DOI 10.1016/j.mce.2009.08.007; Rong X, 2010, DIABETOLOGIA, V53, P1727, DOI 10.1007/s00125-010-1744-6; Rong X, 2009, J PHARMACOL EXP THER, V331, P1096, DOI 10.1124/jpet.109.157099; Savarese G, 2013, J AM COLL CARDIOL, V61, P131, DOI 10.1016/j.jacc.2012.10.011; Shiota A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-139; Skurk T, 2005, OBES RES, V13, P969, DOI 10.1038/oby.2005.113; Soleimani M, 2015, KIDNEY INT, V87, P497, DOI 10.1038/ki.2014.392; Taylor R, 2012, DIABETES, V61, P778, DOI 10.2337/db12-0073; van der Zijl NJ, 2011, DIABETES CARE, V34, P845, DOI 10.2337/dc10-2224; Wang ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010095; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Younis F, 2010, METABOLISM, V59, P1200, DOI 10.1016/j.metabol.2009.11.013; Zhang HR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012341; Zhao SG, 2019, CELL METAB, V30, P706, DOI 10.1016/j.cmet.2019.08.005	42	3	3	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000300R	http://dx.doi.org/10.1096/fj.202000300R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33155736				2022-12-28	WOS:000592446700001
J	Zhang, J; Zhu, M; Ruan, L; Jiang, C; Yang, Q; Chang, Q; Huang, X				Zhang, Juan; Zhu, Min; Ruan, Lu; Jiang, Chen; Yang, Qian; Chang, Qing; Huang, Xin			Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model	FASEB JOURNAL			English	Article						angiogenesis; rapamycin; retinopathy of prematurity; vaso&#8208; obliteration	ANGIOGENESIS; PREMATURITY; GROWTH; BEVACIZUMAB; TARGET; ANGIOPOIETIN-1; REACTIVATION; INHIBITION; METABOLISM; MECHANISMS	Retinopathy of prematurity (ROP) is a vision-threatening disorder characterized with retinal vaso-obliteration in phase 1 and pathological neovascularization (NV) in phase 2. However, there has been no effective and safe treatment for ROP. Current management is mainly focused on the reduction of abnormal NV in phase 2, and anti-vascular endothelial growth factor (VEGF) therapy is the first-line treatment, yet, with great risks of late recurrence and systemic side effects. It has been reported that the severity of vaso-obliteration in phase 1 largely influences subsequent NV, suggesting that it may be a promising target to develop novel treatments for ROP. Here, we investigated the therapeutic potential and safety of early rapamycin intervention in treating phase 1 ROP and possible underlying mechanisms using the mouse model of oxygen-induced retinopathy (OIR). We found that intravitreal injection of rapamycin at postnatal day 7 (P7) significantly reduced retinal avascular area, increased vascular density, and reversed the suppression of deep capillaries development in phase 1 of OIR mice. Rapamycin treatment not only reduced vascular apoptosis, but also promoted proliferation and tip cell functions. Additionally, rapamycin did not interfere with normal retinal vascular development. Further investigation showed that Ang1/Tie2 pathway might be involved in rapamycin's vascular protection in phase 1 OIR retinas. Moreover, early rapamycin treatment at P7 had long-term protective effects of reducing retinal NV and avascular area, as well as enhancing vascular maturity in phase 2 of OIR mice. Together, our data suggest that rapamycin may be a safe and promising strategy for early intervention of ROP.	[Zhang, Juan; Zhu, Min; Ruan, Lu; Jiang, Chen; Yang, Qian; Chang, Qing; Huang, Xin] Fudan Univ, Shanghai Med Coll, Eye & Ear Nose & Throat Hosp, Shanghai, Peoples R China; [Zhang, Juan; Zhu, Min; Jiang, Chen; Yang, Qian; Chang, Qing; Huang, Xin] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China	Fudan University; Fudan University	Chang, Q; Huang, X (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, 83 Fenyang Rd, Shanghai, Peoples R China.	qngchang@aliyun.com; fd2017huangxin@163.com			National Natural Science Foundation of China [NSFC81870670]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was sponsored by the National Natural Science Foundation of China [NSFC81870670]	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Chan-Ling T, 2018, PROG RETIN EYE RES, V62, P77, DOI 10.1016/j.preteyeres.2017.09.002; Chong ZZ, 2011, TRENDS CARDIOVAS MED, V21, P151, DOI 10.1016/j.tcm.2012.04.005; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dejneka NS, 2004, MOL VIS, V10, P964; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hu J, 2012, ARCH OPHTHALMOL-CHIC, V130, P1000, DOI 10.1001/archophthalmol.2012.592; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Kanda S, 2005, CANCER RES, V65, P6820, DOI 10.1158/0008-5472.CAN-05-0522; Kim CB, 2016, EYE BRAIN, V8, P67, DOI 10.2147/EB.S94447; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Lee J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006666; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Lutty GA, 2011, INVEST OPHTH VIS SCI, V52, P4039, DOI 10.1167/iovs.10-6798; Pasquier B, 2016, CELL MOL LIFE SCI, V73, P985, DOI 10.1007/s00018-015-2104-y; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Selvam S, 2018, PROG RETIN EYE RES, V63, P1, DOI 10.1016/j.preteyeres.2017.11.001; Seront E, 2019, CURR OPIN HEMATOL, V26, P185, DOI 10.1097/MOH.0000000000000498; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Sinha SS, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2008.02.004; Smith LE, 2013, CLIN PERINATOL, V40, P201, DOI 10.1016/j.clp.2013.02.002; Stahl A, 2008, FEBS LETT, V582, P3097, DOI 10.1016/j.febslet.2008.08.005; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tee AR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030880; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wong RK, 2015, RETINA-J RET VIT DIS, V35, P675, DOI 10.1097/IAE.0000000000000578; Wu WC, 2015, JAMA OPHTHALMOL, V133, P391, DOI 10.1001/jamaophthalmol.2014.5373; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Yagasaki R, 2014, BIOL PHARM BULL, V37, P1838, DOI 10.1248/bpb.b14-00487; Yamaguchi M, 2016, INVEST OPHTH VIS SCI, V57, P2264, DOI 10.1167/iovs.15-17411; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838	42	3	3	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15822	15836		10.1096/fj.202001295R	http://dx.doi.org/10.1096/fj.202001295R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33103304				2022-12-28	WOS:000586261400001
J	Tamura, K; Chiu, YW; Shiohara, A; Hori, Y; Tomita, T				Tamura, Kensuke; Chiu, Yung-Wen; Shiohara, Azusa; Hori, Yukiko; Tomita, Taisuke			EphA4 regulates A beta production via BACE1 expression in neurons	FASEB JOURNAL			English	Article						Alzheimer&apos; s disease; A&#946; BACE1; EphA4	AMYLOID-BETA; ALZHEIMERS-DISEASE; MOUSE MODELS; SAM DOMAIN; SECRETASE; PROTEIN; PHOSPHORYLATION; RECEPTORS; OLIGOMERS; KINASE	Several lines of evidence suggest that the aggregation and deposition of amyloid-beta peptide (A beta) initiate the pathology of Alzheimer's disease (AD). Recently, a genome-wide association study demonstrated that a single-nucleotide polymorphism proximal to the EPHA4 gene, which encodes a receptor tyrosine kinase, is associated with AD risk. However, the molecular mechanism of EphA4 in the pathogenesis of AD, particularly in A beta production, remains unknown. Here, we performed several pharmacological and biological experiments both in vitro and in vivo and demonstrated that EphA4 is responsible for the regulation of A beta production. Pharmacological inhibition of EphA4 signaling and knockdown of Epha4 led to increased A beta levels accompanied by increased expression of beta-site APP cleaving enzyme 1 (BACE1), which is an enzyme responsible for A beta production. Moreover, EPHA4 overexpression and activation of EphA4 signaling via ephrin ligands decreased A beta levels. In particular, the sterile-alpha motif domain of EphA4 was necessary for the regulation of A beta production. Finally, EPHA4 mRNA levels were significantly reduced in the brains of AD patients, and negatively correlated with BACE1 mRNA levels. Our results indicate a novel mechanism of A beta regulation by EphA4, which is involved in AD pathogenesis.	[Tamura, Kensuke; Chiu, Yung-Wen; Shiohara, Azusa; Hori, Yukiko; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan	University of Tokyo	Hori, Y; Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan.	yukiko-hori@mol.f.u-tokyo.ac.jp; taisuke@mol.f.u-tokyo.ac.jp			Japan-Taiwan Exchange Association; Japan Agency for Medical Research and Development (AMED) [JP18dm0207014]; MEXT \ Japan Society for the Promotion of Science (JSPS) [15H02492, 19H01015, 16K18871]	Japan-Taiwan Exchange Association; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan-Taiwan Exchange Association; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP18dm0207014; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H02492, 19H01015 and 16K18871	Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Castello MA, 2014, AGEING RES REV, V13, P10, DOI 10.1016/j.arr.2013.10.001; Dai DD, 2014, BBA-PROTEINS PROTEOM, V1844, P1729, DOI 10.1016/j.bbapap.2014.07.002; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Gong B, 2010, AGING CELL, V9, P1018, DOI 10.1111/j.1474-9726.2010.00632.x; Green JB, 2003, MOL CELL, V11, P1537, DOI 10.1016/S1097-2765(03)00178-3; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hooli BV, 2014, MOL PSYCHIATR, V19, P676, DOI 10.1038/mp.2013.77; Huan XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074040; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kimura K, 2011, P NATL ACAD SCI USA, V108, P9981, DOI 10.1073/pnas.1107592108; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Liang LY, 2019, ONCOGENE, V38, P6567, DOI 10.1038/s41388-019-0931-2; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Matsui C, 2012, BRAIN PATHOL, V22, P776, DOI 10.1111/j.1750-3639.2012.00587.x; Miyagawa T, 2016, HUM MOL GENET, V25, P2948, DOI 10.1093/hmg/ddw146; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Noberini R, 2012, CELL ADHES MIGR, V6, P102, DOI 10.4161/cam.19620; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Ohno M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00022; Rosenberger AFN, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0079-9; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tamagno E, 2012, IUBMB LIFE, V64, P943, DOI 10.1002/iub.1099; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2014, J BIOCHEM, V156, P195, DOI 10.1093/jb/mvu049; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Vargas LM, 2018, BBA-MOL BASIS DIS, V1864, P1148, DOI 10.1016/j.bbadis.2018.01.023; Vargas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092309; Wang MH, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.185; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823	56	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16383	16396		10.1096/fj.202001510R	http://dx.doi.org/10.1096/fj.202001510R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33090569	Green Submitted			2022-12-28	WOS:000586225200001
J	Zeng, SF; Querfeld, U; Feger, M; Haffner, D; Hasan, AA; Chu, C; Slowinski, T; Dschietzig, TB; Schafer, F; Xiong, YQ; Zhang, BB; Rausch, S; Horvathova, K; Lang, FR; Kramer, BK; Foller, M; Hocher, B				Zeng, Shufei; Querfeld, Uwe; Feger, Martina; Haffner, Dieter; Hasan, Ahmed A.; Chu, Chang; Slowinski, Torsten; Bernd Dschietzig, Thomas; Schaefer, Franz; Xiong, Yingquan; Zhang, Bingbing; Rausch, Steffen; Horvathova, Katarina; Lang, Florian; Karl Kraemer, Bernhard; Foeller, Michael; Hocher, Berthold			Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD	FASEB JOURNAL			English	Article						CKD; FGF23; GFR; non-oxidized; oxidized; PTH	GROWTH-FACTOR 23; PARATHYROID-HORMONE; INTERLEUKIN-6 PRODUCTION; CIRCULATING LEVELS; N-OXPTH; RECEPTOR; EXPRESSION; OXIDATION; GENE; HEMODIALYSIS	Fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) are regulators of renal phosphate excretion and vitamin D metabolism. In chronic kidney disease (CKD), circulating FGF23 and PTH concentrations progressively increase as renal function declines. Oxidation of PTH at two methionine residues (positions 8 and 18) causes a loss of function. The impact of n-oxPTH and oxPTH on FGF23 synthesis, however, and how n-oxPTH and oxPTH concentrations are affected by CKD, is yet unknown. The effects of oxidized and non-oxidized PTH 1-34 onFgf23gene expression were analyzed in UMR106 osteoblast-like cells. Furthermore, we investigated the relationship between n-oxPTH and oxPTH, respectively, with FGF23 in two independent patients' cohorts (620 children with CKD and 600 kidney transplant recipients). While n-oxPTH stimulatedFgf23mRNA synthesis in vitro, oxidation of PTH in particular at Met8 led to a markedly weaker stimulation ofFgf23. The effect was even stronger when both Met8 and Met18 were oxidized. In both clinical cohorts, n-oxPTH-but not oxPTH-was significantly associated with FGF23 concentrations, independent of known confounding factors. Moreover, with progressive deterioration of kidney function, intact PTH (iPTH) and oxPTH increased substantially, whereas n-oxPTH increased only moderately. In conclusion, n-oxPTH, but not oxPTH, stimulatesFgf23gene expression. The increase in PTH with decreasing GFR is mainly due to an increase in oxPTH in more advanced stages of CKD.	[Zeng, Shufei; Hasan, Ahmed A.; Chu, Chang; Xiong, Yingquan; Karl Kraemer, Bernhard; Hocher, Berthold] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Heidelberg, Germany; [Zeng, Shufei; Chu, Chang; Slowinski, Torsten] Charite Univ Med Berlin, Dept Nephrol, Berlin, Germany; [Querfeld, Uwe] Charite Univ Med Berlin, Dept Pediat, Div Gastroenterol Nephrol & Metab Dis, Berlin, Germany; [Feger, Martina; Rausch, Steffen; Foeller, Michael] Univ Hohenheim, Dept Physiol, Stuttgart, Germany; [Haffner, Dieter] Hannover Med Sch, Pediat Res Ctr, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany; [Hasan, Ahmed A.; Xiong, Yingquan; Lang, Florian] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Bernd Dschietzig, Thomas] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Zhang, Bingbing] Univ Tubingen, Inst Physiol, Tubingen, Germany; [Zhang, Bingbing] Heilongjiang Bayi Agr Univ, Coll Life Sci & Technol, Daqing, Peoples R China; [Horvathova, Katarina] Biomed Slovakia Sro, Bratislava, Slovakia; [Hocher, Berthold] Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha, Peoples R China; [Hocher, Berthold] Reprod & Genet Hosp CITIC Xiangya, Changsha, Peoples R China; [Hocher, Berthold] IMD, Inst Med Diagnost, Berlin, Germany	Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University Hohenheim; Hannover Medical School; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Heilongjiang Bayi Agricultural University; Hunan Normal University; Central South University	Hocher, B (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Heidelberg, Germany.	berthold.hocher@medma.uni-heidelberg.de	Chu, Chang/ABB-5967-2021; Hasan, Ahmed A./AAR-5857-2020	Hasan, Ahmed A./0000-0002-0382-4916; Querfeld, Uwe/0000-0001-6783-3822	China Scholarship Council	China Scholarship Council(China Scholarship Council)	China Scholarship Council supported SZ, C.C, and YX This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector	Bar L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211309; Burnett-Bowie SAM, 2009, J BONE MINER RES, V24, P1681, DOI [10.1359/jbmr.090406, 10.1359/JBMR.090406]; Cavalier E, 2020, CLIN CHIM ACTA, V506, P107, DOI 10.1016/j.cca.2020.03.025; Cheloha RW, 2015, NAT REV ENDOCRINOL, V11, P712, DOI 10.1038/nrendo.2015.139; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Doyon A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113482; Feger M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05226-y; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; FRELINGER AL, 1986, ARCH BIOCHEM BIOPHYS, V244, P641, DOI 10.1016/0003-9861(86)90632-6; Graciolli FG, 2017, KIDNEY INT, V91, P1436, DOI 10.1016/j.kint.2016.12.029; GREENFIELD EM, 1993, J BONE MINER RES, V8, P1163; Gutierrez OM, 2012, CLIN J AM SOC NEPHRO, V7, P139, DOI 10.2215/CJN.06240611; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Hocher B, 2018, CLIN CHEM LAB MED, V56, P183, DOI 10.1515/cclm-2017-0617; Hocher B, 2013, KIDNEY BLOOD PRESS R, V37, P240, DOI 10.1159/000350149; Hocher B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040242; Isakova T, 2018, J AM SOC NEPHROL, V29, P579, DOI 10.1681/ASN.2017070772; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Krajisnik T, 2007, J ENDOCRINOL, V195, P125, DOI 10.1677/JOE-07-0267; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Kuro-o M, 2017, BONE, V100, P4, DOI 10.1016/j.bone.2016.11.013; Lang F, 2018, KIDNEY BLOOD PRESS R, V43, P1742, DOI 10.1159/000495393; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Lopez I, 2011, KIDNEY INT, V80, P475, DOI 10.1038/ki.2011.107; LOWIK CWGM, 1989, BIOCHEM BIOPH RES CO, V162, P1546, DOI 10.1016/0006-291X(89)90851-6; Lu YP, 2020, CLIN CHIM ACTA, V508, P92, DOI 10.1016/j.cca.2020.05.022; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Panah F, 2018, CLIN BIOCHEM, V55, P3, DOI 10.1016/j.clinbiochem.2018.03.022; Querfeld U, 2010, CLIN J AM SOC NEPHRO, V5, P1642, DOI 10.2215/CJN.08791209; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Saji F, 2009, NEPHRON PHYSIOL, V111, P59, DOI 10.1159/000210389; SAKAGAMI Y, 1993, J BONE MINER RES, V8, P811; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Tepel M, 2013, J CLIN ENDOCR METAB, V98, P4744, DOI 10.1210/jc.2013-2139; Ursem S, 2019, ENDOCR CONNECT, V8, P518, DOI 10.1530/EC-19-0097; Ursem SR, 2020, CLIN CHIM ACTA, V506, P84, DOI 10.1016/j.cca.2020.03.020; Ursem SR, 2018, CLIN CHEM LAB MED, V56, P249, DOI 10.1515/cclm-2017-0313; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Xu GS, 2015, RENAL FAILURE, V37, P45, DOI 10.3109/0886022X.2014.964141; Yang HL, 2016, ANN NY ACAD SCI, V1385, P41, DOI 10.1111/nyas.13221; ZULL JE, 1990, J BIOL CHEM, V265, P5671	47	6	6	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15269	15281		10.1096/fj.202000596R	http://dx.doi.org/10.1096/fj.202000596R		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32964520	hybrid			2022-12-28	WOS:000573907900001
J	Chakroborty, D; Goswami, S; Basu, S; Sarkar, C				Chakroborty, Debanjan; Goswami, Sandeep; Basu, Sujit; Sarkar, Chandrani			Catecholamines in the regulation of angiogenesis in cutaneous wound healing	FASEB JOURNAL			English	Review						angiogenesis; catecholamines; skin; wound	ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; BETA-ADRENERGIC-RECEPTORS; GENE DELETION; TUMOR-GROWTH; 1 EXPRESSION; BONE-MARROW; DOPAMINE; REPAIR; SKIN	Angiogenesis involves the formation of new blood vessels from preexisting ones, and it is an essential step during cutaneous wound healing, which supports cells at the wound site with nutrition and oxygen. Impaired angiogenesis in the wound tissues results in delayed wound closure and healing. Among the regulators of angiogenesis, the role of catecholamines (epinephrine, norepinephrine, and dopamine) is of interest due to their diverse roles in the process of wound healing. While both norepinephrine and epinephrine mostly inhibit the angiogenic process in cutaneous wounds, dopamine, the other member of the catecholamine family, has interesting and contradictory roles in the regulation of angiogenesis in the wound beds, depending on the type of dopamine receptor involved. The stimulation of dopamine D2 receptors negatively regulates the angiogenic process in normal dermal wounds and thereby delays healing, whereas the stimulation of dopamine D1 receptors promotes angiogenesis and expedites healing in diabetic wounds. Importantly, catecholamines also play important roles in other pathological conditions, and specific agonists and antagonists of catecholamines are available for the treatment of some disorders. Therefore, such drugs may be utilized for the management of angiogenesis to promote the healing of dermal wounds. This review provides a broad overview of the angiogenic process during cutaneous wound healing and the regulatory roles played by catecholamines during the process.	[Chakroborty, Debanjan; Goswami, Sandeep; Basu, Sujit; Sarkar, Chandrani] Ohio State Univ, Dept Pathol, 1645 Neil Ave, Columbus, OH 43210 USA; [Basu, Sujit; Sarkar, Chandrani] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Dept Med Oncol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Basu, S; Sarkar, C (corresponding author), Ohio State Univ, Dept Pathol, 1645 Neil Ave, Columbus, OH 43210 USA.	Sujit.Basu@osumc.edu; Chandrani.Sarkar@osumc.edu			National Institutes of Health, USA [R01DK098045]	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grant from the National Institutes of Health, USA (R01DK098045 to S.Basu)	Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Alvarez C, 2007, J CLIN ENDOCR METAB, V92, P2931, DOI 10.1210/jc.2007-0409; Antoine P, 2016, PROCEEDINGS OF THE 8TH INTERNATIONAL CONGRESS ON ARCHAEOLOGY, COMPUTER GRAPHICS, CULTURAL HERITAGE AND INNOVATION ( ARQUEOLOGICA 2.0): ADVANCED 3D DOCUMENTATION, MODELLING AND RECONSTRUCTION OF CULTURAL HERITAGE OBJECTS, MONUMENTS AND SITES, P419; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Berger AC, 2000, J SURG RES, V91, P26, DOI 10.1006/jsre.2000.5890; Borrel V, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00155; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Caley MP, 2015, ADV WOUND CARE, V4, P225, DOI 10.1089/wound.2014.0581; Chakroborty D, 2004, CLIN CANCER RES, V10, P4349, DOI 10.1158/1078-0432.CCR-04-0059; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chakroborty D, 2016, AM J PATHOL, V186, P2262, DOI 10.1016/j.ajpath.2016.05.008; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Chakroborty D, 2009, CANCER RES, V69, P3727, DOI 10.1158/0008-5472.CAN-08-4289; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; Demidova-Rice TN, 2012, ADV WOUND CARE, V1, P17, DOI 10.1089/wound.2011.0308; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P349, DOI 10.1097/01.ASW.0000418541.31366.a3; DiPietro LA, 2016, J LEUKOCYTE BIOL, V100, P979, DOI 10.1189/jlb.4MR0316-102R; Dulmovits BM, 2012, INT J BIOCHEM CELL B, V44, P1800, DOI 10.1016/j.biocel.2012.06.031; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Franz MG, 2008, WOUND REPAIR REGEN, V16, P723, DOI 10.1111/j.1524-475X.2008.00427.x; Fu YC, 2004, CARDIOVASC RES, V61, P143, DOI 10.1016/j.cardiores.2003.10.014; Ganong WF, 2005, REV MED PHYSL, P85; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Gosain A, 2006, J TRAUMA, V60, P736, DOI 10.1097/01.ta.0000196802.91829.cc; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; Gosain A, 2007, SURGERY, V142, P170, DOI 10.1016/j.surg.2007.04.015; Grotendorst G R, 1988, Prog Clin Biol Res, V266, P47; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Isidori AM, 2016, J ENDOCRINOL INVEST, V39, P1235, DOI 10.1007/s40618-016-0502-0; Johnson KE, 2014, ADV WOUND CARE, V3, P647, DOI 10.1089/wound.2013.0517; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Kampfer H, 2001, LAB INVEST, V81, P361, DOI 10.1038/labinvest.3780244; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Kim Lincoln R., 1998, Wound Repair and Regeneration, V6, P194, DOI 10.1046/j.1524-475X.1998.60305.x; Kim MH, 2014, J INVEST DERMATOL, V134, P809, DOI 10.1038/jid.2013.415; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Mathieu D, 2006, HDB HYPERBARIC MED, P401, DOI [10.1007/1-4020-4448-8_20, DOI 10.1007/1-4020-4448-8_20]; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Michalczyk ER, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29465-9; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nissen NN, 1996, SURGERY, V119, P457, DOI 10.1016/S0039-6060(96)80148-6; O'Leary AP, 2015, J CELL PHYSIOL, V230, P356, DOI 10.1002/jcp.24716; Ohnstedt E, 2019, EXPERT OPIN DRUG DIS, V14, P485, DOI 10.1080/17460441.2019.1588879; Okonkwo UA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231962; Okonkwo UA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071419; Padgett DA, 1998, BRAIN BEHAV IMMUN, V12, P64, DOI 10.1006/brbi.1997.0512; Perron L, 2004, CANCER CAUSE CONTROL, V15, P535, DOI 10.1023/B:CACO.0000036152.58271.5e; Pullar CE, 2008, PHARMACOL RES, V58, P158, DOI 10.1016/j.phrs.2008.07.012; Pullar CE, 2012, J INVEST DERMATOL, V132, P2076, DOI 10.1038/jid.2012.108; Roman CD, 2002, J SURG RES, V105, P43, DOI 10.1006/jsre.2002.6444; Romana-Souza B, 2014, INT J EXP PATHOL, V95, P330, DOI 10.1111/iep.12093; Romana-Souza B, 2010, EXP DERMATOL, V19, P821, DOI 10.1111/j.1600-0625.2010.01113.x; Romana-Souza B, 2010, BRAIN BEHAV IMMUN, V24, P427, DOI 10.1016/j.bbi.2009.11.012; Romana-Souza B, 2009, EUR J PHARMACOL, V611, P77, DOI 10.1016/j.ejphar.2009.03.053; Sarkar C, 2004, AM J PHYSIOL-HEART C, V287, pH1554, DOI 10.1152/ajpheart.00272.2004; Sarkar C, 2017, ANGIOGENESIS, V20, P97, DOI 10.1007/s10456-016-9531-8; Sarkar C, 2013, J NEUROIMMUNE PHARM, V8, P7, DOI 10.1007/s11481-012-9395-7; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; SCHALLREUTER KU, 1992, BIOCHEM BIOPH RES CO, V189, P72, DOI 10.1016/0006-291X(92)91527-W; Schultz GS, 2011, MECH VASCULAR DIS RE, V23; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Shome S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031682; Shome S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025215; Sivamani RK, 2007, DERMATOL CLIN, V25, P643, DOI 10.1016/j.det.2007.06.012; Sivamani RK, 2009, PLOS MED, V6, P105, DOI 10.1371/journal.pmed.1000012; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Sorg H, 2017, EUR SURG RES, V58, P81, DOI 10.1159/000454919; STEINKRAUS V, 1992, J INVEST DERMATOL, V98, P475, DOI 10.1111/1523-1747.ep12499860; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Thomas HM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061129; Tilan J, 2010, J ONCOL, V2010, DOI 10.1155/2010/539706; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Vaughn AR, 2018, MOLECULES, V23, DOI 10.3390/molecules23010050; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yamakawa S, 2019, BURNS TRAUMA, V7, DOI 10.1186/s41038-019-0148-1; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; Zhang H, 2004, AM J PHYSIOL-HEART C, V287, pH2106, DOI 10.1152/ajpheart.00290.2004	89	12	12	4	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14093	14102		10.1096/fj.202001701R	http://dx.doi.org/10.1096/fj.202001701R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32949437	Green Accepted			2022-12-28	WOS:000572344800001
J	Shi, CH; Deng, JT; Chiu, M; Chen, YX; O'Brien, ER				Shi, Chunhua; Deng, Jingti; Chiu, Michael; Chen, Yong-Xiang; O'Brien, Edward R.			Heat shock protein 27 immune complex altered signaling and transport (ICAST): Novel mechanisms of attenuating inflammation	FASEB JOURNAL			English	Article						antibodies; atherosclerosis; CD-36; cholesterol; Heat Shock Protein 27; immune complex; Inflammation; macrophage; scavenger receptors; Isignaling; SR-AI; TLR4; vaccination	NF-KAPPA-B; ISOTHERMAL TITRATION CALORIMETRY; PROTEOMIC APPROACH; HEAT-SHOCK-PROTEIN-27; ATHEROSCLEROSIS; EXPRESSION; ACTIVATION; ESTROGEN; PLAQUES; BINDING	Blood levels of heat shock protein (HSP27) and natural IgG auto-antibodies to HSP27 (AAbs) are higher in healthy controls compared to cardiovascular disease patients. Vaccination of mice with recombinant HSP25 (rHSP25, murine ortholog of human rHSP27) increased AAb levels, attenuated atherogenesis and reduced plaque inflammation and cholesterol content. We sought to determine if the HSP27 immune complex (IC) altered M phi inflammation signaling (Toll Like Receptor 4; TLR4), and scavenger receptors involved in cholesterol uptake (SR-AI, CD-36). Combining a validated polyclonal IgG anti-HSP27 antibody (PAb) with rHSP27 enhanced binding to THP-1 M phi cell membranes and activation of NF-kappa B signaling via TLR4, competing away LPS and effecting an anti-inflammatory cytokine profile. Similarly, adding the PAb with rHSP27 enhanced binding to SR-AI and CD-36, as well as lowered oxLDL binding in HEK293 cells separately transfected with SR-AI and CD-36, or THP-1 M phi. Finally, the PAb enhanced the uptake and internalization of rHSP27 in THP-1 M phi. Thus, the HSP27 IC potentiates HSP27 cell membrane signaling with receptors involved in modulating inflammation and cholesterol uptake, as well as HSP27 internalization. Going forward, we are focusing on the development of HSP27 Immune Complex Altered Signaling and Transport (ICAST) as a means of modulating inflammation.	[Shi, Chunhua; Deng, Jingti; Chiu, Michael; Chen, Yong-Xiang; O'Brien, Edward R.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst, Div Cardiol,Dept Cardiac Sci, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	O'Brien, ER (corresponding author), Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst, Div Cardiol,Dept Cardiac Sci,Hlth Res & Innovat C, GC68,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	ermobrie@ucalgary.ca			CIHR [PJT-149015] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Chen Y-X, 2020, HEAT SHOCK PROTEIN 2; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; Cuerrier CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055867; Feig AL, 2007, BIOPOLYMERS, V87, P293, DOI 10.1002/bip.20816; Gaisford S, 2005, CURR PHARM BIOTECHNO, V6, P181, DOI 10.2174/1389201054022913; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lepedda AJ, 2009, ATHEROSCLEROSIS, V203, P112, DOI 10.1016/j.atherosclerosis.2008.07.001; Liang WZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26231; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Raizman JE, 2013, BBA-MOL CELL BIOL L, V1831, P1721, DOI 10.1016/j.bbalip.2013.07.015; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Shevtsov M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051263; Steinbrecher UP, 1999, BBA-MOL CELL BIOL L, V1436, P279, DOI 10.1016/S0005-2760(98)00127-1; Thuringer D, 2013, FASEB J, V27, P4169, DOI 10.1096/fj.12-226977; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Venu VKP, 2017, FASEB J, V31, P2364, DOI 10.1096/fj.201601188R	29	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14287	14301		10.1096/fj.202001389RR	http://dx.doi.org/10.1096/fj.202001389RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32888229	Green Submitted			2022-12-28	WOS:000568289700001
J	Barha, CK; Liu-Ambrose, T				Barha, Cindy K.; Liu-Ambrose, Teresa			Sex differences in exercise efficacy: Is midlife a critical window for promoting healthy cognitive aging?	FASEB JOURNAL			English	Article						aerobic training; Alzheimer's disease; brain health; dementia	TIME PHYSICAL-ACTIVITY; OLDER-ADULTS; AEROBIC EXERCISE; LEISURE-TIME; ALZHEIMER-DISEASE; NEUROTROPHIC FACTOR; CARDIORESPIRATORY FITNESS; APOE-EPSILON-4 GENOTYPE; SYNAPTIC PLASTICITY; HIPPOCAMPAL VOLUME	Dementia is one of the most pressing health care issues of this century. As no curative treatment for dementia exists, research efforts are growing to identify effective lifestyle interventions to prevent or delay onset. One such promising strategy that promotes cognitive and brain health is engaging in physical exercise. However, current exercise recommendations are imprecise. To advance the potential of exercise as a preventative and treatment strategy, important questions regarding moderators (ie, biological sex and age) are being addressed in the literature. Biological sex is recognized as an important variable to consider in exercise efficacy on brain health, with females showing greater cognitive gains. This may be related to sex differences in underlying mechanisms. Here, we argue to better understand the sex differences in exercise efficacy, the timing of exercise intervention should also be considered. Specifically, we present the hypothesis that midlife in females is a critical window for the implementation of exercise as an early intervention to promote brain health and prevent dementia. Further, we speculate that exercise interventions targeting midlife will be of critical importance for the female brain, as females exit this period of the lifespan at greater risk for cognitive impairment. Given the potential sex differences in dementia risk and prevalence, it is imperative to assess potential sex differences in exercise efficacy as an early intervention during midlife.	[Barha, Cindy K.; Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Barha, Cindy K.; Liu-Ambrose, Teresa] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC, Canada; [Barha, Cindy K.; Liu-Ambrose, Teresa] Univ British Columbia, Phys Act Precis Hlth Res Cluster, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Liu-Ambrose, T (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Aging Mobil & Cognit Neurosci Lab, Liu Ambrose Lab, 2215 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	teresa.ambrose@ubc.ca			Alzheimer's Association; Canada Research Chairs (Chaires de recherche du Canada); Fondation Brain Canada (Brain Canada)	Alzheimer's Association(Alzheimer's Association); Canada Research Chairs (Chaires de recherche du Canada)(Canada Research Chairs); Fondation Brain Canada (Brain Canada)	Alzheimer's Association; Canada Research Chairs (Chaires de recherche du Canada); Fondation Brain Canada (Brain Canada)	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Allard JS, 2017, EXP GERONTOL, V87, P129, DOI 10.1016/j.exger.2016.11.001; Alzheimer's A, 2015, CHANGING TRAJECTORY; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Ardekani BA, 2016, J ALZHEIMERS DIS, V50, P847, DOI 10.3233/JAD-150780; Armstrong NM, 2019, AM J EPIDEMIOL, V188, P2175, DOI 10.1093/aje/kwz210; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Barha CK, 2020, J GERONTOL A-BIOL, V75, P764, DOI 10.1093/gerona/glz093; Barha Cindy K, 2018, Brain Plast, V4, P53, DOI 10.3233/BPL-180067; Barha CK, 2017, J ALZHEIMERS DIS, V60, P1397, DOI 10.3233/JAD-170221; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P71, DOI 10.1016/j.yfrne.2017.04.002; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P86, DOI 10.1016/j.yfrne.2017.06.001; Barha CK, 2017, BRIT J SPORT MED, V51, P636, DOI 10.1136/bjsports-2016-096710; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Barrios H, 2013, AGING MENT HEALTH, V17, P287, DOI 10.1080/13607863.2012.747083; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Burton NW, 2000, PREV MED, V31, P673, DOI 10.1006/pmed.2000.0763; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chan CB, 2017, J NEUROSCI RES, V95, P328, DOI 10.1002/jnr.23863; Chang ML, 2010, J GERONTOL A-BIOL, V65, P1369, DOI 10.1093/gerona/glq152; Childs E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00161; Christie BR, 2008, NEUROMOL MED, V10, P47, DOI 10.1007/s12017-008-8033-2; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cooper C, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029736; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Davis JC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014387; Davis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063031; Davis JC, 2011, BRIT J SPORT MED, V45, P470, DOI 10.1136/bjsm.2010.077990; De Marco M, 2015, BEHAV GENET, V45, P106, DOI 10.1007/s10519-014-9675-5; DeFina LF, 2013, ANN INTERN MED, V158, P162, DOI 10.7326/0003-4819-158-3-201302050-00005; Ennis GE, 2017, NEUROLOGY, V88, P371, DOI 10.1212/WNL.0000000000003537; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2019, MED SCI SPORT EXER, V51, P1242, DOI 10.1249/MSS.0000000000001936; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Etnier JL, 2007, MED SCI SPORT EXER, V39, P199, DOI 10.1249/01.mss.0000239399.85955.5e; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Firth J, 2018, NEUROIMAGE, V166, P230, DOI 10.1016/j.neuroimage.2017.11.007; Gardner M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40566-x; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Hackney Anthony C, 2006, Expert Rev Endocrinol Metab, V1, P783, DOI 10.1586/17446651.1.6.783; Haeger A, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101933; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hansson O, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0538-4; Hare BD, 2014, NEUROPSYCHOPHARMACOL, V39, P1262, DOI 10.1038/npp.2013.329; Head D, 2012, ARCH NEUROL-CHICAGO, V69, P636, DOI 10.1001/archneurol.2011.845; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hill EE, 2008, J ENDOCRINOL INVEST, V31, P587, DOI 10.1007/BF03345606; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Howden EJ, 2015, J APPL PHYSIOL, V119, P37, DOI 10.1152/japplphysiol.00092.2015; Huang WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184011; Hui LY, 2016, J WOMENS HEALTH, V25, P71, DOI 10.1089/jwh.2015.5214; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Koran MEI, 2017, BRAIN IMAGING BEHAV, V11, P205, DOI 10.1007/s11682-016-9523-8; Krell-Roesch J, 2018, J ALZHEIMERS DIS, V63, P149, DOI 10.3233/JAD-171141; Lachman ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013297; Liu-Ambrose T, 2009, BRIT J SPORT MED, V43, P25, DOI 10.1136/bjsm.2008.055616; Liu-Ambrose T, 2018, APPL PHYSIOL NUTR ME, V43, P1105, DOI 10.1139/apnm-2018-0260; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Maass A, 2016, NEUROIMAGE, V131, P142, DOI 10.1016/j.neuroimage.2015.10.084; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; Mastorakos George, 2005, Hormones (Athens), V4, P73; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Nagamatsu Lindsay S, 2013, J Aging Res, V2013, P861893, DOI 10.1155/2013/861893; Najar J, 2019, NEUROLOGY, V92, pE1322, DOI 10.1212/WNL.0000000000007021; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Niti M, 2008, INT PSYCHOGERIATR, V20, P237, DOI 10.1017/S1041610207006655; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Ohman H, 2014, DEMENT GERIATR COGN, V38, P347, DOI 10.1159/000365388; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Palta P, 2019, ALZHEIMERS DEMENT, V15, P273, DOI 10.1016/j.jalz.2018.08.008; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Power MC, 2018, ALZHEIMERS DEMENT, V14, P167, DOI 10.1016/j.jalz.2017.07.757; Prakash RS, 2015, ANNU REV PSYCHOL, V66, P769, DOI 10.1146/annurev-psych-010814-015249; Prince M, 2015, WORLD ALZHEIMERS REP; Ratnakumar A, 2019, ALZH DEMENT-TRCI, V5, P906, DOI 10.1016/j.trci.2019.09.004; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Sanders LMJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210036; Scharfman HE, 2014, NEUROPHARMACOLOGY, V76, P696, DOI 10.1016/j.neuropharm.2013.04.029; Schubert CR, 2019, J AM GERIATR SOC, V67, P1610, DOI 10.1111/jgs.15886; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Seeman TE, 1997, J CLIN ENDOCR METAB, V82, P2458, DOI 10.1210/jc.82.8.2458; Sharman JE, 2015, AM J HYPERTENS, V28, P147, DOI 10.1093/ajh/hpu191; Shih IF, 2018, ALZHEIMERS DEMENT, V14, P1, DOI 10.1016/j.jalz.2017.05.005; Smith JC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00061; Smith JC, 2013, BRAIN SCI, V3, P54, DOI 10.3390/brainsci3010054; Smith JC, 2011, NEUROIMAGE, V54, P635, DOI 10.1016/j.neuroimage.2010.07.070; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Stillman CM, 2020, TRENDS NEUROSCI, V43, P533, DOI 10.1016/j.tins.2020.04.010; Stillman CM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00626; Stranahan AM, 2008, NEUROMOL MED, V10, P118, DOI 10.1007/s12017-008-8027-0; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Trivino-Paredes J, 2016, FRONT NEUROENDOCRIN, V41, P23, DOI 10.1016/j.yfrne.2016.03.001; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; Verstynen Timothy D, 2012, J Aging Res, V2012, P939285, DOI 10.1155/2012/939285; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Wang YX, 2019, FRONT AGING NEUROSCI, V11, DOI [10.3389/fnagi.2019.00129, 10.3389/fnagi.2019.00259]; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Wilson RS, 2013, NEUROLOGY, V81, P314, DOI 10.1212/WNL.0b013e31829c5e8a; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Yan Y, 2018, NEUROBIOL STRESS, V8, P120, DOI 10.1016/j.ynstr.2018.03.002; Yin F, 2015, NEUROBIOL AGING, V36, P2282, DOI 10.1016/j.neurobiolaging.2015.03.013; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4; Zhao LQ, 2016, NEUROBIOL AGING, V42, P69, DOI 10.1016/j.neurobiolaging.2016.02.011; Zhu N, 2014, NEUROLOGY, V82, P1339, DOI 10.1212/WNL.0000000000000310	131	13	15	2	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11329	11336		10.1096/fj.202000857R	http://dx.doi.org/10.1096/fj.202000857R		AUG 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32761860				2022-12-28	WOS:000558192800001
J	Meng, J; Lv, ZY; Sun, CX; Qiao, XH; Chen, C				Meng, Jiao; Lv, Zhenyu; Sun, Chuanxin; Qiao, Xinhua; Chen, Chang			An extract ofLycium barbarummimics exercise to improve muscle endurance through increasing type IIa oxidative muscle fibers by activating ERR gamma	FASEB JOURNAL			English	Article						Chinese traditional medicine; exercise mimetic; skeletal muscle remodeling	SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; HEPATIC STEATOSIS; HEALTH; SIRT1; EXPRESSION; CAPACITY; PROTECTS; IMPACT; FRUIT	Lycium barbarumberry (gouqi, Goji, goji berry, or wolfberry), a traditional medicine and functional food, has a wide range of biological effects, including immuno-modulation, anti-aging, antitumor, neuro-protection, and hepato-protection. However, thus far, little is known about the traditional effects ofL. barbarumon strengthening muscles. Therefore, this study focused on the effects of an extract ofL. barbarumon skeletal muscles. First, the extract ofL. barbarumsignificantly increased the mass of the tibial anterior muscle and gastrocnemius muscle and improved the average running distance of mice. Then, in vivo and in vitro experiments showed that the extract enhanced muscle endurance by increasing the proportion of type IIa oxidative muscle fibers and aerobic respiration. In an in-depth study of the molecular mechanism of these effects, we found that the extract upregulated the proportion of type IIa oxidative muscle fibers by activating ERR gamma and that the PKA-CREB signaling pathway was involved in its activation. This study is the first to show thatL. barbarumextract modulates skeletal muscle remodeling and has mimetic effects on skeletal muscles in a manner similar to exercise. It provides a scientific explanation based on modern biological technologies and concepts for the traditional function ofL. barbarumin improving muscle fitness. This study lays a theoretical foundation for the application ofL. barbarumin skeletal muscles as an exercise mimetic.	[Meng, Jiao; Lv, Zhenyu; Sun, Chuanxin; Qiao, Xinhua; Chen, Chang] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Lv, Zhenyu; Chen, Chang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Chang] Beijing Inst Brain Disorders, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, C (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	changchen@moon.ibp.ac.cn			Ningxia Key Research and Development Program Grant; Regional key projects of science and technology service network plan of Chinese Academy of Science [KFJ-STS-QYZD-181]; National Key R&D Program of China [2017YFA0504000]; NSFC \ National Natural Science Foundation of China-Key program project [91849203]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB39000000]; Goji Berry Technology Cooperation Project in Agricultural Comprehensive Development of Ningxia Autonomous Region [NTKJ-2015-05]	Ningxia Key Research and Development Program Grant; Regional key projects of science and technology service network plan of Chinese Academy of Science; National Key R&D Program of China; NSFC \ National Natural Science Foundation of China-Key program project(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Goji Berry Technology Cooperation Project in Agricultural Comprehensive Development of Ningxia Autonomous Region	Ningxia Key Research and Development Program Grant; Regional key projects of science and technology service network plan of Chinese Academy of Science, Grant/Award Number: KFJ-STS-QYZD-181; National Key R&D Program of China, Grant/Award Number: 2017YFA0504000; NSFC vertical bar National Natural Science Foundation of China-Key program project, Grant/Award Number: 91849203; The Strategic Priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDB39000000; Goji Berry Technology Cooperation Project in Agricultural Comprehensive Development of Ningxia Autonomous Region, Grant/Award Number: NTKJ-2015-05	Ahn M, 2014, ACTA HISTOCHEM, V116, P1104, DOI 10.1016/j.acthis.2014.05.004; Argiles JM, 2016, J AM MED DIR ASSOC, V17, P789, DOI 10.1016/j.jamda.2016.04.019; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Calabrese EJ, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0013-z; Cheng J, 2015, DRUG DES DEV THER, V9, P33, DOI [10.2147/DDDT.S72892, 10.2147/DDDT.572892]; Fan WW, 2017, CELL METAB, V25, P242, DOI 10.1016/j.cmet.2016.10.022; Fan WW, 2015, CURR OPIN CELL BIOL, V33, P49, DOI 10.1016/j.ceb.2014.11.002; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fielding RA, 2015, CALCIFIED TISSUE INT, V96, P181, DOI 10.1007/s00223-015-9964-x; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Guerrieri Davide, 2017, Brain Plast, V2, P153, DOI 10.3233/BPL-160043; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Ha KT, 2005, J ETHNOPHARMACOL, V96, P529, DOI 10.1016/j.jep.2004.09.054; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jia L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36209; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li S. Z., 1982, COMPENDIUM MAT MED; Lin DB, 2014, MOL NUTR FOOD RES, V58, P1005, DOI 10.1002/mnfr.201300186; Ljubicic V, 2014, AM J PHYSIOL-CELL PH, V307, pC66, DOI 10.1152/ajpcell.00357.2013; Martel J, 2019, TRENDS ENDOCRIN MET, V30, P335, DOI 10.1016/j.tem.2019.04.001; Merritt EK, 2013, J APPL PHYSIOL, V115, P937, DOI 10.1152/japplphysiol.00019.2013; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Seifarth C, 2013, EXP CLIN ENDOCR DIAB, V121, P27, DOI 10.1055/s-0032-1327734; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Yu HF, 2013, MOL NUTR FOOD RES, V57, P1158, DOI 10.1002/mnfr.201200642; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	34	7	7	4	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11460	11473		10.1096/fj.202000136R	http://dx.doi.org/10.1096/fj.202000136R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	33411401				2022-12-28	WOS:000556804700001
J	Panickar, KS; Singh, AK; Hollar, RL; Jewell, DE				Panickar, Kiran; Singh, Atul; Hollar, Regina; Jewell, Dennis			Bone Morphogenetic Protein (BMP) Transcripts in Kidney Tissue of Cats with Renal Dysfunction	FASEB JOURNAL			English	Meeting Abstract	Annual Meeting on Experimental Biology	APR 04-07, 2020	San Diego, CA	Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut					[Panickar, Kiran; Singh, Atul; Hollar, Regina] Hills PNC, Philadelphia, PA USA; [Jewell, Dennis] Kansas State Univ, Manhattan, KS 66506 USA	Kansas State University				Jewell, Dennis/0000-0003-2305-1014	Hill's Pet Nutrition, Inc	Hill's Pet Nutrition, Inc	This study was funded by Hill's Pet Nutrition, Inc		0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34			1						10.1096/fasebj.2020.34.s1.03106	http://dx.doi.org/10.1096/fasebj.2020.34.s1.03106			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG5YS	33503319				2022-12-28	WOS:000546107900129
J	Donepudi, AC; Lee, Y; Lee, JY; Schuetz, JD; Manautou, JE				Donepudi, Ajay C.; Lee, Yoojin; Lee, Ji-Young; Schuetz, John D.; Manautou, Jose E.			Multidrug resistance-associated protein 4 (Mrp4) is a novel genetic factor in the pathogenesis of obesity and diabetes	FASEB JOURNAL			English	Article						Adipogenesis; Drug transporters; Mrp4	TRANSPORTER EXPRESSION; BILE-ACID; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DIFFERENTIATION; EFFLUX TRANSPORTER; LIPID-ACCUMULATION; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ADIPOSE-TISSUE; CAMP	Multidrug resistance protein 4 (Mrp4) is an efflux transporter known to transport several xenobiotics and endogenous molecules. We recently identified that the lack of Mrp4 increases adipose tissue and body weights in mice. However, the role of Mrp4 in adipose tissue physiology are unknown. The current study aimed at characterizing these specific roles of Mrp4 using wild-type (WT) and knockout (Mrp4(-/-)) mice. Our studies determined that Mrp4 is expressed in mouse adipose tissue and that the lack of Mrp4 expression is associated with adipocyte hypertrophy. Furthermore, the lack of Mrp4 increased blood glucose and leptin levels, and impaired glucose tolerance. Additionally, in 3T3-L1 cells and human pre-adipocytes, pharmacological inhibition of Mrp4 increased adipogenesis and altered expression of adipogenic genes. Lack of Mrp4 activity in both of our in vivo and in vitro models leads to increased activation of adipose tissue cAMP response element-binding protein (Creb) and decreased plasma prostaglandin E (PGE) metabolite levels. These changes in Creb activation, coupled with decreased PGE levels, together promoted the observed metabolic phenotype in Mrp4(-/-) mice. In conclusion, our results indicate that Mrp4 as a novel genetic factor involved in the pathogenesis of metabolic diseases, such as obesity and diabetes.	[Donepudi, Ajay C.; Manautou, Jose E.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 North Eagleville Rd,Unit 3092, Storrs, CT 06269 USA; [Lee, Yoojin; Lee, Ji-Young] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA; [Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN USA	University of Connecticut; University of Connecticut; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Manautou, JE (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 North Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	jose.manautou@uconn.edu			NCI NIH HHS [P30 CA021765, R01 CA194206] Funding Source: Medline; NIDDK NIH HHS [R01 DK069557] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Cheepala SB, 2015, BLOOD, V126, P2307, DOI 10.1182/blood-2014-08-595942; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; Cheung L, 2014, BIOCHEM PHARMACOL, V91, P97, DOI 10.1016/j.bcp.2014.05.023; Cyranka M, 2019, OBESITY, V27, P1292, DOI 10.1002/oby.22521; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Donepudi AC, 2020, TOXICOL SCI, V175, P301, DOI 10.1093/toxsci/kfaa032; Donepudi AC, 2019, TOXICOL REP, V6, P841, DOI 10.1016/j.toxrep.2019.08.005; Donepudi AC, 2018, HEPATOL COMMUN, V2, P99, DOI 10.1002/hep4.1129; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Donepudi AC, 2016, DRUG METAB DISPOS, V44, P518, DOI 10.1124/dmd.115.066779; Donepudi AC, 2012, LIVER INT, V32, P560, DOI 10.1111/j.1478-3231.2011.02724.x; Fujimori K, 2012, PPAR RES, V2012, DOI 10.1155/2012/527607; Fujimori K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044698; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Lee MJ, 2014, METHOD ENZYMOL, V538, P49, DOI 10.1016/B978-0-12-800280-3.00004-9; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Maher JM, 2005, DRUG METAB DISPOS, V33, P947, DOI 10.1124/dmd.105.003780; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; More VR, 2011, DRUG METAB DISPOS, V39, P992, DOI 10.1124/dmd.110.037507; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Pezzolesi MG, 2010, SEMIN NEPHROL, V30, P126, DOI 10.1016/j.semnephrol.2010.01.004; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Tanaka Y, 2015, PHARMACOGENOMICS J, V15, P380, DOI 10.1038/tpj.2014.74; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xu H, 2016, J MOL CELL BIOL, V8, P518, DOI 10.1093/jmcb/mjw035; Xu JL, 2016, TOXICOL APPL PHARM, V290, P21, DOI 10.1016/j.taap.2015.11.002; Xu JL, 2015, OBESITY, V23, P335, DOI 10.1002/oby.20929; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Yacovino LL, 2012, TOXICOL LETT, V211, P304, DOI 10.1016/j.toxlet.2012.04.008; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	45	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21304	10.1096/fj.202001299RR	http://dx.doi.org/10.1096/fj.202001299RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417247	Green Accepted			2022-12-28	WOS:000647789600090
J	Quittot, N; Fortier, M; Babych, M; Nguyen, PT; Sebastiao, M; Bourgault, S				Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve			Cell surface glycosaminoglycans exacerbate plasma membrane perturbation induced by the islet amyloid polypeptide	FASEB JOURNAL			English	Article						amyloid; glycosaminoglycans; islet amyloid polypeptide; self&#8208; assembly; membrane perturbation	HEPARAN-SULFATE PROTEOGLYCANS; BETA-CELLS; HUMAN-IAPP; TYPE-2; PEPTIDE; AGGREGATION; PROTEIN; MECHANISM; TOXICITY; INTERNALIZATION	Glycosaminoglycans (GAGs) are long and unbranched anionic heteropolysaccharides that have been associated with virtually all amyloid deposits. Soluble sulfated GAGs are known for their propensity to promote the self-assembly of numerous amyloidogenic proteins and to modulate their cytotoxicity. Nonetheless, although GAGs are prevalent on the outer leaflet of eukaryotic cell plasma membrane as part of proteoglycans, their contributions in the perturbation of lipid bilayer induced by amyloid polypeptides remain unknown. Herein, we investigate the roles of GAGs in the cytotoxicity and plasma membrane perturbation induced by the islet amyloid polypeptide (IAPP), whose deposition in the pancreatic islets is associated with type II diabetes. Cellular assays using GAG-deficient cells reveal that GAGs exacerbate IAPP-induced cytotoxicity and permeabilization of the plasma membrane. Confocal microscopy and flow cytometry analyses show that IAPP sequestration at the cell surface is dependent of GAGs and of the aggregation propensity of the peptide. Using giant plasma membrane vesicles (GPMVs) prepared from GAG-deficient cells, we investigate the direct contributions of membrane-embedded proteoglycans in IAPP-induced membrane disassembly. In sharp contrast to soluble sulfated GAGs, kinetics of amyloid self-assembly expose that the presence of GAGs on GPMVs does not significantly modulate in vitro amyloid formation. Overall, this study indicates that cell surface GAGs increase the local concentration of IAPP in the vicinity of the plasma membrane, promoting lipid bilayer perturbation and cell death.	[Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve] Univ Quebec Montreal, Dept Chem, CP 8888, Montreal, PQ H3C 3P8, Canada; [Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve] Courtois Fdn, Ctr Excellence Res Orphan Dis, Montreal, PQ, Canada; [Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada	University of Quebec; University of Quebec Montreal	Bourgault, S (corresponding author), Univ Quebec Montreal, Dept Chem, CP 8888, Montreal, PQ H3C 3P8, Canada.	bourgault.steve@ugam.ca						Abedini A, 2005, ORG LETT, V7, P693, DOI 10.1021/ol047480+; Abedini A, 2018, J CLIN INVEST, V128, P682, DOI 10.1172/JCI85210; Abedini A, 2016, ELIFE, V5, DOI 10.7554/eLife.12977; Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Aston-Mourney K, 2011, DIABETOLOGIA, V54, P1756, DOI 10.1007/s00125-011-2143-3; Bejoy J, 2018, ACS BIOMATER SCI ENG, V4, P2922, DOI 10.1021/acsbiomaterials.8b00021; Bergamaschini L, 2002, NEUROBIOL AGING, V23, P531, DOI 10.1016/S0197-4580(02)00003-9; Birol M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03651-9; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Caillon L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5639875; CARLES J, 1956, B SOC CHIM BIOL, V38, P255; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; De Carufel C. A., 2015, ANGEW CHEM, V127, P14591, DOI DOI 10.1002/ANGE.201507092; De Carufel CA, 2013, BIOPOLYMERS, V100, P645, DOI 10.1002/bip.22243; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Godin E, 2019, J BIOL CHEM, V294, P8452, DOI 10.1074/jbc.RA118.006454; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hong YN, 2012, J AM CHEM SOC, V134, P1680, DOI 10.1021/ja208720a; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Jeong HR, 2015, CLIN INTERV AGING, V10, P1873, DOI 10.2147/CIA.S95297; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Kisilevsky R, 2000, AMYLOID, V7, P23, DOI 10.3109/13506120009146820; Krotee P, 2017, ELIFE, V6, DOI 10.7554/eLife.19273; Last NB, 2013, PROTEIN SCI, V22, P870, DOI 10.1002/pro.2274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Madine J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190327; Madine J, 2010, EUR BIOPHYS J BIOPHY, V39, P1281, DOI 10.1007/s00249-010-0581-3; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; Maiza A, 2018, FEBS LETT, V592, P3806, DOI 10.1002/1873-3468.13082; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mukherjee A, 2017, J EXP MED, V214, P2591, DOI 10.1084/jem.20161134; Oskarsson ME, 2015, J BIOL CHEM, V290, P15121, DOI 10.1074/jbc.M114.631697; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; Park YJ, 2012, DIABETOLOGIA, V55, P1035, DOI 10.1007/s00125-012-2451-2; PEPYS MB, 1994, P NATL ACAD SCI USA, V91, P5602, DOI 10.1073/pnas.91.12.5602; Nguyen PT, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/515307; Potter KJ, 2015, AM J TRANSPLANT, V15, P1519, DOI 10.1111/ajt.13134; Quittot N, 2018, BIOCONJUGATE CHEM, V29, P517, DOI 10.1021/acs.bioconjchem.7b00827; Quittot N, 2017, BIOCHEM CELL BIOL, V95, P329, DOI 10.1139/bcb-2016-0236; Raleigh D, 2017, J MOL ENDOCRINOL, V59, pR121, DOI 10.1530/JME-17-0105; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Schlamadinger DE, 2014, BIOPHYS J, V107, P2559, DOI 10.1016/j.bpj.2014.09.047; Sebastiao M, 2019, BIOCHEMISTRY-US, V58, P1214, DOI 10.1021/acs.biochem.8b01206; Sebastiao M, 2017, ANAL BIOCHEM, V532, P83, DOI 10.1016/j.ab.2017.06.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Templin AT, 2019, PROTEIN ENG DES SEL, V32, P95, DOI 10.1093/protein/gzz041; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Trikha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073080; Vidal J, 2003, DIABETOLOGIA, V46, P71, DOI 10.1007/s00125-002-0984-5; Wang H, 2013, J MOL BIOL, V425, P492, DOI 10.1016/j.jmb.2012.11.003; Wesen E, 2018, BBA-BIOMEMBRANES, V1860, P2204, DOI 10.1016/j.bbamem.2018.08.010; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951	80	3	3	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21306	10.1096/fj.202001845R	http://dx.doi.org/10.1096/fj.202001845R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475205				2022-12-28	WOS:000647789600044
J	Rahimi, R; Malek, I; Lerrer-Goldshtein, T; Elkis, Y; Shoval, I; Jacob, A; Shpungin, S; Nir, U				Rahimi, Roni; Malek, Israel; Lerrer-Goldshtein, Tali; Elkis, Yoav; Shoval, Irit; Jacob, Avi; Shpungin, Sally; Nir, Uri			TMF1 is upregulated by insulin and is required for a sustained glucose homeostasis	FASEB JOURNAL			English	Article						golgi; glucose&#8208; uptake; glucose&#8208; homeostasis; GLUT4; insulin; plasma membrane; TMF1; trafficking; vesicle; VAMP2	GLUT4; TMF/ARA160; PROTEIN; MUSCLE; GOLGI; SUSCEPTIBILITY; ABNORMALITIES; TRANSLOCATION; TRANSPORTERS; COACTIVATOR	Insulin-regulated glucose homeostasis is a critical and intricate physiological process, of which not all regulatory components have been deciphered. One of the key players in modulating glucose uptake by cells is the glucose transporter-GLUT4. In this study, we aimed to explore the regulatory role of the trans-Golgi-associated protein-TATA Element Modulatory Factor (TMF1) in the GLUT4 mediated, insulin-directed glucose uptake. By establishing and using TMF1-/- myoblasts and mice, we examined the effect of TMF1 absence on the insulin driven functioning of GLUT4. We show that TMF1 is upregulated by insulin in myoblasts, and is essential for the formation of insulin responsive, glucose transporter GLUT4-containing vesicles. Absence of TMF1 leads to the retention of GLUT4 in perinuclear compartments, and to severe impairment of insulin-stimulated GLUT4 trafficking throughout the cytoplasm and to the cell plasma membrane. Accordingly, glucose uptake is impaired in TMF1-/- cells, and TMF1-/- mice are hyperglycemic. This is reflected by the mice impaired blood glucose clearance and increased blood glucose level. Correspondingly, TMF1-/- animals are leaner than their normal littermates. Thus, TMF1 is a novel effector of insulin-regulated glucose homeostasis, and dys-functioning of this protein may contribute to the onset of a diabetes-like disorder.	[Rahimi, Roni; Malek, Israel; Lerrer-Goldshtein, Tali; Elkis, Yoav; Shoval, Irit; Jacob, Avi; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	uri.nir@biu.ac.il		Shoval, Irit/0000-0002-3009-3418; Jacob, Avi/0000-0002-0096-9888				Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bel S, 2014, P NATL ACAD SCI USA, V111, P4964, DOI 10.1073/pnas.1319114111; Bel S, 2012, J BIOL CHEM, V287, P25631, DOI 10.1074/jbc.M112.364786; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Elkis Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145277; Elkis Y, 2013, MOL CELL ENDOCRINOL, V365, P52, DOI 10.1016/j.mce.2012.09.003; Feng Y, 2020, J CELL PHYSIOL, V235, P5702, DOI 10.1002/jcp.29502; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Folgmann D., 2016, OPTIMIZED PROTOCOL M; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; GARCIA JA, 1992, P NATL ACAD SCI USA, V89, P9372, DOI 10.1073/pnas.89.20.9372; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Hindi L., BIOPROTOC, V7; Hsiao JJ, 2016, J BIOL CHEM, V291, P18818, DOI 10.1074/jbc.M116.732313; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; KRAEGEN EW, 1993, BIOCHEM J, V295, P287, DOI 10.1042/bj2950287; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; Li HB, 2017, FEBS LETT, V591, P491, DOI 10.1002/1873-3468.12555; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Liu ZQ, 2015, TOXICOL APPL PHARM, V285, P61, DOI 10.1016/j.taap.2015.03.011; MAINS PE, 1990, GENETICS, V125, P351; Matsuzaka T, 2012, J DIABETES INVEST, V3, P130, DOI 10.1111/j.2040-1124.2011.00177.x; Miller VJ, 2013, J BIOL CHEM, V288, P4229, DOI 10.1074/jbc.M112.426767; Mori K, 2002, FEBS LETT, V520, P127, DOI 10.1016/S0014-5793(02)02803-X; OLEFSKY JM, 1993, ADV EXP MED BIOL, V334, P129; Papadopoulos N, 2018, J CELL BIOL, V217, P1701, DOI 10.1083/jcb.201706118; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Rose AJ, 2009, AM J PHYSIOL-REG I, V297, pR1228, DOI 10.1152/ajpregu.00258.2009; Rudich A, 2003, ACTA PHYSIOL SCAND, V178, P297, DOI 10.1046/j.1365-201X.2003.01163.x; Sun Y, 2014, MOL BIOL CELL, V25, P1159, DOI 10.1091/mbc.E13-08-0493; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010	39	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21295	10.1096/fj.202001995R	http://dx.doi.org/10.1096/fj.202001995R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475194				2022-12-28	WOS:000647789600021
J	Alexander, CJ; Barzik, M; Fujiwara, I; Remmert, K; Wang, YX; Petralia, RS; Friedman, TB; Hammer, JA				Alexander, Christopher J.; Barzik, Melanie; Fujiwara, Ikuko; Remmert, Kirsten; Wang, Ya-Xian; Petralia, Ronald S.; Friedman, Thomas B.; Hammer, John A.			Myosin 18A alpha targets the guanine nucleotide exchange factor beta-Pix to the dendritic spines of cerebellar Purkinje neurons and promotes spine maturation	FASEB JOURNAL			English	Article						F&#8208; actin; myosin 2; spine development	ACENTROSOMAL MICROTUBULE NUCLEATION; ACTIN DYNAMICS; LONG-TERM; SYNAPTIC PLASTICITY; ARP2/3 COMPLEX; MORPHOLOGICAL-CHANGES; MOLECULAR-MECHANISMS; RAT HIPPOCAMPUS; GOLGI OUTPOSTS; RHO GTPASES	Myosin 18A alpha is a myosin 2-like protein containing unique N- and C-terminal protein interaction domains that co-assembles with myosin 2. One protein known to bind to myosin 18A alpha is beta-Pix, a guanine nucleotide exchange factor (GEF) for Rac1 and Cdc42 that has been shown to promote dendritic spine maturation by activating the assembly of actin and myosin filaments in spines. Here, we show that myosin 18A; concentrates in the spines of cerebellar Purkinje neurons via co-assembly with myosin 2 and through an actin binding site in its N-terminal extension. miRNA-mediated knockdown of myosin 18A results in a significant defect in spine maturation that is rescued by an RNAi-immune version of myosin 18A. Importantly, beta-Pix co-localizes with myosin 18A in spines, and its spine localization is lost upon myosin 18A knockdown or when its myosin 18A binding site is deleted. Finally, we show that the spines of myosin 18A knockdown Purkinje neurons contain significantly less F-actin and myosin 2. Together, these data argue that mixed filaments of myosin 2 and myosin 18A form a complex with beta-Pix in Purkinje neuron spines that promotes spine maturation by enhancing the assembly of actin and myosin filaments downstream of beta-Pix's GEF activity.	[Alexander, Christopher J.; Hammer, John A.] NHLBI, Mol Cell Biol Lab, Cell & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Barzik, Melanie; Friedman, Thomas B.] NIDCD, Lab Mol Genet, NIH, Bethesda, MD USA; [Fujiwara, Ikuko] Osaka City Univ, Grad Sch Sci, Osaka, Japan; [Remmert, Kirsten] NCI, Surg Oncol Program, NIH, Betheda, MD USA; [Wang, Ya-Xian; Petralia, Ronald S.] NIDCD, Adv Imaging Core, NIH, Betheda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Osaka Metropolitan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Hammer, JA (corresponding author), NHLBI, Mol Cell Biol Lab, Cell & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov	Barzik, Melanie/AAJ-9269-2021	Barzik, Melanie/0000-0003-3003-1281	Intramural NIH HHS [Z01 DC000039, ZIC DC000081, ZIA HL006123] Funding Source: Medline; National Heart, Lung, and Blood Institute (NHLBI) [ZIAHL006123] Funding Source: Medline; National Institute on Deafness and Other Communication Disorders (NIDCD) [DC000081, DC000039] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alexander CJ, 2016, METHOD CELL BIOL, V131, P177, DOI 10.1016/bs.mcb.2015.06.004; Alexander CJ, 2019, CEREBELLUM, V18, P406, DOI 10.1007/s12311-019-1007-0; Alexander CJ, 2018, CYTOSKELETON, V75, P395, DOI 10.1002/cm.21474; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Basu S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00143; Beach JR, 2017, NAT CELL BIOL, V19, P85, DOI 10.1038/ncb3463; Beach JR, 2015, EXP CELL RES, V334, P2, DOI 10.1016/j.yexcr.2015.01.012; Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Bonn BR, 2013, EXP CELL RES, V319, P402, DOI 10.1016/j.yexcr.2012.12.005; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Briggs SB, 2018, LEARN MEMORY, V25, P391, DOI 10.1101/lm.046763.117; Bruun K, 2017, CYTOSKELETON, V74, P205, DOI 10.1002/cm.21364; Caldeira GL, 2019, CURR OPIN NEUROBIOL, V57, P62, DOI 10.1016/j.conb.2019.01.004; Chazeau A, 2016, CELL MOL LIFE SCI, V73, P3053, DOI 10.1007/s00018-016-2214-1; Chen C, 2012, INT J BIOCHEM CELL B, V44, P447, DOI 10.1016/j.biocel.2011.11.022; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Fu MM, 2019, CELL, V179, P132, DOI 10.1016/j.cell.2019.08.025; Fujiwara I, 2014, P NATL ACAD SCI USA, V111, pE1970, DOI 10.1073/pnas.1313738111; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Gao YZ, 2011, J NEUROSCI, V31, P16581, DOI 10.1523/JNEUROSCI.3332-11.2011; Gavin CF, 2012, LEARN MEMORY, V19, P9, DOI 10.1101/lm.024042.111; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Hanus C, 2016, CURR OPIN NEUROBIOL, V39, P8, DOI 10.1016/j.conb.2016.03.004; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; He S, 2014, J NEUROSCI, V34, P5261, DOI 10.1523/JNEUROSCI.3728-13.2014; Heintz TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158558; Hlushchenko I, 2016, CYTOSKELETON, V73, P435, DOI 10.1002/cm.21280; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horsthemke M, 2019, J BIOL CHEM, V294, P7202, DOI 10.1074/jbc.RA118.004560; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hsu RM, 2014, BBA-MOL CELL RES, V1843, P2513, DOI 10.1016/j.bbamcr.2014.06.023; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kanjhan R, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3423267; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kennedy MJ, 2019, ANNU REV CELL DEV BI, V35, P543, DOI 10.1146/annurev-cellbio-100818-125418; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kiraly DD, 2010, ACS CHEM NEUROSCI, V1, P348, DOI 10.1021/cn100012x; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Koskinen M, 2014, MOL CELL NEUROSCI, V61, P56, DOI 10.1016/j.mcn.2014.05.008; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Laure-Kamionowska M, 2009, FOLIA NEUROPATHOL, V47, P300; Lee KJ, 2007, NEUROBIOL LEARN MEM, V88, P445, DOI 10.1016/j.nlm.2007.06.001; Lee KJ, 2005, CEREBELLUM, V4, P97, DOI 10.1080/14734220510007842; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis TL, 2012, NEURON, V76, P862, DOI 10.1016/j.neuron.2012.11.019; Long M, 2017, TISSUE CELL, V49, P163, DOI 10.1016/j.tice.2016.09.007; Mar XF, 2006, MOL BIOL CELL, V17, P2138, DOI 10.1091/mbc.E05-10-0097; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meseke M, 2013, EUR J NEUROSCI, V37, P1404, DOI 10.1111/ejn.12153; Mikhaylova M, 2016, CELL REP, V14, P189, DOI 10.1016/j.celrep.2015.12.024; MORALES M, 1989, J COMP NEUROL, V279, P666, DOI 10.1002/cne.902790412; Murugesan S, 2016, J CELL BIOL, V215, P383, DOI 10.1083/jcb.201603080; Nakahata Y, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00029; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Nitta K, 2017, MOL THER-METH CLIN D, V6, P159, DOI 10.1016/j.omtm.2017.07.006; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oray S, 2006, CEREB CORTEX, V16, P730, DOI 10.1093/cercor/bhj019; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Ozkan ED, 2015, J NEUROCHEM, V134, P429, DOI 10.1111/jnc.13146; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Penzes P, 2012, CYTOSKELETON, V69, P426, DOI 10.1002/cm.21015; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Racz B, 2008, J NEUROSCI, V28, P5654, DOI 10.1523/JNEUROSCI.0756-08.2008; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Rubio MD, 2011, J NEUROSCI, V31, P1448, DOI 10.1523/JNEUROSCI.3294-10.2011; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Seil FJ, 2014, NEUROSCI BIOBEHAV R, V45, P212, DOI 10.1016/j.neubiorev.2014.06.003; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Spence EF, 2016, J NEUROSCI, V36, P9696, DOI 10.1523/JNEUROSCI.0876-16.2016; Stein IS, 2019, NEUROSCIENTIST, V25, P27, DOI 10.1177/1073858418769644; Sugawara T, 2013, J NEUROSCI, V33, P12186, DOI 10.1523/JNEUROSCI.0545-13.2013; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Taft MH, 2013, J BIOL CHEM, V288, P30029, DOI 10.1074/jbc.M113.497180; Takahashi H, 2003, J NEUROSCI, V23, P6586; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Tejada-Simon MV, 2015, J NEUROCHEM, V133, P767, DOI 10.1111/jnc.13100; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Valenzuela JI, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00358; Velazquez-Zamora DA, 2011, INT J DEV NEUROSCI, V29, P515, DOI 10.1016/j.ijdevneu.2011.04.005; Wagner W, 2011, J NEUROSCI METH, V200, P95, DOI 10.1016/j.jneumeth.2011.06.006; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Woolfrey KM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3025948; Yan Z, 2016, J NEUROSCI, V36, P11411, DOI 10.1523/JNEUROSCI.2360-16.2016; Yang Q, 2000, ACTA NEUROPATHOL, V100, P371, DOI 10.1007/s004010000201; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang XM, 2004, GENESIS, V40, P45, DOI 10.1002/gene.20062	114	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21092	10.1096/fj.202001449R	http://dx.doi.org/10.1096/fj.202001449R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33378124	Bronze, Green Accepted			2022-12-28	WOS:000605626600045
J	Matsubayashi, M; Sakaguchi, YM; Sahara, Y; Nanaura, H; Kikuchi, S; Asghari, A; Bui, L; Kobashigawa, S; Nakanishi, M; Nagata, R; Matsui, TK; Kashino, G; Hasegawa, M; Takasawa, S; Eriguchi, M; Tsuruya, K; Nagamori, S; Sugie, K; Nakagawa, T; Takasato, M; Umetani, M; Mori, E				Matsubayashi, Masaya; Sakaguchi, Yoshihiko M.; Sahara, Yoshiki; Nanaura, Hitoki; Kikuchi, Sotaro; Asghari, Arvand; Bui, Linh; Kobashigawa, Shinko; Nakanishi, Mari; Nagata, Riko; Matsui, Takeshi K.; Kashino, Genro; Hasegawa, Masatoshi; Takasawa, Shin; Eriguchi, Masahiro; Tsuruya, Kazuhiko; Nagamori, Shushi; Sugie, Kazuma; Nakagawa, Takahiko; Takasato, Minoru; Umetani, Michihisa; Mori, Eiichiro			27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action	FASEB JOURNAL			English	Article						27&#8208; hydroxycholesterol; estrogen receptor; transcriptional regulatory element; uric acid	SERUM URIC-ACID; METABOLIC SYNDROME; INSULIN-RESISTANCE; GENDER-DIFFERENCES; NATIONAL-HEALTH; HYPERURICEMIA; PREVALENCE; SYSTEMS; LEVEL; URAT1	The excretion and reabsorption of uric acid both to and from urine are tightly regulated by uric acid transporters. Metabolic syndrome conditions, such as obesity, hypercholesterolemia, and insulin resistance, are believed to regulate the expression of uric acid transporters and decrease the excretion of uric acid. However, the mechanisms driving cholesterol impacts on uric acid transporters have been unknown. Here, we show that cholesterol metabolite 27-hydroxycholesterol (27HC) upregulates the uric acid reabsorption transporter URAT1 encoded by SLC22A12 via estrogen receptors (ER). Transcriptional motif analysis showed that the SLC22A12 gene promoter has more estrogen response elements (EREs) than other uric acid reabsorption transporters such as SLC22A11 and SLC22A13, and 27HC-activated SLC22A12 gene promoter via ER through EREs. Furthermore, 27HC increased SLC22A12 gene expression in human kidney organoids. Our results suggest that in hypercholesterolemic conditions, elevated levels of 27HC derived from cholesterol induce URAT1/SLC22A12 expression to increase uric acid reabsorption, and thereby, could increase serum uric acid levels.	[Matsubayashi, Masaya; Sakaguchi, Yoshihiko M.; Nanaura, Hitoki; Kikuchi, Sotaro; Kobashigawa, Shinko; Nakanishi, Mari; Nagata, Riko; Matsui, Takeshi K.; Nakagawa, Takahiko; Mori, Eiichiro] Nara Med Univ, Dept Future Basic Med, Kashihara, Nara 6348521, Japan; [Sahara, Yoshiki; Takasato, Minoru] RIKEN Ctr Biosyst Dynam Res, Kobe, Hyogo, Japan; [Sahara, Yoshiki; Takasato, Minoru] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Nanaura, Hitoki; Matsui, Takeshi K.; Sugie, Kazuma] Nara Med Univ, Dept Neurol, Kashihara, Nara, Japan; [Asghari, Arvand; Bui, Linh; Umetani, Michihisa] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Kashino, Genro] Nara Med Univ, Radioisotope Res Ctr, Kashihara, Nara, Japan; [Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara, Japan; [Takasawa, Shin] Nara Med Univ, Dept Biochem, Kashihara, Nara, Japan; [Eriguchi, Masahiro; Tsuruya, Kazuhiko] Nara Med Univ, Dept Nephrol, Kashihara, Nara, Japan; [Nagamori, Shushi] Nara Med Univ, Dept Collaborat Res, Nara, Japan; [Umetani, Michihisa] Univ Houston, HLTH Res Inst, Houston, TX USA; [Mori, Eiichiro] Nara Med Univ, iCliniX Lab 5, Kashihara, Nara, Japan	Nara Medical University; RIKEN; Kyoto University; Nara Medical University; University of Houston System; University of Houston; Nara Medical University; Nara Medical University; Nara Medical University; Nara Medical University; Nara Medical University; University of Houston System; University of Houston; Nara Medical University	Mori, E (corresponding author), Nara Med Univ, Dept Future Basic Med, Kashihara, Nara 6348521, Japan.; Umetani, M (corresponding author), Univ Houston, HLTH Res Inst, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA.	mumetani@uh.edu; emori@naramed-u.ac.jp	Takasato, Minoru/K-2035-2014; Nagamori, Shushi/P-4530-2018; Asghari, Arvand/C-7005-2019	Takasato, Minoru/0000-0002-0458-7414; Nagamori, Shushi/0000-0003-0203-2754; Asghari, Arvand/0000-0001-6184-0861; Matsui, Takeshi/0000-0002-1678-284X				Acimovic J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068031; Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045; Barthelson RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-340; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Burkard I, 2007, ATHEROSCLEROSIS, V194, P71, DOI 10.1016/j.atherosclerosis.2006.09.026; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen-Xu M, 2019, ARTHRITIS RHEUMATOL, V71, P991, DOI 10.1002/art.40807; Cicero AFG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29955-w; Cobo G, 2016, CLIN SCI, V130, P1147, DOI 10.1042/CS20160047; Cooke JP, 2002, CIRCULATION, V106, P1904, DOI 10.1161/01.CIR.0000036864.14101.1B; Doshi M, 2011, NUCLEOS NUCLEOT NUCL, V30, P1290, DOI 10.1080/15257770.2011.603711; Dudley MW, 2000, P NATL ACAD SCI USA, V97, P3696, DOI 10.1073/pnas.040558197; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Enomoto Atsushi, 2005, Clin Exp Nephrol, V9, P195, DOI 10.1007/s10157-005-0368-5; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Hosoyamada M, 2004, J AM SOC NEPHROL, V15, P261, DOI 10.1097/01.ASN.0000107560.80107.19; Ioannou GN, 2013, ATHEROSCLEROSIS, V226, P220, DOI 10.1016/j.atherosclerosis.2012.10.044; Ishikawa-Takata K, 2002, EUR J CLIN NUTR, V56, P601, DOI 10.1038/sj.ejcn.1601364; Kuzuya M, 2002, J GERONTOL A-BIOL, V57, pM660, DOI 10.1093/gerona/57.10.M660; Lake BB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04426-w; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE J, 1995, AM J EPIDEMIOL, V142, P288, DOI 10.1093/oxfordjournals.aje.a117634; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Liu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/762820; Marelli C, 2018, BRAIN, V141, P72, DOI 10.1093/brain/awx297; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Miao ZM, 2009, INFLAMM RES, V58, P659, DOI 10.1007/s00011-009-0031-9; Misawa K, 2020, GENETICS, V214, P1079, DOI 10.1534/genetics.119.303006; Nakagawa T, 2008, INTERN EMERG MED, V3, P313, DOI 10.1007/s11739-008-0141-3; Nigam SK, 2018, CURR OPIN NEPHROL HY, V27, P305, DOI 10.1097/MNH.0000000000000427; Ohno S, 2018, INT HEART J, V59, P559, DOI 10.1536/ihj.17-143; Onizuka Y, 2019, CLIN BIOCHEM, V73, P105, DOI 10.1016/j.clinbiochem.2019.08.009; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Ren P, 2018, CLIN LAB, V64, P719, DOI 10.7754/Clin.Lab.2017.171037; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Shirasawa T, 2020, BMC ENDOCR DISORD, V20, DOI 10.1186/s12902-019-0481-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sumiyoshi H, 2019, INT HEART J, V60, P830, DOI 10.1536/ihj.18-444; Takasato M, 2016, NATURE, V536, P238, DOI 10.1038/nature17982; Takiue Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P113, DOI 10.1080/15257770.2010.551645; Tan PK, 2016, MOL BIOL EVOL, V33, P2193, DOI 10.1093/molbev/msw116; Thomas MP, 2013, J STEROID BIOCHEM, V137, P27, DOI 10.1016/j.jsbmb.2012.12.014; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Umetani M, 2016, J STEROID BIOCHEM, V157, P20, DOI 10.1016/j.jsbmb.2015.11.002; Umetani M, 2014, CELL METAB, V20, P172, DOI 10.1016/j.cmet.2014.05.013; Umetani M, 2011, TRENDS ENDOCRIN MET, V22, P130, DOI 10.1016/j.tem.2011.01.003; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang HJ, 2018, OPEN MED-WARSAW, V13, P172, DOI 10.1515/med-2018-0027; Wu HJ, 2018, CELL STEM CELL, V23, P869, DOI 10.1016/j.stem.2018.10.010; Wu XL, 2015, J PHYSIOL BIOCHEM, V71, P217, DOI 10.1007/s13105-015-0399-7; Yahyaoui R, 2008, J CLIN ENDOCR METAB, V93, P2230, DOI 10.1210/jc.2007-2467; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014; Zhang X, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0882-6; Zhen HT, 2017, BIOMED REP, V7, P325, DOI 10.3892/br.2017.966; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zoccali C, 2013, CURR HYPERTENS REP, V15, P531, DOI 10.1007/s11906-013-0391-y	68	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1							e21262	10.1096/fj.202002077R	http://dx.doi.org/10.1096/fj.202002077R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33368618	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000605626600031
J	Zhou, JJ; Yan, QM; Tang, CC; Liao, Y; Zhang, QJ; Wang, XM; Zhou, XQ; Lai, LX; Zou, QJ				Zhou, Juanjuan; Yan, Quanmei; Tang, Chengcheng; Liao, Yuan; Zhang, Quanjun; Wang, Xiaomin; Zhou, Xiaoqing; Lai, Liangxue; Zou, Qingjian			Development of a rabbit model of Wiskott-Aldrich syndrome	FASEB JOURNAL			English	Article						CRISPR; Wiskott&#8211; Aldrich syndrome; thrombocytopenia; rabbit	WASP; MUTATIONS; DISEASE	The Wiskott-Aldrich syndrome (WAS) is a severe recessive X-linked immunodeficiency resulting from loss-of-function mutations in the WAS gene. Mouse is the only mammalian model used for investigation of WAS pathogenesis. However, the mouse model does not accurately recapitulate WAS clinical phenotypes, thus, limiting its application in WAS clinical research. Herein, we report the generation of WAS knockout (KO) rabbits via embryo co-injection of Cas9 mRNA and a pair of sgRNAs targeting exons 2 and 7. WAS KO rabbits exhibited many symptoms similar to those of WAS patients, including thrombocytopenia, bleeding tendency, infections, and reduced numbers of T cell in the spleen and peripheral blood. The WAS KO rabbit model provides a new valuable tool for preclinical trials of WAS treatment.	[Zhou, Juanjuan] Univ Sci & Technol China, Sch Life Sci, Hefei, Peoples R China; [Zhou, Juanjuan; Yan, Quanmei; Liao, Yuan; Zhang, Quanjun; Wang, Xiaomin; Lai, Liangxue] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed, CAS Key Lab Regenerat Biol,Guangdong Prov Key Lab, 90 Kaiyuan Ave,Guangzhou Sci Pk, Guangzhou 510530, Peoples R China; [Zhou, Juanjuan; Yan, Quanmei; Liao, Yuan; Zhang, Quanjun; Wang, Xiaomin; Lai, Liangxue] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Hlth, CAS Key Lab Regenerat Biol,Guangdong Prov Key Lab, 90 Kaiyuan Ave,Guangzhou Sci Pk, Guangzhou 510530, Peoples R China; [Tang, Chengcheng; Zhou, Xiaoqing; Zou, Qingjian] Wuyi Univ, Sch Biotechnol & Hlth Sci, 22 Dongcheng Village, Jiangmen 529020, Guangdong, Peoples R China; [Liao, Yuan] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei, Peoples R China; [Zhang, Quanjun; Lai, Liangxue] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China; [Zhang, Quanjun; Lai, Liangxue] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Zhang, Quanjun; Lai, Liangxue] Chinese Acad Med Sci 2019RU015, Res Unit Generat Large Anim Dis Models, Guangzhou, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Wuyi University; Anhui University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences	Lai, LX (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed, CAS Key Lab Regenerat Biol,Guangdong Prov Key Lab, 90 Kaiyuan Ave,Guangzhou Sci Pk, Guangzhou 510530, Peoples R China.; Lai, LX (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Hlth, CAS Key Lab Regenerat Biol,Guangdong Prov Key Lab, 90 Kaiyuan Ave,Guangzhou Sci Pk, Guangzhou 510530, Peoples R China.; Zou, QJ (corresponding author), Wuyi Univ, Sch Biotechnol & Hlth Sci, 22 Dongcheng Village, Jiangmen 529020, Guangdong, Peoples R China.	lai_liangxue@gibh.ac.cn; wyuchemzqj@126.com			National Key Research and Development Program of China [2017YFA0105103]; Science Fundation for Young Teachers of Wuyi University [2019TD05]	National Key Research and Development Program of China; Science Fundation for Young Teachers of Wuyi University	National Key Research and Development Program of China, Grant/Award Number: 2017YFA0105103; the Science Fundation for Young Teachers of Wuyi University, Grant/Award Number: 2019TD05	Albert MH, 2011, CURR OPIN HEMATOL, V18, P42, DOI 10.1097/MOH.0b013e32834114bc; Ariga T, 2012, ALLERGOL INT, V61, P183, DOI 10.2332/allergolint.11-RAI-0412; BASILE GD, 1989, LANCET, V2, P1319; Candotti F, 2018, J CLIN IMMUNOL, V38, P13, DOI 10.1007/s10875-017-0453-z; Choi S, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/2791632; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curcio C, 2007, J PATHOL, V211, P67, DOI 10.1002/path.2088; Cvejic A, 2008, J CELL SCI, V121, P3196, DOI 10.1242/jcs.032235; Esteves PJ, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0094-1; Fan JL, 2018, J ATHEROSCLER THROMB, V25, P213, DOI 10.5551/jat.RV17018; Fan Jianglin, 2015, Pharmacol Ther, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hashikawa Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66780-6; Janssen E, 2019, IMMUNOL REV, V287, P121, DOI 10.1111/imr.12716; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Jones RA, 2013, J CELL SCI, V126, P4077, DOI 10.1242/jcs.128728; Kim JW, 2017, GRAEF ARCH CLIN EXP, V255, P2363, DOI 10.1007/s00417-017-3805-8; Lamas-Toranzo I, 2019, ELIFE, V8, DOI 10.7554/eLife.48904; Li L, 2017, J BIOL CHEM, V292, P4755, DOI 10.1074/jbc.M116.764787; Moratto Daniele, 2007, Expert Rev Clin Immunol, V3, P813, DOI 10.1586/1744666X.3.5.813; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Perez-Garmendia R, 2014, J ALZHEIMERS DIS, V39, P441, DOI 10.3233/JAD-130590; Rivers E, 2017, EUR J IMMUNOL, V47, P1857, DOI 10.1002/eji.201646715; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Sui TT, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032201; SULLIVAN KE, 1993, J IMMUNOL, V150, pA163; Sun XZ, 2019, CELL IMMUNOL, V341, DOI 10.1016/j.cellimm.2019.04.007; Thrasher Adrian J, 2009, Hematology Am Soc Hematol Educ Program, P132, DOI 10.1182/asheducation-2009.1.132; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tomozawa Y, 2017, CARDIOVASC INTER RAD, V40, P1763, DOI 10.1007/s00270-017-1719-9; Wang W, 2015, INT J MOL SCI, V16, P12076, DOI 10.3390/ijms160612076; Wang Yu, 2014, Cell Regen, V3, P3, DOI 10.1186/2045-9769-3-3; WoodruffPak DS, 1996, NEUROBIOL AGING, V17, P283, DOI 10.1016/0197-4580(95)02064-0; Worth AJJ, 2015, EXPERT REV CLIN IMMU, V11, P1015, DOI 10.1586/1744666X.2015.1062366; Yuan TT, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1013-8; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhou LN, 2017, HUM IMMUNOL, V78, P565, DOI 10.1016/j.humimm.2017.05.004	38	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002118RR	http://dx.doi.org/10.1096/fj.202002118RR		NOV 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33236397				2022-12-28	WOS:000593295800001
J	Li, TT; Zhuang, YT; Yang, WQ; Xie, YL; Shang, WD; Su, S; Dong, X; Wu, JX; Jiang, WM; Zhou, Y; Li, Y; Zhou, X; Zhang, MY; Lu, YJ; Pan, ZW				Li, Tingting; Zhuang, Yuting; Yang, Wanqi; Xie, Yilin; Shang, Wendi; Su, Shuang; Dong, Xue; Wu, Jiaxu; Jiang, Wenmei; Zhou, Yang; Li, Ying; Zhou, Xin; Zhang, Mingyu; Lu, Yanjie; Pan, Zhenwei			Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts	FASEB JOURNAL			English	Article						cardiac fibrosis; m(6)A RNA modification; METTL3; myocardial infarction; TGF&#8208; &#946; 1	MESSENGER-RNA METHYLATION; M(6)A MODIFICATION; N-6-METHYLADENOSINE; DIFFERENTIATION; LEUKEMIA	Cardiac fibrosis is characterized by the activation of cardiac fibroblasts and accumulation of extracellular matrix. METTL3, a component of methyltransferase complex, participates in multiple biological processes associated with mammalian development and disease progression. However, the role of METTL3 in cardiac fibrosis is still unknown. We performed fibroblasts activation with TGF-beta 1 (20 ng/mL) in vitro and established in vivo mouse models with lentivirus to assess the effects of METTL3 on cardiac fibroblasts proliferation and collagen formation. Methylated RNA immunoprecipitation (MeRIP) was used to define the potential fibrosis-regulated gene. The expression level of METTL3 was increased in cardiac fibrotic tissue of mice with chronic myocardial infarction and cultured cardiac fibroblats (CFs) treated with TGF-beta 1. Enforced expression of METTL3 promoted proliferation and fibroblast-to-myofibroblast transition and collagens accumulation, while silence of METTL3 did the opposite. Silence of METTL3 by lentivirus carrying METTL3 siRNA markedly alleviated cardiac fibrosis in MI mice. Transcriptome and N6-methyladenosine (m(6)A) profiling analyses revealed that the expression and m(6)A level of collagen-related genes were altered after silence of METTL3. METTL3-mediated m(6)A modification is critical for the development of cardiac fibrosis, providing a molecular target for manipulating fibrosis and the associated cardiac diseases.	[Li, Tingting; Zhuang, Yuting; Yang, Wanqi; Xie, Yilin; Shang, Wendi; Su, Shuang; Dong, Xue; Wu, Jiaxu; Jiang, Wenmei; Zhou, Yang; Li, Ying; Zhang, Mingyu; Lu, Yanjie; Pan, Zhenwei] Harbin Med Univ, Coll Pharm, Minist Educ,Key Lab Cardiovasc Res, Dept Pharmacol,State Prov Key Labs Biomed Pharmac, Harbin, Peoples R China; [Zhou, Xin] Harbin Med Univ, Minist Educ, Key Lab Myocardial Ischemia, Harbin, Peoples R China; [Lu, Yanjie] Harbin Med Univ, Heilongjiang Acad Med Sci, Northern Translat Med Res & Cooperat Ctr, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Lu, YJ (corresponding author), Harbin Med Univ, Heilongjiang Acad Med Sci, Northern Translat Med Res & Cooperat Ctr, Harbin, Peoples R China.; Lu, YJ; Pan, ZW (corresponding author), Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin 150081, Heilongjiang, Peoples R China.	panzw@ems.hrbmu.edu.cn; panzw@ems.hrbmu.edu.cn	Zhang, mingyu/HGB-1069-2022		National Natural Science Foundation of China [81530010, 81872871, 81700219, 81703510, 81600192]; National Key R&D Program of China [2017YFC1307404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	The work was supported partly by the National Natural Science Foundation of China (No 81530010, 81872871, 81700219, 81703510, and 81600192) and National Key R&D Program of China (2017YFC1307404)	Aguilo F, 2015, CELL STEM CELL, V17, P689, DOI 10.1016/j.stem.2015.09.005; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Bacmeister L, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0722-5; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Bokar JA, 1997, RNA, V3, P1233; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dorn LE, 2019, CIRCULATION, V139, P533, DOI 10.1161/CIRCULATIONAHA.118.036146; Du WJ, 2016, CELL PHYSIOL BIOCHEM, V39, P827, DOI 10.1159/000447793; Feng ZH, 2018, J CELL MOL MED, V22, P2558, DOI 10.1111/jcmm.13491; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gao YM, 2020, IMMUNITY, V52, P1007, DOI 10.1016/j.immuni.2020.05.003; Gonzalez A, 2018, J AM COLL CARDIOL, V71, P1696, DOI 10.1016/j.jacc.2018.02.021; Hinderer S, 2019, ADV DRUG DELIVER REV, V146, P77, DOI 10.1016/j.addr.2019.05.011; Huang H, 2020, CANCER RES, V80, P3200, DOI 10.1158/0008-5472.CAN-19-4044; Janicki JS, 2002, J CARD FAIL, V8, pS319, DOI 10.1054/jcaf.2002.129260; Jin D, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0830-6; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1; Li D, 2020, KOREAN J RADIOL, V21, pe37; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore-Morris T, 2016, J MOL CELL CARDIOL, V91, P1, DOI 10.1016/j.yjmcc.2015.12.031; Moore-Morris T, 2015, J MOL MED, V93, P823, DOI 10.1007/s00109-015-1314-y; Nagpal V, 2016, CIRCULATION, V133, P291, DOI 10.1161/CIRCULATIONAHA.115.018174; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Song HW, 2019, AUTOPHAGY, V15, P1419, DOI 10.1080/15548627.2019.1586246; Tian C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030551; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang HM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09903-6; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xu H, 2020, NEURON, V105, P293, DOI 10.1016/j.neuron.2019.12.013; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yao YX, 2019, FASEB J, V33, P7529, DOI 10.1096/fj.201802644R; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0821-5; Yoon KJ, 2018, J CELL BIOL, V217, P1901, DOI 10.1083/jcb.201802117; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830	45	39	39	8	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.201903169R	http://dx.doi.org/10.1096/fj.201903169R		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33150686				2022-12-28	WOS:000589711600001
J	Guo, SM; Zhang, FX; Chen, Y; Chen, YT; Shushakova, N; Yao, Y; Zeng, R; Li, JH; Lu, X; Chen, RJ; Haller, H; Gueler, F; Xu, G; Rong, S				Guo, Shuiming; Zhang, Fuxiang; Chen, Ying; Chen, Yuetao; Shushakova, Nelli; Yao, Ying; Zeng, Rui; Li, Junhua; Lu, Xia; Chen, Rongjun; Haller, Hermann; Gueler, Faikah; Xu, Gang; Rong, Song			Pre-ischemic renal lavage protects against renal ischemia-reperfusion injury by attenuation of local and systemic inflammatory responses	FASEB JOURNAL			English	Article						hypoxic; reoxygenation; inflammation; macrophage; pre-ischemic renal lavage; renal IRI	HYPOXIA; IMPACT; CELLS	Postischemic acute kidney injury (AKI) is a common clinical complication and often fatal, with no effective treatment available. Little is known about the role of leukocytes trapped in renal vessels during ischemia-reperfusion injury (IRI) in the postischemic AKI. We designed a new animal model in rats with preforming renal artery lavage prior to IRI to investigate the effect of diminishing the residual circulating leukocytes on kidney damage and inflammation. Moreover, the functional changes of macrophages in hypoxia reoxygenation condition were also analyzed. We found pre-ischemic renal lavage significantly decreased the serum creatinine and blood urea nitrogen levels, and downregulated the mRNA and protein expressions in kidneys and urinary secretion of kidney injury molecule-1 of rats after IRI. The renal pathological damage caused by IRI was also ameliorated by pre-ischemic renal lavage, as evidenced by fewer cast formation, diminished morphological signs of AKI in the tissue at 24 hours after IRI. Pre-ischemic renal lavage reduced the numbers of infiltrating CD68(+)macrophages and MPO(+)neutrophils. The mRNA expression of pro-inflammatory mediator in IRI kidneys and the levels of pro-inflammatory cytokines in circulatory system and urine were also reduced due to pre-ischemic lavage. Compared with nontreated rats with IRI, pre-ischemic renal lavage significantly reduced the phosphorylation levels of ERK and p65 subunit of NF-kappa B in the kidney after IRI. In addition, we found hypoxia/reoxygenation could promote the expression of pro-inflammatory mediators and inhibit the expression of anti-inflammatory factors by regulating ERK/NF-kappa B signaling pathway. Thus, pre-ischemic renal lavage could clearly reduce the renal damage after IRI by attenuating inflammation, and macrophages trapped in renal vessels during IRI could be important pathogenic factors driving tissue injury.	[Guo, Shuiming; Yao, Ying; Zeng, Rui; Li, Junhua; Xu, Gang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol,Div Internal Med, 1095 Jiefang Ave, Wuhan 430030, Peoples R China; [Zhang, Fuxiang] Shandong First Med Univ, Shandong Prov Qianfoshan Hosp, Hosp 1, ICU, Jinan, Peoples R China; [Chen, Ying] First Peoples Hosp Yichang, Dept Nephrol, Yichang, Peoples R China; [Chen, Yuetao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Resp,Div Internal Med, Wuhan, Peoples R China; [Shushakova, Nelli; Haller, Hermann; Gueler, Faikah; Rong, Song] Hannover Med Sch, Dept Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Lu, Xia] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Organ Transplantat, Wuhan, Peoples R China; [Chen, Rongjun] Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany	Huazhong University of Science & Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Huazhong University of Science & Technology; Hannover Medical School; Huazhong University of Science & Technology; Hannover Medical School	Guo, SM (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol,Div Internal Med, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.; Rong, S (corresponding author), Hannover Med Sch, Dept Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gsm91@163.com; rong.song@mh-hannover.de	Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198; /0000-0001-9985-1515	Huazhong University of Science and Technology [2014KYQD01, 2018YJJA04]	Huazhong University of Science and Technology	Huazhong University of Science and Technology, Grant/Award Number: 2014KYQD01 and 2018YJJA04	Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Barrera-Chimal J, 2018, KIDNEY INT, V93, P1344, DOI 10.1016/j.kint.2017.12.016; Cao Q, 2018, J AM SOC NEPHROL, V29, P961, DOI 10.1681/ASN.2017070774; Chen JC, 2018, J AM SOC NEPHROL, V29, P2372, DOI 10.1681/ASN.2017121272; Doi K, 2016, KIDNEY INT, V89, P555, DOI 10.1016/j.kint.2015.11.019; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Gueler F, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026609.45827.3D; Han HI, 2019, PEDIATR NEPHROL, V34, P561, DOI 10.1007/s00467-017-3883-1; Haydar D, 2019, J IMMUNOL, V203, P1021, DOI 10.4049/jimmunol.1801228; Henze AT, 2016, J CLIN INVEST, V126, P3672, DOI 10.1172/JCI84427; Huber R, 2016, SCI REP-UK, V6, DOI 10.1038/srep29914; Jia P, 2020, FASEB J, V34, P11729, DOI 10.1096/fj.201903222RR; Kanno M, 2018, NEPHROLOGY, V23, P1046, DOI 10.1111/nep.13169; Kavvadas P, 2018, KIDNEY INT, V94, P126, DOI 10.1016/j.kint.2018.01.031; Liang H, 2019, INFLAMM RES, V68, P325, DOI 10.1007/s00011-019-01221-3; Luo R, 2019, NEPHROL DIAL TRANSPL, V34, P1549, DOI 10.1093/ndt/gfy169; Masola V, 2018, FASEB J, V32, P742, DOI 10.1096/fj.201700597R; Molema G, 2012, SEMIN NEPHROL, V32, P145, DOI 10.1016/j.semnephrol.2012.02.001; Nishikawa H, 2018, KIDNEY INT, V93, P599, DOI 10.1016/j.kint.2017.09.017; Raup-Konsavage WM, 2018, KIDNEY INT, V93, P365, DOI 10.1016/j.kint.2017.08.014; Smith SF, 2019, KIDNEY INT, V95, P50, DOI 10.1016/j.kint.2018.10.009; Snodgrass RG, 2016, J BIOL CHEM, V291, P413, DOI 10.1074/jbc.M115.686709; Trzepizur W, 2018, METABOLISM, V84, P44, DOI 10.1016/j.metabol.2017.11.008; Yan Y, 2020, AM J PHYSIOL-RENAL, V318, pF878, DOI 10.1152/ajprenal.00567.2019; Zhang J, 2016, AM J TRANSL RES, V8, P4054; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	26	2	4	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16307	16318		10.1096/fj.201902943R	http://dx.doi.org/10.1096/fj.201902943R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33089923	hybrid			2022-12-28	WOS:000582257100001
J	Yu, YB; Yang, WJ; Bilotta, AJ; Yu, Y; Zhao, XJ; Zhou, Z; Yao, SX; Xu, JM; Zhou, J; Dann, SM; Li, YQ; Cong, YZ				Yu, Yanbo; Yang, Wenjing; Bilotta, Anthony J.; Yu, Yu; Zhao, Xiaojing; Zhou, Zheng; Yao, Suxia; Xu, Jimin; Zhou, Jia; Dann, Sara M.; Li, Yanqing; Cong, Yingzi			STING controls intestinal homeostasis through promoting antimicrobial peptide expression in epithelial cells	FASEB JOURNAL			English	Article						IEC; intestinal homeostasis; REG3 gamma; STING	EMERGING ROLES; HOST-DEFENSE; MICROBIOTA; RECOGNITION; CANCER; ESTABLISHMENT; GLYCOLYSIS; METABOLISM; INHIBITOR; IMMUNITY	Stimulator of interferon genes (STING) has been shown to play a critical role in orchestrating immune responses to various pathogens through sensing cyclic dinucleotides. However, how STING regulates intestinal homeostasis is still not completely understood. In this study, we found that STING(-/-)mice were more susceptible to enteric infection withCitrobacter rodentiumcompared to wild-type (WT) mice evidenced by more severe intestinal inflammation and impaired bacterial clearance. STING(-/-)mice demonstrated lower expression of REG3 gamma but not beta-defensins and Cramp in IECs. Consistently, STING(-/-)IECs showed reduced capacity to inhibit bacterial growth. STING agonists, both 10-carboxymethyl-9-acridanone (CMA) and 5,6-dimethylxanthenone-4-acetic acid (DMXAA), promoted REG3 gamma expression IECs. Furthermore, STING agonists promoted WT but not REG3 gamma-deficient IEC bacterial killing. Mechanistically, STING agonists activated STAT3 and promoted glycolysis in IECs. Inhibition of STAT3 pathway and glycolysis suppressed STING-induced REG3 gamma production in IECs, and abrogated STING-mediated IEC killing ofC. rodentium. Additionally, treatment with the STING ligand, 2,3-cGAMP, inhibitedC. rodentium-induced colitis in vivo. Overall, STING promotes IEC REG3 gamma expression to inhibit enteric infection and intestinal inflammation, thus, maintaining the intestinal homeostasis.u	[Yu, Yanbo; Yang, Wenjing; Bilotta, Anthony J.; Yu, Yu; Zhao, Xiaojing; Zhou, Zheng; Yao, Suxia; Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, 4-142C Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA; [Yu, Yanbo; Yu, Yu; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Peoples R China; [Xu, Jimin; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA; [Dann, Sara M.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cong, YZ (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 4-142C Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	yicong@utmb.edu	Xu, Jimin/AAA-7584-2021; yu, yanbo/GZM-8474-2022; Yang, Wenjing/AAE-5924-2021	Yang, Wenjing/0000-0003-1541-1892; xu, jimin/0000-0001-8245-7263	Foundation for the National Institutes of Health (FNIH) [DK105585, DK112436, DK125011, AI150210]; University of Texas system STARs award; McLaughlin postdoctoral Fellowship, UTMB	Foundation for the National Institutes of Health (FNIH); University of Texas system STARs award; McLaughlin postdoctoral Fellowship, UTMB	Foundation for the National Institutes of Health (FNIH), Grant/Award Number: DK105585, DK112436, DK125011 and AI150210; University of Texas system STARs award; McLaughlin postdoctoral Fellowship, UTMB	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ahn J, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0333-0; Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Canesso MCC, 2018, MUCOSAL IMMUNOL, V11, P820, DOI 10.1038/mi.2017.88; Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082; Ching CB, 2018, KIDNEY INT, V93, P1320, DOI 10.1016/j.kint.2017.12.006; Choi SM, 2013, J EXP MED, V210, P551, DOI 10.1084/jem.20120260; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Douros JD, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00465; Duffy MM, 1998, DIS COLON RECTUM, V41, P1399, DOI 10.1007/BF02237056; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Fukata M, 2013, MUCOSAL IMMUNOL, V6, P451, DOI 10.1038/mi.2013.13; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Goto Y, 2013, IMMUNOL CELL BIOL, V91, P204, DOI 10.1038/icb.2012.80; Hu QY, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13194; Huang CC, 2015, DIS MODEL MECH, V8, P1247, DOI 10.1242/dmm.021667; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Li M, 2017, ONCOTARGET, V8, P24777, DOI 10.18632/oncotarget.15801; Li ZQ, 2019, AM J CANCER RES, V9, P699; Liu S, 2015, INFLAMM BOWEL DIS, V21, P901, DOI 10.1097/MIB.0000000000000299; Liu X, 2016, IMMUNOLOGY, V147, P285, DOI 10.1111/imm.12561; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marinho FV, 2017, TRENDS MICROBIOL, V25, P906, DOI 10.1016/j.tim.2017.05.008; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Shin JH, 2019, ENDOCRINOLOGY, V160, P1506, DOI 10.1210/en.2019-00073; Sola-Penna M, 2020, BRIT J CANCER, V122, P194, DOI 10.1038/s41416-019-0640-1; Sun M, 2015, MUCOSAL IMMUNOL, V8, P969, DOI 10.1038/mi.2015.49; Taboada B, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq254; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Xiao Y, 2019, CELL MOL GASTROENTER, V8, P21, DOI 10.1016/j.jcmgh.2019.02.006; Zasloff M, 2019, ADV EXP MED BIOL, V1117, P3, DOI 10.1007/978-981-13-3588-4_1; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao Y, 2018, MUCOSAL IMMUNOL, V11, P752, DOI 10.1038/mi.2017.118	49	6	6	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15417	15430		10.1096/fj.202001524R	http://dx.doi.org/10.1096/fj.202001524R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32969062	Green Accepted			2022-12-28	WOS:000574532600001
J	Lopez, DM; Kahlau, L; Jungnickel, KEJ; Low, C; Damme, M				Lopez, David Massa; Kaehlau, Lea; Jungnickel, Katharina Esther Julia; Loew, Christian; Damme, Markus			Characterization of the complex of the lysosomal membrane transporter MFSD1 and its accessory subunit GLMP	FASEB JOURNAL			English	Article						accessory subunit; GLMP; lysosomal; MFSD1; transporter	REQUIRES OSTM1; PROTEINS; LAMP-1; TRAFFICKING; REVEALS; NCU-G1; ATPASE	The two lysosomal integral membrane proteins MFSD1 and GLMP form a tight complex that confers protection of both interaction partners against lysosomal proteolysis. We here refined the molecular interaction of the two proteins and found that the luminal domain of GLMP alone, but not its transmembrane domain or its short cytosolic tail, conveys protection and mediates the interaction with MFSD1. Our data support the finding that the interaction is essential for the stabilization of the complex. These results are complemented by the observation that N-glycosylation of GLMP in general, but not the type of N-glycans (high-mannose-type or complex-type) or individual N-glycan chains, are essential for protection. We observed that the interaction of both proteins already starts in the endoplasmic reticulum, and quantitatively depends on each other. Both proteins can affect vice versa their intracellular trafficking to lysosomes in addition to the protection from proteolysis. Finally, we provide evidence that MFSD1 can form homodimers both in vitro and in vivo. Our data refine the complex interplay between an intimate couple of a lysosomal transporter and its accessory subunit.	[Lopez, David Massa; Kaehlau, Lea; Damme, Markus] Christian Albrechts Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany; [Jungnickel, Katharina Esther Julia; Loew, Christian] DESY, Ctr Struct Syst Biol CSSB, Hamburg, Germany; [Jungnickel, Katharina Esther Julia; Loew, Christian] European Mol Biol Lab Hamburg, Hamburg, Germany	University of Kiel; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Molecular Biology Laboratory (EMBL)	Damme, M (corresponding author), Christian Albrechts Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany.	mdamme@biochem.uni-kiel.de		Jungnickel, Katharina E. J./0000-0002-2850-5911; Loew, Christian/0000-0003-0764-7483	Deutsche Forschungsgemeinschaft (DFG) [DA 1785-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was in part supported by the Deutsche Forschungsgemeinschaft (DFG) to MD (DA 1785-1).	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Adams JN, 2019, ELIFE, V8, DOI 10.7554/eLife.49132; Alguel Y, 2016, BIOCHEM SOC T, V44, P1737, DOI 10.1042/BST20160217; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; CARLSSON SR, 1989, J BIOL CHEM, V264, P20526; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Demirel O, 2012, J CELL SCI, V125, P4230, DOI 10.1242/jcs.087346; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Fettelschoss V, 2017, J BIOL CHEM, V292, P11980, DOI 10.1074/jbc.M117.784819; Fontenot EB, 2015, PLANT CELL ENVIRON, V38, P2012, DOI 10.1111/pce.12522; Gonzalez AC, 2018, CELL REP, V22, P1040, DOI 10.1016/j.celrep.2017.12.100; Kong XY, 2014, DIS MODEL MECH, V7, P351, DOI 10.1242/dmm.014050; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schieweck O, 2009, BIOCHEM J, V422, P83, DOI 10.1042/BJ20090567; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Visser WE, 2009, ENDOCRINOLOGY, V150, P5163, DOI 10.1210/en.2009-0699; Weinert S, 2014, EMBO REP, V15, P784, DOI 10.15252/embr.201438553; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Yu Z, 2018, ELIFE, V7, DOI 10.7554/eLife.36620	26	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14695	14709		10.1096/fj.202000912RR	http://dx.doi.org/10.1096/fj.202000912RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959924	hybrid, Green Published			2022-12-28	WOS:000573860500001
J	Li, T; Li, XZ; Guo, YY; Zheng, GY; Yu, TT; Zeng, WH; Qiu, L; He, XY; Yang, Y; Zheng, XG; Li, YC; Huang, HF; Liu, XM				Li, Tong; Li, Xinzhu; Guo, Yanyan; Zheng, Guangyong; Yu, Tiantian; Zeng, Weihong; Qiu, Lin; He, Xiaoying; Yang, Yu; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei			Distinct mRNA and long non-coding RNA expression profiles of decidual natural killer cells in patients with early missed abortion	FASEB JOURNAL			English	Article						functional annotation; lncRNA-mRNA interaction network; mRNA and lncRNA profiles; protein-protein interaction; RNA sequencing	NK CELLS; EXTRACELLULAR-MATRIX; PREGNANCY; IL-2; TOOL	Early non-chromosome-related missed abortion (MA) is commonly associated with an altered immunological environment during pregnancy. Human decidual natural killer (dNK) cells, the most abundant lymphocyte population within the first-trimester maternal-fetal interface, are vital maternal regulators of immune tolerance mediating successful embryo implantation and placentation. Previous studies have shown that dNK cells may play a role in MA. However, the gene expression status and specific altered manifestations of dNK cells in patients with early MA remain largely unknown. Here, we show that MA dNK cells have distinct mRNA and lncRNA expression profiles through RNA sequencing, with a total of 276 mRNAs and 67 lncRNAs being differentially expressed compared with controls. Protein-protein interaction analysis of differentially expressed mRNAs was performed to identify hub genes and key modules. An lncRNA-mRNA regulatory network characterized by the small-world property was constructed to reveal the regulation of mRNA transcription by differential hub lncRNAs. Functional annotation of differentially expressed mRNAs and lncRNAs was performed to disclose their potential roles in MA pathogenesis. Our data highlight several enriched biological processes (immune response, inflammatory response, cell adhesion, and extracellular matrix [ECM] organization) and signaling pathways (cytokine-cytokine receptor interaction, ECM-receptor interaction, Toll-like receptor signaling pathway, and phosphatidylinositol signaling system) that may influence MA. This study is the first to demonstrate the involvement of altered mRNA and lncRNA expression profiles in the dNK cell pathogenesis of early MA, facilitating a better understanding of the underlying molecular mechanisms and the development of novel MA therapeutic strategies targeting key mRNAs and lncRNAs.	[Li, Tong; Li, Xinzhu; Guo, Yanyan; Yu, Tiantian; Zeng, Weihong; He, Xiaoying; Yang, Yu; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Li, Tong; Li, Xinzhu; Guo, Yanyan; Yu, Tiantian; Zeng, Weihong; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei] Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China; [Li, Tong; Li, Xinzhu; Guo, Yanyan; Yu, Tiantian; Zeng, Weihong; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei] Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China; [Zheng, Guangyong] Chinese Acad Sci, Biomed Big Data Ctr, Key Lab Computat Biol,Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol,Shanghai Inst, Shanghai, Peoples R China; [Qiu, Lin] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr & Hlth,Key Lab Nutr & Metab, Shanghai, Peoples R China; [He, Xiaoying] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Dept Gynecol & Obstet, Sch Med, Shanghai, Peoples R China; [Yang, Yu] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Dept Ultrasonog, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, HF; Liu, XM (corresponding author), Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, 910 Hengshan Rd, Shanghai 200030, Peoples R China.	huanghefg@sjtu.edu.cn; 183747@shsmu.edu.cn	Yang, Yu/GYJ-1931-2022; Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020	Yang, Yu/0000-0002-4518-3299; 	National Key R&D Program of China [2018YFC1004500, 2017YFC1001303, 2017YFC1201200]; National Natural Science Foundation of China [81671456,81801409]; Shanghai Sailing Program [18YF1424700]; Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University [YG2017QN41]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University	This work was supported by the National Key R&D Program of China (2018YFC1004500, 2017YFC1001303, 2017YFC1201200), the National Natural Science Foundation of China (81671456,81801409), Shanghai Sailing Program (18YF1424700), Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University (YG2017QN41).	Alijotas-Reig J, 2014, PLACENTA, V35, P241, DOI 10.1016/j.placenta.2014.02.004; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BURROWS TD, 1995, CELL IMMUNOL, V166, P53, DOI 10.1006/cimm.1995.0007; Cao WP, 2014, EXP THER MED, V7, P417, DOI 10.3892/etm.2013.1422; Castellana B, 2018, IMMUNOL CELL BIOL, V96, P805, DOI 10.1111/imcb.12041; Chen JQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00615; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Cocco L, 2015, J LIPID RES, V56, P1853, DOI 10.1194/jlr.R057984; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Duriez M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00316; Edsparr K, 2009, IMMUNOL CELL BIOL, V87, P489, DOI 10.1038/icb.2009.35; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fu BQ, 2017, IMMUNITY, V47, P1100, DOI [10.1016/j.immuni.2017.11.018, 10.15585/mmwr.ss6904a1]; Fu BQ, 2016, SCI CHINA LIFE SCI, V59, P1224, DOI 10.1007/s11427-016-0337-1; Fu Q, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12769; Gardiner CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00367; Gaynor LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00467; Guennewig B, 2014, INT REV NEUROBIOL, V116, P153, DOI 10.1016/B978-0-12-801105-8.00007-2; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Huang GY, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108826; Iwahashi M, 1998, J CLIN PATHOL, V51, P44, DOI 10.1136/jcp.51.1.44; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P339, DOI 10.1016/j.bbi.2009.09.015; Keating SE, 2016, J IMMUNOL, V196, P2552, DOI 10.4049/jimmunol.1501783; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Le Bouteiller Philippe, 2017, F1000Res, V6, P1216, DOI 10.12688/f1000research.11690.1; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Li L, 2017, ONCOL REP, V38, P2607, DOI 10.3892/or.2017.5946; Lin Y, 2009, J REPROD IMMUNOL, V83, P95, DOI 10.1016/j.jri.2009.09.004; Liu S, 2017, J REPROD IMMUNOL, V124, P44, DOI 10.1016/j.jri.2017.10.045; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marwah S, 2016, J CLIN DIAGN RES, V10, pQC14, DOI 10.7860/JCDR/2016/18178.7891; Mjosberg J, 2010, BIOL REPROD, V82, P698, DOI 10.1095/biolreprod.109.081208; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Muter J, 2016, ENDOCRINOLOGY, V157, P2883, DOI 10.1210/en.2015-1914; Myers KA, 2019, PEDIATR NEUROL, V91, P62, DOI 10.1016/j.pediatrneurol.2018.11.007; Nakashima A, 2010, AM J REPROD IMMUNOL, V64, P4, DOI 10.1111/j.1600-0897.2010.00812.x; Pesce S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00414; Sague SL, 2004, J INTERF CYTOK RES, V24, P301, DOI 10.1089/107999004323065093; Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharkey AM, 2015, J IMMUNOL, V195, P3026, DOI 10.4049/jimmunol.1501229; Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uchida Shizuka, 2017, High Throughput, V6, DOI 10.3390/ht6030012; Wang FY, 2015, EUR J IMMUNOL, V45, P661, DOI 10.1002/eji.201444998; Wang FY, 2014, EUR J IMMUNOL, V44, P2771, DOI 10.1002/eji.201344183; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Yamamoto T, 1999, CLIN EXP IMMUNOL, V116, P449; Yang C, 2019, J LEUKOCYTE BIOL, V105, P63, DOI 10.1002/JLB.1RU0518-197RR; Zeng WH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00682; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhang RY, 2016, ONCOTARGET, V7, P72546, DOI 10.18632/oncotarget.12466	62	5	6	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14264	14286		10.1096/fj.202000621R	http://dx.doi.org/10.1096/fj.202000621R		SEP 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32915478	hybrid			2022-12-28	WOS:000570522400001
J	Ou, RY; Lv, MF; Liu, X; Lv, JM; Zhao, JD; Zhao, Y; Li, XY; Li, WF; Zhao, L; Li, JR; Ren, Y; Xu, YS				Ou, Rongying; Lv, Mingfen; Liu, Xuan; Lv, Jiangmin; Zhao, Jinduo; Zhao, Ye; Li, Xiangyun; Li, Wenfeng; Zhao, Liang; Li, Jianrong; Ren, Yi; Xu, Yunsheng			HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis	FASEB JOURNAL			English	Article						cervical cancer; GABPB1-AS1; lncRNA; miR-519e-5p; Notch2	LONG NONCODING RNA; HUMAN-PAPILLOMAVIRUS INFECTION; CELL-PROLIFERATION; CARCINOMA; EXPRESSION; PATHWAYS; PROTEIN	Human papillomaviruses 16 (HPV16) is the primary causative agent of cervical cancer (CC). E6 oncoprotein plays a crucial role in cervical carcinogenesis and commonly cause the dysregulation of the long noncoding RNAs (lncRNAs) expression. However, the biological function of lncRNAs in HPV16-related CC remains largely unexplored. In the present study HPV16 E6-induced differential expression of lncRNAs, miRNA, and mRNA were identified using microarray-based analysis and verified in tumor r cell lines and tumor tissues, and the function of lncRNA in CC was investigated in vitro and in vivo. We found that an lncRNA, named GABPB1-AS1, was significantly upregulated in HPV16-positive CC tissues and cell lines. GABPB1-AS1 expression in HPV16-positive CC tissues was positively associated with tumor size, lymph node metastasis, and FIGO stage. High expression of GABPB1-AS1 was correlated with a poor prognosis for HPV16-positive CC patients. Functionally, E6-induced GABPB1-AS1 overexpression facilitated CC cells proliferation and invasion in vitro and in vivo. Mechanistically, GABPB1-AS1 acted as a competing endogenous RNA (ceRNA) by sponging miR-519e-5p, resulting in the de-repression of its target gene Notch2 which is well known as an oncogene. Therefore, GABPB1-AS1 functioned as a tumor activator in CC pathogenesis by binding to miR-519e-5p and destroying its tumor suppressive function. Collectively, current results demonstrate that GABPB1-AS1 is associated with CC progression, and may be a promising biomarker or target for the clinical management of CC.	[Ou, Rongying; Li, Wenfeng; Zhao, Liang; Xu, Yunsheng] Wenzhou Med Univ, Affiliated Hosp 1, Inst Translat Med, Lab Adv Interdisciplinary Res, Wenzhou, Peoples R China; [Ou, Rongying; Liu, Xuan; Lv, Jiangmin; Zhao, Jinduo; Zhao, Ye] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Wenzhou, Peoples R China; [Lv, Mingfen; Xu, Yunsheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Dermatovenereol, Wenzhou, Peoples R China; [Li, Xiangyun] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Dermatovenereol, Shenzhen, Peoples R China; [Li, Jianrong] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Ren, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Sun Yat Sen University; University System of Ohio; Ohio State University; State University System of Florida; Florida State University	Ou, RY; Xu, YS (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Inst Translat Med, Lab Adv Interdisciplinary Res, Wenzhou, Peoples R China.	ourongying@163.com; xuyunsheng1018@163.com	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022; Li, Jin/GYQ-5363-2022; Li, Jing/GYU-5036-2022		National Natural Science Foundation of China (NSFC) [81671408, 81771531, 81701634, 81871129]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671408, 81771531, 81701634 and 81871129	Aalijahan H, 2019, EXP MOL PATHOL, V106, P7, DOI 10.1016/j.yexmp.2018.11.010; Alkhateeb A, 2019, CANCER INFORM, V18, DOI 10.1177/1176935119835522; [Anonymous], 2018, NAT PROD RES; Bach DH, 2018, CANCER LETT, V419, P152, DOI 10.1016/j.canlet.2018.01.053; Bai Xia, 2019, Entomotaxonomia, V41, P119, DOI 10.11680/entomotax.2019015; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Barr JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40094-8; Bruera G, 2011, EXPERT OPIN BIOL TH, V11, P821, DOI 10.1517/14712598.2011.582462; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chernock RD, 2013, MODERN PATHOL, V26, P223, DOI 10.1038/modpathol.2012.159; de Oliveira JC, 2019, J GENE MED, V21, DOI 10.1002/jgm.3065; Ding XY, 2019, CELL DEATH DIFFER, V26, P2807, DOI 10.1038/s41418-019-0273-1; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Feng SJ, 2019, CANCER LETT, V465, P105, DOI 10.1016/j.canlet.2019.09.002; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Guitarte C, 2014, GYNECOL ONCOL, V133, P186, DOI 10.1016/j.ygyno.2014.01.048; He HP, 2019, J VIROL, V93, DOI 10.1128/JVI.01808-18; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Hosseini ES, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0671-2; Huibregtse JM, 1996, SEMIN CANCER BIOL, V7, P317, DOI 10.1006/scbi.1996.0041; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Liu F, 2016, ONCOTARGET, V7, P19666, DOI 10.18632/oncotarget.7531; Liu YC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00065; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Mwapagha LM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00258; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Peta E, 2018, ONCOGENE, V37, P1654, DOI 10.1038/s41388-017-0083-1; Qi WC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52837-8; Porras GOR, 2018, REP PRACT ONCOL RADI, V23, P533, DOI 10.1016/j.rpor.2018.09.002; Rodrigues C, 2019, EXP CELL RES, V385, DOI 10.1016/j.yexcr.2019.111682; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Shan D, 2018, ONCOL LETT, V15, P3490, DOI 10.3892/ol.2018.7773; Sharma S, 2018, VIROLOGY, V518, P8, DOI 10.1016/j.virol.2018.01.031; Taheri M., 2018, KLIN ONKOL, V31, P403, DOI DOI 10.14735/amko2018403; Tani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106282; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Xiu MX, 2019, AM J CANCER RES, V9, P837; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808	44	9	12	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13211	13223		10.1096/fj.202000762R	http://dx.doi.org/10.1096/fj.202000762R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32844486	hybrid			2022-12-28	WOS:000564884300001
J	Zhu, JY; Peng, QW; Xu, Y; Xu, HX; Wan, Y; Li, ZF; Qiu, YM; Xia, WG; Guo, ZL; Li, HK; Jin, HJ; Hu, B				Zhu, Jiayi; Peng, Qiwei; Xu, Yi; Xu, Hexiang; Wan, Yan; Li, Zhifang; Qiu, Yanmei; Xia, Wenguang; Guo, Zhenli; Li, Hongkai; Jin, Huijuan; Hu, Bo			Morinda officinalis oligosaccharides ameliorate depressive-like behaviors in poststroke rats through upregulating GLUT3 to improve synaptic activity	FASEB JOURNAL			English	Article						GLUT3; glucose metabolism; Morinda officinalis oligosaccharides; poststroke depression; synaptic activity	GLUCOSE-TRANSPORTER ISOFORM; BRAIN; STRESS; CELLS; LOCALIZATION; DYSFUNCTION; INHIBITION; NEURONS; MODEL; DEMONSTRATE	Poststroke depression (PSD) is one of the most common psychiatric diseases afflicting stroke survivors, yet the underlying mechanism is poorly understood. The pathophysiology of PSD is presumably multifactorial, involving ischemia-induced disturbance in the context of psychosocial distress. The homeostasis of glucose metabolism is crucial to neural activity. In this study, we showed that glucose consumption was decreased in the medial prefrontal cortex (mPFC) of PSD rats. The suppressed glucose metabolism was due to decreased glucose transporter-3 (GLUT3) expression, the most abundant and specific glucose transporter of neurons. We also found Morinda officinalis oligosaccharides (MOOs), approved as an antidepressive Chinese medicine, through upregulating GLUT3 expression in the mPFC, improved glucose metabolism, and enhanced synaptic activity, which ultimately ameliorated depressive-like behavior in PSD rats. We further confirmed the mechanism that MOOs induce GLUT3 expression via the PKA/pCREB pathway in PSD rats. Our work showed that MOOs treatment is capable of restoring GLUT3 level to improve depressive-like behaviors in PSD rats. We also propose GLUT3 as a potential therapeutic target for PSD and emphasize the importance of metabolism disturbance in PSD pathology.	[Zhu, Jiayi; Peng, Qiwei; Xu, Hexiang; Wan, Yan; Li, Zhifang; Qiu, Yanmei; Jin, Huijuan; Hu, Bo] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430022, Hubei, Peoples R China; [Xu, Yi; Li, Hongkai] Beijing Tongrentang Co Ltd, Inst Sci, Beijing, Peoples R China; [Xia, Wenguang; Guo, Zhenli] Hubei Prov Hosp Integrated Chinese & Western Med, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Jin, HJ; Hu, B (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430022, Hubei, Peoples R China.	jinhuijuan1983@163.com; hubo@mail.hust.edu.cn			National Natural Science Foundation of China [81571119, 81671147]; National Key Research and Development Program of China [2018YFC1312200]; Chinese & Western Medicine [SATCM-20180339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Chinese & Western Medicine	National Natural Science Foundation of China, Grant/Award Number: 81571119 and 81671147; National Key Research and Development Program of China, Grant/Award Number: 2018YFC1312200; Chinese & Western Medicine, Grant/Award Number: SATCM-20180339	Agostini M, 2016, CELL DEATH DIFFER, V23, P1502, DOI 10.1038/cdd.2016.36; Akasu T, 1996, SYNAPSE, V24, P125, DOI 10.1002/(SICI)1098-2396(199610)24:2<125::AID-SYN4>3.0.CO;2-H; Apelt J, 1999, J NEUROSCI RES, V57, P693, DOI 10.1002/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO;2-X; Bigio B, 2016, P NATL ACAD SCI USA, V113, P7906, DOI 10.1073/pnas.1603111113; Cao W, 2018, NEURON, V97, DOI 10.1016/j.neuron.2018.03.006; Cappa SF, 1997, BRAIN LANG, V56, P55, DOI 10.1006/brln.1997.1737; Chen DL, 2014, J ETHNOPHARMACOL, V154, P206, DOI 10.1016/j.jep.2014.04.004; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Csabai D, 2017, HIPPOCAMPUS, V27, P17, DOI 10.1002/hipo.22650; Devilbiss DM, 2017, CEREB CORTEX, V27, P2970, DOI 10.1093/cercor/bhw140; Duman RS, 2014, DEPRESS ANXIETY, V31, P291, DOI 10.1002/da.22227; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; Etievant A, 2015, EBIOMEDICINE, V2, P898, DOI 10.1016/j.ebiom.2015.06.023; Fu C, 2018, EXP THER MED, V16, P1873, DOI 10.3892/etm.2018.6434; Garbuzova-Davis S, 2014, J COMP NEUROL, V522, P3120, DOI 10.1002/cne.23582; Gonzalez-Burgos G, 2019, J NEUROSCI, V39, P7277, DOI 10.1523/JNEUROSCI.1210-19.2019; Grosse J, 2000, BIOL REPROD, V63, P643, DOI 10.1095/biolreprod63.2.643; Homayoun H, 2006, CEREB CORTEX, V16, P93, DOI 10.1093/cercor/bhi087; Husaini B, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/846732; Jiang KM, 2018, INT J BIOL MACROMOL, V120, P170, DOI 10.1016/j.ijbiomac.2018.08.082; Jin HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13929-5; Jin NN, 2013, NUCLEIC ACIDS RES, V41, P3240, DOI 10.1093/nar/gks1227; Kong L, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00388; Lee Y, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0028-y; Li S, 1988, CHINA J CHINESE MAT, V13, P17; Li YF, 2004, LIFE SCI, V75, P1531, DOI 10.1016/j.lfs.2004.02.029; Li YF, 2003, LIFE SCI, V72, P933, DOI 10.1016/S0024-3205(02)02331-7; Li YM, 2018, J VIROL, V92, DOI 10.1128/JVI.02083-17; London E, 2017, J MOL ENDOCRINOL, V59, P1, DOI 10.1530/JME-16-0188; MAHER F, 1995, J NEUROSCI RES, V42, P459, DOI 10.1002/jnr.490420404; Maher F, 1996, BIOCHEM J, V315, P827, DOI 10.1042/bj3150827; MANTYCH GJ, 1992, ENDOCRINOLOGY, V131, P1270, DOI 10.1210/en.131.3.1270; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Meader N, 2014, J NEUROL NEUROSUR PS, V85, P198, DOI 10.1136/jnnp-2012-304194; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Merker S, 2017, J CHILD PSYCHOL PSYC, V58, P798, DOI 10.1111/jcpp.12702; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Patching SG, 2017, MOL NEUROBIOL, V54, P1046, DOI 10.1007/s12035-015-9672-6; Paxinos G., 1998, RAT BRAIN STEREOTAXI, V3, P6; Price JB, 2018, NEUROSCI BIOBEHAV R, V90, P212, DOI 10.1016/j.neubiorev.2018.04.002; Qin YH, 2019, PSYCHONEUROENDOCRINO, V107, P59, DOI 10.1016/j.psyneuen.2019.05.007; Segarra-Mondejar M, 2018, EMBO J, V37, DOI 10.15252/embj.201797368; Shi PY, 2018, DRUG METAB REV, V50, P161, DOI 10.1080/03602532.2017.1417424; Shin BC, 2018, J NEUROSCI, V38, P9579, DOI 10.1523/JNEUROSCI.0503-18.2018; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Stuart CA, 2011, BRAIN RES, V1384, P15, DOI 10.1016/j.brainres.2011.02.014; Tabrizian K, 2019, HUM EXP TOXICOL, V38, P775, DOI 10.1177/0960327119839160; Tejeda GS, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809950; Villa RF, 2018, PHARMACOL THERAPEUT, V184, P131, DOI 10.1016/j.pharmthera.2017.11.005; Villar PS, 2017, J NEUROSCI, V37, P5736, DOI 10.1523/JNEUROSCI.2640-16.2017; Wan Y, 2018, FASEB J, V32, P3133, DOI 10.1096/fj.201701121R; Wang GL, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01034; Wang SS, 2016, BRAIN RES BULL, V121, P91, DOI 10.1016/j.brainresbull.2016.01.006; Wei K, 2018, NEUROSCI LETT, V665, P104, DOI 10.1016/j.neulet.2017.11.047; Wu ZQ, 2015, J ETHNOPHARMACOL, V164, P283, DOI 10.1016/j.jep.2015.02.016; Wurtz M, 2016, J INTERN MED, V280, P407, DOI 10.1111/joim.12512; Xu LZ, 2017, INT J NEUROPSYCHOPH, V20, DOI 10.1093/ijnp/pyw088; Zhang H, 2015, J NUCL MED, V56, P1774, DOI 10.2967/jnumed.115.163170; Zhang JH, 2018, J ETHNOPHARMACOL, V213, P230, DOI 10.1016/j.jep.2017.10.028; Zhang ZQ, 2002, PHARMACOL BIOCHEM BE, V72, P39, DOI 10.1016/S0091-3057(01)00730-4; Zhao Y, 2010, MOL PSYCHIATR, V15, P286, DOI 10.1038/mp.2009.51; Zheng C, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00417	64	6	8	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13376	13395		10.1096/fj.201902546RR	http://dx.doi.org/10.1096/fj.201902546RR		AUG 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32812265				2022-12-28	WOS:000562900500001
J	Wang, X; Chen, QZ; Zan, YX; Wang, MR; Yan, J; Guo, WW; Li, KJ; Liu, YY; Luo, F; Feng, Y; Hou, W; Xiong, HR				Wang, Xin; Chen, Qing-Zhou; Zan, Yu-Xing; Wang, Mei-Rong; Yan, Jie; Guo, Wei-Wei; Li, Kai-Ji; Liu, Yuan-Yuan; Luo, Fan; Feng, Yong; Hou, Wei; Xiong, Hai-Rong			Exosomal miR-145-5p derived from orthohantavirus-infected endothelial cells inhibits HTNV infection	FASEB JOURNAL			English	Article						exosomes; HTNV; IFN-beta; miR-145-5p	BETA INTERFERON; MESSENGER-RNAS; VIRUS; MICRORNAS; TRANSMISSION; HANTAVIRUSES; ESTABLISHES; EXPRESSION; MECHANISM; VESICLES	Human infection of orthohantavirus can cause potentially fatal diseases, such as hemorrhagic fever with renal syndrome (HFRS) caused by Hantaan virus (HTNV) in Eurasia. Exosomes are new carriers for information exchange between cells. Cumulative findings suggest that exosomes released from parental infected cells can block or promote viral infection in recipient cells, but the role of exosomes in hantavirus infection is poorly understood. In our study, we identified the exosomes derived from HTNV-infected human vascular endothelial cells (HUVECs) (Exo-HV) and found the antiviral properties of Exo-HV in the uninfected recipient cells. High-throughput sequencing revealed the distinctly expressed miRNAs transcriptomes in Exo-HV. MiR-145-5p, one of the abundant miRNAs packaged into Exo-HV, was found to be able to transferred to recipient cells and functioned by directly targeting M RNA of HTNV 76-118 and inducing type I interferon (IFN-I) response, thus, blocking the viral replication. Concluding, this study indicated that exosomes released by HTNV-infected HUVECs were able to transfer active molecules, miR-145-5p as a proving sample, to mediate novel anti-HTNV activity in the neighboring uninfected cells, which will help us to explore new strategies for the treatment of infectious disease utilizing exosomes with miRNA.	[Wang, Xin; Chen, Qing-Zhou; Zan, Yu-Xing; Wang, Mei-Rong; Yan, Jie; Guo, Wei-Wei; Li, Kai-Ji; Liu, Yuan-Yuan; Luo, Fan; Feng, Yong; Hou, Wei; Xiong, Hai-Rong] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Allergy & Immunol, State Key Lab Virol,Inst Med Virol, Wuhan, Peoples R China; [Wang, Xin] Wuhan Univ, Zhongnan Hosp, Chinese Acad Med Sci, Wuhan Res Ctr Infect Dis & Canc, Wuhan, Peoples R China; [Chen, Qing-Zhou] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China	Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Wuhan University; Zhengzhou University	Hou, W; Xiong, HR (corresponding author), Wuhan Univ, Sch Basic Med Sci, Inst Med Virol, 185 Donghu Rd, Wuhan 430071, Peoples R China.	houwei@whu.edu.cn; hrxiong@whu.edu.cn	xiong, hai/GVT-7305-2022; hou, wei/GWM-4800-2022; FENG, YONG/G-2538-2013; liu, yuanyuan/GWZ-5838-2022	FENG, YONG/0000-0003-1590-0186; 	National Natural Science Foundation of China [81772186, 81971942]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 81772186, No. 81971942) to Hai-rong Xiong.	Abrami L, 2013, CELL REP, V5, P986, DOI 10.1016/j.celrep.2013.10.019; Anderson MR, 2016, NEUROTHERAPEUTICS, V13, P535, DOI 10.1007/s13311-016-0450-6; Avsic-Zupanc T, 2019, CLIN MICROBIOL INFEC, V21, pE6, DOI 10.1111/1469-0691.12291; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106006; Castro FL, 2019, ASN NEURO, V11, DOI 10.1177/1759091419850983; Chelbi-Alix MK, 2007, BIOCHIMIE, V89, P713, DOI 10.1016/j.biochi.2007.05.001; Chen Z, 2019, REPROD DOMEST ANIM, V54, P882, DOI 10.1111/rda.13438; Cosset FL, 2014, J HEPATOL, V60, P674, DOI 10.1016/j.jhep.2013.10.015; Deng HY, 2009, ACTA PHARMACOL SIN, V30, P1015, DOI 10.1038/aps.2009.53; Devhare PB, 2017, J VIROL, V91, DOI 10.1128/JVI.00349-17; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Gavrilovskaya IN, 2008, J VIROL, V82, P5797, DOI 10.1128/JVI.02397-07; Gunasekharan V, 2013, J VIROL, V87, P6037, DOI 10.1128/JVI.00153-13; Handke W, 2009, J IMMUNOL, V182, P2849, DOI 10.4049/jimmunol.0802893; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Huang R, 2019, J STROKE CEREBROVASC, V28, P1, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.023; Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659; Jiang H, 2008, VIROLOGY, V380, P52, DOI 10.1016/j.virol.2008.07.002; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kouwaki T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00335; Lagana Alessandro, 2013, Frontiers in Genetics, V4, P120, DOI 10.3389/fgene.2013.00120; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Levine JR, 2010, J VIROL, V84, P11790, DOI 10.1128/JVI.00916-10; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Liu YM, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0553-6; Ma HW, 2017, J VIROL, V91, DOI 10.1128/JVI.02250-16; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Mao LX, 2016, VIRUS GENES, V52, P189, DOI 10.1007/s11262-016-1292-3; Matthys VS, 2014, J VIROL, V88, P2246, DOI 10.1128/JVI.02647-13; Noguchi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.11; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Plyusnin A, 2001, ADV VIRUS RES, V57, P105, DOI 10.1016/S0065-3527(01)57002-5; Qian XJ, 2016, STEM CELL TRANSL MED, V5, P1190, DOI 10.5966/sctm.2015-0348; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171; Taverna S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-169; Teow SY, 2016, ADV VIROL, V2016, DOI 10.1155/2016/9852494; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tian HY, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006901; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang JY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071537; Wang L, 2018, MOL THER, V26, P1032, DOI 10.1016/j.ymthe.2018.02.016; Xu WX, 2019, AM J TRANSL RES, V11, P6739; Zhang YS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/697837; Zheng XY, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00535; Zheng Xuyang, 2016, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V32, P1522; Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339	55	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13809	13825		10.1096/fj.202001114R	http://dx.doi.org/10.1096/fj.202001114R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32808389				2022-12-28	WOS:000563082400001
J	Jia, YH; Xie, H; Zhang, JQ; Ying, H				Jia, Yuanhui; Xie, Han; Zhang, Jiqin; Ying, Hao			Induction of TGF-beta receptor I expression in a DNA methylation-independent manner mediated by DNMT3A downregulation is involved in early-onset severe preeclampsia	FASEB JOURNAL			English	Article						DNMT3A; preeclampsia; TGFBR1; TGF-beta signaling; trophoblast cells	GENE-EXPRESSION; H3K27ME3; INVASION; MECHANISMS; TGF-BETA-1; MANAGEMENT; COMPLEXES; MYC	Preeclampsia, especially early-onset severe preeclampsia is one of the leading causes of maternal and fetal morbidity and mortality. Although it has been well known that the pathophysiology of early-onset severe preeclampsia begins with abnormal placentation and aberrant activation of TGF-beta signaling inhibits trophoblast cell invasion, the mechanisms underlying dysregulation of TGF-beta signaling in early-onset severe preeclampsia remain elusive to date. Here, we revealed that induction of TGFBR1/TGF-beta signaling mediated by DNMT3A downregulation plays a critical role in early-onset severe preeclampsia. Our results show that DNMT3A downregulation elevates TGFBR1 expression in trophoblast cells. Moreover, inhibition of TGFBR1 and TGF-beta/Smad signaling can rescue the deficiencies of trophoblast cell migration and invasion caused by DNMT3A knockdown. Mechanistically, DNMT3A suppresses the transcription of TGFBR1 through recruiting EZH2 to its promoter but not changing DNA methylation ofTGFBR1promoter. In human samples, we detected lowly expressed DNMT3A, highly expressed TGFBR1 and hyperactivation of TGF-beta/Smad signaling in decidua-embedded extravillous trophoblasts in early-onset severe preeclampsia, which provides the clinical evidence for the correlation between DNMT3A and TGFBR1. Collectively, our findings demonstrate that DNA methylation-independent induction of TGFBR1 mediated by DNMT3A downregulation is relevant to the development of early-onset severe preeclampsia.	[Jia, Yuanhui] Tongji Univ, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Sch Med, Shanghai, Peoples R China; [Xie, Han; Ying, Hao] Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Obstet, Sch Med, Shanghai 201204, Peoples R China; [Zhang, Jiqin] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Zhang, Jiqin] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China	Tongji University; Tongji University; East China Normal University; East China Normal University	Ying, H (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Obstet, Sch Med, Shanghai 201204, Peoples R China.	stephenying_2011@163.com			NSFC \ National Natural Science Foundation of China [81871178, 81771600, 81772622]; Shanghai municipal medical and health discipline construction projects [2017ZZ02015]; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation) [18ZR1412300]	NSFC \ National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai municipal medical and health discipline construction projects; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation)	NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81871178, 81771600 and 81772622; Shanghai municipal medical and health discipline construction projects, Grant/Award Number: 2017ZZ02015; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation), Grant/Award Number: 18ZR1412300	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Branco MR, 2016, DEV CELL, V36, P152, DOI 10.1016/j.devcel.2015.12.027; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheng JC, 2017, ENDOCRINOLOGY, V158, P3620, DOI 10.1210/en.2017-00536; Cheng SF, 2018, NUCLEIC ACIDS RES, V46, P2356, DOI 10.1093/nar/gky017; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Haney SL, 2015, ONCOGENE, V34, P5436, DOI 10.1038/onc.2014.472; Haney SL, 2016, CELL REP, V15, P1190, DOI 10.1016/j.celrep.2016.04.004; Intapad S, 2014, AM J PHYSIOL-REG I, V307, pR1353, DOI 10.1152/ajpregu.00268.2014; Jia YH, 2017, HYPERTENSION, V69, P356, DOI 10.1161/HYPERTENSIONAHA.116.08483; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kane NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012970; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karmakar S, 2004, J REPROD IMMUNOL, V64, P9, DOI 10.1016/j.jri.2004.04.005; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim J, 2018, CELL REP, V24, P224, DOI 10.1016/j.celrep.2018.06.020; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Lv SJ, 2019, MOL THER-NUCL ACIDS, V14, P377, DOI 10.1016/j.omtn.2018.12.011; Martin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141294; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Oda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068846; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Qu YP, 2017, THERANOSTICS, V7, P2092, DOI 10.7150/thno.19884; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rush Margaret, 2009, Epigenetics, V4, P404; Sarsam DS, 2008, SINGAP MED J, V49, P698; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih JC, 2019, FASEB J, V33, P6281, DOI 10.1096/fj.201801898RR; Sibai BM, 2011, AM J OBSTET GYNECOL, V205, P191, DOI 10.1016/j.ajog.2011.07.017; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Spradley FT, 2016, HYPERTENSION, V67, P740, DOI 10.1161/HYPERTENSIONAHA.115.06783; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tse WK, 2002, PLACENTA, V23, P699, DOI 10.1053/plac.2002.0866; Wang Y, 2017, J CLIN ENDOCR METAB, V102, P3065, DOI 10.1210/jc.2017-01150; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Wu KJ, 2019, EUR J OBSTET GYN R B, V240, P130, DOI 10.1016/j.ejogrb.2019.06.034; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Y, 2011, INT J CANCER, V128, P551, DOI 10.1002/ijc.25365; Zhao JY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14712	50	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13224	13238		10.1096/fj.202000253RR	http://dx.doi.org/10.1096/fj.202000253RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32794622				2022-12-28	WOS:000561437700001
J	Srivastava, N; Tauseef, M; Amin, R; Joshi, B; Joshi, JC; Kini, V; Klomp, J; Li, W; Knezevic, N; Barbera, N; Siddiqui, S; Obukhov, A; Karginov, A; Levitan, I; Komarova, Y; Mehta, D				Srivastava, Nityanand; Tauseef, Mohammad; Amin, Ruhul; Joshi, Bhagwati; Joshi, Jagdish Chandra; Kini, Vidisha; Klomp, Jennifer; Li, Weenan; Knezevic, Nebojsa; Barbera, Nicolas; Siddiqui, Shahid; Obukhov, Alexander; Karginov, Andrei; Levitan, Irena; Komarova, Yulia; Mehta, Dolly			Noncanonical function of long myosin light chain kinase in increasing ER-PM junctions and augmentation of SOCE	FASEB JOURNAL			English	Article						endoplasmic reticulum-plasma membrane junctions; long myosin light chain kinase; store-operated calcium entry; stromal interacting molecule 1; vascular permeability	OPERATED CALCIUM-ENTRY; CA2+ ENTRY; LUNG INJURY; ACTIN CYTOSKELETON; CONFER RISK; STIM1; ACTIVATION; PHOSPHORYLATION; PERMEABILITY; GENE	Increased endothelial permeability leads to excessive exudation of plasma proteins and leukocytes in the interstitium, which characterizes several vascular diseases including acute lung injury. The myosin light chain kinase long (MYLK-L) isoform is canonically known to regulate the endothelial permeability by phosphorylating myosin light chain (MLC-P). Compared to the short MYLK isoform, MYLK-L contains an additional stretch of similar to 919 amino acid at the N-terminus of unknown function. We show that thapsigargin and thrombin-induced SOCE was markedly reduced in Mylk-L-/- endothelial cells (EC) or MYLK-L-depleted human EC. These agonists also failed to increase endothelial permeability in MYLK-L-depleted EC andMylk-L(-/-)lungs, thus demonstrating the novel role of MYLK-L-induced SOCE in increasing vascular permeability. MYLK-L augmented SOCE by increasing endoplasmic reticulum (ER)-plasma membrane (PM) junctions and STIM1 translocation to these junctions. Transduction of N-MYLK domain (amino acids 1-919 devoid of catalytic activity) into Mylk-L-/- EC rescued SOCE to the level seen in control EC in a STIM1-dependent manner. N-MYLK-induced SOCE augmented endothelial permeability without MLC-P via an actin-binding motif, DVRGLL. Liposomal-mediated delivery of N-MYLK mutant but not increment DVRGLL-N-MYLK mutant inMylk-L-/- mice rescued vascular permeability increase in response to endotoxin, indicating that targeting of DVRGLL motif within MYLK-L may limit SOCE-induced vascular hyperpermeability.	[Srivastava, Nityanand; Tauseef, Mohammad; Amin, Ruhul; Joshi, Bhagwati; Joshi, Jagdish Chandra; Kini, Vidisha; Klomp, Jennifer; Knezevic, Nebojsa; Siddiqui, Shahid; Karginov, Andrei; Komarova, Yulia; Mehta, Dolly] Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA; [Srivastava, Nityanand; Tauseef, Mohammad; Amin, Ruhul; Joshi, Bhagwati; Joshi, Jagdish Chandra; Kini, Vidisha; Klomp, Jennifer; Knezevic, Nebojsa; Siddiqui, Shahid; Karginov, Andrei; Komarova, Yulia; Mehta, Dolly] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA; [Tauseef, Mohammad; Mehta, Dolly] Chicago State Univ, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL USA; [Li, Weenan; Obukhov, Alexander] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Barbera, Nicolas; Levitan, Irena] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chicago State University; Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.; Mehta, D (corresponding author), Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA.	dmehta@uic.edu	Joshi, JC/ABA-3242-2021; Knezevic, Nebojsa Nick/H-9921-2019; Srivastava, Nityanand/AFU-0615-2022; Obukhov, Alexander G./C-7246-2008	Joshi, JC/0000-0002-9468-3046; Knezevic, Nebojsa Nick/0000-0001-8028-1495; Klomp, Jennifer/0000-0003-1781-648X; Obukhov, Alexander G./0000-0002-3862-6004	NIH| National Heart, Lung, and Blood Institute (NHLBI) [HL84153, HL137179-01, PO1-HL60678, HL077806]	NIH| National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH| National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL84153, HL137179-01, PO1-HL60678 and HL077806	Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Bogatcheva NV, 2011, J CELL PHYSIOL, V226, P3132, DOI 10.1002/jcp.22669; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Casas-Rua V, 2015, BBA-MOL CELL RES, V1853, P233, DOI 10.1016/j.bbamcr.2014.10.027; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Chen YJ, 2017, J CELL BIOL, V216, P2011, DOI 10.1083/jcb.201606047; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Dudek S.M, 2001, J APPL PHYSIOL, V91, P1487; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; GALLAGHER PJ, 1993, J BIOL CHEM, V268, P26578; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gao L, 2007, J ALLERGY CLIN IMMUN, V119, P1111, DOI 10.1016/j.jaci.2007.03.019; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Hsieh TS, 2017, MOL BIOL CELL, V28, P3171, DOI 10.1091/mbc.E17-06-0377; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Kudryashov DS, 2004, EXP CELL RES, V298, P407, DOI 10.1016/j.yexcr.2004.04.025; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lynch CD, 2011, MOL BIOL CELL, V22, P1263, DOI 10.1091/mbc.E10-08-0661; Lynch CD, 2011, CURR BIOL, V21, pR916, DOI 10.1016/j.cub.2011.10.020; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mehta D, 2004, AM J PHYSIOL-LUNG C, V287, pL1081, DOI 10.1152/ajplung.00268.2004; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Muallem S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaq0618; Ong HL, 2017, ADV EXP MED BIOL, V993, P159, DOI 10.1007/978-3-319-57732-6_9; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com; Pozo-Guisado E, 2013, J CELL SCI, V126, P3170, DOI 10.1242/jcs.125054; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Srikanth S, 2012, J PHYSIOL-LONDON, V590, P4169, DOI 10.1113/jphysiol.2012.231522; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Stolwijk JA, 2016, J BIOL CHEM, V291, P22894, DOI 10.1074/jbc.M116.756114; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Tauseef M, 2016, FASEB J, V30, P102, DOI 10.1096/fj.15-275891; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Townsley MI, 2017, PULM CIRC, V8, DOI 10.1177/2045893217738218; van Vliet AR, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1340105; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Wu SW, 2005, CIRC RES, V96, P856, DOI 10.1161/01.RES.0000163632.67282.1f; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yazbeck P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42758; Yu Y, 2012, FEBS J, V279, P1485, DOI 10.1111/j.1742-4658.2012.08541.x; Yuan Y, 1997, AM J PHYSIOL-HEART C, V272, pH1437, DOI 10.1152/ajpheart.1997.272.3.H1437; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625	68	2	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12805	12819		10.1096/fj.201902462RR	http://dx.doi.org/10.1096/fj.201902462RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772419	Green Published			2022-12-28	WOS:000558816800001
J	Ye, CT; Yang, HY; Cheng, MS; Shultz, LD; Greiner, DL; Brehm, MA; Keck, JG				Ye, Chunting; Yang, Hongyuan; Cheng, Mingshan; Shultz, Leonard D.; Greiner, Dale L.; Brehm, Michael A.; Keck, James G.			A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic-related cytokine release syndrome	FASEB JOURNAL			English	Article						cytokine release syndrome; cytokine storm; humanized mouse; immune toxicity; therapeutic	MONOCLONAL-ANTIBODY TGN1412; IMMUNE-SYSTEM; MOUSE MODEL; CELL-DEVELOPMENT; MICE; TRIAL; RESPONSES; MUTATION; INNATE; ASSAYS	Immunotherapy is a powerful treatment strategy being applied to cancer, autoimmune diseases, allergies, and transplantation. Although therapeutic monoclonal antibodies (mAbs) have demonstrated significant clinical efficacy, there is also the potential for severe adverse events, including cytokine release syndrome (CRS). CRS is characterized by the rapid production of inflammatory cytokines following delivery of therapy, with symptoms ranging from mild fever to life-threating pathology and multi-organ failure. Overall there is a paucity of models to reliably and accurately predict the induction of CRS by immune therapeutics. Here, we describe the development of a humanized mouse model based on the NOD-scid IL2rg(null)(NSG) mouse to study CRS in vivo. PBMC-engrafted NSG, NSG-MHC-DKO, and NSG-SGM3 mice were used to study cytokine release in response to treatment with mAb immunotherapies. Our data show that therapeutic-stimulated cytokine release in these PBMC-based NSG models captures the variation in cytokine release between individual donors, is drug dependent, occurs in the absence of acute xeno-GVHD, highlighting the specificity of the assay, and shows a robust response following treatment with a TGN1412 analog, a CD28 superagonist. Overall our results demonstrate that PBMC-engrafted NSG models are rapid, sensitive, and reproducible platforms to screen novel therapeutics for CRS.	[Ye, Chunting; Yang, Hongyuan; Cheng, Mingshan; Keck, James G.] Jackson Lab, 1650 Santa Ana Ave, Sacramento, CA 95838 USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Program Mol Med, Worcester, MA USA	Jackson Laboratory; Jackson Laboratory; University of Massachusetts System; University of Massachusetts Worcester	Keck, JG (corresponding author), Jackson Lab, 1650 Santa Ana Ave, Sacramento, CA 95838 USA.	james.keck@jax.org			HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK104218-02, DP 3DK111898]; HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI132963]; HHS \ NIH \ NIH Office of the Director (OD) [R24OD0426640]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID); HHS \ NIH \ NIH Office of the Director (OD)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: U01DK104218-02 and DP 3DK111898; HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R01 AI132963; HHS vertical bar NIH vertical bar NIH Office of the Director (OD), Grant/Award Number: R24OD0426640	Aryee KE, 2014, METHODS MOL BIOL, V1185, P267, DOI 10.1007/978-1-4939-1133-2_18; Attarwala H, 2010, J Young Pharm, V2, P332, DOI 10.4103/0975-1483.66810; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brady JL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.28; Brehm MA, 2019, FASEB J, V33, P3137, DOI 10.1096/fj.201800636R; CHATENOUD L, 1989, NEW ENGL J MED, V320, P1420; Christofi T, 2019, CANCERS, V11, DOI 10.3390/cancers11101472; Dougan M, 2019, ANNU REV CANC BIOL, V3, P55, DOI 10.1146/annurev-cancerbio-030518-055552; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; Felices M, 2016, METHODS MOL BIOL, V1441, P333, DOI 10.1007/978-1-4939-3684-7_28; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; Goulet DR, 2020, J PHARM SCI-US, V109, P74, DOI 10.1016/j.xphs.2019.05.031; Grimaldi C, 2016, CYTOKINE, V85, P101, DOI 10.1016/j.cyto.2016.06.006; Hall KH, 2020, PHARMACOTHERAPY, V40, P133, DOI 10.1002/phar.2354; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Jangalwe S, 2016, IMMUN INFLAMM DIS, V4, P427, DOI 10.1002/iid3.124; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Lai YP, 2016, INT IMMUNOL, V28, P181, DOI 10.1093/intimm/dxv063; Malcolm SL, 2012, J IMMUNOL METHODS, V384, P33, DOI 10.1016/j.jim.2012.07.001; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McDonald-Hyman C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6853; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller PH, 2013, BLOOD, V121, pE1, DOI 10.1182/blood-2012-09-456566; Moote W, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0282-5; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Murthy H, 2019, IMMUNOTARGETS THER, V8, P43, DOI 10.2147/ITT.S202015; Parakh Sagun, 2020, Recent Results Cancer Res, V214, P1, DOI 10.1007/978-3-030-23765-3_1; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647; Redman JM, 2015, MOL IMMUNOL, V67, P28, DOI 10.1016/j.molimm.2015.04.002; Semple KM, 2019, CTS-CLIN TRANSL SCI, V12, P283, DOI 10.1111/cts.12613; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2019, MAMM GENOME, V30, P123, DOI 10.1007/s00335-019-09796-2; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Stebbings R, 2013, J IMMUNOTOXICOL, V10, P75, DOI 10.3109/1547691X.2012.711783; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vessillier S, 2015, J IMMUNOL METHODS, V424, P43, DOI 10.1016/j.jim.2015.04.020; Weaver JL, 2019, TOXICOL SCI, V169, P194, DOI 10.1093/toxsci/kfz045; Weissmuller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149093; Wraith DC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01668; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Yan HY, 2019, TRANSL RES, V210, P43, DOI 10.1016/j.trsl.2019.04.007; Yan HY, 2019, TOXICOL APPL PHARM, V372, P57, DOI 10.1016/j.taap.2019.03.020	52	10	10	6	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12963	12975		10.1096/fj.202001203R	http://dx.doi.org/10.1096/fj.202001203R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772418	Bronze, Green Published			2022-12-28	WOS:000558817700001
J	Garwain, O; Pearce, KM; Jackson, L; Carley, S; Rosati, B; Scarlata, S				Garwain, Osama; Pearce, Katherine M.; Jackson, Lela; Carley, Samuel; Rosati, Barbara; Scarlata, Suzanne			Stimulation of the G alpha q/phospholipase C beta 1 signaling pathway returns differentiated cells to a stem-like state	FASEB JOURNAL			English	Article						de-differentiation; G proteins; phospholipase C beta; RNAseq		Phospholipase C beta 1 is activated by G alpha q to generate calcium signals in response to hormones and neurotransmitters. Besides carrying out this plasma membrane function, PLC beta 1 has a cytosolic population that helps to drive the differentiation of PC12 cells by inhibiting a nuclease that promotes RNA-induced silencing (C3PO). Here, we show that down-regulating PLC beta 1 or reducing its cytosolic population by activating G alpha q to localize it to the plasma membrane returns differentiated PC12 and SK-N-SH cells to an undifferentiated state. In this state, PC12 cells have a spherical morphology, resume proliferation, and express the stem cell transcription factors nanog and Oct4. Similar changes are seen when C3PO is down-regulated. This return to a stem-like state is accompanied by shifts in multiple miR populations. Surprisingly, de-differentiation can be induced by extended stimulation of G alpha q where cells return to a spherical morphology and levels of specific miRs return to their undifferentiated values. In complementary studies, we followed the real-time hydrolysis of a fluorescent-tagged miR in cells where PLC beta 1 or C3PO were down-regulated in PC12 cells and find substantial differences in miR processing in the undifferentiated and differentiated states. Taken together, our studies suggest that PLC beta 1, through its ability to regulate C3PO and endogenous miR populations, mediates the differentiation of two types of cultured neuronal cells.	[Garwain, Osama; Pearce, Katherine M.; Jackson, Lela; Carley, Samuel; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA; [Rosati, Barbara] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Worcester Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			NIH [GM-116187]; Richard Whitcomb Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Whitcomb Foundation	NIH, Grant/Award Number: GM-116187; Richard Whitcomb Foundation	Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Alshanwani AR, 2018, IUBMB LIFE, V70, P649, DOI 10.1002/iub.1751; Benito-Gutierrez E, 2006, MOL CELL NEUROSCI, V31, P179, DOI 10.1016/j.mcn.2005.09.007; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Cao YL, 2018, MOL MED REP, V18, P5807, DOI 10.3892/mmr.2018.9573; Gao J, 2011, ONCOL LETT, V2, P1019, DOI 10.3892/ol.2011.413; Garwain O, 2018, FASEB J, V32, P2891, DOI 10.1096/fj.201701284R; Garwain O, 2016, J BIOL CHEM, V291, P22970, DOI 10.1074/jbc.M116.744953; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kamato Danielle, 2015, Front Cardiovasc Med, V2, P14, DOI 10.3389/fcvm.2015.00014; Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037039; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; McCain Jack, 2013, P T, V38, P96; Milanovic M, 2018, TRENDS CELL BIOL, V28, P1049, DOI 10.1016/j.tcb.2018.09.001; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mousavi SI, 2020, ANAL BIOCHEM, V596, DOI 10.1016/j.ab.2020.113626; Pearce KM, 2020, MOL BIOL CELL, V31, P683, DOI 10.1091/mbc.E19-09-0536; Philip F, 2016, FASEB J, V30, P1958, DOI 10.1096/fj.201500140; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Qifti A, 521369 BIORXIV; Sahu S, 2017, PROTEIN SCI, V26, P1807, DOI 10.1002/pro.3219; Thangaraju A, 2011, EUR J PHARMACOL, V650, P534, DOI 10.1016/j.ejphar.2010.10.054; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Yanagi T, 2015, CELL CYCLE, V14, P463, DOI 10.1080/15384101.2015.1006539	27	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12663	12676		10.1096/fj.201902668R	http://dx.doi.org/10.1096/fj.201902668R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32761888				2022-12-28	WOS:000558193200001
J	Lu, JF; Zhu, MQ; Zhang, H; Liu, H; Xia, B; Wang, YL; Shi, XE; Peng, L; Wu, JW				Lu, Jun Feng; Zhu, Meng Qing; Zhang, Heng; Liu, Hao; Xia, Bo; Wang, Yong Liang; Shi, Xin'e; Peng, Liang; Wu, Jiang Wei			Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice	FASEB JOURNAL			English	Article						fecal microbiota transplantation; flavonoids compound; intestinal microbiota; metabolic syndrome	CITRUS-AURANTIUM L.; INTESTINAL INFLAMMATION; POLYPHENOLS; ACTIVATION; FLAVONOIDS; QUERCETIN; GROWTH	Obesity and related metabolic disorders are associated with intestinal microbiota dysbiosis, disrupted intestinal barrier, and chronic inflammation. Neohesperidin (Neo), a natural polyphenol abundant in citrus fruits, is known for its preventative and therapeutic effects on numerous diseases. Here, we report that Neo administration attenuates weight gain, low-grade inflammation, and insulin resistance in mice fed high-fat diet (HFD). Also, Neo administration substantially restores gut barrier damage, metabolic endotoxemia, and systemic inflammation. Sequencing of 16S rRNA genes in fecal samples revealed that Neo administration reverses HFD-induced intestinal microbiota dysbiosis: an increase in the diversity of gut microbiota and alteration in the composition of intestinal microbiota (particularly in the relative abundances of Bacteroidetes and Firmicutes). Furthermore, systemic antibiotic treatment abolishes the beneficial effects of Neo in body weight control, suggesting that the effect of Neo on obesity attenuation largely depends on the gut microbiota. More importantly, we demonstrate that the impact of Neo on the regulation of obesity could be transferred from Neo-treated mice to HFD-fed mice via fecal microbiota transplantation. Collectively, our data highlight the efficacy of Neo as a prebiotic agent for attenuating obesity, implying a potential mechanism for gut microbiota mediated the beneficial effect of Neo.	[Lu, Jun Feng; Zhu, Meng Qing; Xia, Bo; Wang, Yong Liang; Shi, Xin'e; Wu, Jiang Wei] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Yangling 712100, Shaanxi, Peoples R China; [Lu, Jun Feng; Zhang, Heng; Liu, Hao; Peng, Liang] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing 10029, Peoples R China	Northwest A&F University - China; China-Japan Friendship Hospital	Wu, JW (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Yangling 712100, Shaanxi, Peoples R China.; Peng, L (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing 10029, Peoples R China.	pengliang8028@163.com; wujiangwei@nwafu.edu.cn	Lu, Junfeng/AFN-9843-2022; Zhu, Mengqing/GLT-5795-2022	Lu, Junfeng/0000-0002-2640-8595; Zhu, Mengqing/0000-0001-9422-6550	National Natural Science Foundation of China (NSFC) [81670758, 81970713]; Beijing Municipal Natural Science Foundation [7182147]; Capital's Funds for Health Improvement and Research [2018-2-4062]; Fundamental Research Funds of the Chinese Academy of Medical Science [2018RC310023]; Special Talent Recruitment Fund of China; Programs for Shaanx Science Technology [2020NY-01]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Capital's Funds for Health Improvement and Research; Fundamental Research Funds of the Chinese Academy of Medical Science; Special Talent Recruitment Fund of China; Programs for Shaanx Science Technology	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670758 and 81970713; Beijing Municipal Natural Science Foundation, Grant/Award Number: 7182147; Capital's Funds for Health Improvement and Research, Grant/Award Number: 2018-2-4062; Fundamental Research Funds of the Chinese Academy of Medical Science, Grant/Award Number: 2018RC310023; Programs for Shaanx Science & Technology: 2020NY-01; Special Talent Recruitment Fund of China to JWW	Anhe FF, 2019, GUT, V68, P453, DOI 10.1136/gutjnl-2017-315565; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Assini JM, 2015, ENDOCRINOLOGY, V156, P2087, DOI 10.1210/en.2014-2003; Bak EJ, 2014, CLIN NUTR, V33, P156, DOI 10.1016/j.clnu.2013.03.013; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Chelakkot C, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0126-x; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gong YL, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104460; Guo JS, 2019, EUR J PHARMACOL, V864, DOI 10.1016/j.ejphar.2019.172712; Hernandez JB, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8216, 10.1038/ncomms8489]; Hersoug LG, 2016, OBES REV, V17, P297, DOI 10.1111/obr.12370; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Hussain T, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2020.104629; Jia S, 2015, FOOD FUNCT, V6, P878, DOI 10.1039/c4fo00993b; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Lee JH, 2009, PHYTOTHER RES, V23, P1748, DOI 10.1002/ptr.2840; Lee P, 2019, DIABETES OBES METAB, V21, P479, DOI 10.1111/dom.13561; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lieber AD, 2019, FASEB J, V33, P1098, DOI [10.1096/fj.201701586R, 10.1096/fj.201701586r]; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Ma XL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00987; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maruvada P, 2017, CELL HOST MICROBE, V22, P589, DOI 10.1016/j.chom.2017.10.005; Moayyedi P, 2008, DIGEST DIS SCI, V53, P2293, DOI 10.1007/s10620-008-0410-z; Moco S, 2012, J PROTEOME RES, V11, P4781, DOI 10.1021/pr300581s; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Petersen C, 2019, SCIENCE, V365, P340, DOI 10.1126/science.aat9351; Porras D, 2017, FREE RADICAL BIO MED, V102, P188, DOI 10.1016/j.freeradbiomed.2016.11.037; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sawa T, 1999, J AGR FOOD CHEM, V47, P397, DOI 10.1021/jf980765e; Schneider KM, 2015, HEPATOLOGY, V62, P1405, DOI 10.1002/hep.27982; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen CY, 2017, J AGR FOOD CHEM, V65, P9061, DOI 10.1021/acs.jafc.7b03759; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sinha D., 2019, J DRUG DELIVERY THER, V9, P102, DOI [10.22270/jddt.v9i6.3633, DOI 10.22270/JDDT.V9I6.3633]; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4; Sun YJ, 2019, FOOD CHEM, V279, P321, DOI 10.1016/j.foodchem.2018.12.019; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tan Z, 2017, MOL CELL ENDOCRINOL, V439, P369, DOI 10.1016/j.mce.2016.09.026; Teng H, 2019, CRIT REV FOOD SCI, V59, P2040, DOI 10.1080/10408398.2018.1437023; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Wang P, 2020, INT J OBESITY, V44, P213, DOI 10.1038/s41366-019-0332-1; Wang WJ, 2018, BRIT J PHARMACOL, V175, P469, DOI 10.1111/bph.14095; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Wu TR, 2019, GUT, V68, P248, DOI 10.1136/gutjnl-2017-315458; Xi WP, 2014, FOOD CHEM, V161, P230, DOI 10.1016/j.foodchem.2014.04.001; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; Yuan C, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00055-20; Zeng SL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6208; Zhang JK, 2012, FOOD CHEM, V135, P1471, DOI 10.1016/j.foodchem.2012.06.004; Zhang L, 2019, FASEB J, V33, P10339, DOI 10.1096/fj.201900488R; Zhao TT, 2019, PHYTOTHER RES, V33, P2034, DOI 10.1002/ptr.6385	68	25	26	7	52	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12053	12071		10.1096/fj.201903102RR	http://dx.doi.org/10.1096/fj.201903102RR		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729978				2022-12-28	WOS:000556800400001
